Citrus Sinensis ID: 037010

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------59
Protein Sequence
MKQLCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHccEEEEcccccccHHHHHHEEEEcccccHHHHHHHHccccccccccccccccccccccccccccccccEEEEEEEcccccccEEEEEEEEEEcccccccccccccccccccHHHHHHHccccccccccccEEEEEEccccccccccccccEEEEEEccccccHHHHHHHccccccccccccccccccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHcccccccccccccccEEEEEEEcccccccccccEEEEEEHHHHHHHHHccccHHHHHHHHHHHHHHccccccccEEEEEEcccEEEEEEEEccccHHHHHcccccccccHHHHHHHHHHHcHHHHHHcccccccEEEcccccccEEcccccccccccccccccccccccccccccccccccccHHHHccccccccccccHHHHHHHHHHHccccHHcccccccccccHHHHHHHHHccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHccccccccccccccccccccEEccccc
Secondary Structure Prediction (SSPRO)
cccEEEEEEEEEEEEEEEccccccccccccHHHHcccccccccHHHHHHHcccccccccccccccccccccccccccHcccccccccccccccccccccccccccEcccccccccccccHHccccHHHHHHccccccccccccccEEEEEEcccccccccccccccEEccccccccccccccccccccccccccccccccccccccEEEEcccccccccccHHcccHHHHHEHccccccccccccccccccccccccccEEEEHHHHHHHHccccHHcccccccccEEEEEEEcccccccccccEEEEEEccHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHEEEEEEcccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccHHHEEEEHHHEEEEccccHHHHccccccEEEEEEEcccccccHHHHHccccccHHHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHcccccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MKQLCMIFFVLIVPSLISVtveskctkgcDTALASYYVWIGSNLTFIAQTLRsslvdpndveLTTILSYNkqlsnkdslladtrinvpfpcdcingeflghtfqfsinsgdtYEKVATRYYSnltdaaslqrinnypptripdrgtlnvtvncscgdadvskqYRLFvtyplrpgdslqSIARNVGLSESllqnynpgvnftrgsglvfipgrdangvfpalessstgglvfpayktvestgpaagtptslnaitvdKSVEFSYEELSkatdnfsmshkigqggfGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIEngnlsehlrgsgrdplpwssRVQIALDSArgleyihehtvpvyihrdiksanilidknfhakvADFGltkltevgsaslptrlvgtfgymppeyaqygdvspkvdVYAFGVVLYELISAKEaivkgngssadsKGLVALFEEVlnlpdpiedlrklvdprlgdncpldSVLKMAQLAKVCtqeypqlrpSMRSIVVALMTLSsttedwdvgsfyeNHALVNLMSGR
Flexible Loop (DISEMBL)
MKQLCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSynkqlsnkdslLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSnltdaaslqrinnypptripdrgtLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKTVestgpaagtptslnaITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLtkltevgsaslpTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTqeypqlrpsMRSIVVALMTLSSttedwdvgsfyENHALVNLMSGR
Low Complexity Region (SEG)
MKQLCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR
Disordered region (IsUnstruct)
***LCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKTV************LNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRG***DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS*ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNL****
Disordered Region (DISOPRED)
***LCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPG******************NYNPGVNFTRGSGLVFIPGR***********************************************EFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM**********QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA************GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS************************
Disordered Region (DISEMBL)
MKQLCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR
Disordered Region (DISPRO)
*KQLCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYK*******************VDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKQLCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	589	2.2.26 [Sep-21-2011]
A8R7E6	617	Chitin elicitor receptor	yes	no	0.947	0.904	0.575	0.0
D7UPN3	605	Chitin elicitor receptor	yes	no	0.891	0.867	0.519	1e-159
F4IB81	651	LysM domain receptor-like	no	no	0.538	0.486	0.419	3e-70
Q9LV48	652	Proline-rich receptor-lik	no	no	0.483	0.437	0.428	3e-60
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.500	0.415	0.408	5e-59
Q9SGY7	718	Putative proline-rich rec	no	no	0.533	0.437	0.389	1e-58
Q9LK03	717	Proline-rich receptor-lik	no	no	0.483	0.397	0.408	4e-58
Q9C660	762	Proline-rich receptor-lik	no	no	0.519	0.401	0.404	1e-57
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.497	0.430	0.408	2e-57
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.536	0.438	0.386	5e-57

>sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1

 Score =  689 bits (1777), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 364/632 (57%), Positives = 431/632 (68%), Gaps = 74/632 (11%)

Query: 11  LIVPSLISVT----VESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTI 66
           LI P L+  +    VESKC   C  ALASYY+  G+ L+ I Q L SS+   + +    I
Sbjct: 7   LIAPILLLFSFFFAVESKCRTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPI 66

Query: 67  LSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTD 126
           L YN  + +KD +   +R+ VPFPC+C  G+FLGH F +S+   DTYE+VA   Y+NLT 
Sbjct: 67  LRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTT 126

Query: 127 AASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVG 186
             SLQ  N +P T IP   TLNV VNCSCGD  VSK + LFVTYPLRP DSL SIAR+ G
Sbjct: 127 MESLQARNPFPATNIPLSATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARSSG 186

Query: 187 LSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGG----------------- 229
           +S  +LQ YNPGVNF  G+G+V++PGRD NG FP  +SS   G                 
Sbjct: 187 VSADILQRYNPGVNFNSGNGIVYVPGRDPNGAFPPFKSSKQDGVGAGVIAGIVIGVIVAL 246

Query: 230 -----LVFPAYKTVESTGPA--------------------------AGTPTSLNAITVDK 258
                +V+ AY+  +S G +                          AG    + AI+VDK
Sbjct: 247 LLILFIVYYAYRKNKSKGDSFSSSIPLSTKADHASSTSLQSGGLGGAGVSPGIAAISVDK 306

Query: 259 SVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK 318
           SVEFS EEL+KATDNF++S KIGQGGFGAVYYAELRGE                 KAAIK
Sbjct: 307 SVEFSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGE-----------------KAAIK 349

Query: 319 KMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDP 378
           KMDM+AS++FLAELKVLT VHH+NLVRLIGYCVEGSLFLVYEY+ENGNL +HL GSGR+P
Sbjct: 350 KMDMEASKQFLAELKVLTRVHHVNLVRLIGYCVEGSLFLVYEYVENGNLGQHLHGSGREP 409

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG 438
           LPW+ RVQIALDSARGLEYIHEHTVPVY+HRDIKSANILID+ F AKVADFGLTKLTEVG
Sbjct: 410 LPWTKRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEVG 469

Query: 439 SASLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
            ++  TR  +GTFGYM PE   YG+VS KVDVYAFGVVLYELISAK A+VK   +  + +
Sbjct: 470 GSA--TRGAMGTFGYMAPETV-YGEVSAKVDVYAFGVVLYELISAKGAVVKMTEAVGEFR 526

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           GLV +FEE     D  E LRK++DPRLGD+ P DSV KMA+L K CTQE  QLRPSMR I
Sbjct: 527 GLVGVFEESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLRPSMRYI 586

Query: 558 VVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
           VVAL TL S+T +WDVG+F +N  LV+LMSGR
Sbjct: 587 VVALSTLFSSTGNWDVGNF-QNEDLVSLMSGR 617

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI).
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1

 Score =  562 bits (1449), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 311/599 (51%), Positives = 393/599 (65%), Gaps = 74/599 (12%)

Query: 25  CTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTR 84
           C  GC  A+A+YY   GSNLTFIA     ++          +L YN  ++N D ++   R
Sbjct: 26  CRAGCSLAIAAYYFSEGSNLTFIA-----TIFAIGGGGYQALLPYNPAITNPDYVVTGDR 80

Query: 85  INVPFPCDCIN------GEFLGHTFQFSI----NSGDTYEKVATRYYSNLTDAASLQRIN 134
           + VPFPC C+         FL     + +      GDTY+ VA  Y ++LT AA L+  N
Sbjct: 81  VLVPFPCSCLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVAANY-ADLTTAAWLEATN 139

Query: 135 NYPPTRIPD-RGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSE---- 189
            YPP RIP   G +NVT+NCSCGD  VS +Y LF+TYPL  G++L+S+A   G S     
Sbjct: 140 AYPPGRIPGGDGRVNVTINCSCGDERVSPRYGLFLTYPLWDGETLESVAAQYGFSSPAEM 199

Query: 190 SLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGG-------------------- 229
            L++ YNPG+    G G+VFIP +D NG +  L+S   G                     
Sbjct: 200 ELIRRYNPGMGGVSGKGIVFIPVKDPNGSYHPLKSGGMGNSLSGGAIAGIVIACIAIFIV 259

Query: 230 ---LVFPAYKTVE----STGPAAGTPTSLN------AITVDKSVEFSYEELSKATDNFSM 276
              L+   Y+  +    ++ P+    + L+       I V++S+EFSYEE+  AT  FSM
Sbjct: 260 AIWLIIMFYRWQKFRKATSRPSPEETSHLDDASQAEGIKVERSIEFSYEEIFNATQGFSM 319

Query: 277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLT 336
            HKIGQGGFG+VYYAELRGE                 K AIKKM MQA++EFLAELKVLT
Sbjct: 320 EHKIGQGGFGSVYYAELRGE-----------------KTAIKKMGMQATQEFLAELKVLT 362

Query: 337 HVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
           HVHHLNLVRLIGYCVE  LFLVYE+I+NGNLS+HL+ +G  PL W++RVQIALDSARGLE
Sbjct: 363 HVHHLNLVRLIGYCVENCLFLVYEFIDNGNLSQHLQRTGYAPLSWATRVQIALDSARGLE 422

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG--SASLPTRLVGTFGYMP 454
           Y+HEH VPVY+HRDIKSANIL+DK+F AK+ADFGL KLTEVG  S SL TR+ GTFGYMP
Sbjct: 423 YLHEHVVPVYVHRDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGYMP 482

Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE 514
           PE A+YG+VSPKVDVYAFGVVLYEL+SAK+AIV+ + S ++SKGLV LFEE L+ P+P E
Sbjct: 483 PE-ARYGEVSPKVDVYAFGVVLYELLSAKQAIVRSSESVSESKGLVFLFEEALSAPNPTE 541

Query: 515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDV 573
            L +L+DP L  + P+DS LK+A LAK CT E P +RP+MRS+VVALM L++ T+  D+
Sbjct: 542 ALDELIDPSLQGDYPVDSALKIASLAKSCTHEEPGMRPTMRSVVVALMALTANTDLRDM 600

Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP).

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|F4IB81|LYK3_ARATH LysM domain receptor-like kinase 3 OS=Arabidopsis thaliana GN=LYK3 PE=2 SV=1

 Score =  266 bits (680), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 145/346 (41%), Positives = 209/346 (60%), Gaps = 29/346 (8%)

Query: 256 VDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           ++K + F+YEE+  ATD FS S+ +G G +G+VY+  LR                  Q+ 
Sbjct: 323 IEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLR-----------------EQEV 365

Query: 316 AIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHL--- 371
           A+K+M    ++EF AE+KVL  VHH NLV LIGY      LF+VYEY+  G L  HL   
Sbjct: 366 AVKRMTATKTKEFAAEMKVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDP 425

Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
           +  G  PL W  R QIALD+ARGLEYIHEHT   Y+HRDIK++NIL+D+ F AK++DFGL
Sbjct: 426 QSKGNTPLSWIMRNQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGL 485

Query: 432 TKLTE-VGSASLP-TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
            KL E  G   +  T++VGT+GY+ PEY   G  + K D+YAFGVVL+E+IS +EA+++ 
Sbjct: 486 AKLVEKTGEGEISVTKVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRT 545

Query: 490 NG---SSADSKGLVALFEEVL-NLPDP--IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVC 543
                 + + + L ++   VL N PD   +  L++ VDP + D  P D + K+A LAK C
Sbjct: 546 EAIGTKNPERRPLASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQC 605

Query: 544 TQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
             + P LRP+M+ +V++L  +  ++ +W+      +     L+ GR
Sbjct: 606 VDDDPILRPNMKQVVISLSQILLSSIEWEATLAGNSQVFSGLVQGR 651

Putative Lysin motif (LysM) receptor kinase that may recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  233 bits (595), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 129/301 (42%), Positives = 177/301 (58%), Gaps = 16/301 (5%)

Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           F+YEELS+AT+ FS ++ +GQGGFG V+   L          + + V  L      K   
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPS-------GKEVAVKQL------KAGS 314

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLP 380
            Q  REF AE+++++ VHH +LV LIGYC+ G    LVYE++ N NL  HL G GR  + 
Sbjct: 315 GQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTME 374

Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
           WS+R++IAL SA+GL Y+HE   P  IHRDIK++NILID  F AKVADFGL K+    + 
Sbjct: 375 WSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT 434

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            + TR++GTFGY+ PEYA  G ++ K DV++FGVVL ELI+ +  +   N    DS  LV
Sbjct: 435 HVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDS--LV 492

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
                +LN      D   L D ++G+    + + +M   A  C +   + RP M  IV A
Sbjct: 493 DWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRA 552

Query: 561 L 561
           L
Sbjct: 553 L 553

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  229 bits (583), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 127/311 (40%), Positives = 180/311 (57%), Gaps = 16/311 (5%)

Query: 252 NAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLL 311
           +A+       F+YEEL+  T+ FS  + +G+GGFG VY  +L          +L+ V  L
Sbjct: 331 SAVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLND-------GKLVAVKQL 383

Query: 312 MQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEH 370
                 K    Q  REF AE+++++ VHH +LV L+GYC+  S   L+YEY+ N  L  H
Sbjct: 384 ------KVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHH 437

Query: 371 LRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
           L G GR  L W+ RV+IA+ SA+GL Y+HE   P  IHRDIKSANIL+D  F A+VADFG
Sbjct: 438 LHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFG 497

Query: 431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           L KL +     + TR++GTFGY+ PEYAQ G ++ + DV++FGVVL ELI+ ++ + +  
Sbjct: 498 LAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQ 557

Query: 491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQL 550
               +S  LV     +L+      D  +LVD RL  +   + V +M + A  C +     
Sbjct: 558 PLGEES--LVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPK 615

Query: 551 RPSMRSIVVAL 561
           RP M  +V AL
Sbjct: 616 RPRMVQVVRAL 626

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  228 bits (580), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 132/339 (38%), Positives = 193/339 (56%), Gaps = 25/339 (7%)

Query: 243 PAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYL 302
           P  G  T  +A+     + F+YEELS+ T+ F  S  +G+GGFG VY   L       + 
Sbjct: 339 PKHGRGTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGIL-------FE 391

Query: 303 SRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY 361
            + + +  L      K +  +  REF AE+++++ VHH +LV L+GYC+ E   FL+YE+
Sbjct: 392 GKPVAIKQL------KSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEF 445

Query: 362 IENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN 421
           + N  L  HL G     L WS RV+IA+ +A+GL Y+HE   P  IHRDIKS+NIL+D  
Sbjct: 446 VPNNTLDYHLHGKNLPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDE 505

Query: 422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           F A+VADFGL +L +   + + TR++GTFGY+ PEYA  G ++ + DV++FGVVL ELI+
Sbjct: 506 FEAQVADFGLARLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELIT 565

Query: 482 AKEAIVKGNGSSADSKGLVALFEEVL-NLPDPIE--DLRKLVDPRLGDNCPLDSVLKMAQ 538
            ++ +      ++   G  +L E     L + IE  D+ ++VDPRL ++     V KM +
Sbjct: 566 GRKPV-----DTSQPLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIE 620

Query: 539 LAKVCTQEYPQLRPSMRSIVVALMT---LSSTTEDWDVG 574
            A  C +     RP M  +V AL T   LS  T    VG
Sbjct: 621 TAASCVRHSALKRPRMVQVVRALDTRDDLSDLTNGVKVG 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  226 bits (576), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 123/301 (40%), Positives = 177/301 (58%), Gaps = 16/301 (5%)

Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           F+YEELS+AT+ FS ++ +GQGGFG V+   LR         + + V  L      K+  
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRN-------GKEVAVKQL------KEGS 388

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
            Q  REF AE+ +++ VHH +LV L+GYC+ +    LVYE++ N  L  HL G GR  + 
Sbjct: 389 SQGEREFQAEVGIISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTME 448

Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
           WSSR++IA+ SA+GL Y+HE+  P  IHRDIK++NILID  F AKVADFGL K+    + 
Sbjct: 449 WSSRLKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT 508

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            + TR++GTFGY+ PEYA  G ++ K DV++FGVVL ELI+ +  I   N  + +S  LV
Sbjct: 509 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNS--LV 566

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
                +LN    + +   +VD +L +    + + +M   A  C +     RP M  +   
Sbjct: 567 DWARPLLNQVSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARV 626

Query: 561 L 561
           L
Sbjct: 627 L 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  224 bits (571), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 131/324 (40%), Positives = 182/324 (56%), Gaps = 18/324 (5%)

Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           FSYEEL  AT+ FS  + +G+GGFG VY   L  E       R++ V  L      K   
Sbjct: 418 FSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDE-------RVVAVKQL------KIGG 464

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
            Q  REF AE+  ++ VHH NL+ ++GYC+ E    L+Y+Y+ N NL  HL  +G   L 
Sbjct: 465 GQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPGLD 524

Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
           W++RV+IA  +ARGL Y+HE   P  IHRDIKS+NIL++ NFHA V+DFGL KL    + 
Sbjct: 525 WATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNT 584

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            + TR++GTFGYM PEYA  G ++ K DV++FGVVL ELI+ ++ +        +S  LV
Sbjct: 585 HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDES--LV 642

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
                +L+     E+   L DP+LG N     + +M + A  C +     RP M  IV A
Sbjct: 643 EWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRA 702

Query: 561 LMTLSSTTEDWDVGSFYENHALVN 584
             +L+   ED   G       ++N
Sbjct: 703 FDSLAE--EDLTNGMRLGESEIIN 724

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  224 bits (570), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 127/311 (40%), Positives = 177/311 (56%), Gaps = 18/311 (5%)

Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           FSY+ELS+ T  FS  + +G+GGFG VY   L          R + V  L      K   
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSD-------GREVAVKQL------KIGG 373

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
            Q  REF AE+++++ VHH +LV L+GYC+ E    LVY+Y+ N  L  HL   GR  + 
Sbjct: 374 SQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMT 433

Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--G 438
           W +RV++A  +ARG+ Y+HE   P  IHRDIKS+NIL+D +F A VADFGL K+ +    
Sbjct: 434 WETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDL 493

Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
           +  + TR++GTFGYM PEYA  G +S K DVY++GV+L ELI+ ++ +        +S  
Sbjct: 494 NTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDES-- 551

Query: 499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           LV     +L      E+  +LVDPRLG N     + +M + A  C +     RP M  +V
Sbjct: 552 LVEWARPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVV 611

Query: 559 VALMTLSSTTE 569
            AL TL   T+
Sbjct: 612 RALDTLEEATD 622

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  222 bits (566), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 131/339 (38%), Positives = 187/339 (55%), Gaps = 23/339 (6%)

Query: 224 SSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQG 283
           S  T G  +P ++   S     GTP S  AI       FSYEEL++ T  F+  + +G+G
Sbjct: 328 SYGTAGGGYPHHQMQSS-----GTPDS--AILGSGQTHFSYEELAEITQGFARKNILGEG 380

Query: 284 GFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNL 343
           GFG VY   L+         +++ V  L      K    Q  REF AE+++++ VHH +L
Sbjct: 381 GFGCVYKGTLQD-------GKVVAVKQL------KAGSGQGDREFKAEVEIISRVHHRHL 427

Query: 344 VRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT 402
           V L+GYC+ +    L+YEY+ N  L  HL G G   L WS RV+IA+ SA+GL Y+HE  
Sbjct: 428 VSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAYLHEDC 487

Query: 403 VPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD 462
            P  IHRDIKSANIL+D  + A+VADFGL +L +     + TR++GTFGY+ PEYA  G 
Sbjct: 488 HPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYASSGK 547

Query: 463 VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDP 522
           ++ + DV++FGVVL EL++ ++ + +      +S  LV     +L       DL +L+D 
Sbjct: 548 LTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEES--LVEWARPLLLKAIETGDLSELIDT 605

Query: 523 RLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           RL        V +M + A  C +     RP M  +V AL
Sbjct: 606 RLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL 644

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	589
255568675	603	receptor protein kinase, putative [Ricin	0.925	0.903	0.699	0.0
359485632	619	PREDICTED: proline-rich receptor-like pr	0.925	0.880	0.686	0.0
224064938	581	predicted protein [Populus trichocarpa]	0.935	0.948	0.699	0.0
297739193	625	unnamed protein product [Vitis vinifera]	0.950	0.896	0.646	0.0
356574906	618	PREDICTED: proline-rich receptor-like pr	0.943	0.899	0.652	0.0
224131642	580	predicted protein [Populus trichocarpa]	0.933	0.948	0.680	0.0
290490572	622	LysM type receptor kinase [Lotus japonic	0.943	0.893	0.644	0.0
359483329	619	PREDICTED: proline-rich receptor-like pr	0.932	0.886	0.630	0.0
345843162	623	Bti9 [Nicotiana benthamiana]	0.940	0.889	0.620	0.0
302144092	650	unnamed protein product [Vitis vinifera]	0.921	0.835	0.629	0.0

>gi|255568675|ref|XP_002525309.1| receptor protein kinase, putative [Ricinus communis] gi|223535368|gb|EEF37042.1| receptor protein kinase, putative [Ricinus communis]

 Score =  827 bits (2137), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 425/608 (69%), Positives = 472/608 (77%), Gaps = 63/608 (10%)

Query: 20  TVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNK-QLSNKDS 78
           T  SKCT+GCD A ASYYVW  +N +FIA+ ++SS++D  D    TI++YN  Q+SNKDS
Sbjct: 21  TAHSKCTRGCDLAFASYYVWQEANTSFIAEVMKSSILDSPD----TIVTYNSDQVSNKDS 76

Query: 79  LLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPP 138
           L +  RIN+PFPC CI+GEFLGH F + + SGDTY  VA +YYSNLT  + L ++N+YPP
Sbjct: 77  LPSFIRINLPFPCGCIDGEFLGHVFNYDVRSGDTYLVVAEKYYSNLTTVSWLSQLNSYPP 136

Query: 139 TRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPG 198
           T IPD G LNVTVNCSCG++ +SK Y LF+TYPLRP DSL+SIA    +   LLQ+YNPG
Sbjct: 137 TNIPDTGILNVTVNCSCGNSQISKDYGLFITYPLRPEDSLESIANQTSIRADLLQSYNPG 196

Query: 199 VNFTRGSGLVFIPGRD------------------------------ANGVFPALESS--S 226
           VNF+RGSGLV+IPG+                                  V  AL S   S
Sbjct: 197 VNFSRGSGLVYIPGQGISGGAIAGICIAAAAVVVLVAVCMYFGLYRKKKVKGALLSQDIS 256

Query: 227 TGGLVFPAY---KTVESTG--PAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIG 281
              L  P     K VESTG  P+ G    L  ITVDKSVEFSYEEL+ ATDNFS+++KIG
Sbjct: 257 AHALQGPGSNSDKPVESTGLAPSPG----LTGITVDKSVEFSYEELALATDNFSLANKIG 312

Query: 282 QGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHL 341
           QGGFG+VYYAELRGE                 KAAI+KMDMQAS+EF AELKVLTHVHHL
Sbjct: 313 QGGFGSVYYAELRGE-----------------KAAIRKMDMQASKEFFAELKVLTHVHHL 355

Query: 342 NLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH 401
           NLVRLIGYCVEGSLFLVYEYIENGNLS+HL GSGRDPLPWS+RVQIALDSARGLEYIHEH
Sbjct: 356 NLVRLIGYCVEGSLFLVYEYIENGNLSQHLHGSGRDPLPWSTRVQIALDSARGLEYIHEH 415

Query: 402 TVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG 461
           TVPVYIHRDIKSANILIDKNF  KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG
Sbjct: 416 TVPVYIHRDIKSANILIDKNFRGKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG 475

Query: 462 DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVD 521
           DVSPKVDVYA GVVLYELISAKEAI+KGN SSA+S+GLVALFE+VLN PDP ED+RKLVD
Sbjct: 476 DVSPKVDVYALGVVLYELISAKEAIIKGNSSSAESRGLVALFEDVLNQPDPKEDVRKLVD 535

Query: 522 PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHA 581
           PRLGDN PLDSV KMAQLAK CTQE PQLRPSMRSIVVALMTLSS+TEDWDVGSFYEN A
Sbjct: 536 PRLGDNYPLDSVRKMAQLAKACTQENPQLRPSMRSIVVALMTLSSSTEDWDVGSFYENQA 595

Query: 582 LVNLMSGR 589
           LVNLMSGR
Sbjct: 596 LVNLMSGR 603

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485632|ref|XP_002270987.2| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Vitis vinifera]

 Score =  825 bits (2130), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 418/609 (68%), Positives = 475/609 (77%), Gaps = 64/609 (10%)

Query: 20  TVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSL 79
           T +S+C++GCD AL SYYVW GSNLTFI+Q  ++++        + ILSYN Q++N+DS+
Sbjct: 36  TFDSQCSRGCDLALGSYYVWQGSNLTFISQLFQTTI--------SEILSYNSQIANQDSV 87

Query: 80  LADTRINVPFP-CDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPP 138
            ADTRI VP+  CDCINGEFLG  F +++ SGDTY+ VA  YYSNLT +A LQ  N+Y  
Sbjct: 88  EADTRIRVPYSSCDCINGEFLGKVFNYTVQSGDTYDLVAETYYSNLTTSAWLQNFNSYAA 147

Query: 139 TRIPDRGT-LNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNP 197
            +IPD    LNVT+NCSCG++ VSK Y LF++YPLRP D+L S+A + GL+ SLLQ+YNP
Sbjct: 148 NQIPDTDAYLNVTLNCSCGNSTVSKDYGLFLSYPLRPEDNLTSVAESEGLNASLLQSYNP 207

Query: 198 GVNFTRGSGLVFIPGRD-ANGVFPALESSSTGGLVF------------------------ 232
             NF+ GSGLV+IP +  A GV   +  ++  G++                         
Sbjct: 208 DSNFSAGSGLVYIPTKGLAGGVIAGISIAAVVGVLLLTVCIYIGFYRKRKVKEAALLPTE 267

Query: 233 -----PAY-------KTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKI 280
                P +       K VESTGPA G+   L  ITVDKSVEFSYEEL+KA+DNF++++KI
Sbjct: 268 EHSLQPGHGPGIASDKAVESTGPAFGSSAGLTGITVDKSVEFSYEELAKASDNFNLANKI 327

Query: 281 GQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH 340
           GQGGFG+VYYAELRGE                 KAAIKKMDMQASREFLAELKVLTHVHH
Sbjct: 328 GQGGFGSVYYAELRGE-----------------KAAIKKMDMQASREFLAELKVLTHVHH 370

Query: 341 LNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE 400
           LNLVRLIGYCVEGSLFLVYEYIENGNLS+HLRGSGRDPL WSSRVQIALDSARGLEYIHE
Sbjct: 371 LNLVRLIGYCVEGSLFLVYEYIENGNLSQHLRGSGRDPLQWSSRVQIALDSARGLEYIHE 430

Query: 401 HTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY 460
           HTVPVYIHRDIKSANILIDKNFH KVADFGLTKLTEVGS+SLPTRLVGTFGYMPPEYAQY
Sbjct: 431 HTVPVYIHRDIKSANILIDKNFHGKVADFGLTKLTEVGSSSLPTRLVGTFGYMPPEYAQY 490

Query: 461 GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLV 520
           GDVSPKVDVYAFGVVLYELISAKEA+VK NGS A+SKGLVALFE+VLN PDP EDLRKLV
Sbjct: 491 GDVSPKVDVYAFGVVLYELISAKEAVVKDNGSVAESKGLVALFEDVLNKPDPREDLRKLV 550

Query: 521 DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENH 580
           DPRL DN PLDSV KMAQLAK CTQE PQLRPSMR+IVVALMTLSS+TEDWDVGSFY+N 
Sbjct: 551 DPRLEDNYPLDSVRKMAQLAKACTQENPQLRPSMRTIVVALMTLSSSTEDWDVGSFYDNQ 610

Query: 581 ALVNLMSGR 589
           ALVNLMSGR
Sbjct: 611 ALVNLMSGR 619

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224064938|ref|XP_002301610.1| predicted protein [Populus trichocarpa] gi|222843336|gb|EEE80883.1| predicted protein [Populus trichocarpa]

 Score =  822 bits (2124), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 408/583 (69%), Positives = 467/583 (80%), Gaps = 32/583 (5%)

Query: 20  TVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSL 79
           +++SKC+KGCD ALASYYVW G+NL+FIA+ ++SS++   D +  TIL YN Q++NKDSL
Sbjct: 18  SIDSKCSKGCDLALASYYVWQGANLSFIAEVMQSSILKSTDFD--TILRYNPQVTNKDSL 75

Query: 80  LADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPT 139
            +  RI++PFPC+CINGEFLGH F +++ S DTY  VA  YY+NLT   SL   N+YP  
Sbjct: 76  PSFIRISIPFPCECINGEFLGHFFTYNVRSQDTYGTVADTYYANLTTTPSLINFNSYPEV 135

Query: 140 RIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGV 199
            IPD G LNV+VNCSCGD+ VSK Y LF+TYPLRP D+L SIA    L++SLLQ YN G 
Sbjct: 136 NIPDNGVLNVSVNCSCGDSSVSKDYGLFMTYPLRPNDTLASIANQTNLTQSLLQRYNVGF 195

Query: 200 NFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKTVESTGPAAGTPTS--------- 250
           +F +GSG+V+IP +D +G +  L+S ++         +  S G   G P S         
Sbjct: 196 DFNQGSGVVYIPTKDPDGSYLPLKSRNSRRRCCWHMHSSSSRGTVVGIPGSNSNKPVDAT 255

Query: 251 ----LNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLI 306
               L  +TVDKSV FSYEEL+KATD+FS+++KIGQGGFG+VYYAELRGE          
Sbjct: 256 GFQGLTGLTVDKSVVFSYEELAKATDDFSLANKIGQGGFGSVYYAELRGE---------- 305

Query: 307 CVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
                  KAAIKKMDMQAS+EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYE+IENGN
Sbjct: 306 -------KAAIKKMDMQASKEFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEFIENGN 358

Query: 367 LSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
           LS+HLRGS +DPLPWS+RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  KV
Sbjct: 359 LSQHLRGSEKDPLPWSTRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFRGKV 418

Query: 427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
           ADFGLTKLTEVGS SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYA GVVLYELISAKEAI
Sbjct: 419 ADFGLTKLTEVGSTSLPTRLVGTFGYMPPEYAQYGDVSPKVDVYALGVVLYELISAKEAI 478

Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
           VK NGSSA+S+GLVALFE+VLN PDP EDLRK+VDPRLG++ PLDSV KMAQL K CTQE
Sbjct: 479 VKSNGSSAESRGLVALFEDVLNQPDPREDLRKVVDPRLGEDYPLDSVRKMAQLGKACTQE 538

Query: 547 YPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
            PQLRPSMRSIVVALMTLSS+TEDWDVGSFYEN ALVNLMSGR
Sbjct: 539 NPQLRPSMRSIVVALMTLSSSTEDWDVGSFYENQALVNLMSGR 581

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297739193|emb|CBI28844.3| unnamed protein product [Vitis vinifera]

 Score =  805 bits (2080), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 423/654 (64%), Positives = 484/654 (74%), Gaps = 94/654 (14%)

Query: 1   MKQ-LCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPN 59
           MKQ + + FFVL+    +   V+S+C++GCD AL SYYVW GSNLTFI+Q  ++++    
Sbjct: 1   MKQKVGLGFFVLLS---VFCAVDSQCSRGCDLALGSYYVWQGSNLTFISQLFQTTI---- 53

Query: 60  DVELTTILSYNKQLSNKDSLLADTRINVPFP-CDCINGEFLGHTFQFSINSGDTYEKVAT 118
               + ILSYN Q++N+DS+ ADTRI VP+  CDCINGEFLG  F +++ SGDTY+ VA 
Sbjct: 54  ----SEILSYNSQIANQDSVEADTRIRVPYSSCDCINGEFLGKVFNYTVQSGDTYDLVAE 109

Query: 119 RYYSNLTDAASLQRINNYPPTRIPDRGT-LNVTVNCSCGDADVSKQYRLFVTYPLRPGDS 177
            YYSNLT +A LQ  N+Y   +IPD    LNVT+NCSCG++ VSK Y LF++YPLRP D+
Sbjct: 110 TYYSNLTTSAWLQNFNSYAANQIPDTDAYLNVTLNCSCGNSTVSKDYGLFLSYPLRPEDN 169

Query: 178 LQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKT 237
           L S+A + GL+ SLLQ+YNP  NF+ GSGLV+IP +D +G + AL+ SSTG  +F AY  
Sbjct: 170 LTSVAESEGLNASLLQSYNPDSNFSAGSGLVYIPTKDTSGSYRALK-SSTGDFLFSAYWF 228

Query: 238 VESTG--------------------------------PAAGTPTSLNA--------ITVD 257
               G                                 AA  PT  ++        I  D
Sbjct: 229 AGLAGGVIAGISIAAVVGVLLLTVCIYIGFYRKRKVKEAALLPTEEHSLQPGHGPGIASD 288

Query: 258 KSVE----------------------FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRG 295
           K+VE                      FSYEEL+KA+DNF++++KIGQGGFG+VYYAELRG
Sbjct: 289 KAVESTGPAFGSSAGLTGITVDKSVEFSYEELAKASDNFNLANKIGQGGFGSVYYAELRG 348

Query: 296 EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL 355
           E                 KAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL
Sbjct: 349 E-----------------KAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL 391

Query: 356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN 415
           FLVYEYIENGNLS+HLRGSGRDPL WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN
Sbjct: 392 FLVYEYIENGNLSQHLRGSGRDPLQWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN 451

Query: 416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVV 475
           ILIDKNFH KVADFGLTKLTEVGS+SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVV
Sbjct: 452 ILIDKNFHGKVADFGLTKLTEVGSSSLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVV 511

Query: 476 LYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLK 535
           LYELISAKEA+VK NGS A+SKGLVALFE+VLN PDP EDLRKLVDPRL DN PLDSV K
Sbjct: 512 LYELISAKEAVVKDNGSVAESKGLVALFEDVLNKPDPREDLRKLVDPRLEDNYPLDSVRK 571

Query: 536 MAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
           MAQLAK CTQE PQLRPSMR+IVVALMTLSS+TEDWDVGSFY+N ALVNLMSGR
Sbjct: 572 MAQLAKACTQENPQLRPSMRTIVVALMTLSSSTEDWDVGSFYDNQALVNLMSGR 625

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574906|ref|XP_003555584.1| PREDICTED: proline-rich receptor-like protein kinase PERK8-like [Glycine max]

 Score =  795 bits (2052), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 415/636 (65%), Positives = 476/636 (74%), Gaps = 80/636 (12%)

Query: 9   FVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVD-PNDVELTTIL 67
           ++L+   L+  T ES C +GC  AL SYY+W GSNLT+I+  + SSL+  P+D     I+
Sbjct: 8   YLLLPWWLVFSTAESACKEGCGVALGSYYLWRGSNLTYISSIMASSLLTTPDD-----IV 62

Query: 68  SYNKQ-LSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTD 126
           +YNK  + +KD ++AD R+NVPFPCDCI+G+FLGHTF++ + S DTYE VA  +++NLTD
Sbjct: 63  NYNKDTVPSKDIIIADQRVNVPFPCDCIDGQFLGHTFRYDVQSQDTYETVARSWFANLTD 122

Query: 127 AASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVG 186
            A L+R N YPP  IPD GTLNVTVNCSCG+ DV+  Y LFVTYPLR GD+L S+A N+ 
Sbjct: 123 VAWLRRFNTYPPDNIPDTGTLNVTVNCSCGNTDVA-NYGLFVTYPLRIGDTLGSVAANLS 181

Query: 187 LSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTG-----------GLV---- 231
           L  +LLQ YNP VNF +G+GLV++PG+D NG F  L SSS G           G+V    
Sbjct: 182 LDSALLQRYNPDVNFNQGTGLVYVPGKDQNGSFVRLPSSSGGLTGRAIAGIAVGIVAALL 241

Query: 232 --------------------FPAYKTV----------------ESTGPAAGTPTSLNAIT 255
                                P   T                 E++GP  G P  +  IT
Sbjct: 242 LLGVCIYVGYFRKKIQKDEFLPRDSTALFAQDGKDETSRSSANETSGP--GGPAIITDIT 299

Query: 256 VDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           V+KSVEFSYEEL+ ATDNFS+++KIGQGGFG+VYYAELRGE                 KA
Sbjct: 300 VNKSVEFSYEELATATDNFSLANKIGQGGFGSVYYAELRGE-----------------KA 342

Query: 316 AIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSG 375
           AIKKMDMQAS+EFLAEL VLT VHHLNLVRLIGY +EGSLFLVYEYIENGNLS+HLRGSG
Sbjct: 343 AIKKMDMQASKEFLAELNVLTRVHHLNLVRLIGYSIEGSLFLVYEYIENGNLSQHLRGSG 402

Query: 376 -RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL 434
            R+PLPW++RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  KVADFGLTKL
Sbjct: 403 SREPLPWATRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFRGKVADFGLTKL 462

Query: 435 TEVGSASLPT-RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS 493
           TEVGS+SLPT RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK N S 
Sbjct: 463 TEVGSSSLPTGRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKTNDSV 522

Query: 494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
           ADSKGLVALF+ VL+ PDP E+L KLVDPRLGDN P+DSV KMAQLAK CTQ+ PQLRPS
Sbjct: 523 ADSKGLVALFDGVLSQPDPTEELCKLVDPRLGDNYPIDSVRKMAQLAKACTQDNPQLRPS 582

Query: 554 MRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
           MRSIVVALMTLSSTT+DWDVGSFYEN  LVNLMSGR
Sbjct: 583 MRSIVVALMTLSSTTDDWDVGSFYENQNLVNLMSGR 618

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224131642|ref|XP_002321141.1| predicted protein [Populus trichocarpa] gi|222861914|gb|EEE99456.1| predicted protein [Populus trichocarpa]

 Score =  793 bits (2049), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/583 (68%), Positives = 459/583 (78%), Gaps = 33/583 (5%)

Query: 20  TVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSL 79
           ++ESKC KGCD ALASYYVW  +NLTFIA+ ++S ++  +D +  TIL YN QL +KDSL
Sbjct: 18  SIESKCRKGCDLALASYYVWQDANLTFIAEVMQSRILKSSDFD--TILRYNPQLPSKDSL 75

Query: 80  LADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPT 139
            +  RIN+PFPCDCI G+FLGH F F++ S +TY  VA  YY+ LT   SL   NNY   
Sbjct: 76  SSFIRINIPFPCDCIEGQFLGHFFNFNVRSQNTYTVVADTYYAKLTTIPSLMYFNNYSEF 135

Query: 140 RIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGV 199
            IPD G LNV+VNCSCGD+ VSK Y LF+TYPL+P D+L SIA    +++ LLQ YN G 
Sbjct: 136 NIPDNGKLNVSVNCSCGDSSVSKDYGLFMTYPLQPNDTLNSIANQTNVTQELLQRYNVGF 195

Query: 200 NFTRGSGLVFIPGRDANGVFPALES---SSTGGLVFPAY-----KTVESTGP-----AAG 246
           NF+RG+G+V+IP +DA+G +  L+S      G ++  A      + +  TG      A G
Sbjct: 196 NFSRGTGVVYIPTKDADGSYRPLKSRKKKEKGAILLSASPQLSPRILHVTGSNRPVNAIG 255

Query: 247 TPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLI 306
           +   L  ITVDKSVEFSYEEL+KATD+FS+++KIG+GGFG VYYAELRGE          
Sbjct: 256 S-QGLTGITVDKSVEFSYEELAKATDDFSLANKIGEGGFGTVYYAELRGE---------- 304

Query: 307 CVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
                  KAAIKKMD+Q S+EF AELKVLTHVHHLNLVRLIGYCVEGSLF+VYEYIENGN
Sbjct: 305 -------KAAIKKMDVQDSKEFFAELKVLTHVHHLNLVRLIGYCVEGSLFVVYEYIENGN 357

Query: 367 LSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
           LS+HLRGSG+DPL WS+RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  KV
Sbjct: 358 LSQHLRGSGKDPLTWSTRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFRGKV 417

Query: 427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
           ADFGL KLT+VGSASL TRLVGTFGYM PEYAQYGDVSPK+DV+AFGVVLYELISAKEAI
Sbjct: 418 ADFGLAKLTKVGSASLLTRLVGTFGYMSPEYAQYGDVSPKLDVFAFGVVLYELISAKEAI 477

Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
           VK N SSA+S+GL+ALFE VLN PDP EDLRKLVDPRLG++ PLDSV K+ QLAK CT E
Sbjct: 478 VKANDSSAESRGLIALFENVLNQPDPGEDLRKLVDPRLGEDYPLDSVRKVTQLAKACTHE 537

Query: 547 YPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
            PQ+RPSMRSIVVALMTLSS+TEDWDVGSFYEN ALVNLMSGR
Sbjct: 538 NPQMRPSMRSIVVALMTLSSSTEDWDVGSFYENKALVNLMSGR 580

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290490572|dbj|BAI79273.1| LysM type receptor kinase [Lotus japonicus]

 Score =  784 bits (2024), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 411/638 (64%), Positives = 472/638 (73%), Gaps = 82/638 (12%)

Query: 6   MIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLV-DPNDVELT 64
           ++F  +++PS    T +SKCT GC  A ASYY+  GSNLT+I++ ++SSL+  P D    
Sbjct: 13  LLFSFILLPS----TSQSKCTHGCALAQASYYLLNGSNLTYISEIMQSSLLTKPED---- 64

Query: 65  TILSYNKQ-LSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSN 123
            I+SYN+  +++KDS+ A  RINVPFPCDCI GEFLGHTFQ+ +  GD Y+ +A   Y+N
Sbjct: 65  -IVSYNQDTIASKDSVQAGQRINVPFPCDCIEGEFLGHTFQYDVQKGDRYDTIAGTNYAN 123

Query: 124 LTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIAR 183
           LT    L+R N+YPP  IPD GTLNVTVNCSCGD+ V   Y LFVTYPLRPG++L S+A 
Sbjct: 124 LTTVEWLRRFNSYPPDNIPDTGTLNVTVNCSCGDSGVG-DYGLFVTYPLRPGETLGSVAS 182

Query: 184 NVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSST---------------- 227
           NV L  +LLQ YNP VNF +GSG+V+IP +D NG +  L SSS                 
Sbjct: 183 NVKLDSALLQKYNPNVNFNQGSGIVYIPAKDQNGSYVLLGSSSGGLAGGAIAGIAAGVAV 242

Query: 228 -----GGLVFPAY------------------------------KTVESTGPAAGTPTSLN 252
                 G ++  Y                               TV  T P  G P ++ 
Sbjct: 243 CLLLLAGFIYVGYFRKKRIQKEELLSQETRAIFPQDGKDENPRSTVNET-PGPGGPAAMA 301

Query: 253 AITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM 312
            ITVDKSVEFSY+EL+ ATDNFS+++KIGQGGFG+VYYAELRGE                
Sbjct: 302 GITVDKSVEFSYDELATATDNFSLANKIGQGGFGSVYYAELRGE---------------- 345

Query: 313 QKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLR 372
            +AAIKKMDMQAS+EFLAELKVLT VHHLNLVRLIGY +EGSLFLVYE+IENGNLS+HLR
Sbjct: 346 -RAAIKKMDMQASKEFLAELKVLTRVHHLNLVRLIGYSIEGSLFLVYEFIENGNLSQHLR 404

Query: 373 GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
           GSGRDPLPW++RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN+  KVADFGLT
Sbjct: 405 GSGRDPLPWATRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNYRGKVADFGLT 464

Query: 433 KLTEVGSASLPT-RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG 491
           KLTEVGS+SLPT RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK+AIVK + 
Sbjct: 465 KLTEVGSSSLPTGRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKDAIVKTSE 524

Query: 492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR 551
           S  DSKGLVALFE VL+ PDP EDLRKLVD RLGDN P+DSV KMAQLAK CTQ+ PQLR
Sbjct: 525 SITDSKGLVALFEGVLSQPDPTEDLRKLVDQRLGDNYPVDSVRKMAQLAKACTQDNPQLR 584

Query: 552 PSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
           PSMRSIVVALMTLSSTT+DWDVGSFYEN  LVNLMSGR
Sbjct: 585 PSMRSIVVALMTLSSTTDDWDVGSFYENQNLVNLMSGR 622

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483329|ref|XP_002264327.2| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Vitis vinifera]

 Score =  779 bits (2011), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 392/622 (63%), Positives = 457/622 (73%), Gaps = 73/622 (11%)

Query: 16  LISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSN 75
           L+     +KC++GCD ALASYYVW GSNLT+I +            E++ IL YN Q+ N
Sbjct: 23  LLCSKANAKCSRGCDLALASYYVWDGSNLTYIRKIFGR--------EISEILKYNPQIEN 74

Query: 76  KDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINN 135
           +DS+   +RINVPF CDC+NG+FLGHTF+++   GDTY+++A R +SNLT    + R+N 
Sbjct: 75  QDSIDTGSRINVPFRCDCLNGDFLGHTFEYTTQFGDTYDRIAERAFSNLTTEDWVHRVNE 134

Query: 136 YPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNY 195
           YPPTRIPD   +NVTVNCSCG+  VS +Y LF TYPLR G++L ++A   G+++ L++ Y
Sbjct: 135 YPPTRIPDDVQINVTVNCSCGNRRVSMKYGLFATYPLRDGENLSTVAAAAGITDDLVRRY 194

Query: 196 NPGVNFTRGSGLVFIPGRDANGVFPALESS------STGGLV------------------ 231
           NP  +F+ G+GLVF+P +D N  +P L+ S      S  G+V                  
Sbjct: 195 NPAADFSAGTGLVFVPAKDQNETYPPLKLSGVIAGISVAGIVGSLLFAFFLFARICKRKK 254

Query: 232 ------FPAY-----------------KTVESTGPAAGTPTSLNAITVDKSVEFSYEELS 268
                 FPA                  +T +S          L  ITVDKSVEFSYEEL+
Sbjct: 255 VKKVLFFPAASEQQYMQHRQAHGSASEETSDSAALVGAASLGLVGITVDKSVEFSYEELA 314

Query: 269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
            ATDNFS+++KIGQGGFG+VYYAELRGE                 KAAIKKMDMQAS+EF
Sbjct: 315 TATDNFSLANKIGQGGFGSVYYAELRGE-----------------KAAIKKMDMQASKEF 357

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYE+I+NGNLS HLRGSG+DPLPWSSRVQIA
Sbjct: 358 LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEFIDNGNLSHHLRGSGKDPLPWSSRVQIA 417

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           LDSARGLEYIHEHTVPVYIHRDIK ANILIDK F AKVADFGLTKLTEVGSAS+PTRLVG
Sbjct: 418 LDSARGLEYIHEHTVPVYIHRDIKPANILIDKKFRAKVADFGLTKLTEVGSASIPTRLVG 477

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS-SADSKGLVALFEEVL 507
           TFGYMPPEYAQYGDVSPK+DV+AFGVVLYELISAKEAIVK N     +SKGLVALFE+VL
Sbjct: 478 TFGYMPPEYAQYGDVSPKIDVFAFGVVLYELISAKEAIVKTNEPIMPESKGLVALFEDVL 537

Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
           + PDP ED  KL+D RLGD+ PLDS+ KMA LAK CTQE PQLRPSMRSIVVALMTLSS+
Sbjct: 538 SQPDPREDFVKLIDQRLGDDYPLDSIWKMAHLAKACTQENPQLRPSMRSIVVALMTLSSS 597

Query: 568 TEDWDVGSFYENHALVNLMSGR 589
           TEDWDVGSFYEN AL+NLMSGR
Sbjct: 598 TEDWDVGSFYENEALMNLMSGR 619

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|345843162|gb|AEO18237.1| Bti9 [Nicotiana benthamiana]

 Score =  773 bits (1997), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/637 (62%), Positives = 463/637 (72%), Gaps = 83/637 (13%)

Query: 9   FVLIVPSLIS--VTVESKCTKGCDTALASYYVWIGSNLTFIAQ----TLRSSLVDPNDVE 62
           F+LI   L S  + VES+C KGCD AL S++VW G+NL  I+Q    + R  ++D N+ E
Sbjct: 14  FILITVYLSSNSLPVESRCNKGCDLALGSFFVWRGTNLIHISQLFSVSTRQEIIDYNNKE 73

Query: 63  LTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYS 122
                     + N+DS++A TRIN+PF CDC++GEFLGH F + + SGDTY +VA+ Y S
Sbjct: 74  ---------NIPNQDSVIAGTRINIPFSCDCLDGEFLGHVFPYKVISGDTYARVASNY-S 123

Query: 123 NLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIA 182
           +LT    L+R N++   +IPD  TL V VNCSCG+ D+SK + LF TYPLRP D+L ++A
Sbjct: 124 DLTTVDLLKRFNSHSENKIPDDVTLKVVVNCSCGNKDISKDFGLFATYPLRPEDNLTAVA 183

Query: 183 RNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSS---------------- 226
               +S  L+++YNPG NF+ G G+VFIPGRD +G FP L +S+                
Sbjct: 184 STANVSAELIRSYNPGANFSAGKGIVFIPGRDKSGNFPPLPTSTGISGGAIAGISIGAIA 243

Query: 227 ----TGGLVFPAY------------------------------KTVESTGPAAGTPTSLN 252
                 GLV+  Y                              K  +S   A G    L+
Sbjct: 244 VVLLLAGLVYVGYYRKKAQKVSLLSSEDRLHQSSHGPESSTIVKAADSGRLANGNSPELS 303

Query: 253 AITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM 312
            ITVDKSVEF+YEEL+ AT++FS+++KIGQGGFGAVYYAELRGE                
Sbjct: 304 GITVDKSVEFTYEELATATNDFSIANKIGQGGFGAVYYAELRGE---------------- 347

Query: 313 QKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLR 372
            KAAIKKMDM+A+REFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEY+ENGN+ +HLR
Sbjct: 348 -KAAIKKMDMEATREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYVENGNIGQHLR 406

Query: 373 GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
           G+GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK+ANILIDKNFHAKVADFGLT
Sbjct: 407 GTGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKTANILIDKNFHAKVADFGLT 466

Query: 433 KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           KLTEVGS+SL TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK N S
Sbjct: 467 KLTEVGSSSLQTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKPNES 526

Query: 493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
             +SKGLV LFEEVLN P+P EDLRK+VDPRLG++ PLDSV KMAQLAK CT E P +RP
Sbjct: 527 VTESKGLVGLFEEVLNQPEPDEDLRKVVDPRLGNDYPLDSVRKMAQLAKACTHENPLIRP 586

Query: 553 SMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
           SMRSIVVALMTLSS+TEDWDVGSFY N  L+NLMSGR
Sbjct: 587 SMRSIVVALMTLSSSTEDWDVGSFYGNQGLINLMSGR 623

Source: Nicotiana benthamiana

Species: Nicotiana benthamiana

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302144092|emb|CBI23197.3| unnamed protein product [Vitis vinifera]

 Score =  764 bits (1974), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 392/623 (62%), Positives = 447/623 (71%), Gaps = 80/623 (12%)

Query: 22  ESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLA 81
           ESKC++ CD ALASY +W G +L FIA T           +++ I S+N Q++N D ++A
Sbjct: 53  ESKCSRTCDLALASYNLWKGVDLNFIATTFSR--------DVSEIQSFNPQITNIDLIIA 104

Query: 82  DTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRI 141
             R+NVPF C CI+ EFLG TF +S    DTY  +A +Y++NLT    LQR N Y PT I
Sbjct: 105 GERVNVPFSCGCIDREFLGTTFVYSAKQNDTYSIIAEKYFANLTTVEWLQRFNTYAPTNI 164

Query: 142 PDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNF 201
           P    +NVTVNCSCG++ VSK Y LFVTYPL PG++L +IA   GL   LLQ+YNP  +F
Sbjct: 165 PIDAPINVTVNCSCGNSSVSKDYGLFVTYPLEPGENLSTIANQSGLPPQLLQDYNPDSDF 224

Query: 202 TRGSGLVFIPGRDANGVFPALESSSTGG-------------------------------- 229
           +RGSGLVFIPG+D N  +P L+ S++ G                                
Sbjct: 225 SRGSGLVFIPGKDQNETYPPLKLSNSAGISSGVIAGISVAGIVGSLLFAFFLFARICKRK 284

Query: 230 -----LVFPAY-----------------KTVESTGPAAGTPTSLNAITVDKSVEFSYEEL 267
                L FPA                  +T +S          L  ITVDKSVEFSYEEL
Sbjct: 285 KVKKVLFFPAASEQQYMQHRQAHGSASEETSDSAALVGAASLGLVGITVDKSVEFSYEEL 344

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + ATDNFS+++KIGQGGFG+VYYAELRGE                 KAAIKKMDMQAS+E
Sbjct: 345 ATATDNFSLANKIGQGGFGSVYYAELRGE-----------------KAAIKKMDMQASKE 387

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYE+I+NGNLS HLRGSG+DPLPWSSRVQI
Sbjct: 388 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEFIDNGNLSHHLRGSGKDPLPWSSRVQI 447

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           ALDSARGLEYIHEHTVPVYIHRDIK ANILIDK F AKVADFGLTKLTEVGSAS+PTRLV
Sbjct: 448 ALDSARGLEYIHEHTVPVYIHRDIKPANILIDKKFRAKVADFGLTKLTEVGSASIPTRLV 507

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS-SADSKGLVALFEEV 506
           GTFGYMPPEYAQYGDVSPK+DV+AFGVVLYELISAKEAIVK N     +SKGLVALFE+V
Sbjct: 508 GTFGYMPPEYAQYGDVSPKIDVFAFGVVLYELISAKEAIVKTNEPIMPESKGLVALFEDV 567

Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS 566
           L+ PDP ED  KL+D RLGD+ PLDS+ KMA LAK CTQE PQLRPSMRSIVVALMTLSS
Sbjct: 568 LSQPDPREDFVKLIDQRLGDDYPLDSIWKMAHLAKACTQENPQLRPSMRSIVVALMTLSS 627

Query: 567 TTEDWDVGSFYENHALVNLMSGR 589
           +TEDWDVGSFYEN AL+NLMSGR
Sbjct: 628 STEDWDVGSFYENEALMNLMSGR 650

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	589
TAIR|locus:2089860	617	CERK1 "chitin elicitor recepto	0.463	0.442	0.730	2.1e-182
UNIPROTKB|D7UPN3	605	CERK1 "Chitin elicitor recepto	0.653	0.636	0.539	7.2e-139
TAIR|locus:2195814	651	LYK3 "LysM-containing receptor	0.538	0.486	0.419	3.7e-72
TAIR|locus:2050987	664	LYK5 "LysM-containing receptor	0.432	0.384	0.387	6.1e-62
TAIR|locus:2028911	720	PERK12 "proline-rich extensin-	0.511	0.418	0.398	1.8e-56
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.528	0.476	0.413	8.6e-56
TAIR|locus:2139474	670	PERK5 "proline-rich extensin-l	0.516	0.453	0.416	1.6e-55
TAIR|locus:2019938	718	PERK11 "proline-rich extensin-	0.614	0.504	0.370	1.8e-55
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.607	0.504	0.370	2.3e-55
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.533	0.485	0.401	4.8e-55

TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1011 (360.9 bits), Expect = 2.1e-182, Sum P(3) = 2.1e-182
 Identities = 203/278 (73%), Positives = 232/278 (83%)

Query:   313 QKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLR 372
             +KAAIKKMDM+AS++FLAELKVLT VHH+NLVRLIGYCVEGSLFLVYEY+ENGNL +HL 
Sbjct:   344 EKAAIKKMDMEASKQFLAELKVLTRVHHVNLVRLIGYCVEGSLFLVYEYVENGNLGQHLH 403

Query:   373 GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
             GSGR+PLPW+ RVQIALDSARGLEYIHEHTVPVY+HRDIKSANILID+ F AKVADFGLT
Sbjct:   404 GSGREPLPWTKRVQIALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLT 463

Query:   433 KLTEVGSASLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG 491
             KLTEVG ++  TR  +GTFGYM PE   YG+VS KVDVYAFGVVLYELISAK A+VK   
Sbjct:   464 KLTEVGGSA--TRGAMGTFGYMAPETV-YGEVSAKVDVYAFGVVLYELISAKGAVVKMTE 520

Query:   492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR 551
             +  + +GLV +FEE     D  E LRK++DPRLGD+ P DSV KMA+L K CTQE  QLR
Sbjct:   521 AVGEFRGLVGVFEESFKETDKEEALRKIIDPRLGDSYPFDSVYKMAELGKACTQENAQLR 580

Query:   552 PSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
             PSMR IVVAL TL S+T +WDVG+F +N  LV+LMSGR
Sbjct:   581 PSMRYIVVALSTLFSSTGNWDVGNF-QNEDLVSLMSGR 617

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=IMP;IDA

GO:0032491 "detection of molecule of fungal origin" evidence=IEP;IMP

GO:0035556 "intracellular signal transduction" evidence=RCA;IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009817 "defense response to fungus, incompatible interaction" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0002752 "cell surface pattern recognition receptor signaling pathway" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:2001080 "chitosan binding" evidence=IDA

GO:0032499 "detection of peptidoglycan" evidence=IMP

GO:0045087 "innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

UNIPROTKB|D7UPN3 CERK1 "Chitin elicitor receptor kinase 1" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 982 (350.7 bits), Expect = 7.2e-139, Sum P(2) = 7.2e-139
 Identities = 219/406 (53%), Positives = 271/406 (66%)

Query:   191 LLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGG-LVFPAYKTVESTGPAAGTPT 249
             L++ YNPG+    G G+VFIP +D NG +  L+S   G  L   A   +     A     
Sbjct:   201 LIRRYNPGMGGVSGKGIVFIPVKDPNGSYHPLKSGGMGNSLSGGAIAGIVIACIAIFIVA 260

Query:   250 SLNAITVDKSVEF-------SYEELSKATD-----NFSMSHKIG---QGGFGAVYYAELR 294
                 I   +  +F       S EE S   D        +   I    +  F A     + 
Sbjct:   261 IWLIIMFYRWQKFRKATSRPSPEETSHLDDASQAEGIKVERSIEFSYEEIFNATQGFSME 320

Query:   295 GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS 354
              + G      +    L  +K AIKKM MQA++EFLAELKVLTHVHHLNLVRLIGYCVE  
Sbjct:   321 HKIGQGGFGSVYYAELRGEKTAIKKMGMQATQEFLAELKVLTHVHHLNLVRLIGYCVENC 380

Query:   355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
             LFLVYE+I+NGNLS+HL+ +G  PL W++RVQIALDSARGLEY+HEH VPVY+HRDIKSA
Sbjct:   381 LFLVYEFIDNGNLSQHLQRTGYAPLSWATRVQIALDSARGLEYLHEHVVPVYVHRDIKSA 440

Query:   415 NILIDKNFHAKVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAF 472
             NIL+DK+F AK+ADFGL KLTEVGS S  L TR+ GTFGYMPPE A+YG+VSPKVDVYAF
Sbjct:   441 NILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGYMPPE-ARYGEVSPKVDVYAF 499

Query:   473 GVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDS 532
             GVVLYEL+SAK+AIV+ + S ++SKGLV LFEE L+ P+P E L +L+DP L  + P+DS
Sbjct:   500 GVVLYELLSAKQAIVRSSESVSESKGLVFLFEEALSAPNPTEALDELIDPSLQGDYPVDS 559

Query:   533 VLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE--DWDVGSF 576
              LK+A LAK CT E P +RP+MRS+VVALM L++ T+  D D   F
Sbjct:   560 ALKIASLAKSCTHEEPGMRPTMRSVVVALMALTANTDLRDMDYHPF 605

GO:0005515 "protein binding" evidence=IPI

GO:0008061 "chitin binding" evidence=IDA

GO:0010200 "response to chitin" evidence=IDA

GO:0043621 "protein self-association" evidence=IDA

TAIR|locus:2195814 LYK3 "LysM-containing receptor-like kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 666 (239.5 bits), Expect = 3.7e-72, Sum P(2) = 3.7e-72
 Identities = 145/346 (41%), Positives = 209/346 (60%)

Query:   256 VDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
             ++K + F+YEE+  ATD FS S+ +G G +G+VY+  LR                  Q+ 
Sbjct:   323 IEKPMVFTYEEIRAATDEFSDSNLLGHGNYGSVYFGLLRE-----------------QEV 365

Query:   316 AIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHL--- 371
             A+K+M    ++EF AE+KVL  VHH NLV LIGY      LF+VYEY+  G L  HL   
Sbjct:   366 AVKRMTATKTKEFAAEMKVLCKVHHSNLVELIGYAATVDELFVVYEYVRKGMLKSHLHDP 425

Query:   372 RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
             +  G  PL W  R QIALD+ARGLEYIHEHT   Y+HRDIK++NIL+D+ F AK++DFGL
Sbjct:   426 QSKGNTPLSWIMRNQIALDAARGLEYIHEHTKTHYVHRDIKTSNILLDEAFRAKISDFGL 485

Query:   432 TKLTE-VGSASLP-TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
              KL E  G   +  T++VGT+GY+ PEY   G  + K D+YAFGVVL+E+IS +EA+++ 
Sbjct:   486 AKLVEKTGEGEISVTKVVGTYGYLAPEYLSDGLATSKSDIYAFGVVLFEIISGREAVIRT 545

Query:   490 NG---SSADSKGLVALFEEVL-NLPDPIE--DLRKLVDPRLGDNCPLDSVLKMAQLAKVC 543
                   + + + L ++   VL N PD +    L++ VDP + D  P D + K+A LAK C
Sbjct:   546 EAIGTKNPERRPLASIMLAVLKNSPDSMNMSSLKEFVDPNMMDLYPHDCLFKIATLAKQC 605

Query:   544 TQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNLMSGR 589
               + P LRP+M+ +V++L  +  ++ +W+      +     L+ GR
Sbjct:   606 VDDDPILRPNMKQVVISLSQILLSSIEWEATLAGNSQVFSGLVQGR 651

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016998 "cell wall macromolecule catabolic process" evidence=IEA

GO:0007020 "microtubule nucleation" evidence=RCA

TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 496 (179.7 bits), Expect = 6.1e-62, Sum P(3) = 6.1e-62
 Identities = 102/263 (38%), Positives = 162/263 (61%)

Query:   315 AAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRG 373
             AA+K +    S    +E+ +L  ++H N++RL G+C+ EG+ +LV+EY ENG++S+ L  
Sbjct:   392 AAVKVIKGDVSS---SEINLLKKLNHSNIIRLSGFCIREGTSYLVFEYSENGSISDWLHS 448

Query:   374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
             SG+  L W  RV+IA D A  L+Y+H +  P +IH++++S NIL+D NF AK+A+FG+ +
Sbjct:   449 SGKKSLTWKQRVEIARDVAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVAR 508

Query:   434 LTEVGSASLP-TRLV-GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIV--KG 489
             + + G   L  TR V GT GY+ PEY + G ++ K+DV+AFGV + EL+S +EA+   K 
Sbjct:   509 ILDEGDLDLQLTRHVEGTQGYLAPEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKK 568

Query:   490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQ 549
                  + + L  +   VL   +  E L++ +DP LG+  PL+    MAQLAK C      
Sbjct:   569 KEGEEEVEMLCKVINSVLGGENVREKLKEFMDPSLGNEYPLELAYTMAQLAKSCVATDLN 628

Query:   550 LRPSMRSIVVALMTLSSTTEDWD 572
              RPS+  ++  L  + S++ DW+
Sbjct:   629 SRPSVTQVLTTLSMIVSSSIDWE 651

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0008061 "chitin binding" evidence=IDA

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 558 (201.5 bits), Expect = 1.8e-56, Sum P(2) = 1.8e-56
 Identities = 127/319 (39%), Positives = 181/319 (56%)

Query:   244 AAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLS 303
             ++GTP S  AI       FSYEEL++ T  F+  + +G+GGFG VY   L+         
Sbjct:   343 SSGTPDS--AILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQD-------G 393

Query:   304 RLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYI 362
             +++ V  L  KA       Q  REF AE+++++ VHH +LV L+GYC+      L+YEY+
Sbjct:   394 KVVAVKQL--KAG----SGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYV 447

Query:   363 ENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF 422
              N  L  HL G G   L WS RV+IA+ SA+GL Y+HE   P  IHRDIKSANIL+D  +
Sbjct:   448 SNQTLEHHLHGKGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEY 507

Query:   423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
              A+VADFGL +L +     + TR++GTFGY+ PEYA  G ++ + DV++FGVVL EL++ 
Sbjct:   508 EAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTG 567

Query:   483 KEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKV 542
             ++ + +      +S  LV     +L       DL +L+D RL        V +M + A  
Sbjct:   568 RKPVDQTQPLGEES--LVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAA 625

Query:   543 CTQEYPQLRPSMRSIVVAL 561
             C +     RP M  +V AL
Sbjct:   626 CVRHSGPKRPRMVQVVRAL 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032502 "developmental process" evidence=IMP

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 575 (207.5 bits), Expect = 8.6e-56, P = 8.6e-56
 Identities = 137/331 (41%), Positives = 189/331 (57%)

Query:   243 PAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYL 302
             P    P+    +   KS  F+YEELS+AT+ FS ++ +GQGGFG V+   L         
Sbjct:   250 PVLPPPSPGLVLGFSKST-FTYEELSRATNGFSEANLLGQGGFGYVHKGILPS------- 301

Query:   303 SRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEY 361
              + + V  L  KA       Q  REF AE+++++ VHH +LV LIGYC+ G    LVYE+
Sbjct:   302 GKEVAVKQL--KAG----SGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEF 355

Query:   362 IENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN 421
             + N NL  HL G GR  + WS+R++IAL SA+GL Y+HE   P  IHRDIK++NILID  
Sbjct:   356 VPNNNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFK 415

Query:   422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             F AKVADFGL K+    +  + TR++GTFGY+ PEYA  G ++ K DV++FGVVL ELI+
Sbjct:   416 FEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELIT 475

Query:   482 AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAK 541
              +  +   N    DS  LV     +LN      D   L D ++G+    + + +M   A 
Sbjct:   476 GRRPVDANNVYVDDS--LVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAA 533

Query:   542 VCTQEYPQLRPSMRSIVVAL---MTLSSTTE 569
              C +   + RP M  IV AL   ++LS   E
Sbjct:   534 ACVRHSARRRPRMSQIVRALEGNVSLSDLNE 564

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 547 (197.6 bits), Expect = 1.6e-55, Sum P(2) = 1.6e-55
 Identities = 134/322 (41%), Positives = 180/322 (55%)

Query:   241 TGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNS 300
             TG  A  P+   A        F+Y+ELS AT+ F+ S+ +GQGGFG V+   L       
Sbjct:   280 TGRTA-IPSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPS----- 333

Query:   301 YLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVY 359
                + + V       ++K    Q  REF AE+ +++ VHH +LV L+GYC+ G    LVY
Sbjct:   334 --GKEVAVK------SLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVY 385

Query:   360 EYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID 419
             E+I N  L  HL G GR  L W +RV+IAL SARGL Y+HE   P  IHRDIK+ANIL+D
Sbjct:   386 EFIPNNTLEFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLD 445

Query:   420 KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
              +F  KVADFGL KL++     + TR++GTFGY+ PEYA  G +S K DV++FGV+L EL
Sbjct:   446 FSFETKVADFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLEL 505

Query:   480 ISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQL 539
             I+ +  +    G   DS  LV     +        D  +L DPRL  N     +++MA  
Sbjct:   506 ITGRPPLDL-TGEMEDS--LVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASC 562

Query:   540 AKVCTQEYPQLRPSMRSIVVAL 561
             A    +   + RP M  IV AL
Sbjct:   563 AAAAIRHSARRRPKMSQIVRAL 584

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
 Identities = 147/397 (37%), Positives = 210/397 (52%)

Query:   186 GLSESLLQNYNPGVNFTRGS-GLVFIPGRDANGVFPALESS-STGGLVFPAYKTVESTGP 243
             G S      Y P  N +  + G +    +  NG   A  SS  T  L  P +        
Sbjct:   290 GSSSPRSNQYLPPANVSVNTEGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKH-------- 341

Query:   244 AAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLS 303
               GTP S  A+     + F+YEELS+ T+ F  S  +G+GGFG VY   L       +  
Sbjct:   342 GRGTPDS--AVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGIL-------FEG 392

Query:   304 RLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYI 362
             + + +  L      K +  +  REF AE+++++ VHH +LV L+GYC+ E   FL+YE++
Sbjct:   393 KPVAIKQL------KSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFV 446

Query:   363 ENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF 422
              N  L  HL G     L WS RV+IA+ +A+GL Y+HE   P  IHRDIKS+NIL+D  F
Sbjct:   447 PNNTLDYHLHGKNLPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEF 506

Query:   423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
              A+VADFGL +L +   + + TR++GTFGY+ PEYA  G ++ + DV++FGVVL ELI+ 
Sbjct:   507 EAQVADFGLARLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITG 566

Query:   483 KEAIVKGNGSSADSKGLVALFEEVLNLPDPIE--DLRKLVDPRLGDNCPLDSVLKMAQLA 540
             ++ +        +S  LV        L + IE  D+ ++VDPRL ++     V KM + A
Sbjct:   567 RKPVDTSQPLGEES--LVEWARP--RLIEAIEKGDISEVVDPRLENDYVESEVYKMIETA 622

Query:   541 KVCTQEYPQLRPSMRSIVVALMT---LSSTTEDWDVG 574
               C +     RP M  +V AL T   LS  T    VG
Sbjct:   623 ASCVRHSALKRPRMVQVVRALDTRDDLSDLTNGVKVG 659

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 571 (206.1 bits), Expect = 2.3e-55, P = 2.3e-55
 Identities = 143/386 (37%), Positives = 209/386 (54%)

Query:   183 RNV-GLSESLLQNYNPGVNFT-RGSGLVF----IPGRDANGVFPALESSSTGGLVFPAYK 236
             RN+   S+S    Y P  NF+ +  G ++      G    G + + + S++G   F + +
Sbjct:   262 RNIDAYSDS---QYLPPSNFSIKSDGFLYGQNPTKGYSGPGGYNSQQQSNSGNS-FGSQR 317

Query:   237 TVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGE 296
                    +   P S  A+       F+YEEL+  T+ FS  + +G+GGFG VY  +L   
Sbjct:   318 GGGGYTRSGSAPDS--AVMGSGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLND- 374

Query:   297 YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-L 355
                    +L+ V  L      K    Q  REF AE+++++ VHH +LV L+GYC+  S  
Sbjct:   375 ------GKLVAVKQL------KVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSER 422

Query:   356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN 415
              L+YEY+ N  L  HL G GR  L W+ RV+IA+ SA+GL Y+HE   P  IHRDIKSAN
Sbjct:   423 LLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSAN 482

Query:   416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVV 475
             IL+D  F A+VADFGL KL +     + TR++GTFGY+ PEYAQ G ++ + DV++FGVV
Sbjct:   483 ILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVV 542

Query:   476 LYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLK 535
             L ELI+ ++ + +      +S  LV     +L+      D  +LVD RL  +   + V +
Sbjct:   543 LLELITGRKPVDQYQPLGEES--LVEWARPLLHKAIETGDFSELVDRRLEKHYVENEVFR 600

Query:   536 MAQLAKVCTQEYPQLRPSMRSIVVAL 561
             M + A  C +     RP M  +V AL
Sbjct:   601 MIETAAACVRHSGPKRPRMVQVVRAL 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 568 (205.0 bits), Expect = 4.8e-55, P = 4.8e-55
 Identities = 134/334 (40%), Positives = 189/334 (56%)

Query:   240 STGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGN 299
             S  P    P+    +   KS  F+YEEL++AT+ FS ++ +GQGGFG V+   L      
Sbjct:   242 SDRPVLPPPSPGLVLGFSKST-FTYEELARATNGFSEANLLGQGGFGYVHKGVLPS---- 296

Query:   300 SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLV 358
                 + + V  L      K    Q  REF AE+++++ VHH +LV L+GYC+ G+   LV
Sbjct:   297 ---GKEVAVKQL------KVGSGQGEREFQAEVEIISRVHHRHLVSLVGYCIAGAKRLLV 347

Query:   359 YEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI 418
             YE++ N NL  HL G GR  + WS+R++IAL SA+GL Y+HE   P  IHRDIK++NILI
Sbjct:   348 YEFVPNNNLELHLHGEGRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILI 407

Query:   419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYE 478
             D  F AKVADFGL K+    +  + TR++GTFGY+ PEYA  G ++ K DV++FGVVL E
Sbjct:   408 DFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLE 467

Query:   479 LISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQ 538
             LI+ +  +   N    DS  LV     +LN      D   L D ++ +    + + +M  
Sbjct:   468 LITGRRPVDANNVYVDDS--LVDWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVA 525

Query:   539 LAKVCTQEYPQLRPSMRSIVVAL---MTLSSTTE 569
              A  C +   + RP M  IV AL   ++LS   E
Sbjct:   526 CAAACVRHSARRRPRMSQIVRALEGNVSLSDLNE 559

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
D7UPN3	CERK1_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.5191	0.8913	0.8677	yes	no
A8R7E6	CERK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.5759	0.9473	0.9043	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	589
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-57
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-56
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-54
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-52
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-51
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-36
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-35
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-32
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-31
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-30
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-30
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-29
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-29
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-28
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-28
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-27
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-27
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-26
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-26
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-26
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-25
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-25
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	5e-25
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-25
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-25
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-24
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-24
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-24
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-23
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-23
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-23
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-23
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-23
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-22
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-22
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-22
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-22
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-22
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-22
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-22
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-22
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	5e-22
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-21
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-21
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-21
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-21
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-21
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-20
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-20
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-20
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-20
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-20
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-20
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	8e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-19
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-19
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-19
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-19
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-19
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-19
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-19
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-18
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-18
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-18
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-18
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	7e-18
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-17
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-17
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-16
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-16
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-16
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-16
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-15
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-15
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	4e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	6e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-15
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	8e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-14
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-14
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-14
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-13
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-13
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	8e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-12
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-12
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-12
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	8e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-10
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-10
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-04
PRK10783	456	PRK10783, mltD, membrane-bound lytic murein transg	9e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.001
smart00257	44	smart00257, LysM, Lysin motif	0.002
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.002

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  191 bits (489), Expect = 4e-57
 Identities = 83/302 (27%), Positives = 136/302 (45%), Gaps = 61/302 (20%)

Query: 275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLA 330
           ++  K+G+G FG VY  +L+G+ G               + A+K +      Q   EFL 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKK-----------VEVAVKTLKEDASEQQIEEFLR 50

Query: 331 ELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E +++  + H N+V+L+G C E   L++V EY+E G+L  +LR + R  L  S  +  AL
Sbjct: 51  EARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFAL 109

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE------VGSASLP 443
             ARG+EY+       +IHRD+ + N L+ +N   K++DFGL++              LP
Sbjct: 110 QIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
            R      +M PE  + G  + K DV++FGV+L+E+ +                      
Sbjct: 167 IR------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT---------------------L 199

Query: 504 EEVLNLPDPIEDLRKLVD----PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
            E        E++ + +          NCP +    +  L   C  E P+ RP+   +V 
Sbjct: 200 GEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPE----LYDLMLQCWAEDPEDRPTFSELVE 255

Query: 560 AL 561
            L
Sbjct: 256 IL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  190 bits (486), Expect = 1e-56
 Identities = 80/302 (26%), Positives = 133/302 (44%), Gaps = 60/302 (19%)

Query: 275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLA 330
           ++  K+G+G FG VY   L+G+                 + A+K +      Q   EFL 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKE-----------VEVAVKTLKEDASEQQIEEFLR 50

Query: 331 ELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E +++  + H N+V+L+G C E   L +V EY+  G+L ++LR +    L  S  +  AL
Sbjct: 51  EARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFAL 110

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE------VGSASLP 443
             ARG+EY+       +IHRD+ + N L+ +N   K++DFGL++         V    LP
Sbjct: 111 QIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP 167

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
            R      +M PE  + G  + K DV++FGV+L+E+ +                      
Sbjct: 168 IR------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT---------------------L 200

Query: 504 EEVLNLPDPIEDLRKLVD----PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
            E         ++ + +          NCP +    + +L   C  E P+ RP+   +V 
Sbjct: 201 GEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPE----LYKLMLQCWAEDPEDRPTFSELVE 256

Query: 560 AL 561
            L
Sbjct: 257 IL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  183 bits (468), Expect = 6e-54
 Identities = 89/300 (29%), Positives = 144/300 (48%), Gaps = 54/300 (18%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFL 329
             +  K+G+G FG VY   L+G+   +             K A+K +   AS     EFL
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTE-----------TKVAVKTLKEGASEEEREEFL 49

Query: 330 AELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E  ++  + H N+VRL+G C +G  L++V EY+  G+L + LR    + L     +Q+A
Sbjct: 50  EEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMA 108

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV-------GSAS 441
           L  A+G+EY+       ++HRD+ + N L+ +N   K++DFGL++           G   
Sbjct: 109 LQIAKGMEYLESKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGK 165

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
           LP +      +M PE  + G  + K DV++FGV+L+E+ +         G      G+  
Sbjct: 166 LPIK------WMAPESLKDGKFTSKSDVWSFGVLLWEIFT--------LGEQ-PYPGMSN 210

Query: 502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
             EEVL L   +ED  +L  P   +NCP +    + +L   C    P+ RP+   +V  L
Sbjct: 211 --EEVLEL---LEDGYRLPRP---ENCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  180 bits (459), Expect = 1e-52
 Identities = 86/305 (28%), Positives = 144/305 (47%), Gaps = 67/305 (21%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKV 334
           K+G+G FG VY  +L+G+ G +               A+K +   AS    ++FL E +V
Sbjct: 2   KLGEGAFGEVYKGKLKGKDGKTTE------------VAVKTLKEDASEEERKDFLKEARV 49

Query: 335 LTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGS-------GRDPLPWSSRVQ 386
           +  + H N+VRL+G C E   L+LV EY+E G+L ++LR S        +  L     + 
Sbjct: 50  MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV-------GS 439
            A+  A+G+EY+        +HRD+ + N L+ ++   K++DFGL++             
Sbjct: 110 FAIQIAKGMEYLASKKF---VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTG 166

Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
             LP R      +M PE  + G  + K DV++FGV+L+E+ +         G++      
Sbjct: 167 GKLPIR------WMAPESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATP----- 207

Query: 500 VALFEEVLNLPDPIEDLRK---LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
              +  + N  + +E LRK   L  P   + CP +    + +L   C Q  P+ RP+   
Sbjct: 208 ---YPGLSNE-EVLEYLRKGYRLPKP---EYCPDE----LYELMLSCWQLDPEDRPTFSE 256

Query: 557 IVVAL 561
           +V  L
Sbjct: 257 LVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  175 bits (446), Expect = 2e-51
 Identities = 78/216 (36%), Positives = 109/216 (50%), Gaps = 27/216 (12%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVL 335
           +G+GGFG VY          +            +K AIK +          E L E+++L
Sbjct: 1   LGEGGFGTVY----LARDKKT-----------GKKVAIKIIKKEDSSSLLEELLREIEIL 45

Query: 336 THVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
             ++H N+V+L G    E  L+LV EY E G+L + L+      L     ++I L    G
Sbjct: 46  KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEG 104

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDK-NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYM 453
           LEY+H + +   IHRD+K  NIL+D  N   K+ADFGL+KL      SL   +VGT  YM
Sbjct: 105 LEYLHSNGI---IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYM 160

Query: 454 PPE-YAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
            PE     G  S K D+++ GV+LYEL   K+ I K
Sbjct: 161 APEVLLGKGYYSEKSDIWSLGVILYELPELKDLIRK 196

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  167 bits (426), Expect = 7e-48
 Identities = 97/289 (33%), Positives = 142/289 (49%), Gaps = 48/289 (16%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-----DMQASREFLAELK 333
           K+G G FG VY A+ +G                 +  A+K +       +  +    E++
Sbjct: 6   KLGSGSFGTVYKAKHKGTG---------------KIVAVKILKKRSEKSKKDQTARREIR 50

Query: 334 VLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
           +L  + H N+VRLI    +   L+LV EY E G+L ++L   G  PL      +IAL   
Sbjct: 51  ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQIL 108

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           RGLEY+H + +   IHRD+K  NIL+D+N   K+ADFGL K     S+SL T  VGT  Y
Sbjct: 109 RGLEYLHSNGI---IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF-VGTPWY 164

Query: 453 MPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD 511
           M PE    G    PKVDV++ GV+LYEL++ K                   F    N+ D
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGK-----------------PPFSG-ENILD 206

Query: 512 PIEDLRKLVDPRLGDNCP-LDSVLKMAQ-LAKVCTQEYPQLRPSMRSIV 558
            ++ +R+++ P L  + P   S  + A+ L K C  + P  RP+   I+
Sbjct: 207 QLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (422), Expect = 2e-47
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 27/213 (12%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE----FL 329
           + +  K+G+G FG VY A  +                  +  AIK +  +  ++     L
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTG---------------KLVAIKVIKKKKIKKDRERIL 45

Query: 330 AELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+K+L  + H N+VRL      E  L+LV EY E G+L + L+  GR     +      
Sbjct: 46  REIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YL 103

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
                 LEY+H   +   +HRD+K  NIL+D++ H K+ADFGL +  ++      T  VG
Sbjct: 104 RQILSALEYLHSKGI---VHRDLKPENILLDEDGHVKLADFGLAR--QLDPGEKLTTFVG 158

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           T  YM PE          VD+++ GV+LYEL++
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT 191

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  138 bits (349), Expect = 4e-37
 Identities = 72/207 (34%), Positives = 114/207 (55%), Gaps = 31/207 (14%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFLAELKVLTH 337
           IG+G FG V   + RG                 QK A+K +  D  A++ FLAE  V+T 
Sbjct: 14  IGKGEFGDVMLGDYRG-----------------QKVAVKCLKDDSTAAQAFLAEASVMTT 56

Query: 338 VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
           + H NLV+L+G  ++G+ L++V EY+  G+L ++LR  GR  +  + ++  ALD   G+E
Sbjct: 57  LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG--SASLPTRLVGTFGYMP 454
           Y+ E      +HRD+ + N+L+ ++  AKV+DFGL K    G  S  LP +      +  
Sbjct: 117 YLEEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK------WTA 167

Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELIS 481
           PE  +    S K DV++FG++L+E+ S
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (342), Expect = 5e-36
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 33/222 (14%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-----ASRE 327
            ++    +G+G FG+VY A  +   G              +  A+K +++          
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKD-TG--------------ELMAVKSVELSGDSEEELEA 45

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
              E+++L+ + H N+VR  G   +    +L +  EY+  G+LS  L+  G+ P P   +
Sbjct: 46  LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK 105

Query: 385 V--QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
              QI      GL Y+H + +   +HRDIK ANIL+D +   K+ADFG  K         
Sbjct: 106 YTRQIL----EGLAYLHSNGI---VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE 158

Query: 443 PTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            T  + GT  +M PE  +  +     D+++ G  + E+ + K
Sbjct: 159 GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  134 bits (339), Expect = 1e-35
 Identities = 83/297 (27%), Positives = 129/297 (43%), Gaps = 69/297 (23%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----QASREF-LAELK 333
           +IG+G FG VY    R   G  Y               +K++D+    +  RE  L E+K
Sbjct: 7   QIGKGSFGKVYLVR-RKSDGKLY--------------VLKEIDLSNMSEKEREDALNEVK 51

Query: 334 VLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHL--RGSGRDPLP----WSSRVQ 386
           +L  ++H N+++      E G L +V EY + G+LS+ +  +     P P        VQ
Sbjct: 52  ILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           + L     L+Y+H   +   +HRDIK  NI +  N   K+ DFG++K+         T +
Sbjct: 112 LCL----ALKYLHSRKI---LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-V 163

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV 506
           VGT  Y+ PE  Q    + K D+++ G VLYEL + K           + + L+ L  ++
Sbjct: 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF--------EGENLLELALKI 215

Query: 507 LNL-PDPI-----EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           L     PI      +LR LV               +  L K      P+ RPS+  I
Sbjct: 216 LKGQYPPIPSQYSSELRNLVS-------------SL--LQKD-----PEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  131 bits (333), Expect = 7e-35
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK-AAIKKMD---MQASREFL 329
           F +  KIG+GGFG VY A                 +    K  AIK +     +   + +
Sbjct: 2   FEILEKIGKGGFGEVYKAR----------------HKRTGKEVAIKVIKLESKEKKEKII 45

Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++L    H N+V+  G Y  +  L++V E+   G+L + L+ + +  L  S   QIA
Sbjct: 46  NEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ-TLTES---QIA 101

Query: 389 ---LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
               +  +GLEY+H + +   IHRDIK+ANIL+  +   K+ DFGL+   ++        
Sbjct: 102 YVCKELLKGLEYLHSNGI---IHRDIKAANILLTSDGEVKLIDFGLS--AQLSDTKARNT 156

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           +VGT  +M PE         K D+++ G+   EL 
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELA 191

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  128 bits (324), Expect = 9e-34
 Identities = 75/212 (35%), Positives = 117/212 (55%), Gaps = 31/212 (14%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFLAE 331
            ++   IG+G FGAV    L+GEY               QK A+K  K D+ A + FL E
Sbjct: 8   LTLGEIIGEGEFGAV----LQGEY-------------TGQKVAVKNIKCDVTA-QAFLEE 49

Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
             V+T +HH NLVRL+G  +   L++V E +  GNL   LR  GR  +     +Q +LD 
Sbjct: 50  TAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV 109

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG--SASLPTRLVGT 449
           A G+EY+    +   +HRD+ + NIL+ ++  AKV+DFGL ++  +G  ++ LP +    
Sbjct: 110 AEGMEYLESKKL---VHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK---- 162

Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             +  PE  ++   S K DV+++GV+L+E+ S
Sbjct: 163 --WTAPEALKHKKFSSKSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  126 bits (319), Expect = 1e-32
 Identities = 81/290 (27%), Positives = 126/290 (43%), Gaps = 51/290 (17%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            + +    KIG+G  G VY A  R                  ++ AIKKM ++   + L 
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATG---------------KEVAIKKMRLRKQNKELI 62

Query: 331 --ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
             E+ ++    H N+V     Y V   L++V EY++ G+L++ +  +    +      QI
Sbjct: 63  INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-FVRMNEP---QI 118

Query: 388 A---LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLP 443
           A    +  +GLEY+H   V   IHRDIKS NIL+ K+   K+ADFG   +LT+    S  
Sbjct: 119 AYVCREVLQGLEYLHSQNV---IHRDIKSDNILLSKDGSVKLADFGFAAQLTK--EKSKR 173

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
             +VGT  +M PE  +  D  PKVD+++ G++  E+        +G         L ALF
Sbjct: 174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA-------EGEPPYLREPPLRALF 226

Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
                   P+++  K                K       C  + P+ RPS
Sbjct: 227 LITTKGIPPLKNPEK-----------WSPEFK--DFLNKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  124 bits (312), Expect = 4e-32
 Identities = 85/297 (28%), Positives = 133/297 (44%), Gaps = 50/297 (16%)

Query: 275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV 334
           +M HK+G G +G VY    + +Y  +     + V  L       K D     EFL E  V
Sbjct: 9   TMKHKLGGGQYGEVYEGVWK-KYSLT-----VAVKTL-------KEDTMEVEEFLKEAAV 55

Query: 335 LTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
           +  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +     + +A   + 
Sbjct: 56  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISS 115

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLPTRLV 447
            +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T    A  P +  
Sbjct: 116 AMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-- 170

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
               +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D   +  L E+  
Sbjct: 171 ----WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQVYELLEKGY 222

Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            +  P             + CP     K+ +L + C Q  P  RPS   I  A  T+
Sbjct: 223 RMERP-------------EGCP----PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 2e-31
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V     +   G  Y  ++      ++K  I K         L E  +L+ ++
Sbjct: 1   LGKGSFGKVLLVRKKDT-GKLYAMKV------LKKKKIIKRKEVEH--TLTERNILSRIN 51

Query: 340 HLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR--VQIALDSARG 394
           H  +V+L  +     E  L+LV EY   G L  HL   GR     +     +I L     
Sbjct: 52  HPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVL----A 105

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           LEY+H   +   I+RD+K  NIL+D + H K+ DFGL K      +   T   GT  Y+ 
Sbjct: 106 LEYLHSLGI---IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLA 161

Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELIS 481
           PE          VD ++ GV+LYE+++
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  122 bits (307), Expect = 4e-31
 Identities = 71/234 (30%), Positives = 116/234 (49%), Gaps = 43/234 (18%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELR-GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D   +  ++G+G FG V+  E    E  N     L+ V  L + A        A ++F  
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKE--LVAVKTLKETA-----SNDARKDFER 57

Query: 331 ELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRD------------ 377
           E ++LT+  H N+V+  G C EG    +V+EY+E+G+L++ LR  G D            
Sbjct: 58  EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117

Query: 378 PLPWSSRVQIALDSARGLEYI-HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE 436
            L  S  +QIA+  A G+ Y+  +H    ++HRD+ + N L+  +   K+ DFG+++  +
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQH----FVHRDLATRNCLVGYDLVVKIGDFGMSR--D 171

Query: 437 V---------GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           V         G   LP R      +MPPE   Y   + + DV++FGVVL+E+ +
Sbjct: 172 VYTTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 4e-31
 Identities = 71/230 (30%), Positives = 112/230 (48%), Gaps = 44/230 (19%)

Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-----FLAEL 332
            +IG+G +G VY A    + G              +  A+KK+ M+  +E      + E+
Sbjct: 5   AQIGEGTYGQVYKAR-NKKTG--------------ELVALKKIRMENEKEGFPITAIREI 49

Query: 333 KVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-- 387
           K+L  + H N+VRL         GS+++V+EY+++      L G    P    +  QI  
Sbjct: 50  KLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-----DLTGLLDSPEVKFTESQIKC 104

Query: 388 -ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTR 445
                  GL+Y+H + +   +HRDIK +NILI+ +   K+ADFGL    T+  SA   T 
Sbjct: 105 YMKQLLEGLQYLHSNGI---LHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY-TN 160

Query: 446 LVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG 491
            V T  Y PPE      +YG   P+VD+++ G +L EL    + I +G+ 
Sbjct: 161 RVITLWYRPPELLLGATRYG---PEVDMWSVGCILAELFL-GKPIFQGST 206

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 4e-30
 Identities = 70/220 (31%), Positives = 109/220 (49%), Gaps = 33/220 (15%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-----DMQASRE 327
           N+ +   IG+G FG VY   L  E G                 AIK++       +A + 
Sbjct: 1   NYQLGDLIGRGAFGVVYKG-LNLETG--------------DFVAIKQISLEKIKEEALKS 45

Query: 328 FLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-- 384
            + E+ +L ++ H N+V+ IG      SL+++ EY ENG+L + ++  G  P    +   
Sbjct: 46  IMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV 105

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLP 443
            Q+     +GL Y+HE  V   IHRDIK+ANIL  K+   K+ADFG+ TKL +V      
Sbjct: 106 YQVL----QGLAYLHEQGV---IHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDD 156

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             +VGT  +M PE  +    S   D+++ G  + EL++  
Sbjct: 157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (302), Expect = 7e-30
 Identities = 90/298 (30%), Positives = 133/298 (44%), Gaps = 49/298 (16%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM------DMQASREFLAEL 332
           K+G+G FG VY A  R                     A+K +        +    FL E+
Sbjct: 7   KLGEGSFGEVYLARDRKLV------------------ALKVLAKKLESKSKEVERFLREI 48

Query: 333 KVLTHV-HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIAL 389
           ++L  + H  N+V+L  +   EGSL+LV EY++ G+L + L+  GR  PL  S  + I  
Sbjct: 49  QILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHAKVADFGLTKL-----TEVGSASLP 443
                LEY+H   +   IHRDIK  NIL+D++    K+ DFGL KL     +     +LP
Sbjct: 109 QILSALEYLHSKGI---IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165

Query: 444 TRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
           +  VGT GYM PE          S   D+++ G+ LYEL++          SSA S+   
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ--- 222

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
              + +L LP P       +   L  + P       + L K    + P+ R S  S +
Sbjct: 223 -TLKIILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  118 bits (296), Expect = 8e-30
 Identities = 81/299 (27%), Positives = 136/299 (45%), Gaps = 59/299 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---F 328
           +   +  K+G G FG V+     G Y                K AIK +  Q S     F
Sbjct: 6   ETLKLVKKLGAGQFGEVWM----GYYNGH------------TKVAIKSLK-QGSMSPEAF 48

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           LAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +  + +A
Sbjct: 49  LAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA 108

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS------ASL 442
              A G+ +I       YIHRD+++ANIL+ +    K+ADFGL +L E         A  
Sbjct: 109 AQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF 165

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
           P +      +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 166 PIK------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG------------- 206

Query: 503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---MRSIV 558
               +  P+ I++L +       DNCP +    + +L ++C +E P+ RP+   +RS++
Sbjct: 207 ----MTNPEVIQNLERGYRMPRPDNCPEE----LYELMRLCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  116 bits (291), Expect = 3e-29
 Identities = 71/216 (32%), Positives = 112/216 (51%), Gaps = 35/216 (16%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-FLAE 331
              +   IG+G FG V   + RG                  K A+K +   A+ + FLAE
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRG-----------------NKVAVKCIKNDATAQAFLAE 49

Query: 332 LKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
             V+T + H NLV+L+G  VE  G L++V EY+  G+L ++LR  GR  L     ++ +L
Sbjct: 50  ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL 109

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS----ASLPTR 445
           D    +EY+  +    ++HRD+ + N+L+ ++  AKV+DFGLTK  E  S      LP +
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVK 164

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                 +  PE  +    S K DV++FG++L+E+ S
Sbjct: 165 ------WTAPEALREKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 5e-29
 Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 42/221 (19%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK-----KMDMQASREF 328
             +  K+G G FG V+     G +  +             K A+K      M  +A   F
Sbjct: 8   LKLERKLGAGQFGEVWM----GTWNGT------------TKVAVKTLKPGTMSPEA---F 48

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR-GSGRDPLPWSSRVQ 386
           L E +++  + H  LV+L   C E   +++V EY+  G+L + L+ G G+  L     V 
Sbjct: 49  LQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVD 107

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG------SA 440
           +A   A G+ Y+       YIHRD+ + NIL+ +N   K+ADFGL +L E         A
Sbjct: 108 MAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             P +      +  PE A YG  + K DV++FG++L E+++
Sbjct: 165 KFPIK------WTAPEAANYGRFTIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  116 bits (291), Expect = 6e-29
 Identities = 85/325 (26%), Positives = 139/325 (42%), Gaps = 68/325 (20%)

Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           E+  +   F    ++G+G FG VY  EL G       +  + +  L + A  K       
Sbjct: 1   EIPLSAVRFL--EELGEGAFGKVYKGELTGPN-ERLSATSVAIKTLKENAEPKVQQ---- 53

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHL------------- 371
            EF  E ++++ + H N+V L+G C  E    +++EY+ +G+L E L             
Sbjct: 54  -EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112

Query: 372 -RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
              + +  L  S  + IA+  A G+EY+  H    ++HRD+ + N L+ +    K++DFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFG 169

Query: 431 LTKLT-------EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           L++             + LP R      +MPPE   YG  + + D+++FGVVL+E+ S  
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVR------WMPPEAILYGKFTTESDIWSFGVVLWEIFSY- 222

Query: 484 EAIVKGNGSSADSKGLVALF----EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQL 539
                         GL   +    +EV      IE +R     R    CP D   ++  L
Sbjct: 223 --------------GLQPYYGFSNQEV------IEMIRS----RQLLPCPEDCPARVYAL 258

Query: 540 AKVCTQEYPQLRPSMRSIVVALMTL 564
              C  E P  RP  + I   L + 
Sbjct: 259 MIECWNEIPARRPRFKDIHTRLRSW 283

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  115 bits (289), Expect = 1e-28
 Identities = 94/333 (28%), Positives = 147/333 (44%), Gaps = 94/333 (28%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +N      IGQG FG V+ A   G       + ++ V +L ++A+    DMQA  +F  E
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFT-MVAVKMLKEEAS---ADMQA--DFQRE 58

Query: 332 LKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR------------------ 372
             ++    H N+V+L+G C  G  + L++EY+  G+L+E LR                  
Sbjct: 59  AALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 373 --GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
             G    PL  + ++ IA   A G+ Y+ E     ++HRD+ + N L+ +N   K+ADFG
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFG 175

Query: 431 LT---------KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           L+         K +E  + ++P R      +MPPE   Y   + + DV+A+GVVL+E+ S
Sbjct: 176 LSRNIYSADYYKASE--NDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Query: 482 ---------AKEAIVK----GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNC 528
                    A E ++     GN               VL+ P               DNC
Sbjct: 228 YGMQPYYGMAHEEVIYYVRDGN---------------VLSCP---------------DNC 257

Query: 529 PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           PL+    +  L ++C  + P  RPS  SI   L
Sbjct: 258 PLE----LYNLMRLCWSKLPSDRPSFASINRIL 286

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 8e-28
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 35/211 (16%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--FLAELKVLTH 337
           +G G FG V+  + RG+                   AIK +   A  E  F+ E KV+  
Sbjct: 12  LGSGQFGVVHLGKWRGKI----------------DVAIKMIREGAMSEDDFIEEAKVMMK 55

Query: 338 VHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
           + H NLV+L G C +   +F+V EY+ NG L  +LR   +  L     + +  D    +E
Sbjct: 56  LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDVCEAME 114

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLPTRLVGTF 450
           Y+  +    +IHRD+ + N L+ ++   KV+DFGL +       T       P +     
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK----- 166

Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            + PPE   Y   S K DV++FGV+++E+ S
Sbjct: 167 -WAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  111 bits (280), Expect = 1e-27
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 23/216 (10%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           +F + +KIG+G FG V+   +R      Y          M++  + KM+ +   E + E 
Sbjct: 1   DFEILNKIGKGSFGVVFKV-VRKADKRVYA---------MKQIDLSKMNRREREEAIDEA 50

Query: 333 KVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLP----WSSRVQI 387
           +VL  +    ++R     ++ G L +V EY ENG+L + L+     PLP    W   +QI
Sbjct: 51  RVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQI 110

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
            L    GL ++H   +   +HRDIKS N+ +D   + K+ D G+ KL    + +    +V
Sbjct: 111 LL----GLAHLHSKKI---LHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIV 162

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           GT  Y+ PE  +    + K DV+A GVVLYE  + K
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  111 bits (278), Expect = 2e-27
 Identities = 71/211 (33%), Positives = 108/211 (51%), Gaps = 33/211 (15%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V Y + RG+Y          V + M    IK+  M +  EF+ E KV+  +
Sbjct: 11  ELGTGQFGVVKYGKWRGQYD---------VAIKM----IKEGSM-SEDEFIEEAKVMMKL 56

Query: 339 HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV+L G C  +  +++V EY+ NG L  +LR  G+   P S  +++  D   G+ Y
Sbjct: 57  SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP-SQLLEMCKDVCEGMAY 115

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-------LTEVGSASLPTRLVGTF 450
           +       +IHRD+ + N L+D     KV+DFGL++        + VGS   P R     
Sbjct: 116 LESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS-KFPVR----- 166

Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            + PPE   Y   S K DV+AFGV+++E+ S
Sbjct: 167 -WSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  110 bits (278), Expect = 3e-27
 Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 33/297 (11%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASRE 327
            +     ++G+G FG V          N+             + A+K      + Q   +
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGE-----------QVAVKSLNHSGEEQHRSD 52

Query: 328 FLAELKVLTHVHHLNLVRLIGYC---VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
           F  E+++L  + H N+V+  G C      SL L+ EY+ +G+L ++L+   RD +     
Sbjct: 53  FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRL 111

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
           +  +    +G++Y+       YIHRD+ + NIL++     K++DFGL K+          
Sbjct: 112 LLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV 168

Query: 445 RLVG---TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
           +  G    F Y P         S   DV++FGV LYEL +  +             G+  
Sbjct: 169 KEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQ 227

Query: 502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
               V  L + +++  +L  P    +CP D V     L K+C +  PQ RPS   ++
Sbjct: 228 GQMIVTRLLELLKEGERLPRP---PSCP-DEVY---DLMKLCWEAEPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 8e-27
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 28/210 (13%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQAS--REFLAELKV 334
           KIG+G FG VY   L+G                  + A+K  +  +     R+FL E ++
Sbjct: 2   KIGKGNFGDVYKGVLKGN----------------TEVAVKTCRSTLPPDLKRKFLQEAEI 45

Query: 335 LTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
           L    H N+V+LIG CV+   +++V E +  G+L   LR    + L     +Q++LD+A 
Sbjct: 46  LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAA 104

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG--SASLPTRLVGTFG 451
           G+EY+        IHRD+ + N L+ +N   K++DFG+++  E G  + S   + +    
Sbjct: 105 GMEYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI-PIK 160

Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           +  PE   YG  + + DV+++G++L+E  S
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  109 bits (274), Expect = 9e-27
 Identities = 81/297 (27%), Positives = 132/297 (44%), Gaps = 51/297 (17%)

Query: 280 IGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           +G+G FG V+ A+ +G E             L++ KA  K  D     EF  EL +   +
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGET-------LVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 339 HHLNLVRLIGYCVEGSLF-LVYEYIENGNLSEHLRGS-GRD------PLPWSSRVQIALD 390
            H N+VRL+G C E     ++ EY + G+L + LR +  +D      PL    +V +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT------EVGSASLPT 444
            A G++++       ++HRD+ + N L+      KV+   L+K        ++ +A +P 
Sbjct: 126 IALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           R      ++ PE  Q  D S K DV++FGV+++E+ +  E    G    +D + L  L  
Sbjct: 183 R------WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG---LSDEEVLNRLQA 233

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
             L LP P             + CP   + K+      C    P+ RPS   +V AL
Sbjct: 234 GKLELPVP-------------EGCP-SRLYKLMT---RCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 9e-27
 Identities = 85/310 (27%), Positives = 141/310 (45%), Gaps = 60/310 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           +  ++  ++GQG FG VY    +G       +R+          AIK ++  AS     E
Sbjct: 6   EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRV----------AIKTVNENASMRERIE 55

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG--------SGRDP 378
           FL E  V+   +  ++VRL+G    G    +V E +  G+L  +LR          G  P
Sbjct: 56  FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT--- 435
                 +Q+A + A G+ Y+       ++HRD+ + N ++ ++   K+ DFG+T+     
Sbjct: 116 PTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET 172

Query: 436 ----EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG 491
               + G   LP R      +M PE  + G  + K DV++FGVVL+E+ +  E   +G  
Sbjct: 173 DYYRKGGKGLLPVR------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226

Query: 492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR 551
           +           EEVL     + D   L  P   +NCP     K+ +L ++C Q  P++R
Sbjct: 227 N-----------EEVLKF---VIDGGHLDLP---ENCP----DKLLELMRMCWQYNPKMR 265

Query: 552 PSMRSIVVAL 561
           P+   IV +L
Sbjct: 266 PTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  109 bits (274), Expect = 1e-26
 Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 43/237 (18%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F     IG+G F  V  A+ + E    Y  +++    L+++   KK+      E    
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEK-ETNKEYAIKILDKRQLIKE---KKVK-YVKIE---- 51

Query: 332 LKVLTHV-HHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV-- 385
            +VLT +  H  +++L  Y     E +L+ V EY  NG L +++R  G      +     
Sbjct: 52  KEVLTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA 109

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG--------------- 430
           +I L     LEY+H   +   IHRD+K  NIL+DK+ H K+ DFG               
Sbjct: 110 EILL----ALEYLHSKGI---IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNK 162

Query: 431 -LTKLTEVGSASLPTR---LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
                 +        R    VGT  Y+ PE           D++A G ++Y++++ K
Sbjct: 163 GDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  107 bits (268), Expect = 5e-26
 Identities = 66/217 (30%), Positives = 110/217 (50%), Gaps = 34/217 (15%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREFLA 330
           F++  K+G G FG V+     G + N              + AIK +   D+   ++F  
Sbjct: 8   FTLERKLGSGYFGEVW----EGLWKNR------------VRVAIKILKSDDLLKQQDFQK 51

Query: 331 ELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E++ L  + H +L+ L   C  G  ++++ E +E G+L   LR      LP +S + +A 
Sbjct: 52  EVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMAC 111

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE--VGSAS---LPT 444
             A G+ Y+ E      IHRD+ + NIL+ ++   KVADFGL +L +  V  +S   +P 
Sbjct: 112 QVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY 168

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           +      +  PE A +G  S K DV++FG++LYE+ +
Sbjct: 169 K------WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  107 bits (269), Expect = 6e-26
 Identities = 98/323 (30%), Positives = 149/323 (46%), Gaps = 67/323 (20%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKVL 335
           IG+G FG V  A ++ +              L   AAIK+M   AS    R+F  EL+VL
Sbjct: 15  IGEGNFGQVLKARIKKDG-------------LRMDAAIKRMKEYASKDDHRDFAGELEVL 61

Query: 336 THV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGS---GRDP-----------L 379
             + HH N++ L+G C   G L+L  EY  +GNL + LR S     DP           L
Sbjct: 62  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV-- 437
                +  A D ARG++Y+ +     +IHRD+ + NIL+ +N+ AK+ADFGL++  EV  
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178

Query: 438 --GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
                 LP R      +M  E   Y   +   DV+++GV+L+E++S         G+   
Sbjct: 179 KKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-------GGTPYC 225

Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
                 L+E+   LP     L K          PL+   ++  L + C +E P  RPS  
Sbjct: 226 GMTCAELYEK---LPQGYR-LEK----------PLNCDDEVYDLMRQCWREKPYERPSFA 271

Query: 556 SIVVALMTLSSTTEDWDVGSFYE 578
            I+V+L  +    + +   + YE
Sbjct: 272 QILVSLNRMLEERKTYVNTTLYE 294

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score =  107 bits (267), Expect = 8e-26
 Identities = 86/312 (27%), Positives = 147/312 (47%), Gaps = 60/312 (19%)

Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--- 326
           A +  +MS ++GQG FG VY    +G   +   +R+          AIK ++  AS    
Sbjct: 4   AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRV----------AIKTVNEAASMRER 53

Query: 327 -EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV-YEYIENGNLSEHLRG--------SGR 376
            EFL E  V+   +  ++VRL+G   +G   LV  E +  G+L  +LR           +
Sbjct: 54  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQ 113

Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK--- 433
            P      +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+   
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 170

Query: 434 ----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
                 + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +G
Sbjct: 171 ETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224

Query: 490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQ 549
             +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P+
Sbjct: 225 MSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNPK 263

Query: 550 LRPSMRSIVVAL 561
           +RPS   I+ ++
Sbjct: 264 MRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 8e-26
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 36/215 (16%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG VY      E     +   I       K   ++   +A++E L E  V+  V 
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAI-------KVLREETSPKANKEILDEAYVMASVD 67

Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLR------GSGRDPLPWSSRVQIALDSAR 393
           H ++VRL+G C+   + L+ + +  G L +++R      GS +  L W   VQI    A+
Sbjct: 68  HPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNWC--VQI----AK 120

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS-------ASLPTRL 446
           G+ Y+ E  +   +HRD+ + N+L+    H K+ DFGL KL +V           +P + 
Sbjct: 121 GMSYLEEKRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK- 176

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                +M  E   +   + K DV+++GV ++EL++
Sbjct: 177 -----WMALESILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  104 bits (261), Expect = 5e-25
 Identities = 79/271 (29%), Positives = 119/271 (43%), Gaps = 45/271 (16%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF---LAELKVLT 336
           I +G +G V+ A+ +   G+ Y  +            IKK DM    +    L E  +L+
Sbjct: 1   ISKGAYGRVFLAK-KKSTGDIYAIK-----------VIKKADMIRKNQVDQVLTERDILS 48

Query: 337 HVHHLNLVRLIGYCVEG--SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
                 +V+L  Y  +G  +L+LV EY+  G+L+  L   G   L          +    
Sbjct: 49  QAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGS--LDEDVARIYIAEIVLA 105

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-------TRLV 447
           LEY+H + +   IHRD+K  NILID N H K+ DFGL+K+  V              R+V
Sbjct: 106 LEYLHSNGI---IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS------KGLVA 501
           GT  Y+ PE       S  VD ++ G +LYE +     I   +G + +        G + 
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV---GIPPFHGETPEEIFQNILNGKIE 219

Query: 502 LFEEVLNLPDPIEDL-RKLVDP----RLGDN 527
            + E + + D   DL  KL+ P    RLG  
Sbjct: 220 -WPEDVEVSDEAIDLISKLLVPDPEKRLGAK 249

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 5e-25
 Identities = 83/292 (28%), Positives = 132/292 (45%), Gaps = 51/292 (17%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKVL 335
           IG G FG V    L+   G   +             AIK +   +S     +FL E  ++
Sbjct: 12  IGGGEFGEVCRGRLK-LPGKKEI-----------DVAIKTLKAGSSDKQRLDFLTEASIM 59

Query: 336 THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
               H N++RL G   +   + ++ EY+ENG+L + LR            V +    A G
Sbjct: 60  GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLVGMLRGIASG 118

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           ++Y+ E     Y+HRD+ + NIL++ N   KV+DFGL++  E   A+  T+  G  G +P
Sbjct: 119 MKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--G--GKIP 171

Query: 455 -----PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
                PE   Y   +   DV++FG+V++E++S  E     + S+          ++V+  
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY-WDMSN----------QDVI-- 218

Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
              +ED  +L  P    +CP  S L   QL   C Q+    RP+   IV  L
Sbjct: 219 -KAVEDGYRLPPPM---DCP--SALY--QLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  104 bits (263), Expect = 5e-25
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 29/207 (14%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG V     +G       S       ++ KA I K+  Q     L E ++L  + 
Sbjct: 9   LGTGSFGRVMLVRHKG-------SGKYYALKILSKAKIVKLK-QVE-HVLNEKRILQSIR 59

Query: 340 HLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS--RVQIALDSARGLE 396
           H  LV L G +  + +L+LV EY+  G L  HLR SGR P P +     Q+ L     LE
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL----ALE 115

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR---LVGTFGYM 453
           Y+H       ++RD+K  N+L+D + + K+ DFG  K        +  R   L GT  Y+
Sbjct: 116 YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKR-------VKGRTYTLCGTPEYL 165

Query: 454 PPEYAQYGDVSPKVDVYAFGVVLYELI 480
            PE          VD +A G+++YE++
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  104 bits (261), Expect = 6e-25
 Identities = 85/309 (27%), Positives = 137/309 (44%), Gaps = 76/309 (24%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK-------AAIKKMDMQASREFLAE 331
           ++G+G FG V+ AE              C NLL ++        A+K+    A ++F  E
Sbjct: 12  ELGEGAFGKVFLAE--------------CHNLLPEQDKMLVAVKALKEASESARQDFQRE 57

Query: 332 LKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------------- 377
            ++LT + H ++VR  G C EG  L +V+EY+ +G+L+  LR  G D             
Sbjct: 58  AELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG 117

Query: 378 PLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGL----- 431
            L     + IA   A G+ Y+   H    ++HRD+ + N L+ +    K+ DFG+     
Sbjct: 118 QLTLGQMLAIASQIASGMVYLASLH----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173

Query: 432 -TKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVK 488
            T    VG  + LP R      +MPPE   Y   + + D+++FGVVL+E+ +  K+   +
Sbjct: 174 STDYYRVGGRTMLPIR------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227

Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
            + + A                + I   R+L  PR    CP +    M    + C Q  P
Sbjct: 228 LSNTEA---------------IECITQGRELERPR---TCPPEVYAIM----QGCWQREP 265

Query: 549 QLRPSMRSI 557
           Q R  ++ I
Sbjct: 266 QQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score =  104 bits (261), Expect = 6e-25
 Identities = 88/323 (27%), Positives = 146/323 (45%), Gaps = 72/323 (22%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL-------LMQKAAIKKMDMQAS 325
           N  +  ++G+G FG V+ AE              C NL       L+    +K     A 
Sbjct: 6   NIVLKRELGEGAFGKVFLAE--------------CYNLCPEQDKILVAVKTLKDASDNAR 51

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDP------ 378
           ++F  E ++LT++ H ++V+  G CVEG  L +V+EY+++G+L++ LR  G D       
Sbjct: 52  KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 111

Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-- 431
                L  S  + IA   A G+ Y+       ++HRD+ + N L+ +N   K+ DFG+  
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSR 168

Query: 432 ----TKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEA 485
               T    VG  + LP R      +MPPE   Y   + + DV++ GVVL+E+ +  K+ 
Sbjct: 169 DVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
             + + +            EV+   + I   R L  PR    CP +    +  L   C Q
Sbjct: 223 WYQLSNN------------EVI---ECITQGRVLQRPR---TCPKE----VYDLMLGCWQ 260

Query: 546 EYPQLRPSMRSIVVALMTLSSTT 568
             P +R +++ I   L  L+  +
Sbjct: 261 REPHMRLNIKEIHSLLQNLAKAS 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  104 bits (261), Expect = 8e-25
 Identities = 97/324 (29%), Positives = 147/324 (45%), Gaps = 67/324 (20%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKVL 335
           IG+G FG V  A ++ + G                AAIK +   AS    R+F  EL+VL
Sbjct: 10  IGEGNFGQVIRAMIKKD-GLK------------MNAAIKMLKEFASENDHRDFAGELEVL 56

Query: 336 THV-HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGS---GRDP-----------L 379
             + HH N++ L+G C   G L++  EY   GNL + LR S     DP           L
Sbjct: 57  CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV-- 437
                +Q A D A G++Y+ E     +IHRD+ + N+L+ +N  +K+ADFGL++  EV  
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV 173

Query: 438 --GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
                 LP R      +M  E   Y   + K DV++FGV+L+E++S         G+   
Sbjct: 174 KKTMGRLPVR------WMAIESLNYSVYTTKSDVWSFGVLLWEIVSL-------GGTPYC 220

Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
                 L+E+   LP       ++  PR   NC  D V    +L + C ++ P  RP   
Sbjct: 221 GMTCAELYEK---LPQGY----RMEKPR---NCD-DEVY---ELMRQCWRDRPYERPPFA 266

Query: 556 SIVVALMTLSSTTEDWDVGSFYEN 579
            I V L  +    + +   + +EN
Sbjct: 267 QISVQLSRMLEARKAYVNMALFEN 290

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  102 bits (257), Expect = 2e-24
 Identities = 69/249 (27%), Positives = 106/249 (42%), Gaps = 36/249 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASRE 327
            +      +GQG  G VY    +   G  Y              A+KK     D +  ++
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKP-TGKIY--------------ALKKIHVDGDEEFRKQ 45

Query: 328 FLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV- 385
            L ELK L       +V+  G +  EG + +V EY++ G+L++ L+  G         V 
Sbjct: 46  LLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG----KIPEPVL 101

Query: 386 -QIALDSARGLEYIH-EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
             IA    +GL+Y+H +  +   IHRDIK +N+LI+     K+ADFG++K+ E       
Sbjct: 102 AYIARQILKGLDYLHTKRHI---IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           T  VGT  YM PE  Q    S   D+++ G+ L E    K                  L 
Sbjct: 159 T-FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF-----LPPGQPSFFELM 212

Query: 504 EEVLNLPDP 512
           + + + P P
Sbjct: 213 QAICDGPPP 221

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  103 bits (257), Expect = 2e-24
 Identities = 87/308 (28%), Positives = 133/308 (43%), Gaps = 64/308 (20%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G+  FG +Y   L       YL  +    L+  K      + Q   EF  E  ++  +
Sbjct: 12  ELGECAFGKIYKGHL-------YLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL 64

Query: 339 HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHL---------------RGSGRDPLPWS 382
           HH N+V L+G    E  + +++EY+  G+L E L                G+ +  L   
Sbjct: 65  HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124

Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS- 441
             + IA+  A G+EY+  H    ++H+D+ + NILI +  H K++D GL++  E+ SA  
Sbjct: 125 DFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSR--EIYSADY 179

Query: 442 --------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS 493
                   LP R      +MPPE   YG  S   D+++FGVVL+E+ S       G  + 
Sbjct: 180 YRVQPKSLLPIR------WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN- 232

Query: 494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
                     +EV      IE +RK    R    C  D   +M  L   C QE P  RP 
Sbjct: 233 ----------QEV------IEMVRK----RQLLPCSEDCPPRMYSLMTECWQEGPSRRPR 272

Query: 554 MRSIVVAL 561
            + I   L
Sbjct: 273 FKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  102 bits (257), Expect = 2e-24
 Identities = 65/223 (29%), Positives = 92/223 (41%), Gaps = 40/223 (17%)

Query: 277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL----LMQKAAIKKMDMQASREFLA-- 330
            +KIG G FG VY                  VNL    LM   A+K++ +Q +       
Sbjct: 5   GNKIGGGTFGKVY----------------TAVNLDTGELM---AVKEIRIQDNDPKTIKE 45

Query: 331 ---ELKVLTHVHHLNLVRLIGYCVEGSLFLVY-EYIENGNLSEHLRGSGRDPLPWSSRVQ 386
              E+KVL  + H NLV+  G  V      ++ EY   G L E L               
Sbjct: 46  IADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYT 105

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR- 445
           + L    GL Y+H H +   +HRDIK ANI +D N   K+ DFG     +  + ++    
Sbjct: 106 LQL--LEGLAYLHSHGI---VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160

Query: 446 --LVGTFGYMPPEYAQYGDVSPK---VDVYAFGVVLYELISAK 483
             L GT  YM PE    G         D+++ G V+ E+ + K
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  103 bits (257), Expect = 2e-24
 Identities = 67/235 (28%), Positives = 115/235 (48%), Gaps = 52/235 (22%)

Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL-------LMQKAAIKKMDMQASREF 328
           +  ++G+G FG V+ AE              C NL       L+   A+K   + A ++F
Sbjct: 9   LKRELGEGAFGKVFLAE--------------CYNLSPTKDKMLVAVKALKDPTLAARKDF 54

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDP--------- 378
             E ++LT++ H ++V+  G C +G  L +V+EY+++G+L++ LR  G D          
Sbjct: 55  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 114

Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                L  S  + IA   A G+ Y+       ++HRD+ + N L+  N   K+ DFG+++
Sbjct: 115 QAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 434 ------LTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                    VG  + LP R      +MPPE   Y   + + DV++FGV+L+E+ +
Sbjct: 172 DVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 3e-24
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 38/214 (17%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD---MQASREFLAELKVL 335
           K+G G FG V+     G + N+               A+K +    M    +FLAE +++
Sbjct: 13  KLGAGQFGEVW----EGLWNNT------------TPVAVKTLKPGTMDPK-DFLAEAQIM 55

Query: 336 THVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
             + H  L++L   C +E  +++V E ++ G+L E+L+G     L     + +A   A G
Sbjct: 56  KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASG 115

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-------TEVGSASLPTRLV 447
           + Y+       YIHRD+ + N+L+ +N   KVADFGL ++          G A  P +  
Sbjct: 116 MAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG-AKFPIK-- 169

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
               +  PE A Y   S K DV++FG++L E+++
Sbjct: 170 ----WTAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  101 bits (254), Expect = 3e-24
 Identities = 78/294 (26%), Positives = 133/294 (45%), Gaps = 62/294 (21%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFL 329
              ++  +IG G FG V+           +L +        +K AIK +     +  +F+
Sbjct: 4   SELTLVQEIGSGQFGLVWLG--------YWLEK--------RKVAIKTIREGAMSEEDFI 47

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E +V+  + H  LV+L G C E S + LV+E++E+G LS++LR + R      + + + 
Sbjct: 48  EEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR-AQRGKFSQETLLGMC 106

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASL 442
           LD   G+ Y+    V   IHRD+ + N L+ +N   KV+DFG+T+       T       
Sbjct: 107 LDVCEGMAYLESSNV---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
           P +      +  PE   +   S K DV++FGV+++E+ S  +   +   +S         
Sbjct: 164 PVK------WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------- 208

Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
             EV      +E +    +L  PRL           + +L + C +E P+ RPS
Sbjct: 209 --EV------VETINAGFRLYKPRL---AS----QSVYELMQHCWKERPEDRPS 247

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  102 bits (255), Expect = 3e-24
 Identities = 79/278 (28%), Positives = 122/278 (43%), Gaps = 39/278 (14%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGE---YGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           +F +   IG+G FG V   + R     +   Y+++  CV            +  + R  L
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV------------EKGSVRNVL 48

Query: 330 AELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI- 387
            E ++L  ++H  LV L   +  E +++LV + +  G+L  HL    +       +V+  
Sbjct: 49  NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKFW 105

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
             +    LEY+H   +   IHRDIK  NIL+D+  H  + DF +   T+V   +L T   
Sbjct: 106 ICEIVLALEYLHSKGI---IHRDIKPDNILLDEQGHVHITDFNIA--TKVTPDTLTTSTS 160

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           GT GYM PE       S  VD ++ GV  YE +  K    +G+ S      + A  E   
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY-RGH-SRTIRDQIRAKQETAD 218

Query: 508 NL------PDPIEDLRKL--VDP--RLGDNCPLDSVLK 535
            L       + I+ + KL   DP  RLGDN  L  +  
Sbjct: 219 VLYPATWSTEAIDAINKLLERDPQKRLGDN--LKDLKN 254

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  100 bits (251), Expect = 6e-24
 Identities = 77/287 (26%), Positives = 126/287 (43%), Gaps = 44/287 (15%)

Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASRE 327
             ++  +  K+G G FG V+     G                  K A+K  K    +   
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGN----------------TKVAVKTLKPGTMSPES 47

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLR-GSGRDPLPWSSRVQ 386
           FL E +++  + H  LV+L     E  +++V EY+  G+L + L+ G GR  L   + V 
Sbjct: 48  FLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRA-LKLPNLVD 106

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           +A   A G+ YI       YIHRD++SANIL+      K+ADFGL +L E    +     
Sbjct: 107 MAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV 506
                +  PE A YG  + K DV++FG++L EL++       G     +++ ++   E  
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG----MNNREVLEQVERG 219

Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
             +P                 CP D  + + +L   C ++ P+ RP+
Sbjct: 220 YRMP-----------------CPQDCPISLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  100 bits (250), Expect = 1e-23
 Identities = 99/306 (32%), Positives = 145/306 (47%), Gaps = 67/306 (21%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKVL 335
           IG+G FG V  A ++ +              L   AAIK+M   AS    R+F  EL+VL
Sbjct: 3   IGEGNFGQVLKARIKKDG-------------LRMDAAIKRMKEYASKDDHRDFAGELEVL 49

Query: 336 THV-HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGS---GRDPL---------PW 381
             + HH N++ L+G C   G L+L  EY  +GNL + LR S     DP            
Sbjct: 50  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 109

Query: 382 SSR--VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV-- 437
           SS+  +  A D ARG++Y+ +     +IHRD+ + NIL+ +N+ AK+ADFGL++  EV  
Sbjct: 110 SSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 166

Query: 438 --GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
                 LP R      +M  E   Y   +   DV+++GV+L+E++S         G+   
Sbjct: 167 KKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-------GGTPYC 213

Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
                 L+E+   LP       +L  P    NC  D V     L + C +E P  RPS  
Sbjct: 214 GMTCAELYEK---LPQGY----RLEKPL---NCD-DEVY---DLMRQCWREKPYERPSFA 259

Query: 556 SIVVAL 561
            I+V+L
Sbjct: 260 QILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  100 bits (249), Expect = 1e-23
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 21/212 (9%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G +  +             + AIK  K    +   FL
Sbjct: 6   ESLRLEVKLGQGCFGEVW----MGTWNGT------------TRVAIKTLKPGTMSPEAFL 49

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 50  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 110 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 166

Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             +  PE A YG  + K DV++FG++L EL +
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  100 bits (250), Expect = 2e-23
 Identities = 69/233 (29%), Positives = 109/233 (46%), Gaps = 41/233 (17%)

Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
             D+ ++   +G G FG VY    RG  G++          +  + A+K +    S +  
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDA----------VELQVAVKTLPESCSEQDE 53

Query: 328 --FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------P 378
             FL E  +++  +H N+VRLIG   E    F++ E +  G+L   LR   R        
Sbjct: 54  SDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSS 112

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-- 433
           L     +  A D A+G +Y+ E+    +IHRDI + N L+        AK+ADFG+ +  
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169

Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                  + G A LP +      +MPPE    G  + K DV++FGV+L+E+ S
Sbjct: 170 YRASYYRKGGRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 98.7 bits (246), Expect = 5e-23
 Identities = 80/303 (26%), Positives = 136/303 (44%), Gaps = 58/303 (19%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVL 335
           IG+G FG VY+  L    G                 A+K +    D++   +FL E  ++
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQK------------IHCAVKSLNRITDLEEVEQFLKEGIIM 50

Query: 336 THVHHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
               H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+
Sbjct: 51  KDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV-KDLIGFGLQVAK 109

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT---------KLTEVGSASLPT 444
           G+EY+       ++HRD+ + N ++D++F  KVADFGL           +     A LP 
Sbjct: 110 GMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV 166

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           +      +M  E  Q    + K DV++FGV+L+EL++      +G     D    V  F+
Sbjct: 167 K------WMALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPD----VDSFD 210

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
             + L       R+L+ P     CP D    + ++   C    P++RP+   +V  +  +
Sbjct: 211 ITVYLLQG----RRLLQPEY---CP-DP---LYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Query: 565 SST 567
            ST
Sbjct: 260 FST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 76/288 (26%), Positives = 119/288 (41%), Gaps = 45/288 (15%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMD--MQASREFLAELKV 334
           K+G G FG V     RGE+  S   ++I V       A+K  K D       +FL E  +
Sbjct: 2   KLGDGSFGVVR----RGEWSTS-GGKVIPV-------AVKCLKSDKLSDIMDDFLKEAAI 49

Query: 335 LTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
           +  + H NL+RL G  +   L +V E    G+L + LR         S+    A+  A G
Sbjct: 50  MHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG 109

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS---ASLPTRLVGTFG 451
           + Y+       +IHRD+ + NIL+  +   K+ DFGL +                V  F 
Sbjct: 110 MRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFA 165

Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG-NGSSADSKGLVALFEEVLNLP 510
           +  PE  +    S   DV+ FGV L+E+ +  E    G +GS            ++L   
Sbjct: 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------------QILKKI 213

Query: 511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           D  ++  +L  P   + CP D    +  +   C    P  RP+  ++ 
Sbjct: 214 D--KEGERLERP---EACPQD----IYNVMLQCWAHNPADRPTFAALR 252

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 67/223 (30%), Positives = 97/223 (43%), Gaps = 39/223 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-----DMQASR 326
           + + +   +G+G +G V          N     ++         AIKK      D    +
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCR------NKATGEIV---------AIKKFKESEDDEDVKK 45

Query: 327 EFLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSS 383
             L E+KVL  + H N+V L      +G L+LV+EY+E   L E L  S  G  P    S
Sbjct: 46  TALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS 104

Query: 384 RV-QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
            + Q+     + + Y H H +   IHRDIK  NIL+ ++   K+ DFG  +      AS 
Sbjct: 105 YIWQLL----QAIAYCHSHNI---IHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157

Query: 443 PTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELIS 481
            T  V T  Y  PE       YG     VDV+A G ++ EL+ 
Sbjct: 158 LTDYVATRWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLD 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 98.1 bits (245), Expect = 7e-23
 Identities = 68/222 (30%), Positives = 107/222 (48%), Gaps = 41/222 (18%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK-AAIKKMDMQASREF-- 328
           +++ +  +IG G +G VY A                 ++   +  AIK + ++   +F  
Sbjct: 3   EDYELIQRIGSGTYGDVYKA----------------RDIATGELVAIKVIKLEPGDDFEI 46

Query: 329 -LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
              E+ +L    H N+V   G Y     L++V EY   G+L + +    R PL   S +Q
Sbjct: 47  IQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPL---SELQ 102

Query: 387 IAL---DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASL 442
           IA    ++ +GL Y+HE      IHRDIK ANIL+ ++   K+ADFG+  +LT    A++
Sbjct: 103 IAYVCRETLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQLT----ATI 155

Query: 443 PTR--LVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYEL 479
             R   +GT  +M PE A     G    K D++A G+   EL
Sbjct: 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 67/301 (22%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----QASRE- 327
           +F +  K+G+G +G+VY  + R      Y              A+K++D+    Q  RE 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVK-RLSDNQFY--------------ALKEVDLGSMSQKERED 45

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSG--RDPLP---- 380
            + E+++L  V+H N++      ++G  L +V EY   G+LS+ +      R  +P    
Sbjct: 46  AVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI 105

Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
           W   +Q+     RGL+ +HE  +   +HRD+KSANIL+  N   K+ D G++K+ +   A
Sbjct: 106 WRIFIQLL----RGLQALHEQKI---LHRDLKSANILLVANDLVKIGDLGISKVLKKNMA 158

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
                  GT  YM PE  +    S K D+++ G +LYE+ +           S       
Sbjct: 159 KTQI---GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA---PPFEARSM------ 206

Query: 501 ALFEEVLNLPDPIEDLRKLVD----PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                        +DLR  V     P +      D    +    +   Q  P+LRP+   
Sbjct: 207 -------------QDLRYKVQRGKYPPIPPIYSQD----LQNFIRSMLQVKPKLRPNCDK 249

Query: 557 I 557
           I
Sbjct: 250 I 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 68/213 (31%), Positives = 104/213 (48%), Gaps = 23/213 (10%)

Query: 273 NFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            + +  +IG+G  G V+ A+ R  GE           V L  +K A+++++     + L 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGE----------TVAL--KKVALRRLEGGIPNQALR 48

Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLF-LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+K L    H  +V+L+     GS F LV EY+ +  LSE LR     PLP +       
Sbjct: 49  EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDE-ERPLPEAQVKSYMR 106

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
              +G+ Y+H + +   +HRD+K AN+LI  +   K+ADFGL +L       L +  V T
Sbjct: 107 MLLKGVAYMHANGI---MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVAT 163

Query: 450 FGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
             Y  PE   YG     P VD++A G +  EL+
Sbjct: 164 RWYRAPELL-YGARKYDPGVDLWAVGCIFAELL 195

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 70/236 (29%), Positives = 117/236 (49%), Gaps = 46/236 (19%)

Query: 279 KIGQGGFGAVYYAELRG----------EYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
           K+G+G FG V+  E  G          E  N+    L+ V +L   A+       A  +F
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN-----AREDF 66

Query: 329 LAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGS---------GRDP 378
           L E+K+L+ +   N+ RL+G C V+  L ++ EY+ENG+L++ L+               
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT------ 432
           L +S+ + +A   A G+ Y+       ++HRD+ + N L+ KN+  K+ADFG++      
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183

Query: 433 ---KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKE 484
              ++   G A LP R      +M  E    G  + K DV+AFGV L+E+++  +E
Sbjct: 184 DYYRVQ--GRAPLPIR------WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 21/205 (10%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV- 338
           +G+G FG V  AEL+G         L  V +L +   ++  D++ +   + E +VL    
Sbjct: 3   LGKGSFGKVLLAELKGT------DELYAVKVLKKDVILQDDDVECT---MTEKRVLALAG 53

Query: 339 HHLNLVRLIGYC---VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
            H  L +L  +     +  LF V EY+  G+L  H++ SGR   P +     A +   GL
Sbjct: 54  KHPFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRA--RFYAAEIVLGL 109

Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
           +++HE  +   I+RD+K  N+L+D   H K+ADFG+ K   +G  +  T   GT  Y+ P
Sbjct: 110 QFLHERGI---IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAP 165

Query: 456 EYAQYGDVSPKVDVYAFGVVLYELI 480
           E   Y    P VD +A GV+LYE++
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEML 190

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 96.2 bits (239), Expect = 3e-22
 Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 65/296 (21%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK-----KMDMQASR 326
           ++  +  K+G G FG V+     G Y NS             K A+K      M +QA  
Sbjct: 6   ESIKLVKKLGAGQFGEVWM----GYYNNS------------TKVAVKTLKPGTMSVQA-- 47

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
            FL E  ++  + H  LVRL  Y V   E  ++++ EY+  G+L + L+      +    
Sbjct: 48  -FLEEANLMKTLQHDKLVRL--YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK 104

Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS---- 439
            +  +   A G+ YI       YIHRD+++AN+L+ ++   K+ADFGL ++ E       
Sbjct: 105 LIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161

Query: 440 --ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
             A  P +      +  PE   +G  + K DV++FG++LYE+++  +    G    ++S 
Sbjct: 162 EGAKFPIK------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG---MSNSD 212

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
            + AL +    +P               +NCP +    +  + K C +E  + RP+
Sbjct: 213 VMSAL-QRGYRMPRM-------------ENCPDE----LYDIMKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 47/226 (20%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM------------ 320
            +    K+G+G +  VY A                     +  AIKK+            
Sbjct: 1   RYEKGKKLGEGTYAVVYKA---------------RDKETGRIVAIKKIKLGERKEAKDGI 45

Query: 321 DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
           +  A RE    +K+L  + H N++ L+  +  + ++ LV+E++E  +L E +       L
Sbjct: 46  NFTALRE----IKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDL-EKVIKDKSIVL 99

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
             +      L + RGLEY+H + +   +HRD+K  N+LI  +   K+ADFGL +    GS
Sbjct: 100 TPADIKSYMLMTLRGLEYLHSNWI---LHRDLKPNNLLIASDGVLKLADFGLAR--SFGS 154

Query: 440 ASLP-TRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELI 480
            +   T  V T  Y  PE       YG     VD+++ G +  EL+
Sbjct: 155 PNRKMTHQVVTRWYRAPELLFGARHYG---VGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 95.9 bits (238), Expect = 3e-22
 Identities = 78/288 (27%), Positives = 141/288 (48%), Gaps = 40/288 (13%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           +IG+G FG V+   LR +  N+ ++   C   L         D++A  +FL E ++L   
Sbjct: 2   RIGRGNFGEVFSGRLRAD--NTPVAVKSCRETL-------PPDLKA--KFLQEARILKQY 50

Query: 339 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H N+VRLIG C +   +++V E ++ G+    LR  G   L     +Q+  ++A G+EY
Sbjct: 51  SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEY 109

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG--SASLPTRLVGTFGYMPP 455
           +        IHRD+ + N L+ +    K++DFG+++  E G  +++   + +    +  P
Sbjct: 110 LESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI-PVKWTAP 165

Query: 456 EYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED 515
           E   YG  S + DV++FG++L+E  S   A+   N S+  ++  +   E+ + LP P   
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLG-AVPYANLSNQQTREAI---EQGVRLPCP--- 218

Query: 516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
                     + CP D+V ++ +    C +  P  RPS  ++   L +
Sbjct: 219 ----------ELCP-DAVYRLMER---CWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 61/227 (26%), Positives = 99/227 (43%), Gaps = 36/227 (15%)

Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           YE L            IG+G FG V     R   G   + + I             M  +
Sbjct: 2   YEVLET----------IGKGSFGTVRKVR-RKSDGKILVWKEIDYG---------NMTEK 41

Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS---LFLVYEYIENGNLSEHLRGSGRD--P 378
             ++ ++E+ +L  + H N+VR     ++ S   L++V EY E G+L++ ++   ++   
Sbjct: 42  EKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY 101

Query: 379 LP----WSSRVQIALDSARGLEYIH--EHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
           +     W    Q+ L     L   H         +HRD+K ANI +D N + K+ DFGL 
Sbjct: 102 IEEEFIWRILTQLLL----ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157

Query: 433 KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           K+     +S     VGT  YM PE   +     K D+++ G ++YEL
Sbjct: 158 KILG-HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 82/313 (26%), Positives = 133/313 (42%), Gaps = 81/313 (25%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK------MDMQA 324
             NF +  KIG+G F  VY A    +       R++         A+KK      MD +A
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLD------GRVV---------ALKKVQIFEMMDAKA 45

Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLS---EHLRGSGRDPLP 380
            ++ L E+ +L  + H N+++ +   +E + L +V E  + G+LS   +H +   R  +P
Sbjct: 46  RQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIP 104

Query: 381 ----WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL----- 431
               W   VQ+       LE++H   +   +HRDIK AN+ I      K+ D GL     
Sbjct: 105 ERTIWKYFVQLC----SALEHMHSKRI---MHRDIKPANVFITATGVVKLGDLGLGRFFS 157

Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG 491
           +K T   S      LVGT  YM PE       + K D+++ G +LYE+ +A ++   G+ 
Sbjct: 158 SKTTAAHS------LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDK 210

Query: 492 SSADSKGLVALFEEVLN-----LPDPI--EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCT 544
            +     L +L +++       LP     E+LR LV                      C 
Sbjct: 211 MN-----LYSLCKKIEKCDYPPLPADHYSEELRDLVS--------------------RCI 245

Query: 545 QEYPQLRPSMRSI 557
              P+ RP +  +
Sbjct: 246 NPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 95.4 bits (237), Expect = 5e-22
 Identities = 89/294 (30%), Positives = 136/294 (46%), Gaps = 50/294 (17%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            + +  KIG+G FG +Y A  + +  + +     CV   +++  + KM ++       E+
Sbjct: 1   RYEIIKKIGEGSFGKIYLA--KAKSDSEH-----CV---IKEIDLTKMPVKEKEASKKEV 50

Query: 333 KVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHL---RG---SGRDPLPWSSRV 385
            +L  + H N+V     +   G LF+V EY + G+L + +   RG   S    L W   V
Sbjct: 51  ILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--V 108

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHAKVADFGLTKLTEVGSASLPT 444
           QI+L    GL++IH+  +   +HRDIKS NI + KN   AK+ DFG+ +     S  L  
Sbjct: 109 QISL----GLKHIHDRKI---LHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAY 160

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
             VGT  Y+ PE  Q    + K D+++ G VLYEL + K      N      K     F 
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA 220

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
            +   P+   DLR L+                +QL KV     P+ RPS+ SI+
Sbjct: 221 PI--SPNFSRDLRSLI----------------SQLFKVS----PRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 95.4 bits (237), Expect = 1e-21
 Identities = 71/238 (29%), Positives = 115/238 (48%), Gaps = 49/238 (20%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYL----------SRLICVNLLMQKAAIKKMDMQASREF 328
           K+G+G FG V+  E+        L            L+ V +L   A     +  A  +F
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-----NKNARNDF 66

Query: 329 LAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLR--------GSGRD-- 377
           L E+K+L+ +   N++RL+G CV E  L ++ EY+ENG+L++ L          +G D  
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 378 ----PLP---WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
                LP   +SS + +AL  A G++Y+       ++HRD+ + N L+ +N   K+ADFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFG 183

Query: 431 LTKLTEVGS-------ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           +++    G        A LP R      +M  E    G  +   DV+AFGV L+E++ 
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIR------WMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 84/312 (26%), Positives = 141/312 (45%), Gaps = 60/312 (19%)

Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--- 326
           + +  ++  ++GQG FG VY             +R I       + A+K ++  AS    
Sbjct: 4   SREKITLLRELGQGSFGMVYEG----------NARDIIKGEAETRVAVKTVNESASLRER 53

Query: 327 -EFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG--------SGR 376
            EFL E  V+      ++VRL+G   +G    +V E + +G+L  +LR          GR
Sbjct: 54  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113

Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK--- 433
            P      +Q+A + A G+ Y++      ++HRD+ + N ++  +F  K+ DFG+T+   
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 170

Query: 434 ----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
                 + G   LP R      +M PE  + G  +   D+++FGVVL+E+ S  E   +G
Sbjct: 171 ETDYYRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224

Query: 490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQ 549
             +           E+VL     + D   L  P   DNCP     ++  L ++C Q  P+
Sbjct: 225 LSN-----------EQVLKF---VMDGGYLDQP---DNCP----ERVTDLMRMCWQFNPK 263

Query: 550 LRPSMRSIVVAL 561
           +RP+   IV  L
Sbjct: 264 MRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 43/216 (19%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--FLAELKVLT 336
           ++G G FG V+  + R +                 K AIK ++  A  E  F+ E KV+ 
Sbjct: 11  ELGSGQFGVVHLGKWRAQI----------------KVAIKAINEGAMSEEDFIEEAKVMM 54

Query: 337 HVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGS----GRDPLPWSSRVQIALDS 391
            + H  LV+L G C +   L++V E++ENG L  +LR       +D L     + +  D 
Sbjct: 55  KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML-----LSMCQDV 109

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLPTR 445
             G+EY+  ++   +IHRD+ + N L+      KV+DFG+T+       T    A  P +
Sbjct: 110 CEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK 166

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                 + PPE   +   S K DV++FGV+++E+ +
Sbjct: 167 ------WSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 94.4 bits (234), Expect = 1e-21
 Identities = 82/288 (28%), Positives = 124/288 (43%), Gaps = 42/288 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  K AIK  K        FL
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNG----------------TTKVAIKTLKPGTMMPEAFL 49

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +++  + H  LV L     E  +++V E++  G+L + L+      L     V +A 
Sbjct: 50  QEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ YI       YIHRD+++ANIL+  N   K+ADFGL +L E    +        
Sbjct: 110 QIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP 166

Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL++      KG        G+V    EVL  
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVT------KGR---VPYPGMVN--REVLEQ 215

Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
            +     R    P     CP      + +L K+C ++ P  RP+   I
Sbjct: 216 VE-----RGYRMP-----CPQGCPESLHELMKLCWKKDPDERPTFEYI 253

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 81/321 (25%), Positives = 135/321 (42%), Gaps = 75/321 (23%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR----E 327
           D  ++   +G+G FG V  AE  G         L   N      A+K +   A+     +
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVG---------LDNPNETS-TVAVKMLKDDATEKDLSD 61

Query: 328 FLAELKVLTHV-HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRG------------ 373
            ++E++++  +  H N++ L+G C  EG L++V EY  +GNL + LR             
Sbjct: 62  LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121

Query: 374 --SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
                + L     V  A   ARG+E++        IHRD+ + N+L+ ++   K+ADFGL
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKC---IHRDLAARNVLVTEDHVMKIADFGL 178

Query: 432 TK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAK 483
            +         +  +  LP +      +M PE A +  V + + DV++FGV+L+E     
Sbjct: 179 ARDIHHIDYYRKTTNGRLPVK------WMAPE-ALFDRVYTHQSDVWSFGVLLWE----- 226

Query: 484 EAIVKGNGS---SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLA 540
             I    GS       + L  L +E   +  P              NC  +    +  L 
Sbjct: 227 --IFTLGGSPYPGIPVEELFKLLKEGYRMEKPQ-------------NCTQE----LYHLM 267

Query: 541 KVCTQEYPQLRPSMRSIVVAL 561
           + C  E P  RP+ + +V  L
Sbjct: 268 RDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 73/277 (26%), Positives = 132/277 (47%), Gaps = 50/277 (18%)

Query: 276 MSHKIGQGGFGAVYY------AELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           +  K+G+G FG V+       AE  GE    +  + + V + M +A + K    A  +FL
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTK---TARNDFL 65

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD---------PL 379
            E+K+++ + + N++RL+G CV    L ++ EY+ENG+L++ L  S R+          +
Sbjct: 66  KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANNI 123

Query: 380 PWSSR---VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK--- 433
           P  S    + +A+  A G++Y+       ++HRD+ + N L+  ++  K+ADFG+++   
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180

Query: 434 ----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-------- 481
                   G A LP R      +M  E    G  +   DV+AFGV L+E+ +        
Sbjct: 181 SGDYYRIQGRAVLPIR------WMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234

Query: 482 --AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
             + E +++  G    ++G      +    P P+  L
Sbjct: 235 LLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKL 271

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 93.4 bits (233), Expect = 4e-21
 Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 46/221 (20%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF--------LA 330
           ++G G FG+VY A  +                  +  AIKKM     ++F        L 
Sbjct: 6   QLGDGTFGSVYLARNKETG---------------ELVAIKKM----KKKFYSWEECMNLR 46

Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--- 385
           E+K L  +  H N+V+L     E   L+ V+EY+E GNL + ++     P    S +   
Sbjct: 47  EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFS-ESVIRSI 104

Query: 386 --QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
             QI      GL +IH+H    + HRD+K  N+L+      K+ADFGL +  E+ S    
Sbjct: 105 IYQILQ----GLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPY 155

Query: 444 TRLVGTFGYMPPE-YAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  V T  Y  PE   +    S  VD++A G ++ EL + +
Sbjct: 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 4e-21
 Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 54/287 (18%)

Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH 337
            ++G G FG+V    ++G Y       +      +++  I        +EFL E  V+  
Sbjct: 1   KELGHGNFGSV----VKGVYLMKSGKEVEVAVKTLKQEHIA----AGKKEFLREASVMAQ 52

Query: 338 VHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGR----DPLPWSSRVQIALDSAR 393
           + H  +VRLIG C    L LV E    G L ++L+        D    + +V      A 
Sbjct: 53  LDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AM 106

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYM 453
           G+ Y+       ++HRD+ + N+L+     AK++DFG+++    GS         T G  
Sbjct: 107 GMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT---TAGRW 160

Query: 454 P-----PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG--LVALFEEV 506
           P     PE   YG  S K DV+++GV L+E  S       G     + KG  ++A+ E  
Sbjct: 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS------YGAKPYGEMKGAEVIAMLESG 214

Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
             LP P             + CP +    +  +   C +  P+ RP+
Sbjct: 215 ERLPRP-------------EECPQE----IYSIMLSCWKYRPEDRPT 244

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 33/218 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFL 329
           ++  +  K+G G FG V+ A                      K A+K M     +   FL
Sbjct: 6   ESLKLEKKLGAGQFGEVWMATYNKH----------------TKVAVKTMKPGSMSVEAFL 49

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           AE  V+  + H  LV+L     +  ++++ E++  G+L + L+       P    +  + 
Sbjct: 50  AEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS------ASLP 443
             A G+ +I +     YIHRD+++ANIL+  +   K+ADFGL ++ E         A  P
Sbjct: 110 QIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 166

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            +      +  PE   +G  + K DV++FG++L E+++
Sbjct: 167 IK------WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 93.6 bits (233), Expect = 5e-21
 Identities = 82/258 (31%), Positives = 126/258 (48%), Gaps = 58/258 (22%)

Query: 259 SVEFSY-EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI 317
             EF + +E+SK    +    KIGQG FG V+ A  +                  Q  A+
Sbjct: 2   QYEFPFCDEVSK----YEKLAKIGQGTFGEVFKARHK---------------KTKQIVAL 42

Query: 318 KKMDMQASRE-F----LAELKVLTHVHHLNLVRLIGYC---------VEGSLFLVYEYIE 363
           KK+ M+  +E F    L E+K+L  + H N+V LI  C          +GS +LV+E+ E
Sbjct: 43  KKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE 102

Query: 364 N---GNLSE-HLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID 419
           +   G LS  +++ +    L    +V   L +  GL YIH + +   +HRD+K+ANILI 
Sbjct: 103 HDLAGLLSNKNVKFT----LSEIKKVMKMLLN--GLYYIHRNKI---LHRDMKAANILIT 153

Query: 420 KNFHAKVADFGLTKLTEVGSASLPTRL---VGTFGYMPPEY----AQYGDVSPKVDVYAF 472
           K+   K+ADFGL +   +   S P R    V T  Y PPE       YG   P +D++  
Sbjct: 154 KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYG---PPIDMWGA 210

Query: 473 GVVLYELISAKEAIVKGN 490
           G ++ E+ + +  I++GN
Sbjct: 211 GCIMAEMWT-RSPIMQGN 227

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.8 bits (231), Expect = 7e-21
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 44/218 (20%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF---------L 329
           KIG+G +G VY A                  L  +  AIKK+       F         L
Sbjct: 6   KIGEGTYGVVYKAR---------------DKLTGEIVAIKKI----KLRFESEGIPKTAL 46

Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+K+L  ++H N+++L+  +  +G L+LV+E+++  +L + ++   R  LP S      
Sbjct: 47  REIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQR-GLPESLIKSYL 104

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLV 447
               +GL + H H +   +HRD+K  N+LI+     K+ADFGL +    GS   P T  V
Sbjct: 105 YQLLQGLAFCHSHGI---LHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYV 159

Query: 448 GTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELIS 481
            T  Y  PE       Y      VD+++ G +  EL+S
Sbjct: 160 VTRWYRAPELLLGDKGYS---TPVDIWSVGCIFAELLS 194

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 80/298 (26%), Positives = 126/298 (42%), Gaps = 53/298 (17%)

Query: 280 IGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLT 336
           +G+G FG+V    Y  L+   G      ++ V  L    A      +  R+F  E+++L 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTG-----EVVAVKKLQHSTA------EHLRDFEREIEILK 60

Query: 337 HVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
            + H N+V+  G C      +L LV EY+  G+L ++L+   R+ L     +  A    +
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICK 119

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG---TF 450
           G+EY+       Y+HRD+ + NIL++     K+ DFGLTK+          R  G    F
Sbjct: 120 GMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176

Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE----- 505
            Y P    +    S   DV++FGVVLYEL +           S  S    A F       
Sbjct: 177 WYAPESLTE-SKFSVASDVWSFGVVLYELFT----------YSDKSCSPPAEFMRMMGND 225

Query: 506 ------VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                 V +L + +++  +L  P     CP     ++  + K C    P  RPS   +
Sbjct: 226 KQGQMIVYHLIELLKNNGRLPAP---PGCP----AEIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 53/241 (21%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
            +  D F +  +IG+G +G VY A  +  GE                   A+KK+ +   
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGEL-----------------VALKKVRLDNE 45

Query: 326 RE-----FLAELKVLTHVHHLNLVRLIGYCVE-----------GSLFLVYEYIEN---GN 366
           +E      + E+K+L  ++H N+V L     +           G+ +LV+EY+++   G 
Sbjct: 46  KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGL 105

Query: 367 LSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
           L   L     D +   S ++  L+   GL Y H+     ++HRDIK +NIL++     K+
Sbjct: 106 LESGLVHFSEDHI--KSFMKQLLE---GLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157

Query: 427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISA 482
           ADFGL +L     +   T  V T  Y PPE      +YG   P +DV++ G +L EL + 
Sbjct: 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYG---PAIDVWSCGCILGELFTK 214

Query: 483 K 483
           K
Sbjct: 215 K 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 90.8 bits (225), Expect = 1e-20
 Identities = 66/232 (28%), Positives = 111/232 (47%), Gaps = 30/232 (12%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V+   L+ +   + ++   C   L Q+  IK         FL+E ++L    
Sbjct: 3   LGKGNFGEVFKGTLKDK---TPVAVKTCKEDLPQELKIK---------FLSEARILKQYD 50

Query: 340 HLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
           H N+V+LIG C +   +++V E +  G+    LR   +D L     V+ ALD+A G+ Y+
Sbjct: 51  HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYL 109

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA 458
                   IHRD+ + N L+ +N   K++DFG+++  + G  S          +  PE  
Sbjct: 110 ESKNC---IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEAL 166

Query: 459 QYGDVSPKVDVYAFGVVLYELIS-------------AKEAIVKGNGSSADSK 497
            YG  S + DV+++G++L+E  S             A+E + KG   S   K
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQK 218

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 45/221 (20%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           DNF    KIG+G  G V  A  +   G              ++ A+KKMD+  Q  RE L
Sbjct: 22  DNFV---KIGEGSTGIVCIATDK-STG--------------RQVAVKKMDLRKQQRRELL 63

Query: 330 -AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSE---HLRGSGRDPLPWSSR 384
             E+ ++    H N+V +   Y V   L++V E++E G L++   H R          + 
Sbjct: 64  FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR---------MNE 114

Query: 385 VQIA---LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
            QIA   L   + L ++H   V   IHRDIKS +IL+  +   K++DFG        S  
Sbjct: 115 EQIATVCLAVLKALSFLHAQGV---IHRDIKSDSILLTSDGRVKLSDFGFCAQV---SKE 168

Query: 442 LPTR--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           +P R  LVGT  +M PE         +VD+++ G+++ E++
Sbjct: 169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 87/298 (29%), Positives = 117/298 (39%), Gaps = 68/298 (22%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR------E 327
           F+   +IG G FGAVY+A                     +  AIKKM     +      +
Sbjct: 17  FTDLREIGHGSFGAVYFAR---------------DVRTNEVVAIKKMSYSGKQSNEKWQD 61

Query: 328 FLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            + E++ L  + H N +   G Y  E + +LV EY   G+ S+ L    + PL       
Sbjct: 62  IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILE-VHKKPLQEVEIAA 119

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL---P 443
           I   + +GL Y+H H     IHRDIK+ NIL+ +    K+ADFG        SASL    
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG--------SASLVSPA 168

Query: 444 TRLVGTFGYMPPEY------AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
              VGT  +M PE        QY     KVDV++ G+   EL   K  +   N  SA   
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDG---KVDVWSLGITCIELAERKPPLFNMNAMSA--- 222

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
               L+    N             P L  N   D           C Q+ PQ RPS  
Sbjct: 223 ----LYHIAQNDS-----------PTLSSN---DWSDYFRNFVDSCLQKIPQDRPSSE 262

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 91.4 bits (228), Expect = 2e-20
 Identities = 64/228 (28%), Positives = 107/228 (46%), Gaps = 37/228 (16%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-----F 328
           +    K+G+G +G VY A  R +                +  A+KK+ +    E      
Sbjct: 1   YEKLEKLGEGTYGVVYKA--RDKKTG-------------EIVALKKIRLDNEEEGIPSTA 45

Query: 329 LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ- 386
           L E+ +L  + H N+V+L+     E  L+LV+EY +  +L ++L      PL   + ++ 
Sbjct: 46  LREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG-PLS-PNLIKS 102

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           I     RGL Y H H +   +HRD+K  NILI+++   K+ADFGL +   +   +  T  
Sbjct: 103 IMYQLLRGLAYCHSHRI---LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THE 158

Query: 447 VGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           V T  Y  PE       Y   S  VD+++ G +  E+I+  + +  G+
Sbjct: 159 VVTLWYRAPEILLGSKHY---STAVDIWSVGCIFAEMIT-GKPLFPGD 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 90.3 bits (224), Expect = 3e-20
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 17/205 (8%)

Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKK------MDMQASREFLAELKVLTHVHHLNLVRLI 347
           RG +G  +L    C     QK  I K      M          E +VL  + H N++   
Sbjct: 10  RGAFGIVHL----CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65

Query: 348 -GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVY 406
             +  + +L +V EY   G L+E+++      L   + +   +     L ++H   +   
Sbjct: 66  ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI--- 122

Query: 407 IHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSP 465
           +HRD+K+ NIL+DK+    K+ DFG++K   + S S    +VGT  Y+ PE  +    + 
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 466 KVDVYAFGVVLYELISAKEAIVKGN 490
           K D++A G VLYEL S K A    N
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAAN 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 91.0 bits (226), Expect = 5e-20
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 33/216 (15%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           +F M   +G G FG V  A+ +G     Y +        ++K  I KM     +    E 
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGT--GEYYAIKC-----LKKREILKMKQV--QHVAQEK 69

Query: 333 KVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP----WSSRVQI 387
            +L  + H  +V ++  +  E  ++ + E++  G L  HLR +GR P      + + + +
Sbjct: 70  SILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL 129

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-- 445
           A       EY+H   +   I+RD+K  N+L+D   H KV DFG  K        +P R  
Sbjct: 130 AF------EYLHSKDI---IYRDLKPENLLLDNKGHVKVTDFGFAK-------KVPDRTF 173

Query: 446 -LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            L GT  Y+ PE  Q       VD +  GV+LYE I
Sbjct: 174 TLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 89.5 bits (222), Expect = 5e-20
 Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 55/290 (18%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           KIG+G FG     + + E G  Y+ + I          I KM  +   E   E+ VL+++
Sbjct: 7   KIGEGSFGKAILVKSK-EDGKQYVIKEI---------NISKMSPKEREESRKEVAVLSNM 56

Query: 339 HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHL---RG---SGRDPLPWSSRVQIALDS 391
            H N+V+      E G+L++V +Y E G+L + +   RG        L W   VQI L  
Sbjct: 57  KHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF--VQICL-- 112

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
              L+++H+  +   +HRDIKS NI + K+   K+ DFG+ ++    +  L    +GT  
Sbjct: 113 --ALKHVHDRKI---LHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPY 166

Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD 511
           Y+ PE  +    + K D++A G VLYE+ + K A   GN      K LV         P 
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKIIRGSYPPV 221

Query: 512 PIE---DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
                 DLR LV                +QL K      P+ RPS+ SI+
Sbjct: 222 SSHYSYDLRNLV----------------SQLFK----RNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 89.9 bits (223), Expect = 5e-20
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 17/206 (8%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGFG V   +++   G  Y  +   ++    K  +KK   +  +  L E K+L  V 
Sbjct: 1   LGKGGFGEVCACQVKAT-GKMYACK--KLD----KKRLKKR--KGEQMALNEKKILEKVS 51

Query: 340 HLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
              +V L  Y  E    L LV   +  G+L  H+   G    P +  +  A     GLE+
Sbjct: 52  SRFIVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEH 110

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H+  +   ++RD+K  N+L+D + + +++D GL    E+          GT GYM PE 
Sbjct: 111 LHQRRI---VYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEV 165

Query: 458 AQYGDVSPKVDVYAFGVVLYELISAK 483
            Q       VD +A G  LYE+I+ +
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 90.5 bits (225), Expect = 6e-20
 Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 44/227 (19%)

Query: 273 NFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--- 327
            F   ++IG+G +G VY A     GE                   A+KK+ M   R+   
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEI-----------------VALKKVRMDNERDGIP 50

Query: 328 --FLAELKVLTHVHHLNLVRLIGYCVEG----SLFLVYEYIEN--GNLSEHLRGSGRDPL 379
              L E+ +L ++ H N+V L    V G    S+FLV EY E    +L +++      P 
Sbjct: 51  ISSLREITLLLNLRHPNIVELK-EVVVGKHLDSIFLVMEYCEQDLASLLDNM------PT 103

Query: 380 PWS-SRVQ-IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
           P+S S+V+ + L   RGL+Y+HE+ +   IHRD+K +N+L+      K+ADFGL +   +
Sbjct: 104 PFSESQVKCLMLQLLRGLQYLHENFI---IHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160

Query: 438 GSASLPTRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            +  +  ++V T  Y  PE           +D++A G +L EL++ K
Sbjct: 161 PAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 90.5 bits (224), Expect = 6e-20
 Identities = 85/286 (29%), Positives = 120/286 (41%), Gaps = 56/286 (19%)

Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR------EFLAE 331
           H+IG G FGAVY+A       NS+ + ++         A+KKM     +      + + E
Sbjct: 27  HEIGHGSFGAVYFAT------NSHTNEVV---------AVKKMSYSGKQTNEKWQDIIKE 71

Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +K L  + H N +   G Y  E + +LV EY   G+ S+ L    + PL       I   
Sbjct: 72  VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAAITHG 129

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
           + +GL Y+H H +   IHRDIK+ NIL+ +    K+ADFG         +S     VGT 
Sbjct: 130 ALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTP 181

Query: 451 GYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
            +M PE       G    KVDV++ G+   EL   K  +   N  S       AL+    
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQ 234

Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
           N             P L  N   DS          C Q+ PQ RP+
Sbjct: 235 N-----------DSPTLQSNEWTDS---FRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 90.0 bits (223), Expect = 7e-20
 Identities = 63/237 (26%), Positives = 117/237 (49%), Gaps = 41/237 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRG--EYGNSYLSR--------LICVNLLMQKAAIKKMD 321
              +   K+G+G FG V+  E  G  ++ +   S         L+ V +L + A     +
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-----N 59

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHL-----RGSG 375
             A  +FL E+K+++ +   N++RL+  C+    L ++ EY+ENG+L++ L     + + 
Sbjct: 60  KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA 119

Query: 376 RDP----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
                  + +S+ + +A   A G++Y+       ++HRD+ + N L+ KN+  K+ADFG+
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 432 TK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           ++           G A LP R      +M  E    G  +   DV+AFGV L+E+++
Sbjct: 177 SRNLYSGDYYRIQGRAVLPIR------WMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 89.0 bits (221), Expect = 8e-20
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 22/209 (10%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG+VY   L  + G+ +  + + +    Q         +A ++   E+ +L+ + 
Sbjct: 8   LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQ------EAVKQLEQEIALLSKLQ 60

Query: 340 HLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLR--GSGRDPLPWSSRVQIALDSARGLE 396
           H N+V+ +G   E  +L++  E +  G+L++ L+  GS  +P+      QI L    GLE
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL----GLE 116

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGTFGYMPP 455
           Y+H+      +HRDIK ANIL+D N   K+ADFG+ K + E   A       G+  +M P
Sbjct: 117 YLHDRNT---VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK---SFKGSPYWMAP 170

Query: 456 EY-AQYGDVSPKVDVYAFGVVLYELISAK 483
           E  AQ G      D+++ G  + E+ + K
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 15/223 (6%)

Query: 294 RGEYGNSYLSRLICVNLLMQKAAIK-KMDMQASREFLAELKVLTHVHHLNLVRLIGYC-V 351
            G  G            +M    I+ +++    ++ L EL +L   +   +V   G    
Sbjct: 11  AGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN 70

Query: 352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRD 410
            G + +  EY++ G+L + L+   +  +P     +IA+   +GL Y+HE H +   IHRD
Sbjct: 71  NGDISICMEYMDGGSLDKILK-EVQGRIPERILGKIAVAVLKGLTYLHEKHKI---IHRD 126

Query: 411 IKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDV 469
           +K +NIL++     K+ DFG+  +L      SL    VGT  YM PE  Q  D S K D+
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTSSYMAPERIQGNDYSVKSDI 182

Query: 470 YAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
           ++ G+ L EL + +      N       G+  L + ++N P P
Sbjct: 183 WSLGLSLIELATGRFPYPPEN---DPPDGIFELLQYIVNEPPP 222

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 75/295 (25%), Positives = 127/295 (43%), Gaps = 27/295 (9%)

Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL 335
               +G+G FG V  +    +  N     ++ V     K   ++   Q +  +  E+ +L
Sbjct: 8   KIRVLGEGHFGKV--SLYCYDPANDGTGEMVAV-----KTLKRECGQQNTSGWKKEINIL 60

Query: 336 THVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
             ++H N+V+  G C E     L L+ EY+  G+L ++L    +  L  +  +  A    
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQIC 117

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG---T 449
            G+ Y+H      YIHRD+ + N+L+D +   K+ DFGL K    G      R  G    
Sbjct: 118 EGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174

Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
           F Y      +    S   DV++FGV LYEL++  ++         +  G       V+ L
Sbjct: 175 FWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233

Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            + +E   +L  P    NCP +    +  L K C +   + RP+ RS++  L  +
Sbjct: 234 IELLERGMRLPCP---KNCPQE----VYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 89.6 bits (222), Expect = 1e-19
 Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 21/205 (10%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV- 338
           +G+G FG V+ AEL+G       ++   +  L +   +   D++ +   + E +VL+   
Sbjct: 3   LGKGSFGKVFLAELKGT------NQFFAIKALKKDVVLMDDDVECT---MVEKRVLSLAW 53

Query: 339 HHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
            H  L  L  YC    + +LF V EY+  G+L  H++   +  LP ++    A +   GL
Sbjct: 54  EHPFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGL 109

Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
           +++H   +   ++RD+K  NIL+D + H K+ADFG+ K   +G A   T   GT  Y+ P
Sbjct: 110 QFLHSKGI---VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAP 165

Query: 456 EYAQYGDVSPKVDVYAFGVVLYELI 480
           E       +  VD ++FGV+LYE++
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 78/296 (26%), Positives = 127/296 (42%), Gaps = 53/296 (17%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG VY        G       + V  L + A       Q  +EFL E  ++++ +
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD-----QEKKEFLKEAHLMSNFN 57

Query: 340 HLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGS-----GRDPLPWSSRVQIALDSAR 393
           H N+V+L+G C+     +++ E +E G+L  +LR +     G   L     + I LD A+
Sbjct: 58  HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 394 GLEYIHEHTVPVYIHRDIKSANILI-DKNFHA----KVADFGLTK-------LTEVGSAS 441
           G  Y+ +     +IHRD+ + N L+ +K + A    K+ DFGL +         + G   
Sbjct: 118 GCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGL 174

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
           LP R      +M PE    G  + + DV++FGV+++E+++       G            
Sbjct: 175 LPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTL------GQQPYPALNNQ-- 220

Query: 502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
              EVL     +    +L  P    NCP      + QL   C  + P  RP+   I
Sbjct: 221 ---EVLQH---VTAGGRLQKPE---NCPDK----IYQLMTNCWAQDPSERPTFDRI 263

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 46/291 (15%)

Query: 280 IGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH 337
           IG G FG V    L+  G+       R I V +   K+   +   +  R+FL+E  ++  
Sbjct: 12  IGAGEFGEVCRGRLKLPGK-------REIFVAIKTLKSGYTE---KQRRDFLSEASIMGQ 61

Query: 338 VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR-GSGRDPLPWSSRVQIALDSARGL 395
             H N++ L G   +   + ++ E++ENG L   LR   G+        V +    A G+
Sbjct: 62  FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ--FTVIQLVGMLRGIAAGM 119

Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP- 454
           +Y+ E     Y+HRD+ + NIL++ N   KV+DFGL++  E  + S PT      G +P 
Sbjct: 120 KYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT-SDPTYTSSLGGKIPI 175

Query: 455 ----PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP 510
               PE   Y   +   DV+++G+V++E++S  E     + S+ D   ++   E+   LP
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-WDMSNQD---VINAIEQDYRLP 231

Query: 511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
            P++             CP  + L   QL   C Q+    RP    IV  L
Sbjct: 232 PPMD-------------CP--TALH--QLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 35/210 (16%)

Query: 280 IGQGGFGAVYYAELR--GEY-------GNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           I +G FG+VY A+ R  G+Y        +  +++    N+  ++A    M +Q    ++A
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAI---MMIQGESPYVA 60

Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +L                +  +  L+LV EY+  G+ +  ++  G  P  W+   Q   +
Sbjct: 61  KL-------------YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAE 105

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
              G+E +H+  +   IHRDIK  N+LID+  H K+ DFGL++           + VGT 
Sbjct: 106 VVLGVEDLHQRGI---IHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKFVGTP 157

Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            Y+ PE           D ++ G V++E +
Sbjct: 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.0 bits (218), Expect = 2e-19
 Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 30/207 (14%)

Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDMQAS------REFLAELKVLTHVHHLNLVRLIG 348
           G + + Y +R +    LM    +  +   +S           E++++  ++H +++R++G
Sbjct: 11  GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70

Query: 349 YCVEGSLFLVY-EYIENGNLSEHLRGSGRDPLPWSSRVQIA--LDSARGLEYIHEHTVPV 405
              E S F ++ E++  G++S  L   G     +   V I       RGL Y+HE+ +  
Sbjct: 71  ATCEDSHFNLFVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQI-- 124

Query: 406 YIHRDIKSANILIDKN-FHAKVADFGL-----TKLTEVGSASLPTRLVGTFGYMPPEY-- 457
            IHRD+K AN+LID      ++ADFG       K T  G+     +L+GT  +M PE   
Sbjct: 125 -IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT--GAGEFQGQLLGTIAFMAPEVLR 181

Query: 458 -AQYGDVSPKVDVYAFGVVLYELISAK 483
             QYG      DV++ G V+ E+ +AK
Sbjct: 182 GEQYGRSC---DVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 29/213 (13%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA--- 330
           F++   IG+G FG VY    +                  Q  AIK +D++ + + +    
Sbjct: 3   FTLLECIGKGSFGEVY----KAID-----------KRTNQVVAIKVIDLEEAEDEIEDIQ 47

Query: 331 -ELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E++ L+      + +  G  ++GS L+++ EY   G+  + L+      L  +    I 
Sbjct: 48  QEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFIL 104

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LV 447
            +   GLEY+HE      IHRDIK+ANIL+ +    K+ADFG++   ++ S        V
Sbjct: 105 REVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFV 159

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           GT  +M PE  +      K D+++ G+   EL 
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 77/326 (23%), Positives = 144/326 (44%), Gaps = 64/326 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 69

Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGS-------------- 374
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR                
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 375 GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
             + + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL + 
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARD 186

Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAI 486
                   +  +  LP +      +M PE A +  V + + DV++FGV+++E+ +   + 
Sbjct: 187 VNNIDYYKKTTNGRLPVK------WMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239

Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 240 YPG---------------------IPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 278

Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 279 IPSHRPTFKQLVEDLDRILTLTTNEE 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 59/219 (26%), Positives = 103/219 (47%), Gaps = 24/219 (10%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +N S    +G G FG V  A     YG S    ++ V + M K      + +A    ++E
Sbjct: 35  NNLSFGKTLGAGAFGKVVEAT---AYGLSKSDAVMKVAVKMLKPTAHSSEREA---LMSE 88

Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           LK+++H+ +H N+V L+G C   G + ++ EY   G+L   LR      L     +  + 
Sbjct: 89  LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-------LTEVGSASL 442
             A+G+ ++        IHRD+ + N+L+      K+ DFGL +           G+A L
Sbjct: 149 QVAKGMAFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           P +      +M PE       + + DV+++G++L+E+ S
Sbjct: 206 PVK------WMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 28/219 (12%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D++ +   IG G    VY A              IC+     K AIK++D++  +  + E
Sbjct: 1   DDYELIEVIGVGATAVVYAA--------------ICLPNNE-KVAIKRIDLEKCQTSVDE 45

Query: 332 L----KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGS-GRDPLPWSSRV 385
           L    + ++  +H N+V+     V G  L+LV  Y+  G+L + ++ S  R  L  +   
Sbjct: 46  LRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA 105

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPT 444
            +  +  +GLEY+H +     IHRDIK+ NIL+ ++   K+ADFG++  L + G  +   
Sbjct: 106 TVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162

Query: 445 R--LVGTFGYMPPE-YAQYGDVSPKVDVYAFGVVLYELI 480
           R   VGT  +M PE   Q      K D+++FG+   EL 
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 62/212 (29%), Positives = 109/212 (51%), Gaps = 30/212 (14%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA-SREFLAEL 332
           F +  K+G+G +G+VY A +  E G                 AIK + ++   +E + E+
Sbjct: 5   FDILEKLGEGSYGSVYKA-IHKETGQVV--------------AIKVVPVEEDLQEIIKEI 49

Query: 333 KVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL-- 389
            +L       +V+  G Y     L++V EY   G++S+ ++ + +  L   +  +IA   
Sbjct: 50  SILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TL---TEEEIAAIL 105

Query: 390 -DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLV 447
             + +GLEY+H +     IHRDIK+ NIL+++   AK+ADFG+  +LT+   A   T ++
Sbjct: 106 YQTLKGLEYLHSNKK---IHRDIKAGNILLNEEGQAKLADFGVSGQLTD-TMAKRNT-VI 160

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           GT  +M PE  Q    + K D+++ G+   E+
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 87.0 bits (216), Expect = 5e-19
 Identities = 73/231 (31%), Positives = 103/231 (44%), Gaps = 50/231 (21%)

Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--- 320
           YE+LSK          IG+G +G V+    R E G              Q  AIKK    
Sbjct: 3   YEKLSK----------IGEGSYGVVFKCRNR-ETG--------------QIVAIKKFVES 37

Query: 321 --DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSE---HLRGS 374
             D    +  L E+++L  + H NLV LI  +  +  L LV+EY ++  L+E   + RG 
Sbjct: 38  EDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG- 96

Query: 375 GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL 434
               +P     +I   + + + + H+H     IHRD+K  NILI K    K+ DFG  ++
Sbjct: 97  ----VPEHLIKKIIWQTLQAVNFCHKHNC---IHRDVKPENILITKQGQIKLCDFGFARI 149

Query: 435 TEVGSASLPTRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELIS 481
                    T  V T  Y  PE      QYG   P VDV+A G V  EL++
Sbjct: 150 LTGPGDDY-TDYVATRWYRAPELLVGDTQYG---PPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 87.6 bits (217), Expect = 6e-19
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 25/231 (10%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V  A L+         RL  V +L +   ++  D++ +   + E ++L+   
Sbjct: 3   LGKGSFGKVMLARLKES------GRLYAVKVLKKDVILQDDDVECT---MTEKRILSLAR 53

Query: 340 HLNLVRLIGYCVEGS--LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           +   +  +  C +    LF V E++  G+L  H++ S R     +      + SA  L +
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSA--LMF 111

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H+  +   I+RD+K  N+L+D   H K+ADFG+ K   + +    +   GT  Y+ PE 
Sbjct: 112 LHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEI 167

Query: 458 AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
            Q     P VD +A GV+LYE++         N           LFE +LN
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 86.9 bits (215), Expect = 9e-19
 Identities = 81/336 (24%), Positives = 148/336 (44%), Gaps = 61/336 (18%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G    S   + + V + M K      D+    + ++E
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYG-IDKSRPDQTVTVAVKMLKDNATDKDLA---DLISE 67

Query: 332 LKVLTHV-HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRG--------------SG 375
           ++++  +  H N++ L+G C  EG L+++ EY   GNL E LR                 
Sbjct: 68  MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127

Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
            + L +   V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 128 EEQLSFKDLVSCAYQVARGMEYLESRRC---IHRDLAARNVLVTEDNVMKIADFGLARGV 184

Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIV 487
                  +  +  LP +      +M PE A +  V + + DV++FG++++E+ +   +  
Sbjct: 185 HDIDYYKKTSNGRLPVK------WMAPE-ALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237

Query: 488 KGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEY 547
            G                      P+E+L KL+      + P +   ++  L + C    
Sbjct: 238 PG---------------------IPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAV 276

Query: 548 PQLRPSMRSIVVAL--MTLSSTTEDWDVGSFYENHA 581
           P  RP+ + +V AL  +  + + E  D+   +E ++
Sbjct: 277 PTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQYS 312

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 87.4 bits (216), Expect = 9e-19
 Identities = 87/347 (25%), Positives = 158/347 (45%), Gaps = 72/347 (20%)

Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRG---EYGNSYLSRLICVNLLMQKAAIKKMDM 322
           ELS+     ++   +G+G FG V  AE  G   +  N  ++  + V +L   A  K +  
Sbjct: 8   ELSRT--RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVT--VAVKMLKDDATDKDLS- 62

Query: 323 QASREFLAELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP-- 378
               + ++E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P  
Sbjct: 63  ----DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRAR-RPPGM 117

Query: 379 -------------LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK 425
                        L +   V  A   ARG+EY+        IHRD+ + N+L+ ++   K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC---IHRDLAARNVLVTEDNVMK 174

Query: 426 VADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLY 477
           +ADFGL +         +  +  LP +      +M PE A +  V + + DV++FGV+L+
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVK------WMAPE-ALFDRVYTHQSDVWSFGVLLW 227

Query: 478 ELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMA 537
           E+ +   +   G                      P+E+L KL+      + P +   ++ 
Sbjct: 228 EIFTLGGSPYPG---------------------IPVEELFKLLKEGHRMDKPANCTHELY 266

Query: 538 QLAKVCTQEYPQLRPSMRSIVVAL---MTLSSTTEDWDVGSFYENHA 581
            + + C    P  RP+ + +V  L   +T++ST E  D+   +E ++
Sbjct: 267 MIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQYS 313

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 69/243 (28%), Positives = 109/243 (44%), Gaps = 71/243 (29%)

Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK-AAIKKMDM 322
           YEEL++          IG+G +G VY A                 +L   +  A+KK+ +
Sbjct: 1   YEELAE----------IGEGAYGTVYKAR----------------DLNTGRFVALKKVRV 34

Query: 323 QAS---------REFLAELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNL 367
             S         RE +A LK L    H N+VRL+  C       E  L LV+E+++  +L
Sbjct: 35  PLSEEGIPLSTLRE-IALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DL 92

Query: 368 SEHLR-----GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF 422
           + +L      G   + +    R Q+     RG++++H H +   +HRD+K  NIL+  + 
Sbjct: 93  ATYLSKCPKPGLPPETIKDLMR-QLL----RGVDFLHSHRI---VHRDLKPQNILVTSDG 144

Query: 423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVL 476
             K+ADFGL ++         T +V T  Y  PE      YA     +P VD+++ G + 
Sbjct: 145 QVKIADFGLARI--YSFEMALTSVVVTLWYRAPEVLLQSSYA-----TP-VDMWSVGCIF 196

Query: 477 YEL 479
            EL
Sbjct: 197 AEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 65/206 (31%), Positives = 108/206 (52%), Gaps = 23/206 (11%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV- 338
           +G+G FG V  AEL+G   N + +    +  L +   ++  D++ +   + E +VL    
Sbjct: 3   LGKGSFGKVMLAELKGT--NEFFA----IKALKKDVVLEDDDVECT---MVERRVLALAW 53

Query: 339 HHLNLVRLIGYC---VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-ALDSARG 394
            H  L  L  +C    +  LF V EY+  G+L  H++ SGR      +R +  A +   G
Sbjct: 54  EHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE---ARARFYAAEIICG 108

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           L+++H+  +   I+RD+K  N+L+DK+ H K+ADFG+ K    G     T   GT  Y+ 
Sbjct: 109 LQFLHKKGI---IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164

Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELI 480
           PE  +    +  VD ++FGV+LYE++
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 66/252 (26%), Positives = 113/252 (44%), Gaps = 37/252 (14%)

Query: 280 IGQGGFG-AVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           +G+G FG A  Y   R    +S +        + ++  + ++  +  R+ L E+ +L+ +
Sbjct: 8   LGKGAFGEATLY---RRTEDDSLV--------VWKEVNLTRLSEKERRDALNEIVILSLL 56

Query: 339 HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H N++    + ++  +L +  EY   G L + +             +         + Y
Sbjct: 57  QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL--TEVGSASLPTRLVGTFGYMPP 455
           IH+  +   +HRDIK+ NI + K    K+ DFG++K+  +E   A     +VGT  YM P
Sbjct: 117 IHKAGI---LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE---TVVGTPYYMSP 170

Query: 456 EYAQYGDVSPKVDVYAFGVVLYELISAKEA------------IVKGN---GSSADSKGLV 500
           E  Q    + K D++A G VLYEL++ K              IV+GN     S  S  L+
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELI 230

Query: 501 ALFEEVLNLPDP 512
           +L   +L   DP
Sbjct: 231 SLVHSLLQQ-DP 241

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 80/292 (27%), Positives = 127/292 (43%), Gaps = 50/292 (17%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG G FG V    L+         R I V +   KA     + Q  R+FL+E  ++    
Sbjct: 12  IGAGEFGEVCSGRLKLPG-----KREIPVAIKTLKAGY--TEKQ-RRDFLSEASIMGQFD 63

Query: 340 HLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR-GSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L G   +   + +V EY+ENG+L   LR   G+        V +    A G++Y
Sbjct: 64  HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ--FTVIQLVGMLRGIASGMKY 121

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE--------VGSASLPTRLVGT 449
           + +     Y+HRD+ + NIL++ N   KV+DFGL+++ E             +P R    
Sbjct: 122 LSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR---- 174

Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE   Y   +   DV+++G+V++E++S  E       S+ D   ++   EE   L
Sbjct: 175 --WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-WEMSNQD---VIKAIEEGYRL 228

Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           P P+             +CP      + QL   C Q+    RP    IV  L
Sbjct: 229 PAPM-------------DCP----AALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 2e-18
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 39/219 (17%)

Query: 274 FSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           F +  ++GQGG+G V+ A+ +  GE         I     M+K+ + K++    R  L E
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGE---------IVALKRMKKSLLFKLN--EVRHVLTE 51

Query: 332 LKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
             +LT      LV+L+ Y  +    L+L  EY+  G+    L   G             L
Sbjct: 52  RDILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLG------------VL 98

Query: 390 DSARGLEYIHEHTVPV-------YIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
                  Y+ E    V       YIHRD+K  N LID + H K+ DFGL+K    G  + 
Sbjct: 99  SEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTY 154

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +VG+  YM PE  +       VD ++ G +LYE + 
Sbjct: 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 44/231 (19%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASRE---F 328
             +   +G+G FG+V   +L  + G+              K A+K  K+D+    E   F
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQ------------LKVAVKTMKLDIHTYSEIEEF 48

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEGSL-------FLVYEYIENGNLSEHLRGS--GRDP- 378
           L+E   +    H N+++LIG C E S         ++  ++++G+L   L  S  G  P 
Sbjct: 49  LSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPE 108

Query: 379 -LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
            LP  + ++  +D A G+EY+       +IHRD+ + N ++ ++    VADFGL+K    
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165

Query: 438 GS-------ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           G        A +P +      ++  E       + K DV+AFGV ++E+ +
Sbjct: 166 GDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 19/215 (8%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
             NF M   +G+G FG V  AE +G         L  + +L +   I+  D++ +   + 
Sbjct: 1   DFNFLMV--LGKGSFGKVMLAERKGT------DELYAIKILKKDVVIQDDDVECT---MV 49

Query: 331 ELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           E +VL        +  +  C +    L+ V EY+  G+L  H++  G+   P +  V  A
Sbjct: 50  EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA--VFYA 107

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + + GL ++H   +   I+RD+K  N+++D   H K+ADFG+ K   V   +  T   G
Sbjct: 108 AEISVGLFFLHRRGI---IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT-FCG 163

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+ PE   Y      VD +A+GV+LYE+++ +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 44/231 (19%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQAS---REF 328
           F++   +G+G FG+V  A+L+ E G+             QK A+K  K D+ +S    EF
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGS------------FQKVAVKMLKADIFSSSDIEEF 48

Query: 329 LAELKVLTHVHHLNLVRLIGYCV----EGSL---FLVYEYIENGNLSEHLRGS--GRDP- 378
           L E   +    H N+++LIG  +    +G L    ++  ++++G+L   L  S  G +P 
Sbjct: 49  LREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPF 108

Query: 379 -LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---- 433
            LP  + V+  +D A G+EY+       +IHRD+ + N ++++N    VADFGL+K    
Sbjct: 109 TLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165

Query: 434 --LTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                 G AS LP + +         Y  +       DV+AFGV ++E+++
Sbjct: 166 GDYYRQGCASKLPVKWLALESLADNVYTTHS------DVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 80/327 (24%), Positives = 143/327 (43%), Gaps = 62/327 (18%)

Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
             D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + +
Sbjct: 16  PRDRLVLGKPLGEGCFGQVVMAEAIG-LDKEKPNRVTKVAVKMLKSDATEKDLS---DLI 71

Query: 330 AELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP--------- 378
           +E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P         
Sbjct: 72  SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYCYNPT 130

Query: 379 ------LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
                 L +   V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL 
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLA 187

Query: 433 K-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +         +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +
Sbjct: 188 RDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 241

Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
              G                      P+E+L KL+      + P +   ++  + + C  
Sbjct: 242 PYPGV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWH 280

Query: 546 EYPQLRPSMRSIVVAL---MTLSSTTE 569
             P  RP+ + +V  L   + L+S  E
Sbjct: 281 AVPSQRPTFKQLVEDLDRILALTSNQE 307

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 84.8 bits (209), Expect = 6e-18
 Identities = 72/231 (31%), Positives = 104/231 (45%), Gaps = 35/231 (15%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR------E 327
           F+   +IG G FGAVY+A       +   + ++         AIKKM     +      +
Sbjct: 27  FTDLREIGHGSFGAVYFAR------DVRTNEVV---------AIKKMSYSGKQSNEKWQD 71

Query: 328 FLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            + E+K L  + H N +   G Y  E + +LV EY   G+ S+ L    + PL       
Sbjct: 72  IIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAA 129

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           I   + +GL Y+H H +   IHRDIK+ NIL+ +    K+ADFG   +     AS     
Sbjct: 130 ITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASI-----ASPANSF 181

Query: 447 VGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
           VGT  +M PE       G    KVDV++ G+   EL   K  +   N  SA
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 72/237 (30%), Positives = 102/237 (43%), Gaps = 50/237 (21%)

Query: 267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           L   T  F +   IG+G +G VY A  + + G              Q  AIK MD+    
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHK-KTG--------------QLVAIKIMDIIEDE 45

Query: 327 --EFLAELKVLT-HVHHLNLVRLIG-------YCVEGSLFLVYEYIENG---NLSEHLRG 373
             E   E  +L  + +H N+    G          +  L+LV E    G   +L + LR 
Sbjct: 46  EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK 105

Query: 374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            G+  L       I  ++ RGL Y+HE+ V   IHRDIK  NIL+ KN   K+ DFG+  
Sbjct: 106 KGK-RLKEEWIAYILRETLRGLAYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGV-- 159

Query: 434 LTEVGSASLPTRL------VGTFGYMPPEY---AQYGDVS--PKVDVYAFGVVLYEL 479
                SA L + L      +GT  +M PE     +  D S   + DV++ G+   EL
Sbjct: 160 -----SAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 36/272 (13%)

Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQ--ASREFLA---ELKVLTHVHHLNLV--RL 346
           +G YG   L R        ++  IKK++++  + RE  A   E ++L+ + H N+V  R 
Sbjct: 10  KGSYGEVSLVRH---RTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 347 IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVY 406
                +G L++V  + E G+L   L+      LP +  V+  +  A  L+Y+HE  +   
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI--- 123

Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           +HRD+K+ N+ + +    KV D G+ ++ E     + + L+GT  YM PE       + K
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPYNYK 182

Query: 467 VDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGD 526
            DV+A G  +YE+ + K A      ++ D   LV    E    P P     K   P LG+
Sbjct: 183 SDVWALGCCVYEMATLKHAF-----NAKDMNSLVYRIIEGKLPPMP-----KDYSPELGE 232

Query: 527 NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
                       L      + P+ RPS++SI+
Sbjct: 233 ------------LIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 84.3 bits (208), Expect = 8e-18
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 19/213 (8%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           NF M   +G+G FG V  AE +G         L  + +L +   I+  D++ +   + E 
Sbjct: 3   NFLMV--LGKGSFGKVMLAERKGT------DELYAIKILKKDVVIQDDDVECT---MVEK 51

Query: 333 KVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +VL        +  +  C +    L+ V EY+  G+L   ++  GR   P +  V  A +
Sbjct: 52  RVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA--VFYAAE 109

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
            A GL ++H   +   I+RD+K  N+++D   H K+ADFG+ K       +  T   GT 
Sbjct: 110 IAIGLFFLHSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT-FCGTP 165

Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            Y+ PE   Y      VD +AFGV+LYE+++ +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 87.2 bits (216), Expect = 1e-17
 Identities = 55/191 (28%), Positives = 87/191 (45%), Gaps = 22/191 (11%)

Query: 313 QKAAIKKMDMQASRE------FLAELKVLTHVHHLNLVRLI--GYCVEGSLFLVYEYIEN 364
            + AIK +   A  E      F  E  +   ++H N+V L+  G    G LF V+EY+  
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63

Query: 365 GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKN 421
             L E L   G   LP     ++ L     L   H   +   +HRD+K  NI++      
Sbjct: 64  RTLREVLAADG--ALPAGETGRLMLQVLDALACAHNQGI---VHRDLKPQNIMVSQTGVR 118

Query: 422 FHAKVADFGLTKL------TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVV 475
            HAKV DFG+  L       +V + +  T ++GT  Y  PE  +   V+P  D+YA+G++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLI 178

Query: 476 LYELISAKEAI 486
             E ++ +  +
Sbjct: 179 FLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 24/215 (11%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICV-NLLMQKAAIKKMDMQASR-EFLA-ELKVLT 336
           IG G FG+VY         N+    L+ V  + +   +    D + S  + LA E+ +L 
Sbjct: 8   IGSGSFGSVYLGM------NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 337 HVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR--GSGRDPLPWSSRVQIALDSAR 393
            + H N+V+ +G  ++   L +  EY+  G+++  L   G+  + L  +   QI     +
Sbjct: 62  ELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----K 117

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-----LVG 448
           GL Y+H   +   IHRDIK ANIL+D     K++DFG++K  E  S S  T      L G
Sbjct: 118 GLNYLHNRGI---IHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           +  +M PE  +    + K D+++ G ++ E+++ K
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 20/208 (9%)

Query: 326 REFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
           ++ L EL+++       +V   G +  E ++ +  E+++ G+L    +  G  P+P    
Sbjct: 48  KQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEIL 105

Query: 385 VQIALDSARGLEYIH-EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
            +IA+    GL Y++  H +   +HRDIK +NIL++     K+ DFG++   E+ + S+ 
Sbjct: 106 GKIAVAVVEGLTYLYNVHRI---MHRDIKPSNILVNSRGQIKLCDFGVSG--ELIN-SIA 159

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG---SSADSKGLV 500
              VGT  YM PE  Q G  + K DV++ G+ + EL   K      N       D  G++
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL 219

Query: 501 ALFEEVLNLPDPI-------EDLRKLVD 521
            L ++++  P P        EDLR  VD
Sbjct: 220 DLLQQIVQEPPPRLPSSDFPEDLRDFVD 247

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 75/228 (32%), Positives = 106/228 (46%), Gaps = 62/228 (27%)

Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD------MQA--SREFL 329
            KIG+G F  V  A+ R + G  Y              AIK M        Q    RE  
Sbjct: 5   GKIGEGTFSEVLKAQSR-KTGKYY--------------AIKCMKKHFKSLEQVNNLREIQ 49

Query: 330 AELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV- 385
           A L+ L+   H N++RLI    +   G L LV+E ++  NL E ++G  + PLP   RV 
Sbjct: 50  A-LRRLSP--HPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGR-KRPLP-EKRVK 103

Query: 386 ----QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
               Q+     + L+++H + +    HRDIK  NILI  +   K+ADFG  +    G  S
Sbjct: 104 SYMYQLL----KSLDHMHRNGI---FHRDIKPENILIKDD-ILKLADFGSCR----GIYS 151

Query: 442 LP--TRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELIS 481
            P  T  + T  Y  PE      Y  YG   PK+D++A G V +E++S
Sbjct: 152 KPPYTEYISTRWYRAPECLLTDGY--YG---PKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 56/214 (26%), Positives = 105/214 (49%), Gaps = 23/214 (10%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL----AELKVL 335
           IG+G +G VY A       N     ++ V  +   A I        ++ +    +E++ L
Sbjct: 9   IGKGTYGRVYLAL------NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 336 THVHHLNLVRLIGY-CVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIALDSA 392
             + HLN+V+ +G+   E  L +  EY+  G++   LR  GR  + L      Q+     
Sbjct: 63  KDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL---- 118

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE-VGSASLPTRLVGTFG 451
            GL Y+H   +   +HRD+K+ N+L+D +   K++DFG++K ++ +        + G+  
Sbjct: 119 EGLAYLHSKGI---LHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175

Query: 452 YMPPE--YAQYGDVSPKVDVYAFGVVLYELISAK 483
           +M PE  ++     S KVD+++ G V+ E+ + +
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 38/293 (12%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           +IG+G +G V+ A      G     R + +  +  +   + M +   RE +A L+ L   
Sbjct: 8   EIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETF 61

Query: 339 HHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            H N+VRL   C       E  L LV+E+++  +L+ +L       +P  +   +     
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLL 120

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           RGL+++H H V   +HRD+K  NIL+  +   K+ADFGL ++     A   T +V T  Y
Sbjct: 121 RGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWY 175

Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
             PE       +  VD+++ G +  E+   ++ + +G+   +D   L  +  +V+ LP  
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS---SDVDQLGKIL-DVIGLPGE 230

Query: 513 IEDL-------RKLVDPRLGDNCPLDS-VLKMAQLAK----VCTQEYPQLRPS 553
            ED        R+    +     P++  V  + +L K     C    P  R S
Sbjct: 231 -EDWPRDVALPRQAFHSKSAQ--PIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 70/252 (27%), Positives = 106/252 (42%), Gaps = 71/252 (28%)

Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQASRE- 327
              ++ +  K+G+G FG VY A                  +   +  A+KK+ M   ++ 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKA----------------RQIKTGRVVALKKILMHNEKDG 49

Query: 328 F----LAELKVLTHVHHLNLVRLIGYCVE---------GSLFLVYEYIEN------GNLS 368
           F    L E+K+L  + H N+V LI   VE         GS+++V  Y+++       N S
Sbjct: 50  FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109

Query: 369 EHLRGSGRDPLPWSSRVQIA---LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK 425
             L  S           QI    L    G+ Y+HE+     +HRDIK+ANILID     K
Sbjct: 110 VKLTES-----------QIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILK 155

Query: 426 VADFGLTKLTEVGSASLP----------TRLVGTFGYMPPEY----AQYGDVSPKVDVYA 471
           +ADFGL +  +    +            T LV T  Y PPE      +Y      VD++ 
Sbjct: 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYT---TAVDIWG 212

Query: 472 FGVVLYELISAK 483
            G V  E+ + +
Sbjct: 213 IGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 68/233 (29%), Positives = 112/233 (48%), Gaps = 29/233 (12%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLT-HV 338
           +G+G FG V  AEL+G         +  + +L +   ++  D+  +   + E ++L    
Sbjct: 3   LGKGSFGKVMLAELKGT------DEVYAIKVLKKDVILQDDDVDCT---MTEKRILALAA 53

Query: 339 HHLNLVRLIGYC---VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
            H  L  L  +C    +  LF V EY+  G+L   ++ S +   P S      +  A  L
Sbjct: 54  KHPFLTAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLA--L 109

Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
            ++H H V   I+RD+K  NIL+D   H K+ADFG+ K   + +    T   GT  Y+ P
Sbjct: 110 MFLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAP 165

Query: 456 EYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
           E  Q  +  P VD +A GV++YE+++ +          AD++    LFE +L+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPF------EADNED--DLFESILH 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 82.3 bits (203), Expect = 4e-17
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 25/207 (12%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLA---ELK 333
           +G+G FG V  AEL+G+    Y +    V  L +   +   D++ +   +  LA   E  
Sbjct: 3   LGKGSFGKVLLAELKGK--GEYFA----VKALKKDVVLIDDDVECTMVEKRVLALAWENP 56

Query: 334 VLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
            LTH++         +  +  LF V E++  G+L  H++  GR  L  ++    A +   
Sbjct: 57  FLTHLY-------CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVC 107

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYM 453
           GL+++H   +   I+RD+K  N+++D++ H K+ADFG+ K    G     T   GT  Y+
Sbjct: 108 GLQFLHSKGI---IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYI 163

Query: 454 PPEYAQYGDVSPKVDVYAFGVVLYELI 480
            PE  Q    +  VD ++FGV+LYE++
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 39/223 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK-MDMQASREFLA 330
           D+      +G G FG V+    R      Y +        ++  AI + + ++  +    
Sbjct: 1   DDLERIKTVGTGTFGRVHLV--RDRISEHYYA--------LKVMAIPEVIRLKQEQHVHN 50

Query: 331 ELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGR----DPLPWSS 383
           E +VL  V H  ++RL  +     +  L+++ EY+  G L  +LR SGR      L ++S
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS 108

Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
            +  AL      EY+H   +   ++RD+K  NIL+DK  H K+ DFG  K        L 
Sbjct: 109 EIVCAL------EYLHSKEI---VYRDLKPENILLDKEGHIKLTDFGFAK-------KLR 152

Query: 444 TR---LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            R   L GT  Y+ PE  Q    +  VD +A G+++YE++   
Sbjct: 153 DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 35/221 (15%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--- 327
            D + +  ++G G FG VY A+ +                    AA K + +++  E   
Sbjct: 4   NDIWEIIGELGDGAFGKVYKAQHKET---------------GLFAAAKIIQIESEEELED 48

Query: 328 FLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           F+ E+ +L+   H N+V L   Y  E  L+++ E+ + G L   +    R  L       
Sbjct: 49  FMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER-GLTEPQIRY 107

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR- 445
           +       L ++H H V   IHRD+K+ NIL+  +   K+ADFG++       ++L  R 
Sbjct: 108 VCRQMLEALNFLHSHKV---IHRDLKAGNILLTLDGDVKLADFGVSAK---NKSTLQKRD 161

Query: 446 -LVGTFGYMPPEYA---QYGDVSP---KVDVYAFGVVLYEL 479
             +GT  +M PE      + D +P   K D+++ G+ L EL
Sbjct: 162 TFIGTPYWMAPEVVACETFKD-NPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 81.4 bits (201), Expect = 8e-17
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 19/213 (8%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           NF M   +G+G FG V  AE +G         L  + +L +   I+  D++ +   + E 
Sbjct: 3   NFLMV--LGKGSFGKVMLAERKGT------DELYAIKILKKDVIIQDDDVECT---MVEK 51

Query: 333 KVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +VL        +  +  C      L+ V EY+  G+L  H++  G+   P +  V  A +
Sbjct: 52  RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHA--VFYAAE 109

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
            A GL ++H   +   I+RD+K  N+++D   H K+ADFG+ K    G  +  T   GT 
Sbjct: 110 IAIGLFFLHSKGI---IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            Y+ PE   Y      VD +AFGV+LYE+++ +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 32/218 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA-SREFLA 330
           +      ++G+G  G+V    L+               ++     I         ++ L 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNT------------GMIFALKTITTDPNPDLQKQILR 48

Query: 331 ELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNL----SEHLRGSGRDPLPWSS 383
           EL++        +V+  G  +     S+ +  EY E G+L     +  +  GR       
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI----GE 104

Query: 384 RV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
           +V  +IA    +GL Y+H   +   IHRDIK +NIL+ +    K+ DFG++   E+ + S
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKI---IHRDIKPSNILLTRKGQVKLCDFGVSG--ELVN-S 158

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           L     GT  YM PE  Q    S   DV++ G+ L E+
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 27/214 (12%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG G FG V+   L+   G   ++    V +   K    +   Q   +FL+E  ++    
Sbjct: 13  IGAGEFGEVFRGILKMP-GRKEVA----VAIKTLKPGYTEKQRQ---DFLSEASIMGQFS 64

Query: 340 HLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
           H N++RL G   +     ++ EY+ENG L ++LR    +   +   V +    A G++Y+
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ-LVGMLRGIAAGMKYL 123

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE--------VGSASLPTRLVGTF 450
            +     Y+HRD+ + NIL++ N   KV+DFGL+++ E             +P R     
Sbjct: 124 SDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIR----- 175

Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKE 484
            +  PE   Y   +   DV++FG+V++E++S  E
Sbjct: 176 -WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 70/260 (26%), Positives = 117/260 (45%), Gaps = 31/260 (11%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           NF +  KIG+G F  VY A    +     L ++   +L         MD +A  + + E+
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL---------MDAKARADCIKEI 53

Query: 333 KVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLR--GSGRDPLP----WSSRV 385
            +L  ++H N+++     +E   L +V E  + G+LS  ++     +  +P    W   V
Sbjct: 54  DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV 113

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
           Q+       LE++H   V   +HRDIK AN+ I      K+ D GL +     + +  + 
Sbjct: 114 QLC----SALEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS- 165

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
           LVGT  YM PE       + K D+++ G +LYE+ + +       G   +   L    E+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY---GDKMNLYSLCKKIEQ 222

Query: 506 VLNLPDP----IEDLRKLVD 521
               P P     E+LR+LV+
Sbjct: 223 CDYPPLPSDHYSEELRQLVN 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 51/208 (24%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +         + I V + + K   +K       E + E +++  +
Sbjct: 2   ELGSGNFGCVKKGVYKMR------KKQIDVAIKVLKNENEKSVRD---EMMREAEIMHQL 52

Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   +L LV E    G L++ L    +D +  S+ V++    + G++Y+
Sbjct: 53  DNPYIVRMIGVCEAEALMLVMEMASGGPLNKFL-SGKKDEITVSNVVELMHQVSMGMKYL 111

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP---- 454
                  ++HRD+ + N+L+    +AK++DFGL+K      +    R   + G  P    
Sbjct: 112 EGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR---SAGKWPLKWY 165

Query: 455 -PEYAQYGDVSPKVDVYAFGVVLYELIS 481
            PE   +   S + DV+++G+ ++E  S
Sbjct: 166 APECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 71/277 (25%), Positives = 118/277 (42%), Gaps = 36/277 (12%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y      + + V +L         D     E L E  V+  +
Sbjct: 2   ELGSGNFGTV----KKGMYKMKKSEKTVAVKILKNDNN----DPALKDELLREANVMQQL 53

Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L++ L+ +    +   +  ++    + G++Y+
Sbjct: 54  DNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYL 111

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 112 EETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168

Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   KG       KG      EV  +   IE  
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG------MKG-----NEVTQM---IESG 214

Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
            ++        CP     +M  L K+C       RP 
Sbjct: 215 ERM-------ECPQRCPPEMYDLMKLCWTYGVDERPG 244

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 20/216 (9%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRG--EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           NF +   +G G +G V+     G  + G  Y  +++    ++QKA   +           
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTR-------T 53

Query: 331 ELKVLTHVHHLN-LVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           E +VL  V     LV L   +  +  L L+ +Y+  G L  HL           S V++ 
Sbjct: 54  ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE---SEVRVY 110

Query: 389 L-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           + +    L+++H+  +   I+RDIK  NIL+D   H  + DFGL+K              
Sbjct: 111 IAEIVLALDHLHQLGI---IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC 167

Query: 448 GTFGYMPPEYAQYGDV--SPKVDVYAFGVVLYELIS 481
           GT  YM PE  + G       VD ++ GV+ +EL++
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 80.1 bits (197), Expect = 2e-16
 Identities = 69/235 (29%), Positives = 112/235 (47%), Gaps = 45/235 (19%)

Query: 313 QKAAIKKMDM--QASREFL-AELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLS 368
           ++ A+KKMD+  Q  RE L  E+ ++   HH N+V +   Y V   L++V E++E G L+
Sbjct: 48  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107

Query: 369 E---HLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK 425
           +   H R      +       + L   R L Y+H   V   IHRDIKS +IL+  +   K
Sbjct: 108 DIVTHTR------MNEEQIATVCLSVLRALSYLHNQGV---IHRDIKSDSILLTSDGRIK 158

Query: 426 VADFGLTKLTEVGSASLPTR--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           ++DFG        S  +P R  LVGT  +M PE         +VD+++ G+++ E+I  +
Sbjct: 159 LSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Query: 484 EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVD---PRLGDNCPLDSVLK 535
                                   N P P++ +R++ D   PR+ D+  + SVL+
Sbjct: 216 PP--------------------YFNEP-PLQAMRRIRDNLPPRVKDSHKVSSVLR 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 79.2 bits (195), Expect = 3e-16
 Identities = 68/210 (32%), Positives = 105/210 (50%), Gaps = 34/210 (16%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLA-ELKVL 335
           KIGQG  G VY A              I V    Q+ AIK+M++  Q  +E +  E+ V+
Sbjct: 26  KIGQGASGTVYTA--------------IDVAT-GQEVAIKQMNLQQQPKKELIINEILVM 70

Query: 336 THVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL---DS 391
               H N+V  L  Y V   L++V EY+  G+L++ +  +  D        QIA    + 
Sbjct: 71  RENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD------EGQIAAVCREC 124

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVGTF 450
            + LE++H + V   IHRDIKS NIL+  +   K+ DFG   ++T     S  + +VGT 
Sbjct: 125 LQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTP 179

Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            +M PE        PKVD+++ G++  E++
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 36/220 (16%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK------MDMQASR 326
           NF +  KIG+G F  VY              R  C+ L  +  A+KK      MD +A +
Sbjct: 3   NFQIEKKIGRGQFSEVY--------------RATCL-LDRKPVALKKVQIFEMMDAKARQ 47

Query: 327 EFLAELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLR--GSGRDPLP--- 380
           + + E+ +L  ++H N+++ L  +  +  L +V E  + G+LS+ ++     +  +P   
Sbjct: 48  DCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT 107

Query: 381 -WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
            W   VQ+       +E++H   V   +HRDIK AN+ I      K+ D GL +     +
Sbjct: 108 VWKYFVQLC----SAVEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160

Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
            +  + LVGT  YM PE       + K D+++ G +LYE+
Sbjct: 161 TAAHS-LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 30/212 (14%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-------DMQASREFLAEL 332
           +G+G FG                + L+      QK A+K++        ++ SR+   E 
Sbjct: 8   VGEGSFGR---------------ALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EA 49

Query: 333 KVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
            +L  + H N+V     +  +G L++V EY + G+L + ++       P  + +Q  +  
Sbjct: 50  VLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM 109

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
             G+++IHE  V   +HRDIKS NI + +N   K+ DFG  +L      +     VGT  
Sbjct: 110 CLGVQHIHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGSARLL-TSPGAYACTYVGTPY 165

Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           Y+PPE  +    + K D+++ G +LYEL + K
Sbjct: 166 YVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.3 bits (193), Expect = 5e-16
 Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 31/220 (14%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE----- 327
           NF    KIG+G +G VY A       N     ++         A+KK+ +    E     
Sbjct: 1   NFQKVEKIGEGTYGVVYKAR------NKLTGEVV---------ALKKIRLDTETEGVPST 45

Query: 328 FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            + E+ +L  ++H N+V+L+     E  L+LV+E++ + +L + +  S    +P      
Sbjct: 46  AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKS 104

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
                 +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  T  
Sbjct: 105 YLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THE 160

Query: 447 VGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAK 483
           V T  Y  PE     +Y   S  VD+++ G +  E+++ +
Sbjct: 161 VVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 38/223 (17%)

Query: 272 DNFSMSHKIGQGGFGAVY---YAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASR 326
           ++ ++   IG+G FG VY   Y     E                   A+K  K     S 
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIA---------------VAVKTCKNCTSPSV 50

Query: 327 --EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
             +FL E  ++    H ++V+LIG   E  +++V E    G L  +L+   +  L  +S 
Sbjct: 51  REKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQ-VNKYSLDLASL 109

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS---AS 441
           +  +   +  L Y+       ++HRDI + N+L+      K+ DFGL++  E  S   AS
Sbjct: 110 ILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS 166

Query: 442 ---LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              LP +      +M PE   +   +   DV+ FGV ++E++ 
Sbjct: 167 KGKLPIK------WMAPESINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 78.6 bits (193), Expect = 6e-16
 Identities = 72/235 (30%), Positives = 107/235 (45%), Gaps = 43/235 (18%)

Query: 274 FSMSHKIGQGGFGAVYYA-ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR------ 326
           FS   +IG G FGAVY+A ++R                  +  AIKKM     +      
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNS----------------EVVAIKKMSYSGKQSNEKWQ 60

Query: 327 EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
           + + E++ L  + H N ++  G Y  E + +LV EY   G+ S+ L    + PL      
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIA 118

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL--- 442
            +   + +GL Y+H H +   IHRD+K+ NIL+        ++ GL KL + GSAS+   
Sbjct: 119 AVTHGALQGLAYLHSHNM---IHRDVKAGNILL--------SEPGLVKLGDFGSASIMAP 167

Query: 443 PTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
               VGT  +M PE       G    KVDV++ G+   EL   K  +   N  SA
Sbjct: 168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.3 bits (193), Expect = 9e-16
 Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 26/209 (12%)

Query: 280 IGQGGFGAVYYA-ELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH 337
           +GQG FG V+   ++ G + G  Y  ++      ++KA +K  D   ++    E  +L  
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKV------LKKATLKVRDRVRTK---MERDILAE 54

Query: 338 VHHLNLVRL-IGYCVEGSLFLVYEYIENGN----LSEHLRGSGRDPLPWSSRVQIALDSA 392
           V+H  +V+L   +  EG L+L+ +++  G+    LS+ +  +  D   + + + +ALD  
Sbjct: 55  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD-- 112

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
                 H H++ + I+RD+K  NIL+D+  H K+ DFGL+K   +          GT  Y
Sbjct: 113 ------HLHSLGI-IYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEY 164

Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           M PE       +   D ++FGV+++E+++
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 78/262 (29%), Positives = 120/262 (45%), Gaps = 47/262 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           DNF    KIG+G  G V  A ++         +L+         A+KKMD+  Q  RE L
Sbjct: 23  DNFI---KIGEGSTGIVCIATVKSS------GKLV---------AVKKMDLRKQQRRELL 64

Query: 330 -AELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSE---HLRGSGRDPLPWSSR 384
             E+ ++    H N+V +   Y V   L++V E++E G L++   H R      +     
Sbjct: 65  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQI 118

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
             + L   + L  +H   V   IHRDIKS +IL+  +   K++DFG        S  +P 
Sbjct: 119 AAVCLAVLKALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPR 172

Query: 445 R--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
           R  LVGT  +M PE        P+VD+++ G+++ E+       V G     +   L A+
Sbjct: 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM-------VDGEPPYFNEPPLKAM 225

Query: 503 FEEVLNLPDPIEDLRKLVDPRL 524
                NLP  +++L K V P L
Sbjct: 226 KMIRDNLPPKLKNLHK-VSPSL 246

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 80.7 bits (199), Expect = 1e-15
 Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 25/278 (8%)

Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC-VE 352
           RG+ G SY  + I   +      I  ++   S E  A++  L    H N+V+LIG C  E
Sbjct: 700 RGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEI-ADMGKL---QHPNIVKLIGLCRSE 755

Query: 353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK 412
              +L++EYIE  NLSE LR      L W  R +IA+  A+ L ++H    P  +  ++ 
Sbjct: 756 KGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810

Query: 413 SANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAF 472
              I+ID        D    +L+  G     T+   +  Y+ PE  +  D++ K D+Y F
Sbjct: 811 PEKIIID------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGF 864

Query: 473 GVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDS 532
           G++L EL++ K      + + A+     ++ E           L   +DP +  +  ++ 
Sbjct: 865 GLILIELLTGK------SPADAEFGVHGSIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQ 917

Query: 533 --VLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT 568
             ++++  LA  CT   P  RP    ++  L + S ++
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS 955

Length = 968

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 62/229 (27%), Positives = 103/229 (44%), Gaps = 35/229 (15%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G GGFG V   +++ +   ++   L CV     K  I +   Q      +E ++L   +
Sbjct: 1   LGVGGFGRVELVKVKSK-NRTFA--LKCVK----KRHIVETGQQ--EHIFSEKEILEECN 51

Query: 340 HLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
           H  +V+L  Y     +  ++++ EY   G L   LR  G     +++R  IA       E
Sbjct: 52  HPFIVKL--YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIAC-VVLAFE 107

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y+H   +   I+RD+K  N+L+D N + K+ DFG  K  ++ S        GT  Y+ PE
Sbjct: 108 YLHNRGI---IYRDLKPENLLLDSNGYVKLVDFGFAK--KLKSGQKTWTFCGTPEYVAPE 162

Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAK--------------EAIVKGNG 491
                     VD ++ G++LYEL++ +                I+KGNG
Sbjct: 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 59/230 (25%), Positives = 110/230 (47%), Gaps = 20/230 (8%)

Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEG 353
           +G YG  Y +R +   + +    I + D +  +    E+ + +++ H N+V+ +G   E 
Sbjct: 18  KGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN 77

Query: 354 SLFLVY-EYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA--RGLEYIHEHTVPVYIHRD 410
             F ++ E +  G+LS  LR S   PL  + +  I        GL+Y+H++ +   +HRD
Sbjct: 78  GFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI---VHRD 133

Query: 411 IKSANILIDKNFHA---KVADFGLTK-LTEVGSASLPTRLVGTFGYMPPEYAQYG--DVS 464
           IK  N+L+  N ++   K++DFG +K L  +   +      GT  YM PE    G     
Sbjct: 134 IKGDNVLV--NTYSGVVKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEVIDKGPRGYG 189

Query: 465 PKVDVYAFGVVLYELISAKEAIVK-GNGSSADSKGLVALFEEVLNLPDPI 513
              D+++ G  + E+ + K   ++ G   +A  K  V +F+    +P+ +
Sbjct: 190 APADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VGMFKIHPEIPESL 237

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.1 bits (189), Expect = 2e-15
 Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 28/222 (12%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FLA 330
           ++   KIGQG  G V+ A                     Q+ AIK++++Q   +    + 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVA---------------TGQEVAIKQINLQKQPKKELIIN 65

Query: 331 ELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ V+  + + N+V  +  + V   LF+V EY+  G+L++ +  +  D    +    +  
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDE---AQIAAVCR 122

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVG 448
           +  + LE++H + V   IHRDIKS N+L+  +   K+ DFG   ++T     S  + +VG
Sbjct: 123 ECLQALEFLHANQV---IHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMVG 177

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           T  +M PE        PKVD+++ G++  E++  +   +  N
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 15/211 (7%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK 333
           F     +G+GGFG V   ++R   G  Y     C  L  +K  IKK   ++    L E +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT-GKMY----ACKKL--EKKRIKKRKGESMA--LNEKQ 52

Query: 334 VLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
           +L  V+   +V L   Y  + +L LV   +  G+L  H+   G         V  A +  
Sbjct: 53  ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEIC 112

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
            GLE +H+  +   ++RD+K  NIL+D + H +++D GL      G  ++  R VGT GY
Sbjct: 113 CGLEDLHQERI---VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR-VGTVGY 167

Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           M PE  +    +   D +A G +LYE+I+ +
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 60/222 (27%), Positives = 111/222 (50%), Gaps = 33/222 (14%)

Query: 275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI-KKMDMQASREFLAELK 333
           ++   +G+G FG+V   +L  +        ++ V +   K AI  + +M+   +FL+E  
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQD------DSILKVAVKTMKIAICTRSEME---DFLSEAV 52

Query: 334 VLTHVHHLNLVRLIGYCVEG-------SLFLVYEYIENGNLSEHLRGS--GRDP--LPWS 382
            +    H N++RLIG C++        S  ++  ++++G+L   L  S  G  P  LP  
Sbjct: 53  CMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQ 112

Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V+   D A G+EY+   +   +IHRD+ + N ++++N +  VADFGL+K    G    
Sbjct: 113 MLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYR 169

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKV-----DVYAFGVVLYEL 479
             R+      MP ++     ++ +V     DV++FGV ++E+
Sbjct: 170 QGRI----AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 79/278 (28%), Positives = 131/278 (47%), Gaps = 42/278 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F +   IG+G FG V   +L+         ++  + +L +   +K+ +    RE   E
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNA------DKVFAMKILNKWEMLKRAETACFRE---E 51

Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP------WSSR 384
             VL +  +  +  L   +  E +L+LV +Y   G+L   L     D LP      + + 
Sbjct: 52  RDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARFYLAE 110

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LTKLTEVGSASLP 443
           + IA+DS   L Y+H         RDIK  NIL+D N H ++ADFG   KL E G+    
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-S 160

Query: 444 TRLVGTFGYMPPEYAQY-----GDVSPKVDVYAFGVVLYELISAK-----EAIVKGNGSS 493
           +  VGT  Y+ PE  Q      G   P+ D ++ GV +YE++  +     E++V+  G  
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220

Query: 494 ADSKGLVALFEEVLNLPDPIEDL-RKLV---DPRLGDN 527
            + K       +V ++ +  +DL R+L+   + RLG N
Sbjct: 221 MNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQN 258

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 64/219 (29%), Positives = 104/219 (47%), Gaps = 36/219 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           ++F +  +IG G +G VY A       N     L         AAIK + ++   +F   
Sbjct: 9   EDFELIQRIGSGTYGDVYKAR------NVNTGEL---------AAIKVIKLEPGEDFAVV 53

Query: 331 --ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSE--HLRGSGRDPLPWSSRV 385
             E+ ++    H N+V   G Y     L++  E+   G+L +  H+ G    PL  S   
Sbjct: 54  QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG----PLSESQIA 109

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
            ++ ++ +GL Y+H       +HRDIK ANIL+  N H K+ADFG++      +A++  R
Sbjct: 110 YVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKR 163

Query: 446 --LVGTFGYMPPEYA---QYGDVSPKVDVYAFGVVLYEL 479
              +GT  +M PE A   + G  +   D++A G+   EL
Sbjct: 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 71/305 (23%), Positives = 137/305 (44%), Gaps = 53/305 (17%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK----VL 335
           +G+G FG V       E  N+            ++ A+K +  ++    +A+LK    +L
Sbjct: 12  LGEGHFGKVELCRYDPEGDNT-----------GEQVAVKSLKPESGGNHIADLKKEIEIL 60

Query: 336 THVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            +++H N+V+  G C E     + L+ E++ +G+L E+L    ++ +    +++ A+   
Sbjct: 61  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQIC 119

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL--TEVGSASLPTRLVGTF 450
           +G++Y+       Y+HRD+ + N+L++     K+ DFGLTK   T+    ++   L    
Sbjct: 120 KGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176

Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA-----------IVKGNGSSADSKGL 499
            +  PE           DV++FGV LYEL++  ++           I   +G    ++ L
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR-L 235

Query: 500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
           V + EE   LP P              NCP     ++ QL + C +  P  R + ++++ 
Sbjct: 236 VRVLEEGKRLPRP-------------PNCP----EEVYQLMRKCWEFQPSKRTTFQNLIE 278

Query: 560 ALMTL 564
               +
Sbjct: 279 GFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGFG V   ++R         +L     L +K   K+   + +   + E ++L  VH
Sbjct: 1   LGKGGFGEVSACQMRAT------GKLYACKKLNKKRLKKRKGYEGA---MVEKRILAKVH 51

Query: 340 HLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDP--LPWSSRVQIALDSARGLE 396
              +V L   +  +  L LV   +  G+L  H+     +    P             GLE
Sbjct: 52  SRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLE 111

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LVGTFGYMPP 455
           ++H+  +   I+RD+K  N+L+D + + +++D GL    E+      T+   GT G+M P
Sbjct: 112 HLHQRRI---IYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGTPGFMAP 166

Query: 456 EYAQYGDVSPKVDVYAFGVVLYELISAK 483
           E  Q  +    VD +A GV LYE+I+A+
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 68/227 (29%), Positives = 112/227 (49%), Gaps = 42/227 (18%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D +    KIG+G +G VY A  R    N  ++        ++K  +++ D       + E
Sbjct: 2   DQYEKVEKIGEGTYGVVYKA--RDRVTNETIA--------LKKIRLEQEDEGVPSTAIRE 51

Query: 332 LKVLTHVHHLNLVRL--IGYCVEGSLFLVYEYIENGNLSEHLRGS---GRDP-LPWSSRV 385
           + +L  + H N+VRL  + +  E  L+LV+EY++  +L +H+  S    ++P L  +   
Sbjct: 52  ISLLKEMQHGNIVRLQDVVHS-EKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLY 109

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSASLPT 444
           QI     RG+ Y H H V   +HRD+K  N+LID+  +A K+ADFGL +     +  +P 
Sbjct: 110 QIL----RGIAYCHSHRV---LHRDLKPQNLLIDRRTNALKLADFGLAR-----AFGIPV 157

Query: 445 RL----VGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
           R     V T  Y  PE       Y   S  VD+++ G +  E+++ K
Sbjct: 158 RTFTHEVVTLWYRAPEILLGSRHY---STPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 75.7 bits (187), Expect = 4e-15
 Identities = 66/238 (27%), Positives = 116/238 (48%), Gaps = 49/238 (20%)

Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-F 328
           D +   ++I +G +G VY A  +  GE         I         A+KK+ M+  +E F
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGE---------IV--------ALKKLKMEKEKEGF 47

Query: 329 ----LAELKVLTHVHHLNLVRLIGYCVEGS----LFLVYEYIENG--NLSEHLRGSGRDP 378
               L E+ +L  + H N+V  +   V GS    +++V EY+E+   +L E ++     P
Sbjct: 48  PITSLREINILLKLQHPNIVT-VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQ----P 102

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG 438
              S    + L    G+ ++H++ +   +HRD+K++N+L++     K+ DFGL +  E G
Sbjct: 103 FLQSEVKCLMLQLLSGVAHLHDNWI---LHRDLKTSNLLLNNRGILKICDFGLAR--EYG 157

Query: 439 SASLP-TRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG 491
           S   P T+LV T  Y  PE      +Y   S  +D+++ G +  EL++ K+ +  G  
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEY---STAIDMWSVGCIFAELLT-KKPLFPGKS 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 66/204 (32%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL-THV 338
           IG+G FG V  A+     G  Y  ++      +QK AI K   Q  +  +AE  VL  +V
Sbjct: 3   IGKGSFGKVLLAK-HKADGKFYAVKV------LQKKAILKKKEQ--KHIMAERNVLLKNV 53

Query: 339 HHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV L   +     L+ V +Y+  G L  HL+     P P +      + SA G  Y
Sbjct: 54  KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALG--Y 111

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H   +   I+RD+K  NIL+D   H  + DFGL K     S +  T   GT  Y+ PE 
Sbjct: 112 LHSLNI---IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEV 167

Query: 458 AQYGDVSPKVDVYAFGVVLYELIS 481
            +       VD +  G VLYE++ 
Sbjct: 168 LRKQPYDRTVDWWCLGAVLYEMLY 191

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 59/236 (25%), Positives = 111/236 (47%), Gaps = 39/236 (16%)

Query: 273 NFSMSHKIGQGGFGAVYYA---ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           N  +   +G+G FG V  A    L+G  G +     + V +L + A+  ++     R+ L
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYT----TVAVKMLKENASSSEL-----RDLL 51

Query: 330 AELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGS-------------- 374
           +E  +L  V+H ++++L G C + G L L+ EY + G+L   LR S              
Sbjct: 52  SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNR 111

Query: 375 --------GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
                       L     +  A   +RG++Y+ E  +   +HRD+ + N+L+ +    K+
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKL---VHRDLAARNVLVAEGRKMKI 168

Query: 427 ADFGLTK-LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           +DFGL++ + E  S    ++      +M  E       + + DV++FGV+L+E+++
Sbjct: 169 SDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 41/253 (16%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FLA 330
           ++   KIGQG  G VY A +    G              Q+ AI++M++Q   +    + 
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATG--------------QEVAIRQMNLQQQPKKELIIN 66

Query: 331 ELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ V+    + N+V  L  Y V   L++V EY+  G+L++ +  +  D         +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 123

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVG 448
           +  + LE++H + V   IHRDIKS NIL+  +   K+ DFG   ++T     S  + +VG
Sbjct: 124 ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVG 178

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA-----------IVKGNGSS--AD 495
           T  +M PE        PKVD+++ G++  E+I  +             ++  NG+    +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238

Query: 496 SKGLVALFEEVLN 508
            + L A+F + LN
Sbjct: 239 PEKLSAIFRDFLN 251

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 75.1 bits (184), Expect = 6e-15
 Identities = 70/292 (23%), Positives = 123/292 (42%), Gaps = 53/292 (18%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL---- 329
           F+   +IG+G FG V+                   N   Q  AIK +D++ + + +    
Sbjct: 6   FTKLERIGKGSFGEVFKG---------------IDNRTQQVVAIKIIDLEEAEDEIEDIQ 50

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ VL+      + +  G  ++G+ L+++ EY+  G+  + LR    D    ++ ++  
Sbjct: 51  QEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEI 110

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
           L   +GL+Y+H       IHRDIK+AN+L+ +    K+ADFG+  +LT+          V
Sbjct: 111 L---KGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFV 162

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE-EV 506
           GT  +M PE  Q      K D+++ G+   EL        KG   ++D   +  LF    
Sbjct: 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIEL-------AKGEPPNSDMHPMRVLFLIPK 215

Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
            N P    +  K                   +    C  + P  RP+ + ++
Sbjct: 216 NNPPTLTGEFSK----------------PFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.5 bits (185), Expect = 6e-15
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 24/209 (11%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG VY      E     +   + + +L +    K     A+ EF+ E  ++  + 
Sbjct: 15  LGSGAFGTVYKGIWVPE--GETVKIPVAIKILNETTGPK-----ANVEFMDEALIMASMD 67

Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH 399
           H +LVRL+G C+  ++ LV + + +G L +++    +D +     +   +  A+G+ Y+ 
Sbjct: 68  HPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 400 EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE-------VGSASLPTRLVGTFGY 452
           E  +   +HRD+ + N+L+    H K+ DFGL +L E            +P +      +
Sbjct: 127 ERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------W 177

Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           M  E   Y   + + DV+++GV ++EL++
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 75.0 bits (184), Expect = 7e-15
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 20/217 (9%)

Query: 273 NFSMSHKIGQGGFGAVYYA-ELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           NF +   +G G +G V+   ++ G + G  Y  +++    ++QKA       + +     
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKA-------KTTEHTRT 53

Query: 331 ELKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           E +VL H+     +  + Y    +  L L+ +YI  G L  HL  S R+       VQI 
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL--SQRERFK-EQEVQIY 110

Query: 389 L-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
             +    LE++H+  +   I+RDIK  NIL+D N H  + DFGL+K              
Sbjct: 111 SGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC 167

Query: 448 GTFGYMPPEYAQYGDV--SPKVDVYAFGVVLYELISA 482
           GT  YM P+  + GD      VD ++ GV++YEL++ 
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 74.6 bits (183), Expect = 8e-15
 Identities = 71/253 (28%), Positives = 111/253 (43%), Gaps = 34/253 (13%)

Query: 316 AIKKMDMQAS----REFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEH 370
           AI  +    S    R FLAE   L    H N+VRL G    G+ + +V EY+ NG L   
Sbjct: 37  AIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSF 96

Query: 371 LRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
           LR      L     + +    A G++Y+ E     Y+H+ + +  +L++ +   K++ F 
Sbjct: 97  LR-KHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFR 152

Query: 431 LTKLTEVGSASLPTRLVG--TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
             +L E  S ++ T + G     +  PE  QY   S   DV++FG+V++E++S       
Sbjct: 153 --RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY------ 204

Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G     D  G     ++V+     +ED  +L  PR   NCP      + QL   C Q+  
Sbjct: 205 GERPYWDMSG-----QDVIK---AVEDGFRLPAPR---NCP----NLLHQLMLDCWQKER 249

Query: 549 QLRPSMRSIVVAL 561
             RP    I   L
Sbjct: 250 GERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 35/217 (16%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVN------LLMQKAAIKKMDMQASREFLA--- 330
           +GQG FG VY                +C +      L +++        +  +E  A   
Sbjct: 10  LGQGAFGRVY----------------LCYDVDTGRELAVKQVPFDPDSPETKKEVNALEC 53

Query: 331 ELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           E+++L ++ H  +V+  G C+    +L +  EY+  G++ + L+  G   L  +   +  
Sbjct: 54  EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYT 110

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLV 447
                G+EY+H + +   +HRDIK ANIL D   + K+ DFG +K L  + S+    + V
Sbjct: 111 RQILEGVEYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV 167

Query: 448 -GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            GT  +M PE         K DV++ G  + E+++ K
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 15/205 (7%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGFG V   ++R   G  Y     C  L  +K  IKK   +A    L E ++L  V+
Sbjct: 8   LGKGGFGEVCACQVRAT-GKMY----ACKKL--EKKRIKKRKGEAMA--LNEKQILEKVN 58

Query: 340 HLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
              +V L   Y  + +L LV   +  G+L  H+   G         V  A +   GLE +
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA 458
           H   +   ++RD+K  NIL+D   H +++D GL    E+         VGT GYM PE  
Sbjct: 119 HRERI---VYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVV 173

Query: 459 QYGDVSPKVDVYAFGVVLYELISAK 483
           +    +   D +  G ++YE+I  K
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 21/173 (12%)

Query: 315 AAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSE-HLR 372
             +KK+ M+       E+++L  + H NLV LI        L+LV+E++++  L +    
Sbjct: 41  KMVKKIAMR-------EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY 93

Query: 373 GSGRDPLPWSSRVQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
            +G D     SRV+  L    RG+E+ H H +   IHRDIK  NIL+ ++   K+ DFG 
Sbjct: 94  PNGLD----ESRVRKYLFQILRGIEFCHSHNI---IHRDIKPENILVSQSGVVKLCDFGF 146

Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS--PKVDVYAFGVVLYELISA 482
            + T      + T  V T  Y  PE    GD      VD++A G ++ E+++ 
Sbjct: 147 AR-TLAAPGEVYTDYVATRWYRAPELL-VGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 45/221 (20%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-----FLAELK 333
           KIG+G +G VY A  R +                +  A+KK+ ++   E      + E+ 
Sbjct: 6   KIGEGTYGVVYKA--RDKLTG-------------EIVALKKIRLETEDEGVPSTAIREIS 50

Query: 334 VLTHVHHLNLVRL--IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
           +L  ++H N+VRL  + +  E  L+LV+E++ + +L +++  S    L     ++  L  
Sbjct: 51  LLKELNHPNIVRLLDVVHS-ENKLYLVFEFL-DLDLKKYMDSSPLTGLD-PPLIKSYLYQ 107

Query: 392 -ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL---- 446
             +G+ Y H H V   +HRD+K  N+LID+    K+ADFGL +     +  +P R     
Sbjct: 108 LLQGIAYCHSHRV---LHRDLKPQNLLIDREGALKLADFGLAR-----AFGVPVRTYTHE 159

Query: 447 VGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
           V T  Y  PE      QY   S  VD+++ G +  E+++ +
Sbjct: 160 VVTLWYRAPEILLGSRQY---STPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 61/254 (24%), Positives = 120/254 (47%), Gaps = 32/254 (12%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK 333
           + +  ++G+G FG VY  + +       L        ++++  + +++   + +   E +
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLK-------VLKEIPVGELNPNETVQANQEAQ 54

Query: 334 VLTHVHHLNLVRLIGYCVEGSLF-LVYEYIENGNLS---EHLRGSGRDPLPWSSRVQIAL 389
           +L+ + H  +V+     +E   F ++ EY E  +L    E L+ +G+  L  +   +  +
Sbjct: 55  LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFI 113

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
               G+ Y+H+  +   +HRD+K+ NI +  N   K+ DFG+++L  +GS  L T   GT
Sbjct: 114 QLLLGVHYMHQRRI---LHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGT 168

Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA------------IVKGNGSSAD-- 495
             YM PE  ++     K D+++ G +LYE+     A            IV+G   S    
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPET 228

Query: 496 -SKGLVALFEEVLN 508
            S+ L ++ + +LN
Sbjct: 229 YSRQLNSIMQSMLN 242

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 74.0 bits (181), Expect = 2e-14
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 28/222 (12%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FLA 330
           ++   KIGQG  G VY A +    G              Q+ AIK+M++Q   +    + 
Sbjct: 21  YTRFEKIGQGASGTVYTA-IDIATG--------------QEVAIKQMNLQQQPKKELIIN 65

Query: 331 ELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ V+    + N+V  L  Y V   L++V EY+  G+L++ +  +  D         +  
Sbjct: 66  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 122

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVG 448
           +  + L+++H + V   IHRDIKS NIL+  +   K+ DFG   ++T     S  + +VG
Sbjct: 123 ECLQALDFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVG 177

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           T  +M PE        PKVD+++ G++  E++  +   +  N
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 71/299 (23%), Positives = 130/299 (43%), Gaps = 57/299 (19%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG VY      +  N  +   + + +L +  + K     A++E L E  V+  V 
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIP--VAIKVLRENTSPK-----ANKEILDEAYVMAGVG 67

Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLR------GSGRDPLPWSSRVQIALDSAR 393
              + RL+G C+  ++ LV + +  G L +++R      GS +D L W   VQIA    +
Sbjct: 68  SPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGS-QDLLNWC--VQIA----K 120

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS-------ASLPTRL 446
           G+ Y+ E  +   +HRD+ + N+L+    H K+ DFGL +L ++           +P + 
Sbjct: 121 GMSYLEEVRL---VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK- 176

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV 506
                +M  E   +   + + DV+++GV ++EL++       G  +              
Sbjct: 177 -----WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR------------- 218

Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS 565
             +PD +E   +L  P     C +D  + M +    C     + RP  R +V     ++
Sbjct: 219 -EIPDLLEKGERLPQP---PICTIDVYMIMVK----CWMIDSECRPRFRELVDEFSRMA 269

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)

Query: 282 QGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHL 341
           +G FG ++Y  L  E         + V  +   A+  ++ +      L E  +L  + H 
Sbjct: 16  EGTFGRIFYGILIDEKPGK--EEEVFVKTVKDHASEIQVTL-----LLQESCLLYGLSHQ 68

Query: 342 NLVRLIGYCVEGSL--FLVYEYIENGNLSEHLR----GSGRDPLPWSSR--VQIALDSAR 393
           N++ ++  C+E     F++Y Y+  GNL   L+    G   +P   S++  V +A+  A 
Sbjct: 69  NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASL------PTRL 446
           G+ Y+H+  V   IH+DI + N +ID+    K+ D  L++ L  +    L      P + 
Sbjct: 129 GMSYLHKRGV---IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK- 184

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                +M  E     + S   DV++FGV+L+EL++
Sbjct: 185 -----WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 34/238 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQ---KAAIKKMDMQASREF 328
           D+F    ++G G  G V   + +        S LI    L+    K AI+        + 
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKP-------SGLIMARKLIHLEIKPAIRN-------QI 50

Query: 329 LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           + EL+VL   +   +V   G +  +G + +  E+++ G+L + L+ + R P     +V I
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI 110

Query: 388 ALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTR 445
           A+   RGL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+   
Sbjct: 111 AV--LRGLAYLREKHQI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANS 161

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
            VGT  YM PE  Q    S + D+++ G+ L EL   +  I        D+K L A+F
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI-----PPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 51/291 (17%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL---- 329
           F+   +IG+G FG VY                   N   +  AIK +D++ + + +    
Sbjct: 6   FTKLERIGKGSFGEVYKG---------------IDNRTKEVVAIKIIDLEEAEDEIEDIQ 50

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ VL+      + R  G  ++G+ L+++ EY+  G+  + L+     PL  +    I 
Sbjct: 51  QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATIL 107

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
            +  +GL+Y+H       IHRDIK+AN+L+ +    K+ADFG+  +LT+          V
Sbjct: 108 REILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFV 162

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           GT  +M PE  +      K D+++ G+   EL        KG   ++D   +  LF    
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIEL-------AKGEPPNSDLHPMRVLFLIPK 215

Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           N P  +E   +   P               +  + C  + P+ RP+ + ++
Sbjct: 216 NSPPTLEG--QYSKP-------------FKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 73.5 bits (180), Expect = 4e-14
 Identities = 66/234 (28%), Positives = 102/234 (43%), Gaps = 27/234 (11%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL-THV 338
           IG+G FG V  A  + E       +   V +L +KA +KK   +  +  ++E  VL  +V
Sbjct: 3   IGKGSFGKVLLARHKAE------EKFYAVKVLQKKAILKK---KEEKHIMSERNVLLKNV 53

Query: 339 HHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-ALDSARGLE 396
            H  LV L   +     L+ V +YI  G L  HL+   R+      R +  A + A  L 
Sbjct: 54  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALG 110

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y+H   +   ++RD+K  NIL+D   H  + DFGL K   +      +   GT  Y+ PE
Sbjct: 111 YLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPE 166

Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP 510
                     VD +  G VLYE++               S+    +++ +LN P
Sbjct: 167 VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY--------SRNTAEMYDNILNKP 212

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 80/283 (28%), Positives = 122/283 (43%), Gaps = 52/283 (18%)

Query: 280 IGQGGFGAVYYAELRG---EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLT 336
           IG+G +GAVY    RG     G     ++I  NL      +   D+Q     L++L+   
Sbjct: 9   IGRGAYGAVY----RGKHVPTGRVVALKII--NLDTPDDDVS--DIQREVALLSQLR--- 57

Query: 337 HVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
                N+ +  G Y     L+++ EY E G++   ++     P+       I  +    L
Sbjct: 58  QSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVAL 114

Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
           +YIH+  V   IHRDIK+ANIL+    + K+ DFG+  L    S+   T  VGT  +M P
Sbjct: 115 KYIHKVGV---IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAP 170

Query: 456 EYAQYG---DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
           E    G   D   K D+++ G+ +YE       +  GN   +D    V  F  ++ +P  
Sbjct: 171 EVITEGKYYDT--KADIWSLGITIYE-------MATGNPPYSD----VDAFRAMMLIP-- 215

Query: 513 IEDLRKLVDPRLGDN--CPLDSVLKMAQLAKVCTQEYPQLRPS 553
                K   PRL DN    L     + +    C  E P+ R S
Sbjct: 216 -----KSKPPRLEDNGYSKL-----LREFVAACLDEEPKERLS 248

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 18/206 (8%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V     +   G  Y  +++   +++ K  +           L E +VL +  
Sbjct: 3   LGKGTFGKVILVREKAS-GKYYAMKILKKEVIIAKDEVAHT--------LTESRVLKNTR 53

Query: 340 HLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-ALDSARGLEY 397
           H  L  L   +  +  L  V EY+  G L  HL    R+ +    R +    +    L+Y
Sbjct: 54  HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDY 110

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H   +   ++RD+K  N+++DK+ H K+ DFGL K     +A++ T   GT  Y+ PE 
Sbjct: 111 LHSGKI---VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEV 166

Query: 458 AQYGDVSPKVDVYAFGVVLYELISAK 483
            +  D    VD +  GVV+YE++  +
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 66/261 (25%), Positives = 118/261 (45%), Gaps = 28/261 (10%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF---L 329
            +++   +G G FG VY    +    N+  + L    + +   A  K   +  +     +
Sbjct: 1   EYAVLEHLGSGAFGCVY----KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIV 56

Query: 330 AELKVLT-HVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHL------RGSGRDPLPW 381
           +E+ ++   + H N+VR     +E   L++V + IE   L EH       +    +   W
Sbjct: 57  SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW 116

Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
           +  VQ+ L     L Y+H+    V  HRD+   NI++ ++    + DFGL K  +    S
Sbjct: 117 NIFVQMVL----ALRYLHKEKRIV--HRDLTPNNIMLGEDDKVTITDFGLAK--QKQPES 168

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
             T +VGT  Y  PE  +      K DV+AFG +LY++ + +      N  S  +K + A
Sbjct: 169 KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEA 228

Query: 502 LFEEVLNLPDPI--EDLRKLV 520
           ++E    LP+ +  ED+  ++
Sbjct: 229 VYEP---LPEGMYSEDVTDVI 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 65/252 (25%), Positives = 106/252 (42%), Gaps = 71/252 (28%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----------MQ 323
           + +   IG+G +G VY A+ +    N    +           AIKK              
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRK----NGKDGKEY---------AIKKFKGDKEQYTGISQS 48

Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIEN--GNLSEHLRGSGRDP 378
           A RE    + +L  + H N+V L+   +E    S++L+++Y E+    + +  R + R  
Sbjct: 49  ACRE----IALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVS 104

Query: 379 LP--------WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI--DKNFHA--KV 426
           +P        W    QI L+   G+ Y+H + V   +HRD+K ANIL+  +       K+
Sbjct: 105 IPPSMVKSLLW----QI-LN---GVHYLHSNWV---LHRDLKPANILVMGEGPERGVVKI 153

Query: 427 ADFGLTKLTEVGSASLPT--RLVGTFGYMPPE-------YAQYGDVSPKVDVYAFGVVLY 477
            D GL +L       L     +V T  Y  PE       Y      +  +D++A G +  
Sbjct: 154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHY------TKAIDIWAIGCIFA 207

Query: 478 ELISAKEAIVKG 489
           EL++  E I KG
Sbjct: 208 ELLTL-EPIFKG 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 72.5 bits (178), Expect = 7e-14
 Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 41/213 (19%)

Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDMQA------SREFLAELKVLTHVHHLNLVRLIG 348
           G YG  YL R        Q+ A+KK++ Q        ++   E  +LT   +  +V +  
Sbjct: 12  GAYGAVYLVRH---KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM-- 66

Query: 349 YC---VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS-SRVQIALDSARGLEYIHEHTVP 404
           +C    +  L +V EY+E G+ +  L+  G   LP   +R+  A ++   LEY+H + + 
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFA-ETVLALEYLHNYGI- 122

Query: 405 VYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL-----------------V 447
             +HRD+K  N+LI    H K+ DFGL+K   +G  SL T L                  
Sbjct: 123 --VHRDLKPDNLLITSMGHIKLTDFGLSK---IGLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           GT  Y+ PE          VD +A G++LYE +
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 72.8 bits (179), Expect = 7e-14
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 32/211 (15%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FLAELKVL- 335
           +G+G FG V  AE +                L    A+KK D+ A  E    + E ++  
Sbjct: 7   LGRGHFGKVLLAEYKKT------------GELYAIKALKKGDIIARDEVESLMCEKRIFE 54

Query: 336 --THVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
                 H  LV L   +  E  +  V EY   G+L  H+     D       V  A    
Sbjct: 55  TANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVV 111

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
            GL+Y+HE+ +   ++RD+K  N+L+D     K+ADFGL K   +G     +   GT  +
Sbjct: 112 LGLQYLHENKI---VYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGTPEF 167

Query: 453 MPPEY---AQYGDVSPKVDVYAFGVVLYELI 480
           + PE      Y      VD +  GV++YE++
Sbjct: 168 LAPEVLTETSYTRA---VDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 65/239 (27%), Positives = 96/239 (40%), Gaps = 61/239 (25%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG V+      + G  Y  ++      ++K+ + K +        AE  +L    
Sbjct: 9   IGRGAFGEVWLVR-DKDTGQVYAMKV------LRKSDMIKRNQ--IAHVRAERDILADAD 59

Query: 340 HLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWS----SRVQIALDSA 392
              +V+L  Y     E  L+LV EY+  G+L   L      P   +    + + +ALDS 
Sbjct: 60  SPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK------------LTEVGSA 440
             L +IH         RDIK  NILID + H K+ADFGL K                   
Sbjct: 118 HKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 441 SLPTRL----------------VGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELI 480
                L                VGT  Y+ PE  +   YG    + D ++ GV+LYE++
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 24/209 (11%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI--KKMDMQASREFLAELKVLTH 337
           +G+GG+G V+  ++R   G     ++  + +L +KA I   + D   ++   AE  +L  
Sbjct: 4   LGKGGYGKVF--QVRKVTGAD-TGKIFAMKVL-KKATIVRNQKDTAHTK---AERNILEA 56

Query: 338 VHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSG---RDPLP-WSSRVQIALDSA 392
           V H  +V LI  +   G L+L+ EY+  G L  HL   G    D    + S + +AL   
Sbjct: 57  VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLAL--- 113

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
              E++H+  +   I+RD+K  NIL+D   H K+ DFGL K   +   ++     GT  Y
Sbjct: 114 ---EHLHQQGI---IYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEY 166

Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           M PE          VD ++ G ++Y++++
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLT 195

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.1 bits (177), Expect = 8e-14
 Identities = 67/236 (28%), Positives = 112/236 (47%), Gaps = 30/236 (12%)

Query: 309 NLLMQKAAIKKMDMQASR-EFLAELKVLTHVHHLNLVRLIGY----CVEGSLFLVYEYIE 363
            L+M +  I      A R + + ELKVL   H  N   ++G+      +G + +  E+++
Sbjct: 26  GLIMARKLIHLEIKPAIRNQIIRELKVL---HECNSPYIVGFYGAFYSDGEISICMEHMD 82

Query: 364 NGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNF 422
            G+L + L+ +GR P     ++ IA+   RGL Y+ E H +   +HRD+K +NIL++   
Sbjct: 83  GGSLDQVLKKAGRIPENILGKISIAV--LRGLTYLREKHKI---MHRDVKPSNILVNSRG 137

Query: 423 HAKVADFGLT-KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             K+ DFG++ +L +    S+    VGT  YM PE  Q    + + D+++ G+ L E+  
Sbjct: 138 EIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193

Query: 482 AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMA 537
            +  I        D+K L A+F        P+ +       R     P DS   MA
Sbjct: 194 GRYPI-----PPPDAKELEAMF------GRPVSEGEAKESHRPVSGHPPDSPRPMA 238

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 9/171 (5%)

Query: 316 AIKKMDMQASREFLAELK----VLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHL 371
           AIK +  ++ R+   E+      +  + H  +VRL+G C   SL LV +    G+L +H+
Sbjct: 40  AIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHV 99

Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
           R   RD L     +   +  A+G+ Y+ EH +   +HR++ + NIL+  +   ++ADFG+
Sbjct: 100 R-QHRDSLDPQRLLNWCVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGV 155

Query: 432 TKLTEVGSASLPTRLVGT-FGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             L              T   +M  E   +G  + + DV+++GV ++E++S
Sbjct: 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 80/324 (24%), Positives = 130/324 (40%), Gaps = 68/324 (20%)

Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK----KMD 321
           E++ +T  F    ++G+  FG VY   L G                 Q  AIK    K +
Sbjct: 1   EINLSTVRFM--EELGEDRFGKVYKGHLFGTAPGEQ----------TQAVAIKTLKDKAE 48

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLR-------- 372
                EF  E  + + + H N+V L+G    E  L +++ Y  + +L E L         
Sbjct: 49  GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDV 108

Query: 373 GSGRD------PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
           GS  D       L  +  V I    A G+E++  H V   +H+D+ + N+L+    + K+
Sbjct: 109 GSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKI 165

Query: 427 ADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           +D GL +          +G++ LP R      +M PE   YG  S   D++++GVVL+E+
Sbjct: 166 SDLGLFREVYAADYYKLMGNSLLPIR------WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Query: 480 ISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQL 539
            S       G  +                     +D+ +++  R    CP D    +  L
Sbjct: 220 FSYGLQPYCGYSN---------------------QDVIEMIRNRQVLPCPDDCPAWVYTL 258

Query: 540 AKVCTQEYPQLRPSMRSIVVALMT 563
              C  E+P  RP  + I   L T
Sbjct: 259 MLECWNEFPSRRPRFKDIHSRLRT 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 33/257 (12%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           D+F +   IG+G FG V   +++      +  R+  + +L +   +K+ +    RE    
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMK------HTERIYAMKILNKWEMLKRAETACFREERNV 54

Query: 328 -FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS-SRV 385
               + + +T +H+        +  E  L+LV +Y   G+L   L     D LP   +R 
Sbjct: 55  LVNGDCQWITTLHY-------AFQDENYLYLVMDYYVGGDLLT-LLSKFEDRLPEDMARF 106

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LTKLTEVGSASLPT 444
            IA +    +  IH+     Y+HRDIK  N+L+D N H ++ADFG   K+ + G+    +
Sbjct: 107 YIA-EMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ-SS 161

Query: 445 RLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
             VGT  Y+ PE  Q      G   P+ D ++ GV +YE++  +        S  ++ G 
Sbjct: 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGK 219

Query: 500 VALFEEVLNLPDPIEDL 516
           +   EE    P  I D+
Sbjct: 220 IMNHEERFQFPSHITDV 236

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK 333
           F     +G+GGFG V   ++R   G  Y  +       ++K  IKK   ++    L E +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRAT-GKMYACKR------LEKKRIKKRKGESMA--LNEKQ 52

Query: 334 VLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
           +L  V+   +V L   Y  + +L LV   +  G+L  H+   G         +  A +  
Sbjct: 53  ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEIL 112

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
            GLE +H       ++RD+K  NIL+D   H +++D GL    ++         VGT GY
Sbjct: 113 CGLEDLHRENT---VYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGY 167

Query: 453 MPPEY---AQYGDVSPKVDVYAFGVVLYELISAK 483
           M PE     +Y  +SP  D +  G ++YE+I  +
Sbjct: 168 MAPEVLNNQRYT-LSP--DYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 79/282 (28%), Positives = 127/282 (45%), Gaps = 54/282 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F +   IG+G FG V     +         ++  + LL +   IK+ D   S  F  E
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSS------KQVYAMKLLSKFEMIKRSD---SAFFWEE 93

Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS----SRVQ 386
             ++ H +   +V+L   +  +  L++V EY+  G+L  +L  +   P  W+    + V 
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEKWARFYTAEVV 152

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTR 445
           +ALD+      IH      +IHRD+K  N+L+DK+ H K+ADFG   K+   G     T 
Sbjct: 153 LALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA 203

Query: 446 LVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
            VGT  Y+ PE        G    + D ++ GV LYE+      +V      ADS  LV 
Sbjct: 204 -VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM------LVGDTPFYADS--LVG 254

Query: 502 LFEEVLN------LPDPIE---DLRKLV-------DPRLGDN 527
            + ++++       PD IE     + L+       + RLG N
Sbjct: 255 TYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRN 296

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 22/225 (9%)

Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-----HHLNLVRLIG 348
           RG Y    L RL     +     +KK ++    E +  ++   HV     +H  LV L  
Sbjct: 5   RGSYAKVLLVRLKKTERIYAMKVVKK-ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 63

Query: 349 -YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP----WSSRVQIALDSARGLEYIHEHTV 403
            +  E  LF V EY+  G+L  H++   + P      +S+ + +AL+      Y+HE  +
Sbjct: 64  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHERGI 117

Query: 404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV 463
              I+RD+K  N+L+D   H K+ D+G+ K   +      +   GT  Y+ PE  +  D 
Sbjct: 118 ---IYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDY 173

Query: 464 SPKVDVYAFGVVLYELISAKEAI-VKGNGSSADSKGLVALFEEVL 507
              VD +A GV+++E+++ +    + G+  + D      LF+ +L
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 218

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 15/210 (7%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGFG V   ++R   G  Y     C  L  +K  IKK   +A    L E ++L  V+
Sbjct: 8   LGKGGFGEVCACQVRAT-GKMY----ACKKL--EKKRIKKRKGEAMA--LNEKRILEKVN 58

Query: 340 HLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
              +V L   Y  + +L LV   +  G+L  H+   G         +  A +   GLE +
Sbjct: 59  SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA 458
               +   ++RD+K  NIL+D   H +++D GL    ++         VGT GYM PE  
Sbjct: 119 QRERI---VYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVI 173

Query: 459 QYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                +   D +  G ++YE+I  +    K
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 18/206 (8%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V     +         R   + +L ++  I K ++  +   + E +VL +  
Sbjct: 3   LGKGTFGKVILVREKAT------GRYYAMKILRKEVIIAKDEVAHT---VTESRVLQNTR 53

Query: 340 HLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-ALDSARGLEY 397
           H  L  L   +     L  V EY   G L  HL    R+ +    R +    +    LEY
Sbjct: 54  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEY 110

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H   V   ++RDIK  N+++DK+ H K+ DFGL K      A++ T   GT  Y+ PE 
Sbjct: 111 LHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEV 166

Query: 458 AQYGDVSPKVDVYAFGVVLYELISAK 483
            +  D    VD +  GVV+YE++  +
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 58/239 (24%), Positives = 93/239 (38%), Gaps = 59/239 (24%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-------DMQASREF---- 328
           +G+G +G V  A                  L  +  AIKK+       D+   R+     
Sbjct: 17  LGEGTYGKVEKAY---------------DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61

Query: 329 ------LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 L ELK++  + H N++ L+  Y     + LV + +   +L + +    R  L  
Sbjct: 62  GIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR--LTE 118

Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL---------- 431
           S    I L    GL  +H+     ++HRD+  ANI I+     K+ADFGL          
Sbjct: 119 SQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175

Query: 432 ---TKLTEVGSASLPTRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
              +K   +      T  V T  Y  PE      +Y      VD+++ G +  EL++ K
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFA---VDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.4 bits (176), Expect = 2e-13
 Identities = 60/235 (25%), Positives = 99/235 (42%), Gaps = 65/235 (27%)

Query: 278 HKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKM-----DMQASREFLA 330
             IG G +G V  A  +  G                  K AIKK+     D+  ++  L 
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGR-----------------KVAIKKISNVFDDLIDAKRILR 48

Query: 331 ELKVLTHVHHLNLVRLI------GYCVEGSLFLVYEYIE---------NGNLSE-HLRGS 374
           E+K+L H+ H N++ L+             +++V E +E            L++ H++  
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQ-- 106

Query: 375 GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL 434
                      QI     RGL+Y+H   V   IHRD+K +NIL++ N   K+ DFGL + 
Sbjct: 107 -------YFLYQIL----RGLKYLHSANV---IHRDLKPSNILVNSNCDLKICDFGLARG 152

Query: 435 TEVGSASLP--TRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAK 483
            +         T  V T  Y  PE     ++Y   +  +D+++ G +  EL++ K
Sbjct: 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY---TKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.8 bits (174), Expect = 3e-13
 Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 47/233 (20%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DM-QASR 326
             +     IG G +G V  A +    G              +K AIKK+    D+   ++
Sbjct: 5   SRYKPIENIGSGAYGVVCSA-IDTRSG--------------KKVAIKKIPHAFDVPTLAK 49

Query: 327 EFLAELKVLTHVHHLNLV--RLIGYCVEGSLF----LVYEYIENGNLSEHLRGSGRDPLP 380
             L ELK+L H  H N++  R I     G+ F    +V + +E+ +L   +      PL 
Sbjct: 50  RTLRELKILRHFKHDNIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQ--PLT 105

Query: 381 WSSRVQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
               ++  L    RGL+YIH   V   IHRD+K +N+L++++   ++ DFG+ +    G 
Sbjct: 106 -EEHIRYFLYQLLRGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGMAR----GL 157

Query: 440 ASLP-------TRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKE 484
           +S P       T  V T  Y  PE      + +  +D+++ G +  E++  ++
Sbjct: 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 17/203 (8%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL-THV 338
           IG+G FG V  A+ R   G  Y  ++      +QK  +  ++ +  +  +AE  VL  +V
Sbjct: 3   IGKGSFGKVLLAK-RKLDGKCYAVKV------LQKKIV--LNRKEQKHIMAERNVLLKNV 53

Query: 339 HHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV L   +     L+ V +++  G L  HL+     P P  +R   A + A  L Y
Sbjct: 54  KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-RARFYAA-EIASALGY 111

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H   +   ++RD+K  NIL+D   H  + DFGL K   +  +   T   GT  Y+ PE 
Sbjct: 112 LHSINI---VYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEV 167

Query: 458 AQYGDVSPKVDVYAFGVVLYELI 480
            +       VD +  G VLYE++
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 79/292 (27%), Positives = 121/292 (41%), Gaps = 34/292 (11%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG V     R         R+  +  + +   + + ++  +   LAE  VL  V+
Sbjct: 1   IGKGSFGKVMQVRKRDT------QRIYALKTIRKAHIVSRSEVTHT---LAERTVLAQVN 51

Query: 340 HLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
              +V L   +     L+LV  +I  G L  HL+  GR  L   +R   A +    LE +
Sbjct: 52  CPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDL-SRARFYTA-ELLCALENL 109

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA 458
           H+  V   I+RD+K  NIL+D   H  + DFGL KL         T   GT  Y+ PE  
Sbjct: 110 HKFNV---IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELL 165

Query: 459 QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPI-EDLR 517
                +  VD +  GV+LYE+++        N +    K    + +E L  PD    D +
Sbjct: 166 LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPDGFDRDAK 221

Query: 518 KLV------DP--RLGDNCPLD----SVLKMAQLAKVCTQEY-PQLRPSMRS 556
            L+      DP  RLG N   +             K+  +   P  +P++ S
Sbjct: 222 DLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSS 273

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 62/204 (30%), Positives = 95/204 (46%), Gaps = 19/204 (9%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL-THV 338
           IG+G FG V  A+ + + G+ Y      V +L +K  +KK   +     +AE  VL  ++
Sbjct: 3   IGKGSFGKVLLAKRKSD-GSFY-----AVKVLQKKTILKK---KEQNHIMAERNVLLKNL 53

Query: 339 HHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-ALDSARGLE 396
            H  LV L   +     L+ V +Y+  G L  HL+   R+      R +  A + A  + 
Sbjct: 54  KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFLEPRARFYAAEVASAIG 110

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y+H   +   I+RD+K  NIL+D   H  + DFGL K   V      +   GT  Y+ PE
Sbjct: 111 YLHSLNI---IYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE 166

Query: 457 YAQYGDVSPKVDVYAFGVVLYELI 480
             +       VD +  G VLYE++
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 32/200 (16%)

Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF---LAELKVLTHVHHLNLVRLIG-YC 350
           G YG+ Y +R +    L   AA+K + ++   +F     E+ ++    H N+V   G Y 
Sbjct: 20  GTYGDVYKARNLHTGEL---AAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 351 VEGSLFLVYEYIENGNLSE--HLRGSGRDPLPWSSRVQIAL---DSARGLEYIHEHTVPV 405
               L++  EY   G+L +  H+ G    PL   S +QIA    ++ +GL Y+H      
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTG----PL---SELQIAYVCRETLQGLAYLHSKG--- 126

Query: 406 YIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTR--LVGTFGYMPPEYA---Q 459
            +HRDIK ANIL+  N   K+ADFG+  K+T    A++  R   +GT  +M PE A   +
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKIT----ATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 460 YGDVSPKVDVYAFGVVLYEL 479
            G  +   D++A G+   EL
Sbjct: 183 NGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 45/171 (26%), Positives = 70/171 (40%), Gaps = 26/171 (15%)

Query: 354 SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPV-------Y 406
           +L+LV EY   G+L           L   +R +   D      Y+ E  + +       Y
Sbjct: 75  NLYLVMEYQPGGDL-----------LSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY 123

Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           +HRDIK  N+LID+  H K+ADFG                VGT  Y+ PE     +   K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 467 ------VDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD 511
                  D ++ GV+ YE+I  +    +G  +   +   +  F+  L  P+
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN--IMNFQRFLKFPE 232

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 35/225 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D +    KIG+G +G VY A    +     L  L    L M +  I      A RE ++ 
Sbjct: 1   DAYEKLEKIGEGTYGKVYKAR---DKNTGKLVALKKTRLEMDEEGIPPT---ALRE-ISL 53

Query: 332 LKVLTHVHHLNLVRLIGYCVEG--------SLFLVYEYIEN---GNLSEHLRGSGRDPLP 380
           L++L+   ++  VRL+   VE         SL+LV+EY+++     +  + RG GR PLP
Sbjct: 54  LQMLSESIYI--VRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGR-PLP 108

Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGS 439
             +         +G+ + H+H V   +HRD+K  N+L+DK     K+AD GL +   +  
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGV---MHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV 165

Query: 440 ASLPTRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELI 480
            S    +V T  Y  PE       Y   S  VD+++ G +  E+ 
Sbjct: 166 KSYTHEIV-TLWYRAPEVLLGSTHY---STPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 46/228 (20%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-----FLAELK 333
           KIG+G +G V+ A+ R                  +  A+K++ +    E      L E+ 
Sbjct: 7   KIGEGTYGTVFKAKNRET---------------HEIVALKRVRLDDDDEGVPSSALREIC 51

Query: 334 VLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ-IAL 389
           +L  + H N+VRL  Y V   +  L LV+EY +  +L ++      D  P    V+    
Sbjct: 52  LLKELKHKNIVRL--YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDP--EIVKSFMF 106

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL--- 446
              +GL + H H V   +HRD+K  N+LI+KN   K+ADFGL +     +  +P R    
Sbjct: 107 QLLKGLAFCHSHNV---LHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSA 158

Query: 447 -VGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            V T  Y PP+    A+    S  +D+++ G +  EL +A   +  GN
Sbjct: 159 EVVTLWYRPPDVLFGAKLYSTS--IDMWSAGCIFAELANAGRPLFPGN 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 68/291 (23%), Positives = 122/291 (41%), Gaps = 51/291 (17%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL---- 329
           F+   KIG+G FG V+                   N   +  AIK +D++ + + +    
Sbjct: 6   FTKLEKIGKGSFGEVFKG---------------IDNRTQKVVAIKIIDLEEAEDEIEDIQ 50

Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ VL+      + +  G Y  +  L+++ EY+  G+  + L      PL  +    I 
Sbjct: 51  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATIL 107

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
            +  +GL+Y+H       IHRDIK+AN+L+ ++   K+ADFG+  +LT+          V
Sbjct: 108 REILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFV 162

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           GT  +M PE  +      K D+++ G+   EL        KG    ++   +  LF    
Sbjct: 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL-------AKGEPPHSELHPMKVLFLIPK 215

Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           N P  +E                +    + +  + C  + P  RP+ + ++
Sbjct: 216 NNPPTLEG---------------NYSKPLKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 17/206 (8%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V   + +   G  Y  ++      ++K  I   D  A    L E +VL +  
Sbjct: 3   LGKGTFGKVILVKEKAT-GRYYAMKI------LKKEVIVAKDEVAHT--LTENRVLQNSR 53

Query: 340 HLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-ALDSARGLEY 397
           H  L  L   +     L  V EY   G L  HL    R+ +    R +    +    L+Y
Sbjct: 54  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDY 110

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H     VY  RD+K  N+++DK+ H K+ DFGL K      A++ T   GT  Y+ PE 
Sbjct: 111 LHSEKNVVY--RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEV 167

Query: 458 AQYGDVSPKVDVYAFGVVLYELISAK 483
            +  D    VD +  GVV+YE++  +
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 46/280 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F +   IG+G FG V   +++         ++  + +L +   +K+ +    RE   E
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNT------GQVYAMKILNKWEMLKRAETACFRE---E 51

Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP------WSSR 384
             VL +     +  L   +  E +L+LV +Y   G+L   L     D LP      + + 
Sbjct: 52  RDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAE 110

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LTKLTEVGSASLP 443
           + +A+DS   L Y+H         RDIK  N+L+DKN H ++ADFG   +L   G+    
Sbjct: 111 MVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-S 160

Query: 444 TRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
              VGT  Y+ PE  Q      G   P+ D ++ GV +YE++  +        S  ++ G
Sbjct: 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYG 218

Query: 499 LVALFEEVLNLPDPIED--------LRKLV---DPRLGDN 527
            +   +E    P  + D        +R+L+   + RLG N
Sbjct: 219 KIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRN 258

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (170), Expect = 7e-13
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY    + +    Y  +++    ++ K  +           + E  +L    
Sbjct: 1   IGKGTFGQVYQVR-KKDTRRIYAMKVLSKKEIVAKKEVAHT--------IGERNILVRTL 51

Query: 340 HLNLVRLIG----YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
                 ++G    +  +  L+LV +Y+  G L  HL+  GR      ++  IA +    L
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS-EDRAKFYIA-ELVLAL 109

Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
           E++H++ +   ++RD+K  NIL+D   H  + DFGL+K     + +  T   GT  Y+ P
Sbjct: 110 EHLHKYDI---VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAP 165

Query: 456 EY----AQYGDVSPKVDVYAFGVVLYEL 479
           E       Y      VD ++ GV+++E+
Sbjct: 166 EVLLDEKGYTK---HVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 23/211 (10%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V +       G     +LI + +   K AI+        + + E
Sbjct: 5   DDFEKISELGAGN-GGVVFKVSHKPSGLIMARKLIHLEI---KPAIRN-------QIIRE 53

Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 54  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 112

Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 113 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 164

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           T  YM PE  Q    S + D+++ G+ L E+
Sbjct: 165 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 34/214 (15%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG VY      E     +   + +  L +  + K     A++E L E  V+  V 
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEAYVMASVD 67

Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGS-----GRDPLPWSSRVQIALDSARG 394
           + ++ RL+G C+  ++ L+ + +  G L +++R        +  L W   VQIA    +G
Sbjct: 68  NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIA----KG 121

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT-------EVGSASLPTRLV 447
           + Y+ E  +   +HRD+ + N+L+    H K+ DFGL KL              +P +  
Sbjct: 122 MNYLEERRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK-- 176

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
               +M  E   +   + + DV+++GV ++EL++
Sbjct: 177 ----WMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 17/206 (8%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGFG V   +++   G  Y  + +    L +K+  +KM        L E ++L  V+
Sbjct: 1   LGKGGFGEVCAVQVKNT-GKMYACKKLDKKRLKKKSG-EKMA-------LLEKEILEKVN 51

Query: 340 HLNLVRLIGYCVEGS--LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
              +V L  Y  E    L LV   +  G+L  H+   G   L     +  +     G+ +
Sbjct: 52  SPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILH 110

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H   +   ++RD+K  N+L+D   + +++D GL    E+      T+  GT GYM PE 
Sbjct: 111 LHSMDI---VYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEI 165

Query: 458 AQYGDVSPKVDVYAFGVVLYELISAK 483
            +    S  VD +A G  +YE+++ +
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 16/202 (7%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V     +         +   + +L ++  I K ++  +   L E +VL +  
Sbjct: 3   LGKGTFGKVILVREKAT------GKYYAMKILKKEVIIAKDEVAHT---LTESRVLQNTR 53

Query: 340 HLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
           H  L  L   +     L  V EY   G L  HL          +      + SA  L Y+
Sbjct: 54  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA--LGYL 111

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA 458
           H   V   ++RD+K  N+++DK+ H K+ DFGL K   +   +      GT  Y+ PE  
Sbjct: 112 HSCDV---VYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVL 167

Query: 459 QYGDVSPKVDVYAFGVVLYELI 480
           +  D    VD +  GVV+YE++
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 21/208 (10%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           K+G+G +  V+        G S L+     NL+  K    + +  A    + E+ +L ++
Sbjct: 12  KLGEGTYATVFK-------GRSKLTE----NLVALKEIRLEHEEGAPCTAIREVSLLKNL 60

Query: 339 HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL-DSARGLE 396
            H N+V L      E  L LV+EY+++ +L ++L   G   L     V+I +    RGL 
Sbjct: 61  KHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLS 117

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y H+  +   +HRD+K  N+LI++    K+ADFGL +   V + +    +V T  Y PP+
Sbjct: 118 YCHKRKI---LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD 173

Query: 457 -YAQYGDVSPKVDVYAFGVVLYELISAK 483
                 + S  +D++  G +LYE+ + +
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 67/248 (27%), Positives = 109/248 (43%), Gaps = 44/248 (17%)

Query: 279 KIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL------- 329
           +IG G +G VY A     G +                  A+K + +Q + + L       
Sbjct: 7   EIGVGAYGTVYKARDPHSGHF-----------------VALKSVRVQTNEDGLPLSTVRE 49

Query: 330 -AELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            A LK L    H N+VRL+  C       E  + LV+E+++  +L  +L       LP  
Sbjct: 50  VALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAE 108

Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
           +   +     RGL+++H + +   +HRD+K  NIL+      K+ADFGL ++     A  
Sbjct: 109 TIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT 165

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
           P  +V T  Y  PE       +  VD+++ G +  E+   K  +  GN S AD  G +  
Sbjct: 166 P--VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGN-SEADQLGKIF- 220

Query: 503 FEEVLNLP 510
             +++ LP
Sbjct: 221 --DLIGLP 226

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 58/226 (25%), Positives = 106/226 (46%), Gaps = 42/226 (18%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE----- 327
           +++   KIG+G +G VY    +G    +            Q  A+KK+ +++  E     
Sbjct: 1   DYTKIEKIGEGTYGVVY----KGRNKKT-----------GQIVAMKKIRLESEEEGVPST 45

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            + E+ +L  + H N+V L    ++ S L+L++E++   +L ++L    +     +  V+
Sbjct: 46  AIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVK 104

Query: 387 IAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
             L    +G+ + H   V   +HRD+K  N+LID     K+ADFGL +     +  +P R
Sbjct: 105 SYLYQILQGILFCHSRRV---LHRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVR 156

Query: 446 L----VGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
           +    V T  Y  PE      +Y   S  VD+++ G +  E+ + K
Sbjct: 157 VYTHEVVTLWYRAPEVLLGSPRY---STPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 24/201 (11%)

Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDMQA--SREFLAELKVLT-HVHHLNLVRLIGYCV 351
           G YG  Y  R +      Q AAIK MD+      E   E+ +L  + HH N+    G  +
Sbjct: 17  GTYGQVYKGRHVKTG---QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 352 -------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVP 404
                  +  L+LV E+   G++++ ++ +  + L       I  +  RGL ++H+H V 
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV- 132

Query: 405 VYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS 464
             IHRDIK  N+L+ +N   K+ DFG++   +       T  +GT  +M PE     D +
Sbjct: 133 --IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIAC-DEN 188

Query: 465 P------KVDVYAFGVVLYEL 479
           P      K D+++ G+   E+
Sbjct: 189 PDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 39/132 (29%), Positives = 69/132 (52%), Gaps = 6/132 (4%)

Query: 352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDI 411
              LFLV EY+  G+L  H++   +  LP       A +    L ++HE  +   I+RD+
Sbjct: 68  TSRLFLVIEYVNGGDLMFHMQRQRK--LPEEHARFYAAEICIALNFLHERGI---IYRDL 122

Query: 412 KSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYA 471
           K  N+L+D + H K+ D+G+ K   +G     +   GT  Y+ PE  +  +    VD +A
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181

Query: 472 FGVVLYELISAK 483
            GV+++E+++ +
Sbjct: 182 LGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 29/212 (13%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           K+G+G +  VY        G S L+     NL+  K    + +  A    + E+ +L  +
Sbjct: 13  KLGEGTYATVYK-------GRSKLTD----NLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 339 HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL-DSARGLE 396
            H N+V L      E SL LV+EY++  +L ++L   G         V++ L    RGL 
Sbjct: 62  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN--SINMHNVKLFLFQLLRGLN 118

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL----VGTFGY 452
           Y H   V   +HRD+K  N+LI++    K+ADFGL +     + S+PT+     V T  Y
Sbjct: 119 YCHRRKV---LHRDLKPQNLLINERGELKLADFGLAR-----AKSIPTKTYSNEVVTLWY 170

Query: 453 MPPE-YAQYGDVSPKVDVYAFGVVLYELISAK 483
            PP+      D S ++D++  G + YE+ + +
Sbjct: 171 RPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 53/224 (23%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD------MQASREFLAELK 333
           +G G +G V  A                     +K AIKK+       + A R +  EL+
Sbjct: 23  VGSGAYGQVCSAFDTK---------------TGRKVAIKKLSRPFQSAIHAKRTY-RELR 66

Query: 334 VLTHVHHLNLVRLIG-YCVEGSL------FLVYEYIEN--GNLSEHLRGSGRDPLPWSSR 384
           +L H+ H N++ L+  +    SL      +LV   +     N+ +  + S          
Sbjct: 67  LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-------DDH 119

Query: 385 VQ-IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
           +Q +     RGL+YIH   +   IHRD+K +NI ++++   K+ DFGL + T+       
Sbjct: 120 IQFLVYQILRGLKYIHSAGI---IHRDLKPSNIAVNEDCELKILDFGLARHTD----DEM 172

Query: 444 TRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  V T  Y  PE    +  Y      VD+++ G ++ EL++ K
Sbjct: 173 TGYVATRWYRAPEIMLNWMHYNQT---VDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 24/201 (11%)

Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLT-HVHHLNLVRLIGYCV 351
           G YG  Y  R +      Q AAIK MD+      E   E+ +L  + HH N+    G  +
Sbjct: 27  GTYGQVYKGRHVKTG---QLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 352 EGS-------LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVP 404
           + S       L+LV E+   G++++ ++ +  + L       I  +  RGL ++H H V 
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKV- 142

Query: 405 VYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS 464
             IHRDIK  N+L+ +N   K+ DFG++   +       T  +GT  +M PE     D +
Sbjct: 143 --IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIAC-DEN 198

Query: 465 P------KVDVYAFGVVLYEL 479
           P      + D+++ G+   E+
Sbjct: 199 PDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 4e-12
 Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 67/241 (27%)

Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQA 324
             +     IG+G +G V  A  +  G                  K AIKK+         
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTG-----------------VKVAIKKISPFEHQTFC 47

Query: 325 SREFLAELKVLTHVHH------LNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDP 378
            R  L E+K+L    H      L+++R   +     +++V E +E  +L + ++      
Sbjct: 48  QRT-LREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK------ 99

Query: 379 LPWSSRV----------QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
              +  +          QI     RGL+YIH   V   +HRD+K +N+L++ N   K+ D
Sbjct: 100 ---TQHLSNDHIQYFLYQIL----RGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICD 149

Query: 429 FGLTKLT--EVGSASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISA 482
           FGL ++   E       T  V T  Y  PE       Y   +  +D+++ G +L E++S 
Sbjct: 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGY---TKAIDIWSVGCILAEMLSN 206

Query: 483 K 483
           +
Sbjct: 207 R 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 43/164 (26%), Positives = 80/164 (48%), Gaps = 15/164 (9%)

Query: 352 EGSLFLVYEYIENGNLSEHLRGSGRDPLP----WSSRVQIALDSARGLEYIHEHTVPVYI 407
           E  LF V E++  G+L  H++   + P      +S+ + +AL+      ++HE  +   I
Sbjct: 68  ESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------FLHERGI---I 118

Query: 408 HRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKV 467
           +RD+K  N+L+D   H K+ D+G+ K   +      +   GT  Y+ PE  +  D    V
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV 177

Query: 468 DVYAFGVVLYELISAKEAI-VKGNGSSADSKGLVALFEEVLNLP 510
           D +A GV+++E+++ +    + G   + D      LF+ +L   
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ 221

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 68/279 (24%), Positives = 105/279 (37%), Gaps = 84/279 (30%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A   G    S   R + V +L + A   +      +  + E
Sbjct: 7   DRLKLGKPLGRGAFGKVIQASAFG-IEKSASCRTVAVKMLKEGATASE-----YKALMTE 60

Query: 332 LKVLTHV-HHLNLVRLIG--------------YCVEGSL----------FLVYE------ 360
           LK+L H+ HHLN+V L+G              YC  G+L          F  Y       
Sbjct: 61  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRK 120

Query: 361 ------YIENGNL--------------SEHLRGS-----------GRDPLPWSSRVQIAL 389
                   +   L               E    S            ++PL     +  + 
Sbjct: 121 REMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSF 180

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-------LTEVGSASL 442
             ARG+E++        IHRD+ + NIL+ +N   K+ DFGL +           G A L
Sbjct: 181 QVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           P +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 238 PLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 68/241 (28%), Positives = 105/241 (43%), Gaps = 41/241 (17%)

Query: 258 KSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI 317
            S     E L   TD + +   IG+G +G VY      +  N     L  V +L     I
Sbjct: 8   NSSMLGLESLGDPTDTWEIIETIGKGTYGKVY------KVTNKKDGSLAAVKIL---DPI 58

Query: 318 KKMDMQASREFLAELKVLTHV-HHLNLVRLIG------YCVEGSLFLVYEYIENGNLSEH 370
             +D     E  AE  +L  + +H N+V+  G        V G L+LV E    G+++E 
Sbjct: 59  SDVD----EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL 114

Query: 371 LRGSGRDPLPWSSRVQ------IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
           ++G     L    R+       I   +  GL+++H + +   IHRD+K  NIL+      
Sbjct: 115 VKGL----LICGQRLDEAMISYILYGALLGLQHLHNNRI---IHRDVKGNNILLTTEGGV 167

Query: 425 KVADFGLTKLTEVGSASLPTRL-VGTFGYMPPEY---AQYGDVS--PKVDVYAFGVVLYE 478
           K+ DFG++   ++ S  L     VGT  +M PE     Q  D S   + DV++ G+   E
Sbjct: 168 KLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225

Query: 479 L 479
           L
Sbjct: 226 L 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 18/210 (8%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G +G VY        G +   +LI V  +    +      +   +   E+ +L  + 
Sbjct: 8   LGKGAYGTVYC-------GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60

Query: 340 HLNLVRLIGYCVEGSLFLVY-EYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
           H+N+V+ +G C++ +   ++ E++  G++S  L   G  PLP     +       G+ Y+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYL 118

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLV----GTFGYM 453
           H + V   +HRDIK  N+++  N   K+ DFG   +L  VG     + ++    GT  +M
Sbjct: 119 HNNCV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM 175

Query: 454 PPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            PE         K D+++ G  ++E+ + K
Sbjct: 176 APEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 68.3 bits (167), Expect = 6e-12
 Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 51/236 (21%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS------REFLAEL 332
            IG+GG G VY A       +   SR         + A+KK+    S      + FL E 
Sbjct: 9   LIGKGGMGEVYLAY------DPVCSR---------RVALKKIREDLSENPLLKKRFLREA 53

Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGS-GRDPLPWSSRVQIALD 390
           K+   + H  +V +   C +G  ++    YIE   L   L+    ++ L      + ++ 
Sbjct: 54  KIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG 113

Query: 391 S--------ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV----- 437
           +           +EY+H   V   +HRD+K  NIL+       + D+G     ++     
Sbjct: 114 AFLSIFHKICATIEYVHSKGV---LHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170

Query: 438 ------------GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                        S ++P ++VGT  YM PE       S   D+YA GV+LY++++
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 67.0 bits (163), Expect = 6e-12
 Identities = 72/253 (28%), Positives = 120/253 (47%), Gaps = 38/253 (15%)

Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           +L    +++ +   IG+G FG V          +    ++  + LL +   IK+ D   S
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVR------HKSTRKVYAMKLLSKFEMIKRSD---S 87

Query: 326 REFLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPW--- 381
             F  E  ++   +   +V+L   +  +  L++V EY+  G+L  +L  +   P  W   
Sbjct: 88  AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARF 146

Query: 382 -SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGS 439
            ++ V +ALD+      IH      +IHRD+K  N+L+DK+ H K+ADFG   K+ + G 
Sbjct: 147 YTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197

Query: 440 ASLPTRLVGTFGYMPPEY--AQYGD--VSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               T  VGT  Y+ PE   +Q GD     + D ++ GV LYE+      +V      AD
Sbjct: 198 VRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM------LVGDTPFYAD 250

Query: 496 SKGLVALFEEVLN 508
           S  LV  + +++N
Sbjct: 251 S--LVGTYSKIMN 261

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 50/177 (28%), Positives = 92/177 (51%), Gaps = 15/177 (8%)

Query: 313 QKAAIKKMDM--QASREFL-AELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLS 368
           ++ A+K MD+  Q  RE L  E+ ++    H N+V +   Y V   L+++ E+++ G L+
Sbjct: 47  RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106

Query: 369 EHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
           + +  +  +    ++  +  L   + L Y+H   V   IHRDIKS +IL+  +   K++D
Sbjct: 107 DIVSQTRLNEEQIATVCESVL---QALCYLHSQGV---IHRDIKSDSILLTLDGRVKLSD 160

Query: 429 FGLTKLTEVGSASLPTR--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           FG        S  +P R  LVGT  +M PE         +VD+++ G+++ E++  +
Sbjct: 161 FGFCAQI---SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 21/208 (10%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           K+G+G +  V+        G S L+     NL+  K    + +  A    + E+ +L  +
Sbjct: 13  KLGEGTYATVFK-------GRSKLTE----NLVALKEIRLEHEEGAPCTAIREVSLLKDL 61

Query: 339 HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL-DSARGLE 396
            H N+V L      + SL LV+EY++  +L +++   G   +     V+I L    RGL 
Sbjct: 62  KHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLA 118

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y H   V   +HRD+K  N+LI++    K+ADFGL +   V + +    +V T  Y PP+
Sbjct: 119 YCHRRKV---LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD 174

Query: 457 -YAQYGDVSPKVDVYAFGVVLYELISAK 483
                 + S ++D++  G + +E+ S +
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 34/226 (15%)

Query: 267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           L    +++ +   IG+G FG V     +         ++  + LL +   IK+ D   S 
Sbjct: 38  LQMKAEDYDVVKVIGRGAFGEVQLVRHKSS------QKVYAMKLLSKFEMIKRSD---SA 88

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPW-- 381
            F  E  ++   +   +V+L  +C    +  L++V EY+  G+L  +L  +   P  W  
Sbjct: 89  FFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAK 145

Query: 382 --SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVG 438
             ++ V +ALD+      IH   +   IHRD+K  N+L+DK+ H K+ADFG   K+ E G
Sbjct: 146 FYTAEVVLALDA------IHSMGL---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196

Query: 439 SASLPTRLVGTFGYMPPEY--AQYGD--VSPKVDVYAFGVVLYELI 480
                T  VGT  Y+ PE   +Q GD     + D ++ GV L+E++
Sbjct: 197 MVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 43/226 (19%)

Query: 273 NFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASR---- 326
           NF    K+G+G +  VY    R  GE                   A+K++ + A      
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEI-----------------VALKEIHLDAEEGTPS 43

Query: 327 EFLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSG-RDPLPWSSR 384
             + E+ ++  + H N+VRL      E  L LV+EY++  +L +++   G R  L  ++ 
Sbjct: 44  TAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTV 102

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
                   +G+ + HE+ V   +HRD+K  N+LI+K    K+ADFGL +   +   +   
Sbjct: 103 KSFTYQLLKGIAFCHENRV---LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159

Query: 445 RLVGTFGYMPPEYAQYGDV-------SPKVDVYAFGVVLYELISAK 483
            +V T  Y  P      DV       S  +D+++ G ++ E+I+ +
Sbjct: 160 EVV-TLWYRAP------DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 19/207 (9%)

Query: 330 AELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR---- 384
           +EL  L    H  +V+    +  +  L L+ EY   G+L++ ++   ++ LP+       
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 385 --VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSAS 441
              QI L     L+ +H   +   +HRD+KSANI +      K+ DFG +K  ++  S  
Sbjct: 174 LFYQIVL----ALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
           + +   GT  Y+ PE  +    S K D+++ GV+LYEL++         G S        
Sbjct: 227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF---KGPSQREIMQQV 283

Query: 502 LFEEVLNLPDPIED-LRKLVDPRLGDN 527
           L+ +    P P+   ++ L+DP L  N
Sbjct: 284 LYGKYDPFPCPVSSGMKALLDPLLSKN 310

Length = 478

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 22/206 (10%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+GGFG VY    + + G  Y  +  C++   ++  +K+ +  A  E +    V T   
Sbjct: 2   IGRGGFGEVYGCR-KADTGKMYAMK--CLD--KKRIKMKQGETLALNERIMLSLVSTGDC 56

Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSG----RDPLPWSSRVQIALDSARGL 395
              +     +     L  + + +  G+L  HL   G    ++   +++ + +      GL
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GL 110

Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
           E++H   V   ++RD+K ANIL+D++ H +++D GL       S   P   VGT GYM P
Sbjct: 111 EHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGYMAP 164

Query: 456 EYAQYGDV-SPKVDVYAFGVVLYELI 480
           E  Q G       D ++ G +L++L+
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 63.6 bits (154), Expect = 4e-11
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 37/219 (16%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNL-LMQKAAIKKMDM-----QASREFLA--- 330
           +GQG FG VY                +C ++   ++ A K++       + S+E  A   
Sbjct: 10  LGQGAFGRVY----------------LCYDVDTGRELAAKQVQFDPESPETSKEVSALEC 53

Query: 331 ELKVLTHVHHLNLVRLIGYCV----EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           E+++L ++ H  +V+  G C+    E +L +  EY+  G++ + L+  G   L  S   +
Sbjct: 54  EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRK 110

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTR 445
                  G+ Y+H + +   +HRDIK ANIL D   + K+ DFG +K L  +  +    R
Sbjct: 111 YTRQILEGMSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167

Query: 446 LV-GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            V GT  +M PE         K DV++ G  + E+++ K
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 41/134 (30%), Positives = 67/134 (50%), Gaps = 14/134 (10%)

Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSR------VQIALDSARGLEYIHEHTVPVYIHRD 410
           LV +Y   G+L + ++   +    +         +Q+ L     + ++H   +   IHRD
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL----AVHHVHSKHM---IHRD 168

Query: 411 IKSANILIDKNFHAKVADFGLTKL-TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDV 469
           IKSANIL+  N   K+ DFG +K+     S  +     GT  Y+ PE  +    S K D+
Sbjct: 169 IKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM 228

Query: 470 YAFGVVLYELISAK 483
           ++ GV+LYEL++ K
Sbjct: 229 FSLGVLLYELLTLK 242

Length = 496

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 58/173 (33%), Positives = 83/173 (47%), Gaps = 17/173 (9%)

Query: 316 AIKKM-DMQASREF----LAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSE 369
           AIKK  D + + E     L ELK+L  +   N+V L   +   G L+LV+EY+E  N+ E
Sbjct: 30  AIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK-NMLE 88

Query: 370 HLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF 429
            L        P   R  I     + + + H++ +   +HRDIK  N+LI  N   K+ DF
Sbjct: 89  LLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKNDI---VHRDIKPENLLISHNDVLKLCDF 144

Query: 430 GLTKLTEVGSASLPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYEL 479
           G  +    GS +  T  V T  Y  PE    A YG     VD+++ G +L EL
Sbjct: 145 GFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK---AVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 54/231 (23%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM------DMQASREFLAELK 333
           +G G +G V  A L    G               K AIKK+      ++ A R +  EL+
Sbjct: 23  VGSGAYGTVCSA-LDRRTG--------------AKVAIKKLYRPFQSELFAKRAY-RELR 66

Query: 334 VLTHVHHLNLVRLIG-YCVEGSL------FLVYEYI--ENGNLSEHLRGSGRDPLPWSSR 384
           +L H+ H N++ L+  +  + SL      +LV  ++  + G L +H + S         R
Sbjct: 67  LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-------EDR 119

Query: 385 VQ-IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
           +Q +     +GL+YIH   +   IHRD+K  N+ ++++   K+ DFGL + T+    S  
Sbjct: 120 IQFLVYQMLKGLKYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQTD----SEM 172

Query: 444 TRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           T  V T  Y  PE    +  Y   +  VD+++ G ++ E+++ K  + KG+
Sbjct: 173 TGYVVTRWYRAPEVILNWMHY---TQTVDIWSVGCIMAEMLTGK-PLFKGH 219

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 33/212 (15%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FLAELKVL 335
           ++G G FG VY A+      N     L         AA K +D ++  E   ++ E+ +L
Sbjct: 12  ELGDGAFGKVYKAQ------NKETGVL---------AAAKVIDTKSEEELEDYMVEIDIL 56

Query: 336 THVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
               H N+V+L+  +  E +L+++ E+   G +   +    R PL       +   +   
Sbjct: 57  ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEA 115

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR--LVGTFGY 452
           L Y+HE+ +   IHRD+K+ NIL   +   K+ADFG++      + ++  R   +GT  +
Sbjct: 116 LNYLHENKI---IHRDLKAGNILFTLDGDIKLADFGVSAKN---TRTIQRRDSFIGTPYW 169

Query: 453 MPPEYA--QYGDVSP---KVDVYAFGVVLYEL 479
           M PE    +     P   K DV++ G+ L E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 87/338 (25%), Positives = 138/338 (40%), Gaps = 68/338 (20%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           NF +   +G G +G V+   L  +       +L  + +L + A ++K           E 
Sbjct: 1   NFELLKVLGTGAYGKVF---LVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTR--TER 55

Query: 333 KVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
            VL HV     +  + Y    E  L L+ +Y+  G +  HL            R   + D
Sbjct: 56  NVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHL----------YQRDNFSED 105

Query: 391 SAR--------GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK--LTEVGSA 440
             R         LE++H+  +   ++RDIK  NIL+D   H  + DFGL+K  L+E    
Sbjct: 106 EVRFYSGEIILALEHLHKLGI---VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162

Query: 441 SLPTRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELIS-AKEAIVKG--NGSSADS 496
           +      GT  YM PE  +  G     VD ++ G++++EL++ A    ++G  N  S  S
Sbjct: 163 TY--SFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220

Query: 497 KGLVAL---FEEVLNLPDPIEDLRKLV--DP--RLG---------DNCPLDSVLKMAQLA 540
           + ++     F   +  P+  + L KL+  DP  RLG            P    L    LA
Sbjct: 221 RRILKCDPPFPSFIG-PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALA 279

Query: 541 KVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYE 578
                  P  RPS+R+             + DVG+F E
Sbjct: 280 LRKVN--PPFRPSIRN-------------ELDVGNFAE 302

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.0 bits (153), Expect = 7e-11
 Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 48/219 (21%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+GGFG VY    + + G  Y              A+K +D +  +    E   L    
Sbjct: 2   IGRGGFGEVYGCR-KADTGKMY--------------AMKCLDKKRIKMKQGETLALNERI 46

Query: 340 HLNLVRLIGYC-----------VEGSLFLVYEYIENGNLSEHLRGSG----RDPLPWSSR 384
            L+LV   G C               L  + + +  G+L  HL   G     +   +++ 
Sbjct: 47  MLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE 105

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
           + +      GLE++H   V   ++RD+K ANIL+D++ H +++D GL       S   P 
Sbjct: 106 IIL------GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPH 153

Query: 445 RLVGTFGYMPPEYAQYG---DVSPKVDVYAFGVVLYELI 480
             VGT GYM PE  Q G   D S   D ++ G +L++L+
Sbjct: 154 ASVGTHGYMAPEVLQKGVAYDSS--ADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 63.5 bits (154), Expect = 8e-11
 Identities = 68/285 (23%), Positives = 113/285 (39%), Gaps = 90/285 (31%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A   +      R  ++E
Sbjct: 7   DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGATHSE-----HRALMSE 60

Query: 332 LKVLTHV-HHLNLVRLIG--------------YCVEGSL----------FLVYEYIEN-- 364
           LK+L H+ HHLN+V L+G              +C  G+L          F+ Y+  +   
Sbjct: 61  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARF 120

Query: 365 -------GNLSEHLR-------------GSG---------------------RDPLPWSS 383
                  G++SE L+              SG                     +  L    
Sbjct: 121 RQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLED 180

Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-------LTE 436
            +  +   A+G+E++        IHRD+ + NIL+ +N   K+ DFGL +          
Sbjct: 181 LICYSFQVAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237

Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 238 KGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 63.3 bits (154), Expect = 9e-11
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 56/232 (24%)

Query: 271 TDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
           T+ +     +G G FG V  A  +L G                 Q  AIKK+    S   
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTG-----------------QNVAIKKIMKPFSTPV 51

Query: 329 LA-----ELKVLTHVHHLNLVRLIGYCVEGS--LFLVYEYIENGNLSEHLRGSGRDPLPW 381
           LA     ELK+L H+ H N++ L    +     ++ V E          L G+    L  
Sbjct: 52  LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE----------LLGTDLHRLLT 101

Query: 382 SSRVQ------IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT 435
           S  ++            RGL+Y+H   V   +HRD+K +NILI++N   K+ DFGL ++ 
Sbjct: 102 SRPLEKQFIQYFLYQILRGLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQ 158

Query: 436 EVGSASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAK 483
           +       T  V T  Y  PE    + +Y     +VD+++ G +  E++  K
Sbjct: 159 D----PQMTGYVSTRYYRAPEIMLTWQKYDV---EVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 61/243 (25%), Positives = 112/243 (46%), Gaps = 55/243 (22%)

Query: 326 REFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
           ++ ++EL++L       ++   G + VE  + +  E+++ G+L  +     + P     R
Sbjct: 44  KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGR 99

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLP 443
           + +A+   +GL Y+    +   +HRD+K +N+L++     K+ DFG+ T+L      S+ 
Sbjct: 100 IAVAV--VKGLTYLWSLKI---LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA 150

Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAK---EAIVKGNGSSADSK 497
              VGT  YM PE     QYG  S   DV++ G+   EL   +     I K  GS     
Sbjct: 151 KTYVGTNAYMAPERISGEQYGIHS---DVWSLGISFMELALGRFPYPQIQKNQGS----- 202

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKV-------CTQEYPQL 550
            L+           P++ L+ +VD    ++ P   VL + Q ++        C ++ P+ 
Sbjct: 203 -LM-----------PLQLLQCIVD----EDPP---VLPVGQFSEKFVHFITQCMRKQPKE 243

Query: 551 RPS 553
           RP+
Sbjct: 244 RPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 41/166 (24%), Positives = 82/166 (49%), Gaps = 15/166 (9%)

Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHLRGSGRDPL 379
                 E+K L  +   N++++ G+ ++       L L+ EY   G L E L    +D L
Sbjct: 62  IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KD-L 119

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
            + +++ +A+D  +GL  ++++T   Y +  + S + L+ +N+  K+   GL K+     
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYTNKPYKN--LTSVSFLVTENYKLKIICHGLEKIL---- 173

Query: 440 ASLPTRLVGTFGYMPPEYAQ--YGDVSPKVDVYAFGVVLYELISAK 483
           +S P + V    Y   +     + + + K D+Y+ GVVL+E+ + K
Sbjct: 174 SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELR-GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           ++F+    +G G FG V  A  +  ++    + R     ++ QK        Q    F +
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQK--------QVDHVF-S 80

Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDP--LPWSSRVQI 387
           E K+L +++H   V L G +  E  L+LV E++  G     LR + R P  +      QI
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
            L      EY+    +   ++RD+K  N+L+DK+   K+ DFG  K+ +  + +    L 
Sbjct: 141 VLI----FEYLQSLNI---VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT----LC 189

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           GT  Y+ PE           D +  G+ +YE++
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 16/196 (8%)

Query: 294 RGEYGNSYLSRLICVNLLMQKAAIK-KMDMQASREFLAELKVLTHVHHLNLVRLIG-YCV 351
           +G YG+ Y        + M    I+ ++D     + + EL +L       +V   G + +
Sbjct: 11  KGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70

Query: 352 EGSLFLVYEYIENGNLSE-HLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHR 409
           EG++++  EY++ G+L + +  G   + +P     +I     +GL+++ E H +   IHR
Sbjct: 71  EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI---IHR 127

Query: 410 DIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY------AQYGDV 463
           D+K  N+L++ N   K+ DFG++       ASL    +G   YM PE        Q    
Sbjct: 128 DVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPERIKSGGPNQNPTY 184

Query: 464 SPKVDVYAFGVVLYEL 479
           + + DV++ G+ + E+
Sbjct: 185 TVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 45/219 (20%)

Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--EFLA--ELK 333
            K+G+G +  VY        G S L+         Q  A+K++ ++      F A  E  
Sbjct: 11  DKLGEGSYATVYK-------GRSKLTG--------QLVALKEIRLEHEEGAPFTAIREAS 55

Query: 334 VLTHVHHLNLVRL--IGYCVEGSLFLVYEYIENGNLSEHLR--GSGRDPLPWSSRVQIAL 389
           +L  + H N+V L  I +  + +L LV+EY++  +L +++   G G         V++ L
Sbjct: 56  LLKDLKHANIVTLHDIIH-TKKTLTLVFEYLDT-DLKQYMDDCGGGLSM----HNVRLFL 109

Query: 390 -DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL-- 446
               RGL Y H+  V   +HRD+K  N+LI +    K+ADFGL +     + S+P++   
Sbjct: 110 FQLLRGLAYCHQRRV---LHRDLKPQNLLISERGELKLADFGLAR-----AKSVPSKTYS 161

Query: 447 --VGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELIS 481
             V T  Y PP+    G  + S  +D++  G + YE+ +
Sbjct: 162 NEVVTLWYRPPD-VLLGSTEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 62/250 (24%), Positives = 107/250 (42%), Gaps = 54/250 (21%)

Query: 245 AGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSR 304
           + + +S +A     S   S  EL +        ++IG G  G VY    R   G  Y  +
Sbjct: 54  SSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPT-GRLYALK 105

Query: 305 LICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIE 363
           +I  N           +    R+   E+++L  V+H N+V+    +   G + ++ E+++
Sbjct: 106 VIYGN----------HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155

Query: 364 NGNLSEHLRGSGRDPLPWSSRVQIALDSAR----GLEYIHEHTVPVYIHRDIKSANILID 419
            G+L        +          +A D AR    G+ Y+H   +   +HRDIK +N+LI+
Sbjct: 156 GGSLEGTHIADEQ---------FLA-DVARQILSGIAYLHRRHI---VHRDIKPSNLLIN 202

Query: 420 KNFHAKVADFGLTKLTEVGSASLP-TRLVGTFGYMPPE----------YAQYGDVSPKVD 468
              + K+ADFG++++  +     P    VGT  YM PE          Y  Y       D
Sbjct: 203 SAKNVKIADFGVSRI--LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG-----D 255

Query: 469 VYAFGVVLYE 478
           +++ GV + E
Sbjct: 256 IWSLGVSILE 265

Length = 353

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 68/281 (24%), Positives = 108/281 (38%), Gaps = 87/281 (30%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D   +   +G G FG V  A   G +  +S     + V +L + A   +      +  ++
Sbjct: 7   DRLRLGKVLGHGAFGKVVEASAFGIDKKSS--CNTVAVKMLKEGATASE-----HKALMS 59

Query: 331 ELKVLTHV-HHLNLVRLIG--------------YCVEGSL----------FLVY------ 359
           ELK+L H+ +HLN+V L+G              +C  G+L          F  Y      
Sbjct: 60  ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPK 119

Query: 360 ---------------EYIENGN----LSEHLRGSGRDPLP-------WSSRVQI------ 387
                            IE G      S     +     P       W S + +      
Sbjct: 120 QRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICY 179

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-------LTEVGSA 440
           +   ARG+E++        IHRD+ + NIL+ +N   K+ DFGL +           GSA
Sbjct: 180 SFQVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 237 RLPLK------WMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 64/251 (25%), Positives = 107/251 (42%), Gaps = 76/251 (30%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM---------QASREFLA 330
           IG+G FG V   + + + G+ Y          M+K  ++K +M         +A R+ LA
Sbjct: 9   IGRGAFGEVRLVQKK-DTGHIYA---------MKK--LRKSEMLEKEQVAHVRAERDILA 56

Query: 331 ELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWS-SRVQ 386
           E        +  +V+L  Y     E  L+L+ EY+  G++   L    +D      +R  
Sbjct: 57  E------ADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL--MKKDTFTEEETRFY 106

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL---------TKLTEV 437
           IA ++   ++ IH+     YIHRDIK  N+L+D   H K++DFGL         T+   +
Sbjct: 107 IA-ETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162

Query: 438 GSASLPTRL----------------------------VGTFGYMPPEYAQYGDVSPKVDV 469
            S +LP+                              VGT  Y+ PE       + + D 
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222

Query: 470 YAFGVVLYELI 480
           ++ GV++YE++
Sbjct: 223 WSLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 55/172 (31%), Positives = 85/172 (49%), Gaps = 29/172 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI--KKM--DMQASRE 327
           + F +   I +G FG VY     G   N+  S+L  V + ++KA +  K M   +QA R+
Sbjct: 4   EEFVIVKPISRGAFGKVYL----GRKKNN--SKLYAVKV-VKKADMINKNMVHQVQAERD 56

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSE--HLRGSGRDP--LPWSS 383
            LA  K    VH    ++         ++LV EY+  G++    H+ G   +   + + S
Sbjct: 57  ALALSKSPFIVHLYYSLQSANN-----VYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS 111

Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT 435
            V +ALD      Y+H H +   IHRD+K  N+LI    H K+ DFGL+K+T
Sbjct: 112 EVALALD------YLHRHGI---IHRDLKPDNMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 6/167 (3%)

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           L E  +L +V+H +++R+    V G++  +     + +L  +L    R PLP    + I 
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSR-PLPIDQALIIE 163

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
                GL Y+H   +   IHRD+K+ NI I+      + D G  +   V  A L   L G
Sbjct: 164 KQILEGLRYLHAQRI---IHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAG 218

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
           T     PE       + K D+++ G+VL+E+++    I +   S+ +
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265

Length = 357

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 30/216 (13%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           +IG G FG V    + GE  + Y    + V  L   A++     Q   +FL E +    +
Sbjct: 2   EIGNGWFGKV----ILGEVNSGYTPAQVVVKELRVSASV-----QEQMKFLEEAQPYRSL 52

Query: 339 HHLNLVRLIGYCVEGSLFL-VYEYIENGNLSEHLRGSGR------DPLPWSSRVQIALDS 391
            H NL++ +G C E + +L V E+   G+L  +LR   +      DP       ++A + 
Sbjct: 53  QHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ---RMACEI 109

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL-PTRLVGTF 450
           A GL ++H++    +IH D+   N L+  +   K+ D+GL+         + P +L    
Sbjct: 110 ALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166

Query: 451 GYMPPEYAQ-------YGDVSPKVDVYAFGVVLYEL 479
            ++ PE            D + + +V++ GV ++EL
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 55/212 (25%), Positives = 100/212 (47%), Gaps = 38/212 (17%)

Query: 294 RGEYGNSYLSRLICV---NLLMQKAAIKKMD------MQASREFLAELKVLTHVHHLNLV 344
           +G YG      ++C        +K AIKK++        A+R  L E+K+L  + H ++V
Sbjct: 10  KGSYG------VVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIV 62

Query: 345 RLIGYCVEGS------LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +    +  S      +++V+E +E+ +L + ++ +  D L             R L+YI
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN--DDLTPEHHQFFLYQLLRALKYI 119

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK--LTEVGSASLPTRLVGTFGYMPPE 456
           H   V    HRD+K  NIL + +   K+ DFGL +    +  +A   T  V T  Y  PE
Sbjct: 120 HTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE 176

Query: 457 -----YAQYGDVSPKVDVYAFGVVLYELISAK 483
                +++Y   +P +D+++ G +  E+++ K
Sbjct: 177 LCGSFFSKY---TPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 60.6 bits (148), Expect = 4e-10
 Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 31/161 (19%)

Query: 337 HVHHL-----NLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            VH L     N ++L  Y V       L+ +YI++G+L + L+  G+  L  +   +I  
Sbjct: 60  MVHQLMKDNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK--LSEAEVKKIIR 116

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILID-KNFHAKVADFGLTKLTEVGSASLPTRLVG 448
                L  +H+H     IH DIK  N+L D       + D+GL K+  +G+ S      G
Sbjct: 117 QLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSC---YDG 168

Query: 449 TFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y  PE      Y    DVS   D +A GV+ YEL++ K
Sbjct: 169 TLDYFSPEKIKGHNY----DVS--FDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 60.7 bits (148), Expect = 5e-10
 Identities = 73/264 (27%), Positives = 109/264 (41%), Gaps = 90/264 (34%)

Query: 256 VDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQ 313
           +DK +   YE          +  K+G+G +G V+ A  R   E           V     
Sbjct: 1   IDKHILRKYE----------ILQKLGKGAYGIVWKAIDRRTKE----------VV----- 35

Query: 314 KAAIKKM--------DMQAS-RE--FLAELKVLTHVHHLNLVRLIG-YCVEGS--LFLVY 359
             A+KK+        D Q + RE  FL EL       H N+V+L+     E    ++LV+
Sbjct: 36  --ALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNIVKLLNVIKAENDKDIYLVF 88

Query: 360 EYIEN-------GNLSE--HLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRD 410
           EY+E         N+ E  H R              I     + L+YIH   V   IHRD
Sbjct: 89  EYMETDLHAVIRANILEDVHKR-------------YIMYQLLKALKYIHSGNV---IHRD 132

Query: 411 IKSANILIDKNFHAKVADFGL----TKLTEVGSASLPTRLVGTFGYMPPE-------YAQ 459
           +K +NIL++ +   K+ADFGL    ++L E     + T  V T  Y  PE       Y  
Sbjct: 133 LKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRY-- 190

Query: 460 YGDVSPKVDVYAFGVVLYELISAK 483
               +  VD+++ G +L E++  K
Sbjct: 191 ----TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 57/225 (25%), Positives = 101/225 (44%), Gaps = 35/225 (15%)

Query: 273 NFSMSHKIGQGGFGAVY--YAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           N+ +   +GQG FG VY  Y    G              L +++        + S+E  A
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGR------------ELAVKQVQFDPESPETSKEVNA 50

Query: 331 ---ELKVLTHVHHLNLVRLIGYC---VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
              E+++L ++ H  +V+  G     +E +L +  E++  G++ + L+  G   L  +  
Sbjct: 51  LECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVT 108

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK------LTEVG 438
            +       G+ Y+H + +   +HRDIK ANIL D   + K+ DFG +K      L+  G
Sbjct: 109 RKYTRQILEGVSYLHSNMI---VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG 165

Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             S    + GT  +M PE         K D+++ G  + E+++ K
Sbjct: 166 MKS----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 43/241 (17%)

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGS-GRDPLPWSSRV 385
           F     +++ V H++L  + G CV GS   +V E++E+G L   LR   GR P+ W   V
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-------KVADFGLTKLTEVG 438
              L SA  L Y+ +  +   +H ++ + NIL+ +   A       K++D G++      
Sbjct: 123 AQQLASA--LSYLEDKNL---VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS----FT 173

Query: 439 SASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
           + S   R V    ++ PE    G  +S   D ++FG  L E+    E  +K    S   +
Sbjct: 174 ALSREER-VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                +E+   LP+P              +C      ++A L   C    P  RPS R+I
Sbjct: 233 ----FYEKKHRLPEP--------------SCK-----ELATLISQCLTYEPTQRPSFRTI 269

Query: 558 V 558
           +
Sbjct: 270 L 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 65/292 (22%), Positives = 126/292 (43%), Gaps = 53/292 (18%)

Query: 280 IGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDM---QASREFLAELKV 334
           +GQG F  ++    R  G+YG  + + ++          +K +D      S  F     +
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVL----------LKVLDKSHRNYSESFFEAASM 52

Query: 335 LTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
           ++ + H +LV   G CV      +V EY++ G+L  +L+   ++ +  S ++++A   A 
Sbjct: 53  MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAW 111

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG--SASLPTR-LVGTF 450
            L ++ +  +    H ++ + N+L+ +    K  +    KL++ G     LP   L+   
Sbjct: 112 ALHFLEDKGLT---HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI 168

Query: 451 GYMPPE-YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
            ++PPE      ++S   D ++FG  L+E+ S  +  +    S+ DS+  +  +E+   L
Sbjct: 169 PWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL----SALDSQKKLQFYEDRHQL 224

Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKV---CTQEYPQLRPSMRSIV 558
           P P                      K  +LA +   C    P  RPS R+I+
Sbjct: 225 PAP----------------------KWTELANLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 74/266 (27%), Positives = 122/266 (45%), Gaps = 40/266 (15%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           ++ + + IG G FG VY A              IC++   +K AIKK+ +Q  +    EL
Sbjct: 67  SYKLGNIIGNGSFGVVYEA--------------ICIDT-SEKVAIKKV-LQDPQYKNREL 110

Query: 333 KVLTHVHHLNLVRLIGY----CV---EGSLFL--VYEYIENGNLSEHLRGSGRD--PLPW 381
            ++ +++H+N++ L  Y    C    E ++FL  V E+I    + ++++   R+   LP 
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPL 169

Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                 +    R L YIH   +    HRD+K  N+LID N H  K+ DFG  K    G  
Sbjct: 170 FLVKLYSYQLCRALAYIHSKFI---CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
           S+ + +   F   P       + +  +D+++ G ++ E+I     I  G  SS D   LV
Sbjct: 227 SV-SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY-PIFSGQ-SSVDQ--LV 281

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGD 526
            + +    L  P ED  K ++P   D
Sbjct: 282 RIIQV---LGTPTEDQLKEMNPNYAD 304

Length = 440

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 35/224 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           ++     +IG G  G VY              R      +M   A+K+M    ++E    
Sbjct: 15  NDLENLGEIGSGTCGQVYKM------------RFKKTGHVM---AVKQMRRTGNKEENKR 59

Query: 328 FLAELKVLTHVHHL-NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
            L +L V+   H    +V+  GY + +  +F+  E +      + L    + P+P     
Sbjct: 60  ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILG 117

Query: 386 QIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLP 443
           ++ +   + L Y+ E H V   IHRD+K +NIL+D + + K+ DFG++ +L +   +   
Sbjct: 118 KMTVAIVKALHYLKEKHGV---IHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAK 171

Query: 444 TRLVGTFGYMPPEYAQYGDVSPK----VDVYAFGVVLYELISAK 483
           TR  G   YM PE     D +PK     DV++ G+ L EL + +
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 72/270 (26%), Positives = 110/270 (40%), Gaps = 48/270 (17%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA-- 330
            + +  ++GQG +G V  A                        AIKK+    S++ LA  
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEE-------------TVAIKKITNVFSKKILAKR 47

Query: 331 ---ELKVLTHVH-HLNLVRLIGYCV--EGSLFLVYEYIE--NGNLSEHLRGSGR--DPLP 380
              ELK+L H   H N+  L    +   G+   +Y Y E    +L + +R      D   
Sbjct: 48  ALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHF 107

Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
            S   QI      GL+YIH   V   +HRD+K  N+L++ +   K+ DFGL +       
Sbjct: 108 QSFIYQIL----CGLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPG 160

Query: 441 SLP---TRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS 493
                 T  V T  Y  PE    +  Y   +  +DV++ G +L EL+  K  + KG    
Sbjct: 161 ENAGFMTEYVATRWYRAPEIMLSFQSY---TKAIDVWSVGCILAELLGRK-PVFKGK--- 213

Query: 494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
            D    +    +VL  PD  E L ++  P+
Sbjct: 214 -DYVDQLNQILQVLGTPDE-ETLSRIGSPK 241

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 49/255 (19%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKV 334
           +G G +G+V  A         Y +RL       QK A+KK+      +  +R    EL++
Sbjct: 23  VGSGAYGSVCSA---------YDTRL------RQKVAVKKLSRPFQSLIHARRTYRELRL 67

Query: 335 LTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN---LSEHLRGSGRDPLPWSSRVQ----- 386
           L H+ H N++ L+       +F     IEN N   L  +L G+  + +    ++      
Sbjct: 68  LKHMKHENVIGLL------DVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQ 121

Query: 387 -IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
            +     RGL+YIH   +   IHRD+K +N+ ++++   ++ DFGL +  +       T 
Sbjct: 122 FLIYQLLRGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTG 174

Query: 446 LVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
            V T  Y  PE    +   +  VD+++ G ++ EL+  K A+  GN      K ++    
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK-ALFPGNDYIDQLKRIM---- 229

Query: 505 EVLNLPDPIEDLRKL 519
           EV+  P P E L+K+
Sbjct: 230 EVVGTPSP-EVLKKI 243

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--EFLA--ELKV 334
           K+G+G +  VY            +SR   +N   Q  A+K + M+      F A  E  +
Sbjct: 12  KLGEGSYATVYKG----------ISR---IN--GQLVALKVISMKTEEGVPFTAIREASL 56

Query: 335 LTHVHHLNLVRL--IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
           L  + H N+V L  I +  E +L  V+EY+   +L++++        P++ R+       
Sbjct: 57  LKGLKHANIVLLHDIIHTKE-TLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRL-FMFQLL 113

Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           RGL YIH   +   +HRD+K  N+LI      K+ADFGL +   + S +  + +V T  Y
Sbjct: 114 RGLAYIHGQHI---LHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWY 169

Query: 453 MPPEYAQYG--DVSPKVDVYAFGVVLYELISAKEA 485
            PP+    G  D S  +D++  G +  E++  + A
Sbjct: 170 RPPD-VLLGATDYSSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 60/222 (27%), Positives = 101/222 (45%), Gaps = 31/222 (13%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D++    K+G+G +  VY  + +             VN  +    + ++  +    F A 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSK-------------VNGKLVALKVIRLQEEEGTPFTAI 51

Query: 331 -ELKVLTHVHHLNLVRL--IGYCVEGSLFLVYEYIENGNLSEHL--RGSGRDPLPWSSRV 385
            E  +L  + H N+V L  I +  E +L LV+EY+   +L +++     G  P      V
Sbjct: 52  REASLLKGLKHANIVLLHDIIHTKE-TLTLVFEYVHT-DLCQYMDKHPGGLHP----ENV 105

Query: 386 QIAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
           ++ L    RGL YIH+  +   +HRD+K  N+LI      K+ADFGL +   V S +   
Sbjct: 106 KLFLFQLLRGLSYIHQRYI---LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162

Query: 445 RLVGTFGYMPPE-YAQYGDVSPKVDVYAFGVVLYELISAKEA 485
            +V T  Y PP+      + S  +D++  G +  E+I    A
Sbjct: 163 EVV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.4 bits (144), Expect = 2e-09
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 26/187 (13%)

Query: 313 QKAAIKKM-----DMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYE-YIENGN 366
           ++ A+KKM     ++ + +    ELK+L    H N++  +       +    E Y+    
Sbjct: 26  KRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTEL 85

Query: 367 LSEHLRGSGRDPLPWSS---RV---QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK 420
           +   L      P P SS   +V   QI     RGL+Y+H   +   +HRDIK  N+L++ 
Sbjct: 86  MQSDLHKIIVSPQPLSSDHVKVFLYQIL----RGLKYLHSAGI---LHRDIKPGNLLVNS 138

Query: 421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVL 476
           N   K+ DFGL ++ E   +   T+ V T  Y  PE       Y      VD+++ G + 
Sbjct: 139 NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTS---AVDIWSVGCIF 195

Query: 477 YELISAK 483
            EL+  +
Sbjct: 196 AELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 51/207 (24%), Positives = 97/207 (46%), Gaps = 23/207 (11%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG VY A+ + E G            L     I+    +   +++ E+++L   
Sbjct: 19  ELGDGAFGKVYKAKNK-ETG-----------ALAAAKVIETKSEEELEDYMVEIEILATC 66

Query: 339 HHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           +H  +V+L+G +  +G L+++ E+   G +   +    R       +V I       L+Y
Sbjct: 67  NHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQMLEALQY 125

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H   +   IHRD+K+ N+L+  +   K+ADFG++    V +       +GT  +M PE 
Sbjct: 126 LHSMKI---IHRDLKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEV 181

Query: 458 AQYGDV--SP---KVDVYAFGVVLYEL 479
                +  +P   K D+++ G+ L E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 45/224 (20%)

Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH 337
            +IG G FG V  +E+   Y ++ ++R++ V  L   A+ K+ +     EFL +      
Sbjct: 1   QEIGNGWFGKVLLSEI---YTDTGVARVV-VKELKANASSKEQN-----EFLQQGDPYRI 51

Query: 338 VHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-------VQIAL 389
           + H N+++ +G CVE     LV+EY E G+L  +L         W  R        ++A 
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMAC 106

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-------TKLTEVGSASL 442
           + A G+ ++H+H    ++H D+   N  +  +   KV D+G+         +       +
Sbjct: 107 EIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV 163

Query: 443 PTR-----LVGTF--GYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           P R     LVG F  G +  E  +        +V+A GV L+EL
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPS------NVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 63/246 (25%), Positives = 109/246 (44%), Gaps = 58/246 (23%)

Query: 262 FSYEELSKAT----DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKA 315
           F  EE++K      + ++   ++G G +G+V  A  +  GE                 K 
Sbjct: 1   FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGE-----------------KV 43

Query: 316 AIKKMDMQASREFLA-----ELKVLTHVHHLNLVRLIGYCVEGS-------LFLVYEYIE 363
           AIKK+      E  A     EL +L H+ H N++ L+               +LV  Y++
Sbjct: 44  AIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ 103

Query: 364 NGNLSEHLRGSGRDPLPWSS-RVQ-IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN 421
             +L + + G      P S  +VQ +      GL+YIH   +   IHRD+K  N+ ++++
Sbjct: 104 T-DLQK-IMG-----HPLSEDKVQYLVYQMLCGLKYIHSAGI---IHRDLKPGNLAVNED 153

Query: 422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLY 477
              K+ DFGL +  +   A + T  V T  Y  PE    +  Y   +  VD+++ G ++ 
Sbjct: 154 CELKILDFGLARHAD---AEM-TGYVVTRWYRAPEVILNWMHY---NQTVDIWSVGCIMA 206

Query: 478 ELISAK 483
           E+++ K
Sbjct: 207 EMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 40/211 (18%)

Query: 294 RGEYGNSYLSRLIC--VNLLMQ-KAAIKKMD------MQASREFLAELKVLTHVHHLNLV 344
           RG YG      ++C   N     K AIKK+       + A R  L E+K+L H+ H N++
Sbjct: 15  RGAYG------IVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVI 67

Query: 345 RLIGYCVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL-DSARGLE 396
            +    +          +++VYE ++  +L + +R S    L      Q  L    RGL+
Sbjct: 68  AIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSS--QTLS-DDHCQYFLYQLLRGLK 122

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           YIH   V   +HRD+K +N+L++ N   K+ DFGL + T        T  V T  Y  PE
Sbjct: 123 YIHSANV---LHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPE 178

Query: 457 Y----AQYGDVSPKVDVYAFGVVLYELISAK 483
                ++Y      +DV++ G +  EL+  K
Sbjct: 179 LLLNCSEYT---TAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 54/229 (23%), Positives = 99/229 (43%), Gaps = 50/229 (21%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR------EFLAEL 332
           +IG G FG V    L GE            +  M KA +   +++AS        FL E+
Sbjct: 2   EIGNGWFGKV----LLGE-----------AHRGMSKARVVVKELRASATPDEQLLFLQEV 46

Query: 333 KVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGS----GRDPLPWSSRVQI 387
           +    ++H N+++ +G C+E     LV E+   G+L  +LR +     +         ++
Sbjct: 47  QPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK-DVLQRM 105

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL--TKLTE-----VGSA 440
           A + A GL ++H+     +IH D+   N  +  +   K+ D+GL   +  E         
Sbjct: 106 ACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH 162

Query: 441 SLPTRLVGTFGYMPPEYAQY-------GDVSPKVDVYAFGVVLYELISA 482
           ++P R +       PE  +         D + K ++++ GV ++EL +A
Sbjct: 163 AVPLRWLA------PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 14/101 (13%)

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
           +IA+   + LEY+H   + V IHRD+K +N+LI++N   K+ DFG++    V S +  T 
Sbjct: 107 KIAVSIVKALEYLHS-KLSV-IHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVA-KTI 162

Query: 446 LVGTFGYMPPE-------YAQYGDVSPKVDVYAFGVVLYEL 479
             G   YM PE          Y DV  K DV++ G+ + EL
Sbjct: 163 DAGCKPYMAPERINPELNQKGY-DV--KSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (137), Expect = 5e-09
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 29/222 (13%)

Query: 273 NFSMSHKIGQGGFGAVY--YAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           N+ +   +G+G FG VY  Y    G              L +++        + S+E  A
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGR------------ELAVKQVPFDPDSQETSKEVNA 50

Query: 331 ---ELKVLTHVHHLNLVRLIGYCV----EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
              E+++L ++ H  +V+  G C+    E  L +  EY+  G++ + L+  G   L  + 
Sbjct: 51  LECEIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENV 107

Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSAS 441
             +      +G+ Y+H + +   +HRDIK ANIL D   + K+ DFG +K  +    S +
Sbjct: 108 TRRYTRQILQGVSYLHSNMI---VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
               + GT  +M PE         K DV++    + E+++ K
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 66/288 (22%), Positives = 116/288 (40%), Gaps = 44/288 (15%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +GQG F  +Y   LR +     +     V+++++   +   D + S  F     +++ + 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLK---VLGSDHRDSLAFFETASLMSQLS 59

Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH 399
           H +LV+L G CV     +V EY++ G L   L    ++ +    ++ +A   A  L Y+ 
Sbjct: 60  HKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLH-REKNNVSLHWKLDVAKQLASALHYLE 118

Query: 400 EHTVPVYIHRDIKSANILIDKN-------FHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +  +   +H ++   NIL+ +           K++D G+     V S       V    +
Sbjct: 119 DKKL---VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--ITVLSREER---VERIPW 170

Query: 453 MPPEYAQYGDVSPKV--DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP 510
           + PE  + G  S  +  D ++FG  L E+ S        NG            EE L+  
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICS--------NG------------EEPLSTL 210

Query: 511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
              E  R   D       P+    ++A L   C    P  RPS R+I+
Sbjct: 211 SSSEKERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAIL 255

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 57.8 bits (139), Expect = 1e-08
 Identities = 60/258 (23%), Positives = 105/258 (40%), Gaps = 40/258 (15%)

Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           Y++     + + +  KIG G FG V+  +      +       C     +  + + +  +
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVK------HKRTQEFFC----WKAISYRGLKER 54

Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS---LFLVYEYIENGNLSEHLRGSGR--DP 378
              + + E+ V+  + H N+VR I   +  +   L+++ E+ + G+LS +++   +    
Sbjct: 55  EKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114

Query: 379 LPWSSRVQIALDSARGLEYIHE----HTVPVYIHRDIKSANILIDKNFH----------- 423
           +   + V I       L Y H           +HRD+K  NI +                
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174

Query: 424 ------AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS--PKVDVYAFGVV 475
                 AK+ DFGL+K   +G  S+    VGT  Y  PE   +   S   K D++A G +
Sbjct: 175 LNGRPIAKIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232

Query: 476 LYELISAKEAIVKGNGSS 493
           +YEL S K    K N  S
Sbjct: 233 IYELCSGKTPFHKANNFS 250

Length = 1021

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 26/133 (19%)

Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI-HEHTVPVYIHRDIKSAN 415
            VYE +    + E + G            +IA+ + + L Y+  E  +   IHRD+K +N
Sbjct: 95  YVYE-VLKSVIPEEILG------------KIAVATVKALNYLKEELKI---IHRDVKPSN 138

Query: 416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE-----YAQYGDVSPKVDVY 470
           IL+D+N + K+ DFG++       A   TR  G   YM PE          DV  + DV+
Sbjct: 139 ILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSARDGYDV--RSDVW 194

Query: 471 AFGVVLYELISAK 483
           + G+ LYE+ + K
Sbjct: 195 SLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 65/258 (25%), Positives = 101/258 (39%), Gaps = 72/258 (27%)

Query: 275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM---------QAS 325
           SM  KI   G GA         +G   L R +  N L     ++K D+         +A 
Sbjct: 1   SMFVKIKTIGIGA---------FGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAE 51

Query: 326 REFLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
           R+ LAE        +  +V+L   +  + +L+ V +YI  G++   L   G      + R
Sbjct: 52  RDILAE------ADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-R 104

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL------------- 431
             IA +    +E +H+     +IHRDIK  NILID++ H K+ DFGL             
Sbjct: 105 FYIA-ELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160

Query: 432 --------------TKLTEVGSASLPT---------------RLVGTFGYMPPEYAQYGD 462
                          + +E+    L                  LVGT  Y+ PE      
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220

Query: 463 VSPKVDVYAFGVVLYELI 480
            +   D ++ GV+LYE++
Sbjct: 221 YTQLCDWWSVGVILYEML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 24/183 (13%)

Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNL 367
           + A+KK+       + A R +  EL++L H+ H N++ L+            E   +  L
Sbjct: 44  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPARSL---EEFNDVYL 99

Query: 368 SEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKN 421
             HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ ++++
Sbjct: 100 VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNED 156

Query: 422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELI 480
              K+ DFGL + T        T  V T  Y  PE    +   +  VD+++ G ++ EL+
Sbjct: 157 CELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212

Query: 481 SAK 483
           + +
Sbjct: 213 TGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 39/173 (22%), Positives = 75/173 (43%), Gaps = 21/173 (12%)

Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           E  +L  ++H ++++L G         +       +L  +L  + +  +     + I   
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERS 190

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL---- 446
             R ++Y+HE+ +   IHRDIK+ NI I+      + DF        G+A  P  +    
Sbjct: 191 VLRAIQYLHENRI---IHRDIKAENIFINHPGDVCLGDF--------GAACFPVDINANK 239

Query: 447 ----VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
                GT     PE        P VD+++ G+VL+E+ +  +++ + +G   D
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292

Length = 391

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (131), Expect = 7e-08
 Identities = 58/243 (23%), Positives = 94/243 (38%), Gaps = 65/243 (26%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--EFLAELKVLT 336
            +G+G  G V+   L+G        +L  +     K   KK  ++ ++    L E ++L 
Sbjct: 8   LLGKGDVGRVFLVRLKGT------GKLFAL-----KVLDKKEMIKRNKVKRVLTEQEILA 56

Query: 337 HVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
            + H  L  L  Y     E  L LV +Y   G L   L+   R P      +    + AR
Sbjct: 57  TLDHPFLPTL--YASFQTETYLCLVMDYCPGGELFRLLQ---RQP---GKCLSE--EVAR 106

Query: 394 --------GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV-------- 437
                    LEY+H       ++RD+K  NIL+ ++ H  ++DF L+K ++V        
Sbjct: 107 FYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163

Query: 438 -------GSASLPTRL-------------VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLY 477
                   S +                  VGT  Y+ PE          VD +  G++LY
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223

Query: 478 ELI 480
           E++
Sbjct: 224 EML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 84/323 (26%), Positives = 136/323 (42%), Gaps = 79/323 (24%)

Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-- 321
           ++     +D + +   IG+G +G V+   L  + G               KAA+K +D  
Sbjct: 10  FDSFPDPSDTWEIIETIGKGTYGKVFKV-LNKKNG--------------SKAAVKILDPI 54

Query: 322 MQASREFLAELKVLTHVH-HLNLVRLIGYCVE------GSLFLVYEYIENGNLSEHLRGS 374
                E  AE  +L  +  H N+V+  G   +        L+LV E    G++++ ++G 
Sbjct: 55  HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF 114

Query: 375 GRDPLPWSSRVQ------IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
               L    R++      I  ++  GL+++H +     IHRD+K  NIL+      K+ D
Sbjct: 115 ----LKRGERMEEPIIAYILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVD 167

Query: 429 FGLTKLTEVGSASLP-TRL-----VGTFGYMPPEY---AQYGDVS--PKVDVYAFGVVLY 477
           FG+       SA L  TRL     VGT  +M PE     Q  D +   + DV++ G+   
Sbjct: 168 FGV-------SAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAI 220

Query: 478 ELISAKEAIVKGNGSS--ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLK 535
           EL         G+G    AD   + ALF+   N P P      L  P L  N   D +  
Sbjct: 221 EL---------GDGDPPLADLHPMRALFKIPRN-PPP-----TLHQPELWSNEFNDFI-- 263

Query: 536 MAQLAKVCTQEYPQLRPSMRSIV 558
                K  T++Y + RP++  ++
Sbjct: 264 ----RKCLTKDY-EKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 56/247 (22%), Positives = 103/247 (41%), Gaps = 55/247 (22%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---F 328
           ++F     IG+G FG V   + + + G+ Y  +++           +K DM    +    
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQ-KKDTGHVYAMKIL-----------RKADMLEKEQVGHI 48

Query: 329 LAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
            AE  +L     L +V++   +  + +L+L+ E++  G++   L    +D L        
Sbjct: 49  RAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFY 106

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL---------TKLTEVG 438
             ++   ++ IH+     +IHRDIK  N+L+D   H K++DFGL         T+     
Sbjct: 107 IAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNL 163

Query: 439 SASLPTRL-------------------------VGTFGYMPPEYAQYGDVSPKVDVYAFG 473
           + SLP+                           VGT  Y+ PE       +   D ++ G
Sbjct: 164 NHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223

Query: 474 VVLYELI 480
           V++YE++
Sbjct: 224 VIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 44/194 (22%)

Query: 310 LLMQKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +  Q  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 39  VTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97

Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E ++  NL +               +Q+ LD  R          G++++H   +   
Sbjct: 98  LVMELMD-ANLCQ--------------VIQMDLDHERMSYLLYQMLCGIKHLHSAGI--- 139

Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 140 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 197

Query: 467 VDVYAFGVVLYELI 480
           VD+++ G ++ E+I
Sbjct: 198 VDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 35/196 (17%)

Query: 313 QKAAIKKM---DMQASREFLAELKVLTHVHHLNLVRL--------------IGYCVE-GS 354
           ++ A+KK+   D Q+ +  L E+K++  + H N+V++              +G   E  S
Sbjct: 31  KRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90

Query: 355 LFLVYEYIEN--GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK 412
           +++V EY+E    N+ E        PL             RGL+YIH   V   +HRD+K
Sbjct: 91  VYIVQEYMETDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSANV---LHRDLK 141

Query: 413 SANILID-KNFHAKVADFGLTKLTE---VGSASLPTRLVGTFGYMPPEYA-QYGDVSPKV 467
            AN+ I+ ++   K+ DFGL ++ +        L   LV  + Y  P       + +  +
Sbjct: 142 PANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAI 200

Query: 468 DVYAFGVVLYELISAK 483
           D++A G +  E+++ K
Sbjct: 201 DMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 32/102 (31%), Positives = 57/102 (55%), Gaps = 8/102 (7%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           DN  +   +G G FG V  A     +G S+    + V + M K+  +  + QA    ++E
Sbjct: 37  DNLVLGRTLGSGAFGRVVEAT---AHGLSHSQSTMKVAVKMLKSTARSSEKQA---LMSE 90

Query: 332 LKVLTHVH-HLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHL 371
           LK+++H+  HLN+V L+G C + G ++++ EY   G+L ++L
Sbjct: 91  LKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 8/173 (4%)

Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           E+ +L  + H  ++ LI      S   +       +L  ++  SG  PLP    + I   
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRR 193

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVGT 449
               L Y+H   +   IHRD+K+ NI +D+  +A + DFG   KL             GT
Sbjct: 194 LLEALAYLHGRGI---IHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250

Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI--VKGNGSSADSKGLV 500
                PE         K D+++ G+VL+E+      +   +   SS+  + ++
Sbjct: 251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII 303

Length = 392

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 31/221 (14%)

Query: 279 KIGQGGFGAVYYAELR-GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH 337
           K+G+G +G VY A+ + G+    Y          +++     + M A RE +A L+ L H
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYA---------LKQIEGTGISMSACRE-IALLRELKH 57

Query: 338 VHHLNLVRLIGYCVEGSLFLVYEYIENG--NLSEHLRGS--GRDP--LPWSSRVQIALDS 391
            + ++L ++     +  ++L+++Y E+   ++ +  R S   + P  LP      +    
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILI----DKNFHAKVADFGLTKLTEVGSASLP--TR 445
             G+ Y+H + V   +HRD+K ANIL+     +    K+AD G  +L       L     
Sbjct: 118 LDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 446 LVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAK 483
           +V TF Y  PE    A++   +  +D++A G +  EL++++
Sbjct: 175 VVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 18/147 (12%)

Query: 342 NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLP----WSSRVQIALDSARGLE 396
           N+V L  Y V E S+FLV ++ E G L  H+      P      W++ + +ALD+     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
            +H   +   + RD+   NIL+D   H ++  F   + +EV   S     V    Y  PE
Sbjct: 101 -LHREGI---VCRDLNPNNILLDDRGHIQLTYFS--RWSEV-EDSCDGEAVENM-YCAPE 152

Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAK 483
                + +   D ++ G +L+EL++ K
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 31/221 (14%)

Query: 279 KIGQGGFGAVYYAELR-GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH 337
           K+G+G +G VY A+ + G+    Y          +++     + M A RE +A L+ L H
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYA---------LKQIEGTGISMSACRE-IALLRELKH 57

Query: 338 VHHLNLVRLIGYCVEGSLFLVYEYIENG--NLSEHLRGS--GRDP--LPWSSRVQIALDS 391
            + + L ++     +  ++L+++Y E+   ++ +  R S   + P  LP S    +    
Sbjct: 58  PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILI----DKNFHAKVADFGLTKLTEVGSASLP--TR 445
             G+ Y+H + V   +HRD+K ANIL+     +    K+AD G  +L       L     
Sbjct: 118 LDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 446 LVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAK 483
           +V TF Y  PE    A++   +  +D++A G +  EL++++
Sbjct: 175 VVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 18/161 (11%)

Query: 275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL---AE 331
           SM  KI   G GA         +G   L+R +    L     ++K D+    +     AE
Sbjct: 1   SMFVKIKTLGIGA---------FGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAE 51

Query: 332 LKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             +L    +  +VRL   +  + +L+ V +YI  G++   L   G  P   +      L 
Sbjct: 52  RDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELT 111

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
            A  +E +H+     +IHRDIK  NILID++ H K+ DFGL
Sbjct: 112 CA--VESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 55/246 (22%), Positives = 101/246 (41%), Gaps = 53/246 (21%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F     IG+G FG V   + + + G+ Y  +++    +++K  +  +  +A R+ L E
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQ-KKDTGHIYAMKILRKADMLEKEQVAHI--RAERDILVE 57

Query: 332 LK---VLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
                V+   +     R        +L+L+ E++  G++   L    +D L   +     
Sbjct: 58  ADGAWVVKMFYSFQDKR--------NLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYI 107

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRL- 446
            ++   ++ IH+     +IHRDIK  N+L+D   H K++DFGL T L +         L 
Sbjct: 108 AETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLT 164

Query: 447 --------------------------------VGTFGYMPPEYAQYGDVSPKVDVYAFGV 474
                                           VGT  Y+ PE       +   D ++ GV
Sbjct: 165 HNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224

Query: 475 VLYELI 480
           ++YE++
Sbjct: 225 IMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 46/178 (25%), Positives = 66/178 (37%), Gaps = 58/178 (32%)

Query: 406 YIHRDIKSANILIDKNFHAKVADFGL-------------TKLTEVGSASLPT-------- 444
           +IHRDIK  NILID+  H K++DFGL              KL +  S             
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAV 181

Query: 445 --------------------RL-----VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
                               RL     VGT  Y+ PE         + D ++ G +++E 
Sbjct: 182 DSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFEC 241

Query: 480 ISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPI------EDL-RKLV---DPRLGDN 527
           +         N  S ++   +  + E L  PD I      EDL R+L+   + RLG  
Sbjct: 242 LIGWPPFCSEN--SHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRG 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.8 bits (113), Expect = 1e-05
 Identities = 78/361 (21%), Positives = 132/361 (36%), Gaps = 49/361 (13%)

Query: 239 ESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYG 298
           +   P A  P  L    +    EF    L+     F +   +  G FG ++   LR    
Sbjct: 123 DEAPPDAAGPVPLAQAKLKHDDEF----LAH----FRVIDDLPAGAFGKIFICALRASTE 174

Query: 299 NSYLSRLI---------CVNLLMQKA-AIKKMDMQASREFLAELKVLTHVHHLNLVRLIG 348
            +   R +         C  L+ ++  A  +  +Q   E LA L  L H + L +  ++ 
Sbjct: 175 EAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILA-LGRLNHENILKIEEILR 233

Query: 349 Y------CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT 402
                    +   F +Y ++ +       R     PL   +R  I       +EYIH+  
Sbjct: 234 SEANTYMITQKYDFDLYSFMYDEAFDWKDR-----PLLKQTR-AIMKQLLCAVEYIHDKK 287

Query: 403 VPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD 462
           +   IHRDIK  NI ++ +    + DFG     E    +     VGT     PE      
Sbjct: 288 L---IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG 344

Query: 463 VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL----NLPDPIEDLRK 518
                D+++ G++L +++S  +    G+G     K L+ + + +       PDP   L  
Sbjct: 345 YCEITDIWSCGLILLDMLS-HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFD 403

Query: 519 LVDPRLGDNCPLDSVLKMAQLAKVCTQEYP---------QLRPSMRSIVVALMTLSSTTE 569
            +D    D+        +  L      EYP          LRP   + ++AL   S+  E
Sbjct: 404 YIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA-AELLALPLFSAEEE 462

Query: 570 D 570
           +
Sbjct: 463 E 463

Length = 501

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 44/197 (22%)

Query: 310 LLMQKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98

Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E ++  NL +               +Q+ LD  R          G++++H   +   
Sbjct: 99  LVMELMD-ANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 140

Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198

Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 199 VDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 67/293 (22%)

Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL---AELKVLTHVHHLNLVRLI-GYC 350
           G +G   L+  +  + L     ++K D+    +     AE  +L    +  +V+L   + 
Sbjct: 12  GAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ 71

Query: 351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRD 410
            + +L+ V +YI  G++   L      P    +R  IA +    +E +H+     +IHRD
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRMEVFP-EVLARFYIA-ELTLAIESVHKMG---FIHRD 126

Query: 411 IKSANILIDKNFHAKVADFGL---------TKLTEVGS---------------------- 439
           IK  NILID + H K+ DFGL         +K  + GS                      
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 440 ---ASLPTR------------LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKE 484
               +L  R            LVGT  Y+ PE       +   D ++ GV+L+E++  + 
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQP 246

Query: 485 AIVKGNGSSADSKGLVALFEEVLNLP----------DPIEDLRKLVDPRLGDN 527
             +    +    K  V  +E  L++P          D I  L    + RLG N
Sbjct: 247 PFLAPTPTETQLK--VINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN 297

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 44/197 (22%)

Query: 310 LLMQKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105

Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E ++  NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELMD-ANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147

Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205

Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E+I   
Sbjct: 206 VDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 26/135 (19%), Positives = 58/135 (42%), Gaps = 6/135 (4%)

Query: 298 GNSYLSRLICVN--LLMQKAAIKKMDMQASREFLAELKVLTHVHHLN-LVRLIGYCVEGS 354
              +L++    N  + ++K  +     +  +    E+     + H N L  +  + V+  
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE 73

Query: 355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
           L++V   +  G+  + L+    + LP  +   I  D    L+YIH      +IHR +K++
Sbjct: 74  LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKAS 130

Query: 415 NILIDKNFHAKVADF 429
           +IL+  +    ++  
Sbjct: 131 HILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 22/102 (21%), Positives = 41/102 (40%), Gaps = 12/102 (11%)

Query: 323 QASREFLAELKVLTHVHHLNLV--RLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
           +   +   E+ +L  +    L   +++     +G  +L+ E+IE         G   D +
Sbjct: 33  EKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE---------GETLDEV 83

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN 421
               +  IA   A  L  +H+  + V  H D+   NIL+D  
Sbjct: 84  SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 29/111 (26%), Positives = 55/111 (49%), Gaps = 16/111 (14%)

Query: 378 PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE- 436
           PL     ++ +   A+G++++        IHRD+ + N+L+     AK+ DFGL +    
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMN 264

Query: 437 ------VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                  G+A LP +      +M PE       + + DV+++G++L+E+ S
Sbjct: 265 DSNYVVKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 8/102 (7%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G G FG V        YG S    ++ V + M K   +  + QA    ++E
Sbjct: 37  DGLVLGRILGSGAFGKVVEGT---AYGLSRSQPVMKVAVKMLKPTARSSEKQA---LMSE 90

Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHL 371
           LK++TH+  HLN+V L+G C + G ++++ EY   G+L  +L
Sbjct: 91  LKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 8/103 (7%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           DN      +G G FG V  A     +G      ++ V + M KA+    + +A    ++E
Sbjct: 38  DNLQFGKTLGAGAFGKVVEAT---AFGLGKEDNVLRVAVKMLKASAHTDEREA---LMSE 91

Query: 332 LKVLTHV-HHLNLVRLIGYCVEGSLFLVY-EYIENGNLSEHLR 372
           LK+L+H+  H N+V L+G C  G   LV  EY   G+L   LR
Sbjct: 92  LKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 42/174 (24%), Positives = 76/174 (43%), Gaps = 36/174 (20%)

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV-------GSASLPT 444
           A+G+ ++        IHRD+ + NIL+      K+ DFGL +           G+A LP 
Sbjct: 224 AKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           +      +M PE       + + DV+++G++L+E+ S   +     G   DSK     F 
Sbjct: 281 K------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP--GMPVDSK-----FY 327

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           ++      I++  +++ P         +  +M  + K C    P  RP+ + IV
Sbjct: 328 KM------IKEGYRMLSPEC-------APSEMYDIMKSCWDADPLKRPTFKQIV 368

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 28/86 (32%), Positives = 44/86 (51%), Gaps = 6/86 (6%)

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR--LVGTFGY 452
           ++YIH   +   IHRDIK+ N+L++      + DFG       GS S P    + GT   
Sbjct: 273 IDYIHGEGI---IHRDIKTENVLVNGPEDICLGDFGAACFAR-GSWSTPFHYGIAGTVDT 328

Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYE 478
             PE       +P VD+++ G+V++E
Sbjct: 329 NAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 32/103 (31%), Positives = 51/103 (49%), Gaps = 8/103 (7%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +  S    +G G FG V  A     YG       + V + M K +    + +A    ++E
Sbjct: 35  NRLSFGKTLGAGAFGKVVEAT---AYGLFKSDAAMTVAVKMLKPSAHLTEREA---LMSE 88

Query: 332 LKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLR 372
           LKVL+++ +H+N+V L+G C V G   ++ EY   G+L   LR
Sbjct: 89  LKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLR 131

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 44/198 (22%), Positives = 86/198 (43%), Gaps = 37/198 (18%)

Query: 300 SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL--- 355
           +    ++ +N+ ++K +    +   ++    EL +L  V+H N++ L+  +  + SL   
Sbjct: 39  AAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98

Query: 356 ---FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHT 402
              +LV E ++  NL +               + + LD  R          G++++H   
Sbjct: 99  QDVYLVMELMD-ANLCQ--------------VIHMELDHERMSYLLYQMLCGIKHLHSAG 143

Query: 403 VPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD 462
           +   IHRD+K +NI++  +   K+ DFGL +         P   V T  Y  PE      
Sbjct: 144 I---IHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP--YVVTRYYRAPEVILGMG 198

Query: 463 VSPKVDVYAFGVVLYELI 480
               VD+++ G ++ EL+
Sbjct: 199 YKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 31/130 (23%), Positives = 57/130 (43%), Gaps = 16/130 (12%)

Query: 359 YEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI 418
           Y+   +  +   L   G + L     +      ARG+E++        +HRD+ + N+L+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC---VHRDLAARNVLL 270

Query: 419 DKNFHAKVADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYA 471
            +    K+ DFGL +           GS  LP +      +M PE       +   DV++
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK------WMAPESIFDNLYTTLSDVWS 324

Query: 472 FGVVLYELIS 481
           +G++L+E+ S
Sbjct: 325 YGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 30/120 (25%), Positives = 47/120 (39%), Gaps = 26/120 (21%)

Query: 365 GNLSEHLRGSGRDPLP----WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK 420
            +L++ L   GR PL     W+    + L     L  +H         R  KS NIL+  
Sbjct: 1   VSLADILEVRGR-PLNEEEIWA----VCLQCLGALRELH---------RQAKSGNILLTW 46

Query: 421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           +   K+   G      V   +        + +M PE  Q    + K D+Y+ G+ LYE +
Sbjct: 47  DGLLKL--DG-----SVAFKTPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEAL 98

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|182727 PRK10783, mltD, membrane-bound lytic murein transglycosylase D; Provisional

 Score = 41.6 bits (98), Expect = 9e-04
 Identities = 28/98 (28%), Positives = 46/98 (46%), Gaps = 8/98 (8%)

Query: 104 QFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGD-ADVSK 162
            + + SGDT   +A+R   +  D   LQ+ NN   +++    TL +    S    A+ S 
Sbjct: 345 SYKVRSGDTLSGIASRLNVSTKD---LQQWNNLRGSKLKVGQTLTIGAGSSAQRLANNSD 401

Query: 163 QYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVN 200
                +TY +R GDSL SIA+  G++   +  +N    
Sbjct: 402 S----ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTA 435

Length = 456

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 16/97 (16%)

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-------LTEVGSASLPT 444
           A G+E++        +HRD+ + N+LI +    K+ DFGL +           GS  LP 
Sbjct: 249 ANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           +      +M PE       +   DV++FG++L+E+ +
Sbjct: 306 K------WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|197609 smart00257, LysM, Lysin motif

 Score = 35.9 bits (84), Expect = 0.002
 Identities = 14/32 (43%), Positives = 20/32 (62%)

Query: 169 TYPLRPGDSLQSIARNVGLSESLLQNYNPGVN 200
           TY ++ GD+L SIAR  G+S S L   N  ++
Sbjct: 1   TYTVKKGDTLSSIARRYGISVSDLLELNNILD 32

Length = 44

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 19/45 (42%), Positives = 25/45 (55%), Gaps = 3/45 (6%)

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
           I  D    LEYIHEH +    H DIK  NI++D N    + D+G+
Sbjct: 131 IMKDMLTTLEYIHEHGIS---HGDIKPENIMVDGNNRGYIIDYGI 172

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	589
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.98
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
PRK06347	592	autolysin; Reviewed	99.92
PRK06347	592	autolysin; Reviewed	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.78
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
PRK10345	210	hypothetical protein; Provisional	99.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.67
smart00090	237	RIO RIO-like kinase.	99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.65
PRK14879	211	serine/threonine protein kinase; Provisional	99.63
PRK13914	481	invasion associated secreted endopeptidase; Provis	99.6
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.59
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.59
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.45
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.22
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.19
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.18
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.12
KOG1243	690	consensus Protein kinase [General function predict	99.08
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	99.06
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	99.05
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.04
COG4248	637	Uncharacterized protein with protein kinase and he	99.04
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.0
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.99
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.94
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.89
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.83
PRK14125	103	cell division suppressor protein YneA; Provisional	98.81
PRK14125	103	cell division suppressor protein YneA; Provisional	98.77
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.69
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.68
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.65
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.64
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.57
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.51
PRK09902	216	hypothetical protein; Provisional	98.5
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.46
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.37
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.37
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.37
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.33
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.32
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.3
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.28
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.27
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.25
PRK13914	481	invasion associated secreted endopeptidase; Provis	98.25
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.24
PRK11198	147	LysM domain/BON superfamily protein; Provisional	98.04
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	97.99
PF01636	239	APH: Phosphotransferase enzyme family This family	97.99
smart00257	44	LysM Lysin motif.	97.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.93
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.9
smart00257	44	LysM Lysin motif.	97.9
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.86
PRK11198	147	LysM domain/BON superfamily protein; Provisional	97.8
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.76
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.65
PLN02876	822	acyl-CoA dehydrogenase	97.49
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.48
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.48
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.46
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.36
PRK10593	297	hypothetical protein; Provisional	97.29
PRK10260	306	L,D-transpeptidase; Provisional	97.25
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.21
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.19
PRK10190	310	L,D-transpeptidase; Provisional	97.18
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.04
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.91
COG1652	269	XkdP Uncharacterized protein containing LysM domai	96.64

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=392.91  Aligned_cols=286  Identities=46%  Similarity=0.801  Sum_probs=237.0

Q ss_pred             CCccccHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHH---HHHHHHHHHH
Q 037010          258 KSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA---SREFLAELKV  334 (589)
Q Consensus       258 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~E~~i  334 (589)
                      ....|+++++..++++|...+.||+|+||.||+|...+.                ..+++|++....   ..+|.+|+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~----------------~~vAVK~~~~~~~~~~~eF~~Ei~~  124 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG----------------TVVAVKRLSSNSGQGEREFLNEVEI  124 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC----------------CEEEEEEecCCCCcchhHHHHHHHH
Confidence            567799999999999999999999999999999998764                134455444322   4569999999


Q ss_pred             HccCCCCcceeEeeEEEeCc--EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          335 LTHVHHLNLVRLIGYCVEGS--LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       335 l~~l~hpnIv~l~~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      +.+++|||+|+++|||.++.  .+||+|||.+|+|.+++......+++|.++.+|+.++|.||+|||+..-++|||||||
T Consensus       125 ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiK  204 (361)
T KOG1187|consen  125 LSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIK  204 (361)
T ss_pred             HhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCC
Confidence            99999999999999998654  8999999999999999988654379999999999999999999999887788999999


Q ss_pred             CCcEEEcCCCcEEEEeccCcccccc-CCCCCCccc-ccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEV-GSASLPTRL-VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~-~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      |+|||+|+++.+||+|||+|+.... ....  ... .||.+|+|||+...+..+.++|||||||+|+||+||+.+.....
T Consensus       205 ssNILLD~~~~aKlsDFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~  282 (361)
T KOG1187|consen  205 SSNILLDEDFNAKLSDFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR  282 (361)
T ss_pred             HHHeeECCCCCEEccCccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC
Confidence            9999999999999999999976543 2211  112 79999999999999999999999999999999999998875443


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCC-CCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLG-DNCPL-DSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      .  .....+..+....+..    ..+.+++|+.+. ..++. +....+..++.+|++.+|.+||+|.||++.|..+...
T Consensus       283 ~--~~~~~l~~w~~~~~~~----~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  283 P--RGELSLVEWAKPLLEE----GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             C--cccccHHHHHHHHHHC----cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            1  1122244444333332    268899999987 56664 6888899999999999999999999999999666543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-48  Score=374.89  Aligned_cols=266  Identities=26%  Similarity=0.442  Sum_probs=212.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++++.++.||+|..|+||++.++.++ ..++.|.+          .-..+....+++.+|++++++.+||+||++||.|.
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~-~i~AlK~I----------~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~  147 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTG-KIYALKVI----------LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFY  147 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCC-eEEEEEee----------cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEE
Confidence            34556789999999999999988762 22222111          11235566788999999999999999999999665


Q ss_pred             -eC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 -EG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 -~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                       ++ .++|+||||++|+|.+++...++  +++.....++.+|++||.|||+ ++|   |||||||+|||++..|.|||||
T Consensus       148 ~~~~~isI~mEYMDgGSLd~~~k~~g~--i~E~~L~~ia~~VL~GL~YLh~~~~I---IHRDIKPsNlLvNskGeVKicD  222 (364)
T KOG0581|consen  148 SNGEEISICMEYMDGGSLDDILKRVGR--IPEPVLGKIARAVLRGLSYLHEERKI---IHRDIKPSNLLVNSKGEVKICD  222 (364)
T ss_pred             eCCceEEeehhhcCCCCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHhhccCe---eeccCCHHHeeeccCCCEEecc
Confidence             55 39999999999999999987644  9999999999999999999996 887   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||.+......   ....++||..|||||.+.+..|+.++||||||++++|+.+|+.|+......   +.....++..+..
T Consensus       223 FGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~---~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  223 FGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP---YLDIFELLCAIVD  296 (364)
T ss_pred             ccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC---CCCHHHHHHHHhc
Confidence            9999866433   556689999999999999999999999999999999999999999665222   2233444444443


Q ss_pred             CCChHHhhHhhcCCCCCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccccC
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLD-SVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDV  573 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~  573 (589)
                      .+.          |    ..|.+ ++.++..|+..||++||.+|||++|+++|-.-......+-+.
T Consensus       297 ~pp----------P----~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~  348 (364)
T KOG0581|consen  297 EPP----------P----RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDM  348 (364)
T ss_pred             CCC----------C----CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccH
Confidence            222          2    23333 667899999999999999999999999996655555544443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-46  Score=365.97  Aligned_cols=261  Identities=25%  Similarity=0.369  Sum_probs=199.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..+.|.+.+.||+|+||.|-+|..+.+ ++.++.|++........    .........+.+|+++|++|+|||||+++++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~t-gk~vAiKIi~krk~~~~----s~~~~~~~~v~~EieILkkL~HP~IV~~~d~  244 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKT-GKQVAIKIINKRKSTGC----SRAIAKTRDVQNEIEILKKLSHPNIVRIKDF  244 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEccc-CcEEEeeeeehhhcccc----cccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence            456788999999999999999987766 33333333322111100    0011123346789999999999999999999


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC---CcEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN---FHAK  425 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~---~~vk  425 (589)
                      +.+ +..||||||++||+|.+++..+..  +.+..-+.+++|++.|+.|||++||   +||||||+|||+..+   ..+|
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~GI---~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQGI---IHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcCc---ccccCCcceEEeccCCcceEEE
Confidence            875 457999999999999999988765  7777889999999999999999999   999999999999765   7899


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCC---cccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS---PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |+|||+|+...  ......+.+|||.|.|||++....+.   .++|+||+||+||-+|+|..||.......    .+   
T Consensus       320 ItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~----sl---  390 (475)
T KOG0615|consen  320 ITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP----SL---  390 (475)
T ss_pred             ecccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----cH---
Confidence            99999999865  34455668999999999999766433   37899999999999999999996544322    11   


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+++....           -...........++..+|+.+||..||++|||+.|+++|
T Consensus       391 ~eQI~~G~-----------y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  391 KEQILKGR-----------YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HHHHhcCc-----------ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            11111100           000112233456689999999999999999999999998

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-45  Score=374.36  Aligned_cols=256  Identities=33%  Similarity=0.557  Sum_probs=205.7

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-----HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-----QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      .+.+.+.||+|+||+||++.+++..                .+++|.+..     ...++|.+|+.+|.+++|||||+++
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~----------------~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~  105 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTD----------------VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFY  105 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCce----------------eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            3445667999999999999998862                133443332     2266899999999999999999999


Q ss_pred             eEEEeCc--EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEeeccCCCcEEEcCCC-c
Q 037010          348 GYCVEGS--LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT-VPVYIHRDIKSANILIDKNF-H  423 (589)
Q Consensus       348 ~~~~~~~--~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~-i~~~vH~Dlkp~NILl~~~~-~  423 (589)
                      |+|.+..  +++||||+++|+|.+++.......+++..++.|+.|||.||+|||+++ |   |||||||+|||++.++ +
T Consensus       106 G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~i---IHrDLK~~NiLv~~~~~~  182 (362)
T KOG0192|consen  106 GACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPI---IHRDLKSDNILVDLKGKT  182 (362)
T ss_pred             EEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCe---eecccChhhEEEcCCCCE
Confidence            9998764  899999999999999998854456999999999999999999999999 7   9999999999999997 9


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhccc--CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ--YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      +||+|||+++...... ...+...||+.|||||++.  ...|+.++||||||+++|||+||+.||.....        ..
T Consensus       183 ~KI~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~  253 (362)
T KOG0192|consen  183 LKIADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQ  253 (362)
T ss_pred             EEECCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HH
Confidence            9999999998654322 2223368999999999999  56999999999999999999999999954322        11


Q ss_pred             HHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       502 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      ....+.         ....++    ..|.+++..+..|+.+||..||..||++.+++..|+.+.....
T Consensus       254 ~~~~v~---------~~~~Rp----~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  254 VASAVV---------VGGLRP----PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             HHHHHH---------hcCCCC----CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            111111         111222    2333455679999999999999999999999999998766433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=376.39  Aligned_cols=255  Identities=28%  Similarity=0.500  Sum_probs=214.0

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH--HHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ--ASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      +.+++.||+|.||.||+|.+++..                ++++|.++..  ..+.|.+|+++|++|+|+|||+++++|.
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~----------------~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~  271 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGST----------------KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCT  271 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCC----------------cccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEe
Confidence            456899999999999999998862                4455544432  2357889999999999999999999998


Q ss_pred             eC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 EG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      ++ .+|||||||..|+|.+||+...+..+...+.+.++.|||+|++||+++++   |||||...|||++++..+||+|||
T Consensus       272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~---IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY---IHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc---cchhhhhhheeeccCceEEEcccc
Confidence            75 49999999999999999998666779999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      +|+....+.............|.|||.++.+.++.+||||||||+||||+| |+.|+....                   
T Consensus       349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------------------  409 (468)
T KOG0197|consen  349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------------------  409 (468)
T ss_pred             cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------------------
Confidence            999654444433444455778999999999999999999999999999998 445542221                   


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                         ..++.+.++...+..+|..++..+.++|..||+.+|++|||++.+...|.++....+
T Consensus       410 ---n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  410 ---NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             ---HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence               233445555666667788888899999999999999999999999999998876543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-45  Score=374.25  Aligned_cols=254  Identities=22%  Similarity=0.407  Sum_probs=207.0

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .+|...+.||+|||+.||.+++..+ +..++.|++..+     ...   +....+.+.+|++|.+.|+|||||+++++|+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~t-ge~~A~KvVpk~-----~l~---k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE   88 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDT-GEVVAVKVVPKK-----LLK---KPKQREKVLNEIEIHRSLKHPNIVQFYHFFE   88 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCC-CcEEEEEEeehH-----Hhc---CcchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence            6799999999999999999987554 344444444322     111   2234456888999999999999999999998


Q ss_pred             eC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 EG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      +. ++|||+|+|..++|..++..+  .++++.+++.+++||+.||.|||+++|   +|||||..|+|++++.+|||+|||
T Consensus        89 Ds~nVYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~I---iHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   89 DSNNVYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGI---IHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             cCCceEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCc---eecccchhheeecCcCcEEecccc
Confidence            65 699999999999999999843  459999999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +|....... ++..+.+|||.|.|||++....++..+||||+||+||.||.|++||....        +.+....     
T Consensus       164 LAt~le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------vkety~~-----  229 (592)
T KOG0575|consen  164 LATQLEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------VKETYNK-----  229 (592)
T ss_pred             eeeeecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------HHHHHHH-----
Confidence            999876543 34466899999999999999999999999999999999999999995432        1111111     


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                              +.....  ..|........+||.++|+.||.+|||+++|+.|=.-
T Consensus       230 --------Ik~~~Y--~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  230 --------IKLNEY--SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             --------HHhcCc--ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence                    111111  2344555678999999999999999999999998543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-45  Score=354.40  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=201.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++++.||+|+||+||.++.+++ +..++.     +.+.++..++.   ...+....|..||.+++||+||+++-.
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt-~kiYAm-----Kvl~K~~iv~~---~e~~~~~~Er~IL~~v~hPFiv~l~ys   93 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDT-GKIYAM-----KVLKKKKIVEK---KEVRHTKAERNILSKIKHPFIVKLIYS   93 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEccc-Cceeeh-----hhhhhhHhhhh---hhHHHHHHHHHHHHhCCCCcEeeeEEe
Confidence            357899999999999999999998744 334433     33333333332   455678889999999999999999864


Q ss_pred             E-EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 C-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      + ..+++|+|+||+.||.|+.+|++.+.  +++..++.++.+|+.||.|||++||   |||||||+|||+|.+|+++|+|
T Consensus        94 FQt~~kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~gI---iyRDlKPENILLd~~GHi~LtD  168 (357)
T KOG0598|consen   94 FQTEEKLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKGI---IYRDLKPENILLDEQGHIKLTD  168 (357)
T ss_pred             cccCCeEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCCe---eeccCCHHHeeecCCCcEEEec
Confidence            4 56789999999999999999998765  9999999999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||+++..... .......+||+.|||||++...+|+.++|.||||+++||||+|..||...+.        ....+.+..
T Consensus       169 FgL~k~~~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~--------~~~~~~I~~  239 (357)
T KOG0598|consen  169 FGLCKEDLKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV--------KKMYDKILK  239 (357)
T ss_pred             cccchhcccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH--------HHHHHHHhc
Confidence            9999854322 2334458999999999999999999999999999999999999999955432        111222211


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP----SMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~  560 (589)
                      .             .+ ...|.-......++++.+|..||++|.    .+++|-+|
T Consensus       240 ~-------------k~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  240 G-------------KL-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             C-------------cC-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence            1             10 112222445789999999999999995    56666555

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-44  Score=352.90  Aligned_cols=201  Identities=30%  Similarity=0.552  Sum_probs=173.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|.+.++||+|+||+||+|+++.++. ..+.|         .+..+++..+..+.+..|+.+|++++|||||++++++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~-~VAIK---------~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~   78 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGT-EVAIK---------CIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI   78 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCc-eEEee---------eehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE
Confidence            4678999999999999999999988742 22211         2333444555667788999999999999999999988


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC------Cc
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN------FH  423 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~------~~  423 (589)
                      . ++.+|||||||+||+|.+||+.++.  +++..++.++.|++.||++||+++|   |||||||+|||++..      -.
T Consensus        79 ~~~~~i~lVMEyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~~I---iHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   79 EDDDFIYLVMEYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHENNI---IHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             ecCCeEEEEEEeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCe---eeccCCcceEEeccCCCCCCCce
Confidence            6 4569999999999999999998764  9999999999999999999999999   999999999999764      46


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCccccc
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK  488 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~  488 (589)
                      +||+|||+|+...  ........+|++-|||||++..+.|+.|+|+||+|+++|++++|+.||..
T Consensus       154 LKIADFGfAR~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  154 LKIADFGFARFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             EEecccchhhhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            8999999999876  33445668999999999999999999999999999999999999999954

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-45  Score=343.05  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=200.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|+++++||.|.||.||++....++. ..+.|         ++....++....+++..|+.+|++|+|||||+++++.
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~-l~a~K---------~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~   87 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGK-LVALK---------KIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS   87 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcc-hhhhh---------hcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh
Confidence            3468899999999999999998766521 11111         1222344556677889999999999999999999833


Q ss_pred             --EeCc-EEEEEEecCCCChHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCceEeeccCCCcEEEcCCCc
Q 037010          351 --VEGS-LFLVYEYIENGNLSEHLRG--SGRDPLPWSSRVQIALDSARGLEYIHE--HTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       351 --~~~~-~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qia~aL~~LH~--~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                        .+.. ++||||+|.+|+|.+.|+.  ..++.+++..+++++.|++.||.++|+  .. ..++||||||.||+++.+|.
T Consensus        88 f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r-~~VmHRDIKPaNIFl~~~gv  166 (375)
T KOG0591|consen   88 FIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPR-GTVMHRDIKPANIFLTANGV  166 (375)
T ss_pred             hhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccc-cceeeccCcchheEEcCCCc
Confidence              3445 8999999999999999864  344569999999999999999999999  33 12599999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +||+|||+++.+.... ......+|||.||+||.+...+|+.+|||||+||++|||+.-+.||.+.        ++..+.
T Consensus       167 vKLGDfGL~r~l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~  237 (375)
T KOG0591|consen  167 VKLGDFGLGRFLSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLC  237 (375)
T ss_pred             eeeccchhHhHhcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHH
Confidence            9999999999875433 3345589999999999999999999999999999999999999999654        233333


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCC-hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCP-LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..+..-             .+ ..+| .-.+..+.+|+..|+..||+.||+.-.+++.+
T Consensus       238 ~KI~qg-------------d~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  238 KKIEQG-------------DY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             HHHHcC-------------CC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            222111             11 1234 45677899999999999999999964444433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=358.19  Aligned_cols=258  Identities=27%  Similarity=0.438  Sum_probs=212.5

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeE
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRL  346 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l  346 (589)
                      .+...+|.+++.||+|+|++|++|+...+      .+.++++++.+++.+|..+.   +-+..|-++|.+| .||.|+++
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t------~keYAiKVl~K~~Iike~Kv---kYV~~Ek~~l~~L~~hPgivkL  139 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKAT------GKEYAIKVLDKRYIIKEKKV---KYVTREKEALTQLSGHPGIVKL  139 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCC------CceeeHhhhhHHHHHhhccc---chhhHHHHHHHHhhCCCCeEEE
Confidence            45568899999999999999999998775      45566666667776665443   3456688888888 89999999


Q ss_pred             eeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      +--|. +..+|+|+||+++|+|.++|...+.  |++...+.++.+|+.||+|||++||   |||||||+|||+|+++++|
T Consensus       140 y~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~GI---IHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  140 YFTFQDEESLYFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSNGI---IHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             EEEeecccceEEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhcCc---eeccCChhheeEcCCCcEE
Confidence            97555 5679999999999999999998865  9999999999999999999999999   9999999999999999999


Q ss_pred             EEeccCccccccCCCC------------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCC
Q 037010          426 VADFGLTKLTEVGSAS------------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS  493 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~  493 (589)
                      |+|||.|+.+......            ....++||..|.+||++..+..++.+|+|+|||++|+|+.|+.||...+.  
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--  292 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--  292 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--
Confidence            9999999976532211            11348999999999999999999999999999999999999999966543  


Q ss_pred             CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                            ...++.++..           +-    ..|+..++...+|+++.|..||.+|+|.+||-+|..
T Consensus       293 ------yliFqkI~~l-----------~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF  340 (604)
T KOG0592|consen  293 ------YLIFQKIQAL-----------DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF  340 (604)
T ss_pred             ------HHHHHHHHHh-----------cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence                  1223333221           12    234445567899999999999999999999999953

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=5.2e-43  Score=330.53  Aligned_cols=261  Identities=25%  Similarity=0.329  Sum_probs=197.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-----HHHHHHHHHHHHHHccCCCCcceeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-----~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      +.|+.+.++|+|+||.||+|++++++.               .+|+|++.     ....+-.++|+++|++++|+|+|.+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~Tgq---------------IVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnL   66 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQ---------------IVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNL   66 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCccc---------------EEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHH
Confidence            468888999999999999999888732               33333332     2223456789999999999999999


Q ss_pred             eeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      +++|. ...++||||||+. ++.+-++..+. .++...+.++++|++.|+.|+|++++   |||||||+|||++.+|.+|
T Consensus        67 iEVFrrkrklhLVFE~~dh-TvL~eLe~~p~-G~~~~~vk~~l~Q~l~ai~~cHk~n~---IHRDIKPENILit~~gvvK  141 (396)
T KOG0593|consen   67 IEVFRRKRKLHLVFEYCDH-TVLHELERYPN-GVPSELVKKYLYQLLKAIHFCHKNNC---IHRDIKPENILITQNGVVK  141 (396)
T ss_pred             HHHHHhcceeEEEeeecch-HHHHHHHhccC-CCCHHHHHHHHHHHHHHhhhhhhcCe---ecccCChhheEEecCCcEE
Confidence            99886 5679999999988 56566665544 48999999999999999999999999   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |||||+|+.... .....+.++-|.+|+|||.+.+ ..|...+||||+||++.||++|...|-+..+  .+  .+.....
T Consensus       142 LCDFGFAR~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iD--QLy~I~k  216 (396)
T KOG0593|consen  142 LCDFGFARTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--ID--QLYLIRK  216 (396)
T ss_pred             eccchhhHhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HH--HHHHHHH
Confidence            999999997653 4455677899999999999876 6899999999999999999999977733221  11  1111111


Q ss_pred             HHhcCCChHHhhHhhc----------CCCCC--C---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLV----------DPRLG--D---NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~----------d~~l~--~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+-+..   ....++.          -|...  +   ..-+.....+.+|++.||+.||.+|++-+|++.|
T Consensus       217 tLG~L~---prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  217 TLGNLI---PRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             HHcccC---HHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111111   1111111          11111  1   1112344578999999999999999999999987

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-43  Score=345.76  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=200.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHH---HHHHHHHHHHHccCCCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA---SREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++..++.||+|+||+||++....+ +.              ..++|......   .+.+.+|+.+|.+++|||||+++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~-g~--------------~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~   80 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKT-GE--------------LMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYY   80 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCC-Cc--------------ceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeC
Confidence            34577789999999999999988764 22              23333332222   45688899999999999999999


Q ss_pred             eEEE--eC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-CCc
Q 037010          348 GYCV--EG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-NFH  423 (589)
Q Consensus       348 ~~~~--~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-~~~  423 (589)
                      |...  ++ .++++|||+.+|+|.+++...+. .+++..++.+.+|+++||+|||++|+   +||||||+|||++. ++.
T Consensus        81 G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~---vH~DiK~~NiLl~~~~~~  156 (313)
T KOG0198|consen   81 GSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGI---VHCDIKPANILLDPSNGD  156 (313)
T ss_pred             CccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCE---eccCcccceEEEeCCCCe
Confidence            9632  33 58899999999999999998876 69999999999999999999999998   99999999999999 799


Q ss_pred             EEEEeccCcccccc--CCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          424 AKVADFGLTKLTEV--GSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       424 vkl~Dfgla~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      +||+|||+++....  ..........||+.|||||++..+ ....++|||||||++.||+||+.||..-..      ...
T Consensus       157 ~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~------~~~  230 (313)
T KOG0198|consen  157 VKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE------EAE  230 (313)
T ss_pred             EEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc------hHH
Confidence            99999999986653  122223447899999999999863 333599999999999999999999843200      001


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ..+              .+.........|...+....+|+..|+..||++|||++++++|.......
T Consensus       231 ~~~--------------~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  231 ALL--------------LIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHH--------------HHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            111              11111111144556667899999999999999999999999997654433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-42  Score=348.08  Aligned_cols=270  Identities=27%  Similarity=0.370  Sum_probs=202.4

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...+.|+.+++||+|.||.||+|++..++....+.          ++.+...+.+...-..+||.||++|.||||+++.+
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALK----------Kvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~e  183 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALK----------KVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEE  183 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEE----------EeecccCCCcchHHHHHHHHHHHhcCCCcccceee
Confidence            34567888999999999999999987763322221          11111222233344678999999999999999999


Q ss_pred             EEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          349 YCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       349 ~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ...+   +.+|||||||++ +|..++...+- .|++.++..++.|++.||+|||.+|+   +|||||.+|||||.+|.+|
T Consensus       184 ivt~~~~~siYlVFeYMdh-DL~GLl~~p~v-kft~~qIKc~mkQLl~Gl~~cH~~gv---lHRDIK~SNiLidn~G~LK  258 (560)
T KOG0600|consen  184 IVTSKLSGSIYLVFEYMDH-DLSGLLSSPGV-KFTEPQIKCYMKQLLEGLEYCHSRGV---LHRDIKGSNILIDNNGVLK  258 (560)
T ss_pred             EEEecCCceEEEEEecccc-hhhhhhcCCCc-ccChHHHHHHHHHHHHHHHHHhhcCe---eeccccccceEEcCCCCEE
Confidence            7764   469999999998 88888776443 49999999999999999999999999   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |+|||+|+++........+..+.|.+|+|||++.+. .|+.+.|+||+||||.||++|+..|..... ......+++   
T Consensus       259 iaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfk---  334 (560)
T KOG0600|consen  259 IADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFK---  334 (560)
T ss_pred             eccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHH---
Confidence            999999998877766667888999999999998764 799999999999999999999987754332 111112222   


Q ss_pred             HHhcCCChH----HhhH--hhcCCCCCCCCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPI----EDLR--KLVDPRLGDNCP-------LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~----~~l~--~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                       +...|...    ..+.  ..+.+.  ..+.       ...+....+|+..+|..||.+|.|+.+++++
T Consensus       335 -lcGSP~e~~W~~~kLP~~~~~kp~--~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  335 -LCGSPTEDYWPVSKLPHATIFKPQ--QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             -HhCCCChhccccccCCcccccCCC--CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence             22222111    1111  011111  1111       1233467889999999999999999998876

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=346.36  Aligned_cols=265  Identities=29%  Similarity=0.382  Sum_probs=207.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH----HHHHHHHHHHHHccCC-CCcce
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ----ASREFLAELKVLTHVH-HLNLV  344 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~E~~il~~l~-hpnIv  344 (589)
                      .-++|.+.++||.|.||.||+|....+++.               +|+|+++..    ..-.-++|++-|+++. |||||
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~---------------VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpnii   72 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGEL---------------VAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNII   72 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCce---------------eeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcch
Confidence            457899999999999999999987766432               344443321    1223467999999998 99999


Q ss_pred             eEeeEEEeC--cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          345 RLIGYCVEG--SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       345 ~l~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      ++.+++.|.  .+|+|||||+. +|.+.+..+ ++.|++..++.|+.||++||+|+|.+|+   .|||+||+|||+....
T Consensus        73 kL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~Gf---FHRDlKPENiLi~~~~  147 (538)
T KOG0661|consen   73 KLKEVIRDNDRILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGF---FHRDLKPENILISGND  147 (538)
T ss_pred             hhHHHhhccCceEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCc---ccccCChhheEecccc
Confidence            999987654  59999999987 999999988 6679999999999999999999999998   9999999999999888


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcc-cCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      .+||+|||+|+...  .....+.++.|.+|+|||++ +.+.|+.+.|+||+||+++|+.+-+..|-+.++    ...+..
T Consensus       148 ~iKiaDFGLARev~--SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE----~Dqi~K  221 (538)
T KOG0661|consen  148 VIKIADFGLAREVR--SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE----IDQIYK  221 (538)
T ss_pred             eeEecccccccccc--cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH----HHHHHH
Confidence            99999999999654  34456789999999999976 567899999999999999999998877733322    112222


Q ss_pred             HHHHHhcCCChH-----HhhHhhcCCCCCCC-------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          502 LFEEVLNLPDPI-----EDLRKLVDPRLGDN-------CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       502 ~~~~~~~~~~~~-----~~l~~~~d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                       ..++++.|...     ..+...+.-.++..       .-++...+..+|+.+|+.+||.+|||++|.++|-
T Consensus       222 -Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  222 -ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             -HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence             33455544332     22333333333211       1123666899999999999999999999999994

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-41  Score=316.13  Aligned_cols=240  Identities=29%  Similarity=0.456  Sum_probs=196.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|+..+.||.|+||.|.+++.+.+ +..++.|.....     ..+   +....+...+|..+|+.+.||+++++++.+
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~-g~yYAmKvL~k~-----~vV---klKQveH~~nEk~vL~~v~~PFlv~l~~t~  113 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHS-GNYYAMKVLDKQ-----KVV---KLKQVEHTHNEKRVLKAVSHPFLVKLYGTF  113 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccC-CceeehhhcCHH-----HHH---HHHHHHHHhhHHHHHhhccCceeEEEEEee
Confidence            35788999999999999999998876 555555544322     211   223345678899999999999999999866


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.+||||||++||.|+.+++..++  +++..++.++.||+.||+|||++++   ++|||||+|||+|.+|.+||+||
T Consensus       114 ~d~~~lymvmeyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~~i---iYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  114 KDNSNLYMVMEYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSLDI---IYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             ccCCeEEEEEeccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhcCe---eeccCChHHeeeccCCcEEEEec
Confidence            65 569999999999999999998765  9999999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+|+.....    .-+.+|||.|+|||++...+|..++|.|||||++|||+.|..||...+.        ....+     
T Consensus       189 GFAK~v~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~-----  251 (355)
T KOG0616|consen  189 GFAKRVSGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYE-----  251 (355)
T ss_pred             cceEEecCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHH-----
Confidence            999976432    3458999999999999999999999999999999999999999965543        11122     


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCC
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR  551 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  551 (589)
                              +++...+  ..|.-....+.+|++..|+.|-.+|
T Consensus       252 --------KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  252 --------KILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --------HHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                    2222222  2344455578999999999999988

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-41  Score=346.55  Aligned_cols=258  Identities=23%  Similarity=0.364  Sum_probs=202.1

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEe
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLI  347 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~  347 (589)
                      ....+|.+++.||+|+||+|++|.+..++... +.|.+..     ....+.. ....+.+.+|+.++++++ ||||++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~v-AiKii~~-----~~~~~~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~   86 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKV-AIKIIDR-----KKVSSKS-QKLDELIKREISILRRLRSHPNIIRLL   86 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeE-EEEEech-----hcccccc-cccchhhHHHHHHHHHhccCCCEeEEE
Confidence            34678999999999999999999887764222 2222211     1111111 123345668999999998 99999999


Q ss_pred             eEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC-CcEE
Q 037010          348 GYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHAK  425 (589)
Q Consensus       348 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~-~~vk  425 (589)
                      +++. ....|+||||+.||+|.+++...+  ++.+..+..+++|++.|++|||++|+   +||||||+|||++.+ +.+|
T Consensus        87 ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi---~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   87 EVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGI---VHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             EEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCE---eeCCCCHHHEEecCCCCCEE
Confidence            9886 556999999999999999999844  48889999999999999999999999   999999999999999 9999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCC-CC-cccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD-VS-PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      |+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+.        ....
T Consensus       162 l~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~  232 (370)
T KOG0583|consen  162 LSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLY  232 (370)
T ss_pred             EeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHH
Confidence            99999998764 2334456689999999999999877 86 789999999999999999999965221        1111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDS-VLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ..+..             ..  -.+|... ..++..|+.+||..||.+|+|+.++++|=.
T Consensus       233 ~ki~~-------------~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w  277 (370)
T KOG0583|consen  233 RKIRK-------------GE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW  277 (370)
T ss_pred             HHHhc-------------CC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence            11111             11  1233333 567899999999999999999999997743

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=348.69  Aligned_cols=247  Identities=28%  Similarity=0.451  Sum_probs=203.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH---HHHHHHHHHHHHccCCCCcceeEee
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ---ASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ..|...++||+|+.|.||.|....+..               .+++|+++..   ..+-+.+|+.+|+..+|+|||++++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~---------------~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~  337 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQ---------------EVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLD  337 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCc---------------eEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHH
Confidence            578889999999999999998776632               3455544322   2345788999999999999999998


Q ss_pred             -EEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 -YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                       |...+++|+|||||+||+|.|.+....   +++.++..|++++++||+|||.+||   +|||||.+|||++.+|.+||+
T Consensus       338 Sylv~deLWVVMEym~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gI---iHrDIKSDnILL~~~g~vKlt  411 (550)
T KOG0578|consen  338 SYLVGDELWVVMEYMEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGI---IHRDIKSDNILLTMDGSVKLT  411 (550)
T ss_pred             HhcccceeEEEEeecCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcce---eeeccccceeEeccCCcEEEe
Confidence             556788999999999999999987654   9999999999999999999999999   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||++........ .....+|||.|||||++....|+++.||||||++++||+-|+.||.....       +.+      
T Consensus       412 DFGFcaqi~~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrA------  477 (550)
T KOG0578|consen  412 DFGFCAQISEEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRA------  477 (550)
T ss_pred             eeeeeeccccccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHH------
Confidence            9999987654433 44568999999999999999999999999999999999999999965322       111      


Q ss_pred             cCCChHHhhHhhcCC-CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDP-RLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~-~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                              +..+.+. .+.-..+...+..+.+|+.+||+.|+++|+++.|+|+|=
T Consensus       478 --------lyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~Hp  524 (550)
T KOG0578|consen  478 --------LYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHP  524 (550)
T ss_pred             --------HHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcCh
Confidence                    1111111 111233455666899999999999999999999999994

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-41  Score=340.52  Aligned_cols=254  Identities=31%  Similarity=0.485  Sum_probs=206.0

Q ss_pred             CCCccccHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHc
Q 037010          257 DKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLT  336 (589)
Q Consensus       257 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~  336 (589)
                      ++..++.+|++.       .++.||.|+.|.||+|++++.                 .+++|+++...    ..+++-|+
T Consensus       116 ~e~WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~ne-----------------tVAVKKV~elk----ETdIKHLR  167 (904)
T KOG4721|consen  116 EELWEIPFEEIS-------ELEWLGSGAQGAVFLGRLHNE-----------------TVAVKKVRELK----ETDIKHLR  167 (904)
T ss_pred             hhhccCCHHHhh-------hhhhhccCcccceeeeeccCc-----------------eehhHHHhhhh----hhhHHHHH
Confidence            455667777765       368999999999999998875                 66777665322    23788899


Q ss_pred             cCCCCcceeEeeEEEeCc-EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          337 HVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       337 ~l~hpnIv~l~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      +|+||||+.+.|+|.+.. ++||||||..|.|...|+...  ++.......|..+||.|+.|||.+.|   ||||||.-|
T Consensus       168 kLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKI---IHRDLKSPN  242 (904)
T KOG4721|consen  168 KLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKI---IHRDLKSPN  242 (904)
T ss_pred             hccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhH---hhhccCCCc
Confidence            999999999999998765 669999999999999998754  48889999999999999999999999   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD  495 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~  495 (589)
                      |||..+..|||+|||-++.....  .....+.||..|||||++++.+.+.|+|||||||+|||||||..||..-....+ 
T Consensus       243 iLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-  319 (904)
T KOG4721|consen  243 ILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-  319 (904)
T ss_pred             eEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee-
Confidence            99999999999999998854322  223447899999999999999999999999999999999999999843221110 


Q ss_pred             hhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                         +       +...          ...+.-..|.++++.+.-|+++||+-.|..|||+++++.||.....
T Consensus       320 ---I-------wGVG----------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  320 ---I-------WGVG----------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             ---E-------Eecc----------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence               0       0000          0112223456666789999999999999999999999999976543

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.5e-41  Score=343.63  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=204.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHh-hcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK-KMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik-~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ++|.+.+.||+|+||+||+|+.+.+..      .++.+     ...| .......+.+.+|++|+++++||||+.+++++
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~------~vAik-----~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf   70 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQ------VVAIK-----FIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF   70 (808)
T ss_pred             cchhHHHHhcCCccceeeeccccccee------EEEEE-----EehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh
Confidence            579999999999999999998666521      11111     1111 11233556788999999999999999999988


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      + ..++|+|.||+.| +|+.++...+.  ++++.+..++.+++.||.|||+.+|   +|||+||.|||++.+|.+|++||
T Consensus        71 Et~~~~~vVte~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~ri---lhrd~kPqniLl~~~~~~KlcdF  144 (808)
T KOG0597|consen   71 ETSAHLWVVTEYAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSNRI---LHRDMKPQNILLEKGGTLKLCDF  144 (808)
T ss_pred             cccceEEEEehhhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhcCc---ccccCCcceeeecCCCceeechh
Confidence            6 5679999999988 99999988765  9999999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+|+.+... ....+...|||-|||||++.+.+|+..+|+|||||++|||++|++||...        .+..+.+.+...
T Consensus       145 g~Ar~m~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d  215 (808)
T KOG0597|consen  145 GLARAMSTN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKD  215 (808)
T ss_pred             hhhhhcccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcC
Confidence            999976543 33445678999999999999999999999999999999999999999432        334444444332


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      +               -..|.+....+..|+...|.+||..|.|..+++.|-
T Consensus       216 ~---------------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  216 P---------------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             C---------------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence            1               123456677899999999999999999999999983

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-40  Score=327.48  Aligned_cols=261  Identities=24%  Similarity=0.354  Sum_probs=202.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH----HHHHHHHHHHHHccCCCCccee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ----ASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      ..+.|++.+.||.|..++||+|+.....               ..+++|.++.+    ..+.+.+|+..|+.++||||++
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~---------------e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~   88 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTN---------------EVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVT   88 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccC---------------CEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcce
Confidence            3567999999999999999999876553               24555555432    3577899999999999999999


Q ss_pred             EeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          346 LIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       346 l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      ++..|. +..+|+||.||.+|++.+.+.......+++..+..|++++++||.|||.+|.   ||||||+.||||+.+|.|
T Consensus        89 ~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~---IHRdvKAgnILi~~dG~V  165 (516)
T KOG0582|consen   89 YHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH---IHRDVKAGNILIDSDGTV  165 (516)
T ss_pred             EEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc---eecccccccEEEcCCCcE
Confidence            998665 6779999999999999999998877789999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCCC---CCcccccCCCCCchhccc--CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          425 KVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQ--YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~--~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      ||+|||.+.........   .....+||+.|||||++.  ...|+.|+||||||++..||.+|..||...-+    .+. 
T Consensus       166 kLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP----mkv-  240 (516)
T KOG0582|consen  166 KLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP----MKV-  240 (516)
T ss_pred             EEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh----HHH-
Confidence            99999977643322211   114468999999999953  45799999999999999999999999954322    111 


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                        ++..+.+.+....  ....+.    +........+.+++..||++||.+|||+++++.|-
T Consensus       241 --Ll~tLqn~pp~~~--t~~~~~----d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~  294 (516)
T KOG0582|consen  241 --LLLTLQNDPPTLL--TSGLDK----DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA  294 (516)
T ss_pred             --HHHHhcCCCCCcc--cccCCh----HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence              1112222211000  111111    11122334789999999999999999999999883

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.8e-40  Score=339.46  Aligned_cols=262  Identities=27%  Similarity=0.458  Sum_probs=197.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccC-CCCccee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHV-HHLNLVR  345 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l-~hpnIv~  345 (589)
                      .++|++.++||+|+||.||+|.+.+.... ...         ..+++|.+.    ......+.+|++++.++ +||||++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~-~~~---------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~   75 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKK-SSC---------NTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVN   75 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCc-ccc---------hhhheeccccccchHHHHHHHHHHHHHHHhccCcceee
Confidence            46899999999999999999986432111 001         123333332    23345688999999999 8999999


Q ss_pred             EeeEEEe--CcEEEEEEecCCCChHHHHhcCC------------------------------------------------
Q 037010          346 LIGYCVE--GSLFLVYEYIENGNLSEHLRGSG------------------------------------------------  375 (589)
Q Consensus       346 l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------  375 (589)
                      +++++.+  +.++++|||+++|+|.+++....                                                
T Consensus        76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (338)
T cd05102          76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG  155 (338)
T ss_pred             EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence            9998764  35899999999999999997532                                                


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCC-C
Q 037010          376 ------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-L  442 (589)
Q Consensus       376 ------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~  442 (589)
                                  ..++++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||+++........ .
T Consensus       156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~  232 (338)
T cd05102         156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR  232 (338)
T ss_pred             ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCE---ECCCCccceEEEcCCCcEEEeecccccccccCcchhc
Confidence                        1347788889999999999999999998   99999999999999999999999999754322211 1


Q ss_pred             CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcC
Q 037010          443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVD  521 (589)
Q Consensus       443 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  521 (589)
                      .....+++.|+|||++.+..++.++|||||||++|||++ |..||......    ...   .......          ..
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~~~---~~~~~~~----------~~  295 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----EEF---CQRLKDG----------TR  295 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----HHH---HHHHhcC----------CC
Confidence            122346678999999988899999999999999999997 98888432210    111   1111110          01


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          522 PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       522 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      .    ..+...+..+.+++.+||+.||.+|||+.|+++.|+.+..
T Consensus       296 ~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         296 M----RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1    1122344578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=330.03  Aligned_cols=278  Identities=25%  Similarity=0.396  Sum_probs=208.8

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc---CHHHHHHHHHHHHHHccCCCC
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREFLAELKVLTHVHHL  341 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~---~~~~~~~~~~E~~il~~l~hp  341 (589)
                      .+-.+..++|++.+.||+|.||.|-+|.+..+ ++.++.|++..+...........   .....+.+.+|+.+|++++||
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~-~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVD-GKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeecCC-CcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            34455678999999999999999999987665 44555555444433332221111   112245788999999999999


Q ss_pred             cceeEeeEEEe---CcEEEEEEecCCCChHHHHhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          342 NLVRLIGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDP-LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       342 nIv~l~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      |||+++++..+   +.+|||+|||..|.+...   ....+ +.+.++++++++++.||+|||.+||   |||||||+|+|
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgi---iHRDIKPsNLL  242 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGI---IHRDIKPSNLL  242 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCe---eccccchhheE
Confidence            99999998864   469999999998876543   22334 8999999999999999999999999   99999999999


Q ss_pred             EcCCCcEEEEeccCccccccCCC----CCCcccccCCCCCchhcccCCC----CCcccchhhHHHHHHHHHcCCcccccC
Q 037010          418 IDKNFHAKVADFGLTKLTEVGSA----SLPTRLVGTFGYMPPEYAQYGD----VSPKVDVYAFGVVLYELISAKEAIVKG  489 (589)
Q Consensus       418 l~~~~~vkl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwSlGvll~elltG~~p~~~~  489 (589)
                      ++++|++||+|||.+..+..+..    ......+|||.|+|||.+..+.    .+.+.||||+||+||.|+.|+.||...
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            99999999999999886633211    1123368999999999987632    356889999999999999999999543


Q ss_pred             CCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      .        ....+..             ++...+.-...++..+.+.+|++++|++||+.|.+..+|..|...-.....
T Consensus       323 ~--------~~~l~~K-------------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~  381 (576)
T KOG0585|consen  323 F--------ELELFDK-------------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS  381 (576)
T ss_pred             h--------HHHHHHH-------------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence            2        2223332             232222222223456689999999999999999999999999876665443


Q ss_pred             c
Q 037010          570 D  570 (589)
Q Consensus       570 ~  570 (589)
                      .
T Consensus       382 ~  382 (576)
T KOG0585|consen  382 P  382 (576)
T ss_pred             C
Confidence            3

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-40  Score=353.55  Aligned_cols=263  Identities=32%  Similarity=0.563  Sum_probs=207.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH----HHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----QASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      ..+.+..+.||+|.||+||+|+..+-....          ...-+++|.++.    +...+|++|+++|..++|||||++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~----------~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrL  554 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQ----------DEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRL  554 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCc----------cceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence            345567899999999999999865531100          112344444432    356789999999999999999999


Q ss_pred             eeEEEeCc-EEEEEEecCCCChHHHHhcCC--------CC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          347 IGYCVEGS-LFLVYEYIENGNLSEHLRGSG--------RD----PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       347 ~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~--------~~----~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      +|+|.+++ ++||||||..|+|.+||....        ..    +++..+.+.|+.|||.|++||-++.+   |||||-.
T Consensus       555 lGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~F---VHRDLAT  631 (774)
T KOG1026|consen  555 LGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHF---VHRDLAT  631 (774)
T ss_pred             EEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcc---cccchhh
Confidence            99998665 889999999999999997542        12    38889999999999999999999998   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCCCCC-cccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~  491 (589)
                      +|+|+.++..|||+|||+++........+. ....-.++|||||.+..+.+|.+||||||||+|||++| |+.|+..-..
T Consensus       632 RNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn  711 (774)
T KOG1026|consen  632 RNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN  711 (774)
T ss_pred             hhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch
Confidence            999999999999999999986543322221 13345679999999999999999999999999999986 6667643221


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhc-CCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLV-DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                                            ++..+.+ +..+ -.+|.+++.++++||..||+.+|.+||+++||-..|+.....++
T Consensus       712 ----------------------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  712 ----------------------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             ----------------------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence                                  1111222 2222 46788888899999999999999999999999999988765443

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=338.89  Aligned_cols=262  Identities=27%  Similarity=0.456  Sum_probs=208.2

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc-----CHHHHHHHHHHHHHHccCC
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-----DMQASREFLAELKVLTHVH  339 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~-----~~~~~~~~~~E~~il~~l~  339 (589)
                      ++.....+.+.+.++||+|.||+||+|+|.++                  +|+|.+     ..+..+.|.+|+.++++-+
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd------------------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR  446 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD------------------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTR  446 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc------------------eEEEEEecCCCCHHHHHHHHHHHHHHhhcc
Confidence            33444456677899999999999999999986                  333333     3456788999999999999


Q ss_pred             CCcceeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc
Q 037010          340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID  419 (589)
Q Consensus       340 hpnIv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~  419 (589)
                      |.||+-+.|+|.+..+.||+-+|+|.+|..+++-... .|...+.++|++|+++|+.|||.++|   ||||||..|||++
T Consensus       447 H~NIlLFMG~~~~p~~AIiTqwCeGsSLY~hlHv~et-kfdm~~~idIAqQiaqGM~YLHAK~I---IHrDLKSnNIFl~  522 (678)
T KOG0193|consen  447 HENILLFMGACMNPPLAIITQWCEGSSLYTHLHVQET-KFDMNTTIDIAQQIAQGMDYLHAKNI---IHRDLKSNNIFLH  522 (678)
T ss_pred             hhhheeeehhhcCCceeeeehhccCchhhhhccchhh-hhhHHHHHHHHHHHHHhhhhhhhhhh---hhhhccccceEEc
Confidence            9999999999998888999999999999999987653 49999999999999999999999999   9999999999999


Q ss_pred             CCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccC---CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC
Q 037010          420 KNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQY---GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD  495 (589)
Q Consensus       420 ~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~  495 (589)
                      +++.|||+|||++.....-... ......|...|||||+++.   .+|++.+||||||+++|||+||..||.....+.+-
T Consensus       523 ~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi  602 (678)
T KOG0193|consen  523 EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII  602 (678)
T ss_pred             cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE
Confidence            9999999999998754332211 1223567889999999854   47999999999999999999999999633221110


Q ss_pred             hhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      +.     ..+.            .+.+++ .....+++..+.+|+..||..++++||.+.+|+..|+.+..
T Consensus       603 fm-----VGrG------------~l~pd~-s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  603 FM-----VGRG------------YLMPDL-SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             EE-----eccc------------ccCccc-hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            00     0000            011111 11223556689999999999999999999999998887776

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4e-40  Score=306.23  Aligned_cols=267  Identities=25%  Similarity=0.365  Sum_probs=198.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|...++||+|.||.||+|++..++....++|          +.+.+.+........+|++.|+.++|+||+.+++.+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKK----------Ikl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~   71 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKK----------IKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP   71 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEE----------eeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc
Confidence            578889999999999999999877643222111          1111222222345678999999999999999999876


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       .+.+-||+|||+. +|...|+.... .+...++..++.++++||+|||.+.|   +||||||.|+|++.+|.+||+|||
T Consensus        72 ~~~~l~lVfEfm~t-dLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~~I---lHRDlKPnNLLis~~g~lKiADFG  146 (318)
T KOG0659|consen   72 HKSNLSLVFEFMPT-DLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSKWI---LHRDLKPNNLLISSDGQLKIADFG  146 (318)
T ss_pred             CCCceEEEEEeccc-cHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhhhh---hcccCCccceEEcCCCcEEeeccc
Confidence             4568899999987 99999887654 58999999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      +++.+....... +..+.|.+|+|||.+.+. .|+...|+||.||++.||+-|.. |.++..+..   .+...+ ..+..
T Consensus       147 LAr~f~~p~~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P-~fpG~sDid---QL~~If-~~LGT  220 (318)
T KOG0659|consen  147 LARFFGSPNRIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP-FFPGDSDID---QLSKIF-RALGT  220 (318)
T ss_pred             chhccCCCCccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC-CCCCCchHH---HHHHHH-HHcCC
Confidence            999876544433 334789999999988764 69999999999999999998764 444443221   222222 22232


Q ss_pred             CChH--HhhHhhcC---------CCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPI--EDLRKLVD---------PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~--~~l~~~~d---------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      |.+.  .++..+.|         +.+.. .=..+.....+|+..+|..||.+|+|+.|+++|
T Consensus       221 P~~~~WP~~~~lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  221 PTPDQWPEMTSLPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCcccCccccccccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            2211  11111111         11111 222344567999999999999999999999988

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-40  Score=303.39  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=206.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++++.||+|.||.||+|+.+.+.      .+++.+++.+....   ..+...++.+|++|-.+|+||||+++|+++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~------~IvalKVlfKsqi~---~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSL------FIVALKVLFKSQIL---KTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCC------cEEEEeeeeHHHHH---HhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            467899999999999999999877652      12222222222211   123346788999999999999999999998


Q ss_pred             EeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+. ..||++||..+|+|...+.......+++.....++.|+|.||.|+|.+++   +||||||+|+|++..+..||+||
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~V---IhRdiKpenlLlg~~~~lkiAdf  168 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRV---IHRDIKPENLLLGSAGELKIADF  168 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCc---ccCCCCHHHhccCCCCCeeccCC
Confidence            765 59999999999999999998777779999999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |.+....   .......+||..|.+||...+..++...|+|++|++.||++.|..||.....        .+....+.. 
T Consensus       169 GwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~--------~etYkrI~k-  236 (281)
T KOG0580|consen  169 GWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH--------SETYKRIRK-  236 (281)
T ss_pred             CceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh--------HHHHHHHHH-
Confidence            9987653   3344568999999999999999999999999999999999999999944321        111222211 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                                +|    -..|........++|.+|+.++|.+|.+..|+++|--.
T Consensus       237 ----------~~----~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  237 ----------VD----LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             ----------cc----ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence                      11    12344555678999999999999999999999998543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-40  Score=337.22  Aligned_cols=259  Identities=23%  Similarity=0.347  Sum_probs=205.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .-|++++-||.|+.|.|-+|++..++ ...+.|.+....        .........+.+|+-||+-+.|||++++|+++.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TG-qlaaiKii~k~~--------~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe   82 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETG-QLAAIKIIPKRS--------ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE   82 (786)
T ss_pred             cceeccccccCCCCceehhhhccccc-ceeEEEeecccc--------ccccccccchhhhhHHHHHhcCCCeeeeeeeec
Confidence            45788999999999999999987763 333333222110        122223345778999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + .++|+|.||++||.|++++...+.  +++.++.+++.||+.|+.|+|..++   +||||||+|+|+|..+++||+|||
T Consensus        83 ~~~~lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~i---cHRDLKpENlLLd~~~nIKIADFG  157 (786)
T KOG0588|consen   83 NKQHLYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFNI---CHRDLKPENLLLDVKNNIKIADFG  157 (786)
T ss_pred             cCceEEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhcc---eeccCCchhhhhhcccCEeeeccc
Confidence            5 569999999999999999988765  9999999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCC-cccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH-HHHHHhc
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA-LFEEVLN  508 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~-~~~~~~~  508 (589)
                      +|.....+  ....+.+|+|.|.|||++.+.+|+ .++||||.|||||.||||+.||.+.+.     +.+.. .....+ 
T Consensus       158 MAsLe~~g--klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-----r~LLlKV~~G~f-  229 (786)
T KOG0588|consen  158 MASLEVPG--KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-----RVLLLKVQRGVF-  229 (786)
T ss_pred             eeecccCC--ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-----HHHHHHHHcCcc-
Confidence            99875433  334567999999999999999885 689999999999999999999953321     11111 111111 


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED  570 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~  570 (589)
                                        ..|.+.+.+.++|+++|++.||..|.|++||++|-.-......+
T Consensus       230 ------------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  230 ------------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             ------------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence                              23444555789999999999999999999999996655544444

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-40  Score=330.35  Aligned_cols=246  Identities=26%  Similarity=0.424  Sum_probs=199.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH----HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..|+..++||+|.||.||+|.+..+.               +.+++|.+..    ...+++++|+.+|.+++++||.++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~---------------k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yy   77 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTK---------------KVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYY   77 (467)
T ss_pred             cccccchhccccccceeeeeeecccc---------------ceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhh
Confidence            45777899999999999999987762               2344444432    3456788999999999999999999


Q ss_pred             eEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +.+. +..+|++||||.||++.+.+....-  +.+..+..++++++.||.|||.++.   +|||||+.|||+..+|.+||
T Consensus        78 gsyl~g~~LwiiMey~~gGsv~~lL~~~~~--~~E~~i~~ilre~l~~l~ylH~~~k---iHrDIKaanil~s~~g~vkl  152 (467)
T KOG0201|consen   78 GSYLKGTKLWIIMEYCGGGSVLDLLKSGNI--LDEFEIAVILREVLKGLDYLHSEKK---IHRDIKAANILLSESGDVKL  152 (467)
T ss_pred             hheeecccHHHHHHHhcCcchhhhhccCCC--CccceeeeehHHHHHHhhhhhhcce---ecccccccceeEeccCcEEE
Confidence            8665 4568999999999999999976542  5888888999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      +|||.+-........+ .+++|||.|||||++....|+.++||||||++.+||.+|..|+.....           +.-+
T Consensus       153 ~DfgVa~ql~~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP-----------mrvl  220 (467)
T KOG0201|consen  153 ADFGVAGQLTNTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP-----------MRVL  220 (467)
T ss_pred             Eecceeeeeechhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc-----------ceEE
Confidence            9999998765444333 668999999999999988999999999999999999999999854332           1111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +..       .+-..|.+.+    .....+.+|+..||++||+.|||+.+++.|
T Consensus       221 flI-------pk~~PP~L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  221 FLI-------PKSAPPRLDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             Eec-------cCCCCCcccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            110       0111223322    455579999999999999999999999988

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-38  Score=321.54  Aligned_cols=248  Identities=21%  Similarity=0.356  Sum_probs=190.4

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-----
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-----  352 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----  352 (589)
                      ..||+|+++.||+|.+.+.   ..+.|.+.     ..   +.......+.+.+|+++|++++||||+++++++.+     
T Consensus        26 ~~i~~g~~~~v~~~~~~~~---~vavK~~~-----~~---~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNNK---EVIIRTFK-----KF---HKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             eEEeeCCceEEEEEEECCE---EEEEEecc-----cc---ccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            6799999999999988543   22221111     00   01111224667899999999999999999998765     


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ...++||||+++|+|.+++....  .+++...+.++.+++.||.|||+. ++   +||||||+|||+++++.+||+|||+
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~---~Hrdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCC---CCCcCChhhEEECCCCcEEEcccch
Confidence            24789999999999999997654  488999999999999999999985 77   8999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccC--CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++.....    .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....     .   .....+.. 
T Consensus       170 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~---~~~~~i~~-  236 (283)
T PHA02988        170 EKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----K---EIYDLIIN-  236 (283)
T ss_pred             Hhhhccc----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----H---HHHHHHHh-
Confidence            8754321    123468899999999975  6899999999999999999999999953221     1   11111111 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                                  .......+..++..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus       237 ------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        237 ------------KNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ------------cCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                        001111223345679999999999999999999999999998764

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=299.13  Aligned_cols=264  Identities=22%  Similarity=0.310  Sum_probs=202.0

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC---HHHHHHHHHHHHHHccCCCCcc
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD---MQASREFLAELKVLTHVHHLNL  343 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~---~~~~~~~~~E~~il~~l~hpnI  343 (589)
                      +....++|++.++||+|||+.||+++.-.+.+               .+++|++.   .+..+..++|++..++++|||+
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~---------------~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~v   80 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGH---------------LYALKKILCHSQEDIEEALREIDNHRKFNSPNV   80 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCccc---------------chhhheeeccchHHHHHHHHHHHHHHhhCCcch
Confidence            34456899999999999999999998555432               33444332   3556778899999999999999


Q ss_pred             eeEeeEEEe------CcEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          344 VRLIGYCVE------GSLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       344 v~l~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      +++++++..      ...|++++|...|+|.+.++...  +..+++.+++.|+.++++||++||+.. ++|.||||||.|
T Consensus        81 l~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~N  159 (302)
T KOG2345|consen   81 LRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPAN  159 (302)
T ss_pred             HHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcce
Confidence            999987642      23899999999999999997643  345999999999999999999999998 577999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCCCCC--------cccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCc
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSASLP--------TRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKE  484 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~  484 (589)
                      ||+.+.+.++|.|||.+...........        ....+|..|+|||.+.   +...+.++|||||||+||+|+.|..
T Consensus       160 ILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~s  239 (302)
T KOG2345|consen  160 ILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGES  239 (302)
T ss_pred             eEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCC
Confidence            9999999999999999886543322211        1135799999999885   4567889999999999999999999


Q ss_pred             ccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          485 AIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       485 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ||..-.. ..++-.+.                  .....+......-.++.+.+++++|++.||.+||++.+++.++..+
T Consensus       240 Pfe~~~~-~GgSlaLA------------------v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  240 PFERIYQ-QGGSLALA------------------VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             cchHHhh-cCCeEEEe------------------eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            9943221 00000000                  0001110000111456899999999999999999999999999876


Q ss_pred             c
Q 037010          565 S  565 (589)
Q Consensus       565 ~  565 (589)
                      .
T Consensus       301 i  301 (302)
T KOG2345|consen  301 I  301 (302)
T ss_pred             c
Confidence            4

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.7e-40  Score=332.73  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=206.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|..++.+|+|+||.+++++++.+.. .++.|.         +.+........+...+|+.++++++|||||.+.+.+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~-~~vlK~---------I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~   72 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDK-LYVLKK---------INLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSF   72 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCc-eEEEEE---------EeccccCchhhHHHHHHHHHHHhccCCCeeeeccch
Confidence            3678999999999999999998877643 222221         111122223334677899999999999999999977


Q ss_pred             E-eCc-EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          351 V-EGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       351 ~-~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      . ++. ++|||+||+||+|.+.|..+.+.-+++..+..|+.|++.|+.|||++.|   +|||||+.|||++.++.|||+|
T Consensus        73 ~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~i---LHRDlK~~Nifltk~~~VkLgD  149 (426)
T KOG0589|consen   73 EEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRV---LHRDLKCANIFLTKDKKVKLGD  149 (426)
T ss_pred             hcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhh---hcccchhhhhhccccCceeecc
Confidence            6 455 8999999999999999988876679999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||+|+...... ......+||+.||+||.+.+.+|..++|||||||++|||++-+++|...+.        ..+...+  
T Consensus       150 fGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki--  218 (426)
T KOG0589|consen  150 FGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKI--  218 (426)
T ss_pred             hhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHH--
Confidence            99999876543 244568999999999999999999999999999999999999999854332        1111111  


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                  -.......|.....++..+++.|+..+|..||++.+++.+.
T Consensus       219 ------------~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  219 ------------NRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             ------------hhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence                        11112334555667899999999999999999999999873

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.6e-39  Score=323.96  Aligned_cols=255  Identities=23%  Similarity=0.330  Sum_probs=194.1

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      .|++.+.||+|+||.||+|.+..++. .++.|.+..     . ..+  .......+.+|++++++++|+||+++++.+. 
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~-~~avK~~~~-----~-~~~--~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~   71 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGK-MYACKKLEK-----K-RIK--KRKGEAMALNEKRILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCc-eEEEEEeeH-----h-hhh--hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence            37788999999999999998876532 222221111     0 001  1112235678999999999999999998775 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ++..++||||+++|+|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||+++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---iH~dikp~Nill~~~~~~kl~Dfg~  148 (285)
T cd05631          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI---VYRDLKPENILLDDRGHIRISDLGL  148 (285)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---EeCCCCHHHEEECCCCCEEEeeCCC
Confidence            4568999999999999998876555568999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     .......      
T Consensus       149 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~------  215 (285)
T cd05631         149 AVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-----KREEVDR------  215 (285)
T ss_pred             cEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-----hHHHHHH------
Confidence            87643221  1234578999999999999999999999999999999999999996443211     0000100      


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                             .+. .....++...+..+.+|+++||+.||.+||+     ++++++|
T Consensus       216 -------~~~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         216 -------RVK-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             -------Hhh-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                   000 0011223344557899999999999999997     8999987

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=313.33  Aligned_cols=258  Identities=22%  Similarity=0.316  Sum_probs=204.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|+++++||+|.-|+||+|+.+++. ..++.|++..     ....+   .+...+.+.|-+||..++||.+..+|..
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~-~~fAmKVmdK-----~~l~~---rkKl~Ra~tE~eIL~~lDHPFlPTLYa~  145 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTN-CLFAMKVMDK-----ESLAS---RKKLKRAQTEREILSLLDHPFLPTLYAS  145 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCC-ceEEEEEecH-----HHHhh---hhHHHHHHHHHHHHHhcCCCccchhhhe
Confidence            3467889999999999999999988864 3444443332     22221   2344567789999999999999999997


Q ss_pred             EE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +. +...|++||||.||+|...++.+....+++..++.++.+++.||+|||..||   |+|||||+|||+.++|++.|+|
T Consensus       146 fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGi---vYRDLKPENILvredGHIMLsD  222 (459)
T KOG0610|consen  146 FETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGI---VYRDLKPENILVREDGHIMLSD  222 (459)
T ss_pred             eeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhce---eeccCCcceeEEecCCcEEeee
Confidence            76 4558999999999999999999999999999999999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccC---------------------------------CC----------------------CCCcccccCCCCC
Q 037010          429 FGLTKLTEVG---------------------------------SA----------------------SLPTRLVGTFGYM  453 (589)
Q Consensus       429 fgla~~~~~~---------------------------------~~----------------------~~~~~~~gt~~y~  453 (589)
                      |.++......                                 ..                      .+...++||-+|+
T Consensus       223 FDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYl  302 (459)
T KOG0610|consen  223 FDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYL  302 (459)
T ss_pred             ccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccc
Confidence            9887532110                                 00                      0111257999999


Q ss_pred             chhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHH
Q 037010          454 PPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSV  533 (589)
Q Consensus       454 aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~  533 (589)
                      |||++.+..++.++|+|+|||++||||.|..||.+.+...        .+..++..             .+.-.-.++..
T Consensus       303 APEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--------Tl~NIv~~-------------~l~Fp~~~~vs  361 (459)
T KOG0610|consen  303 APEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--------TLRNIVGQ-------------PLKFPEEPEVS  361 (459)
T ss_pred             cceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--------hHHHHhcC-------------CCcCCCCCcch
Confidence            9999999999999999999999999999999996654321        12222221             11111112455


Q ss_pred             HHHHHHHHHhcccCCCCCCC----HHHHHHH
Q 037010          534 LKMAQLAKVCTQEYPQLRPS----MRSIVVA  560 (589)
Q Consensus       534 ~~l~~li~~cl~~dP~~RPs----~~evl~~  560 (589)
                      ..+.+||++.|.+||.+|.-    +.||-+|
T Consensus       362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             hHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence            67999999999999999999    8888888

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=345.60  Aligned_cols=263  Identities=21%  Similarity=0.321  Sum_probs=209.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc---CHHHHHHHHHHHHHHccCC-CCccee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREFLAELKVLTHVH-HLNLVR  345 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~---~~~~~~~~~~E~~il~~l~-hpnIv~  345 (589)
                      ...++++.+.|.+|||+.||+|.+.+.+.               ++++|++   +....+.+.+|+++|++|+ |+|||.
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~---------------~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~   99 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGK---------------KYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVS   99 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCc---------------eeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceee
Confidence            45678899999999999999999877642               2233322   4566778899999999996 999999


Q ss_pred             Eee-EEE----eC---cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          346 LIG-YCV----EG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       346 l~~-~~~----~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      +++ ...    ++   +++|+||||.||.|-|++..+....|++.++++|++|+++|+.+||... |++||||||-||||
T Consensus       100 yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvL  178 (738)
T KOG1989|consen  100 YIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVL  178 (738)
T ss_pred             EeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheE
Confidence            998 332    12   3789999999999999999877767999999999999999999999999 56799999999999


Q ss_pred             EcCCCcEEEEeccCccccccCCCCCC--------cccccCCCCCchhcc---cCCCCCcccchhhHHHHHHHHHcCCccc
Q 037010          418 IDKNFHAKVADFGLTKLTEVGSASLP--------TRLVGTFGYMPPEYA---QYGDVSPKVDVYAFGVVLYELISAKEAI  486 (589)
Q Consensus       418 l~~~~~vkl~Dfgla~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~s~~sDvwSlGvll~elltG~~p~  486 (589)
                      |+.++..||||||.+.-.-.......        -...-|+.|+|||.+   .+.+++.|+|||+|||+||-|+....||
T Consensus       179 ls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PF  258 (738)
T KOG1989|consen  179 LSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPF  258 (738)
T ss_pred             EcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCc
Confidence            99999999999999874322111100        113468999999977   5778999999999999999999999999


Q ss_pred             ccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      ......                         .+++..+.-.-.+.....+.+||+.||+.||.+||++-+|++++..++.
T Consensus       259 e~sg~l-------------------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  259 EESGKL-------------------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             CcCcce-------------------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence            654221                         1222222212224667789999999999999999999999999999987


Q ss_pred             ccccccC
Q 037010          567 TTEDWDV  573 (589)
Q Consensus       567 ~~~~~~~  573 (589)
                      +.-....
T Consensus       314 ~~~~~~~  320 (738)
T KOG1989|consen  314 KPCPIPD  320 (738)
T ss_pred             CCCCccc
Confidence            7654443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.7e-40  Score=313.92  Aligned_cols=263  Identities=25%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHH-----HHHHHHHHHHccCCCCcceeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-----REFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~-----~~~~~E~~il~~l~hpnIv~l  346 (589)
                      +.|+.+++|++|+||.||+|+++.+..               .+|+|+++.+..     ---++|+.+|.+++|||||.+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~e---------------IVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~v  140 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDE---------------IVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEV  140 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcce---------------eEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeee
Confidence            467889999999999999999887743               334444443321     125689999999999999999


Q ss_pred             eeEEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          347 IGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       347 ~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      .++...   +.+|||||||+. +|...+.... .+|...+.+-++.|++.|++|||.+.|   +||||||+|+|++..|.
T Consensus       141 kEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wi---lHRDLK~SNLLm~~~G~  215 (419)
T KOG0663|consen  141 KEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWI---LHRDLKTSNLLLSHKGI  215 (419)
T ss_pred             EEEEeccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhcee---EecccchhheeeccCCc
Confidence            998764   459999999998 9999998766 469999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +||+|||+|+.+... ....+..+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||++++..|.+... ..   .+...
T Consensus       216 lKiaDFGLAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-~d---Ql~~I  290 (419)
T KOG0663|consen  216 LKIADFGLAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-ID---QLDKI  290 (419)
T ss_pred             EEecccchhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-HH---HHHHH
Confidence            999999999976543 334566788999999998865 4799999999999999999999877743321 11   11111


Q ss_pred             HHHHhcCCC----hH-HhhH---hhcCC-----CCCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPD----PI-EDLR---KLVDP-----RLGDNCPLD-SVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~----~~-~~l~---~~~d~-----~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      + ..+..|.    +. ..+.   ..-.+     .+....+.. ..+.-.+|+..+|..||.+|.|++|.++|
T Consensus       291 f-~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  291 F-KLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             H-HHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            1 1222211    10 0000   00000     011111111 34567899999999999999999999987

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-38  Score=317.43  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=194.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.+.||+|+||.||+|.+.......   .         .+++|..    .......+.+|+.++++++||||+++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~---~---------~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   71 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRE---L---------PVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL   71 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCce---e---------eEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeE
Confidence            457899999999999999999865432111   0         1122211    12334568889999999999999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++++.. +..++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.++
T Consensus        72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~i---iH~dikp~nili~~~~~~~  147 (266)
T cd05064          72 EGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGY---VHKGLAAHKVLVNSDLVCK  147 (266)
T ss_pred             EEEEecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---eeccccHhhEEEcCCCcEE
Confidence            998764 56899999999999999997653 358999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ++|||.+...............++..|+|||.+.+..++.++|||||||++||+++ |+.||.....     .   ....
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-----~---~~~~  219 (266)
T cd05064         148 ISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-----Q---DVIK  219 (266)
T ss_pred             ECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----H---HHHH
Confidence            99999876432221111112345678999999998999999999999999999775 9999843321     1   1111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      .+.          +.    .....+..++..+.+++.+||+.+|.+||++++|++.|.++
T Consensus       220 ~~~----------~~----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         220 AVE----------DG----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHH----------CC----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            111          00    01112334455789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.1e-38  Score=319.68  Aligned_cols=262  Identities=27%  Similarity=0.523  Sum_probs=199.2

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+.+.... ...+.++.+...     .........++.+|++++++++||||+++++++.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~v~~K~~~-----~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   78 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNER-LSATSVAIKTLK-----ENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT   78 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCC-cceeeEEEEecc-----cCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence            4788999999999999999987665321 111112221111     0112234456889999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcE
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGR--------------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI  416 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NI  416 (589)
                      + +..|++|||+++++|.+++.....              ..+++..++.++.|++.||+|||++++   +|+||||+||
T Consensus        79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i---~H~dlkp~Ni  155 (283)
T cd05048          79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHF---VHRDLAARNC  155 (283)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCe---eccccccceE
Confidence            4 458999999999999999975421              347888999999999999999999998   9999999999


Q ss_pred             EEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCC
Q 037010          417 LIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSA  494 (589)
Q Consensus       417 Ll~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~  494 (589)
                      ++++++.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....   
T Consensus       156 l~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---  232 (283)
T cd05048         156 LVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---  232 (283)
T ss_pred             EEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            999999999999999875432221 12233456889999999988899999999999999999998 9989854321   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                        .   .....              +........+.+++..+.+|+.+||+.||.+||+++||+++|..+
T Consensus       233 --~---~~~~~--------------i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         233 --Q---EVIEM--------------IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             --H---HHHHH--------------HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence              1   11111              111111223445556899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=322.48  Aligned_cols=257  Identities=25%  Similarity=0.354  Sum_probs=194.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|+++..||+|+||.||+|+-+.+ +..++.|....     ..   .+.....+.+..|-++|....+|.||+++-.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~T-g~iyAmK~LkK-----S~---M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs  209 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDT-GEIYAMKILKK-----SE---MLKKNQVEHVRAERDILAEVDSPWVVKLYYS  209 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccC-CcEEeeecccH-----HH---HHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE
Confidence            357899999999999999999987766 34443333221     11   1123445678889999999999999999875


Q ss_pred             EE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      |. .+.+||||||++||++..+|...+.  +++..++.++.+++.|++.||++|+   |||||||+|+|||..|++||+|
T Consensus       210 FQD~~~LYLiMEylPGGD~mTLL~~~~~--L~e~~arfYiaE~vlAI~~iH~~gy---IHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  210 FQDKEYLYLIMEYLPGGDMMTLLMRKDT--LTEDWARFYIAETVLAIESIHQLGY---IHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             ecCCCeeEEEEEecCCccHHHHHHhcCc--CchHHHHHHHHHHHHHHHHHHHcCc---ccccCChhheeecCCCCEeecc
Confidence            55 5679999999999999999987654  9999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccC--------------------CCC-------CCc-------------------ccccCCCCCchhcccCCC
Q 037010          429 FGLTKLTEVG--------------------SAS-------LPT-------------------RLVGTFGYMPPEYAQYGD  462 (589)
Q Consensus       429 fgla~~~~~~--------------------~~~-------~~~-------------------~~~gt~~y~aPE~~~~~~  462 (589)
                      ||++.-....                    ...       ..+                   ..+|||.|+|||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            9998632110                    000       000                   137999999999999999


Q ss_pred             CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHH
Q 037010          463 VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKV  542 (589)
Q Consensus       463 ~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~  542 (589)
                      |+..+|+||||||+||||.|.+||........ ++.+..+ ...+..|                 .......+..+||.+
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T-~rkI~nw-r~~l~fP-----------------~~~~~s~eA~DLI~r  425 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQET-YRKIVNW-RETLKFP-----------------EEVDLSDEAKDLITR  425 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHH-hhhccCC-----------------CcCcccHHHHHHHHH
Confidence            99999999999999999999999965543211 1111111 1111111                 111223578999999


Q ss_pred             hcccCCCCCCC---HHHHHHH
Q 037010          543 CTQEYPQLRPS---MRSIVVA  560 (589)
Q Consensus       543 cl~~dP~~RPs---~~evl~~  560 (589)
                      |+. ||++|.-   ++||-+|
T Consensus       426 ll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  426 LLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             Hhc-CHHHhcCcccHHHHhcC
Confidence            999 9999975   6777666

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=333.14  Aligned_cols=267  Identities=28%  Similarity=0.470  Sum_probs=207.4

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +-.+.++||+|+||.||+|......+.....  ++++....   -.....+...++++|.++|++++|||||+++|++.+
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~--VAvK~~k~---~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~  232 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVP--VAVKTTKG---SSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL  232 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeee--eEEEeecc---cccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            3445699999999999999987654311110  22211111   011335667889999999999999999999999875


Q ss_pred             C-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 G-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      . .+|+|||+|.||+|.+||+..+. .++..++..++.+.|.||+|||++++   +||||-.+|+|++.++.+||+|||+
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~---IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNC---IHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCC---cchhHhHHHheecCCCeEEeCcccc
Confidence            4 58999999999999999998765 49999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++........ .....-...|+|||.+..+.++.++|||||||++||+++ |..||.+...        .          
T Consensus       309 s~~~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--------~----------  369 (474)
T KOG0194|consen  309 SRAGSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--------Y----------  369 (474)
T ss_pred             ccCCcceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------H----------
Confidence            8764311111 111134678999999999999999999999999999998 7778744322        1          


Q ss_pred             ChHHhhHhhc-CCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccc
Q 037010          511 DPIEDLRKLV-DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDW  571 (589)
Q Consensus       511 ~~~~~l~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~  571 (589)
                          +++..+ ....+...|...+..+..++.+||..+|++||||.++.+.|..+......-
T Consensus       370 ----~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  370 ----EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             ----HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence                111111 223334445566678999999999999999999999999999988776653

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-39  Score=324.51  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=193.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..++. ..+.|.+...     .   .......+.+.+|++++++++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~aiK~~~~~-----~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   71 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEH-YYALKVMAIP-----E---VIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH   71 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCC-EEEEEEEEHH-----H---HhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence            478999999999999999998876532 2222221110     0   001123456788999999999999999998776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+.+|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          72 DQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEI---VYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             cCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHeEECCCCCEEEEecC
Confidence            4 56899999999999999997654  48899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++......    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        ......+....
T Consensus       147 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~  214 (291)
T cd05612         147 FAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGK  214 (291)
T ss_pred             cchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence            98765321    1235789999999999988999999999999999999999999854321        11111111110


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVAL  561 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L  561 (589)
                                 .    ..+......+.+|+++||+.||.+||+     ++|+++|-
T Consensus       215 -----------~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         215 -----------L----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             -----------c----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence                       0    112223446899999999999999995     99999884

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.8e-38  Score=324.29  Aligned_cols=263  Identities=21%  Similarity=0.361  Sum_probs=202.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      .+|++.+.||+|+||.||+|.+..++....  .         .+++|..    .....+++.+|+.+++.++||||++++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~--~---------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~   75 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVK--I---------PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL   75 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccc--e---------eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            569999999999999999998765422210  0         1222222    233456788899999999999999999


Q ss_pred             eEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          348 GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       348 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +++..+..++++||+.+|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+
T Consensus        76 g~~~~~~~~~v~e~~~~g~l~~~l~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i---iH~dlkp~Nill~~~~~~kl~  151 (316)
T cd05108          76 GICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEERRL---VHRDLAARNVLVKTPQHVKIT  151 (316)
T ss_pred             EEEcCCCceeeeecCCCCCHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHHHhcCe---eccccchhheEecCCCcEEEc
Confidence            99988888999999999999999986543 38889999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCC-CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          428 DFGLTKLTEVGSASL-PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       428 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |||+++......... .....++..|+|||.+....++.++|||||||++|||++ |+.||....     ......    
T Consensus       152 DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~-----~~~~~~----  222 (316)
T cd05108         152 DFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISS----  222 (316)
T ss_pred             cccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH----
Confidence            999998654332221 112334678999999998999999999999999999998 888874321     111111    


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDW  571 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~  571 (589)
                      ....             ......+..+...+.+++.+||..+|.+||++.+++.+|.++......|
T Consensus       223 ~~~~-------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~  275 (316)
T cd05108         223 ILEK-------------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY  275 (316)
T ss_pred             HHhC-------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence            1110             0000112223346899999999999999999999999999888766543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-39  Score=310.81  Aligned_cols=277  Identities=25%  Similarity=0.376  Sum_probs=207.6

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-----HHHHHHHHHHHHHHccCCCCc
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKVLTHVHHLN  342 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-----~~~~~~~~~E~~il~~l~hpn  342 (589)
                      ......|...+.||+|+||.|..+.+..++.               ++|+|++.     .-..++..+|+++|++++|+|
T Consensus        18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~---------------~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeN   82 (359)
T KOG0660|consen   18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGE---------------KVAIKKILNPFENQIDAKRTLRELKLLRHLRHEN   82 (359)
T ss_pred             EeccceecccccccCcceeeEEEEEEcCCCC---------------EeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCC
Confidence            4456677778999999999999999888742               34444433     234567889999999999999


Q ss_pred             ceeEeeEEEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcE
Q 037010          343 LVRLIGYCVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI  416 (589)
Q Consensus       343 Iv~l~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NI  416 (589)
                      |+.+.+.+..      ..+|+|+|+|+. +|.+.|+.+..  ++......+++|++.||.|+|+.++   +||||||+|+
T Consensus        83 Ii~l~di~~p~~~~~f~DvYiV~elMet-DL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSAnV---iHRDLKPsNl  156 (359)
T KOG0660|consen   83 IIGLLDIFRPPSRDKFNDVYLVFELMET-DLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSANV---IHRDLKPSNL  156 (359)
T ss_pred             cceEEeecccccccccceeEEehhHHhh-HHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcccc---cccccchhhe
Confidence            9999997753      348999999955 99999987643  8999999999999999999999999   9999999999


Q ss_pred             EEcCCCcEEEEeccCccccccCC-CCCCcccccCCCCCchhcc-cCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCC
Q 037010          417 LIDKNFHAKVADFGLTKLTEVGS-ASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA  494 (589)
Q Consensus       417 Ll~~~~~vkl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~  494 (589)
                      |++.+..+||+|||+|+...... ....+.++-|.+|+|||++ +...|+.+.||||+||++.|||+|+..|.+.+.   
T Consensus       157 l~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~---  233 (359)
T KOG0660|consen  157 LLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY---  233 (359)
T ss_pred             eeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch---
Confidence            99999999999999999764321 2223567889999999976 567899999999999999999999988844321   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhc--------CCCCC-CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLV--------DPRLG-DNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~--------d~~l~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                        .......-+++..+. .+.+..+-        ..... ...|     ++......+|+.+||..||.+|+|++|.++|
T Consensus       234 --v~Ql~lI~~~lGtP~-~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  234 --VHQLQLILELLGTPS-EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             --HHHHHHHHHhcCCCC-HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence              122233333333332 22222111        11000 0001     1334468899999999999999999999999


Q ss_pred             --HHhcccccccc
Q 037010          561 --LMTLSSTTEDW  571 (589)
Q Consensus       561 --L~~l~~~~~~~  571 (589)
                        |.....-+.+.
T Consensus       311 PYl~~~hdp~dEP  323 (359)
T KOG0660|consen  311 PYLAPYHDPEDEP  323 (359)
T ss_pred             hhhhhhcCCccCC
Confidence              45554444433

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=298.41  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=202.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..+.|++.+.||+|.|+.||++.+..+ +..++.|.+..         +++.....+++.+|+.|-+.|+||||+++.+.
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~t-g~~fa~kiin~---------~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t   78 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKIINT---------KKLSARDFQKLEREARICRKLQHPNIVRLHDS   78 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccc-hHHHHHHHhhh---------hhhccccHHHHHHHHHHHHhcCCCcEeehhhh
Confidence            457789999999999999999875544 44444443333         33344466788899999999999999999985


Q ss_pred             E-EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC---CCcEE
Q 037010          350 C-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---NFHAK  425 (589)
Q Consensus       350 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~---~~~vk  425 (589)
                      . .++..|||||+|.|++|..-|..+.  .+++..+-..++||+++|.|+|.++|   ||||+||+|+|+..   .--+|
T Consensus        79 i~~~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH~n~I---vHRDvkP~nllLASK~~~A~vK  153 (355)
T KOG0033|consen   79 IQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCHSNGI---VHRDLKPENLLLASKAKGAAVK  153 (355)
T ss_pred             hcccceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHhcCc---eeccCChhheeeeeccCCCcee
Confidence            5 4566899999999999988776653  37788888999999999999999999   99999999999943   34699


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++....  ........+|||.|||||++...+|+..+|||+.||+||-||.|..||.....        ..++++
T Consensus       154 L~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------~rlye~  223 (355)
T KOG0033|consen  154 LADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYEQ  223 (355)
T ss_pred             ecccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------HHHHHH
Confidence            99999998766  34444568999999999999999999999999999999999999999954221        122333


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +...           +.......-++..++..+|+++||..||.+|.|+.|.+.|
T Consensus       224 I~~g-----------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  224 IKAG-----------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             Hhcc-----------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            3221           1122233334556678999999999999999999998877

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.3e-38  Score=318.98  Aligned_cols=268  Identities=23%  Similarity=0.283  Sum_probs=193.0

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|+++.++. ..+.|.+..         ........+.+.+|++++++++||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-~~avK~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   70 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKE-IVAIKKFKD---------SEENEEVKETTLRELKMLRTLKQENIVELKEAFR   70 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCc-EEEEEEEec---------ccccccchhhHHHHHHHHHhCCCccccchhhhEe
Confidence            479999999999999999999876532 222221110         0111122355778999999999999999998776


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       ++..|+||||+.++.+..+....  ..+++..++.++.|++.||+|||++++   +||||||+||+++.++.+||+|||
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~dlkp~Nill~~~~~~kl~Dfg  145 (287)
T cd07848          71 RRGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDI---VHRDIKPENLLISHNDVLKLCDFG  145 (287)
T ss_pred             cCCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCcEEEeecc
Confidence             45689999999987666554332  348999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++...............|++.|+|||++.+..++.++|||||||++|||++|+.||.....    ...... ....... 
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~----~~~~~~-~~~~~~~-  219 (287)
T cd07848         146 FARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESE----IDQLFT-IQKVLGP-  219 (287)
T ss_pred             CcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCH----HHHHHH-HHHhhCC-
Confidence            9986543333233345789999999999888899999999999999999999999854321    111111 1111111 


Q ss_pred             ChHHhhHh---------hcCCCCC------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIEDLRK---------LVDPRLG------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~---------~~d~~l~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+.+....         ...+...      ..+....+..+.+|+++||+.||++|||++|+++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11111100         0000000      00111234579999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.2e-38  Score=315.65  Aligned_cols=255  Identities=22%  Similarity=0.415  Sum_probs=195.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||.||+|...+.  ...+.|.+.            ......+.+.+|++++++++|+||+++++.+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~--~~v~iK~~~------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNS--TKVAVKTLK------------PGTMSVQAFLEEANLMKTLQHDKLVRLYAVV   70 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCC--ceEEEEEcc------------CCchhHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            46789999999999999999986543  112111110            0111245688899999999999999999877


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..+++|||+.+++|.+++.......+++..++.++.|++.||+|||++++   +|+||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i---~H~dl~p~nili~~~~~~~l~df  147 (261)
T cd05072          71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDLRAANVLVSESLMCKIADF  147 (261)
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eccccchhhEEecCCCcEEECCC
Confidence            54 558999999999999999987655568899999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++...............++..|+|||.+....++.++|||||||++|+|+| |+.||.....     ...   ...+..
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~---~~~~~~  219 (261)
T cd05072         148 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----SDV---MSALQR  219 (261)
T ss_pred             ccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----HHH---HHHHHc
Confidence            9998654322222223345678999999988889999999999999999998 8888843211     111   111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                                .....    .....+..+.+++.+||..+|++||+++++++.|+++
T Consensus       220 ----------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         220 ----------GYRMP----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ----------CCCCC----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                      00111    1122345689999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-38  Score=335.39  Aligned_cols=268  Identities=21%  Similarity=0.286  Sum_probs=195.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||+|+||.||+|.+..+..               .+++|...   ...+.+|+++|++++||||+++++++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~---------------~vaiK~~~---~~~~~~E~~il~~l~HpnIv~~~~~~  152 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCE---------------HVVIKAGQ---RGGTATEAHILRAINHPSIIQLKGTF  152 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCC---------------EEEEechh---hhhhHHHHHHHHhCCCCCCCCEeEEE
Confidence            4679999999999999999999876532               22222221   23467899999999999999999977


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..++|||++. ++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus       153 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~I---vHrDiKP~NIll~~~~~vkL~DF  226 (391)
T PHA03212        153 TYNKFTCLILPRYK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRI---IHRDIKAENIFINHPGDVCLGDF  226 (391)
T ss_pred             EECCeeEEEEecCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChHhEEEcCCCCEEEEeC
Confidence            6 456889999995 58998887654  48899999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC--hhhHHHHHHHHh
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD--SKGLVALFEEVL  507 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~  507 (589)
                      |++...............||+.|+|||++.+..++.++|||||||++|||+||+.||.........  ............
T Consensus       227 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~  306 (391)
T PHA03212        227 GAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRS  306 (391)
T ss_pred             CcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHh
Confidence            999753322222334467999999999999889999999999999999999999888654321111  111111111111


Q ss_pred             cCC------ChHHhhHhhc----CC--CCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          508 NLP------DPIEDLRKLV----DP--RLGDNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       508 ~~~------~~~~~l~~~~----d~--~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ...      .....+....    ..  ......+     ...+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       307 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~  378 (391)
T PHA03212        307 GTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA  378 (391)
T ss_pred             cCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence            100      0000111100    00  0000111     123557899999999999999999999998743

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-38  Score=321.36  Aligned_cols=257  Identities=23%  Similarity=0.378  Sum_probs=199.6

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCccee
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVR  345 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~  345 (589)
                      +......|+++++||+||.+.||++...+. ...+          ..++..+..+.+...-+.+|++.|.+|+ |.+||+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iya----------lkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIq  424 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYA----------LKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQ  424 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCC-cchh----------hhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEE
Confidence            344567899999999999999999975443 1111          1234444555666778999999999995 999999


Q ss_pred             EeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          346 LIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       346 l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      +++|.. |+.+||||||-+. +|..+|.........| .++.++.||+.++.++|++||   ||.||||.|+|+- .|++
T Consensus       425 L~DYEv~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~gI---VHSDLKPANFLlV-kG~L  498 (677)
T KOG0596|consen  425 LYDYEVTDGYLYMVMECGDI-DLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHGI---VHSDLKPANFLLV-KGRL  498 (677)
T ss_pred             EeeeeccCceEEEEeecccc-cHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhce---eecCCCcccEEEE-eeeE
Confidence            999986 6779999999876 9999998877654445 778899999999999999999   9999999999985 4699


Q ss_pred             EEEeccCccccccCCCC-CCcccccCCCCCchhcccCC-----------CCCcccchhhHHHHHHHHHcCCcccccCCCC
Q 037010          425 KVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYG-----------DVSPKVDVYAFGVVLYELISAKEAIVKGNGS  492 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~s~~sDvwSlGvll~elltG~~p~~~~~~~  492 (589)
                      ||+|||+|.....+... .....+||+.||+||.+...           ..+.++|||||||+||+|+.|+.||..    
T Consensus       499 KLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~----  574 (677)
T KOG0596|consen  499 KLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ----  574 (677)
T ss_pred             EeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH----
Confidence            99999999987765544 33447999999999987422           256789999999999999999999932    


Q ss_pred             CCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHH-HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDS-VLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                            +...+          ..+..+.+|...-.+|.-- ...+.++++.||..||.+|||..|+|+|
T Consensus       575 ------~~n~~----------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  575 ------IINQI----------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ------HHHHH----------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                  11111          2344555664422222211 1138999999999999999999999998

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.1e-38  Score=322.54  Aligned_cols=268  Identities=23%  Similarity=0.358  Sum_probs=197.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||++.+..++. ..+.|.+..          .......+++.+|+++|++++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~a~k~~~~----------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   72 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGL-IMARKLIHL----------EIKPAIRNQIIRELQVLHECNSPYIVGFYGAF   72 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCc-EEEEEEeec----------ccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            4789999999999999999998876532 222222110          11233446788999999999999999999977


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      . ++..++||||+++++|.+++....  .+++..+..++.|++.||.|||++ ++   +||||||+|||++.++.+||+|
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i---vH~dlkp~Nil~~~~~~~kl~D  147 (331)
T cd06649          73 YSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQI---MHRDVKPSNILVNSRGEIKLCD  147 (331)
T ss_pred             EECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCE---EcCCCChhhEEEcCCCcEEEcc
Confidence            6 456899999999999999997654  388999999999999999999986 46   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh-
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL-  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-  507 (589)
                      ||++......   ......|++.|+|||++.+..++.++|||||||++|||+||+.||.....     ..+........ 
T Consensus       148 fg~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~~~~~~~  219 (331)
T cd06649         148 FGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-----KELEAIFGRPVV  219 (331)
T ss_pred             Cccccccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhccccc
Confidence            9998754321   22345789999999999988999999999999999999999999954321     11111110000 


Q ss_pred             cCC-------------------------C---hHHhhHh-hcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 037010          508 NLP-------------------------D---PIEDLRK-LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV  558 (589)
Q Consensus       508 ~~~-------------------------~---~~~~l~~-~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  558 (589)
                      ...                         .   ...++.. +................+.+|+.+||+.||++|||++|++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell  299 (331)
T cd06649         220 DGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM  299 (331)
T ss_pred             ccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence            000                         0   0000001 1111111111112445799999999999999999999999


Q ss_pred             HHHH
Q 037010          559 VALM  562 (589)
Q Consensus       559 ~~L~  562 (589)
                      +|..
T Consensus       300 ~h~~  303 (331)
T cd06649         300 NHTF  303 (331)
T ss_pred             cChH
Confidence            9964

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-38  Score=326.18  Aligned_cols=249  Identities=26%  Similarity=0.409  Sum_probs=194.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|.+..     ..   .......+.+.+|++++++++||||+++++++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~aiK~~~~-----~~---~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   87 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGE-YYAIKCLKK-----RE---ILKMKQVQHVAQEKSILMELSHPFIVNMMCSF   87 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCC-EEEEEEEEH-----HH---HhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3678999999999999999999876532 222222211     10   01112345678899999999999999999977


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..|+||||+.+|+|.+++....  .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        88 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~dlkp~NIll~~~~~~kl~Df  162 (329)
T PTZ00263         88 QDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDI---IYRDLKPENLLLDNKGHVKVTDF  162 (329)
T ss_pred             EcCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHEEECCCCCEEEeec
Confidence            6 456899999999999999998654  38889999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.. 
T Consensus       163 g~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~-  229 (329)
T PTZ00263        163 GFAKKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILA-  229 (329)
T ss_pred             cCceEcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhc-
Confidence            998765322    1235789999999999988999999999999999999999999953221        111111111 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                                  ..+  ..|......+.+|+.+||+.||.+||+     +++++.|
T Consensus       230 ------------~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        230 ------------GRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ------------CCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                        111  112223446889999999999999997     7898888

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.5e-38  Score=314.54  Aligned_cols=253  Identities=28%  Similarity=0.488  Sum_probs=196.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.++||+|+||.||+|.+.++.  ..              ++|....  ...+++.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~--~v--------------alK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~   68 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTT--RV--------------AIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA   68 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCc--eE--------------EEEecccCccCHHHHHHHHHHHHhCCCCCcceEEE
Confidence            357999999999999999999875541  11              1221111  11246788999999999999999999


Q ss_pred             EEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          349 YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       349 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      ++.++..|+||||+.+|+|.+++.......+++..++.++.|++.||+|||+.++   +|+||||+||++++++.++|+|
T Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i---~H~dl~p~Nill~~~~~~~L~d  145 (262)
T cd05071          69 VVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVAD  145 (262)
T ss_pred             EECCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc---cccccCcccEEEcCCCcEEecc
Confidence            8877789999999999999999986554558899999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||.+...............++..|+|||+..+..++.++|||||||++|||+| |+.||.....     ...   .....
T Consensus       146 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~-----~~~---~~~~~  217 (262)
T cd05071         146 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REV---LDQVE  217 (262)
T ss_pred             CCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh-----HHH---HHHHh
Confidence            99997654332222223446678999999988899999999999999999999 7777733211     111   11110


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      .              ......+.+.+..+.+++.+||+.+|++||+++++++.|+..
T Consensus       218 ~--------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         218 R--------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             c--------------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            0              001112334556789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.4e-38  Score=319.31  Aligned_cols=269  Identities=25%  Similarity=0.376  Sum_probs=191.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC---CCCcceeEee
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV---HHLNLVRLIG  348 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~  348 (589)
                      ++|++.+.||+|+||.||+|.+...++...+.|.+...         .........+.+|+++++++   +||||+++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~   71 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ---------TGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD   71 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecc---------cCCCCchHHHHHHHHHHHhhcccCCCCcceEEE
Confidence            47999999999999999999876544433333222111         00111122344566665554   7999999999


Q ss_pred             EEE------eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          349 YCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       349 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      ++.      +..+++||||+. ++|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.++
T Consensus        72 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i---iH~dlkp~Nil~~~~~  147 (290)
T cd07862          72 VCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSG  147 (290)
T ss_pred             EEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHHHEEEcCCC
Confidence            874      234899999997 599999987665668999999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+||+|||++......  .......||+.|+|||.+....++.++|||||||++|||++|+.||.....    ...+...
T Consensus       148 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~----~~~~~~i  221 (290)
T cd07862         148 QIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKI  221 (290)
T ss_pred             CEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH----HHHHHHH
Confidence            9999999999765432  223345789999999999888999999999999999999999999854332    1111111


Q ss_pred             HHHHhcCCChHHhhH------hhcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLR------KLVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      . .....+.+.+...      ....+...   ....++....+.+++.+||+.||++|||+.|+++|
T Consensus       222 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         222 L-DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             H-HHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            1 1111111111000      00000000   00112234568899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3e-38  Score=326.89  Aligned_cols=250  Identities=21%  Similarity=0.313  Sum_probs=195.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+........+.|.+..     ..   .......+.+.+|+++++.++||||+++++++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~-----~~---~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~  100 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK-----SK---IIKQKQVDHVFSERKILNYINHPFCVNLYGSF  100 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEH-----HH---hhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence            45799999999999999999987665433333332211     10   01122345678899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+.+|+|.+++....  .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus       101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDLkp~NILl~~~~~ikL~DF  175 (340)
T PTZ00426        101 KDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNI---VYRDLKPENLLLDKDGFIKMTDF  175 (340)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EccCCCHHHEEECCCCCEEEecC
Confidence            65 46899999999999999998654  48899999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++......    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+...
T Consensus       176 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~  243 (340)
T PTZ00426        176 GFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEG  243 (340)
T ss_pred             CCCeecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcC
Confidence            999764321    2345799999999999888899999999999999999999999954321        1111111111


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                                   .  ...|......+.+++++||+.||.+|+     +++++++|
T Consensus       244 -------------~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        244 -------------I--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -------------C--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                         0  012333345688999999999999995     89999988

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=331.12  Aligned_cols=254  Identities=25%  Similarity=0.443  Sum_probs=200.8

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeE
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRL  346 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l  346 (589)
                      ....++|++++.||+|+||+|+++..++++. .     ++++.+.+...+   ..++.+..+.|-+|+... +||.++++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e-~-----yAIK~LKK~~Il---~~d~Ve~~~~EkrI~~la~~HPFL~~L  434 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNE-Y-----YAIKVLKKGDIL---QRDEVESLMCEKRIFELANRHPFLVNL  434 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCc-E-----EEEEEeecccee---ccccHHHHHHHHHHHHHhccCCeEeec
Confidence            3456789999999999999999999988743 2     233333222222   234455667788887766 59999999


Q ss_pred             eeEE-EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      +..+ ..+++|+||||+.||++..+++   ...+++..++.++..|+.||.|||++||   ||||||.+|||+|.+|++|
T Consensus       435 ~~~fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~I---IYRDlKLdNiLLD~eGh~k  508 (694)
T KOG0694|consen  435 FSCFQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGI---IYRDLKLDNLLLDTEGHVK  508 (694)
T ss_pred             ccccccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCc---eeeecchhheEEcccCcEE
Confidence            9855 4778999999999999544433   2349999999999999999999999999   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||+++.. ........+++|||.|||||++....|+.++|.|||||+|||||.|..||...+..        +.+. 
T Consensus       509 iADFGlcKe~-m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------e~Fd-  578 (694)
T KOG0694|consen  509 IADFGLCKEG-MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------EVFD-  578 (694)
T ss_pred             eccccccccc-CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHH-
Confidence            9999999853 33344667799999999999999999999999999999999999999999544321        1122 


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM-----RSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  560 (589)
                                  .++...  -.+|..++.+...+++++|.++|++|.-+     ++|.+|
T Consensus       579 ------------sI~~d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~h  624 (694)
T KOG0694|consen  579 ------------SIVNDE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKH  624 (694)
T ss_pred             ------------HHhcCC--CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhC
Confidence                        222222  24677777889999999999999999876     555555

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.5e-38  Score=314.84  Aligned_cols=264  Identities=20%  Similarity=0.333  Sum_probs=198.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..++....  ..++.+...     .........++..|+.++.++.||||+++++++.
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~--~~~~~k~~~-----~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~   79 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIK--IPVAIKTIQ-----DRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP   79 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCcee--eEEEEeecc-----cccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence            578889999999999999998765432211  011111110     0111233456778888999999999999999988


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      +...++++||+.+|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||+++++.+||+|||+
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i---iH~dlkp~nili~~~~~~kl~Dfg~  155 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHRM---VHRNLAARNILLKSDSIVQIADFGV  155 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCE---eccccCcceEEEcCCCcEEEcCCcc
Confidence            7788999999999999999976443 48999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          432 TKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       432 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++........ ......++..|+|||.+.++.++.++|||||||++|||++ |+.||.....     .......    ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~----~~  226 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEVPDLL----EK  226 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH----HC
Confidence            9765332221 1223456778999999988899999999999999999998 8888843211     1111111    10


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      .         ..+..    +..+...+.+++.+||..||++|||+.|+++.|..+....
T Consensus       227 ~---------~~~~~----~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         227 G---------ERLAQ----PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             C---------CcCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            0         00011    1112346788999999999999999999999998877544

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.8e-38  Score=313.80  Aligned_cols=254  Identities=28%  Similarity=0.496  Sum_probs=196.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||.||+|.+.+.  ...+.|.+..         ..   ...+.+.+|++++++++|+|++++++++
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~--~~~~~k~~~~---------~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~   70 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGN--TKVAVKTLKP---------GT---MSPESFLEEAQIMKKLRHDKLVQLYAVV   70 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCC--ceeEEEEecC---------CC---CCHHHHHHHHHHHHhcCCCceEEEEeEE
Confidence            45789999999999999999976543  1122111110         01   1124578899999999999999999988


Q ss_pred             EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       351 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      .++..|++|||+.+++|.+++.......+++..++.++.|++.||+|||++++   +|+||||+||++++++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i---~H~di~p~Nili~~~~~~~l~dfg  147 (260)
T cd05070          71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---IHRDLRSANILVGDGLVCKIADFG  147 (260)
T ss_pred             CCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCccceEEEeCCceEEeCCce
Confidence            77789999999999999999987655568999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++...............++..|+|||.+....++.++|+||||+++|+|++ |..||....     ..   ........ 
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~---~~~~~~~~-  218 (260)
T cd05070         148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-----NR---EVLEQVER-  218 (260)
T ss_pred             eeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-----HH---HHHHHHHc-
Confidence            997654322222222345678999999988889999999999999999999 788874321     11   11111111 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                                   ......+.+.+..+.+++.+||..+|.+|||+.++.+.|+.
T Consensus       219 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         219 -------------GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -------------CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                         11112233445679999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-38  Score=310.52  Aligned_cols=252  Identities=21%  Similarity=0.373  Sum_probs=200.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ...+|++.+.||+|.||.|-+|..+..      .+.++++...+. .  .-..++.-.+.+|++||..|+||||+.+|++
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~s------gR~VAiKsIrKd-k--IkdeqDlvhIRREIeIMSsLNHPhII~IyEV  121 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKS------GREVAIKSIRKD-K--IKDEQDLVHIRREIEIMSSLNHPHIIQIYEV  121 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccC------CcEeehhhhhhh-h--cccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence            456899999999999999999976543      222333222111 1  1123445568899999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      |.+ +...|||||..+|.|.+|+.+.+.  +++.+++.+++||..|+.|+|.+++   +|||||.+|||+|+++.+||+|
T Consensus       122 FENkdKIvivMEYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHknrV---vHRDLKLENILLD~N~NiKIAD  196 (668)
T KOG0611|consen  122 FENKDKIVIVMEYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKNRV---VHRDLKLENILLDQNNNIKIAD  196 (668)
T ss_pred             hcCCceEEEEEEecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhccc---eecccchhheeecCCCCeeeec
Confidence            875 568999999999999999998765  9999999999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCC-cccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++..+...  ...++++|+|-|.+||++++.+|. +.+|.|||||+||.|+.|..||.+.+     .+.+   ..++.
T Consensus       197 FGLSNly~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~l---vrQIs  266 (668)
T KOG0611|consen  197 FGLSNLYADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRL---VRQIS  266 (668)
T ss_pred             cchhhhhccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHH---HHHhh
Confidence            9999877543  334678999999999999998884 78999999999999999999995432     1222   22221


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .             ..+.   .++.+....-||++||-.||++|-|+++|..|-
T Consensus       267 ~-------------GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  267 R-------------GAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             c-------------cccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            1             1111   112223567899999999999999999999884

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.3e-38  Score=330.90  Aligned_cols=261  Identities=24%  Similarity=0.393  Sum_probs=195.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccC-CCCccee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHV-HHLNLVR  345 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l-~hpnIv~  345 (589)
                      .++|++.+.||+|+||.||+|.+....... ..+         .+++|.+    .......+.+|+++++.+ +|+||++
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~-~~~---------~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~  106 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKED-NVL---------RVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVN  106 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCccc-ccc---------eeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceee
Confidence            457899999999999999999875432211 011         1222222    223345688899999999 8999999


Q ss_pred             EeeEEEe-CcEEEEEEecCCCChHHHHhcCC-------------------------------------------------
Q 037010          346 LIGYCVE-GSLFLVYEYIENGNLSEHLRGSG-------------------------------------------------  375 (589)
Q Consensus       346 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------  375 (589)
                      +++++.+ +..|+||||+.+|+|.+++....                                                 
T Consensus       107 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (374)
T cd05106         107 LLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP  186 (374)
T ss_pred             EeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence            9998864 56899999999999999986421                                                 


Q ss_pred             -------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          376 -------------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       376 -------------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                                         ..++++.+++.++.|++.||.|||++++   +||||||+|||+++++.+||+|||++....
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gi---iHrDLkp~Nil~~~~~~~kL~DfGla~~~~  263 (374)
T cd05106         187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIM  263 (374)
T ss_pred             ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCE---EeccCchheEEEeCCCeEEEeeceeeeecc
Confidence                               1247888899999999999999999998   999999999999999999999999987543


Q ss_pred             cCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHH
Q 037010          437 VGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE  514 (589)
Q Consensus       437 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (589)
                      ..... ......+++.|+|||++....++.++|||||||++|||++ |+.||.....    .........          
T Consensus       264 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~~~~~----------  329 (374)
T cd05106         264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFYKMVK----------  329 (374)
T ss_pred             CCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHHHHHH----------
Confidence            32211 1112335678999999988899999999999999999997 9999843211    011111110          


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                             .......+...+..+.+++.+||+.||.+|||+++|++.|+++.
T Consensus       330 -------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         330 -------RGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             -------cccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                   00011112223357899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-37  Score=311.14  Aligned_cols=255  Identities=29%  Similarity=0.442  Sum_probs=196.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .+|.+.+.||+|+||.||+|.+....... +.|...            .......++.+|++++++++||||+++++++.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~-~~K~~~------------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTV-AVKTLK------------EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT   72 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceE-EEEEec------------CCchHHHHHHHHHHHHHhCCCCChhheEEEEc
Confidence            45788899999999999999887643221 111110            01122456888999999999999999999876


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       ++..+++|||+++++|.+++.......+++..++.++.|++.||+|||++++   +||||||+||++++++.+||+|||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i---~H~dlkp~nil~~~~~~~kl~df~  149 (263)
T cd05052          73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFG  149 (263)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---eecccCcceEEEcCCCcEEeCCCc
Confidence             4568999999999999999987665568999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.....        ...+..... 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~~~-  220 (263)
T cd05052         150 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELLEK-  220 (263)
T ss_pred             cccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHC-
Confidence            987654322221122334678999999988899999999999999999998 8888743211        111111111 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                               ...+    ..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       221 ---------~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         221 ---------GYRM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---------CCCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                     1111    12233345789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=325.78  Aligned_cols=255  Identities=24%  Similarity=0.348  Sum_probs=194.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..++. ..+.|.+..     .. .  ........+.+|++++..++||||+++++++.
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~-~vaiK~~~~-----~~-~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~   71 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGE-IVALKRMKK-----SL-L--FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ   71 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCC-EEEEEEEEH-----HH-H--hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            479999999999999999999876532 222222111     10 0  01123456788999999999999999998776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+++|+|.+++....  .+++..++.++.|++.||.|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          72 DDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGY---IHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             cCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEECCCCCEEEEeCc
Confidence            4 56899999999999999997654  48899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .   ..+..+....
T Consensus       147 ~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~---~~~~~i~~~~  214 (333)
T cd05600         147 LSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-----N---ETWENLKYWK  214 (333)
T ss_pred             CCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-----H---HHHHHHHhcc
Confidence            9875432    22346799999999999988999999999999999999999999854321     1   1111111100


Q ss_pred             ChHHhhHhhc-CCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIEDLRKLV-DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~-d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                             ..+ .+.. .......+..+.+++.+||..+|.+||+++++++|
T Consensus       215 -------~~~~~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         215 -------ETLQRPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -------ccccCCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                   000 0100 00001234578999999999999999999999988

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.8e-38  Score=313.80  Aligned_cols=255  Identities=25%  Similarity=0.468  Sum_probs=197.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||.||+|.....  ...+.|...     .       ......++.+|++++++++|+||++++++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~--~~~a~K~~~-----~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   69 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGH--TKVAIKSLK-----Q-------GSMSPEAFLAEANLMKQLQHPRLVRLYAV   69 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCC--ceEEEEEec-----C-------CCCcHHHHHHHHHHHHhcCCcCeeeEEEE
Confidence            356799999999999999999986442  222222111     0       01112467889999999999999999998


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +.++..+++|||+.+++|.+++.......+++.++..++.|++.||+|||++++   +|+||||+||++++++.++|+||
T Consensus        70 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i---~H~dl~p~ni~i~~~~~~~l~df  146 (260)
T cd05067          70 VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADF  146 (260)
T ss_pred             EccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe---ecccccHHhEEEcCCCCEEEccC
Confidence            877889999999999999999977665668999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++...............++..|+|||++....++.++||||||+++|||++ |+.||.....     ........    
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~----  217 (260)
T cd05067         147 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQNLE----  217 (260)
T ss_pred             cceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHH----
Confidence            9987654222222223345678999999988889999999999999999999 9988843221     11111111    


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                               .....    ..+...+..+.+++.+||..+|++||+++++++.|+.
T Consensus       218 ---------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         218 ---------RGYRM----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---------cCCCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                     00111    1222334579999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.7e-38  Score=329.93  Aligned_cols=264  Identities=24%  Similarity=0.396  Sum_probs=192.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|.+.+..... ..+.++++...     ........+.+.+|+++|+.+ +||||++++++
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~-~~~~vavK~l~-----~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSD-AAMTVAVKMLK-----PSAHLTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCc-cceeEEEEecc-----CCcCcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            457899999999999999999754321100 01111111111     011122345688899999999 89999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCC-----------------------------------------------------
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSG-----------------------------------------------------  375 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------  375 (589)
                      +.+ +..++||||+++|+|.+++....                                                     
T Consensus       108 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  187 (375)
T cd05104         108 CTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR  187 (375)
T ss_pred             eccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence            865 46899999999999999996532                                                     


Q ss_pred             --------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          376 --------------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       376 --------------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                                          ...+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||++...
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp~Nill~~~~~~kl~DfG~a~~~  264 (375)
T cd05104         188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDI  264 (375)
T ss_pred             ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCchhhEEEECCCcEEEecCccceec
Confidence                                1247788899999999999999999998   99999999999999999999999999765


Q ss_pred             ccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChH
Q 037010          436 EVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPI  513 (589)
Q Consensus       436 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (589)
                      ...... ......++..|+|||++....++.++|||||||++|||++ |..||.....    ..........        
T Consensus       265 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~----~~~~~~~~~~--------  332 (375)
T cd05104         265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV----DSKFYKMIKE--------  332 (375)
T ss_pred             cCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc----hHHHHHHHHh--------
Confidence            332211 1122345678999999998999999999999999999998 7777743211    1111111110        


Q ss_pred             HhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          514 EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       514 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                           ...+    ..+...+..+.+|+.+||+.||++|||+.||++.|++.
T Consensus       333 -----~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         333 -----GYRM----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -----CccC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                 0001    11122234789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6.1e-38  Score=322.69  Aligned_cols=245  Identities=24%  Similarity=0.345  Sum_probs=188.8

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLF  356 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  356 (589)
                      +.||+|+||.||+|.+..++ ..++.|.+..     ...   ........+.+|++++++++||||+++++++.+ +..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~-~~~aiK~~~~-----~~~---~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05571           1 KLLGKGTFGKVILVREKATG-KYYAMKILKK-----EVI---IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCC-CEEEEEEEEH-----HHh---hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEE
Confidence            46999999999999876653 2232222211     110   112234567789999999999999999987764 5689


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      +||||+.+|+|.+++....  .+++..+..++.||+.||+|||++++   +||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i---vHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDV---VYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            9999999999999997654  48999999999999999999999998   999999999999999999999999987532


Q ss_pred             cCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhh
Q 037010          437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL  516 (589)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  516 (589)
                      .. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+...       
T Consensus       147 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~-------  210 (323)
T cd05571         147 SD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILME-------  210 (323)
T ss_pred             cC-CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcC-------
Confidence            21 1222346799999999999988999999999999999999999999954221        1111111110       


Q ss_pred             HhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       517 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                          +.    ..+......+.+|+.+||+.||++||     ++.++++|
T Consensus       211 ----~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 ----EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             ----CC----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                11    12333445789999999999999999     89999887

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=5.2e-38  Score=317.90  Aligned_cols=268  Identities=23%  Similarity=0.340  Sum_probs=192.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||.||+|.+..+.. ..+.|.+..          .........+.+|++++++++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~vaiK~~~~----------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   72 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTEN-LVALKEIRL----------EHEEGAPCTAIREVSLLKNLKHANIVTLHDII   72 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCC-EEEEEEecc----------cccCCcchhHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4679999999999999999998776532 222221110          00111223567899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..++||||+.+ +|.+++..... .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        73 ~~~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~dlkp~Nil~~~~~~~kl~Df  147 (288)
T cd07871          73 HTERCLTLVFEYLDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKRKI---LHRDLKPQNLLINEKGELKLADF  147 (288)
T ss_pred             cCCCeEEEEEeCCCc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEECCCCCEEECcC
Confidence            64 458999999975 99999876543 47889999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++........ ......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.....     ............
T Consensus       148 G~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~  221 (288)
T cd07871         148 GLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-----KEELHLIFRLLG  221 (288)
T ss_pred             cceeeccCCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhC
Confidence            99875432221 1233568999999998865 5689999999999999999999999854321     111111222222


Q ss_pred             CCChH--------HhhHhhcCCCCCC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPI--------EDLRKLVDPRLGD----NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~--------~~l~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+...        +.+.....+....    .........+.+|+.+||+.||.+|||++|+++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             CCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            11110        1111111111100    0011223467899999999999999999999876

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.4e-38  Score=319.26  Aligned_cols=274  Identities=26%  Similarity=0.416  Sum_probs=193.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhh-hhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCccee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL-LMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~-~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      .++|++.++||+|+||.||+|.+...............+. ....+++|..    ......++.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4679999999999999999998755322111000000000 0011233322    2334567889999999999999999


Q ss_pred             EeeEEEe-CcEEEEEEecCCCChHHHHhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 037010          346 LIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR-----------------DPLPWSSRVQIALDSARGLEYIHEHTVPVYI  407 (589)
Q Consensus       346 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~v  407 (589)
                      +++++.+ +..++||||+.+|+|.+++.....                 ..+++..++.++.|++.||.|||++++   +
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i---v  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---V  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc---c
Confidence            9998864 568999999999999999865321                 236778899999999999999999998   9


Q ss_pred             eeccCCCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc--CCc
Q 037010          408 HRDIKSANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS--AKE  484 (589)
Q Consensus       408 H~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt--G~~  484 (589)
                      ||||||+|||++.++.+||+|||++........ .......++..|+|||++..+.++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999875432221 11223456788999999988899999999999999999987  445


Q ss_pred             ccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          485 AIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       485 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ||.....     .............         .. .......++.++..+.+|+.+||+.||.+|||++||.+.|+
T Consensus       241 p~~~~~~-----~~~~~~~~~~~~~---------~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTD-----EQVIENAGEFFRD---------QG-RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCH-----HHHHHHHHHHhhh---------cc-ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            6532211     1111111111100         00 00001112234457899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-37  Score=322.95  Aligned_cols=267  Identities=21%  Similarity=0.323  Sum_probs=191.2

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|+||.||+|.+..++. ..+.|.+.     .    .........++.+|++++++++||||+++++++..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~-----~----~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   70 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGE-KVAIKKIN-----D----VFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLP   70 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCC-EEEEEEec-----h----hhccchhHHHHHHHHHHHHhCCCCCEeeecceEec
Confidence            58899999999999999998776532 22222111     0    01112233467889999999999999999997752


Q ss_pred             ------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          353 ------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       353 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                            ...|+||||+. ++|.+++....  .+++..+..++.|++.||.|||++++   +||||||+|||++.++.+||
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~NIll~~~~~~kL  144 (338)
T cd07859          71 PSRREFKDIYVVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANV---FHRDLKPKNILANADCKLKI  144 (338)
T ss_pred             cCCCCCceEEEEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCCCcEEE
Confidence                  23799999995 58999987654  38999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCC--CCCcccccCCCCCchhcccC--CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          427 ADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       427 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +|||+++.......  .......||+.|+|||++..  ..++.++|||||||++|||+||+.||.....     ......
T Consensus       145 ~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~  219 (338)
T cd07859         145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDL  219 (338)
T ss_pred             ccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHH
Confidence            99999875432211  11234578999999999865  6789999999999999999999999854321     111111


Q ss_pred             HHHHhcCCChH----------HhhHhhcCCCCCCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPI----------EDLRKLVDPRLGDNC---PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~----------~~l~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .......+...          ......+........   -+.....+.+++.+||+.||++|||++|+++|
T Consensus       220 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         220 ITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            12222211110          000011111100000   01223467899999999999999999999998

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7.5e-38  Score=311.72  Aligned_cols=253  Identities=28%  Similarity=0.466  Sum_probs=196.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.++||+|+||.||++.+.+..  ..+.|.+..            .....+.+.+|++++++++|+|++++++++.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~--~~~lK~~~~------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   71 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT--KVAIKTLKP------------GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS   71 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc--eEEEEEccc------------CCccHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            56899999999999999999875541  111111100            0112245778999999999999999999887


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ++..+++|||+.+++|.+++.......+++..+..++.|++.||+|||+.++   +|+||||+||++++++.++|+|||+
T Consensus        72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i---~H~dl~~~Nill~~~~~~~l~dfg~  148 (260)
T cd05069          72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRDLRAANILVGDNLVCKIADFGL  148 (260)
T ss_pred             CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---eecccCcceEEEcCCCeEEECCCcc
Confidence            7788999999999999999987655568899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +...............++..|+|||...+..++.++||||||+++|||+| |+.||.....     .   ......... 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~---~~~~~~~~~-  219 (260)
T cd05069         149 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN-----R---EVLEQVERG-  219 (260)
T ss_pred             ceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHHHcC-
Confidence            97654332222222346678999999988889999999999999999999 8888743211     1   111111110 


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                                   .....+.+.+..+.+++.+||..+|++||+++++++.|+.
T Consensus       220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 -------------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                         0111233445679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.6e-38  Score=322.90  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=192.2

Q ss_pred             CCccceeeccCCcEEEEEEEEccc--cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGE--YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      +|++.+.||+|+||.||+++....  .+..++.|.+.     .....  ......+.+..|+++++++ +||||++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~-----~~~~~--~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~   73 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQ-----KAALV--QKAKTVEHTRTERNVLEHVRQSPFLVTLHYA   73 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEE-----HHHHh--hhhhHHHHHHHHHHHHHhccCCCCcccEEEE
Confidence            588999999999999999986432  22222222221     11111  1122345677899999999 59999999987


Q ss_pred             EE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +. ++..|+||||+.+|+|.+++....  .+++..+..++.||+.||+|||++++   +||||||+|||++.++.+||+|
T Consensus        74 ~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vHrDlkp~Nili~~~~~~kl~D  148 (332)
T cd05614          74 FQTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGI---VYRDIKLENILLDSEGHVVLTD  148 (332)
T ss_pred             EecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---EecCCCHHHeEECCCCCEEEee
Confidence            76 456899999999999999997654  48899999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++...............||+.|+|||++.+. .++.++|||||||++|||+||+.||........    .........
T Consensus       149 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~~~~~~~~~  224 (332)
T cd05614         149 FGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT----QSEVSRRIL  224 (332)
T ss_pred             CcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC----HHHHHHHHh
Confidence            999986543333333346799999999998764 478899999999999999999999954322111    111111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                      .           .++.+    +......+.+++.+||+.||++||     +++++++|
T Consensus       225 ~-----------~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         225 K-----------CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             c-----------CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            1           11222    223345689999999999999999     78899887

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-37  Score=309.40  Aligned_cols=258  Identities=25%  Similarity=0.411  Sum_probs=196.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCC--ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGN--SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|.+....+.  ..+.|...          +........++.+|+.++++++||||+++++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~----------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   72 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK----------AGSSDKQRLDFLTEASIMGQFDHPNIIRLEG   72 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcC----------CCCChHHHHHHHHHHHHHHhCCCCCcceEeE
Confidence            35789999999999999999988654221  11111110          1112334456888999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +..+++|||+++++|.+++..... .+++..++.++.|++.||+|||++++   +|+||||+|||+++++.++|+
T Consensus        73 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~i---~H~di~p~nili~~~~~~~l~  148 (266)
T cd05033          73 VVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVS  148 (266)
T ss_pred             EEecCCceEEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCcceEEEcCCCCEEEC
Confidence            8764 468999999999999999976543 58999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCC-CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          428 DFGLTKLTEVGSASL-PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       428 Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....     ...   ...
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~---~~~  220 (266)
T cd05033         149 DFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDV---IKA  220 (266)
T ss_pred             ccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHH---HHH
Confidence            999998764222111 112334678999999998899999999999999999998 8888743211     111   111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ...          ...    ...+...+..+.+++.+||+.+|++||+++||+++|.++
T Consensus       221 ~~~----------~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         221 VED----------GYR----LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHc----------CCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            110          000    011223345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-37  Score=322.44  Aligned_cols=262  Identities=28%  Similarity=0.469  Sum_probs=196.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccC-CCCccee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHV-HHLNLVR  345 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l-~hpnIv~  345 (589)
                      .++|++.+.||+|+||.||+|...+..+.. ..+         .+++|.+    .....+.+.+|+++++++ +|+||++
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~-~~~---------~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~   75 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSA-SCR---------TVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVN   75 (337)
T ss_pred             HHHhhhhcccccCcCceEEecccccccccc-ccc---------eeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhh
Confidence            457999999999999999999765432111 111         2233322    123345677899999999 7999999


Q ss_pred             EeeEEEe--CcEEEEEEecCCCChHHHHhcCC------------------------------------------------
Q 037010          346 LIGYCVE--GSLFLVYEYIENGNLSEHLRGSG------------------------------------------------  375 (589)
Q Consensus       346 l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~------------------------------------------------  375 (589)
                      +++++..  ..++++|||+++++|.+++....                                                
T Consensus        76 ~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (337)
T cd05054          76 LLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD  155 (337)
T ss_pred             eeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence            9997753  45889999999999999986432                                                


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCC-CC
Q 037010          376 -----------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP  443 (589)
Q Consensus       376 -----------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~  443 (589)
                                 ..++++..+..++.||+.||+|||++++   +||||||+|||+++++.++|+|||++......... ..
T Consensus       156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i---vHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~  232 (337)
T cd05054         156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  232 (337)
T ss_pred             cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhc
Confidence                       1257899999999999999999999998   99999999999999999999999999865332221 12


Q ss_pred             cccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCC
Q 037010          444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDP  522 (589)
Q Consensus       444 ~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  522 (589)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||......    ....    ...         ..... 
T Consensus       233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~~----~~~---------~~~~~-  294 (337)
T cd05054         233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEFC----RRL---------KEGTR-  294 (337)
T ss_pred             cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHHH----HHH---------hccCC-
Confidence            22455678999999999999999999999999999998 98888432111    0111    110         00011 


Q ss_pred             CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          523 RLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       523 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                         ...+......+.+++.+||+.+|++||+++|++++|.++..
T Consensus       295 ---~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         295 ---MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               11122334578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=8.8e-38  Score=310.39  Aligned_cols=248  Identities=27%  Similarity=0.466  Sum_probs=189.8

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ++|++.+.||+|+||.||++.+...  ...              ++|...  .....++.+|++++++++||||++++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~--~~~--------------a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQ--IKV--------------AIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGV   67 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccC--ceE--------------EEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEE
Confidence            5688899999999999999987543  111              112111  1123467889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++++   +|+||||+||++++++.+||+|
T Consensus        68 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~ni~i~~~~~~kl~d  143 (256)
T cd05114          68 CTQQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNSF---IHRDLAARNCLVSSTGVVKVSD  143 (256)
T ss_pred             EccCCCEEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCc---cccccCcceEEEcCCCeEEECC
Confidence            764 468999999999999999976433 48899999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||.+...............++..|+|||.+.+..++.++|+||||+++|||++ |+.||.....        ......+.
T Consensus       144 ~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~  215 (256)
T cd05114         144 FGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMIS  215 (256)
T ss_pred             CCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH
Confidence            99887543222221222345678999999988889999999999999999999 8888843321        11111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ...          .+    ..+...+..+.+++.+||+.+|++|||++++++.|
T Consensus       216 ~~~----------~~----~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         216 RGF----------RL----YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCC----------CC----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            100          00    11112234689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-38  Score=311.15  Aligned_cols=255  Identities=24%  Similarity=0.432  Sum_probs=195.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+.++  ...+.|.+..            .....+++.+|++++++++||||+++++++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~--~~v~iK~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNT--TPVAVKTLKP------------GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC   70 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCC--eEEEEEeeCC------------CcccHHHHHHHHHHHHHCCCCCccceeEEE
Confidence            46799999999999999999986543  1222221110            011235678899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .. +..|++|||+.+++|.+++.......+++..+..++.|++.||.|||++++   +|+||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~l~df  147 (261)
T cd05068          71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDLAARNVLVGENNICKVADF  147 (261)
T ss_pred             ecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eeccCCcceEEEcCCCCEEECCc
Confidence            64 568999999999999999987665568999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++................+..|+|||.+.+..++.++||||||+++|||+| |+.||.....     .   .....+. 
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~---~~~~~~~-  218 (261)
T cd05068         148 GLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----A---EVLQQVD-  218 (261)
T ss_pred             ceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----H---HHHHHHH-
Confidence            9998654222111111223457999999988899999999999999999999 8888743211     1   1111111 


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                                   .......+...+..+.+++.+||+.+|.+||+++++++.|+.+
T Consensus       219 -------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         219 -------------QGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -------------cCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                         1111112333456799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-37  Score=311.66  Aligned_cols=269  Identities=21%  Similarity=0.356  Sum_probs=203.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||+||+|.+..++....  +.++.+...     .........++.+|+.++..++||||+++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~--~~va~K~~~-----~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVK--IPVAIKVLR-----ENTSPKANKEILDEAYVMAGVGSPYVCRLLGIC   78 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccc--eEEEEEEec-----CCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            4678899999999999999998765533210  001111110     112233445688899999999999999999999


Q ss_pred             EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       351 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      .....+++|||+++|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||+++++.+||+|||
T Consensus        79 ~~~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i---iH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          79 LTSTVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRL---VHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             cCCCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eccccccceEEEcCCCcEEECCCC
Confidence            8888899999999999999997643 348999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCC-CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          431 LTKLTEVGSASL-PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       431 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      +++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||....     ..........   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~---  226 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----AREIPDLLEK---  226 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHC---
Confidence            998654322211 112234678999999988899999999999999999998 888873221     1111111110   


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWD  572 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~  572 (589)
                                    ......+...+..+.+++.+||..||++||++.++++.|.++......|.
T Consensus       227 --------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~~~  276 (279)
T cd05109         227 --------------GERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSRFV  276 (279)
T ss_pred             --------------CCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcCeE
Confidence                          00011122334578899999999999999999999999999987776654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-38  Score=309.32  Aligned_cols=269  Identities=24%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH-----HHHHHHHHHHHHccCCCCc-ce
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-----ASREFLAELKVLTHVHHLN-LV  344 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~E~~il~~l~hpn-Iv  344 (589)
                      ...|...++||+|+||+||+|+...++.               .+++|+++.+     ......+|+.+|++++|+| |+
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~---------------~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv   74 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGK---------------FVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIV   74 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCC---------------EEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceE
Confidence            3457778899999999999999887642               2233332221     2234578999999999999 99


Q ss_pred             eEeeEEEe-C------cEEEEEEecCCCChHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          345 RLIGYCVE-G------SLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       345 ~l~~~~~~-~------~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      ++++++.. +      .+++||||++. +|.+++.....  ..++...++.+++||+.||+|||+++|   +||||||+|
T Consensus        75 ~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~I---lHRDLKPQN  150 (323)
T KOG0594|consen   75 RLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGI---LHRDLKPQN  150 (323)
T ss_pred             EEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCe---ecccCCcce
Confidence            99998863 3      58899999976 99999988664  357778999999999999999999999   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA  494 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~  494 (589)
                      ||+++.|.+||+|||+|+........ .+..++|.+|+|||++.+. .|+...||||+||+++||++++..|.....   
T Consensus       151 lLi~~~G~lKlaDFGlAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---  226 (323)
T KOG0594|consen  151 LLISSSGVLKLADFGLARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---  226 (323)
T ss_pred             EEECCCCcEeeeccchHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---
Confidence            99999999999999999966543332 4557889999999999876 799999999999999999998877744332   


Q ss_pred             ChhhHHHHHHHHhcCCChH--HhhHhhcCCC--CCCCC-C-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--
Q 037010          495 DSKGLVALFEEVLNLPDPI--EDLRKLVDPR--LGDNC-P-------LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--  560 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~--~~l~~~~d~~--l~~~~-~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--  560 (589)
                       ...+... .+.+..|...  .......+-.  .+... +       +.......+++.+||+.+|.+|.|++..++|  
T Consensus       227 -~~ql~~I-f~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~y  304 (323)
T KOG0594|consen  227 -IDQLFRI-FRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPY  304 (323)
T ss_pred             -HHHHHHH-HHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChh
Confidence             1222222 2333332111  1111111111  00000 1       1111368899999999999999999999998  


Q ss_pred             HHhc
Q 037010          561 LMTL  564 (589)
Q Consensus       561 L~~l  564 (589)
                      +..+
T Consensus       305 f~~~  308 (323)
T KOG0594|consen  305 FSEL  308 (323)
T ss_pred             hccc
Confidence            5544

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.3e-37  Score=322.49  Aligned_cols=251  Identities=23%  Similarity=0.359  Sum_probs=185.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|+..++||+|+||.||+|.+..++ ..++.|.+.          +.........+.+|++++++++|+||+++++++.
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  142 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTG-RLYALKVIY----------GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD  142 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCC-CEEEEEEEe----------cCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec
Confidence            45677899999999999999876542 222222111          0112233456889999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||+++|+|.+..      ...+..+..++.||+.||+|||++++   +||||||+|||+++++.+||+|||
T Consensus       143 ~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~~~~kL~DfG  213 (353)
T PLN00034        143 HNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRHI---VHRDIKPSNLLINSAKNVKIADFG  213 (353)
T ss_pred             cCCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCCE---eecCCCHHHEEEcCCCCEEEcccc
Confidence            4 5689999999999986532      25677788999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-----CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-----GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      ++....... .......||..|+|||++..     ...+.++|||||||++|||++|+.||.....  .++   ......
T Consensus       214 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~--~~~---~~~~~~  287 (353)
T PLN00034        214 VSRILAQTM-DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ--GDW---ASLMCA  287 (353)
T ss_pred             cceeccccc-ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--ccH---HHHHHH
Confidence            988653221 11234578999999998743     2345689999999999999999999953221  111   111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ...              ......+......+.+|+.+||+.||++|||++|+++|-.
T Consensus       288 ~~~--------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~  330 (353)
T PLN00034        288 ICM--------------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF  330 (353)
T ss_pred             Hhc--------------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence            100              0011122334457899999999999999999999999843

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-38  Score=326.67  Aligned_cols=256  Identities=25%  Similarity=0.326  Sum_probs=194.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..++ ..++.|.+..     ...   ........+.+|++++..++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~-----~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTG-QVYAMKVLRK-----SDM---IKRNQIAHVRAERDILADADSPWIVKLYYSFQ   71 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCC-CEEEEEEEEH-----HHH---hhccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence            47999999999999999999987642 2222222111     100   11123456788999999999999999998776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+.+++|.+++...  ..+++..++.++.|++.||+|||++|+   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~gi---iH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          72 DEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGF---IHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             cCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHeEECCCCCEEeecCC
Confidence            4 5689999999999999999876  348999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCC----------------------------CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcC
Q 037010          431 LTKLTEVGS----------------------------ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA  482 (589)
Q Consensus       431 la~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG  482 (589)
                      ++.......                            ........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            987654332                            1122335799999999999999999999999999999999999


Q ss_pred             CcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHH
Q 037010          483 KEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-MRSIVVAL  561 (589)
Q Consensus       483 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L  561 (589)
                      +.||.....        ......+....           ..+.-......+..+.+++.+|+. ||.+||+ ++++++|.
T Consensus       227 ~~Pf~~~~~--------~~~~~~i~~~~-----------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         227 FPPFYSDTL--------QETYNKIINWK-----------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             CCCCCCCCH--------HHHHHHHhccC-----------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            999954321        11111111100           000000011134578999999997 9999999 99999983

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.1e-37  Score=310.55  Aligned_cols=256  Identities=26%  Similarity=0.509  Sum_probs=197.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ...+|++.++||.|+||.||+|.+.+.  ...+.|.+           +........++..|+++++.++||||++++++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~--~~~~~k~~-----------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   70 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNR--VRVAIKIL-----------KSDDLLKQQDFQKEVQALKRLRHKHLISLFAV   70 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCC--CcEEEEec-----------cccchhhHHHHHHHHHHHhcCCCcchhheeee
Confidence            345789999999999999999987662  22222111           11112234567889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..++||||+++++|.+++.......+++..++.++.|++.||+|||++++   +|+||||+||+++.++.+||+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i---~h~dl~~~nilv~~~~~~kl~d  147 (261)
T cd05148          71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS---IHRDLAARNILVGEDLVCKVAD  147 (261)
T ss_pred             EecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eccccCcceEEEcCCceEEEcc
Confidence            764 458899999999999999987666668999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++......... .....++..|+|||.+....++.++||||||+++|+|++ |+.||.....     ...   +....
T Consensus       148 ~g~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-----~~~---~~~~~  218 (261)
T cd05148         148 FGLARLIKEDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-----HEV---YDQIT  218 (261)
T ss_pred             ccchhhcCCcccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-----HHH---HHHHH
Confidence            9998765332221 123345678999999988899999999999999999998 7888843221     111   11111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                                    .......+..++..+.+++.+||+.||.+|||++++++.|+.+
T Consensus       219 --------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         219 --------------AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --------------hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                          1111122334455789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.1e-38  Score=327.17  Aligned_cols=258  Identities=22%  Similarity=0.334  Sum_probs=193.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||.||++.+..++. .++.|.+..     ..   .........+.+|++++++++||||++++++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~aiK~~~~-----~~---~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~  111 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQ-VYAMKLLSK-----FE---MIKRSDSAFFWEERDIMAHANSEWIVQLHYA  111 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCC-EEEEEEEEH-----HH---hhhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            45689999999999999999998876532 222222211     00   0111223456789999999999999999987


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+++|+|.+++...   .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus       112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDLkp~NILl~~~~~~kL~D  185 (370)
T cd05596         112 FQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLAD  185 (370)
T ss_pred             EecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHEEEcCCCCEEEEe
Confidence            765 4589999999999999998754   37888899999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCC----CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG----DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||++...............||+.|+|||++...    .++.++|||||||++|||++|+.||.....        ...+.
T Consensus       186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~  257 (370)
T cd05596         186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYS  257 (370)
T ss_pred             ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHH
Confidence            999876543222222346799999999988643    478899999999999999999999954321        11222


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQL--RPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  561 (589)
                      .+.....         ....+.  ....+..+.+|+.+||+.+|.+  |||++|+++|-
T Consensus       258 ~i~~~~~---------~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         258 KIMDHKN---------SLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             HHHcCCC---------cCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence            2221100         000101  1123457899999999999987  99999999884

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=318.19  Aligned_cols=243  Identities=27%  Similarity=0.352  Sum_probs=186.6

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEEEE
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV  358 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv  358 (589)
                      ||+|+||.||+|.+..+.. .++.|.+..     ..   .........+.+|++++++++||||+++++++.+ +..|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~-~~aiK~i~~-----~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   71 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQR-IYALKTIRK-----AH---IVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLV   71 (312)
T ss_pred             CCcCCCeEEEEEEECCCCC-EEEEEEEEH-----HH---hhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEE
Confidence            7999999999998876532 222222211     10   0112234567789999999999999999987764 568999


Q ss_pred             EEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccC
Q 037010          359 YEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG  438 (589)
Q Consensus       359 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~  438 (589)
                      |||+++|+|.+++....  .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||+++.....
T Consensus        72 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          72 LAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNV---IYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             EcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            99999999999997654  48999999999999999999999998   99999999999999999999999998753222


Q ss_pred             CCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHh
Q 037010          439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRK  518 (589)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  518 (589)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||....        ...........+        
T Consensus       147 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~--------  209 (312)
T cd05585         147 D-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEP--------  209 (312)
T ss_pred             C-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC--------
Confidence            2 22234679999999999999999999999999999999999999995422        111122221110        


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 037010          519 LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---MRSIVVA  560 (589)
Q Consensus       519 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~  560 (589)
                             ...+......+.+++.+||+.||.+||+   +.|++.|
T Consensus       210 -------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         210 -------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             -------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence                   1123334457899999999999999974   6777776

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-37  Score=320.23  Aligned_cols=245  Identities=24%  Similarity=0.350  Sum_probs=187.8

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLF  356 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~  356 (589)
                      +.||+|+||.||++.+..++ ..++.|.+..     ...   ........+.+|++++++++||||+++++.+. ++..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~-~~vaiK~~~~-----~~~---~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~   71 (323)
T cd05595           1 KLLGKGTFGKVILVREKATG-RYYAMKILRK-----EVI---IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   71 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCC-CEEEEEEEEH-----HHh---hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEE
Confidence            46999999999999876653 2222222211     111   11223456778999999999999999998776 45689


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      +||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||++....
T Consensus        72 lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          72 FVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            9999999999999887654  48999999999999999999999998   999999999999999999999999987432


Q ss_pred             cCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhh
Q 037010          437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL  516 (589)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  516 (589)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ..........       
T Consensus       147 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~-------  210 (323)
T cd05595         147 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME-------  210 (323)
T ss_pred             CCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-------
Confidence            211 122335799999999999989999999999999999999999999854321        1111111110       


Q ss_pred             HhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       517 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                          +.    ..+...+..+.+++.+||+.||.+||     ++.++++|
T Consensus       211 ----~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         211 ----EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             ----CC----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence                01    12233445789999999999999998     89999887

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.7e-37  Score=324.58  Aligned_cols=267  Identities=22%  Similarity=0.374  Sum_probs=197.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~  348 (589)
                      ..++|+++++||+|+||.||+|.+........ ...++++...     +.......+.+.+|+++|+++. ||||+++++
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~-~~~vavK~l~-----~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQP-VMKVAVKMLK-----PTARSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCC-ceEEEEEecC-----CCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            35789999999999999999998754321110 1111111110     0112233457889999999996 999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCC----------------------------------------------------
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSG----------------------------------------------------  375 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------  375 (589)
                      ++.+ +..|+||||+++|+|.+++....                                                    
T Consensus       109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (400)
T cd05105         109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY  188 (400)
T ss_pred             EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence            8865 56899999999999999886431                                                    


Q ss_pred             ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          376 ------------------------------------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       376 ------------------------------------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                                                                ...+++..++.++.|++.||+|||++++   +||||||
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i---vH~dikp  265 (400)
T cd05105         189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNC---VHRDLAA  265 (400)
T ss_pred             chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCCh
Confidence                                                      1247788889999999999999999998   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~  491 (589)
                      +|||++.++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       266 ~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~  345 (400)
T cd05105         266 RNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV  345 (400)
T ss_pred             HhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence            9999999999999999998754322211 1222456788999999988899999999999999999997 8888743211


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      .    ...   .....          ....    ...+...+..+.+++.+||+.+|++||++.+|.+.|.++..
T Consensus       346 ~----~~~---~~~~~----------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         346 D----STF---YNKIK----------SGYR----MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             h----HHH---HHHHh----------cCCC----CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            0    000   11110          0001    11223344578999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-38  Score=294.60  Aligned_cols=262  Identities=22%  Similarity=0.313  Sum_probs=203.6

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeE
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRL  346 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l  346 (589)
                      ......|.-.+.||.|..++|-++.++.+++...+.+...........    ...+..+.-.+|+.||+++ .||+|+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e----~~~~~~EaT~~Ev~ILRqv~GHP~II~l   88 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGE----TPYEMREATRQEISILRQVMGHPYIIDL   88 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCc----cHHHHHHHHHHHHHHHHHhcCCCcEEEe
Confidence            445678888999999999999999888776555444332211111110    1123345567899999998 69999999


Q ss_pred             eeEEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      .+++..+ -+++|+|.|+.|.|+|++.....  +++.+.+.|++|+..|++|||.++|   |||||||+|||++++.++|
T Consensus        89 ~D~yes~sF~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~~I---VHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   89 QDVYESDAFVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHARNI---VHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             eeeccCcchhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHhhh---hhcccChhheeeccccceE
Confidence            9988755 47899999999999999987664  8999999999999999999999999   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccC------CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY------GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      |+|||+++....+.  .....+|||+|+|||.+.+      ..|+...|+||+||+||.||.|-.||...       +.+
T Consensus       164 isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQm  234 (411)
T KOG0599|consen  164 ISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQM  234 (411)
T ss_pred             EeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHH
Confidence            99999999876443  3456899999999998853      36788999999999999999999999321       111


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCC--CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRL--GDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                       -+             ++.++...+  ...--.+......+|+.+||+.||.+|.|++|.++|-
T Consensus       235 -lM-------------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  235 -LM-------------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             -HH-------------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence             11             111222211  1222235566789999999999999999999999984

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-37  Score=317.97  Aligned_cols=270  Identities=24%  Similarity=0.325  Sum_probs=190.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||.||+|.+..++. ..+.|.+..          .........+.+|++++++++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~aiK~~~~----------~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   72 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGK-LVALKVIRL----------QEEEGTPFTAIREASLLKGLKHANIVLLHDII   72 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCC-EEEEEEecc----------ccccccchhHHHHHHHHhhCCCCCcCeEEEEE
Confidence            4789999999999999999998865422 222222110          00111223467799999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+. ++|.+++.... ..+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        73 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dlkp~Nill~~~~~~kl~Df  147 (303)
T cd07869          73 HTKETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYI---LHRDLKPQNLLISDTGELKLADF  147 (303)
T ss_pred             ecCCeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEECCC
Confidence            64 45899999996 58888887643 348889999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++....... .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.....    .............
T Consensus       148 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~  222 (303)
T cd07869         148 GLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD----IQDQLERIFLVLG  222 (303)
T ss_pred             CcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhC
Confidence            9987543222 12234568999999998864 4688899999999999999999999954321    1111111111111


Q ss_pred             CCChHHh--hHh--hcCC-CCCCCCCh---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIED--LRK--LVDP-RLGDNCPL---------DSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~--l~~--~~d~-~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+.....  ...  ...+ ......+.         .....+.+|+.+||+.||++|||++|+++|=
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~  289 (303)
T cd07869         223 TPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHE  289 (303)
T ss_pred             CCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCc
Confidence            1110000  000  0000 00000000         1123578999999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6e-37  Score=305.23  Aligned_cols=252  Identities=23%  Similarity=0.452  Sum_probs=196.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.++||+|+||.||++.+...  ..              +++|...  ....+.+.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~--~~--------------~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   68 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKH--TK--------------VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA   68 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCC--cc--------------EEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            57899999999999999999976543  11              1222111  123456788999999999999999999


Q ss_pred             EEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          349 YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       349 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      ++.+...|++|||+++++|.+++.......+++..+..++.|++.||+|||+.++   +|+||||+||+++.++.+||+|
T Consensus        69 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i---~H~dl~p~ni~i~~~~~~~l~d  145 (260)
T cd05073          69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIAD  145 (260)
T ss_pred             EEcCCCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCc---cccccCcceEEEcCCCcEEECC
Confidence            8887789999999999999999987655568899999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||.+...............++..|+|||++....++.++|+|||||++|+|+| |+.||.....     ...   .....
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~---~~~~~  217 (260)
T cd05073         146 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEV---IRALE  217 (260)
T ss_pred             CcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HHH---HHHHh
Confidence            99987654322222222345678999999988889999999999999999999 8888743211     111   11110


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                      .              ......+...+..+.+++.+||+.+|++||++.++++.|..
T Consensus       218 ~--------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         218 R--------------GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             C--------------CCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0              00011122334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.2e-37  Score=317.74  Aligned_cols=268  Identities=22%  Similarity=0.359  Sum_probs=194.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||.||++.+..++. ..+.|.+..          .........+.+|++++++++||||+++++++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~-~~a~k~~~~----------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   72 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGL-IMARKLIHL----------EIKPAIRNQIIRELQVLHECNSPYIVGFYGAF   72 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCc-EEEEEEeec----------ccCHHHHHHHHHHHHHHHHCCCCcccceeEEE
Confidence            4789999999999999999998875532 222221110          11223345688899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      .+ +..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||+. ++   +|+||||+|||++.++.+||+|
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~i---vH~dlkp~Nili~~~~~~kL~D  147 (333)
T cd06650          73 YSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCD  147 (333)
T ss_pred             EECCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCE---EecCCChhhEEEcCCCCEEEee
Confidence            64 56899999999999999997654  388899999999999999999985 56   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++......   ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......     ...........
T Consensus       148 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~  219 (333)
T cd06650         148 FGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-----ELELMFGCPVE  219 (333)
T ss_pred             CCcchhhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-----HHHHHhcCccc
Confidence            9998754221   123356899999999999888999999999999999999999998543211     11000000000


Q ss_pred             C------------------------C---ChHHhhHh-hcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 L------------------------P---DPIEDLRK-LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~------------------------~---~~~~~l~~-~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .                        .   .....+.. .................+.+|+.+||+.||++|||++|+++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         220 GDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence            0                        0   00000000 000000000011133568999999999999999999999988


Q ss_pred             HH
Q 037010          561 LM  562 (589)
Q Consensus       561 L~  562 (589)
                      -.
T Consensus       300 ~~  301 (333)
T cd06650         300 AF  301 (333)
T ss_pred             HH
Confidence            43

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.9e-37  Score=308.27  Aligned_cols=249  Identities=29%  Similarity=0.498  Sum_probs=190.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ++|++.+.||+|+||.||++.+.+..  ..              ++|....  ...+++.+|+.++++++||||++++++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~--~~--------------aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   67 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQY--DV--------------AIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGV   67 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCC--cE--------------EEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence            56889999999999999999765431  11              1121111  113467889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|++|||+.+|+|.+++..... .+++..++.++.|++.||+|||++++   +|+||||+||+++.++.+||+|
T Consensus        68 ~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~nili~~~~~~kl~d  143 (256)
T cd05113          68 CTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSD  143 (256)
T ss_pred             EccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCe---eccccCcceEEEcCCCCEEECC
Confidence            864 458999999999999999976543 58999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||.+...............++..|++||.+.+..++.++|||||||++|+|++ |+.||.....     .   .......
T Consensus       144 ~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~---~~~~~~~  215 (256)
T cd05113         144 FGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-----S---ETVEKVS  215 (256)
T ss_pred             CccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-----H---HHHHHHh
Confidence            99987543322211122345678999999988889999999999999999999 8888743221     1   1111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ..          ...    ..+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       216 ~~----------~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         216 QG----------LRL----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             cC----------CCC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            10          000    111223457899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.4e-37  Score=317.30  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=186.5

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHH---HccCCCCcceeEeeEE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV---LTHVHHLNLVRLIGYC  350 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~i---l~~l~hpnIv~l~~~~  350 (589)
                      |++.+.||+|+||.||+|.+..++. .++.|.+..     ....   .....+.+.+|.++   +++++||||+++++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~-~~aiK~~~~-----~~~~---~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~   71 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGE-LYAIKALKK-----GDII---ARDEVESLMCEKRIFETANSERHPFLVNLFACF   71 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCC-EEEEEEEEH-----HHhh---hhhHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence            6788999999999999998876532 222222211     1100   11122345555544   5677899999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+.+++|..++...   .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~i---vHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          72 QTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKI---VYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCe---EecCCCHHHeEECCCCcEEeCcc
Confidence            64 5689999999999999888643   48999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++...... ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.....        ......+...
T Consensus       146 g~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~  216 (324)
T cd05589         146 GLCKEGMGF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVND  216 (324)
T ss_pred             cCCccCCCC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC
Confidence            998743221 1222346799999999999988999999999999999999999999853321        1111111110


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVAL  561 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  561 (589)
                                 ..    ..+...+..+.+++.+||+.||.+||     +++++++|-
T Consensus       217 -----------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         217 -----------EV----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             -----------CC----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence                       01    12333445788999999999999999     678888763

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.9e-37  Score=306.69  Aligned_cols=247  Identities=30%  Similarity=0.490  Sum_probs=192.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-HHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-MQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ++|++.+.||+|+||.||++...+.                 .+++|... ....+.+.+|+.++++++|+|++++++++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-----------------~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   68 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGN-----------------KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI   68 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCC-----------------cEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            5788999999999999999976543                 11222221 11234678899999999999999999865


Q ss_pred             E--eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          351 V--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       351 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      .  ++..|++|||+++++|.+++.......+++..++.++.|++.||+|||++++   +||||||+||++++++.+||+|
T Consensus        69 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~nil~~~~~~~kl~d  145 (256)
T cd05082          69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNF---VHRDLAARNVLVSEDNVAKVSD  145 (256)
T ss_pred             EcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---eccccchheEEEcCCCcEEecC
Confidence            4  3458999999999999999987665568999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++.......    ....++..|+|||++....++.++|||||||++|||++ |+.||....        .......+.
T Consensus       146 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~  213 (256)
T cd05082         146 FGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVE  213 (256)
T ss_pred             CccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHh
Confidence            99987543221    22344668999999988899999999999999999997 888874221        111111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      .              ......+...+..+.+++.+||+.+|++|||+.+++++|..+
T Consensus       214 ~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         214 K--------------GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             c--------------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            1              111122233445789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.8e-38  Score=312.53  Aligned_cols=250  Identities=31%  Similarity=0.582  Sum_probs=185.4

Q ss_pred             cceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       276 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      +.+.||.|.||.||+|.++......  ..         .+++|..    ..+..+++.+|++.+++++||||+++++++.
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~--~~---------~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~   71 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDK--NQ---------PVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI   71 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSS--EE---------EEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCC--CE---------EEEEEEeccccccccceeeeeccccccccccccccccccccc
Confidence            5688999999999999998311111  11         2233332    3344678999999999999999999999998


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..++||||+++|+|.+++.......+++..+..|+.|++.||+|||++++   +|+||+++|||+++++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~i---iH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   72 ENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNI---IHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             SSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTE---EEST-SGGGEEEETTTEEEEESTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccc
Confidence            4 568999999999999999998855569999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          431 LTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       431 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ++........ ...........|+|||.+....++.++||||||+++|||++ |+.||....     ....   ...+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-----~~~~---~~~~~~  220 (259)
T PF07714_consen  149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-----NEEI---IEKLKQ  220 (259)
T ss_dssp             TGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-----HHHH---HHHHHT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccc---cccccc
Confidence            9876521111 11222456778999999988889999999999999999999 677763221     1111   111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                ...    ...+..++..+.+++.+||..+|++|||++++++.|
T Consensus       221 ----------~~~----~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  221 ----------GQR----LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----------TEE----TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----------ccc----ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                      001    112233455789999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.5e-37  Score=310.38  Aligned_cols=266  Identities=26%  Similarity=0.464  Sum_probs=199.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh---cCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK---MDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~---~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      .++|.+.+.||+|+||.||++......... -..         .+++|.   ......+.+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~-~~~---------~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   73 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQ-DKI---------LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFY   73 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCC-cce---------EEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            457899999999999999999754321100 000         112222   1233456688999999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSG-----------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      +++.+ +..+++|||+++++|.+++....           ...+++..++.++.|++.||+|||++++   +||||||+|
T Consensus        74 ~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i---~H~dlkp~N  150 (288)
T cd05093          74 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRN  150 (288)
T ss_pred             EEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccCcce
Confidence            98864 56899999999999999997543           1248999999999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSS  493 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~  493 (589)
                      ||+++++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|+| |..||.....  
T Consensus       151 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--  228 (288)
T cd05093         151 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--  228 (288)
T ss_pred             EEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999875432211 11222345778999999998899999999999999999998 8888743221  


Q ss_pred             CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccc
Q 037010          494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDW  571 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~  571 (589)
                            ..........          .....    +...+..+.+++.+||+.+|.+|||++++++.|+.+...+..|
T Consensus       229 ------~~~~~~i~~~----------~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~~~~  286 (288)
T cd05093         229 ------NEVIECITQG----------RVLQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKASPVY  286 (288)
T ss_pred             ------HHHHHHHHcC----------CcCCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhcccc
Confidence                  1111111110          00111    1123346899999999999999999999999999998766554

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.9e-37  Score=304.36  Aligned_cols=250  Identities=22%  Similarity=0.413  Sum_probs=190.0

Q ss_pred             eeccCCcEEEEEEEEccccCC-ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEeCcEEE
Q 037010          279 KIGQGGFGAVYYAELRGEYGN-SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFL  357 (589)
Q Consensus       279 ~LG~G~~g~Vy~~~~~~~~~~-~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~l  357 (589)
                      .||+|+||.||+|.+...... ..+.|...          ........+++.+|++++++++||||+++++++..+..++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~l   71 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK----------NENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALML   71 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcc----------cccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEE
Confidence            389999999999987643221 11111110          1112233456889999999999999999999988778999


Q ss_pred             EEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccccc
Q 037010          358 VYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV  437 (589)
Q Consensus       358 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~  437 (589)
                      ||||+++++|.+++.... ..+++..++.++.|++.||.|||++++   +||||||+|||++.++.+||+|||++.....
T Consensus        72 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  147 (257)
T cd05115          72 VMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNF---VHRDLAARNVLLVNQHYAKISDFGLSKALGA  147 (257)
T ss_pred             EEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCe---eecccchheEEEcCCCcEEeccCCccccccC
Confidence            999999999999997543 348999999999999999999999998   9999999999999999999999999875433


Q ss_pred             CCCCC--CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHH
Q 037010          438 GSASL--PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE  514 (589)
Q Consensus       438 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (589)
                      .....  .....+++.|+|||.+....++.++|||||||++|||++ |+.||.....     ..   ....+        
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~---~~~~~--------  211 (257)
T cd05115         148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----PE---VMSFI--------  211 (257)
T ss_pred             CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----HH---HHHHH--------
Confidence            22211  111233578999999988889999999999999999996 9988843321     11   11111        


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                            ........+..++..+.+++.+||..+|++||++.+|.+.|...
T Consensus       212 ------~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         212 ------EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ------HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                  11111123334456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.7e-37  Score=332.96  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=194.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ..|.+.+.||+|+||.||+|....+.+...+.|.+           ..........+.+|+++|+.++||||+++++++.
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~-----------~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~  135 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFV-----------MLNDERQAAYARSELHCLAACDHFGIVKHFDDFK  135 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEc-----------ccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            34899999999999999999876553333222211           0112233345778999999999999999999876


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                       ++..|+||||+++|+|.+++...  ...++++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus       136 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i---vHrDlkp~NIll~~~~~~kL~D  212 (478)
T PTZ00267        136 SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKM---MHRDLKSANIFLMPTGIIKLGD  212 (478)
T ss_pred             ECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCE---EECCcCHHhEEECCCCcEEEEe
Confidence             45699999999999999988643  23458899999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....        ....+....
T Consensus       213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~  284 (478)
T PTZ00267        213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVL  284 (478)
T ss_pred             CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence            999986543221 12334579999999999998999999999999999999999999984321        111122211


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..             .. ...+...+..+.+++.+||..||++||++++++.+
T Consensus       285 ~~-------------~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        285 YG-------------KY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             hC-------------CC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            10             00 01122334578999999999999999999998765

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.9e-37  Score=323.23  Aligned_cols=255  Identities=24%  Similarity=0.300  Sum_probs=188.1

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      .|++++.||+|+||+||+|.+..+. ..++.|.+..     ..   .........+.+|++++++++||||+++++++.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~-~~~aiK~i~~-----~~---~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~   72 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTH-ALYAMKTLRK-----KD---VLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD   72 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCC-CEEEEEEEEH-----HH---hhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence            6889999999999999999877653 2222222111     00   1112334568889999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +.+|+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++++||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~gi---vHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          73 KDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGF---IHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eecCCcHHHEEECCCCCEEEeeCcC
Confidence             56899999999999999997654  48889999999999999999999998   9999999999999999999999998


Q ss_pred             ccccccCCC----------------------------------------------CCCcccccCCCCCchhcccCCCCCc
Q 037010          432 TKLTEVGSA----------------------------------------------SLPTRLVGTFGYMPPEYAQYGDVSP  465 (589)
Q Consensus       432 a~~~~~~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~  465 (589)
                      +........                                              .......||+.|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            753211000                                              0012357999999999998889999


Q ss_pred             ccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHH--h
Q 037010          466 KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKV--C  543 (589)
Q Consensus       466 ~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~--c  543 (589)
                      ++|||||||++|||+||+.||......     .   ....+....           ..+...........+.+|+.+  |
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~~~~-----~---~~~~i~~~~-----------~~~~~~~~~~~s~~~~dli~~ll~  288 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAPTPT-----E---TQLKVINWE-----------NTLHIPPQVKLSPEAVDLITKLCC  288 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCCCHH-----H---HHHHHHccc-----------cccCCCCCCCCCHHHHHHHHHHcc
Confidence            999999999999999999999543210     0   011111000           000000011223467788877  5


Q ss_pred             cccCCCCCCCHHHHHHH
Q 037010          544 TQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       544 l~~dP~~RPs~~evl~~  560 (589)
                      +..++..||+++|++.|
T Consensus       289 ~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         289 SAEERLGRNGADDIKAH  305 (381)
T ss_pred             CcccccCCCCHHHHhcC
Confidence            56666779999999998

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-37  Score=311.76  Aligned_cols=255  Identities=24%  Similarity=0.335  Sum_probs=193.8

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|+||.||++.+..+.. ..+.|.+..     .. .+  .......+.+|++++++++||||+++++.+.+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~-----~~-~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGK-MYACKKLEK-----KR-IK--KRKGEAMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCc-eEEEEEEeh-----hh-hh--hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence            48889999999999999998765422 222221110     00 00  11123456789999999999999999987764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +.+++||||+.+|+|.+++.......+++..+..++.|++.||+|||++++   +||||||+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI---VYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc---EecCCCHHHEEECCCCCEEEeeCCC
Confidence             568999999999999999876555568999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +.......  ......|++.|+|||++.+..++.++|||||||++|||++|+.||......     .......       
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~-------  214 (285)
T cd05605         149 AVEIPEGE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVE-------  214 (285)
T ss_pred             ceecCCCC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHH-------
Confidence            87643222  122357899999999998889999999999999999999999999543221     0001111       


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                            ..+... ....+...+..+.+|+.+||..||.+||     +++++++|
T Consensus       215 ------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         215 ------RRVKED-QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ------HHhhhc-ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                  111100 1122334455789999999999999999     89999887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.6e-37  Score=322.44  Aligned_cols=259  Identities=20%  Similarity=0.315  Sum_probs=192.5

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||++.+..+.. .++.|.+.     ..   +.........+.+|+++++.++||||+++++
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~-~~aiK~~~-----~~---~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~  110 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQK-VYAMKLLS-----KF---EMIKRSDSAFFWEERDIMAFANSPWVVQLFC  110 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCC-EEEEEEEE-----HH---HhhhhhhHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            345789999999999999999999876532 22222211     10   0111223345778999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +.+|+||||+++|+|.+++...   .+++..+..++.||+.||+|||++++   +||||||+|||+++++.+||+
T Consensus       111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~I---vHrDLKp~NILl~~~~~~kL~  184 (370)
T cd05621         111 AFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGL---IHRDVKPDNMLLDKHGHLKLA  184 (370)
T ss_pred             EEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHEEECCCCCEEEE
Confidence            7764 5689999999999999999654   38889999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCC----CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG----DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      |||++...............||+.|+|||++...    .++.++|||||||++|||++|+.||.....        ...+
T Consensus       185 DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~  256 (370)
T cd05621         185 DFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTY  256 (370)
T ss_pred             ecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHH
Confidence            9999986543222223346799999999998654    378899999999999999999999954321        1112


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQL--RPSMRSIVVAL  561 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  561 (589)
                      ..+.....         ....+  ........+.+++..|+..++.+  |++++|+++|-
T Consensus       257 ~~i~~~~~---------~~~~p--~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         257 SKIMDHKN---------SLNFP--EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             HHHHhCCc---------ccCCC--CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence            22211100         00010  11123456888999999865543  89999999994

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.8e-37  Score=317.42  Aligned_cols=245  Identities=25%  Similarity=0.365  Sum_probs=188.4

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLF  356 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~  356 (589)
                      +.||+|+||.||++.+..++ ..++.|.+.     ....   ........+.+|+++++.++||||+++++++. ++..|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~-~~~avK~~~-----~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   71 (328)
T cd05593           1 KLLGKGTFGKVILVREKASG-KYYAMKILK-----KEVI---IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLC   71 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCC-CEEEEEEEE-----HHHh---hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEE
Confidence            46999999999999876653 223322221     1111   11233456788999999999999999998776 45689


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      +||||+++|+|.+++....  .+++.+++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||+++...
T Consensus        72 lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          72 FVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKI---VYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             EEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            9999999999999987653  48999999999999999999999998   999999999999999999999999987532


Q ss_pred             cCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhh
Q 037010          437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL  516 (589)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  516 (589)
                      .. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        ......+...       
T Consensus       147 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~~-------  210 (328)
T cd05593         147 TD-AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILME-------  210 (328)
T ss_pred             Cc-ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhccC-------
Confidence            21 1122345799999999999988999999999999999999999999953221        1111111110       


Q ss_pred             HhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       517 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                          +.    ..+......+.+++.+||+.||.+||     +++|+++|
T Consensus       211 ----~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 ----DI----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             ----Cc----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                11    12233445789999999999999997     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.6e-37  Score=310.04  Aligned_cols=264  Identities=25%  Similarity=0.417  Sum_probs=195.7

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      +|++.+.||+|+||.||+|......+... .+.++.+..     .+........++.+|+++++.++||||+++++.+. 
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~-~~~~~~k~~-----~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAG-YTTVAVKML-----KENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ   74 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCc-ceeEEEEec-----CCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence            57889999999999999998754322111 011111111     01112233467888999999999999999999776 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEee
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSG----------------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHR  409 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~  409 (589)
                      ++..+++|||+.+++|.+++....                      ..++++..++.++.|++.||+|||++++   +||
T Consensus        75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i---vH~  151 (290)
T cd05045          75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKL---VHR  151 (290)
T ss_pred             CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCe---ehh
Confidence            456899999999999999986421                      1347889999999999999999999998   999


Q ss_pred             ccCCCcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccc
Q 037010          410 DIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIV  487 (589)
Q Consensus       410 Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~  487 (589)
                      ||||+|||+++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       152 dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~  231 (290)
T cd05045         152 DLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  231 (290)
T ss_pred             hhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence            99999999999999999999998754322211 1122345678999999988889999999999999999998 888874


Q ss_pred             cCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          488 KGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ....     ..+...                 +........+...+..+.+++.+||+.+|++||++.|+++.|+++..+
T Consensus       232 ~~~~-----~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         232 GIAP-----ERLFNL-----------------LKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             CCCH-----HHHHHH-----------------HhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            3211     111111                 111111112233445789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.1e-37  Score=304.60  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=189.4

Q ss_pred             eeccCCcEEEEEEEEcccc-CCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEeCcEEE
Q 037010          279 KIGQGGFGAVYYAELRGEY-GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFL  357 (589)
Q Consensus       279 ~LG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~l  357 (589)
                      +||+|+||.||+|.++... +...+.|...         .+.......+++.+|++++++++||||+++++++.++..++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~---------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~l   72 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILK---------NDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWML   72 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEcc---------CCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEE
Confidence            5899999999999765332 2222222111         01112234567888999999999999999999988888899


Q ss_pred             EEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccccc
Q 037010          358 VYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV  437 (589)
Q Consensus       358 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~  437 (589)
                      ||||+.+|+|.+++....  .+++..+..++.|++.||+|||++++   +||||||.||+++.++.+||+|||++.....
T Consensus        73 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i---~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~  147 (257)
T cd05116          73 VMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNF---VHRDLAARNVLLVTQHYAKISDFGLSKALGA  147 (257)
T ss_pred             EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---eecccchhhEEEcCCCeEEECCCccccccCC
Confidence            999999999999997543  48899999999999999999999998   9999999999999999999999999876543


Q ss_pred             CCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHH
Q 037010          438 GSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE  514 (589)
Q Consensus       438 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (589)
                      ....  ......++..|+|||.+....++.++|+|||||++|||++ |+.||.....     ......   +        
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~---i--------  211 (257)
T cd05116         148 DENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVTQM---I--------  211 (257)
T ss_pred             CCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHH---H--------
Confidence            2221  1112234578999999988889999999999999999998 8888843211     111111   1        


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                            +.......+...+..+.+++.+||+.||++||++.+|.+.|+.
T Consensus       212 ------~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         212 ------ESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             ------HCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence                  1111112233345578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.5e-38  Score=322.30  Aligned_cols=256  Identities=21%  Similarity=0.311  Sum_probs=193.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||++.+..++. .++.|.+..     ..   ....+..+.+.+|+++++.++||||+++++++.
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~aiK~~~~-----~~---~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~   71 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGD-IYAMKVMKK-----SV---LLAQETVSFFEEERDILSISNSPWIPQLQYAFQ   71 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCC-EEEEEEEEH-----HH---hhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence            478999999999999999998776532 222222211     10   011223456778999999999999999998776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i---~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          72 DKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             cCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---EcccCchHheEECCCCCEEeccCC
Confidence            4 56899999999999999998653 348999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhccc------CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQ------YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ++...............||+.|+|||++.      ...++.++|||||||++|||++|+.||.....        ...+.
T Consensus       148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~  219 (330)
T cd05601         148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYN  219 (330)
T ss_pred             CCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHH
Confidence            99865433322223357899999999986      45678999999999999999999999954321        11122


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+.....       ..  ..  ......+..+.+|+..||. +|.+|||+++++.|
T Consensus       220 ~i~~~~~-------~~--~~--~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         220 NIMNFQR-------FL--KF--PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HHHcCCC-------cc--CC--CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            2211100       00  00  0111234568899999998 99999999999987

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.2e-37  Score=333.81  Aligned_cols=259  Identities=23%  Similarity=0.356  Sum_probs=197.9

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .....++|++.+.||+|+||+||+|.+..++ ..++.|.+.         .+.........+.+|+.++..++|+||+++
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g-~~vAvK~i~---------~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~   96 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDG-EPFAVKVVD---------MEGMSEADKNRAQAEVCCLLNCDFFSIVKC   96 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCC-CEEEEEEEe---------cccCCHHHHHHHHHHHHHHhcCCCCcEEEe
Confidence            3445679999999999999999999876653 222222211         111233445567889999999999999999


Q ss_pred             eeEEEeC---------cEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          347 IGYCVEG---------SLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       347 ~~~~~~~---------~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      ++.+...         .+++||||+++|+|.+++....  ...+++..+..++.|++.||+|||++++   +||||||+|
T Consensus        97 ~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~I---iHrDLKP~N  173 (496)
T PTZ00283         97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHM---IHRDIKSAN  173 (496)
T ss_pred             ecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHH
Confidence            8755321         2679999999999999997542  3468899999999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCC-CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGS-ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA  494 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~  494 (589)
                      ||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....    
T Consensus       174 ILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----  249 (496)
T PTZ00283        174 ILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----  249 (496)
T ss_pred             EEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----
Confidence            999999999999999987653221 122234679999999999999999999999999999999999999984321    


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                          ....+.....             .. ....+...+..+.+++.+||+.||.+||++.++++|
T Consensus       250 ----~~~~~~~~~~-------------~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        250 ----MEEVMHKTLA-------------GR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----HHHHHHHHhc-------------CC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                1111111111             00 011233445579999999999999999999999886

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-37  Score=306.46  Aligned_cols=250  Identities=27%  Similarity=0.448  Sum_probs=189.0

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .+|++.+.||+|+||.||++.+...  ...+.|.+..+         .   ....++.+|++++++++||||+++++++.
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~--~~~~iK~~~~~---------~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGK--IDVAIKMIREG---------A---MSEDDFIEEAKVMMKLSHPNLVQLYGVCT   69 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCC--ccEEEEEeccC---------C---CCHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            4588899999999999999987532  22222211100         0   11245778999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+++++|.+++..... .+++..++.++.|++.||.|||++++   +||||||+||+++.++.+||+|||
T Consensus        70 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dl~p~ni~i~~~~~~kl~dfg  145 (256)
T cd05059          70 KQRPIFIVTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNGF---IHRDLAARNCLVGEDNVVKVSDFG  145 (256)
T ss_pred             CCCceEEEEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCCc---ccccccHhhEEECCCCcEEECCcc
Confidence            4 458999999999999999976543 58999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      +++..............++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.....     ...   ....   
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~---~~~~---  214 (256)
T cd05059         146 LARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-----SEV---VESV---  214 (256)
T ss_pred             cceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-----HHH---HHHH---
Confidence            987543222111112234567999999988899999999999999999999 7888743211     111   1111   


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                             ....+.    ..+...+..+.+++.+||..+|++|||++|+++.|
T Consensus       215 -------~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         215 -------SAGYRL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -------HcCCcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                   111111    11223445799999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.5e-37  Score=305.09  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=198.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|....++.... .|.+..        ...........+.+|++++++++||||+++++++.
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~-iK~~~~--------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVA-LKKVQI--------FEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI   72 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEE-EEEeec--------cccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE
Confidence            579999999999999999998766532221 111000        00112334456788999999999999999999776


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                       .+..+++|||+++++|.+++...  ....+++..+..++.|++.||+|||++++   +|+||||+||+++.++.++|+|
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dl~~~nil~~~~~~~~l~d  149 (267)
T cd08228          73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV---MHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             ECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCe---eCCCCCHHHEEEcCCCCEEECc
Confidence             45689999999999999988642  22347889999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++........ ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||......      .......+..
T Consensus       150 ~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~  222 (267)
T cd08228         150 LGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQ  222 (267)
T ss_pred             cccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhc
Confidence            999876532221 112346888999999998888999999999999999999999998543211      1111111110


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                                   .......+...+..+.+++.+||+.+|.+||+++++++.|++++
T Consensus       223 -------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         223 -------------CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -------------CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                         00111112234457899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.1e-37  Score=321.72  Aligned_cols=256  Identities=21%  Similarity=0.325  Sum_probs=187.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||+||+|.+..++ ..++.|.+..     ..   .........+.+|++++.+++||||+++++.+.
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~-~~~aiK~~~~-----~~---~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~   71 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTG-HVYAMKILRK-----AD---MLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ   71 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCC-CEEEEEEEEH-----HH---HHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            47899999999999999999876652 2233222211     10   011223356778999999999999999999776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~gi---vHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          72 DKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             cCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EecCCCHHHeEECCCCCEEEeecc
Confidence            5 46899999999999999998654  48999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCC----------------------------------CCCcccccCCCCCchhcccCCCCCcccchhhHHHHH
Q 037010          431 LTKLTEVGSA----------------------------------SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVL  476 (589)
Q Consensus       431 la~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll  476 (589)
                      +++.......                                  ......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            9875321100                                  001235799999999999989999999999999999


Q ss_pred             HHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcc--cCCCCCCCH
Q 037010          477 YELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ--EYPQLRPSM  554 (589)
Q Consensus       477 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~  554 (589)
                      |||++|+.||.....        ......+......         ...+...  .....+.+++.+++.  .++..||++
T Consensus       227 ~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~---------~~~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~  287 (363)
T cd05628         227 YEMLIGYPPFCSETP--------QETYKKVMNWKET---------LIFPPEV--PISEKAKDLILRFCCEWEHRIGAPGV  287 (363)
T ss_pred             HHHHhCCCCCCCCCH--------HHHHHHHHcCcCc---------ccCCCcC--CCCHHHHHHHHHHcCChhhcCCCCCH
Confidence            999999999954321        1112222111000         0011111  122356677776443  334457999


Q ss_pred             HHHHHH
Q 037010          555 RSIVVA  560 (589)
Q Consensus       555 ~evl~~  560 (589)
                      +|+++|
T Consensus       288 ~ei~~h  293 (363)
T cd05628         288 EEIKTN  293 (363)
T ss_pred             HHHhCC
Confidence            999998

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.3e-37  Score=315.16  Aligned_cols=248  Identities=24%  Similarity=0.388  Sum_probs=187.5

Q ss_pred             ceeeccCCcEEEEEEEEccc--cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eC
Q 037010          277 SHKIGQGGFGAVYYAELRGE--YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EG  353 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~  353 (589)
                      .+.||+|+||.||++.....  .+..++.|.+.     .....  ........+.+|+++|+.++||||+++++++. ++
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~-----~~~~~--~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   73 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLK-----KATIV--RNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG   73 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEE-----HHHHH--hhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC
Confidence            36899999999999986432  22222222211     11000  01122345678999999999999999998776 45


Q ss_pred             cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          354 SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       354 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                      ..|+||||+.+++|.+++....  .+.+..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||+++
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (323)
T cd05584          74 KLYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGI---IYRDLKPENILLDAQGHVKLTDFGLCK  148 (323)
T ss_pred             eEEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence            6899999999999999997654  37888899999999999999999998   999999999999999999999999987


Q ss_pred             ccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChH
Q 037010          434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPI  513 (589)
Q Consensus       434 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (589)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+..     
T Consensus       149 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~-----  214 (323)
T cd05584         149 ESIHEG-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILK-----  214 (323)
T ss_pred             ecccCC-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-----
Confidence            432221 222335799999999999888899999999999999999999999954321        111111111     


Q ss_pred             HhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          514 EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       514 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                              ..  ...+......+.+++.+||+.+|++||     +++++++|
T Consensus       215 --------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         215 --------GK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             --------CC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                    11  112333445789999999999999999     89999887

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=342.01  Aligned_cols=272  Identities=29%  Similarity=0.442  Sum_probs=212.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      ..+.++.+.||+|+||.||.|...+..+... ..         .+++|.+    +.+...+|++|..+|++++|||||++
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~-~~---------~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~l  760 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVS-PI---------QVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSL  760 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCcc-ce---------EEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeE
Confidence            4566788999999999999999887655432 11         2333333    35667889999999999999999999


Q ss_pred             eeEEEeC-cEEEEEEecCCCChHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          347 IGYCVEG-SLFLVYEYIENGNLSEHLRGSG-----RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       347 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      +|++.+. ..+|++|||+||+|..||++..     ...+.....+.++.|||+|++|||+++.   |||||..+|+|++.
T Consensus       761 iGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~f---vHRDLAaRNCLL~~  837 (1025)
T KOG1095|consen  761 IGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHF---VHRDLAARNCLLDE  837 (1025)
T ss_pred             EEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCC---cCcchhhhheeecc
Confidence            9999764 5889999999999999998762     2348899999999999999999999998   99999999999999


Q ss_pred             CCcEEEEeccCccccccCC-CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCC-cccccCCCCCCChhh
Q 037010          421 NFHAKVADFGLTKLTEVGS-ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK-EAIVKGNGSSADSKG  498 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~-~p~~~~~~~~~~~~~  498 (589)
                      ...|||+|||+|+...... ........-...|||||.+..+.++.++|||||||++||++|-. .||...        .
T Consensus       838 ~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~--------~  909 (1025)
T KOG1095|consen  838 RRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR--------S  909 (1025)
T ss_pred             cCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc--------c
Confidence            9999999999999433222 22222223457899999999999999999999999999999854 455222        1


Q ss_pred             HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccccCCCcc
Q 037010          499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFY  577 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~~~  577 (589)
                      ..+.+..++..             . +-..|..++..+.++|..||+.+|++||++..|++.+..+......-+-+.+-
T Consensus       910 n~~v~~~~~~g-------------g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~~~~~  974 (1025)
T KOG1095|consen  910 NFEVLLDVLEG-------------G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIYGPLP  974 (1025)
T ss_pred             hHHHHHHHHhC-------------C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcccccc
Confidence            22222222221             1 12346667778999999999999999999999999998887766655444443

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.1e-37  Score=312.95  Aligned_cols=268  Identities=29%  Similarity=0.477  Sum_probs=199.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|.+..++....+.    .+..     ...........+.+|++++.++ +||||++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~----ik~~-----~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~   76 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAA----IKRM-----KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA   76 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEE----EEEe-----cccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            457889999999999999999876542211110    0000     0011223445788899999999 89999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCC
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA  414 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~  414 (589)
                      +.+ +..|+||||+++++|.+++....              ...+++..++.++.|++.||+|||++++   +||||||+
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi---~H~dlkp~  153 (303)
T cd05088          77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAAR  153 (303)
T ss_pred             ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCc---cccccchh
Confidence            864 56899999999999999997542              1247899999999999999999999998   99999999


Q ss_pred             cEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCC
Q 037010          415 NILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSS  493 (589)
Q Consensus       415 NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~  493 (589)
                      |||++.++.+||+|||++.......  ......++..|+|||.+....++.++|||||||++|||+| |..||.....  
T Consensus       154 Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--  229 (303)
T cd05088         154 NILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--  229 (303)
T ss_pred             eEEecCCCcEEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--
Confidence            9999999999999999986322111  1111234667999999988889999999999999999998 9988843221  


Q ss_pred             CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccccC
Q 037010          494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDV  573 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~  573 (589)
                         .   ........              ......+...+..+.+++.+||+.+|++||+++++++.|..+......|-.
T Consensus       230 ---~---~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~  289 (303)
T cd05088         230 ---A---ELYEKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN  289 (303)
T ss_pred             ---H---HHHHHHhc--------------CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhh
Confidence               1   11111100              000111222344689999999999999999999999999988766655544


Q ss_pred             C
Q 037010          574 G  574 (589)
Q Consensus       574 ~  574 (589)
                      .
T Consensus       290 ~  290 (303)
T cd05088         290 T  290 (303)
T ss_pred             h
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7.3e-37  Score=310.90  Aligned_cols=262  Identities=29%  Similarity=0.478  Sum_probs=196.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh-cCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK-MDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~-~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      ++|++.+.||+|+||.||+|....++....+    +.+      ..+. ......+.+.+|++++.++ +||||++++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~----~ik------~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   71 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNA----AIK------MLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGA   71 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCccee----EEE------EccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEE
Confidence            5789999999999999999987665321110    000      0111 1223345688899999999 79999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCC
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA  414 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~  414 (589)
                      +.+ +..|++|||+++++|.+++....              ...+++..++.++.|++.||+|||++++   +||||||+
T Consensus        72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~i---vH~dlkp~  148 (297)
T cd05089          72 CENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQF---IHRDLAAR  148 (297)
T ss_pred             EccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCcCCcc
Confidence            864 45899999999999999997532              1247889999999999999999999998   99999999


Q ss_pred             cEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCC
Q 037010          415 NILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSS  493 (589)
Q Consensus       415 NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~  493 (589)
                      |||+++++.+||+|||++.......  .......+..|+|||.+....++.++|||||||++|||++ |..||.....  
T Consensus       149 Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--  224 (297)
T cd05089         149 NVLVGENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--  224 (297)
T ss_pred             eEEECCCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            9999999999999999986432111  1111223557999999988889999999999999999997 9999843321  


Q ss_pred             CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccc
Q 037010          494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED  570 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~  570 (589)
                         ..   ......          .....    ..+...+..+.+|+.+||+.+|.+|||++++++.|..+..+...
T Consensus       225 ---~~---~~~~~~----------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~  281 (297)
T cd05089         225 ---AE---LYEKLP----------QGYRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA  281 (297)
T ss_pred             ---HH---HHHHHh----------cCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence               11   111111          11111    12223445789999999999999999999999999888765544

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-36  Score=305.20  Aligned_cols=259  Identities=22%  Similarity=0.367  Sum_probs=199.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh----cCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~----~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|.+.+.||+|+||.||+|.+....+...            .+++|.    ...+..+.+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~------------~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~   72 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKI------------AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL   72 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCc------------ceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhce
Confidence            4568899999999999999998754321110            111121    113345678889999999999999999


Q ss_pred             eeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          347 IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       347 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++++.++..|+||||+++|+|.+++..... .+++..++.++.|++.||+|||++++   +|+||||+||+++.++.++|
T Consensus        73 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~---~H~dl~p~nili~~~~~~~l  148 (270)
T cd05056          73 IGVITENPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRF---VHRDIAARNVLVSSPDCVKL  148 (270)
T ss_pred             eEEEcCCCcEEEEEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCe---eccccChheEEEecCCCeEE
Confidence            999988889999999999999999976443 48999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||++...............++..|+|||.+....++.++||||||+++|||++ |..||.....     .   .....
T Consensus       149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~---~~~~~  220 (270)
T cd05056         149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----N---DVIGR  220 (270)
T ss_pred             ccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----H---HHHHH
Confidence            9999987654332222222334568999999988889999999999999999986 9999844321     1   11111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ...          .....    .+...+..+.+++.+||..+|.+|||+.++++.|..+...
T Consensus       221 ~~~----------~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         221 IEN----------GERLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHc----------CCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            111          00111    1223345789999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.6e-37  Score=308.61  Aligned_cols=261  Identities=26%  Similarity=0.459  Sum_probs=195.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|.+.+.||+|+||.||+|........ ...+.++++..     .+....+..+.+.+|++++++++|+||+++++++
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~-~~~~~vaiK~~-----~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   77 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPE-NDKELVAVKTL-----KETASNDARKDFEREAELLTNFQHENIVKFYGVC   77 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCc-CCcceEEEEee-----cccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence            35688999999999999999987543110 00111111111     0111223456788999999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSG------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      .+ +..+++|||+++++|.+++...+            ...+++..+..++.|++.||.|||++++   +||||||+||+
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i---~h~dlkp~nil  154 (280)
T cd05049          78 TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHF---VHRDLATRNCL  154 (280)
T ss_pred             ecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCe---eccccccceEE
Confidence            64 56899999999999999997543            2347888999999999999999999998   99999999999


Q ss_pred             EcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCC
Q 037010          418 IDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSAD  495 (589)
Q Consensus       418 l~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~  495 (589)
                      ++.++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....    
T Consensus       155 i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~----  230 (280)
T cd05049         155 VGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN----  230 (280)
T ss_pred             EcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH----
Confidence            99999999999999875422211 11223456788999999999999999999999999999998 9999853321    


Q ss_pred             hhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                       ...   ......              ......+...+..+.+++.+||+.||++||+++||++.|.
T Consensus       231 -~~~---~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         231 -EEV---IECITQ--------------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HHH---HHHHHc--------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             111   111110              0001112234457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=317.58  Aligned_cols=259  Identities=30%  Similarity=0.487  Sum_probs=214.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH--HHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ--ASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ...+..+.++||.|.||.||.|.|+...               -.+++|.++.+  ..++|+.|..+|+.++|||+|+++
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkys---------------lTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLL  329 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYS---------------LTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL  329 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccc---------------eeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHh
Confidence            3445667899999999999999987642               24556655544  357899999999999999999999


Q ss_pred             eEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      |+|. +..+|||.|||..|+|.+|+++-.+..++....+.++.||..|++||..+++   |||||...|+|+.++..||+
T Consensus       330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknF---IHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhccccccceEEe
Confidence            9997 4569999999999999999999887778888999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||+++++..+...........+.|.|||-+....++.++|||+|||+|||+.| |..|| ++    .+...       
T Consensus       407 ADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY-PG----idlSq-------  474 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY-PG----IDLSQ-------  474 (1157)
T ss_pred             eccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC-CC----ccHHH-------
Confidence            9999999887665554444556778999999999999999999999999999987 44454 11    12222       


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                                ...++...++..-|..|+..+++||+.||+++|.+||++.|+.+.++.+....
T Consensus       475 ----------VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  475 ----------VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             ----------HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence                      22344444555566777788999999999999999999999999998876543

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-37  Score=321.42  Aligned_cols=255  Identities=22%  Similarity=0.335  Sum_probs=191.0

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|++..++. ..+.|.+...        ..........+.+|+++++.++||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-~vaiK~~~~~--------~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGH-IYAMKKLRKS--------EMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ   71 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCC-EEEEEEEEHH--------HhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            479999999999999999999876532 2222222110        0011223456778999999999999999999776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+.+|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~i---vH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          72 DENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             cCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCCHHHeEECCCCCEEEeecc
Confidence            4 56899999999999999997654  48999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCC-------------------------------------CCcccccCCCCCchhcccCCCCCcccchhhHH
Q 037010          431 LTKLTEVGSAS-------------------------------------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFG  473 (589)
Q Consensus       431 la~~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlG  473 (589)
                      ++.........                                     .....+||+.|+|||++....++.++||||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            98753221100                                     01124699999999999989999999999999


Q ss_pred             HHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 037010          474 VVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS  553 (589)
Q Consensus       474 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  553 (589)
                      |++|||++|..||.....        ......+.....         ......  .......+.+|+.+|+. +|.+|++
T Consensus       227 ~il~el~~G~~Pf~~~~~--------~~~~~~i~~~~~---------~~~~~~--~~~~s~~~~~li~~ll~-~p~~R~~  286 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNP--------QETYRKIINWKE---------TLQFPD--EVPLSPEAKDLIKRLCC-EAERRLG  286 (364)
T ss_pred             hHHHHhhcCCCCCCCCCH--------HHHHHHHHcCCC---------ccCCCC--CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence            999999999999953321        111111111100         000001  11223467889999996 9999998


Q ss_pred             ---HHHHHHH
Q 037010          554 ---MRSIVVA  560 (589)
Q Consensus       554 ---~~evl~~  560 (589)
                         ++|+++|
T Consensus       287 ~~~~~~ll~h  296 (364)
T cd05599         287 NNGVNEIKSH  296 (364)
T ss_pred             CCCHHHHhcC
Confidence               9999887

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.1e-36  Score=301.96  Aligned_cols=252  Identities=29%  Similarity=0.469  Sum_probs=196.3

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|.+.+.||+|++|.||++.+..++. .++.+.+         ...........++.+|++++++++||||+++++++.+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~-~~~~k~~---------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKR-VYAMKQI---------DLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD   70 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCc-EEEEEEe---------ehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc
Confidence            47888999999999999998876532 2222211         1112233445678889999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..|+||||+.+++|.+++.......+++..++.++.|++.||.|||+.++   +|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i---~h~dl~~~nili~~~~~~~l~df~~  147 (256)
T cd08529          71 KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI---LHRDIKSLNLFLDAYDNVKIGDLGV  147 (256)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCcceEEEeCCCCEEEccccc
Confidence             568999999999999999987655568999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +........ ......|++.|+|||+..+..++.++|+||||+++|+|++|+.||.....     .   ........   
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~---~~~~~~~~---  215 (256)
T cd08529         148 AKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----G---ALILKIIR---  215 (256)
T ss_pred             ceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHHHHc---
Confidence            876543222 12335688999999999988999999999999999999999999843321     1   11111111   


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                             ...+    ..+......+.+++.+||+.+|++||++.+++++
T Consensus       216 -------~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         216 -------GVFP----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -------CCCC----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                   0011    1222334578999999999999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9e-37  Score=309.28  Aligned_cols=261  Identities=26%  Similarity=0.486  Sum_probs=197.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc---CHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .+|.+.+.||+|+||.||+|.+........ .+         .+++|..   .....+.+.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~-~~---------~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   74 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKD-KM---------LVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYG   74 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCc-ce---------eeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence            468889999999999999998654311100 00         1122222   2233456888999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      ++.+ +..++||||+++++|.+++....              ...+++..++.++.|++.||+|||++++   +||||||
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i---~H~dlkp  151 (291)
T cd05094          75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF---VHRDLAT  151 (291)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccCc
Confidence            8875 45899999999999999997542              1247899999999999999999999998   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~  491 (589)
                      +|||++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus       152 ~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             ceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999875432211 12233456788999999988899999999999999999999 9988743321


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                           ..   .......             ... ...+...+..+.+++.+||+.+|.+|||+++|++.|.++...
T Consensus       232 -----~~---~~~~~~~-------------~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         232 -----TE---VIECITQ-------------GRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -----HH---HHHHHhC-------------CCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                 11   1111110             000 011222345789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1e-36  Score=307.55  Aligned_cols=260  Identities=28%  Similarity=0.481  Sum_probs=192.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+...+...  .+.++.+...     +....+...++.+|++++++++||||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~--~~~~~ik~~~-----~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   77 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDH--AQLVAIKTLK-----DINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT   77 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCC--cceEEEEecc-----CCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Confidence            56888999999999999999864321110  0111111110     1112334467888999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSG---------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      . +..|++|||+++++|.+++....               ...+++.+.+.++.|++.||+|||++++   +|+||||+|
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i---~H~dlkp~n  154 (283)
T cd05090          78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFF---VHKDLAARN  154 (283)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCe---ehhccccce
Confidence            4 56899999999999999985332               1247888899999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSS  493 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~  493 (589)
                      ||+++++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.....  
T Consensus       155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--  232 (283)
T cd05090         155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--  232 (283)
T ss_pred             EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            9999999999999999975432221 11222445678999999988889999999999999999998 8888743211  


Q ss_pred             CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                            ....+....              ......+...+..+.+++.+||+.||++||++.+|+++|..
T Consensus       233 ------~~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 ------QEVIEMVRK--------------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ------HHHHHHHHc--------------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                  111111111              00011222334578999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-37  Score=315.38  Aligned_cols=255  Identities=23%  Similarity=0.357  Sum_probs=204.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~  348 (589)
                      ..+.|++.+.||.|.||.||+|..+.+ +..++.|.+......        .......+.+|+++|+++. ||||+.+++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~t-g~~~A~K~i~k~~~~--------~~~~~~~v~~Ev~il~~l~~hpniv~l~~  103 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKST-GKEVACKVIPKRKLR--------GKEDREDVRREVAILQQLSGHPNIVQLKD  103 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCC-CceeEEEEeehhhcc--------ccccHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            457899999999999999999998876 333333332211111        1114467889999999998 999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC----CCc
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK----NFH  423 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~----~~~  423 (589)
                      .+.+ ..+++|||++.||.|++.|...  . +++..+..++.|++.+++|||+.|+   +||||||+|+|+..    ++.
T Consensus       104 ~~e~~~~~~lvmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~gv---vHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  104 AFEDPDSVYLVMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSLGV---VHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             EEEcCCeEEEEEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhCCc---eeccCCHHHeeeccccCCCCc
Confidence            8764 5699999999999999999887  2 9999999999999999999999999   99999999999953    357


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +|++|||++.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......        .+
T Consensus       178 ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------~~  247 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------IF  247 (382)
T ss_pred             EEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------HH
Confidence            99999999998765  344566899999999999999999999999999999999999999996543211        11


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..+...           +.......-++....+.++++.|+..||.+|+|+.++++|
T Consensus       248 ~~i~~~-----------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  248 LAILRG-----------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             HHHHcC-----------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            111111           1122233344556789999999999999999999999997

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=301.39  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=192.0

Q ss_pred             eeeccCCcEEEEEEEEccccC--CccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEeCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYG--NSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~--~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  355 (589)
                      ++||+|+||.||+|.+....+  ...+.|....          .......+++.+|+++++++.||||+++++++..+..
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~----------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   70 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ----------EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPL   70 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEeccc----------ccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCce
Confidence            479999999999998765532  1111111110          0111234568889999999999999999999887789


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      ++||||+++++|.+++....  .+++..++.++.|++.||+|||.+++   +|+||||+|||++.++.+||+|||++...
T Consensus        71 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i---~H~di~p~nili~~~~~~kl~df~~~~~~  145 (257)
T cd05060          71 MLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHF---VHRDLAARNVLLVNRHQAKISDFGMSRAL  145 (257)
T ss_pred             EEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCe---eccCcccceEEEcCCCcEEecccccccee
Confidence            99999999999999998765  48999999999999999999999998   99999999999999999999999999865


Q ss_pred             ccCCCCCCc--ccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCCh
Q 037010          436 EVGSASLPT--RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDP  512 (589)
Q Consensus       436 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (589)
                      .........  ...++..|+|||.+....++.++|||||||++|+|++ |+.||.....     .....   .+...   
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~---~~~~~---  214 (257)
T cd05060         146 GAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIA---MLESG---  214 (257)
T ss_pred             ecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHH---HHHcC---
Confidence            433322111  1223567999999988899999999999999999998 8888843211     11111   11110   


Q ss_pred             HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          513 IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       513 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                                 .....+...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus       215 -----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         215 -----------ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             -----------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                       011223334457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-36  Score=306.40  Aligned_cols=271  Identities=24%  Similarity=0.385  Sum_probs=196.1

Q ss_pred             CCC-ccceeeccCCcEEEEEEEEccc---cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          272 DNF-SMSHKIGQGGFGAVYYAELRGE---YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       272 ~~y-~~~~~LG~G~~g~Vy~~~~~~~---~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ++| ++.+.||+|+||+||++.....   .+...+.|.+.          ..........+.+|++++++++||||++++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   72 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK----------RECGQQNTSGWKKEINILKTLYHENIVKYK   72 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEec----------cccChHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            345 8899999999999998764322   11111111110          011122345678899999999999999999


Q ss_pred             eEEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          348 GYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       348 ~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      +++..   ...+++|||+.+++|.+++...   .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~  146 (283)
T cd05080          73 GCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHY---IHRDLAARNVLLDNDRLV  146 (283)
T ss_pred             EEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCe---eccccChheEEEcCCCcE
Confidence            98753   2488999999999999999764   38999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          425 KVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +|+|||++.........  ......++..|+|||.+....++.++||||||+++|||+||..|+.......      ...
T Consensus       147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~------~~~  220 (283)
T cd05080         147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF------EEM  220 (283)
T ss_pred             EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh------hhh
Confidence            99999998765432211  1122345667999999988889999999999999999999999974332110      000


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ...... ......+....+.......+...+..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus       221 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         221 IGPKQG-QMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hccccc-ccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            000000 00011122222222222234445568999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=8.1e-37  Score=309.75  Aligned_cols=265  Identities=26%  Similarity=0.447  Sum_probs=196.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||++........ .....++.+...     +........++.+|+++++++ +|+||+++++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~-~~~~~~a~k~~~-----~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNP-NETSTVAVKMLK-----DDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCC-CCceeEEEEEcc-----CCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            346788999999999999999987654211 001111111110     111223345688899999999 7999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGS--------------GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      ++.+ +..+++|||+.+|+|.+++...              ....+++..++.++.|++.||+|||++++   +||||||
T Consensus        84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i---vH~dlkp  160 (293)
T cd05053          84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKC---IHRDLAA  160 (293)
T ss_pred             EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCc---cccccce
Confidence            8764 4689999999999999999653              23458899999999999999999999998   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~  491 (589)
                      +|||+++++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  240 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  240 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence            999999999999999999886432211 11122335678999999988899999999999999999998 8888743211


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                              ........              .......+......+.+|+.+||..+|++|||++|++++|..+.
T Consensus       241 --------~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         241 --------EELFKLLK--------------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --------HHHHHHHH--------------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                    11111111              11111123334457899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.9e-37  Score=325.96  Aligned_cols=255  Identities=23%  Similarity=0.282  Sum_probs=188.8

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .+|++.+.||+|+||.||+|++..++ ..++.|.+..     ...   ........+.+|+++|++++||||+++++.+.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~avK~~~~-----~~~---~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~   71 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTN-ALYAMKTLRK-----ADV---LMRNQAAHVKAERDILAEADNEWVVKLYYSFQ   71 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCC-CEEEEEEEcH-----HHH---HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            37999999999999999999877652 2222222211     100   11122355778999999999999999998776


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       ++.+|+||||+++|+|.+++....  .+++..+..++.||+.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i---vHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          72 DKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCCHHHEEECCCCCEEEEeCC
Confidence             456899999999999999997654  48888999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCC------------------------------------------CCCCcccccCCCCCchhcccCCCCCcccc
Q 037010          431 LTKLTEVGS------------------------------------------ASLPTRLVGTFGYMPPEYAQYGDVSPKVD  468 (589)
Q Consensus       431 la~~~~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sD  468 (589)
                      ++..+....                                          ........||+.|+|||++.+..++.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            975321000                                          00011247999999999999999999999


Q ss_pred             hhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCC
Q 037010          469 VYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP  548 (589)
Q Consensus       469 vwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP  548 (589)
                      ||||||++|||++|+.||......        .....+....           ..+...........+.+++.+|+ .+|
T Consensus       227 iwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~~~~-----------~~~~~~~~~~~s~~~~~li~~l~-~~p  286 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLADTPA--------ETQLKVINWE-----------TTLHIPSQAKLSREASDLILRLC-CGA  286 (376)
T ss_pred             eeeccceeeehhhCCCCCCCCCHH--------HHHHHHhccC-----------ccccCCCCCCCCHHHHHHHHHHh-cCH
Confidence            999999999999999999543210        1111111100           00000111123345777888876 499


Q ss_pred             CCCC---CHHHHHHH
Q 037010          549 QLRP---SMRSIVVA  560 (589)
Q Consensus       549 ~~RP---s~~evl~~  560 (589)
                      .+|+   ++.|+++|
T Consensus       287 ~~R~~~~t~~ell~h  301 (376)
T cd05598         287 EDRLGKNGADEIKAH  301 (376)
T ss_pred             hhcCCCCCHHHHhCC
Confidence            9999   99999988

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.3e-37  Score=302.90  Aligned_cols=265  Identities=27%  Similarity=0.382  Sum_probs=196.6

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      .|.-.+++|.|+||.||+|....+.+               .+|+|+.-.+. +.-.+|+++|++++|||||++.-++..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~---------------~vAIKKv~~d~-r~knrEl~im~~l~HpNIV~L~~~f~~   88 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEE---------------EVAIKKVLQDK-RYKNRELQIMRKLDHPNIVRLLYFFSS   88 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCc---------------eeEEEEecCCC-CcCcHHHHHHHhcCCcCeeeEEEEEEe
Confidence            46667999999999999999887633               33444332111 112359999999999999999876642


Q ss_pred             ---C-c--EEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC-Cc
Q 037010          353 ---G-S--LFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FH  423 (589)
Q Consensus       353 ---~-~--~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~-~~  423 (589)
                         . .  +.+|||||+. +|.++++..  .+..++...++-+..||++||.|||+++|   +||||||.|+|+|.+ |.
T Consensus        89 ~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~I---cHRDIKPqNlLvD~~tg~  164 (364)
T KOG0658|consen   89 STESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGI---CHRDIKPQNLLVDPDTGV  164 (364)
T ss_pred             cCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCc---ccCCCChheEEEcCCCCe
Confidence               2 2  3489999987 999998852  23458888899999999999999999999   999999999999876 89


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +||||||.|+....+...  ..+..|..|+|||.+.+ ..|+.+.||||.||++.||+-|+..|.+..     ......+
T Consensus       165 LKicDFGSAK~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-----~~dQL~e  237 (364)
T KOG0658|consen  165 LKICDFGSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-----SVDQLVE  237 (364)
T ss_pred             EEeccCCcceeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-----HHHHHHH
Confidence            999999999987654433  56788999999998865 579999999999999999999998874422     2233333


Q ss_pred             HHHHhcCCChHHhhHhhcCCC--------CC-----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPR--------LG-----DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTLSS  566 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~--------l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l~~  566 (589)
                      .-.+++.|.. +++. .+.+.        +.     .-.......+..+|+.++|+.+|.+|.++.|++.|  +..++.
T Consensus       238 Iik~lG~Pt~-e~I~-~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~  314 (364)
T KOG0658|consen  238 IIKVLGTPTR-EDIK-SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD  314 (364)
T ss_pred             HHHHhCCCCH-HHHh-hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence            3344444432 2221 12211        11     01223344578999999999999999999999988  444443

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.8e-37  Score=312.19  Aligned_cols=263  Identities=26%  Similarity=0.439  Sum_probs=196.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCc-cchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccC-CCCcce
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNS-YLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHV-HHLNLV  344 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~-~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l-~hpnIv  344 (589)
                      .++|.+.+.||+|+||.||++.+.+..... .-..         .+++|..    ......++.+|+++++++ +||||+
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~---------~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVT---------KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII   87 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccc---------eEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEe
Confidence            357999999999999999999875432110 0001         1222222    123345688899999999 799999


Q ss_pred             eEeeEEEe-CcEEEEEEecCCCChHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEee
Q 037010          345 RLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR--------------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHR  409 (589)
Q Consensus       345 ~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~  409 (589)
                      ++++++.+ +..|+||||+.+|+|.+++.....              ..+++.+++.++.|++.||+|||++++   +||
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi---~H~  164 (307)
T cd05098          88 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC---IHR  164 (307)
T ss_pred             eEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCc---ccc
Confidence            99998764 568999999999999999976421              248889999999999999999999998   999


Q ss_pred             ccCCCcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccc
Q 037010          410 DIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIV  487 (589)
Q Consensus       410 Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~  487 (589)
                      ||||+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.
T Consensus       165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            99999999999999999999998754321111 1111234568999999988889999999999999999998 777773


Q ss_pred             cCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          488 KGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ...     ...   ......              .......+...+..+.+++.+||..+|.+|||+.++++.|.++...
T Consensus       245 ~~~-----~~~---~~~~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         245 GVP-----VEE---LFKLLK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             cCC-----HHH---HHHHHH--------------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            211     111   111110              1111122333455789999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=302.97  Aligned_cols=257  Identities=23%  Similarity=0.357  Sum_probs=193.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|.+.+.||+|++|.||++....++. ..+.|.+.....      ..........+.+|++++++++||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~-~~~lk~~~~~~~------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   74 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGR-ELAVKQVPFDPD------SPETKKEVNALECEIQLLKNLQHERIVQYYGCLR   74 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCc-EEEEEEEeeccc------chhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc
Confidence            578999999999999999998765432 222221111000      0001122356788999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..+++|||+++++|.+++....  .+++..+..++.|++.||.|||+.++   +|+||+|+||++++++.++|+|||
T Consensus        75 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i---~H~dl~p~nilv~~~~~~~l~dfg  149 (263)
T cd06625          75 DDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMI---VHRDIKGANILRDSAGNVKLGDFG  149 (263)
T ss_pred             cCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEeecc
Confidence            4 56899999999999999987654  38889999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCC--cccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          431 LTKLTEVGSASLP--TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       431 la~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ++...........  ....++..|+|||.+.+..++.++||||||+++|||++|+.||.....       ..... ..  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~-~~--  219 (263)
T cd06625         150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIF-KI--  219 (263)
T ss_pred             cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHH-HH--
Confidence            9875432211111  234678899999999988899999999999999999999999843211       00011 11  


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                 .........+......+.+++.+||..+|.+|||++|+++|.
T Consensus       220 -----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         220 -----------ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             -----------hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence                       111111123334455789999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=304.04  Aligned_cols=257  Identities=23%  Similarity=0.393  Sum_probs=192.4

Q ss_pred             CccceeeccCCcEEEEEEEEccccC--CccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYG--NSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~--~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      |++.+.||+|+||.||+|....+.+  ...+.|.+         ............+.+|+++++.++||||+++++++.
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~---------~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   71 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM---------KLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCF   71 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEe---------ccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeec
Confidence            5788999999999999998765431  11111111         011122334567889999999999999999999775


Q ss_pred             eC-------cEEEEEEecCCCChHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          352 EG-------SLFLVYEYIENGNLSEHLRGS----GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       352 ~~-------~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      +.       ..+++|||+++|+|.+++...    ....+++..++.++.|++.||.|||++++   +||||||+||++++
T Consensus        72 ~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i---~H~dlkp~Nil~~~  148 (273)
T cd05035          72 EASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNF---IHRDLAARNCMLRE  148 (273)
T ss_pred             cCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCe---eccccchheEEECC
Confidence            32       268999999999999998543    22358899999999999999999999998   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCCC-CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhh
Q 037010          421 NFHAKVADFGLTKLTEVGSASL-PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKG  498 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~  498 (589)
                      ++.+||+|||+++......... .....++..|+|||.+....++.++|||||||++|||++ |..||.....       
T Consensus       149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------  221 (273)
T cd05035         149 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------  221 (273)
T ss_pred             CCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence            9999999999988654332211 112335678999999988899999999999999999999 7777733211       


Q ss_pred             HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                       .........          ...    ...+......+.+++.+||+.||++|||+.|++++|.++
T Consensus       222 -~~~~~~~~~----------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         222 -HEIYDYLRH----------GNR----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -HHHHHHHHc----------CCC----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             111111111          001    112334455799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-36  Score=302.58  Aligned_cols=248  Identities=30%  Similarity=0.532  Sum_probs=195.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH--HHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ--ASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||.|+||.||+|...+.                 .+++|.....  ..+++.+|+.++++++|+||+++++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~-----------------~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~   67 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQ-----------------KVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG   67 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCc-----------------EEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEE
Confidence            45788999999999999999987542                 2223322211  3467888999999999999999999


Q ss_pred             EEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++. ++..++||||+++++|.+++.......+++..++.++.|++.||.|||++++   +|+||||+||+++.++.++|+
T Consensus        68 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i---~H~di~p~Nili~~~~~~~l~  144 (256)
T cd05039          68 VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF---VHRDLAARNVLVSEDLVAKVS  144 (256)
T ss_pred             EEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc---cchhcccceEEEeCCCCEEEc
Confidence            877 5568999999999999999987765569999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||.+.......    .....+..|+|||.+..+.++.++||||||+++|||++ |..||....     ...   .....
T Consensus       145 d~g~~~~~~~~~----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~---~~~~~  212 (256)
T cd05039         145 DFGLAKEASQGQ----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKD---VVPHV  212 (256)
T ss_pred             cccccccccccc----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHH---HHHHH
Confidence            999987653211    12334667999999988889999999999999999997 888873221     111   11111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      .              .......+...+..+.+++.+||..+|++|||++|+++.|..+
T Consensus       213 ~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         213 E--------------KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             h--------------cCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            1              0111112223345789999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.9e-37  Score=316.77  Aligned_cols=253  Identities=24%  Similarity=0.355  Sum_probs=187.3

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||.||+|.+..+. ..++.|.+..     ..   .......+.+..|..++.++ +||||+++++++.+ +.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~-~~~aiK~i~~-----~~---~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~   71 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTR-RIYAMKVIKK-----EL---VNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCC-CEEEEEEEEH-----HH---hhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEE
Confidence            46999999999999877653 2222222111     10   01112335577899999888 69999999998764 568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          72 FFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGI---IYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHeEECCCCCEEECcCcccccc
Confidence            99999999999999987653  49999999999999999999999998   99999999999999999999999998742


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH-HHHHhcCCChHH
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL-FEEVLNLPDPIE  514 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  514 (589)
                      ... ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||................ .....       
T Consensus       147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-------  218 (329)
T cd05588         147 IRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-------  218 (329)
T ss_pred             ccC-CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-------
Confidence            211 122234679999999999999999999999999999999999999995322111000001111 11111       


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS------MRSIVVA  560 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  560 (589)
                            ...  ...|......+.+++.+||+.||.+||+      ++++++|
T Consensus       219 ------~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         219 ------EKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ------cCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                  111  1123334456899999999999999997      7888877

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.4e-37  Score=323.12  Aligned_cols=254  Identities=25%  Similarity=0.317  Sum_probs=186.7

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.++||+|+||.||+|++..+.. .++.|.+.     ...   .........+.+|++++++++||||+++++.+.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~-~~aiK~i~-----~~~---~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~   72 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKA-LYAMKTLR-----KKD---VLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD   72 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCC-EEEEEEEe-----HHH---hhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence            68899999999999999998766532 22222211     110   0112234567889999999999999999997764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +.+|+||||+++|+|.+++....  .+++..+..++.||+.||+|||++++   +||||||+|||++.++.+||+|||+
T Consensus        73 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~i---vHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          73 KDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCCCCEEEeECCC
Confidence             56899999999999999997653  48889999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCC----------------------------------------------CCCCcccccCCCCCchhcccCCCCCc
Q 037010          432 TKLTEVGS----------------------------------------------ASLPTRLVGTFGYMPPEYAQYGDVSP  465 (589)
Q Consensus       432 a~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~  465 (589)
                      +.......                                              ........||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            75321000                                              00011246999999999999899999


Q ss_pred             ccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcc
Q 037010          466 KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ  545 (589)
Q Consensus       466 ~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~  545 (589)
                      ++|||||||++|||++|+.||.....       . .....+...           ...+...........+.+++.+|+ 
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~~-------~-~~~~~i~~~-----------~~~~~~p~~~~~s~~~~~li~~l~-  287 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQTP-------L-ETQMKVINW-----------QTSLHIPPQAKLSPEASDLIIKLC-  287 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCCCH-------H-HHHHHHHcc-----------CCCcCCCCcccCCHHHHHHHHHHc-
Confidence            99999999999999999999954321       0 011111110           000000011122345677777765 


Q ss_pred             cCCCCCCC---HHHHHHH
Q 037010          546 EYPQLRPS---MRSIVVA  560 (589)
Q Consensus       546 ~dP~~RPs---~~evl~~  560 (589)
                      .+|.+|++   ++|+++|
T Consensus       288 ~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         288 RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             cCHhHcCCCCCHHHHhcC
Confidence            49999997   9998887

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-36  Score=310.68  Aligned_cols=267  Identities=25%  Similarity=0.440  Sum_probs=198.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccC-CccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccC-CCCcc
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYG-NSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHV-HHLNL  343 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l-~hpnI  343 (589)
                      ..++|.+.+.||+|+||.||+|....... ...-..         .+++|..    ......++.+|+++++.+ +||||
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~---------~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i   83 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAV---------TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI   83 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcce---------eEEeeecccccchHHHHHHHHHHHHHHhhccCCCc
Confidence            35678899999999999999997643211 000000         1222222    223446688899999999 89999


Q ss_pred             eeEeeEEEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 037010          344 VRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIH  408 (589)
Q Consensus       344 v~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH  408 (589)
                      +++++++.+ +..|++|||+.+|+|.+++....              ...+++..++.++.|++.||.|||++++   +|
T Consensus        84 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~gi---vH  160 (304)
T cd05101          84 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC---IH  160 (304)
T ss_pred             hheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCe---ee
Confidence            999998764 56899999999999999997642              1347888899999999999999999998   99


Q ss_pred             eccCCCcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCccc
Q 037010          409 RDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAI  486 (589)
Q Consensus       409 ~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~  486 (589)
                      |||||+||+++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       161 ~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  240 (304)
T cd05101         161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  240 (304)
T ss_pred             cccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999999999865432221 1122345678999999988889999999999999999998 66776


Q ss_pred             ccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      ....        ..........              ......+...+..+.+++.+||..+|.+|||+.|+++.|.++..
T Consensus       241 ~~~~--------~~~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         241 PGIP--------VEELFKLLKE--------------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ccCC--------HHHHHHHHHc--------------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            3211        1111111111              01111223445578999999999999999999999999998876


Q ss_pred             cccc
Q 037010          567 TTED  570 (589)
Q Consensus       567 ~~~~  570 (589)
                      ...+
T Consensus       299 ~~~~  302 (304)
T cd05101         299 LTTN  302 (304)
T ss_pred             hhhc
Confidence            5443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-37  Score=321.84  Aligned_cols=256  Identities=21%  Similarity=0.307  Sum_probs=189.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.++||+|+||.||++.+..++. .++.|.+.     ...   .......+.+.+|++++++++||||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~aiK~~~-----~~~---~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~   71 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGK-IYAMKTLL-----KSE---MFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ   71 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCC-EEEEEEEE-----HHH---HHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence            478999999999999999998776532 22222211     110   111233456788999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~gi---vHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          72 DAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGF---IHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             cCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHEEECCCCCEEEeecc
Confidence            5 45899999999999999997653  48899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCC------------C----------------------------------CCcccccCCCCCchhcccCCCCC
Q 037010          431 LTKLTEVGSA------------S----------------------------------LPTRLVGTFGYMPPEYAQYGDVS  464 (589)
Q Consensus       431 la~~~~~~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s  464 (589)
                      +++.......            .                                  ......||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            9863211000            0                                  00124699999999999988999


Q ss_pred             cccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhc
Q 037010          465 PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCT  544 (589)
Q Consensus       465 ~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl  544 (589)
                      .++|||||||++|||+||+.||.....        ...+..+......         ..++.  .......+.+|+.+|+
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~---------~~~p~--~~~~s~~~~dli~~lL  287 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCSENS--------HETYRKIINWRET---------LYFPD--DIHLSVEAEDLIRRLI  287 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCCCCH--------HHHHHHHHccCCc---------cCCCC--CCCCCHHHHHHHHHHh
Confidence            999999999999999999999953321        1111111111000         00000  0112346889999999


Q ss_pred             ccCCCCC---CCHHHHHHHH
Q 037010          545 QEYPQLR---PSMRSIVVAL  561 (589)
Q Consensus       545 ~~dP~~R---Ps~~evl~~L  561 (589)
                      . +|.+|   +++.|+++|-
T Consensus       288 ~-~~~~r~~r~~~~~~l~hp  306 (377)
T cd05629         288 T-NAENRLGRGGAHEIKSHP  306 (377)
T ss_pred             c-CHhhcCCCCCHHHHhcCC
Confidence            7 66665   6999999984

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.9e-37  Score=307.70  Aligned_cols=262  Identities=25%  Similarity=0.440  Sum_probs=192.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+.+..... ..+.++++...     +........++.+|+.++++++||||++++++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~-~~~~~aik~~~-----~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~   77 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDE-PETRVAIKTVN-----EAASMRERIEFLNEASVMKEFNCHHVVRLLGV   77 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCC-ceeEEEEEecc-----ccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            4578999999999999999999876431110 01111111110     01112234568889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSG--------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      +.+ +..++||||+.+++|.+++....        ...+++..++.++.|++.||+|||+.++   +|+||||+||++++
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---vH~dlkp~Nil~~~  154 (277)
T cd05062          78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAE  154 (277)
T ss_pred             EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCcchheEEEcC
Confidence            864 46899999999999999997532        1235778889999999999999999998   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhh
Q 037010          421 NFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKG  498 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~  498 (589)
                      ++.++|+|||++......... ......+++.|+|||++..+.++.++|||||||++|||++ |..||.....     . 
T Consensus       155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-----~-  228 (277)
T cd05062         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-----E-  228 (277)
T ss_pred             CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----H-
Confidence            999999999998754322111 1122345778999999988899999999999999999999 6777733211     1 


Q ss_pred             HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                        .........             .. ...+...+..+.+++.+||+.+|++|||+.|++++|.
T Consensus       229 --~~~~~~~~~-------------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         229 --QVLRFVMEG-------------GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             --HHHHHHHcC-------------Cc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence              111111110             00 0112233457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=8.1e-37  Score=307.27  Aligned_cols=257  Identities=29%  Similarity=0.444  Sum_probs=191.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|.+.+.||+|+||.||+|.+....+... ..         .+++|..    .......+.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~-~~---------~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   74 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAV-EL---------QVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRL   74 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCC-ce---------eEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            4678999999999999999998865221100 00         1122211    22334568889999999999999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGR-----DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ++++.+ +..++||||+++++|.+++.....     ..+++..++.++.||+.||+|||++++   +|+||||+||+++.
T Consensus        75 ~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i---vH~dlkp~nil~~~  151 (277)
T cd05036          75 IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHF---IHRDIAARNCLLTC  151 (277)
T ss_pred             EEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCE---eecccchheEEEec
Confidence            997754 568999999999999999976432     248899999999999999999999998   99999999999986


Q ss_pred             CC---cEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCC
Q 037010          421 NF---HAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSAD  495 (589)
Q Consensus       421 ~~---~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~  495 (589)
                      ++   .+||+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||.....    
T Consensus       152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----  227 (277)
T cd05036         152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----  227 (277)
T ss_pred             cCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----
Confidence            54   5999999998865322111 1112234568999999988899999999999999999997 8888743221    


Q ss_pred             hhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                       ..   ....+..              ......+...+..+.+++.+||+.+|++|||+.+|+++|.
T Consensus       228 -~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         228 -QE---VMEFVTG--------------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HH---HHHHHHc--------------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             11   1111111              0011123334457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.2e-37  Score=315.39  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=189.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCC-cceeEeeEEE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHL-NLVRLIGYCV  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~  351 (589)
                      +|++.+.||+|+||.||+|.+.++.. .++.|.+..     ...   ......+.+..|.+++..++|+ +|+++++++.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~avK~~~~-----~~~---~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDE-LYAIKILKK-----DVI---IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ   71 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCC-EEEEEEEEH-----HHh---hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence            58899999999999999998776532 222222211     110   1122345677899999999765 5788887765


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       ++.+|+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          72 TMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGI---IYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHeEEcCCCCEEEeecC
Confidence             456999999999999999997654  38899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....        ......+..  
T Consensus       147 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~--  215 (324)
T cd05587         147 MCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIME--  215 (324)
T ss_pred             cceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc--
Confidence            987432211 122335789999999999999999999999999999999999999953221        111111111  


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM-----RSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  560 (589)
                                 ..  ...+......+.+++.+||..||.+|++.     +++++|
T Consensus       216 -----------~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         216 -----------HN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -----------CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                       10  11223344578899999999999999986     677766

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6e-37  Score=316.03  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=186.7

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEE-eCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-~~~~  355 (589)
                      +.||+|+||.||+|.+..+.. .++.|.+..     ..   .........+.+|+.++.++ +||||+++++++. ++..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~-~~aiK~~~~-----~~---~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTER-IYAMKVVKK-----EL---VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL   71 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCC-EEEEEEEEh-----hH---hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEE
Confidence            469999999999998776532 222222111     10   01122344577788888776 7999999999776 4568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          72 FFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            99999999999999887654  48999999999999999999999998   99999999999999999999999998753


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH-HHHHhcCCChHH
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL-FEEVLNLPDPIE  514 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  514 (589)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++|+.||................ ......      
T Consensus       147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~------  219 (329)
T cd05618         147 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------  219 (329)
T ss_pred             cCC-CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc------
Confidence            221 112234678999999999999999999999999999999999999995321111111111111 111111      


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS------MRSIVVA  560 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  560 (589)
                             ..  ...|......+.+++.+||+.||.+||+      +.++++|
T Consensus       220 -------~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 -------KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -------CC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence                   11  1223344457889999999999999998      5788777

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-36  Score=300.76  Aligned_cols=248  Identities=26%  Similarity=0.465  Sum_probs=186.4

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLF  356 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  356 (589)
                      +.||+|+||.||+|.+..++.. .+.|.+          .+....+....+.+|++++++++||||+++++++.+ +..|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~-~a~k~~----------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   69 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTP-VAVKSC----------RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY   69 (252)
T ss_pred             CccCcccCccEEEEEEecCCce-EEEEec----------CccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeE
Confidence            4699999999999988655322 111111          112233445678899999999999999999998864 4689


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      +||||+.+++|.+++.... ..+++..++.++.|++.||.|||++++   +|+||||+||+++.++.+||+|||++....
T Consensus        70 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          70 IVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             EEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---cccccchheEEEcCCCcEEECccccCcccc
Confidence            9999999999999997543 348899999999999999999999998   999999999999999999999999987543


Q ss_pred             cCCCCC-CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHH
Q 037010          437 VGSASL-PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE  514 (589)
Q Consensus       437 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (589)
                      ...... ......+..|+|||.+..+.++.++|||||||++|||++ |..||.....     ....              
T Consensus       146 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~~~~--------------  206 (252)
T cd05084         146 DGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTR--------------  206 (252)
T ss_pred             cccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----HHHH--------------
Confidence            211110 011123457999999988889999999999999999998 7777732211     1110              


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                         ..+........+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       207 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         207 ---EAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ---HHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence               111111111223334557899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-37  Score=303.71  Aligned_cols=255  Identities=25%  Similarity=0.470  Sum_probs=196.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||++.+.+.  ...+.|.+..            .....+++.+|++++++++|+||++++++
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~--~~~~vK~~~~------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   69 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGT--TKVAVKTLKP------------GTMSPEAFLQEAQIMKKLRHDKLVQLYAV   69 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCC--ceEEEEEecC------------CccCHHHHHHHHHHHhhCCCCCEeeeeee
Confidence            357899999999999999999986543  1111111110            01123467889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ ...+++|||+++++|.+++.......+++..+..++.|++.||.|||++++   +|+||||+||+++.++.++|+|
T Consensus        70 ~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i---~h~di~p~nili~~~~~~~l~d  146 (261)
T cd05034          70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY---IHRDLAARNILVGENLVCKIAD  146 (261)
T ss_pred             eecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCcchheEEEcCCCCEEECc
Confidence            775 568999999999999999987665568999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++...............++..|+|||.+.+..++.++|+||||+++|+|+| |+.||.....     .   .......
T Consensus       147 ~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~---~~~~~~~  218 (261)
T cd05034         147 FGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-----R---EVLEQVE  218 (261)
T ss_pred             cccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHHH
Confidence            99987654322111122334678999999998889999999999999999998 8888843211     1   1111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                      .              ......+.+.+..+.+++.+||..+|.+||+++++++.|+.
T Consensus       219 ~--------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         219 R--------------GYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             c--------------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1              00111122234578999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2e-36  Score=303.34  Aligned_cols=257  Identities=24%  Similarity=0.378  Sum_probs=190.9

Q ss_pred             CccceeeccCCcEEEEEEEEccccCC-ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGN-SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~-~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      |.+.+.||+|+||.||+|.+...... ..+.|.+.         .........+.+.+|++++++++||||+++++++.+
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMK---------IAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQ   71 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecc---------cCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcc
Confidence            45778999999999999987665321 11111110         011223445678889999999999999999997642


Q ss_pred             -------CcEEEEEEecCCCChHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          353 -------GSLFLVYEYIENGNLSEHLRGS----GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       353 -------~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                             ...+++|||+.+|+|.+++...    ....+++..+..++.|++.||+|||++++   +||||||+|||++++
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~  148 (272)
T cd05075          72 TVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSF---IHRDLAARNCMLNEN  148 (272)
T ss_pred             CCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCe---eccccchhheEEcCC
Confidence                   1368999999999999988532    12347899999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCCC-CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhH
Q 037010          422 FHAKVADFGLTKLTEVGSASL-PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~  499 (589)
                      +.+||+|||++.......... .....+++.|++||.+....++.++|||||||++|||++ |+.||....     ... 
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~-  222 (272)
T cd05075         149 MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-----NSE-  222 (272)
T ss_pred             CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHH-
Confidence            999999999988654322111 122345678999999998899999999999999999999 777773311     111 


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                        .........          ..    ..+...+..+.+++.+||+.+|++|||+.+++++|..+
T Consensus       223 --~~~~~~~~~----------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         223 --IYDYLRQGN----------RL----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --HHHHHHcCC----------CC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              111111100          00    11223445689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.7e-36  Score=324.95  Aligned_cols=286  Identities=19%  Similarity=0.298  Sum_probs=194.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhh----hhhHhHHHhhc--CHHHHHHHHHHHHHHccCCCCcc
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN----LLMQKAAIKKM--DMQASREFLAELKVLTHVHHLNL  343 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~----~~~~~~~ik~~--~~~~~~~~~~E~~il~~l~hpnI  343 (589)
                      ..++|++.++||+|+||+||+|..+...+.....+.+...    ........+..  .......+.+|+++|++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4578999999999999999999876543333222211100    00111122222  22344568899999999999999


Q ss_pred             eeEeeEEEe-CcEEEEEEecCCCChHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc
Q 037010          344 VRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSG---RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID  419 (589)
Q Consensus       344 v~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~  419 (589)
                      +++++++.+ +..|+++|++.+ +|.+++....   ........++.++.||+.||+|||++++   +||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gI---iHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKL---IHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEC
Confidence            999998864 458899999854 7888775432   1123456678899999999999999998   9999999999999


Q ss_pred             CCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          420 KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       420 ~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      .++.+||+|||++...............||+.|+|||++.+..++.++|||||||++|||++|..++....... ....+
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~-~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK-PGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC-HHHHH
Confidence            99999999999998664433333334679999999999999999999999999999999999986553322211 11112


Q ss_pred             HHHHHHHh----cCCChHHhhHhhcCCCC----CCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          500 VALFEEVL----NLPDPIEDLRKLVDPRL----GDNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       500 ~~~~~~~~----~~~~~~~~l~~~~d~~l----~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ......+.    ..++....+...++...    ....+     ......+.+++.+||+.||++|||+.|+++|
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            22111110    01111111111111100    00000     0122357788999999999999999999987

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.1e-36  Score=308.23  Aligned_cols=261  Identities=24%  Similarity=0.408  Sum_probs=196.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccC-CCCcce
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHV-HHLNLV  344 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l-~hpnIv  344 (589)
                      ..++|.+.+.||+|+||.||++.+....... ...         .+++|..    .....+.+.+|+++++++ +||||+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~-~~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv  102 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSD-AVM---------KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV  102 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCC-cee---------EEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcc
Confidence            3457999999999999999999864321111 011         1222211    223346788999999999 799999


Q ss_pred             eEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          345 RLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       345 ~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      ++++++.. +..|++|||+.+|+|.+++.......+++.++..++.|++.||+|||++++   +|+||||+|||++.++.
T Consensus       103 ~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~  179 (302)
T cd05055         103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNVLLTHGKI  179 (302)
T ss_pred             eEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---ehhhhccceEEEcCCCe
Confidence            99998764 568999999999999999986554458999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHH
Q 037010          424 AKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~  501 (589)
                      ++|+|||++......... ......++..|+|||.+....++.++|||||||++|||++ |..||.....    ...   
T Consensus       180 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~---  252 (302)
T cd05055         180 VKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSK---  252 (302)
T ss_pred             EEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHH---
Confidence            999999998754332211 1122345778999999988899999999999999999998 8888743221    000   


Q ss_pred             HHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       502 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                       +...             +........+...+..+.+++.+||..+|++|||+.|+++.|.++
T Consensus       253 -~~~~-------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         253 -FYKL-------------IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -HHHH-------------HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence             1111             111111111222345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.9e-37  Score=318.02  Aligned_cols=245  Identities=24%  Similarity=0.351  Sum_probs=186.6

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLF  356 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~  356 (589)
                      +.||+|+||.||++.+..++ ..++.|.+..     ...   .......++..|+++++.++||||+++++++. ++..|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~-~~~a~K~~~~-----~~~---~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~   71 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATG-RYYAMKILKK-----EVI---VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC   71 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCC-CEEEEEEEEH-----HHh---hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEE
Confidence            46999999999999876653 2222222211     110   11223455678999999999999999998776 45689


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      +||||+++|+|.+++....  .+++..+..++.||+.||+|||+ +++   +||||||+|||++.++.+||+|||+++..
T Consensus        72 lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~i---vHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          72 FVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNV---VYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCE---EecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            9999999999999887654  48999999999999999999997 787   99999999999999999999999998753


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      .... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....        ..........      
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~~~------  211 (325)
T cd05594         147 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILME------  211 (325)
T ss_pred             CCCC-cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHhcC------
Confidence            2221 122335799999999999988999999999999999999999999954321        1111111110      


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                           ..    ..+......+.+++.+||+.||++|+     ++.++++|
T Consensus       212 -----~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 -----EI----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -----CC----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                 11    12223345689999999999999996     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=312.55  Aligned_cols=261  Identities=28%  Similarity=0.465  Sum_probs=203.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH----HHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----QASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .+...+.++||+|-||.|.+|+..+.                .++|+|.++.    ....+|.+|+++|.+|+||||+++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~----------------lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveL  600 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGP----------------LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVEL  600 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCc----------------eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEE
Confidence            46778899999999999999987762                2556665553    345789999999999999999999


Q ss_pred             eeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      +++|. ++.+++++|||++|+|.+|+..+............|+.||+.|++||.+.++   |||||.+.|+|++.++++|
T Consensus       601 vGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nf---VHrd~a~rNcLv~~e~~iK  677 (807)
T KOG1094|consen  601 LGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNF---VHRDLATRNCLVDGEFTIK  677 (807)
T ss_pred             EeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhch---hhccccccceeecCcccEE
Confidence            99997 5568899999999999999988754334556677899999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHH--cCCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI--SAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ell--tG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |+|||+++-...+.. ....+.+-..+|||||.+..++++.+||+|+||+++||++  +...||....+     +...+-
T Consensus       678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~-----e~vven  752 (807)
T KOG1094|consen  678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD-----EQVVEN  752 (807)
T ss_pred             ecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH-----HHHHHh
Confidence            999999985433332 2334456678999999999999999999999999999975  56677743221     111111


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ...++....          ....-..|.-++..+.+++.+||..+-.+|||++++..+|....
T Consensus       753 ~~~~~~~~~----------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  753 AGEFFRDQG----------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             hhhhcCCCC----------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            112211110          01111235556678999999999999999999999999987653

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=8.6e-37  Score=302.91  Aligned_cols=245  Identities=32%  Similarity=0.518  Sum_probs=191.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ++|++.+.||+|+||.||++...+.   .              +++|.... .....+.+|+.++++++|||++++++++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~---~--------------~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   68 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQ---K--------------VAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI   68 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCC---c--------------eEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence            5688999999999999999864332   1              22222211 1234678899999999999999999998


Q ss_pred             EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       351 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      .++..+++|||+.+++|.+++.......+++..++.++.|++.||.|||+.++   +||||||+||+++.++.+||+|||
T Consensus        69 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~H~dl~p~nili~~~~~~kl~Dfg  145 (254)
T cd05083          69 LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL---VHRDLAARNILVSEDGVAKVSDFG  145 (254)
T ss_pred             cCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCe---eccccCcceEEEcCCCcEEECCCc
Confidence            88889999999999999999987665568999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++.......    .....+..|+|||.+.++.++.++|+|||||++|||++ |+.||.....     ...   .....  
T Consensus       146 ~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~---~~~~~--  211 (254)
T cd05083         146 LARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEV---KECVE--  211 (254)
T ss_pred             cceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHH---HHHHh--
Confidence            987543211    12234567999999988899999999999999999998 8888743211     111   11110  


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                              +...+    ..+...+..+.+++.+||+.+|++||+++++++.|.
T Consensus       212 --------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         212 --------KGYRM----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             --------CCCCC----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence                    00011    112233457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-36  Score=318.89  Aligned_cols=267  Identities=21%  Similarity=0.295  Sum_probs=193.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|+||.||++.+..++. ..+.|.+.     .    ........+++.+|+++++.++||||+++++++..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~-----~----~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   70 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGK-RVALKKMP-----N----VFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQP   70 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCC-EEEEEecc-----c----cccchHHHHHHHHHHHHHHhCCCCCcCCHhheecC
Confidence            47889999999999999998765432 22222110     0    00112234567889999999999999999998764


Q ss_pred             C------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          353 G------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       353 ~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      .      ..|+||||+. ++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus        71 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~i---vH~dlkp~Nili~~~~~~kL  144 (372)
T cd07853          71 PHIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGI---LHRDIKPGNLLVNSNCVLKI  144 (372)
T ss_pred             CCccccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCChHHEEECCCCCEEe
Confidence            3      5899999997 48888886543  48999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||++...............+++.|+|||++.+. .++.++|||||||++|||++|+.||.....     .........
T Consensus       145 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~  219 (372)
T cd07853         145 CDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-----IQQLDLITD  219 (372)
T ss_pred             ccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHH
Confidence            99999986543333333445689999999998764 578999999999999999999999954321     111122222


Q ss_pred             HhcCCChHHhh-------HhhcCCCC--C------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          506 VLNLPDPIEDL-------RKLVDPRL--G------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       506 ~~~~~~~~~~l-------~~~~d~~l--~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ....+.. +++       ...+....  .      ..........+.+|+.+||+.||++|||++|+++|-
T Consensus       220 ~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         220 LLGTPSL-EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             HcCCCCH-HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence            2222111 111       00000000  0      011122345789999999999999999999999884

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.2e-37  Score=328.12  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=188.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ...+|++.+.||+|+||.||+|.+..++..               +++|.+... .....+|+.+|++++||||++++++
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~---------------vAiK~i~~~-~~~~~~Ei~il~~l~h~niv~l~~~  127 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEK---------------VAIKKVLQD-PQYKNRELLIMKNLNHINIIFLKDY  127 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCE---------------EEEEEEecC-cchHHHHHHHHHhcCCCCCcceeee
Confidence            356899999999999999999987655322               222222111 1123469999999999999999886


Q ss_pred             EEe-------C--cEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE
Q 037010          350 CVE-------G--SLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI  418 (589)
Q Consensus       350 ~~~-------~--~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl  418 (589)
                      +..       .  .+++||||+.+ +|.+++...  ....+++..++.++.||+.||+|||++++   +||||||+|||+
T Consensus       128 ~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~I---iHrDLKp~NILl  203 (440)
T PTZ00036        128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFI---CHRDLKPQNLLI  203 (440)
T ss_pred             EeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCcCHHHEEE
Confidence            532       1  26789999975 787777532  33458999999999999999999999998   999999999999


Q ss_pred             cCCC-cEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          419 DKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       419 ~~~~-~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      +.++ .+||+|||+++......  ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.....    .
T Consensus       204 ~~~~~~vkL~DFGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~----~  277 (440)
T PTZ00036        204 DPNTHTLKLCDFGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS----V  277 (440)
T ss_pred             cCCCCceeeeccccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----H
Confidence            8665 69999999998654322  2234678999999998865 4689999999999999999999999854322    1


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCC-------------CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPR-------------LGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~-------------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..+... ...+..+.. +.+.. ..+.             +....|...+.++.+|+.+||+.||.+|||+.|+++|
T Consensus       278 ~~~~~i-~~~~~~p~~-~~~~~-~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        278 DQLVRI-IQVLGTPTE-DQLKE-MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHH-HHHhCCCCH-HHHHH-hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            111111 112221111 11111 1110             0011222334578999999999999999999999988

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.5e-36  Score=317.97  Aligned_cols=264  Identities=22%  Similarity=0.314  Sum_probs=195.1

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcce
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLV  344 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv  344 (589)
                      .+.....++|++.+.||+|+||.||+|.+..+.. .++.|.+..     ..   .........+.+|+.+++.++||||+
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~-~~aiK~i~~-----~~---~~~~~~~~~~~~e~~i~~~~~hp~iv  106 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK-VYAMKLLSK-----FE---MIKRSDSAFFWEERDIMAFANSPWVV  106 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCc-EEEEEEEEH-----HH---hhhhHHHHHHHHHHHHHHhCCCCCCC
Confidence            3445556899999999999999999998876532 222222111     00   11112234577899999999999999


Q ss_pred             eEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          345 RLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       345 ~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      ++++.+.+ +..|+||||+++|+|.+++...   .+++..+..++.||+.||+|||++++   +||||||+|||++.++.
T Consensus       107 ~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDLkp~NIll~~~~~  180 (371)
T cd05622         107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGH  180 (371)
T ss_pred             eEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCE---EeCCCCHHHEEECCCCC
Confidence            99987765 4589999999999999998754   37888899999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCC----CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG----DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      +||+|||++...............||+.|+|||++...    .++.++|||||||++|||++|+.||.....        
T Consensus       181 ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------  252 (371)
T cd05622         181 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------  252 (371)
T ss_pred             EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------
Confidence            99999999986543322223346799999999998653    378899999999999999999999954321        


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQL--RPSMRSIVVALM  562 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~  562 (589)
                      ...+..+.....           .+.-......+..+.+++..|+..++.+  ||+++|+++|..
T Consensus       253 ~~~~~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~  306 (371)
T cd05622         253 VGTYSKIMNHKN-----------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  306 (371)
T ss_pred             HHHHHHHHcCCC-----------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence            122222221110           0000111234457889999999844443  789999999863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-36  Score=307.04  Aligned_cols=261  Identities=25%  Similarity=0.429  Sum_probs=193.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .+|++.+.||+|+||.||+|.+.++.... ..+.++.+...     ..........+.+|+.++.+++||||+++++++.
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~-~~~~vaiK~~~-----~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~   78 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGE-QTQAVAIKTLK-----DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT   78 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCC-ceeEEEEEEcc-----CCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            45778899999999999999876532110 01111221111     0111233456888999999999999999999886


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcE
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI  416 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NI  416 (589)
                      + +..++++||+.+++|.+++....              ...+++..++.++.|++.||+|||++++   +||||||+||
T Consensus        79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi---~H~dlkp~Ni  155 (283)
T cd05091          79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNV  155 (283)
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCc---cccccchhhe
Confidence            4 56899999999999999985321              2347888899999999999999999998   9999999999


Q ss_pred             EEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCC
Q 037010          417 LIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSA  494 (589)
Q Consensus       417 Ll~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~  494 (589)
                      ++++++.+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||.....   
T Consensus       156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---  232 (283)
T cd05091         156 LVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---  232 (283)
T ss_pred             EecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            999999999999999875432221 11223456789999999988889999999999999999998 7777643211   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                           ......+..             .. ...++.+++..+.+++.+||+.+|.+||++++|+..|..
T Consensus       233 -----~~~~~~i~~-------------~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 -----QDVIEMIRN-------------RQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----HHHHHHHHc-------------CC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                 111111111             11 112334455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1e-36  Score=307.19  Aligned_cols=249  Identities=23%  Similarity=0.341  Sum_probs=186.8

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcEEEE
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLV  358 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv  358 (589)
                      ||+|+||+||++.+..++. .++.|.+...     .   .......+.+..|++++++++|+||+++.+++. ++..|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~-~~avK~~~~~-----~---~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv   71 (280)
T cd05608           1 LGKGGFGEVSACQMRATGK-LYACKKLNKK-----R---LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLV   71 (280)
T ss_pred             CCCCCceeEEEEEEccCCc-EEEEEeeeHH-----H---HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEE
Confidence            7999999999998776532 2222221110     0   001122345678999999999999999998776 4568999


Q ss_pred             EEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          359 YEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       359 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      |||+++|+|.+++...  ....+++..++.++.|++.||+|||++++   +||||||+||+++.++.++|+|||++....
T Consensus        72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  148 (280)
T cd05608          72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI---IYRDLKPENVLLDNDGNVRISDLGLAVELK  148 (280)
T ss_pred             EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence            9999999999887542  23458999999999999999999999998   999999999999999999999999987543


Q ss_pred             cCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhh
Q 037010          437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL  516 (589)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  516 (589)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    .........          
T Consensus       149 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~----------  213 (280)
T cd05608         149 DGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRI----------  213 (280)
T ss_pred             CCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhh----------
Confidence            3222 2233578999999999999999999999999999999999999995432211    001111111          


Q ss_pred             HhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       517 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                         ....  ...+...+..+.+++.+||+.||++||     +++++++|
T Consensus       214 ---~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         214 ---LNDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ---cccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence               1110  122333455789999999999999999     77888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=301.78  Aligned_cols=257  Identities=25%  Similarity=0.366  Sum_probs=203.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeE-eeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL-IGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l-~~~  349 (589)
                      .+.|+.-+.||+||||.||-+..+.+ ++.++.|     .+. +..+|+...  ....++|-.||.+++.+.||.+ |+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraT-GKMYAcK-----kL~-KKRiKkr~g--e~maLnEk~iL~kV~s~FiVslaYAf  254 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRAT-GKMYACK-----KLD-KKRIKKRKG--ETMALNEKQILEKVSSPFIVSLAYAF  254 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecc-hhhHHHH-----HHH-HHHHHHhhh--hHHhhHHHHHHHHhccCcEEEEeeee
Confidence            46788999999999999999987765 3333333     222 223333222  2345679999999999999998 466


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      ...+.+++||..|+||+|.-+|...+...+++..++.++.+|+.||+|||+++|   |.|||||+|||+|+.|+++|+|+
T Consensus       255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~i---VYRDLKPeNILLDd~GhvRISDL  331 (591)
T KOG0986|consen  255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRI---VYRDLKPENILLDDHGHVRISDL  331 (591)
T ss_pred             cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcce---eeccCChhheeeccCCCeEeecc
Confidence            667889999999999999999988887789999999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+|..+..+..  ....+||.+|||||++.++.|+...|.|||||++|||+.|+.||.......                
T Consensus       332 GLAvei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv----------------  393 (591)
T KOG0986|consen  332 GLAVEIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV----------------  393 (591)
T ss_pred             ceEEecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh----------------
Confidence            99987654333  244599999999999999999999999999999999999999994332211                


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                        ..+++.+.+... ...++...+++...|.+..|++||.+|.-     +++|-+|
T Consensus       394 --k~eEvdrr~~~~-~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  394 --KREEVDRRTLED-PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             --hHHHHHHHHhcc-hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence              112222222111 23566777788999999999999999864     4566666

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=304.23  Aligned_cols=247  Identities=25%  Similarity=0.421  Sum_probs=201.6

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-HHHHHHHHHHHHHHccCCCCcceeEee-EEE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-MQASREFLAELKVLTHVHHLNLVRLIG-YCV  351 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~-~~~  351 (589)
                      |.++++||+|+||.||+|.++..+               +.+++|++. ..+.+++..|+.||++++.|++|++|| |+.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG---------------~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK   99 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESG---------------HVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFK   99 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccC---------------cEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhcc
Confidence            667899999999999999887652               244555544 345678899999999999999999998 455


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ...+|+|||||-.|+..+.++.+. +++.+.++..+++..+.||+|||...-   +|||||..|||++.+|..||+|||.
T Consensus       100 ~sDLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~K---IHRDIKAGNILLNT~G~AKLADFGV  175 (502)
T KOG0574|consen  100 HSDLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKK---IHRDIKAGNILLNTDGIAKLADFGV  175 (502)
T ss_pred             CCceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHH---HHhhcccccEEEcccchhhhhhccc
Confidence            667999999999999999998765 469999999999999999999999987   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +-.....-. ......|||.|||||++..-.|+.++||||||++..||..|+.||..-.+           ++.++-.+.
T Consensus       176 AGQLTDTMA-KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP-----------MRAIFMIPT  243 (502)
T KOG0574|consen  176 AGQLTDTMA-KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP-----------MRAIFMIPT  243 (502)
T ss_pred             cchhhhhHH-hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc-----------cceeEeccC
Confidence            875432222 23447899999999999999999999999999999999999999843221           111111110


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                               .|...-..|...+..+-+++++||-++|++|-|+-++++|
T Consensus       244 ---------~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  244 ---------KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ---------CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence                     1111123466677789999999999999999999999988

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.2e-36  Score=301.17  Aligned_cols=258  Identities=25%  Similarity=0.418  Sum_probs=194.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCC--ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGN--SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|+..+.||+|+||.||+|.+..+.+.  ..+.|.+.          +.......+++.+|++++++++||||+++++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~----------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   73 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK----------PGYTEKQRQDFLSEASIMGQFSHHNIIRLEG   73 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecc----------ccCCHHHHHHHHHHHHHHhcCCCCCeeEEEE
Confidence            35688899999999999999987654322  11111110          0112233456888999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +..|+||||+.+++|.+++.... ..+++..+..++.|++.||+|||+.++   +|+||||+||+++.++.+||+
T Consensus        74 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i---~H~dlkp~Nili~~~~~~kl~  149 (268)
T cd05063          74 VVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNY---VHRDLAARNILVNSNLECKVS  149 (268)
T ss_pred             EEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eccccchhhEEEcCCCcEEEC
Confidence            8764 56899999999999999997643 348999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCc--ccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPT--RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |||++............  ....+..|+|||++.+..++.++|||||||++|||++ |+.||.....     .   ....
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~---~~~~  221 (268)
T cd05063         150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----H---EVMK  221 (268)
T ss_pred             CCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----H---HHHH
Confidence            99998755332221111  1223457999999988889999999999999999997 9999843221     1   1111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      .+..              ......+.+.+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       222 ~i~~--------------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         222 AIND--------------GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111              000111223345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-36  Score=312.19  Aligned_cols=250  Identities=26%  Similarity=0.410  Sum_probs=189.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCV  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  351 (589)
                      +|++.+.||+|+||.||+|.+..+. ...+.|.+.     ....   ........+..|..++..+ +|++|+++++++.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~-----~~~~---~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTD-ELYAIKILK-----KDVV---IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCC-CEEEEEEEE-----HHHh---hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence            5888999999999999999887653 222222211     1110   1112234566688888777 5889999998776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          72 TMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGI---IYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---EecCCCHHHeEECCCCcEEEccCC
Confidence            4 56899999999999999987654  38899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....        ......+... 
T Consensus       147 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~-  216 (323)
T cd05616         147 MCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH-  216 (323)
T ss_pred             CceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-
Confidence            987532211 122346789999999999999999999999999999999999999953221        1111111111 


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM-----RSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  560 (589)
                                  .  ...|......+.+++.+||+.+|.+|++.     +++++|
T Consensus       217 ------------~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         217 ------------N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ------------C--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                        1  11233345578999999999999999984     677665

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1e-36  Score=313.14  Aligned_cols=245  Identities=26%  Similarity=0.398  Sum_probs=185.4

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||.||+|.+..++. .++.|.+.     ....   ......+.+..|.+++..+ +||||+++++++.+ +.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~-~~aiK~~~-----~~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   71 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGR-LYAVKVLK-----KDVI---LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRL   71 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCC-EEEEEEEE-----HHHH---hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEE
Confidence            469999999999998766532 22222211     1110   1112334566788888776 69999999997764 568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+++|+|.+++....  .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||++...
T Consensus        72 ~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~i---vH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          72 FFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             EEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            99999999999999987654  48899999999999999999999998   99999999999999999999999998753


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+....     
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~-----  212 (320)
T cd05590         147 IFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDE-----  212 (320)
T ss_pred             CcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCC-----
Confidence            2221 222346799999999999988999999999999999999999999953321        11122221110     


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM------RSIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  560 (589)
                            .    ..+......+.+++.+||+.||.+||++      ++++.|
T Consensus       213 ------~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 ------V----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             ------C----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                  0    1122234578999999999999999998      777776

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-36  Score=324.07  Aligned_cols=268  Identities=19%  Similarity=0.272  Sum_probs=192.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ...+|.+.+.||+|+||.||+|.+.....               .+++|...   ...+.+|+++|++++|+||++++++
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~---------------~vavK~~~---~~~~~~E~~iL~~L~HpnIv~l~~~  228 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQ---------------RVVVKAGW---YASSVHEARLLRRLSHPAVLALLDV  228 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCC---------------EEEEeccc---ccCHHHHHHHHHHCCCCCCCcEEEE
Confidence            35579999999999999999998876522               22222211   1235679999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.. +..++|||++. ++|.+++..... .+++.+++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus       229 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gI---vHrDLKP~NILl~~~~~vkL~D  303 (461)
T PHA03211        229 RVVGGLTCLVLPKYR-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGEGI---IHRDIKTENVLVNGPEDICLGD  303 (461)
T ss_pred             EEECCEEEEEEEccC-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCE---EECcCCHHHEEECCCCCEEEcc
Confidence            764 56899999995 689998876433 59999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCC---ChhhHHHHHH
Q 037010          429 FGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA---DSKGLVALFE  504 (589)
Q Consensus       429 fgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~---~~~~~~~~~~  504 (589)
                      ||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|..++........   ....+.....
T Consensus       304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~  383 (461)
T PHA03211        304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR  383 (461)
T ss_pred             cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence            9999865332211 12235799999999999989999999999999999999999877654322111   1112222222


Q ss_pred             HHhc----CCC-h----HHhhHhhcCCCCC--CCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLN----LPD-P----IEDLRKLVDPRLG--DNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~----~~~-~----~~~l~~~~d~~l~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ....    .+. .    ...+.........  ...+     ......+.+|+.+||+.||.+|||+.|+++|
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1110    000 0    0000000000000  0000     0122368899999999999999999999987

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-36  Score=300.17  Aligned_cols=262  Identities=24%  Similarity=0.381  Sum_probs=198.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||++....++.. .+.|.+..        .+........++.+|+++++.++||||+++++++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~-~~vK~~~~--------~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   72 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVP-VALKKVQI--------FDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI   72 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCce-EEEEeeee--------hhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE
Confidence            5788999999999999999987655322 22211100        00112233457888999999999999999999776


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                       ++..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||++++   +|+||||+||+++.++.++|+|
T Consensus        73 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dl~p~nili~~~~~~~l~d  149 (267)
T cd08229          73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV---MHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             eCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCCEEECc
Confidence             45689999999999999998642  23458999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++........ ......++..|+|||.+....++.++|+||||+++|+|++|..||......      ......... 
T Consensus       150 fg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-  221 (267)
T cd08229         150 LGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIE-  221 (267)
T ss_pred             chhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhh-
Confidence            999876543222 122356889999999998888999999999999999999999998533211      111111111 


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                               ....+   ...+...+..+.+++.+||+.+|++|||+.+|++.++++.
T Consensus       222 ---------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 ---------QCDYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ---------cCCCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                     00011   1112234557999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.8e-36  Score=304.86  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=185.3

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEEEE
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV  358 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv  358 (589)
                      ||+|+||.||++....++ ..++.|.+..+      ..+.  ......+..|++++++++||||+++++++.+ ...|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~-~~~a~K~~~~~------~~~~--~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv   71 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTG-KMYACKKLDKK------RLKK--KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLV   71 (277)
T ss_pred             CCCCCceEEEEEEEccCC-cEEEEEEEcHH------Hhhc--chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEE
Confidence            799999999999877652 33333322111      0110  1112334569999999999999999987764 568999


Q ss_pred             EEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccC
Q 037010          359 YEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG  438 (589)
Q Consensus       359 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~  438 (589)
                      |||+++++|.+++.......+++..+..++.|++.||+|||++++   +||||||+||+++.++.++|+|||++......
T Consensus        72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI---VYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE---EEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            999999999999877666668999999999999999999999998   99999999999999999999999998765322


Q ss_pred             CCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHh
Q 037010          439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRK  518 (589)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  518 (589)
                      .  ......|++.|+|||++.+..++.++|||||||++|||++|+.||.......    ........             
T Consensus       149 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~-------------  209 (277)
T cd05607         149 K--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRR-------------  209 (277)
T ss_pred             c--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHH-------------
Confidence            1  2233568999999999988889999999999999999999999984322110    00111111             


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          519 LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       519 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+...... .....+..+.+|+.+||+.||++||+++|+++++
T Consensus       210 ~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         210 TLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             hhcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            11111100 0112344689999999999999999997665443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.2e-36  Score=312.72  Aligned_cols=245  Identities=28%  Similarity=0.401  Sum_probs=186.0

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||.||+|++..++. .++.|.+..     ...   ........+..|.+++..+ +||||+++++++.+ +..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~-~~aiK~~~~-----~~~---~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~   71 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDE-VYAIKVLKK-----DVI---LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRL   71 (321)
T ss_pred             CccccCCCeEEEEEEECCCCC-EEEEEEEeH-----HHh---hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeE
Confidence            469999999999998766522 222222111     100   1122334566788888766 79999999998764 568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+++|+|.+++....  .+++..+..++.|++.||.|||++++   +||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          72 FFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGV---IYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHeEECCCCCEEEeecccceec
Confidence            99999999999999987654  48899999999999999999999998   99999999999999999999999998753


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+....     
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~-----  212 (321)
T cd05591         147 ILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDD-----  212 (321)
T ss_pred             ccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC-----
Confidence            2222 222345789999999999988999999999999999999999999953321        11122221110     


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-------SMRSIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~  560 (589)
                            .    ..|......+.+++.+||+.||++||       +++++++|
T Consensus       213 ------~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 ------V----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ------C----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                  0    11222345789999999999999999       88999887

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.7e-36  Score=302.09  Aligned_cols=273  Identities=23%  Similarity=0.388  Sum_probs=194.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEcc---ccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRG---EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .+|++.+.||+|+||.||++....   ..+...+.|.+           +.......+.+.+|++++++++||||+++++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~-----------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   72 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL-----------QHSTAEHLRDFEREIEILKSLQHDNIVKYKG   72 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEe-----------ccCCHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence            578899999999999999997532   11222221111           1112234457888999999999999999999


Q ss_pred             EEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          349 YCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       349 ~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++..   ...++||||+++++|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+||+++.++.+|
T Consensus        73 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i---~H~dlkp~nili~~~~~~~  148 (284)
T cd05081          73 VCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRY---VHRDLATRNILVESENRVK  148 (284)
T ss_pred             EEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCCHhhEEECCCCeEE
Confidence            7642   35899999999999999997543 248899999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCCC--CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          426 VADFGLTKLTEVGSASL--PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      |+|||++..........  .....++..|+|||.+.+..++.++|||||||++|||++|..++......      .....
T Consensus       149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~~~~  222 (284)
T cd05081         149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------FMRMM  222 (284)
T ss_pred             ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------hhhhc
Confidence            99999998654322111  11122345699999998888999999999999999999988765322110      00000


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ............+.+.+........+...+..+.+++.+||..+|++|||++||++.|..++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         223 GNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             ccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            00000000111111112111111122334457999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.2e-36  Score=303.48  Aligned_cols=260  Identities=27%  Similarity=0.479  Sum_probs=192.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.++||+|+||.||++.......... ...++.+      ..+.........+.+|+++++.++|+||+++++++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~-~~~~~~k------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQD-KMLVAVK------ALKEASESARQDFQREAELLTVLQHQHIVRFYGVC   76 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCC-ceEEEEE------ecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEE
Confidence            3568889999999999999997543211000 0001110      11122234456788999999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGR-------------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI  416 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NI  416 (589)
                      .+ +..+++|||+.+++|.+++.....             ..+++..++.++.|++.||+|||++++   +|+||||+||
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i---~H~dlkp~ni  153 (280)
T cd05092          77 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF---VHRDLATRNC  153 (280)
T ss_pred             ecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCe---ecccccHhhE
Confidence            75 458999999999999999976431             247889999999999999999999998   9999999999


Q ss_pred             EEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCC
Q 037010          417 LIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSA  494 (589)
Q Consensus       417 Ll~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~  494 (589)
                      |+++++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.....   
T Consensus       154 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  230 (280)
T cd05092         154 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---  230 (280)
T ss_pred             EEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---
Confidence            999999999999999875432211 11122345678999999998899999999999999999998 8888743211   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                        ..   .......          ....    ..+...+..+.+++.+||+.||++||+++||++.|+
T Consensus       231 --~~---~~~~~~~----------~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         231 --TE---AIECITQ----------GREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --HH---HHHHHHc----------CccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              01   1111100          0011    112223346899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.3e-36  Score=301.13  Aligned_cols=258  Identities=24%  Similarity=0.409  Sum_probs=195.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCC--ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGN--SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|.+..+++.  ..+.+.+.          +.......+.+.+|++++++++||||+++++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~----------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   72 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK----------AGYTEKQRRDFLSEASIMGQFDHPNIIHLEG   72 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECC----------CCCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            35788999999999999999987544321  11111110          0111233457888999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +..|+||||+++++|.+++..... .+++.++..++.|++.||+|||++++   +||||||+|||++.++.++|+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i---~h~dlkp~nili~~~~~~~l~  148 (267)
T cd05066          73 VVTKSKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILVNSNLVCKVS  148 (267)
T ss_pred             EEecCCccEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCE---eehhhchhcEEECCCCeEEeC
Confidence            8764 568999999999999999976543 48999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCC--cccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHH
Q 037010          428 DFGLTKLTEVGSASLP--TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |||++...........  ....++..|+|||.+.+..++.++|+||||+++||+++ |+.||.....     ...   ..
T Consensus       149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~---~~  220 (267)
T cd05066         149 DFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDV---IK  220 (267)
T ss_pred             CCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHH---HH
Confidence            9999886543222111  11233568999999998899999999999999999886 9999854321     111   11


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ....          ....    ..+...+..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       221 ~~~~----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         221 AIEE----------GYRL----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHhC----------CCcC----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            1111          0000    11223345789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.3e-36  Score=314.47  Aligned_cols=267  Identities=20%  Similarity=0.253  Sum_probs=190.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||++.+..++. ..+.|.+..     .    .........+.+|+.+++.++||||++++++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~-----~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   88 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGI-NVAVKKLSR-----P----FQNQTHAKRAYRELVLLKCVNHKNIISLLNV   88 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCc-eeEEEEecc-----c----ccchhHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence            45789999999999999999998765532 222221110     0    1122334567789999999999999999998


Q ss_pred             EEeC-------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVEG-------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~~-------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +...       ..|+||||+.+ +|.+.+..    .+++..+..++.|++.||+|||++++   +||||||+|||++.++
T Consensus        89 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~i---vHrDlkp~NIl~~~~~  160 (359)
T cd07876          89 FTPQKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDC  160 (359)
T ss_pred             eccCCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEECCCC
Confidence            7532       37999999976 67776643    37888999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+||+|||++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......    ......
T Consensus       161 ~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~----~~~~~~  234 (359)
T cd07876         161 TLKILDFGLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI----DQWNKV  234 (359)
T ss_pred             CEEEecCCCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence            9999999998754322  2223457899999999999899999999999999999999999999643210    111111


Q ss_pred             HHHHhcCCCh--H----HhhHhhcC--CCCC----------------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 037010          503 FEEVLNLPDP--I----EDLRKLVD--PRLG----------------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV  558 (589)
Q Consensus       503 ~~~~~~~~~~--~----~~l~~~~d--~~l~----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  558 (589)
                      . .....+..  .    ........  +...                ..........+.+|+.+||+.||++|||+.|++
T Consensus       235 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l  313 (359)
T cd07876         235 I-EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL  313 (359)
T ss_pred             H-HhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence            1 11110000  0    00000000  0000                001111234689999999999999999999999


Q ss_pred             HHH
Q 037010          559 VAL  561 (589)
Q Consensus       559 ~~L  561 (589)
                      +|-
T Consensus       314 ~hp  316 (359)
T cd07876         314 RHP  316 (359)
T ss_pred             cCc
Confidence            984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-36  Score=317.03  Aligned_cols=263  Identities=25%  Similarity=0.340  Sum_probs=199.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCC-C-----Ccc
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVH-H-----LNL  343 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~-h-----pnI  343 (589)
                      -+|++.+.||+|+||.|.+|.+..++.               .+++|.++  ..-..+...|+.+|..|+ |     -|+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e---------------~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~  250 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGE---------------IVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNI  250 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCc---------------EEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeE
Confidence            389999999999999999999888732               34444333  233456677999999986 3     389


Q ss_pred             eeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC-
Q 037010          344 VRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-  421 (589)
Q Consensus       344 v~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~-  421 (589)
                      |++++++. .+++|||+|.+.. +|.++|..+.-.+++...++.++.||+.||.+||+.+|   ||+||||+||||.+. 
T Consensus       251 Vrm~d~F~fr~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~I---IHcDLKPENILL~~~~  326 (586)
T KOG0667|consen  251 VRMLDYFYFRNHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGI---IHCDLKPENILLKDPK  326 (586)
T ss_pred             EEeeeccccccceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eeccCChhheeeccCC
Confidence            99999775 6789999999976 99999999988889999999999999999999999999   999999999999654 


Q ss_pred             -CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          422 -FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       422 -~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                       ..+||+|||.|+......    -.++.+..|+|||++.+.+|+.+.||||||||+.||++|...| ++....    ...
T Consensus       327 r~~vKVIDFGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf-pG~ne~----DQl  397 (586)
T KOG0667|consen  327 RSRIKVIDFGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF-PGDNEY----DQL  397 (586)
T ss_pred             cCceeEEecccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc-CCCCHH----HHH
Confidence             379999999998754222    2567788999999999999999999999999999999996555 433221    222


Q ss_pred             HHHHHHhcCCChH------------Hh---------------------hHh-----hcCCCCC-------CCCChHHHHH
Q 037010          501 ALFEEVLNLPDPI------------ED---------------------LRK-----LVDPRLG-------DNCPLDSVLK  535 (589)
Q Consensus       501 ~~~~~~~~~~~~~------------~~---------------------l~~-----~~d~~l~-------~~~~~~~~~~  535 (589)
                      ..+.+++..|...            +.                     .+.     ..+...+       ...+......
T Consensus       398 ~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~  477 (586)
T KOG0667|consen  398 ARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKL  477 (586)
T ss_pred             HHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHH
Confidence            2233333332211            00                     000     0010011       1111234557


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          536 MAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       536 l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      +.+++++||+.||.+|+|..|.++|-.
T Consensus       478 F~dflk~~L~~dP~~R~tp~qal~Hpf  504 (586)
T KOG0667|consen  478 FIDFLKRCLEWDPAERITPAQALNHPF  504 (586)
T ss_pred             HHHHHHHHhccCchhcCCHHHHhcCcc
Confidence            899999999999999999999999943

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3.9e-36  Score=308.03  Aligned_cols=268  Identities=24%  Similarity=0.427  Sum_probs=195.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCc-cchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNS-YLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~-~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      .++|.+.+.||+|+||.||++...+..... .-...++.+..     .+........++.+|+++++++ +||||+++++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~-----~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-----KDNATDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEec-----CCCCChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            357889999999999999999864321110 00011111111     0111223445688899999999 6999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      ++.+ +..|++|||+.+|+|.+++....              ...+++..+..++.|++.||.|||++++   +||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi---~H~dlkp  162 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRC---IHRDLAA  162 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCe---eeccccc
Confidence            8864 45899999999999999997642              1348888999999999999999999998   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~  491 (589)
                      +|||++.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.... 
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-  241 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-  241 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-
Confidence            9999999999999999999755322111 1111234567999999988899999999999999999999 787773221 


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                          ......   ....              ......+...+..+.+++.+||..+|++|||+.|+++.|.++....
T Consensus       242 ----~~~~~~---~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         242 ----VEELFK---LLRE--------------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             ----HHHHHH---HHHc--------------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence                111111   1110              0001123334457889999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-36  Score=312.96  Aligned_cols=248  Identities=24%  Similarity=0.416  Sum_probs=195.1

Q ss_pred             cceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc--CHHHHHHHHHHHHHHccCCCCcceeEeeEEEeC
Q 037010          276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFLAELKVLTHVHHLNLVRLIGYCVEG  353 (589)
Q Consensus       276 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  353 (589)
                      ...+||+|+|-+||+|.+..++      ..++.+    .+.+.++  ..+..++|..|+++|+.|+||||+++|.++.+.
T Consensus        44 ~~evLGrGafKtVYka~De~~g------iEVAWn----qvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEG------IEVAWN----QVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT  113 (632)
T ss_pred             hhhhcccccceeeeeccccccc------hhhHHH----HHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence            4577999999999999985542      122222    1222222  234568899999999999999999999977643


Q ss_pred             ---cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC-CcEEEEec
Q 037010          354 ---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHAKVADF  429 (589)
Q Consensus       354 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~-~~vkl~Df  429 (589)
                         .+-+|+|.+..|+|..|+.+..+  ++...++.|++||++||.|||++. |||||||||-+||||+.+ |.|||+|+
T Consensus       114 ~n~~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDL  190 (632)
T KOG0584|consen  114 DNKTINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDL  190 (632)
T ss_pred             CCceeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecch
Confidence               36799999999999999988765  888899999999999999999998 889999999999999764 89999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+|........   ...+|||.|||||+.. ..|+..+||||||+.|+||.|+..||..-..       -...++.+...
T Consensus       191 GLAtl~r~s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SG  259 (632)
T KOG0584|consen  191 GLATLLRKSHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSG  259 (632)
T ss_pred             hHHHHhhcccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcC
Confidence            99998754332   3379999999999987 7899999999999999999999999953322       22223333322


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .. ...+.+.-||            ++.+||.+|+.. ..+|||+.|+|.+=
T Consensus       260 iK-P~sl~kV~dP------------evr~fIekCl~~-~~~R~sa~eLL~d~  297 (632)
T KOG0584|consen  260 IK-PAALSKVKDP------------EVREFIEKCLAT-KSERLSAKELLKDP  297 (632)
T ss_pred             CC-HHHhhccCCH------------HHHHHHHHHhcC-chhccCHHHHhhCh
Confidence            11 1333333333            589999999999 99999999999884

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-36  Score=317.52  Aligned_cols=265  Identities=23%  Similarity=0.421  Sum_probs=195.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  349 (589)
                      .++|.+.++||+|+||.||+|.+++..... ..+.++.+....     .......+.+.+|+++|.++. ||||+++++.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~-~~~~vavK~l~~-----~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQ-STMKVAVKMLKS-----TARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCC-CceEEEEEecCC-----CCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            456788999999999999999976532111 111122221110     112223456888999999997 9999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCC----------------------------------------------------
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGR----------------------------------------------------  376 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------  376 (589)
                      +.. +..++||||+.+|+|.+++.....                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            865 568999999999999999965321                                                    


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          377 --------------------------------------------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       377 --------------------------------------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                                                                  ..+++..++.++.|++.||+|||+.++   +|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC---VHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCc---CcccCC
Confidence                                                        235677788999999999999999998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGN  490 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~  490 (589)
                      |+|||+++++.+||+|||+++....... .......+++.|+|||.+....++.++|||||||++|||++ |+.||....
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            9999999999999999999875432221 11122456789999999988889999999999999999998 888873221


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      .    .    .......             ........+......+.+++.+||..+|.+||+++||++.|+.+.
T Consensus       347 ~----~----~~~~~~~-------------~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         347 M----N----EQFYNAI-------------KRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             c----h----HHHHHHH-------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1    0    0111110             011111123334457999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-36  Score=301.53  Aligned_cols=265  Identities=21%  Similarity=0.344  Sum_probs=200.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||+|+||.||+|.+..++...  .+.++.+..     .+........++.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~--~~~~aik~~-----~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKV--KIPVAIKVL-----REETSPKANKEILDEAYVMASVDHPHVVRLLGIC   78 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCc--ceEEEEEec-----cCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            357889999999999999999876543221  011111111     0111233456788899999999999999999999


Q ss_pred             EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       351 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      ..+..+++|||+.+|+|.+++..... .+++..++.++.|++.||+|||++++   +|+||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i---~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          79 LSSQVQLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKRL---VHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             ecCceEEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCE---EecccCcceEEEcCCCeEEECCCc
Confidence            88889999999999999999976543 38999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCC-cccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          431 LTKLTEVGSASLP-TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       431 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ++........... ....++..|+|||.+....++.++|+||||+++||+++ |+.||.....     ....   ..+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~---~~~~~  226 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIP---DLLEK  226 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHH---HHHhC
Confidence            9986543222111 11223568999999988889999999999999999999 9998843211     1111   11110


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                                    ......+..+...+.+++.+||..+|++||++.++++.|..+....
T Consensus       227 --------------~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         227 --------------GERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             --------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence                          0001112223346889999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.3e-36  Score=297.47  Aligned_cols=252  Identities=25%  Similarity=0.455  Sum_probs=195.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      +|++.+.||+|++|.||++.+..++. ..+.|.+.         .+.......+.+.+|++++++++|+|++++++.+. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~-~~~~k~~~---------~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGK-QYVIKKLN---------LRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG   70 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCc-EEEEEEEe---------hhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC
Confidence            48899999999999999998866532 22222111         11122233456788999999999999999998765 


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       ++.+|++|||+++++|.+++.......+++.+++.++.+++.||++||+.++   +|+||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i---~H~di~p~nil~~~~~~~~l~df~  147 (257)
T cd08223          71 EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI---LHRDLKTQNVFLTRTNIIKVGDLG  147 (257)
T ss_pred             CCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCchhEEEecCCcEEEeccc
Confidence             2347899999999999999987655568999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++....... .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||....        ..........  
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~--  216 (257)
T cd08223         148 IARVLENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIE--  216 (257)
T ss_pred             ceEEecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh--
Confidence            987653322 22234568899999999998899999999999999999999999984321        1111111111  


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                 ..+ ...+...+..+.+++.+||+.+|++||++.++++|
T Consensus       217 -----------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         217 -----------GKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             -----------cCC-CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                       000 11223444578999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.5e-36  Score=302.32  Aligned_cols=261  Identities=25%  Similarity=0.437  Sum_probs=194.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||++.+....... ..+.++.+...     ..........+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~-~~~~~aik~~~-----~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGE-PETRVAIKTVN-----ENASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCC-cceeEEEEecC-----CccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence            467899999999999999999876542100 01111111110     011223345678899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSG--------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      .+ +..|+||||+.+|+|.+++....        ...+++..++.++.|++.||.|||+.++   +||||||+|||++.+
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~di~p~nill~~~  155 (277)
T cd05032          79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKF---VHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCc---cccccChheEEEcCC
Confidence            64 46899999999999999997532        1236788999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhH
Q 037010          422 FHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~  499 (589)
                      +.+||+|||+++....... .......++..|+|||.+..+.++.++|||||||++|||+| |+.||.....     ...
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----~~~  230 (277)
T cd05032         156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEV  230 (277)
T ss_pred             CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----HHH
Confidence            9999999999875433221 12223456789999999988889999999999999999998 8888743211     111


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                         ......             .. ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       231 ---~~~~~~-------------~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         231 ---LKFVID-------------GG-HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ---HHHHhc-------------CC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence               111110             00 01123333567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=283.84  Aligned_cols=255  Identities=20%  Similarity=0.260  Sum_probs=202.1

Q ss_pred             hcCCCccc-eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEe
Q 037010          270 ATDNFSMS-HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  347 (589)
                      .+++|.+. ++||-|-.|.|-.|.++.+               .+++++|.+..  .....+|+++--.. .|||||.++
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T---------------~ekfALKvL~D--s~KARrEVeLHw~~s~h~~iV~Ii  121 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRT---------------QEKFALKVLLD--SPKARREVELHWMASGHPHIVSII  121 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccc---------------hhhhHHHHHhc--CHHHHhHhhhhhhhcCCCceEEee
Confidence            46777764 6799999999999988776               34667776543  23456688775444 699999999


Q ss_pred             eEEEe---C--cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC--
Q 037010          348 GYCVE---G--SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK--  420 (589)
Q Consensus       348 ~~~~~---~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~--  420 (589)
                      +++.+   +  .+.+|||.|+||.|++.|++++...+++.++.+|+.||+.|+.|||+.+|   .||||||+|+|...  
T Consensus       122 dVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nI---AHRDlKpENLLyt~t~  198 (400)
T KOG0604|consen  122 DVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNI---AHRDLKPENLLYTTTS  198 (400)
T ss_pred             hhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcch---hhccCChhheeeecCC
Confidence            97753   2  37799999999999999999999999999999999999999999999999   99999999999964  


Q ss_pred             -CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          421 -NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       421 -~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                       +..+||+|||+|+.....  ......+.||.|.|||++....|+...|+||+||++|-||+|..||....+........
T Consensus       199 ~na~lKLtDfGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk  276 (400)
T KOG0604|consen  199 PNAPLKLTDFGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK  276 (400)
T ss_pred             CCcceEecccccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH
Confidence             457999999999865432  22345688999999999999999999999999999999999999997766543332222


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ......-...               +..--.+.++...++++.+|..+|.+|.|++|++.|-
T Consensus       277 ~rI~~gqy~F---------------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  277 RRIRTGQYEF---------------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             hHhhccCccC---------------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            2221111111               1122235667889999999999999999999999883

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.3e-36  Score=303.18  Aligned_cols=262  Identities=24%  Similarity=0.380  Sum_probs=199.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEcccc---CCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEY---GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~---~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      ..++|++.+.||+|+||.||+|.+..+.   +...+.|.     .     ...........+.+|+.++++++||||+++
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~-----~-----~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~   73 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKT-----V-----KDHASEIQVTLLLQESCLLYGLSHQNILPI   73 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEE-----c-----cCCCCHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3578999999999999999999987632   11111111     1     112233445678889999999999999999


Q ss_pred             eeEEEe--CcEEEEEEecCCCChHHHHhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE
Q 037010          347 IGYCVE--GSLFLVYEYIENGNLSEHLRGSGR------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI  418 (589)
Q Consensus       347 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl  418 (589)
                      ++++.+  ...++++||+.+++|.+++.....      ..+++..++.++.|++.||+|||++++   +|+||||+||++
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i---~H~di~p~nil~  150 (280)
T cd05043          74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGV---IHKDIAARNCVI  150 (280)
T ss_pred             EEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCE---eecccCHhhEEE
Confidence            998765  458999999999999999975422      458899999999999999999999998   999999999999


Q ss_pred             cCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCCh
Q 037010          419 DKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADS  496 (589)
Q Consensus       419 ~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~  496 (589)
                      ++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++||+++ |+.||.....     
T Consensus       151 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----  225 (280)
T cd05043         151 DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----  225 (280)
T ss_pred             cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----
Confidence            99999999999999754322211 1122345678999999988889999999999999999999 9998843211     


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      ......   ...          ....    ..+..++..+.+++.+||..+|++|||+.++++.|..+..
T Consensus       226 ~~~~~~---~~~----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         226 FEMAAY---LKD----------GYRL----AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHHHH---HHc----------CCCC----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            111111   110          0011    1112234468999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4e-36  Score=303.61  Aligned_cols=256  Identities=25%  Similarity=0.336  Sum_probs=193.2

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      .|+..+.||+|+||.||++.+..++. .++.|.+..     . .  .........+.+|+.++++++|++|+++++.+. 
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~-~~avK~~~~-----~-~--~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGK-MYACKKLEK-----K-R--IKKRKGESMALNEKQILEKVNSRFVVSLAYAYET   71 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCc-eEEEEEEeh-----h-h--ccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence            37788999999999999999877632 222221110     0 0  011122345678999999999999999998775 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ++..|+||||+.+++|.+++.......+++..++.++.|++.||.|||++++   +||||||+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i---iH~dikp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05630          72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI---VYRDLKPENILLDDHGHIRISDLGL  148 (285)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE---EeCCCCHHHEEECCCCCEEEeeccc
Confidence            4568999999999999999976655569999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +.......  ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......     ..........   
T Consensus       149 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~---  218 (285)
T cd05630         149 AVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVK---  218 (285)
T ss_pred             eeecCCCc--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhh---
Confidence            87543222  1123478999999999998899999999999999999999999995432211     0001111100   


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVAL  561 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L  561 (589)
                             ....    ..+......+.+|+.+||+.||++|||     ++|+++|-
T Consensus       219 -------~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~  262 (285)
T cd05630         219 -------EVQE----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHP  262 (285)
T ss_pred             -------hhhh----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence                   0001    112223346899999999999999999     88999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.9e-36  Score=306.50  Aligned_cols=266  Identities=20%  Similarity=0.359  Sum_probs=199.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|+..+.||+|+||.||++.+..++...  ...++.+..     .+........++.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~--~~~vaiK~~-----~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~   78 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETV--KIPVAIKIL-----NETTGPKANVEFMDEALIMASMDHPHLVRLLGVC   78 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcc--eeeEEEEec-----cccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            356888999999999999999876553321  011111111     0111222334678899999999999999999998


Q ss_pred             EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       351 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      .....++++||+++|+|.+++..... .+++..++.++.|++.||.|||++++   +|+||||+||+++.++.+||+|||
T Consensus        79 ~~~~~~~v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~~i---vH~dikp~Nill~~~~~~kL~Dfg  154 (303)
T cd05110          79 LSPTIQLVTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEERRL---VHRDLAARNVLVKSPNHVKITDFG  154 (303)
T ss_pred             cCCCceeeehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhcCe---eccccccceeeecCCCceEEcccc
Confidence            87778899999999999999876543 48899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          431 LTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       431 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ++......... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||....     ........    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~----~  225 (303)
T cd05110         155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLL----E  225 (303)
T ss_pred             ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH----H
Confidence            99865432221 1122345778999999988899999999999999999997 888874321     11111111    1


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      ..             .....+..+...+.+++..||..+|++||+++++++.|..+.....
T Consensus       226 ~~-------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         226 KG-------------ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             CC-------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            00             0001112233468999999999999999999999999998865543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.4e-36  Score=311.65  Aligned_cols=245  Identities=25%  Similarity=0.395  Sum_probs=183.0

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||.||+|.+..++. ..+.|.+..     ....   ..........|..++... +||||+++++++.+ +.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~-~~avK~~~~-----~~~~---~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~   71 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGE-YFAVKALKK-----DVVL---IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCC-EEEEEEEEH-----HHhh---hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEE
Confidence            469999999999999876532 222222211     1100   111233456677777654 89999999997764 568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+.+|+|.+++....  .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          72 FFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGI---IYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            99999999999999987653  48899999999999999999999998   99999999999999999999999998743


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .   .....+..       
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~---~~~~~~~~-------  210 (316)
T cd05620         147 VFGD-NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----D---ELFESIRV-------  210 (316)
T ss_pred             ccCC-CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----H---HHHHHHHh-------
Confidence            2211 122346799999999999999999999999999999999999999953221     1   11111111       


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR-SIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  560 (589)
                          ..+.+    +......+.+++.+||+.||.+||++. ++++|
T Consensus       211 ----~~~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         211 ----DTPHY----PRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             ----CCCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                01111    222345688999999999999999984 67655

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.6e-36  Score=305.11  Aligned_cols=267  Identities=24%  Similarity=0.329  Sum_probs=187.9

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHcc---CCCCcceeEeeE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH---VHHLNLVRLIGY  349 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~---l~hpnIv~l~~~  349 (589)
                      +|++.+.||+|+||.||+|.+..++. ..+.|.+...         .........+.+|++++++   ++||||++++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~-~~aiK~~~~~---------~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~   70 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGH-FVALKSVRVQ---------TNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV   70 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCc-EEEEEEeccC---------cCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeee
Confidence            58899999999999999999876532 2222221110         0001111223446665554   479999999997


Q ss_pred             EEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          350 CVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       350 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      +..      ...+++||++.+ +|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.++.
T Consensus        71 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dikp~Nili~~~~~  146 (288)
T cd07863          71 CATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGQ  146 (288)
T ss_pred             eccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCCCC
Confidence            753      237899999985 89999887655568999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +||+|||++......  .......||..|+|||++.+..++.++|||||||++|+|++|+.||.....    ........
T Consensus       147 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~----~~~~~~~~  220 (288)
T cd07863         147 VKLADFGLARIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE----ADQLGKIF  220 (288)
T ss_pred             EEECccCccccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH----HHHHHHHH
Confidence            999999998765322  122345689999999999888999999999999999999999998843321    11111111


Q ss_pred             HHHhcCCChHHhhH------hhcCCCC---CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          504 EEVLNLPDPIEDLR------KLVDPRL---GDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       504 ~~~~~~~~~~~~l~------~~~d~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                       .....+.......      ....+..   .....++....+.+++.+||+.||++|||+.|++.|
T Consensus       221 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         221 -DLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             -HHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence             1111111100000      0000000   001112344578999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.9e-36  Score=300.12  Aligned_cols=257  Identities=24%  Similarity=0.413  Sum_probs=193.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCC--ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGN--SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      .+|++.+.||+|+||.||+|.+..+...  .++.|...          +........++..|++++++++||||++++++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~----------~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~   73 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK----------SGYTEKQRRDFLSEASIMGQFDHPNIIHLEGV   73 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcC----------CCCCHHHHHHHHHHHHHHHhCCCcCcceEEEE
Confidence            4578899999999999999998765332  11211110          11223445678899999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..++||||+.+++|.+++..... .+++.+++.++.|++.||+|||++++   +|+||||+||+++.++.+||+|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~l~~al~~lH~~g~---~H~dl~p~nili~~~~~~kl~d  149 (269)
T cd05065          74 VTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSD  149 (269)
T ss_pred             ECCCCceEEEEecCCCCcHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCE---eecccChheEEEcCCCcEEECC
Confidence            764 458999999999999999976543 48999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCC--Ccccc--cCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHH
Q 037010          429 FGLTKLTEVGSASL--PTRLV--GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       429 fgla~~~~~~~~~~--~~~~~--gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      ||++..........  .....  .+..|+|||.+....++.++|||||||++|||++ |..||.....     .   ...
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~---~~~  221 (269)
T cd05065         150 FGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----Q---DVI  221 (269)
T ss_pred             CccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----H---HHH
Confidence            99987543322111  11111  2457999999998899999999999999999986 9988843321     1   111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ..+..          ...    ...+.+.+..+.+++.+||..+|.+||++++++..|..+
T Consensus       222 ~~i~~----------~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         222 NAIEQ----------DYR----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHc----------CCc----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11110          000    011223345689999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-36  Score=299.74  Aligned_cols=251  Identities=31%  Similarity=0.500  Sum_probs=187.0

Q ss_pred             eeeccCCcEEEEEEEEccccCCcc-chhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEEe-Cc
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSY-LSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVE-GS  354 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~-~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~  354 (589)
                      +.||+|+||.||+|.+.+++.... +.+..          .+.......+.+.+|++++.++ +||||+++++++.. +.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~----------~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   70 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM----------KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   70 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEc----------cccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC
Confidence            468999999999998866532211 11100          0011223445688899999999 79999999998864 45


Q ss_pred             EEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          355 LFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       355 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      .|++|||+++|+|.+++....              ...+++..++.++.|++.||+|||++++   +|+||||+|||+++
T Consensus        71 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i---~H~dikp~nili~~  147 (270)
T cd05047          71 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGE  147 (270)
T ss_pred             ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCE---eecccccceEEEcC
Confidence            899999999999999997542              1247889999999999999999999998   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~  499 (589)
                      ++.+||+|||++.......  .......+..|+|||++....++.++|||||||++|||++ |..||.....        
T Consensus       148 ~~~~kl~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------  217 (270)
T cd05047         148 NYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------  217 (270)
T ss_pred             CCeEEECCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------
Confidence            9999999999985322111  1111233567999999988889999999999999999997 9998843211        


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      .........              ......+......+.+++.+||..+|.+|||+.+++..|.++.
T Consensus       218 ~~~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         218 AELYEKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHHHhC--------------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            111111110              0001112223446899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.9e-36  Score=297.58  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=193.4

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      +|++.+.||+|+||.||++.+..+.. .++.|.+..          .......+.+.+|+.++++++|+||+++++.+. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~-~~~iK~~~~----------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   69 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQ-KYAMKEIRL----------PKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA   69 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCc-eEEEEEEEc----------CcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE
Confidence            58889999999999999998776532 222222110          011223456778999999999999999998776 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ++.+|++|||+++++|.+++.......+++..++.++.|++.||.|||++++   +|+||||+||++++++.++|+|||.
T Consensus        70 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i---~H~dl~p~nili~~~~~~~l~dfg~  146 (255)
T cd08219          70 DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV---LHRDIKSKNIFLTQNGKVKLGDFGS  146 (255)
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCc---ccCCCCcceEEECCCCcEEEcccCc
Confidence            4568999999999999999876555568999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +....... .......|++.|+|||++.+..++.++|+||||+++|+|++|+.||.....     ..   .......   
T Consensus       147 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~---~~~~~~~---  214 (255)
T cd08219         147 ARLLTSPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KN---LILKVCQ---  214 (255)
T ss_pred             ceeecccc-cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HH---HHHHHhc---
Confidence            87553221 122335688999999999888899999999999999999999999853211     11   1111110   


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                .. ....+...+..+.+++.+||+.||++|||+.+++..
T Consensus       215 ----------~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         215 ----------GS-YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----------CC-CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                      00 011223344568999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=9.1e-36  Score=321.80  Aligned_cols=280  Identities=21%  Similarity=0.267  Sum_probs=190.3

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-----
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-----  339 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-----  339 (589)
                      +++....++|++.++||+|+||+||+|.+..... .++.|.+.     .       ......+...|++++++++     
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~-~vAvK~i~-----~-------~~~~~~~~~~e~~~l~~l~~~~~~  188 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKE-YCAVKIVR-----N-------VPKYTRDAKIEIQFMEKVRQADPA  188 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCe-EEEEEEEe-----c-------chhhHHHHHHHHHHHHHHhhcCcc
Confidence            3444557899999999999999999998765422 22222110     0       0111223344555555554     


Q ss_pred             -CCcceeEeeEEEe--CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCc
Q 037010          340 -HLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSAN  415 (589)
Q Consensus       340 -hpnIv~l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~N  415 (589)
                       |.+++++++++..  +..|+|||++ +++|.+++....  .+++..+..++.||+.||+|||+ .++   +||||||+|
T Consensus       189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gI---iHrDlKP~N  262 (467)
T PTZ00284        189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHL---MHTDLKPEN  262 (467)
T ss_pred             cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCe---ecCCCCHHH
Confidence             5568888888764  3588999988 679999987653  48999999999999999999998 588   999999999


Q ss_pred             EEEcCCC----------------cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHH
Q 037010          416 ILIDKNF----------------HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL  479 (589)
Q Consensus       416 ILl~~~~----------------~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~el  479 (589)
                      ||++.++                .+||+|||.+....    .......||+.|+|||++.+..++.++|||||||++|||
T Consensus       263 ILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el  338 (467)
T PTZ00284        263 ILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL  338 (467)
T ss_pred             EEEecCCcccccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence            9998665                49999999876432    122346899999999999999999999999999999999


Q ss_pred             HcCCcccccCCCCCCChhhHHHHHHHHhcCCCh-------HHhhHhhcC------CCCC--------CCC---ChHHHHH
Q 037010          480 ISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP-------IEDLRKLVD------PRLG--------DNC---PLDSVLK  535 (589)
Q Consensus       480 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~~~d------~~l~--------~~~---~~~~~~~  535 (589)
                      ++|+.||.....     ......+...+.....       .++...+.+      +...        ...   .......
T Consensus       339 ltG~~pf~~~~~-----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  413 (467)
T PTZ00284        339 YTGKLLYDTHDN-----LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL  413 (467)
T ss_pred             HhCCCCCCCCCh-----HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHH
Confidence            999999954321     1222222222111000       000000000      0000        000   0011346


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhccccccccc
Q 037010          536 MAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWD  572 (589)
Q Consensus       536 l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~  572 (589)
                      +.+|+.+||+.||++|||++|+++|-.-.....+..+
T Consensus       414 ~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~  450 (467)
T PTZ00284        414 LCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQ  450 (467)
T ss_pred             HHHHHHHhCCcChhhCCCHHHHhcCccccccCCcccc
Confidence            7899999999999999999999998554443333333

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.4e-36  Score=308.71  Aligned_cols=245  Identities=27%  Similarity=0.422  Sum_probs=182.7

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHcc-CCCCcceeEeeEEE-eCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH-VHHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~-~~~~  355 (589)
                      +.||+|+||.||+|.+.++.. .++.|.+..     ...   ......+.+..|.+++.. .+||||+++++++. ++..
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~-~vaiK~~~~-----~~~---~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~   71 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNE-FFAIKALKK-----DVV---LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHL   71 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCC-EEEEEEEEH-----HHh---hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999999876532 222222111     110   011223344556677664 48999999998776 4568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+++|+|.+++....  .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~i---vH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          72 FFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGI---IYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---EeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            99999999999999997654  48999999999999999999999998   99999999999999999999999998754


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+...      
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~------  211 (316)
T cd05592         147 MNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILND------  211 (316)
T ss_pred             CCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC------
Confidence            3222 223346799999999999988999999999999999999999999953221        1111111110      


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR-SIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  560 (589)
                           .+    ..+......+.+++.+||+.||.+||++. ++++|
T Consensus       212 -----~~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         212 -----RP----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             -----CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                 11    12233445688999999999999999875 66555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=314.35  Aligned_cols=252  Identities=23%  Similarity=0.405  Sum_probs=198.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee-E
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG-Y  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~  349 (589)
                      .+.|+++..||.|+||.||+|..+.+ +           .+.....+.....+..++++-|++||..+.||+||++++ |
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket-~-----------~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ay   98 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKET-K-----------LLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAY   98 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccc-h-----------hhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHH
Confidence            35577888999999999999987644 1           111122233334566788999999999999999999997 7


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +.++.+||+.|||.||.....+...++ ++.+.++..+++|++.||.|||+++|   ||||||..|||++-+|.++|+||
T Consensus        99 y~enkLwiliEFC~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~~i---IHRDLKAGNiL~TldGdirLADF  174 (1187)
T KOG0579|consen   99 YFENKLWILIEFCGGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQNI---IHRDLKAGNILLTLDGDIRLADF  174 (1187)
T ss_pred             hccCceEEEEeecCCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhcch---hhhhccccceEEEecCcEeeecc
Confidence            789999999999999999988877654 59999999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |.+.... ........+.|||+|||||+..     ..+|+.++||||||++|.||..+.+|-+.-+.           + 
T Consensus       175 GVSAKn~-~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-----------M-  241 (1187)
T KOG0579|consen  175 GVSAKNK-STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-----------M-  241 (1187)
T ss_pred             cccccch-hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-----------H-
Confidence            9876432 1223345589999999999874     45899999999999999999999988633211           1 


Q ss_pred             HHhcCCChHHhhHhhcCCCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLG-DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                               ..+.++.....+ ---|......+.+++++||.+||..||++.++++|
T Consensus       242 ---------RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  242 ---------RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ---------HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                     111111111111 11233455679999999999999999999999988

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.5e-36  Score=302.98  Aligned_cols=271  Identities=21%  Similarity=0.388  Sum_probs=194.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..|++.+.||+|+||.||++.........  .+         .+++|..    .......+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~--~~---------~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   72 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNT--GE---------QVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK   72 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCc--cc---------eEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeee
Confidence            34788999999999999999764211100  11         1222221    233345688999999999999999999


Q ss_pred             eEEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          348 GYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       348 ~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      +++.+   ...++||||+++++|.+++..... .+++..+..++.|++.||+|||++++   +||||||+||+++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~i~~~i~~aL~~lH~~gi---~H~dlkp~Nil~~~~~~~  148 (284)
T cd05079          73 GICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN-KINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQV  148 (284)
T ss_pred             eEEecCCCCceEEEEEccCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCe---eecccchheEEEcCCCCE
Confidence            98864   348899999999999999976532 48999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          425 KVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +|+|||++.........  ......++..|+|||.+.+..++.++|||||||++|||+|++.|........      ...
T Consensus       149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~------~~~  222 (284)
T cd05079         149 KIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF------LKM  222 (284)
T ss_pred             EECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh------hhh
Confidence            99999998865432211  1123456778999999988889999999999999999999876643221100      000


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ...... ..........+........+...+..+.+|+.+||+.+|++|||++++++.|+.+
T Consensus       223 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         223 IGPTHG-QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccccc-cccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            000000 0000011111111111112233456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-37  Score=305.30  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=205.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..-|.+.+.||+|.|+.|.+|++--++.+.. .|++         ...+++.-....+.+|++.|+-++|||||++|++.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVA-VKvi---------DKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi   86 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVA-VKVI---------DKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI   86 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeE-EEEe---------cccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh
Confidence            4568888999999999999997654432221 1111         11123333456688899999999999999999987


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE-cCCCcEEEEe
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI-DKNFHAKVAD  428 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl-~~~~~vkl~D  428 (589)
                      . +-.+|||+|+-++|+|++||-.... .+.+....++++||+.|+.|+|+..+   |||||||+|+.+ .+-|-|||+|
T Consensus        87 DTQTKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHV---VHRDLKPENVVFFEKlGlVKLTD  162 (864)
T KOG4717|consen   87 DTQTKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHV---VHRDLKPENVVFFEKLGLVKLTD  162 (864)
T ss_pred             cccceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhh---hcccCCcceeEEeeecCceEeee
Confidence            6 4569999999999999999987654 49999999999999999999999998   999999999876 6678999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCC-cccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++..+..+.  ..+..+|+..|-|||++.+..|+ +++|||||||+||.|.+|+.||...+++               
T Consensus       163 FGFSNkf~PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------  225 (864)
T KOG4717|consen  163 FGFSNKFQPGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------  225 (864)
T ss_pred             ccccccCCCcc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------
Confidence            99998776543  34668999999999999999887 5899999999999999999999766543               


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                            +.+..++|=.+  ..|.....++.+||..||..||++|.|.+||..+
T Consensus       226 ------ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  226 ------ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ------hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                  23444555433  5677788899999999999999999999999876

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-36  Score=317.09  Aligned_cols=268  Identities=20%  Similarity=0.302  Sum_probs=193.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||+|+||.||+|...+.....             ++++|.....  ....+|+++|++++||||+++++++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~-------------~v~vK~~~~~--~~~~~E~~il~~l~h~~iv~~~~~~  155 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRK-------------KVIVKAVTGG--KTPGREIDILKTISHRAIINLIHAY  155 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccce-------------eEEEEecccc--ccHHHHHHHHHhcCCCCccceeeeE
Confidence            468999999999999999999765432111             1222222211  2345799999999999999999877


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..|++||++. ++|.+++...  ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.++|+||
T Consensus       156 ~~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~gi---vHrDlkp~Nill~~~~~~~l~Df  229 (392)
T PHA03207        156 RWKSTVCMVMPKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGI---IHRDVKTENIFLDEPENAVLGDF  229 (392)
T ss_pred             eeCCEEEEEehhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEEcCCCCEEEccC
Confidence            6 456899999996 5899998543  348999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++......... ......||+.|+|||++....++.++|||||||++|||++|+.||....... ....+.........
T Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~  308 (392)
T PHA03207        230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQV  308 (392)
T ss_pred             ccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhcc
Confidence            998755433221 2234679999999999998999999999999999999999999996544322 11111111111100


Q ss_pred             C----CC-----hHHhhHhhcCCCCCCC--CC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 L----PD-----PIEDLRKLVDPRLGDN--CP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~----~~-----~~~~l~~~~d~~l~~~--~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .    +.     ....+.... ......  .+     ......+.+++.+||..||++|||+.|++.|-
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        309 HPLEFPQNGSTNLCKHFKQYA-IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             CccccCCccchhHHHHHHhhc-ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            0    00     000111110 000000  00     11234688999999999999999999999984

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.5e-35  Score=295.88  Aligned_cols=261  Identities=24%  Similarity=0.395  Sum_probs=199.2

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|....++. ..+.|.+..        .+.......+.+.+|++++++++|+|++++++++.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-~~~ik~~~~--------~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~   72 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGR-VVALKKVQI--------FEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI   72 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCC-EEEEEEeec--------ccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence            579999999999999999998874422 222221100        01112233466888999999999999999999776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      + +..+++|||+++++|.+++...  ....+++.+++.++.+++.||.|||++++   +|+||||+||+++.++.++|+|
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i---~h~dl~p~nil~~~~~~~~l~d  149 (267)
T cd08224          73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI---MHRDIKPANVFITATGVVKLGD  149 (267)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCE---ecCCcChhhEEECCCCcEEEec
Confidence            4 5689999999999999998653  23458899999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++......... .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.....      ...........
T Consensus       150 ~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~  222 (267)
T cd08224         150 LGLGRFFSSKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEK  222 (267)
T ss_pred             cceeeeccCCCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhc
Confidence            9998754332221 2235688899999999888899999999999999999999999854321      11111111110


Q ss_pred             CCChHHhhHhhcCCCCCCCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPL-DSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                                    ......+. ..+..+.+++.+||..+|++|||+.+|++.|..+.
T Consensus       223 --------------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 --------------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --------------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                          00011122 34457899999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.7e-36  Score=305.04  Aligned_cols=277  Identities=23%  Similarity=0.359  Sum_probs=198.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||++.+..++ ...+.+.+.          .........++.+|++++++++||||+++++.+.
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~-~~~a~k~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   69 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSG-LIMARKLIH----------LEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY   69 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCC-eEEEEEEec----------cccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            46899999999999999999876653 222222111          1112334456888999999999999999999776


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                       ++.+|+||||+++++|.+++....  .+++..+..++.|++.||.|||+ +++   +|+||||+|||++.++.+||+||
T Consensus        70 ~~~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i---~H~dl~p~nil~~~~~~~~l~df  144 (308)
T cd06615          70 SDGEISICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDF  144 (308)
T ss_pred             eCCEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCE---EECCCChHHEEEecCCcEEEccC
Confidence             567999999999999999997653  48899999999999999999998 577   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++......   ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......     .....+......
T Consensus       145 g~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~  216 (308)
T cd06615         145 GVSGQLIDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSE  216 (308)
T ss_pred             CCccccccc---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCcccc
Confidence            988654221   123357889999999998888999999999999999999999998533211     111111000000


Q ss_pred             -CC-------------------hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          510 -PD-------------------PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       510 -~~-------------------~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                       ..                   ..+..........+..........+.+++.+||..+|++|||++++++|..-.....+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  296 (308)
T cd06615         217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE  296 (308)
T ss_pred             ccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence             00                   0000011111100000011234568999999999999999999999999665443333


Q ss_pred             ccc
Q 037010          570 DWD  572 (589)
Q Consensus       570 ~~~  572 (589)
                      +++
T Consensus       297 ~~~  299 (308)
T cd06615         297 EVD  299 (308)
T ss_pred             cch
Confidence            333

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-36  Score=312.39  Aligned_cols=245  Identities=23%  Similarity=0.350  Sum_probs=185.1

Q ss_pred             eeeccCCcEEEEEEEEcc--ccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCc
Q 037010          278 HKIGQGGFGAVYYAELRG--EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGS  354 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~  354 (589)
                      +.||+|+||.||++....  ..+..++.|.+..     .    .........+.+|++++++++||||+++++++. ++.
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-----~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   72 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKK-----A----TLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK   72 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEH-----H----HhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE
Confidence            679999999999997642  2233333322211     0    011122345677999999999999999999776 456


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       355 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .|+||||+.+|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||++..
T Consensus        73 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  147 (318)
T cd05582          73 LYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSKE  147 (318)
T ss_pred             EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence            899999999999999997643  48999999999999999999999998   9999999999999999999999999875


Q ss_pred             cccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHH
Q 037010          435 TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE  514 (589)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (589)
                      ..... .......|++.|+|||.+....++.++|||||||++|||++|+.||.....        ......+..      
T Consensus       148 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~------  212 (318)
T cd05582         148 SIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILK------  212 (318)
T ss_pred             cCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHc------
Confidence            43221 122345789999999999888899999999999999999999999853221        111111111      


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                             ..  ...+...+..+.+++.+||+.||++||+     +++++.|
T Consensus       213 -------~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         213 -------AK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             -------CC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence                   11  1123334457899999999999999999     4556554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.4e-36  Score=310.19  Aligned_cols=245  Identities=28%  Similarity=0.455  Sum_probs=186.0

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEE-eCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~-~~~~  355 (589)
                      +.||+|+||.||+|.+..+.. .++.|.+.     ....   ........+..|.+++..+ +||||+++++++. .+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~-~~aiK~~~-----~~~~---~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~   71 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDE-LYAVKVLK-----KDVI---LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRL   71 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCC-EEEEEEEE-----HHHH---hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEE
Confidence            469999999999998876532 22222211     1100   1112334566788888877 6999999999776 4568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+++|+|.+++....  .+++..+..++.|++.||.|||++++   +||||||+|||+++++.+||+|||++...
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i---vH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          72 FFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGI---IYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EccCCCHHHeEECCCCcEEecccCCCeec
Confidence            99999999999999987654  48999999999999999999999998   99999999999999999999999998643


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      .... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.....        ..........      
T Consensus       147 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~~------  211 (318)
T cd05570         147 ILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILED------  211 (318)
T ss_pred             CcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcC------
Confidence            2211 122335689999999999999999999999999999999999999943221        1111111110      


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM-----RSIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  560 (589)
                           ..    ..+...+..+.+|+.+||+.||.+|||+     .++++|
T Consensus       212 -----~~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         212 -----EV----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -----CC----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                 01    1222344578999999999999999999     888876

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-36  Score=310.27  Aligned_cols=245  Identities=25%  Similarity=0.402  Sum_probs=182.9

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHcc-CCCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH-VHHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||.||+|.+..++. .++.|.+..     ....   ..........|..++.. ++||||+++++++.+ +.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~-~vaiK~~~~-----~~~~---~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~   71 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQ-FFAIKALKK-----DVVL---MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENL   71 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCC-EEEEEEEEH-----HHhh---hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEE
Confidence            469999999999999876532 222222211     1100   01123345567777775 489999999998764 568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+++|+|.+++....  .+++.++..++.|++.||+|||++++   +||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~i---vHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          72 FFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGI---VYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            99999999999999997643  48899999999999999999999998   99999999999999999999999998743


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .   .....+..       
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~---~~~~~i~~-------  210 (316)
T cd05619         147 MLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----E---ELFQSIRM-------  210 (316)
T ss_pred             CCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----H---HHHHHHHh-------
Confidence            2211 122345789999999999988999999999999999999999999953221     1   11111110       


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR-SIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  560 (589)
                          ..+.    .+......+.+++.+||+.||++||++. ++++|
T Consensus       211 ----~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         211 ----DNPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             ----CCCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence                1111    1222345688999999999999999997 67665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.6e-36  Score=301.44  Aligned_cols=253  Identities=22%  Similarity=0.362  Sum_probs=191.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..+.|++.+.||+|+||.||+|.+..+.. ..+.|...            .......++.+|+++++++ +|+||+++++
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~-~~aik~~~------------~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   70 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQ-LAAIKVMD------------VTGDEEEEIKQEINMLKKYSHHRNIATYYG   70 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCc-EEEEEEEE------------cCCccHHHHHHHHHHHHHhcCCCCeeeEee
Confidence            45678899999999999999998766532 21111110            0111234577899999998 6999999999


Q ss_pred             EEEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          349 YCVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       349 ~~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      ++.+       ...|++|||+.+++|.+++.......+++..+..++.|++.||+|||++++   +|+||||+||+++++
T Consensus        71 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i---vh~dl~~~nili~~~  147 (272)
T cd06637          71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTEN  147 (272)
T ss_pred             EEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCCHHHEEECCC
Confidence            8753       347899999999999999987655568999999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      +.++|+|||++........ ......|++.|+|||++.     ...++.++|||||||++|||++|+.||.....     
T Consensus       148 ~~~~l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-----  221 (272)
T cd06637         148 AEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-----  221 (272)
T ss_pred             CCEEEccCCCceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-----
Confidence            9999999999875432221 223457899999999885     34688899999999999999999999843211     


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                        ..... ....          ...+   ...+...+..+.+|+.+||..+|.+|||+.++++|
T Consensus       222 --~~~~~-~~~~----------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         222 --MRALF-LIPR----------NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             --HHHHH-HHhc----------CCCC---CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence              00000 0000          0000   11112233468999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.1e-36  Score=309.16  Aligned_cols=245  Identities=27%  Similarity=0.392  Sum_probs=182.3

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHH-HHccCCCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK-VLTHVHHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||+||+|.+..++. ..+.|.+..     ...   .......++..|.. +++.++||||+++++.+.+ +..
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~~-----~~~---~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~   71 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGK-FYAVKVLQK-----KAI---LKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKL   71 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCC-EEEEEEEEH-----HHH---hhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEE
Confidence            469999999999999866532 222222211     100   01112234445554 5678999999999987764 568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+.+|+|.+++....  .+++..+..++.||+.||+|||++++   +||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~gi---vH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          72 YFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNI---IYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             EEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            99999999999999997654  48899999999999999999999998   99999999999999999999999998753


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....        .......+....     
T Consensus       147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-----  212 (323)
T cd05575         147 IEH-SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKP-----  212 (323)
T ss_pred             ccC-CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCC-----
Confidence            221 222334579999999999999999999999999999999999999995432        111222222111     


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM----RSIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~  560 (589)
                              .  ..+...+..+.+++.+||+.||.+||++    +++++|
T Consensus       213 --------~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         213 --------L--RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             --------C--CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence                    0  1122334578999999999999999998    466654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.8e-36  Score=333.69  Aligned_cols=271  Identities=23%  Similarity=0.355  Sum_probs=199.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.++||+|+||.||+|.+..++.. .+.|.+..     ..   .......+++.+|++++++++||||+++++++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~-VAIK~I~~-----~l---~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~   72 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRR-VALKKIRE-----DL---SENPLLKKRFLREAKIAADLIHPGIVPVYSICS   72 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcE-EEEEEECc-----cc---ccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe
Confidence            5799999999999999999987665322 22221110     00   011223456889999999999999999999886


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSG---------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      + +..|++|||++||+|.+++....         ....++..++.++.|++.||+|||++++   +||||||+|||++.+
T Consensus        73 d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GI---IHRDLKPeNILLd~d  149 (932)
T PRK13184         73 DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGV---LHRDLKPDNILLGLF  149 (932)
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCc---cccCCchheEEEcCC
Confidence            5 46899999999999999986421         1235667788999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCC-----------------CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCc
Q 037010          422 FHAKVADFGLTKLTEVGS-----------------ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKE  484 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~  484 (589)
                      +.++|+|||++.......                 ........||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus       150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~  229 (932)
T PRK13184        150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF  229 (932)
T ss_pred             CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence            999999999998652110                 011123579999999999999999999999999999999999999


Q ss_pred             ccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHh
Q 037010          485 AIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-SMRSIVVALMT  563 (589)
Q Consensus       485 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~  563 (589)
                      ||.......     .  ........+.         ....    ..+.+..+.+++.+||..||++|| +++++++.|..
T Consensus       230 PF~~~~~~k-----i--~~~~~i~~P~---------~~~p----~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        230 PYRRKKGRK-----I--SYRDVILSPI---------EVAP----YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             CCCCcchhh-----h--hhhhhccChh---------hccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            985422110     0  0001000000         0000    112334688999999999999995 67788888888


Q ss_pred             cccccccccCC
Q 037010          564 LSSTTEDWDVG  574 (589)
Q Consensus       564 l~~~~~~~~~~  574 (589)
                      .......|...
T Consensus       290 ~lq~~p~w~~~  300 (932)
T PRK13184        290 HLQGSPEWTVK  300 (932)
T ss_pred             HHhcCcccccc
Confidence            87766666543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=324.39  Aligned_cols=264  Identities=27%  Similarity=0.455  Sum_probs=216.0

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ....+.+.||.|.||.|++|+++..+...            ..++||.++    .....+|+.|..||-+++||||+++.
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre------------~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLE  696 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKRE------------ITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLE  696 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcc------------eeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEE
Confidence            34567899999999999999987653222            145666554    34456799999999999999999999


Q ss_pred             eEEEeCc-EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      |+..... +.||.|||++|+|..||+.+.++ |.+.+..-++++|+.|++||-+.+.   |||||...|||++.+...|+
T Consensus       697 GVVTks~PvMIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~Y---VHRDLAARNILVNsnLvCKV  772 (996)
T KOG0196|consen  697 GVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNY---VHRDLAARNILVNSNLVCKV  772 (996)
T ss_pred             EEEecCceeEEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCc---hhhhhhhhheeeccceEEEe
Confidence            9888654 78999999999999999988765 9999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCccccc--CCCCCchhcccCCCCCcccchhhHHHHHHHHH-cCCcccccCCCCCCChhhHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVG--TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI-SAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~sDvwSlGvll~ell-tG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +|||+++....+.....+..-|  ..+|.|||.+....++.+|||||+|++|||.+ .|.+||.....            
T Consensus       773 sDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN------------  840 (996)
T KOG0196|consen  773 SDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------------  840 (996)
T ss_pred             ccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch------------
Confidence            9999999776555333333322  46899999999999999999999999999976 48888854332            


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccccC
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDV  573 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~  573 (589)
                                .+..+.++..++-..|.+++..|.+|+..||++|-.+||++.||+.+|.++..+......
T Consensus       841 ----------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~  900 (996)
T KOG0196|consen  841 ----------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKT  900 (996)
T ss_pred             ----------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcc
Confidence                      222233333444455677888999999999999999999999999999998876655443

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.3e-36  Score=313.20  Aligned_cols=268  Identities=20%  Similarity=0.251  Sum_probs=191.5

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||++.+...... .+.|.+.     .    ..........+.+|+.+++.++||||+++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~-----~----~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   83 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----R----PFQNQTHAKRAYRELVLMKCVNHKNIISLLN   83 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCce-EEEEEeC-----C----cccChHHHHHHHHHHHHHHHhCCCchhceee
Confidence            3467999999999999999999987654222 1111110     0    0112233456778999999999999999999


Q ss_pred             EEEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          349 YCVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       349 ~~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      ++..       ...|+||||+++ +|.+++..    .+++..+..++.|++.||+|||++++   +||||||+|||++.+
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~gi---vHrDikp~Nill~~~  155 (355)
T cd07874          84 VFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSD  155 (355)
T ss_pred             eeeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChHHEEECCC
Confidence            7652       237999999976 67777653    37888999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      +.+||+|||++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....    ......
T Consensus       156 ~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~  229 (355)
T cd07874         156 CTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNK  229 (355)
T ss_pred             CCEEEeeCcccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Confidence            99999999999754322  222345789999999999988999999999999999999999999954321    011111


Q ss_pred             HHHHHhcCCChH------HhhHhhcCC----------------CC--CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 037010          502 LFEEVLNLPDPI------EDLRKLVDP----------------RL--GDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI  557 (589)
Q Consensus       502 ~~~~~~~~~~~~------~~l~~~~d~----------------~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  557 (589)
                      ..... ..+.+.      ......++.                ..  ....+......+.+|+.+||+.||++|||++|+
T Consensus       230 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el  308 (355)
T cd07874         230 VIEQL-GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA  308 (355)
T ss_pred             HHHHh-CCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence            11111 000000      000000000                00  001112234578999999999999999999999


Q ss_pred             HHHH
Q 037010          558 VVAL  561 (589)
Q Consensus       558 l~~L  561 (589)
                      ++|-
T Consensus       309 l~hp  312 (355)
T cd07874         309 LQHP  312 (355)
T ss_pred             hcCc
Confidence            9983

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=310.17  Aligned_cols=259  Identities=24%  Similarity=0.416  Sum_probs=210.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh----cCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~----~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .+...+.++||+|.||.||+|....-.....+           .+++|.    ...+..+.|+.|.-+|++++||||+++
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~i-----------aVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikL  456 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERI-----------AVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKL  456 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcce-----------eeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhe
Confidence            34556788999999999999987654221111           122222    334567889999999999999999999


Q ss_pred             eeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          347 IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       347 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +|+|.+...|||||.++.|.|..|++.+.. .++......++.||+.||.|||+...   |||||..+|||+....-|||
T Consensus       457 IGv~~e~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkrf---VHRDIAaRNiLVsSp~CVKL  532 (974)
T KOG4257|consen  457 IGVCVEQPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKRF---VHRDIAARNILVSSPQCVKL  532 (974)
T ss_pred             eeeeeccceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhch---hhhhhhhhheeecCcceeee
Confidence            999999999999999999999999987654 48899999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHH-cCCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI-SAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ell-tG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||+++..........+...-..-|||||.++...++.+||||-|||.+||++ .|..||..-..+.            
T Consensus       533 aDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------------  600 (974)
T KOG4257|consen  533 ADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------------  600 (974)
T ss_pred             cccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc------------
Confidence            999999987766554444445567899999999999999999999999999986 5888885432211            


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                                ....+...-+-.+|++|+..|..|+.+||..+|.+||.+.|+...|.++..
T Consensus       601 ----------VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  601 ----------VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ----------eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                      111111112235677788889999999999999999999999999877764

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.6e-36  Score=294.84  Aligned_cols=247  Identities=26%  Similarity=0.461  Sum_probs=186.2

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLF  356 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  356 (589)
                      ++||+|+||.||++...+.  ...+.|.+.          +.........+.+|++++++++||||+++++++.+ +..+
T Consensus         1 ~~ig~g~~g~vy~~~~~~~--~~~a~K~~~----------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   68 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDK--TPVAVKTCK----------EDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIY   68 (250)
T ss_pred             CccCCCCCceEEEEEecCC--cEEEEEecC----------CcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccE
Confidence            4699999999999985432  222221110          11122334468889999999999999999998864 4689


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      +||||+++++|.+++.... ..+++..++.++.|++.+|.|||++++   +|+||||+||+++.++.+||+|||++....
T Consensus        69 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~---~H~dl~p~nili~~~~~~~l~d~g~~~~~~  144 (250)
T cd05085          69 IVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSRQED  144 (250)
T ss_pred             EEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccChheEEEcCCCeEEECCCccceecc
Confidence            9999999999999987654 347899999999999999999999998   999999999999999999999999987543


Q ss_pred             cCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       437 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      ...........++..|+|||++..+.++.++||||||+++|+|++ |..||.....        ........        
T Consensus       145 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~~~~~--------  208 (250)
T cd05085         145 DGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAREQVE--------  208 (250)
T ss_pred             ccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHH--------
Confidence            222211122344678999999988889999999999999999998 8888843211        01111111        


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                        ..    .....+...+..+.+++.+||..+|++||++.|+++.|.
T Consensus       209 --~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         209 --KG----YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             --cC----CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence              00    111223334557999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-36  Score=307.58  Aligned_cols=258  Identities=23%  Similarity=0.334  Sum_probs=188.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||++.+..+.. .++.|.+.     ..   ........+.+.+|+.++..++|+||+++++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~aiK~~~-----~~---~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQ-VYAMKILN-----KW---EMLKRAETACFREERDVLVNGDRRWITNLHYAFQ   71 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCC-EEEEEEEE-----HH---HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence            479999999999999999998876532 22222221     10   0111223455778999999999999999998776


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       ++.+|+||||+.+|+|.+++.... ..+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          72 DENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGY---VHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---EECCCCHHHEEECCCCCEEEEECC
Confidence             456899999999999999997643 348899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-----CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-----GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      ++...............||+.|+|||++..     ..++.++|||||||++|||++|+.||.....        ......
T Consensus       148 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~  219 (331)
T cd05597         148 SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGK  219 (331)
T ss_pred             ceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHH
Confidence            987554332222233569999999999863     4578899999999999999999999853211        111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCC--CCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP--QLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~  560 (589)
                      +......         ..+... ....+..+.+++.+|+..++  ..||+++++++|
T Consensus       220 i~~~~~~---------~~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         220 IMNHKEH---------FQFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHcCCCc---------ccCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1111000         000000 11234567888888775433  348899999999

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8e-36  Score=308.15  Aligned_cols=258  Identities=22%  Similarity=0.327  Sum_probs=189.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.++||+|+||.||++.+..+. ..++.|.+.     +..   .........+.+|+.++..++|+||+++++.+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~aiK~~~-----~~~---~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNAD-KVFAMKILN-----KWE---MLKRAETACFREERDVLVNGDNQWITTLHYAFQ   71 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCC-CEEEEEEEe-----HHH---HHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence            47899999999999999999887653 222222211     111   111122345778999999999999999998776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+.+|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i---iHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          72 DENNLYLVMDYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQLHY---VHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             cCCEEEEEEeccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHEEECCCCCEEEeecc
Confidence            4 568999999999999999976432 48899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      ++...............||+.|+|||++.     ...++.++|||||||++|||++|+.||....        .......
T Consensus       148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~  219 (332)
T cd05623         148 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGK  219 (332)
T ss_pred             hheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHH
Confidence            98754332222223357999999999885     3468899999999999999999999995332        1112222


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQ--LRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~  560 (589)
                      +......         ...+ ......+..+.+|+++|+..++.  .|++++|+++|
T Consensus       220 i~~~~~~---------~~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         220 IMNHKER---------FQFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HhCCCcc---------ccCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            2211100         0000 01122345688899998865444  47899999998

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.2e-36  Score=311.66  Aligned_cols=267  Identities=27%  Similarity=0.437  Sum_probs=193.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|.+.+... ....+.++++...     ..........+.+|++++.++ +||||++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLK-----EGATHSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCc-cccceeEEEEEec-----cCCChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            4679999999999999999998654211 1111112222111     011223345688899999999 68999999997


Q ss_pred             EEe--CcEEEEEEecCCCChHHHHhcCC----------------------------------------------------
Q 037010          350 CVE--GSLFLVYEYIENGNLSEHLRGSG----------------------------------------------------  375 (589)
Q Consensus       350 ~~~--~~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------  375 (589)
                      +.+  ...+++|||+++|+|.+++....                                                    
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            753  35789999999999999986532                                                    


Q ss_pred             -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCC-C
Q 037010          376 -------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA-S  441 (589)
Q Consensus       376 -------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~-~  441 (589)
                                   ...+++..+..++.|++.||+|||++++   +||||||+|||+++++.+||+|||++........ .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  236 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV  236 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCccCeEEEcCCCcEEEEecccccccccCcchh
Confidence                         1236778889999999999999999998   9999999999999999999999999875432211 1


Q ss_pred             CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhc
Q 037010          442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLV  520 (589)
Q Consensus       442 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  520 (589)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......    .....   ...          ...
T Consensus       237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~---~~~----------~~~  299 (343)
T cd05103         237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCR---RLK----------EGT  299 (343)
T ss_pred             hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHH---HHh----------ccC
Confidence            1122345678999999988899999999999999999997 88887432110    11111   110          000


Q ss_pred             CCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          521 DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       521 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ...    .+......+.+++.+||+.+|++|||+.||+++|..+...
T Consensus       300 ~~~----~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         300 RMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            111    1112234689999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.5e-35  Score=294.40  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=191.7

Q ss_pred             eeeccCCcEEEEEEEEccccCCc--cchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEeCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNS--YLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~--~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  355 (589)
                      +.||+|++|.||+|.+....+..  .+.|.+..          .......+.+.+|++++++++||||+++++++.+...
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~----------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   70 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS----------DKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPL   70 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCC----------cccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeE
Confidence            46899999999999986643221  11111110          0011445678899999999999999999998877778


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      +++|||+++++|.+++.......+++..++.++.|++.||+|||++++   +|+||||+||+++.++.+||+|||++...
T Consensus        71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~di~p~nil~~~~~~~kl~dfg~~~~~  147 (257)
T cd05040          71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRF---IHRDLAARNILLASDDKVKIGDFGLMRAL  147 (257)
T ss_pred             EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCc---cccccCcccEEEecCCEEEeccccccccc
Confidence            999999999999999987653468999999999999999999999998   99999999999999999999999998865


Q ss_pred             ccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCCh
Q 037010          436 EVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDP  512 (589)
Q Consensus       436 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (589)
                      ......  ......++..|+|||.+....++.++|||||||++|||++ |+.||.....        ...........  
T Consensus       148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~--  217 (257)
T cd05040         148 PQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEG--  217 (257)
T ss_pred             cccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcC--
Confidence            432211  1112456788999999988899999999999999999999 9998843211        11111111000  


Q ss_pred             HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          513 IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       513 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                               .  ....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       218 ---------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ---------E--RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---------C--cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                     0  01112233457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.3e-36  Score=302.71  Aligned_cols=274  Identities=25%  Similarity=0.391  Sum_probs=196.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhh-hhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCccee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRL-ICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~-~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      ..+|++.+.||+|+||.||+|.+............ .........+++|...    ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            46799999999999999999987654322110000 0000001122333322    234567889999999999999999


Q ss_pred             EeeEEEe-CcEEEEEEecCCCChHHHHhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          346 LIGYCVE-GSLFLVYEYIENGNLSEHLRGSG---------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       346 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      +++++.+ +..+++||++.+++|.+++....         ...+++..++.++.|++.||+|||++++   +|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i---~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCc---cccccchhc
Confidence            9998865 56899999999999999997644         1258899999999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc--CCcccccCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS--AKEAIVKGNGS  492 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt--G~~p~~~~~~~  492 (589)
                      |+++.++.++|+|||++........ .......+++.|+|||.+....++.++|||||||++|||++  +..||..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence            9999999999999999875432211 12223456788999999988889999999999999999998  5566632211 


Q ss_pred             CCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                          ..............          ........+...+..+.+++.+||+.||++|||+.||++.|.
T Consensus       240 ----~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 ----QQVIENAGHFFRDD----------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ----HHHHHHHHhccccc----------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence                11111111110000          000001112233457999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.5e-37  Score=311.86  Aligned_cols=268  Identities=22%  Similarity=0.317  Sum_probs=191.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|.+.++||+|+||.||+|.+..+... .+.|.+..          .........+.+|++++++++||||+++++++
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-vaiK~~~~----------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   73 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENL-VALKEIRL----------EHEEGAPCTAIREVSLLKDLKHANIVTLHDIV   73 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCe-EEEEEeec----------cccCCcchhHHHHHHHHHhCCCCCcceEEEEE
Confidence            36799999999999999999987655322 22221110          00011123466799999999999999999987


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..++||||+.+ +|.+++..... .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i---vH~dlkp~Nill~~~~~~kl~Df  148 (309)
T cd07872          74 HTDKSLTLVFEYLDK-DLKQYMDDCGN-IMSMHNVKIFLYQILRGLAYCHRRKV---LHRDLKPQNLLINERGELKLADF  148 (309)
T ss_pred             eeCCeEEEEEeCCCC-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEECcc
Confidence            6 4568999999976 88888876543 47889999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||.....     ............
T Consensus       149 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~-----~~~~~~~~~~~~  222 (309)
T cd07872         149 GLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV-----EDELHLIFRLLG  222 (309)
T ss_pred             ccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhC
Confidence            99875433222 1223567899999998854 4688999999999999999999999854322     111111222221


Q ss_pred             CCChHHhhHhh------cCCCCCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKL------VDPRLGD-------NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~------~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+... ....+      .+.....       .........+.+|+.+||+.||.+|||++|+++|-
T Consensus       223 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  287 (309)
T cd07872         223 TPTEE-TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA  287 (309)
T ss_pred             CCCHH-HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence            11110 00000      0000000       00112345688999999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6e-36  Score=302.33  Aligned_cols=255  Identities=23%  Similarity=0.325  Sum_probs=192.2

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      .|+..+.||+|+||+||++.+..+.. ..+.|.+..     .. .  ........+.+|++++++++|+||+++++.+. 
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~-~~aiK~~~~-----~~-~--~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~   71 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGK-MYACKRLEK-----KR-I--KKRKGESMALNEKQILEKVNSQFVVNLAYAYET   71 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCc-EEEEEEeeh-----hh-h--hhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec
Confidence            37778999999999999998876532 222222111     00 0  01122345678999999999999999988665 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ++..+++|||+.+++|.+++......++++..+..++.|++.||.|||++++   +||||||+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i---iH~dikp~Nili~~~~~~kl~Dfg~  148 (285)
T cd05632          72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT---VYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eecCCCHHHEEECCCCCEEEecCCc
Confidence            4568999999999999999876655569999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +.......  ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||......    .........+...  
T Consensus       149 ~~~~~~~~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~----~~~~~~~~~~~~~--  220 (285)
T cd05632         149 AVKIPEGE--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK----VKREEVDRRVLET--  220 (285)
T ss_pred             ceecCCCC--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhhhcc--
Confidence            86543221  123357899999999998889999999999999999999999998533210    0111111111110  


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                               .    ...+......+.+|+..||+.||++||+     +.+++.|
T Consensus       221 ---------~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         221 ---------E----EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---------c----cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                     0    1122333446889999999999999999     7788887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.2e-35  Score=294.88  Aligned_cols=253  Identities=22%  Similarity=0.364  Sum_probs=196.4

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|+..+.||.|+||.||.+....+... .+.|.+         ..+........++.+|++++++++|+||+++++++.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~-~~~k~~---------~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   70 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSL-VVWKEV---------NLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD   70 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcE-EEEEEE---------eecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec
Confidence            588999999999999999987655322 222211         1112233445667889999999999999999998765


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..+++|||+++++|.+++.......+++..+..++.|++.+|.|||+.++   +|+||+|+||++++++.+||+|||+
T Consensus        71 ~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i---~h~dl~p~ni~~~~~~~~kl~d~~~  147 (256)
T cd08221          71 DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI---LHRDIKTLNIFLTKAGLIKLGDFGI  147 (256)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCc---cccCCChHhEEEeCCCCEEECcCcc
Confidence             458999999999999999987655568999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +........ ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||.....        .........   
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~---  215 (256)
T cd08221         148 SKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQ---  215 (256)
T ss_pred             eEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHc---
Confidence            876533221 22345689999999999888899999999999999999999999843211        111111111   


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                ... ...+...+..+.+++.+||..+|.+||+++++++++
T Consensus       216 ----------~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         216 ----------GNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----------CCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                      011 011223345789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.7e-36  Score=314.20  Aligned_cols=255  Identities=21%  Similarity=0.321  Sum_probs=188.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||++....++. .++.|.+.     ...   ....+....+.+|++++.+++||||+++++.+.
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~-~~aiK~~~-----~~~---~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   71 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGH-IYAMKILR-----KAD---MLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ   71 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCC-EEEEEEEE-----HHH---HhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            478999999999999999998876532 22222211     110   111223456778999999999999999998776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~gi---vHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          72 DKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             cCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EccCCCHHHEEECCCCCEEEeecc
Confidence            4 56899999999999999997654  48899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCC----------------------------------CCCcccccCCCCCchhcccCCCCCcccchhhHHHHH
Q 037010          431 LTKLTEVGSA----------------------------------SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVL  476 (589)
Q Consensus       431 la~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll  476 (589)
                      ++........                                  ......+||+.|+|||++.+..++.++|||||||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            9864321100                                  001234799999999999999999999999999999


Q ss_pred             HHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC---
Q 037010          477 YELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---  553 (589)
Q Consensus       477 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs---  553 (589)
                      |||++|+.||.....        ......+.....       .  ...+...  .....+.+++.+|+. ||.+|++   
T Consensus       227 yel~tG~~Pf~~~~~--------~~~~~~i~~~~~-------~--~~~p~~~--~~s~~~~~li~~l~~-~p~~R~~~~~  286 (360)
T cd05627         227 YEMLIGYPPFCSETP--------QETYRKVMNWKE-------T--LVFPPEV--PISEKAKDLILRFCT-DSENRIGSNG  286 (360)
T ss_pred             eecccCCCCCCCCCH--------HHHHHHHHcCCC-------c--eecCCCC--CCCHHHHHHHHHhcc-ChhhcCCCCC
Confidence            999999999954321        111111111100       0  0000111  123467888888764 9999984   


Q ss_pred             HHHHHHH
Q 037010          554 MRSIVVA  560 (589)
Q Consensus       554 ~~evl~~  560 (589)
                      ++|+++|
T Consensus       287 ~~ei~~h  293 (360)
T cd05627         287 VEEIKSH  293 (360)
T ss_pred             HHHHhcC
Confidence            7888887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=7.8e-36  Score=306.15  Aligned_cols=266  Identities=23%  Similarity=0.347  Sum_probs=181.6

Q ss_pred             ceeeccCCcEEEEEEEEcccc-CCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCCCcceeEeeEEEe--
Q 037010          277 SHKIGQGGFGAVYYAELRGEY-GNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHHLNLVRLIGYCVE--  352 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--  352 (589)
                      +++||+|+||.||+|.+.... +..++              +|.... .....+.+|+++|++++||||+++++++.+  
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~a--------------iK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   71 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYA--------------LKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA   71 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEE--------------EEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCC
Confidence            578999999999999875421 22222              222211 112346679999999999999999997753  


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE----cC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSG-------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI----DK  420 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl----~~  420 (589)
                       ...|++|||+.+ +|.+++....       ...+++..++.++.|++.||+|||++++   +||||||+|||+    +.
T Consensus        72 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i---vHrDlkp~Nil~~~~~~~  147 (317)
T cd07868          72 DRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPE  147 (317)
T ss_pred             CcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCE---EcCCCCHHHEEEecCCCC
Confidence             358899999965 8888875321       2248899999999999999999999998   999999999999    45


Q ss_pred             CCcEEEEeccCccccccCCC--CCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC--
Q 037010          421 NFHAKVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD--  495 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~--  495 (589)
                      ++.+||+|||++........  .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.........  
T Consensus       148 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~  227 (317)
T cd07868         148 RGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN  227 (317)
T ss_pred             cCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccc
Confidence            67899999999986543221  12234678999999998876 45899999999999999999999999644322111  


Q ss_pred             --hhhHHHHHHHHhcCCChH--HhhHh---------hcCCCCCCCC---------ChHHHHHHHHHHHHhcccCCCCCCC
Q 037010          496 --SKGLVALFEEVLNLPDPI--EDLRK---------LVDPRLGDNC---------PLDSVLKMAQLAKVCTQEYPQLRPS  553 (589)
Q Consensus       496 --~~~~~~~~~~~~~~~~~~--~~l~~---------~~d~~l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs  553 (589)
                        ...........+..+...  +.+..         .........+         .......+.+|+.+||+.||.+|||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  307 (317)
T cd07868         228 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT  307 (317)
T ss_pred             cccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC
Confidence              011111111111111100  00000         0000000000         0011235789999999999999999


Q ss_pred             HHHHHHH
Q 037010          554 MRSIVVA  560 (589)
Q Consensus       554 ~~evl~~  560 (589)
                      ++|+++|
T Consensus       308 ~~e~l~h  314 (317)
T cd07868         308 SEQAMQD  314 (317)
T ss_pred             HHHHhcC
Confidence            9999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=312.74  Aligned_cols=248  Identities=31%  Similarity=0.467  Sum_probs=198.4

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC------HHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~------~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      |.-++.||.|+||.||.|++..+..               .++||++.      .+.-++++.|+..|++++|||++.+.
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~e---------------vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYk   92 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSE---------------VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYK   92 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccc---------------eeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccc
Confidence            4556889999999999999876633               45555543      23456788999999999999999999


Q ss_pred             eEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      |++. +...|||||||-| +-.|.+.-. .+++-+.++..|..+.+.||+|||+++.   ||||||..|||+.+.|.|||
T Consensus        93 gCyLre~TaWLVMEYClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~---IHRDiKAGNILLse~g~VKL  167 (948)
T KOG0577|consen   93 GCYLREHTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNR---IHRDIKAGNILLSEPGLVKL  167 (948)
T ss_pred             ceeeccchHHHHHHHHhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhH---HhhhccccceEecCCCeeee
Confidence            9775 5568999999966 777776543 3569999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcc---cCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA---QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +|||.+.....     ...++|||.|||||++   ..+.|+-++||||||++..||.-.++|++.++.-    ..+.+..
T Consensus       168 aDFGSAsi~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM----SALYHIA  238 (948)
T KOG0577|consen  168 ADFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIA  238 (948)
T ss_pred             ccccchhhcCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH----HHHHHHH
Confidence            99999886543     3458999999999987   4578999999999999999999999998665421    1111111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                         .+.           .|.+   -..+.+..+..|+..||++-|.+|||.++++.|-.-++..
T Consensus       239 ---QNe-----------sPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  239 ---QNE-----------SPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             ---hcC-----------CCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence               111           1222   1345667899999999999999999999999986655543

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1e-35  Score=299.58  Aligned_cols=253  Identities=20%  Similarity=0.319  Sum_probs=189.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..+.. .++.|.+.          +........++.+|++++++++||||+++++++.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-~~aiK~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   69 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRR-ILAVKVIP----------LDITVELQKQIMSELEILYKCDSPYIIGFYGAFF   69 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCc-EEEEEEEe----------cCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            468889999999999999998765532 22222111          1112334456888999999999999999999776


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       ++..++||||+++++|..+.      .+++..+..++.|++.||.|||++++   +|+||||+|||++.++.++|+|||
T Consensus        70 ~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nill~~~~~~~l~dfg  140 (279)
T cd06619          70 VENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKI---LHRDVKPSNMLVNTRGQVKLCDFG  140 (279)
T ss_pred             ECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCE---eeCCCCHHHEEECCCCCEEEeeCC
Confidence             45689999999999997652      37788899999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++......   ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.......... .......      
T Consensus       141 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~------  210 (279)
T cd06619         141 VSTQLVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQ------  210 (279)
T ss_pred             cceecccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHH------
Confidence            98754322   2233578999999999998899999999999999999999999985422211100 0001111      


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                             ...+..............+.+++.+||+.+|++||+++|+++|-
T Consensus       211 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         211 -------CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             -------HHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence                   11111110101112334689999999999999999999999884

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.7e-36  Score=308.56  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=186.6

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||.||+|.+..+.. .++.|.+..     ..   .......+.+.+|..++.++ +||||+++++++.+ +.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~-~~aiK~~~~-----~~---~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   71 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQ-IYAMKVVKK-----EL---VHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRL   71 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCC-EEEEEEEEH-----HH---hhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEE
Confidence            469999999999998766522 222222111     10   01122345577899999888 69999999997764 568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i---vHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          72 FLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGI---IYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHEEEeCCCCEEEeccccceec
Confidence            99999999999999887654  48999999999999999999999998   99999999999999999999999998743


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......... ............       
T Consensus       147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~-------  217 (327)
T cd05617         147 LGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDM-NTEDYLFQVILE-------  217 (327)
T ss_pred             cCC-CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccc-ccHHHHHHHHHh-------
Confidence            221 11223467999999999999999999999999999999999999999532211100 000111111111       


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS------MRSIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~  560 (589)
                            ..  ...|...+..+.+++.+||..||.+|++      ++++++|
T Consensus       218 ------~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         218 ------KP--IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             ------CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence                  10  1223334457899999999999999998      5687776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.4e-36  Score=307.85  Aligned_cols=258  Identities=22%  Similarity=0.328  Sum_probs=189.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||++++..+.. .++.|.+.     ..   +.........+.+|..++..++|+||+++++++.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~-~~aiK~~~-----~~---~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~   71 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTER-IYAMKILN-----KW---EMLKRAETACFREERNVLVNGDCQWITTLHYAFQ   71 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCC-EEEEEEEe-----HH---HHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            579999999999999999998776532 22222211     10   0111223345778999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+.+|+|.+++.... ..+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~i---iHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          72 DENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHY---VHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCchHHEEEcCCCCEEEEecc
Confidence            4 56899999999999999998643 248899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-----CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-----GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      ++...............||+.|+|||++..     +.++.++|||||||++|||++|+.||.....        ......
T Consensus       148 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~  219 (331)
T cd05624         148 SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGK  219 (331)
T ss_pred             ceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHH
Confidence            987654332222233579999999998865     5678899999999999999999999953221        111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQL--RPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~  560 (589)
                      +.....         ...++.. ..+.+..+.+++.+|+..++++  |++++++++|
T Consensus       220 i~~~~~---------~~~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         220 IMNHEE---------RFQFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHcCCC---------cccCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            111100         0001111 1123457888999999866554  5689999887

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=7.9e-36  Score=306.77  Aligned_cols=240  Identities=24%  Similarity=0.377  Sum_probs=179.0

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHH-HHccCCCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK-VLTHVHHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||.||+|++..++ ..++.|.+..     ....   ......++..|.. +++.++||||+++++++.+ +..
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~-----~~~~---~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~   71 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDG-SFYAVKVLQK-----KTIL---KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKL   71 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCC-CEEEEEEEEH-----HHHH---HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEE
Confidence            46999999999999876653 2222222211     1110   1112233444544 6788999999999987764 568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+++|+|.+++....  .+++..+..++.||+.||+|||++++   +||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i---vH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          72 YFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNI---IYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            99999999999999887543  48889999999999999999999998   99999999999999999999999998743


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....        .......+...+     
T Consensus       147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~-----  212 (321)
T cd05603         147 VEP-EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHKP-----  212 (321)
T ss_pred             CCC-CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcCC-----
Confidence            221 122234578999999999998899999999999999999999999995432        111122221110     


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR  555 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  555 (589)
                                ...+......+.+++.+||+.||.+||+..
T Consensus       213 ----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 ----------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                      122333445789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.4e-36  Score=307.53  Aligned_cols=241  Identities=26%  Similarity=0.374  Sum_probs=179.2

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHH-HHHccCCCCcceeEeeEEE-eCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL-KVLTHVHHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~-~il~~l~hpnIv~l~~~~~-~~~~  355 (589)
                      +.||+|+||.||+|.+..+. ..++.|.+..     ....   ......++..|. .+++.++||||+++++++. ++..
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~-~~~aiK~~~~-----~~~~---~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~   71 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEE-KFYAVKVLQK-----KAIL---KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL   71 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCC-CEEEEEEEEH-----HHHH---hhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeE
Confidence            46999999999999877653 2222222211     1000   011122334444 4568889999999998776 4568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+.+|+|.+++....  .+.+..+..++.||+.||+|||++|+   +||||||+|||++.++.+||+|||+++..
T Consensus        72 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~gi---iHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          72 YFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            99999999999999997654  37888899999999999999999998   99999999999999999999999998753


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ...+..+...+     
T Consensus       147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~-----  212 (325)
T cd05602         147 IEH-NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKP-----  212 (325)
T ss_pred             ccC-CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCC-----
Confidence            221 1223346799999999999999999999999999999999999999953221        11122221111     


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS  556 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  556 (589)
                                ...+.+.+..+.+++.+||+.||.+||++.+
T Consensus       213 ----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         213 ----------LQLKPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             ----------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence                      0112234457899999999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-35  Score=305.98  Aligned_cols=250  Identities=26%  Similarity=0.415  Sum_probs=187.7

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeEEE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYCV  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~  351 (589)
                      +|+..+.||+|+||.||+|.+..++. .++.|.+.     ....   ......+.+..|.+++..+. |++|+++++++.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~-~vaiK~~~-----~~~~---~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~   71 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDE-LYAIKILK-----KDVV---IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ   71 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCC-EEEEEEEE-----HHHh---hhhhHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence            47788999999999999998776532 22222221     1111   11223345677888888885 577888888765


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       ++.+|+||||+++|+|.+++....  .+++.+++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~i---vHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          72 TVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGI---IYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHeEECCCCCEEEeccc
Confidence             456899999999999999997654  38999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+... 
T Consensus       147 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~-  216 (323)
T cd05615         147 MCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEH-  216 (323)
T ss_pred             cccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC-
Confidence            987532221 122335689999999999988999999999999999999999999854321        1111111111 


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM-----RSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  560 (589)
                                  .  ...|...+..+.+++.+||+.+|.+|++.     +++.+|
T Consensus       217 ------------~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         217 ------------N--VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             ------------C--CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence                        1  11233344578999999999999999984     566665

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.8e-36  Score=297.16  Aligned_cols=251  Identities=27%  Similarity=0.462  Sum_probs=189.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .+|++.+.||+|+||.||++.+...  ...+.|.+..         ...   ...++.+|++++++++|||++++++++.
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~--~~~~~k~~~~---------~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEK--RKVAIKTIRE---------GAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCT   69 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCC--CeEEEEECCC---------CCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            5688899999999999999987532  1222221110         011   1245778999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + ...+++|||+.+++|.+++..... .+++..++.++.|++.+|+|||++++   +|+||||+||+++.++.++|+|||
T Consensus        70 ~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i---~h~dl~p~ni~i~~~~~~~l~d~g  145 (256)
T cd05112          70 ERSPICLVFEFMEHGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESSNV---IHRDLAARNCLVGENQVVKVSDFG  145 (256)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCCc---cccccccceEEEcCCCeEEECCCc
Confidence            4 568899999999999999876433 47899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++...............++..|+|||.+.++.++.++||||||+++|||++ |+.||.....        ........  
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~--  215 (256)
T cd05112         146 MTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETIN--  215 (256)
T ss_pred             ceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHh--
Confidence            987543222111122345678999999988889999999999999999998 8888843221        11111111  


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                              +....    ..+...+..+.+|+.+||+.+|++|||+.|++++|.
T Consensus       216 --------~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         216 --------AGFRL----YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --------CCCCC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                    00010    011112357899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-35  Score=307.51  Aligned_cols=267  Identities=25%  Similarity=0.435  Sum_probs=196.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCcc-chhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSY-LSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~-~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      .+|++.+.||+|+||.||+|.+.+...... ....++.+..     .+.......+++.+|+++++++ +||||++++++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~-----~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-----KDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEc-----ccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            468999999999999999998654321110 0001111110     0112233456788899999999 79999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCC
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA  414 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~  414 (589)
                      +.+ +..+++|||+.+|+|.+++....              ...+++..++.++.|++.||.|||++++   +||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi---vH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKC---IHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCe---eccccccc
Confidence            864 45899999999999999997532              2347888899999999999999999998   99999999


Q ss_pred             cEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCC
Q 037010          415 NILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGS  492 (589)
Q Consensus       415 NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~  492 (589)
                      |||++.++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++ |..||....  
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--  241 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--  241 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence            999999999999999998754332211 1122334567999999998899999999999999999998 777773221  


Q ss_pred             CCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                            .......+..              ......+...+..+.+++.+||+.+|.+|||+.|++++|..+....
T Consensus       242 ------~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         242 ------VEELFKLLKE--------------GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             ------HHHHHHHHHc--------------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence                  1111111111              0011122233457899999999999999999999999999888544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-35  Score=297.86  Aligned_cols=261  Identities=26%  Similarity=0.421  Sum_probs=194.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|+....... ...+.++.+..     .........+++.+|++++++++|+||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~-~~~~~~~~k~~-----~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   78 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEE-GGETLVLVKAL-----QKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR   78 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcC-CCcceEEEEcc-----CCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence            5788999999999999999987654221 11111111111     01111224567889999999999999999999886


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGR-------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      + +..|+||||+++|+|.+++.....       ..+++..+..++.|++.||+|||++++   +||||||+||+++.++.
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i---~H~dlkp~Nili~~~~~  155 (275)
T cd05046          79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARF---VHRDLAARNCLVSSQRE  155 (275)
T ss_pred             CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCc---ccCcCccceEEEeCCCc
Confidence            5 458999999999999999976542       158999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~  502 (589)
                      ++++|||++...............++..|+|||.+....++.++||||||+++|+|++ |..||.....     ..   .
T Consensus       156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-----~~---~  227 (275)
T cd05046         156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EE---V  227 (275)
T ss_pred             EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-----HH---H
Confidence            9999999987543222222233456778999999988889999999999999999998 7777732211     11   1


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ......             .......+...+..+.+++.+||..+|.+||++.|++.+|.
T Consensus       228 ~~~~~~-------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         228 LNRLQA-------------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHc-------------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111110             00111112233457899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.4e-35  Score=310.26  Aligned_cols=266  Identities=20%  Similarity=0.261  Sum_probs=190.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||++.+...... .+.|.+     ..    ..........+.+|+.+++.++||||++++++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~-----~~----~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~   91 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERN-VAIKKL-----SR----PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV   91 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcE-EEEEEe-----Cc----cccCchhHHHHHHHHHHHHhcCCCCcccccee
Confidence            457899999999999999999987654322 111111     00    01112334567789999999999999999987


Q ss_pred             EEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +..       ..+|+||||+.+ +|.+++..    .+++..+..++.|++.||+|||++++   +||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~  163 (364)
T cd07875          92 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDC  163 (364)
T ss_pred             ecccccccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCe---ecCCCCHHHEEECCCC
Confidence            642       247999999976 78777753    37888999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+||+|||++......  .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||......    ......
T Consensus       164 ~~kL~DfG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~~  237 (364)
T cd07875         164 TLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI----DQWNKV  237 (364)
T ss_pred             cEEEEeCCCccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence            9999999999754322  2223457899999999999999999999999999999999999999543210    111111


Q ss_pred             HHHHhcCCChH--Hhh----HhhcC--CCC----------------CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 037010          503 FEEVLNLPDPI--EDL----RKLVD--PRL----------------GDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV  558 (589)
Q Consensus       503 ~~~~~~~~~~~--~~l----~~~~d--~~l----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  558 (589)
                      . .....+.+.  ..+    .....  +..                ...........+.+|+.+||+.||.+|||++|++
T Consensus       238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L  316 (364)
T cd07875         238 I-EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL  316 (364)
T ss_pred             H-HhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            1 111111000  000    00000  000                0001111234688999999999999999999999


Q ss_pred             HH
Q 037010          559 VA  560 (589)
Q Consensus       559 ~~  560 (589)
                      +|
T Consensus       317 ~h  318 (364)
T cd07875         317 QH  318 (364)
T ss_pred             cC
Confidence            98

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.4e-36  Score=298.85  Aligned_cols=255  Identities=23%  Similarity=0.382  Sum_probs=190.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|....           ........+.+|+.++++++||||+++++++
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~-~~aik~~~~-----------~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~   75 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGE-LAAVKIIKL-----------EPGDDFSLIQQEIFMVKECKHCNIVAYFGSY   75 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCe-EEEEEEEec-----------CccchHHHHHHHHHHHHhcCCCCeeeeeEEE
Confidence            4579999999999999999998765532 222221110           0112234567899999999999999999977


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..|+||||+.+++|.+++....  ++++..+..++.|++.||.|||++++   +||||||+||+++.++.++|+||
T Consensus        76 ~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~nill~~~~~~~l~df  150 (267)
T cd06646          76 LSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADF  150 (267)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEECCCCCEEECcC
Confidence            6 456899999999999999987543  48899999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |++....... .......|++.|+|||.+.   ...++.++|+|||||++|||++|+.||.......           ..
T Consensus       151 g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-----------~~  218 (267)
T cd06646         151 GVAAKITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----------AL  218 (267)
T ss_pred             ccceeecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-----------hh
Confidence            9987653221 1123356889999999874   3457889999999999999999999984332110           00


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .....  .   ....+...  .....+..+.+++.+||..+|++|||+++++++|
T Consensus       219 ~~~~~--~---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         219 FLMSK--S---NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             eeeec--C---CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00000  0   00001110  0112345789999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-35  Score=293.68  Aligned_cols=252  Identities=27%  Similarity=0.440  Sum_probs=185.9

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeEeeEEE--
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRLIGYCV--  351 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--  351 (589)
                      +.||+|+||.||+|.+.......   .         .+++|..    .....+.+.+|+.+++.++||||+++++++.  
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~---~---------~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   68 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQK---I---------HCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS   68 (262)
T ss_pred             CcccccCCceEEEEEEecCCCce---E---------EEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC
Confidence            46899999999999865432111   0         1222221    2234567888999999999999999999765  


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ++..+++|||+.+|+|.+++..... ..++..+..++.|++.||+|||+.++   +||||||+|||+++++.+||+|||+
T Consensus        69 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlk~~nili~~~~~~kl~dfg~  144 (262)
T cd05058          69 EGSPLVVLPYMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKKF---VHRDLAARNCMLDESFTVKVADFGL  144 (262)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCc---cccccCcceEEEcCCCcEEECCccc
Confidence            3458899999999999999976543 36777888999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCC---CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          432 TKLTEVGSA---SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       432 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      +........   .......++..|+|||.+....++.++|||||||++|||++|..|+.....    ..   ........
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~----~~---~~~~~~~~  217 (262)
T cd05058         145 ARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----SF---DITVYLLQ  217 (262)
T ss_pred             cccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC----HH---HHHHHHhc
Confidence            875432110   111123457789999999888999999999999999999996655422211    11   11111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      .          ..+..    +...+..+.+++.+||..+|++||++.||++.|+.+..
T Consensus       218 ~----------~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         218 G----------RRLLQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             C----------CCCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            0          01111    11223468899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.4e-35  Score=300.03  Aligned_cols=262  Identities=29%  Similarity=0.496  Sum_probs=192.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+.+.... ...+.++.+..     .+........++.+|++++++++||||+++++++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~-~~~~~~aiK~~-----~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~   77 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPY-EPFTMVAVKML-----KEEASADMQADFQREAALMAEFDHPNIVKLLGVC   77 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCC-CcceeEEEEec-----CCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence            46799999999999999999987541100 00011111111     0111233446688899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEee
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSG--------------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHR  409 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~  409 (589)
                      .+ +..+++|||+.+|+|.+++....                    ...+++..++.++.|++.||+|||++++   +||
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i---~H~  154 (288)
T cd05050          78 AVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKF---VHR  154 (288)
T ss_pred             cCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCe---ecc
Confidence            65 45899999999999999997432                    1247788899999999999999999998   999


Q ss_pred             ccCCCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccc
Q 037010          410 DIKSANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIV  487 (589)
Q Consensus       410 Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~  487 (589)
                      ||||+||++++++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~  234 (288)
T cd05050         155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999875432211 11122345678999999988899999999999999999997 777874


Q ss_pred             cCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          488 KGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       488 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                      ....        ........             +... ...+...+..+.+++.+||+.+|.+|||++|+++.|++
T Consensus       235 ~~~~--------~~~~~~~~-------------~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         235 GMAH--------EEVIYYVR-------------DGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCCH--------HHHHHHHh-------------cCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            3211        11111111             1111 11233345579999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.9e-35  Score=294.40  Aligned_cols=255  Identities=26%  Similarity=0.418  Sum_probs=187.2

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLF  356 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  356 (589)
                      +.||+|+||.||+|.+..........+.++++..     .+........++.+|+++++.++||||+++++++.+ +..+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~-----~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL-----RKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhh-----hcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeE
Confidence            3699999999999987643211111111111111     111112345578889999999999999999998764 5689


Q ss_pred             EEEEecCCCChHHHHhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-----cEEE
Q 037010          357 LVYEYIENGNLSEHLRGSG-----RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-----HAKV  426 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~-----~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-----~vkl  426 (589)
                      ++|||+++++|.+++....     ...+++..++.++.|++.||+|||+.++   +|+||||+||+++.++     .++|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i---~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChheEEEecCCCCCCcceEE
Confidence            9999999999999997532     2337889999999999999999999998   9999999999999877     8999


Q ss_pred             EeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHH
Q 037010          427 ADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       427 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      +|||++........ .......++..|+|||.+..+.++.++|||||||++|||+| |+.||.....     ..   ...
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-----~~---~~~  224 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-----QE---VLQ  224 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-----HH---HHH
Confidence            99999875432211 11122355788999999998999999999999999999998 8988843211     11   111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ....              ......+...+..+.+++.+||..+|.+||++++|++.|.
T Consensus       225 ~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         225 HVTA--------------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             HHhc--------------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1100              0001122334557899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.6e-35  Score=300.82  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=193.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||+|+||.||++.+..++.. .+.|.+.           .......+.+.+|+++++.++|+||+++++.+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-v~ik~~~-----------~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~   86 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQE-VAIRQMN-----------LQQQPKKELIINEILVMRENKNPNIVNYLDSY   86 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcE-EEEEEEe-----------cCCcchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            36899999999999999999987654322 1111110           01112235677899999999999999999877


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . +...|+||||+++++|.+++...   .+++.++..++.|++.||+|||++++   +|+||||+||+++.++.++|+||
T Consensus        87 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi---~H~dLkp~Nill~~~~~~kl~df  160 (296)
T cd06654          87 LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDF  160 (296)
T ss_pred             EeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEcCCCCEEECcc
Confidence            5 45689999999999999998653   37899999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++........ ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||......    .   ...... . 
T Consensus       161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~----~---~~~~~~-~-  230 (296)
T cd06654         161 GFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----R---ALYLIA-T-  230 (296)
T ss_pred             ccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH----H---hHHHHh-c-
Confidence            99875432221 122356889999999998888999999999999999999999999543210    0   000000 0 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                                 ........+......+.+++.+||..+|++|||+++++++-.
T Consensus       231 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~  272 (296)
T cd06654         231 -----------NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF  272 (296)
T ss_pred             -----------CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence                       000001122334457899999999999999999999999743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-36  Score=300.52  Aligned_cols=255  Identities=28%  Similarity=0.487  Sum_probs=190.4

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-e
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-E  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~  352 (589)
                      |++.+.||+|+||+||++....+.. .++.|.+....         ..........+|+.++++++||||+++++++. +
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~-~~~~K~~~~~~---------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~   70 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQ-KVAVKIIDKSE---------IEEEEREENIREIKILRRLRHPNIVQILDVFQDD   70 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTE-EEEEEEEESTT---------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCe-EEEEEEecccc---------ccccccchhhhhhhcccccccccccccccccccc
Confidence            6789999999999999999877632 22222211110         01111223345999999999999999999886 4


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      ...+++||++.+++|.+++....  .+++..++.++.|++.||++||++++   +|+||||+||++++++.++|+|||.+
T Consensus        71 ~~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i---~H~dikp~NIl~~~~~~~~l~Dfg~~  145 (260)
T PF00069_consen   71 NYLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGI---VHRDIKPENILLDENGEVKLIDFGSS  145 (260)
T ss_dssp             SEEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTE---EESSBSGGGEEESTTSEEEESSGTTT
T ss_pred             ccccccccccccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccc
Confidence            56899999999999999998333  38999999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCCCcccccCCCCCchhccc-CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      .... ..........++..|+|||++. ...++.++||||||+++|+|++|..||...     ................ 
T Consensus       146 ~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-----~~~~~~~~~~~~~~~~-  218 (260)
T PF00069_consen  146 VKLS-ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-----NSDDQLEIIEKILKRP-  218 (260)
T ss_dssp             EEST-STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-----SHHHHHHHHHHHHHTH-
T ss_pred             cccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cchhhhhhhhhccccc-
Confidence            7531 1222334467899999999998 888999999999999999999999998543     1112222222211110 


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                          .....      .........+.+++.+||+.||++|||+.++++|
T Consensus       219 ----~~~~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  219 ----LPSSS------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             ----HHHHT------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ----ccccc------cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                00000      0000112579999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.1e-36  Score=332.71  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=191.8

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ....++|++.++||+|+||+||+|.+.... ..++.+.+.         ...........+..|+.+|++++||||++++
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg-~~vAlKvIk---------~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~   78 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQ-EFFCWKAIS---------YRGLKEREKSQLVIEVNVMRELKHKNIVRYI   78 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCC-eEEEEEEEe---------ccccCHHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence            445678999999999999999999987642 222222111         1112333456788899999999999999999


Q ss_pred             eEEEe---CcEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEeeccCCCcEEE
Q 037010          348 GYCVE---GSLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTV----PVYIHRDIKSANILI  418 (589)
Q Consensus       348 ~~~~~---~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i----~~~vH~Dlkp~NILl  418 (589)
                      +++.+   +.+||||||+.+|+|.++|....  ...+++..++.|+.||+.||.|||+.+.    ..||||||||+|||+
T Consensus        79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL  158 (1021)
T PTZ00266         79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL  158 (1021)
T ss_pred             EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence            97753   35899999999999999997532  2359999999999999999999999541    113999999999999


Q ss_pred             cC-----------------CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC--CCCCcccchhhHHHHHHHH
Q 037010          419 DK-----------------NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGVVLYEL  479 (589)
Q Consensus       419 ~~-----------------~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGvll~el  479 (589)
                      +.                 .+.+||+|||++......  .......||+.|+|||++..  ..++.++|||||||+||||
T Consensus       159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             ecCccccccccccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence            64                 235899999999765322  22234579999999999854  4588999999999999999


Q ss_pred             HcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 037010          480 ISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV  559 (589)
Q Consensus       480 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  559 (589)
                      +||+.||.....       ....+..+...            +.+.   ....+..+.+|+..||..+|.+||++.|++.
T Consensus       237 LTGk~PF~~~~~-------~~qli~~lk~~------------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        237 CSGKTPFHKANN-------FSQLISELKRG------------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHCCCCCCcCCc-------HHHHHHHHhcC------------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            999999954321       11111111111            1110   0112346899999999999999999999996


Q ss_pred             H
Q 037010          560 A  560 (589)
Q Consensus       560 ~  560 (589)
                      +
T Consensus       295 h  295 (1021)
T PTZ00266        295 Y  295 (1021)
T ss_pred             c
Confidence            5

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-36  Score=303.23  Aligned_cols=274  Identities=23%  Similarity=0.373  Sum_probs=192.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.+.||+|+||.||+|...+...... ............+++|..    .......+.+|++++++++|+|++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~-~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLG-EGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhcc-ccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            3579999999999999999998754311000 000000000001222222    23344568899999999999999999


Q ss_pred             eeEEE-eCcEEEEEEecCCCChHHHHhcCCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          347 IGYCV-EGSLFLVYEYIENGNLSEHLRGSGR----------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       347 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      ++++. ++..++||||+.+++|.+++.....          ..+++..++.++.|++.||+|||++++   +|+||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i---~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCe---eccccChhh
Confidence            99876 4568999999999999999965321          236788999999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc--CCcccccCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS--AKEAIVKGNGS  492 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt--G~~p~~~~~~~  492 (589)
                      |++++++.+||+|||++........ .......++..|+|||.+..+.++.++|||||||++|+|++  |..||..... 
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-  238 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-  238 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-
Confidence            9999999999999999875432221 11122345678999999988899999999999999999998  4456532111 


Q ss_pred             CCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                          .............          .........+...+..+.+|+.+||+.+|++|||+++|++.|.+
T Consensus       239 ----~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 ----EQVIENTGEFFRN----------QGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ----HHHHHHHHHhhhh----------ccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence                1111111110000          00000011122234579999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.5e-35  Score=299.88  Aligned_cols=265  Identities=25%  Similarity=0.428  Sum_probs=192.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||.||+|..+...... ....++.+....     ........++.+|+.++++++||||++++++
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~-~~~~vavK~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   77 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGE-AETRVAVKTVNE-----SASLRERIEFLNEASVMKGFTCHHVVRLLGV   77 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCC-cceEEEEEECCC-----cCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            4578999999999999999999765321100 001111111100     1112233457789999999999999999997


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSG--------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      +.+ +..|+||||+.+|+|.+++....        ...+.+..+..++.|++.||.|||++++   +||||||+||+++.
T Consensus        78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i---~H~dikp~nili~~  154 (288)
T cd05061          78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKF---VHRDLAARNCMVAH  154 (288)
T ss_pred             EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC---cCCCCChheEEEcC
Confidence            764 45899999999999999997532        1235677888999999999999999998   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhh
Q 037010          421 NFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKG  498 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~  498 (589)
                      ++.++|+|||++........ .......++..|+|||.+.++.++.++|+|||||++|||++ |..||....     ...
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-----~~~  229 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-----NEQ  229 (288)
T ss_pred             CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-----HHH
Confidence            99999999999875432211 11122345678999999988899999999999999999998 677773211     111


Q ss_pred             HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                         ......             +... ...+...+..+.+++.+||+.+|++|||+.++++.|....
T Consensus       230 ---~~~~~~-------------~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         230 ---VLKFVM-------------DGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ---HHHHHH-------------cCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence               111111             1100 0112233457999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-35  Score=310.38  Aligned_cols=266  Identities=22%  Similarity=0.319  Sum_probs=188.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ...+|++.+.||+|+||.||+|.+..+....               ++|....   .....|+.++++++||||++++++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v---------------alK~~~~---~~~~~E~~~l~~l~h~~iv~~~~~  125 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPV---------------VLKIGQK---GTTLIEAMLLQNVNHPSVIRMKDT  125 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceE---------------EEEeCCc---cccHHHHHHHHhCCCCCCcChhhe
Confidence            3467999999999999999999987653211               1221111   123458999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.++ ..++|||++. ++|.+++.... .++++..++.++.||+.||.|||++++   +||||||+|||++.++.+||+|
T Consensus       126 ~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~Nill~~~~~~kl~D  200 (357)
T PHA03209        126 LVSGAITCMVLPHYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRI---IHRDVKTENIFINDVDQVCIGD  200 (357)
T ss_pred             EEeCCeeEEEEEccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEEec
Confidence            7654 5889999995 58999887644 358999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh------hhHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS------KGLVAL  502 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~------~~~~~~  502 (589)
                      ||++......  .......||+.|+|||++.+..++.++|||||||++|||+++..++..........      ..+...
T Consensus       201 fG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~  278 (357)
T PHA03209        201 LGAAQFPVVA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKI  278 (357)
T ss_pred             CccccccccC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHH
Confidence            9998743221  12234578999999999998899999999999999999999777664433221110      011111


Q ss_pred             HHHHhcCC------ChHHhhHhhcCCCCCCCC---------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLP------DPIEDLRKLVDPRLGDNC---------PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~------~~~~~l~~~~d~~l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ....-..+      .........++.......         ..+....+.+|+.+||+.||.+|||++|+++|
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        279 ISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             HHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            11100000      000011111110000000         01223356779999999999999999999987

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.9e-35  Score=294.06  Aligned_cols=258  Identities=23%  Similarity=0.380  Sum_probs=192.8

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|.+.+.||+|++|.||+|.+..+.. ..+.|.+......  ...+....+..+.+.+|++++++++||||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~-~~~~k~~~~~~~~--~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGE-LMAVKQVELPSVS--ASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCc-EEEEEEecCCCcc--cchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Confidence            47788999999999999998765432 2222221111000  00011122234568889999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..+++|||+++++|.+++....  .+++..+..++.|++.||+|||++++   +||||+|+||++++++.++|+|||+
T Consensus        78 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~i---vH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          78 ADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGI---IHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             CCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCc---ccccCCHHHEEEcCCCCEEecccCC
Confidence             56899999999999999997653  48889999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCC-----CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          432 TKLTEVGSA-----SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       432 a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ++.......     .......|+..|+|||.+....++.++|+|||||++|+|++|+.||.....       .... ...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~-~~~  224 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQAI-FKI  224 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HHHH-HHH
Confidence            876542111     111224578899999999888899999999999999999999999853211       0010 010


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                .....+.    .+...+..+.+++.+||+.||.+||++.|++++
T Consensus       225 ----------~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         225 ----------GENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ----------hccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                      1111122    223344578999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=283.83  Aligned_cols=261  Identities=23%  Similarity=0.380  Sum_probs=195.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCC-CCcceeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVH-HLNLVRL  346 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~-hpnIv~l  346 (589)
                      ++.+.+..||.|+.|.|++++++.++.               ..++|.+    +.+..++++..++++.+.+ +|+||+.
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~---------------iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c  156 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGH---------------IIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQC  156 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccce---------------EEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeee
Confidence            455667889999999999999887522               2333333    3456677888888876664 8999999


Q ss_pred             eeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      +|+|. +..+++.||.|.. .+..++.. -..++++..+-++...+..||.||.++.-  ++|||+||+|||+|+.|.+|
T Consensus       157 ~GyFi~n~dV~IcMelMs~-C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniK  232 (391)
T KOG0983|consen  157 FGYFITNTDVFICMELMST-CAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIK  232 (391)
T ss_pred             eeEEeeCchHHHHHHHHHH-HHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEE
Confidence            99887 5568999999854 44454443 34569999999999999999999987642  49999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |||||++-..-.  ....++..|.+.|||||.+.   ...|+.++||||||++++||.||+.||.....+       ++.
T Consensus       233 lCDFGIsGrlvd--SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~  303 (391)
T KOG0983|consen  233 LCDFGISGRLVD--SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEV  303 (391)
T ss_pred             eecccccceeec--ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHH
Confidence            999999876532  23345678999999999985   346899999999999999999999999543321       122


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWD  572 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~  572 (589)
                      +..+++..          .|.++..  ...+..+.+++..||++|+.+||.+.++++|-.-.......-+
T Consensus       304 ltkvln~e----------PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~d  361 (391)
T KOG0983|consen  304 LTKVLNEE----------PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVD  361 (391)
T ss_pred             HHHHHhcC----------CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhcc
Confidence            22222211          1222211  1245679999999999999999999999999665555444433

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.4e-35  Score=297.22  Aligned_cols=259  Identities=22%  Similarity=0.361  Sum_probs=194.0

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCc
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLN  342 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpn  342 (589)
                      ..++....+.|++.+.||.|+||.||+|.+.... ...+.|...            .......++..|+.+++++ +|+|
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~a~K~~~------------~~~~~~~~~~~e~~~l~~~~~h~~   74 (282)
T cd06636           8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTG-QLAAIKVMD------------VTEDEEEEIKLEINMLKKYSHHRN   74 (282)
T ss_pred             hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCC-cEEEEEEEe------------cChHHHHHHHHHHHHHHHhcCCCc
Confidence            3444456678999999999999999999986542 222222111            1122334577799999888 6999


Q ss_pred             ceeEeeEEE-------eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          343 LVRLIGYCV-------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       343 Iv~l~~~~~-------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      |+++++++.       ++..|++|||+.+|+|.+++.......+++..+..++.|++.||.|||++++   +|+||||+|
T Consensus        75 i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i---vH~dl~~~n  151 (282)
T cd06636          75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKV---IHRDIKGQN  151 (282)
T ss_pred             EEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHH
Confidence            999999774       2358999999999999999987655568888899999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      |++++++.++|+|||++........ ......|++.|+|||.+.     ...++.++|+|||||++|||++|+.||....
T Consensus       152 ili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         152 VLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             EEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            9999999999999999875432211 223356899999999875     3467889999999999999999999984322


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..    ...   . ...          ....+.   ......+..+.+++.+||..||.+||++.|+++|
T Consensus       231 ~~----~~~---~-~~~----------~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         231 PM----RAL---F-LIP----------RNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             HH----hhh---h-hHh----------hCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            10    000   0 000          000111   1112234578999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.5e-35  Score=299.41  Aligned_cols=273  Identities=25%  Similarity=0.439  Sum_probs=192.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhh---hhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcc
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICV---NLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNL  343 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~---~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnI  343 (589)
                      .++|++.++||+|+||.||++.+.+....  ..+....   ......+++|..    ......++.+|++++++++|+||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~--~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKF--MDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhhceeeeeccCCCCCeEEeccccccccc--ccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc
Confidence            35799999999999999999875442110  0000000   000011222222    22344678899999999999999


Q ss_pred             eeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          344 VRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR---------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       344 v~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      +++++++.+ +..+++|||+.+++|.+++.....         ..+++..++.++.|++.||+|||++++   +|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i---~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCe---ecccCCh
Confidence            999998764 568999999999999999976432         236778899999999999999999998   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc--CCcccccCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS--AKEAIVKGN  490 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt--G~~p~~~~~  490 (589)
                      +|||++.++.++|+|||++........ .......+++.|++||....+.++.++|+|||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            999999999999999999875432221 11122344678999999888889999999999999999998  667774322


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                      ..     ...........         .. ........+..++..+.+|+.+||+.||.+||++.+|++.|++
T Consensus       239 ~~-----~~~~~~~~~~~---------~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         239 DE-----QVIENTGEFFR---------DQ-GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             hH-----HHHHHHHHHHh---------hc-cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11     11110001000         00 0000001122234578999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=312.80  Aligned_cols=252  Identities=24%  Similarity=0.388  Sum_probs=201.9

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH----HHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----QASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      .++.++||+|.||.|++|.|...+++..            .+++|-++.    ....+|++|+.+|.+|+|+|++++||+
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V------------~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGv  179 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHV------------NVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGV  179 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEE------------eEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeee
Confidence            3467899999999999999988655443            233333221    256789999999999999999999999


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      ..+....||||++..|+|.+.|+......|.......++.|||.||.||..+++   |||||-..|+|+.....|||+||
T Consensus       180 Vl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrl---vHRDLAARNlllasprtVKI~DF  256 (1039)
T KOG0199|consen  180 VLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRL---VHRDLAARNLLLASPRTVKICDF  256 (1039)
T ss_pred             eccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhh---hhhhhhhhhheecccceeeeecc
Confidence            988888999999999999999998666678899999999999999999999998   99999999999999889999999


Q ss_pred             cCccccccCCCCC--CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCC-cccccCCCCCCChhhHHHHHHHH
Q 037010          430 GLTKLTEVGSASL--PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK-EAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       430 gla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |+.+.........  .....-...|+|||.++...++.++|||+|||++|||+|+. .||.+-.+               
T Consensus       257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------  321 (1039)
T KOG0199|consen  257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------  321 (1039)
T ss_pred             cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------
Confidence            9998665433221  11123456799999999999999999999999999999854 45532221               


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                             -.+.+.+|..-.-..|..+++.++++++.||..+|++|||+..|.+.+.
T Consensus       322 -------~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  322 -------IQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             -------HHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence                   1122233322223456778889999999999999999999999986543

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3e-35  Score=291.97  Aligned_cols=252  Identities=27%  Similarity=0.440  Sum_probs=194.8

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|+||.||++....++. .++.|.+.         .........+++.+|++++++++||||+++++++.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~-~~~ik~~~---------~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGK-QYVIKEIN---------ISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE   70 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCC-EEEEEEEE---------hHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC
Confidence            58899999999999999998766432 22222111         111222334567889999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..|+||||+.+++|.+++.......+++.+++.++.|++.||.|||++++   +|+||+|+||+++.++.++|+|||+
T Consensus        71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i---~h~~l~~~nil~~~~~~~~l~d~~~  147 (256)
T cd08218          71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI---LHRDIKSQNIFLTKDGTIKLGDFGI  147 (256)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEEcCCCCEEEeeccc
Confidence             568999999999999999987655568899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +........ ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.....        .........   
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~---  215 (256)
T cd08218         148 ARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIR---  215 (256)
T ss_pred             eeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhc---
Confidence            875432211 11234678899999999888899999999999999999999999843211        111111111   


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                ... ...+......+.+++.+||+.+|.+||++.+|++|
T Consensus       216 ----------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         216 ----------GSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ----------CCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                      010 11233445578999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=313.72  Aligned_cols=243  Identities=26%  Similarity=0.424  Sum_probs=195.9

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH---HHHHHHHHHHHHccCCCCcceeEeeEEEeCc
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ---ASREFLAELKVLTHVHHLNLVRLIGYCVEGS  354 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~  354 (589)
                      -.||+|.||+||.|++..+.               ..+++|.+...   ..+-+..|+.+-++|+|.|||+++|.+.++.
T Consensus       581 vVLGKGTYG~VYA~RD~~tq---------------vrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG  645 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQ---------------VRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG  645 (1226)
T ss_pred             EEeecCceeEEEeeccccce---------------eEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC
Confidence            46999999999999988761               23455555432   3345778999999999999999999887554


Q ss_pred             -EEEEEEecCCCChHHHHhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-CCcEEEEecc
Q 037010          355 -LFLVYEYIENGNLSEHLRGSGRDPL--PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-NFHAKVADFG  430 (589)
Q Consensus       355 -~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-~~~vkl~Dfg  430 (589)
                       +-|.||.++||+|.+.++..- .|+  ++..+-.+..||++||.|||++.|   ||||||-+|+|++. .|.+||+|||
T Consensus       646 f~kIFMEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~I---VHRDIKGDNVLvNTySGvlKISDFG  721 (1226)
T KOG4279|consen  646 FFKIFMEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKI---VHRDIKGDNVLVNTYSGVLKISDFG  721 (1226)
T ss_pred             eEEEEeecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcce---eeccccCCcEEEeeccceEEecccc
Confidence             568999999999999998643 235  788889999999999999999998   99999999999964 6889999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCC--CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      -++....-+. -..++.||..|||||++..+  .|..++|||||||++.||.||++||..-...      ...+++-.+ 
T Consensus       722 TsKRLAginP-~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------qAAMFkVGm-  793 (1226)
T KOG4279|consen  722 TSKRLAGINP-CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------QAAMFKVGM-  793 (1226)
T ss_pred             cchhhccCCc-cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------hHhhhhhcc-
Confidence            9987654333 34558899999999999765  5889999999999999999999999654431      112222111 


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                   -......|.+...+...++.+|+..||.+||+++++++-
T Consensus       794 -------------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  794 -------------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             -------------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence                         112346788889999999999999999999999999875

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-35  Score=294.21  Aligned_cols=244  Identities=23%  Similarity=0.404  Sum_probs=182.3

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC---HHHHHHHHHHHHHHccCCCCcceeEeeEEEe-C
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD---MQASREFLAELKVLTHVHHLNLVRLIGYCVE-G  353 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~  353 (589)
                      +.||+|+||.||+|............        ..++++|...   ....+.+.+|+.+++.++||||+++++++.. +
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~--------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   72 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELH--------KTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD   72 (258)
T ss_pred             CCCCcccchhheeeeecccccccccc--------cchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence            46999999999999876543221110        1123333332   2334568889999999999999999998765 5


Q ss_pred             cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc--------EE
Q 037010          354 SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH--------AK  425 (589)
Q Consensus       354 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~--------vk  425 (589)
                      ..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+||+++.++.        ++
T Consensus        73 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i---iH~dlkp~nili~~~~~~~~~~~~~~~  148 (258)
T cd05078          73 ESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKGL---THGNVCAKNVLLIREEDRKTGNPPFIK  148 (258)
T ss_pred             CcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCccceEEEecccccccCCCceEE
Confidence            68999999999999999986543 48899999999999999999999998   99999999999987664        69


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ++|||++.....     .....+++.|+|||++.+ ..++.++|||||||++|||++|..++.....    .........
T Consensus       149 l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~----~~~~~~~~~  219 (258)
T cd05078         149 LSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD----SQKKLQFYE  219 (258)
T ss_pred             ecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc----HHHHHHHHH
Confidence            999998764422     123467889999999876 4578999999999999999999644322111    011010000


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .               .    ...+......+.+++.+||+.+|++|||++++++.|
T Consensus       220 ~---------------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 D---------------R----HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             c---------------c----ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            0               0    112222335689999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.2e-35  Score=293.80  Aligned_cols=255  Identities=22%  Similarity=0.343  Sum_probs=188.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .+|+..+.||+|+||.||++.+..++. ..+.|.+....      ...........+.+|++++++++||||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~k~~~~~~------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   74 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGR-ELAAKQVQFDP------ESPETSKEVSALECEIQLLKNLQHERIVQYYGCLR   74 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCc-EEEEEEeecCc------CCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEE
Confidence            468899999999999999998766532 22222111000      00011123456788999999999999999999775


Q ss_pred             e---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 E---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +   +..+++|||+++++|.+++....  .+++...+.++.|++.||+|||++++   +|+||||+||+++.++.++|+|
T Consensus        75 ~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i---~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          75 DRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMI---VHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             cCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEECCCCCEEEcc
Confidence            4   35789999999999999997654  38889999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCC--CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGS--ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ||++.......  ........++..|+|||.+.+..++.++|||||||++|||++|+.||.....    ...    ....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~----~~~~  221 (266)
T cd06651         150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAA----IFKI  221 (266)
T ss_pred             CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHH----HHHH
Confidence            99987543211  1111224578899999999888899999999999999999999999843211    000    0000


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..         ....+    ..+......+.+++ +||..+|++||+++||++|
T Consensus       222 ~~---------~~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         222 AT---------QPTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             hc---------CCCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            00         00111    22333344667777 6888999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-35  Score=296.41  Aligned_cols=250  Identities=22%  Similarity=0.363  Sum_probs=193.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ..|+..++||.|+||.||+|.+..+... .+.|.+..          .........+.+|+++++++.||||+++++.+.
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~-vaiK~~~~----------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQV-VAIKIIDL----------EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL   72 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEE-EEEEEEec----------cccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            4577889999999999999987664322 22221110          111233467888999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+.+++|.+++...   ++++.....++.|++.||+|||+.++   +|+||+|+||+++.++.++|+|||
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~i---vH~dl~p~Nil~~~~~~~~l~dfg  146 (277)
T cd06640          73 KGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFG  146 (277)
T ss_pred             ECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCc---cCcCCChhhEEEcCCCCEEEcccc
Confidence            5 4589999999999999998753   48889999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++........ ......++..|+|||.+.+..++.++|+|||||++|||+||+.||......     ..   ..      
T Consensus       147 ~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~---~~------  211 (277)
T cd06640         147 VAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-----RV---LF------  211 (277)
T ss_pred             cceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-----hH---hh------
Confidence            9875533221 122346788999999998888999999999999999999999998432210     00   00      


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                              ..........+...+..+.+++.+||+.+|++||++++++.|-
T Consensus       212 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         212 --------LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             --------hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence                    0011111223445566899999999999999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-35  Score=292.89  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=193.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH-HHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-ASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ++|++.+.||+|+||.||++.+..+. ...+              +|..... ..+++.+|++++++++||||+++++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~-~~~~--------------~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~   67 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETG-QVVA--------------IKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY   67 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCC-cEEE--------------EEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeee
Confidence            67999999999999999999877642 2222              2222211 156788999999999999999999977


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ ...|+++||+.+++|.+++.... ..+++..+..++.|++.||.|||+.++   +|+||+|+||+++.++.++|+||
T Consensus        68 ~~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i---~H~dl~~~ni~~~~~~~~~l~df  143 (256)
T cd06612          68 FKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKK---IHRDIKAGNILLNEEGQAKLADF  143 (256)
T ss_pred             ecCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCcceEEECCCCcEEEccc
Confidence            64 56899999999999999997544 358999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++........ ......++..|+|||++.+..++.++||||||+++|+|++|+.||......        ........ 
T Consensus       144 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~~~~~~-  213 (256)
T cd06612         144 GVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIFMIPN-  213 (256)
T ss_pred             ccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhhhhhcc-
Confidence            99886543221 222345788999999998889999999999999999999999998532110        00000000 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                               ...+.  ...+......+.+++.+||+.+|.+|||++|+++|
T Consensus       214 ---------~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         214 ---------KPPPT--LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             ---------CCCCC--CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence                     00000  11223344578999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.7e-35  Score=298.92  Aligned_cols=261  Identities=20%  Similarity=0.334  Sum_probs=193.3

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCc
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLN  342 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpn  342 (589)
                      ++.+....++|++.+.||+|+||.||++.+..+.. .++.|...            .......++.+|+++++++ +|||
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~-~~~ik~~~------------~~~~~~~~~~~e~~~l~~l~~h~~   76 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGS-KAAVKILD------------PIHDIDEEIEAEYNILKALSDHPN   76 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCc-eeEEEeec------------cccchHHHHHHHHHHHHHHhcCCC
Confidence            45556678899999999999999999998766532 22222110            0111234567899999999 6999


Q ss_pred             ceeEeeEEE------eCcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCC
Q 037010          343 LVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA  414 (589)
Q Consensus       343 Iv~l~~~~~------~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~  414 (589)
                      |+++++++.      ++..++||||+++++|.+++...  ....+++..+..++.|++.||.|||++++   +||||||+
T Consensus        77 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~  153 (286)
T cd06638          77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT---IHRDVKGN  153 (286)
T ss_pred             eeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCc---cccCCCHH
Confidence            999999763      23489999999999999988642  23458889999999999999999999998   99999999


Q ss_pred             cEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-----CCCCcccchhhHHHHHHHHHcCCcccccC
Q 037010          415 NILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-----GDVSPKVDVYAFGVVLYELISAKEAIVKG  489 (589)
Q Consensus       415 NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSlGvll~elltG~~p~~~~  489 (589)
                      ||+++.++.++|+|||++........ ......|++.|+|||++..     ..++.++|||||||++|||++|+.||...
T Consensus       154 nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         154 NILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             hEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999876532211 2233568999999998753     45788999999999999999999998533


Q ss_pred             CCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ...        ........          ...+..  ..+......+.+++.+||+.||++|||++|+++|+
T Consensus       233 ~~~--------~~~~~~~~----------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         233 HPM--------RALFKIPR----------NPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             chh--------HHHhhccc----------cCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            210        00000000          000000  01112234689999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.2e-35  Score=291.60  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=193.3

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      +|++.+.||+|+||.||++....+.. ..+.|.+.         ...........+.+|++++++++|||++++++.+. 
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~-~~~ik~~~---------~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQK-LVIIKQIP---------VEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE   70 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCc-EEEEEEEe---------ccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec
Confidence            58899999999999999998766432 22222211         11122334567888999999999999999998765 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC-CcEEEEecc
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHAKVADFG  430 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~-~~vkl~Dfg  430 (589)
                      ++..++||||+++++|.+++.......+++..+..++.+++.+|+|||++++   +|+||||+||+++.+ +.+||+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i---~h~dl~~~nil~~~~~~~~~l~d~~  147 (256)
T cd08220          71 DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI---LHRDLKTQNILLDKHKMVVKIGDFG  147 (256)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEEccCC
Confidence            4568999999999999999987655568999999999999999999999998   999999999999855 468999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++.......  ......++..|+|||.+....++.++||||||+++|+|++|+.||.....        .........  
T Consensus       148 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~--  215 (256)
T cd08220         148 ISKILSSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMS--  215 (256)
T ss_pred             CceecCCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHh--
Confidence            988654322  22335688999999999888899999999999999999999999843321        011111110  


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                 .. ....+...+..+.+++.+||..+|.+|||++|+++|
T Consensus       216 -----------~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         216 -----------GT-FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             -----------cC-CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                       00 011122334568999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-35  Score=305.52  Aligned_cols=245  Identities=25%  Similarity=0.373  Sum_probs=181.8

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHH-HHccCCCCcceeEeeEEE-eCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK-VLTHVHHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~~~-~~~~  355 (589)
                      +.||+|+||.||+|.+..++ ..++.|.+..     ...   .......++..|.. +++.++||||+++++.+. ++..
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~-----~~~---~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~   71 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDG-KCYAVKVLQK-----KIV---LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKL   71 (325)
T ss_pred             CceeeCCCeEEEEEEECCCC-CEEEEEEEEH-----HHh---hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEE
Confidence            46999999999999876542 2333222211     110   11122234455554 467889999999998776 4568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+.+|+|..++....  .+++..+..++.||+.||+|||++|+   +||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~gi---vH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          72 YFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINI---VYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            99999999999999887644  48999999999999999999999998   99999999999999999999999998743


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ...+..+...      
T Consensus       147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~~------  211 (325)
T cd05604         147 IAQ-SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILHK------  211 (325)
T ss_pred             CCC-CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHcC------
Confidence            221 1222346799999999999999999999999999999999999999954321        1122222111      


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR----SIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~----evl~~  560 (589)
                             .+  ..++.....+.+++.+|++.+|.+||+++    ++++|
T Consensus       212 -------~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         212 -------PL--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             -------Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence                   00  11122345688999999999999999875    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5e-35  Score=290.62  Aligned_cols=248  Identities=30%  Similarity=0.522  Sum_probs=190.5

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCcceeEeeEEEe-
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNLVRLIGYCVE-  352 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  352 (589)
                      +.||+|+||.||+|.+......   ..         .+++|...    ....+.+.+|+++++.++|+||+++++++.+ 
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~---~~---------~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   68 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGK---TT---------EVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE   68 (262)
T ss_pred             CccccCCceEEEEEEEecCCCC---Cc---------eEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC
Confidence            4699999999999988753100   00         12222221    1135678889999999999999999998765 


Q ss_pred             CcEEEEEEecCCCChHHHHhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSG-------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      +..+++|||+++++|.+++....       ...+++..++.++.|++.||+|||++++   +|+||||+||+++.++.++
T Consensus        69 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i---~H~di~p~nili~~~~~~~  145 (262)
T cd00192          69 EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKF---VHRDLAARNCLVGEDLVVK  145 (262)
T ss_pred             CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCc---ccCccCcceEEECCCCcEE
Confidence            56899999999999999998752       2458999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHH
Q 037010          426 VADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       426 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      |+|||.+........ .......+++.|+|||.+....++.++||||||+++|+|++ |..||.....     .   ...
T Consensus       146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~---~~~  217 (262)
T cd00192         146 ISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----E---EVL  217 (262)
T ss_pred             EcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----H---HHH
Confidence            999999986543321 11233567889999999988889999999999999999999 5888743311     1   111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      .....              ......+...+..+.+++.+||+.+|.+|||++|++++|+
T Consensus       218 ~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         218 EYLRK--------------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHc--------------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11111              0011223344567999999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.7e-35  Score=305.11  Aligned_cols=269  Identities=19%  Similarity=0.244  Sum_probs=186.1

Q ss_pred             cceeeccC--CcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-
Q 037010          276 MSHKIGQG--GFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-  352 (589)
Q Consensus       276 ~~~~LG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  352 (589)
                      +.++||+|  +|++||++..+.++... +.|.+.         .........+.+.+|+++++.++||||+++++++.+ 
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~v-aiK~~~---------~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~   71 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYV-TVRRIN---------LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   71 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEE-EEEEec---------hhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Confidence            56789999  78999999887663222 111111         111112234557789999999999999999998764 


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      +..|+||||+++|+|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.++.++++||+..
T Consensus        72 ~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i---iH~dlkp~Nil~~~~~~~~l~~~~~~  148 (327)
T cd08227          72 NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSN  148 (327)
T ss_pred             CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCChhhEEEecCCcEEEcccchh
Confidence            568999999999999999976554568999999999999999999999998   99999999999999999999999865


Q ss_pred             cccccCCC------CCCcccccCCCCCchhcccC--CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          433 KLTEVGSA------SLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       433 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ........      .......++..|+|||++..  ..++.++|||||||++|||++|+.||.......    .......
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~  224 (327)
T cd08227         149 LSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKLN  224 (327)
T ss_pred             hccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH----HHHHHhc
Confidence            43211110      01112356778999999865  468999999999999999999999995322110    0000000


Q ss_pred             HH----hcC-CChHHhhHh-----hcCC-----------------CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 037010          505 EV----LNL-PDPIEDLRK-----LVDP-----------------RLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI  557 (589)
Q Consensus       505 ~~----~~~-~~~~~~l~~-----~~d~-----------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  557 (589)
                      ..    ... ..+.+++..     ..+.                 .............+.+|+.+||+.||++|||++|+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~el  304 (327)
T cd08227         225 GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTL  304 (327)
T ss_pred             CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHH
Confidence            00    000 000000000     0000                 00001122334578999999999999999999999


Q ss_pred             HHHH
Q 037010          558 VVAL  561 (589)
Q Consensus       558 l~~L  561 (589)
                      ++|-
T Consensus       305 l~~p  308 (327)
T cd08227         305 LNHS  308 (327)
T ss_pred             hcCh
Confidence            9873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-35  Score=297.32  Aligned_cols=263  Identities=22%  Similarity=0.374  Sum_probs=196.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||+||++.+..++ ..++.|...          ........+.+.+|+++++.++||||+++++++
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~a~k~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   72 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTG-TVMAKKVVH----------IGAKSSVRKQILRELQIMHECRSPYIVSFYGAF   72 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCC-cEEEEEEEE----------ecCcchHHHHHHHHHHHHHHcCCCCcceEeeeE
Confidence            357889999999999999999876542 222222111          011223345688899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      .+ +.+|+||||+++++|.+++...+  ++++.....++.+++.+|.|||+ +++   +|+||||+||++++++.++|+|
T Consensus        73 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i---~H~dl~p~nil~~~~~~~~l~d  147 (284)
T cd06620          73 LNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRI---MHRDIKPSNILVNSRGQIKLCD  147 (284)
T ss_pred             ecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCe---eccCCCHHHEEECCCCcEEEcc
Confidence            64 56899999999999999987643  48999999999999999999997 577   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC---hhhHHHHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD---SKGLVALFEE  505 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~---~~~~~~~~~~  505 (589)
                      ||++.......   .....|+..|+|||++.+..++.++|+|||||++|+|+||+.||.........   ..........
T Consensus       148 ~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~  224 (284)
T cd06620         148 FGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ  224 (284)
T ss_pred             CCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence            99886432211   12357899999999998889999999999999999999999999643321110   0111111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                                   .+..........+.+..+.+|+.+||+.||.+|||++|++++..-+.
T Consensus       225 -------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         225 -------------IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             -------------HhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence                         11111101111124457899999999999999999999999854444

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-35  Score=293.11  Aligned_cols=248  Identities=21%  Similarity=0.316  Sum_probs=179.5

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC---HHHHHHHHHHHHHHccCCCCcceeEeeEEEe-C
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD---MQASREFLAELKVLTHVHHLNLVRLIGYCVE-G  353 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~---~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~  353 (589)
                      +.||+|+||.||+|....+.......   .......++++|...   ......+.+|+.+++.++||||+++++++.+ .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~---~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDG---YSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccc---cchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            46899999999999865432111000   000001122333222   2334567889999999999999999998864 4


Q ss_pred             cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc-------EEE
Q 037010          354 SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH-------AKV  426 (589)
Q Consensus       354 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~-------vkl  426 (589)
                      ..+++|||+++|+|..++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.       +++
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDL---VHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCe---ECCCCCcccEEEecCCccCCCCceeEe
Confidence            5899999999999998887543 348999999999999999999999998   99999999999987654       899


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhccc-CCCCCcccchhhHHHHHHHHH-cCCcccccCCCCCCChhhHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELI-SAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSlGvll~ell-tG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      +|||++......     ....++..|+|||.+. ...++.++|||||||++|||+ +|..|+......     .    ..
T Consensus       154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----~----~~  219 (262)
T cd05077         154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-----E----KE  219 (262)
T ss_pred             CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-----H----HH
Confidence            999988654211     2245788999999886 467899999999999999998 577766322110     0    00


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ....             ....  ........+.+|+.+||+.||.+||++++|++++
T Consensus       220 ~~~~-------------~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         220 RFYE-------------GQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHHh-------------cCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            0000             0000  0111234689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.5e-35  Score=292.49  Aligned_cols=255  Identities=21%  Similarity=0.316  Sum_probs=190.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .+|++.+.||+|+||.||++.+..++.. .+.|.+..     .. .........+.+.+|++++++++||||+++++++.
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~-v~ik~~~~-----~~-~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   74 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRE-LAVKQVQF-----DP-ESPETSKEVNALECEIQLLKNLLHERIVQYYGCLR   74 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcE-EEEEEeec-----Cc-CCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEec
Confidence            5789999999999999999987665322 22111100     00 00011233456788999999999999999999776


Q ss_pred             e---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 E---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +   ..++++|||+++++|.+++....  .+++...+.++.|++.||+|||++++   +|+||||+||+++.++.++|+|
T Consensus        75 ~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i---~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          75 DPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMI---VHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             cCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEecCCCCEEECc
Confidence            4   34789999999999999987653  37888899999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCC--CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ||++........  .......++..|+|||.+.+..++.++|||||||++|||++|+.||.....       .... ...
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~-~~~  221 (265)
T cd06652         150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAAI-FKI  221 (265)
T ss_pred             CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHHH-HHH
Confidence            999875432111  111234688899999999888899999999999999999999999842210       1111 111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .             ........+......+.+++.+||. +|++||+++|+++|
T Consensus       222 ~-------------~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         222 A-------------TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             h-------------cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            1             0111122344555678899999995 99999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=295.42  Aligned_cols=251  Identities=25%  Similarity=0.380  Sum_probs=193.8

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||.|+||.||+|.+..++ ...+.|.+..          .........+.+|++++++++|+||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~ik~~~~----------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   69 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTN-QVVAIKVIDL----------EEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL   69 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCC-eEEEEEEeec----------cccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE
Confidence            46889999999999999999877643 2222222110          011223456788999999999999999999776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + ...|+|+||+.+++|.+++...   ++++..++.++.|++.||.|||++++   +|+||+|+||++++++.++|+|||
T Consensus        70 ~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i---~h~dl~p~ni~i~~~~~~~l~d~g  143 (274)
T cd06609          70 KGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFG  143 (274)
T ss_pred             ECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEECCCCCEEEcccc
Confidence            4 4689999999999999999765   58999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++....... .......+++.|+|||.+.+..++.++||||||+++|+|+||+.||.....     ...   ....    
T Consensus       144 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-----~~~---~~~~----  210 (274)
T cd06609         144 VSGQLTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-----MRV---LFLI----  210 (274)
T ss_pred             cceeecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-----HHH---HHHh----
Confidence            998664332 122335688899999999888899999999999999999999999843221     000   0000    


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                            .....+.+...   ..+..+.+++.+||..+|++|||++++++|-
T Consensus       211 ------~~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~  252 (274)
T cd06609         211 ------PKNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKHK  252 (274)
T ss_pred             ------hhcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence                  01111111111   1344689999999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-35  Score=299.66  Aligned_cols=255  Identities=23%  Similarity=0.324  Sum_probs=194.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-HHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-MQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ++|++.+.||+|+||.||+|....++ ..++.|.+...         ... ....+.+..|++++++++||||+++++.+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~-~~~aiK~~~~~---------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   70 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTG-KLFALKVLDKK---------EMIKRNKVKRVLTEQEILATLDHPFLPTLYASF   70 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCC-cEEEEEEEecc---------ccchHHHHHHHHHHHHHHHhCCCCCchhheeee
Confidence            47899999999999999999887642 22222221111         111 12345688899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|++|||+.+++|.+++.......+++..++.++.|++.||+|||+.++   +|+||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~~l~df  147 (316)
T cd05574          71 QTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGI---VYRDLKPENILLHESGHIMLSDF  147 (316)
T ss_pred             ecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCe---eccCCChHHeEEcCCCCEEEeec
Confidence            65 458999999999999999987655679999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCC----------------------------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc
Q 037010          430 GLTKLTEVGSAS----------------------------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS  481 (589)
Q Consensus       430 gla~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt  481 (589)
                      |++.........                            ......|+..|+|||++.+..++.++||||||+++|+|++
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~  227 (316)
T cd05574         148 DLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLY  227 (316)
T ss_pred             chhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhh
Confidence            988754221110                            0112468899999999988889999999999999999999


Q ss_pred             CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHH
Q 037010          482 AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS----MRSI  557 (589)
Q Consensus       482 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ev  557 (589)
                      |+.||......        ..+....             .....-......+..+.+++.+||..+|++|||    ++|+
T Consensus       228 g~~pf~~~~~~--------~~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l  286 (316)
T cd05574         228 GTTPFKGSNRD--------ETFSNIL-------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI  286 (316)
T ss_pred             CCCCCCCCchH--------HHHHHHh-------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence            99998543210        1111111             111100011114557999999999999999999    8888


Q ss_pred             HHH
Q 037010          558 VVA  560 (589)
Q Consensus       558 l~~  560 (589)
                      +.|
T Consensus       287 l~~  289 (316)
T cd05574         287 KQH  289 (316)
T ss_pred             HcC
Confidence            876

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4e-35  Score=292.75  Aligned_cols=256  Identities=21%  Similarity=0.387  Sum_probs=190.5

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|+||.||+|....  +...+.|.+..+...     ..........+.+|++++++++|+||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~--~~~~avk~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQ--GQLIAVKQVELDTSN-----VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcC--CCeEEEEEeecCccc-----hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            57889999999999999997532  222222222111000     00112233568889999999999999999998865


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..+++|||+++++|.+++....  ++++..+..++.|++.||+|||+.++   +|+||+|+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~nil~~~~~~~~l~dfg~  148 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCV---VHRDIKGNNVMLMPNGIIKLIDFGC  148 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCcCHHhEEECCCCeEEeccchh
Confidence             45899999999999999997654  47899999999999999999999998   9999999999999999999999998


Q ss_pred             ccccccCC-----CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          432 TKLTEVGS-----ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       432 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      +.......     ........++..|+|||++.+..++.++|+|||||++|+|++|+.||.....     ..  . ....
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~--~-~~~~  220 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LA--A-MFYI  220 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HH--H-HHHh
Confidence            87542111     1111235688999999999988899999999999999999999999953211     00  0 0000


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...        ....+.+    +......+.+++.+||+.+|.+||++.|+++|
T Consensus       221 ~~~--------~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         221 GAH--------RGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             hhc--------cCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000        0011112    22334568999999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.9e-35  Score=300.86  Aligned_cols=267  Identities=22%  Similarity=0.339  Sum_probs=181.5

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCCCcceeEeeEEE---e
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHHLNLVRLIGYCV---E  352 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~---~  352 (589)
                      +.+||+|+||.||+|.........             .+++|.... .....+.+|++++++++||||+++++++.   +
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~-------------~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   72 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEK-------------EYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSD   72 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccc-------------eEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCC
Confidence            468999999999999875432111             122222211 11234677999999999999999999775   3


Q ss_pred             CcEEEEEEecCCCChHHHHhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE----cCC
Q 037010          353 GSLFLVYEYIENGNLSEHLRGS-------GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI----DKN  421 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl----~~~  421 (589)
                      ...|+||||+.+ +|.+++...       ....+++..++.++.|++.||+|||++++   +||||||+|||+    +.+
T Consensus        73 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i---vH~Dlkp~Nil~~~~~~~~  148 (317)
T cd07867          73 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWV---LHRDLKPANILVMGEGPER  148 (317)
T ss_pred             CeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCE---EcCCCCHHHEEEccCCCCC
Confidence            458999999875 888877532       12347888999999999999999999998   999999999999    566


Q ss_pred             CcEEEEeccCccccccCCCC--CCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC---
Q 037010          422 FHAKVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD---  495 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~---  495 (589)
                      +.+||+|||+++........  ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........   
T Consensus       149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~  228 (317)
T cd07867         149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  228 (317)
T ss_pred             CcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccccccccccc
Confidence            79999999999865432211  1233578999999998866 45889999999999999999999999644322111   


Q ss_pred             -hhhHHHHHHHHhcCCCh--HHhhH---------hhc-CCCCC--------CCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 037010          496 -SKGLVALFEEVLNLPDP--IEDLR---------KLV-DPRLG--------DNCPLDSVLKMAQLAKVCTQEYPQLRPSM  554 (589)
Q Consensus       496 -~~~~~~~~~~~~~~~~~--~~~l~---------~~~-d~~l~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~  554 (589)
                       ...........+..+..  ...+.         ... .....        ..........+.+|+.+||+.||.+|||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~  308 (317)
T cd07867         229 FHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS  308 (317)
T ss_pred             ccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH
Confidence             01111111111111100  00000         000 00000        00011123468889999999999999999


Q ss_pred             HHHHHH
Q 037010          555 RSIVVA  560 (589)
Q Consensus       555 ~evl~~  560 (589)
                      +|+++|
T Consensus       309 ~e~l~h  314 (317)
T cd07867         309 EQALQD  314 (317)
T ss_pred             HHHhcC
Confidence            999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-35  Score=287.69  Aligned_cols=247  Identities=28%  Similarity=0.483  Sum_probs=185.8

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLF  356 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~  356 (589)
                      ++||+|+||.||++.+..  +...+.|.+..          .........+.+|++++++++|+||+++++++.+ +..+
T Consensus         1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~----------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   68 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRS----------TLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIY   68 (251)
T ss_pred             CccccCCCceEEEEEEeC--CCcEEEEeccc----------cCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeE
Confidence            469999999999998765  22222221110          1111344578889999999999999999998764 5689


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      +||||+.+++|.+++..... .+++..+..++.+++.+|+|||++++   +||||||+||+++.++.++|+|||++....
T Consensus        69 ~v~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~~i---~h~di~p~nili~~~~~~~l~d~g~~~~~~  144 (251)
T cd05041          69 IVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSREEE  144 (251)
T ss_pred             EEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCE---ehhhcCcceEEEcCCCcEEEeecccccccc
Confidence            99999999999999976433 47889999999999999999999998   999999999999999999999999987543


Q ss_pred             cCCCCCC-cccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHH
Q 037010          437 VGSASLP-TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE  514 (589)
Q Consensus       437 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (589)
                      ....... ....++..|+|||.+.++.++.++|+||||+++|||+| |..||.....     ...   ....        
T Consensus       145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~~---~~~~--------  208 (251)
T cd05041         145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQT---RERI--------  208 (251)
T ss_pred             CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HHH---HHHH--------
Confidence            2111111 11234567999999988899999999999999999999 7777733211     011   1111        


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                            ........+...+..+.+++.+||..+|.+|||++||++.|.
T Consensus       209 ------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         209 ------ESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ------hcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                  111111123334557999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.4e-35  Score=290.48  Aligned_cols=246  Identities=23%  Similarity=0.400  Sum_probs=184.2

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEeeEEEeCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLIGYCVEGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~  355 (589)
                      +.||+|+||.||++.+..........+...     ..+++|....  .....+.+|+.++++++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~-----~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQE-----VSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccc-----eeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEecCCc
Confidence            469999999999999876542211111100     1122232221  114678889999999999999999998877778


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-------cEEEEe
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-------HAKVAD  428 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-------~vkl~D  428 (589)
                      ++||||+.+|+|.+++..... .+++..+..++.|++.||+|||++++   +||||||+|||++.++       .+||+|
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKKL---VHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCe---ecccCccceEEEecCccccCCceeEEeCC
Confidence            999999999999999987553 58899999999999999999999998   9999999999999887       799999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCC--CCCcccchhhHHHHHHHHHcC-CcccccCCCCCCChhhHHHHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELISA-KEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      ||++.....     .....++..|+|||++...  .++.++||||||+++|||++| ..|+.....     ......+. 
T Consensus       152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----~~~~~~~~-  220 (259)
T cd05037         152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----SEKERFYQ-  220 (259)
T ss_pred             CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----hhHHHHHh-
Confidence            999876432     1224567789999998776  789999999999999999995 556533211     00000000 


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                     ...   ..+......+.+++.+||..+|.+|||+.++++.|
T Consensus       221 ---------------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 ---------------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ---------------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                           000   00111115789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.9e-35  Score=295.58  Aligned_cols=253  Identities=21%  Similarity=0.377  Sum_probs=191.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .+.|++.++||.|+||.||+|.+..++. ..+.+..           +.......+.+.+|++++++++||||+++++.+
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~-~~~~k~~-----------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   78 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGA-LAAAKVI-----------ETKSEEELEDYMVEIEILATCNHPYIVKLLGAF   78 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCc-eEEEEEe-----------ccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEE
Confidence            4679999999999999999998766532 1211111           111234456788899999999999999999976


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..|+||||+++++|..++.... ..+++..++.++.|++.+|.|||++++   +||||||+||+++.++.++|+||
T Consensus        79 ~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~kl~df  154 (292)
T cd06644          79 YWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKI---IHRDLKAGNVLLTLDGDIKLADF  154 (292)
T ss_pred             EeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCe---eecCCCcceEEEcCCCCEEEccC
Confidence            5 566999999999999988876543 348999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |++...... ........+++.|+|||++.     ...++.++|+|||||++|||++|+.||.....        .....
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~  225 (292)
T cd06644         155 GVSAKNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLL  225 (292)
T ss_pred             ccceecccc-ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHH
Confidence            988653221 11223356889999999884     34578899999999999999999999843221        01111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ......          .+.  ...+......+.+++.+||..+|++||+++++++|
T Consensus       226 ~~~~~~----------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         226 KIAKSE----------PPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             HHhcCC----------Ccc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            111110          000  01122334568999999999999999999999987

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.6e-35  Score=290.94  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=194.6

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||.|+||.||++.+..++. ..+.+.+.         .........+++..|++++++++||||+++++++..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~-~~~~k~~~---------~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGK-ILVWKEID---------YGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID   70 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCC-EEEEEEEe---------cccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec
Confidence            58889999999999999998776532 22222111         112233345668889999999999999999987653


Q ss_pred             ---CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceEeeccCCCcEEEcCCC
Q 037010          353 ---GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIH-----EHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       353 ---~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH-----~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                         ...|++|||+++++|.+++...  ...++++..++.++.|++.||.|||     +.++   +|+||||+||+++.++
T Consensus        71 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i---~h~dl~p~nili~~~~  147 (265)
T cd08217          71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTV---LHRDLKPANIFLDANN  147 (265)
T ss_pred             CCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcc---eecCCCHHHEEEecCC
Confidence               3479999999999999999753  2345899999999999999999999     7777   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+||+|||++......... .....+++.|+|||.+....++.++|+||||+++|+|++|+.||.....     ..   .
T Consensus       148 ~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~---~  218 (265)
T cd08217         148 NVKLGDFGLAKILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQ---L  218 (265)
T ss_pred             CEEEecccccccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HH---H
Confidence            9999999998865433221 2335689999999999888899999999999999999999999853321     11   1


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .....          ..    .....+...+..+.+++.+||+.+|.+||++++|++|
T Consensus       219 ~~~~~----------~~----~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         219 ASKIK----------EG----KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHh----------cC----CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            11111          11    1112233445678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-35  Score=299.20  Aligned_cols=269  Identities=20%  Similarity=0.277  Sum_probs=189.2

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|++|.||+|.+..++. ..+.|.+.         ...........+.+|+.++++++||||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-~~~ik~~~---------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQ-IVAMKKIR---------LESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ   70 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCc-EEEEEEec---------cccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee
Confidence            58889999999999999998765532 22222111         001111223457789999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       +..|+||||+. ++|.+++..... ..+++..++.++.|++.||.|||++++   +|+||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~dl~p~nil~~~~~~~~l~dfg  146 (285)
T cd07861          71 ESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV---LHRDLKPQNLLIDNKGVIKLADFG  146 (285)
T ss_pred             CCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCe---eecCCCHHHEEEcCCCcEEECccc
Confidence             56899999997 589998875432 468999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||......    .............
T Consensus       147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~  221 (285)
T cd07861         147 LARAFGIPVR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFRILGTP  221 (285)
T ss_pred             ceeecCCCcc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCC
Confidence            9875433221 1223467889999998765 35788999999999999999999998543211    1111111111000


Q ss_pred             -------CChHHhhHhhcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 -------PDPIEDLRKLVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 -------~~~~~~l~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                             ...........+....   .......+.++.+++.+||+.||.+|||++++++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             ChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                   0000011111100000   00111234567899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3e-35  Score=299.60  Aligned_cols=268  Identities=23%  Similarity=0.345  Sum_probs=191.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||.||+|.+..+.. ..+.|.+...          ........+.+|++++++++||||+++++++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~-~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~   73 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDN-LVALKEIRLE----------HEEGAPCTAIREVSLLKDLKHANIVTLHDII   73 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCc-EEEEEEEecc----------cccCchhHHHHHHHHHHhcCCCCcceEEEEE
Confidence            4679999999999999999998765432 2222211100          0111223466799999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..++||||+.+ +|.+++..... .+++..+..++.|++.||+|||++++   +|+||||+|||++.++.++|+||
T Consensus        74 ~~~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~df  148 (301)
T cd07873          74 HTEKSLTLVFEYLDK-DLKQYLDDCGN-SINMHNVKLFLFQLLRGLNYCHRRKV---LHRDLKPQNLLINERGELKLADF  148 (301)
T ss_pred             ecCCeEEEEEecccc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCCHHHEEECCCCcEEECcC
Confidence            64 568999999974 99998876533 48899999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++......... .....+++.|+|||.+.+ ..++.++|||||||++|||+||+.||.....     ..........+.
T Consensus       149 g~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~  222 (301)
T cd07873         149 GLARAKSIPTKT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILG  222 (301)
T ss_pred             cchhccCCCCCc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcC
Confidence            998754322211 223467889999998764 4578899999999999999999999854321     111111112211


Q ss_pred             CCChHHhhHhhcC---------CCCCCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVD---------PRLGDN----CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d---------~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+.. ......++         +.....    ........+.+|+.+||+.||.+|||++|+++|-
T Consensus       223 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~  287 (301)
T cd07873         223 TPTE-ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP  287 (301)
T ss_pred             CCCh-hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1110 00001100         110000    1122344688999999999999999999999873

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.5e-35  Score=294.71  Aligned_cols=252  Identities=21%  Similarity=0.357  Sum_probs=189.2

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-e
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-E  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~  352 (589)
                      |++.+.||+|+||.||++.+..+.. ..+.+.+           ........+.+.+|+++++.++||||+++++++. +
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~-~~~~k~~-----------~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~   74 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGV-LAAAKVI-----------DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE   74 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCe-EEEEEEe-----------CCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC
Confidence            6788999999999999998776532 1111111           0112234456788999999999999999999776 4


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      +..|+||||+++++|..++.... .++++..+..++.|++.||.|||+.++   +||||||+||+++.++.+||+|||++
T Consensus        75 ~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i---~H~dlkp~nili~~~~~~kl~dfg~~  150 (282)
T cd06643          75 NNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKI---IHRDLKAGNILFTLDGDIKLADFGVS  150 (282)
T ss_pred             CEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCcccEEEccCCCEEEcccccc
Confidence            56899999999999998876533 358999999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ....... .......+++.|+|||++.     ...++.++|||||||++|||++|+.||.....        ........
T Consensus       151 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~  221 (282)
T cd06643         151 AKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIA  221 (282)
T ss_pred             ccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHh
Confidence            7543221 1223356899999999873     44578899999999999999999999843211        01111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ..          ..+.  ...+...+..+.+++.+||+.+|.+||++.++++|-.
T Consensus       222 ~~----------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         222 KS----------EPPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             hc----------CCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence            00          0000  0112233457899999999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-35  Score=302.38  Aligned_cols=266  Identities=21%  Similarity=0.306  Sum_probs=189.8

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ....++|++.+.||+|+||.||+|.+..+.. ..+.|.+.     ..    .........+.+|++++++++||||++++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~-----~~----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   80 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQ-KVAVKKLS-----RP----FQSLIHARRTYRELRLLKHMKHENVIGLL   80 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCC-EEEEEEeC-----ch----hhhhHHHHHHHHHHHHHHhcCCCchhhhh
Confidence            3456899999999999999999998766532 22222111     00    01112234567899999999999999999


Q ss_pred             eEEEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          348 GYCVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       348 ~~~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      +++..       ...|+++|++ +++|.+++...   .+++..+..++.|++.||+|||++++   +||||||+|||++.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~i---vHrdikp~Nil~~~  153 (343)
T cd07878          81 DVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGI---IHRDLKPSNVAVNE  153 (343)
T ss_pred             hhhcccccccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecccCChhhEEECC
Confidence            87642       2368999988 67998887643   48999999999999999999999998   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      ++.+||+|||++......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....     ...
T Consensus       154 ~~~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~  224 (343)
T cd07878         154 DCELRILDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY-----IDQ  224 (343)
T ss_pred             CCCEEEcCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence            999999999998864322    234578999999999866 5688999999999999999999999844321     111


Q ss_pred             HHHHHHHhcCCChH-------HhhHhhcCCCCCCCCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          500 VALFEEVLNLPDPI-------EDLRKLVDPRLGDNCP-------LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       500 ~~~~~~~~~~~~~~-------~~l~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..........+...       ......+. .+.....       ......+.+|+.+||+.||.+|||++|+++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         225 LKRIMEVVGTPSPEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHHHHhCCCCHHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11111111111100       00000000 0000000       0122357899999999999999999999998

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.4e-35  Score=296.76  Aligned_cols=260  Identities=25%  Similarity=0.383  Sum_probs=193.0

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCc
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLN  342 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpn  342 (589)
                      .+++....++|++.+.||+|+||.||++....+.. .++.|.+..            .......+.+|+.+++++ +|||
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~-~~aik~~~~------------~~~~~~~~~~e~~~l~~l~~h~n   80 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGS-LAAVKILDP------------ISDVDEEIEAEYNILQSLPNHPN   80 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCC-EEEEEEecc------------cccHHHHHHHHHHHHHHhcCCCC
Confidence            34555667899999999999999999998765532 222221110            011234566789999988 7999


Q ss_pred             ceeEeeEEEe------CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCC
Q 037010          343 LVRLIGYCVE------GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA  414 (589)
Q Consensus       343 Iv~l~~~~~~------~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~  414 (589)
                      ++++++++..      +..|+||||+++++|.+++...  ....+++..++.++.|++.||+|||++++   +|+||||+
T Consensus        81 i~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---vH~dlkp~  157 (291)
T cd06639          81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRI---IHRDVKGN  157 (291)
T ss_pred             eEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHH
Confidence            9999998753      2489999999999999988642  23458999999999999999999999998   99999999


Q ss_pred             cEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-----CCCcccchhhHHHHHHHHHcCCcccccC
Q 037010          415 NILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-----DVSPKVDVYAFGVVLYELISAKEAIVKG  489 (589)
Q Consensus       415 NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwSlGvll~elltG~~p~~~~  489 (589)
                      ||+++.++.+||+|||++......... .....|+..|+|||.+...     .++.++|||||||++|||++|+.||...
T Consensus       158 nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         158 NILLTTEGGVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             HEEEcCCCCEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            999999999999999998754322211 1234688999999987543     3688999999999999999999998532


Q ss_pred             CCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..    .....    ......          .+.+  ..+......+.+++.+||+.+|++||++.|+++|
T Consensus       237 ~~----~~~~~----~~~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         237 HP----VKTLF----KIPRNP----------PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             cH----HHHHH----HHhcCC----------CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            21    01111    111100          0011  1122334468999999999999999999999987

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4e-35  Score=294.59  Aligned_cols=251  Identities=25%  Similarity=0.382  Sum_probs=179.6

Q ss_pred             eeccCCcEEEEEEEEccccCCccchhh---------hhhhhhhHhHHHhhcCH---HHHHHHHHHHHHHccCCCCcceeE
Q 037010          279 KIGQGGFGAVYYAELRGEYGNSYLSRL---------ICVNLLMQKAAIKKMDM---QASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       279 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ik~~~~---~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .||+|+||.||+|....+.+.......         .........+++|....   ....++.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999986543221110000         00000011233333322   233567889999999999999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC---
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF---  422 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~---  422 (589)
                      ++++.+ +..++||||+++|+|..++.... ..+++..+..++.|++.||+|||++++   +||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---iH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNL---VHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCc---cCCCCCcccEEEeccCccc
Confidence            998875 45899999999999999987543 348899999999999999999999998   9999999999997643   


Q ss_pred             ----cEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHH-cCCcccccCCCCCCCh
Q 037010          423 ----HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELI-SAKEAIVKGNGSSADS  496 (589)
Q Consensus       423 ----~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~ell-tG~~p~~~~~~~~~~~  496 (589)
                          .+|++|||++......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......    
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----  228 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS----  228 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH----
Confidence                4899999987643211     22357788999998865 56899999999999999994 788887432211    


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                       ........               ....    +......+.+++.+||+.+|++|||+++++++|+
T Consensus       229 -~~~~~~~~---------------~~~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 -EKERFYEK---------------KHRL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -HHHHHHHh---------------ccCC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             11111100               0011    1111236889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9.2e-35  Score=290.72  Aligned_cols=255  Identities=23%  Similarity=0.367  Sum_probs=189.4

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ..++.+.....||+|+||.||+|.+..+.. ..+.|.+           +.......+.+.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~v~~k~~-----------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   72 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQV-RIAIKEI-----------PERDSRYVQPLHEEIALHSYLKHRNIVQYLG   72 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCc-EEEEEEe-----------cCCCHHHHHHHHHHHHHHHhcCCCCeeeeee
Confidence            345566667899999999999998765421 1211111           1112234457888999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-CCcE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPL--PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-NFHA  424 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-~~~v  424 (589)
                      ++.. +..+++|||+++++|.+++..... ++  ++..+..++.|++.||+|||++++   +||||||+||+++. ++.+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i---~h~dl~p~nil~~~~~~~~  148 (268)
T cd06624          73 SDSENGFFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQI---VHRDIKGDNVLVNTYSGVV  148 (268)
T ss_pred             eeccCCEEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCE---eecCCCHHHEEEcCCCCeE
Confidence            8765 568999999999999999976432 24  788889999999999999999998   99999999999976 6799


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCC--CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD--VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +|+|||++........ ......+++.|+|||.+....  ++.++|+||||+++|+|++|+.||.......      ...
T Consensus       149 ~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~------~~~  221 (268)
T cd06624         149 KISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ------AAM  221 (268)
T ss_pred             EEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh------hhH
Confidence            9999999875432221 122346889999999986543  7889999999999999999999984322100      000


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +...            ..  ......+......+.+++.+||+.+|.+|||++|+++|
T Consensus       222 ~~~~------------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         222 FKVG------------MF--KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             hhhh------------hh--ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0000            00  00112233445578999999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.3e-35  Score=293.68  Aligned_cols=254  Identities=25%  Similarity=0.403  Sum_probs=189.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..+.. .++.|.+.           .........+.+|+.+++.++||||+++++.+
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~-~~~ik~~~-----------~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~   75 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGE-LAAIKVIK-----------LEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY   75 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCc-EEEEEEEe-----------cCchhHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            3578889999999999999998765532 22222111           01112234577899999999999999999977


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..|++|||+.+++|.+++....  .+++.+++.++.|++.||.|||++++   +|+||||+||+++.++.++|+||
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~nili~~~~~~~l~df  150 (267)
T cd06645          76 LRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADF  150 (267)
T ss_pred             EeCCEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEECcc
Confidence            5 456899999999999999987654  48999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |++....... .......|+..|+|||++.   ...++.++|+|||||++|+|++|+.||......    ...   ....
T Consensus       151 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~----~~~---~~~~  222 (267)
T cd06645         151 GVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM----RAL---FLMT  222 (267)
T ss_pred             eeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch----hhH---Hhhh
Confidence            9987543221 1223457899999999874   456889999999999999999999998543210    000   0000


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...         ...+....  ....+..+.+++.+||..+|++||+++++++|
T Consensus       223 ~~~---------~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         223 KSN---------FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ccC---------CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            000         00000100  11223468899999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-35  Score=294.03  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=192.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|++|.||+|.+..+. ...+.|.+.            ......+++.+|+++++++ +|+||+++++
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~-~~~~~k~~~------------~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~   70 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTG-QLVAIKIMD------------IIEDEEEEIKEEYNILRKYSNHPNIATFYG   70 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCC-cEEEEEEEe------------cCchhHHHHHHHHHHHHHhcCCCChheEEE
Confidence            4688999999999999999999876542 222222111            0112335678899999999 6999999999


Q ss_pred             EEEeC-------cEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc
Q 037010          349 YCVEG-------SLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID  419 (589)
Q Consensus       349 ~~~~~-------~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~  419 (589)
                      ++.+.       ..|+||||+++++|.+++....  ...+++..+..++.|++.||.|||++++   +|+||+|+||+++
T Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i---~H~~l~p~ni~~~  147 (275)
T cd06608          71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKV---IHRDIKGQNILLT  147 (275)
T ss_pred             EEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCc---ccCCCCHHHEEEc
Confidence            87643       3799999999999999987543  4568999999999999999999999998   9999999999999


Q ss_pred             CCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-----CCCCcccchhhHHHHHHHHHcCCcccccCCCCCC
Q 037010          420 KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-----GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA  494 (589)
Q Consensus       420 ~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~  494 (589)
                      +++.++|+|||++....... .......|+..|+|||++..     ..++.++|||||||++|+|++|+.||.....   
T Consensus       148 ~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---  223 (275)
T cd06608         148 KNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP---  223 (275)
T ss_pred             cCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch---
Confidence            99999999999987543222 22233568899999998753     3467899999999999999999999843211   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                       ..    ........          ..+.  ...+.+....+.+++.+||..||++|||++++++|
T Consensus       224 -~~----~~~~~~~~----------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         224 -MR----ALFKIPRN----------PPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -HH----HHHHhhcc----------CCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             01    11111110          0011  11223345678999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=292.31  Aligned_cols=270  Identities=24%  Similarity=0.349  Sum_probs=193.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..++. ..+.|.+.         .+.......+.+.+|++++++++|+||+++++++.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~-~v~vK~~~---------~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   70 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGE-IVAIKKFK---------ESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR   70 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCc-EEEEehhh---------hhcccccchhHHHHHHHHHHhcCCCCeeehhheEE
Confidence            468999999999999999998876532 22222111         11112223456788999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..+++|||++++.+..+....  ..+++..+..++.|++.||.|||++++   +|+||+|+||++++++.+||+|||
T Consensus        71 ~~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dl~~~ni~~~~~~~~kl~d~g  145 (288)
T cd07833          71 RKGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNI---IHRDIKPENILVSESGVLKLCDFG  145 (288)
T ss_pred             ECCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCCCCEEEEeee
Confidence            5 5689999999987766655443  348999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++...............++..|+|||++... .++.++||||||+++|+|++|+.||.....    ...+..........
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~~~~~~  221 (288)
T cd07833         146 FARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD----IDQLYLIQKCLGPL  221 (288)
T ss_pred             cccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCC
Confidence            9886554433233446788999999999877 889999999999999999999998853321    11111111100000


Q ss_pred             CChHHhh-------H--hhcCCC----CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDL-------R--KLVDPR----LGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l-------~--~~~d~~----l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +......       .  ......    ....++...+..+.+++++||..+|++|||+++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         222 PPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             CHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0000000       0  000000    0001222235679999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.8e-35  Score=292.41  Aligned_cols=254  Identities=24%  Similarity=0.378  Sum_probs=179.5

Q ss_pred             eeeccCCcEEEEEEEEccccCC-ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGN-SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~-~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||.||+|...+.... ..+.|.+.          ..........+.+|+.++++++||||+++++++.+ ...
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   70 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELR----------VSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY   70 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecC----------CCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCc
Confidence            3689999999999987543221 11111110          00112233468889999999999999999998764 458


Q ss_pred             EEEEEecCCCChHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          356 FLVYEYIENGNLSEHLRGSG---RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      ++||||+++|+|.+++....   ....++..++.++.|++.||+|||++++   +|+||||+||+++.++.+||+|||++
T Consensus        71 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i---~H~dlkp~nil~~~~~~~kL~dfg~~  147 (269)
T cd05087          71 LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF---IHSDLALRNCLLTADLTVKIGDYGLS  147 (269)
T ss_pred             EEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCE---eccccCcceEEEcCCCcEEECCcccc
Confidence            99999999999999997532   2245677888999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCC-CCcccccCCCCCchhcccCC-------CCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHH
Q 037010          433 KLTEVGSAS-LPTRLVGTFGYMPPEYAQYG-------DVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       433 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-------~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      ......... ......++..|+|||++...       .++.++|+||||+++|||++ |+.||.....     .....  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-----~~~~~--  220 (269)
T cd05087         148 HNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD-----EQVLT--  220 (269)
T ss_pred             ccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh-----HHHHH--
Confidence            754322211 11234577889999988532       35789999999999999996 9989843211     11100  


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      .....      ......++.+..    .....+.+++..|| .+|++|||++||+..|+
T Consensus       221 ~~~~~------~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         221 YTVRE------QQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             HHhhc------ccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00000      000111222211    12345788999999 58999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.4e-35  Score=297.05  Aligned_cols=251  Identities=22%  Similarity=0.367  Sum_probs=192.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||.|+||.||++.+..++.. .+.|.+.         .+  .....+.+.+|+++++.++||||+++++++
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~-v~iK~~~---------~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQE-VAIKQIN---------LQ--KQPKKELIINEILVMKELKNPNIVNFLDSF   85 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcE-EEEEEEe---------cc--cCchHHHHHHHHHHHHhcCCCceeeeeeeE
Confidence            35799999999999999999987655322 2222111         01  112234677899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+++++|.+++...   .+++.++..++.|++.||+|||++++   +|+||||+||+++.++.++|+||
T Consensus        86 ~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i---~H~dL~p~Nili~~~~~~kl~df  159 (296)
T cd06655          86 LVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV---IHRDIKSDNVLLGMDGSVKLTDF  159 (296)
T ss_pred             ecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEccC
Confidence            64 5689999999999999998653   38999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++........ ......++..|+|||.+....++.++|+|||||++|+|++|+.||.....       . .........
T Consensus       160 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~-~~~~~~~~~  230 (296)
T cd06655         160 GFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------L-RALYLIATN  230 (296)
T ss_pred             ccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------H-HHHHHHHhc
Confidence            99875433222 12234688999999999888899999999999999999999999844321       0 001111000


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .          .+.  ...+...+..+.+++.+||..+|.+|||+++++.|
T Consensus       231 ~----------~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         231 G----------TPE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             C----------Ccc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            0          000  11222334568899999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.9e-35  Score=295.90  Aligned_cols=249  Identities=23%  Similarity=0.370  Sum_probs=190.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      .|+..+.||+|+||.||+|.+..++. ..+.|.+..          .......+.+.+|++++++++||||+++++++..
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~-~vaiK~~~~----------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKE-VVAIKIIDL----------EEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK   73 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCe-EEEEEEecc----------ccchHHHHHHHHHHHHHHcCCCCccHhhhccccc
Confidence            46677889999999999998765422 222221110          1112234568889999999999999999997764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..|+||||+.+++|.+++...   .+++..+..++.|++.||.|||++++   +|+||+|+||++++++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i---vH~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06642          74 GTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             CCceEEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCe---eccCCChheEEEeCCCCEEEccccc
Confidence             5689999999999999998643   48899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +........ ......++..|+|||.+.+..++.++|+|||||++|||++|+.|+......     ..   ....     
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~~---~~~~-----  213 (277)
T cd06642         148 AGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----RV---LFLI-----  213 (277)
T ss_pred             cccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----hH---Hhhh-----
Confidence            875432221 112246788999999999889999999999999999999999998432210     00   0000     


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                           .....+.    .+...+..+.+++.+||+.+|++||++.++++|-
T Consensus       214 -----~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         214 -----PKNSPPT----LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             -----hcCCCCC----CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence                 0001111    1223445789999999999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.4e-35  Score=297.82  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=192.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||+|+||.||++....++.. .+.|.+.           .......+.+.+|+.+++.++|+||+++++++
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~-vaiK~~~-----------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   85 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQE-VAIKQMN-----------LQQQPKKELIINEILVMRENKNPNIVNYLDSY   85 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCE-EEEEEEe-----------cCccchHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            46899999999999999999987654332 2222111           01112234577899999999999999999977


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .. +..|+||||+++++|.+++...   .+++..+..++.|++.||.|||+.++   +|+||||+|||++.++.++|+||
T Consensus        86 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i---~H~dL~p~Nili~~~~~~~l~Df  159 (297)
T cd06656          86 LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQV---IHRDIKSDNILLGMDGSVKLTDF  159 (297)
T ss_pred             ecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEECcC
Confidence            64 5689999999999999998653   37889999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++........ ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.......    ...    .... 
T Consensus       160 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~----~~~----~~~~-  229 (297)
T cd06656         160 GFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----ALY----LIAT-  229 (297)
T ss_pred             ccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch----hee----eecc-
Confidence            99875433221 1233568899999999988889999999999999999999999995432110    000    0000 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                 ........+...+..+.+++.+||+.+|++||+++++++|
T Consensus       230 -----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         230 -----------NGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             -----------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       0000011223344568899999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1e-34  Score=292.58  Aligned_cols=272  Identities=24%  Similarity=0.375  Sum_probs=197.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccc---cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGE---YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~---~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ++|++.+.||+|+||.||++.+...   .+...+.|.     ..     +........++.+|++++++++||||+++++
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~-----~~-----~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~   73 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKS-----LN-----HSGEEQHRSDFEREIEILRTLDHENIVKYKG   73 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEE-----ec-----cccchHHHHHHHHHHHHHHhCCCCChheEEe
Confidence            5678889999999999999986532   111121111     10     0111123567889999999999999999999


Q ss_pred             EEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          349 YCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       349 ~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++..   ...+++|||+++++|.+++..... .+++..+..++.|++.||+|||++++   +|+||||+||+++.++.++
T Consensus        74 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~i---~H~dl~p~nil~~~~~~~~  149 (284)
T cd05038          74 VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQRY---IHRDLAARNILVESEDLVK  149 (284)
T ss_pred             eeecCCCCceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHhEEEcCCCCEE
Confidence            8764   258999999999999999976543 48999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          426 VADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      |+|||++.........  ......++..|++||.+....++.++||||||+++|||+||+.|+.............    
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~----  225 (284)
T cd05038         150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI----  225 (284)
T ss_pred             EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc----
Confidence            9999999865422211  1112344567999999988899999999999999999999999874432211000000    


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                         .........+...+........+..++..+.+++.+||+.+|++|||+.||++.|..+
T Consensus       226 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         226 ---AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             ---ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence               0000011111122222211222333446799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=288.46  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=193.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||.|+||.||+|.+..+.. ..+.|.+.           .......+.+.+|++++++++||||+++++++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~-~~~ik~~~-----------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   69 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGE-LVAIKVIK-----------LEPGDDFEIIQQEISMLKECRHPNIVAYFGSY   69 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCC-EEEEEEEE-----------cCchhhHHHHHHHHHHHHhCCCCChhceEEEE
Confidence            3679999999999999999998766432 22222111           01112346678899999999999999999977


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.+|++|||+.+++|.+++.... ..+++..+..++.|++.||.|||++++   +|+||||+||++++++.++|+||
T Consensus        70 ~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i---~h~dl~p~ni~i~~~~~~~l~d~  145 (262)
T cd06613          70 LRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGK---IHRDIKGANILLTEDGDVKLADF  145 (262)
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCc---eecCCChhhEEECCCCCEEECcc
Confidence            64 56899999999999999987652 348999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCC---CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG---DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |++........ ......++..|+|||.+...   .++.++|+||||+++|+|+||+.||.....    ...........
T Consensus       146 g~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~----~~~~~~~~~~~  220 (262)
T cd06613         146 GVSAQLTATIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----MRALFLISKSN  220 (262)
T ss_pred             ccchhhhhhhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcc
Confidence            99876543221 22335688899999998766   889999999999999999999999853221    11111100000


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                  ...+.  ...+...+..+.+++.+||..+|.+|||+++|+.|
T Consensus       221 ------------~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         221 ------------FPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ------------CCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                        00000  01123345578999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-34  Score=287.19  Aligned_cols=253  Identities=30%  Similarity=0.494  Sum_probs=191.1

Q ss_pred             CccceeeccCCcEEEEEEEEccccC---CccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYG---NSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~---~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      +++.+.||.|+||.||++.+....+   ...+.|..          ......+..+.+..|++++++++|+||+++++++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~----------~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   70 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTL----------KEDADEQQIEEFLREARIMRKLDHPNIVKLLGVC   70 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEc----------cCCCChHHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence            4577899999999999999876531   11111111          0011112456788899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..+++|||+++++|.+++.......+++..+..++.|++.||+|||++++   +|+||||+||+++.++.++|+||
T Consensus        71 ~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~---~h~dl~~~nil~~~~~~~~l~df  147 (258)
T smart00219       71 TEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF---IHRDLAARNCLVGENLVVKISDF  147 (258)
T ss_pred             cCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCe---eecccccceEEEccCCeEEEccc
Confidence            65 568999999999999999987554348999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++...............+++.|+|||.+....++.++|+||||+++|+|++ |+.||....        ..........
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~  219 (258)
T smart00219      148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--------NEEVLEYLKK  219 (258)
T ss_pred             CCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhc
Confidence            9987654332222112336789999999988889999999999999999998 667763311        1111111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..          .    ...+...+..+.+++.+||..+|++|||+.|+++.|
T Consensus       220 ~~----------~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 GY----------R----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CC----------C----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            10          0    111222445789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.5e-35  Score=296.42  Aligned_cols=268  Identities=26%  Similarity=0.386  Sum_probs=192.7

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|+||.||+|.+..++. ..+.|.+.         ...........+.+|+.++++++||||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-~~~vK~~~---------~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGE-TVALKKVA---------LRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH   70 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCc-eEEEEEEE---------cccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence            58899999999999999998766532 22222111         111112234568889999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       ...|+||||+ +++|.+++.... .++++.+++.++.|++.||+|||++++   +|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~ni~~~~~~~~~l~dfg~  145 (286)
T cd07832          71 GSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGI---MHRDLKPANLLISADGVLKIADFGL  145 (286)
T ss_pred             CCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCcCHHHEEEcCCCcEEEeeeee
Confidence             4589999999 999999987654 458999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +...............++..|+|||.+... .++.++||||||+++|||+||+.+|.....    ........ .....+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~-~~~~~~  220 (286)
T cd07832         146 ARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVF-RTLGTP  220 (286)
T ss_pred             cccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHH-HHcCCC
Confidence            886544332223345789999999988654 468999999999999999999766633221    11111111 111111


Q ss_pred             ChHH--------hhHhhcCCCCC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIE--------DLRKLVDPRLG----DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~--------~l~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ....        +......+...    .....+....+.+++.+||+.+|++|||++++++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            1000        00000000000    00112334688999999999999999999999987

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.4e-34  Score=289.57  Aligned_cols=263  Identities=22%  Similarity=0.389  Sum_probs=194.6

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHcc-CCCCcceeEeeEEE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH-VHHLNLVRLIGYCV  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~~~~  351 (589)
                      +|++.+.||+|+||.||++.+..+.+...+.|.+........ ..+........++.+|+.++.+ ++||||+++++++.
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~-~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFG-KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccc-cccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence            478889999999999999998774444333332221111000 0112233445667789998865 79999999999776


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                       ++..+++|||+.+++|.+++...  ....+++..++.++.|++.+|.|||+ .++   +|+||||+||+++.++.++|+
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i---~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          80 ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRI---VHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCce---eecCCCHHHEEECCCCcEEEe
Confidence             45689999999999999988542  23458899999999999999999996 667   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||.+.......  ......|+..|++||.+.+..++.++|+||||+++|+|++|+.||.....        ........
T Consensus       157 dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~~  226 (269)
T cd08528         157 DFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSLATKIV  226 (269)
T ss_pred             cccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHHHHHHh
Confidence            999987654322  22345788999999999988899999999999999999999999843211        11111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ..         ...+....    .....+.+++.+||+.||++||++.|+.+++.
T Consensus       227 ~~---------~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         227 EA---------VYEPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             hc---------cCCcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            10         00010111    22346899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.4e-34  Score=293.62  Aligned_cols=270  Identities=18%  Similarity=0.216  Sum_probs=182.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEcccc--CCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEY--GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.++||+|+||.||+|.+.++.  ....+.+..........................+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            468999999999999999999876652  112222211110000000000000111122334556677789999999998


Q ss_pred             EEEeC-----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          349 YCVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       349 ~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      .+...     ..++++|++.. ++.+.+....  ..++..++.++.|++.||+|||++++   +||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---iHrDiKp~Nill~~~~~  164 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGI---SHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCc
Confidence            65432     24678887744 6766665432  25788889999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCC------CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          424 AKVADFGLTKLTEVGSA------SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      ++|+|||+++.......      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~----  240 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG----  240 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch----
Confidence            99999999986532211      11122469999999999999999999999999999999999999995432111    


Q ss_pred             hHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ........        +.+..+....+   ...+.+..+.+++..||..+|++||+++++++.|
T Consensus       241 ~~~~~~~~--------~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKC--------DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHH--------HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11110000        00011111111   0112345789999999999999999999999876

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=304.71  Aligned_cols=244  Identities=22%  Similarity=0.320  Sum_probs=179.0

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC---CCCcceeEeeEEE-eCcE
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV---HHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~~-~~~~  355 (589)
                      ||+|+||+||+|++..++ ...+.|.+.....        ...........|.+++.++   +||||+++++.+. ++..
T Consensus         1 lG~G~~g~Vy~~~~~~~~-~~~avK~~~~~~~--------~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~   71 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTR-RIYAMKVLSKKEI--------VAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDL   71 (330)
T ss_pred             CCCCCceEEEEEEECCCC-CEEEEEEEeHHHH--------hhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeE
Confidence            799999999999876553 2333332211100        0111223445567776655   6999999998776 4568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||||+.+|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||++...
T Consensus        72 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~i---vHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          72 YLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDI---VYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             EEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            99999999999999987654  48999999999999999999999998   99999999999999999999999998753


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHH
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE  514 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (589)
                      .... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....        ......+...     
T Consensus       147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~-----  212 (330)
T cd05586         147 LTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFG-----  212 (330)
T ss_pred             CCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcC-----
Confidence            2221 222346799999999998654 589999999999999999999999854321        1111111110     


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC----CHHHHHHH
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP----SMRSIVVA  560 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~~  560 (589)
                            ...+..   ......+.+++.+||+.||.+||    +++++++|
T Consensus       213 ------~~~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         213 ------KVRFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ------CCCCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence                  001110   11234678999999999999998    67888776

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=293.90  Aligned_cols=254  Identities=24%  Similarity=0.385  Sum_probs=193.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||.|+||.||++.+..+. ...+.|...           .......+.+.+|++++++++||||+++++++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~-~~~~iK~~~-----------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETG-LFAAAKIIQ-----------IESEEELEDFMVEIDILSECKHPNIVGLYEAY   71 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCC-cEEEEEEEe-----------eCCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence            467999999999999999999876542 222222211           11233445688899999999999999999977


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..|+||||+++++|.+++.... .++++..++.++.|++.||.|||++++   +|+||||+||+++.++.++|+||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i---~h~dl~p~nili~~~~~~~l~d~  147 (280)
T cd06611          72 FYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKV---IHRDLKAGNILLTLDGDVKLADF  147 (280)
T ss_pred             ecCCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChhhEEECCCCCEEEccC
Confidence            6 456899999999999999987644 348999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |++........ ......+++.|+|||.+.     ...++.++|+||||+++|+|++|+.||.....        .....
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~  218 (280)
T cd06611         148 GVSAKNKSTLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLL  218 (280)
T ss_pred             ccchhhccccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHH
Confidence            98865432221 223356899999999874     34577899999999999999999999843211        11111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ......          .+.+  ..+......+.+++.+||+.+|.+||+++++++|-
T Consensus       219 ~~~~~~----------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (280)
T cd06611         219 KILKSE----------PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP  263 (280)
T ss_pred             HHhcCC----------CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence            111110          0111  11223345789999999999999999999999883

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.8e-35  Score=290.23  Aligned_cols=259  Identities=22%  Similarity=0.386  Sum_probs=192.9

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|+..+.||+|+||.||++....++. ..+.|.+...     ...+.......+.+.+|++++++++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~-~~alk~~~~~-----~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGT-LMAVKQVTYV-----RNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCc-EEEEEEeecc-----cCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            47888999999999999998765532 2222221100     00000111234678889999999999999999998765


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-cEEEEecc
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-HAKVADFG  430 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-~vkl~Dfg  430 (589)
                       +..++||||+++++|.+++....  ++++..++.++.|++.||+|||++++   +|+||||+||+++.++ .++|+|||
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i---~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQI---IHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEEcccc
Confidence             56899999999999999997643  48899999999999999999999998   9999999999998776 59999999


Q ss_pred             CccccccCCCC---CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          431 LTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       431 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      .+.........   ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......     ......... 
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-  223 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKI-  223 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHH-
Confidence            98755432111   112346788999999998888999999999999999999999998433211     111111110 


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                  .........+......+.+++.+||+.+|.+||++.+++.|
T Consensus       224 ------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         224 ------------ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ------------hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                        00011122344455678999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.7e-34  Score=292.44  Aligned_cols=248  Identities=27%  Similarity=0.438  Sum_probs=193.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||++.+..+. ...+.|.+..     .   +.......+.+.+|++++++++||||+++++++.
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~-~~~aiK~~~~-----~---~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSG-KYYALKILSK-----A---KIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ   71 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCC-CEEEEEEEEH-----H---HhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence            47899999999999999999987642 2222222110     0   0111223456788999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+++++|.+++....  .+++..+..++.|++.||.|||++++   +|+||+|+|||++.++.+||+|||
T Consensus        72 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i---~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          72 DDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDI---VYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             cCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHEEECCCCCEEEeeCC
Confidence            5 45899999999999999997764  48999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ++......    .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....        .......... 
T Consensus       147 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~-  213 (290)
T cd05580         147 FAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEG-  213 (290)
T ss_pred             CccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC-
Confidence            98765432    2335689999999999888899999999999999999999999843321        1111111110 


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                                ..    ..+......+.+++.+||..||.+|+     +++|+++|
T Consensus       214 ----------~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         214 ----------KV----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ----------Cc----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                      01    12223345789999999999999999     88888877

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.6e-34  Score=288.33  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=194.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||.|+||.||+|....++ ...+.|...         . .......+.+.+|+++++.++|+||+++++.+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~~ik~~~---------~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNN-EKVAIKRID---------L-EKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV   69 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCC-cEEEEEEec---------c-CCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe
Confidence            47899999999999999999876542 222222111         0 111124467888999999999999999998765


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                       ++..|++||++++++|.+++..... ..+++..+..++.|++.||+|||++++   +|+||||+||++++++.++|+||
T Consensus        70 ~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i---~h~~l~p~ni~~~~~~~~~l~df  146 (267)
T cd06610          70 VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADF  146 (267)
T ss_pred             eCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHhEEEcCCCCEEEccc
Confidence             4568999999999999999976432 458999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCC---CCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          430 GLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       430 gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |++.........   ......|+..|+|||.+... .++.++|+|||||++|+|++|+.||......        .....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~  218 (267)
T cd06610         147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLML  218 (267)
T ss_pred             chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHH
Confidence            998765433222   12335688999999998766 7899999999999999999999998533221        11111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNC-PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .....          .+.+.... ....+..+.+++.+||..||++||+++++++|
T Consensus       219 ~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         219 TLQND----------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             HhcCC----------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            11110          01111111 12344578999999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.9e-35  Score=293.38  Aligned_cols=255  Identities=23%  Similarity=0.420  Sum_probs=192.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||++.+...+. .++.|.+.          ..........+.+|++++++++||||+++++.+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~a~k~~~----------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGV-TMAMKEIR----------LELDESKFNQIIMELDILHKAVSPYIVDFYGAFF   69 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCc-EEEEEEee----------cccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee
Confidence            468899999999999999998875432 22222110          0112333467888999999999999999999665


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSG-RDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                       ++..|+||||+++++|.+++.... ...+++..+..++.|++.||.|||+ .++   +|+||||+||+++.++.++|+|
T Consensus        70 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i---~H~dl~p~nil~~~~~~~~l~d  146 (286)
T cd06622          70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI---IHRDVKPTNVLVNGNGQVKLCD  146 (286)
T ss_pred             cCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCE---eeCCCCHHHEEECCCCCEEEee
Confidence             567899999999999999887632 2358999999999999999999997 477   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCC------CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG------DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      ||++......   ......+++.|+|||.+...      .++.++|+|||||++|+|++|+.||.....     ......
T Consensus       147 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~  218 (286)
T cd06622         147 FGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQ  218 (286)
T ss_pred             cCCcccccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHH
Confidence            9998754321   12234678899999988543      357899999999999999999999843211     111111


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ...             ..+.. ....+.+....+.+++.+||+.+|.+||++++++++-.
T Consensus       219 ~~~-------------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~  264 (286)
T cd06622         219 LSA-------------IVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW  264 (286)
T ss_pred             HHH-------------HhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence            111             11111 11233445567899999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=4.5e-35  Score=295.47  Aligned_cols=268  Identities=25%  Similarity=0.322  Sum_probs=189.7

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|+||.||+|.+..++. ..+.|.+..         +.........+.+|++++++++||||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~-~~~~k~~~~---------~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   70 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHE-IVALKRVRL---------DDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS   70 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCc-EEEEEEeec---------ccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc
Confidence            58889999999999999999876532 222221111         11111122346679999999999999999997764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..|+++||+.+ +|.+++.... ..+++..++.++.||+.||.|||++++   +|+||||+||+++.++.+||+|||+
T Consensus        71 ~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i---~H~dl~~~nil~~~~~~~~l~dfg~  145 (284)
T cd07839          71 DKKLTLVFEYCDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNV---LHRDLKPQNLLINKNGELKLADFGL  145 (284)
T ss_pred             CCceEEEEecCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHEEEcCCCcEEECccch
Confidence             568999999975 8888876543 348999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +......... .....+++.|+|||.+.+. .++.++|||||||++|+|+||+.|+..+....    ............+
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~  220 (284)
T cd07839         146 ARAFGIPVRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTP  220 (284)
T ss_pred             hhccCCCCCC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH----HHHHHHHHHhCCC
Confidence            8755332221 2234678899999988664 47899999999999999999999975543311    1111111111111


Q ss_pred             ChH--HhhHhhcCCC----CC-----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPI--EDLRKLVDPR----LG-----DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~--~~l~~~~d~~----l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...  .......+..    ..     ....+.....+.+++.+||+.||.+|||++++++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            100  0000111100    00     01112234578899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-34  Score=287.37  Aligned_cols=264  Identities=22%  Similarity=0.391  Sum_probs=191.7

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|.+.+.||+|+||.||+|....++ ...+.|.+........ ..+.......+.+.+|++++++++|||++++++++..
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~-~~~a~K~~~~~~~~~~-~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   79 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTG-EMMAVKQVELPATIAG-RHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT   79 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCC-ceeeeeeeechhhhhc-ccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc
Confidence            5778899999999999999876543 2222222211100000 0001111233567889999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..++||||+++++|.+++....  .+++..+..++.|++.||.|||++++   +|+||+|+||+++.++.++|+|||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          80 EEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGI---LHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             CCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCe---eecCCChhhEEEcCCCeEEEeeccc
Confidence             45899999999999999998763  48899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCC-CCcccccCCCCCchhcccCCC--CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          432 TKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGD--VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       432 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      +......... ......++..|+|||.+....  ++.++|+||||+++|+|++|..||.....       ..... ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~-~~~~  226 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMF-KLGN  226 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHH-Hhhc
Confidence            8754322111 122346889999999987654  88999999999999999999999842211       11111 1100


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                               ....+........+.+..+.+++.+||..+|.+|||++++++|
T Consensus       227 ---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         227 ---------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ---------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                     0001111111222345679999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-34  Score=290.20  Aligned_cols=251  Identities=22%  Similarity=0.379  Sum_probs=178.4

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh----cCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-  352 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  352 (589)
                      +.||+|+||.||+|.........             .+++|.    ........+.+|+++++.++||||+++++.+.+ 
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~-------------~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~   67 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKA-------------RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES   67 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCe-------------EEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC
Confidence            36999999999999754331110             111221    122334568889999999999999999998764 


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGR---DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +..|+||||+.+|+|.+++.....   ...++...+.++.|++.||+|||++++   +||||||+|||+++++.+||+||
T Consensus        68 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nill~~~~~~kl~df  144 (269)
T cd05042          68 IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF---IHSDLALRNCQLTADLSVKIGDY  144 (269)
T ss_pred             CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCE---ecccccHhheEecCCCcEEEecc
Confidence            568999999999999999976432   234677888999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCC-CCCcccccCCCCCchhcccC-------CCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHH
Q 037010          430 GLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQY-------GDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       430 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~  500 (589)
                      |++........ .......+++.|+|||++..       ..++.++|||||||++|||++ |..||.....     ..  
T Consensus       145 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~--  217 (269)
T cd05042         145 GLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD-----EQ--  217 (269)
T ss_pred             ccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH-----HH--
Confidence            99864322211 11122345778999998742       356889999999999999999 6677633211     11  


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                       .........     ......+.+    +...+..+.+++..|| .||.+|||+++|++.|.
T Consensus       218 -~~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         218 -VLKQVVREQ-----DIKLPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             -HHHHHhhcc-----CccCCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence             111111100     001112222    2233346778888998 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=8.5e-35  Score=290.18  Aligned_cols=254  Identities=27%  Similarity=0.453  Sum_probs=194.2

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|+..+.||+|+||.||++.+..++.. .+.|.+.          +........++.+|++++++++||||+++++.+.
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~-~~ik~~~----------~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKI-MAVKTIR----------LEINEAIQKQILRELDILHKCNSPYIVGFYGAFY   69 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcE-EEEEEEe----------cccChHHHHHHHHHHHHHHHCCCCchhhhheeee
Confidence            4678889999999999999988654321 1111110          0111234466888999999999999999998775


Q ss_pred             -eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          352 -EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                       ++..++++||+.+++|.+++.... ..+++..+..++.|++.||+|||+ .++   +|+||||+||++++++.++|+||
T Consensus        70 ~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i---~H~dl~~~ni~~~~~~~~~l~d~  145 (265)
T cd06605          70 NNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKI---IHRDVKPSNILVNSRGQIKLCDF  145 (265)
T ss_pred             cCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCe---ecCCCCHHHEEECCCCCEEEeec
Confidence             456899999999999999998653 458899999999999999999999 898   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |.+........   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......   .............
T Consensus       146 g~~~~~~~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~  219 (265)
T cd06605         146 GVSGQLVNSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIVNE  219 (265)
T ss_pred             ccchhhHHHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHhcC
Confidence            99875432211   12568889999999988899999999999999999999999985443211   1111222221111


Q ss_pred             CChHHhhHhhcCCCCCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLD-SVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .          .+    ..+.. ....+.+++.+||..+|++|||+.+++.+
T Consensus       220 ~----------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         220 P----------PP----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             C----------CC----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            0          11    11222 45578999999999999999999999977

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.5e-34  Score=289.73  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=193.8

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|+..++||.|++|.||++.+..+. ...+.+.+.          +........++.+|++++++++||||+++++++.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~k~~~----------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   69 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTG-MIFALKTIT----------TDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL   69 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCC-eEEEEEEEe----------cCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Confidence            46888999999999999999986642 222222111          0111234466888999999999999999999875


Q ss_pred             e---CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          352 E---GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       352 ~---~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +   +.+|+||||+++++|.+++...  ....+++..+..++.|++.||.|||+.++   +|+||+|+||+++.++.++|
T Consensus        70 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i---~H~dl~~~nil~~~~~~~~l  146 (287)
T cd06621          70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKI---IHRDIKPSNILLTRKGQVKL  146 (287)
T ss_pred             ccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEecCCeEEE
Confidence            3   3589999999999999987542  23458889999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      +|||++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........   ......
T Consensus       147 ~dfg~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~  220 (287)
T cd06621         147 CDFGVSGELVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI---ELLSYI  220 (287)
T ss_pred             eeccccccccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH---HHHHHH
Confidence            9999987543221   1234578899999999988999999999999999999999999864422111111   111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCC--hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCP--LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .....          +.+....+  ......+.+++.+||+.+|.+|||+.|+++|-
T Consensus       221 ~~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         221 VNMPN----------PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             hcCCc----------hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            11110          01111111  12345789999999999999999999999974

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-34  Score=285.60  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=191.3

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|+..+.||+|+||.||+|....+.. ..+.|.+...      .......+..+.+.+|++++++++|+||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~-~~~ik~~~~~------~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGD-FFAVKEVSLA------DDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE   73 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCc-EEEEEEEEEc------cccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec
Confidence            57788999999999999998764422 2222211100      0000112345668889999999999999999998765


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..|++|||+++++|.+++....  .+++..+..++.|++.||+|||+.++   +|+||+|+||+++.++.+||+|||+
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          74 EDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNT---VHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEccCcc
Confidence             46899999999999999997654  48899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCC-CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGD-VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +.......  ......++..|++||.+.... ++.++|+||||+++|+|++|+.||.....       ..... ..... 
T Consensus       149 ~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~-~~~~~-  217 (258)
T cd06632         149 AKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVF-KIGRS-  217 (258)
T ss_pred             ceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHH-HHHhc-
Confidence            87653322  223456889999999987666 89999999999999999999999843221       00000 00000 


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                 .. ....+......+.+++.+||+.+|.+||+++++++|
T Consensus       218 -----------~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         218 -----------KE-LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -----------cc-CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                       00 011223344578999999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.7e-34  Score=289.49  Aligned_cols=257  Identities=24%  Similarity=0.417  Sum_probs=189.5

Q ss_pred             CccceeeccCCcEEEEEEEEccccC--CccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYG--NSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~--~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      |++.+.||+|+||.||+|.+....+  ...+.|.+.         .+.......+++.+|++++++++||||+++++++.
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   71 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK---------ADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSL   71 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEec---------cccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEc
Confidence            6678899999999999998754321  122211110         11122334566888999999999999999999775


Q ss_pred             eC-------cEEEEEEecCCCChHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          352 EG-------SLFLVYEYIENGNLSEHLRGSG----RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       352 ~~-------~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ..       ..++++||+.+|+|.+++....    ...+++...+.++.|++.||+|||++++   +||||||+||+++.
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i---~H~dikp~nili~~  148 (273)
T cd05074          72 RSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNF---IHRDLAARNCMLNE  148 (273)
T ss_pred             cCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE---eecccchhhEEEcC
Confidence            32       1478999999999998875321    1247888999999999999999999998   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhh
Q 037010          421 NFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKG  498 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~  498 (589)
                      ++.+||+|||++......... ......+++.|++||.+....++.++|||||||++|||++ |+.||.....     . 
T Consensus       149 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~-  222 (273)
T cd05074         149 NMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----S-  222 (273)
T ss_pred             CCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----H-
Confidence            999999999998865322211 1122345678999999988889999999999999999999 7777743211     1 


Q ss_pred             HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                        ..........          ..    ..+...+..+.+++.+||..+|.+|||+.|+++.|..+
T Consensus       223 --~~~~~~~~~~----------~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         223 --EIYNYLIKGN----------RL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --HHHHHHHcCC----------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              1111111100          00    11223445799999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.8e-34  Score=289.76  Aligned_cols=269  Identities=25%  Similarity=0.337  Sum_probs=190.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..++. ..+.|.+..         ........+.+.+|++++++++|||++++++++.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-~~~iK~~~~---------~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   70 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQ-IVAIKKFVE---------SEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR   70 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCc-EEEEEEEee---------cccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe
Confidence            478999999999999999998875422 222221110         0011112245678999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + ...++||||++++.|..++....  .+++..++.++.|++.||+|||++++   +|+||||+||+++.++.++|+|||
T Consensus        71 ~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i---~H~dl~p~nil~~~~~~~~l~dfg  145 (286)
T cd07847          71 RKRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNC---IHRDVKPENILITKQGQIKLCDFG  145 (286)
T ss_pred             eCCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCChhhEEEcCCCcEEECccc
Confidence            5 46899999999988887765433  48999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......    .............
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~  220 (286)
T cd07847         146 FARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV----DQLYLIRKTLGDL  220 (286)
T ss_pred             cceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCC
Confidence            9986543221 1223467889999998865 45788999999999999999999998543221    1111111111000


Q ss_pred             CChHHh-------hHhhcCCCCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIED-------LRKLVDPRLGDNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~-------l~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ......       ......+......+     ...+..+.+|+.+||+.+|++||++.|++.|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         221 IPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            000000       00000111100001     1224578999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.5e-34  Score=285.90  Aligned_cols=254  Identities=22%  Similarity=0.361  Sum_probs=179.5

Q ss_pred             eeeccCCcEEEEEEEEccccCCc-cchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNS-YLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~-~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~  355 (589)
                      ++||+|+||.||++......... .+.+..          .+.......+.+.+|+++++.++||||+++++.+.+ ...
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~----------~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   70 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKEL----------KANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY   70 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEe----------cCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCcc
Confidence            36999999999999764432111 111100          001112345678899999999999999999998875 458


Q ss_pred             EEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          356 FLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                      |+||||+++|+|.+++....  ....++..++.++.|++.||+|||++++   +||||||+|||++.++.++|+|||++.
T Consensus        71 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i---~H~dikp~nil~~~~~~~~l~Dfg~~~  147 (268)
T cd05086          71 LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF---LHSDLALRNCFLTSDLTVKVGDYGIGP  147 (268)
T ss_pred             EEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCe---eccCCccceEEEcCCccEEeccccccc
Confidence            99999999999999997642  2346677788999999999999999998   999999999999999999999999876


Q ss_pred             ccccCC-CCCCcccccCCCCCchhcccC-------CCCCcccchhhHHHHHHHHHcC-CcccccCCCCCCChhhHHHHHH
Q 037010          434 LTEVGS-ASLPTRLVGTFGYMPPEYAQY-------GDVSPKVDVYAFGVVLYELISA-KEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       434 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ...... ........++..|+|||++..       ..++.++|||||||++|||+++ ..||.....        .....
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~  219 (268)
T cd05086         148 SRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--------REVLN  219 (268)
T ss_pred             ccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence            422111 112233567889999998742       2457899999999999999975 556532211        11111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      .....     ......++.+...    ....+.+++..|| .+|++||++++|++.|.
T Consensus       220 ~~~~~-----~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         220 HVIKD-----QQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             HHHhh-----cccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11111     0112223333222    3346788999999 67999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=281.03  Aligned_cols=265  Identities=25%  Similarity=0.385  Sum_probs=202.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe-eE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI-GY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~-~~  349 (589)
                      -++|..++.||+|.||+|.+|+.+.+      .|.++.+.+.+.+.+.   .+....-+.|-++|+..+||.+..+. .|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat------~k~YAiKIlkKeviia---kdEVAHTlTE~RVL~~~~HPFLt~LKYsF  237 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKAT------GKLYAIKILKKEVIIA---KDEVAHTLTENRVLQNCRHPFLTSLKYSF  237 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeeccc------Cceeehhhhhhhheee---hHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence            36788899999999999999986655      3444444444444332   23445567799999999999998874 56


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      ...+.+++||||.+||.|+-++....  .+++...+.+-..|+.||.|||+++|   |.||||.+|.|+|++|++||+||
T Consensus       238 Qt~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~i---vYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  238 QTQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNI---VYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             ccCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCe---eeeechhhhheeccCCceEeeec
Confidence            66788999999999999998887643  48999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+++.. .........++|||.|+|||++....|+.+.|.|.+||++|||++|+.||.....        ..+++-++..
T Consensus       313 GLCKE~-I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------~kLFeLIl~e  383 (516)
T KOG0690|consen  313 GLCKEE-IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------EKLFELILME  383 (516)
T ss_pred             ccchhc-ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------hHHHHHHHhh
Confidence            999843 3334455668999999999999999999999999999999999999999965432        1222222111


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHHHhcccccccccC
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM--RSIVVALMTLSSTTEDWDV  573 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~L~~l~~~~~~~~~  573 (589)
                                 |-    ..|.....+...|+...|.+||.+|.--  +++.+....--..+.+|++
T Consensus       384 -----------d~----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~  434 (516)
T KOG0690|consen  384 -----------DL----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA  434 (516)
T ss_pred             -----------hc----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence                       11    1233334467889999999999999642  3344443333445566654

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.8e-34  Score=286.35  Aligned_cols=252  Identities=28%  Similarity=0.439  Sum_probs=192.3

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|+||.||++..+.++.. .+.|.+..         ........+.+.+|++++++++|+||+++++.+.+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~-~~ik~~~~---------~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~   70 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEH-CVIKEIDL---------TKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE   70 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCce-EEEEEeeH---------hhccchhhHHHHHHHHHHHhCCCCChhhhhheecc
Confidence            588899999999999999998765332 22221111         11111233567789999999999999999997764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-cEEEEecc
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-HAKVADFG  430 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-~vkl~Dfg  430 (589)
                       +..|+++||+.+++|.+++.......+++..++.++.|++.||.|||++++   +|+||||+||++++++ .+||+|||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i---~H~dl~~~nil~~~~~~~~~l~d~~  147 (257)
T cd08225          71 NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI---LHRDIKSQNIFLSKNGMVAKLGDFG  147 (257)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCCHHHEEEcCCCCeEEecccc
Confidence             468999999999999999987655568999999999999999999999998   9999999999998875 46999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      .+....... .......|++.|+|||++....++.++|+||||+++|||++|+.||....        ..........  
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~--  216 (257)
T cd08225         148 IARQLNDSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQ--  216 (257)
T ss_pred             cchhccCCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhc--
Confidence            987654322 12223468899999999988889999999999999999999999984321        1111111111  


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                 ... ...++..+..+.+++.+||..+|++|||++|++.|
T Consensus       217 -----------~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         217 -----------GYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             -----------ccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                       000 01122234578999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.1e-34  Score=290.81  Aligned_cols=269  Identities=23%  Similarity=0.331  Sum_probs=190.8

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.++||+|+||.||+|.+..++ ...+.|.+.         .........+.+.+|++++++++||||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~~iK~~~---------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   70 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETG-QIVAIKKFL---------ESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR   70 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCC-CEEEEEeHh---------hccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc
Confidence            47889999999999999999986542 222222111         01111123345778999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+++++|.++.....  .+++..++.++.|++.||.|||+.++   +|+||+|+||++++++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i---~h~~l~p~ni~~~~~~~~~l~dfg  145 (286)
T cd07846          71 RKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNI---IHRDIKPENILVSQSGVVKLCDFG  145 (286)
T ss_pred             cCCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEECCCCcEEEEeee
Confidence            4 56899999999988888765443  38999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.....    ..............
T Consensus       146 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~~~~~~~  220 (286)
T cd07846         146 FARTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHIIKCLGNL  220 (286)
T ss_pred             eeeeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHHHHhCCC
Confidence            987654332 22233567899999998865 4578899999999999999999988743221    11111111100000


Q ss_pred             CChHHhh-------HhhcCCCCCC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDL-------RKLVDPRLGD-----NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l-------~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .......       .....+....     ...+..+..+.+++.+||+.+|++||+++++++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             chhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            0000000       0000011000     0112345679999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3e-34  Score=288.55  Aligned_cols=248  Identities=22%  Similarity=0.372  Sum_probs=189.4

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      -|++.+.||+|+||.||+|.+..+.. ..+.|....          .........+.+|++++++++||||+++++++.+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~-~~aiK~~~~----------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   73 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQK-VVAIKIIDL----------EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK   73 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCc-EEEEEEecc----------ccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe
Confidence            36788999999999999998765422 222221100          0111233568889999999999999999998765


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..|+||||+.+++|.+++...   .+++..+..++.|++.++.|||++++   +|+||||+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i---~h~dl~p~Ni~i~~~~~~~l~dfg~  147 (277)
T cd06641          74 DTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGV  147 (277)
T ss_pred             CCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCe---ecCCCCHHhEEECCCCCEEEeeccc
Confidence             4589999999999999998643   48899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.....     .   .....+...  
T Consensus       148 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~---~~~~~~~~~--  216 (277)
T cd06641         148 AGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-----M---KVLFLIPKN--  216 (277)
T ss_pred             ceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-----H---HHHHHHhcC--
Confidence            875433221 11234678899999999888899999999999999999999999843211     0   001111000  


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                              -.+    ..+...+..+.+++.+||+.+|.+||++.++++|
T Consensus       217 --------~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 --------NPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             --------CCC----CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                    011    1222334568999999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=6.2e-35  Score=276.59  Aligned_cols=279  Identities=25%  Similarity=0.326  Sum_probs=200.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH-----HHHHHHHHHHHHccCCCCcce
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-----ASREFLAELKVLTHVHHLNLV  344 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~-----~~~~~~~E~~il~~l~hpnIv  344 (589)
                      ....|+...+||+|.||.||+|...++.+..           .+.+++|+++.+     ......+|+.++++++|||++
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-----------~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi   90 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKR-----------TKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVI   90 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCccc-----------chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcch
Confidence            3467999999999999999999655543221           235666666543     234567899999999999999


Q ss_pred             eEeeEEE--eCcEEEEEEecCCCChHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc
Q 037010          345 RLIGYCV--EGSLFLVYEYIENGNLSEHLRGSG---RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID  419 (589)
Q Consensus       345 ~l~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~  419 (589)
                      .+..++.  +..+++++||.+. +|...|+...   ...++....+.|+.||+.|+.|||++=+   +||||||.|||+.
T Consensus        91 ~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWv---lHRDLKPaNIlvm  166 (438)
T KOG0666|consen   91 SLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWV---LHRDLKPANILVM  166 (438)
T ss_pred             hHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhhe---eeccCCcceEEEe
Confidence            9998664  5679999999998 8998886432   2458888999999999999999999987   9999999999997


Q ss_pred             CC----CcEEEEeccCccccccCCCCC--CcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCC
Q 037010          420 KN----FHAKVADFGLTKLTEVGSASL--PTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGS  492 (589)
Q Consensus       420 ~~----~~vkl~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~  492 (589)
                      .+    |+|||+|||+++.+...-...  ....+-|.+|+|||.+.+. .|+.+.||||.||++.||||-+..|...+..
T Consensus       167 gdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k  246 (438)
T KOG0666|consen  167 GDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK  246 (438)
T ss_pred             ccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence            77    899999999999876543322  2346789999999988764 6899999999999999999998888654432


Q ss_pred             CCCh----hhHHHHHHHHhcCCChH--HhhHhhcCC---------CCCCCCCh--------HHHHHHHHHHHHhcccCCC
Q 037010          493 SADS----KGLVALFEEVLNLPDPI--EDLRKLVDP---------RLGDNCPL--------DSVLKMAQLAKVCTQEYPQ  549 (589)
Q Consensus       493 ~~~~----~~~~~~~~~~~~~~~~~--~~l~~~~d~---------~l~~~~~~--------~~~~~l~~li~~cl~~dP~  549 (589)
                      ....    .......-+++..|...  ..+.++.+-         .....+..        .-.....+|+..+|+.||.
T Consensus       247 ~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~  326 (438)
T KOG0666|consen  247 IKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPI  326 (438)
T ss_pred             cccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCch
Confidence            2211    11111122233322211  111111110         00011100        0111367899999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 037010          550 LRPSMRSIVVALMT  563 (589)
Q Consensus       550 ~RPs~~evl~~L~~  563 (589)
                      +|.|+++.++|.--
T Consensus       327 kRIta~qAleh~yF  340 (438)
T KOG0666|consen  327 KRITAEQALEHPYF  340 (438)
T ss_pred             hhccHHHHhccccc
Confidence            99999999998643

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-34  Score=285.53  Aligned_cols=255  Identities=21%  Similarity=0.314  Sum_probs=192.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      .+|++.+.||+|+||.||++.+..++. ..+.|.+...     .. ..........+.+|++++++++|+||+++++++.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~ik~~~~~-----~~-~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   74 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGR-ELAVKQVPFD-----PD-SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLR   74 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCC-EEEEEEEecC-----cc-cchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEE
Confidence            579999999999999999998765432 2222221100     00 0011233457888999999999999999999876


Q ss_pred             e---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 E---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +   +.++++|||+++++|.+++....  .+++...+.++.|++.||.|||++++   +|+||||+||+++.++.++|+|
T Consensus        75 ~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i---~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          75 DPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMI---VHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEEcCCCCEEECc
Confidence            4   34789999999999999997654  37889999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCC--CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGS--ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ||++.......  ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....       ... ..  
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~-~~--  219 (264)
T cd06653         150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAA-IF--  219 (264)
T ss_pred             cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHH-HH--
Confidence            99987543211  1111235688999999999888899999999999999999999999843211       111 11  


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                 +..........|......+.+++.+||+ +|..||++.+++.|
T Consensus       220 -----------~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         220 -----------KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -----------HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                       1111111123344556679999999999 57999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4e-34  Score=298.12  Aligned_cols=268  Identities=20%  Similarity=0.252  Sum_probs=192.6

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||+|.+..++.. .+.|.+.     .    .........++.+|++++++++||||+++++
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~-vaiK~~~-----~----~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   82 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQN-VAIKKLS-----R----PFQNVTHAKRAYRELVLMKLVNHKNIIGLLN   82 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCE-EEEEecC-----c----cccChhHHHHHHHHHHHHHhcCCCCCcceee
Confidence            3568899999999999999999987765322 2221110     0    0112233456778999999999999999998


Q ss_pred             EEEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          349 YCVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       349 ~~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      ++..       ...|+||||+.+ +|.+.+...    ++...+..++.|++.||+|||++++   +||||||+||+++.+
T Consensus        83 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi---~H~dlkp~Nil~~~~  154 (353)
T cd07850          83 VFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSD  154 (353)
T ss_pred             eeccCCCccccCcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEECCC
Confidence            7642       247999999965 888887643    7888999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      +.+||+|||++.......  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.....     .....
T Consensus       155 ~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~-----~~~~~  227 (353)
T cd07850         155 CTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH-----IDQWN  227 (353)
T ss_pred             CCEEEccCccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH-----HHHHH
Confidence            999999999997653321  22335688999999999999999999999999999999999999854321     00000


Q ss_pred             HHHHHhcCCCh--HHh-------------------hHhhcC----CCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 037010          502 LFEEVLNLPDP--IED-------------------LRKLVD----PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS  556 (589)
Q Consensus       502 ~~~~~~~~~~~--~~~-------------------l~~~~d----~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  556 (589)
                      .....+..+..  .+.                   +.....    +......+...+..+.+++.+||+.||++|||+.|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e  307 (353)
T cd07850         228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD  307 (353)
T ss_pred             HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence            00011111100  000                   000000    00001112234557899999999999999999999


Q ss_pred             HHHHH
Q 037010          557 IVVAL  561 (589)
Q Consensus       557 vl~~L  561 (589)
                      +++|=
T Consensus       308 iL~~~  312 (353)
T cd07850         308 ALQHP  312 (353)
T ss_pred             HhcCh
Confidence            99883

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.6e-34  Score=285.22  Aligned_cols=253  Identities=28%  Similarity=0.445  Sum_probs=196.2

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|++|.||+|.+..++. ..+.|.+..          .........+.+|++++.+++|+||+++++++.
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~-~~~vk~~~~----------~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGK-IYALKKIHV----------DGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY   69 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCc-EEEEEEecc----------CcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc
Confidence            468899999999999999998876432 222221110          111133567889999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      + +..+++|||+++++|.+++...  .++++..++.++.|++.||+|||+ .++   +|+||+|+||+++.++.++|+||
T Consensus        70 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~---~H~~l~~~ni~~~~~~~~~l~df  144 (264)
T cd06623          70 KEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHI---IHRDIKPSNLLINSKGEVKIADF  144 (264)
T ss_pred             cCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCC---ccCCCCHHHEEECCCCCEEEccC
Confidence            4 5689999999999999999865  348999999999999999999999 998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++......... .....++..|+|||.+....++.++|+||||+++|+|+||+.||.....     .............
T Consensus       145 ~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~  218 (264)
T cd06623         145 GISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDG  218 (264)
T ss_pred             ccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcC
Confidence            998865432221 2245688999999999988999999999999999999999999854332     0111111111111


Q ss_pred             CChHHhhHhhcCCCCCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLD-SVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                ..+    ..+.. .+..+.+++.+||..+|++||+++|++++
T Consensus       219 ----------~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 ----------PPP----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----------CCC----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                      111    11222 45579999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6.1e-35  Score=296.72  Aligned_cols=270  Identities=23%  Similarity=0.277  Sum_probs=190.9

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|+||.||+|.+..++. ..+.|.+....      ...........+..|++++++++|+||+++++++.+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~-~v~iK~~~~~~------~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   73 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGR-IVAIKKIKLGE------RKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH   73 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCc-EEEEEEEeccc------cccccchhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence            58889999999999999999766532 22222211100      000011223456779999999999999999998875


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++++   +|+||||+||+++.++.++|+|||+
T Consensus        74 ~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i---~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          74 KSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWI---LHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             CCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eecCCChhhEEEcCCCCEEEcccee
Confidence             4689999999 889999997654 358999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +........ ......+++.|+|||.+.+ ..++.++|+|||||++|||++|..+|.....    ...+..... ....+
T Consensus       149 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~----~~~~~~~~~-~~~~~  222 (298)
T cd07841         149 ARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD----IDQLGKIFE-ALGTP  222 (298)
T ss_pred             eeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc----HHHHHHHHH-HcCCC
Confidence            976543221 2233456888999998854 4678899999999999999999766643221    111111111 11111


Q ss_pred             ChHH--hhH---hhcCCCCCC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIE--DLR---KLVDPRLGD-----NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~--~l~---~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ....  ...   .........     .........+.+++.+||..+|++|||++|+++|
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            1000  000   000000000     1112335678999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-34  Score=290.26  Aligned_cols=268  Identities=24%  Similarity=0.346  Sum_probs=188.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|++|.||+|....++ ..++.|.+...          ........+.+|++++++++|+||+++++++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~-~~~~iK~~~~~----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   72 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTG-QLVALKEIRLE----------HEEGAPFTAIREASLLKDLKHANIVTLHDII   72 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCC-cEEEEEEEecc----------cccCCchhHHHHHHHHhhCCCcceeeEEEEE
Confidence            468999999999999999999876542 22222211110          0011123456799999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+.+ +|.+++..... .+++..++.++.|++.||.|||++++   +||||||+||+++.++.+||+||
T Consensus        73 ~~~~~~~lv~e~~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~i---~H~dl~p~nil~~~~~~~kl~df  147 (291)
T cd07844          73 HTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRRV---LHRDLKPQNLLISERGELKLADF  147 (291)
T ss_pred             ecCCeEEEEEecCCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCe---ecccCCHHHEEEcCCCCEEECcc
Confidence            64 468999999985 99999876543 58899999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++......... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....    ...........+.
T Consensus       148 g~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~~~~~~~~  222 (291)
T cd07844         148 GLARAKSVPSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD----VEDQLHKIFRVLG  222 (291)
T ss_pred             ccccccCCCCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHhcC
Confidence            998754322111 122356889999998865 4588999999999999999999999854321    1111111111111


Q ss_pred             CCChHHhhHhhcC--------------CCCCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPIEDLRKLVD--------------PRLGDNC-PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d--------------~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+... .......              ..+.... .......+.+++.+||+.+|.+|||+.|+++|
T Consensus       223 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         223 TPTEE-TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             CCChh-hhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            11110 0000000              0000000 00112467899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.5e-34  Score=288.75  Aligned_cols=253  Identities=22%  Similarity=0.352  Sum_probs=183.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHH-HccCCCCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV-LTHVHHLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~  350 (589)
                      ++|++.+.||+|+||.||++.+..++.. .+.|.+..          ....+...++..|+++ ++.++||||+++++++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~-vaiK~~~~----------~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~   69 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTI-MAVKRIRA----------TVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL   69 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcE-EEEEEEec----------CCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE
Confidence            4789999999999999999998765322 22221110          1111222344556665 5667899999999977


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcEEE
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      . ++..|++|||++ |+|.+++...  ....+++..++.++.|++.||+|||++ ++   +||||||+||+++.++.+||
T Consensus        70 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i---~h~dlkp~nil~~~~~~~kl  145 (283)
T cd06617          70 FREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV---IHRDVKPSNVLINRNGQVKL  145 (283)
T ss_pred             ecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCe---ecCCCCHHHEEECCCCCEEE
Confidence            6 456999999997 5888887653  234689999999999999999999997 77   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccC----CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY----GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +|||++......  .......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||......      . ..
T Consensus       146 ~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~  216 (283)
T cd06617         146 CDFGISGYLVDS--VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP------F-QQ  216 (283)
T ss_pred             eecccccccccc--cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC------H-HH
Confidence            999998754321  11233568889999998754    45688999999999999999999998432110      0 01


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ......          ...+.+.   ....+..+.+++.+||..+|.+||+++++++|-
T Consensus       217 ~~~~~~----------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  262 (283)
T cd06617         217 LKQVVE----------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHP  262 (283)
T ss_pred             HHHHHh----------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            111110          0111111   112345689999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.6e-34  Score=283.49  Aligned_cols=254  Identities=28%  Similarity=0.410  Sum_probs=191.3

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|.+.+.||+|+||.||++....+.. .++.|.+..         ........+.+.+|++++++++|+||+++++++.+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~-~~~ik~~~~---------~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~   70 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGE-LMAVKEIRI---------QDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH   70 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCc-EEEEEEEEC---------cccchHHHHHHHHHHHHHHhCCCCChhheeeeEec
Confidence            58889999999999999998765422 222222111         11113355678899999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..++|+||+++++|.+++....  .+++..+..++.+++.||+|||++++   +|+||+|+||++++++.+||+|||+
T Consensus        71 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i---~H~dl~~~nil~~~~~~~kl~d~g~  145 (264)
T cd06626          71 REKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGI---VHRDIKPANIFLDHNGVIKLGDFGC  145 (264)
T ss_pred             CCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEccccc
Confidence             46899999999999999997653  37888999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCC---cccccCCCCCchhcccCCC---CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          432 TKLTEVGSASLP---TRLVGTFGYMPPEYAQYGD---VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       432 a~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +...........   ....+++.|+|||++....   ++.++||||||+++|+|++|+.||......   ..    ....
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~----~~~~  218 (264)
T cd06626         146 AVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQ----IMFH  218 (264)
T ss_pred             ccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HH----HHHH
Confidence            886543322211   1346788999999987665   889999999999999999999999533210   00    0000


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ....          ..+.++.  .......+.+++.+||+.+|.+|||+++++.+
T Consensus       219 ~~~~----------~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         219 VGAG----------HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HhcC----------CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000          0111111  11124568899999999999999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-36  Score=327.08  Aligned_cols=259  Identities=26%  Similarity=0.331  Sum_probs=198.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      +-++.-+.+||.|.||.||-|....++. ..+.|.         ..+........+.+.+|+.+|..++|||+|+++|+.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGe-llAvKE---------I~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVE 1303 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGE-LLAVKE---------IKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVE 1303 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccc-hhhhhh---------hhcCccccccCcchHHHHHHHHhccCccccccCcee
Confidence            3467778999999999999998776532 222221         111122233445677899999999999999999998


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.++|.||||++|+|.+.++....  .++.....+..|++.|+.|||++||   |||||||+|||++.+|.+|++||
T Consensus      1304 vHRekv~IFMEyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~gI---VHRDIK~aNI~Ld~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1304 VHREKVYIFMEYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEHGI---VHRDIKPANILLDFNGLIKYGDF 1378 (1509)
T ss_pred             ecHHHHHHHHHHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhcCc---eecCCCccceeeecCCcEEeecc
Confidence            75 568999999999999999876543  6667777788899999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCC---CcccccCCCCCchhcccC---CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          430 GLTKLTEVGSASL---PTRLVGTFGYMPPEYAQY---GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       430 gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      |.|..........   .....||+.|||||++.+   .+...+.|||||||++.||.||++||..-+..   +    ..+
T Consensus      1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~----aIM 1451 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---W----AIM 1451 (1509)
T ss_pred             cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---h----HHH
Confidence            9998765543221   234689999999999854   45677999999999999999999999654331   1    111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ..+-..              -....|......-.+++.+||+.||++|.++.|+++|=..=.
T Consensus      1452 y~V~~g--------------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1452 YHVAAG--------------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             hHHhcc--------------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            111110              012344456667899999999999999999999998854333

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9.2e-35  Score=293.22  Aligned_cols=267  Identities=24%  Similarity=0.345  Sum_probs=189.9

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||.|++|.||+|.+..++. ..+.|.+.         .+.........+.+|++++++++||||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-~~~ik~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   70 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIR---------LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT   70 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCC-EEEEEEcc---------ccccccccchHHHHHHHHHHhcCCCCCcchhhhccc
Confidence            48889999999999999998765532 22222111         011111122467789999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..++||||+. ++|.+++.......+++..++.++.|++.||+|||++++   +|+||+|+||+++.++.+||+|||+
T Consensus        71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i---~H~~l~p~nill~~~~~~~l~dfg~  146 (284)
T cd07860          71 ENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGL  146 (284)
T ss_pred             CCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEEeeccc
Confidence             56899999996 589999987666668999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +........ ......+++.|+|||.+.+. .++.++||||||+++|||+||+.||.....    ........... ..+
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~-~~~  220 (284)
T cd07860         147 ARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTL-GTP  220 (284)
T ss_pred             hhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHh-CCC
Confidence            875432221 12234568899999988654 468899999999999999999999854321    11122111111 111


Q ss_pred             Ch------------HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DP------------IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~------------~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..            ...+.......+ ....+.....+.+++.+||+.||.+|||+++++.|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         221 DEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             ChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            00            000000000000 00111233467899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.6e-34  Score=285.73  Aligned_cols=252  Identities=24%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||.|+||.||+|.+..++. .++.|.+..     ..   .......+.+.+|++++++++||||+++++.+.+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~-~~~ik~~~~-----~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   71 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKK-MFAMKYMNK-----QK---CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD   71 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCc-EEEEEEEeh-----hh---hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence            58899999999999999998765432 222222211     10   1112345678889999999999999999987764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..|+|+||+.+++|.+++...  .++++..+..++.|++.||.|||++++   +|+||+|+||++++++.++|+|||+
T Consensus        72 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i---~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          72 EENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGI---IHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHeEEcCCCCEEEeeccc
Confidence             4689999999999999999765  358999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +.......  ......|+..|+|||.+....++.++|+||||+++|+|++|+.||......      ....+.....   
T Consensus       147 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~---  215 (258)
T cd05578         147 ATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQE---  215 (258)
T ss_pred             ccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhc---
Confidence            87654322  123356888999999998888999999999999999999999998544321      0111111100   


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH--HHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM--RSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~  560 (589)
                                . .....+...+..+.+++.+||+.||.+||++  +|+++|
T Consensus       216 ----------~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         216 ----------T-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             ----------c-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence                      0 1112233445678999999999999999999  776643

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=298.65  Aligned_cols=272  Identities=22%  Similarity=0.328  Sum_probs=194.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||.||+|.+..++.. .+.|.+.          +.........+.+|+.++++++||||++++++
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~-vaiK~~~----------~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   71 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVK-VAIKKIS----------PFEHQTFCQRTLREIKILRRFKHENIIGILDI   71 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCe-EEEEEec----------ccccchhHHHHHHHHHHHHhCCCCCcCchhhe
Confidence            357899999999999999999988765322 2222110          00112234557789999999999999999987


Q ss_pred             EEeC------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          350 CVEG------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       350 ~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      +...      ..|+++||+.+ +|.+++...   .+++..+..++.|++.||+|||++++   +||||||+||+++.++.
T Consensus        72 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~i---vH~dlkp~Nill~~~~~  144 (336)
T cd07849          72 IRPPSFESFNDVYIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTNCD  144 (336)
T ss_pred             eecccccccceEEEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHEEECCCCC
Confidence            6532      47999999975 888877543   48999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCC--CCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          424 AKVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      +||+|||++.........  ......|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.....     ....
T Consensus       145 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~  219 (336)
T cd07849         145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQL  219 (336)
T ss_pred             EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence            999999998754322211  1223568999999998644 5689999999999999999999999844321     1122


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCC---------CCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhc
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRL---------GDNC-----PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTL  564 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l---------~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l  564 (589)
                      ..+...+..+.. +.+..+.+...         ....     .+.....+.+++.+||+.+|++|||+.|+++|  +...
T Consensus       220 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         220 NLILGVLGTPSQ-EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHHHcCCCCH-HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            222222222211 11111111100         0000     01224568999999999999999999999999  5544


Q ss_pred             c
Q 037010          565 S  565 (589)
Q Consensus       565 ~  565 (589)
                      .
T Consensus       299 ~  299 (336)
T cd07849         299 H  299 (336)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.7e-34  Score=291.39  Aligned_cols=257  Identities=23%  Similarity=0.345  Sum_probs=188.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||++.+..... ..+.|.+..     ..   .........+.+|+++++.++||||+++++.+.
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-~v~ik~~~~-----~~---~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   71 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQ-RFAMKKINK-----QN---LILRNQIQQVFVERDILTFAENPFVVSMFCSFE   71 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCc-EEEEEEeeh-----hh---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence            468999999999999999998776532 222221111     00   011123356778999999999999999998776


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..++||||+++++|.+++....  .+++..+..++.|++.||+|||++++   +||||||+||+++.++.++|+|||
T Consensus        72 ~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          72 TKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGI---VHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             cCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCchHHEEECCCCCEEEeeCC
Confidence            4 45899999999999999997654  48899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCC--------------CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          431 LTKLTEVGSA--------------SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       431 la~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      +++.......              .......++..|+|||.+....++.++|+|||||++|||++|..||.....     
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----  221 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----  221 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            8864211100              011124578899999999888899999999999999999999999853211     


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                         ..........        ....+..    +...+..+.+++.+||+.+|++||++.++.+.|.
T Consensus       222 ---~~~~~~~~~~--------~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         222 ---EELFGQVISD--------DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ---HHHHHHHHhc--------ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence               1111111110        0001111    1123446899999999999999999544444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=281.88  Aligned_cols=269  Identities=21%  Similarity=0.293  Sum_probs=206.0

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCC-C
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVH-H  340 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~-h  340 (589)
                      ++......++|.+...+|+|.||.|-.+.++.. +..              +++|.++  ....+..+-|+++|.++. +
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~-~~~--------------vAlKIik~V~kYreAa~iEi~vLqki~~~  145 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRET-KEH--------------VALKIIKNVDKYREAALIEIEVLQKINES  145 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCC-Cce--------------ehHHHHHHHHHHhhHHHHHHHHHHHHHhc
Confidence            333344589999999999999999999988876 222              2222222  122344566999999993 2


Q ss_pred             -C----cceeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCC
Q 037010          341 -L----NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA  414 (589)
Q Consensus       341 -p----nIv~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~  414 (589)
                       |    -++.+.+|++ .++.++|+|.+ |.|+.+++..++..+++...++.|+.|++.++++||+.++   +|.||||+
T Consensus       146 DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl---~HTDLKPE  221 (415)
T KOG0671|consen  146 DPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKL---THTDLKPE  221 (415)
T ss_pred             CCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcce---eecCCChh
Confidence             2    2567777775 67899999998 5599999999988899999999999999999999999999   99999999


Q ss_pred             cEEEc--------------------CCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHH
Q 037010          415 NILID--------------------KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGV  474 (589)
Q Consensus       415 NILl~--------------------~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGv  474 (589)
                      |||+.                    ++..++++|||.|.......    ...+.|..|+|||++.+-+|+..+||||+||
T Consensus       222 NILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGC  297 (415)
T KOG0671|consen  222 NILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGC  297 (415)
T ss_pred             eEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeee
Confidence            99983                    13458999999998654332    4578899999999999999999999999999


Q ss_pred             HHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhh----------cC---------------CCC----C
Q 037010          475 VLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKL----------VD---------------PRL----G  525 (589)
Q Consensus       475 ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~----------~d---------------~~l----~  525 (589)
                      ||+|+.||...|....     ......+++.++.. -+...+.+.          +|               +..    .
T Consensus       298 IL~ElytG~~LFqtHe-----n~EHLaMMerIlGp-~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~  371 (415)
T KOG0671|consen  298 ILVELYTGETLFQTHE-----NLEHLAMMERILGP-IPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKY  371 (415)
T ss_pred             EEEEeeccceecccCC-----cHHHHHHHHHhhCC-CcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHH
Confidence            9999999999996554     33445777777763 222222111          01               000    0


Q ss_pred             CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          526 DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       526 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ......+...|.+|+++||..||.+|+|+.|++.|=
T Consensus       372 ~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~Hp  407 (415)
T KOG0671|consen  372 MLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHP  407 (415)
T ss_pred             hccCcHHHhHHHHHHHHHHccCccccccHHHHhcCH
Confidence            122345566899999999999999999999999883

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.8e-34  Score=284.46  Aligned_cols=247  Identities=21%  Similarity=0.352  Sum_probs=188.3

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEEEE
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLV  358 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv  358 (589)
                      ||.|+||.||+|.+..+. ...+.|.+....        .......+.+.+|++++++++||||+++++++.+ ...|++
T Consensus         1 lg~g~~~~v~~~~~~~~~-~~~~iK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   71 (262)
T cd05572           1 LGVGGFGRVELVKVKSKN-RTFALKCVKKRH--------IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYML   71 (262)
T ss_pred             CCCCCceEEEEEEECCCC-cEEEEEEEehhc--------chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEE
Confidence            699999999999987542 222222221100        0011234568889999999999999999998764 458999


Q ss_pred             EEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccC
Q 037010          359 YEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG  438 (589)
Q Consensus       359 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~  438 (589)
                      |||+++++|.+++....  .+++..+..++.|++.||+|||++++   +|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~---~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          72 MEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI---IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             EecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCc---ccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            99999999999997653  38899999999999999999999998   99999999999999999999999998865432


Q ss_pred             CCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHh
Q 037010          439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRK  518 (589)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  518 (589)
                      .  ......+++.|++||.+....++.++|+||||+++|+|++|..||......      ........            
T Consensus       147 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~------------  206 (262)
T cd05572         147 Q--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED------PMEIYNDI------------  206 (262)
T ss_pred             c--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC------HHHHHHHH------------
Confidence            2  223356889999999998888999999999999999999999999544320      11111111            


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 037010          519 LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVAL  561 (589)
Q Consensus       519 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L  561 (589)
                       .+.......+......+.+++.+||..+|.+||+     ++|+++|=
T Consensus       207 -~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~  253 (262)
T cd05572         207 -LKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHK  253 (262)
T ss_pred             -hccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcCh
Confidence             1111111233333567999999999999999999     88888863

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.6e-34  Score=289.75  Aligned_cols=251  Identities=22%  Similarity=0.338  Sum_probs=191.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|.+.+.||+|+||.||++....+.. ..+.|.+.           .......+.+.+|+.++++++||||+++++++
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~v~iK~~~-----------~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~   85 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQ-EVAIKQMN-----------LQQQPKKELIINEILVMRENKHPNIVNYLDSY   85 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCC-EEEEEEec-----------cccchHHHHHHHHHHHHhhcCCCCeeehhhee
Confidence            3689999999999999999998655422 22222110           01112235678899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .. +..|+|+||+++++|.+++...   .+++..+..++.|++.||.|||++++   +|+||||+||+++.++.++|+||
T Consensus        86 ~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi---~H~dL~p~Nili~~~~~~kL~df  159 (293)
T cd06647          86 LVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDF  159 (293)
T ss_pred             eeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCE---eeccCCHHHEEEcCCCCEEEccC
Confidence            64 5689999999999999998754   37889999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++........ ......+++.|++||.+....++.++|+||||+++|+|++|+.||.......        ....... 
T Consensus       160 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--------~~~~~~~-  229 (293)
T cd06647         160 GFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--------ALYLIAT-  229 (293)
T ss_pred             cceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--------heeehhc-
Confidence            98875433222 1223468889999999988889999999999999999999999994332110        0000000 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                 ........+......+.+++.+||..+|++||++++++.|
T Consensus       230 -----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 -----------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -----------CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                       0000011122334578899999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-34  Score=286.72  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=188.6

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC---CCcceeEeeE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH---HLNLVRLIGY  349 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~  349 (589)
                      .|++.+.||+|+||.||+|.+..++ ...+.|.+..          ........++.+|++++++++   |||+++++++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~-~~~~iK~~~~----------~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~   70 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTG-RVVALKIINL----------DTPDDDVSDIQREVALLSQLRQSQPPNITKYYGS   70 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCC-cEEEEEEecC----------CCCchhHHHHHHHHHHHHHhccCCCCCeeeEeee
Confidence            4778899999999999999976542 2222221110          112233456778999988886   9999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ ...|++|||+++++|.+++...   .+++..++.++.|++.||.|||+.++   +|+||+|+||+++.++.++|+|
T Consensus        71 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i---~H~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06917          71 YLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGV---IHRDIKAANILVTNTGNVKLCD  144 (277)
T ss_pred             eeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCcCHHHEEEcCCCCEEEcc
Confidence            765 4589999999999999998654   48999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++........ ......|+..|+|||.+.. ..++.++|+|||||++|+|++|+.||.....        ........
T Consensus       145 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~~~  215 (277)
T cd06917         145 FGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMMLIP  215 (277)
T ss_pred             CCceeecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhccc
Confidence            999886543332 2233568899999998865 4568899999999999999999999843211        00000000


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                ....+.+...   .....+.+++.+||+.||.+||++.+++.+-
T Consensus       216 ----------~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~  256 (277)
T cd06917         216 ----------KSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKSK  256 (277)
T ss_pred             ----------cCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence                      0001111111   1345789999999999999999999998863

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.1e-34  Score=292.04  Aligned_cols=249  Identities=22%  Similarity=0.350  Sum_probs=188.1

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      .|.....||+|+||.||++....++. ..+.|.+.           .......+.+.+|+.++++++|+||+++++.+. 
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~-~vaiK~~~-----------~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~   90 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGK-QVAVKKMD-----------LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV   90 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCC-EEEEEEEe-----------cchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec
Confidence            34455779999999999998765532 22222110           111223456788999999999999999998765 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      .+..|+||||+++++|.+++...   .+++..+..++.|++.||+|||++++   +||||||+||++++++.++|+|||+
T Consensus        91 ~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~i---vH~dlkp~Nill~~~~~~kL~dfg~  164 (292)
T cd06658          91 GDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGV---IHRDIKSDSILLTSDGRIKLSDFGF  164 (292)
T ss_pred             CCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCE---eecCCCHHHEEEcCCCCEEEccCcc
Confidence            45689999999999999988543   38899999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +........ ......|+..|+|||.+....++.++|+||||+++|||++|+.||.....     ...   ...      
T Consensus       165 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~~---~~~------  229 (292)
T cd06658         165 CAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----LQA---MRR------  229 (292)
T ss_pred             hhhcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH---HHH------
Confidence            875432221 22335689999999999888899999999999999999999999853221     011   111      


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                          +...+.+.+..  .......+.+++.+||..||.+|||++|++++
T Consensus       230 ----~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         230 ----IRDNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ----HHhcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                11111111111  11223468899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.5e-34  Score=280.86  Aligned_cols=250  Identities=26%  Similarity=0.414  Sum_probs=193.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      +|++.++||+|+||.||++.+..++. .++.|...         ..........++.+|++++++++|+||+++++++. 
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~-~~~ik~~~---------~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQ-FYALKEVD---------LGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD   70 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCC-EEEEEEEe---------hhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc
Confidence            58889999999999999998765532 22222111         11112233456778999999999999999998765 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +...|+||||+++++|.+++....  ...+++..+..++.|++.||+|||+.++   +|+||+|+||+++.++.+||+||
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i---~h~~l~~~ni~~~~~~~~kl~d~  147 (256)
T cd08530          71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKI---LHRDLKSANILLVANDLVKIGDL  147 (256)
T ss_pred             CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc---ccCCCCcceEEEecCCcEEEeec
Confidence            456899999999999999987632  2458899999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++......   ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||.....     ..   ......  
T Consensus       148 g~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~---~~~~~~--  214 (256)
T cd08530         148 GISKVLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QD---LRYKVQ--  214 (256)
T ss_pred             cchhhhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HH---HHHHHh--
Confidence            998765433   22235678899999999888899999999999999999999999843221     11   111110  


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                  .......+......+.+++.+||..+|++|||+.++++|
T Consensus       215 ------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         215 ------------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             ------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                        011112233455679999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-33  Score=286.38  Aligned_cols=270  Identities=23%  Similarity=0.306  Sum_probs=187.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      +..+|++.+.||+|+||.||+|....++.. ++.|.+..+          ........+.+|+++++.++|+||++++++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~-~~iK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~   71 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQL-VALKVISMK----------TEEGVPFTAIREASLLKGLKHANIVLLHDI   71 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcE-EEEEEeccc----------CcCCCcHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            357899999999999999999987765332 222211100          011112345679999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||++++   +|+||||+|||++.++.++|+|
T Consensus        72 ~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i---~H~dlkp~Nil~~~~~~~~l~D  146 (291)
T cd07870          72 IHTKETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHI---LHRDLKPQNLLISYLGELKLAD  146 (291)
T ss_pred             EecCCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChHHEEEcCCCcEEEec
Confidence            765 45899999996 68888776543 347888899999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++......... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||......    ...........
T Consensus       147 fg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~  221 (291)
T cd07870         147 FGLARAKSIPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV----FEQLEKIWTVL  221 (291)
T ss_pred             cccccccCCCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH----HHHHHHHHHHc
Confidence            9998754322211 223457899999999865 35788999999999999999999998543221    11111111111


Q ss_pred             cCCChHH--hhHh-------hcCCCCCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPIE--DLRK-------LVDPRLGDNC-----PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~--~l~~-------~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..+....  .+..       ..........     .......+.+++.+|+..||.+|||++|++.|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         222 GVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             CCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            1111000  0000       0000000000     00113468899999999999999999999865

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.1e-33  Score=288.16  Aligned_cols=259  Identities=27%  Similarity=0.394  Sum_probs=193.3

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      .|...+.||+|+||.||++.+..++. ..+.|.+..        ......+....+.+|++++++++|||++++++++.+
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~-~valK~~~~--------~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNE-VVAIKKMSY--------SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR   96 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCc-EEEEEEEec--------CCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            37778999999999999998765432 222111100        001112334568889999999999999999998865


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..|+||||+.+ +|.+++.... .++++..+..++.|++.||.|||++++   +|+||+|+||+++.++.++|+|||+
T Consensus        97 ~~~~~lv~e~~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i---~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635          97 EHTAWLVMEYCLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             CCeEEEEEeCCCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCcccEEECCCCCEEEecCCC
Confidence             458899999975 8888776443 358999999999999999999999998   9999999999999999999999998


Q ss_pred             ccccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      +.....     .....+++.|+|||++.   .+.++.++|||||||++|||++|+.||.....     ..   ...... 
T Consensus       172 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~~---~~~~~~-  237 (317)
T cd06635         172 ASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MS---ALYHIA-  237 (317)
T ss_pred             ccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HH---HHHHHH-
Confidence            865332     12346888999999873   45788999999999999999999999843211     00   011110 


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDW  571 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~  571 (589)
                                  ...............+.+++.+||+.+|.+||++.++++|+..+......+
T Consensus       238 ------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         238 ------------QNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             ------------hccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence                        000001112233456899999999999999999999999988777666554

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.6e-34  Score=286.59  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=194.6

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeE
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      ...+.|+..+.||+|++|.||++.+..+.. ..+.|              ....  ...+.+.+|++++++++|+|++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~-~~~iK--------------~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   80 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGK-EVAIK--------------KMRLRKQNKELIINEILIMKDCKHPNIVDY   80 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCc-EEEEE--------------EEecCchhHHHHHHHHHHHHHCCCCCeeEE
Confidence            345678899999999999999998875422 22222              1111  134567889999999999999999


Q ss_pred             eeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++.+. ++..|+++||+++++|.+++.... ..+++..+..++.|++.||.|||+.|+   +|+||+|+||+++.++.++
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi---~H~dl~p~ni~i~~~~~~~  156 (286)
T cd06614          81 YDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNV---IHRDIKSDNILLSKDGSVK  156 (286)
T ss_pred             EEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCChhhEEEcCCCCEE
Confidence            99776 456899999999999999998765 359999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++........ ......++..|++||.+.+..++.++|+||||+++|+|++|+.||.....     .   .....
T Consensus       157 l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~-----~---~~~~~  227 (286)
T cd06614         157 LADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP-----L---RALFL  227 (286)
T ss_pred             ECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHH
Confidence            999998765432221 11234578899999999888899999999999999999999999843211     0   01111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      .....         . +..  ..+...+..+.+++.+||+.+|.+|||+.+++++..
T Consensus       228 ~~~~~---------~-~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  272 (286)
T cd06614         228 ITTKG---------I-PPL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF  272 (286)
T ss_pred             HHhcC---------C-CCC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence            10000         0 000  111123457899999999999999999999998743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-33  Score=279.71  Aligned_cols=253  Identities=24%  Similarity=0.362  Sum_probs=196.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|+..+.||+|++|.||+|.+..+.. ..+.|....         ........+.+.+|++++++++||||+++++.+.+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~-~~~ik~~~~---------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGE-LMAVKSVEL---------SGDSEEELEALEREIRILSSLQHPNIVRYYGSERD   70 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCc-EEEEEEeec---------cccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEec
Confidence            47888999999999999998875422 222211110         01112345678889999999999999999998775


Q ss_pred             C---cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          353 G---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       353 ~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .   ..++++||+.+++|.+++....  .+++..++.++.|++.+|+|||+.++   +|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~---~h~dl~p~ni~i~~~~~~~l~d~  145 (260)
T cd06606          71 EEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGI---VHRDIKGANILVDSDGVVKLADF  145 (260)
T ss_pred             CCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEEcCCCCEEEccc
Confidence            4   5899999999999999998765  58999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |.+......... ......++..|+|||.+.....+.++||||||+++|+|++|+.||.....       ......    
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~----  214 (260)
T cd06606         146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALY----  214 (260)
T ss_pred             ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHH----
Confidence            998865543321 12335688999999999888899999999999999999999999854331       001111    


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                               ...........+...+..+.+++.+||..+|++||++.+++.|
T Consensus       215 ---------~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         215 ---------KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ---------hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                     1111111122333445689999999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.3e-33  Score=279.76  Aligned_cols=252  Identities=28%  Similarity=0.486  Sum_probs=195.5

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||.|+||.||++.+..++. .++.|.+         ............+.+|++++++++|||++++++.+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-~~~ik~~---------~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~   70 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGK-LYVLKEI---------DLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE   70 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCc-EEEEEEe---------ecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec
Confidence            58889999999999999999875422 2222211         1111223445668889999999999999999987654


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                       +..++++|++++++|.+++....  ...+++..+..++.+++.||.|||++++   +|+||+|+||+++.++.++|+||
T Consensus        71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---~H~dl~~~nil~~~~~~~~l~d~  147 (258)
T cd08215          71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI---LHRDIKPQNIFLTSNGLVKLGDF  147 (258)
T ss_pred             CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCE---ecccCChHHeEEcCCCcEEECCc
Confidence             56899999999999999998753  3569999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |.+....... .......|++.|+|||.+....++.++|+||+|+++|+|++|+.||.....        ..........
T Consensus       148 ~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~  218 (258)
T cd08215         148 GISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL--------LELALKILKG  218 (258)
T ss_pred             cceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH--------HHHHHHHhcC
Confidence            9987654332 122335688999999999888899999999999999999999999843321        1111111110


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                   . ....+......+.+++.+||..+|.+|||++|++++
T Consensus       219 -------------~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         219 -------------Q-YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -------------C-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                         0 111222344578999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-33  Score=286.05  Aligned_cols=249  Identities=20%  Similarity=0.328  Sum_probs=189.1

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      .|...+.||+|++|.||++.+..+.. ..+.|..           +.......+.+.+|+.+++.++||||+++++++. 
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~iK~~-----------~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~   87 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGR-QVAVKKM-----------DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV   87 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCC-EEEEEEE-----------eccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc
Confidence            35556899999999999998765432 1211110           1111223345788999999999999999999765 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      .+..++++||+.+++|.+++..   .++++..+..++.|++.||+|||++++   +||||+|+||+++.++.++|+|||.
T Consensus        88 ~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~l~d~g~  161 (285)
T cd06648          88 GDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGV---IHRDIKSDSILLTSDGRVKLSDFGF  161 (285)
T ss_pred             CCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCChhhEEEcCCCcEEEccccc
Confidence            4568999999999999999876   248899999999999999999999998   9999999999999999999999998


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +........ ......|++.|+|||.+....++.++||||||+++|+|++|+.||.....        .........   
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~~---  229 (285)
T cd06648         162 CAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIRD---  229 (285)
T ss_pred             chhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHh---
Confidence            765432221 12235689999999999888899999999999999999999999854221        111111111   


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                             ...+...  .+...+..+.+++.+||+.+|++|||++++++|
T Consensus       230 -------~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         230 -------NLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -------cCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence                   0011111  111234579999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.7e-33  Score=286.02  Aligned_cols=252  Identities=27%  Similarity=0.399  Sum_probs=189.0

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ..|.+.+.||+|+||.||+|....++. ..+.|.+...        .....+..+++.+|++++++++||||+++++++.
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~-~v~iK~~~~~--------~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~   85 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNE-VVAIKKMSYS--------GKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL   85 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCc-EEEEEEEecc--------ccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence            568889999999999999998765422 2222211000        0111233456888999999999999999999886


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.++   +|+||+|+||++++++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~g-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i---~H~dl~p~nIl~~~~~~~kL~dfg  160 (307)
T cd06607          86 REHTAWLVMEYCLG-SASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG  160 (307)
T ss_pred             eCCeEEEEHHhhCC-CHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCcccEEECCCCCEEEeecC
Confidence            5 568999999974 7877776433 348999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ++......     ....+++.|+|||++.   ...++.++||||||+++|||+||+.||.....        ........
T Consensus       161 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~  227 (307)
T cd06607         161 SASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIA  227 (307)
T ss_pred             cceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHh
Confidence            98754322     2346788999999873   45688999999999999999999999843321        00000110


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                      .             .......+...+..+.+++.+||..+|++||++++++.|..-
T Consensus       228 ~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  270 (307)
T cd06607         228 Q-------------NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV  270 (307)
T ss_pred             c-------------CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence            0             000111122345578999999999999999999999987543

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.3e-34  Score=287.36  Aligned_cols=268  Identities=22%  Similarity=0.312  Sum_probs=190.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..+.. ..+.|.+..         ..........+.+|++++++++||||+++++++.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~-~~~ik~~~~---------~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   74 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGE-IVALKKLKM---------EKEKEGFPITSLREINILLKLQHPNIVTVKEVVV   74 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCc-EEEEEEEee---------ccccccchhhHHHHHHHHHhcCCCCEEEEEEEEE
Confidence            578899999999999999998875422 222221110         0111112234667999999999999999999876


Q ss_pred             e---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          352 E---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       352 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +   +..|+||||+.+ +|.+++..... .+++..++.++.|++.||+|||++++   +|+||||+||+++.++.++|+|
T Consensus        75 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i---~H~dl~p~nili~~~~~~~l~d  149 (293)
T cd07843          75 GSNLDKIYMVMEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNWI---LHRDLKTSNLLLNNRGILKICD  149 (293)
T ss_pred             ecCCCcEEEEehhcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCCHHHEEECCCCcEEEee
Confidence            4   569999999975 99998876443 58999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.....    ......... ..
T Consensus       150 ~g~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~----~~~~~~~~~-~~  223 (293)
T cd07843         150 FGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE----IDQLNKIFK-LL  223 (293)
T ss_pred             cCceeeccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH-Hh
Confidence            99988654322 122334678899999988654 468899999999999999999999854321    111111111 11


Q ss_pred             cCCChH--Hhh-----------HhhcCCCCCCCCChH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPI--EDL-----------RKLVDPRLGDNCPLD-SVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~--~~l-----------~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..+...  ..+           .......+....+.. ....+.+++.+||+.+|++|||++|+++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             CCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            110000  000           000000111112221 35578999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-33  Score=284.94  Aligned_cols=246  Identities=23%  Similarity=0.309  Sum_probs=177.9

Q ss_pred             eeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHH---HHHccCCCCcceeEeeEEE-eCc
Q 037010          279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL---KVLTHVHHLNLVRLIGYCV-EGS  354 (589)
Q Consensus       279 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~---~il~~l~hpnIv~l~~~~~-~~~  354 (589)
                      .||+|+||.||++.+..++ ...+.|.+.....      .  .......+.+|.   .++...+||||+.+++++. ++.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~-~~~aiK~~~~~~~------~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTG-KMYAMKCLDKKRI------K--MKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK   71 (279)
T ss_pred             CcccCCCeEEEEEEECCCC-cEEEEEEEEcccc------c--cchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe
Confidence            4899999999999876542 2222221111000      0  001111223333   3344457999999998776 456


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       355 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .++||||+++++|.+++....  .+++..+..++.|++.||+|||++++   +|+||||+|||+++++.++|+|||++..
T Consensus        72 ~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~i---vH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          72 LCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---CCCCCCHHHEEECCCCCEEEccCCccee
Confidence            899999999999999987654  48999999999999999999999998   9999999999999999999999999865


Q ss_pred             cccCCCCCCcccccCCCCCchhccc-CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChH
Q 037010          435 TEVGSASLPTRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPI  513 (589)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (589)
                      .....   .....|+..|+|||.+. +..++.++|||||||++|+|++|+.||.......  ..   . .....      
T Consensus       147 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~---~-~~~~~------  211 (279)
T cd05633         147 FSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KH---E-IDRMT------  211 (279)
T ss_pred             ccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HH---H-HHHHh------
Confidence            43221   12346899999999886 4568899999999999999999999995432211  00   0 11100      


Q ss_pred             HhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 037010          514 EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVAL  561 (589)
Q Consensus       514 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  561 (589)
                          ...+    ...+...+..+.+++.+||..||.+||     |++|+++|.
T Consensus       212 ----~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         212 ----LTVN----VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             ----hcCC----cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence                0011    122334456789999999999999999     699999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-34  Score=289.02  Aligned_cols=266  Identities=24%  Similarity=0.340  Sum_probs=190.2

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  352 (589)
                      |++.+.||.|++|.||+|.+..++. ..+.|.+.         .+.........+.+|++++++++|||++++++++.+ 
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~-~~~ik~~~---------~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~   70 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGE-IVALKKIR---------LETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE   70 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCC-EEEEEEee---------cccccccchhHHHHHHHHHHhcCCCCccCHhheeccC
Confidence            6778999999999999998766432 22222111         111111223457789999999999999999998764 


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      +..|++|||++ ++|.+++.......+++..++.++.|++.||+|||++++   +|+||+|+||+++.++.++|+|||++
T Consensus        71 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~---~H~dl~p~nil~~~~~~~~l~df~~~  146 (283)
T cd07835          71 NKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV---LHRDLKPQNLLIDREGALKLADFGLA  146 (283)
T ss_pred             CeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eCCCCCHHHEEEcCCCcEEEeecccc
Confidence            56899999995 599999987665568999999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      ......... .....+++.|+|||++.+. .++.++|+||||+++|+|++|+.||.....    ...+...+... ..+.
T Consensus       147 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~-~~~~  220 (283)
T cd07835         147 RAFGVPVRT-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE----IDQLFRIFRTL-GTPD  220 (283)
T ss_pred             cccCCCccc-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHh-CCCC
Confidence            754322211 1223568899999987654 578899999999999999999999854321    11112211111 1111


Q ss_pred             h------------HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 P------------IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~------------~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .            ...+........ ..........+.+++.+||+.+|.+|||++|++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         221 EDVWPGVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hHHhhhhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0            000000000000 11122334578899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.8e-34  Score=286.48  Aligned_cols=248  Identities=25%  Similarity=0.359  Sum_probs=186.2

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcEEEE
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLV  358 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv  358 (589)
                      ||+|+||+||+|.+..++ ..++.|.+..+      ..+  .......+..|++++++++||||+++++.+. ++..|+|
T Consensus         1 lg~g~~g~vy~~~~~~~~-~~~~ik~~~~~------~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   71 (277)
T cd05577           1 LGKGGFGEVCACQVKATG-KMYACKKLDKK------RLK--KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLV   71 (277)
T ss_pred             CCCCCceeEEEEEEcCCC-cEEEEEEEehh------hhh--hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEE
Confidence            699999999999876653 22222222110      000  1122345677999999999999999998775 4568999


Q ss_pred             EEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccC
Q 037010          359 YEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG  438 (589)
Q Consensus       359 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~  438 (589)
                      |||+++++|.+++.......+++..++.++.|++.||.|||++++   +|+||+|+||+++.++.++|+|||.+......
T Consensus        72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i---~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI---VYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            999999999999987665569999999999999999999999998   99999999999999999999999988754321


Q ss_pred             CCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHh
Q 037010          439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRK  518 (589)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  518 (589)
                        .......++..|+|||.+.+..++.++||||||+++|+|++|+.||........    ..........          
T Consensus       149 --~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~----------  212 (277)
T cd05577         149 --KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRTLE----------  212 (277)
T ss_pred             --CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhcccc----------
Confidence              112334678899999999888899999999999999999999999854332110    0000000000          


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          519 LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       519 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                           .....+......+.+++.+||+.+|.+||     ++.++++|
T Consensus       213 -----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         213 -----MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             -----ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence                 01122333455789999999999999999     77778776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.4e-34  Score=290.45  Aligned_cols=249  Identities=21%  Similarity=0.347  Sum_probs=187.4

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-e
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-E  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~  352 (589)
                      |.....||+|+||.||++.+..++. ..+.|.+..         +  .....+.+.+|+.+++.++||||+++++++. +
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~-~v~iK~~~~---------~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~   90 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGR-QVAVKMMDL---------R--KQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG   90 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCC-EEEEEEEEe---------c--ccchHHHHHHHHHHHHhCCCCchhhhhhheeeC
Confidence            4445679999999999998765422 222221110         0  1122345778999999999999999999765 5


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      +..|++|||+++++|.+++...   .+++..++.++.|++.||+|||++++   +|+||||+||+++.++.++|+|||++
T Consensus        91 ~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~i---vH~dl~p~Nill~~~~~~kL~dfg~~  164 (297)
T cd06659          91 EELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGV---IHRDIKSDSILLTLDGRVKLSDFGFC  164 (297)
T ss_pred             CeEEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHeEEccCCcEEEeechhH
Confidence            5689999999999999987543   38899999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCCh
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP  512 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (589)
                      ........ ......|+..|+|||++....++.++|||||||++|||++|+.||.....        ......+....  
T Consensus       165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~--  233 (297)
T cd06659         165 AQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP--------VQAMKRLRDSP--  233 (297)
T ss_pred             hhcccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhccC--
Confidence            75432221 12235689999999999888899999999999999999999999853221        01111111100  


Q ss_pred             HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          513 IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       513 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                              .+..  .........+.+++.+||+.+|++||+++++++|-
T Consensus       234 --------~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~  272 (297)
T cd06659         234 --------PPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDHP  272 (297)
T ss_pred             --------CCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence                    0000  01112334688999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=7.7e-34  Score=287.18  Aligned_cols=256  Identities=23%  Similarity=0.366  Sum_probs=186.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~  350 (589)
                      ++|+..+.||+|+||.||++.+..++. ..+.|.+.          +.........+.+|+.++.++. |+||+++++++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~aiK~~~----------~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~   72 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGT-IMAVKRIR----------STVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGAL   72 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCC-EEEEEEeh----------hccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEE
Confidence            356677899999999999998876532 22222111          0111134456788999999996 99999999976


Q ss_pred             E-eCcEEEEEEecCCCChHHHH---hcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcEE
Q 037010          351 V-EGSLFLVYEYIENGNLSEHL---RGSGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l---~~~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      . ++..+++|||+.. +|.++.   .......+++..+..++.|++.||+|||+. ++   +||||||+||+++.++.++
T Consensus        73 ~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i---~H~dlkp~Nil~~~~~~~k  148 (288)
T cd06616          73 FREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKI---IHRDVKPSNILLDRNGNIK  148 (288)
T ss_pred             ecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCe---eccCCCHHHEEEccCCcEE
Confidence            5 4568999999865 555443   333334589999999999999999999975 77   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCC---CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG---DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |+|||++.......  ......|+..|+|||++...   .++.++|||||||++|+|++|+.||....       .....
T Consensus       149 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~  219 (288)
T cd06616         149 LCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQ  219 (288)
T ss_pred             EeecchhHHhccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHH
Confidence            99999987543221  12334688999999998765   68999999999999999999999984321       11111


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ........          .+.+....+...+..+.+|+.+||+.+|.+|||+++|++|-
T Consensus       220 ~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~  268 (288)
T cd06616         220 LTQVVKGD----------PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP  268 (288)
T ss_pred             HhhhcCCC----------CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            11111110          11111222223455799999999999999999999999883

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.8e-33  Score=280.91  Aligned_cols=261  Identities=27%  Similarity=0.366  Sum_probs=185.6

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeEEEe
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYCVE  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~  352 (589)
                      |++.++||+|+||.||++....+.. ..+.|...          +...........+|+.++.++. |+|++++++++.+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~-~~aik~~~----------~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   69 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGK-YYAIKCMK----------KHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD   69 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCc-EEEEEEeh----------hccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec
Confidence            6788999999999999998765432 22222110          0111111223456888898885 9999999998764


Q ss_pred             ---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          353 ---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       353 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                         +..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+||+++. +.+||+||
T Consensus        70 ~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i---~H~dl~p~ni~l~~-~~~kl~df  143 (282)
T cd07831          70 RKTGRLALVFELMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGI---FHRDIKPENILIKD-DILKLADF  143 (282)
T ss_pred             CCCCcEEEEEecCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCc---eecccCHHHEEEcC-CCeEEEec
Confidence               468999999975 8888887643 358999999999999999999999998   99999999999999 99999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhccc-CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++.......  ......++..|+|||.+. .+.++.++|||||||++|||++|+.||.....     ............
T Consensus       144 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-----~~~~~~~~~~~~  216 (282)
T cd07831         144 GSCRGIYSKP--PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-----LDQIAKIHDVLG  216 (282)
T ss_pred             ccccccccCC--CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-----HHHHHHHHHHcC
Confidence            9987653222  123356789999999764 45678899999999999999999999844322     111111222222


Q ss_pred             CCChHHhhHhhcCCC------CCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPR------LGD-------NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~------l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+..  .+.......      ...       ......+..+.+++.+||+.+|++||+++++++|
T Consensus       217 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         217 TPDA--EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             CCCH--HHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            1111  111111000      000       0112345689999999999999999999999976

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2e-33  Score=285.13  Aligned_cols=269  Identities=26%  Similarity=0.360  Sum_probs=189.2

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|++|.||+|.+..++. ..+.|.+         ..........+.+.+|++++++++||||+++++++.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-~~~iK~~---------~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNE-TIALKKI---------RLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH   71 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCc-EEEEEeh---------hhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe
Confidence            579999999999999999998766532 2222211         111111122345778999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-CCcEEEEec
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-NFHAKVADF  429 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-~~~vkl~Df  429 (589)
                      + +..|+||||+.+ +|.+++.......+++..++.++.||+.||+|||++++   +|+||+|+||+++. ++.+||+||
T Consensus        72 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i---~H~dl~p~nill~~~~~~~kl~df  147 (294)
T PLN00009         72 SEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV---LHRDLKPQNLLIDRRTNALKLADF  147 (294)
T ss_pred             cCCeEEEEEecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCCcceEEEECCCCEEEEccc
Confidence            4 568999999964 88888876655557888889999999999999999998   99999999999985 567999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++........ ......+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||.....    .......+. ...
T Consensus       148 g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~----~~~~~~~~~-~~~  221 (294)
T PLN00009        148 GLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE----IDELFKIFR-ILG  221 (294)
T ss_pred             ccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHH-HhC
Confidence            99875433211 1233467889999998865 4578999999999999999999999854321    111111111 111


Q ss_pred             CCChH--------HhhHhhcC---CCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPI--------EDLRKLVD---PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~--------~~l~~~~d---~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+...        .+......   +.......++....+.+++.+|++.+|++||+++++++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        222 TPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             CCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11000        00000000   000000112234568999999999999999999999986

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-33  Score=277.68  Aligned_cols=250  Identities=27%  Similarity=0.442  Sum_probs=191.6

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|+..+.||+|++|.||++.+..+. ...+.|....           ........+.+|++++++++|+|++++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~-~~~~~k~~~~-----------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   68 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTG-KEVAIKVIKL-----------ESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK   68 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCC-cEEEEEEecc-----------cchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence            4788899999999999999987542 2222211110           011244678889999999999999999997764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..++++||+++++|.+++.... ..+++..+..++.|++.+|.+||++++   +|+||+|+||++++++.++|+|||.
T Consensus        69 ~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i---~h~dl~p~ni~i~~~~~~~l~d~~~  144 (253)
T cd05122          69 KDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGI---IHRDIKAANILLTSDGEVKLIDFGL  144 (253)
T ss_pred             CCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCE---ecCCCCHHHEEEccCCeEEEeeccc
Confidence             56899999999999999998754 358999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +........  .....++..|++||.+....++.++|+||||+++|+|++|+.||.....     ...   ......   
T Consensus       145 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~---~~~~~~---  211 (253)
T cd05122         145 SAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKA---LFKIAT---  211 (253)
T ss_pred             ccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHH---HHHHHh---
Confidence            876543322  2345788999999999888899999999999999999999999843221     000   000000   


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                             ...+...  .+...+..+.+++.+||+.||++|||+.|+++|
T Consensus       212 -------~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         212 -------NGPPGLR--NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -------cCCCCcC--cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   0000010  011124578999999999999999999999876

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.8e-33  Score=284.55  Aligned_cols=269  Identities=23%  Similarity=0.330  Sum_probs=196.4

Q ss_pred             CCccceeeccCCcEEEEEEEEcccc--CCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEY--GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      +|++.+.||+|+||.||++......  +...+.|.+     .....  .......+.+.+|++++.++ +||||+++++.
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~-----~~~~~--~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~   73 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVL-----KKATI--VQKAKTAEHTRTERQVLEAVRRCPFLVTLHYA   73 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEE-----ehHHH--HhhhhHHHHHHHHHHHHHhccCCcchhhhhee
Confidence            4788999999999999999865432  122222211     11100  11122345677899999999 59999999987


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.. ...|+||||+.+|+|.+++....  .+++..++.++.|++.+|.|||+.++   +|+||||+||+++.++.++|+|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~---~H~dl~p~nil~~~~~~~~l~d  148 (288)
T cd05583          74 FQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGI---IYRDIKLENILLDSEGHVVLTD  148 (288)
T ss_pred             eecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHeEECCCCCEEEEE
Confidence            654 46889999999999999987543  48899999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCC--CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD--VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ||++...............|+..|+|||.+.+..  .+.++|+||||+++|||++|..||....... .   ........
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~---~~~~~~~~  224 (288)
T cd05583         149 FGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN-S---QSEISRRI  224 (288)
T ss_pred             CccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc-h---HHHHHHHH
Confidence            9998765433322223356889999999987654  7889999999999999999999985322111 0   11111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWD  572 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~  572 (589)
                      ...           .+    ..+......+.+++.+||+.+|++|||+.++.+.|...-.+..+|+
T Consensus       225 ~~~-----------~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~  275 (288)
T cd05583         225 LKS-----------KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD  275 (288)
T ss_pred             Hcc-----------CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence            110           11    1222334568999999999999999999888877776655556664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.4e-33  Score=282.85  Aligned_cols=266  Identities=23%  Similarity=0.368  Sum_probs=189.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.++||.|++|.||+|++..++. ..+.|.+..          .........+.+|++++++++||||+++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-~~~iK~~~~----------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   69 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGE-IVALKEIHL----------DAEEGTPSTAIREISLMKELKHENIVRLHDVIHT   69 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCe-EEEEEEecc----------cccccchHHHHHHHHHHHhhcCCCEeeeeeeEee
Confidence            58899999999999999999865432 222221110          0011123456679999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSG-RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                       +..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||++++   +|+||||+||++++++.++|+|||
T Consensus        70 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---~h~dl~p~ni~~~~~~~~~l~d~g  145 (284)
T cd07836          70 ENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV---LHRDLKPQNLLINKRGELKLADFG  145 (284)
T ss_pred             CCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHHHEEECCCCcEEEeecc
Confidence             568999999985 8999887644 2458999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++........ ......++..|++||.+.+ ..++.++|||||||++|+|++|+.||.....    ........ .....
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~-~~~~~  219 (284)
T cd07836         146 LARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN----EDQLLKIF-RIMGT  219 (284)
T ss_pred             hhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHH-HHhCC
Confidence            9875433221 1123457889999998765 3578899999999999999999999854322    11111111 11111


Q ss_pred             CChHHhhHhhcC-CCCCC-----------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVD-PRLGD-----------NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d-~~l~~-----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +.. ..+..+.+ +.+..           ...+..+..+.+++.+||+.||.+||+++|++++
T Consensus       220 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         220 PTE-STWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             CCh-hhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            110 00000000 00000           0111234578899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-33  Score=280.91  Aligned_cols=254  Identities=22%  Similarity=0.424  Sum_probs=189.6

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-  351 (589)
                      +|.+.+.||+|+||.||++.+........+ +.      .+.............++..|++++++++||||+++++++. 
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERL-KV------LKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE   73 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceE-EE------eccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc
Confidence            588999999999999999987654221111 00      0111111222233345667999999999999999998765 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +...++||||+++++|.+++...  ....+++..++.++.|++.||.|||++++   +|+||||+||+++. +.++|+||
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i---~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI---LHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCc---cccCCChhheEeec-CCEeeccc
Confidence            45689999999999999988642  23458999999999999999999999998   99999999999975 56999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++....... .......|++.|+|||.+....++.++|+||||+++|+|++|..||....        .......... 
T Consensus       150 g~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~-  219 (260)
T cd08222         150 GVSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVE-  219 (260)
T ss_pred             CceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHc-
Confidence            9987653322 12233567889999999988888999999999999999999999984221        1111111111 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                               ...+    ..+...+..+.+++.+||+.+|++||++.|+++|
T Consensus       220 ---------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 ---------GPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ---------CCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                     0111    1233445578999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.3e-33  Score=282.49  Aligned_cols=250  Identities=22%  Similarity=0.341  Sum_probs=184.1

Q ss_pred             HHHHhhcCCCccceee--ccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCC
Q 037010          265 EELSKATDNFSMSHKI--GQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHL  341 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~L--G~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hp  341 (589)
                      .+.....++|++.+.+  |+|+||.||++....++ ..++.+.+...         ...     ..  |+.....+ +||
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~k~~~~~---------~~~-----~~--e~~~~~~~~~h~   69 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQ-KLFVQKIIKAK---------NFN-----AI--EPMVHQLMKDNP   69 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCC-cEEEEEEEehh---------hcc-----hh--hHHHHHHhhcCC
Confidence            3444455677777776  99999999999876653 22333322111         001     01  22222212 699


Q ss_pred             cceeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          342 NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       342 nIv~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ||+++++.+. ++..|+||||+++++|.+++....  ++++..++.++.|++.||.|||+.++   +||||||+||+++.
T Consensus        70 ~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~nil~~~  144 (267)
T PHA03390         70 NFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNI---IHNDIKLENVLYDR  144 (267)
T ss_pred             CEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEEeC
Confidence            9999998775 556899999999999999997654  58999999999999999999999998   99999999999999


Q ss_pred             CC-cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          421 NF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       421 ~~-~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      ++ .++|+|||++......     ....++..|+|||++.+..++.++||||||+++|||++|+.||.........   .
T Consensus       145 ~~~~~~l~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~---~  216 (267)
T PHA03390        145 AKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD---L  216 (267)
T ss_pred             CCCeEEEecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh---H
Confidence            88 9999999998754322     2246889999999999889999999999999999999999999633222111   1


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-MRSIVVA  560 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  560 (589)
                      .......              ...  ...+...+..+.+++.+||+.+|.+||+ ++|+++|
T Consensus       217 ~~~~~~~--------------~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        217 ESLLKRQ--------------QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             HHHHHhh--------------ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            1111100              000  0112234457899999999999999996 6999865

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=288.49  Aligned_cols=275  Identities=23%  Similarity=0.324  Sum_probs=189.5

Q ss_pred             CCccceeeccCCcEEEEEEEEccc-cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGE-YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~-~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      +|++.+.||+|+||.||+|.+... .+..++.|.+.....        ......+.+.+|++++++++||||+++++++.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE--------QYTGISQSACREIALLRELKHENVVSLVEVFL   72 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc--------cccCccHHHHHHHHHHHhcCCCCccceEEEEe
Confidence            588899999999999999998662 223332222211100        00112345677999999999999999999886


Q ss_pred             eC---cEEEEEEecCCCChHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC----C
Q 037010          352 EG---SLFLVYEYIENGNLSEHLRGSG---RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK----N  421 (589)
Q Consensus       352 ~~---~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~----~  421 (589)
                      +.   .+|+||||+.+ +|.+++....   ...+++..++.++.|++.||+|||++++   +||||||+||+++.    +
T Consensus        73 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~h~dlkp~Nil~~~~~~~~  148 (316)
T cd07842          73 EHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWV---LHRDLKPANILVMGEGPER  148 (316)
T ss_pred             CCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCE---eeCCCCHHHEEEcCCCCcc
Confidence            44   58999999975 7777765332   2358899999999999999999999998   99999999999999    8


Q ss_pred             CcEEEEeccCccccccCCC--CCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC---
Q 037010          422 FHAKVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD---  495 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~---  495 (589)
                      +.+||+|||++........  .......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.........   
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~  228 (316)
T cd07842         149 GVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP  228 (316)
T ss_pred             ceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccch
Confidence            9999999999886543222  11223567899999998765 45789999999999999999999999654432210   


Q ss_pred             --hhhHHHHHHHHhcCCChHHh--------hHhhcCCCCCCCCC---------h--HHHHHHHHHHHHhcccCCCCCCCH
Q 037010          496 --SKGLVALFEEVLNLPDPIED--------LRKLVDPRLGDNCP---------L--DSVLKMAQLAKVCTQEYPQLRPSM  554 (589)
Q Consensus       496 --~~~~~~~~~~~~~~~~~~~~--------l~~~~d~~l~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPs~  554 (589)
                        ...+...+ ..+..+.....        .....+.......+         .  .....+.+++.+||+.||++|||+
T Consensus       229 ~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~  307 (316)
T cd07842         229 FQRDQLERIF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA  307 (316)
T ss_pred             hHHHHHHHHH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH
Confidence              01111111 11111111000        00000000000011         0  233468899999999999999999


Q ss_pred             HHHHHH
Q 037010          555 RSIVVA  560 (589)
Q Consensus       555 ~evl~~  560 (589)
                      .|+++|
T Consensus       308 ~eil~~  313 (316)
T cd07842         308 EEALEH  313 (316)
T ss_pred             HHHhcC
Confidence            999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-34  Score=287.21  Aligned_cols=267  Identities=25%  Similarity=0.315  Sum_probs=189.3

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEeC
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEG  353 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  353 (589)
                      |++.+.||+|+||.||+|.+..++. ..+.|.+..     .    .........+.+|++++++++|+|++++++++.+.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~-~~~~K~~~~-----~----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   70 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGE-LVALKKIRM-----E----NEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK   70 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCe-EEEEEEEec-----c----cccccchHHHHHHHHHHHhccCCCeeeheeeEecC
Confidence            6788999999999999998876422 222221110     0    01112235677899999999999999999988644


Q ss_pred             ---cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          354 ---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       354 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                         ..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++++   +|+||||+||++++++.++|+|||
T Consensus        71 ~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~---~h~dl~p~nil~~~~~~~~l~d~g  145 (287)
T cd07840          71 GKGSIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGI---LHRDIKGSNILINNDGVLKLADFG  145 (287)
T ss_pred             CCCcEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCcHHHeEEcCCCCEEEcccc
Confidence               69999999975 8999887653 358999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++...............++..|+|||.+.+ ..++.++||||||+++|||+||+.||.....     .............
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-----~~~~~~~~~~~~~  220 (287)
T cd07840         146 LARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-----LEQLEKIFELCGS  220 (287)
T ss_pred             ceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCC
Confidence            988664433222333567889999997754 4678999999999999999999999854331     1111111111111


Q ss_pred             CChHH-----hh--HhhcCCC------CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIE-----DL--RKLVDPR------LGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~-----~l--~~~~d~~------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +....     .+  .....+.      +.......++..+.+++.+||..+|.+||++++++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             CchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            10000     00  0000000      0000001124578999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.1e-33  Score=283.69  Aligned_cols=269  Identities=23%  Similarity=0.347  Sum_probs=187.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~  350 (589)
                      ++|++.+.||+|+||.||+|.+..++. ..+.|...         .+.........+.+|+++++.++ ||||+++++++
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~-~v~lK~~~---------~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~   70 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGK-LVALKKTR---------LEMDEEGIPPTALREISLLQMLSESIYIVRLLDVE   70 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCc-EEEEEeeh---------hhccccCCchHHHHHHHHHHHccCCCCccceeeeE
Confidence            478999999999999999999876532 22211110         01111112345778999999995 69999999877


Q ss_pred             Ee-Cc-----EEEEEEecCCCChHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-
Q 037010          351 VE-GS-----LFLVYEYIENGNLSEHLRGSG---RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-  420 (589)
Q Consensus       351 ~~-~~-----~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-  420 (589)
                      .. +.     .|++|||+++ +|.+++....   ...+++..++.++.||+.||.|||++++   +||||||+||+++. 
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i---~H~dl~~~nil~~~~  146 (295)
T cd07837          71 HVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGV---MHRDLKPQNLLVDKQ  146 (295)
T ss_pred             eecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCChHHEEEecC
Confidence            53 23     7999999986 8999886543   2458999999999999999999999998   99999999999998 


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      ++.+||+|||++........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.....    ...+
T Consensus       147 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~  221 (295)
T cd07837         147 KGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQL  221 (295)
T ss_pred             CCeEEEeecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHH
Confidence            88999999999875432211 1122356889999998754 4578999999999999999999998854321    1112


Q ss_pred             HHHHHHHhcCCChH-----HhhHhhcC-CCC----CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          500 VALFEEVLNLPDPI-----EDLRKLVD-PRL----GDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       500 ~~~~~~~~~~~~~~-----~~l~~~~d-~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...+... ..+...     ........ +..    .....+.....+.+++.+||..||.+||+++|++.|
T Consensus       222 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         222 LHIFKLL-GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             HHHHHHh-CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            2211111 100000     00000000 000    000112244578999999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.1e-33  Score=286.76  Aligned_cols=267  Identities=18%  Similarity=0.254  Sum_probs=185.0

Q ss_pred             eeeccC--CcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-Cc
Q 037010          278 HKIGQG--GFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GS  354 (589)
Q Consensus       278 ~~LG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  354 (589)
                      ..||.|  +||+||++.+..++. ..+.|...         ......+..+.+.+|+.+++.++||||+++++++.. +.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~-~vaiK~~~---------~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~   73 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGT-LVTVRITD---------LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW   73 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCc-EEEEEEec---------cccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc
Confidence            456666  999999998765532 22222111         111223344678889999999999999999998864 56


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       355 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .++||||+.+++|.+++.......+++..+..++.|++.||+|||++++   +||||||+|||++.++.++++||+....
T Consensus        74 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i---vHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          74 LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             eEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            8999999999999999987655568999999999999999999999998   9999999999999999999999975432


Q ss_pred             cccCCCCC------CcccccCCCCCchhcccCC--CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          435 TEVGSASL------PTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       435 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ........      .....++..|+|||++.+.  .++.++|||||||++|||++|+.||......    ..........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~  226 (328)
T cd08226         151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QMLLQKLKGP  226 (328)
T ss_pred             hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHHHHHhcCC
Confidence            21111100      1112346679999998653  4789999999999999999999998543210    0110000000


Q ss_pred             hcCCCh-------HH----------------hhH-----hhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 037010          507 LNLPDP-------IE----------------DLR-----KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV  558 (589)
Q Consensus       507 ~~~~~~-------~~----------------~l~-----~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  558 (589)
                      ...+..       ..                ...     ...+..+....+......+.+|+++||+.||++|||++|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l  306 (328)
T cd08226         227 PYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL  306 (328)
T ss_pred             CCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence            000000       00                000     00011111222334567899999999999999999999999


Q ss_pred             HHH
Q 037010          559 VAL  561 (589)
Q Consensus       559 ~~L  561 (589)
                      +|-
T Consensus       307 ~~~  309 (328)
T cd08226         307 SHA  309 (328)
T ss_pred             hCH
Confidence            884

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-33  Score=290.60  Aligned_cols=276  Identities=23%  Similarity=0.334  Sum_probs=195.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|.+.+.||+|+||+||++.+..++.. .+.|.+.     ..    .........+.+|+.++++++|+||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~-vaiK~~~-----~~----~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~   73 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEK-VAIKKIA-----NA----FDNRIDAKRTLREIKLLRHLDHENVIAIKDIM   73 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCe-EEEEEec-----cc----ccccchhHHHHHHHHHHHhcCCCCccchHHhe
Confidence            46899999999999999999987654322 2222111     00    01112234567799999999999999999876


Q ss_pred             EeC------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          351 VEG------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       351 ~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      ...      ..|++|||+. ++|.+++....  .+++..+..++.|++.||.|||++++   +|+||||+||+++.++.+
T Consensus        74 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i---~H~dlkp~Nil~~~~~~~  147 (337)
T cd07858          74 PPPHREAFNDVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANV---LHRDLKPSNLLLNANCDL  147 (337)
T ss_pred             ecccccccCcEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEEcCCCCE
Confidence            532      3799999996 58999887653  48999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      ||+|||++....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.....     .......
T Consensus       148 kL~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~  221 (337)
T cd07858         148 KICDFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLI  221 (337)
T ss_pred             EECcCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHH
Confidence            999999988654322 22233567889999998764 4688999999999999999999999854321     1111111


Q ss_pred             HHHhcCCChH-------HhhHhhc---CCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhccccc
Q 037010          504 EEVLNLPDPI-------EDLRKLV---DPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTLSSTT  568 (589)
Q Consensus       504 ~~~~~~~~~~-------~~l~~~~---d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l~~~~  568 (589)
                      ......+...       ....+.+   .....   ....++.+..+.+++.+||+.+|++|||++|+++|  +..+....
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~  301 (337)
T cd07858         222 TELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS  301 (337)
T ss_pred             HHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence            1111111000       0000000   00000   00112345578999999999999999999999999  66554443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.4e-33  Score=329.38  Aligned_cols=264  Identities=25%  Similarity=0.420  Sum_probs=195.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ..|...+.||+|+||.||+|.+..++.               .+++|...... .....|++++++++||||+++++++.
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~---------------~vavK~~~~~~-~~~~~~~~~l~~l~HpnIv~~~~~~~  753 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGM---------------QFVVKEINDVN-SIPSSEIADMGKLQHPNIVKLIGLCR  753 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCc---------------EEEEEEccCCc-cccHHHHHHHhhCCCCCcceEEEEEE
Confidence            457778899999999999998765422               12222221110 11124688899999999999999987


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+++|+|.++++.     ++|.++..++.|++.||+|||.+.-+.++||||||+||+++.++..++. |+
T Consensus       754 ~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~  827 (968)
T PLN00113        754 SEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS  827 (968)
T ss_pred             cCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence            5 458999999999999999963     8899999999999999999995422334999999999999998888775 65


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      .......     .....+|+.|+|||++.+..++.++|||||||++|||+||+.||.......   .....+....... 
T Consensus       828 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~-  898 (968)
T PLN00113        828 LPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH---GSIVEWARYCYSD-  898 (968)
T ss_pred             ccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC---CcHHHHHHHhcCc-
Confidence            5433211     122467899999999999999999999999999999999999984332221   1222222222111 


Q ss_pred             ChHHhhHhhcCCCCCC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          511 DPIEDLRKLVDPRLGD--NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                         .....++|+.+..  ..+.++...+.+++.+||+.||++||||+|+++.|+.+.....
T Consensus       899 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        899 ---CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             ---cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence               1233445555433  2345566788999999999999999999999999998876443

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=267.70  Aligned_cols=264  Identities=20%  Similarity=0.325  Sum_probs=195.1

Q ss_pred             cHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc---CHHHHHHHHHHHHHHccCC
Q 037010          263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREFLAELKVLTHVH  339 (589)
Q Consensus       263 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~---~~~~~~~~~~E~~il~~l~  339 (589)
                      .+++.-+.+     .+.||+|+|+.|--+....++               ..+++|.+   ......++.+|++++.+++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~---------------~EYAVKiidKq~gHsR~RvfREVe~f~~Cq  133 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTG---------------KEYAVKIIDKQPGHSRSRVFREVETFYQCQ  133 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccc---------------hhhhhhhhhcCCchHHHHHHHHHHHHHHhc
Confidence            355554444     478999999999988765442               23333333   3445678899999999995


Q ss_pred             -CCcceeEeeEEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          340 -HLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       340 -hpnIv~l~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                       |+||+.+++|+.++ .+|||||-|.||+|.++|+++..  +++.++.++..+|+.||.|||.+||   .||||||+|||
T Consensus       134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kgI---AHRDlKPENiL  208 (463)
T KOG0607|consen  134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKGI---AHRDLKPENIL  208 (463)
T ss_pred             CCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcCc---ccccCCcccee
Confidence             99999999998765 59999999999999999988764  9999999999999999999999999   99999999999


Q ss_pred             EcCCC---cEEEEeccCccccccCC--C----CCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCC
Q 037010          418 IDKNF---HAKVADFGLTKLTEVGS--A----SLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAK  483 (589)
Q Consensus       418 l~~~~---~vkl~Dfgla~~~~~~~--~----~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~  483 (589)
                      .....   -+||+||.+..-.....  .    ......+|+..|||||+..     ...|+.+.|.|||||++|-||+|.
T Consensus       209 C~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY  288 (463)
T KOG0607|consen  209 CESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY  288 (463)
T ss_pred             ecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence            96554   48999998876322111  1    1122368999999999762     346889999999999999999999


Q ss_pred             cccccCCCCCCCh--hhHHHHHHHHhcCCChHHhhHhhcCC-C--CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 037010          484 EAIVKGNGSSADS--KGLVALFEEVLNLPDPIEDLRKLVDP-R--LGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV  558 (589)
Q Consensus       484 ~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~~d~-~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  558 (589)
                      .||.+..+....|  ...-...++.         +.+-+.. .  .++..-...+.+..+++...+..++.+|.++.+++
T Consensus       289 pPFvG~Cg~dCGWdrGe~Cr~CQ~~---------LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl  359 (463)
T KOG0607|consen  289 PPFVGHCGADCGWDRGEVCRVCQNK---------LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL  359 (463)
T ss_pred             CCccCccCCcCCccCCCccHHHHHH---------HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence            9998877644332  2211111111         1111100 0  11111223455788999999999999999999999


Q ss_pred             HH
Q 037010          559 VA  560 (589)
Q Consensus       559 ~~  560 (589)
                      .|
T Consensus       360 nh  361 (463)
T KOG0607|consen  360 NH  361 (463)
T ss_pred             CC
Confidence            86

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.1e-33  Score=289.50  Aligned_cols=269  Identities=23%  Similarity=0.312  Sum_probs=190.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|.+..++.. .+.|.+.     ..    .........+.+|+.+++++ +||||+++++
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-~~vK~~~-----~~----~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~   74 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEV-VALKKIF-----DA----FRNATDAQRTFREIMFLQELGDHPNIVKLLN   74 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeE-EEEEeec-----cc----cCcchhhhhhhHHHHHHHHhcCCCCccceee
Confidence            457899999999999999999987654322 2222110     00    01112234567799999999 9999999999


Q ss_pred             EEEeC---cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          349 YCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       349 ~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++...   ..|+||||+.+ +|.+++...   .+++..+..++.|++.||.|||++++   +|+||||+||+++.++.+|
T Consensus        75 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i---~H~dl~p~nill~~~~~~k  147 (337)
T cd07852          75 VIKAENDKDIYLVFEYMET-DLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNV---IHRDLKPSNILLNSDCRVK  147 (337)
T ss_pred             eeccCCCceEEEEeccccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCcEE
Confidence            87532   47999999975 999998764   48899999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCC----CCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          426 VADFGLTKLTEVGSA----SLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       426 l~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      |+|||++........    .......|+..|+|||.+.. ..++.++|+||||+++|+|+||+.||.....     ....
T Consensus       148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~-----~~~~  222 (337)
T cd07852         148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST-----LNQL  222 (337)
T ss_pred             EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh-----HHHH
Confidence            999999886543322    12233568999999998754 5678899999999999999999999843221     1111


Q ss_pred             HHHHHHhcCCCh----------HHhhHhhcC-CCC--CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          501 ALFEEVLNLPDP----------IEDLRKLVD-PRL--GDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       501 ~~~~~~~~~~~~----------~~~l~~~~d-~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .........+..          ...+...+. ...  ......+.+..+.+++.+||+.+|.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         223 EKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            111111111100          000000000 000  000111235578999999999999999999999998

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.6e-33  Score=283.13  Aligned_cols=252  Identities=27%  Similarity=0.435  Sum_probs=193.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~  350 (589)
                      ++|.+.+.||+|+||.||++....++. ..+.|....     .   ..........+.+|.+++++++ ||||+++++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~-~~~ik~~~~-----~---~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~   71 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNK-EYAIKILDK-----R---QLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF   71 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCC-EEEEEEech-----H---hccchHHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence            478999999999999999998876432 222222111     0   0112233456788999999998 99999999977


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..+++||++.+++|.+++....  .+++..++.++.|++.||.|||++++   +|+||+|+||+++.++.++|+||
T Consensus        72 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~---~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          72 QDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGI---IHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             cCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHeEECCCCCEEecCC
Confidence            5 456899999999999999998764  49999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCC-------------------CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          430 GLTKLTEVGSA-------------------SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       430 gla~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      |++........                   .......++..|+|||......++.++|+||||++++++++|+.||....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            99875543221                   11223467889999999988889999999999999999999999985432


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH----HHHHHH
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM----RSIVVA  560 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~  560 (589)
                      .        ...+.....               .....+...+..+.+++.+||+.+|.+||++    ++++.|
T Consensus       227 ~--------~~~~~~~~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         227 E--------YLTFQKILK---------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             H--------HHHHHHHHh---------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            1        111111110               0112233334578999999999999999999    888765

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=292.78  Aligned_cols=244  Identities=23%  Similarity=0.366  Sum_probs=191.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      .++.|.+...+|.|+|+.|..+.+..+..               ..++|.+... ..+..+|+.++... +||||+++++
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~---------------~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~  383 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQ---------------EPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHD  383 (612)
T ss_pred             cchhhccccccCCCCccceeeeecccccc---------------chhheecccc-ccccccccchhhhhcCCCcceeecc
Confidence            46789999999999999999998776522               2333333222 22344577666655 6999999999


Q ss_pred             EEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE-cCCCcEEE
Q 037010          349 YCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI-DKNFHAKV  426 (589)
Q Consensus       349 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl-~~~~~vkl  426 (589)
                      .+.++ +.|+|||.++|+-|.+.+.....   ...++..|+++|+.|+.|||++|+   |||||||+|||+ +..++++|
T Consensus       384 v~~~~~~~~~v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~gv---vhRDLkp~NIL~~~~~g~lrl  457 (612)
T KOG0603|consen  384 VYEDGKEIYLVMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQGV---VHRDLKPGNILLDGSAGHLRL  457 (612)
T ss_pred             eecCCceeeeeehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhcCe---eecCCChhheeecCCCCcEEE
Confidence            88765 69999999999999998876653   237788899999999999999998   999999999999 58899999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      +|||.++.....    ....+-|..|.|||++...+|++++|+||||++||+||+|+.||...-..       ......+
T Consensus       458 tyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i  526 (612)
T KOG0603|consen  458 TYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRI  526 (612)
T ss_pred             EEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhh
Confidence            999999865443    22345688999999999999999999999999999999999999654331       1111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                                   -.+    ......+....+|+.+||+.||.+||++.++..|-..
T Consensus       527 -------------~~~----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  527 -------------QMP----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             -------------cCC----ccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence                         111    1124556678999999999999999999999998554

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.8e-33  Score=286.14  Aligned_cols=271  Identities=25%  Similarity=0.306  Sum_probs=190.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|.+..         +.........+.+|++++++++|+||+++++++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~-~vaiK~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   75 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGE-IVALKKVRM---------DNERDGIPISSLREITLLLNLRHPNIVELKEVV   75 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCc-EEEEEEEEe---------ccCCCCCcchhhHHHHHHHhCCCCCCcceEEEE
Confidence            4689999999999999999999876532 222221110         011111122355799999999999999999987


Q ss_pred             Ee---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          351 VE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       351 ~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      .+   +..|+||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+||+++.++.+||+
T Consensus        76 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~nil~~~~~~~kL~  150 (309)
T cd07845          76 VGKHLDSIFLVMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFI---IHRDLKVSNLLLTDKGCLKIA  150 (309)
T ss_pred             ecCCCCeEEEEEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCCCCEEEC
Confidence            64   348999999975 8988887543 458999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||++........ ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.....     ..........
T Consensus       151 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-----~~~~~~~~~~  224 (309)
T cd07845         151 DFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-----IEQLDLIIQL  224 (309)
T ss_pred             ccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHh
Confidence            9999886543221 1223356788999998864 5678999999999999999999999853321     1111111121


Q ss_pred             hcCCChH--HhhHhhcC---CCCCC-C------CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          507 LNLPDPI--EDLRKLVD---PRLGD-N------CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       507 ~~~~~~~--~~l~~~~d---~~l~~-~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ...+...  ..+.....   ..+.. .      ........+.+++.+||+.||++|||++|+++|-.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~  292 (309)
T cd07845         225 LGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY  292 (309)
T ss_pred             cCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence            1111100  00000000   00000 0      00112456789999999999999999999998743

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-33  Score=291.84  Aligned_cols=253  Identities=23%  Similarity=0.375  Sum_probs=202.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ....|.+...||+|.|+.|.++.+..+..+..++ .+.         ....+......+.+|+++|+.+.|||||+++.+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK-~id---------kt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v  123 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIK-IID---------KTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV  123 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEE-Eeh---------hcccChHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            4567999999999999999999988774432221 100         001222334557889999999999999999997


Q ss_pred             EE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      .. +..+|+||||+.+|.+++|+...++  +.+..+..++.|+..|++|||++++   +|||||.+|||++.+..+||+|
T Consensus       124 ~~t~~~lylV~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k~i---vHrdLk~eNilL~~~mnikIaD  198 (596)
T KOG0586|consen  124 IETEATLYLVMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSKNI---VHRDLKAENILLDENMNIKIAD  198 (596)
T ss_pred             eeecceeEEEEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhcce---eccccchhhcccccccceeeec
Confidence            76 6789999999999999999998876  5568888999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++..+..  .......+|++.|.|||+..+..| .+.+|+||+|+++|.|+.|..||....-.....+.         
T Consensus       199 fgfS~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------  267 (596)
T KOG0586|consen  199 FGFSTFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------  267 (596)
T ss_pred             cccceeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------
Confidence            999998763  344566899999999999988776 46899999999999999999999655432211111         


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                                  +...+  ..|.-...++.++++++|..+|.+|++++++.++-.
T Consensus       268 ------------l~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  268 ------------LRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             ------------eeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence                        11111  223334447889999999999999999999998843

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.6e-33  Score=281.20  Aligned_cols=257  Identities=24%  Similarity=0.360  Sum_probs=189.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccc--cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGE--YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      +|++.+.||.|+||.||+|.....  .+..++.|.+.     ....  .......+.+.+|+++++++ +|+||+++++.
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~-----~~~~--~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~   73 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLK-----KATI--VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYA   73 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEee-----hhhh--hhcchHHHHHHHHHHHHHhcccCCChhceeeE
Confidence            478899999999999999987532  22222222211     1100  01112235577899999999 59999999987


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.. +..|+||||+++++|.+++....  ++++..+..++.|++.||.|||++++   +||||||+|||++.++.+||+|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i---~H~dl~p~nil~~~~~~~kl~d  148 (290)
T cd05613          74 FQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTD  148 (290)
T ss_pred             eecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHeEECCCCCEEEee
Confidence            764 45889999999999999997654  48889999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccC--CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ||++...............|+..|+|||.+..  ..++.++||||||+++|+|++|+.||......    ..........
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~  224 (290)
T cd05613         149 FGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRI  224 (290)
T ss_pred             CccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHh
Confidence            99987654332222234568899999998865  34678999999999999999999998432111    1111111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                      ...           .+    ..+......+.+++.+||+.+|.+||     ++++++.|
T Consensus       225 ~~~-----------~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         225 LKS-----------EP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             hcc-----------CC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            110           11    12333445789999999999999997     78888877

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.7e-33  Score=288.60  Aligned_cols=270  Identities=21%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|....++. .++.|.+..         +.........+.+|+.+|++++||||+++++++
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~-~valK~~~~---------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   73 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGK-KVAIKKIPH---------AFDVPTLAKRTLRELKILRHFKHDNIIAIRDIL   73 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCC-EEEEEEecc---------ccccccchHHHHHHHHHHHhcCCCCccCHHHhc
Confidence            4789999999999999999998776532 222222111         011112334567899999999999999999876


Q ss_pred             Ee-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          351 VE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       351 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ..     ...|+||||+. ++|.+++....  .+++..++.++.|++.||.|||++++   +||||||+||++++++.+|
T Consensus        74 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~Nil~~~~~~~k  147 (334)
T cd07855          74 RPPGADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANV---IHRDLKPSNLLVNEDCELR  147 (334)
T ss_pred             cccCCCCceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCcEE
Confidence            42     35899999996 58999987543  38999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCC---CCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          426 VADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      |+|||++.........   ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......     ....
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~  222 (334)
T cd07855         148 IGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLK  222 (334)
T ss_pred             ecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHH
Confidence            9999998754332221   1123578899999998755 46889999999999999999999999543221     1111


Q ss_pred             HHHHHhcCCCh-------HHhhHhhcCCC-CCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          502 LFEEVLNLPDP-------IEDLRKLVDPR-LGDNC-----PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       502 ~~~~~~~~~~~-------~~~l~~~~d~~-l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ........+..       .+.+.+..+.. .....     .++.+..+.+++.+||+.+|.+|||+++++.|-
T Consensus       223 ~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         223 LILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             HHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence            11111111110       01111111100 00011     123356799999999999999999999999984

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.1e-33  Score=283.04  Aligned_cols=271  Identities=25%  Similarity=0.368  Sum_probs=191.3

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||+|.+..++. ..+.|.+..         ..........+.+|++++++++||||+++++
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~v~iK~~~~---------~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~   73 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGE-LVALKKVRL---------DNEKEGFPITAIREIKILRQLNHRNIVNLKE   73 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCc-EEEEEEEee---------cccccCchHHHHHHHHHHHhCCCCCeeeeeh
Confidence            356789999999999999999999876532 222221110         0001112235667999999999999999999


Q ss_pred             EEEeC-----------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          349 YCVEG-----------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       349 ~~~~~-----------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      ++.+.           .+|+||||+++ +|.+++... ...+++..++.++.|++.||+|||+.++   +|+||||+||+
T Consensus        74 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i---~H~dl~p~nil  148 (302)
T cd07864          74 IVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNF---LHRDIKCSNIL  148 (302)
T ss_pred             eecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEE
Confidence            77532           58999999986 777777654 2358999999999999999999999998   99999999999


Q ss_pred             EcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       418 l~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      +++++.+||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....    .
T Consensus       149 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~----~  224 (302)
T cd07864         149 LNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE----L  224 (302)
T ss_pred             ECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh----H
Confidence            9999999999999988654433222233456788999998754 4578899999999999999999998853221    1


Q ss_pred             hhHHHHHHHHhcCCChH--HhhHhh-----cCC------CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          497 KGLVALFEEVLNLPDPI--EDLRKL-----VDP------RLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~--~~l~~~-----~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..+ .........+.+.  ..+...     .+.      ..... ....+..+.+++.+||+.+|.+|||++++++|
T Consensus       225 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         225 AQL-ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHH-HHHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111 1122221111110  000000     000      00000 01234578999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2.1e-33  Score=287.70  Aligned_cols=233  Identities=18%  Similarity=0.311  Sum_probs=170.5

Q ss_pred             HHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 037010          323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH  401 (589)
Q Consensus       323 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~  401 (589)
                      ...+.+.+|++++++++|+||+++++++. ++..|++|||+.+|+|.+++.......+++..+..++.|++.||+|||++
T Consensus        41 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~  120 (314)
T cd08216          41 EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK  120 (314)
T ss_pred             hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            44567889999999999999999999776 45689999999999999999876555689999999999999999999999


Q ss_pred             CCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCC------CCCcccccCCCCCchhcccC--CCCCcccchhhHH
Q 037010          402 TVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA------SLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFG  473 (589)
Q Consensus       402 ~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlG  473 (589)
                      ++   +||||||+||+++.++.+||+|||.+........      .......++..|+|||++..  ..++.++|+||||
T Consensus       121 ~i---vH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G  197 (314)
T cd08216         121 GF---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG  197 (314)
T ss_pred             Ce---ecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHH
Confidence            98   9999999999999999999999998864422111      11123457788999999865  3588999999999


Q ss_pred             HHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh----cCCC-hH--HhhHh----hcCCC----CCCCCChHHHHHHHH
Q 037010          474 VVLYELISAKEAIVKGNGSSADSKGLVALFEEVL----NLPD-PI--EDLRK----LVDPR----LGDNCPLDSVLKMAQ  538 (589)
Q Consensus       474 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~--~~l~~----~~d~~----l~~~~~~~~~~~l~~  538 (589)
                      |++|||++|+.||......    ...........    .... +.  .....    ..++.    ............+.+
T Consensus       198 ~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (314)
T cd08216         198 ITACELANGHVPFKDMPAT----QMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQ  273 (314)
T ss_pred             HHHHHHHhCCCCCCCCCHH----HHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHH
Confidence            9999999999999543211    11111100000    0000 00  00000    00000    011223344567899


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHH
Q 037010          539 LAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       539 li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ++.+||..||++|||++++++|-.
T Consensus       274 li~~~l~~~P~~Rpt~~~ll~~p~  297 (314)
T cd08216         274 FVELCLQRDPESRPSASQLLNHSF  297 (314)
T ss_pred             HHHHHhhcCCCcCcCHHHHhcCch
Confidence            999999999999999999999843

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=294.15  Aligned_cols=268  Identities=23%  Similarity=0.373  Sum_probs=192.1

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH----HHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----QASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      +...+.||+|+||.||+++++.++.               .+|+|..+.    ...+.+.+|+++|++++|+|||+++++
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~---------------~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~i   79 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGR---------------LVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDI   79 (732)
T ss_pred             eeehhhhcCCccceeeeeccccccc---------------chhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhccc
Confidence            3456789999999999998776532               344444332    345678899999999999999999987


Q ss_pred             EEeC-------cEEEEEEecCCCChHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc--
Q 037010          350 CVEG-------SLFLVYEYIENGNLSEHLRGS-GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID--  419 (589)
Q Consensus       350 ~~~~-------~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~--  419 (589)
                      -.+.       ...+|||||.||||...+++. +..++++.+.+.++.++..||.|||++||   +||||||.||++-  
T Consensus        80 ee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~I---vHRDlKP~NIvl~~G  156 (732)
T KOG4250|consen   80 EETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGI---VHRDLKPGNIVLQIG  156 (732)
T ss_pred             CCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCc---eeccCCCCcEEEeec
Confidence            6533       357999999999999999764 34579999999999999999999999999   9999999999983  


Q ss_pred             CCC--cEEEEeccCccccccCCCCCCcccccCCCCCchhccc-CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          420 KNF--HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       420 ~~~--~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      ++|  ..||+|||.|+-...+.  ..+..+||..|++||+.. .+.|+.-+|.|||||++|+..||..||.+.....   
T Consensus       157 edgq~IyKLtDfG~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk---  231 (732)
T KOG4250|consen  157 EDGQSIYKLTDFGAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPK---  231 (732)
T ss_pred             CCCceEEeeecccccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcc---
Confidence            333  47999999999765443  556789999999999987 4788999999999999999999999996554322   


Q ss_pred             hhHHHHHHHHh-cCCChHHhh-----HhhcC--CCC--CCCCChHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhc
Q 037010          497 KGLVALFEEVL-NLPDPIEDL-----RKLVD--PRL--GDNCPLDSVLKMAQLAKVCTQEYPQLRP--SMRSIVVALMTL  564 (589)
Q Consensus       497 ~~~~~~~~~~~-~~~~~~~~l-----~~~~d--~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~l  564 (589)
                       .+.+.+.... +.+......     ...++  ..+  +..........+...+..+|..+|++|-  .+.+....+..+
T Consensus       232 -~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  232 -NNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             -ccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence             1222222211 111111000     00000  000  1122233444566667777888888887  555555555444


Q ss_pred             c
Q 037010          565 S  565 (589)
Q Consensus       565 ~  565 (589)
                      .
T Consensus       311 L  311 (732)
T KOG4250|consen  311 L  311 (732)
T ss_pred             H
Confidence            3

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-32  Score=272.67  Aligned_cols=250  Identities=30%  Similarity=0.492  Sum_probs=193.0

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||+|++|.||++.+...+. .++.|.+..         ..........+.+|++++++++|||++++++++.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~-~~~ik~~~~---------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGD-FVAIKQISL---------EKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET   70 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCc-EEEEEEecc---------cccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe
Confidence            58889999999999999998765432 222222111         11112345678899999999999999999998764


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +..+++|||+++++|.+++...  ..+++..+..++.|++.+|.|||++++   +|+||||+||+++.++.++|+|||+
T Consensus        71 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~ni~i~~~~~~~l~d~~~  145 (254)
T cd06627          71 SDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGV---IHRDIKAANILTTKDGVVKLADFGV  145 (254)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCc---ccCCCCHHHEEECCCCCEEEecccc
Confidence             5689999999999999999765  348999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +......... .....++..|+|||.+....++.++||||||+++|+|++|+.||.....       ....+.....   
T Consensus       146 ~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~---  214 (254)
T cd06627         146 ATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFRIVQD---  214 (254)
T ss_pred             ceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcc---
Confidence            9865433322 2235688899999999887889999999999999999999999843221       1111111000   


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                              ..+    ..+......+.+++.+||..+|++|||+.+++.+
T Consensus       215 --------~~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 --------DHP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             --------CCC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                    011    1222334578999999999999999999999854

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-33  Score=281.61  Aligned_cols=265  Identities=25%  Similarity=0.359  Sum_probs=190.4

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-e
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-E  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~  352 (589)
                      |++.+.||+|++|.||++....++ ...+.|.+.         ...........+.+|++++++++|+||+++++++. +
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~-~~~~ik~~~---------~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   70 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTG-EIVAIKKIK---------LRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK   70 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCC-cEEEEEEec---------cccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC
Confidence            567899999999999999876542 222222111         01111123456778999999999999999999776 4


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      +..+++|||+.+ +|.+++.... ..+++..+..++.|++.||.|||++++   +|+||||+||+++.++.++|+|||.+
T Consensus        71 ~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~dl~p~nili~~~~~~~l~df~~~  145 (283)
T cd05118          71 GDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGI---LHRDLKPENLLINTEGVLKLADFGLA  145 (283)
T ss_pred             CCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCe---eecCcCHHHEEECCCCcEEEeeeeee
Confidence            568999999976 8988887654 358999999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      ....... .......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||......    ....... .....+.
T Consensus       146 ~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~-~~~~~~~  219 (283)
T cd05118         146 RSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI----DQLFKIF-RTLGTPD  219 (283)
T ss_pred             EecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHH-HHcCCCc
Confidence            7654332 122235678899999998766 7899999999999999999999988443210    1111111 1111110


Q ss_pred             hHHhhHhhcC------CCCC-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLVD------PRLG-------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~d------~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      + +......+      ....       .....+.+..+.+++.+||+.||.+||++++++.|
T Consensus       220 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         220 P-EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             h-HhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            0 00000000      0000       11123455689999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.6e-33  Score=283.67  Aligned_cols=270  Identities=26%  Similarity=0.364  Sum_probs=186.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      -++|++.++||+|+||.||+|....++. .++.|.+..         ..........+.+|++++++++||||+++++++
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~-~~aik~~~~---------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   80 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQ-IVALKKVLM---------ENEKEGFPITALREIKILQLLKHENVVNLIEIC   80 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCc-EEEEEEEec---------cCCcCCchhHHHHHHHHHHhCCCCCccceEEEE
Confidence            4579999999999999999998776532 222221110         000111123456799999999999999999987


Q ss_pred             EeC---------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          351 VEG---------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       351 ~~~---------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      ...         ..++||||+.+ +|.+++.... ..+++.+++.++.|++.||+|||++++   +|+||||+||+++.+
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i---~H~dl~p~nil~~~~  155 (310)
T cd07865          81 RTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKI---LHRDMKAANILITKD  155 (310)
T ss_pred             ecccccccCCCceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHEEECCC
Confidence            532         35899999965 8888886543 348999999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCC---CCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          422 FHAKVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      +.+||+|||++.........   ......++..|+|||.+.+. .++.++||||||+++|||+||+.||.....     .
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~  230 (310)
T cd07865         156 GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----Q  230 (310)
T ss_pred             CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence            99999999998755332211   11234678899999988654 478899999999999999999988843321     1


Q ss_pred             hHHHHHHHHhcCCCh--------HHhhHhhcCCC-CCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          498 GLVALFEEVLNLPDP--------IEDLRKLVDPR-LGDNC-----PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       498 ~~~~~~~~~~~~~~~--------~~~l~~~~d~~-l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..............+        .+.......+. .....     +......+.+++.+||..||.+|||++|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         231 HQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             HHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            111112221111000        00000000000 00000     00112357899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.5e-33  Score=279.12  Aligned_cols=245  Identities=23%  Similarity=0.300  Sum_probs=177.2

Q ss_pred             eeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHH---HHHHHccCCCCcceeEeeEEEe-Cc
Q 037010          279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA---ELKVLTHVHHLNLVRLIGYCVE-GS  354 (589)
Q Consensus       279 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~---E~~il~~l~hpnIv~l~~~~~~-~~  354 (589)
                      .||+|+||.||++.+..++. ..+.|.+..+..      +.  ......+..   .+.+++...||+|+++++.+.+ +.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~-~vaiK~~~~~~~------~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~   71 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGK-MYAMKCLDKKRI------KM--KQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   71 (278)
T ss_pred             CcccCCCeEEEEEEEecCCC-EEEEEEeecccc------cc--chhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE
Confidence            48999999999998765422 222222111100      00  000111222   3345556689999999987764 56


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       355 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .|+||||+.+++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+||+++.++.++|+|||++..
T Consensus        72 ~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i---~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          72 LSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---EcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            899999999999999987543  48999999999999999999999998   9999999999999999999999999875


Q ss_pred             cccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChH
Q 037010          435 TEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPI  513 (589)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (589)
                      ....   ......|+..|+|||.+..+ .++.++||||+||++|||++|+.||........  .   .....        
T Consensus       147 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~---~~~~~--------  210 (278)
T cd05606         147 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--H---EIDRM--------  210 (278)
T ss_pred             cCcc---CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--H---HHHHH--------
Confidence            4322   11235789999999998754 689999999999999999999999954322110  0   00000        


Q ss_pred             HhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          514 EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       514 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                         ....++.    .+...+..+.+++.+||..+|.+||     +++++++|
T Consensus       211 ---~~~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         211 ---TLTMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ---hhccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence               0011111    2223345789999999999999999     99999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.1e-33  Score=287.84  Aligned_cols=273  Identities=19%  Similarity=0.317  Sum_probs=192.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|.+.+.||+|+||.||+|.+..++. ..+.|.+..     .    .........+.+|++++++++||||+++++++
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~-~vaiK~~~~-----~----~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~   83 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGE-KVAIKKLSR-----P----FQSEIFAKRAYRELTLLKHMQHENVIGLLDVF   83 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCc-EEEEEEecC-----c----cccccchhHHHHHHHHHHhcCCCCccchhhee
Confidence            4789999999999999999998765432 222221110     0    01111234577899999999999999999987


Q ss_pred             EeC-------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          351 VEG-------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       351 ~~~-------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      ...       ..|+|+||+.. +|.+++.    ..+++..+..++.|++.||+|||++++   +||||||+||+++.++.
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i---~H~dlkp~NIll~~~~~  155 (342)
T cd07879          84 TSAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGI---IHRDLKPGNLAVNEDCE  155 (342)
T ss_pred             cccccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCC
Confidence            532       36899999965 7776652    248899999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +||+|||++......    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....     ......
T Consensus       156 ~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-----~~~~~~  226 (342)
T cd07879         156 LKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLTQ  226 (342)
T ss_pred             EEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence            999999998754221    223567889999998865 4688999999999999999999999954321     111111


Q ss_pred             HHHHhcCCChHHhhHhhcC-----------CCC-CCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhcc
Q 037010          503 FEEVLNLPDPIEDLRKLVD-----------PRL-GDN---CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTLS  565 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d-----------~~l-~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l~  565 (589)
                      .......+.  ..+....+           +.. ...   ..+.....+.+++.+||+.||.+||++++++.|  ++..+
T Consensus       227 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         227 ILKVTGVPG--PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHHhcCCCC--HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            111111111  00100000           000 000   001233468899999999999999999999988  76666


Q ss_pred             ccccccc
Q 037010          566 STTEDWD  572 (589)
Q Consensus       566 ~~~~~~~  572 (589)
                      ...+.-+
T Consensus       305 ~~~~~~~  311 (342)
T cd07879         305 DADEETE  311 (342)
T ss_pred             cccccCC
Confidence            5444433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=253.90  Aligned_cols=263  Identities=27%  Similarity=0.378  Sum_probs=197.9

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-----HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-----QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-----~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      +|...++||+|.||+||+++...+.+               .++.|+.+.     .......+|+.+|+.++|.|||+++
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~e---------------ivalkrvrlddddegvpssalreicllkelkhknivrl~   67 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHE---------------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH   67 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccc---------------eEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehh
Confidence            46677999999999999998776632               233333322     1234567899999999999999999


Q ss_pred             eEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++.. +..+-+|+|||+. +|..|...-.+. ++....+.++.|++.||.++|++++   .|||+||.|.|++.+|.+|+
T Consensus        68 dvlhsdkkltlvfe~cdq-dlkkyfdslng~-~d~~~~rsfmlqllrgl~fchshnv---lhrdlkpqnllin~ngelkl  142 (292)
T KOG0662|consen   68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGD-LDPEIVRSFMLQLLRGLGFCHSHNV---LHRDLKPQNLLINRNGELKL  142 (292)
T ss_pred             hhhccCceeEEeHHHhhH-HHHHHHHhcCCc-CCHHHHHHHHHHHHhhhhhhhhhhh---hhccCCcceEEeccCCcEEe
Confidence            9776 5568899999976 899988765543 8889999999999999999999999   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||+++.+....... ...+-|.+|++|.++.+. -|+...|+||-||++.|+....+|..++.+.....+.++.    
T Consensus       143 adfglarafgipvrcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~----  217 (292)
T KOG0662|consen  143 ADFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR----  217 (292)
T ss_pred             cccchhhhcCCceEee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHH----
Confidence            9999999876544332 234678999999998764 5888999999999999999888888777654322222222    


Q ss_pred             HhcCCC--hHHhhHhhcCCCCCCCCCh---------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPD--PIEDLRKLVDPRLGDNCPL---------DSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~--~~~~l~~~~d~~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+..+.  ....+.++.|......+|.         .....=.+++...+.-+|..|.++++.++|
T Consensus       218 ~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  218 LLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             HhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            222221  1122334444333333332         222245788889999999999999999887

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=276.49  Aligned_cols=266  Identities=25%  Similarity=0.363  Sum_probs=187.3

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC---CCCcceeEeeEE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV---HHLNLVRLIGYC  350 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l---~hpnIv~l~~~~  350 (589)
                      |++.+.||+|+||.||+|.++.+ +..++.|.+...         .........+.+|+++++++   .|||++++++++
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~-~~~~aiK~~~~~---------~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~   70 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNT-GRFVALKKVRVP---------LSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVC   70 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCC-CCEEEEEEeccc---------cccchhhhhHHHHHHHHHHhhccCCCCcceEEEEE
Confidence            67889999999999999998764 223332222111         11111223455677766655   699999999987


Q ss_pred             Ee-Cc-----EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          351 VE-GS-----LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       351 ~~-~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      .+ +.     .+++|||+.+ +|.+++.......+++..++.++.|++.||.|||++++   +|+||+|+||+++.++.+
T Consensus        71 ~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i---~h~~l~~~nili~~~~~~  146 (287)
T cd07838          71 HGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRI---VHRDLKPQNILVTSDGQV  146 (287)
T ss_pred             eeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCChhhEEEccCCCE
Confidence            64 33     8899999975 89999877555468999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      +|+|||++........  .....++..|+|||.+.+..++.++|+|||||++|||++|+.||.....    .........
T Consensus       147 ~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~----~~~~~~~~~  220 (287)
T cd07838         147 KIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE----ADQLDKIFD  220 (287)
T ss_pred             EEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh----HHHHHHHHH
Confidence            9999999876533221  1234578899999999888899999999999999999999888743221    111111111


Q ss_pred             HHhcCCChHHhh------HhhcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPIEDL------RKLVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~~~l------~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .. ..+......      .........   ....++....+.+++.+||+.||.+||+++|++.|
T Consensus       221 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         221 VI-GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             Hc-CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            11 110000000      000000000   11122345678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-33  Score=277.73  Aligned_cols=263  Identities=29%  Similarity=0.452  Sum_probs=204.8

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHcc--CCCCcceeE
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH--VHHLNLVRL  346 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~--l~hpnIv~l  346 (589)
                      ....+..+.+.||+|.||.||+|.+++.                 .+|+|.+...+.+.+.+|.+|.+.  |+|+||+.+
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wrGe-----------------~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgF  270 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWRGE-----------------DVAVKIFSSRDERSWFRETEIYQTVMLRHENILGF  270 (513)
T ss_pred             hhhheeEEEEEecCccccceeeccccCC-----------------ceEEEEecccchhhhhhHHHHHHHHHhccchhhhh
Confidence            3456678899999999999999999987                 788888877677778889998765  499999999


Q ss_pred             eeEEE--eC---cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEeeccCCCcE
Q 037010          347 IGYCV--EG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-----HTVPVYIHRDIKSANI  416 (589)
Q Consensus       347 ~~~~~--~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-----~~i~~~vH~Dlkp~NI  416 (589)
                      ++.-.  .+   ++|||.+|.+.|||+|||...   .++....++++..+|.||+|||.     +|-|.|.|||||+.||
T Consensus       271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI  347 (513)
T KOG2052|consen  271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI  347 (513)
T ss_pred             hhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence            97553  22   389999999999999999874   38999999999999999999995     5668889999999999


Q ss_pred             EEcCCCcEEEEeccCccccccCCCC---CCcccccCCCCCchhcccCCC----C--CcccchhhHHHHHHHHHc----CC
Q 037010          417 LIDKNFHAKVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYGD----V--SPKVDVYAFGVVLYELIS----AK  483 (589)
Q Consensus       417 Ll~~~~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~--s~~sDvwSlGvll~ellt----G~  483 (589)
                      |+.+++...|+|+|+|.........   .....+||.+|||||++...-    +  -..+||||||.++||+.-    |.
T Consensus       348 LVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~gg  427 (513)
T KOG2052|consen  348 LVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGG  427 (513)
T ss_pred             EEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCC
Confidence            9999999999999999876544322   234478999999999985431    1  136999999999999863    21


Q ss_pred             ------cccccCCCCCCChhhHHHHHHHHhcCCChHHhhH-----hhcCCCCCCCC-ChHHHHHHHHHHHHhcccCCCCC
Q 037010          484 ------EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLR-----KLVDPRLGDNC-PLDSVLKMAQLAKVCTQEYPQLR  551 (589)
Q Consensus       484 ------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-----~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~R  551 (589)
                            .||..-.+.                 .+..++.+     +.++|.++... ..+....+.++++.||..+|.-|
T Consensus       428 i~eey~~Pyyd~Vp~-----------------DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aR  490 (513)
T KOG2052|consen  428 IVEEYQLPYYDVVPS-----------------DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAAR  490 (513)
T ss_pred             EehhhcCCcccCCCC-----------------CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence                  344322221                 12222222     23344444332 34567789999999999999999


Q ss_pred             CCHHHHHHHHHhccccc
Q 037010          552 PSMRSIVVALMTLSSTT  568 (589)
Q Consensus       552 Ps~~evl~~L~~l~~~~  568 (589)
                      -|+=-+-..|.++....
T Consensus       491 ltALriKKtl~~l~~~~  507 (513)
T KOG2052|consen  491 LTALRIKKTLAKLSNSD  507 (513)
T ss_pred             hHHHHHHHHHHHHhcCh
Confidence            99998988888887543

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-32  Score=281.52  Aligned_cols=255  Identities=26%  Similarity=0.397  Sum_probs=188.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      +.|...+.||+|+||.||+|.+..++. ..+.+.+..        ..........++.+|+++++.++|+|++++++++.
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~ik~~~~--------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   85 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSE-VVAIKKMSY--------SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL   85 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCc-EEEEEEEec--------ccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence            347778899999999999999765432 222111110        00111223456778999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+. |+|.+++.... .++++..+..++.|++.||.|||++++   +|+||||+||+++.++.++|+|||
T Consensus        86 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i---~H~dl~p~nil~~~~~~~kl~dfg  160 (308)
T cd06634          86 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFG  160 (308)
T ss_pred             cCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHhEEECCCCcEEECCcc
Confidence            5 45889999996 58888776443 348899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ++......     ....+++.|+|||.+.   .+.++.++|||||||++|+|++|+.||.....     ..   ......
T Consensus       161 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~---~~~~~~  227 (308)
T cd06634         161 SASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MS---ALYHIA  227 (308)
T ss_pred             cceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-----HH---HHHHHh
Confidence            98754321     2346788999999874   35678899999999999999999999843211     00   000000


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      .          ...+   ...+......+.+++.+||..+|++||++++++++...+..
T Consensus       228 ~----------~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         228 Q----------NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             h----------cCCC---CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            0          0001   11122344568999999999999999999999998665553

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=274.09  Aligned_cols=245  Identities=23%  Similarity=0.328  Sum_probs=176.8

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHH-HccCCCCcceeEeeEEEe-CcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV-LTHVHHLNLVRLIGYCVE-GSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~~~~-~~~  355 (589)
                      +.||+|+||.||+|.+...+. ..+.|.+.....        ........+..|..+ ....+|+|++++++++.+ +..
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~-~vavK~~~~~~~--------~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~   72 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGD-YFAIKVLKKSDM--------IAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYL   72 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCC-eEEEEEecchhh--------hHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeE
Confidence            569999999999998766532 222222110000        001111223345444 445589999999998865 568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |++|||+++++|.+++....  ++++..+..++.|++.||.|||+.++   +|+||+|+||++++++.++|+|||++...
T Consensus        73 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i---~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          73 YLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGI---IHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCCCcEEEeecccceec
Confidence            99999999999999997654  48899999999999999999999998   99999999999999999999999988754


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      ..     .....+++.|++||.+.+..++.++||||||+++|+|++|..||.....     ..   .+......      
T Consensus       148 ~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~---~~~~~~~~------  208 (260)
T cd05611         148 LE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DA---VFDNILSR------  208 (260)
T ss_pred             cc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HH---HHHHHHhc------
Confidence            32     2234688899999999888889999999999999999999999843321     11   11111100      


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH---HHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR---SIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~---evl~~  560 (589)
                           ............+..+.+++.+||+.+|++||++.   |++.|
T Consensus       209 -----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         209 -----RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             -----ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence                 00001111123345789999999999999999665   55444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-33  Score=287.22  Aligned_cols=272  Identities=24%  Similarity=0.342  Sum_probs=195.8

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|++.+.||.|++|.||+|....+... .+.|.+..         ........+.+.+|+++++.++|+||+++++++.+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~-~~iK~~~~---------~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRK-VAIKKISN---------VFDDLIDAKRILREIKLLRHLRHENIIGLLDILRP   70 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcE-EEEEeecc---------ccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcc
Confidence            588999999999999999987654222 22211110         00112334568889999999999999999998764


Q ss_pred             C------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          353 G------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       353 ~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      .      ..|++|||+.+ +|.+++....  ++++..++.++.|++.||+|||++++   +|+||||+|||++.++.++|
T Consensus        71 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi---~H~dlkp~nili~~~~~~~L  144 (330)
T cd07834          71 PSPEDFNDVYIVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANV---IHRDLKPSNILVNSNCDLKI  144 (330)
T ss_pred             cCcccccceEEEecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEE
Confidence            3      58999999985 8999887654  59999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCC--CCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          427 ADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       427 ~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +|||++........  .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......     ......
T Consensus       145 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i  219 (330)
T cd07834         145 CDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLI  219 (330)
T ss_pred             cccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHH
Confidence            99999986544321  122335678899999999877 8899999999999999999999998544321     111111


Q ss_pred             HHHhcCCChH----------HhhHhhcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhcc
Q 037010          504 EEVLNLPDPI----------EDLRKLVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTLS  565 (589)
Q Consensus       504 ~~~~~~~~~~----------~~l~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l~  565 (589)
                      ......+.+.          ............   .....+.+..+.+++.+||+.+|.+|||++++++|  ++.+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         220 VEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             HHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence            1111111100          000000000000   00112234578999999999999999999999998  44444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-32  Score=284.82  Aligned_cols=271  Identities=19%  Similarity=0.277  Sum_probs=191.6

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcce
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLV  344 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv  344 (589)
                      +++....++|++.+.||+|+||.||++.+..++. ..+.|.+..     .    .......+.+.+|++++++++||||+
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~-~vaiK~~~~-----~----~~~~~~~~~~~~Ei~~l~~l~h~~iv   79 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL-RVAVKKLSR-----P----FQSIIHAKRTYRELRLLKHMKHENVI   79 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCe-EEEEEEecC-----c----chhhHHHHHHHHHHHHHHHcCCCccc
Confidence            4556678999999999999999999998765432 222221110     0    01112234577899999999999999


Q ss_pred             eEeeEEEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          345 RLIGYCVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       345 ~l~~~~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      ++++++..       ...|++++++ +++|.+++...   .+++..+..++.|++.||+|||++++   +||||||+||+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~NIl  152 (345)
T cd07877          80 GLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA  152 (345)
T ss_pred             ceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCChHHEE
Confidence            99987643       2367888887 77998887643   38999999999999999999999998   99999999999


Q ss_pred             EcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       418 l~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      ++.++.+||+|||++.....    ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....    .
T Consensus       153 l~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~----~  224 (345)
T cd07877         153 VNEDCELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH----I  224 (345)
T ss_pred             EcCCCCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----H
Confidence            99999999999999875432    1233567899999998765 5688999999999999999999999843221    1


Q ss_pred             hhHHHHHHHHhcCCCh----------HHhhHhhcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          497 KGLVALFEEVLNLPDP----------IEDLRKLVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~----------~~~l~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..+. ........+.+          .......+.....   ..........+.+++.+|++.||.+||++.++++|=
T Consensus       225 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         225 DQLK-LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HHHH-HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence            1111 11111111000          0000011110000   000111244688999999999999999999999983

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.8e-33  Score=276.40  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=183.7

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcEEEE
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLV  358 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv  358 (589)
                      ||.|+||.||++.+..++ ...+.|.+....        .........+.+|++++++++||||+++++.+. +...|++
T Consensus         1 lg~g~~~~vy~~~~~~~~-~~~~~k~~~~~~--------~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   71 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTG-DIYAIKVIKKAD--------MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLV   71 (265)
T ss_pred             CCCCCceEEEEEEECCCC-CEEEEEEecchh--------hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEE
Confidence            689999999999987543 222222211100        001233456888999999999999999998665 4568999


Q ss_pred             EEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccC
Q 037010          359 YEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG  438 (589)
Q Consensus       359 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~  438 (589)
                      |||+.+++|.+++....  .+++..+..++.|++.||.|||++++   +|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i---~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          72 MEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGI---IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCe---ecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            99999999999998654  48999999999999999999999998   99999999999999999999999998754322


Q ss_pred             CC-------CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          439 SA-------SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       439 ~~-------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      ..       .......++..|++||......++.++|+||||+++|+|++|+.||.....        ..........  
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~--  216 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILNG--  216 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC--
Confidence            11       012235678899999999888899999999999999999999999843321        1111111110  


Q ss_pred             hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       512 ~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                               ........  ..+..+.+++.+||+.+|.+|||+.++.+.|.
T Consensus       217 ---------~~~~~~~~--~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         217 ---------KIEWPEDV--EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ---------CcCCCccc--cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                     00000111  12457899999999999999999955444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-33  Score=304.49  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=203.8

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcc
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNL  343 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnI  343 (589)
                      ..+++...++|++++.||+|+||.|.+++++.+. ..|+.|.+     .+--.   ++.....-|..|-++|..-..+=|
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~-~VYAMK~l-----nK~eM---lKr~~tA~F~EERDimv~~ns~Wi  137 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTE-KVYAMKIL-----NKWEM---LKRAETACFREERDIMVFGNSEWI  137 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccc-cchhHHHh-----hHHHH---hhchhHHHHHHHhHHHHcCCcHHH
Confidence            3445556789999999999999999999988762 22222221     11111   222344568889999998888889


Q ss_pred             eeEe-eEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          344 VRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       344 v~l~-~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +.++ .|.++.++|+|||||+||+|..++....  ++++..++.++..|+.||.-||+.|.   |||||||+|||+|..|
T Consensus       138 v~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgy---VHRDiKPDNvLld~~G  212 (1317)
T KOG0612|consen  138 VQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGY---VHRDIKPDNVLLDKSG  212 (1317)
T ss_pred             HHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccc---eeccCCcceeEecccC
Confidence            9986 4566778999999999999999998776  59999999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhccc----C-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ----Y-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      ++||+|||.+-.+..+........+|||.|.+||++.    + +.|++.+|.||+||++||||.|..||...        
T Consensus       213 HikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------  284 (1317)
T KOG0612|consen  213 HIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------  284 (1317)
T ss_pred             cEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------
Confidence            9999999998877766655666689999999999984    3 67899999999999999999999999543        


Q ss_pred             hHHHHHHHHhcCCChHHhhHhhcCCCCCCCCC--hHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 037010          498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCP--LDSVLKMAQLAKVCTQEYPQLRPS---MRSIVVALM  562 (589)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~L~  562 (589)
                      .+.+.+..+++-..           .  -..|  .+.+....+||.+.+. +|+.|..   ++++-.|..
T Consensus       285 slveTY~KIm~hk~-----------~--l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF  340 (1317)
T KOG0612|consen  285 SLVETYGKIMNHKE-----------S--LSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF  340 (1317)
T ss_pred             HHHHHHHHHhchhh-----------h--cCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence            33333333332110           0  0112  2355678888888766 7888888   888888853

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-33  Score=279.51  Aligned_cols=265  Identities=25%  Similarity=0.347  Sum_probs=187.1

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeEEE-
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYCV-  351 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~-  351 (589)
                      |++.+.||+|++|.||+|....+..... .|     ...     +...........+|+..+++++ |+||+++++++. 
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~-ik-----~~~-----~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   69 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVA-IK-----KMK-----KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE   69 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEE-EE-----Eeh-----hhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc
Confidence            6788999999999999999865522111 11     110     0111112223456899999999 999999999765 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ++..|+||||+ +|+|.+++.......+++..++.++.|++.+|.|||++++   +|+||+|+||++++++.++|+|||+
T Consensus        70 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i---~H~dl~~~ni~i~~~~~~~l~d~~~  145 (283)
T cd07830          70 NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF---FHRDLKPENLLVSGPEVVKIADFGL  145 (283)
T ss_pred             CCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChhhEEEcCCCCEEEeeccc
Confidence            45689999999 7799999887654568999999999999999999999998   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhccc-CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +......  .......++..|+|||.+. ...++.++|+||||+++|||++|+.||......    .. ..........+
T Consensus       146 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~----~~-~~~~~~~~~~~  218 (283)
T cd07830         146 AREIRSR--PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI----DQ-LYKICSVLGTP  218 (283)
T ss_pred             ceeccCC--CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChH----HH-HHHHHHhcCCC
Confidence            8755322  1223356888999999874 456789999999999999999999888433210    11 11111111111


Q ss_pred             ChHH-----hhHhhcCCCCCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIE-----DLRKLVDPRLGD-------NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~-----~l~~~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ....     .+...++..+..       ...+.....+.+++++||+.+|++|||++|++.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         219 TKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            1000     000001100000       0011123578999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8e-33  Score=276.19  Aligned_cols=274  Identities=28%  Similarity=0.437  Sum_probs=206.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC--CCCcceeEeeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV--HHLNLVRLIGY  349 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l--~hpnIv~l~~~  349 (589)
                      ...++.+.+|+|.||.||+|...+.                 .+|+|.+..+..+.|+.|-+|.+..  +|+||+++++.
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~~-----------------~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~  272 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDNR-----------------LVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGA  272 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccCc-----------------eeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhch
Confidence            4456678999999999999988764                 7889999999999999999987654  79999999987


Q ss_pred             EEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEeeccCCCcEEE
Q 037010          350 CVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH------TVPVYIHRDIKSANILI  418 (589)
Q Consensus       350 ~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~------~i~~~vH~Dlkp~NILl  418 (589)
                      ...     -+++||+||.+.|+|.+|+..+.   ++|....+|+..+++||+|||+.      .-|+|+|||||..|||+
T Consensus       273 ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv  349 (534)
T KOG3653|consen  273 EKRGTADRMEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV  349 (534)
T ss_pred             hccCCccccceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE
Confidence            642     25899999999999999998765   99999999999999999999963      23568999999999999


Q ss_pred             cCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCC-CCC-----cccchhhHHHHHHHHHcCCcccccCCC
Q 037010          419 DKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYG-DVS-----PKVDVYAFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       419 ~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s-----~~sDvwSlGvll~elltG~~p~~~~~~  491 (589)
                      ..|++..|+|||+|..+..+... ..-..+||.+|||||++.+. ++.     .+.||||+|.+||||++.-..+.++..
T Consensus       350 K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~v  429 (534)
T KOG3653|consen  350 KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPV  429 (534)
T ss_pred             ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCC
Confidence            99999999999999987654332 12237899999999998643 122     368999999999999986654432111


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhH-----hhcCCCCCCCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLR-----KLVDPRLGDNCPL-DSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~-----~~~d~~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ..     +.--++......+..+++.     +..+|.++..... .-...+.+.+..||+.||+.|.|+.=+.+.+..+.
T Consensus       430 p~-----Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  430 PE-----YQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             Cc-----ccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            11     1111222222222233332     2233333221111 23457899999999999999999999999888887


Q ss_pred             ccccc
Q 037010          566 STTED  570 (589)
Q Consensus       566 ~~~~~  570 (589)
                      ...+.
T Consensus       505 ~~~~~  509 (534)
T KOG3653|consen  505 MLWED  509 (534)
T ss_pred             ccCCc
Confidence            66654

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.6e-33  Score=286.26  Aligned_cols=270  Identities=27%  Similarity=0.324  Sum_probs=186.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||.||+|.+..++.. .+.|.+...         .........+.+|++++++++||||+++++++
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~-~~ik~~~~~---------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   76 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRV-VALKKILMH---------NEKDGFPITALREIKILKKLKHPNVVPLIDMA   76 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcE-EEEEEEEec---------cCCCCcchhHHHHHHHHHhcCCCCccchhhhe
Confidence            57899999999999999999997765332 222211100         01111123456799999999999999999866


Q ss_pred             Ee---------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          351 VE---------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       351 ~~---------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      .+         ..+|+||||+.+ +|.+.+.... ..+++..+..++.|++.||+|||++++   +|+||||+||+++++
T Consensus        77 ~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i---~H~dl~p~nil~~~~  151 (311)
T cd07866          77 VERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHI---LHRDIKAANILIDNQ  151 (311)
T ss_pred             ecccccccccCceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCC
Confidence            42         236899999976 7777776543 349999999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCC----------CCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          422 FHAKVADFGLTKLTEVGSAS----------LPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      +.++|+|||++.........          ..+...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus       152 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~  231 (311)
T cd07866         152 GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS  231 (311)
T ss_pred             CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999998754322111          1122457888999998764 357899999999999999999999985432


Q ss_pred             CCCCChhhHHHHHHHHhcCCChH--Hh---hHhhcCCCCCCCCC-------hHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 037010          491 GSSADSKGLVALFEEVLNLPDPI--ED---LRKLVDPRLGDNCP-------LDSVLKMAQLAKVCTQEYPQLRPSMRSIV  558 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~--~~---l~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl  558 (589)
                      ..     ............+.+.  ..   +....+.......+       ......+.+++.+||+.||.+|||+.|++
T Consensus       232 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell  306 (311)
T cd07866         232 DI-----DQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL  306 (311)
T ss_pred             HH-----HHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence            21     1111111111111000  00   00000000000011       11224688999999999999999999998


Q ss_pred             HH
Q 037010          559 VA  560 (589)
Q Consensus       559 ~~  560 (589)
                      .|
T Consensus       307 ~~  308 (311)
T cd07866         307 EH  308 (311)
T ss_pred             cC
Confidence            75

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=7.9e-33  Score=280.52  Aligned_cols=245  Identities=21%  Similarity=0.332  Sum_probs=185.2

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcE
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~  355 (589)
                      ..+||+|+||.||++....++....+ |.+.           .........+.+|+.++++++|+||+++++++. ++..
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~i-K~~~-----------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   92 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAV-KKMD-----------LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL   92 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEE-EEec-----------ccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEE
Confidence            46799999999999987665332221 1110           011223456888999999999999999999776 4568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |++|||+++++|.+++...   .+++..+..++.|++.+|+|||++++   +|+||+|+||+++.++.++|+|||++...
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~gi---vH~dl~p~Nilv~~~~~~~l~dfg~~~~~  166 (292)
T cd06657          93 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV  166 (292)
T ss_pred             EEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEECCCCCEEEcccccceec
Confidence            9999999999999987543   38899999999999999999999998   99999999999999999999999988754


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      ..... ......|++.|+|||.+....++.++|+||||+++|+|++|..||.....     ........           
T Consensus       167 ~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-----~~~~~~~~-----------  229 (292)
T cd06657         167 SKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIR-----------  229 (292)
T ss_pred             ccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH-----------
Confidence            32221 12235688999999999888899999999999999999999999843211     11111111           


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                        ....+.+..  ....+..+.+++.+||+.+|.+||+++++++|
T Consensus       230 --~~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         230 --DNLPPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             --hhCCcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence              111111100  11223468899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.6e-32  Score=278.58  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=183.6

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEeC
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEG  353 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  353 (589)
                      |...++||+|+||.||+|.+..++. ..+.+.+...        ..........+.+|++++++++|||++++++++.++
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~-~v~ik~~~~~--------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   93 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNE-VVAVKKMSYS--------GKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE   93 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCc-EEEEEEEecc--------ccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC
Confidence            6667889999999999998755422 2221111100        011122345678899999999999999999987754


Q ss_pred             -cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          354 -SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       354 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                       ..|+||||+. |+|.+++.... .++++..++.++.|++.+|.|||++++   +|+||+|+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi---~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          94 HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNM---IHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             CEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCChhhEEECCCCCEEEeecCCC
Confidence             5899999996 48888876543 358999999999999999999999998   99999999999999999999999987


Q ss_pred             cccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ....     ......|+..|+|||++.   ...++.++|||||||++|+|++|..||.....       ... .......
T Consensus       169 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~-~~~~~~~  235 (313)
T cd06633         169 SKSS-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSA-LYHIAQN  235 (313)
T ss_pred             cccC-----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHH-HHHHHhc
Confidence            6432     122356889999999873   45688899999999999999999999844321       000 1111000


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                   .............+.+++.+||+.+|.+||++.+++.|
T Consensus       236 -------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         236 -------------DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -------------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                         00011111223468999999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.3e-32  Score=285.57  Aligned_cols=265  Identities=18%  Similarity=0.293  Sum_probs=189.5

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ....++|++.+.||+|+||.||++.+..++. ..+.|.+..         ..........+.+|++++++++||||++++
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   80 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGA-KVAIKKLYR---------PFQSELFAKRAYRELRLLKHMKHENVIGLL   80 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCc-EEEEEEecc---------cccchHHHHHHHHHHHHHHhcCCCCcccee
Confidence            3357889999999999999999998766532 222221110         001122334577899999999999999999


Q ss_pred             eEEEeC-------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          348 GYCVEG-------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       348 ~~~~~~-------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      +++..+       ..++||||+ +++|.+++...   .+++..++.++.|++.||+|||++++   +||||||+||+++.
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi---~H~dlkp~Nill~~  153 (343)
T cd07880          81 DVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGI---IHRDLKPGNLAVNE  153 (343)
T ss_pred             eeecCCccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcC
Confidence            977532       358999999 67998888642   48999999999999999999999998   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      ++.++|+|||++......    .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.....    ....
T Consensus       154 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~----~~~~  225 (343)
T cd07880         154 DCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH----LDQL  225 (343)
T ss_pred             CCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHH
Confidence            999999999998754321    223467889999998865 4588899999999999999999999854321    1111


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCC-----------CCC----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDP-----------RLG----DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~-----------~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...... ... .+ ..+...+..           ...    .....+....+.+++.+|+..||.+|||+.+++.|
T Consensus       226 ~~~~~~-~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         226 MEIMKV-TGT-PS-KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHHHh-cCC-CC-HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111110 000 00 001000000           000    00112234468899999999999999999999977

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-32  Score=263.59  Aligned_cols=268  Identities=25%  Similarity=0.347  Sum_probs=207.1

Q ss_pred             cHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH----HHHHHHHHHHHHccC
Q 037010          263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ----ASREFLAELKVLTHV  338 (589)
Q Consensus       263 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~E~~il~~l  338 (589)
                      ...++....+++++...+-+|.||.||+|.++.....-.          .+.+.+|..+..    ....++.|--.+..+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~----------~q~v~vKTvk~~AS~iQv~~~L~es~lly~~  344 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYND----------CQEVLVKTVKQHASQIQVNLLLQESMLLYGA  344 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcch----------HHHHHHHHHHhcccHHHHHHHHHHHHHHhcC
Confidence            446666677889999999999999999998876422111          112333333222    235678899999999


Q ss_pred             CCCcceeEeeEEEeC--cEEEEEEecCCCChHHHHhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 037010          339 HHLNLVRLIGYCVEG--SLFLVYEYIENGNLSEHLRG------SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRD  410 (589)
Q Consensus       339 ~hpnIv~l~~~~~~~--~~~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~D  410 (589)
                      .|||+..+.+++.++  ..+.++.++.-|+|..|+..      ...+.+...+...++.|++.|++|||.+++   ||.|
T Consensus       345 sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~V---iHkD  421 (563)
T KOG1024|consen  345 SHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGV---IHKD  421 (563)
T ss_pred             cCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCc---ccch
Confidence            999999999988754  48899999999999999972      233457788889999999999999999999   9999


Q ss_pred             cCCCcEEEcCCCcEEEEeccCcccc-ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCccccc
Q 037010          411 IKSANILIDKNFHAKVADFGLTKLT-EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVK  488 (589)
Q Consensus       411 lkp~NILl~~~~~vkl~Dfgla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~  488 (589)
                      |..+|++||+..++||+|=.+++.. ..+.............||+||.+.+..|+.++|+|||||+||||+| |+.|+..
T Consensus       422 iAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pyae  501 (563)
T KOG1024|consen  422 IAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAE  501 (563)
T ss_pred             hhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccc
Confidence            9999999999999999999998844 3333334444455778999999999999999999999999999987 6667632


Q ss_pred             CCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                           .+......+...                 ..+-.-|.++++++..++..||...|++||+++|++.-|...-
T Consensus       502 -----IDPfEm~~ylkd-----------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  502 -----IDPFEMEHYLKD-----------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             -----cCHHHHHHHHhc-----------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                 222232222222                 2222345667778999999999999999999999999887643

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.2e-32  Score=301.38  Aligned_cols=251  Identities=27%  Similarity=0.395  Sum_probs=180.7

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCcc
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNL  343 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnI  343 (589)
                      .+-..+|+.++.||+||||.||+++.+-++               ..+|+|++.    ......+.+|+..|.+|+||||
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDG---------------r~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNV  539 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDG---------------REYAIKKIPLKASDKLYSKILREVKLLARLNHPNV  539 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccc---------------hhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcce
Confidence            445678899999999999999999977663               244444443    2334567889999999999999


Q ss_pred             eeEeeEEEe-----------------------------------------------------------------------
Q 037010          344 VRLIGYCVE-----------------------------------------------------------------------  352 (589)
Q Consensus       344 v~l~~~~~~-----------------------------------------------------------------------  352 (589)
                      |+++..+.+                                                                       
T Consensus       540 VRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e  619 (1351)
T KOG1035|consen  540 VRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEE  619 (1351)
T ss_pred             eeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcc
Confidence            988631100                                                                       


Q ss_pred             -------------------------------------------------CcEEEEEEecCCCChHHHHhcCCCCCCCHHH
Q 037010          353 -------------------------------------------------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSS  383 (589)
Q Consensus       353 -------------------------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~  383 (589)
                                                                       -.+||-||||+.-.|.+++..+... -....
T Consensus       620 ~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~  698 (1351)
T KOG1035|consen  620 NDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDE  698 (1351)
T ss_pred             cccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHH
Confidence                                                             0136788888886666666554321 14677


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccccc----------------C-CCCCCccc
Q 037010          384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV----------------G-SASLPTRL  446 (589)
Q Consensus       384 ~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~----------------~-~~~~~~~~  446 (589)
                      .++++++|+.||.|+|++|+   |||||||.|||++.+..|||+|||+|+....                + ...-.+..
T Consensus       699 ~wrLFreIlEGLaYIH~~gi---IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~  775 (1351)
T KOG1035|consen  699 AWRLFREILEGLAYIHDQGI---IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQ  775 (1351)
T ss_pred             HHHHHHHHHHHHHHHHhCce---eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccc
Confidence            89999999999999999998   9999999999999999999999999986210                0 01123457


Q ss_pred             ccCCCCCchhcccCC---CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCC
Q 037010          447 VGTFGYMPPEYAQYG---DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPR  523 (589)
Q Consensus       447 ~gt~~y~aPE~~~~~---~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~  523 (589)
                      +||.-|+|||++.+.   .|+.|+|+|||||+|+||+.   ||.+..       ....             .+..+-++.
T Consensus       776 VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-------ERa~-------------iL~~LR~g~  832 (1351)
T KOG1035|consen  776 VGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-------ERAS-------------ILTNLRKGS  832 (1351)
T ss_pred             cceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH-------HHHH-------------HHHhcccCC
Confidence            899999999999654   49999999999999999995   453221       1111             111222222


Q ss_pred             CCCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          524 LGDN--CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       524 l~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ++..  ...+....=..++++++++||.+|||+.|+|..
T Consensus       833 iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  833 IPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             CCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            2222  111222234789999999999999999999864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=273.09  Aligned_cols=247  Identities=26%  Similarity=0.428  Sum_probs=192.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ...+|..+..||+|+||.|.+++.+++.      ..++++.+.+.+.+..   ++.+--+.|-++|.-. +-|.+++++.
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtd------ELyAiKiLkKDViiQd---DDvectm~EKrvLAL~~kppFL~qlHS  417 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTD------ELYAIKILKKDVIIQD---DDVECTMVEKRVLALPGKPPFLVQLHS  417 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcc------hhhhhhhhccceeeec---CcccceehhhhheecCCCCchHHHHHH
Confidence            3467889999999999999999877762      2333333333333322   1222234566777655 4678888887


Q ss_pred             EE-EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      .+ .-+.+|+||||+.||+|--+|++-++  +.+..+..++.+|+-||=+||++||   +.||||.+||++|.+|++||+
T Consensus       418 cFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kgI---iYRDLKLDNvmLd~eGHiKi~  492 (683)
T KOG0696|consen  418 CFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKGI---IYRDLKLDNVMLDSEGHIKIA  492 (683)
T ss_pred             HhhhhhheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCCe---eeeeccccceEeccCCceEee
Confidence            55 46789999999999999999988776  8888999999999999999999999   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++.--. ......+.+|||.|+|||++...+|+.++|.||+||+|||||.|+.||.....                
T Consensus       493 DFGmcKEni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE----------------  555 (683)
T KOG0696|consen  493 DFGMCKENIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----------------  555 (683)
T ss_pred             eccccccccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH----------------
Confidence            9999874322 22233458999999999999999999999999999999999999999954322                


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM  554 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  554 (589)
                           .+-+..+++...  .+|...+.+...+.+..+.++|.+|.-.
T Consensus       556 -----~elF~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRLGc  595 (683)
T KOG0696|consen  556 -----DELFQAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLGC  595 (683)
T ss_pred             -----HHHHHHHHHccC--cCcccccHHHHHHHHHHhhcCCccccCC
Confidence                 122233334333  5677777888999999999999998543

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.2e-32  Score=279.71  Aligned_cols=256  Identities=23%  Similarity=0.387  Sum_probs=184.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|.+..+. ...+.|.+.          +........++..|++++.+.. ||||+++++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~avK~~~----------~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~   81 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTG-HVMAVKQMR----------RTGNKEENKRILMDLDVVLKSHDCPYIVKCYG   81 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCC-eEEEEEEEe----------ccCChHHHHHHHHHHHHHHhccCCCchHhhhe
Confidence            3467889999999999999999987542 222222111          0111223345666777666664 999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++.+ ...|++|||+.+ +|.+++..... .+++..+..++.|++.||+|||+ +++   +||||+|+||++++++.+||
T Consensus        82 ~~~~~~~~~~v~e~~~~-~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~~i---~H~dl~p~nill~~~~~~kL  156 (296)
T cd06618          82 YFITDSDVFICMELMST-CLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKHGV---IHRDVKPSNILLDASGNVKL  156 (296)
T ss_pred             eeecCCeEEEEeeccCc-CHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhCCE---ecCCCcHHHEEEcCCCCEEE
Confidence            8865 468999999854 77777665433 58999999999999999999997 577   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCC----CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG----DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +|||++........  .....++..|+|||.+...    .++.++||||||+++|+|++|+.||.....       ....
T Consensus       157 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~  227 (296)
T cd06618         157 CDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEV  227 (296)
T ss_pred             CccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHH
Confidence            99999875432211  1234578899999998654    378899999999999999999999843211       0111


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ........          .+...  ........+.+++.+||..||.+||+++++++|..
T Consensus       228 ~~~~~~~~----------~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         228 LTKILQEE----------PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             HHHHhcCC----------CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence            11111110          00010  01123457899999999999999999999998854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-32  Score=284.42  Aligned_cols=279  Identities=22%  Similarity=0.235  Sum_probs=187.7

Q ss_pred             cCCCcc-ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHh-HHHh-hcC-HHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSM-SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK-AAIK-KMD-MQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~-~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-~~ik-~~~-~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|.. .+.||+|+||.||+|.+...+. ..+.|.+........ .... ... ......+.+|++++++++|+||+++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~-~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGK-IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCC-eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            456764 5779999999999998765432 222222211100000 0000 000 0011246789999999999999999


Q ss_pred             eeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++++. ++..+++|||+. |+|.+++....  .+++.....++.|++.||+|||++++   +|+||+|+||+++.++.++
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i---~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYF---MHRDLSPANIFINSKGICK  159 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecccccHHHeEECCCCCEE
Confidence            99876 456899999997 59999987543  38899999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCC-------------CCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCC
Q 037010          426 VADFGLTKLTEVGS-------------ASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       426 l~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~  491 (589)
                      |+|||++.......             ........+++.|+|||.+.+. .++.++|+|||||++|||++|+.||.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999987554111             1111223568889999988654 468899999999999999999999854322


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHh--hHhh-----cCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          492 SSADSKGLVALFEEVLNLPDPIED--LRKL-----VDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~--l~~~-----~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                          ...+.. .......+.....  ....     ......   ..........+.+++.+||+.+|.+|||++|++.|-
T Consensus       240 ----~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        240 ----IDQLGR-IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             ----HHHHHH-HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence                111111 1111111111000  0000     000000   001112345688999999999999999999999874

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-33  Score=281.96  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=199.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ...+++.+..||-||||.|=++..++...      .++.+.+.++..+   +....+.+..|-+||.+++.|.||++|--
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~------~fAlKilkK~hIV---dtkQqeHv~sEr~Im~~~~s~fIvrLYrT  488 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKA------TFALKILKKKHIV---DTKQQEHVFSERNIMMECRSDFIVRLYRT  488 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccch------HHHHHHHhHhhcc---chhHHHHHHhHHHHHHhcCchHHHHHHHH
Confidence            34567788899999999999998776521      1222222222222   22344567889999999999999999986


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ ..+|++||-|-||.|+..++.++.  |+....+.++..+++|++|||.+||   |+|||||+|++++.+|.+||.|
T Consensus       489 frd~kyvYmLmEaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k~i---IYRDLKPENllLd~~Gy~KLVD  563 (732)
T KOG0614|consen  489 FRDSKYVYMLMEACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRKGI---IYRDLKPENLLLDNRGYLKLVD  563 (732)
T ss_pred             hccchhhhhhHHhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhcCc---eeccCChhheeeccCCceEEee
Confidence            654 569999999999999999998875  8999999999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||+|+....+  ...-+++|||.|.|||++.+..++.++|.||||+++||||+|..||...+.-     .   .+..++.
T Consensus       564 FGFAKki~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-----k---tYn~ILk  633 (732)
T KOG0614|consen  564 FGFAKKIGSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-----K---TYNLILK  633 (732)
T ss_pred             hhhHHHhccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-----H---HHHHHHh
Confidence            9999987544  3445689999999999999999999999999999999999999999654331     1   1111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L  561 (589)
                      ..+      .       ...|........+|+++....+|.+|.-     +.+|-.|-
T Consensus       634 Gid------~-------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  634 GID------K-------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             hhh------h-------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence            100      0       1223334446788999999999999977     56777774

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.3e-32  Score=279.09  Aligned_cols=274  Identities=23%  Similarity=0.332  Sum_probs=194.6

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      +....++|++.+.||.|+||.||++.+..++....+ |.+.     ..    .......+.+.+|++++++++||||+++
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vai-K~~~-----~~----~~~~~~~~~~~~E~~~l~~l~hpniv~~   74 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAI-KKIM-----KP----FSTPVLAKRTYRELKLLKHLRHENIISL   74 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEE-EEec-----cc----ccccchhHHHHHHHHHHHhcCCCCeeeE
Confidence            345678999999999999999999987765332221 1110     00    1111223557789999999999999999


Q ss_pred             eeEEEe--CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          347 IGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       347 ~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      ++++..  ...|++|||+ +++|.+++...   ++++..+..++.|++.||.|||++++   +|+||+|+||++++++.+
T Consensus        75 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~i---iH~dl~p~Nili~~~~~~  147 (328)
T cd07856          75 SDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGV---VHRDLKPSNILINENCDL  147 (328)
T ss_pred             eeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEeECCCCCE
Confidence            997753  4589999998 55898888643   37888888999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +|+|||++.....    ......++..|+|||.+.. ..++.++|||||||++|+|+||+.||.....     .......
T Consensus       148 ~l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-----~~~~~~~  218 (328)
T cd07856         148 KICDFGLARIQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-----VNQFSII  218 (328)
T ss_pred             EeCccccccccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence            9999999875322    1123467889999998765 5689999999999999999999999843321     1111111


Q ss_pred             HHHhcCCChHHhhHhhc---------CCCCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhcccc
Q 037010          504 EEVLNLPDPIEDLRKLV---------DPRLGDNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTLSST  567 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~---------d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l~~~  567 (589)
                      ......+. .+......         ........+     ......+.+++.+||+.+|++|||+++++.+  +......
T Consensus       219 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         219 TDLLGTPP-DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HHHhCCCC-HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence            12111110 00000000         000001111     1234578999999999999999999999988  5444444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7.6e-33  Score=287.15  Aligned_cols=266  Identities=21%  Similarity=0.309  Sum_probs=185.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||.|+||.||+|....++.. .+.|.+..           ......+.+.+|++++++++||||+++++++
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~-v~iK~i~~-----------~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~   71 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKR-VAVKKIVL-----------TDPQSVKHALREIKIIRRLDHDNIVKVYEVL   71 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcE-EEEEEEec-----------CCCchHHHHHHHHHHHHhcCCCcchhhHhhh
Confidence            47899999999999999999987765332 22221110           0112345677899999999999999998755


Q ss_pred             Ee---------------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          351 VE---------------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       351 ~~---------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      ..               ...|+||||+.+ +|.+++...   .+++..++.++.|++.||+|||++++   +||||||+|
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~gi---vH~dikp~N  144 (342)
T cd07854          72 GPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANV---LHRDLKPAN  144 (342)
T ss_pred             cccccccccccccccccceEEEEeecccc-cHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHH
Confidence            42               247899999974 898888643   48899999999999999999999998   999999999


Q ss_pred             EEEc-CCCcEEEEeccCccccccCCC--CCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCC
Q 037010          416 ILID-KNFHAKVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       416 ILl~-~~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~  491 (589)
                      |+++ +++.+||+|||++........  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.....
T Consensus       145 ili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~  224 (342)
T cd07854         145 VFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE  224 (342)
T ss_pred             EEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9997 456789999999875432211  11123467889999997643 5688899999999999999999999954432


Q ss_pred             CCCChhhHHHHHHHHhcCCCh--HHhhH----hhcC-CCCCCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 037010          492 SSADSKGLVALFEEVLNLPDP--IEDLR----KLVD-PRLGDN-----CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV  559 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~--~~~l~----~~~d-~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  559 (589)
                      .    .......... .....  ...+.    .... ......     ........+.+|+.+||+.||.+|||++|++.
T Consensus       225 ~----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         225 L----EQMQLILESV-PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             H----HHHHHHHHhc-CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            1    0111111000 00000  00000    0000 000000     11123457889999999999999999999998


Q ss_pred             H
Q 037010          560 A  560 (589)
Q Consensus       560 ~  560 (589)
                      |
T Consensus       300 h  300 (342)
T cd07854         300 H  300 (342)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-32  Score=292.24  Aligned_cols=258  Identities=22%  Similarity=0.364  Sum_probs=205.2

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCccee
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVR  345 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~  345 (589)
                      +...++.|++.+.||.|.+|.||++....+....             .++|+....+..+++..|.++|+.+ .|||++.
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~a-------------a~kI~~~~~d~deEiE~eynil~~~~~hpnv~~   80 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLA-------------AIKIMDPTEDEEEEIELEYNMLKKYSHHPNVAT   80 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCcee-------------eeEeecCCccccHHHHHHHHHHHhccCCCCcce
Confidence            3445677899999999999999999876652211             2223334445556777899999888 6999999


Q ss_pred             EeeEEE------eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc
Q 037010          346 LIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID  419 (589)
Q Consensus       346 l~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~  419 (589)
                      +++++.      ++.+|||||||.+||..|++....+..+.|..+..|++.++.|+.|||...+   +|||||-.|||++
T Consensus        81 fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkv---iHRDikG~NiLLT  157 (953)
T KOG0587|consen   81 FYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKV---IHRDIKGQNVLLT  157 (953)
T ss_pred             EEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcce---eeecccCceEEEe
Confidence            999764      3569999999999999999988767779999999999999999999999998   9999999999999


Q ss_pred             CCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-----CCCcccchhhHHHHHHHHHcCCcccccCCCCCC
Q 037010          420 KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-----DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA  494 (589)
Q Consensus       420 ~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~  494 (589)
                      .++.|||.|||.+...... ..+....+|||.|||||++...     .|+.++|+||||++..||--|..|+..+.+   
T Consensus       158 ~e~~VKLvDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---  233 (953)
T KOG0587|consen  158 ENAEVKLVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---  233 (953)
T ss_pred             ccCcEEEeeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---
Confidence            9999999999998865433 3334557899999999999643     477899999999999999999999855432   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                              +.-++..+         -.|.+.-..|..-..++-++|..||.+|...||++.++++|-
T Consensus       234 --------mraLF~Ip---------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  234 --------MRALFLIP---------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             --------hhhhccCC---------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence                    11111111         112222234667788999999999999999999999999873

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.5e-32  Score=285.13  Aligned_cols=266  Identities=21%  Similarity=0.303  Sum_probs=189.7

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||+|.+..+... .+.|.+..         ..........+.+|+.++++++||||+++++
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~-~aiK~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   81 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRK-VAIKKLSR---------PFQSAIHAKRTYRELRLLKHMDHENVIGLLD   81 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcE-EEEEeccc---------ccchhhHHHHHHHHHHHHHhccCCCHHHHHH
Confidence            4567899999999999999999988765322 22221110         0111223355778999999999999999988


Q ss_pred             EEEe-C------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          349 YCVE-G------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       349 ~~~~-~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      ++.. +      ..++|+||+ +++|.+++...   ++++..+..++.|++.||+|||+.++   +|+||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi---~H~dlkp~Nill~~~  154 (343)
T cd07851          82 VFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGI---IHRDLKPSNIAVNED  154 (343)
T ss_pred             HhhccccccccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEECCC
Confidence            6543 2      279999999 56999988753   48999999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      +.++|+|||++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....    ...+.
T Consensus       155 ~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~~~~~  226 (343)
T cd07851         155 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH----IDQLK  226 (343)
T ss_pred             CCEEEcccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHH
Confidence            99999999998754322    233467889999998854 3678899999999999999999999853321    11111


Q ss_pred             HHHHHHhcCCCh-------HHhhHhhcC---CCCCCCC---ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          501 ALFEEVLNLPDP-------IEDLRKLVD---PRLGDNC---PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       501 ~~~~~~~~~~~~-------~~~l~~~~d---~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      . .......+.+       .+.....+.   .......   .......+.+++.+||..+|++|||++||++|
T Consensus       227 ~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         227 R-IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             H-HHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            1 1111111110       000000000   0000000   01124578999999999999999999999988

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=1.1e-31  Score=277.46  Aligned_cols=267  Identities=24%  Similarity=0.329  Sum_probs=186.6

Q ss_pred             CCccceeeccCCcEEEEEEEEcccc-CCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEY-GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYC  350 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  350 (589)
                      +|++.+.||+|+||.||++.+.... +..++.|.+.     ..    .......+.+.+|+++++++ +||||+++++.+
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~-----~~----~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   71 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKIT-----NV----FSKKILAKRALRELKLLRHFRGHKNITCLYDMD   71 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEec-----cc----cccchhHHHHHHHHHHHHHhcCCCChheeeeee
Confidence            5888999999999999999986541 2222222111     00    00112234577899999999 599999999864


Q ss_pred             Ee-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          351 VE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       351 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ..     ...|+++|++. ++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+|
T Consensus        72 ~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gi---vH~dlkp~Nili~~~~~~k  145 (332)
T cd07857          72 IVFPGNFNELYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANV---LHRDLKPGNLLVNADCELK  145 (332)
T ss_pred             eeccccCCcEEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHeEEcCCCCEE
Confidence            31     24788999986 58999986543  48999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCC---CCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          426 VADFGLTKLTEVGSA---SLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       426 l~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      |+|||++........   .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....     .....
T Consensus       146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~-----~~~~~  220 (332)
T cd07857         146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY-----VDQLN  220 (332)
T ss_pred             eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH-----HHHHH
Confidence            999999975432221   11233578999999998754 5689999999999999999999998854321     11111


Q ss_pred             HHHHHhcCCChHHhhHhhcCC-----------CC---CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          502 LFEEVLNLPDPIEDLRKLVDP-----------RL---GDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       502 ~~~~~~~~~~~~~~l~~~~d~-----------~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .....+..+.. +.+..+..+           ..   .....+.....+.+++.+||+.||.+|||+++++.+
T Consensus       221 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         221 QILQVLGTPDE-ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHHhCCCCH-HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11111111110 001000000           00   000111224578999999999999999999999887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.7e-32  Score=267.25  Aligned_cols=243  Identities=27%  Similarity=0.389  Sum_probs=184.7

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcEEEE
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLV  358 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv  358 (589)
                      ||.|+||.||++.+..++ ..++.|.+..     ..   .........+..|++++++++||||+++++.+. ++..|++
T Consensus         1 lg~G~~~~v~~~~~~~~~-~~~~~k~~~~-----~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   71 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTG-KLYAMKVLKK-----KK---IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLV   71 (250)
T ss_pred             CCCCCceEEEEEEECCCC-cEEEEEEeeh-----hh---hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEE
Confidence            699999999999876542 2222222111     10   111123456788999999999999999998765 4568999


Q ss_pred             EEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccC
Q 037010          359 YEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG  438 (589)
Q Consensus       359 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~  438 (589)
                      |||+.+++|.+++....  .+++..+..++.|++.||.|||+.++   +|+||+|+||+++.++.++|+|||++......
T Consensus        72 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~---~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          72 LEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGI---IYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            99999999999998654  48999999999999999999999998   99999999999999999999999998765432


Q ss_pred             CCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHh
Q 037010          439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRK  518 (589)
Q Consensus       439 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  518 (589)
                      . .......++..|++||......++.++|+||||+++|+|++|+.||.....        .........          
T Consensus       147 ~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~----------  207 (250)
T cd05123         147 G-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK----------  207 (250)
T ss_pred             C-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc----------
Confidence            2 122345678899999999888889999999999999999999999843321        111111111          


Q ss_pred             hcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 037010          519 LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM---RSIVVA  560 (589)
Q Consensus       519 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~---~evl~~  560 (589)
                         ..  ...+...+..+.+++.+||..||++||++   +++++|
T Consensus       208 ---~~--~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         208 ---DP--LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             ---CC--CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence               00  11222334578999999999999999999   666554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.98  E-value=8.9e-32  Score=270.82  Aligned_cols=265  Identities=26%  Similarity=0.356  Sum_probs=188.6

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  352 (589)
                      |++.+.||+|++|.||+|....++. .++.|.+...         .......+.+..|++++++++|+|++++++++.+ 
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~-~~~iK~~~~~---------~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   70 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGE-IVALKKIRLD---------NEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE   70 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCc-EEEEEEeccc---------cccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC
Confidence            5677899999999999998766522 2222221110         0112223456789999999999999999997764 


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      +..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++++   +|+||+|+||++++++.++|+|||++
T Consensus        71 ~~~~~v~e~~~~-~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i---~H~~l~~~ni~~~~~~~~~l~d~g~~  145 (282)
T cd07829          71 RKLYLVFEYCDM-DLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRI---LHRDLKPQNILINRDGVLKLADFGLA  145 (282)
T ss_pred             CceEEEecCcCc-CHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChheEEEcCCCCEEEecCCcc
Confidence            568999999985 9999998753 348999999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      ........ ......++..|+|||.+... .++.++|||||||++|||++|+.||.....    ...+.. .......+.
T Consensus       146 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~-~~~~~~~~~  219 (282)
T cd07829         146 RAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE----IDQLFK-IFQILGTPT  219 (282)
T ss_pred             cccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH----HHHHHH-HHHHhCCCc
Confidence            76543221 22234567889999988766 789999999999999999999888843321    111111 111111111


Q ss_pred             hHHhhHhhc-----CCCCCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          512 PIEDLRKLV-----DPRLGD-------NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       512 ~~~~l~~~~-----d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      . .......     +.....       ...+.....+.+++.+||+.+|.+||++++++.|
T Consensus       220 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         220 E-ESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             H-HHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            1 0000000     000000       0011224579999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=289.70  Aligned_cols=256  Identities=24%  Similarity=0.388  Sum_probs=206.7

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      .+..++||+|+||+||+|.+--..++..+           ++++|.+    ..+...++++|.-+|.+++|||+++++++
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKi-----------pVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgv  766 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKI-----------PVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGV  766 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecc-----------eeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhh
Confidence            34568899999999999998765333221           3333333    34567889999999999999999999999


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      |....+-||++||++|+|.+|++... ..+-....+.|..|||+||.|||++.+   +||||-.+|+|+..-..+||.||
T Consensus       767 c~~s~~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrl---VHrdLaaRNVLVksP~hvkitdf  842 (1177)
T KOG1025|consen  767 CMLSTLQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRL---VHRDLAARNVLVKSPNHVKITDF  842 (1177)
T ss_pred             cccchHHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcch---hhhhhhhhheeecCCCeEEEEec
Confidence            99888899999999999999998754 358889999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcc-cccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHh
Q 037010          430 GLTKLTEVGSASLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       430 gla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |+++....+....... ..-.+.|||-|.+....|+.++|||||||++||++| |..|+....                 
T Consensus       843 gla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~-----------------  905 (1177)
T KOG1025|consen  843 GLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP-----------------  905 (1177)
T ss_pred             chhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC-----------------
Confidence            9999876555443322 233567999999999999999999999999999987 556663321                 


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                           .+++.+++...-+-..|+.+..++..++.+||-.|+..||+++++...+.+...
T Consensus       906 -----~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  906 -----AEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             -----HHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                 122333333333345677788889999999999999999999999999876654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=276.60  Aligned_cols=245  Identities=21%  Similarity=0.331  Sum_probs=189.0

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcE
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~  355 (589)
                      .+.||+|.||+||-|.++.++.... .|++..         .++.......+.+|+.||++++||.||.+.-.|+ .+.+
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVA-vKvIdK---------lrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv  638 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVA-VKVIDK---------LRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV  638 (888)
T ss_pred             HhhccCCcceeeecceecccCceee-eeeeec---------ccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence            4789999999999999887643222 222111         1222233467889999999999999999998775 5679


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC---CcEEEEeccCc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN---FHAKVADFGLT  432 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~---~~vkl~Dfgla  432 (589)
                      |+|||.+.| ++.+.|-.....++++.....++.||+.||+|||.++|   +|+||||+|||+...   ..+||||||+|
T Consensus       639 FVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knI---vHCDLKPENVLLas~~~FPQvKlCDFGfA  714 (888)
T KOG4236|consen  639 FVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNI---VHCDLKPENVLLASASPFPQVKLCDFGFA  714 (888)
T ss_pred             EEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcce---eeccCCchheeeccCCCCCceeeccccce
Confidence            999999965 77777777666679999999999999999999999999   999999999999643   47999999999


Q ss_pred             cccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH--HhcCC
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE--VLNLP  510 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  510 (589)
                      +.......  ....+|||.|+|||+++++.|...-|+||+||++|.-|+|..||..+++       +-+..+.  .+-.+
T Consensus       715 RiIgEksF--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQIQNAaFMyPp  785 (888)
T KOG4236|consen  715 RIIGEKSF--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQIQNAAFMYPP  785 (888)
T ss_pred             eecchhhh--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHhhccccccCC
Confidence            98754332  2447899999999999999999999999999999999999999944332       1111111  11111


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+                -.+......+||...|+..-.+|-|...-+.|
T Consensus       786 ~P----------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  786 NP----------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             Cc----------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            11                12334467899999999999999999876665

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=1.1e-31  Score=300.50  Aligned_cols=149  Identities=28%  Similarity=0.452  Sum_probs=121.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||.||+|.+..+.. .++.|.+..     .   ..........+..|++++..++||||+++++++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~-~vAiKvi~~-----~---~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   73 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSK-LYAVKVVKK-----A---DMINKNMVHQVQAERDALALSKSPFIVHLYYSL   73 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCc-EEEEEEEeh-----h---hccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE
Confidence            3689999999999999999999875422 222222110     0   011223345688899999999999999999877


Q ss_pred             E-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 V-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      . ++..|+||||+.+++|.+++....  .+++..++.++.||+.||+|||.+++   +||||||+|||++.++.+||+||
T Consensus        74 ~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gI---iHrDLKP~NILl~~~g~vkL~DF  148 (669)
T cd05610          74 QSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGI---IHRDLKPDNMLISNEGHIKLTDF  148 (669)
T ss_pred             EECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---EeCCccHHHEEEcCCCCEEEEeC
Confidence            6 456899999999999999997654  38889999999999999999999998   99999999999999999999999


Q ss_pred             cCcc
Q 037010          430 GLTK  433 (589)
Q Consensus       430 gla~  433 (589)
                      |+++
T Consensus       149 Gls~  152 (669)
T cd05610         149 GLSK  152 (669)
T ss_pred             CCCc
Confidence            9875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=8e-34  Score=263.84  Aligned_cols=253  Identities=22%  Similarity=0.324  Sum_probs=186.6

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHcc-CCCCcceeEee
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTH-VHHLNLVRLIG  348 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~-l~hpnIv~l~~  348 (589)
                      .+-+..||.|+||+|++..++..+.               ..|+|+++    ....++++.|.+...+ -+.||||++||
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~---------------~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG  130 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGK---------------LMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG  130 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCc---------------EEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence            3346779999999999988776532               22223221    2345678888887544 47999999999


Q ss_pred             EE-EeCcEEEEEEecCCCChHHHHh---cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          349 YC-VEGSLFLVYEYIENGNLSEHLR---GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       349 ~~-~~~~~~lv~e~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      .+ .++..|+.||+|+- ||..+..   ......+++...-.|....+.||.||...--  +||||+||+|||++..|.+
T Consensus       131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~v  207 (361)
T KOG1006|consen  131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDV  207 (361)
T ss_pred             hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCE
Confidence            55 57889999999976 7665443   2334458888888999999999999987532  3999999999999999999


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccC--CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      ||||||++-.....  -..+.-.|...|||||.+..  ..|+.+|||||||++|||+.||+.|+.       .|...++.
T Consensus       208 KLCDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr-------~w~svfeq  278 (361)
T KOG1006|consen  208 KLCDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR-------KWDSVFEQ  278 (361)
T ss_pred             eeecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc-------hHHHHHHH
Confidence            99999998654322  22244678999999998843  468999999999999999999999982       23445555


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ..++.....+.      +..   ..-..+....+.+++..|+.+|-.+||++.++..+-.
T Consensus       279 l~~Vv~gdpp~------l~~---~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f  329 (361)
T KOG1006|consen  279 LCQVVIGDPPI------LLF---DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF  329 (361)
T ss_pred             HHHHHcCCCCe------ecC---cccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence            55554432211      000   0111234568999999999999999999999987743

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=7.2e-32  Score=264.94  Aligned_cols=219  Identities=21%  Similarity=0.243  Sum_probs=165.5

Q ss_pred             CCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEEEEEEe
Q 037010          283 GGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEY  361 (589)
Q Consensus       283 G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~e~  361 (589)
                      |.+|.||++.+..++.. +              ++|......  .+.+|...+....||||+++++++.+ +..|++|||
T Consensus         4 g~~~~v~~~~~~~~~~~-~--------------~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   66 (237)
T cd05576           4 GVIDKVLLVMDTRTQQT-F--------------ILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQH   66 (237)
T ss_pred             cccceEEEEEEccCCcE-E--------------EEEeecchh--hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEec
Confidence            88999999998766332 2              222222111  12234444555679999999997764 568999999


Q ss_pred             cCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCC
Q 037010          362 IENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS  441 (589)
Q Consensus       362 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~  441 (589)
                      +++|+|.+++....  ++++..+..++.|++.||+|||++++   +||||||+||+++.++.++++|||.+.......  
T Consensus        67 ~~~~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~--  139 (237)
T cd05576          67 AEGGKLWSHISKFL--NIPEECVKRWAAEMVVALDALHREGI---VCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC--  139 (237)
T ss_pred             CCCCCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHEEEcCCCCEEEecccchhcccccc--
Confidence            99999999997654  38999999999999999999999998   999999999999999999999999876543221  


Q ss_pred             CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcC
Q 037010          442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVD  521 (589)
Q Consensus       442 ~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d  521 (589)
                        ....++..|+|||.+....++.++|+||+|+++|||++|+.|+......             . .         ....
T Consensus       140 --~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~-~---------~~~~  194 (237)
T cd05576         140 --DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------I-N---------THTT  194 (237)
T ss_pred             --ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------c-c---------cccc
Confidence              2234567899999998888999999999999999999999876321100             0 0         0000


Q ss_pred             CCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 037010          522 PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM  554 (589)
Q Consensus       522 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  554 (589)
                          ...+......+.+++.+||+.||.+||++
T Consensus       195 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         195 ----LNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             ----cCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence                01222334568999999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.3e-31  Score=292.64  Aligned_cols=267  Identities=19%  Similarity=0.260  Sum_probs=165.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee-
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG-  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-  348 (589)
                      ..++|++.++||+|+||.||+|.+..+..  ....         .+++|+.......+...+ +.+++..+.++..+.. 
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~--~~~~---------~vAvK~~~~~~~~e~~~~-e~l~~~~~~~~~~~~~~  197 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS--KKEG---------KYVLKKATEYGAVEIWMN-ERVRRACPNSCADFVYG  197 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCcc--ccCc---------EEEEEEecccchhHHHHH-HHHHhhchhhHHHHHHh
Confidence            45789999999999999999999876521  0011         222222221111111101 1112222222222221 


Q ss_pred             E------EEeCcEEEEEEecCCCChHHHHhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 037010          349 Y------CVEGSLFLVYEYIENGNLSEHLRGSGRD------------------PLPWSSRVQIALDSARGLEYIHEHTVP  404 (589)
Q Consensus       349 ~------~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~qia~aL~~LH~~~i~  404 (589)
                      +      ..++..++||||+.+++|.+++......                  ......+..++.|++.||+|||++++ 
T Consensus       198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI-  276 (566)
T PLN03225        198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI-  276 (566)
T ss_pred             hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE-
Confidence            1      1244689999999999999998754310                  01123456799999999999999998 


Q ss_pred             ceEeeccCCCcEEEcC-CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC----------------------
Q 037010          405 VYIHRDIKSANILIDK-NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG----------------------  461 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~-~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------  461 (589)
                        +||||||+|||++. ++.+||+|||+++..............+++.|+|||.+...                      
T Consensus       277 --iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~  354 (566)
T PLN03225        277 --VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL  354 (566)
T ss_pred             --EeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccc
Confidence              99999999999985 57999999999986554444444557889999999965322                      


Q ss_pred             CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCC------CChHHHHH
Q 037010          462 DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDN------CPLDSVLK  535 (589)
Q Consensus       462 ~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~------~~~~~~~~  535 (589)
                      .++.++|||||||++|||+++..++..         ........+.........+.....+.....      ........
T Consensus       355 ~~~~k~DVwSlGviL~el~~~~~~~~~---------~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  425 (566)
T PLN03225        355 NLPDRFDIYSAGLIFLQMAFPNLRSDS---------NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA  425 (566)
T ss_pred             cCCCCcccHHHHHHHHHHHhCcCCCch---------HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence            234467999999999999987654311         111111111111111112222222211000      00001123


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          536 MAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       536 l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..+|+.+||+.||++|||++|+++|
T Consensus       426 ~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        426 GWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhCC
Confidence            5689999999999999999999998

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.7e-33  Score=254.63  Aligned_cols=267  Identities=26%  Similarity=0.366  Sum_probs=189.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-----HHHHHHHHHHHHHHccCCCCccee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-----~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      ...|+-..+||+|.||.||+|+...+..               ++++|+.-     ..-....++|+++|..++|+|++.
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~k---------------kvalkkvlmeneKeGfpitalreikiL~~lkHenv~n   80 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGK---------------KVALKKVLMENEKEGFPITALREIKILQLLKHENVVN   80 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccc---------------hhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHH
Confidence            3456778899999999999998766532               22332221     112234678999999999999999


Q ss_pred             EeeEEEe---------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcE
Q 037010          346 LIGYCVE---------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI  416 (589)
Q Consensus       346 l~~~~~~---------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NI  416 (589)
                      +++.|..         ..+|+||.+|+. +|...+..... .++..++.+++.++..||.|+|...+   +|||+|++|+
T Consensus        81 liEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~v-r~sls~Ikk~Mk~Lm~GL~~iHr~ki---lHRDmKaaNv  155 (376)
T KOG0669|consen   81 LIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKV-RFSLSEIKKVMKGLMNGLYYIHRNKI---LHRDMKAANV  155 (376)
T ss_pred             HHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccc-cccHHHHHHHHHHHHHHHHHHHHhhH---HhhcccHhhE
Confidence            9987741         238999999998 88888876533 49999999999999999999999998   9999999999


Q ss_pred             EEcCCCcEEEEeccCccccccCCC---CCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCC
Q 037010          417 LIDKNFHAKVADFGLTKLTEVGSA---SLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGS  492 (589)
Q Consensus       417 Ll~~~~~vkl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~  492 (589)
                      ||+.+|.+||+|||+++.+.....   ...+..+.|.+|++||.+.+ ..|+++.|||.-||++.||.|+.+.+......
T Consensus       156 LIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq  235 (376)
T KOG0669|consen  156 LITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ  235 (376)
T ss_pred             EEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence            999999999999999976543322   23455678999999998765 57999999999999999999998776543221


Q ss_pred             C----------------CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 037010          493 S----------------ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS  556 (589)
Q Consensus       493 ~----------------~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  556 (589)
                      .                +.......+++.+.-.|.+....+++-+ .+. .+  --.....+|+..++..||.+|+.+.+
T Consensus       236 qql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n-~~k-p~--~kd~~a~dLle~ll~~DP~kR~~ad~  311 (376)
T KOG0669|consen  236 QQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKN-RLK-PY--VKDDEALDLLEKLLKLDPTKRIDADQ  311 (376)
T ss_pred             HHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhh-hcc-cc--cCChhHHHHHHHHhccCcccCcchHh
Confidence            0                0000111111111111111111111100 000 00  01125788999999999999999999


Q ss_pred             HHHHH
Q 037010          557 IVVAL  561 (589)
Q Consensus       557 vl~~L  561 (589)
                      ++.|-
T Consensus       312 alnh~  316 (376)
T KOG0669|consen  312 ALNHD  316 (376)
T ss_pred             hhchh
Confidence            99884

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=290.76  Aligned_cols=262  Identities=28%  Similarity=0.434  Sum_probs=200.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCc-cchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccC-CCCcce
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNS-YLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHV-HHLNLV  344 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~-~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l-~hpnIv  344 (589)
                      .++..+.+.||+|.||.|++|...+..... ....         .+++|..+    ....+.+..|+++|+.+ +|+||+
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~---------~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYV---------TVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             hhhccccceeecccccceEeEEEeecccccccceE---------EEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchh
Confidence            344566779999999999999877643322 1111         23333332    24456789999999999 599999


Q ss_pred             eEeeEEEe-CcEEEEEEecCCCChHHHHhcCC------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEee
Q 037010          345 RLIGYCVE-GSLFLVYEYIENGNLSEHLRGSG------R--------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHR  409 (589)
Q Consensus       345 ~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~------~--------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~  409 (589)
                      .++|.|.+ +.+++|+||+..|+|.+|++...      .        ..+.....+.++.|||.|++||++..+   |||
T Consensus       366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~---vHR  442 (609)
T KOG0200|consen  366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC---VHR  442 (609)
T ss_pred             hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc---cch
Confidence            99999876 66999999999999999998765      0        138888999999999999999999998   999


Q ss_pred             ccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccc--cCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCc-cc
Q 037010          410 DIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV--GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKE-AI  486 (589)
Q Consensus       410 Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~-p~  486 (589)
                      ||-.+|||+.++..+||+|||+++..............  -...|||||.+....|+.++|||||||+|||++|... |+
T Consensus       443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY  522 (609)
T KOG0200|consen  443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY  522 (609)
T ss_pred             hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence            99999999999999999999999854433322212122  2446999999999999999999999999999998554 44


Q ss_pred             ccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                       ++..      .              ..++.+.+....+...|..+..++.++++.||+.+|++||++.|+.+.+....
T Consensus       523 -p~~~------~--------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  523 -PGIP------P--------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             -CCCC------c--------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence             2210      0              11122233333344556666778999999999999999999999999998853

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-32  Score=269.24  Aligned_cols=264  Identities=24%  Similarity=0.367  Sum_probs=192.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhH-hHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQ-KAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      .++|-++++||+|||+.||+|.+....      ++++++.... +-.-...+....+...+|.+|-+.|.||.||++|++
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~Eq------RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQ------RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchh------heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            368999999999999999999876542      2222221111 111111122344667889999999999999999998


Q ss_pred             EE--eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC---CCcE
Q 037010          350 CV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---NFHA  424 (589)
Q Consensus       350 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~---~~~v  424 (589)
                      +.  .+.++-|+|||+|.+|.-|+.....  +++.+++.|+.||+.||.||.+.. ++|||-||||.|||+..   -|.+
T Consensus       536 fslDtdsFCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  536 FSLDTDSFCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             eeeccccceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccccee
Confidence            85  3568899999999999989877654  899999999999999999999998 68899999999999943   4789


Q ss_pred             EEEeccCccccccCCCC------CCcccccCCCCCchhccc----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCC
Q 037010          425 KVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQ----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA  494 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~  494 (589)
                      ||+|||+++.+..+...      ......||.+|++||.+-    ...++.++||||+||++|+.+.|+.||.....   
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---  689 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---  689 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---
Confidence            99999999987654332      334468999999999663    23578899999999999999999999944322   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                          ..+.+++..        +.+...-.+  ...+....+...+|++||+.--++|....++..+
T Consensus       690 ----QQdILqeNT--------IlkAtEVqF--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  690 ----QQDILQENT--------ILKATEVQF--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             ----HHHHHhhhc--------hhcceeccC--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence                111111110        000000011  0112233467899999999999999888777654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.6e-30  Score=277.40  Aligned_cols=279  Identities=18%  Similarity=0.242  Sum_probs=175.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchh-hhhhhhhhHhHHHhhcCH-----------------HHHHHHHHH
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSR-LICVNLLMQKAAIKKMDM-----------------QASREFLAE  331 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~-~~~~~~~~~~~~ik~~~~-----------------~~~~~~~~E  331 (589)
                      ..++|++.++||+|+||.||+|.+..........+ ..........+++|++..                 ...+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            36789999999999999999997643322111000 000000011223332211                 011223457


Q ss_pred             HHHHccCCCCcc-----eeEeeEEE---------eCcEEEEEEecCCCChHHHHhcCCC---------------------
Q 037010          332 LKVLTHVHHLNL-----VRLIGYCV---------EGSLFLVYEYIENGNLSEHLRGSGR---------------------  376 (589)
Q Consensus       332 ~~il~~l~hpnI-----v~l~~~~~---------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------  376 (589)
                      +.++.+++|.++     +++++++.         ++..|+||||+.+++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766554     56666653         3458999999999999999864311                     


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCch
Q 037010          377 -DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP  455 (589)
Q Consensus       377 -~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aP  455 (589)
                       ..+++..++.++.|++.+|.|||++++   +||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~i---vHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGI---VHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence             124667788999999999999999998   9999999999999999999999999875433222222223458899999


Q ss_pred             hcccCCCC----------------------CcccchhhHHHHHHHHHcCCc-ccccCCCCCCChhhHHHHHHHHhcCCCh
Q 037010          456 EYAQYGDV----------------------SPKVDVYAFGVVLYELISAKE-AIVKGNGSSADSKGLVALFEEVLNLPDP  512 (589)
Q Consensus       456 E~~~~~~~----------------------s~~sDvwSlGvll~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (589)
                      |.+.....                      ..+.||||+||++|+|++|.. |+.....-.       .....   ....
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~-------~~~~~---~~~~  449 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN-------TELRQ---YDND  449 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh-------hHHhh---ccch
Confidence            98753221                      124799999999999999875 552211000       00000   0000


Q ss_pred             HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHH
Q 037010          513 IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP---QLRPSMRSIVVAL  561 (589)
Q Consensus       513 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~L  561 (589)
                      ....+........-...........+|+.++|..+|   .+|+|++|+++|-
T Consensus       450 ~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        450 LNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             HHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence            011111111111111112234578899999999866   6899999999884

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-31  Score=237.58  Aligned_cols=217  Identities=23%  Similarity=0.355  Sum_probs=164.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee-
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG-  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~-  348 (589)
                      .+....++.||+|+||.|-+.++...+ ...+.|.+.          ..++.+..++.++|+++..+. .+|.+|++|| 
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg-~imAvKri~----------~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa  113 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSG-TIMAVKRIR----------ATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA  113 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCC-eEEEEeeeh----------hhcChHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence            344556788999999999888776542 222222111          123345566788899986655 7999999998 


Q ss_pred             EEEeCcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          349 YCVEGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       349 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++.++.+|+.||.|+. ||..|..+-  .+..+++..+-+|+..+..||.|||++--  ++|||+||+|||++.+|++|+
T Consensus       114 ~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKi  190 (282)
T KOG0984|consen  114 LFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKI  190 (282)
T ss_pred             hhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEE
Confidence            6678899999999976 888877542  23458999999999999999999999842  499999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhccc----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      ||||.+-.......  .+-..|...|||||.+.    ...|+.++||||||+++.||.+++.||..       |..-+.+
T Consensus       191 CDFGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~-------w~tpF~q  261 (282)
T KOG0984|consen  191 CDFGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES-------WGTPFQQ  261 (282)
T ss_pred             cccccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc-------cCCHHHH
Confidence            99999876543221  23356888999999874    34799999999999999999999999843       2333445


Q ss_pred             HHHHhcCC
Q 037010          503 FEEVLNLP  510 (589)
Q Consensus       503 ~~~~~~~~  510 (589)
                      +.++...+
T Consensus       262 LkqvVeep  269 (282)
T KOG0984|consen  262 LKQVVEEP  269 (282)
T ss_pred             HHHHhcCC
Confidence            55555443

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.7e-30  Score=262.94  Aligned_cols=205  Identities=27%  Similarity=0.381  Sum_probs=164.6

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE-E
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC-V  351 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~  351 (589)
                      -|..++.||-|+||.|.+++-.++ .     ..++-+.+.++-.++   ......+..|-+||..-..+-||++|-.| +
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT-~-----~lYAmKTLrKaDVl~---rnQvaHVKAERDILAEADn~WVVrLyySFQD  700 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDT-R-----ALYAMKTLRKADVLM---RNQVAHVKAERDILAEADNEWVVRLYYSFQD  700 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecch-h-----hHHHHhhhHHHHHHh---hhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence            477889999999999999986555 2     223333333222222   23344577799999999999999998644 4


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ++.+|+||+|++||++-.+|...+-  |++..++.++.++..|+++.|..|+   |||||||+|||||.+|++||+|||+
T Consensus       701 kdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmGF---IHRDiKPDNILIDrdGHIKLTDFGL  775 (1034)
T KOG0608|consen  701 KDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGL  775 (1034)
T ss_pred             CCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhccc---eecccCccceEEccCCceeeeeccc
Confidence            6779999999999999999987764  8889999999999999999999998   9999999999999999999999999


Q ss_pred             cccccc---------CCCCC--------------------------------CcccccCCCCCchhcccCCCCCcccchh
Q 037010          432 TKLTEV---------GSASL--------------------------------PTRLVGTFGYMPPEYAQYGDVSPKVDVY  470 (589)
Q Consensus       432 a~~~~~---------~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~s~~sDvw  470 (589)
                      +.-+.-         +...+                                .-..+||+.|+|||++....|+..+|.|
T Consensus       776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww  855 (1034)
T KOG0608|consen  776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW  855 (1034)
T ss_pred             cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence            863321         11000                                0113799999999999999999999999


Q ss_pred             hHHHHHHHHHcCCcccccCCC
Q 037010          471 AFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       471 SlGvll~elltG~~p~~~~~~  491 (589)
                      |.||+||||+.|+.||.....
T Consensus       856 s~gvil~em~~g~~pf~~~tp  876 (1034)
T KOG0608|consen  856 SVGVILYEMLVGQPPFLADTP  876 (1034)
T ss_pred             HhhHHHHHHhhCCCCccCCCC
Confidence            999999999999999976544

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=248.56  Aligned_cols=251  Identities=24%  Similarity=0.415  Sum_probs=189.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      ..+|++++.||+|+|++|.++++..+. ..++.|++....+        ...++.+-++.|-.+..+. +||.+|.++..
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~-qiyamkvvkkel~--------nddedidwvqtek~vfe~asn~pflvglhsc  319 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTD-QIYAMKVVKKELV--------NDDEDIDWVQTEKHVFEQASNNPFLVGLHSC  319 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccc-eeeehhhHHHHhc--------CCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence            478999999999999999999887652 2222222111110        1123334455676666655 69999999986


Q ss_pred             EE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +. +..+++|.||++||+|--+++.+..  ++++.++.+...|..||.|||++||   |.||||.+|+|+|..|++||+|
T Consensus       320 fqtesrlffvieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~rgi---iyrdlkldnvlldaeghikltd  394 (593)
T KOG0695|consen  320 FQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHERGI---IYRDLKLDNVLLDAEGHIKLTD  394 (593)
T ss_pred             hcccceEEEEEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhcCe---eeeeccccceEEccCCceeecc
Confidence            54 6779999999999999888876654  9999999999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccC--CCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG--NGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~--~~~~~~~~~~~~~~~~~  506 (589)
                      +|+.+.- ........+++|||.|.|||.+++..|....|.|+|||+++||+.|+.||.--  ..+..+.+.  .+++-+
T Consensus       395 ygmcke~-l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nted--ylfqvi  471 (593)
T KOG0695|consen  395 YGMCKEG-LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED--YLFQVI  471 (593)
T ss_pred             cchhhcC-CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhH--HHHHHH
Confidence            9998743 23344556789999999999999999999999999999999999999999532  222222221  122222


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS  553 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs  553 (589)
                      ++             ..+  ++|...+.....+++.-|.+||.+|.-
T Consensus       472 le-------------kqi--riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  472 LE-------------KQI--RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             hh-------------hcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence            22             111  234444456678889999999999853

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=279.11  Aligned_cols=261  Identities=24%  Similarity=0.337  Sum_probs=195.8

Q ss_pred             CccceeeccCCcEE-EEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEEE
Q 037010          274 FSMSHKIGQGGFGA-VYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCV  351 (589)
Q Consensus       274 y~~~~~LG~G~~g~-Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~  351 (589)
                      |.-.+.+|.|+-|+ ||+|...+.                 .+|+|++-.+......+|+..|+.- .|||||++++...
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R-----------------~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~  573 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGR-----------------EVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQ  573 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCc-----------------eehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeecc
Confidence            33457789999875 899988765                 7888888888777888999999988 5999999998776


Q ss_pred             eC-cEEEEEEecCCCChHHHHhcCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC---C--Cc
Q 037010          352 EG-SLFLVYEYIENGNLSEHLRGSGRD--PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---N--FH  423 (589)
Q Consensus       352 ~~-~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~---~--~~  423 (589)
                      +. ..||+.|.|.. +|.+++......  .......+..+.|+++||+|||+.++   |||||||.||||+.   +  .+
T Consensus       574 d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~i---VHRDLkPQNILI~~~~~~~~~r  649 (903)
T KOG1027|consen  574 DRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKI---VHRDLKPQNILISVPSADGTLR  649 (903)
T ss_pred             CCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhccc---ccccCCCceEEEEccCCCccee
Confidence            54 58999999987 999999874111  11113457788899999999999998   99999999999965   2  57


Q ss_pred             EEEEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcC-CcccccCCCCCCChhhHH
Q 037010          424 AKVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA-KEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG-~~p~~~~~~~~~~~~~~~  500 (589)
                      ++|+|||+++....+...  ......||-+|+|||++....-+.++|||||||++|+.++| .+||...-.         
T Consensus       650 a~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~---------  720 (903)
T KOG1027|consen  650 AKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE---------  720 (903)
T ss_pred             EEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH---------
Confidence            899999999987665443  23456899999999999988888899999999999999988 788843211         


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH---------HHhcccccccc
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA---------LMTLSSTTEDW  571 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~---------L~~l~~~~~~~  571 (589)
                       .-..++....   .+.. +      ....++  +..+||.+|+..+|..||++.+|+.|         |+.++..+...
T Consensus       721 -R~~NIl~~~~---~L~~-L------~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRv  787 (903)
T KOG1027|consen  721 -RQANILTGNY---TLVH-L------EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRV  787 (903)
T ss_pred             -hhhhhhcCcc---ceee-e------ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhh
Confidence             0001111000   0000 0      011111  67899999999999999999999988         66666666655


Q ss_pred             cCCCcc
Q 037010          572 DVGSFY  577 (589)
Q Consensus       572 ~~~~~~  577 (589)
                      |.....
T Consensus       788 E~e~r~  793 (903)
T KOG1027|consen  788 EKENRD  793 (903)
T ss_pred             hhhhcc
Confidence            554443

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-30  Score=256.96  Aligned_cols=268  Identities=22%  Similarity=0.297  Sum_probs=198.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCC-----C---
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVH-----H---  340 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~-----h---  340 (589)
                      ..+|.+.++||.|.|++||+|.+.....               .+|+|..+  ....+..+.|+++|++++     |   
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r---------------~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~  141 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKR---------------YVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGK  141 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCe---------------EEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence            3789999999999999999998876521               23333322  234456778999999883     3   


Q ss_pred             CcceeEeeEEEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          341 LNLVRLIGYCVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       341 pnIv~l~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      .+||+++++|..     .+++||||++ |.+|..+|.....+.++...+++|++||+.||.|||.+.-  |||.||||+|
T Consensus       142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPEN  218 (590)
T KOG1290|consen  142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPEN  218 (590)
T ss_pred             ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcce
Confidence            369999998752     3599999999 6699999999888889999999999999999999998753  4999999999


Q ss_pred             EEEc----------------------------------------------------------------------------
Q 037010          416 ILID----------------------------------------------------------------------------  419 (589)
Q Consensus       416 ILl~----------------------------------------------------------------------------  419 (589)
                      ||+.                                                                            
T Consensus       219 vLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~  298 (590)
T KOG1290|consen  219 VLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEP  298 (590)
T ss_pred             eeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccc
Confidence            9983                                                                            


Q ss_pred             --------------------------------------C-----------------------------------------
Q 037010          420 --------------------------------------K-----------------------------------------  420 (589)
Q Consensus       420 --------------------------------------~-----------------------------------------  420 (589)
                                                            .                                         
T Consensus       299 ~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~  378 (590)
T KOG1290|consen  299 NQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNP  378 (590)
T ss_pred             cccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccc
Confidence                                                  0                                         


Q ss_pred             -----------CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccC
Q 037010          421 -----------NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG  489 (589)
Q Consensus       421 -----------~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~  489 (589)
                                 +.++||+|||-|+.....    .+.-+.|..|+|||++.+..|+..+||||++|++|||.||...|.+.
T Consensus       379 ~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePh  454 (590)
T KOG1290|consen  379 LVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPH  454 (590)
T ss_pred             ccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCC
Confidence                       002566666666653221    22345688899999999999999999999999999999999999776


Q ss_pred             CCCCC-ChhhHHHHHHHHhcCCChHH-----hhHhhcCCC--------C-----------CCCCChHHHHHHHHHHHHhc
Q 037010          490 NGSSA-DSKGLVALFEEVLNLPDPIE-----DLRKLVDPR--------L-----------GDNCPLDSVLKMAQLAKVCT  544 (589)
Q Consensus       490 ~~~~~-~~~~~~~~~~~~~~~~~~~~-----~l~~~~d~~--------l-----------~~~~~~~~~~~l~~li~~cl  544 (589)
                      .+... ......+.+-+.+..-++.-     --+.+++..        +           .-..+.+.+.++.+|+.-||
T Consensus       455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL  534 (590)
T KOG1290|consen  455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPML  534 (590)
T ss_pred             CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence            55332 23344444444433222110     011111110        0           01356788899999999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 037010          545 QEYPQLRPSMRSIVVA  560 (589)
Q Consensus       545 ~~dP~~RPs~~evl~~  560 (589)
                      +.+|++|||+.+.++|
T Consensus       535 ef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  535 EFDPEKRPTAAQCLKH  550 (590)
T ss_pred             hcCccccccHHHHhcC
Confidence            9999999999999988

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=1.1e-30  Score=237.86  Aligned_cols=262  Identities=19%  Similarity=0.337  Sum_probs=192.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~  348 (589)
                      ..++|++.+++|+|.|+.||.|..-.+.               ++..+|.++.-..+.+.+|+.||+.|. ||||+++++
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~---------------eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~D  100 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNN---------------EKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLD  100 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCC---------------ceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhh
Confidence            4578999999999999999999754442               244455555555667888999999996 999999999


Q ss_pred             EEEeC---cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC-CcE
Q 037010          349 YCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHA  424 (589)
Q Consensus       349 ~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~-~~v  424 (589)
                      ...+.   ...|+|||+++.+.......     ++...++..+.+++.||.|+|++||   +|||+||.|+++|.. -.+
T Consensus       101 iV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GI---mHRDVKPhNvmIdh~~rkL  172 (338)
T KOG0668|consen  101 IVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGI---MHRDVKPHNVMIDHELRKL  172 (338)
T ss_pred             hhcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCc---ccccCCcceeeechhhcee
Confidence            87643   37799999999777665432     7777889999999999999999999   999999999999865 468


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcc-cCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH-
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL-  502 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~-  502 (589)
                      +|+|+|+|.+...+..-  .-.+.+..|--||.+ ....|+.+-|+|||||++..|+..+.||..+.+...+...+... 
T Consensus       173 rlIDWGLAEFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL  250 (338)
T KOG0668|consen  173 RLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL  250 (338)
T ss_pred             eeeecchHhhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence            99999999977544321  224567778999987 45678999999999999999999999998776543322111111 


Q ss_pred             --------HHH-HhcCCChHHh---------hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 --------FEE-VLNLPDPIED---------LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 --------~~~-~~~~~~~~~~---------l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                              ... .+..+...++         ..+.+.+.-..-.    ..+..+|+...|..|-++|||++|.+.|
T Consensus       251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~----~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  251 GTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLV----SPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccC----ChHHHHHHHHHHhhccccccchHHHhcC
Confidence                    110 0111111111         1111111111111    2367899999999999999999999987

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-30  Score=242.00  Aligned_cols=259  Identities=23%  Similarity=0.350  Sum_probs=193.4

Q ss_pred             cceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-----HHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       276 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-----~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      -.+.||.|+||.||.+.+..++.               .++.|++.     ....+++.+|+++|.-++|.|++..+++.
T Consensus        57 PDRPIGYGAFGVVWsVTDPRdgr---------------rvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDIL  121 (449)
T KOG0664|consen   57 PDRPIGYGAFGVVWSVTDPRSGK---------------RVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDIL  121 (449)
T ss_pred             CCCcccccceeEEEeccCCCCcc---------------chhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhc
Confidence            34789999999999998766532               23333332     23456788999999999999999998876


Q ss_pred             EeC------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          351 VEG------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       351 ~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      ...      ++|++.|.|.. +|.+.|....  +++...++-+++||++||.|||+.+|   +||||||.|.|++.+..+
T Consensus       122 QPph~dfFqEiYV~TELmQS-DLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~I---LHRDIKPGNLLVNSNCvL  195 (449)
T KOG0664|consen  122 QPANPSFFQELYVLTELMQS-DLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANI---LHRDIKPGNLLVNSNCIL  195 (449)
T ss_pred             CCCCchHHHHHHHHHHHHHh-hhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcch---hhccCCCccEEeccCceE
Confidence            532      36889999965 8888876543  48888999999999999999999999   999999999999999999


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      ||+|||+++..+.+.....+..+-|..|+|||.+.+. .|+.+.||||+||++.|||..+..|...++     ....++.
T Consensus       196 KICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-----iqQL~lI  270 (449)
T KOG0664|consen  196 KICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-----IEQLQMI  270 (449)
T ss_pred             EecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-----HHHHHHH
Confidence            9999999998776665555667789999999999765 689999999999999999987777754332     1233333


Q ss_pred             HHHhcCCChHHhh--------HhhcCCCC-----CC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          504 EEVLNLPDPIEDL--------RKLVDPRL-----GD----NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       504 ~~~~~~~~~~~~l--------~~~~d~~l-----~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+.+..+.. +..        ..+++...     ..    .-+.+.-.+...+...++..||.+|.+.++.+.|+
T Consensus       271 tdLLGTPs~-EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  271 IDLLGTPSQ-EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HHHhCCCcH-HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            444443321 111        11221111     00    11223334667788899999999999999998885

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=2.2e-29  Score=246.49  Aligned_cols=239  Identities=31%  Similarity=0.459  Sum_probs=180.8

Q ss_pred             CcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-CcEEEEEEec
Q 037010          284 GFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYI  362 (589)
Q Consensus       284 ~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~e~~  362 (589)
                      +||.||+|.+.+++ ...+.|.....         . .....+.+.+|++.+++++|+|++++++++.. ...+++||++
T Consensus         1 ~~g~v~~~~~~~~~-~~~~~k~~~~~---------~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   69 (244)
T smart00220        1 SFGKVYLARDKKTG-KLVAIKVIKKE---------K-IKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYC   69 (244)
T ss_pred             CceEEEEEEECCCC-cEEEEEEeccc---------c-cccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCC
Confidence            58999999887642 22222211110         0 00114678889999999999999999998765 5689999999


Q ss_pred             CCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCC
Q 037010          363 ENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL  442 (589)
Q Consensus       363 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~  442 (589)
                      .+++|.+++.....  +++..++.++.+++.++.+||+.++   +|+||+|+||+++.++.++|+|||.+.......  .
T Consensus        70 ~~~~L~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~i---~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~  142 (244)
T smart00220       70 DGGDLFDLLKKRGR--LSEDEARFYARQILSALEYLHSNGI---IHRDLKPENILLDEDGHVKLADFGLARQLDPGG--L  142 (244)
T ss_pred             CCCCHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcCe---ecCCcCHHHeEECCCCcEEEccccceeeecccc--c
Confidence            99999999976543  8899999999999999999999998   999999999999999999999999988654332  2


Q ss_pred             CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCC
Q 037010          443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDP  522 (589)
Q Consensus       443 ~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~  522 (589)
                      .....++..|++||.+....++.++||||||+++|+|++|..||.....    ....   ......             .
T Consensus       143 ~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~~~~---~~~~~~-------------~  202 (244)
T smart00220      143 LTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----LLEL---FKKIGK-------------P  202 (244)
T ss_pred             cccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----HHHH---HHHHhc-------------c
Confidence            2345688899999999888899999999999999999999999844211    1111   111110             0


Q ss_pred             CCCCCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          523 RLGDNCPL-DSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       523 ~l~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ........ ..+..+.+++.+||..+|++||++.+++++
T Consensus       203 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      203 KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             CCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            00000000 034578999999999999999999999874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=4.6e-29  Score=253.92  Aligned_cols=206  Identities=21%  Similarity=0.386  Sum_probs=163.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC---CCcceeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH---HLNLVRL  346 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~---hpnIv~l  346 (589)
                      ...+|...+.||+|+||.|++|.++.. ....+.|.+...+....-.+   +....-.+-.|+.||..++   |+||+++
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n-~~eVViK~I~KeRIL~DtWv---rDrkLGtVp~EIqIla~l~~~sH~NIlKl  634 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKEN-NYEVVIKMIFKERILVDTWV---RDRKLGTVPSEIQILATLNKHSHENILKL  634 (772)
T ss_pred             ccccceeeeeccccccceEEEeeeccc-ceEEEeeehhhhhhhhhhhh---cccccCccchhHHHHHHhhhcCccchhhh
Confidence            346799999999999999999998876 22223333222211111111   1111122445899998886   9999999


Q ss_pred             eeEEEeC-cEEEEEEec-CCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          347 IGYCVEG-SLFLVYEYI-ENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       347 ~~~~~~~-~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      ++|++++ .+||+||.. +|-+|+++|...++  +.+.++..|+.|++.|++|||++||   ||||||-+|+.++.+|-+
T Consensus       635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~i---vhrdikdenvivd~~g~~  709 (772)
T KOG1152|consen  635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQGI---VHRDIKDENVIVDSNGFV  709 (772)
T ss_pred             hheeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccCc---eecccccccEEEecCCeE
Confidence            9999865 578999875 35699999998776  8999999999999999999999999   999999999999999999


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCC-cccchhhHHHHHHHHHcCCcccc
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISAKEAIV  487 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSlGvll~elltG~~p~~  487 (589)
                      ||+|||.+.....+   ....++||..|.|||++.+..|- ..-|||++|++||.++....||.
T Consensus       710 klidfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  710 KLIDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEeeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999998865433   34558999999999999988774 56899999999999999888874

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-29  Score=259.75  Aligned_cols=252  Identities=23%  Similarity=0.383  Sum_probs=192.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH---HHHHHHHHHHHHHccCCCCcceeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM---QASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~---~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      -.++|++..++|.|.||.||++++..+.+               ..++|.++.   ....-+++|+-+++..+||||+.+
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~e---------------laavkvVkLep~dd~~~iqqei~~~~dc~h~nivay   77 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGE---------------LAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAY   77 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCc---------------hhhheeeeccCCccccccccceeeeecCCCcChHHH
Confidence            35789999999999999999998776522               333443332   344556789999999999999999


Q ss_pred             eeEE-EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++.+ ..+.+|++||||.||+|.+..+-.  .++++.++...++..++||+|||++|-   +|||||-.|||+++.|.+|
T Consensus        78 ~gsylr~dklwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk---~hRdiKGanilltd~gDvk  152 (829)
T KOG0576|consen   78 FGSYLRRDKLWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGK---IHRDIKGANILLTDEGDVK  152 (829)
T ss_pred             HhhhhhhcCcEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCc---ccccccccceeecccCcee
Confidence            9855 577899999999999999976543  469999999999999999999999998   8999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcc---cCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA---QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      ++|||.+-...... .+...+.||+.|||||+.   +.+.|...+|||++|++..|+---+.|...-..           
T Consensus       153 laDfgvsaqitati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp-----------  220 (829)
T KOG0576|consen  153 LADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP-----------  220 (829)
T ss_pred             ecccCchhhhhhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch-----------
Confidence            99999887554322 233458999999999976   567899999999999999999776666422111           


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ++..+-+.      ....+|-- -..+..-...+.+|++.|+.++|++|||++-+++|
T Consensus       221 mr~l~LmT------kS~~qpp~-lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  221 MRALFLMT------KSGFQPPT-LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             HHHHHHhh------ccCCCCCc-ccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            11100000      01111110 11122334578999999999999999999988776

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-28  Score=231.43  Aligned_cols=264  Identities=21%  Similarity=0.270  Sum_probs=186.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|.-++.+|.|.- .|-.+.+.-...      .+++++....    .......++..+|..++..+.|+||++++.++
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~------~v~ikk~~~p----f~n~~~akra~rel~l~~~v~~~nii~l~n~f   84 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGR------PVAIKKLSRP----FQNQTHAKRAYRELKLMKCVNHKNIISLLNVF   84 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccC------ceehhhhcCc----cccCccchhhhhhhhhhhhhcccceeeeeecc
Confidence            456777788888887 555554332211      1111111111    11122345677899999999999999999987


Q ss_pred             Ee-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          351 VE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       351 ~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      ..       .++|+|||+|.. +|.+.+...    ++-..+..++.|++.|++|||+.||   +||||||+||++..++.
T Consensus        85 tP~~~l~~~~e~y~v~e~m~~-nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~~I---ihRdLkPsnivv~~~~~  156 (369)
T KOG0665|consen   85 TPQKTLEEFQEVYLVMELMDA-NLCQVILME----LDHETISYILYQMLCGIKHLHSAGI---IHRDLKPSNIVVNSDCT  156 (369)
T ss_pred             CccccHHHHHhHHHHHHhhhh-HHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhcce---eecccCcccceecchhh
Confidence            52       248999999976 999988732    6677889999999999999999999   99999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +||.|||++......  -..+.++.|..|.|||++.+-.+...+||||+||++.||++|+..|.+... ...+....   
T Consensus       157 lKi~dfg~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~-idQ~~ki~---  230 (369)
T KOG0665|consen  157 LKILDFGLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDH-IDQWNKII---  230 (369)
T ss_pred             eeeccchhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchH-HHHHHHHH---
Confidence            999999999876543  355778899999999999888899999999999999999999988753221 11111111   


Q ss_pred             HHHhcCCCh--HHh-------------------hH-hhcCCCCCC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 037010          504 EEVLNLPDP--IED-------------------LR-KLVDPRLGD--NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV  559 (589)
Q Consensus       504 ~~~~~~~~~--~~~-------------------l~-~~~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  559 (589)
                       +.++.+++  .++                   +. ...|.....  .-+.-......+++.+||..||++|.|++++|+
T Consensus       231 -~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  231 -EQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             -HHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence             11111110  000                   00 011111110  011123346789999999999999999999999


Q ss_pred             H
Q 037010          560 A  560 (589)
Q Consensus       560 ~  560 (589)
                      |
T Consensus       310 H  310 (369)
T KOG0665|consen  310 H  310 (369)
T ss_pred             C
Confidence            8

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=8.5e-27  Score=222.44  Aligned_cols=208  Identities=39%  Similarity=0.642  Sum_probs=172.5

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH----HHHHHHHHHHHHccCCCCcceeEeeEEEe-Cc
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ----ASREFLAELKVLTHVHHLNLVRLIGYCVE-GS  354 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  354 (589)
                      ||+|++|.||++...++ +...              ++|.....    ..+.+.+|++.++.++|++++++++++.. ..
T Consensus         1 l~~g~~~~v~~~~~~~~-~~~~--------------~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~   65 (215)
T cd00180           1 LGEGGFGTVYLARDKKT-GKKV--------------AIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENH   65 (215)
T ss_pred             CCcCCceEEEEEEecCC-CcEE--------------EEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe
Confidence            68999999999988653 2222              22222221    23568889999999999999999998875 56


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-CCcEEEEeccCcc
Q 037010          355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-NFHAKVADFGLTK  433 (589)
Q Consensus       355 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-~~~vkl~Dfgla~  433 (589)
                      .+++||++.+++|.+++.... ..+++..+..++.+++.++.+||++++   +|+||+|.||+++. ++.++|+|||.+.
T Consensus        66 ~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~---~H~dl~~~ni~~~~~~~~~~l~d~~~~~  141 (215)
T cd00180          66 LYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGI---IHRDLKPENILLDSDNGKVKLADFGLSK  141 (215)
T ss_pred             EEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHhhEEEeCCCCcEEEecCCceE
Confidence            899999999999999998653 348899999999999999999999998   99999999999999 8999999999987


Q ss_pred             ccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCCh
Q 037010          434 LTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP  512 (589)
Q Consensus       434 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (589)
                      ....... ......+...|++||..... .++.++|+|++|+++++|                                 
T Consensus       142 ~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------  187 (215)
T cd00180         142 LLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------  187 (215)
T ss_pred             EccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------
Confidence            6543321 12335678899999998776 888999999999999998                                 


Q ss_pred             HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          513 IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       513 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                           ..+.+++..|++.+|.+||+++++++++
T Consensus       188 ---------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                 2578999999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=1.7e-27  Score=239.63  Aligned_cols=269  Identities=23%  Similarity=0.275  Sum_probs=192.7

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC------C
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH------H  340 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~------h  340 (589)
                      ......+|.+....|+|-|++|.+|.+..... ..+.|++..+..            ..+.=+.|++||++|.      .
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~-~vAiKIIRnNE~------------M~KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQ-EVAIKIIRNNEV------------MHKTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCC-eeEEEEeecchH------------HhhhhhHHHHHHHHhhccCchhh
Confidence            34456899999999999999999998776532 222222222222            2234456999999994      2


Q ss_pred             CcceeEee-EEEeCcEEEEEEecCCCChHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE
Q 037010          341 LNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI  418 (589)
Q Consensus       341 pnIv~l~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl  418 (589)
                      -|+++++. |...+++|||||.+.- +|.+.+...+. -.+....+..++.|+..||.+|...|+   +|.||||.|||+
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~v---lHaDIKPDNiLV  569 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGV---LHADIKPDNILV  569 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCe---eecccCccceEe
Confidence            36788876 4457889999999854 99999987553 357888899999999999999999998   999999999999


Q ss_pred             cCC-CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          419 DKN-FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       419 ~~~-~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      ++. ..+||||||.|.......   -+.+..+..|.|||++.+-+|+...|+||+||+||||.||+..|.+....     
T Consensus       570 NE~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN-----  641 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN-----  641 (752)
T ss_pred             ccCcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH-----
Confidence            875 468999999987654322   23455567799999999999999999999999999999999988544321     


Q ss_pred             hHHHHHHHHhcC-CC----------------------------------------hHHhhHhhcCCCCCCCCCh---HHH
Q 037010          498 GLVALFEEVLNL-PD----------------------------------------PIEDLRKLVDPRLGDNCPL---DSV  533 (589)
Q Consensus       498 ~~~~~~~~~~~~-~~----------------------------------------~~~~l~~~~d~~l~~~~~~---~~~  533 (589)
                      ....++-++-.. |.                                        +..++...+-.  ...+|.   ...
T Consensus       642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~--~q~~~deq~~~~  719 (752)
T KOG0670|consen  642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIA--VQRLPDEQPKIV  719 (752)
T ss_pred             HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhc--cCCCCchhHHHH
Confidence            111111111110 00                                        00111111100  012333   345


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          534 LKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       534 ~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ..+.+|+..||..||++|.|..+.|.|-.
T Consensus       720 ~~~rdLLdkml~LdP~KRit~nqAL~HpF  748 (752)
T KOG0670|consen  720 QQLRDLLDKMLILDPEKRITVNQALKHPF  748 (752)
T ss_pred             HHHHHHHHHHhccChhhcCCHHHHhcCCc
Confidence            57899999999999999999999998843

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.8e-27  Score=222.15  Aligned_cols=248  Identities=21%  Similarity=0.335  Sum_probs=177.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccC-CCCcceeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHV-HHLNLVRL  346 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l-~hpnIv~l  346 (589)
                      ..+.|.+.+.||+|.||.+-+|++++...               .+++|.+..  ....+|.+|...--.| .|.||+.-
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t---------------~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~t   86 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKT---------------RIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDT   86 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCce---------------EEEeeccCcchhhHHHHHHHhccceeeccchhhhHH
Confidence            34679999999999999999999988632               233343332  3456788898877777 58999999


Q ss_pred             eeEE--EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc--CCC
Q 037010          347 IGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID--KNF  422 (589)
Q Consensus       347 ~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~--~~~  422 (589)
                      |+..  ..+..++++||++.|+|.+-+...+   +.+....+++.|+++||.|||++++   ||||||.+|||+-  +..
T Consensus        87 Y~vaFqt~d~YvF~qE~aP~gdL~snv~~~G---igE~~~K~v~~ql~SAi~fMHsknl---VHRdlK~eNiLif~~df~  160 (378)
T KOG1345|consen   87 YEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG---IGEANTKKVFAQLLSAIEFMHSKNL---VHRDLKAENILIFDADFY  160 (378)
T ss_pred             HHHHhhcCceEEEeeccCccchhhhhcCccc---ccHHHHHHHHHHHHHHHHHhhccch---hhcccccceEEEecCCcc
Confidence            8733  3455678999999999999887754   7788889999999999999999999   9999999999983  334


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccC---C--CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY---G--DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      ++||||||++...+..-    ....-+-.|.+||.+..   +  ...+.+|+|.||+++|..|||..||.....   ...
T Consensus       161 rvKlcDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~---~d~  233 (378)
T KOG1345|consen  161 RVKLCDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI---MDK  233 (378)
T ss_pred             EEEeeecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc---cCc
Confidence            89999999987543211    11234557999997632   2  346789999999999999999999963321   122


Q ss_pred             hHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 037010          498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI  557 (589)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  557 (589)
                      .+..+....-+.           .+.++.... -....+.+++++-|..++++|-...++
T Consensus       234 ~Y~~~~~w~~rk-----------~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  234 PYWEWEQWLKRK-----------NPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             hHHHHHHHhccc-----------CccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHH
Confidence            222222221111           111111111 123367889999999999999444443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=2.5e-27  Score=234.62  Aligned_cols=276  Identities=21%  Similarity=0.319  Sum_probs=195.6

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccC-CCCc
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHV-HHLN  342 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l-~hpn  342 (589)
                      +.+....+.|..+++||+|.|++||++.+....            .....+++|.+.. ....++.+|+++|..+ .+.|
T Consensus        29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~------------~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~n   96 (418)
T KOG1167|consen   29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQD------------TKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDN   96 (418)
T ss_pred             hhhhhhhhhhhhhccccccchhhhhhhhHhhhc------------cccceEeeeecccccCchHHHHHHHHHHHhccchh
Confidence            445556678999999999999999999876520            0112445554433 3345688999999999 5999


Q ss_pred             ceeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-
Q 037010          343 LVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-  420 (589)
Q Consensus       343 Iv~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-  420 (589)
                      |+++.+.+. ++++.+||||++..+..++...     ++...+..+++.++.||.++|.+||   |||||||+|+|.+. 
T Consensus        97 i~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GI---vHRDiKpsNFL~n~~  168 (418)
T KOG1167|consen   97 IIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGI---VHRDIKPSNFLYNRR  168 (418)
T ss_pred             hhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCc---cccCCCccccccccc
Confidence            999998776 5679999999999998888765     6688999999999999999999999   99999999999975 


Q ss_pred             CCcEEEEeccCccccccCC--------------C-----------------------------CCCcccccCCCCCchhc
Q 037010          421 NFHAKVADFGLTKLTEVGS--------------A-----------------------------SLPTRLVGTFGYMPPEY  457 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~--------------~-----------------------------~~~~~~~gt~~y~aPE~  457 (589)
                      .++-.|.|||+|...+...              .                             ...-...||++|+|||+
T Consensus       169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv  248 (418)
T KOG1167|consen  169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV  248 (418)
T ss_pred             cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence            4678999999997211000              0                             00011469999999998


Q ss_pred             cc-CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH--------HhcC---------CChHHh---h
Q 037010          458 AQ-YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE--------VLNL---------PDPIED---L  516 (589)
Q Consensus       458 ~~-~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~--------~~~~---------~~~~~~---l  516 (589)
                      +. ...-++++||||.||+++.+++++.||.....+......+...+..        ..+.         +...+.   +
T Consensus       249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f  328 (418)
T KOG1167|consen  249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNF  328 (418)
T ss_pred             HhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhch
Confidence            85 4456889999999999999999999997765544332222222110        0000         000000   0


Q ss_pred             Hhh-cCCCCC--------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          517 RKL-VDPRLG--------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       517 ~~~-~d~~l~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ... ...-..        .......+..+.+|+.+|++.||.+|.|+++.|.|
T Consensus       329 ~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  329 ETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             hccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            111 000000        01111223478999999999999999999999988

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.5e-25  Score=217.11  Aligned_cols=199  Identities=32%  Similarity=0.538  Sum_probs=160.6

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  352 (589)
                      |.+.+.||+|++|.||++....+.. ..+.|.+.....         . ...+.+.+|++.+++++|+|++++++++.. 
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~-~~~iK~~~~~~~---------~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~   69 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGE-LVAVKVLKKEKT---------E-KQREEFLREIRILKKLKHPNIVKLYGVFEDP   69 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCc-EEEEEeeccccc---------h-HHHHHHHHHHHHHHhCCCCChhhheeeeecC
Confidence            5678999999999999998876322 222222111100         0 134678889999999999999999998764 


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      ...++++|++++++|.+++...... +++.....++.+++.++.+||++++   +|+||+|.||+++.++.++|+|||.+
T Consensus        70 ~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i---~h~di~~~ni~v~~~~~~~l~d~g~~  145 (225)
T smart00221       70 EPLYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLGI---VHRDLKPENILLGMDGLVKLADFGLA  145 (225)
T ss_pred             CceEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEeeCcee
Confidence            5689999999999999999865432 7889999999999999999999998   99999999999999999999999998


Q ss_pred             cccccCCCCCCcccccCCCCCchhcc-cCCCCCcccchhhHHHHHHHHHcCCcccc
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKEAIV  487 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwSlGvll~elltG~~p~~  487 (589)
                      ...............++..|++||.+ ....++.++|+|+||+++++|++|+.||.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      146 RFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             eEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            86644321122335678899999998 66778889999999999999999999993

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.2e-26  Score=266.05  Aligned_cols=197  Identities=16%  Similarity=0.197  Sum_probs=137.8

Q ss_pred             ccCCC-CcceeEeeEEE--------eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 037010          336 THVHH-LNLVRLIGYCV--------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVY  406 (589)
Q Consensus       336 ~~l~h-pnIv~l~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~  406 (589)
                      +.++| +||+++++++.        ++.++++||++ +++|.+++... ..++++.+++.++.||+.||+|||++||   
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gI---  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGI---  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCe---
Confidence            34456 57777777651        13467788987 55999999754 3459999999999999999999999998   


Q ss_pred             EeeccCCCcEEEcCCC-------------------cEEEEeccCccccccCC---------------CCCCcccccCCCC
Q 037010          407 IHRDIKSANILIDKNF-------------------HAKVADFGLTKLTEVGS---------------ASLPTRLVGTFGY  452 (589)
Q Consensus       407 vH~Dlkp~NILl~~~~-------------------~vkl~Dfgla~~~~~~~---------------~~~~~~~~gt~~y  452 (589)
                      +||||||+|||++..+                   .+|++|||+++......               ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            9999999999996544                   45555666554321100               0001124588999


Q ss_pred             CchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHH
Q 037010          453 MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDS  532 (589)
Q Consensus       453 ~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~  532 (589)
                      ||||++.+..++.++|||||||+||||++|..|+....          ..+.....         ..+.+...     ..
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~~~---------~~~~~~~~-----~~  237 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSLRH---------RVLPPQIL-----LN  237 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHHHH---------hhcChhhh-----hc
Confidence            99999999999999999999999999999887752110          00111000         00111100     11


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          533 VLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       533 ~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ......++.+||+.+|.+||++.|+++|-
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            12356788999999999999999999884

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=1.5e-25  Score=209.36  Aligned_cols=168  Identities=24%  Similarity=0.281  Sum_probs=126.9

Q ss_pred             CChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCc
Q 037010          365 GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT  444 (589)
Q Consensus       365 gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~  444 (589)
                      |+|.+++.... .++++.+++.++.|++.||+|||+++         ||+|||++.++.+|+  ||++......      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------
Confidence            68999998643 35999999999999999999999986         999999999999999  9998765332      


Q ss_pred             ccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCC
Q 037010          445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRL  524 (589)
Q Consensus       445 ~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l  524 (589)
                      ...||+.|||||++.+..++.++|||||||++|||+||+.||.......   .............           ++. 
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~-----------~~~-  127 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGMPAD-----------DPR-  127 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHhccC-----------Ccc-
Confidence            1268999999999999999999999999999999999999985432111   1111111111100           000 


Q ss_pred             CCCCChHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          525 GDNCPLDSVL--KMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       525 ~~~~~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ....+.....  .+.+++.+||..+|.+||++.|+++|+..+.
T Consensus       128 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      128 DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            0011122222  5899999999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK06347 autolysin; Reviewed

Probab=99.92  E-value=2.8e-25  Score=237.48  Aligned_cols=165  Identities=19%  Similarity=0.250  Sum_probs=132.2

Q ss_pred             hheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeeecccCCC---------------cc
Q 037010           34 ASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCING---------------EF   98 (589)
Q Consensus        34 ~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~~~~~~~---------------~~   98 (589)
                      ..|+|++||||+.||++||++        +++|+++| ++. .+.|.+||.|.||....-...               ..
T Consensus       406 ~~ytVk~GDTL~sIA~kygVS--------v~~L~~~N-~l~-s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~  475 (592)
T PRK06347        406 KVYTVVKGDSLWRIANNNKVT--------IANLKSWN-NLK-SDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNT  475 (592)
T ss_pred             eeEEecCCCCHHHHHHHhCCC--------HHHHHHHh-CCC-cceeccCcEEEEecCCcccccccccccccccccccccc
Confidence            479999999999999999999        99999999 774 568999999999964211000               00


Q ss_pred             cceeeeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEeeecCCCcc------cCCceeEEEEEeC
Q 037010           99 LGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDAD------VSKQYRLFVTYPL  172 (589)
Q Consensus        99 ~~~~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~~~~~~~~~------~~~~~~~~~~y~v  172 (589)
                      ......|+|++|||||+|| ++|+  +++++|++||++.++.|++||.|.||.........      ..........|+|
T Consensus       476 ~~~~~~YtVk~GDTL~sIA-kkyg--VSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~V  552 (592)
T PRK06347        476 NTNAKVYTVAKGDSLWRIA-NNNK--VTIANLKSWNNLKSDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTV  552 (592)
T ss_pred             cccceeeeecCCCCHHHHH-HHHC--CCHHHHHHhcCCCcccccCCcEEEEecCcccccccccCCccCCccCccceeeec
Confidence            0123579999999999999 8899  89999999999988899999999999754321100      0001112457999


Q ss_pred             CCCCCHhHhHhhcCCCHHHHhhcCCCC-CcccCcceEEec
Q 037010          173 RPGDSLQSIARNVGLSESLLQNYNPGV-NFTRGSGLVFIP  211 (589)
Q Consensus       173 ~~gdtl~~ia~~~~~~~~~l~~~N~~~-~~~~~g~~~~iP  211 (589)
                      ++|||||+||++||+++++|++||++. +.+++|+.+.|+
T Consensus       553 k~GDTL~sIA~KygvSv~~L~~~N~L~~~~L~~GQ~L~I~  592 (592)
T PRK06347        553 KKGDSLWAISRQYKTTVDNIKAWNKLTSNMIHVGQKLTIK  592 (592)
T ss_pred             CCCCcHHHHHHHhCCCHHHHHHhcCCCcccCCCCCEEecC
Confidence            999999999999999999999999986 689999998774

>PRK06347 autolysin; Reviewed

Probab=99.91  E-value=4.5e-24  Score=228.31  Aligned_cols=169  Identities=18%  Similarity=0.226  Sum_probs=134.8

Q ss_pred             hhheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeeecccCC------C------c---
Q 037010           33 LASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCIN------G------E---   97 (589)
Q Consensus        33 ~~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~~~~~~------~------~---   97 (589)
                      ...|+|++||||+.||++||++        +++|+++| ++. .+.|.+||.|+||....-..      .      .   
T Consensus       330 ~~~Y~V~sGDTL~~IA~rygvS--------v~eL~~~N-~l~-~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~  399 (592)
T PRK06347        330 AKIYTVVKGDSLWRIANNHKVT--------VANLKAWN-NLK-SDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPST  399 (592)
T ss_pred             ceEEEeCCCCCHHHHHHHhCCC--------HHHHHHHh-CCC-ccccccCcEEEEecccccccccccccccccccccccc
Confidence            4479999999999999999999        99999999 784 57899999999996411000      0      0   


Q ss_pred             -ccceeeeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEeeecCCCc----c--------cCCce
Q 037010           98 -FLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDA----D--------VSKQY  164 (589)
Q Consensus        98 -~~~~~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~~~~~~~~----~--------~~~~~  164 (589)
                       -......|+|++||||+.|| ++|+  +++++|+++|++..+.|.+||.|.||........    .        .+...
T Consensus       400 ~~~~~~~~ytVk~GDTL~sIA-~kyg--VSv~~L~~~N~l~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~  476 (592)
T PRK06347        400 GTSTNAKVYTVVKGDSLWRIA-NNNK--VTIANLKSWNNLKSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTN  476 (592)
T ss_pred             ccccCceeEEecCCCCHHHHH-HHhC--CCHHHHHHHhCCCcceeccCcEEEEecCCccccccccccccccccccccccc
Confidence             01123579999999999999 8999  8999999999988788999999999964221000    0        00011


Q ss_pred             eEEEEEeCCCCCCHhHhHhhcCCCHHHHhhcCCCC-CcccCcceEEecCCC
Q 037010          165 RLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGV-NFTRGSGLVFIPGRD  214 (589)
Q Consensus       165 ~~~~~y~v~~gdtl~~ia~~~~~~~~~l~~~N~~~-~~~~~g~~~~iP~~~  214 (589)
                      .....|+|++|||||+||++||+++++|++||++. +.+++|+.+.||...
T Consensus       477 ~~~~~YtVk~GDTL~sIAkkygVSv~~L~~~N~l~s~~L~~GQ~L~Ip~~~  527 (592)
T PRK06347        477 TNAKVYTVAKGDSLWRIANNNKVTIANLKSWNNLKSDFIYPGQKLKVSAGS  527 (592)
T ss_pred             ccceeeeecCCCCHHHHHHHHCCCHHHHHHhcCCCcccccCCcEEEEecCc
Confidence            12357999999999999999999999999999975 689999999999764

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=3e-22  Score=205.53  Aligned_cols=263  Identities=20%  Similarity=0.252  Sum_probs=185.1

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCC----CcceeEee
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH----LNLVRLIG  348 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~h----pnIv~l~~  348 (589)
                      +|.+.++||+|+||.||+|.+..+....++.|.....           .......+..|..++..+..    +++..+++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~-----------~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~   87 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKE-----------LGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLD   87 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEec-----------ccCCCccchhHHHHHHHHhhhcCCCCCCEEEE
Confidence            8999999999999999999877653222222211110           00000134557777777752    57888887


Q ss_pred             EEE--eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC-----
Q 037010          349 YCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-----  421 (589)
Q Consensus       349 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~-----  421 (589)
                      ...  +...|+||+.+ |.+|.++........++..+.+.++.|++.+|++||+.|+   +||||||+|+++...     
T Consensus        88 ~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~---iHRDiKp~N~~~g~~~~~~~  163 (322)
T KOG1164|consen   88 HGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGF---IHRDIKPENFVVGQSSRSEV  163 (322)
T ss_pred             eccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCc---ccCCcCHHHeeecCCCCccc
Confidence            773  34578999988 7799998876665679999999999999999999999998   999999999999765     


Q ss_pred             CcEEEEeccCcc--ccccCCC-----CC--CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCC
Q 037010          422 FHAKVADFGLTK--LTEVGSA-----SL--PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS  492 (589)
Q Consensus       422 ~~vkl~Dfgla~--~~~~~~~-----~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~  492 (589)
                      ..+.|.|||+++  .......     ..  .....||..|+++....+.+.+.+.|+||++.++.|++.|..||......
T Consensus       164 ~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~  243 (322)
T KOG1164|consen  164 RTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT  243 (322)
T ss_pred             ceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence            368999999998  3221211     11  12356999999999999999999999999999999999999998433221


Q ss_pred             CCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      ..     ...+.....         ......    .....+..+.++...+-..+..++|....+...|..+....
T Consensus       244 ~~-----~~~~~~~~~---------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  244 DL-----KSKFEKDPR---------KLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             ch-----HHHHHHHhh---------hhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            11     111111000         000000    11122235666666666689999999999999987765543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.1e-22  Score=208.54  Aligned_cols=182  Identities=19%  Similarity=0.177  Sum_probs=129.1

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCccee-E
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVR-L  346 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~-l  346 (589)
                      ....++|.+.+.||+|+||+||+|.+....+...+.|....     ... ..........+.+|+++|++++|+|++. +
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~-----~~~-~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l   87 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVS-----EVP-WWSKPLARHLAAREIRALKTVRGIGVVPQL   87 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecc-----ccc-ccccHHHHHHHHHHHHHHHhccCCCCCcEE
Confidence            44567899999999999999999987654333322211100     000 0001223456889999999999999985 4


Q ss_pred             eeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc-CCCcEEEcCCCcEE
Q 037010          347 IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDI-KSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dl-kp~NILl~~~~~vk  425 (589)
                      ++   .+..|+||||++|++|.. +..     ..   ...++.+++.+|.|||++|+   +|||| ||+|||++.++.+|
T Consensus        88 ~~---~~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gI---iHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         88 LA---TGKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGI---THNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             EE---cCCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCC---eeCCCCCcceEEEcCCCCEE
Confidence            43   256899999999999963 211     11   14678899999999999999   99999 99999999999999


Q ss_pred             EEeccCccccccCCCCCC-------cccccCCCCCchhcccCCC------CCcccchh
Q 037010          426 VADFGLTKLTEVGSASLP-------TRLVGTFGYMPPEYAQYGD------VSPKVDVY  470 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~s~~sDvw  470 (589)
                      |+|||+++..........       ....+++.|+|||.+....      .+..+|-|
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            999999986644321111       2356888999999885432      23446666

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.87  E-value=3.1e-22  Score=210.58  Aligned_cols=169  Identities=21%  Similarity=0.213  Sum_probs=132.8

Q ss_pred             HhhheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCC-CeEEeeeecccC------C-------Cc
Q 037010           32 ALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLAD-TRINVPFPCDCI------N-------GE   97 (589)
Q Consensus        32 ~~~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g-~~l~ip~~~~~~------~-------~~   97 (589)
                      .+..+.|..+.+|..||+++|++        +++|+++||++......+.| +.|+||....-.      .       ..
T Consensus       262 ~~~~V~v~~~i~L~~iA~~~gvs--------~~eL~~LNP~~kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~  333 (456)
T PRK10783        262 ALARVDLGQQIELAQAAEMAGMS--------LTKLKTFNAGYKRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQST  333 (456)
T ss_pred             ceEEEecCCCcCHHHHHHHcCCC--------HHHHHHhCccccCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccc
Confidence            34456666677999999999999        99999999999655444456 567799853210      0       00


Q ss_pred             -----ccceeeeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEeeecCCCcccCCceeEEEEEeC
Q 037010           98 -----FLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPL  172 (589)
Q Consensus        98 -----~~~~~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~~~~~~~~~~~~~~~~~~~y~v  172 (589)
                           .......|+|++||||++|| ++|+  +|+++|+++|++.++.|.+||.|.||..+.|....   .....++|+|
T Consensus       334 ~~~~~~~~~~~~y~Vk~GDTL~sIA-~r~g--vs~~~L~~~N~l~~~~L~~Gq~L~Ip~~~~~~~~~---~~~~~~~Y~V  407 (456)
T PRK10783        334 LVADNTPLNSRSYKVRSGDTLSGIA-SRLN--VSTKDLQQWNNLRGSKLKVGQTLTIGAGSSAQRLA---NNSDSITYRV  407 (456)
T ss_pred             cccccCcCCceEEEECCCCcHHHHH-HHHC--cCHHHHHHHcCCCcccCCCCCEEEecCCccccccc---ccccceeEEe
Confidence                 00123579999999999999 7888  89999999999887889999999999776554211   1123468999


Q ss_pred             CCCCCHhHhHhhcCCCHHHHhhcCCCC-CcccCcceEEecCCC
Q 037010          173 RPGDSLQSIARNVGLSESLLQNYNPGV-NFTRGSGLVFIPGRD  214 (589)
Q Consensus       173 ~~gdtl~~ia~~~~~~~~~l~~~N~~~-~~~~~g~~~~iP~~~  214 (589)
                      ++||||++||++||+++++|++||+.. +.+++|+.+.++...
T Consensus       408 r~GDTL~sIA~kygVtv~~L~~~N~l~~~~L~pGq~L~l~v~~  450 (456)
T PRK10783        408 RKGDSLSSIAKRHGVNIKDVMRWNSDTAKNLQPGDKLTLFVKN  450 (456)
T ss_pred             CCCCCHHHHHHHhCCCHHHHHHhcCCCCCcCCCCCEEEEecCC
Confidence            999999999999999999999999975 589999999888765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=3.1e-20  Score=189.28  Aligned_cols=262  Identities=32%  Similarity=0.512  Sum_probs=187.6

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCC-cceeEeeEEEe
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHL-NLVRLIGYCVE  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~  352 (589)
                      |.+.+.||.|+|+.||++.+..    ..+.+.+     .....   ........+.+|+.++..+.|+ +++++.+++..
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~----~~~~k~~-----~~~~~---~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~   69 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRK----LVALKVL-----AKKLE---SKSKEVERFLREIQILASLNHPPNIVKLYDFFQD   69 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEecc----EEEEEee-----chhhc---cchhHHHHHHHHHHHHHHccCCcceeeEEEEEec
Confidence            6788999999999999998771    1111111     11100   0112456788899999999988 79999998865


Q ss_pred             Cc-EEEEEEecCCCChHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-cEEEEec
Q 037010          353 GS-LFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-HAKVADF  429 (589)
Q Consensus       353 ~~-~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-~vkl~Df  429 (589)
                      .. .+++++++.++++.+++..... ..+.......++.|++.++.|+|..++   +|||+||+||+++..+ .++++||
T Consensus        70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~---~hrd~kp~nil~~~~~~~~~l~df  146 (384)
T COG0515          70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGI---IHRDIKPENILLDRDGRVVKLIDF  146 (384)
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHeeecCCCCeEEEecc
Confidence            44 6999999999999977765542 248889999999999999999999998   9999999999999988 7999999


Q ss_pred             cCccccccCCCC-----CCcccccCCCCCchhcccC---CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          430 GLTKLTEVGSAS-----LPTRLVGTFGYMPPEYAQY---GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       430 gla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      |.+.........     ......|+..|++||.+..   ..++...|+||+|++++++++|..||......    .....
T Consensus       147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~  222 (384)
T COG0515         147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQ  222 (384)
T ss_pred             CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHH
Confidence            998754433221     2355789999999999987   57888999999999999999999996433221    00111


Q ss_pred             HHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       502 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ....+.....+      ..........+......+.+++..|+..+|..|.+..+...+
T Consensus       223 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         223 TLKIILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11111111100      000001011111223468899999999999999999988775

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.3e-21  Score=182.99  Aligned_cols=249  Identities=22%  Similarity=0.367  Sum_probs=186.4

Q ss_pred             ccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-C
Q 037010          275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-G  353 (589)
Q Consensus       275 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~  353 (589)
                      .+.-+|.+...|..|+|++++..   .+.         +...+........++|..|.-.|+-+.||||+.+++.|.. .
T Consensus       193 nl~tkl~e~hsgelwrgrwqgnd---iva---------kil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp  260 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQGND---IVA---------KILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP  260 (448)
T ss_pred             hhhhhhccCCCcccccccccCcc---hhh---------hhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence            45667888999999999998751   111         1222333334445678889999999999999999998864 4


Q ss_pred             cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE--eccC
Q 037010          354 SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA--DFGL  431 (589)
Q Consensus       354 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~--Dfgl  431 (589)
                      ++.++..||+.|+|...+++...-..+..++.+++.+++.|++|||+.. |-+----|....+++|++.+.+|.  |--+
T Consensus       261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheeccccee
Confidence            6889999999999999999887777888899999999999999999986 222344688899999999877665  3222


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCC---cccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS---PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s---~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      +...        ....-.|.||+||.++..+-+   .++|+|||++++|||.|...||..-.+-...             
T Consensus       340 sfqe--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------------  398 (448)
T KOG0195|consen  340 SFQE--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------------  398 (448)
T ss_pred             eeec--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------------
Confidence            2110        112346889999999766544   4799999999999999999999543221100             


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                              .++.-..++-.+|+..+..+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus       399 --------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  399 --------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                    0111223334567777778999999999999999999999999888764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=6e-22  Score=216.13  Aligned_cols=259  Identities=19%  Similarity=0.215  Sum_probs=181.3

Q ss_pred             ccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH-HHHHHHHHHHHHccCCCCcceeEeeEEEeC
Q 037010          275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-ASREFLAELKVLTHVHHLNLVRLIGYCVEG  353 (589)
Q Consensus       275 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~  353 (589)
                      ...+.+|.|++|.|+.+........ ...+.++.+ .     .+..... ....+..|+.+-..++|||++.......+.
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~-~~~~~~r~~-~-----~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~  393 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKS-FPEKEFRVR-V-----KPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI  393 (601)
T ss_pred             CccceeeecccCceEEEEecCCCcc-chhhhhhcc-c-----CCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc
Confidence            4578899999998887765443221 111111110 0     0111111 112266688888889999998777654432


Q ss_pred             -cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          354 -SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       354 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                       ..+-.||||++ +|+.++....  .+...++-.++.|++.|++|||+.|+   .|||+|++|+++..+|.+||+|||.+
T Consensus       394 ~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~Gi---ahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  394 DGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGL---AHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             ccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCc---eeccCccccEEEecCCceEEeecCcc
Confidence             23334999999 9999998763  37888899999999999999999999   99999999999999999999999999


Q ss_pred             cccccCCC---CCCcccccCCCCCchhcccCCCCCc-ccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          433 KLTEVGSA---SLPTRLVGTFGYMPPEYAQYGDVSP-KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       433 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~-~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ..+.....   ......+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||..........       .....
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~  540 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNY  540 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhcc
Confidence            87665433   3445578999999999999999987 5899999999999999999995443322110       00000


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      . .....      ..-........+...+.++.++|+.||.+|.|+++|++-
T Consensus       541 ~-~~~~~------~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  541 S-DQRNI------FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             c-ccccc------ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            0 00000      000011122344567889999999999999999999864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=2.4e-20  Score=179.37  Aligned_cols=260  Identities=20%  Similarity=0.232  Sum_probs=183.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCC-CCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVH-HLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~-hpnIv~l~~  348 (589)
                      .-+|+++++||+|.||..+.|..--..               +.+|+|.-.. ....++..|.+..+.|. .++|..+|-
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nn---------------e~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYY   91 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNN---------------EPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYY   91 (449)
T ss_pred             cccceeccccccCcceeeecccccccC---------------ceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceee
Confidence            457999999999999999998754331               2344443221 22345667888887774 688888886


Q ss_pred             EEEeCc-EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC-----C
Q 037010          349 YCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-----F  422 (589)
Q Consensus       349 ~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~-----~  422 (589)
                      |..++. -.||+|++ |-||.|++.--+ +.|+..+...++.|++.-++|+|++.+   |.|||||+|+||...     .
T Consensus        92 FGqeG~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~L---IYRDIKPdNFLIGrp~~k~~n  166 (449)
T KOG1165|consen   92 FGQEGKYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDL---IYRDIKPDNFLIGRPGTKDAN  166 (449)
T ss_pred             eccccchhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcce---eecccCccceeecCCCCCCCc
Confidence            666553 46899998 668888766443 459999999999999999999999999   999999999999643     3


Q ss_pred             cEEEEeccCccccccCCCC------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          423 HAKVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      .+.++|||+|+........      ......||.+||+--...+.+-+.+.|+-|||-++.++|-|..||.+-....   
T Consensus       167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t---  243 (449)
T KOG1165|consen  167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT---  243 (449)
T ss_pred             eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc---
Confidence            5899999999976543222      2234689999999999999999999999999999999999999995432211   


Q ss_pred             hhHHHHHHHHhc--CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          497 KGLVALFEEVLN--LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       497 ~~~~~~~~~~~~--~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                        +....+.+-+  ...+.+++.+            ..+.++..-++..-..+-.+-|..+-+...+..+...
T Consensus       244 --nK~kYeKIGe~Kr~T~i~~Lc~------------g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr  302 (449)
T KOG1165|consen  244 --NKEKYEKIGETKRSTPIEVLCE------------GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR  302 (449)
T ss_pred             --hHHHHHHhccccccCCHHHHHh------------cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence              1111111111  1122222222            2234556666666667888888887766665554433

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=4.8e-20  Score=169.96  Aligned_cols=258  Identities=21%  Similarity=0.248  Sum_probs=179.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCC-CcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHH-LNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~h-pnIv~l~  347 (589)
                      ...+|.++++||+|+||.+|.|..-..+.               .+|+|.-.. ....++..|.++.+.|++ ..|..+.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge---------------~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~   77 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGE---------------EVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIR   77 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCc---------------eEEEEeecccCCCcchhHHHHHHHHhccCCCCchhh
Confidence            35789999999999999999998766533               233332111 112345568888888865 5566666


Q ss_pred             eEEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC---Cc
Q 037010          348 GYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN---FH  423 (589)
Q Consensus       348 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~---~~  423 (589)
                      .|..+. .-.+||+.+ |.+|.+.+.--.+ .++..+.+.++-|++.-++|+|.++.   +||||||+|+|..-+   ..
T Consensus        78 ~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~f---iHRDIKPdNFLMGlgrh~~k  152 (341)
T KOG1163|consen   78 HYGTEKDYNVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNF---IHRDIKPDNFLMGLGRHCNK  152 (341)
T ss_pred             hhccccccceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhcc---ccccCCccceeeccccccce
Confidence            555544 467999998 6689887765433 48999999999999999999999998   999999999998533   46


Q ss_pred             EEEEeccCccccccCCCC------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          424 AKVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      +.|+|||+|+.+......      ......||.+|.+--...+.+-+.+.|+-|+|.+|.++.-|..||..-..... ..
T Consensus       153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-~Q  231 (341)
T KOG1163|consen  153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-KQ  231 (341)
T ss_pred             EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH-HH
Confidence            899999999976533222      22346899999999888888889999999999999999999999964332111 01


Q ss_pred             hHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ......+..  ...+.+.+.        ...|    .++.-.+..|-..--++-|...-+-+.+.
T Consensus       232 KyEkI~EkK--~s~~ie~LC--------~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  232 KYEKISEKK--MSTPIEVLC--------KGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HHHHHHHhh--cCCCHHHHh--------CCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            111111111  111222222        2223    35666777888888888888766555443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.6e-21  Score=200.39  Aligned_cols=245  Identities=22%  Similarity=0.339  Sum_probs=182.7

Q ss_pred             eccCCcEEEEEEEEccc--cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEee-EEEeCcE
Q 037010          280 IGQGGFGAVYYAELRGE--YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIG-YCVEGSL  355 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~-~~~~~~~  355 (589)
                      +|+|+||.|++++-.+.  -+..++.+..........         .......|..++...+ ||.+++++- +..+..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~---------~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl   72 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVR---------DRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKL   72 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccc---------cccccccHHHHHhhccCCCceeeeeeeeccccch
Confidence            79999999998754332  122222222211111100         0113445778888886 999999975 4457789


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      ++++++..||.|...+.....  +.+.........++.+++++|+.++   +|||+|++||+++.+|++++.|||+++..
T Consensus        73 ~l~ld~~rgg~lft~l~~~~~--f~~~~~~~~~aelaLald~lh~l~i---iyrd~k~enilld~~Ghi~~tdfglske~  147 (612)
T KOG0603|consen   73 YLILDFLRGGDLFTRLSKEVM--FDELDVAFYLAELALALDHLHKLGI---AYRDYKLENVLLLLEGHIKLTDFGLSKEA  147 (612)
T ss_pred             hHhhhhcccchhhhccccCCc--hHHHHHHHHHHHHHHHHhhcchhHH---HHhcccccceeecccCccccCCchhhhHh
Confidence            999999999999988876554  6677777788899999999999999   99999999999999999999999999854


Q ss_pred             ccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHh
Q 037010          436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED  515 (589)
Q Consensus       436 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  515 (589)
                      -....     .+||..|||||+++  .+..++|.||||++++||+||-.||..            +.+..++.       
T Consensus       148 v~~~~-----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~-------  201 (612)
T KOG0603|consen  148 VKEKI-----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILK-------  201 (612)
T ss_pred             Hhhhh-----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhh-------
Confidence            32221     28999999999998  678899999999999999999999843            12222222       


Q ss_pred             hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHHHhccccccccc
Q 037010          516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM--RSIVVALMTLSSTTEDWD  572 (589)
Q Consensus       516 l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl~~L~~l~~~~~~~~  572 (589)
                            ..  -..|.+......+++..++..+|..|.-.  ..+.++.+.-.....+|.
T Consensus       202 ------~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  202 ------AE--LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             ------hc--cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence                  11  13466677788999999999999999776  466677766666677776

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=1.5e-19  Score=168.79  Aligned_cols=189  Identities=15%  Similarity=0.140  Sum_probs=132.3

Q ss_pred             ccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeEEEeC
Q 037010          275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYCVEG  353 (589)
Q Consensus       275 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~  353 (589)
                      .+...|++|+||+||.+...+   ...+.+.+...    ...   ...-....+.+|+++|++|+ |+++.+++++   +
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~---~k~~~~~l~~~----~~~---~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~   71 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGE---RKFVRRDLSAA----PWW---LRGVAWWLARREALALRQLDGLPRTPRLLHW---D   71 (218)
T ss_pred             ccceeecCCCcceEEEeecCC---ceeeecccccc----hhh---hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---c
Confidence            356789999999999775422   22221111100    000   00111225788999999995 5889999886   4


Q ss_pred             cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc-CCCcEEEcCCCcEEEEeccCc
Q 037010          354 SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDI-KSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       354 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dl-kp~NILl~~~~~vkl~Dfgla  432 (589)
                      ..|++|||+.|.+|.+.+..         ....++.|++.+|+++|++|+   +|||| ||+|||++.++.++|+|||++
T Consensus        72 ~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GI---vHrDL~kp~NILv~~~g~i~LIDFG~A  139 (218)
T PRK12274         72 GRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGV---AHNDLAKEANWLVQEDGSPAVIDFQLA  139 (218)
T ss_pred             CEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcC---ccCCCCCcceEEEcCCCCEEEEECCCc
Confidence            57999999999998754321         113577899999999999999   99999 799999999999999999999


Q ss_pred             cccccCCCC----C--------CcccccCCCCCchhcccCC-CCC-cccchhhHHHHHHHHHcCCccccc
Q 037010          433 KLTEVGSAS----L--------PTRLVGTFGYMPPEYAQYG-DVS-PKVDVYAFGVVLYELISAKEAIVK  488 (589)
Q Consensus       433 ~~~~~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~~sDvwSlGvll~elltG~~p~~~  488 (589)
                      .........    .        ......++.|+.|+...-- ..+ .+.+.++.|+-+|.++|++.+...
T Consensus       140 ~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        140 VRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             eecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            854432210    0        0112368889999854322 233 567889999999999999987644

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=3e-19  Score=175.53  Aligned_cols=195  Identities=27%  Similarity=0.299  Sum_probs=137.9

Q ss_pred             CCCcceeEeeEEEe----------------------------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHH
Q 037010          339 HHLNLVRLIGYCVE----------------------------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD  390 (589)
Q Consensus       339 ~hpnIv~l~~~~~~----------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~q  390 (589)
                      +|||||++.++|.+                            ..+|+||...+. +|.+|+-.+.   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence            59999999865421                            126899998877 9999987654   455667778889


Q ss_pred             HHHHHHHHHhCCCCceEeeccCCCcEEE--cCCC--cEEEEeccCccccccC-----CCCCCcccccCCCCCchhcccCC
Q 037010          391 SARGLEYIHEHTVPVYIHRDIKSANILI--DKNF--HAKVADFGLTKLTEVG-----SASLPTRLVGTFGYMPPEYAQYG  461 (589)
Q Consensus       391 ia~aL~~LH~~~i~~~vH~Dlkp~NILl--~~~~--~vkl~Dfgla~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~  461 (589)
                      +++|+.|||.+|+   .|||+|++|||+  |+++  .+.++|||.+......     ..+.....-|...-||||+...-
T Consensus       350 lLEav~hL~~hgv---AhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKHGV---AHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHccc---hhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999999999   999999999998  3333  5789999977543221     11222334577789999987432


Q ss_pred             --CC----CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHH
Q 037010          462 --DV----SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLK  535 (589)
Q Consensus       462 --~~----s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~  535 (589)
                        +.    -.++|.|+.|.+.||+++...||........+...+.                 +---|.+++.+|+    .
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq-----------------e~qLPalp~~vpp----~  485 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ-----------------ESQLPALPSRVPP----V  485 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh-----------------hhhCCCCcccCCh----H
Confidence              11    2489999999999999999999976443222222211                 1111333344554    5


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          536 MAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       536 l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      +++++...|+.||.+|+|..-....|
T Consensus       486 ~rqlV~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  486 ARQLVFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHHHHHhcCCccccCCccHHHhHH
Confidence            88899999999999999975444433

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=1.2e-19  Score=173.36  Aligned_cols=179  Identities=14%  Similarity=0.157  Sum_probs=126.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||.|+||.||++...   +...+.|...............+.  ..+.+.+|++.+.++.|++|..+.++
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~---~~~~iiKvf~~~~~~~~~~~~~f~--~g~~~e~Ea~~l~rL~~~GI~~~~d~  103 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTD---YGKYILKVFAPKVKRTERFLKSFV--KGDYYENLIVQTDRVRSEGLASLNDF  103 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecC---CCcEEEEEechhcCchHHHHHhhh--hhHHHHHHHHHHHHHHHCCCCcceEe
Confidence            4689999999999999999997552   223333333322221111111110  12336789999999999999999887


Q ss_pred             EEe---------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          350 CVE---------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       350 ~~~---------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      +..         +..+++|||++|.+|.++..      ++.    ....+++.+|..||+.|+   +|||+||+||+++.
T Consensus       104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi---~H~Dikp~Nili~~  170 (232)
T PRK10359        104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGM---VSGDPHKGNFIVSK  170 (232)
T ss_pred             eeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCC---ccCCCChHHEEEeC
Confidence            442         34789999999999988732      222    245589999999999999   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI  480 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ell  480 (589)
                      ++ ++|+|||..........             ...+.....+..++|+||||+++..+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehHHH
Confidence            88 99999998764321110             011333445667999999999987765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.78  E-value=7.2e-20  Score=199.59  Aligned_cols=246  Identities=24%  Similarity=0.265  Sum_probs=171.1

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc---CHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~---~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      +|...+-||.+.|=+|.+|.++.+.   .+.          ++-+|..   ......+.+.|++ ...++|||.+++.-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~---vVv----------KVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~   89 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL---VVV----------KVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV   89 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce---EEE----------EEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH
Confidence            6777899999999999999876541   111          1112221   2233344445555 555689999998766


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      ... ..-|||-+|..+ +|.|.+.-++-  +...+.+.|+.|++.||..+|..|+   +|||||.+|||++.-..+.|+|
T Consensus        90 ~~t~kAAylvRqyvkh-nLyDRlSTRPF--L~~iEKkWiaFQLL~al~qcH~~gV---cHGDIKsENILiTSWNW~~LtD  163 (1431)
T KOG1240|consen   90 LVTDKAAYLVRQYVKH-NLYDRLSTRPF--LVLIEKKWIAFQLLKALSQCHKLGV---CHGDIKSENILITSWNWLYLTD  163 (1431)
T ss_pred             HHhhHHHHHHHHHHhh-hhhhhhccchH--HHHHHHHHHHHHHHHHHHHHHHcCc---cccccccceEEEeeechhhhhc
Confidence            543 346788888877 99999877654  6777888999999999999999999   9999999999999999999999


Q ss_pred             ccCccccc--cCCCCCCcccc----cCCCCCchhcccCC----------C-CCcccchhhHHHHHHHHHcC-CcccccCC
Q 037010          429 FGLTKLTE--VGSASLPTRLV----GTFGYMPPEYAQYG----------D-VSPKVDVYAFGVVLYELISA-KEAIVKGN  490 (589)
Q Consensus       429 fgla~~~~--~~~~~~~~~~~----gt~~y~aPE~~~~~----------~-~s~~sDvwSlGvll~elltG-~~p~~~~~  490 (589)
                      |..-+...  .++..-.+-+.    .-..|.|||.+...          . .+++.||||+||++.||++- +.+|    
T Consensus       164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF----  239 (1431)
T KOG1240|consen  164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF----  239 (1431)
T ss_pred             ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc----
Confidence            98665322  12221111111    22469999976331          2 67899999999999999875 5555    


Q ss_pred             CCCCChhhHHHHHHHHhc-CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          491 GSSADSKGLVALFEEVLN-LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                             .+..++..... ...+..-+.++-|+            .++.|+..|++.||.+|.|+++.|+..
T Consensus       240 -------~LSQL~aYr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  240 -------TLSQLLAYRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             -------cHHHHHhHhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHhh
Confidence                   23333322222 11222222333232            478999999999999999999999884

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=2.5e-18  Score=179.46  Aligned_cols=220  Identities=25%  Similarity=0.412  Sum_probs=162.8

Q ss_pred             HccCCCCcceeEeeEEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          335 LTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       335 l~~l~hpnIv~l~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      |+.+.|.|+.+++|.+.++ ..++|.+||..|+|.|.+.... ..+++.-...+.++++.||+|||..-+  ..|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPI--GYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeeecc
Confidence            4678999999999988765 5788999999999999998744 348888899999999999999999876  38999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccC-CCCCCcccccCCCCCchhcccCC-------CCCcccchhhHHHHHHHHHcCCcc
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVG-SASLPTRLVGTFGYMPPEYAQYG-------DVSPKVDVYAFGVVLYELISAKEA  485 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~sDvwSlGvll~elltG~~p  485 (589)
                      .|+++|....+||+|||+....... .........-..-|.|||.+...       ..+.+.|+||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998765320 00111111234469999998653       146789999999999999999999


Q ss_pred             cccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      |......... ..+.   ..+.+      .-.....|.+....  +....+..++..||..+|.+||+++++-..+..+.
T Consensus       158 ~~~~~~~~~~-~eii---~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~  225 (484)
T KOG1023|consen  158 FDLRNLVEDP-DEII---LRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN  225 (484)
T ss_pred             cccccccCCh-HHHH---HHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence            9665443322 1111   11111      01112222222111  33336899999999999999999999999998887


Q ss_pred             cccc
Q 037010          566 STTE  569 (589)
Q Consensus       566 ~~~~  569 (589)
                      ....
T Consensus       226 ~~~~  229 (484)
T KOG1023|consen  226 KGGS  229 (484)
T ss_pred             cccc
Confidence            6554

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.77  E-value=1.2e-18  Score=164.29  Aligned_cols=150  Identities=16%  Similarity=0.169  Sum_probs=103.6

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHH------Hhhc-------C-HH-HHHHHHHHHHHHccCCCC
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAA------IKKM-------D-MQ-ASREFLAELKVLTHVHHL  341 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~------ik~~-------~-~~-~~~~~~~E~~il~~l~hp  341 (589)
                      ...||+|+||.||+|.+.  .+...+.|.+..........      ...+       . .+ .......|++++.++.++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA   79 (190)
T ss_pred             CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence            468999999999999875  34455555443221100000      0000       0 00 112334699999999877


Q ss_pred             cceeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeeccCCCcEEEcC
Q 037010          342 NLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI-HEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       342 nIv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~L-H~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ++.....+... ..+|||||+.++++...+...  .+++...+..++.|++.+|.++ |+.|+   +||||||+|||++ 
T Consensus        80 ~v~~p~~~~~~-~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~gi---iHrDlkP~NIli~-  152 (190)
T cd05147          80 GIPCPEPILLK-SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRL---VHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCCcEEEec-CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEEE-
Confidence            76443333222 348999999998776553322  3488899999999999999999 69998   9999999999998 


Q ss_pred             CCcEEEEeccCcccc
Q 037010          421 NFHAKVADFGLTKLT  435 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~  435 (589)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=1.3e-18  Score=171.07  Aligned_cols=235  Identities=19%  Similarity=0.282  Sum_probs=140.2

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC----------CC-
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH----------HL-  341 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~----------hp-  341 (589)
                      .+..++.||.|+++.||.+++..++....++..+... .....        ..+++.+|.-....+.          |- 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~--------~~~~~~~e~l~~~~~~~~~~p~~a~~~~r   83 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASAN--------EYEQLKEEQLAITLFPGVKNPKEAYRHLR   83 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTT--------HHHHHHHHHHGGGGSTT--SHHHHHHHH-
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchH--------HHHHHHHHHHHhhhhccCCCHHHHHHhce
Confidence            4566889999999999999998875444333222221 11111        1222333332222211          11 


Q ss_pred             -----cceeEee---EEEeC---------cEEEEEEecCCCChHHHHhc---CCC--CCCCHHHHHHHHHHHHHHHHHHH
Q 037010          342 -----NLVRLIG---YCVEG---------SLFLVYEYIENGNLSEHLRG---SGR--DPLPWSSRVQIALDSARGLEYIH  399 (589)
Q Consensus       342 -----nIv~l~~---~~~~~---------~~~lv~e~~~~gsL~~~l~~---~~~--~~~~~~~~~~i~~qia~aL~~LH  399 (589)
                           -++++.+   +....         +.+++|+-+.+ +|.+++..   ...  ..+....++.+..|+++.+++||
T Consensus        84 ~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh  162 (288)
T PF14531_consen   84 FLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH  162 (288)
T ss_dssp             B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence                 1222221   22111         24678888855 88887642   221  12344455677789999999999


Q ss_pred             hCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC--------CCCCcccchhh
Q 037010          400 EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY--------GDVSPKVDVYA  471 (589)
Q Consensus       400 ~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwS  471 (589)
                      .+|+   +|+||||+|+|++.+|.++|+||+.........    .....+..|.+||....        -.++.+.|.|+
T Consensus       163 ~~Gl---VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~  235 (288)
T PF14531_consen  163 SYGL---VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ  235 (288)
T ss_dssp             HTTE---EEST-SGGGEEE-TTS-EEE--GGGEEETTEEE----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH
T ss_pred             hcce---EecccceeeEEEcCCCCEEEcChHHHeecCcee----eccCCCcccCChhhhhhhcccCcccceeeeccCHHH
Confidence            9998   999999999999999999999998665432211    11344578999997643        25788999999


Q ss_pred             HHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCC
Q 037010          472 FGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR  551 (589)
Q Consensus       472 lGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  551 (589)
                      ||+++|.|.+|+.||...........                          .-..|. +.++.+.+||..+|+.||.+|
T Consensus       236 LG~~ly~lWC~~lPf~~~~~~~~~~~--------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  236 LGITLYSLWCGRLPFGLSSPEADPEW--------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHSS-STCCCGGGSTSGG--------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHHHHccCCCCCCCccccccc--------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999999943322111000                          114577 788899999999999999988

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=1.1e-18  Score=178.78  Aligned_cols=174  Identities=28%  Similarity=0.431  Sum_probs=130.5

Q ss_pred             cEEEEEEecCCCChHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          354 SLFLVYEYIENGNLSEHLRGS-GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       354 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      .+|+.|++|.-.+|.+||..+ .....++...+.++.|++.|++|   ++.   +|+|+||.||++..+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~---ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGL---IHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccc---hhhhccccccccccchhhhhhhhhhe
Confidence            478999999999999999743 34457888999999999999999   777   99999999999999999999999998


Q ss_pred             cccccCC-----CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          433 KLTEVGS-----ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       433 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      .......     ....+...||..||+||.+.+..|+.++||||||++|+||++ -..++           ...+.+..+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~-----------er~~t~~d~  472 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF-----------ERIATLTDI  472 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH-----------HHHHhhhhh
Confidence            7654433     224456789999999999999999999999999999999997 22222           011111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV  558 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  558 (589)
                      -+         ..++|....++|.     =..|+.+++...|.+||++.++.
T Consensus       473 r~---------g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  473 RD---------GIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             hc---------CCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHHh
Confidence            11         1111122223332     36789999999999999655443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.74  E-value=9.8e-18  Score=158.54  Aligned_cols=151  Identities=15%  Similarity=0.106  Sum_probs=105.9

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHh------h-------cCH--HHHHHHHHHHHHHccCCCC
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK------K-------MDM--QASREFLAELKVLTHVHHL  341 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik------~-------~~~--~~~~~~~~E~~il~~l~hp  341 (589)
                      ...||+|++|.||+|.+.  .+...+.|.............+      .       ...  .....+..|.+.+.++.|+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            578999999999999876  3455555544433110000000      0       000  1122345789999999999


Q ss_pred             cceeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcC
Q 037010          342 NLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       342 nIv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ++.....+... ..|+||||++|+++.......  .+++......++.|++.++.++|+ +|+   +||||||+|||++ 
T Consensus        80 ~i~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~gi---vHrDlkP~NIll~-  152 (190)
T cd05145          80 GVPVPEPILLK-KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGL---VHGDLSEYNILYH-  152 (190)
T ss_pred             CCCCceEEEec-CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCE---ecCCCChhhEEEE-
Confidence            87544443333 348999999988654432222  237788899999999999999999 998   9999999999998 


Q ss_pred             CCcEEEEeccCccccc
Q 037010          421 NFHAKVADFGLTKLTE  436 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~  436 (589)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            7899999999987643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=5.1e-18  Score=188.90  Aligned_cols=197  Identities=20%  Similarity=0.259  Sum_probs=147.5

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC---CCcce
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH---HLNLV  344 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~---hpnIv  344 (589)
                      ....+.|.+.+.||+|+||+||+|...+  +.              .+++|.-+....-+|.--.+++.+|+   -+.|.
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~--~~--------------~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~  757 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN--GK--------------LVALKVEKPPNPWEFYICLQVMERLKPQMLPSIM  757 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC--Cc--------------EEEEEeecCCCceeeeehHHHHHhhchhhhcchH
Confidence            3345789999999999999999998765  22              23333322222222333344445554   12333


Q ss_pred             eEee-EEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC---
Q 037010          345 RLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---  420 (589)
Q Consensus       345 ~l~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~---  420 (589)
                      ++.. +...+.-++|+||.+.|+|.++++..  ..+++.....+..|++..+++||..+|   ||+||||+|+||..   
T Consensus       758 ~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~I---IHgDiKPDNfll~~~~~  832 (974)
T KOG1166|consen  758 HISSAHVFQNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGI---IHGDIKPDNFLLRREIC  832 (974)
T ss_pred             HHHHHHccCCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcce---ecccCCcceeEeecccC
Confidence            3333 23355678999999999999999843  448999999999999999999999999   99999999999932   


Q ss_pred             ----CCcEEEEeccCcccccc-CCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcc
Q 037010          421 ----NFHAKVADFGLTKLTEV-GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA  485 (589)
Q Consensus       421 ----~~~vkl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p  485 (589)
                          ...++|+|||.+..+.. ..........+|-.+-.+|...+..|+...|.|.|+.+++-||.|++.
T Consensus       833 ~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  833 ADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             CCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence                34589999998874332 122344556789999999999999999999999999999999999864

>PRK10345 hypothetical protein; Provisional

Probab=99.73  E-value=1.5e-17  Score=158.34  Aligned_cols=132  Identities=18%  Similarity=0.238  Sum_probs=96.8

Q ss_pred             ccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC---HHHHHHHHHHHHHHccC-----CCCcceeE
Q 037010          275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD---MQASREFLAELKVLTHV-----HHLNLVRL  346 (589)
Q Consensus       275 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~---~~~~~~~~~E~~il~~l-----~hpnIv~l  346 (589)
                      .-.+.||+|+||.||.  +..+ ... +              +|...   ....+.+.+|+++++++     .||||+++
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~-~~k-~--------------IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~   66 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPED-AQR-C--------------IKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRY   66 (210)
T ss_pred             CCcceecCCCceEEEE--CCCC-cCe-E--------------EEEEeccccchHHHHHHHHHHHHHhhccCCCCccccee
Confidence            3457899999999995  3332 111 1              12111   11345688999999999     57999999


Q ss_pred             eeEEEeC----cEE-EEEEe--cCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEeeccCCCcEEE
Q 037010          347 IGYCVEG----SLF-LVYEY--IENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL-EYIHEHTVPVYIHRDIKSANILI  418 (589)
Q Consensus       347 ~~~~~~~----~~~-lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL-~~LH~~~i~~~vH~Dlkp~NILl  418 (589)
                      ++++..+    .++ +|+||  +.+++|.+++....   +++.  ..++.+++.++ +|||+++|   +||||||+|||+
T Consensus        67 yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~~I---vhrDlKp~NILl  138 (210)
T PRK10345         67 YGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDNRI---VTMELKPQNILC  138 (210)
T ss_pred             eEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHCCE---eecCCCHHHEEE
Confidence            9988754    334 78999  55799999997632   5555  35677888777 99999998   999999999999


Q ss_pred             cC----CCcEEEEeccCc
Q 037010          419 DK----NFHAKVADFGLT  432 (589)
Q Consensus       419 ~~----~~~vkl~Dfgla  432 (589)
                      +.    +++++|+||+.+
T Consensus       139 ~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        139 QRISESEVIPVVCDNIGE  156 (210)
T ss_pred             eccCCCCCcEEEEECCCC
Confidence            74    347999995433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=5.6e-18  Score=184.93  Aligned_cols=217  Identities=26%  Similarity=0.411  Sum_probs=142.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|+.++.+..|+||.||+++++.+               .+.++.| ++.+.  .+.+.  ++.....|.+|      
T Consensus        82 e~df~~IklisngAygavylvrh~~t---------------rqrfa~k-iNkq~--lilRn--ilt~a~npfvv------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKET---------------RQRFAMK-INKQN--LILRN--ILTFAGNPFVV------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeecccc---------------ccchhhc-ccccc--hhhhc--cccccCCccee------
Confidence            35788899999999999999987754               2244442 22111  11110  22222233332      


Q ss_pred             EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       351 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                                    |+-...+...+.  ++.        +++.+++|||+.++   +|||+||+|.+|+.-|++|++|||
T Consensus       136 --------------gDc~tllk~~g~--lPv--------dmvla~Eylh~ygi---vhrdlkpdnllIT~mGhiKlTDfg  188 (1205)
T KOG0606|consen  136 --------------GDCATLLKNIGP--LPV--------DMVLAVEYLHSYGI---VHRDLKPDNLLITSMGHIKLTDFG  188 (1205)
T ss_pred             --------------chhhhhcccCCC--Ccc--------hhhHHhHhhccCCe---ecCCCCCCcceeeecccccccchh
Confidence                          233333333332  222        23788999999999   999999999999999999999999


Q ss_pred             CccccccCCCC--------------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          431 LTKLTEVGSAS--------------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       431 la~~~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      +++........              .....+||+.|.|||++....|...+|+|+||+++||++-|..||......    
T Consensus       189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe----  264 (1205)
T KOG0606|consen  189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----  264 (1205)
T ss_pred             hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH----
Confidence            98854332111              122358999999999999999999999999999999999999999665331    


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                       .+++   .+...      ...+.+.  .+..+    .+.++++.++|+.+|.+|--...-++.
T Consensus       265 -elfg---~visd------~i~wpE~--dea~p----~Ea~dli~~LL~qnp~~Rlgt~ga~ev  312 (1205)
T KOG0606|consen  265 -ELFG---QVISD------DIEWPEE--DEALP----PEAQDLIEQLLRQNPLCRLGTGGALEV  312 (1205)
T ss_pred             -HHHh---hhhhh------hcccccc--CcCCC----HHHHHHHHHHHHhChHhhcccchhhhh
Confidence             2222   22110      0011111  11222    357899999999999999544343333

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.67  E-value=1.2e-16  Score=168.31  Aligned_cols=106  Identities=18%  Similarity=0.251  Sum_probs=91.5

Q ss_pred             hheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeeecccCCCcccceeeeEEeccCcch
Q 037010           34 ASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTY  113 (589)
Q Consensus        34 ~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~~~~~~~~~~~~~~~y~V~~Gdtl  113 (589)
                      ..|+|++||||++||++||++        ..+|+++| ++.. +.|.+||.|.||.++.|...........|+|++||||
T Consensus       344 ~~y~Vk~GDTL~sIA~r~gvs--------~~~L~~~N-~l~~-~~L~~Gq~L~Ip~~~~~~~~~~~~~~~~Y~Vr~GDTL  413 (456)
T PRK10783        344 RSYKVRSGDTLSGIASRLNVS--------TKDLQQWN-NLRG-SKLKVGQTLTIGAGSSAQRLANNSDSITYRVRKGDSL  413 (456)
T ss_pred             eEEEECCCCcHHHHHHHHCcC--------HHHHHHHc-CCCc-ccCCCCCEEEecCCcccccccccccceeEEeCCCCCH
Confidence            369999999999999999999        89999999 6644 7899999999998876643222223468999999999


Q ss_pred             hcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEee
Q 037010          114 EKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVN  152 (589)
Q Consensus       114 ~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~~  152 (589)
                      ++|| ++|+  ||+++|++||++..+.|++||+|.|++.
T Consensus       414 ~sIA-~kyg--Vtv~~L~~~N~l~~~~L~pGq~L~l~v~  449 (456)
T PRK10783        414 SSIA-KRHG--VNIKDVMRWNSDTAKNLQPGDKLTLFVK  449 (456)
T ss_pred             HHHH-HHhC--CCHHHHHHhcCCCCCcCCCCCEEEEecC
Confidence            9999 8999  9999999999976559999999999865

>smart00090 RIO RIO-like kinase

Probab=99.66  E-value=1.8e-16  Score=154.64  Aligned_cols=160  Identities=15%  Similarity=0.105  Sum_probs=109.2

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhH-h--------HHH--hhcCH--HHHHHHHHHHH
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQ-K--------AAI--KKMDM--QASREFLAELK  333 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~-~--------~~i--k~~~~--~~~~~~~~E~~  333 (589)
                      +......|.+.+.||+|+||.||+|.+....+...+.|.+....... .        ...  .....  .....+..|++
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            34444568999999999999999998333334444444433221100 0        000  00011  11234567999


Q ss_pred             HHccCCCCc--ceeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEeec
Q 037010          334 VLTHVHHLN--LVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT-VPVYIHRD  410 (589)
Q Consensus       334 il~~l~hpn--Iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~-i~~~vH~D  410 (589)
                      ++.++.+..  +.+++++   +..++||||+.+++|..+.....  .+.......++.|++.++.+||++| +   +|||
T Consensus       103 ~L~~L~~~~i~~p~~~~~---~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~i---iH~D  174 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW---RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGEL---VHGD  174 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe---cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCE---EeCC
Confidence            999997532  3344432   34589999999988877653322  3556667899999999999999999 8   9999


Q ss_pred             cCCCcEEEcCCCcEEEEeccCcccc
Q 037010          411 IKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       411 lkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |||+||+++ ++.++|+|||.+...
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999 889999999988643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.65  E-value=5.5e-16  Score=169.92  Aligned_cols=150  Identities=18%  Similarity=0.277  Sum_probs=111.2

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-HHHHHHHHHHHHHHccCCCCc
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-MQASREFLAELKVLTHVHHLN  342 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-~~~~~~~~~E~~il~~l~hpn  342 (589)
                      ++........|...++||+|+||.||++.+.+..  ..+.+.+ .+    ....+... ....+++.+|++++++++|++
T Consensus       325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~-~~----~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~  397 (535)
T PRK09605        325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERV-PK----GYRHPELDERLRTERTRAEARLLSEARRAG  397 (535)
T ss_pred             eccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEe-cc----cccchhHHHHHHHHHHHHHHHHHHhhcccC
Confidence            3444444556678899999999999998875531  1111111 00    11111111 122356788999999999999


Q ss_pred             ceeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          343 LVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       343 Iv~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      ++....++. +...++||||+++++|.+++.          ....++.+++.+|.+||++++   +||||||+|||+ ++
T Consensus       398 i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~gi---iHrDlkp~NILl-~~  463 (535)
T PRK09605        398 VPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGI---VHGDLTTSNFIV-RD  463 (535)
T ss_pred             CCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCC---ccCCCChHHEEE-EC
Confidence            988766554 346789999999999999875          346789999999999999998   999999999999 67


Q ss_pred             CcEEEEeccCccc
Q 037010          422 FHAKVADFGLTKL  434 (589)
Q Consensus       422 ~~vkl~Dfgla~~  434 (589)
                      +.++|+|||+++.
T Consensus       464 ~~~~liDFGla~~  476 (535)
T PRK09605        464 DRLYLIDFGLGKY  476 (535)
T ss_pred             CcEEEEeCccccc
Confidence            7999999999875

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.63  E-value=1.6e-15  Score=146.07  Aligned_cols=140  Identities=18%  Similarity=0.330  Sum_probs=103.3

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-HHHHHHHHHHHHHHccCCCCcceeEeeEEE-eCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-MQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~  355 (589)
                      +.||+|++|.||+|.+.+.   ..+.|....+...    ..... ......+.+|++++.++.|+++.....++. .+..
T Consensus         2 ~~l~~G~~~~vy~~~~~~~---~~~vK~~~~~~~~----~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGI---KAVIKWRIPKRYR----HPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF   74 (211)
T ss_pred             cccccCceEEEEEEeeCCC---ceEEEEeCCcCCc----ChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence            6799999999999987432   1222211100000    00000 012245778999999999998876665543 4568


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      +++|||++|++|.+++....     . ....++.+++.+|.+||+.++   +|+|++|.|||++ ++.++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i---~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGI---IHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCc---ccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            89999999999999986532     2 778999999999999999998   9999999999999 78899999998764

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=99.60  E-value=3.4e-15  Score=153.96  Aligned_cols=192  Identities=14%  Similarity=0.121  Sum_probs=113.2

Q ss_pred             ChhhHHHHHHHHHhhhhhhccCCCCccchHHHhhheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccC
Q 037010            1 MKQLCMIFFVLIVPSLISVTVESKCTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLL   80 (589)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~   80 (589)
                      ||+..+.+++.+++.+.+.....        +-..|+|++|||||.||++||++        +++|+++| ++ +++.|.
T Consensus         3 mkK~~~~~~~~ia~~~~~~~~~a--------sa~tytVq~GDTLw~IA~~ygvt--------v~~I~~~N-~l-~~~~I~   64 (481)
T PRK13914          3 MKKATIAATAGIAVTAFAAPTIA--------SASTVVVEAGDTLWGIAQSKGTT--------VDAIKKAN-NL-TTDKIV   64 (481)
T ss_pred             hhHHHHHHHHHHHHHHhhccccc--------cCceEEECCCCCHHHHHHHHCCC--------HHHHHHHh-CC-Cccccc
Confidence            88877766654444333322211        11269999999999999999999        99999999 88 467899


Q ss_pred             CCCeEEeeeecccC--------------CCcccceeeeEEeccCcchhcch-hh--hccCcCcHH----------HHhhc
Q 037010           81 ADTRINVPFPCDCI--------------NGEFLGHTFQFSINSGDTYEKVA-TR--YYSNLTDAA----------SLQRI  133 (589)
Q Consensus        81 ~g~~l~ip~~~~~~--------------~~~~~~~~~~y~V~~Gdtl~~Ia-~~--~~~~l~~~~----------~l~~~  133 (589)
                      +||.|.||......              .+........-.+.+||.+.-+. ..  .|.  +...          -|...
T Consensus        65 ~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIgsl~~G~~V~Vl~~~~ngW~k--I~~~~GktGwV~~~YLs~~  142 (481)
T PRK13914         65 PGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIITSIKGGTKVTVETTESNGWHK--ITYNDGKTGFVNGKYLTDK  142 (481)
T ss_pred             CCCEEEeCCCCcccccceeEecceEEEecCCCCCcceeeeecCCCEEEEeecccCCeEE--EEcCCCCEEEEecccccCC
Confidence            99999999652100              01111122344566777665543 11  122  1110          01000


Q ss_pred             CCCCCCCCCCCcEEEE--------Eee-----------ecCCCcc------cCCceeEEEEEeCCCCCCHhHhHhhcCCC
Q 037010          134 NNYPPTRIPDRGTLNV--------TVN-----------CSCGDAD------VSKQYRLFVTYPLRPGDSLQSIARNVGLS  188 (589)
Q Consensus       134 N~~~~~~l~~g~~l~i--------p~~-----------~~~~~~~------~~~~~~~~~~y~v~~gdtl~~ia~~~~~~  188 (589)
                      =.+.+  +..-|+++-        |..           ..-+...      ...-......|+|++|||||.||++||++
T Consensus       143 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVt  220 (481)
T PRK13914        143 VTSTP--VAPTQEVKKETTTQQAAPAAETKTEVKQTTQATTPAPKVAETKETPVVDQNATTHAVKSGDTIWALSVKYGVS  220 (481)
T ss_pred             CccCc--cccchhhhhccccccccchhcccchhccCCcccCCcccccccccCccccCCCeEEEECCCCCHHHHHHHHCCC
Confidence            00000  000011110        000           0000000      00001123579999999999999999999


Q ss_pred             HHHHhhcCCCC-CcccCcceEEecCCC
Q 037010          189 ESLLQNYNPGV-NFTRGSGLVFIPGRD  214 (589)
Q Consensus       189 ~~~l~~~N~~~-~~~~~g~~~~iP~~~  214 (589)
                      +++|++||++. +.+.+|+.+.||...
T Consensus       221 v~eI~~~N~l~s~~L~pGQ~L~Ip~sa  247 (481)
T PRK13914        221 VQDIMSWNNLSSSSIYVGQKLAIKQTA  247 (481)
T ss_pred             HHHHHHhcCCCccccCCCCEEEecCCC
Confidence            99999999976 688899999999764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.59  E-value=4.6e-15  Score=141.36  Aligned_cols=154  Identities=19%  Similarity=0.156  Sum_probs=105.7

Q ss_pred             HHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhh--------hHhHHHhhcC---HHHHHHHHHHHHH
Q 037010          266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLL--------MQKAAIKKMD---MQASREFLAELKV  334 (589)
Q Consensus       266 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~--------~~~~~ik~~~---~~~~~~~~~E~~i  334 (589)
                      ++......|.+.+.||+|+||.||++... + +...+.|.......        .+....+...   .........|..+
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-D-GNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-C-CCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            44444555888999999999999999864 2 33333332221110        0000000000   1112336678999


Q ss_pred             HccCCCCc--ceeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          335 LTHVHHLN--LVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       335 l~~l~hpn--Iv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      +.++.|++  +...++   .+..++||||++|++|.+....        .....++.+++.++.++|++++   +|+|||
T Consensus        87 l~~l~~~~i~v~~~~~---~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi---~H~Dl~  152 (198)
T cd05144          87 LKALYEEGFPVPKPID---WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGI---IHGDLS  152 (198)
T ss_pred             HHHHHHcCCCCCceee---cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCC---CcCCCC
Confidence            99887774  333333   3456899999999998765431        2345788899999999999998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCcccc
Q 037010          413 SANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |+||++++++.++|+|||++...
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccC
Confidence            99999999999999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.59  E-value=2.1e-15  Score=143.81  Aligned_cols=136  Identities=18%  Similarity=0.291  Sum_probs=96.8

Q ss_pred             eeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-HHHHHHHHHHHHHHccCCCCcceeEeeEE-EeCcEE
Q 037010          279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-MQASREFLAELKVLTHVHHLNLVRLIGYC-VEGSLF  356 (589)
Q Consensus       279 ~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~-~~~~~~  356 (589)
                      .||+|+||.||++.+.+.   ..+.|....+    ........ .....++.+|+++++.++|+++.....++ .++..+
T Consensus         1 ~ig~G~~~~vy~~~~~~~---~~viK~~~~~----~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGL---KAVIKERVPK----SYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT   73 (199)
T ss_pred             CCCCCceEEEEEeecCCc---cEEEEEecCC----cCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence            489999999999985432   2222211100    00000000 11235577899999999887654443333 345578


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      ++|||++|++|.+++.....         .++.+++.+|.+||+.++   +|+|++|.||+++ ++.++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~gi---~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAGI---VHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCCe---ecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999999999998754321         788899999999999998   9999999999999 78999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=5e-16  Score=169.86  Aligned_cols=259  Identities=23%  Similarity=0.278  Sum_probs=181.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~  350 (589)
                      ..|.+.+.||+|+|+.|-+.....+.....+.+.+....         ...........|..+-+.+. |+|++++++..
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~---------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~   90 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP---------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS   90 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC---------CccchhhhcCccccccccccccccccccCCcc
Confidence            346667779999999998877655544333333222211         11112233444666666776 99999999977


Q ss_pred             EeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEeeccCCCcEEEcCCC-cEEEE
Q 037010          351 VEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH-EHTVPVYIHRDIKSANILIDKNF-HAKVA  427 (589)
Q Consensus       351 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH-~~~i~~~vH~Dlkp~NILl~~~~-~vkl~  427 (589)
                      .+. ..++.+++..|+++.+.+........+....-..+.|+..++.|+| ..++   .|+||||+|.+++..+ ..+++
T Consensus        91 ~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~---~h~~ikP~n~~l~~s~~~l~~~  167 (601)
T KOG0590|consen   91 SSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGV---THRDIKPSNSLLDESGSALKIA  167 (601)
T ss_pred             CCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccccc---ccCCCCCccchhccCCCcccCC
Confidence            654 5789999999999999884333223666677788999999999999 8888   9999999999999999 99999


Q ss_pred             eccCcccccc--CCCCCCccccc-CCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          428 DFGLTKLTEV--GSASLPTRLVG-TFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       428 Dfgla~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      |||+|..+..  +........+| ++.|+|||..... ...+..|+||.|+++.-+++|..|+............   +.
T Consensus       168 df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~---~~  244 (601)
T KOG0590|consen  168 DFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS---WK  244 (601)
T ss_pred             CchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee---ec
Confidence            9999987665  22233344678 9999999998764 4567899999999999999999998655433211000   00


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..    .       .    ...............+++..++..+|..|.+.+++-..
T Consensus       245 ~~----~-------~----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  245 SN----K-------G----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             cc----c-------c----ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence            00    0       0    00001111223356788888999999999999887654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=1e-13  Score=135.47  Aligned_cols=145  Identities=23%  Similarity=0.292  Sum_probs=99.4

Q ss_pred             ceeec-cCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc--CHHHHHHHHHHHHHHccCCCCcc--eeEeeEEE
Q 037010          277 SHKIG-QGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFLAELKVLTHVHHLNL--VRLIGYCV  351 (589)
Q Consensus       277 ~~~LG-~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~--~~~~~~~~~~E~~il~~l~hpnI--v~l~~~~~  351 (589)
                      ...|| .||.|+||.+...+.   ..+.|.+..+....++.-...  .......+.+|++++.+++|++|  ...+++..
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~---~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGV---NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             CceeecCCCCccEEEEEeCCc---eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            35687 888999998876522   222222221111111111111  11233567889999999998775  66666543


Q ss_pred             e--Cc---EEEEEEecCC-CChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          352 E--GS---LFLVYEYIEN-GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       352 ~--~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      .  +.   .++|||+++| .+|.+++...   +++..    .+.+++.+|.+||++|+   +|+||||+|||++.++.++
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~GI---~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAGV---YHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCCC---CCCCCCchhEEEcCCCCEE
Confidence            2  21   3599999997 6899888653   24443    35689999999999999   9999999999999988999


Q ss_pred             EEeccCccc
Q 037010          426 VADFGLTKL  434 (589)
Q Consensus       426 l~Dfgla~~  434 (589)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.45  E-value=1.9e-13  Score=123.28  Aligned_cols=133  Identities=21%  Similarity=0.283  Sum_probs=100.5

Q ss_pred             cceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHH-HHHHHHHHHHHccCCC--CcceeEeeEEE-
Q 037010          276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA-SREFLAELKVLTHVHH--LNLVRLIGYCV-  351 (589)
Q Consensus       276 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~E~~il~~l~h--pnIv~l~~~~~-  351 (589)
                      +.+.||+|.++.||++...+.   ..+.|              ...... ...+..|..+++.++|  .++.+++.+.. 
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~---~~~iK--------------~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~   64 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDE---DYVLK--------------INPSREKGADREREVAILQLLARKGLPVPKVLASGES   64 (155)
T ss_pred             cceecccccccceEEEEecCC---eEEEE--------------ecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC
Confidence            457899999999999987541   11111              111100 3457789999999976  48888877665 


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                      ++..+++|||+.++.+..+         +......++.+++.++.+||......++|+|++|+||++++.+.+++.|||.
T Consensus        65 ~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~  135 (155)
T cd05120          65 DGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEY  135 (155)
T ss_pred             CCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccc
Confidence            3468999999998777654         4456678889999999999996423349999999999999989999999998


Q ss_pred             ccc
Q 037010          432 TKL  434 (589)
Q Consensus       432 a~~  434 (589)
                      +..
T Consensus       136 ~~~  138 (155)
T cd05120         136 AGY  138 (155)
T ss_pred             ccC
Confidence            764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.42  E-value=5.2e-13  Score=125.86  Aligned_cols=146  Identities=16%  Similarity=0.149  Sum_probs=91.0

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh---------cC----HHHHHHHHHHHHHHccCCCCc-
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK---------MD----MQASREFLAELKVLTHVHHLN-  342 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~---------~~----~~~~~~~~~E~~il~~l~hpn-  342 (589)
                      .+.||+|+||.||+|.+.  .+...+.|.+.............         ..    .........|.+.+.++.+.. 
T Consensus         2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   79 (187)
T cd05119           2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV   79 (187)
T ss_pred             CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence            578999999999999876  23344444332211100000000         00    000111234666666664432 


Q ss_pred             -ceeEeeEEEeCcEEEEEEecCCCChHHH-HhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEc
Q 037010          343 -LVRLIGYCVEGSLFLVYEYIENGNLSEH-LRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILID  419 (589)
Q Consensus       343 -Iv~l~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~  419 (589)
                       +.+.++.   ...++||||++++.+... +....   . ......++.+++.++.++|. +++   +|+||||+||+++
T Consensus        80 ~~~~~~~~---~~~~lv~e~~~g~~~~~~~l~~~~---~-~~~~~~~~~~~~~~l~~lh~~~~i---vH~Dl~p~Nili~  149 (187)
T cd05119          80 PVPKPIDL---NRHVLVMEFIGGDGIPAPRLKDVR---L-LEDPEELYDQILELMRKLYREAGL---VHGDLSEYNILVD  149 (187)
T ss_pred             CCCceEec---CCCEEEEEEeCCCCccChhhhhhh---h-cccHHHHHHHHHHHHHHHhhccCc---CcCCCChhhEEEE
Confidence             3333332   346899999999543221 11111   1 15677899999999999999 998   9999999999999


Q ss_pred             CCCcEEEEeccCcccc
Q 037010          420 KNFHAKVADFGLTKLT  435 (589)
Q Consensus       420 ~~~~vkl~Dfgla~~~  435 (589)
                       ++.++|+|||.+...
T Consensus       150 -~~~~~liDfg~a~~~  164 (187)
T cd05119         150 -DGKVYIIDVPQAVEI  164 (187)
T ss_pred             -CCcEEEEECcccccc
Confidence             889999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=2.7e-13  Score=131.07  Aligned_cols=202  Identities=17%  Similarity=0.273  Sum_probs=139.8

Q ss_pred             HHccCCCCcceeEeeEEEeC------cEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 037010          334 VLTHVHHLNLVRLIGYCVEG------SLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTVPV  405 (589)
Q Consensus       334 il~~l~hpnIv~l~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i~~  405 (589)
                      -|-++.|.|||+++.|+.+.      ...++.|||..|+|.++|++..  ...+......+|+.||+.||.|||+.. |+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence            34455799999999887642      3678999999999999998643  344777777899999999999999998 78


Q ss_pred             eEeeccCCCcEEEcCCCcEEEEeccCcccccc--C-CCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcC
Q 037010          406 YIHRDIKSANILIDKNFHAKVADFGLTKLTEV--G-SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA  482 (589)
Q Consensus       406 ~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~--~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG  482 (589)
                      ++|+++.-+-|++..+|-+|++--........  . .........+-++|.+||.-.....+.++|||+||+..+||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            89999999999999999888764221111000  0 00111223567899999987777778899999999999999877


Q ss_pred             CcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          483 KEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       483 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..-...+............              ....+...           .=+.++..|++..|+.||+|++++.|.
T Consensus       279 Eiq~tnseS~~~~ee~ia~--------------~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIAN--------------VIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eeccCCCcceeehhhhhhh--------------heeeccCc-----------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            6432222111110000000              00000001           114577889999999999999998884

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=2.1e-11  Score=127.97  Aligned_cols=246  Identities=24%  Similarity=0.255  Sum_probs=168.9

Q ss_pred             CCCccceeecc--CCcEEEEEEEE--ccccCCccchhhhhhhhhhHhHHHhhcC-----HHHHHHHHHHHHHHccC-CCC
Q 037010          272 DNFSMSHKIGQ--GGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKVLTHV-HHL  341 (589)
Q Consensus       272 ~~y~~~~~LG~--G~~g~Vy~~~~--~~~~~~~~~~~~~~~~~~~~~~~ik~~~-----~~~~~~~~~E~~il~~l-~hp  341 (589)
                      ..|.+.+.+|.  |.+|.||.+..  .....               .+++|+-+     ......-.+|.....++ .|+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~---------------~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~  178 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPH---------------KFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHE  178 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCc---------------ccccccccCCCCCccccccccchhhcccccCccc
Confidence            45677899999  99999998865  22211               11222110     11112223455555555 499


Q ss_pred             cceeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEeeccCCCcE
Q 037010          342 NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----GLEYIHEHTVPVYIHRDIKSANI  416 (589)
Q Consensus       342 nIv~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~----aL~~LH~~~i~~~vH~Dlkp~NI  416 (589)
                      |.++.+..+. .+..|+-+|++. .+|.++....... ++....+..+.+...    ||.++|..++   +|-|+||.||
T Consensus       179 ~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~-~p~~~l~~~~~~~~~~~~~al~~~hs~~~---~~~~~kp~~i  253 (524)
T KOG0601|consen  179 NPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNF-LPDNLLWNSLRDWLSRDVTALSHLHSNNI---VHDDLKPANI  253 (524)
T ss_pred             cccccCcccccCCcceeeecccc-chhHHhhhccccc-CCchhhhhHHhhhhhcccccccccCCCcc---cccccchhhe
Confidence            9999776555 456888888885 6999988876543 777888888888888    9999999998   9999999999


Q ss_pred             EEcCC-CcEEEEeccCccccccCCCCC----CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCC
Q 037010          417 LIDKN-FHAKVADFGLTKLTEVGSASL----PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       417 Ll~~~-~~vkl~Dfgla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~  491 (589)
                      +...+ ...+++|||+...+....-..    ..+..|...|++||..+ +-++..+|+|++|.++.+..++..+...+..
T Consensus       254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            99998 889999999988665443211    12236778899999986 5678899999999999999998877654422


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..+  ..+.                 ...   ++.++-..-...+...+..+++.+|..|++.+.+..+
T Consensus       333 ~~W--~~~r-----------------~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  333 SSW--SQLR-----------------QGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             CCc--cccc-----------------ccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            111  0000                 000   0000001111245558889999999999998776654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.19  E-value=1.7e-11  Score=113.48  Aligned_cols=130  Identities=18%  Similarity=0.175  Sum_probs=87.4

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcce-eEeeEEEeCcE
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLV-RLIGYCVEGSL  355 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv-~l~~~~~~~~~  355 (589)
                      .+.|+.|.++.||+++..+.   .++.|.....            ......+..|.++++.+.+.+++ +++.+ .....
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~---~~~lK~~~~~------------~~~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~~~~   66 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANK---KYVVRIPGNG------------TELLINRENEAENSKLAAEAGIGPKLYYF-DPETG   66 (170)
T ss_pred             eeecCCcccCceEEEEECCe---EEEEEeCCCC------------cccccCHHHHHHHHHHHHHhCCCCceEEE-eCCCC
Confidence            46789999999999876532   2222221110            00112345688888888655544 34433 33345


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CceEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTV--PVYIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i--~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                      ++||||++|.++.+.    .   .   ....++.+++.+|+.||..++  ..++|+|++|.||+++ ++.++++||+.+.
T Consensus        67 ~lv~e~i~G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          67 VLITEFIEGSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             eEEEEecCCCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            899999999887643    0   1   112456789999999999873  1359999999999998 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.18  E-value=5.3e-11  Score=126.50  Aligned_cols=151  Identities=17%  Similarity=0.170  Sum_probs=94.7

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhH---hH-H-----------------------HhhcCHHHH--HH
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQ---KA-A-----------------------IKKMDMQAS--RE  327 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~---~~-~-----------------------ik~~~~~~~--~~  327 (589)
                      .+.||.|++|.||+|+..+  +...+.|....+....   .. .                       ++.+.....  -+
T Consensus       122 ~~plasaSigQVh~A~l~~--G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eld  199 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVD--GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELD  199 (437)
T ss_pred             CcceeeeehhheEEEEecC--CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHC
Confidence            4689999999999999764  3344444433221100   00 0                       000000001  12


Q ss_pred             HHHHHHHHccC----CCCcceeEeeEEE--eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 037010          328 FLAELKVLTHV----HHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR-GLEYIHE  400 (589)
Q Consensus       328 ~~~E~~il~~l----~hpnIv~l~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~-aL~~LH~  400 (589)
                      +.+|.+.+.++    +|.+-+.+-.++.  ....+|||||++|++|.++...... ...   ...++..++. .+..+|.
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHh
Confidence            55566665555    3333344433332  3457899999999999987653221 122   3345555555 4788999


Q ss_pred             CCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          401 HTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       401 ~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      .|+   +|+|+||.||+++.+++++++|||++....
T Consensus       276 ~g~---~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGF---FHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCc---eeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            998   999999999999999999999999987543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.12  E-value=5.6e-11  Score=124.82  Aligned_cols=255  Identities=21%  Similarity=0.229  Sum_probs=171.3

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCccee
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVR  345 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~  345 (589)
                      ......+|.++..||.|.|+.|+.+..+..++..++.+....+.....-         ...-..|+-+...+ .|.++++
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~---------di~sl~ev~l~~~l~~~~~~~g  330 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFAS---------DIFSLGEVILEAILGSHLPSVG  330 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHh---------hhcchhhhhHhhHhhcccccCC
Confidence            4455678999999999999999998865455554444332221111111         11122344444444 4777777


Q ss_pred             Eee-EEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC-Cc
Q 037010          346 LIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FH  423 (589)
Q Consensus       346 l~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~-~~  423 (589)
                      ++. |....+.|+-.|||+++++...+.-  ...+.+..++.+..|++.++.++|+...   +|+|+||+||++..+ +.
T Consensus       331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~---~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLF---VHLDVKPSNILISNDGFF  405 (524)
T ss_pred             CCCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhh---hcccccccceeeccchhh
Confidence            765 5556677899999999988777632  2237778889999999999999999998   999999999999876 77


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCC--chhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYM--PPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      .+++|||.+.......    ....+.-+++  +++......+..+.|++|||..+.+.+++..-........        
T Consensus       406 ~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~--------  473 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL--------  473 (524)
T ss_pred             hhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccce--------
Confidence            8999999886422111    1122334444  5555566778889999999999999999875332111100        


Q ss_pred             HHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       502 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                                      .+....+ ...+ .....+..+.+.+...++..||++.++..+....+
T Consensus       474 ----------------~i~~~~~-p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  474 ----------------TIRSGDT-PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ----------------eeecccc-cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                            0000000 1111 22257888999999999999999999887765443

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.08  E-value=3.9e-09  Score=112.14  Aligned_cols=143  Identities=17%  Similarity=0.254  Sum_probs=106.6

Q ss_pred             HHHHHHHHccCCCCcceeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 037010          328 FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVY  406 (589)
Q Consensus       328 ~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~  406 (589)
                      ..+-++.|+.++||||+++++... ++..|+|+|-+.  .|..++.+.+     ......-+.||+.||.|||+.+-  +
T Consensus        56 ~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v~~Gl~qIl~AL~FL~~d~~--l  126 (690)
T KOG1243|consen   56 AKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEVCLGLFQILAALSFLNDDCN--L  126 (690)
T ss_pred             HHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHHHHHHHHHHHHHHHHhccCC--e
Confidence            344677788999999999998554 677999999985  5777777644     45566778899999999986543  3


Q ss_pred             EeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcC
Q 037010          407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA  482 (589)
Q Consensus       407 vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG  482 (589)
                      +|++|.-..|+++..|+.||++|.+......... ......---.|..|+.+....  -..|.|-|||+++|++.|
T Consensus       127 vHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  127 VHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             eeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence            9999999999999999999999988764432221 111111223466776554332  246999999999999998

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=99.06  E-value=1e-10  Score=82.01  Aligned_cols=44  Identities=23%  Similarity=0.394  Sum_probs=37.1

Q ss_pred             eeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEee
Q 037010           36 YYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVP   88 (589)
Q Consensus        36 y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip   88 (589)
                      |+|++|||+++||++|+++        .++|+++||++...+ |.+||+|.||
T Consensus         1 y~V~~gDtl~~IA~~~~~~--------~~~l~~~N~~~~~~~-l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYGIS--------VDELMELNPNIDSDN-LQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTTS---------HHHHHHHCCTTHGGC-GGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhhhh--------HhHHHHhcCCCCccc-CCCCCEEEeC
Confidence            8999999999999999999        999999999995544 9999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=99.05  E-value=7.2e-11  Score=82.75  Aligned_cols=43  Identities=21%  Similarity=0.415  Sum_probs=35.9

Q ss_pred             EEeccCcchhcchhhhccCcCcHHHHhhcC-CCCCCCCCCCcEEEEE
Q 037010          105 FSINSGDTYEKVATRYYSNLTDAASLQRIN-NYPPTRIPDRGTLNVT  150 (589)
Q Consensus       105 y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N-~~~~~~l~~g~~l~ip  150 (589)
                      |+||+|||++.|| ++|+  ++.++|+++| .+.++.|.+||+|.||
T Consensus         1 y~V~~gDtl~~IA-~~~~--~~~~~l~~~N~~~~~~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIA-KRYG--ISVDELMELNPNIDSDNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHH-HHTT--S-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred             CEECcCCcHHHHH-hhhh--hhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence            8999999999999 8888  8999999999 5776679999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.04  E-value=1.2e-09  Score=102.27  Aligned_cols=149  Identities=13%  Similarity=0.147  Sum_probs=93.2

Q ss_pred             ceeeccCCcEEEEEEEEccc-----cCCccchhhhhhhhhh---HhHHHh---hc-----CHHHHHH----HHHHHHHHc
Q 037010          277 SHKIGQGGFGAVYYAELRGE-----YGNSYLSRLICVNLLM---QKAAIK---KM-----DMQASRE----FLAELKVLT  336 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~-----~~~~~~~~~~~~~~~~---~~~~ik---~~-----~~~~~~~----~~~E~~il~  336 (589)
                      ...||.|.-+.||.|...+.     .+...+.|++......   ....++   ++     +....+.    ..+|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            35689999999999975431     1233344433322110   011110   00     0111122    337999998


Q ss_pred             cCCC--CcceeEeeEEEeCcEEEEEEecCCCChHH-HHhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeeccC
Q 037010          337 HVHH--LNLVRLIGYCVEGSLFLVYEYIENGNLSE-HLRGSGRDPLPWSSRVQIALDSARGLEYI-HEHTVPVYIHRDIK  412 (589)
Q Consensus       337 ~l~h--pnIv~l~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~qia~aL~~L-H~~~i~~~vH~Dlk  412 (589)
                      ++..  -++...+++   ..-++||||+.+..+.. .+...   .++..+...+..+++.+|..| |..++   +|+||+
T Consensus        82 rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~gl---VHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNL---VHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCe---ecCCCC
Confidence            8843  344455543   45689999997754422 22221   244556677888999999999 89998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCcccc
Q 037010          413 SANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      +.|||++ ++.+.|+|||.+...
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeC
Confidence            9999997 468999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.04  E-value=8.6e-09  Score=103.61  Aligned_cols=204  Identities=16%  Similarity=0.222  Sum_probs=130.3

Q ss_pred             EEEEEEecCCC-ChHHHHhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          355 LFLVYEYIENG-NLSEHLRG----SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       355 ~~lv~e~~~~g-sL~~~l~~----~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      ..++|..+.+. .+..++..    +......|.-.++.++.++.+.+.||.+|.   +-+|+.++|+|+.+++.|.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh---~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGH---VVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCC---cccccCccceeeecCceEEEEcc
Confidence            56788888764 23333322    122347899999999999999999999997   88999999999999999999985


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcC-CcccccCCCCCCChhhHH-HH
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISA-KEAIVKGNGSSADSKGLV-AL  502 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG-~~p~~~~~~~~~~~~~~~-~~  502 (589)
                      ..-...  .+....-..+|...|.+||...     +-.-+...|.|.||++++++|.| ++||.+-.--......+. ..
T Consensus       162 Dsfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         162 DSFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             cceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            433222  2333344568899999999764     33557789999999999999887 888853211000000000 00


Q ss_pred             HHHHh-cCCChHHhhHhhcCCCCCCCCChH-HHHHHHHHHHHhcccC--CCCCCCHHHHHHHHHhccccc
Q 037010          503 FEEVL-NLPDPIEDLRKLVDPRLGDNCPLD-SVLKMAQLAKVCTQEY--PQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       503 ~~~~~-~~~~~~~~l~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~l~~~~  568 (589)
                      ....+ ..++    -..-..+. +...|.. .+..+..|+.+|+...  +.-|||++.++..|..+....
T Consensus       240 a~g~f~ya~~----~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         240 AHGRFAYASD----QRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             hcceeeechh----ccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            00000 0000    00000010 1112211 2346888999999764  568999999999987776543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.00  E-value=1e-10  Score=129.02  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=165.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..+.+.+.+-+-+|.++.++.+.-.+.+ .....+..       ..+ .++.....+....+-.++-..+||-+++..--
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sg-h~~~~~v~-------~~a-p~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s  872 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSG-HTRPSKVH-------GLA-PKIRTNDYESIRSKSNILITPRSPAVVRSFPS  872 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccc-cccchhhh-------ccc-hhhccccccccCCccCccccCCCCceecccCC
Confidence            3466777788899999999987644432 11111110       000 01111112222333344444455666655433


Q ss_pred             E-EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 C-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      + .....+|+++|..+++|...++..+.  .+..-.+..+..+..++++||...+   .|+|++|.|+|...+++.+++|
T Consensus       873 ~~~rsP~~L~~~~~~~~~~~Skl~~~~~--~saepaRs~i~~~vqs~e~L~s~~r---~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  873 FPCRSPLPLVGHYLNGGDLPSKLHNSGC--LSAEPARSPILERVQSLESLHSSLR---KHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             CCCCCCcchhhHHhccCCchhhhhcCCC--cccccccchhHHHHhhhhccccchh---hcccccccchhhcccCCcccCc
Confidence            2 23458999999999999999887663  4444555666678899999999987   8999999999999999999999


Q ss_pred             ccCccccccC-----C-------------------------CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHH
Q 037010          429 FGLTKLTEVG-----S-------------------------ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYE  478 (589)
Q Consensus       429 fgla~~~~~~-----~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~e  478 (589)
                      |+........     .                         ........||+.|.+||.+.+......+|+|++|++++|
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence            9833221100     0                         001122478999999999999999999999999999999


Q ss_pred             HHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 037010          479 LISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLG-DNCPLDSVLKMAQLAKVCTQEYPQLRPSMR  555 (589)
Q Consensus       479 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  555 (589)
                      .++|..||.....+        ..++.+.+.             ... ..-+.+.....++++...+..+|.+|-.+.
T Consensus      1028 ~l~g~pp~na~tpq--------~~f~ni~~~-------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1028 VLTGIPPFNAETPQ--------QIFENILNR-------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhcCCCCCCCcchh--------hhhhccccC-------------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999998543331        122222221             111 112334445678899999999999998876

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=98.99  E-value=4.2e-10  Score=98.41  Aligned_cols=111  Identities=21%  Similarity=0.328  Sum_probs=90.0

Q ss_pred             HHHHhcCCCCCCCccchhhHhhhccCCCC-CcccCCCCeEEeeeecccCCCcccceeeeEEeccCcchhcchhhhccCcC
Q 037010           47 IAQTLRSSLVDPNDVELTTILSYNKQLSN-KDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLT  125 (589)
Q Consensus        47 ia~~~~~~~~~~~~~~~~~i~~~N~~~~~-~~~~~~g~~l~ip~~~~~~~~~~~~~~~~y~V~~Gdtl~~Ia~~~~~~l~  125 (589)
                      ||.+|+++        +++|+.+| .+.. .+.+.+||.|.+|..            ..+.++.|++.+..+.+++.   
T Consensus         1 ia~~~~~~--------v~~l~~~n-~~~~~s~~i~~gq~l~~~~~------------~~~~~~~~~~~~~~~~~~~~---   56 (124)
T COG1388           1 IASKYGVS--------VKALKKAN-ALTGKSDAIKPGQVLKIPGD------------ISSTVNAGQTLSSLSNKVSD---   56 (124)
T ss_pred             Cccccccc--------HHHHHHHh-cccCCCCccccCceEEccCC------------cccccccccccccccceeec---
Confidence            57789999        99999999 7743 778999999999854            35889999999999954444   


Q ss_pred             cHHHHhhcCCCCCCCCCCCcEEEEEeeecCCCcccCCceeEEEEEeCCCCCCHhHhHhhcCCCHHHHhhcCCCC-CcccC
Q 037010          126 DAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGV-NFTRG  204 (589)
Q Consensus       126 ~~~~l~~~N~~~~~~l~~g~~l~ip~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~~~~~~~~l~~~N~~~-~~~~~  204 (589)
                      +..                                .....+..+|+|++||||+.||++|++++.+|+++|+.. +.+..
T Consensus        57 ~~~--------------------------------~~~~~~~~~~~V~~gdtL~~Ia~~~~~tv~~l~~~n~l~~~~i~~  104 (124)
T COG1388          57 SSS--------------------------------ASKAPPVVTYTVKKGDTLSKIARKYGVTVAELKQLNNLSSDKIKV  104 (124)
T ss_pred             ccc--------------------------------ccccCCCceEEEecCCCHHHHHHHhCCCHHHHHHHhccCCCceec
Confidence            222                                001122347999999999999999999999999999976 69999


Q ss_pred             cceEEecCC
Q 037010          205 SGLVFIPGR  213 (589)
Q Consensus       205 g~~~~iP~~  213 (589)
                      |+.+.+|..
T Consensus       105 gq~l~~~~~  113 (124)
T COG1388         105 GQKLKLPVS  113 (124)
T ss_pred             CcEEEEecc
Confidence            999999873

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.99  E-value=2.5e-09  Score=96.28  Aligned_cols=149  Identities=17%  Similarity=0.227  Sum_probs=102.7

Q ss_pred             cceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH-HHHHHHHHHHHHccCCCCcceeEee-EEEeC
Q 037010          276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-ASREFLAELKVLTHVHHLNLVRLIG-YCVEG  353 (589)
Q Consensus       276 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~-~~~~~  353 (589)
                      ....|-+|+-+.|+++.+.+.   ..+.|....    +.+....++.. ...+..+|.++|.++.--.|.--.- +++..
T Consensus        11 ~l~likQGAEArv~~~~~~Ge---~~iIK~Rf~----K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~   83 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGE---AAIIKERFS----KRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY   83 (229)
T ss_pred             cceeeeccceeeEeeeccCCc---eeEEeeccc----ccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence            568899999999999987764   222222111    12222222222 2345778999998885444322222 33334


Q ss_pred             cEEEEEEecCC-CChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC---cEEEEec
Q 037010          354 SLFLVYEYIEN-GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF---HAKVADF  429 (589)
Q Consensus       354 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~---~vkl~Df  429 (589)
                      .-.|.|||++| .++.+++...............++..+-+.+.-||..++   +|+||..+||++..++   .+.++||
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndi---iHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDI---IHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCe---ecccccccceEEecCCCcCceEEEee
Confidence            56789999977 588889887665544445557888999999999999998   9999999999996554   3589999


Q ss_pred             cCccc
Q 037010          430 GLTKL  434 (589)
Q Consensus       430 gla~~  434 (589)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.94  E-value=3e-09  Score=114.62  Aligned_cols=156  Identities=13%  Similarity=0.241  Sum_probs=90.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhH---hHH-H--------------hhcC-----HHHHHH
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQ---KAA-I--------------KKMD-----MQASRE  327 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~---~~~-i--------------k~~~-----~~~~~~  327 (589)
                      ...|+. +.||+|++|.||+|+.+++ +...+.|+...+....   ... +              +.++     .+..+.
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~-G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDN-GREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCC-CCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            456776 8999999999999998764 3444555443332110   000 0              0001     011122


Q ss_pred             ------HHHHHHHHccC----CCCcceeEeeEEE--eCcEEEEEEecCCCChHHHH--hcCCCCCCCHHHHHHHHHHHHH
Q 037010          328 ------FLAELKVLTHV----HHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHL--RGSGRDPLPWSSRVQIALDSAR  393 (589)
Q Consensus       328 ------~~~E~~il~~l----~hpnIv~l~~~~~--~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~i~~qia~  393 (589)
                            +.+|...+.++    .+.+.+.+-.++.  ....+|||||++|+.+.+.-  ...+   .+.......  .+..
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~~~la~~--~v~~  271 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDMKLLAER--GVEV  271 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCHHHHHHH--HHHH
Confidence                  33444444444    2444444434332  24568999999999998742  2222   222221111  1112


Q ss_pred             HHHHHHhCCCCceEeeccCCCcEEEcCCC----cEEEEeccCccccc
Q 037010          394 GLEYIHEHTVPVYIHRDIKSANILIDKNF----HAKVADFGLTKLTE  436 (589)
Q Consensus       394 aL~~LH~~~i~~~vH~Dlkp~NILl~~~~----~vkl~Dfgla~~~~  436 (589)
                      -+..++..|+   +|+|+||.||+++.++    +++++|||+.....
T Consensus       272 ~~~Qif~~Gf---fHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        272 FFTQVFRDGF---FHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHHHhCCe---eeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            2444567887   9999999999999888    99999999987553

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=9.5e-09  Score=93.15  Aligned_cols=137  Identities=21%  Similarity=0.325  Sum_probs=92.4

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHH-HHHHHHHHHHHccCCCCcceeEeeEEE-eCcE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA-SREFLAELKVLTHVHHLNLVRLIGYCV-EGSL  355 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~  355 (589)
                      ..+++|+-+.+|.+.+.+.   ..+.|....    +.+..+.++..- ..+..+|..++.+++--.|.--.-+.. .+.-
T Consensus         2 ~~i~~GAEa~i~~~~~~g~---~av~K~Ri~----K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGL---PAVVKERIP----KRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             chhhCCcceeEEeeeccCc---ceEEEeecC----cccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            3578899999998865432   122222111    122222332221 245677999998886444432222333 3446


Q ss_pred             EEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       356 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .|+|||++|..|.+++...         ...++..+-.-+.-||..|+   +|+||.++||++..+. +.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~gi---vHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGI---VHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCe---ecCCCccceEEEeCCc-EEEEECCcccc
Confidence            7999999999999888765         24566677777889999999   9999999999997664 99999999874

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.83  E-value=1e-08  Score=99.00  Aligned_cols=142  Identities=22%  Similarity=0.332  Sum_probs=98.6

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCC--CcceeEeeEEEe---
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH--LNLVRLIGYCVE---  352 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~h--pnIv~l~~~~~~---  352 (589)
                      +.|+.|..+.||+++..+  +..++.|.......          .....++..|.++++.+.+  .++.+++.+..+   
T Consensus         4 ~~l~~G~~n~~~~v~~~~--g~~~ilK~~~~~~~----------~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~   71 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG--GRRLVLRRPPPGAL----------LPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV   71 (223)
T ss_pred             eecCCCccceEEEEEecC--CcceEEEeCCCccc----------CcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc
Confidence            678999999999998644  23333332211100          0022356778999988865  345666666654   


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT-----------------------------  402 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~-----------------------------  402 (589)
                       +..++||||++|.++.+.+..   ..++......++.+++.+|..||+..                             
T Consensus        72 ~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  148 (223)
T cd05154          72 LGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDA  148 (223)
T ss_pred             cCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHh
Confidence             356899999999888776532   23667777788888888888888531                             


Q ss_pred             ------------------------CCceEeeccCCCcEEEcC--CCcEEEEeccCccc
Q 037010          403 ------------------------VPVYIHRDIKSANILIDK--NFHAKVADFGLTKL  434 (589)
Q Consensus       403 ------------------------i~~~vH~Dlkp~NILl~~--~~~vkl~Dfgla~~  434 (589)
                                              -..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         149 SRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             hcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                    123799999999999988  66789999997754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.81  E-value=5.9e-09  Score=86.42  Aligned_cols=58  Identities=14%  Similarity=0.105  Sum_probs=43.6

Q ss_pred             HhhheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeeec
Q 037010           32 ALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPC   91 (589)
Q Consensus        32 ~~~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~~   91 (589)
                      .|..|+|++|||||+||++|+.+......-.++.|++.| ++. ++.|.+||+|.||...
T Consensus        35 ~~~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N-~l~-~~~I~~Gq~L~IP~~~   92 (103)
T PRK14125         35 QYVEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVN-NLP-SGHIKAGDKLVIPVLK   92 (103)
T ss_pred             CcEEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhc-CCC-CCcCCCCCEEEEecCC
Confidence            667899999999999999998751100001135778889 885 4579999999999873

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.77  E-value=8.9e-09  Score=85.35  Aligned_cols=50  Identities=24%  Similarity=0.337  Sum_probs=41.9

Q ss_pred             eeeEEeccCcchhcchhhhccCcCc--------HHHHhhcCCCCCCCCCCCcEEEEEeeec
Q 037010          102 TFQFSINSGDTYEKVATRYYSNLTD--------AASLQRINNYPPTRIPDRGTLNVTVNCS  154 (589)
Q Consensus       102 ~~~y~V~~Gdtl~~Ia~~~~~~l~~--------~~~l~~~N~~~~~~l~~g~~l~ip~~~~  154 (589)
                      ...|+|++|||||+|| ++|.  ++        +++|++.|.+.++.|++||+|.||...+
T Consensus        36 ~~~~tV~~GDTLW~IA-~~y~--~~~~l~~~~~v~~I~~~N~l~~~~I~~Gq~L~IP~~~~   93 (103)
T PRK14125         36 YVEITVQEGDTLWALA-DQYA--GKHHMAKNEFIEWVEDVNNLPSGHIKAGDKLVIPVLKS   93 (103)
T ss_pred             cEEEEECCCCCHHHHH-HHhC--CCcCCCHHHHHHHHHHhcCCCCCcCCCCCEEEEecCCC
Confidence            3569999999999999 6665  33        5788889999988999999999996543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.69  E-value=8.7e-08  Score=94.90  Aligned_cols=103  Identities=14%  Similarity=0.197  Sum_probs=78.1

Q ss_pred             HHHHHHHHccCCCCcc--eeEeeEEEe------CcEEEEEEecCCC-ChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 037010          328 FLAELKVLTHVHHLNL--VRLIGYCVE------GSLFLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI  398 (589)
Q Consensus       328 ~~~E~~il~~l~hpnI--v~l~~~~~~------~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~L  398 (589)
                      +.+|...+.+|...+|  ...+++...      ..-++|+|++++- +|.+++......+.+......++.+++..+..|
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L  154 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM  154 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            5667777777643222  233344331      2368999999885 899998654334466677789999999999999


Q ss_pred             HhCCCCceEeeccCCCcEEEcC-------CCcEEEEeccCcc
Q 037010          399 HEHTVPVYIHRDIKSANILIDK-------NFHAKVADFGLTK  433 (589)
Q Consensus       399 H~~~i~~~vH~Dlkp~NILl~~-------~~~vkl~Dfgla~  433 (589)
                      |..|+   +|+|+++.|||++.       +..+.|+||+.+.
T Consensus       155 H~~Gi---~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        155 HAAGI---NHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHCcC---ccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99999   99999999999975       4689999999775

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.68  E-value=1.2e-08  Score=102.56  Aligned_cols=94  Identities=21%  Similarity=0.204  Sum_probs=84.3

Q ss_pred             heeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeeecccCCCcccceeeeEEeccCcchh
Q 037010           35 SYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQFSINSGDTYE  114 (589)
Q Consensus        35 ~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~~~~~~~~~~~~~~~y~V~~Gdtl~  114 (589)
                      .|.|++||++..||+.|+.+        ..+|...| .+++ |.+.+||++.||..           ...|.|++|||++
T Consensus         3 i~~~~pg~~~~~i~~~~~~~--------~~~i~~~~-~~~~-d~~~~~q~~~v~~~-----------~~~y~~~~~d~~~   61 (423)
T COG3858           3 IHLVGPGDSRLIIAVYFPYT--------NNRIVNGN-DYTN-DDLVDGQTFVVPPS-----------GHFYDVGPGDTLT   61 (423)
T ss_pred             EEEccCCceeeeehhhcccc--------cccccccc-cccc-ccccCceeEEECCc-----------ceEEEecCCcchh
Confidence            68999999999999999999        77998888 8877 89999999999975           3579999999999


Q ss_pred             cchhhhccCcCcHHHHhhcCCC-CCCCCCCCcEEEEEee
Q 037010          115 KVATRYYSNLTDAASLQRINNY-PPTRIPDRGTLNVTVN  152 (589)
Q Consensus       115 ~Ia~~~~~~l~~~~~l~~~N~~-~~~~l~~g~~l~ip~~  152 (589)
                      +|| +.++  ||.+++...|.+ .+..+.+|-.+.+|-.
T Consensus        62 Sia-~~~~--vt~~~~~~m~~~~~~~~l~~~~~l~~P~~   97 (423)
T COG3858          62 SIA-RTVG--VTQDSAAIMNFVICPGYLQYGLNLYIPSA   97 (423)
T ss_pred             hhh-hhhc--CCHHHHHhhcccccccceeeeeEEeccCC
Confidence            999 8888  899999999985 4778999999999943

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.65  E-value=4e-07  Score=94.18  Aligned_cols=135  Identities=18%  Similarity=0.266  Sum_probs=105.2

Q ss_pred             HHHHHHccCCCCcceeEeeEEE-----eCcEEEEEEecCC-CChHHHHhcCC-------------CCCCCHHHHHHHHHH
Q 037010          330 AELKVLTHVHHLNLVRLIGYCV-----EGSLFLVYEYIEN-GNLSEHLRGSG-------------RDPLPWSSRVQIALD  390 (589)
Q Consensus       330 ~E~~il~~l~hpnIv~l~~~~~-----~~~~~lv~e~~~~-gsL~~~l~~~~-------------~~~~~~~~~~~i~~q  390 (589)
                      .-+++++++.|.|+|++.+++.     +..+.+|++|.++ ++|.++.-...             ....++..+|.++.|
T Consensus       322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q  401 (655)
T KOG3741|consen  322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ  401 (655)
T ss_pred             HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence            3578889999999999998654     4468999999986 57777553221             123678899999999


Q ss_pred             HHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchh
Q 037010          391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVY  470 (589)
Q Consensus       391 ia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvw  470 (589)
                      +..||.++|+.|.   .-+-|.|.+||++.+.+++|...|.......+...            .-|.      -.+-|.-
T Consensus       402 LtaaL~sIHssGL---Ack~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~------------~le~------~Qq~D~~  460 (655)
T KOG3741|consen  402 LTAALYSIHSSGL---ACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTE------------PLES------QQQNDLR  460 (655)
T ss_pred             HHHHHHHHHhcCc---eeecccHhHeEeeCcceEEEecccceeeecCCCCc------------chhH------HhhhhHH
Confidence            9999999999998   67999999999999999999999887765433310            0111      1257999


Q ss_pred             hHHHHHHHHHcCCcc
Q 037010          471 AFGVVLYELISAKEA  485 (589)
Q Consensus       471 SlGvll~elltG~~p  485 (589)
                      .||.+++.|.||...
T Consensus       461 ~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  461 DLGLLLLALATGTEN  475 (655)
T ss_pred             HHHHHHHHHhhcccc
Confidence            999999999999753

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.64  E-value=3.5e-08  Score=68.88  Aligned_cols=44  Identities=27%  Similarity=0.371  Sum_probs=39.3

Q ss_pred             ccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeee
Q 037010           38 VWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPF   89 (589)
Q Consensus        38 v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~   89 (589)
                      |++|||||+||++|+++        .++|.++|+.+.+++.+.+||.|.||.
T Consensus         1 v~~gdtl~~IA~~~~~~--------~~~l~~~N~~~~~~~~~~~g~~l~ip~   44 (44)
T TIGR02899         1 VQKGDTLWKIAKKYGVD--------FDELIQANPQLSNPNLIYPGMKIKIPS   44 (44)
T ss_pred             CCCCCCHHHHHHHHCcC--------HHHHHHHhhcCCCCCCcCCCCEEecCC
Confidence            68999999999999999        999999996665667899999999983

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.57  E-value=2.9e-08  Score=106.08  Aligned_cols=151  Identities=20%  Similarity=0.336  Sum_probs=101.9

Q ss_pred             HHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCC--------CCCcccccCCCCCchhcccCC
Q 037010          390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA--------SLPTRLVGTFGYMPPEYAQYG  461 (589)
Q Consensus       390 qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~  461 (589)
                      +++.|+.|+|.+-  .+||++|.|++|.++.++..||+.|+++........        ....-..-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            4558999999873  359999999999999999999999998764332111        111112345679999999988


Q ss_pred             CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHH
Q 037010          462 DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAK  541 (589)
Q Consensus       462 ~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~  541 (589)
                      ..+.++|+||+|+++|-+..|..+....++....     ..+...             .+..-...++.+.+.++.+-+.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~~~~~~-------------~~~~~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----YSFSRN-------------LLNAGAFGYSNNLPSELRESLK  246 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcch-----hhhhhc-------------ccccccccccccCcHHHHHHHH
Confidence            8899999999999999999555554333321111     001100             0100011233444556888888


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 037010          542 VCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       542 ~cl~~dP~~RPs~~evl~~  560 (589)
                      +++..++..||++.++...
T Consensus       247 k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             HHhcCCcccCcchhhhhcc
Confidence            8999999999988776543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.51  E-value=9.9e-07  Score=84.36  Aligned_cols=103  Identities=19%  Similarity=0.258  Sum_probs=79.0

Q ss_pred             HHHHHHHHHccCCCC--cceeEeeEEEe-----CcEEEEEEecCCC-ChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 037010          327 EFLAELKVLTHVHHL--NLVRLIGYCVE-----GSLFLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI  398 (589)
Q Consensus       327 ~~~~E~~il~~l~hp--nIv~l~~~~~~-----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~L  398 (589)
                      ...+|.+.+.+|...  ...+.+++...     ..-++|+|++++- +|.+++.....  .+......++.+++..+.-|
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHH
Confidence            455677776666432  23444554443     1358999999884 79999886443  55667789999999999999


Q ss_pred             HhCCCCceEeeccCCCcEEEcCCC---cEEEEeccCccc
Q 037010          399 HEHTVPVYIHRDIKSANILIDKNF---HAKVADFGLTKL  434 (589)
Q Consensus       399 H~~~i~~~vH~Dlkp~NILl~~~~---~vkl~Dfgla~~  434 (589)
                      |+.|+   +|+|+++.|||++.++   .+.++||+-+..
T Consensus       135 H~~gi---~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGI---YHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcC---CCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999   9999999999998887   899999997664

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.50  E-value=4.1e-07  Score=85.54  Aligned_cols=141  Identities=13%  Similarity=0.194  Sum_probs=97.1

Q ss_pred             eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-HHHHHHHHHHHHHHccCCCCc--ceeEeeEEE---eC
Q 037010          280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-MQASREFLAELKVLTHVHHLN--LVRLIGYCV---EG  353 (589)
Q Consensus       280 LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-~~~~~~~~~E~~il~~l~hpn--Iv~l~~~~~---~~  353 (589)
                      -|.||.+.|++....+.  ..++++..       ........ ......|.+|...|.+|..-+  +.+.. ++.   .+
T Consensus        26 ~~rgG~SgV~r~~~~g~--~~ylKrq~-------nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~   95 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK--KLYVKRMT-------HHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIE   95 (216)
T ss_pred             cCCCCcceEEEEEeCCc--EEEEEecc-------CcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccC
Confidence            46689999998876554  12222211       00000111 123356788998888884322  33333 332   11


Q ss_pred             ---cEEEEEEecCC-CChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc--EEEE
Q 037010          354 ---SLFLVYEYIEN-GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH--AKVA  427 (589)
Q Consensus       354 ---~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~--vkl~  427 (589)
                         .-+||+|-+.| -+|.+++......+.+......++.+++..+.-||+.|+   .|+|+-+.|||++.++.  ++++
T Consensus        96 ~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv---~Hgdly~khIll~~~g~~~v~lI  172 (216)
T PRK09902         96 GEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNR---QHGCCYVRHIYVKTEGKAEAGFL  172 (216)
T ss_pred             CceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCC---cCCCCCHhheeecCCCCeeEEEE
Confidence               25799997764 589999877665567788888999999999999999999   99999999999986666  9999


Q ss_pred             eccCcc
Q 037010          428 DFGLTK  433 (589)
Q Consensus       428 Dfgla~  433 (589)
                      ||.-++
T Consensus       173 DlEk~r  178 (216)
T PRK09902        173 DLEKSR  178 (216)
T ss_pred             Ehhccc
Confidence            997554

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.46  E-value=2.3e-07  Score=93.54  Aligned_cols=96  Identities=24%  Similarity=0.337  Sum_probs=80.5

Q ss_pred             eEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEeeecCCCcccCCceeEEEEEeCCCCCCHhHhHh
Q 037010          104 QFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIAR  183 (589)
Q Consensus       104 ~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~ia~  183 (589)
                      .|.|++||++..|| ++|.  ++...|...|.+..+.|.+||.+.||..              .-.|.|++|||+++||+
T Consensus         3 i~~~~pg~~~~~i~-~~~~--~~~~~i~~~~~~~~d~~~~~q~~~v~~~--------------~~~y~~~~~d~~~Sia~   65 (423)
T COG3858           3 IHLVGPGDSRLIIA-VYFP--YTNNRIVNGNDYTNDDLVDGQTFVVPPS--------------GHFYDVGPGDTLTSIAR   65 (423)
T ss_pred             EEEccCCceeeeeh-hhcc--ccccccccccccccccccCceeEEECCc--------------ceEEEecCCcchhhhhh
Confidence            58999999999999 8999  8999997777766688999999999942              23699999999999999


Q ss_pred             hcCCCHHHHhhcCCCC--CcccCcceEEecCCCCC
Q 037010          184 NVGLSESLLQNYNPGV--NFTRGSGLVFIPGRDAN  216 (589)
Q Consensus       184 ~~~~~~~~l~~~N~~~--~~~~~g~~~~iP~~~~~  216 (589)
                      +|+++.+.+...|...  .....+-.+.+|.....
T Consensus        66 ~~~vt~~~~~~m~~~~~~~~l~~~~~l~~P~~~~~  100 (423)
T COG3858          66 TVGVTQDSAAIMNFVICPGYLQYGLNLYIPSARKT  100 (423)
T ss_pred             hhcCCHHHHHhhcccccccceeeeeEEeccCCCCC
Confidence            9999999999999765  36666656777765433

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.37  E-value=2.7e-07  Score=90.60  Aligned_cols=47  Identities=21%  Similarity=0.292  Sum_probs=43.8

Q ss_pred             eeeeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEE
Q 037010          101 HTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVT  150 (589)
Q Consensus       101 ~~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip  150 (589)
                      ....|+||+|||||.|| ++|+  |+++.|+++|++.++.|++||.|.||
T Consensus       292 ~~~~YiVq~GDTL~sIA-kRYG--VSV~~L~r~N~L~~~~L~~GQ~L~IP  338 (338)
T TIGR02907       292 KLRMCIVQEGDTIETIA-ERYE--ISVSQLIRHNQLEDFEVNEGQILYIP  338 (338)
T ss_pred             ccEEEEECCCCCHHHHH-HHHC--cCHHHHHHHhCCCccccCCCCEEEeC
Confidence            34689999999999999 8999  89999999999888899999999997

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.37  E-value=3.4e-07  Score=63.89  Aligned_cols=44  Identities=20%  Similarity=0.481  Sum_probs=40.0

Q ss_pred             eEEeccCcchhcchhhhccCcCcHHHHhhcCCC-CCCCCCCCcEEEEE
Q 037010          104 QFSINSGDTYEKVATRYYSNLTDAASLQRINNY-PPTRIPDRGTLNVT  150 (589)
Q Consensus       104 ~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~-~~~~l~~g~~l~ip  150 (589)
                      .|+|++|||+++|| ++|+  ++..+|+++|+. ....+.+|+.|.||
T Consensus         2 ~~~v~~gdt~~~ia-~~~~--~~~~~~~~~N~~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIA-QRYG--ISVEELLKLNGLSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHH-HHHC--cCHHHHHHHcCCCCccccCCCCEEecC
Confidence            59999999999999 7888  899999999997 46789999999987

This domain may have a general peptidoglycan binding function.

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.37  E-value=2.3e-07  Score=64.66  Aligned_cols=41  Identities=27%  Similarity=0.390  Sum_probs=36.4

Q ss_pred             eccCcchhcchhhhccCcCcHHHHhhcCC-CC-CCCCCCCcEEEEE
Q 037010          107 INSGDTYEKVATRYYSNLTDAASLQRINN-YP-PTRIPDRGTLNVT  150 (589)
Q Consensus       107 V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~-~~-~~~l~~g~~l~ip  150 (589)
                      |++|||||+|| ++|+  ++.++|.++|+ +. ++.+.+||.|.||
T Consensus         1 v~~gdtl~~IA-~~~~--~~~~~l~~~N~~~~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIA-KKYG--VDFDELIQANPQLSNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHH-HHHC--cCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence            68999999999 7788  79999999998 54 4679999999998

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.33  E-value=7.2e-07  Score=62.20  Aligned_cols=45  Identities=33%  Similarity=0.505  Sum_probs=40.3

Q ss_pred             heeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEee
Q 037010           35 SYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVP   88 (589)
Q Consensus        35 ~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip   88 (589)
                      .|+|++|||+++||++|+++        ..+|.++|+ ......+.+|+.|.||
T Consensus         2 ~~~v~~gdt~~~ia~~~~~~--------~~~~~~~N~-~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYGIS--------VEELLKLNG-LSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHHHHHCcC--------HHHHHHHcC-CCCccccCCCCEEecC
Confidence            58999999999999999999        999999995 4456689999999987

This domain may have a general peptidoglycan binding function.

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.32  E-value=3.5e-07  Score=91.00  Aligned_cols=47  Identities=26%  Similarity=0.280  Sum_probs=42.8

Q ss_pred             eeEEeccCcchhcchhhhccCcCcHHHHhhcCCCC-CCCCCCCcEEEEEee
Q 037010          103 FQFSINSGDTYEKVATRYYSNLTDAASLQRINNYP-PTRIPDRGTLNVTVN  152 (589)
Q Consensus       103 ~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~-~~~l~~g~~l~ip~~  152 (589)
                      ..|+||+|||||.|| +.|+  +++.+|.++|++. ++.|++||+|.||..
T Consensus        61 ~~y~Vk~GDTL~~IA-~~~g--~~~~~La~~N~l~~p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         61 STYTVKKGDTLFYIA-WITG--NDFRDLAQRNNIQAPYSLNVGQTLQVGNA  108 (319)
T ss_pred             CceEECCCCHHHHHH-HHHC--cCHHHHHHhcCCCCCccccCCCEEEeCCC
Confidence            469999999999999 7888  8999999999986 689999999999854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.30  E-value=2.8e-06  Score=79.41  Aligned_cols=99  Identities=19%  Similarity=0.252  Sum_probs=64.7

Q ss_pred             HHHHHHHHHHccCCCC--cceeEeeEEEeCcEEEEEEecC--CCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHH-HHh
Q 037010          326 REFLAELKVLTHVHHL--NLVRLIGYCVEGSLFLVYEYIE--NGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY-IHE  400 (589)
Q Consensus       326 ~~~~~E~~il~~l~hp--nIv~l~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~-LH~  400 (589)
                      ....+|.+.|.++..-  ++.+.+++  . .-.|||||+.  |..+..+....    ++......++.+++..+.. +|.
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~--~-~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~  125 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDY--N-RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHK  125 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEE--E-TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEE--e-CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHh
Confidence            4567799999999755  34555543  2 3369999998  65554433322    1133455677777775555 579


Q ss_pred             CCCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          401 HTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       401 ~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      .|+   +|+||.+.|||++++ .+.|+|||.+...
T Consensus       126 ~gi---vHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  126 AGI---VHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             TTE---EESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             cCc---eecCCChhhEEeecc-eEEEEecCcceec
Confidence            998   999999999999887 9999999987643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.28  E-value=5.7e-07  Score=88.36  Aligned_cols=47  Identities=21%  Similarity=0.265  Sum_probs=43.3

Q ss_pred             HhhheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEee
Q 037010           32 ALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVP   88 (589)
Q Consensus        32 ~~~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip   88 (589)
                      .+..|+|++|||||.||++||++        +..|+++| ++. ++.|.+||.|+||
T Consensus       292 ~~~~YiVq~GDTL~sIAkRYGVS--------V~~L~r~N-~L~-~~~L~~GQ~L~IP  338 (338)
T TIGR02907       292 KLRMCIVQEGDTIETIAERYEIS--------VSQLIRHN-QLE-DFEVNEGQILYIP  338 (338)
T ss_pred             ccEEEEECCCCCHHHHHHHHCcC--------HHHHHHHh-CCC-ccccCCCCEEEeC
Confidence            45579999999999999999999        99999999 885 7899999999998

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.27  E-value=4.1e-06  Score=80.77  Aligned_cols=145  Identities=19%  Similarity=0.175  Sum_probs=92.8

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc--------C----HHHHHHHHHHHHHHccCCC
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--------D----MQASREFLAELKVLTHVHH  340 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~--------~----~~~~~~~~~E~~il~~l~h  340 (589)
                      =+.++.+||.|.-|.||.|.+..  +...+.|.-......-. .+|..        .    .-......+|.++|.+|..
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~--g~~~~vKfHR~GrtsFr-kvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~  168 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPK--GRKVAVKFHRLGRTSFR-KVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYP  168 (304)
T ss_pred             HHhhccccccCccceEEEEECCC--CCEEEEEEeecCchhhh-hhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhh
Confidence            34567899999999999998653  22333222222111100 11111        1    0123346789999998854


Q ss_pred             C--cceeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE
Q 037010          341 L--NLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI  418 (589)
Q Consensus       341 p--nIv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl  418 (589)
                      .  .+.+.+++   +.-.+|||+++|-.|...-       +.....-.++..|+.-+..+-..|+   ||+|+.+-||++
T Consensus       169 ~G~~VP~P~~~---nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~Gi---VHGDlSefNIlV  235 (304)
T COG0478         169 EGVKVPKPIAW---NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGI---VHGDLSEFNILV  235 (304)
T ss_pred             cCCCCCCcccc---ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCc---cccCCchheEEE
Confidence            3  44444433   4567999999996665432       1233344555566666666678888   999999999999


Q ss_pred             cCCCcEEEEeccCcc
Q 037010          419 DKNFHAKVADFGLTK  433 (589)
Q Consensus       419 ~~~~~vkl~Dfgla~  433 (589)
                      +++|.+.++||-.+.
T Consensus       236 ~~dg~~~vIDwPQ~v  250 (304)
T COG0478         236 TEDGDIVVIDWPQAV  250 (304)
T ss_pred             ecCCCEEEEeCcccc
Confidence            999999999997654

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.25  E-value=8.3e-07  Score=88.38  Aligned_cols=47  Identities=21%  Similarity=0.237  Sum_probs=44.7

Q ss_pred             heeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeee
Q 037010           35 SYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFP   90 (589)
Q Consensus        35 ~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~   90 (589)
                      +|+|++|||||.||..||++        ..+|.++| +|.++..|.+||.|.||..
T Consensus        62 ~y~Vk~GDTL~~IA~~~g~~--------~~~La~~N-~l~~p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         62 TYTVKKGDTLFYIAWITGND--------FRDLAQRN-NIQAPYSLNVGQTLQVGNA  108 (319)
T ss_pred             ceEECCCCHHHHHHHHHCcC--------HHHHHHhc-CCCCCccccCCCEEEeCCC
Confidence            69999999999999999999        99999999 9988899999999999865

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=98.25  E-value=8.3e-07  Score=92.51  Aligned_cols=47  Identities=21%  Similarity=0.267  Sum_probs=43.8

Q ss_pred             eeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEee
Q 037010          103 FQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVN  152 (589)
Q Consensus       103 ~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~~  152 (589)
                      ..|+||+|||||.|| ++|+  +++++|+++|++.++.|++||.|.||..
T Consensus        28 ~tytVq~GDTLw~IA-~~yg--vtv~~I~~~N~l~~~~I~~Gq~L~Ip~~   74 (481)
T PRK13914         28 STVVVEAGDTLWGIA-QSKG--TTVDAIKKANNLTTDKIVPGQKLQVNEV   74 (481)
T ss_pred             ceEEECCCCCHHHHH-HHHC--CCHHHHHHHhCCCcccccCCCEEEeCCC
Confidence            469999999999999 8888  8999999999999889999999999965

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.24  E-value=2.1e-05  Score=74.39  Aligned_cols=147  Identities=14%  Similarity=0.148  Sum_probs=87.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhh-hHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLL-MQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~-~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...+|.+.+.+-......|.+....+.   .++.|....... .+.....-++.+........+..++...--....++.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~---kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGK---KYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCc---EEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            457888888898888888888765542   232222221111 1111111222222333333444443333333333332


Q ss_pred             EEE------eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          349 YCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       349 ~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      ...      -...+++|||++|..|.++..      +++    .+...+.+++.-||..|+   +|+|..|.|+++++++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~---~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGF---YHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCC---ccCCCCcCcEEEECCc
Confidence            221      223568999999988876532      222    244566778999999998   9999999999998664


Q ss_pred             cEEEEeccCcc
Q 037010          423 HAKVADFGLTK  433 (589)
Q Consensus       423 ~vkl~Dfgla~  433 (589)
                       ++++||+..+
T Consensus       173 -i~iID~~~k~  182 (229)
T PF06176_consen  173 -IRIIDTQGKR  182 (229)
T ss_pred             -EEEEECcccc
Confidence             9999997554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=98.04  E-value=5.9e-06  Score=73.99  Aligned_cols=49  Identities=22%  Similarity=0.403  Sum_probs=40.4

Q ss_pred             eeeEEeccCcchhcchhhhccCcCcHHHHhhcCC--CC-CCCCCCCcEEEEE
Q 037010          102 TFQFSINSGDTYEKVATRYYSNLTDAASLQRINN--YP-PTRIPDRGTLNVT  150 (589)
Q Consensus       102 ~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~--~~-~~~l~~g~~l~ip  150 (589)
                      ...|+|++|||||+||.++|+.-..+..|+++|+  +. ++.|++||+|.||
T Consensus        95 ~~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         95 SQFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             CeEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            3579999999999999666663235789999997  55 6789999999998

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=97.99  E-value=5.4e-06  Score=72.37  Aligned_cols=46  Identities=30%  Similarity=0.555  Sum_probs=43.2

Q ss_pred             eeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEe
Q 037010          103 FQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTV  151 (589)
Q Consensus       103 ~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~  151 (589)
                      ..|+|++||||+.|| +.|+  +++.+|+++|++.++.+++||.|.+|.
T Consensus        67 ~~~~V~~gdtL~~Ia-~~~~--~tv~~l~~~n~l~~~~i~~gq~l~~~~  112 (124)
T COG1388          67 VTYTVKKGDTLSKIA-RKYG--VTVAELKQLNNLSSDKIKVGQKLKLPV  112 (124)
T ss_pred             ceEEEecCCCHHHHH-HHhC--CCHHHHHHHhccCCCceecCcEEEEec
Confidence            579999999999999 7888  899999999999988999999999996

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.99  E-value=5.1e-05  Score=73.65  Aligned_cols=140  Identities=21%  Similarity=0.272  Sum_probs=74.4

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCCC--cceeEeeEEEe-
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHHL--NLVRLIGYCVE-  352 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~hp--nIv~l~~~~~~-  352 (589)
                      ++.|+.|..+.||++...+.   .+              .+|.... .....+..|.++++.+...  .+.+++.+... 
T Consensus         2 i~~l~~G~~n~~~~v~~~~~---~~--------------vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~   64 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDG---RY--------------VLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD   64 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTS---EE--------------EEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET
T ss_pred             CccCCCCCeeeEEEEEECCc---EE--------------EEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccc
Confidence            46799999999999986552   22              2222222 2345566788888777432  34555554432 


Q ss_pred             ---CcEEEEEEecCCCChHH----------------HHh---cC--CCCCCCHHHH---------HHH------------
Q 037010          353 ---GSLFLVYEYIENGNLSE----------------HLR---GS--GRDPLPWSSR---------VQI------------  387 (589)
Q Consensus       353 ---~~~~lv~e~~~~gsL~~----------------~l~---~~--~~~~~~~~~~---------~~i------------  387 (589)
                         ...+++|++++|..+..                .+.   ..  ...++.....         ...            
T Consensus        65 ~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (239)
T PF01636_consen   65 EFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDD  144 (239)
T ss_dssp             EETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHH
T ss_pred             cccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhh
Confidence               23689999999987776                111   11  1111111110         000            


Q ss_pred             HHHHHH-HHHHHHhC----CCCceEeeccCCCcEEEc-CCCcEEEEeccCcc
Q 037010          388 ALDSAR-GLEYIHEH----TVPVYIHRDIKSANILID-KNFHAKVADFGLTK  433 (589)
Q Consensus       388 ~~qia~-aL~~LH~~----~i~~~vH~Dlkp~NILl~-~~~~vkl~Dfgla~  433 (589)
                      ...+.. .++.++..    .-..++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  145 LEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hHHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            011222 23333321    223469999999999999 66777899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>smart00257 LysM Lysin motif

Probab=97.93  E-value=9.7e-06  Score=55.63  Aligned_cols=43  Identities=26%  Similarity=0.530  Sum_probs=37.4

Q ss_pred             eEEeccCcchhcchhhhccCcCcHHHHhhcCCC-CCCCCCCCcEEEE
Q 037010          104 QFSINSGDTYEKVATRYYSNLTDAASLQRINNY-PPTRIPDRGTLNV  149 (589)
Q Consensus       104 ~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~-~~~~l~~g~~l~i  149 (589)
                      .|+|++|||+++|| +.|+  ++.++|..+|+. ....+.+|+.|.|
T Consensus         1 ~~~v~~gdt~~~ia-~~~~--~~~~~~~~~N~~~~~~~~~~g~~l~i   44 (44)
T smart00257        1 TYTVKKGDTLSSIA-RRYG--ISVSDLLELNNILDPDNLQVGQKLKI   44 (44)
T ss_pred             CeEeCCCCCHHHHH-HHhC--CCHHHHHHHcCCCCccccCCCCEEeC
Confidence            38999999999999 7888  799999999994 4678999998864

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.93  E-value=9.1e-07  Score=93.76  Aligned_cols=187  Identities=19%  Similarity=0.148  Sum_probs=125.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCc-ceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLN-LVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~  349 (589)
                      +..+...+-+++|++++++|.+...+  +.          +.    .+.+...  ....-++++|.+++||| .++.++-
T Consensus       241 ~kws~~fh~fvK~altknpKkRptae--kl----------L~----h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d  302 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAE--KL----------LQ----HPFVSQT--LSRRLAIELLDKVNNPNPVVRYLED  302 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChh--hh----------ee----ceeeccc--hhhHHHHHHHHHccCCCCccccccc
Confidence            34455557788999999998764332  00          00    1111111  23345899999999999 5555543


Q ss_pred             E-EeCcEEEEEEecCCC-ChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          350 C-VEGSLFLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       350 ~-~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      + .+...++.++++.++ +-..-+... ...+...+...+.+.-+++++++|+..-   +|+|    ||+..+ +..+..
T Consensus       303 ~~~E~~~~i~~~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~---~~~d----~~l~s~-~~~~~~  373 (829)
T KOG0576|consen  303 YDGEDYLWIPMRICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYK---VHRD----NILGSE-EEVKLL  373 (829)
T ss_pred             CCcccccchhhhhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccc---cCcc----cccccc-cccccc
Confidence            3 355688999999876 211111100 1113334455666677889999999865   7999    777755 578999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCccc
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI  486 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~  486 (589)
                      ||+.........  ......+++.++|||+...+.+..+.|+|++|+-..+|--|-.|-
T Consensus       374 ~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  374 DFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            999876554332  234467999999999999999999999999998777777666554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.90  E-value=4.9e-05  Score=73.66  Aligned_cols=28  Identities=18%  Similarity=0.217  Sum_probs=25.0

Q ss_pred             ceEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          405 VYIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                      .++|+|+.|.||++++++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            469999999999999888 9999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>smart00257 LysM Lysin motif

Probab=97.90  E-value=1.9e-05  Score=54.06  Aligned_cols=44  Identities=27%  Similarity=0.446  Sum_probs=37.7

Q ss_pred             heeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEe
Q 037010           35 SYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINV   87 (589)
Q Consensus        35 ~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~i   87 (589)
                      .|+|++|||+++||++|+++        ..+|.++|+.. ....+.+|+.+.|
T Consensus         1 ~~~v~~gdt~~~ia~~~~~~--------~~~~~~~N~~~-~~~~~~~g~~l~i   44 (44)
T smart00257        1 TYTVKKGDTLSSIARRYGIS--------VSDLLELNNIL-DPDNLQVGQKLKI   44 (44)
T ss_pred             CeEeCCCCCHHHHHHHhCCC--------HHHHHHHcCCC-CccccCCCCEEeC
Confidence            38999999999999999999        89999999533 5567889998764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.86  E-value=6.2e-05  Score=70.59  Aligned_cols=101  Identities=24%  Similarity=0.333  Sum_probs=79.2

Q ss_pred             HHHHHHccCCC-CcceeEeeEEEeCcEEEEEEecCCCChHHH---HhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 037010          330 AELKVLTHVHH-LNLVRLIGYCVEGSLFLVYEYIENGNLSEH---LRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPV  405 (589)
Q Consensus       330 ~E~~il~~l~h-pnIv~l~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~  405 (589)
                      .|.-+|+.+++ +++.+++|+|-   .+++.||...+++...   +...  ...+|..+.+|+.++++.+++|++.-...
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG---~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG---RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC---CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            47778888875 68999999983   3678899987765421   1111  12789999999999999999999854444


Q ss_pred             eEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          406 YIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       406 ~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      +.-.|++++|+-+++++++|++|.......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            578999999999999999999999866543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=97.80  E-value=1.9e-05  Score=70.77  Aligned_cols=49  Identities=24%  Similarity=0.373  Sum_probs=40.4

Q ss_pred             heeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccC-CCCCcccCCCCeEEee
Q 037010           35 SYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQ-LSNKDSLLADTRINVP   88 (589)
Q Consensus        35 ~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~-~~~~~~~~~g~~l~ip   88 (589)
                      .|+|++|||||+||++|..+.     ....+|.++|+. +.+++.|.+||.|.||
T Consensus        97 ~y~Vk~GDTL~~IA~~~~g~~-----~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         97 FYTVKSGDTLSAIAKKVYGNA-----NKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             EEEECCCCCHHHHHHHHcCCh-----hhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            699999999999999985431     117799999932 7778889999999998

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.76  E-value=9.3e-05  Score=72.75  Aligned_cols=30  Identities=27%  Similarity=0.296  Sum_probs=26.0

Q ss_pred             CceEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          404 PVYIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       404 ~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                      +.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            347999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.65  E-value=0.00013  Score=82.87  Aligned_cols=197  Identities=19%  Similarity=0.191  Sum_probs=136.8

Q ss_pred             HHHHHHHHccCCCCcceeEeeEEEeCc-----EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 037010          328 FLAELKVLTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT  402 (589)
Q Consensus       328 ~~~E~~il~~l~hpnIv~l~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~  402 (589)
                      ...|.+.+.+..|+|++.++.|..+..     ..+..|++...++.+.+.....  .+....+.+..+...||.|+|+..
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~--i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS--IPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc--cCHHHHHHHHHHHhhhHHHHHHhc
Confidence            334777788889999999998876432     2356678888888888876654  778888889999999999999997


Q ss_pred             CCceEeeccCCC---cEEEcCCCcEEEE--eccCccccccCCCCCCcccccCCCCCchhcccCCCCCc--ccchhhHHHH
Q 037010          403 VPVYIHRDIKSA---NILIDKNFHAKVA--DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSP--KVDVYAFGVV  475 (589)
Q Consensus       403 i~~~vH~Dlkp~---NILl~~~~~vkl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~sDvwSlGvl  475 (589)
                      .   .|.-+..+   +--.+..+.+.++  ||+...........  .....+..+.++|.......+.  ..|+|.+|..
T Consensus       307 l---~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  307 L---EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             c---ceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence            6   66655555   4445566677777  88887765433222  1223455677888776665554  4799999999


Q ss_pred             HHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 037010          476 LYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR  555 (589)
Q Consensus       476 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  555 (589)
                      +..+..|..+-...           ....             .+++..    ..    ..+.+....|+..++++|+++.
T Consensus       382 ~~~~~~~~~i~~~~-----------~~~~-------------~~l~~~----~~----~~~~d~~~~~~~~~~~~Rl~~~  429 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKS-----------AVPV-------------SLLDVL----ST----SELLDALPKCLDEDSEERLSAL  429 (1351)
T ss_pred             HhhhhhcCcccccc-----------cchh-------------hhhccc----cc----hhhhhhhhhhcchhhhhccchh
Confidence            99999887643110           0111             111111    11    1467788899999999999999


Q ss_pred             HHHHHHHh
Q 037010          556 SIVVALMT  563 (589)
Q Consensus       556 evl~~L~~  563 (589)
                      +++.+...
T Consensus       430 ~ll~~~f~  437 (1351)
T KOG1035|consen  430 ELLTHPFL  437 (1351)
T ss_pred             hhhhchhc
Confidence            99998653

>PLN02876 acyl-CoA dehydrogenase

Probab=97.49  E-value=0.00057  Score=79.14  Aligned_cols=81  Identities=20%  Similarity=0.366  Sum_probs=49.8

Q ss_pred             ceeeccCCcEEEEEEEEccccC-CccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcc--eeEeeEEEe
Q 037010          277 SHKIGQGGFGAVYYAELRGEYG-NSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNL--VRLIGYCVE  352 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnI--v~l~~~~~~  352 (589)
                      .+.++.|.+..+|+....+... ..++.+.....          ........+.+|.++|+.+. |.++  .+++.++.+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~----------~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d  112 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPG----------KLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTD  112 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCC----------ccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecC
Confidence            5778999999999987654321 11111111000          00011235678999999885 6654  677777765


Q ss_pred             ----CcEEEEEEecCCCCh
Q 037010          353 ----GSLFLVYEYIENGNL  367 (589)
Q Consensus       353 ----~~~~lv~e~~~~gsL  367 (589)
                          +..|+||||++|..+
T Consensus       113 ~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876        113 ASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             CCcCCCceEEEEecCCccc
Confidence                358999999998643

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.48  E-value=0.00079  Score=72.61  Aligned_cols=162  Identities=16%  Similarity=0.192  Sum_probs=93.8

Q ss_pred             cHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHh-----------HHHhhc-------CH-H
Q 037010          263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK-----------AAIKKM-------DM-Q  323 (589)
Q Consensus       263 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~ik~~-------~~-~  323 (589)
                      ++++.....+    .+.|+.++-|.||+|+.++  |...+.|+...+.....           ..++..       +. +
T Consensus       120 ~iee~F~eF~----~~PiAsASIaQVH~A~L~s--G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~  193 (517)
T COG0661         120 PIEELFSEFE----PEPIASASIAQVHRAVLKS--GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVE  193 (517)
T ss_pred             CHHHHHHHcC----CCchhhhhHhhheeEEecC--CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHH
Confidence            4444444333    3789999999999999886  34444443333211100           000111       10 0


Q ss_pred             HH----H------HHHHHHHHHccC----CCCcceeEeeEEE--eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHH
Q 037010          324 AS----R------EFLAELKVLTHV----HHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI  387 (589)
Q Consensus       324 ~~----~------~~~~E~~il~~l----~hpnIv~l~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i  387 (589)
                      ..    +      ++.+|..-+.++    ++..-+++-.++.  .+.-.|+|||++|-.+.+...-.. ...+...+...
T Consensus       194 vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~  272 (517)
T COG0661         194 VVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAEL  272 (517)
T ss_pred             HHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHH
Confidence            11    1      234455555444    2222233333332  355789999999998888743222 22554444333


Q ss_pred             HHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       388 ~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      ..++.  +..+=..|.   +|.|.+|.||+++.+|++.+.|||+.....
T Consensus       273 ~~~~f--~~q~~~dgf---fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         273 LVRAF--LRQLLRDGF---FHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             HHHHH--HHHHHhcCc---cccCCCccceEEecCCcEEEEcCcceecCC
Confidence            33322  455555777   999999999999999999999999876543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.48  E-value=0.00096  Score=64.04  Aligned_cols=162  Identities=17%  Similarity=0.199  Sum_probs=92.4

Q ss_pred             ccHHHHHhhcCCCccceeec---cCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHH---------hhc--CHH-H-H
Q 037010          262 FSYEELSKATDNFSMSHKIG---QGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI---------KKM--DMQ-A-S  325 (589)
Q Consensus       262 ~~~~~~~~~~~~y~~~~~LG---~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~i---------k~~--~~~-~-~  325 (589)
                      .+.+.+....++..+.+..|   .|.-+.||+|...+  +...+.|++.......+..-         +..  ... . .
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~--~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~  112 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGD--GRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVF  112 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCC--CceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHH
Confidence            34555666667766666555   57777899986422  23334443333222111100         000  000 0 1


Q ss_pred             HHHHHHHHHHccCC--CCcceeEeeEEEeCcEEEEEEecCCCCh-HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 037010          326 REFLAELKVLTHVH--HLNLVRLIGYCVEGSLFLVYEYIENGNL-SEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-H  401 (589)
Q Consensus       326 ~~~~~E~~il~~l~--hpnIv~l~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~  401 (589)
                      .-...|..-|+++.  +-.+.+-+.+.   +-.|||||+....+ .-.|..   -++...+...+..++++.+.-|-. .
T Consensus       113 ~W~~kEf~NL~R~~eAGVrvP~Pi~~~---~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         113 AWARKEFRNLKRAYEAGVRVPEPIAFR---NNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCCceeec---CCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            11345777777763  22222323221   34689999965310 001111   123333567778888888888877 7


Q ss_pred             CCCceEeeccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          402 TVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       402 ~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      ++   ||+||+.-|||+. ++.+.|+||+.|...
T Consensus       187 ~L---VHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         187 GL---VHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             Cc---ccccchhhheEEE-CCeEEEEECcccccc
Confidence            77   9999999999999 779999999988654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.46  E-value=0.0002  Score=64.87  Aligned_cols=129  Identities=19%  Similarity=0.267  Sum_probs=84.9

Q ss_pred             ccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCCCccee-EeeEEEe
Q 037010          275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHHLNLVR-LIGYCVE  352 (589)
Q Consensus       275 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~hpnIv~-l~~~~~~  352 (589)
                      +..+.|++|.+|.||++.+.+.                 .+++|.... .....+..|.++|..+.-.++-+ ++.|   
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~-----------------~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y---   84 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGG-----------------EVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY---   84 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCc-----------------eEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe---
Confidence            3567899999999999998875                 334443332 33456778999998887555432 3322   


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC-CCcEEEcCCCcEEEEeccC
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK-SANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk-p~NILl~~~~~vkl~Dfgl  431 (589)
                      +.-++.|||++|-.|.++-...     +.    +-...+++.---|-..||   -|+.|. |..+++..++.+.|+||..
T Consensus        85 g~~~i~me~i~G~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~GI---~H~El~~~~k~vlv~~~~~~iIDFd~  152 (201)
T COG2112          85 GEDFIRMEYIDGRPLGKLEIGG-----DR----KHLLRVLEKAYKLDRLGI---EHGELSRPWKNVLVNDRDVYIIDFDS  152 (201)
T ss_pred             chhhhhhhhhcCcchhhhhhcc-----cH----HHHHHHHHHHHHHHHhcc---chhhhcCCceeEEecCCcEEEEEccc
Confidence            2334569999998888765431     11    223345555555667777   888887 4444444555999999998


Q ss_pred             cccc
Q 037010          432 TKLT  435 (589)
Q Consensus       432 a~~~  435 (589)
                      |...
T Consensus       153 At~k  156 (201)
T COG2112         153 ATFK  156 (201)
T ss_pred             hhhc
Confidence            8743

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.36  E-value=0.00065  Score=66.36  Aligned_cols=28  Identities=29%  Similarity=0.551  Sum_probs=24.3

Q ss_pred             eEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          406 YIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       406 ~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                      ++|+|+.+.||+++++...-|+||+.+.
T Consensus       166 l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         166 WFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             EEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            6999999999999877656799999765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.29  E-value=0.0014  Score=66.45  Aligned_cols=76  Identities=12%  Similarity=0.062  Sum_probs=48.2

Q ss_pred             ccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH-HHHHHHHHHHHHccCCC---CcceeEeeEE
Q 037010          275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-ASREFLAELKVLTHVHH---LNLVRLIGYC  350 (589)
Q Consensus       275 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~E~~il~~l~h---pnIv~l~~~~  350 (589)
                      .-.+.||.|..+.||+....+.   .++.              |..+.. ....+..|.+.|+.+..   -.+.++++++
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~---~~~~--------------k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~   79 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG---NPMP--------------LMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVM   79 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC---CEEE--------------EEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEe
Confidence            3457799999999999754332   1111              111110 12356778888887742   3566777765


Q ss_pred             E----eCcEEEEEEecCCCCh
Q 037010          351 V----EGSLFLVYEYIENGNL  367 (589)
Q Consensus       351 ~----~~~~~lv~e~~~~gsL  367 (589)
                      .    .+..++|||+++|+++
T Consensus        80 ~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         80 THEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             ccCCcCCCeEEEEeccCCEec
Confidence            4    2458999999998765

>PRK10260 L,D-transpeptidase; Provisional

Probab=97.25  E-value=0.0005  Score=67.86  Aligned_cols=47  Identities=17%  Similarity=0.223  Sum_probs=41.3

Q ss_pred             heeccCCC--CHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeee
Q 037010           35 SYYVWIGS--NLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFP   90 (589)
Q Consensus        35 ~y~v~~g~--~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~   90 (589)
                      .|+|++|+  +|..||++|++.        ...|+++||++ ++-...+|++|.||..
T Consensus        42 ~~~v~~~~~~~le~iA~~f~~g--------~~~l~~aNPgv-dp~lp~~G~~i~iP~~   90 (306)
T PRK10260         42 VITIPEGNTQPLEYFAAEYQMG--------LSNMMEANPGV-DTFLPKGGTVLNIPQQ   90 (306)
T ss_pred             EEEeCCCCCchHHHHHHHhCCC--------HHHHHHhCcCC-CCCcCCCCCEEEeCCc
Confidence            69999965  599999999999        99999999988 5556679999999974

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.21  E-value=0.00069  Score=67.12  Aligned_cols=28  Identities=18%  Similarity=0.298  Sum_probs=24.7

Q ss_pred             eEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          406 YIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       406 ~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      ++|+|+.|.||++++++ +.|+||..+..
T Consensus       148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            69999999999999876 78999987753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.19  E-value=0.0029  Score=59.70  Aligned_cols=97  Identities=24%  Similarity=0.342  Sum_probs=66.4

Q ss_pred             HHHHHHHHHHHccCC------CCcceeEeeEEE-eCcEEEEEEecCC------CChHHHHhcCCCCCCCHHHHHHHHHHH
Q 037010          325 SREFLAELKVLTHVH------HLNLVRLIGYCV-EGSLFLVYEYIEN------GNLSEHLRGSGRDPLPWSSRVQIALDS  391 (589)
Q Consensus       325 ~~~~~~E~~il~~l~------hpnIv~l~~~~~-~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~qi  391 (589)
                      .++..+|+.-...+.      +.+|.+++|+.. +-.+.+|+|.+.+      -+|.+++....   ++. ...+.+   
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L---  127 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQAL---  127 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHH---
Confidence            345555665555444      788999999876 4458889988754      26888885543   444 333333   


Q ss_pred             HHHHHHHHhCCCCceEeeccCCCcEEEcCCC----cEEEEe-ccC
Q 037010          392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNF----HAKVAD-FGL  431 (589)
Q Consensus       392 a~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~----~vkl~D-fgl  431 (589)
                      -.-.+||-+++|   +.+|++|.||++....    .+.|+| ||.
T Consensus       128 ~~f~~~l~~~~I---v~~dl~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  128 DEFKRYLLDHHI---VIRDLNPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             HHHHHHHHHcCC---eecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence            344678888998   9999999999995432    577777 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10190 L,D-transpeptidase; Provisional

Probab=97.18  E-value=0.00065  Score=67.34  Aligned_cols=47  Identities=15%  Similarity=0.092  Sum_probs=41.3

Q ss_pred             heeccCCC--CHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeee
Q 037010           35 SYYVWIGS--NLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFP   90 (589)
Q Consensus        35 ~y~v~~g~--~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~   90 (589)
                      .|+|+++|  +|..||++|++.        ...|+++||++ ++-...+|++|.||..
T Consensus        39 ~~~v~~~~~~~le~iA~~f~~g--------~~~l~~aNPgv-d~~~p~~G~~i~iP~~   87 (310)
T PRK10190         39 TVTVPDHNTQPLETFAAQYGQG--------LSNMLEANPGA-DVFLPKSGSQLTIPQQ   87 (310)
T ss_pred             EEEecCCCCccHHHHHHHhCCC--------HHHHHHhCCCC-CCCCCCCCCEEEecCc
Confidence            69999966  699999999999        99999999988 5555679999999974

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.04  E-value=0.0069  Score=56.87  Aligned_cols=135  Identities=21%  Similarity=0.347  Sum_probs=84.1

Q ss_pred             CCCccceeeccCCc-EEEEEEEEccccCCccchhh---hhhhhh---hHhHHHhhc----CHHHHHHHHHHHHHHccC--
Q 037010          272 DNFSMSHKIGQGGF-GAVYYAELRGEYGNSYLSRL---ICVNLL---MQKAAIKKM----DMQASREFLAELKVLTHV--  338 (589)
Q Consensus       272 ~~y~~~~~LG~G~~-g~Vy~~~~~~~~~~~~~~~~---~~~~~~---~~~~~ik~~----~~~~~~~~~~E~~il~~l--  338 (589)
                      .+++.++.||.|.- |.||+++..+.   .++.|.   ......   .....-+..    ......-|..|.+...+|  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~---~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGR---IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCe---EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            77889999999999 99999988764   333333   111000   000000000    001223466777766655  


Q ss_pred             -CCCcc--eeEeeEEE-e--C----------------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHH
Q 037010          339 -HHLNL--VRLIGYCV-E--G----------------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE  396 (589)
Q Consensus       339 -~hpnI--v~l~~~~~-~--~----------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~  396 (589)
                       .+.++  ++.+||.. .  .                ...||.||+....           .+....    +.+|.+-|.
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHHHHHH
Confidence             45566  89998762 1  0                0347888776533           123333    446667788


Q ss_pred             HHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       397 ~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      .+|..||   +-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~gI---~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLGI---VPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCCe---eeccCcccccc-----CCEEEecccC
Confidence            9999998   99999999986     4589999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.91  E-value=0.0064  Score=59.21  Aligned_cols=29  Identities=28%  Similarity=0.503  Sum_probs=25.5

Q ss_pred             ceEeeccCCCcEEEcC-CCcEEEEeccCcc
Q 037010          405 VYIHRDIKSANILIDK-NFHAKVADFGLTK  433 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~-~~~vkl~Dfgla~  433 (589)
                      .++|+|+.+.|||++. ++.+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            3699999999999997 5789999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG1652 XkdP Uncharacterized protein containing LysM domain [Function unknown]

Probab=96.64  E-value=0.00084  Score=66.94  Aligned_cols=48  Identities=17%  Similarity=0.326  Sum_probs=42.3

Q ss_pred             eEEeccCcchhcchhhhccCcCcHHHHhhcCC---CC-CCCCCCCcEEEEEe
Q 037010          104 QFSINSGDTYEKVATRYYSNLTDAASLQRINN---YP-PTRIPDRGTLNVTV  151 (589)
Q Consensus       104 ~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~---~~-~~~l~~g~~l~ip~  151 (589)
                      +|+|++|||||.||++.|+.=+-+..|..+|.   +. ++.|.+||.|.||-
T Consensus       212 ~~~v~rgDTl~~is~~~Yg~~~~y~~I~~aNk~~~~~~p~~I~pGq~l~iP~  263 (269)
T COG1652         212 TNTVKRGDTLWQISKKVYGDGVEYRKIAEANKALVLDNPDKIKPGQVLRIPD  263 (269)
T ss_pred             EEEeccCCcccccchhhcCcceEEEeHhhhhhhhccCCCCcCCCcceeeCCC
Confidence            79999999999999999985556778999999   54 67999999999994

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	589
4eby_A	212	Crystal Structure Of The Ectodomain Of A Receptor L		2e-58
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-45
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-44
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-41
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-40
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-37
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-35
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-28
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-27
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-25
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-25
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-25
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-25
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-25
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-25
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-25
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-25
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-25
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-25
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-25
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-25
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-25
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-24
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-24
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-24
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-24
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-24
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-24
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-24
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-24
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-24
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-24
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-24
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-24
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-24
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-24
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-24
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-24
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-24
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-24
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-24
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-24
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-24
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-23
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-23
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-23
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-23
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-23
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-23
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-23
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-23
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-23
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-23
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-23
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-23
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-22
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-22
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-22
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-22
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-22
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-22
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-21
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-21
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-21
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-21
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-21
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-21
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-21
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-21
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-21
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-21
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-21
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-21
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-21
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-21
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-21
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-21
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-21
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		7e-21
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-21
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-21
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-21
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		8e-21
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-20
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-20
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-20
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-20
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-20
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-20
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-20
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-19
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-19
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-19
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-19
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-19
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-19
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-18
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-18
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-18
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-18
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-18
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-18
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-18
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-18
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-18
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-18
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-18
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-18
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-17
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-17
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-17
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-17
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-17
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-17
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-17
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-17
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-17
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-17
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-17
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		8e-17
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-17
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-17
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-17
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-17
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-17
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-16
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-16
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-16
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-16
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-16
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-16
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-16
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-15
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-15
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-15
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-15
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-15
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-15
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		7e-15
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		7e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-15
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-15
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-14
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-14
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-14
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-14
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		8e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-14
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		9e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		9e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-14
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-13
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-13
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-13
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-12
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-12
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		7e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		9e-12
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		9e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-11
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-11
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-11
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-11
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		7e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		7e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-10
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		4e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		4e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		6e-10
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		7e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		6e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-08
3soa_A	444	Full-Length Human Camkii Length = 444		1e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		8e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		8e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		8e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		8e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		8e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		8e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		9e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		9e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		9e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		7e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		8e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		9e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		9e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-06
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-06
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		6e-06
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-05
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-05
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		5e-05
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		5e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-05
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		5e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		5e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-05
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-05
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-05
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-05
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-05
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-05
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-05
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-05
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-05
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		7e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-04
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-04

>pdb|4EBY|A Chain A, Crystal Structure Of The Ectodomain Of A Receptor Like Kinase Length = 212

Iteration: 1
 Score =  223 bits (568), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 108/206 (52%), Positives = 136/206 (66%)
Query: 25  CTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTR 84
           C   C  ALASYY+  G+ L+ I Q L SS+   + +    IL YN  + +KD +   +R
Sbjct: 1   CRTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSR 60
Query: 85  INVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDR 144
           + VPFPC+C  G+FLGH F +S+   DTYE+VA   Y+NLT   SLQ  N +P T IP  
Sbjct: 61  VLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLS 120
Query: 145 GTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRG 204
            TLNV VNCSCGD  VSK + LFVTYPLRP DSL SIAR+ G+S  +LQ YNPGVNF  G
Sbjct: 121 ATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVNFNSG 180
Query: 205 SGLVFIPGRDANGVFPALESSSTGGL 230
           +G+V++PGRD NG FP  +SS   G+
Sbjct: 181 NGIVYVPGRDPNGAFPPFKSSKQDGV 206

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  180 bits (457), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 114/315 (36%), Positives = 167/315 (53%), Gaps = 21/315 (6%)
Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           FS  EL  A+DNFS  + +G+GGFG VY              RL    L+  K   ++  
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKG------------RLADGTLVAVKRLKEERX 75
Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG--SGRDP 378
                +F  E+++++   H NL+RL G+C+  +   LVY Y+ NG+++  LR     + P
Sbjct: 76  QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPP 135
Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG 438
           L W  R +IAL SARGL Y+H+H  P  IHRD+K+ANIL+D+ F A V DFGL KL +  
Sbjct: 136 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 195
Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
              +   + GT G++ PEY   G  S K DV+ +GV+L ELI+ + A      ++ D   
Sbjct: 196 DXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVM 255
Query: 499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           L+   + +L      + L  LVD  L  N   + V ++ Q+A +CTQ  P  RP M  +V
Sbjct: 256 LLDWVKGLLK----EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311
Query: 559 VALM--TLSSTTEDW 571
             L    L+   E+W
Sbjct: 312 RMLEGDGLAERWEEW 326

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  177 bits (450), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 114/319 (35%), Positives = 170/319 (53%), Gaps = 29/319 (9%)
Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           FS  EL  A+DNF   + +G+GGFG VY    +G   +  L             A+K++ 
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVY----KGRLADGXL------------VAVKRLK 63
Query: 322 MQASR----EFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG--S 374
            + ++    +F  E+++++   H NL+RL G+C+  +   LVY Y+ NG+++  LR    
Sbjct: 64  EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 375 GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL 434
            + PL W  R +IAL SARGL Y+H+H  P  IHRD+K+ANIL+D+ F A V DFGL KL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 435 TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
            +     +   + G  G++ PEY   G  S K DV+ +GV+L ELI+ + A      ++ 
Sbjct: 184 MDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM 554
           D    V L + V  L    + L  LVD  L  N   + V ++ Q+A +CTQ  P  RP M
Sbjct: 244 DD---VMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299
Query: 555 RSIVVALM--TLSSTTEDW 571
             +V  L    L+   E+W
Sbjct: 300 SEVVRMLEGDGLAERWEEW 318

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 114/309 (36%), Positives = 167/309 (54%), Gaps = 44/309 (14%)
Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           +L +AT+NF     IG G FG VY   LR                   K A+K+   ++S
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDG----------------AKVALKRRTPESS 76
Query: 326 R---EFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRD--PL 379
           +   EF  E++ L+   H +LV LIG+C E   + L+Y+Y+ENGNL  HL GS      +
Sbjct: 77  QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-TEVG 438
            W  R++I + +ARGL Y+H   +   IHRD+KS NIL+D+NF  K+ DFG++K  TE+G
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDENFVPKITDFGISKKGTELG 193
Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
              L   + GT GY+ PEY   G ++ K DVY+FGVVL+E++ A+ AIV+          
Sbjct: 194 QTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ---------- 243
Query: 499 LVALFEEVLNLPD-PIE-----DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
             +L  E++NL +  +E      L ++VDP L D    +S+ K    A  C     + RP
Sbjct: 244 --SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 553 SMRSIVVAL 561
           SM  ++  L
Sbjct: 302 SMGDVLWKL 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  164 bits (416), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 113/309 (36%), Positives = 166/309 (53%), Gaps = 44/309 (14%)
Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           +L +AT+NF     IG G FG VY   LR                   K A+K+   ++S
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDG----------------AKVALKRRTPESS 76
Query: 326 R---EFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRD--PL 379
           +   EF  E++ L+   H +LV LIG+C E   + L+Y+Y+ENGNL  HL GS      +
Sbjct: 77  QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-TEVG 438
            W  R++I + +ARGL Y+H   +   IHRD+KS NIL+D+NF  K+ DFG++K  TE+ 
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINILLDENFVPKITDFGISKKGTELD 193
Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
              L   + GT GY+ PEY   G ++ K DVY+FGVVL+E++ A+ AIV+          
Sbjct: 194 QTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ---------- 243
Query: 499 LVALFEEVLNLPD-PIE-----DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
             +L  E++NL +  +E      L ++VDP L D    +S+ K    A  C     + RP
Sbjct: 244 --SLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 553 SMRSIVVAL 561
           SM  ++  L
Sbjct: 302 SMGDVLWKL 310

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 168/315 (53%), Gaps = 31/315 (9%)
Query: 262 FSYEELSKATDNFSM------SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           FS+ EL   T+NF         +K+G+GGFG VY    +G   N+     + V  L    
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVY----KGYVNNT----TVAVKKLAAMV 66
Query: 316 AIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG- 373
            I   +++  ++F  E+KV+    H NLV L+G+  +G  L LVY Y+ NG+L + L   
Sbjct: 67  DITTEELK--QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            G  PL W  R +IA  +A G+ ++HE+    +IHRDIKSANIL+D+ F AK++DFGL +
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 434 LTE-VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
            +E      + +R+VGT  YM PE A  G+++PK D+Y+FGVVL E+I+   A+      
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAV------ 234
Query: 493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
             + +    L +    + D  + +   +D ++ D     SV  M  +A  C  E    RP
Sbjct: 235 -DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 553 SMRSIVVALMTLSST 567
            ++ +   L  ++++
Sbjct: 293 DIKKVQQLLQEMTAS 307

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  153 bits (386), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 167/315 (53%), Gaps = 31/315 (9%)
Query: 262 FSYEELSKATDNFSM------SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           FS+ EL   T+NF         +K+G+GGFG VY    +G   N+     + V  L    
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVY----KGYVNNT----TVAVKKLAAMV 66
Query: 316 AIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG- 373
            I   +++  ++F  E+KV+    H NLV L+G+  +G  L LVY Y+ NG+L + L   
Sbjct: 67  DITTEELK--QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            G  PL W  R +IA  +A G+ ++HE+    +IHRDIKSANIL+D+ F AK++DFGL +
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 434 LTE-VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
            +E      +  R+VGT  YM PE A  G+++PK D+Y+FGVVL E+I+   A+      
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAV------ 234
Query: 493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
             + +    L +    + D  + +   +D ++ D     SV  M  +A  C  E    RP
Sbjct: 235 -DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 553 SMRSIVVALMTLSST 567
            ++ +   L  ++++
Sbjct: 293 DIKKVQQLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  152 bits (385), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 106/315 (33%), Positives = 167/315 (53%), Gaps = 31/315 (9%)
Query: 262 FSYEELSKATDNFSM------SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           FS+ EL   T+NF         +K+G+GGFG VY    +G   N+     + V  L    
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVY----KGYVNNT----TVAVKKLAAMV 60
Query: 316 AIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG- 373
            I   +++  ++F  E+KV+    H NLV L+G+  +G  L LVY Y+ NG+L + L   
Sbjct: 61  DITTEELK--QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 118
Query: 374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            G  PL W  R +IA  +A G+ ++HE+    +IHRDIKSANIL+D+ F AK++DFGL +
Sbjct: 119 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 175
Query: 434 LTE-VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
            +E      +  R+VGT  YM PE A  G+++PK D+Y+FGVVL E+I+   A+      
Sbjct: 176 ASEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAV------ 228
Query: 493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
             + +    L +    + D  + +   +D ++ D     SV  M  +A  C  E    RP
Sbjct: 229 -DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 286
Query: 553 SMRSIVVALMTLSST 567
            ++ +   L  ++++
Sbjct: 287 DIKKVQQLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  145 bits (365), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 92/234 (39%), Positives = 133/234 (56%), Gaps = 23/234 (9%)
Query: 262 FSYEELSKATDNFSM------SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           FS+ EL   T+NF         +K G+GGFG VY    +G   N+     + V  L    
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVY----KGYVNNT----TVAVKKLAAMV 57
Query: 316 AIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG- 373
            I   +++  ++F  E+KV     H NLV L+G+  +G  L LVY Y  NG+L + L   
Sbjct: 58  DITTEELK--QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL 115
Query: 374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            G  PL W  R +IA  +A G+ ++HE+    +IHRDIKSANIL+D+ F AK++DFGL +
Sbjct: 116 DGTPPLSWHXRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 172
Query: 434 LTE-VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
            +E        +R+VGT  Y  PE A  G+++PK D+Y+FGVVL E+I+   A+
Sbjct: 173 ASEKFAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAV 225

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  121 bits (304), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 92/297 (30%), Positives = 148/297 (49%), Gaps = 43/297 (14%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--EFLA 330
           + ++  KIG G FG V+ AE  G          + V +LM++      D  A R  EFL 
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--------VAVKILMEQ------DFHAERVNEFLR 83
Query: 331 ELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSG-RDPLPWSSRVQIA 388
           E+ ++  + H N+V  +G   +  +L +V EY+  G+L   L  SG R+ L    R+ +A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL-V 447
            D A+G+ Y+H    P+ +HRD+KS N+L+DK +  KV DFGL++L    S  L ++   
Sbjct: 144 YDVAKGMNYLHNRNPPI-VHRDLKSPNLLVDKKYTVKVCDFGLSRLK--ASXFLXSKXAA 200
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           GT  +M PE  +    + K DVY+FGV+L+EL + ++    GN + A     V    + L
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKCKRL 258
Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            +P       + ++P            ++A + + C    P  RPS  +I+  L  L
Sbjct: 259 EIP-------RNLNP------------QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 91/297 (30%), Positives = 148/297 (49%), Gaps = 43/297 (14%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--EFLA 330
           + ++  KIG G FG V+ AE  G          + V +LM++      D  A R  EFL 
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSD--------VAVKILMEQ------DFHAERVNEFLR 83
Query: 331 ELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSG-RDPLPWSSRVQIA 388
           E+ ++  + H N+V  +G   +  +L +V EY+  G+L   L  SG R+ L    R+ +A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LV 447
            D A+G+ Y+H    P+ +HR++KS N+L+DK +  KV DFGL++L    S  L ++   
Sbjct: 144 YDVAKGMNYLHNRNPPI-VHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAA 200
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           GT  +M PE  +    + K DVY+FGV+L+EL + ++    GN + A     V    + L
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKCKRL 258
Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            +P       + ++P            ++A + + C    P  RPS  +I+  L  L
Sbjct: 259 EIP-------RNLNP------------QVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 51/307 (16%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 49
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 50  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 110 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 213
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---MRS 556
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +RS
Sbjct: 214 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 262
Query: 557 IVVALMT 563
           ++    T
Sbjct: 263 VLEDFFT 269

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 137/310 (44%), Gaps = 48/310 (15%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 49
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 50  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 110 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 166
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 213
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +  
Sbjct: 214 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 262
Query: 560 ALMTLSSTTE 569
            L    + TE
Sbjct: 263 VLEDFFTATE 272

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 137/310 (44%), Gaps = 48/310 (15%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 15  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 58
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 59  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 118
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 119 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 175
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 176 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 222
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +  
Sbjct: 223 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 271
Query: 560 ALMTLSSTTE 569
            L    + TE
Sbjct: 272 VLEDFFTATE 281

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 51/307 (16%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 8   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 51
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 52  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 111
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 112 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 168
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 169 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 215
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---MRS 556
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +RS
Sbjct: 216 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 264
Query: 557 IVVALMT 563
           ++    T
Sbjct: 265 VLEDFFT 271

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 137/310 (44%), Gaps = 48/310 (15%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 14  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 57
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 58  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 118 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 174
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 175 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 221
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +  
Sbjct: 222 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 270
Query: 560 ALMTLSSTTE 569
            L    + TE
Sbjct: 271 VLEDFFTATE 280

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 51/307 (16%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 7   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 50
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 51  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 110
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 111 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 167
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 168 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 214
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---MRS 556
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +RS
Sbjct: 215 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 263
Query: 557 IVVALMT 563
           ++    T
Sbjct: 264 VLEDFFT 270

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 137/310 (44%), Gaps = 48/310 (15%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 55
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 56  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 116 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTA 172
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 173 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 219
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +  
Sbjct: 220 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 268
Query: 560 ALMTLSSTTE 569
            L    + TE
Sbjct: 269 VLEDFFTATE 278

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  113 bits (282), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 137/310 (44%), Gaps = 48/310 (15%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 11  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 54
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 55  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 114
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 115 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 171
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 172 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 218
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +  
Sbjct: 219 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 267
Query: 560 ALMTLSSTTE 569
            L    + TE
Sbjct: 268 VLEDFFTATE 277

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 51/307 (16%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 49
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 50  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 110 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 213
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---MRS 556
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +RS
Sbjct: 214 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 262
Query: 557 IVVALMT 563
           ++    T
Sbjct: 263 VLEDFFT 269

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 51/307 (16%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 1   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 44
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 45  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 104
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 105 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 161
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 162 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 208
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---MRS 556
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +RS
Sbjct: 209 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 257
Query: 557 IVVALMT 563
           ++    T
Sbjct: 258 VLEDFFT 264

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 51/307 (16%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 12  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 55
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 56  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 116 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 172
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 173 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 219
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---MRS 556
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +RS
Sbjct: 220 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 268
Query: 557 IVVALMT 563
           ++    T
Sbjct: 269 VLEDFFT 275

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  112 bits (280), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 137/310 (44%), Gaps = 48/310 (15%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDM 322
           +E     +   +  ++G G FG V+     G                  K A+K  K   
Sbjct: 16  DEWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGS 59
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +
Sbjct: 60  MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 119
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L E    + 
Sbjct: 120 KLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 176
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
                    +  PE   YG  + K DV++FG++L E+++       G             
Sbjct: 177 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG------------- 223
Query: 503 FEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
               +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +  
Sbjct: 224 ----MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRS 272
Query: 560 ALMTLSSTTE 569
            L    + TE
Sbjct: 273 VLEDFFTATE 282

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  112 bits (279), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 38/303 (12%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 51
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 52  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 111
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L    + +
Sbjct: 112 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 168
Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
            P        +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D   +  
Sbjct: 169 APAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQVYE 224
Query: 502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           L E+   +  P             + CP     K+ +L + C Q  P  RPS   I  A 
Sbjct: 225 LLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFAEIHQAF 267
Query: 562 MTL 564
            T+
Sbjct: 268 ETM 270

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 137/303 (45%), Gaps = 38/303 (12%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 52
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 53  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 112
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L    + +
Sbjct: 113 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 169
Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
            P        +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D   +  
Sbjct: 170 APAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQVYE 225
Query: 502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           L E+   +  P             + CP     K+ +L + C Q  P  RPS   I  A 
Sbjct: 226 LLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFAEIHQAF 268
Query: 562 MTL 564
            T+
Sbjct: 269 ETM 271

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 137/306 (44%), Gaps = 51/306 (16%)
Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQ 323
           E     +   +  ++G G FG V+     G                  K A+K  K    
Sbjct: 3   EWEVPRETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGSM 46
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
           +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  + 
Sbjct: 47  SPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINK 106
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
            + +A   A G+ +I E     YIHR++++ANIL+      K+ADFGL +L E    +  
Sbjct: 107 LLDMAAQIAEGMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
                   +  PE   YG  + K DV++FG++L E+++       G              
Sbjct: 164 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------------- 209
Query: 504 EEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS---MRSI 557
              +  P+ I++L    ++V P   DNCP +    + QL ++C +E P+ RP+   +RS+
Sbjct: 210 ---MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERPEDRPTFDYLRSV 259
Query: 558 VVALMT 563
           +    T
Sbjct: 260 LEDFFT 265

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 124/261 (47%), Gaps = 32/261 (12%)
Query: 314 KAAIK--KMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHL 371
           K A+K  K    +   FLAE  ++  + H  LVRL     +  ++++ EY+ENG+L + L
Sbjct: 39  KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFL 98
Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
           +      L  +  + +A   A G+ +I E     YIHRD+++ANIL+      K+ADFGL
Sbjct: 99  KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGL 155
Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG 491
            +L E    +          +  PE   YG  + K DV++FG++L E+++       G  
Sbjct: 156 ARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-- 213
Query: 492 SSADSKGLVALFEEVLNLPDPIEDLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
                          +  P+ I++L    ++V P   DNCP +    + QL ++C +E P
Sbjct: 214 ---------------MTNPEVIQNLERGYRMVRP---DNCPEE----LYQLMRLCWKERP 251
Query: 549 QLRPSMRSIVVALMTLSSTTE 569
           + RP+   +   L    + TE
Sbjct: 252 EDRPTFDYLRSVLEDFFTATE 272

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  109 bits (273), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 50/299 (16%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           + +M HK+G G FG VY     G +    L+  + V  L       K D     EFL E 
Sbjct: 12  DITMKHKLGGGQFGEVY----EGVWKKYSLT--VAVKTL-------KEDTMEVEEFLKEA 58
Query: 333 KVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
            V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +     + +A   
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLPTR 445
           +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T    A  P +
Sbjct: 119 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
                 +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D   +  L E+
Sbjct: 176 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDPSQVYELLEK 225
Query: 506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
              +  P             + CP     K+ +L + C Q  P  RPS   I  A  T+
Sbjct: 226 DYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 55
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 56  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 115
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 116 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 172
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 173 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 222
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 223 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 265
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 266 EIHQAFETM 274

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 50
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 51  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 110
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 111 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 168 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 217
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 218 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 260
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 261 EIHQAFETM 269

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  109 bits (272), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 50
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 51  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA 110
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 111 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 168 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 217
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 218 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 260
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 261 EIHQAFETM 269

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 55
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 56  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA 115
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 116 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 172
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 173 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 222
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 223 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 265
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 266 EIHQAFETM 274

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 50
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 51  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSA 110
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 111 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 168 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 217
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 218 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 260
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 261 EIHQAFETM 269

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 55
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 56  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 115
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 116 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT 172
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 173 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 222
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 223 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 265
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 266 EIHQAFETM 274

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 55
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 56  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 115
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 116 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 172
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 173 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 222
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 223 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 265
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 266 EIHQAFETM 274

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  108 bits (271), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 50
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 51  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 110
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 111 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 168 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 217
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 218 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 260
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 261 EIHQAFETM 269

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 51
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 52  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNA 111
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 112 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT 168
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 169 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 218
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 219 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 261
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 262 EIHQAFETM 270

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 50
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 51  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 110
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 111 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 168 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 217
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 218 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 260
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 261 EIHQAFETM 269

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  108 bits (271), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 55
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 56  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 115
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 116 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 172
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 173 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 222
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 223 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 265
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 266 EIHQAFETM 274

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 54
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 55  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 114
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 115 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 172 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 221
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 222 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 264
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 265 EIHQAFETM 273

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 50
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 51  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 110
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 111 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 167
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 168 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 217
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 218 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 260
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 261 EIHQAFETM 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 17  NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 63
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 64  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 123
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 124 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 180
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 181 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 230
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 231 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 273
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 274 EIHQAFETM 282

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 52
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 53  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 112
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 113 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 169
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 170 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 219
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 220 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 262
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 263 EIHQAFETM 271

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 134/299 (44%), Gaps = 50/299 (16%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           + +M HK+G G +G VY     G +    L+  + V  L       K D     EFL E 
Sbjct: 12  DITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDTMEVEEFLKEA 58
Query: 333 KVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
            V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +     + +A   
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLPTR 445
           +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T    A  P +
Sbjct: 119 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
                 +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D   +  L E+
Sbjct: 176 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDPSQVYELLEK 225
Query: 506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
              +  P             + CP     K+ +L + C Q  P  RPS   I  A  T+
Sbjct: 226 DYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/309 (28%), Positives = 138/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY     G +    L+  + V  L       K D 
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDT 52
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 53  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 112
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T
Sbjct: 113 VVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 169
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 170 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 219
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 220 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 262
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 263 EIHQAFETM 271

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 134/299 (44%), Gaps = 50/299 (16%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           + +M HK+G G +G VY     G +    L+  + V  L       K D     EFL E 
Sbjct: 12  DITMKHKLGGGQYGEVY----EGVWKKYSLT--VAVKTL-------KEDTMEVEEFLKEA 58
Query: 333 KVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
            V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +     + +A   
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 118
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLPTR 445
           +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T    A  P +
Sbjct: 119 SSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK 175
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
                 +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D   +  L E+
Sbjct: 176 ------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDPSQVYELLEK 225
Query: 506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
              +  P             + CP     K+ +L + C Q  P  RPS   I  A  T+
Sbjct: 226 DYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY    +        S  + V  L       K D 
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTL-------KEDT 257
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 258 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 317
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHR++ + N L+ +N   KVADFGL++L      T
Sbjct: 318 VVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 375 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 424
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 425 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 467
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 468 EIHQAFETM 476

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 97/320 (30%), Positives = 148/320 (46%), Gaps = 59/320 (18%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKVL 335
           IG+G FG V  A ++              + L   AAIK+M   AS    R+F  EL+VL
Sbjct: 23  IGEGNFGQVLKARIKK-------------DGLRMDAAIKRMKEYASKDDHRDFAGELEVL 69
Query: 336 THV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGS---GRDP-----------L 379
             + HH N++ L+G C   G L+L  EY  +GNL + LR S     DP           L
Sbjct: 70  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 129
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
                +  A D ARG++Y+ +     +IHRD+ + NIL+ +N+ AK+ADFGL++  EV  
Sbjct: 130 SSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 186
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
                RL     +M  E   Y   +   DV+++GV+L+E++S         G+       
Sbjct: 187 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-------GGTPYCGMTC 237
Query: 500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
             L+E+   LP     L K          PL+   ++  L + C +E P  RPS   I+V
Sbjct: 238 AELYEK---LPQGYR-LEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILV 283
Query: 560 ALMTLSSTTEDWDVGSFYEN 579
           +L  +    + +   + YE 
Sbjct: 284 SLNRMLEERKTYVNTTLYEK 303

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 140/297 (47%), Gaps = 38/297 (12%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A   +  +QA   F  E+
Sbjct: 13  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQ-QLQA---FKNEV 59
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL  S          + IA  +A
Sbjct: 60  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTA 118
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLVGTFG 451
           RG++Y+H  ++   IHRD+KS NI + ++   K+ DFGL  +    S S    +L G+  
Sbjct: 119 RGMDYLHAKSI---IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
           +M PE  +  D +P   + DVYAFG+VLYEL++ +  +   N ++ D         E++ 
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ--LPYSNINNRDQ------IIEMVG 227
Query: 509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS 565
                 DL K+       NCP     +M +L   C ++    RPS   I+  +  L+
Sbjct: 228 RGSLSPDLSKVR-----SNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEELA 275

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 97/320 (30%), Positives = 148/320 (46%), Gaps = 59/320 (18%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKVL 335
           IG+G FG V  A ++ +              L   AAIK+M   AS    R+F  EL+VL
Sbjct: 33  IGEGNFGQVLKARIKKDG-------------LRMDAAIKRMKEYASKDDHRDFAGELEVL 79
Query: 336 THV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGS---GRDP-----------L 379
             + HH N++ L+G C   G L+L  EY  +GNL + LR S     DP           L
Sbjct: 80  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
                +  A D ARG++Y+ +     +IHRD+ + NIL+ +N+ AK+ADFGL++  EV  
Sbjct: 140 SSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 196
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
                RL     +M  E   Y   +   DV+++GV+L+E++S         G+       
Sbjct: 197 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-------GGTPYCGMTC 247
Query: 500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
             L+E+   LP     L K          PL+   ++  L + C +E P  RPS   I+V
Sbjct: 248 AELYEK---LPQGYR-LEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILV 293
Query: 560 ALMTLSSTTEDWDVGSFYEN 579
           +L  +    + +   + YE 
Sbjct: 294 SLNRMLEERKTYVNTTLYEK 313

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 73/232 (31%), Positives = 117/232 (50%), Gaps = 31/232 (13%)
Query: 255 TVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK 314
           TV    EF     +       +   IG+G FG V   + RG                  K
Sbjct: 176 TVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG-----------------NK 218
Query: 315 AAIKKMDMQASRE-FLAELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHL 371
            A+K +   A+ + FLAE  V+T + H NLV+L+G  VE  G L++V EY+  G+L ++L
Sbjct: 219 VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 278
Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
           R  GR  L     ++ +LD    +EY+  +    ++HRD+ + N+L+ ++  AKV+DFGL
Sbjct: 279 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 432 TKL--TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           TK   +   +  LP +      +  PE  +    S K DV++FG++L+E+ S
Sbjct: 336 TKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEIYS 381

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 50/309 (16%)
Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY    +        S  + V  L       K D 
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK------YSLTVAVKTL-------KEDT 296
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               EFL E  V+  + H NLV+L+G C  E   +++ E++  GNL ++LR   R  +  
Sbjct: 297 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNA 356
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------T 435
              + +A   +  +EY+ +     +IHR++ + N L+ +N   KVADFGL++L      T
Sbjct: 357 VVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 413
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
               A  P +      +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D
Sbjct: 414 AHAGAKFPIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----ID 463
Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
              +  L E+   +  P             + CP     K+ +L + C Q  P  RPS  
Sbjct: 464 LSQVYELLEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFA 506
Query: 556 SIVVALMTL 564
            I  A  T+
Sbjct: 507 EIHQAFETM 515

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 31/207 (14%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-FLAELKVLTHV 338
           IG+G FG V   + RG                  K A+K +   A+ + FLAE  V+T +
Sbjct: 14  IGKGEFGDVMLGDYRG-----------------NKVAVKCIKNDATAQAFLAEASVMTQL 56
Query: 339 HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
            H NLV+L+G  VE  G L++V EY+  G+L ++LR  GR  L     ++ +LD    +E
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL--TEVGSASLPTRLVGTFGYMP 454
           Y+  +    ++HRD+ + N+L+ ++  AKV+DFGLTK   +   +  LP +      +  
Sbjct: 117 YLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTA 167
Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELIS 481
           PE  +    S K DV++FG++L+E+ S
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYS 194

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 133/299 (44%), Gaps = 50/299 (16%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           + +M HK+G G +G VY    +        S  + V  L       K D     EFL E 
Sbjct: 33  DITMKHKLGGGQYGEVYVGVWKK------YSLTVAVKTL-------KEDTMEVEEFLKEA 79
Query: 333 KVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
            V+  + H NLV+L+G C +E   ++V EY+  GNL ++LR   R+ +     + +A   
Sbjct: 80  AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQI 139
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLPTR 445
           +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L      T    A  P +
Sbjct: 140 SSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIK 196
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
                 +  PE   Y   S K DV+AFGV+L+E+ +   +   G     D   +  L E+
Sbjct: 197 ------WTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQVYDLLEK 246
Query: 506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
              +  P             + CP     K+ +L + C +  P  RPS      A  T+
Sbjct: 247 GYRMEQP-------------EGCP----PKVYELMRACWKWSPADRPSFAETHQAFETM 288

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 31/207 (14%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-FLAELKVLTHV 338
           IG+G FG V   + RG                  K A+K +   A+ + FLAE  V+T +
Sbjct: 20  IGKGEFGDVMLGDYRG-----------------NKVAVKCIKNDATAQAFLAEASVMTQL 62
Query: 339 HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
            H NLV+L+G  VE  G L++V EY+  G+L ++LR  GR  L     ++ +LD    +E
Sbjct: 63  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 122
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL--TEVGSASLPTRLVGTFGYMP 454
           Y+  +    ++HRD+ + N+L+ ++  AKV+DFGLTK   +   +  LP +      +  
Sbjct: 123 YLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTA 173
Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELIS 481
           PE  +    S K DV++FG++L+E+ S
Sbjct: 174 PEALREAAFSTKSDVWSFGILLWEIYS 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 111/207 (53%), Gaps = 31/207 (14%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-FLAELKVLTHV 338
           IG+G FG V   + RG                  K A+K +   A+ + FLAE  V+T +
Sbjct: 29  IGKGEFGDVMLGDYRG-----------------NKVAVKCIKNDATAQAFLAEASVMTQL 71
Query: 339 HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
            H NLV+L+G  VE  G L++V EY+  G+L ++LR  GR  L     ++ +LD    +E
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 131
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL--TEVGSASLPTRLVGTFGYMP 454
           Y+  +    ++HRD+ + N+L+ ++  AKV+DFGLTK   +   +  LP +      +  
Sbjct: 132 YLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTA 182
Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELIS 481
           PE  +    S K DV++FG++L+E+ S
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYS 209

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  105 bits (263), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 140/302 (46%), Gaps = 48/302 (15%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A   +  +QA   F  E+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQ-QLQA---FKNEV 71
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL  S          + IA  +A
Sbjct: 72  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTA 130
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVGTFG 451
           RG++Y+H  ++   IHRD+KS NI + ++   K+ DFGL T+ +    +    +L G+  
Sbjct: 131 RGMDYLHAKSI---IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
           +M PE  +  D +P   + DVYAFG+VLYEL++ +                  L    +N
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------------------LPYSNIN 229
Query: 509 LPDPIEDL--RKLVDPRLGD---NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
             D I ++  R  + P L     NCP     +M +L   C ++    RPS   I+  +  
Sbjct: 230 NRDQIIEMVGRGSLSPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEE 285
Query: 564 LS 565
           L+
Sbjct: 286 LA 287

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 96/319 (30%), Positives = 148/319 (46%), Gaps = 59/319 (18%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKVL 335
           IG+G FG V  A ++ +              L   AAIK+M   AS    R+F  EL+VL
Sbjct: 30  IGEGNFGQVLKARIKKDG-------------LRMDAAIKRMKEYASKDDHRDFAGELEVL 76
Query: 336 THV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGS---GRDP-----------L 379
             + HH N++ L+G C   G L+L  EY  +GNL + LR S     DP           L
Sbjct: 77  CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 136
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
                +  A D ARG++Y+ +     +IHR++ + NIL+ +N+ AK+ADFGL++  EV  
Sbjct: 137 SSQQLLHFAADVARGMDYLSQKQ---FIHRNLAARNILVGENYVAKIADFGLSRGQEVYV 193
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
                RL     +M  E   Y   +   DV+++GV+L+E++S         G+       
Sbjct: 194 KKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL-------GGTPYCGMTC 244
Query: 500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
             L+E+   LP     L K          PL+   ++  L + C +E P  RPS   I+V
Sbjct: 245 AELYEK---LPQGYR-LEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILV 290
Query: 560 ALMTLSSTTEDWDVGSFYE 578
           +L  +    + +   + YE
Sbjct: 291 SLNRMLEERKTYVNTTLYE 309

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/302 (28%), Positives = 139/302 (46%), Gaps = 48/302 (15%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A   +  +QA   F  E+
Sbjct: 25  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQ-QLQA---FKNEV 71
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY     L +V ++ E  +L  HL  S          + IA  +A
Sbjct: 72  GVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTA 130
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVGTFG 451
           RG++Y+H  ++   IHRD+KS NI + ++   K+ DFGL T+ +    +    +L G+  
Sbjct: 131 RGMDYLHAKSI---IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
           +M PE  +  D +P   + DVYAFG+VLYEL++ +                  L    +N
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------------------LPYSNIN 229
Query: 509 LPDPIEDL--RKLVDPRLGD---NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
             D I ++  R  + P L     NCP     +M +L   C ++    RPS   I+  +  
Sbjct: 230 NRDQIIEMVGRGSLSPDLSKVRSNCP----KRMKRLMAECLKKKRDERPSFPRILAEIEE 285
Query: 564 LS 565
           L+
Sbjct: 286 LA 287

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 91/328 (27%), Positives = 147/328 (44%), Gaps = 66/328 (20%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +N      IG+G FG V+ A   G       + ++ V +L ++A+    DMQA  +F  E
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT-MVAVKMLKEEASA---DMQA--DFQRE 100
Query: 332 LKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG----------------- 373
             ++    + N+V+L+G C  G  + L++EY+  G+L+E LR                  
Sbjct: 101 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 160
Query: 374 -----SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
                 G  PL  + ++ IA   A G+ Y+ E     ++HRD+ + N L+ +N   K+AD
Sbjct: 161 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIAD 217
Query: 429 FGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           FGL++           G+ ++P R      +MPPE   Y   + + DV+A+GVVL+E+ S
Sbjct: 218 FGLSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 482 AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAK 541
                  G              EEV+     + D   L  P   +NCPL+    +  L +
Sbjct: 272 YGLQPYYGMAH-----------EEVIYY---VRDGNILACP---ENCPLE----LYNLMR 310
Query: 542 VCTQEYPQLRPSMRSIVVALMTLSSTTE 569
           +C  + P  RPS  SI   L  +    E
Sbjct: 311 LCWSKLPADRPSFCSIHRILQRMCERAE 338

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 94/358 (26%), Positives = 153/358 (42%), Gaps = 75/358 (20%)
Query: 240 STGPAAGTPTSLNAITVDKSVEFSYEELSK-ATDNFSMSHKIGQGGFGAVYYAELRGEYG 298
           S  P  G  + L    ++    FS   +      +  +  ++G+G FG V+ AE      
Sbjct: 8   SLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAE------ 61
Query: 299 NSYLSRLICVNLLMQK-------AAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV 351
                   C NLL ++        A+K+    A ++F  E ++LT + H ++VR  G C 
Sbjct: 62  --------CHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT 113
Query: 352 EGS-LFLVYEYIENGNLSEHLRGSGRD-------------PLPWSSRVQIALDSARGLEY 397
           EG  L +V+EY+ +G+L+  LR  G D             PL     + +A   A G+ Y
Sbjct: 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL------TKLTEVGSAS-LPTRLVGTF 450
           +       ++HRD+ + N L+ +    K+ DFG+      T    VG  + LP R     
Sbjct: 174 L---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR----- 225
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNL 509
            +MPPE   Y   + + DV++FGVVL+E+ +  K+   + + + A               
Sbjct: 226 -WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI-------------- 270
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
            D I   R+L  PR    CP +    M    + C Q  PQ R S++ +   L  L+  
Sbjct: 271 -DCITQGRELERPR---ACPPEVYAIM----RGCWQREPQQRHSIKDVHARLQALAQA 320

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 91/333 (27%), Positives = 155/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 3   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 56
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------ 377
             EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR    +      
Sbjct: 57  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 116
Query: 378 --PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
             P   S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 117 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 173
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 174 XETDXXRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 227
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +L   +L ++C Q  P
Sbjct: 228 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLL---ELMRMCWQYNP 266
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 267 KMRPSFLEII------SSIKEEMEPGFREVSFY 293

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/323 (27%), Positives = 147/323 (45%), Gaps = 72/323 (22%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL-------LMQKAAIKKMDMQAS 325
           N  +  ++G+G FG V+ AE              C NL       L+    +K     A 
Sbjct: 14  NIVLKRELGEGAFGKVFLAE--------------CYNLCPEQDKILVAVKTLKDASDNAR 59
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDP------ 378
           ++F  E ++LT++ H ++V+  G CVEG  L +V+EY+++G+L++ LR  G D       
Sbjct: 60  KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 119
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-- 431
                L  S  + IA   A G+ Y+       ++HRD+ + N L+ +N   K+ DFG+  
Sbjct: 120 NPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSR 176
Query: 432 ----TKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEA 485
               T    VG  + LP R      +MPPE   Y   + + DV++ GVVL+E+ +  K+ 
Sbjct: 177 DVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
             + + +            EV+   + I   R L  PR    CP +    + +L   C Q
Sbjct: 231 WYQLSNN------------EVI---ECITQGRVLQRPR---TCPQE----VYELMLGCWQ 268
Query: 546 EYPQLRPSMRSIVVALMTLSSTT 568
             P +R +++ I   L  L+  +
Sbjct: 269 REPHMRKNIKGIHTLLQNLAKAS 291

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/324 (27%), Positives = 143/324 (44%), Gaps = 74/324 (22%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK-------AAIKKMDMQAS 325
           +  +  ++G+G FG V+ AE              C NLL ++        A+K+    A 
Sbjct: 13  DIVLKWELGEGAFGKVFLAE--------------CHNLLPEQDKMLVAVKALKEASESAR 58
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------- 377
           ++F  E ++LT + H ++VR  G C EG  L +V+EY+ +G+L+  LR  G D       
Sbjct: 59  QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 118
Query: 378 ------PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
                 PL     + +A   A G+ Y+       ++HRD+ + N L+ +    K+ DFG+
Sbjct: 119 EDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGM 175
Query: 432 ------TKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AK 483
                 T    VG  + LP R      +MPPE   Y   + + DV++FGVVL+E+ +  K
Sbjct: 176 SRDIYSTDYYRVGGRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229
Query: 484 EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVC 543
           +   + + + A                D I   R+L  PR    CP +    M    + C
Sbjct: 230 QPWYQLSNTEAI---------------DCITQGRELERPR---ACPPEVYAIM----RGC 267
Query: 544 TQEYPQLRPSMRSIVVALMTLSST 567
            Q  PQ R S++ +   L  L+  
Sbjct: 268 WQREPQQRHSIKDVHARLQALAQA 291

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 131/301 (43%), Gaps = 44/301 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  ++G G FG V+     G                  K AIK  K    +   FL
Sbjct: 9   ESLQLIKRLGNGQFGEVWMGTWNGN----------------TKVAIKTLKPGTMSPESFL 52
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLR-GSGRDPLPWSSRVQIA 388
            E +++  + H  LV+L     E  +++V EY+  G+L + L+ G GR  L   + V +A
Sbjct: 53  EEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGR-ALKLPNLVDMA 111
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
              A G+ YI       YIHRD++SANIL+      K+ADFGL +L E    +       
Sbjct: 112 AQVAAGMAYIERMN---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKF 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
              +  PE A YG  + K DV++FG++L EL++       G     +++ ++   E    
Sbjct: 169 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG----MNNREVLEQVERGYR 224
Query: 509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT 568
           +P                 CP D  + + +L   C ++ P+ RP+   +   L    + T
Sbjct: 225 MP-----------------CPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTAT 267
Query: 569 E 569
           E
Sbjct: 268 E 268

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 89/327 (27%), Positives = 144/327 (44%), Gaps = 80/327 (24%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK-------AAIKKMDMQAS 325
           +  +  ++G+G FG V+ AE              C NLL ++        A+K+    A 
Sbjct: 19  DIVLKWELGEGAFGKVFLAE--------------CHNLLPEQDKMLVAVKALKEASESAR 64
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------- 377
           ++F  E ++LT + H ++VR  G C EG  L +V+EY+ +G+L+  LR  G D       
Sbjct: 65  QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 124
Query: 378 ------PLPWSSRVQIALDSARGLEY---IHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
                 PL     + +A   A G+ Y   +H      ++HRD+ + N L+ +    K+ D
Sbjct: 125 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVKIGD 178
Query: 429 FGL------TKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           FG+      T    VG  + LP R      +MPPE   Y   + + DV++FGVVL+E+ +
Sbjct: 179 FGMSRDIYSTDYYRVGGRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFT 232
Query: 482 -AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLA 540
             K+   + + + A                D I   R+L  PR    CP +    M    
Sbjct: 233 YGKQPWYQLSNTEAI---------------DCITQGRELERPR---ACPPEVYAIM---- 270
Query: 541 KVCTQEYPQLRPSMRSIVVALMTLSST 567
           + C Q  PQ R S++ +   L  L+  
Sbjct: 271 RGCWQREPQQRHSIKDVHARLQALAQA 297

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 310
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 371 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +       G            +  EVL  
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-----------MVNREVL-- 474
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 475 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 227
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 288 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +       G            +  EVL  
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-----------MVNREVL-- 391
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 392 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 227
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 288 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 391
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 392 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 91/336 (27%), Positives = 158/336 (47%), Gaps = 62/336 (18%)
Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           F  +E   A +  +MS ++GQG FG VY    +G   +   +R + +  + + A+     
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS----- 59
Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD--- 377
           M+   EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR    +   
Sbjct: 60  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMEN 119
Query: 378 -----PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
                P   S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T
Sbjct: 120 NPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 176
Query: 433 K-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +         + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E 
Sbjct: 177 RDIYETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 230
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
             +G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q
Sbjct: 231 PYQGLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQ 269
Query: 546 EYPQLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
             P++RPS   I+      SS  E+ + G    SFY
Sbjct: 270 YNPKMRPSFLEII------SSIKEEMEPGFREVSFY 299

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 227
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 288 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +       G            +  EVL  
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-----------MVNREVL-- 391
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 392 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 157/333 (47%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R + +  + + A+     M+ 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-VAIKTVNEAAS-----MRE 65
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------ 377
             EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR    +      
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 378 --PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
             P   S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 182
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 183 XETDXXRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 236
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P
Sbjct: 237 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNP 275
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 276 KMRPSFLEII------SSIKEEMEPGFREVSFY 302

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 144/313 (46%), Gaps = 52/313 (16%)
Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           F  +E   + +  ++  ++GQG FG VY    R        +R + V  + + A++++  
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRE-- 63
Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR-------- 372
                EFL E  V+      ++VRL+G   +G    +V E + +G+L  +LR        
Sbjct: 64  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 120
Query: 373 GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
             GR P      +Q+A + A G+ Y++      ++HRD+ + N ++  +F  K+ DFG+T
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 433 K-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +         + G   LP R      +M PE  + G  +   D+++FGVVL+E+ S  E 
Sbjct: 178 RDIXETDXXRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 231
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
             +G  +           E+VL     + D   L  P   DNCP     ++  L ++C Q
Sbjct: 232 PYQGLSN-----------EQVLKF---VMDGGYLDQP---DNCP----ERVTDLMRMCWQ 270
Query: 546 EYPQLRPSMRSIV 558
             P++RP+   IV
Sbjct: 271 FNPKMRPTFLEIV 283

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 54
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 55  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 115 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 171
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 172 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 218
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 219 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 270

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 144/313 (46%), Gaps = 52/313 (16%)
Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           F  +E   + +  ++  ++GQG FG VY    R        +R + V  + + A++++  
Sbjct: 4   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRE-- 60
Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG------- 373
                EFL E  V+      ++VRL+G   +G    +V E + +G+L  +LR        
Sbjct: 61  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 117
Query: 374 -SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
             GR P      +Q+A + A G+ Y++      ++HRD+ + N ++  +F  K+ DFG+T
Sbjct: 118 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT 174
Query: 433 K-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +         + G   LP R      +M PE  + G  +   D+++FGVVL+E+ S  E 
Sbjct: 175 RDIXETDXXRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 228
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
             +G  +           E+VL     + D   L  P   DNCP     ++  L ++C Q
Sbjct: 229 PYQGLSN-----------EQVLKF---VMDGGYLDQP---DNCP----ERVTDLMRMCWQ 267
Query: 546 EYPQLRPSMRSIV 558
             P++RP+   IV
Sbjct: 268 FNPKMRPTFLEIV 280

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 154/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 64
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------ 377
             EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR    +      
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 378 --PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
             P   S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 181
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 182 YETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 235
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P
Sbjct: 236 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNP 274
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 275 KMRPSFLEII------SSIKEEMEPGFREVSFY 301

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 154/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 58
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------ 377
             EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR    +      
Sbjct: 59  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 378 --PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
             P   S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 175
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 176 YETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 229
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P
Sbjct: 230 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNP 268
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 269 KMRPSFLEII------SSIKEEMEPGFREVSFY 295

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 154/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 11  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 64
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------ 377
             EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR    +      
Sbjct: 65  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 124
Query: 378 --PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
             P   S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 125 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 181
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 182 YETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 235
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P
Sbjct: 236 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNP 274
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 275 KMRPSFLEII------SSIKEEMEPGFREVSFY 301

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 62  QEAQVMKKIRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 122 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 225
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 226 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 91/333 (27%), Positives = 154/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 5   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 58
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------ 377
             EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR    +      
Sbjct: 59  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 118
Query: 378 --PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
             P   S  +Q+A + A G+ Y++ +    ++HRD+ + N  + ++F  K+ DFG+T+  
Sbjct: 119 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDI 175
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 176 YETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 229
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +L   +L ++C Q  P
Sbjct: 230 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLL---ELMRMCWQYNP 268
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 269 KMRPSFLEII------SSIKEEMEPGFREVSFY 295

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 154/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 12  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 65
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------ 377
             EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR    +      
Sbjct: 66  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 125
Query: 378 --PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
             P   S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 126 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 182
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 183 YETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 236
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P
Sbjct: 237 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNP 275
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 276 KMRPSFLEII------SSIKEEMEPGFREVSFY 302

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 122 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP 178
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 225
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 226 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 154/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 40  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 93
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD------ 377
             EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR    +      
Sbjct: 94  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 153
Query: 378 --PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
             P   S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 154 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 210
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 211 YETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 264
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P
Sbjct: 265 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNP 303
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 304 KMRPSFLEII------SSIKEEMEPGFREVSFY 330

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 92/333 (27%), Positives = 154/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 71
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV-YEYIENGNLSEHLRGSGRD------ 377
             EFL E  V+   +  ++VRL+G   +G   LV  E +  G+L  +LR    +      
Sbjct: 72  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPV 131
Query: 378 --PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
             P   S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 189 YETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P
Sbjct: 243 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNP 281
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 282 KMRPSFLEII------SSIKEEMEPGFREVSFY 308

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 144/313 (46%), Gaps = 52/313 (16%)
Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           F  +E   + +  ++  ++GQG FG VY    R        +R + V  + + A++++  
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRE-- 63
Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG------- 373
                EFL E  V+      ++VRL+G   +G    +V E + +G+L  +LR        
Sbjct: 64  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 120
Query: 374 -SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
             GR P      +Q+A + A G+ Y++      ++HRD+ + N ++  +F  K+ DFG+T
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 433 K-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +         + G   LP R      +M PE  + G  +   D+++FGVVL+E+ S  E 
Sbjct: 178 RDIYETDYYRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 231
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
             +G  +           E+VL     + D   L  P   DNCP     ++  L ++C Q
Sbjct: 232 PYQGLSN-----------EQVLKF---VMDGGYLDQP---DNCP----ERVTDLMRMCWQ 270
Query: 546 EYPQLRPSMRSIV 558
             P++RP+   IV
Sbjct: 271 FNPKMRPTFLEIV 283

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 58
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V ++ 
Sbjct: 59  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 119 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFP 175
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 222
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 223 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 274

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 132/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 51
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  + +V EY+  G+L + L+G     L     V +A 
Sbjct: 52  QEAQVMKKLRHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 111
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 112 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFP 168
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 169 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 215
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 216 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 267

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/313 (26%), Positives = 144/313 (46%), Gaps = 52/313 (16%)
Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           F  +E   + +  ++  ++GQG FG VY    R        +R + V  + + A++++  
Sbjct: 7   FVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRE-- 63
Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG------- 373
                EFL E  V+      ++VRL+G   +G    +V E + +G+L  +LR        
Sbjct: 64  ---RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAEN 120
Query: 374 -SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
             GR P      +Q+A + A G+ Y++      ++HRD+ + N ++  +F  K+ DFG+T
Sbjct: 121 NPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMT 177
Query: 433 K-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +         + G   LP R      +M PE  + G  +   D+++FGVVL+E+ S  E 
Sbjct: 178 RDIYETAYYRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQ 231
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
             +G  +           E+VL     + D   L  P   DNCP     ++  L ++C Q
Sbjct: 232 PYQGLSN-----------EQVLKF---VMDGGYLDQP---DNCP----ERVTDLMRMCWQ 270
Query: 546 EYPQLRPSMRSIV 558
             P++RP+   IV
Sbjct: 271 FNPKMRPTFLEIV 283

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/333 (27%), Positives = 155/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 8   DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 61
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR----GSGRDPL 379
             EFL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR        +P+
Sbjct: 62  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 121
Query: 380 ----PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
                 S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 122 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 178
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 179 YETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 232
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P
Sbjct: 233 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNP 271
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 272 KMRPSFLEII------SSIKEEMEPGFREVSFY 298

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 50
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 51  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 111 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 167
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 168 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 214
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 215 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 266

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 52
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 53  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 113 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 169
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 170 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 216
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 217 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 268

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 150/313 (47%), Gaps = 41/313 (13%)
Query: 261 EFSYEELSKATDN-FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK 319
           EF    L    DN      +IG+GGFG V+   L  +     +  LI  +   +   I+K
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 320 MDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
                 +EF  E+ ++++++H N+V+L G  +     +V E++  G+L   L      P+
Sbjct: 67  F-----QEFQREVFIMSNLNHPNIVKLYG-LMHNPPRMVMEFVPCGDLYHRLLDKAH-PI 119
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL---IDKN--FHAKVADFGLTKL 434
            WS ++++ LD A G+EY+     P+ +HRD++S NI    +D+N    AKVADFGL++ 
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPI-VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
Query: 435 TEVGSASLPTRLVGTFGYMPPEY--AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           + V S S    L+G F +M PE   A+    + K D Y+F ++LY        I+ G G 
Sbjct: 179 S-VHSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY-------TILTGEGP 227
Query: 493 SAD-SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR 551
             + S G +     +       E LR    P + ++CP     ++  + ++C    P+ R
Sbjct: 228 FDEYSYGKIKFINMIRE-----EGLR----PTIPEDCP----PRLRNVIELCWSGDPKKR 274
Query: 552 PSMRSIVVALMTL 564
           P    IV  L  L
Sbjct: 275 PHFSYIVKELSEL 287

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 92/333 (27%), Positives = 155/333 (46%), Gaps = 62/333 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   A +  +MS ++GQG FG VY    +G   +   +R+        K   +   M+ 
Sbjct: 18  DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI------KTVNEAASMRE 71
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLV-YEYIENGNLSEHLR----GSGRDPL 379
             EFL E  V+   +  ++VRL+G   +G   LV  E +  G+L  +LR        +P+
Sbjct: 72  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131
Query: 380 ----PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
                 S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+  
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   DV++FGVVL+E+ +  E   +
Sbjct: 189 YETDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + +   L  P   DNCP D +    +L ++C Q  P
Sbjct: 243 GLSN-----------EQVLRF---VMEGGLLDKP---DNCP-DMLF---ELMRMCWQYNP 281
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG----SFY 577
           ++RPS   I+      SS  E+ + G    SFY
Sbjct: 282 KMRPSFLEII------SSIKEEMEPGFREVSFY 308

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 122 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 225
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 226 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 122 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 225
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 226 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/300 (27%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 58
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V ++ 
Sbjct: 59  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 119 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 175
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 176 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 222
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 223 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 274

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 133/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 122 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 225
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 226 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGNMSPEAFL 228
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 229 QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 288
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 289 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFP 345
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +       G            +  EVL  
Sbjct: 346 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-----------MVNREVL-- 392
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 393 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 444

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 60
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL             + IA  +A
Sbjct: 61  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 119
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL  +    S S    +L G+  
Sbjct: 120 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 82/310 (26%), Positives = 142/310 (45%), Gaps = 52/310 (16%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   + +  ++  ++GQG FG VY    R        +R + V  + + A++++     
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRE----- 63
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR--------GSG 375
             EFL E  V+      ++VRL+G   +G    +V E + +G+L  +LR          G
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
           R P      +Q+A + A G+ Y++      ++HRD+ + N ++  +F  K+ DFG+T+  
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   D+++FGVVL+E+ S  E   +
Sbjct: 181 XETDXXRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 234
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + D   L  P   DNCP     ++  L ++C Q  P
Sbjct: 235 GLSN-----------EQVLKF---VMDGGYLDQP---DNCP----ERVTDLMRMCWQFNP 273
Query: 549 QLRPSMRSIV 558
            +RP+   IV
Sbjct: 274 NMRPTFLEIV 283

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 36  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 82
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL             + IA  +A
Sbjct: 83  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 141
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL  +    S S    +L G+  
Sbjct: 142 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 55
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL             + IA  +A
Sbjct: 56  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 114
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL  +    S S    +L G+  
Sbjct: 115 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 83
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL             + IA  +A
Sbjct: 84  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 142
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL  +    S S    +L G+  
Sbjct: 143 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 14  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 60
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL             + IA  +A
Sbjct: 61  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 119
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL  +    S S    +L G+  
Sbjct: 120 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 11  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 57
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL             + IA  +A
Sbjct: 58  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 116
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL  +    S S    +L G+  
Sbjct: 117 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 132/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G L + L+G     L     V +A 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 122 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 225
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 226 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 132/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G L + L+G     L     V +A 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 122 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 225
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 226 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 55
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY     L +V ++ E  +L  HL             + IA  +A
Sbjct: 56  GVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 114
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL  +    S S    +L G+  
Sbjct: 115 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 84/300 (28%), Positives = 132/300 (44%), Gaps = 42/300 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNG----------------TTRVAIKTLKPGTMSPEAFL 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 62  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+       Y+HRD+ +ANIL+ +N   KVADFGL +L E    +        
Sbjct: 122 QIASGMAYVERMN---YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 178
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +      KG        G+V    EVL  
Sbjct: 179 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT------KGR---VPYPGMVN--REVL-- 225
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
            D +E   ++        CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 226 -DQVERGYRM-------PCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 277

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 29  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 75
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL             + IA  +A
Sbjct: 76  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 134
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL T+ +    +    +L G+  
Sbjct: 135 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 192 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 141/305 (46%), Gaps = 52/305 (17%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           + +  ++  ++GQG FG VY    R        +R + V  + + A++++       EFL
Sbjct: 14  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRE-----RIEFL 67
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG--------SGRDPLP 380
            E  V+      ++VRL+G   +G    +V E + +G+L  +LR          GR P  
Sbjct: 68  NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 127
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK------- 433
               +Q+A + A G+ Y++      ++HRD+ + N ++  +F  K+ DFG+T+       
Sbjct: 128 LQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 184
Query: 434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS 493
             + G   LP R      +M PE  + G  +   D+++FGVVL+E+ S  E   +G  + 
Sbjct: 185 YRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN- 237
Query: 494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
                     E+VL     + D   L  P   DNCP     ++  L ++C Q  P++RP+
Sbjct: 238 ----------EQVLKF---VMDGGYLDQP---DNCP----ERVTDLMRMCWQFNPKMRPT 277
Query: 554 MRSIV 558
              IV
Sbjct: 278 FLEIV 282

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 37  QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 83
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL             + IA  +A
Sbjct: 84  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 142
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL T+ +    +    +L G+  
Sbjct: 143 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 21/215 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
             ++  +IG G FG VY  +  G+         + V +L   A       Q  + F  E+
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTP----QQLQAFKNEV 55
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            VL    H+N++  +GY  +  L +V ++ E  +L  HL             + IA  +A
Sbjct: 56  GVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 114
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVGTFG 451
           +G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL T+ +    +    +L G+  
Sbjct: 115 QGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 452 YMPPEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           +M PE  +  D +P   + DVYAFG+VLYEL++ +
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 91/313 (29%), Positives = 147/313 (46%), Gaps = 41/313 (13%)
Query: 261 EFSYEELSKATDN-FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK 319
           EF    L    DN      +IG+GGFG V+   L  +     +  LI  +   +   I+K
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 320 MDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
                 +EF  E+ ++++++H N+V+L G  +     +V E++  G+L   L      P+
Sbjct: 67  F-----QEFQREVFIMSNLNHPNIVKLYG-LMHNPPRMVMEFVPCGDLYHRLLDKAH-PI 119
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL---IDKN--FHAKVADFGLTKL 434
            WS ++++ LD A G+EY+     P+ +HRD++S NI    +D+N    AKVADFG T  
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPI-VHRDLRSPNIFLQSLDENAPVCAKVADFG-TSQ 177
Query: 435 TEVGSASLPTRLVGTFGYMPPEY--AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
             V S S    L+G F +M PE   A+    + K D Y+F ++LY        I+ G G 
Sbjct: 178 QSVHSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY-------TILTGEGP 227
Query: 493 SAD-SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR 551
             + S G +     +       E LR    P + ++CP     ++  + ++C    P+ R
Sbjct: 228 FDEYSYGKIKFINMIRE-----EGLR----PTIPEDCP----PRLRNVIELCWSGDPKKR 274
Query: 552 PSMRSIVVALMTL 564
           P    IV  L  L
Sbjct: 275 PHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 90/313 (28%), Positives = 149/313 (47%), Gaps = 41/313 (13%)
Query: 261 EFSYEELSKATDN-FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK 319
           EF    L    DN      +IG+GGFG V+   L  +     +  LI  +   +   I+K
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 320 MDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
                 +EF  E+ ++++++H N+V+L G  +     +V E++  G+L   L      P+
Sbjct: 67  F-----QEFQREVFIMSNLNHPNIVKLYG-LMHNPPRMVMEFVPCGDLYHRLLDKAH-PI 119
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL---IDKN--FHAKVADFGLTKL 434
            WS ++++ LD A G+EY+     P+ +HRD++S NI    +D+N    AKVADF L++ 
Sbjct: 120 KWSVKLRLMLDIALGIEYMQNQNPPI-VHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ 178
Query: 435 TEVGSASLPTRLVGTFGYMPPEY--AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           + V S S    L+G F +M PE   A+    + K D Y+F ++LY        I+ G G 
Sbjct: 179 S-VHSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY-------TILTGEGP 227
Query: 493 SAD-SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR 551
             + S G +     +       E LR    P + ++CP     ++  + ++C    P+ R
Sbjct: 228 FDEYSYGKIKFINMIRE-----EGLR----PTIPEDCP----PRLRNVIELCWSGDPKKR 274
Query: 552 PSMRSIVVALMTL 564
           P    IV  L  L
Sbjct: 275 PHFSYIVKELSEL 287

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 142/310 (45%), Gaps = 52/310 (16%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   + +  ++  ++GQG FG VY    R        +R + V  + + A++++     
Sbjct: 11  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRE----- 64
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR--------GSG 375
             EFL E  V+      ++VRL+G   +G    +V E + +G+L  +LR          G
Sbjct: 65  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 124
Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
           R P      +Q+A + A G+ Y++      ++HR++ + N ++  +F  K+ DFG+T+  
Sbjct: 125 RPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDI 181
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   D+++FGVVL+E+ S  E   +
Sbjct: 182 YETDYYRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 235
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + D   L  P   DNCP     ++  L ++C Q  P
Sbjct: 236 GLSN-----------EQVLKF---VMDGGYLDQP---DNCP----ERVTDLMRMCWQFNP 274
Query: 549 QLRPSMRSIV 558
            +RP+   IV
Sbjct: 275 NMRPTFLEIV 284

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/312 (27%), Positives = 143/312 (45%), Gaps = 55/312 (17%)
Query: 258 KSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI 317
           K V   +E +   +D       IG+G FG VY+    GEY +   +R+ C      K+  
Sbjct: 12  KDVLIPHERVVTHSDRV-----IGKGHFGVVYH----GEYIDQAQNRIQCAI----KSLS 58
Query: 318 KKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSG 375
           +  +MQ    FL E  ++  ++H N++ LIG  +  EG   ++  Y+ +G+L + +R   
Sbjct: 59  RITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ 118
Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
           R+P      +   L  ARG+EY+ E     ++HRD+ + N ++D++F  KVADFGL +  
Sbjct: 119 RNPTV-KDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDI 174
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                  + +   A LP +          E  Q    + K DV++FGV+L+EL++     
Sbjct: 175 LDREYYSVQQHRHARLPVKWTAL------ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
            +      D   L     +   LP P             + CP DS   + Q+ + C + 
Sbjct: 229 YR----HIDPFDLTHFLAQGRRLPQP-------------EYCP-DS---LYQVMQQCWEA 267
Query: 547 YPQLRPSMRSIV 558
            P +RP+ R +V
Sbjct: 268 DPAVRPTFRVLV 279

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 88/326 (26%), Positives = 146/326 (44%), Gaps = 75/326 (23%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL-------LMQKAAIKKMDMQAS 325
           +  +  ++G+G FG V+ AE              C NL       L+   A+K   + A 
Sbjct: 16  DIVLKRELGEGAFGKVFLAE--------------CYNLSPTKDKMLVAVKALKDPTLAAR 61
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDP------ 378
           ++F  E ++LT++ H ++V+  G C +G  L +V+EY+++G+L++ LR  G D       
Sbjct: 62  KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 379 --------LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
                   L  S  + IA   A G+ Y+       ++HRD+ + N L+  N   K+ DFG
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFG 178
Query: 431 L------TKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-A 482
           +      T    VG  + LP R      +MPPE   Y   + + DV++FGV+L+E+ +  
Sbjct: 179 MSRDVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 483 KEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKV 542
           K+   + + +            EV+   + I   R L  PR+   CP +    M      
Sbjct: 233 KQPWFQLSNT------------EVI---ECITQGRVLERPRV---CPKEVYDVMLG---- 270
Query: 543 CTQEYPQLRPSMRSIVVALMTLSSTT 568
           C Q  PQ R +++ I   L  L   T
Sbjct: 271 CWQREPQQRLNIKEIYKILHALGKAT 296

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/310 (26%), Positives = 142/310 (45%), Gaps = 52/310 (16%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E   + +  ++  ++GQG FG VY    R        +R + V  + + A++++     
Sbjct: 10  DEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRE----- 63
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR--------GSG 375
             EFL E  V+      ++VRL+G   +G    +V E + +G+L  +LR          G
Sbjct: 64  RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 123
Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
           R P      +Q+A + A G+ Y++      ++HR++ + N ++  +F  K+ DFG+T+  
Sbjct: 124 RPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARNCMVAHDFTVKIGDFGMTRDI 180
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  + G   LP R      +M PE  + G  +   D+++FGVVL+E+ S  E   +
Sbjct: 181 YETDYYRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 234
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G  +           E+VL     + D   L  P   DNCP     ++  L ++C Q  P
Sbjct: 235 GLSN-----------EQVLKF---VMDGGYLDQP---DNCP----ERVTDLMRMCWQFNP 273
Query: 549 QLRPSMRSIV 558
            +RP+   IV
Sbjct: 274 NMRPTFLEIV 283

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 138/298 (46%), Gaps = 65/298 (21%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-FLAELKVLTHV 338
           +G+G FG V  A+ R                  +  AIK+++ ++ R+ F+ EL+ L+ V
Sbjct: 17  VGRGAFGVVCKAKWRA-----------------KDVAIKQIESESERKAFIVELRQLSRV 59
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPW---SSRVQIALDSARGL 395
           +H N+V+L G C+   + LV EY E G+L   L G+  +PLP+   +  +   L  ++G+
Sbjct: 60  NHPNIVKLYGACL-NPVCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGV 116
Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLV---GTFG 451
            Y+H       IHRD+K  N+L+       VA   + K+ + G+A  + T +    G+  
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLL-------VAGGTVLKICDFGTACDIQTHMTNNKGSAA 169
Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS-----ADSKGLVALFEEV 506
           +M PE  +  + S K DV+++G++L+E+I+ ++   +  G +     A   G       +
Sbjct: 170 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--I 227
Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            NLP PIE L                          C  + P  RPSM  IV  +  L
Sbjct: 228 KNLPKPIESLMTR-----------------------CWSKDPSQRPSMEEIVKIMTHL 262

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 82/298 (27%), Positives = 138/298 (46%), Gaps = 65/298 (21%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-FLAELKVLTHV 338
           +G+G FG V  A+ R                  +  AIK+++ ++ R+ F+ EL+ L+ V
Sbjct: 16  VGRGAFGVVCKAKWRA-----------------KDVAIKQIESESERKAFIVELRQLSRV 58
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPW---SSRVQIALDSARGL 395
           +H N+V+L G C+   + LV EY E G+L   L G+  +PLP+   +  +   L  ++G+
Sbjct: 59  NHPNIVKLYGACL-NPVCLVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGV 115
Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLV---GTFG 451
            Y+H       IHRD+K  N+L+       VA   + K+ + G+A  + T +    G+  
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLL-------VAGGTVLKICDFGTACDIQTHMTNNKGSAA 168
Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS-----ADSKGLVALFEEV 506
           +M PE  +  + S K DV+++G++L+E+I+ ++   +  G +     A   G       +
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--I 226
Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            NLP PIE                        L   C  + P  RPSM  IV  +  L
Sbjct: 227 KNLPKPIES-----------------------LMTRCWSKDPSQRPSMEEIVKIMTHL 261

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 138/296 (46%), Gaps = 50/296 (16%)
Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--FLAELKVL 335
            +IG G FG V+     G + N              K AIK +   A  E  F+ E +V+
Sbjct: 13  QEIGSGQFGLVHL----GYWLNK------------DKVAIKTIREGAMSEEDFIEEAEVM 56
Query: 336 THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
             + H  LV+L G C+E + + LV+E++E+G LS++LR + R      + + + LD   G
Sbjct: 57  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEG 115
Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           + Y+ E +V   IHRD+ + N L+ +N   KV+DFG+T+       +  T       +  
Sbjct: 116 MAYLEEASV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 172
Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE 514
           PE   +   S K DV++FGV+++E+ S  +   +   +S                 + +E
Sbjct: 173 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVE 215
Query: 515 DLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
           D+    +L  PRL           + Q+   C +E P+ RP+   ++  L  ++++
Sbjct: 216 DISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAAIAAS 264

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 129/283 (45%), Gaps = 46/283 (16%)
Query: 281 GQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV--LTHV 338
            +G FG V+ A+L  EY                  A+K   +Q  + +  E +V  L  +
Sbjct: 33  ARGRFGCVWKAQLLNEY-----------------VAVKIFPIQDKQSWQNEYEVYSLPGM 75
Query: 339 HHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
            H N+++ IG    G+     L+L+  + E G+LS+ L+    + + W+    IA   AR
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMAR 132
Query: 394 GLEYIHEHT-------VPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR- 445
           GL Y+HE          P   HRDIKS N+L+  N  A +ADFGL    E G ++  T  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
Query: 446 LVGTFGYMPPEYAQYG-----DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            VGT  YM PE  +       D   ++D+YA G+VL+EL S      +   +       +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS------RCTAADGPVDEYM 246
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVC 543
             FEE +     +ED++++V  +       D   K A +A +C
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLC 289

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 138/296 (46%), Gaps = 44/296 (14%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +  ++  ++G G FG V   + +G+Y        + V +      IK+  M +  EF  E
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYD-------VAVKM------IKEGSM-SEDEFFQE 53
Query: 332 LKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
            + +  + H  LV+  G C  E  +++V EYI NG L  +LR  G+   P S  +++  D
Sbjct: 54  AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP-SQLLEMCYD 112
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK--LTEVGSASLPTRLVG 448
              G+ ++  H    +IHRD+ + N L+D++   KV+DFG+T+  L +   +S+ T+   
Sbjct: 113 VCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF-- 167
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
              +  PE   Y   S K DV+AFG++++E+ S  +       +S          E VL 
Sbjct: 168 PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----------EVVLK 217
Query: 509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
               +    +L  P L  +        + Q+   C  E P+ RP+ + ++ ++  L
Sbjct: 218 ----VSQGHRLYRPHLASD-------TIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 50/296 (16%)
Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--FLAELKVL 335
            +IG G FG V+     G + N              K AIK +   A  E  F+ E +V+
Sbjct: 11  QEIGSGQFGLVHL----GYWLNK------------DKVAIKTIREGAMSEEDFIEEAEVM 54
Query: 336 THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
             + H  LV+L G C+E + + LV+E++E+G LS++LR + R      + + + LD   G
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEG 113
Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           + Y+ E  V   IHRD+ + N L+ +N   KV+DFG+T+       +  T       +  
Sbjct: 114 MAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE 514
           PE   +   S K DV++FGV+++E+ S  +   +   +S                 + +E
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVE 213
Query: 515 DLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
           D+    +L  PRL           + Q+   C +E P+ RP+   ++  L  ++ +
Sbjct: 214 DISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 50/296 (16%)
Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--FLAELKVL 335
            +IG G FG V+     G + N              K AIK +   A  E  F+ E +V+
Sbjct: 13  QEIGSGQFGLVHL----GYWLNK------------DKVAIKTIREGAMSEEDFIEEAEVM 56
Query: 336 THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
             + H  LV+L G C+E + + LV+E++E+G LS++LR + R      + + + LD   G
Sbjct: 57  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEG 115
Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           + Y+ E  V   IHRD+ + N L+ +N   KV+DFG+T+       +  T       +  
Sbjct: 116 MAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 172
Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE 514
           PE   +   S K DV++FGV+++E+ S  +   +   +S                 + +E
Sbjct: 173 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVE 215
Query: 515 DLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
           D+    +L  PRL           + Q+   C +E P+ RP+   ++  L  ++ +
Sbjct: 216 DISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 136/296 (45%), Gaps = 50/296 (16%)
Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--FLAELKVL 335
            +IG G FG V+     G + N              K AIK +   A  E  F+ E +V+
Sbjct: 16  QEIGSGQFGLVHL----GYWLNK------------DKVAIKTIREGAMSEEDFIEEAEVM 59
Query: 336 THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
             + H  LV+L G C+E + + LV+E++E+G LS++LR + R      + + + LD   G
Sbjct: 60  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEG 118
Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           + Y+ E  V   IHRD+ + N L+ +N   KV+DFG+T+       +  T       +  
Sbjct: 119 MAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 175
Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE 514
           PE   +   S K DV++FGV+++E+ S  +   +   +S                 + +E
Sbjct: 176 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVE 218
Query: 515 DLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
           D+    +L  PRL           + Q+   C +E P+ RP+   ++  L  ++ +
Sbjct: 219 DISTGFRLYKPRLAST-------HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 142/296 (47%), Gaps = 40/296 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++  +  +IG+G FG V+   LR +  N+ ++   C   L         D++A  +FL E
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRAD--NTLVAVKSCRETL-------PPDLKA--KFLQE 162
Query: 332 LKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
            ++L    H N+VRLIG C +   +++V E ++ G+    LR  G   L   + +Q+  D
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGD 221
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG--SASLPTRLVG 448
           +A G+EY+        IHRD+ + N L+ +    K++DFG+++    G  +AS   R V 
Sbjct: 222 AAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV- 277
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
              +  PE   YG  S + DV++FG++L+E  S   A    N S+  ++  V   E+   
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLG-ASPYPNLSNQQTREFV---EKGGR 333
Query: 509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
           LP P             + CP D+V +   L + C    P  RPS  +I   L ++
Sbjct: 334 LPCP-------------ELCP-DAVFR---LMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 142/296 (47%), Gaps = 40/296 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++  +  +IG+G FG V+   LR +  N+ ++   C   L         D++A  +FL E
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRAD--NTLVAVKSCRETL-------PPDLKA--KFLQE 162
Query: 332 LKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
            ++L    H N+VRLIG C +   +++V E ++ G+    LR  G   L   + +Q+  D
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGD 221
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG--SASLPTRLVG 448
           +A G+EY+        IHRD+ + N L+ +    K++DFG+++    G  +AS   R V 
Sbjct: 222 AAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQV- 277
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
              +  PE   YG  S + DV++FG++L+E  S   A    N S+  ++  V   E+   
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLG-ASPYPNLSNQQTREFV---EKGGR 333
Query: 509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
           LP P             + CP D+V +   L + C    P  RPS  +I   L ++
Sbjct: 334 LPCP-------------ELCP-DAVFR---LMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 136/296 (45%), Gaps = 50/296 (16%)
Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFLAELKVL 335
            +IG G FG V+     G + N              K AIK  K    +  +F+ E +V+
Sbjct: 33  QEIGSGQFGLVHL----GYWLNK------------DKVAIKTIKEGSMSEDDFIEEAEVM 76
Query: 336 THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
             + H  LV+L G C+E + + LV+E++E+G LS++LR + R      + + + LD   G
Sbjct: 77  MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEG 135
Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           + Y+ E  V   IHRD+ + N L+ +N   KV+DFG+T+       +  T       +  
Sbjct: 136 MAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 192
Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE 514
           PE   +   S K DV++FGV+++E+ S  +   +   +S                 + +E
Sbjct: 193 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVE 235
Query: 515 DLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
           D+    +L  PRL           + Q+   C +E P+ RP+   ++  L  ++ +
Sbjct: 236 DISTGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/302 (23%), Positives = 128/302 (42%), Gaps = 46/302 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFL 329
           ++  +  K+G G FG V+ A                      K A+K M     +   FL
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKH----------------TKVAVKTMKPGSMSVEAFL 231
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQI 387
           AE  V+  + H  LV+L     +  ++++ E++  G+L + L+     + PLP    +  
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDF 289
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           +   A G+ +I +     YIHRD+++ANIL+  +   K+ADFGL ++ E    +      
Sbjct: 290 SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 346
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
               +  PE   +G  + K DV++FG++L E+++       G  +      ++   E   
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRALERGY 402
Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
            +P P             +NCP +    +  +   C +  P+ RP+   I   L    + 
Sbjct: 403 RMPRP-------------ENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445
Query: 568 TE 569
           TE
Sbjct: 446 TE 447

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 33/211 (15%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V Y + RG+Y        + + +      IK+  M +  EF+ E KV+ ++
Sbjct: 31  ELGTGQFGVVKYGKWRGQYD-------VAIKM------IKEGSM-SEDEFIEEAKVMMNL 76
Query: 339 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV+L G C +   +F++ EY+ NG L  +LR   R        +++  D    +EY
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-------TEVGSASLPTRLVGTF 450
           +       ++HRD+ + N L++     KV+DFGL++        + VGS   P R     
Sbjct: 136 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGS-KFPVR----- 186
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            + PPE   Y   S K D++AFGV+++E+ S
Sbjct: 187 -WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 33/211 (15%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V Y + RG+Y        + + +      IK+  M +  EF+ E KV+ ++
Sbjct: 15  ELGTGQFGVVKYGKWRGQYD-------VAIKM------IKEGSM-SEDEFIEEAKVMMNL 60
Query: 339 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV+L G C +   +F++ EY+ NG L  +LR   R        +++  D    +EY
Sbjct: 61  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-------TEVGSASLPTRLVGTF 450
           +       ++HRD+ + N L++     KV+DFGL++        + VGS   P R     
Sbjct: 120 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVR----- 170
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            + PPE   Y   S K D++AFGV+++E+ S
Sbjct: 171 -WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 33/211 (15%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V Y + RG+Y        + + +      IK+  M +  EF+ E KV+ ++
Sbjct: 11  ELGTGQFGVVKYGKWRGQYD-------VAIKM------IKEGSM-SEDEFIEEAKVMMNL 56
Query: 339 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV+L G C +   +F++ EY+ NG L  +LR   R        +++  D    +EY
Sbjct: 57  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-------TEVGSASLPTRLVGTF 450
           +       ++HRD+ + N L++     KV+DFGL++        + VGS   P R     
Sbjct: 116 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVR----- 166
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            + PPE   Y   S K D++AFGV+++E+ S
Sbjct: 167 -WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 33/211 (15%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V Y + RG+Y        + + +      IK+  M +  EF+ E KV+ ++
Sbjct: 31  ELGTGQFGVVKYGKWRGQYD-------VAIKM------IKEGSM-SEDEFIEEAKVMMNL 76
Query: 339 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV+L G C +   +F++ EY+ NG L  +LR   R        +++  D    +EY
Sbjct: 77  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-------TEVGSASLPTRLVGTF 450
           +       ++HRD+ + N L++     KV+DFGL++        + VGS   P R     
Sbjct: 136 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVR----- 186
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            + PPE   Y   S K D++AFGV+++E+ S
Sbjct: 187 -WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL 335
           +S +IG G FG VY  +  G+         + V +L     +     +  + F  E+ VL
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGD---------VAVKIL----KVVDPTPEQFQAFRNEVAVL 86
Query: 336 THVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
               H+N++  +GY  + +L +V ++ E  +L +HL             + IA  +A+G+
Sbjct: 87  RKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGM 145
Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL-VGTFGYMP 454
           +Y+H   +   IHRD+KS NI + +    K+ DFGL  +    S S       G+  +M 
Sbjct: 146 DYLHAKNI---IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 455 PEYAQYGDVSP---KVDVYAFGVVLYELISAK 483
           PE  +  D +P   + DVY++G+VLYEL++ +
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 33/211 (15%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V Y + RG+Y        + + +      IK+  M +  EF+ E KV+ ++
Sbjct: 16  ELGTGQFGVVKYGKWRGQYD-------VAIKM------IKEGSM-SEDEFIEEAKVMMNL 61
Query: 339 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV+L G C +   +F++ EY+ NG L  +LR   R        +++  D    +EY
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-------TEVGSASLPTRLVGTF 450
           +       ++HRD+ + N L++     KV+DFGL++        + VGS   P R     
Sbjct: 121 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVR----- 171
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            + PPE   Y   S K D++AFGV+++E+ S
Sbjct: 172 -WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 33/211 (15%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V Y + RG+Y        + + +      IK+  M +  EF+ E KV+ ++
Sbjct: 22  ELGTGQFGVVKYGKWRGQYD-------VAIKM------IKEGSM-SEDEFIEEAKVMMNL 67
Query: 339 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV+L G C +   +F++ EY+ NG L  +LR   R        +++  D    +EY
Sbjct: 68  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 126
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-------TEVGSASLPTRLVGTF 450
           +       ++HRD+ + N L++     KV+DFGL++        + VGS   P R     
Sbjct: 127 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVR----- 177
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            + PPE   Y   S K D++AFGV+++E+ S
Sbjct: 178 -WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 31/210 (14%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V Y + RG+Y        + + +      IK+  M +  EF+ E KV+ ++
Sbjct: 16  ELGTGQFGVVKYGKWRGQYD-------VAIKM------IKEGSM-SEDEFIEEAKVMMNL 61
Query: 339 HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H  LV+L G C +   +F++ EY+ NG L  +LR   R        +++  D    +EY
Sbjct: 62  SHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLPTRLVGTFG 451
           +       ++HRD+ + N L++     KV+DFGL++       T    +  P R      
Sbjct: 121 LESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVR------ 171
Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           + PPE   Y   S K D++AFGV+++E+ S
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 37/232 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATXRTVAVKMLKEGAT-----HSEHRALMSE 82
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR---- 384
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYK 142
Query: 385 --------VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK--- 433
                   +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL +   
Sbjct: 143 DFLTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 434 ----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                   G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 200 KDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 50/296 (16%)
Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--FLAELKVL 335
            +IG G FG V+     G + N              K AIK +   A  E  F+ E +V+
Sbjct: 14  QEIGSGQFGLVHL----GYWLNK------------DKVAIKTIREGAMSEEDFIEEAEVM 57
Query: 336 THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
             + H  LV+L G C+E + + LV E++E+G LS++LR + R      + + + LD   G
Sbjct: 58  MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEG 116
Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           + Y+ E  V   IHRD+ + N L+ +N   KV+DFG+T+       +  T       +  
Sbjct: 117 MAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 173
Query: 455 PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE 514
           PE   +   S K DV++FGV+++E+ S  +   +   +S                 + +E
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----------------EVVE 216
Query: 515 DLR---KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
           D+    +L  PRL           + Q+   C +E P+ RP+   ++  L  ++ +
Sbjct: 217 DISTGFRLYKPRLAST-------HVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/189 (33%), Positives = 94/189 (49%), Gaps = 18/189 (9%)
Query: 311 LMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSE 369
           +M    + + D +  R FL E+KV+  + H N+++ IG    +  L  + EYI+ G L  
Sbjct: 37  VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG 96
Query: 370 HLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF 429
            ++ S     PWS RV  A D A G+ Y+H   +   IHRD+ S N L+ +N +  VADF
Sbjct: 97  IIK-SMDSQYPWSQRVSFAKDIASGMAYLHSMNI---IHRDLNSHNCLVRENKNVVVADF 152
Query: 430 GLTKLT--------EVGSASLPTR-----LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVL 476
           GL +L          + S   P R     +VG   +M PE         KVDV++FG+VL
Sbjct: 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVL 212
Query: 477 YELISAKEA 485
            E+I    A
Sbjct: 213 CEIIGRVNA 221

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 38/233 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D  ++   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 81
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+ +   + 
Sbjct: 82  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLY 141
Query: 389 LD-------------SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
            D              A+G+E++        IHRD+ + NIL+ +    K+ DFGL +  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                    G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 199 XKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 72/302 (23%), Positives = 129/302 (42%), Gaps = 56/302 (18%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFL 329
           ++  +  K+G G FG V+ A                      K A+K M     +   FL
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKH----------------TKVAVKTMKPGSMSVEAFL 225
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQI 387
           AE  V+  + H  LV+L     +  ++++ E++  G+L + L+     + PLP    +  
Sbjct: 226 AEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDF 283
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           +   A G+ +I +     YIHRD+++ANIL+  +   K+ADFGL ++     A  P +  
Sbjct: 284 SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV----GAKFPIK-- 334
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
               +  PE   +G  + K DV++FG++L E+++       G  +      ++   E   
Sbjct: 335 ----WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRALERGY 386
Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
            +P P             +NCP +    +  +   C +  P+ RP+   I   L    + 
Sbjct: 387 RMPRP-------------ENCPEE----LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 429
Query: 568 TE 569
           TE
Sbjct: 430 TE 431

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 35/230 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D  ++   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFG-IDKTATXRTVAVKMLKEGAT-----HSEHRALMSE 80
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR---- 384
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 385 ------VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK----- 433
                 +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL +     
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKIXDFGLARDIYKD 197
Query: 434 --LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                 G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 198 PDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 111/230 (48%), Gaps = 35/230 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D  ++   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFG-IDKTATXRTVAVKMLKEGAT-----HSEHRALMSE 80
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ-- 386
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+    +  
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 387 --------IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK----- 433
                    +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL +     
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKX---IHRDLAARNILLSEKNVVKICDFGLARDIYKD 197
Query: 434 --LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                 G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 198 PDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 46/290 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFL 329
           ++  +  K+G G FG V+ A                      K A+K M     +   FL
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKH----------------TKVAVKTMKPGSMSVEAFL 58
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQI 387
           AE  V+  + H  LV+L     +  ++++ E++  G+L + L+     + PLP    +  
Sbjct: 59  AEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDF 116
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           +   A G+ +I +     YIHRD+++ANIL+  +   K+ADFGL ++ E    +      
Sbjct: 117 SAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 173
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
               +  PE   +G  + K DV++FG++L E+++       G  +      ++   E   
Sbjct: 174 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRALERGY 229
Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
            +P P             +NCP +    +  +   C +  P+ RP+   I
Sbjct: 230 RMPRP-------------ENCPEE----LYNIMMRCWKNRPEERPTFEYI 262

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 80
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------ 382
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 383 --------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
                     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL + 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 198 IXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/248 (28%), Positives = 117/248 (47%), Gaps = 21/248 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           + + +  K+G GG   VY AE      ++ L+  + +  +      K+   +  + F  E
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAE------DTILNIKVAIKAIFIPPREKE---ETLKRFERE 61
Query: 332 LKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +   + + H N+V +I    E    +LV EYIE   LSE++   G  PL   + +     
Sbjct: 62  VHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQ 119
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
              G+++ H+  +   +HRDIK  NILID N   K+ DFG+ K     S +    ++GT 
Sbjct: 120 ILDGIKHAHDMRI---VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP 510
            Y  PE A+        D+Y+ G+VLYE++  +      NG +A S  +  + + V   P
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF---NGETAVSIAIKHIQDSV---P 230
Query: 511 DPIEDLRK 518
           +   D+RK
Sbjct: 231 NVTTDVRK 238

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 82
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR---- 384
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL 142
Query: 385 ----------VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
                     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL + 
Sbjct: 143 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 199
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 200 IYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 71
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------ 382
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 383 --------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
                     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL + 
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 189 IXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 80
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------ 382
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 383 --------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
                     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL + 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 198 IYKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 71
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------ 382
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 383 --------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
                     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL + 
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 189 IXKDPDXVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 126/274 (45%), Gaps = 32/274 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  ++G G FG V+     G Y NS             K A+K  K    + + FL
Sbjct: 13  ESIKLVKRLGAGQFGEVW----MGYYNNS------------TKVAVKTLKPGTMSVQAFL 56
Query: 330 AELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQ 386
            E  ++  + H  LVRL      E  ++++ EY+  G+L + L+    G+  LP    + 
Sbjct: 57  EEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLID 114
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            +   A G+ YI       YIHRD+++AN+L+ ++   K+ADFGL ++ E    +     
Sbjct: 115 FSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 171
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE-- 504
                +  PE   +G  + K DV++FG++LYE+++  +    G  ++     L   +   
Sbjct: 172 KFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMP 231
Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCP----LDSVL 534
            V N PD + D+ K+      +  P    L SVL
Sbjct: 232 RVENCPDELYDIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 117
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------ 382
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 118 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 177
Query: 383 --------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
                     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL + 
Sbjct: 178 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 234
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 235 IYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 71
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------ 382
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 383 --------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
                     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL + 
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 189 IYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 80
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------ 382
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 383 --------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
                     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL + 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 198 IYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 136/307 (44%), Gaps = 60/307 (19%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF---LA 330
            ++   IG GGFG VY A   G+              +  KAA    D   S+       
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWIGDE-------------VAVKAARHDPDEDISQTIENVRQ 55
Query: 331 ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E K+   + H N++ L G C+ E +L LV E+   G L+  L G     +P    V  A+
Sbjct: 56  EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---IPPDILVNWAV 112
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDK--------NFHAKVADFGLT----KLTEV 437
             ARG+ Y+H+  +   IHRD+KS+NILI +        N   K+ DFGL     + T++
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
Query: 438 GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
            +A       G + +M PE  +    S   DV+++GV+L+EL++  E   +G    A + 
Sbjct: 173 SAA-------GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG-EVPFRGIDGLAVAY 224
Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           G VA+ +  L +P                 CP       A+L + C    P  RPS  +I
Sbjct: 225 G-VAMNKLALPIP---------------STCP----EPFAKLMEDCWNPDPHSRPSFTNI 264
Query: 558 VVALMTL 564
           +  L T+
Sbjct: 265 LDQLTTI 271

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 110/234 (47%), Gaps = 39/234 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 71
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------ 382
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+       
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 383 --------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
                     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL + 
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARD 188
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     G A LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 189 IYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 86/321 (26%), Positives = 139/321 (43%), Gaps = 49/321 (15%)
Query: 263 SYEELSKATDNFS---------MSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLL 311
           +YEE  +A  +F+         +   IG G  G V Y  LR  G+       R + V + 
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ-------RDVPVAIK 83
Query: 312 MQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEH 370
             KA   +   +  R+FL+E  ++    H N++RL G    G L  +V EY+ENG+L   
Sbjct: 84  ALKAGYTE---RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 371 LRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
           LR +          V +      G+ Y+ +     Y+HRD+ + N+L+D N   KV+DFG
Sbjct: 141 LR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 431 LTKLTEVGSASLPTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
           L+++ E    +  T   G     +  PE   +   S   DV++FGVV++E+++  E    
Sbjct: 197 LSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY- 255
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
               +  ++ +++  EE   LP P+              CP      + QL   C  +  
Sbjct: 256 ---WNMTNRDVISSVEEGYRLPAPM-------------GCP----HALHQLMLDCWHKDR 295
Query: 549 QLRPSMRSIVVALMTLSSTTE 569
             RP    IV  L  L  + E
Sbjct: 296 AQRPRFSQIVSVLDALIRSPE 316

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 47/285 (16%)
Query: 281 GQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH--V 338
            +G FG V+ A+L  ++                  A+K   +Q  + + +E ++ +   +
Sbjct: 24  ARGRFGCVWKAQLMNDF-----------------VAVKIFPLQDKQSWQSEREIFSTPGM 66
Query: 339 HHLNLVRLI-----GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
            H NL++ I     G  +E  L+L+  + + G+L+++L+G   + + W+    +A   +R
Sbjct: 67  KHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKG---NIITWNELCHVAETMSR 123
Query: 394 GLEYIHEHT--------VPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
           GL Y+HE           P   HRD KS N+L+  +  A +ADFGL    E G     T 
Sbjct: 124 GLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH 183
Query: 446 -LVGTFGYMPPEYAQYG-----DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
             VGT  YM PE  +       D   ++D+YA G+VL+EL+S      K      D   L
Sbjct: 184 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSR----CKAADGPVDEYML 239
Query: 500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCT 544
              FEE +     +E+L+++V  +       D  LK   LA++C 
Sbjct: 240 P--FEEEIGQHPSLEELQEVVVHKKMRPTIKDHWLKHPGLAQLCV 282

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 86/321 (26%), Positives = 139/321 (43%), Gaps = 49/321 (15%)
Query: 263 SYEELSKATDNFS---------MSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLL 311
           +YEE  +A  +F+         +   IG G  G V Y  LR  G+       R + V + 
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ-------RDVPVAIK 83
Query: 312 MQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEH 370
             KA   +   +  R+FL+E  ++    H N++RL G    G L  +V EY+ENG+L   
Sbjct: 84  ALKAGYTE---RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140
Query: 371 LRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
           LR +          V +      G+ Y+ +     Y+HRD+ + N+L+D N   KV+DFG
Sbjct: 141 LR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 431 LTKLTEVGSASLPTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
           L+++ E    +  T   G     +  PE   +   S   DV++FGVV++E+++  E    
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY- 255
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
               +  ++ +++  EE   LP P+              CP      + QL   C  +  
Sbjct: 256 ---WNMTNRDVISSVEEGYRLPAPM-------------GCP----HALHQLMLDCWHKDR 295
Query: 549 QLRPSMRSIVVALMTLSSTTE 569
             RP    IV  L  L  + E
Sbjct: 296 AQRPRFSQIVSVLDALIRSPE 316

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/234 (32%), Positives = 117/234 (50%), Gaps = 47/234 (20%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-----FLAELK 333
           KIGQG FG V+ A  R                  QK A+KK+ M+  +E      L E+K
Sbjct: 25  KIGQGTFGEVFKARHRKT---------------GQKVALKKVLMENEKEGFPITALREIK 69
Query: 334 VLTHVHHLNLVRLIGYC---------VEGSLFLVYEYIEN---GNLSEHLRGSGRDPLPW 381
           +L  + H N+V LI  C          +GS++LV+++ E+   G LS  L    +  L  
Sbjct: 70  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSE 126
Query: 382 SSRV-QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
             RV Q+ L+   GL YIH + +   +HRD+K+AN+LI ++   K+ADFGL +   +   
Sbjct: 127 IKRVMQMLLN---GLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 180
Query: 441 SLPTRL---VGTFGYMPPE-YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           S P R    V T  Y PPE      D  P +D++  G ++ E+ + +  I++GN
Sbjct: 181 SQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGN 233

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/254 (32%), Positives = 124/254 (48%), Gaps = 50/254 (19%)
Query: 259 SVEFSY-EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI 317
           SVE  + +E+SK    +    KIGQG FG V+ A  R                  QK A+
Sbjct: 8   SVECPFCDEVSK----YEKLAKIGQGTFGEVFKARHRKT---------------GQKVAL 48
Query: 318 KKMDMQASRE-----FLAELKVLTHVHHLNLVRLIGYC---------VEGSLFLVYEYIE 363
           KK+ M+  +E      L E+K+L  + H N+V LI  C          +GS++LV+++ E
Sbjct: 49  KKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE 108
Query: 364 N---GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK 420
           +   G LS  L    +  L    RV   L    GL YIH + +   +HRD+K+AN+LI +
Sbjct: 109 HDLAGLLSNVL---VKFTLSEIKRVMQML--LNGLYYIHRNKI---LHRDMKAANVLITR 160
Query: 421 NFHAKVADFGLTKLTEVGSASLPTRL---VGTFGYMPPE-YAQYGDVSPKVDVYAFGVVL 476
           +   K+ADFGL +   +   S P R    V T  Y PPE      D  P +D++  G ++
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220
Query: 477 YELISAKEAIVKGN 490
            E+ + +  I++GN
Sbjct: 221 AEMWT-RSPIMQGN 233

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/307 (25%), Positives = 137/307 (44%), Gaps = 55/307 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+G G FG V+     G Y NS             K A+K  K    + + FL
Sbjct: 12  ESIKLVKKLGAGQFGEVW----MGYYNNS------------TKVAVKTLKPGTMSVQAFL 55
Query: 330 AELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQ 386
            E  ++  + H  LVRL      E  ++++ E++  G+L + L+    G+  LP    + 
Sbjct: 56  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP--KLID 113
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            +   A G+ YI       YIHRD+++AN+L+ ++   K+ADFGL ++ E    +     
Sbjct: 114 FSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 170
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS----SADSKGLVAL 502
                +  PE   +G  + K +V++FG++LYE+++  +    G  +    SA S+G    
Sbjct: 171 KFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM- 229
Query: 503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM 562
                              PR+ +NCP +    +  + K+C +E  + RP+   +   L 
Sbjct: 230 -------------------PRM-ENCPDE----LYDIMKMCWKEKAEERPTFDYLQSVLD 265
Query: 563 TLSSTTE 569
              + TE
Sbjct: 266 DFYTATE 272

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 56  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 107
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 166
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 167 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK--- 220
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 221 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 37  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 147
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 148 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVK--- 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 202 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 114/233 (48%), Gaps = 45/233 (19%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-----FLAELK 333
           KIGQG FG V+ A  R                  QK A+KK+ M+  +E      L E+K
Sbjct: 24  KIGQGTFGEVFKARHRKT---------------GQKVALKKVLMENEKEGFPITALREIK 68
Query: 334 VLTHVHHLNLVRLIGYC---------VEGSLFLVYEYIEN---GNLSEHLRGSGRDPLPW 381
           +L  + H N+V LI  C          +GS++LV+++ E+   G LS  L    +  L  
Sbjct: 69  ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSE 125
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
             RV   L    GL YIH + +   +HRD+K+AN+LI ++   K+ADFGL +   +   S
Sbjct: 126 IKRVMQML--LNGLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180
Query: 442 LPTRL---VGTFGYMPPE-YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            P R    V T  Y PPE      D  P +D++  G ++ E+ + +  I++GN
Sbjct: 181 QPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGN 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/330 (23%), Positives = 143/330 (43%), Gaps = 52/330 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 89
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINR 148
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 434 -LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
            +  +      T       +M PE       + + DV++FGV+++E+ +   +   G   
Sbjct: 206 DINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-- 263
Query: 493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
                              P+E+L KL+      + P +   ++  + + C    P  RP
Sbjct: 264 -------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 553 SMRSIVVAL---MTLSSTTEDWDVGSFYEN 579
           + + +V  L   +TL++  E  D+    E 
Sbjct: 305 TFKQLVEDLDRILTLTTNEEYLDLSQPLEQ 334

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 25  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 77
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 78  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 135
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 136 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------- 236
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 237 RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 291
Query: 561 LMTL 564
           L  L
Sbjct: 292 LDKL 295

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 57  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 108
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 167
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 168 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK--- 221
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 222 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/330 (23%), Positives = 143/330 (43%), Gaps = 52/330 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 89
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEXSYDINR 148
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 434 -LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
            +  +      T       +M PE       + + DV++FGV+++E+ +   +   G   
Sbjct: 206 DINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-- 263
Query: 493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
                              P+E+L KL+      + P +   ++  + + C    P  RP
Sbjct: 264 -------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP 304
Query: 553 SMRSIVVAL---MTLSSTTEDWDVGSFYEN 579
           + + +V  L   +TL++  E  D+    E 
Sbjct: 305 TFKQLVEDLDRILTLTTNEEYLDLSQPLEQ 334

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 38  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 148
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 149 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK--- 202
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 203 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 30  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 81
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 140
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 141 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK--- 194
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 195 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 8   EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 60
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 61  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 118
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 119 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------- 219
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 220 RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 561 LMTL 564
           L  L
Sbjct: 275 LDKL 278

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 89
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 90  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 147
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------- 248
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 249 RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 561 LMTL 564
           L  L
Sbjct: 304 LDKL 307

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 89
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 90  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 147
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------- 250
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 251 --YWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 561 LMTL 564
           L  L
Sbjct: 304 LDKL 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 89
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 90  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 147
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------- 248
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 249 RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 561 LMTL 564
           L  L
Sbjct: 304 LDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 89
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 90  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 147
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------- 248
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 249 RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 561 LMTL 564
           L  L
Sbjct: 304 LDKL 307

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 35  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 145
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 146 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK--- 199
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 200 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 133/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 35  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 87
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 88  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 145
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 146 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------- 248
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 249 --YWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 301
Query: 561 LMTL 564
           L  L
Sbjct: 302 LDKL 305

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 142/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 89
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 90  EMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINR 148
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                    +  +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 206 DINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 260 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 298
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTTNEE 324

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 144/326 (44%), Gaps = 57/326 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + ++E
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIG-LDKDKPNRVTKVAVKMLKSDATEKDLS---DLISE 124
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------- 382
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+L+      L +S       
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 383 -------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
                    V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +   
Sbjct: 242 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                      P+E+L KL+      + P +   ++  + + C    P
Sbjct: 296 GV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 334
Query: 549 QLRPSMRSIVVALMTLSSTTEDWDVG 574
             RP+ + +V  L  + + T + ++G
Sbjct: 335 SQRPTFKQLVEDLDRIVALTSNQEMG 360

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 38  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 148
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 149 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK--- 202
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 203 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 37  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 88
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 147
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 148 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK--- 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 202 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 36  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 146
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 147 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK--- 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 201 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 142/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 89
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 90  EMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINR 148
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                    +  +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 206 DINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 260 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 298
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTTNEE 324

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 33  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 84
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G++Y
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKY 143
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 144 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK--- 197
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 198 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 132/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 89
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 90  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 147
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL ++ E    + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------- 248
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 249 RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 561 LMTL 564
           L  L
Sbjct: 304 LDKL 307

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 19/230 (8%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           +F +   +G G FG V+    R         R   + +L ++  ++   ++ + +   E 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHN------GRYYAMKVLKKEIVVRLKQVEHTND---ER 57
Query: 333 KVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
            +L+ V H  ++R+ G   +   +F++ +YIE G L   LR S R P P +     A + 
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEV 115
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
              LEY+H   +   I+RD+K  NIL+DKN H K+ DFG  K        +   L GT  
Sbjct: 116 CLALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPD 168
Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
           Y+ PE       +  +D ++FG+++YE+++        N      K L A
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 141/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 89
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINR 148
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                       +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 206 DINNIDYYKNTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 260 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 298
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTTNEE 324

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G + + L+   +            
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYI 119
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 120 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVH---APSSRRTTLCG 173
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 97  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 148
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G+++
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKF 207
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 208 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK--- 261
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 262 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 38/289 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG G FG V    L+         R ICV +   KA       +  R+FL+E  ++    
Sbjct: 16  IGVGEFGEVCSGRLKVPG-----KREICVAIKTLKAGYTD---KQRRDFLSEASIMGQFD 67
Query: 340 HLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR-GSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L G   +   + ++ EY+ENG+L   LR   GR  +     V +      G++Y
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKY 125
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT--FGYMPP 455
           + + +   Y+HRD+ + NIL++ N   KV+DFG++++ E    +  T   G     +  P
Sbjct: 126 LSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAP 182
Query: 456 EYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIED 515
           E   Y   +   DV+++G+V++E++S  E           ++ ++   EE   LP P+  
Sbjct: 183 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPY----WDMSNQDVIKAIEEGYRLPPPM-- 236
Query: 516 LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
                      +CP    + + QL   C Q+    RP    IV  L  L
Sbjct: 237 -----------DCP----IALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 142/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 135
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINR 194
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                    +  +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 252 DINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 306 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 344
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 345 VPSQRPTFKQLVEDLDRILTLTTNEE 370

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 134/305 (43%), Gaps = 40/305 (13%)
Query: 266 ELSKATDN--FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D     +   IG G FG V    L+         R ICV +   KA       +
Sbjct: 6   EFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPG-----KREICVAIKTLKAGYTD---K 57
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR-GSGRDPLPW 381
             R+FL+E  ++    H N++ L G   +   + ++ EY+ENG+L   LR   GR  +  
Sbjct: 58  QRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV-- 115
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
              V +      G++Y+ + +   Y+HRD+ + NIL++ N   KV+DFG++++ E    +
Sbjct: 116 IQLVGMLRGIGSGMKYLSDMS---YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 172
Query: 442 LPTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
             T   G     +  PE   Y   +   DV+++G+V++E++S  E           ++ +
Sbjct: 173 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY----WDMSNQDV 228
Query: 500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
           +   EE   LP P+             +CP    + + QL   C Q+    RP    IV 
Sbjct: 229 IKAIEEGYRLPPPM-------------DCP----IALHQLMLDCWQKERSDRPKFGQIVN 271
Query: 560 ALMTL 564
            L  L
Sbjct: 272 MLDKL 276

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 142/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 78
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 79  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINR 137
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 138 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 194
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                    +  +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 195 DINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 248
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 249 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 287
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 288 VPSQRPTFKQLVEDLDRILTLTTNEE 313

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 39  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G+++
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKF 149
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 150 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVK--- 203
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 204 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 142/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 81
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 82  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINR 140
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 141 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 197
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                    +  +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 198 DINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 251
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 252 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 290
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 291 VPSQRPTFKQLVEDLDRILTLTTNEE 316

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 132/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 89
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 90  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 147
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL ++ E    + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------------- 250
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 251 --YWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 561 LMTL 564
           L  L
Sbjct: 304 LDKL 307

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 36  IGRGHFGCVYHGTLLDNDG----KKIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 87
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G+++
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKF 146
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 147 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK--- 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 201 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/326 (23%), Positives = 142/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 76
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 77  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINR 135
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 136 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLTARNVLVTENNVMKIADFGLAR 192
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                    +  +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 193 DINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 246
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 247 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 285
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 286 VPSQRPTFKQLVEDLDRILTLTTNQE 311

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 39  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 90
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G+++
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKF 149
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 150 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK--- 203
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 204 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 38  IGRGHFGCVYHGTLLDNDG----KKIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G+++
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKF 148
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 149 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK--- 202
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 203 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/326 (23%), Positives = 142/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 89
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P          
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINR 148
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   ++ADFGL +
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMRIADFGLAR 205
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                    +  +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 206 DINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 260 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 298
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTTNEE 324

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/245 (28%), Positives = 112/245 (45%), Gaps = 20/245 (8%)
Query: 242 GPAAGTPTSLNAITVDKSVEFSYEELSKATD-NFSMSHKIGQGGFGAVYYAELRGEYGNS 300
           G     P    A T+ K       +  K TD NF M   +G+G FG V  +E +G     
Sbjct: 312 GQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMV--LGKGSFGKVMLSERKG----- 364
Query: 301 YLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE--GSLFLV 358
               L  V +L +   I+  D++ +   + E +VL        +  +  C +    L+ V
Sbjct: 365 -TDELYAVKILKKDVVIQDDDVECT---MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420
Query: 359 YEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI 418
            EY+  G+L  H++  GR   P +  V  A + A GL ++    +   I+RD+K  N+++
Sbjct: 421 MEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQSKGI---IYRDLKLDNVML 475
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYE 478
           D   H K+ADFG+ K   +          GT  Y+ PE   Y      VD +AFGV+LYE
Sbjct: 476 DSEGHIKIADFGMCK-ENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
Query: 479 LISAK 483
           +++ +
Sbjct: 535 MLAGQ 539

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F +   +G+G FG VY A    E  N +   ++ + +L  K+ ++K  ++   +   E
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAR---EKQNKF---IMALKVLF-KSQLEKEGVE--HQLRRE 65
Query: 332 LKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +++ +H+ H N++R+  Y  +   ++L+ E+   G L + L+  GR     S+     L 
Sbjct: 66  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL- 124
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LVGT 449
            A  L Y HE  V   IHRDIK  N+L+      K+ADFG +    V + SL  R + GT
Sbjct: 125 -ADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGT 176
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             Y+PPE  +      KVD++  GV+ YE +
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/325 (23%), Positives = 141/325 (43%), Gaps = 62/325 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D  ++   +G+G FG V  AE  G          + V + M K    + D+    + ++E
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVG-IDKDKPKEAVTVAVKMLKDDATEEDLS---DLVSE 90
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP----------- 378
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+LR   R P           
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR-RPPGMEYSYDINRV 149
Query: 379 ----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK- 433
               + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL + 
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARD 206
Query: 434 ------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIV 487
                   +  +  LP +      +M PE       + + DV++FGV+++E+ +   +  
Sbjct: 207 INNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 488 KGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEY 547
            G                      P+E+L KL+      + P +   ++  + + C    
Sbjct: 261 PGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAV 299
Query: 548 PQLRPSMRSIVVAL---MTLSSTTE 569
           P  RP+ + +V  L   +TL++  E
Sbjct: 300 PSQRPTFKQLVEDLDRILTLTTNEE 324

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 38  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 89
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G+++
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKF 148
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 149 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK--- 202
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 203 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G FG VY+  L    G     ++ C      K+  +  D+    +FL E  ++    
Sbjct: 43  IGRGHFGCVYHGTLLDNDGK----KIHCA----VKSLNRITDIGEVSQFLTEGIIMKDFS 94
Query: 340 HLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
           H N++ L+G C+  EGS  +V  Y+++G+L   +R    +P      +   L  A+G+++
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKGMKF 153
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---------LTEVGSASLPTRLVG 448
           +       ++HRD+ + N ++D+ F  KVADFGL +         +     A LP +   
Sbjct: 154 LASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK--- 207
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              +M  E  Q    + K DV++FGV+L+EL++
Sbjct: 208 ---WMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 47/316 (14%)
Query: 262 FSYEELSKATDNFS---------MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM 312
           F++E+ ++A   F+         +   IG G FG V    L+         R ICV +  
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPG-----KREICVAIKT 64
Query: 313 QKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHL 371
            KA       +  R+FL+E  ++    H N++ L G   +   + ++ EY+ENG+L   L
Sbjct: 65  LKAGYTD---KQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL 121
Query: 372 R-GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
           R   GR  +     V +      G++Y+ + +    +HRD+ + NIL++ N   KV+DFG
Sbjct: 122 RKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSA---VHRDLAARNILVNSNLVCKVSDFG 176
Query: 431 LTKLTEVGSASLPTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
           ++++ E    +  T   G     +  PE   Y   +   DV+++G+V++E++S  E    
Sbjct: 177 MSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY- 235
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
                  ++ ++   EE   LP P+             +CP    + + QL   C Q+  
Sbjct: 236 ---WDMSNQDVIKAIEEGYRLPPPM-------------DCP----IALHQLMLDCWQKER 275
Query: 549 QLRPSMRSIVVALMTL 564
             RP    IV  L  L
Sbjct: 276 SDRPKFGQIVNMLDKL 291

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 133/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 89
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR          
Sbjct: 90  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVI 147
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     ++HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------- 248
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 249 RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 561 LMTL 564
           L  L
Sbjct: 304 LDKL 307

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/254 (31%), Positives = 123/254 (48%), Gaps = 50/254 (19%)
Query: 259 SVEFSY-EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI 317
           SVE  + +E+SK    +    KIGQG FG V+ A  R                  QK A+
Sbjct: 8   SVECPFCDEVSK----YEKLAKIGQGTFGEVFKARHRKT---------------GQKVAL 48
Query: 318 KKMDMQASRE-----FLAELKVLTHVHHLNLVRLIGYC---------VEGSLFLVYEYIE 363
           KK+ M+  +E      L E+K+L  + H N+V LI  C          + S++LV+++ E
Sbjct: 49  KKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCE 108
Query: 364 N---GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK 420
           +   G LS  L    +  L    RV   L    GL YIH + +   +HRD+K+AN+LI +
Sbjct: 109 HDLAGLLSNVL---VKFTLSEIKRVMQML--LNGLYYIHRNKI---LHRDMKAANVLITR 160
Query: 421 NFHAKVADFGLTKLTEVGSASLPTRL---VGTFGYMPPE-YAQYGDVSPKVDVYAFGVVL 476
           +   K+ADFGL +   +   S P R    V T  Y PPE      D  P +D++  G ++
Sbjct: 161 DGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 220
Query: 477 YELISAKEAIVKGN 490
            E+ + +  I++GN
Sbjct: 221 AEMWT-RSPIMQGN 233

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F +   +G+G FG VY A  R        S+ I    ++ K  ++K  ++   +   E
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQ-------SKFILALKVLFKTQLEKAGVE--HQLRRE 62
Query: 332 LKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   R             +
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITE 120
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
            A  L Y H   V   IHRDIK  N+L+  N   K+ADFG +       +S  T L GT 
Sbjct: 121 LANALSYCHSKRV---IHRDIKPENLLLGSNGELKIADFGWSV---HAPSSRRTTLCGTL 174
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            Y+PPE  +      KVD+++ GV+ YE +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 82
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 140
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 141 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCG 194
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 56
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 114
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 115 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVH---APSSRRTELCG 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F +   +G+G FG VY A    E  N +   ++ + +L  K+ ++K  ++   +   E
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAR---EKQNKF---IMALKVLF-KSQLEKEGVE--HQLRRE 64
Query: 332 LKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +++ +H+ H N++R+  Y  +   ++L+ E+   G L + L+  GR     S+     L 
Sbjct: 65  IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL- 123
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LVGT 449
            A  L Y HE  V   IHRDIK  N+L+      K+ADFG +    V + SL  R + GT
Sbjct: 124 -ADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWS----VHAPSLRRRXMCGT 175
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             Y+PPE  +      KVD++  GV+ YE +
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 119
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 120 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVH---APSSRRTTLCG 173
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 174 TLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/317 (25%), Positives = 141/317 (44%), Gaps = 53/317 (16%)
Query: 262 FSYEELSKATDNFS---------MSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNL 310
           F++E+ ++A   F+         +   IG G FG V    L+  G+       R I V +
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK-------REIFVAI 66
Query: 311 LMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSE 369
              K+   +   +  R+FL+E  ++    H N++ L G   + + + ++ E++ENG+L  
Sbjct: 67  KTLKSGYTE---KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 370 HLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF 429
            LR +          V +    A G++Y+ +     Y+HRD+ + NIL++ N   KV+DF
Sbjct: 124 FLRQNDGQ-FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDF 179
Query: 430 GLTKLTEVGSASLPTRLVGTFGYMP-----PEYAQYGDVSPKVDVYAFGVVLYELISAKE 484
           GL++  E    S PT      G +P     PE  QY   +   DV+++G+V++E++S  E
Sbjct: 180 GLSRFLE-DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 238
Query: 485 AIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCT 544
                      ++ ++   E+   LP P++             CP      + QL   C 
Sbjct: 239 RPY----WDMTNQDVINAIEQDYRLPPPMD-------------CP----SALHQLMLDCW 277
Query: 545 QEYPQLRPSMRSIVVAL 561
           Q+    RP    IV  L
Sbjct: 278 QKDRNHRPKFGQIVNTL 294

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG G FG V    L+            CV +   K    +   +  REFL+E  ++    
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKES-----CVAIKTLKGGYTE---RQRREFLSEASIMGQFE 75
Query: 340 HLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLR-GSGRDPLPWSSRVQIALDSARGLEY 397
           H N++RL G       + ++ E++ENG L   LR   G+  +     V +    A G+ Y
Sbjct: 76  HPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRY 133
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP--- 454
           + E +   Y+HRD+ + NIL++ N   KV+DFGL++  E  S+  PT      G +P   
Sbjct: 134 LAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD-PTETSSLGGKIPIRW 189
Query: 455 --PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
             PE   +   +   D +++G+V++E++S  E           ++ ++   E+   LP P
Sbjct: 190 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY----WDMSNQDVINAIEQDYRLPPP 245
Query: 513 IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                         +CP      + QL   C Q+    RP    +V AL
Sbjct: 246 -------------PDCP----TSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 73
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 74  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 131
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 132 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVH---APSSRRTTLCG 185
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 186 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 56
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 114
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 115 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCG 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 59
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 117
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 118 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCG 171
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/326 (23%), Positives = 141/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 89
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++  Y   GNL E+LR   R P          
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRAR-RPPGMEYSYDINR 148
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                    +  +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 206 DINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 260 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 298
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTTNEE 324

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 119
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 120 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCG 173
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 57
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 115
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 116 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCG 169
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 79/328 (24%), Positives = 144/328 (43%), Gaps = 60/328 (18%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + ++E
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIG-LDKDKPNRVTKVAVKMLKSDATEKDLS---DLISE 83
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------- 382
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+L+      L +S       
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNP 143
Query: 383 -------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
                    V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +   
Sbjct: 201 HHIDXXKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                      P+E+L KL+      + P +   ++  + + C    P
Sbjct: 255 GV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 293
Query: 549 QLRPSMRSIVVAL---MTLSSTTEDWDV 573
             RP+ + +V  L   + L+S  E  D+
Sbjct: 294 SQRPTFKQLVEDLDRIVALTSNQEXLDL 321

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 56
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 114
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 115 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCG 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 56
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 114
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 115 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCG 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G + + L+   +            
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK--FDEQRTATYI 119
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S    L G
Sbjct: 120 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVH---APSSRRXXLXG 173
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 118/271 (43%), Gaps = 32/271 (11%)
Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDM----QASREFLAELKVLTHVHHLNLVRLIGYC 350
           GE+G     RL          AIK + +    +  R+FL E  ++    H N+V L G  
Sbjct: 54  GEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVV 113
Query: 351 VEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHR 409
             G  + +V E++ENG L   LR            V +    A G+ Y+ +     Y+HR
Sbjct: 114 TRGKPVMIVIEFMENGALDAFLRKHD-GQFTVIQLVGMLRGIAAGMRYLADMG---YVHR 169
Query: 410 DIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPEYAQYGDVSPKV 467
           D+ + NIL++ N   KV+DFGL+++ E    ++ T   G     +  PE  QY   +   
Sbjct: 170 DLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSAS 229
Query: 468 DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDN 527
           DV+++G+V++E++S  E           ++ ++   EE   LP P+             +
Sbjct: 230 DVWSYGIVMWEVMSYGERPY----WDMSNQDVIKAIEEGYRLPAPM-------------D 272
Query: 528 CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           CP      + QL   C Q+    RP    IV
Sbjct: 273 CPAG----LHQLMLDCWQKERAERPKFEQIV 299

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 132/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 8   EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 60
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V E +ENG+L   LR          
Sbjct: 61  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVI 118
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 119 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------- 219
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 220 RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 274
Query: 561 LMTL 564
           L  L
Sbjct: 275 LDKL 278

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 56
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 114
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 115 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLCG 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 61
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 62  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 119
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 120 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCG 173
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 55
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 56  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 113
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 114 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCG 167
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 168 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 60
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 61  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 118
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 119 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCG 172
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 173 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/326 (23%), Positives = 141/326 (43%), Gaps = 64/326 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           D  ++   +G+G FG V  AE  G +      +  + V +L   A  K +      + ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS-----DLVS 89
Query: 331 ELKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDP---------- 378
           E++++  +  H N++ L+G C + G L+++  Y   GNL E+LR   R P          
Sbjct: 90  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRAR-RPPGMEYSYDINR 148
Query: 379 -----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 434 -------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                    +  +  LP +      +M PE       + + DV++FGV+++E+ +   + 
Sbjct: 206 DINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
             G                      P+E+L KL+      + P +   ++  + + C   
Sbjct: 260 YPGI---------------------PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHA 298
Query: 547 YPQLRPSMRSIVVAL---MTLSSTTE 569
            P  RP+ + +V  L   +TL++  E
Sbjct: 299 VPSQRPTFKQLVEDLDRILTLTTNEE 324

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG G FG V    L+            CV +   K    +   +  REFL+E  ++    
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKES-----CVAIKTLKGGYTE---RQRREFLSEASIMGQFE 73
Query: 340 HLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLR-GSGRDPLPWSSRVQIALDSARGLEY 397
           H N++RL G       + ++ E++ENG L   LR   G+  +     V +    A G+ Y
Sbjct: 74  HPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRY 131
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP--- 454
           + E +   Y+HRD+ + NIL++ N   KV+DFGL++  E  S+  PT      G +P   
Sbjct: 132 LAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD-PTYTSSLGGKIPIRW 187
Query: 455 --PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
             PE   +   +   D +++G+V++E++S  E           ++ ++   E+   LP P
Sbjct: 188 TAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPY----WDMSNQDVINAIEQDYRLPPP 243
Query: 513 IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                         +CP      + QL   C Q+    RP    +V AL
Sbjct: 244 -------------PDCPTS----LHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           ++    ++F +   +G+G FG V+ AE +        ++   +  L +   +   D++ +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKK------TNQFFAIKALKKDVVLMDDDVECT 65
Query: 326 REFLAELKVLTHV-HHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
              + E +VL+    H  L  +   +  + +LF V EY+  G+L  H++   +  L  S 
Sbjct: 66  ---MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL--SR 120
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
               A +   GL+++H   +   ++RD+K  NIL+DK+ H K+ADFG+ K   +G A   
Sbjct: 121 ATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-T 176
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
               GT  Y+ PE       +  VD ++FGV+LYE++
Sbjct: 177 NEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 213

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 27/229 (11%)
Query: 269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
           ++ + +    KIG+G FG     +   E G  Y+         +++  I +M  +   E 
Sbjct: 21  QSMEKYVRLQKIGEGSFGKAILVK-STEDGRQYV---------IKEINISRMSSKEREES 70
Query: 329 LAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSG------RDPLPW 381
             E+ VL ++ H N+V+      E GSL++V +Y E G+L + +             L W
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
              VQI L     L+++H+  +   +HRDIKS NI + K+   ++ DFG+ ++    +  
Sbjct: 131 F--VQICL----ALKHVHDRKI---LHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVE 180
Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           L    +GT  Y+ PE  +    + K D++A G VLYEL + K A   G+
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 81/304 (26%), Positives = 132/304 (43%), Gaps = 38/304 (12%)
Query: 266 ELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   + Q
Sbjct: 37  EFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYTEKQ 89
Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWS 382
             R+FL E  ++    H N++RL G   +   + +V E +ENG+L   LR          
Sbjct: 90  -RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-FTVI 147
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             V +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL+++ E    + 
Sbjct: 148 QLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 443 PTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            T   G     +  PE   Y   +   DV+++G+VL+E++S  E                
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE---------------- 248
Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
             + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    IV  
Sbjct: 249 RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSI 303
Query: 561 LMTL 564
           L  L
Sbjct: 304 LDKL 307

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 111/219 (50%), Gaps = 22/219 (10%)
Query: 269 KATD-NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           K TD NF M   +G+G FG V  A+ +G         L  + +L +   I+  D++ +  
Sbjct: 17  KLTDFNFLMV--LGKGSFGKVMLADRKG------TEELYAIKILKKDVVIQDDDVECT-- 66
Query: 328 FLAELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
            + E +VL  +     +  +  C +    L+ V EY+  G+L  H++  G+   P +  V
Sbjct: 67  -MVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA--V 123
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
             A + + GL ++H+  +   I+RD+K  N+++D   H K+ADFG+ K  E     + TR
Sbjct: 124 FYAAEISIGLFFLHKRGI---IYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTR 178
Query: 446 -LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
              GT  Y+ PE   Y      VD +A+GV+LYE+++ +
Sbjct: 179 EFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 87/332 (26%), Positives = 147/332 (44%), Gaps = 65/332 (19%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
              M  +IG+G +G V+  + RGE                 K A+K         +  E 
Sbjct: 38  QIQMVKQIGKGRYGEVWMGKWRGE-----------------KVAVKVFFTTEEASWFRET 80
Query: 333 KVLTHV--HHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
           ++   V   H N++  I   ++G+     L+L+ +Y ENG+L ++L+ +  D     S +
Sbjct: 81  EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDA---KSML 137
Query: 386 QIALDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTK--LTEVG 438
           ++A  S  GL ++H         P   HRD+KS NIL+ KN    +AD GL    +++  
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 439 SASLP--TRLVGTFGYMPPEY------AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
              +P  TR VGT  YMPPE         +       D+Y+FG++L+E+  A+  +    
Sbjct: 198 EVDIPPNTR-VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCV---- 250
Query: 491 GSSADSKGLVALFE---EVLNLPDP-IEDLRKLV-----DPRLGDNCPLDSVLKMAQLAK 541
                S G+V  ++     L   DP  ED+R++V      P   +    D  L+  Q+ K
Sbjct: 251 -----SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLR--QMGK 303
Query: 542 VCTQEYPQLRPSMRSIVVALMTLSSTTEDWDV 573
           + T+ +     S  + +    TL+  +E  D+
Sbjct: 304 LMTECWAHNPASRLTALRVKKTLAKMSESQDI 335

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 59
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 117
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 118 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCG 171
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 57
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 115
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 116 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSC---HAPSSRRTTLSG 169
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/320 (23%), Positives = 140/320 (43%), Gaps = 57/320 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + ++E
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIG-LDKDKPNRVTKVAVKMLKSDATEKDLS---DLISE 75
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------- 382
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+L+      L +S       
Sbjct: 76  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 135
Query: 383 -------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
                    V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 136 EEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDI 192
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +   
Sbjct: 193 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 246
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                      P+E+L KL+      + P +   ++  + + C    P
Sbjct: 247 GV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 285
Query: 549 QLRPSMRSIVVALMTLSSTT 568
             RP+ + +V  L  + + T
Sbjct: 286 SQRPTFKQLVEDLDRIVALT 305

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 137/317 (43%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 99
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++ ++H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 100 LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 160 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 217 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 266
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 267 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 306
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 307 FAIILERIEYCTQDPDV 323

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/320 (23%), Positives = 140/320 (43%), Gaps = 57/320 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + ++E
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIG-LDKDKPNRVTKVAVKMLKSDATEKDLS---DLISE 72
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------- 382
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+L+      L +S       
Sbjct: 73  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 132
Query: 383 -------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
                    V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 133 EEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDI 189
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +   
Sbjct: 190 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 243
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                      P+E+L KL+      + P +   ++  + + C    P
Sbjct: 244 GV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 282
Query: 549 QLRPSMRSIVVALMTLSSTT 568
             RP+ + +V  L  + + T
Sbjct: 283 SQRPTFKQLVEDLDRIVALT 302

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/320 (23%), Positives = 140/320 (43%), Gaps = 57/320 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + ++E
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIG-LDKDKPNRVTKVAVKMLKSDATEKDLS---DLISE 83
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------- 382
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+L+      L +S       
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNP 143
Query: 383 -------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
                    V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +   
Sbjct: 201 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                      P+E+L KL+      + P +   ++  + + C    P
Sbjct: 255 GV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 293
Query: 549 QLRPSMRSIVVALMTLSSTT 568
             RP+ + +V  L  + + T
Sbjct: 294 SQRPTFKQLVEDLDRIVALT 313

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 137/317 (43%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 85
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++ ++H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 86  LIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 146 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 202
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 203 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 252
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 253 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 292
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 293 FAIILERIEYCTQDPDV 309

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/320 (23%), Positives = 140/320 (43%), Gaps = 57/320 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + ++E
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIG-LDKDKPNRVTKVAVKMLKSDATEKDLS---DLISE 76
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------- 382
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+L+      L +S       
Sbjct: 77  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 136
Query: 383 -------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
                    V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 137 EEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDI 193
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +   
Sbjct: 194 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 247
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                      P+E+L KL+      + P +   ++  + + C    P
Sbjct: 248 GV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 286
Query: 549 QLRPSMRSIVVALMTLSSTT 568
             RP+ + +V  L  + + T
Sbjct: 287 SQRPTFKQLVEDLDRIVALT 306

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 23/263 (8%)
Query: 267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           L +A   +    +IG+G +G V+ A      G     R + +  +  +   + M +   R
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIR 60
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
           E +A L+ L    H N+VRL   C       E  L LV+E+++  +L+ +L       +P
Sbjct: 61  E-VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
             +   +     RGL+++H H V   +HRD+K  NIL+  +   K+ADFGL ++     A
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
              T +V T  Y  PE       +  VD+++ G +  E+   K  + +G+ S  D  G +
Sbjct: 176 L--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGS-SDVDQLGKI 231
Query: 501 ALFEEVLNLPDPIEDLRKLVDPR 523
               +V+ LP   +  R +  PR
Sbjct: 232 L---DVIGLPGEEDWPRDVALPR 251

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F +   +G+G FG VY A  R        S+ I    ++ K  ++K  ++   +   E
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQ-------SKFILALKVLFKTQLEKAGVE--HQLRRE 62
Query: 332 LKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   R             +
Sbjct: 63  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR--FDEQRTATYITE 120
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
            A  L Y H   V   IHRDIK  N+L+  N   K+ADFG +      S+   T L GT 
Sbjct: 121 LANALSYCHSKRV---IHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDT-LCGTL 174
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            Y+PPE  +      KVD+++ GV+ YE +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 204

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 20/218 (9%)
Query: 269 KATD-NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           K TD NF M   +G+G FG V  +E +G         L  V +L +   I+  D++ +  
Sbjct: 18  KLTDFNFLMV--LGKGSFGKVMLSERKG------TDELYAVKILKKDVVIQDDDVECT-- 67
Query: 328 FLAELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
            + E +VL        +  +  C +    L+ V EY+  G+L  H++  GR   P +  V
Sbjct: 68  -MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--V 124
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
             A + A GL ++    +   I+RD+K  N+++D   H K+ADFG+ K   +        
Sbjct: 125 FYAAEIAIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKX 180
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             GT  Y+ PE   Y      VD +AFGV+LYE+++ +
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/320 (23%), Positives = 140/320 (43%), Gaps = 57/320 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + ++E
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIG-LDKDKPNRVTKVAVKMLKSDATEKDLS---DLISE 83
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWS------- 382
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+L+      L +S       
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 143
Query: 383 -------SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
                    V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +   
Sbjct: 201 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                      P+E+L KL+      + P +   ++  + + C    P
Sbjct: 255 GV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 293
Query: 549 QLRPSMRSIVVALMTLSSTT 568
             RP+ + +V  L  + + T
Sbjct: 294 SQRPTFKQLVEDLDRIVALT 313

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 82
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 83  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 140
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S    L G
Sbjct: 141 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCG 194
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 99
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 160 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 217 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 266
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 267 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 306
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 307 FAIILERIEYCTQDPDV 323

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/328 (23%), Positives = 144/328 (43%), Gaps = 60/328 (18%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + ++E
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIG-LDKDKPNRVTKVAVKMLKSDATEKDLS---DLISE 83
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRG--------------SG 375
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+L+               + 
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 143
Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
            + L     V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +   
Sbjct: 201 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                      P+E+L KL+      + P +   ++  + + C    P
Sbjct: 255 GV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 293
Query: 549 QLRPSMRSIVVAL---MTLSSTTEDWDV 573
             RP+ + +V  L   + L+S  E  D+
Sbjct: 294 SQRPTFKQLVEDLDRIVALTSNQEYLDL 321

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 85
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 146 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 202
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 203 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 252
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 253 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 292
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 293 FAIILERIEYCTQDPDV 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/320 (23%), Positives = 140/320 (43%), Gaps = 57/320 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  AE  G       +R+  V + M K+   + D+    + ++E
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIG-LDKDKPNRVTKVAVKMLKSDATEKDLS---DLISE 68
Query: 332 LKVLTHV-HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRG--------------SG 375
           ++++  +  H N++ L+G C + G L+++ EY   GNL E+L+               + 
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 128
Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-- 433
            + L     V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL +  
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 434 -----LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                  +  +  LP +      +M PE       + + DV++FGV+L+E+ +   +   
Sbjct: 186 HHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239
Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                      P+E+L KL+      + P +   ++  + + C    P
Sbjct: 240 GV---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVP 278
Query: 549 QLRPSMRSIVVALMTLSSTT 568
             RP+ + +V  L  + + T
Sbjct: 279 SQRPTFKQLVEDLDRIVALT 298

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 125
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 126 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 186 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 243 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 292
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 293 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 332
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 333 FAIILERIEYCTQDPDV 349

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 76
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 77  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 136
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 137 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 193
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 194 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 243
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 244 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 283
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 284 FAIILERIEYCTQDPDV 300

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 91
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 92  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 151
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 152 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 208
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 209 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 258
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 259 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 298
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 299 FAIILERIEYCTQDPDV 315

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 58
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 116
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+A+FG +       +S  T L G
Sbjct: 117 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIANFGWSVH---APSSRRTTLCG 170
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 17/217 (7%)
Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           ++    ++F +   +G+G FG V+ AE +        ++   +  L +   +   D++ +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKT------NQFFAIKALKKDVVLMDDDVECT 64
Query: 326 REFLAELKVLTHV-HHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
              + E +VL+    H  L  +   +  + +LF V EY+  G+L  H++   +  L  S 
Sbjct: 65  ---MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDL--SR 119
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
               A +   GL+++H   +   ++RD+K  NIL+DK+ H K+ADFG+ K   +G A   
Sbjct: 120 ATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-T 175
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
               GT  Y+ PE       +  VD ++FGV+LYE++
Sbjct: 176 NXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 84
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 145 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 202 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 251
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 252 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 291
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 292 FAIILERIEYCTQDPDV 308

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 102
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 103 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 162
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 163 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 219
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 220 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 269
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 270 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 309
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 310 FAIILERIEYCTQDPDV 326

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 58
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 59  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 116
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S    L G
Sbjct: 117 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCG 170
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 112/240 (46%), Gaps = 27/240 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           DNF     +G+G FG V  A ++ E G+ Y      V +L +   ++  D++ +   + E
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVK-ETGDLY-----AVKVLKKDVILQDDDVECT---MTE 73
Query: 332 LKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-A 388
            ++L+   +   +  +  C +    LF V E++  G+L  H++ S R      +R +  A
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---EARARFYA 130
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            +    L ++H+  +   I+RD+K  N+L+D   H K+ADFG+ K       +  T   G
Sbjct: 131 AEIISALMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCG 186
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
           T  Y+ PE  Q     P VD +A GV+LYE++         N           LFE +LN
Sbjct: 187 TPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILN 238

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 57
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 115
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +      S+   T L G
Sbjct: 116 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDT-LCG 169
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 23/263 (8%)
Query: 267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           L +A   +    +IG+G +G V+ A      G     R + +  +  +   + M +   R
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIR 60
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
           E +A L+ L    H N+VRL   C       E  L LV+E+++  +L+ +L       +P
Sbjct: 61  E-VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
             +   +     RGL+++H H V   +HRD+K  NIL+  +   K+ADFGL ++     A
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
              T +V T  Y  PE       +  VD+++ G +  E+   K  + +G+ S  D  G +
Sbjct: 176 L--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGS-SDVDQLGKI 231
Query: 501 ALFEEVLNLPDPIEDLRKLVDPR 523
               +V+ LP   +  R +  PR
Sbjct: 232 L---DVIGLPGEEDWPRDVALPR 251

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 84
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 85  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 145 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 202 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 251
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 252 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 291
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 292 FAIILERIEYCTQDPDV 308

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 101
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 102 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 161
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 162 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 218
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 219 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 268
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 269 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 308
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 309 FAIILERIEYCTQDPDV 325

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 121/263 (46%), Gaps = 23/263 (8%)
Query: 267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           L +A   +    +IG+G +G V+ A      G     R + +  +  +   + M +   R
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIR 60
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
           E +A L+ L    H N+VRL   C       E  L LV+E+++  +L+ +L       +P
Sbjct: 61  E-VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP 118
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
             +   +     RGL+++H H V   +HRD+K  NIL+  +   K+ADFGL ++     A
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
              T +V T  Y  PE       +  VD+++ G +  E+   K  + +G+ S  D  G +
Sbjct: 176 L--TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK-PLFRGS-SDVDQLGKI 231
Query: 501 ALFEEVLNLPDPIEDLRKLVDPR 523
               +V+ LP   +  R +  PR
Sbjct: 232 L---DVIGLPGEEDWPRDVALPR 251

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 59
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 117
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S    L G
Sbjct: 118 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCG 171
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKN-------SKFILALKVLFKAQLEKAGVE--HQLR 56
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 114
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S    L G
Sbjct: 115 TELANALSYCHSKKV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCG 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 85
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 86  LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 145
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 146 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRK 202
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 203 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 252
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 253 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 292
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 293 FAIILERIEYCTQDPDV 309

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 59
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 117
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+A+FG +       +S  T L G
Sbjct: 118 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIANFGWSV---HAPSSRRTTLCG 171
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +         + I    ++ KA ++K  ++   +  
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQR-------KFILALKVLFKAQLEKAGVE--HQLR 53
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 54  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 111
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T L G
Sbjct: 112 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCG 165
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 166 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 56
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 114
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S    L G
Sbjct: 115 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCG 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG+V     R         + I V + + K   +K D   + E + E +++  +
Sbjct: 17  ELGCGNFGSVRQGVYRMR------KKQIDVAIKVLKQGTEKAD---TEEMMREAQIMHQL 67
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VRLIG C   +L LV E    G L + L G  R+ +P S+  ++    + G++Y+
Sbjct: 68  DNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL 126
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K      +    R  G +   +  PE
Sbjct: 127 EEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 183
Query: 457 YAQYGDVSPKVDVYAFGVVLYELIS 481
              +   S + DV+++GV ++E +S
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 59
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 117
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S    L G
Sbjct: 118 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCG 171
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 56
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 57  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 114
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S    L G
Sbjct: 115 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCG 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVCS-----EQDELDFLMEA 111
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 112 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 171
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 172 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 228
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 229 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 278
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 279 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 318
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 319 FAIILERIEYCTQDPDV 335

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 55/317 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N ++   +G G FG VY  ++ G   N      + V  L +  +      Q   +FL E 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSG-MPNDPSPLQVAVKTLPEVYS-----EQDELDFLMEA 99
Query: 333 KVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-----VQ 386
            +++  +H N+VR IG  ++    F++ E +  G+L   LR +   P   SS      + 
Sbjct: 100 LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 159
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK-------LTE 436
           +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +         +
Sbjct: 160 VARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 216
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G A LP +      +MPPE    G  + K D ++FGV+L+E+ S          +    
Sbjct: 217 GGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---- 266
Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                  +EVL     +    ++  P+   NCP      M Q    C Q  P+ RP   +
Sbjct: 267 -------QEVLEF---VTSGGRMDPPK---NCPGPVYRIMTQ----CWQHQPEDRP---N 306
Query: 557 IVVALMTLSSTTEDWDV 573
             + L  +   T+D DV
Sbjct: 307 FAIILERIEYCTQDPDV 323

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  ++   +  
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVE--HQLR 59
Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +            
Sbjct: 60  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYI 117
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S    L G
Sbjct: 118 TELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRXXLCG 171
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  Y+PPE  +      KVD+++ GV+ YE +  K
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 125/294 (42%), Gaps = 47/294 (15%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG G FG VY   L+   G     + + V +   KA   +   +   +FL E  ++    
Sbjct: 52  IGAGEFGEVYKGMLKTSSGK----KEVPVAIKTLKAGYTE---KQRVDFLGEAGIMGQFS 104
Query: 340 HLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
           H N++RL G   +   + ++ EY+ENG L + LR    +       V +    A G++Y+
Sbjct: 105 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYL 163
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE--------VGSASLPTRLVGTF 450
                  Y+HRD+ + NIL++ N   KV+DFGL+++ E             +P R     
Sbjct: 164 ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR----- 215
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP 510
            +  PE   Y   +   DV++FG+V++E+++  E                  + E+ N  
Sbjct: 216 -WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP----------------YWELSN-- 256
Query: 511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
               ++ K ++       P+D    + QL   C Q+    RP    IV  L  L
Sbjct: 257 ---HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/307 (26%), Positives = 132/307 (42%), Gaps = 38/307 (12%)
Query: 263 SYEELSKATD--NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM 320
           +  E +K  D  N S+   +G G FG V    L+       L     +++ ++   +   
Sbjct: 34  TVHEFAKELDATNISIDKVVGAGEFGEVCSGRLK-------LPSKKEISVAIKTLKVGYT 86
Query: 321 DMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPL 379
           + Q  R+FL E  ++    H N++RL G   +   + +V E +ENG+L   LR       
Sbjct: 87  EKQ-RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQ-F 144
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
                V +    A G++Y+ +      +HRD+ + NILI+ N   KV+DFGL+++ E   
Sbjct: 145 TVIQLVGMLRGIASGMKYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 201
Query: 440 ASLPTRLVGT--FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
            +  T   G     +  PE   Y   +   DV+++G+VL+E++S  E             
Sbjct: 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE------------- 248
Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                + E+ N     +D+ K VD       P+D    + QL   C Q+    RP    I
Sbjct: 249 ---RPYWEMSN-----QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQI 300
Query: 558 VVALMTL 564
           V  L  L
Sbjct: 301 VSILDKL 307

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 70/303 (23%)
Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL 335
           +   IG+G FG V+  + RGE                 + A+K    +  R +  E ++ 
Sbjct: 33  LQESIGKGRFGEVWRGKWRGE-----------------EVAVKIFSSREERSWFREAEIY 75
Query: 336 THV--HHLNLVRLIGY-----CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
             V   H N++  I            L+LV +Y E+G+L ++L    R  +     +++A
Sbjct: 76  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 132
Query: 389 LDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL- 442
           L +A GL ++H   V     P   HRD+KS NIL+ KN    +AD GL    +  + ++ 
Sbjct: 133 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 192
Query: 443 --PTRLVGTFGYMPPEY------AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
             P   VGT  YM PE        ++ +   + D+YA G+V +E+  A+   + G     
Sbjct: 193 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG----- 245
Query: 495 DSKGLVALFEEVLNLP-------DP-IEDLRKLV-DPRLGDNCP-----LDSVLKMAQLA 540
                     E   LP       DP +E++RK+V + +L  N P      +++  MA++ 
Sbjct: 246 --------IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 297
Query: 541 KVC 543
           + C
Sbjct: 298 REC 300

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 70/303 (23%)
Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL 335
           +   IG+G FG V+  + RGE                 + A+K    +  R +  E ++ 
Sbjct: 46  LQESIGKGRFGEVWRGKWRGE-----------------EVAVKIFSSREERSWFREAEIY 88
Query: 336 THV--HHLNLVRLIGY-----CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
             V   H N++  I            L+LV +Y E+G+L ++L    R  +     +++A
Sbjct: 89  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 145
Query: 389 LDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL- 442
           L +A GL ++H   V     P   HRD+KS NIL+ KN    +AD GL    +  + ++ 
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 443 --PTRLVGTFGYMPPEY------AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
             P   VGT  YM PE        ++ +   + D+YA G+V +E+  A+   + G     
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG----- 258
Query: 495 DSKGLVALFEEVLNLP-------DP-IEDLRKLV-DPRLGDNCP-----LDSVLKMAQLA 540
                     E   LP       DP +E++RK+V + +L  N P      +++  MA++ 
Sbjct: 259 --------IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 310
Query: 541 KVC 543
           + C
Sbjct: 311 REC 313

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F +   +G+G FG VY A  +        S  I    ++ K+ I+K  ++   +   E
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKK-------SHFIVALKVLFKSQIEKEGVE--HQLRRE 73
Query: 332 LKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +++  H+HH N++RL  Y  +   ++L+ EY   G L + L+ S            I  +
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC--TFDEQRTATIMEE 131
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LVGT 449
            A  L Y H   V   IHRDIK  N+L+      K+ADFG +    V + SL  + + GT
Sbjct: 132 LADALMYCHGKKV---IHRDIKPENLLLGLKGELKIADFGWS----VHAPSLRRKTMCGT 184
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             Y+PPE  +    + KVD++  GV+ YEL+
Sbjct: 185 LDYLPPEMIEGRMHNEKVDLWCIGVLCYELL 215

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 70/303 (23%)
Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL 335
           +   IG+G FG V+  + RGE                 + A+K    +  R +  E ++ 
Sbjct: 8   LQESIGKGRFGEVWRGKWRGE-----------------EVAVKIFSSREERSWFREAEIY 50
Query: 336 THV--HHLNLVRLIGY-----CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
             V   H N++  I            L+LV +Y E+G+L ++L    R  +     +++A
Sbjct: 51  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 107
Query: 389 LDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL- 442
           L +A GL ++H   V     P   HRD+KS NIL+ KN    +AD GL    +  + ++ 
Sbjct: 108 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 167
Query: 443 --PTRLVGTFGYMPPEY------AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
             P   VGT  YM PE        ++ +   + D+YA G+V +E+  A+   + G     
Sbjct: 168 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG----- 220
Query: 495 DSKGLVALFEEVLNLP-------DP-IEDLRKLV-DPRLGDNCP-----LDSVLKMAQLA 540
                     E   LP       DP +E++RK+V + +L  N P      +++  MA++ 
Sbjct: 221 --------IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 272
Query: 541 KVC 543
           + C
Sbjct: 273 REC 275

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 70/303 (23%)
Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL 335
           +   IG+G FG V+  + RGE                 + A+K    +  R +  E ++ 
Sbjct: 13  LQESIGKGRFGEVWRGKWRGE-----------------EVAVKIFSSREERSWFREAEIY 55
Query: 336 THV--HHLNLVRLIGY-----CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
             V   H N++  I            L+LV +Y E+G+L ++L    R  +     +++A
Sbjct: 56  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 112
Query: 389 LDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL- 442
           L +A GL ++H   V     P   HRD+KS NIL+ KN    +AD GL    +  + ++ 
Sbjct: 113 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 172
Query: 443 --PTRLVGTFGYMPPEY------AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
             P   VGT  YM PE        ++ +   + D+YA G+V +E+  A+   + G     
Sbjct: 173 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG----- 225
Query: 495 DSKGLVALFEEVLNLP-------DP-IEDLRKLV-DPRLGDNCP-----LDSVLKMAQLA 540
                     E   LP       DP +E++RK+V + +L  N P      +++  MA++ 
Sbjct: 226 --------IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 277
Query: 541 KVC 543
           + C
Sbjct: 278 REC 280

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 70/303 (23%)
Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL 335
           +   IG+G FG V+  + RGE                 + A+K    +  R +  E ++ 
Sbjct: 7   LQESIGKGRFGEVWRGKWRGE-----------------EVAVKIFSSREERSWFREAEIY 49
Query: 336 THV--HHLNLVRLIGY-----CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
             V   H N++  I            L+LV +Y E+G+L ++L    R  +     +++A
Sbjct: 50  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 106
Query: 389 LDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL- 442
           L +A GL ++H   V     P   HRD+KS NIL+ KN    +AD GL    +  + ++ 
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166
Query: 443 --PTRLVGTFGYMPPEY------AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
             P   VGT  YM PE        ++ +   + D+YA G+V +E+  A+   + G     
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG----- 219
Query: 495 DSKGLVALFEEVLNLP-------DP-IEDLRKLV-DPRLGDNCP-----LDSVLKMAQLA 540
                     E   LP       DP +E++RK+V + +L  N P      +++  MA++ 
Sbjct: 220 --------IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 271
Query: 541 KVC 543
           + C
Sbjct: 272 REC 274

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 133/303 (43%), Gaps = 70/303 (23%)
Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL 335
           +   IG+G FG V+  + RGE                 + A+K    +  R +  E ++ 
Sbjct: 10  LQESIGKGRFGEVWRGKWRGE-----------------EVAVKIFSSREERSWFREAEIY 52
Query: 336 THV--HHLNLVRLIGY-----CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
             V   H N++  I            L+LV +Y E+G+L ++L    R  +     +++A
Sbjct: 53  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 109
Query: 389 LDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL- 442
           L +A GL ++H   V     P   HRD+KS NIL+ KN    +AD GL    +  + ++ 
Sbjct: 110 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 169
Query: 443 --PTRLVGTFGYMPPEY------AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
             P   VGT  YM PE        ++ +   + D+YA G+V +E+  A+   + G     
Sbjct: 170 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRCSIGG----- 222
Query: 495 DSKGLVALFEEVLNLP-------DP-IEDLRKLV-DPRLGDNCP-----LDSVLKMAQLA 540
                     E   LP       DP +E++RK+V + +L  N P      +++  MA++ 
Sbjct: 223 --------IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM 274
Query: 541 KVC 543
           + C
Sbjct: 275 REC 277

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 61
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 120
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 178 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 233
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 234 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 286

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 92
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 93  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 152 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 208
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 209 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 264
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 265 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 317

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 68
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 69  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 127
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 128 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 184
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 185 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 240
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 241 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 293

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 110/257 (42%), Gaps = 63/257 (24%)
Query: 255 TVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK 314
           TVDK     ++E+            IG GGFG V+ A+ R + G +Y+ R +  N     
Sbjct: 5   TVDKRFGMDFKEIEL----------IGSGGFGQVFKAKHRID-GKTYVIRRVKYN----- 48
Query: 315 AAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEG--------------------- 353
                 + +A RE    +K L  + H+N+V   G C +G                     
Sbjct: 49  ------NEKAERE----VKALAKLDHVNIVHYNG-CWDGFDYDPETSDDSLESSDYDPEN 97
Query: 354 ----------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTV 403
                      LF+  E+ + G L + +     + L     +++     +G++YIH   +
Sbjct: 98  SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL 157
Query: 404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV 463
              IHRD+K +NI +      K+ DFGL  +T + +    TR  GT  YM PE     D 
Sbjct: 158 ---IHRDLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKRTRSKGTLRYMSPEQISSQDY 212
Query: 464 SPKVDVYAFGVVLYELI 480
             +VD+YA G++L EL+
Sbjct: 213 GKEVDLYALGLILAELL 229

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 60
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 61  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 119
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 120 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 176
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 177 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 232
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 233 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 285

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 66
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 67  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 125
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 126 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 182
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 183 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 238
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 239 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 291

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 67
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 68  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 126
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 127 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 183
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 184 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 239
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 240 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 292

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 61
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 120
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 177
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 178 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 233
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 234 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 286

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 79
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 80  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 138
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 139 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 196 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 251
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 252 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 304

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 61
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 62  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 120
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 121 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 178 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 233
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 234 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 286

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 133/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 64
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+    + +     +Q  
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHA-ERIDHIKLLQYT 123
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 124 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 181 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 236
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 237 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 289

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 137/316 (43%), Gaps = 25/316 (7%)
Query: 170 YPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGG 229
           Y + P D  ++  RN  L+++ L +  P +       +  +P +        LE      
Sbjct: 90  YEVTPDDKRKACGRN--LTQNFLSHTGPDL-------IPEVPRQLVTNCTQRLEQGPCKD 140
Query: 230 LVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDN-FSMSHKIGQGGFGAV 288
           L     +        A     L++I  ++ +++ + E    T N F     +G+GGFG V
Sbjct: 141 LFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEV 200
Query: 289 YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI- 347
              ++R   G  Y     C  L  ++   +K +  A    L E ++L  V+   +V L  
Sbjct: 201 CACQVRAT-GKMY----ACKKLEKKRIKKRKGEAMA----LNEKQILEKVNSRFVVSLAY 251
Query: 348 GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYI 407
            Y  + +L LV   +  G+L  H+   G+   P +  V  A +   GLE +H   +   +
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI---V 308
Query: 408 HRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKV 467
           +RD+K  NIL+D + H +++D GL     V         VGT GYM PE  +    +   
Sbjct: 309 YRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 468 DVYAFGVVLYELISAK 483
           D +A G +LYE+I+ +
Sbjct: 367 DWWALGCLLYEMIAGQ 382

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 16/224 (7%)
Query: 261 EFSYEELSKATDNFSMSH-KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK 319
           E   ++L    DN  ++  ++G G FG+V     R         + I V + + K   +K
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR------KKQIDVAIKVLKQGTEK 377
Query: 320 MDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
            D   + E + E +++  + +  +VRLIG C   +L LV E    G L + L G  R+ +
Sbjct: 378 AD---TEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK-REEI 433
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
           P S+  ++    + G++Y+ E     ++HR++ + N+L+    +AK++DFGL+K      
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
Query: 440 ASLPTRLVGTF--GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           +    R  G +   +  PE   +   S + DV+++GV ++E +S
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 64
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 65  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 123
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 124 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 180
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 181 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 236
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 237 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 289

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 59
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 60  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 118
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 119 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 175
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 176 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 231
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 232 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 284

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/299 (25%), Positives = 134/299 (44%), Gaps = 45/299 (15%)
Query: 279 KIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAEL 332
           ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E+
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFEREI 65
Query: 333 KVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           ++L  + H N+V+  G C      +L L+ E++  G+L E+L+   ++ +     +Q   
Sbjct: 66  EILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQ-KHKERIDHIKLLQYTS 124
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
              +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G 
Sbjct: 125 QICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 450 ---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE- 505
              F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++ 
Sbjct: 182 SPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQG 237
Query: 506 ---VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
              V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 238 QMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 289

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 65
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 66  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 124
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 125 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 181
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 182 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 237
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 238 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 290

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 79
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 80  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 138
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+          +  G
Sbjct: 139 SQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 196 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 251
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 252 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 304

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 112/235 (47%), Gaps = 16/235 (6%)
Query: 251 LNAITVDKSVEFSYEELSKATDN-FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN 309
           L++I  ++ +++ + E    T N F     +G+GGFG V   ++R   G  Y     C  
Sbjct: 162 LDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRA-TGKMY----ACKK 216
Query: 310 LLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLS 368
           L  ++   +K +  A    L E ++L  V+   +V L   Y  + +L LV   +  G+L 
Sbjct: 217 LEKKRIKKRKGEAMA----LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272
Query: 369 EHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
            H+   G+   P +  V  A +   GLE +H   +   ++RD+K  NIL+D + H +++D
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI---VYRDLKPENILLDDHGHIRISD 329
Query: 429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            GL     V         VGT GYM PE  +    +   D +A G +LYE+I+ +
Sbjct: 330 LGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 119/242 (49%), Gaps = 24/242 (9%)
Query: 246 GTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRL 305
           G   S+  I +   V+  +E+   +   F +   +GQG FG V+   L  +   S   +L
Sbjct: 1   GAMGSIKEIAITHHVKEGHEKADPS--QFELLKVLGQGSFGKVF---LVKKISGSDARQL 55
Query: 306 ICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIEN 364
             + +L +KA +K  D   ++    E  +L  V+H  +V+L   +  EG L+L+ +++  
Sbjct: 56  YAMKVL-KKATLKVRDRVRTK---MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRG 111
Query: 365 GNL----SEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK 420
           G+L    S+ +  +  D   + + + +ALD        H H++ + I+RD+K  NIL+D+
Sbjct: 112 GDLFTRLSKEVMFTEEDVKFYLAELALALD--------HLHSLGI-IYRDLKPENILLDE 162
Query: 421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             H K+ DFGL+K   +          GT  YM PE       +   D ++FGV+++E++
Sbjct: 163 EGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 221
Query: 481 SA 482
           + 
Sbjct: 222 TG 223

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/244 (28%), Positives = 122/244 (50%), Gaps = 27/244 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V+    +   G     +LI + +   K AI+        + + E
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEI---KPAIRN-------QIIRE 73
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 74  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 132
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 133 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 184
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
           T  YM PE  Q    S + D+++ G+ L E+   +  I  G+GS A    +  L + ++N
Sbjct: 185 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMA----IFELLDYIVN 240
Query: 509 LPDP 512
            P P
Sbjct: 241 EPPP 244

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 129/290 (44%), Gaps = 44/290 (15%)
Query: 280 IGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH 337
           IG G FG V    L+  G+       R I V +   K+   +   +  R+FL+E  ++  
Sbjct: 15  IGAGEFGEVCSGHLKLPGK-------REIFVAIKTLKSGYTE---KQRRDFLSEASIMGQ 64
Query: 338 VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
             H N++ L G   + + + ++ E++ENG+L   LR +          V +    A G++
Sbjct: 65  FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIAAGMK 123
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP-- 454
           Y+ +     Y+HR + + NIL++ N   KV+DFGL++  E    S PT      G +P  
Sbjct: 124 YLADMN---YVHRALAARNILVNSNLVCKVSDFGLSRFLE-DDTSDPTYTSALGGKIPIR 179
Query: 455 ---PEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD 511
              PE  QY   +   DV+++G+V++E++S  E           ++ ++   E+   LP 
Sbjct: 180 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY----WDMTNQDVINAIEQDYRLPP 235
Query: 512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           P++             CP      + QL   C Q+    RP    IV  L
Sbjct: 236 PMD-------------CP----SALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 110/246 (44%), Gaps = 50/246 (20%)
Query: 253 AITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM 312
           A TVDK     ++E+            IG GGFG V+ A+ R + G +Y+ + +  N   
Sbjct: 2   AHTVDKRFGMDFKEIEL----------IGSGGFGQVFKAKHRID-GKTYVIKRVKYN--- 47
Query: 313 QKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEG------------------S 354
                   + +A RE    +K L  + H+N+V   G C +G                   
Sbjct: 48  --------NEKAERE----VKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKC 94
Query: 355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
           LF+  E+ + G L + +     + L     +++     +G++YIH   +   I+RD+K +
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL---INRDLKPS 151
Query: 415 NILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGV 474
           NI +      K+ DFGL  +T + +     R  GT  YM PE     D   +VD+YA G+
Sbjct: 152 NIFLVDTKQVKIGDFGL--VTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGL 209
Query: 475 VLYELI 480
           +L EL+
Sbjct: 210 ILAELL 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 137/298 (45%), Gaps = 39/298 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK----VL 335
           +G+G FG V       E  N+            ++ A+K +  ++    +A+LK    +L
Sbjct: 29  LGEGHFGKVELCRYDPEGDNT-----------GEQVAVKSLKPESGGNHIADLKKEIEIL 77
Query: 336 THVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            +++H N+V+  G C E     + L+ E++ +G+L E+L    ++ +    +++ A+   
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQIC 136
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT---RLVGT 449
           +G++Y+       Y+HRD+ + N+L++     K+ DFGLTK  E           R    
Sbjct: 137 KGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPV 193
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
           F Y  PE           DV++FGV L+EL++            +DS  + ALF +++  
Sbjct: 194 FWYA-PECLMQSKFYIASDVWSFGVTLHELLTY---------CDSDSSPM-ALFLKMIGP 242
Query: 510 PDPIEDLRKLVDP-RLGDN--CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
                 + +LV+  + G    CP +   ++ QL + C +  P  R S ++++     L
Sbjct: 243 THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 137/298 (45%), Gaps = 39/298 (13%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK----VL 335
           +G+G FG V       E  N+            ++ A+K +  ++    +A+LK    +L
Sbjct: 17  LGEGHFGKVELCRYDPEGDNT-----------GEQVAVKSLKPESGGNHIADLKKEIEIL 65
Query: 336 THVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            +++H N+V+  G C E     + L+ E++ +G+L E+L    ++ +    +++ A+   
Sbjct: 66  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQIC 124
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT---RLVGT 449
           +G++Y+       Y+HRD+ + N+L++     K+ DFGLTK  E           R    
Sbjct: 125 KGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPV 181
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
           F Y  PE           DV++FGV L+EL++            +DS  + ALF +++  
Sbjct: 182 FWYA-PECLMQSKFYIASDVWSFGVTLHELLTY---------CDSDSSPM-ALFLKMIGP 230
Query: 510 PDPIEDLRKLVDP-RLGDN--CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
                 + +LV+  + G    CP +   ++ QL + C +  P  R S ++++     L
Sbjct: 231 THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 288

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 118/238 (49%), Gaps = 24/238 (10%)
Query: 250 SLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN 309
           S+  I +   V+  +E+   +   F +   +GQG FG V+   L  +   S   +L  + 
Sbjct: 4   SIKEIAITHHVKEGHEKADPS--QFELLKVLGQGSFGKVF---LVKKISGSDARQLYAMK 58
Query: 310 LLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNL- 367
           +L +KA +K  D   ++    E  +L  V+H  +V+L   +  EG L+L+ +++  G+L 
Sbjct: 59  VL-KKATLKVRDRVRTK---MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 368 ---SEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
              S+ +  +  D   + + + +ALD        H H++ + I+RD+K  NIL+D+  H 
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALD--------HLHSLGI-IYRDLKPENILLDEEGHI 165
Query: 425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           K+ DFGL+K   +          GT  YM PE       +   D ++FGV+++E+++ 
Sbjct: 166 KLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 118/238 (49%), Gaps = 24/238 (10%)
Query: 250 SLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN 309
           S+  I +   V+  +E+   +   F +   +GQG FG V+   L  +   S   +L  + 
Sbjct: 4   SIKEIAITHHVKEGHEKADPS--QFELLKVLGQGSFGKVF---LVKKISGSDARQLYAMK 58
Query: 310 LLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNL- 367
           +L +KA +K  D   ++    E  +L  V+H  +V+L   +  EG L+L+ +++  G+L 
Sbjct: 59  VL-KKATLKVRDRVRTK---MERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 368 ---SEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
              S+ +  +  D   + + + +ALD        H H++ + I+RD+K  NIL+D+  H 
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALD--------HLHSLGI-IYRDLKPENILLDEEGHI 165
Query: 425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           K+ DFGL+K   +          GT  YM PE       +   D ++FGV+++E+++ 
Sbjct: 166 KLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 32/277 (11%)
Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDM----QASREFLAELKVLTHVHHLNLVRLIGYC 350
           GE+G     RL          AIK + +    +  R+FL E  ++    H N++ L G  
Sbjct: 33  GEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVV 92
Query: 351 VEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHR 409
            +   + +V EY+ENG+L   L+ +          V +    + G++Y+ +     Y+HR
Sbjct: 93  TKSKPVMIVTEYMENGSLDTFLKKNDGQ-FTVIQLVGMLRGISAGMKYLSDMG---YVHR 148
Query: 410 DIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT--FGYMPPEYAQYGDVSPKV 467
           D+ + NILI+ N   KV+DFGL+++ E    +  T   G     +  PE   +   +   
Sbjct: 149 DLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSAS 208
Query: 468 DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDN 527
           DV+++G+V++E++S  E           ++ ++   EE   LP P+             +
Sbjct: 209 DVWSYGIVMWEVVSYGERPY----WEMTNQDVIKAVEEGYRLPSPM-------------D 251
Query: 528 CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
           CP      + QL   C Q+    RP    IV  L  L
Sbjct: 252 CP----AALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 131/282 (46%), Gaps = 50/282 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F +   IG+G FG V   +L+         ++  + +L +   +K+ +    RE    
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNA------DKVFAMKILNKWEMLKRAETACFREERDV 127
Query: 332 L-----KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP------ 380
           L     K +T +H+        +  + +L+LV +Y   G+L   L     D LP      
Sbjct: 128 LVNGDSKWITTLHY-------AFQDDNNLYLVMDYYVGGDLLT-LLSKFEDRLPEEMARF 179
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LTKLTEVGS 439
           + + + IA+DS   L Y+H         RDIK  NIL+D N H ++ADFG   KL E G+
Sbjct: 180 YLAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230
Query: 440 ASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAK-----EAIVKG 489
               +  VGT  Y+ PE  Q      G   P+ D ++ GV +YE++  +     E++V+ 
Sbjct: 231 VQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET 289
Query: 490 NGSSADSKGLVALFEEVLNLPDPIEDL-RKLV---DPRLGDN 527
            G   + K       +V ++ +  +DL R+L+   + RLG N
Sbjct: 290 YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQN 331

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 111/245 (45%), Gaps = 20/245 (8%)
Query: 331 ELKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           E+ +L  ++H ++++  G C +    SL LV EY+  G+L ++L    R  +  +  +  
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLF 139
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           A     G+ Y+H      YIHRD+ + N+L+D +   K+ DFGL K    G      R  
Sbjct: 140 AQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRED 196
Query: 448 G---TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           G    F Y P    +Y       DV++FGV LYEL++  ++         +  G+     
Sbjct: 197 GDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            VL L + +E   +L  P   D CP +    +  L K C +     RP+  +++  L T+
Sbjct: 256 TVLRLTELLERGERLPRP---DKCPAE----VYHLMKNCWETEASFRPTFENLIPILKTV 308
Query: 565 SSTTE 569
               +
Sbjct: 309 HEKYQ 313

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-REFLAE 331
           ++ +   +G G FG V       + G   L+       ++ +  I+ +D+    R  +  
Sbjct: 17  HYILGDTLGVGTFGKV-------KVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN 69
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
           LK+  H H + L ++I       +F+V EY+  G L +++  +GR     S R+   + S
Sbjct: 70  LKLFRHPHIIKLYQVIS--TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
             G++Y H H V   +HRD+K  N+L+D + +AK+ADFGL+ +   G     +   G+  
Sbjct: 128 --GVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS--CGSPN 180
Query: 452 YMPPE------YAQYGDVSPKVDVYAFGVVLYELI 480
           Y  PE      YA      P+VD+++ GV+LY L+
Sbjct: 181 YAAPEVISGRLYA-----GPEVDIWSSGVILYALL 210

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 130/299 (43%), Gaps = 54/299 (18%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV- 338
           +G+G +G V+    +GE                   A+K    +  + +  E ++   V 
Sbjct: 45  VGKGRYGEVWRGSWQGE-----------------NVAVKIFSSRDEKSWFRETELYNTVM 87
Query: 339 -HHLNLVRLIGYCVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
             H N++  I   +        L+L+  Y E G+L ++L+ +  D +   S ++I L  A
Sbjct: 88  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV---SCLRIVLSIA 144
Query: 393 RGLEYIH-----EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-- 445
            GL ++H         P   HRD+KS NIL+ KN    +AD GL  +    +  L     
Sbjct: 145 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 204
Query: 446 -LVGTFGYMPPEYAQYG------DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
             VGT  YM PE           D   +VD++AFG+VL+E+  A+  +   NG   D K 
Sbjct: 205 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV--SNGIVEDYKP 260
Query: 499 LVALFEEVLNLPDPIEDLRKLV-----DPRLGDNCPLDSVL-KMAQLAKVCTQEYPQLR 551
               ++ V N P   ED+RK+V      P + +    D  L  +A+L K C  + P  R
Sbjct: 261 --PFYDVVPNDPS-FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 316

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 104/220 (47%), Gaps = 39/220 (17%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-----REFLAELKV 334
           +G+G FG+V    L+ E G S             K A+K M +  S      EFL+E   
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSL------------KVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 335 LTHVHHLNLVRLIGYCVEGSL------FLVYEYIENGNLSEHLRGS----GRDPLPWSSR 384
           +    H N++RL+G C+E S        ++  +++ G+L  +L  S    G   +P  + 
Sbjct: 90  MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTL 149
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
           ++  +D A G+EY+       ++HRD+ + N ++  +    VADFGL+K    G      
Sbjct: 150 LKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 445 RLVGTFGYMPPEYAQYGDVSPKV-----DVYAFGVVLYEL 479
           R+      MP ++     ++ +V     DV+AFGV ++E+
Sbjct: 207 RIAK----MPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 134/300 (44%), Gaps = 45/300 (15%)
Query: 278 HKIGQGGFGAV---YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---REFLAE 331
            ++G+G FG+V    Y  L+   G              +  A+KK+        R+F  E
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTG--------------EVVAVKKLQHSTEEHLRDFERE 62
Query: 332 LKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +Q  
Sbjct: 63  IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYT 121
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +G+EY+       YIHR++ + NIL++     K+ DFGLTK+          +  G
Sbjct: 122 SQICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG 178
Query: 449 T---FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
               F Y P    +    S   DV++FGVVLYEL +    I K     A+   ++   ++
Sbjct: 179 ESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFT---YIEKSKSPPAEFMRMIGNDKQ 234
Query: 506 ----VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               V +L + +++  +L  P   D CP +  + M +    C       RPS R + + +
Sbjct: 235 GQMIVFHLIELLKNNGRLPRP---DGCPDEIYMIMTE----CWNNNVNQRPSFRDLALRV 287

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 130/299 (43%), Gaps = 54/299 (18%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV- 338
           +G+G +G V+    +GE                   A+K    +  + +  E ++   V 
Sbjct: 16  VGKGRYGEVWRGSWQGE-----------------NVAVKIFSSRDEKSWFRETELYNTVM 58
Query: 339 -HHLNLVRLIGYCVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
             H N++  I   +        L+L+  Y E G+L ++L+ +  D +   S ++I L  A
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV---SCLRIVLSIA 115
Query: 393 RGLEYIH-----EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-- 445
            GL ++H         P   HRD+KS NIL+ KN    +AD GL  +    +  L     
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 446 -LVGTFGYMPPEYAQYG------DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
             VGT  YM PE           D   +VD++AFG+VL+E+  A+  +   NG   D K 
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV--SNGIVEDYKP 231
Query: 499 LVALFEEVLNLPDPIEDLRKLV-----DPRLGDNCPLDSVL-KMAQLAKVCTQEYPQLR 551
               ++ V N P   ED+RK+V      P + +    D  L  +A+L K C  + P  R
Sbjct: 232 --PFYDVVPNDPS-FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 130/299 (43%), Gaps = 54/299 (18%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV- 338
           +G+G +G V+    +GE                   A+K    +  + +  E ++   V 
Sbjct: 16  VGKGRYGEVWRGSWQGE-----------------NVAVKIFSSRDEKSWFRETELYNTVM 58
Query: 339 -HHLNLVRLIGYCVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
             H N++  I   +        L+L+  Y E G+L ++L+ +  D +   S ++I L  A
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTV---SCLRIVLSIA 115
Query: 393 RGLEYIH-----EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-- 445
            GL ++H         P   HRD+KS NIL+ KN    +AD GL  +    +  L     
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175
Query: 446 -LVGTFGYMPPEYAQYG------DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
             VGT  YM PE           D   +VD++AFG+VL+E+  A+  +   NG   D K 
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMV--SNGIVEDYKP 231
Query: 499 LVALFEEVLNLPDPIEDLRKLV-----DPRLGDNCPLDSVL-KMAQLAKVCTQEYPQLR 551
               ++ V N P   ED+RK+V      P + +    D  L  +A+L K C  + P  R
Sbjct: 232 --PFYDVVPNDPS-FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 20/240 (8%)
Query: 331 ELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           E+ +L  ++H ++++  G C    E SL LV EY+  G+L ++L    R  +  +  +  
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLF 122
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           A     G+ Y+H      YIHR++ + N+L+D +   K+ DFGL K    G      R  
Sbjct: 123 AQQICEGMAYLHSQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 448 G---TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           G    F Y P    +Y       DV++FGV LYEL++  ++         +  G+     
Sbjct: 180 GDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 238
Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            VL L + +E   +L  P   D CP +    +  L K C +     RP+  +++  L T+
Sbjct: 239 TVLRLTELLERGERLPRP---DKCPCE----VYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 111/224 (49%), Gaps = 25/224 (11%)
Query: 267 LSKATD------NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM 320
           ++ ATD      N+ +   IG+G F  V  A       +    R + V ++  K  +   
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLAR------HVLTGREVAVKII-DKTQLNPT 56
Query: 321 DMQASREFLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
            +Q   +   E++++  ++H N+V+L      E +L+LV EY   G + ++L   GR   
Sbjct: 57  SLQ---KLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE 113
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
             +      + SA  ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +    VG+
Sbjct: 114 KEARAKFRQIVSA--VQYCHQKYI---VHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN 168
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
             L T   G+  Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 169 -KLDT-FCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 108/234 (46%), Gaps = 41/234 (17%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM------QASRE 327
           FS   +IG G FGAVY+A    +  NS            +  AIKKM        +  ++
Sbjct: 56  FSDLREIGHGSFGAVYFAR---DVRNS------------EVVAIKKMSYSGKQSNEKWQD 100
Query: 328 FLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            + E++ L  + H N ++  G Y  E + +LV EY   G+ S+ L    + PL       
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAA 158
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL---P 443
           +   + +GL Y+H H +   IHRD+K+ NIL+        ++ GL KL + GSAS+    
Sbjct: 159 VTHGALQGLAYLHSHNM---IHRDVKAGNILL--------SEPGLVKLGDFGSASIMAPA 207
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
              VGT  +M PE       G    KVDV++ G+   EL   K  +   N  SA
Sbjct: 208 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 261

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/234 (31%), Positives = 108/234 (46%), Gaps = 41/234 (17%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM------QASRE 327
           FS   +IG G FGAVY+A    +  NS            +  AIKKM        +  ++
Sbjct: 17  FSDLREIGHGSFGAVYFAR---DVRNS------------EVVAIKKMSYSGKQSNEKWQD 61
Query: 328 FLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            + E++ L  + H N ++  G Y  E + +LV EY   G+ S+ L    + PL       
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE-VHKKPLQEVEIAA 119
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL---P 443
           +   + +GL Y+H H +   IHRD+K+ NIL+        ++ GL KL + GSAS+    
Sbjct: 120 VTHGALQGLAYLHSHNM---IHRDVKAGNILL--------SEPGLVKLGDFGSASIMAPA 168
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
              VGT  +M PE       G    KVDV++ G+   EL   K  +   N  SA
Sbjct: 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 110/240 (45%), Gaps = 20/240 (8%)
Query: 331 ELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           E+ +L  ++H ++++  G C    E SL LV EY+  G+L ++L    R  +  +  +  
Sbjct: 66  EIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLF 122
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           A     G+ Y+H      YIHR++ + N+L+D +   K+ DFGL K    G      R  
Sbjct: 123 AQQICEGMAYLHAQH---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 179
Query: 448 G---TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           G    F Y P    +Y       DV++FGV LYEL++  ++         +  G+     
Sbjct: 180 GDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 238
Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            VL L + +E   +L  P   D CP +    +  L K C +     RP+  +++  L T+
Sbjct: 239 TVLRLTELLERGERLPRP---DKCPCE----VYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 41/253 (16%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FLA 330
           ++   KIGQG  G VY A +    G              Q+ AI++M++Q   +    + 
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATG--------------QEVAIRQMNLQQQPKKELIIN 66
Query: 331 ELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ V+    + N+V  L  Y V   L++V EY+  G+L++ +  +  D         +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 123
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVG 448
           +  + LE++H + V   IHRDIKS NIL+  +   K+ DFG   ++T   S    + +VG
Sbjct: 124 ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVG 178
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA-----------IVKGNGSS--AD 495
           T  +M PE        PKVD+++ G++  E+I  +             ++  NG+    +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238
Query: 496 SKGLVALFEEVLN 508
            + L A+F + LN
Sbjct: 239 PEKLSAIFRDFLN 251

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-REFLAEL 332
           F +  K+G+G +G+VY A +  E G              Q  AIK++ +++  +E + E+
Sbjct: 31  FDVLEKLGEGSYGSVYKA-IHKETG--------------QIVAIKQVPVESDLQEIIKEI 75
Query: 333 KVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
            ++      ++V+  G Y     L++V EY   G++S+ +R   +  L       I   +
Sbjct: 76  SIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQST 134
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVGTF 450
            +GLEY+H       IHRDIK+ NIL++   HAK+ADFG+  +LT+  +      ++GT 
Sbjct: 135 LKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKR--NXVIGTP 189
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            +M PE  Q    +   D+++ G+   E+   K
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 18  ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 69
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 70  DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 127
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 128 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPE 184
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 229
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 230 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 268

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     IG G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTIGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G++  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + KVADFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 34  ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 85
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 86  DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 143
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 144 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 245
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 246 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 284

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 34  ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 85
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 86  DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 143
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 144 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 200
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 201 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 245
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 246 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 284

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     IG G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTIGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G++  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + KVADFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     IG G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTIGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + KVADFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 112/240 (46%), Gaps = 45/240 (18%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +N      +G G FG V  A   G    + +S  + V +L +KA     D       ++E
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYG-ISKTGVSIQVAVKMLKEKA-----DSSEREALMSE 98
Query: 332 LKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGS----GRDPLPWSSRV 385
           LK++T +  H N+V L+G C + G ++L++EY   G+L  +LR        D + + ++ 
Sbjct: 99  LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 386 QI-----------------ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
           ++                 A   A+G+E++   +    +HRD+ + N+L+      K+ D
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICD 215
Query: 429 FGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           FGL +           G+A LP +      +M PE    G  + K DV+++G++L+E+ S
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 41/253 (16%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FLA 330
           ++   KIGQG  G VY A +    G              Q+ AI++M++Q   +    + 
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATG--------------QEVAIRQMNLQQQPKKELIIN 66
Query: 331 ELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ V+    + N+V  L  Y V   L++V EY+  G+L++ +  +  D         +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 123
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVG 448
           +  + LE++H + V   IHRDIKS NIL+  +   K+ DFG   ++T   S    + +VG
Sbjct: 124 ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVG 178
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA-----------IVKGNGSS--AD 495
           T  +M PE        PKVD+++ G++  E+I  +             ++  NG+    +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238
Query: 496 SKGLVALFEEVLN 508
            + L A+F + LN
Sbjct: 239 PEKLSAIFRDFLN 251

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYA-ELRG-EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           +NF +   +G G +G V+   ++ G + G  Y  +++    ++QKA       + +    
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA-------KTTEHTR 106
Query: 330 AELKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
            E +VL H+     +  + Y    E  L L+ +YI  G L  HL  S R+       VQI
Sbjct: 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL--SQRERFT-EHEVQI 163
Query: 388 AL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            + +    LE++H+  +   I+RDIK  NIL+D N H  + DFGL+K             
Sbjct: 164 YVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
Query: 447 VGTFGYMPPEYAQYGDV--SPKVDVYAFGVVLYELISA 482
            GT  YM P+  + GD      VD ++ GV++YEL++ 
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 118/261 (45%), Gaps = 33/261 (12%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI-KKMDMQASREFLAE 331
           NF +  KIG+G F  VY A             L  V + ++K  I   MD +A  + + E
Sbjct: 33  NFRIEKKIGRGQFSEVYRAA----------CLLDGVPVALKKVQIFDLMDAKARADCIKE 82
Query: 332 LKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLS---EHLRGSGR---DPLPWSSR 384
           + +L  ++H N+++     +E   L +V E  + G+LS   +H +   R   +   W   
Sbjct: 83  IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYF 142
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
           VQ+       LE++H   V   +HRDIK AN+ I      K+ D GL +     + +  +
Sbjct: 143 VQLC----SALEHMHSRRV---MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195
Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
            LVGT  YM PE       + K D+++ G +LYE+ + +       G   +   L    E
Sbjct: 196 -LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY---GDKMNLYSLCKKIE 251
Query: 505 EVLNLPDP----IEDLRKLVD 521
           +    P P     E+LR+LV+
Sbjct: 252 QCDYPPLPSDHYSEELRQLVN 272

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 119/253 (47%), Gaps = 41/253 (16%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FLA 330
           ++   KIGQG  G VY A +    G              Q+ AI++M++Q   +    + 
Sbjct: 22  YTRFEKIGQGASGTVYTA-MDVATG--------------QEVAIRQMNLQQQPKKELIIN 66
Query: 331 ELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ V+    + N+V  L  Y V   L++V EY+  G+L++ +  +  D         +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 123
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVG 448
           +  + LE++H + V   IHRDIKS NIL+  +   K+ DFG   ++T   S    + +VG
Sbjct: 124 ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVG 178
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA-----------IVKGNGSS--AD 495
           T  +M PE        PKVD+++ G++  E+I  +             ++  NG+    +
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN 238
Query: 496 SKGLVALFEEVLN 508
            + L A+F + LN
Sbjct: 239 PEKLSAIFRDFLN 251

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 14  ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 65
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 66  DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 123
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 124 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 225
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 226 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 108/214 (50%), Gaps = 20/214 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAE--LRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +F +   +GQG FG V+      R + G+ Y  ++      ++KA +K  D   ++    
Sbjct: 29  HFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKV------LKKATLKVRDRVRTK---M 79
Query: 331 ELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E  +L  V+H  +V+L   +  EG L+L+ +++  G+L   L    ++ +     V+  L
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYL 136
Query: 390 -DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            + A GL+++H   +   I+RD+K  NIL+D+  H K+ DFGL+K   +          G
Sbjct: 137 AELALGLDHLHSLGI---IYRDLKPENILLDEEGHIKLTDFGLSK-EAIDHEKKAYSFCG 192
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  YM PE       S   D +++GV+++E+++ 
Sbjct: 193 TVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 12  ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 63
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 64  DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 121
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 122 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 178
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 179 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 223
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 224 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 262

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 32  ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 83
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 84  DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 141
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 142 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 198
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 199 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 243
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 244 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 282

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 28/216 (12%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FL 329
            ++   KIGQG  G VY A +    G              Q+ AI++M++Q   +    +
Sbjct: 22  KYTRFEKIGQGASGTVYTA-MDVATG--------------QEVAIRQMNLQQQPKKELII 66
Query: 330 AELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ V+    + N+V  L  Y V   L++V EY+  G+L++ +  +  D         + 
Sbjct: 67  NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVC 123
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLV 447
            +  + LE++H + V   IHRDIKS NIL+  +   K+ DFG   ++T   S    + +V
Sbjct: 124 RECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMV 178
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           GT  +M PE        PKVD+++ G++  E+I  +
Sbjct: 179 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 18  ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 69
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 70  DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 127
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 128 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 184
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 185 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 229
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 230 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 268

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 24  ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 75
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 76  DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 133
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 134 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 235
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 236 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 376 ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 427
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 428 DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 485
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 486 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 542
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 543 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 587
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 588 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 626

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 111/235 (47%), Gaps = 45/235 (19%)
Query: 313 QKAAIKKMDM--QASREFL-AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLS 368
           ++ A+KKMD+  Q  RE L  E+ ++   HH N+V +   Y V   L++V E++E G L+
Sbjct: 71  KQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT 130
Query: 369 E---HLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK 425
           +   H R      +       + L   R L Y+H   V   IHRDIKS +IL+  +   K
Sbjct: 131 DIVTHTR------MNEEQIATVCLSVLRALSYLHNQGV---IHRDIKSDSILLTSDGRIK 181
Query: 426 VADFGLTKLTEVGSASLPTR--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           ++DFG        S  +P R  LVGT  +M PE         +VD+++ G+++ E+I  +
Sbjct: 182 LSDFGFCAQV---SKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 238
Query: 484 EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVD---PRLGDNCPLDSVLK 535
                                   N P P++ +R++ D   PR+ D   + SVL+
Sbjct: 239 PP--------------------YFNEP-PLQAMRRIRDSLPPRVKDLHKVSSVLR 272

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 33/279 (11%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG V+      E G S +   +C+ ++  K+   +   QA  + +  +  L H H
Sbjct: 39  LGSGVFGTVHKGVWIPE-GES-IKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAH 94
Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH 399
              +VRL+G C   SL LV +Y+  G+L +H+R   R  L     +   +  A+G+ Y+ 
Sbjct: 95  ---IVRLLGLCPGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLE 150
Query: 400 EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT-FGYMPPEYA 458
           EH +   +HR++ + N+L+      +VADFG+  L       L      T   +M  E  
Sbjct: 151 EHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 207
Query: 459 QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRK 518
            +G  + + DV+++GV ++EL++            A+    + L E    +PD +E   +
Sbjct: 208 HFGKYTHQSDVWSYGVTVWELMTF----------GAEPYAGLRLAE----VPDLLEKGER 253
Query: 519 LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           L  P++   C +D  + M +    C      +RP+ + +
Sbjct: 254 LAQPQI---CTIDVYMVMVK----CWMIDENIRPTFKEL 285

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 33/279 (11%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG V+      E G S +   +C+ ++  K+   +   QA  + +  +  L H H
Sbjct: 21  LGSGVFGTVHKGVWIPE-GES-IKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAH 76
Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH 399
              +VRL+G C   SL LV +Y+  G+L +H+R   R  L     +   +  A+G+ Y+ 
Sbjct: 77  ---IVRLLGLCPGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLE 132
Query: 400 EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT-FGYMPPEYA 458
           EH +   +HR++ + N+L+      +VADFG+  L       L      T   +M  E  
Sbjct: 133 EHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESI 189
Query: 459 QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRK 518
            +G  + + DV+++GV ++EL++            A+    + L E    +PD +E   +
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTF----------GAEPYAGLRLAE----VPDLLEKGER 235
Query: 519 LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           L  P++   C +D  + M +    C      +RP+ + +
Sbjct: 236 LAQPQI---CTIDVYMVMVK----CWMIDENIRPTFKEL 267

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 124/247 (50%), Gaps = 27/247 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V+    +   G     +LI + +   K AI+        + + E
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEI---KPAIRN-------QIIRE 54
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 113
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 114 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 165
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE---E 505
           T  YM PE  Q    S + D+++ G+ L E+   +  I   + +  DS+  +A+FE    
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD-AKEDSRPPMAIFELLDY 224
Query: 506 VLNLPDP 512
           ++N P P
Sbjct: 225 IVNEPPP 231

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 46/272 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL------------ISAKEAIVKG-----NG 491
           T  Y+ PE       +  VD +A GV++YE+            I   E IV G     + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
Query: 492 SSADSKGL------VALFEEVLNLPDPIEDLR 517
            S+D K L      V L +   NLP+ + D++
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLPNGVNDIK 292

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG V     +G Y    + + + V +L  +A     D     E LAE  V+  +
Sbjct: 377 ELGSGNFGTV----KKGYYQMKKVVKTVAVKILKNEAN----DPALKDELLAEANVMQQL 428
Query: 339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
            +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + G++Y+
Sbjct: 429 DNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYL 486
Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GYMPPE 456
            E     ++HRD+ + N+L+    +AK++DFGL+K           +  G +   +  PE
Sbjct: 487 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 543
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
              Y   S K DV++FGV+++E  S  +   +G   S     + A+ E+           
Sbjct: 544 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----VTAMLEK----------- 588
Query: 517 RKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 R+G  CP     +M  L  +C     + RP   ++ + L
Sbjct: 589 ----GERMG--CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 627

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 133/306 (43%), Gaps = 30/306 (9%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G+G FG+V          N+    L+ V  L         D Q  R+F  E+++L  +
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNT--GALVAVKQLQHSGP----DQQ--RDFQREIQILKAL 69
Query: 339 HHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
           H   +V+  G        SL LV EY+ +G L + L+   R  L  S  +  +    +G+
Sbjct: 70  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGM 128
Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT---FGY 452
           EY+        +HRD+ + NIL++   H K+ADFGL KL  +       R  G    F Y
Sbjct: 129 EYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
             PE       S + DV++FGVVLYEL +  +   K    SA+   ++    +V  L   
Sbjct: 186 A-PESLSDNIFSRQSDVWSFGVVLYELFTYCD---KSCSPSAEFLRMMGCERDVPAL--- 238
Query: 513 IEDLRKLVDPRLGDNCPLDSVL--KMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED 570
               R L     G   P       ++ +L K+C    PQ RPS  ++   L  L S +  
Sbjct: 239 ---CRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 295
Query: 571 WDVGSF 576
            +  +F
Sbjct: 296 CETHAF 301

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 112
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  + +    L G
Sbjct: 173 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT----LCG 221
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG VY      E     +   + + +L +    K     A+ EF+ E  ++  + 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIP--VAIKILNETTGPK-----ANVEFMDEALIMASMD 98
Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH 399
           H +LVRL+G C+  ++ LV + + +G L E++    +D +     +   +  A+G+ Y+ 
Sbjct: 99  HPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 400 EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE-------VGSASLPTRLVGTFGY 452
           E  +   +HRD+ + N+L+    H K+ DFGL +L E            +P +      +
Sbjct: 158 ERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------W 208
Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           M  E   Y   + + DV+++GV ++EL++
Sbjct: 209 MALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 18/239 (7%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           S AT  +    +IG G +G VY A  R  +   +++ L  V +         + +   RE
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKA--RDPHSGHFVA-LKSVRVPNGGGGGGGLPISTVRE 61
Query: 328 FLAELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
            +A L+ L    H N+VRL+  C       E  + LV+E+++  +L  +L  +    LP 
Sbjct: 62  -VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
            +   +     RGL+++H + +   +HRD+K  NIL+      K+ADFGL ++     A 
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
            P  +V T  Y  PE       +  VD+++ G +  E+   K  +  GN S AD  G +
Sbjct: 177 TP--VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGN-SEADQLGKI 231

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 20/239 (8%)
Query: 331 ELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           E+++L  ++H ++V+  G C    E S+ LV EY+  G+L ++L    R  +  +  +  
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLF 117
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           A     G+ Y+H      YIHR + + N+L+D +   K+ DFGL K    G      R  
Sbjct: 118 AQQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 174
Query: 448 G---TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           G    F Y  PE  +        DV++FGV LYEL++  ++    +    +  G      
Sbjct: 175 GDSPVFWYA-PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQM 233
Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
            VL L + +E   +L  P   D CP +    +  L K C +     RP+ +++V  L T
Sbjct: 234 TVLRLTELLERGERLPRP---DRCPCE----IYHLMKNCWETEASFRPTFQNLVPILQT 285

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 110/239 (46%), Gaps = 20/239 (8%)
Query: 331 ELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           E+++L  ++H ++V+  G C    E S+ LV EY+  G+L ++L    R  +  +  +  
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLF 116
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           A     G+ Y+H      YIHR + + N+L+D +   K+ DFGL K    G      R  
Sbjct: 117 AQQICEGMAYLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 173
Query: 448 G---TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           G    F Y  PE  +        DV++FGV LYEL++  ++    +    +  G      
Sbjct: 174 GDSPVFWYA-PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQM 232
Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
            VL L + +E   +L  P   D CP +    +  L K C +     RP+ +++V  L T
Sbjct: 233 TVLRLTELLERGERLPRP---DRCPCE----IYHLMKNCWETEASFRPTFQNLVPILQT 284

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 107/224 (47%), Gaps = 45/224 (20%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           DNF    KIG+G  G V  A +R         +L+         A+KKMD+  Q  RE L
Sbjct: 154 DNFI---KIGEGSTGIVCIATVRSS------GKLV---------AVKKMDLRKQQRRELL 195
Query: 330 -AELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSE---HLRGSGRDPLPWSSR 384
             E+ ++    H N+V +   Y V   L++V E++E G L++   H R          + 
Sbjct: 196 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---------MNE 246
Query: 385 VQIA---LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
            QIA   L   + L  +H   V   IHRDIKS +IL+  +   K++DFG        S  
Sbjct: 247 EQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKE 300
Query: 442 LPTR--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           +P R  LVGT  +M PE        P+VD+++ G+++ E++  +
Sbjct: 301 VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 24/209 (11%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG VY      E     +   + + +L +    K     A+ EF+ E  ++  + 
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIP--VAIKILNETTGPK-----ANVEFMDEALIMASMD 75
Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH 399
           H +LVRL+G C+  ++ LV + + +G L E++    +D +     +   +  A+G+ Y+ 
Sbjct: 76  HPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVH-EHKDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 400 EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE-------VGSASLPTRLVGTFGY 452
           E  +   +HRD+ + N+L+    H K+ DFGL +L E            +P +      +
Sbjct: 135 ERRL---VHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------W 185
Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           M  E   Y   + + DV+++GV ++EL++
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/317 (25%), Positives = 135/317 (42%), Gaps = 54/317 (17%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV- 338
           +G+G +G V+     GE                   A+K    +  + +  E ++   V 
Sbjct: 16  VGKGRYGEVWRGLWHGE-----------------SVAVKIFSSRDEQSWFRETEIYNTVL 58
Query: 339 -HHLNLVRLIGYCVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
             H N++  I   +        L+L+  Y E+G+L + L+    +P      +++A+ +A
Sbjct: 59  LRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAA 115
Query: 393 RGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP---T 444
            GL ++H         P   HRD KS N+L+  N    +AD GL  +   GS  L     
Sbjct: 116 CGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNN 175
Query: 445 RLVGTFGYMPPEYAQYG------DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
             VGT  YM PE           +     D++AFG+VL+E+  A+  IV  NG   D + 
Sbjct: 176 PRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTIV--NGIVEDYRP 231
Query: 499 LVALFEEVLNLPDPIEDLRKLV-----DPRLGDNCPLDSVLK-MAQLAKVCTQEYPQLRP 552
               ++ V N P   ED++K+V      P + +    D VL  +AQ+ + C    P  R 
Sbjct: 232 --PFYDVVPNDPS-FEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARL 288
Query: 553 SMRSIVVALMTLSSTTE 569
           +   I   L  +S++ E
Sbjct: 289 TALRIKKTLQKISNSPE 305

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 23/214 (10%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N+ +   IG+G F  V  A       +    R + + ++  K  +    +Q   +   E+
Sbjct: 13  NYRLLKTIGKGNFAKVKLAR------HILTGREVAIKII-DKTQLNPTSLQ---KLFREV 62
Query: 333 KVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIAL 389
           +++  ++H N+V+L      E +L+L+ EY   G + ++L   GR  +    S   QI  
Sbjct: 63  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV- 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
                ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +    VG   L T   G+
Sbjct: 122 ---SAVQYCHQKRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDT-FCGS 173
Query: 450 FGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
             Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 89/314 (28%), Positives = 133/314 (42%), Gaps = 46/314 (14%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G+G FG+V          N+    L+ V  L         D Q  R+F  E+++L  +
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNT--GALVAVKQLQHSGP----DQQ--RDFQREIQILKAL 68
Query: 339 HHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
           H   +V+  G        SL LV EY+ +G L + L+   R  L  S  +  +    +G+
Sbjct: 69  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGM 127
Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT---FGY 452
           EY+        +HRD+ + NIL++   H K+ADFGL KL  +       R  G    F Y
Sbjct: 128 EYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELI-------SAKEAIVKGNGSSADSKGLVALFEE 505
             PE       S + DV++FGVVLYEL        S     ++  GS  D   L  L E 
Sbjct: 185 A-PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLEL 243
Query: 506 VL---NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM 562
           +     LP P               CP +    + +L K+C    PQ RPS  ++   L 
Sbjct: 244 LEEGQRLPAP-------------PACPAE----VHELMKLCWAPSPQDRPSFSALGPQLD 286
Query: 563 TLSSTTEDWDVGSF 576
            L S +   +  +F
Sbjct: 287 MLWSGSRGCETHAF 300

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           DNF    KIG+G  G V  A +R         +L+         A+KKMD+  Q  RE L
Sbjct: 34  DNFI---KIGEGSTGIVCIATVRSS------GKLV---------AVKKMDLRKQQRRELL 75
Query: 330 -AELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSE---HLRGSGRDPLPWSSR 384
             E+ ++    H N+V +   Y V   L++V E++E G L++   H R +          
Sbjct: 76  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQI 129
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
             + L   + L  +H   V   IHRDIKS +IL+  +   K++DFG        S  +P 
Sbjct: 130 AAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPR 183
Query: 445 R--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           R  LVGT  +M PE        P+VD+++ G+++ E++  +
Sbjct: 184 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 224

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           DNF    KIG+G  G V  A +R         +L+         A+KKMD+  Q  RE L
Sbjct: 32  DNFI---KIGEGSTGIVCIATVRSS------GKLV---------AVKKMDLRKQQRRELL 73
Query: 330 -AELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSE---HLRGSGRDPLPWSSR 384
             E+ ++    H N+V +   Y V   L++V E++E G L++   H R +          
Sbjct: 74  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQI 127
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
             + L   + L  +H   V   IHRDIKS +IL+  +   K++DFG        S  +P 
Sbjct: 128 AAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPR 181
Query: 445 R--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           R  LVGT  +M PE        P+VD+++ G+++ E++  +
Sbjct: 182 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 222

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 133/306 (43%), Gaps = 30/306 (9%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G+G FG+V          N+    L+ V  L         D Q  R+F  E+++L  +
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNT--GALVAVKQLQHSGP----DQQ--RDFQREIQILKAL 81
Query: 339 HHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
           H   +V+  G        SL LV EY+ +G L + L+   R  L  S  +  +    +G+
Sbjct: 82  HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGM 140
Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT---FGY 452
           EY+        +HRD+ + NIL++   H K+ADFGL KL  +       R  G    F Y
Sbjct: 141 EYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
             PE       S + DV++FGVVLYEL +  +   K    SA+   ++    +V  L   
Sbjct: 198 A-PESLSDNIFSRQSDVWSFGVVLYELFTYCD---KSCSPSAEFLRMMGCERDVPALS-- 251
Query: 513 IEDLRKLVDPRLGDNCPLDSVL--KMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED 570
               R L     G   P       ++ +L K+C    PQ RPS  ++   L  L S +  
Sbjct: 252 ----RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307
Query: 571 WDVGSF 576
            +  +F
Sbjct: 308 CETHAF 313

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           DNF    KIG+G  G V  A +R         +L+         A+KKMD+  Q  RE L
Sbjct: 23  DNFI---KIGEGSTGIVCIATVRSS------GKLV---------AVKKMDLRKQQRRELL 64
Query: 330 -AELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSE---HLRGSGRDPLPWSSR 384
             E+ ++    H N+V +   Y V   L++V E++E G L++   H R +          
Sbjct: 65  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQI 118
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
             + L   + L  +H   V   IHRDIKS +IL+  +   K++DFG        S  +P 
Sbjct: 119 AAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPR 172
Query: 445 R--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           R  LVGT  +M PE        P+VD+++ G+++ E++  +
Sbjct: 173 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 23/214 (10%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS--REFLA 330
           N+ +   IG+G F  V             L+R I     +    I K  + +S  ++   
Sbjct: 15  NYRLLKTIGKGNFAKVK------------LARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 331 ELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E++++  ++H N+V+L      E +L+LV EY   G + ++L   GR     +      +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
            SA  ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +     G+  L T   G+
Sbjct: 123 VSA--VQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-KLDT-FCGS 175
Query: 450 FGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
             Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 105/221 (47%), Gaps = 39/221 (17%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           DNF    KIG+G  G V  A +R         +L+         A+KKMD+  Q  RE L
Sbjct: 27  DNFI---KIGEGSTGIVCIATVRSS------GKLV---------AVKKMDLRKQQRRELL 68
Query: 330 -AELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSE---HLRGSGRDPLPWSSR 384
             E+ ++    H N+V +   Y V   L++V E++E G L++   H R +          
Sbjct: 69  FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE------EQI 122
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
             + L   + L  +H   V   IHRDIKS +IL+  +   K++DFG        S  +P 
Sbjct: 123 AAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPR 176
Query: 445 R--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           R  LVGT  +M PE        P+VD+++ G+++ E++  +
Sbjct: 177 RKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 23/214 (10%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS--REFLA 330
           N+ +   IG+G F  V             L+R I     +    I K  + +S  ++   
Sbjct: 15  NYRLLKTIGKGNFAKVK------------LARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 331 ELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E++++  ++H N+V+L      E +L+LV EY   G + ++L   GR     +      +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
            SA  ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +     G+  L T   G+
Sbjct: 123 VSA--VQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-KLDT-FCGS 175
Query: 450 FGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
             Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 122/254 (48%), Gaps = 44/254 (17%)
Query: 251 LNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL 310
           L+++ +   ++   E++      F++   +G+G FG+V  A+L+ E G+           
Sbjct: 2   LDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGS----------- 50
Query: 311 LMQKAAIK--KMDMQAS---REFLAELKVLTHVHHLNLVRLIGYCV----EGSL---FLV 358
              K A+K  K D+ AS    EFL E   +    H ++ +L+G  +    +G L    ++
Sbjct: 51  -FVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVI 109
Query: 359 YEYIENGNLSEHLRGS--GRDP--LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
             ++++G+L   L  S  G +P  LP  + V+  +D A G+EY+       +IHRD+ + 
Sbjct: 110 LPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAAR 166
Query: 415 NILIDKNFHAKVADFGLTKLTEVG-------SASLPTRLVGTFGYMPPEYAQYGDVSPKV 467
           N ++ ++    VADFGL++    G       ++ LP + +         Y  +       
Sbjct: 167 NCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHS------ 220
Query: 468 DVYAFGVVLYELIS 481
           DV+AFGV ++E+++
Sbjct: 221 DVWAFGVTMWEIMT 234

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 28/215 (13%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---FLA 330
           ++   KIGQG  G VY A +    G              Q+ AI++M++Q   +    + 
Sbjct: 23  YTRFEKIGQGASGTVYTA-MDVATG--------------QEVAIRQMNLQQQPKKELIIN 67
Query: 331 ELKVLTHVHHLNLVR-LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ V+    + N+V  L  Y V   L++V EY+  G+L++ +  +  D         +  
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 124
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVG 448
           +  + LE++H + V   IHR+IKS NIL+  +   K+ DFG   ++T   S    + +VG
Sbjct: 125 ECLQALEFLHSNQV---IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVG 179
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  +M PE        PKVD+++ G++  E+I  +
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/224 (31%), Positives = 107/224 (47%), Gaps = 45/224 (20%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           DNF    KIG+G  G V  A +R         +L+         A+KKMD+  Q  RE L
Sbjct: 77  DNFI---KIGEGSTGIVCIATVRSS------GKLV---------AVKKMDLRKQQRRELL 118
Query: 330 -AELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSE---HLRGSGRDPLPWSSR 384
             E+ ++    H N+V +   Y V   L++V E++E G L++   H R          + 
Sbjct: 119 FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---------MNE 169
Query: 385 VQIA---LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
            QIA   L   + L  +H   V   IHRDIKS +IL+  +   K++DFG        S  
Sbjct: 170 EQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFGFCAQV---SKE 223
Query: 442 LPTR--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           +P R  LVGT  +M PE        P+VD+++ G+++ E++  +
Sbjct: 224 VPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 267

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 122/272 (44%), Gaps = 46/272 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 27  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 77
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 78  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 137
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  + +    L G
Sbjct: 138 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCG 186
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL------------ISAKEAIVKG-----NG 491
           T  Y+ PE       +  VD +A GV++YE+            I   E IV G     + 
Sbjct: 187 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 246
Query: 492 SSADSKGL------VALFEEVLNLPDPIEDLR 517
            S+D K L      V L +   NL D + D++
Sbjct: 247 FSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIK 278

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LAG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 105/214 (49%), Gaps = 23/214 (10%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS--REFLA 330
           N+ +   IG+G F  V             L+R I     +    I K  + +S  ++   
Sbjct: 15  NYRLLKTIGKGNFAKVK------------LARHILTGKEVAVRIIDKTQLNSSSLQKLFR 62
Query: 331 ELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E++++  ++H N+V+L      E +L+LV EY   G + ++L   GR     +      +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
            SA  ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +     G+  L T   G+
Sbjct: 123 VSA--VQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-KLDT-FCGS 175
Query: 450 FGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
             Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHK-ETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 84
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 144
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 145 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 193
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 86
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 87  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 146
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 147 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 195
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 196 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LXG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHK-ETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 84
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 85  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 144
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 145 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 193
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 194 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 27/241 (11%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           +F     IG+G FG V  A  + E           V +L +KA +KK   +  +  ++E 
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAE------EVFYAVKVLQKKAILKK---KEEKHIMSER 89
Query: 333 KVL-THVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-AL 389
            VL  +V H  LV L   +     L+ V +YI  G L  HL+   R+      R +  A 
Sbjct: 90  NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARFYAA 146
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
           + A  L Y+H   +   ++RD+K  NIL+D   H  + DFGL K   +   S  +   GT
Sbjct: 147 EIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGT 202
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             Y+ PE          VD +  G VLYE++               S+    +++ +LN 
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY--------SRNTAEMYDNILNK 254
Query: 510 P 510
           P
Sbjct: 255 P 255

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHK-ETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS--REFLA 330
           N+ +   IG+G F  V             L+R I     +    I K  + +S  ++   
Sbjct: 15  NYRLLKTIGKGNFAKVK------------LARHILTGKEVAVRIIDKTQLNSSSLQKLFR 62
Query: 331 ELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E++++  ++H N+V+L      E +L+LV EY   G + ++L   GR     +      +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
            SA  ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +   E    +      G+
Sbjct: 123 VSA--VQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDEFCGS 175
Query: 450 FGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
             Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 78
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 79  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 138
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 139 LT----FEYLHSLDL---IYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWX----LCG 187
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 188 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K  +++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKEIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + KV DFGL K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHK-ETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 112
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIV 172
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 173 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 221
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHK-ETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  + +    L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHK-ETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 112
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 113 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 172
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 173 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 221
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 222 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G FG V     +         R   + +L ++  I K ++  +   + E
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHT---VTE 58
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-AL 389
            +VL +  H  L  L   +     L  V EY   G L  HL    R+ +    R +    
Sbjct: 59  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 115
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
           +    LEY+H   V   ++RDIK  N+++DK+ H K+ DFGL K      A++ T   GT
Sbjct: 116 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGT 171
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             Y+ PE  +  D    VD +  GVV+YE++  +
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           N+ +   IG+G F  V  A       +    R + + ++  K  +    +Q   +   E+
Sbjct: 16  NYRLLKTIGKGNFAKVKLAR------HILTGREVAIKII-DKTQLNPTSLQ---KLFREV 65
Query: 333 KVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIAL 389
           +++  ++H N+V+L      E +L+L+ EY   G + ++L   GR  +    S   QI  
Sbjct: 66  RIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV- 124
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
                ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +    VG         G 
Sbjct: 125 ---SAVQYCHQKRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL--DAFCGA 176
Query: 450 FGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
             Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G FG V     +         R   + +L ++  I K ++  +   + E
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHT---VTE 55
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-AL 389
            +VL +  H  L  L   +     L  V EY   G L  HL    R+ +    R +    
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
           +    LEY+H   V   ++RDIK  N+++DK+ H K+ DFGL K      A++ T   GT
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGT 168
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             Y+ PE  +  D    VD +  GVV+YE++  +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G FG V     +         R   + +L ++  I K ++  +   + E
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHT---VTE 55
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-AL 389
            +VL +  H  L  L   +     L  V EY   G L  HL    R+ +    R +    
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
           +    LEY+H   V   ++RDIK  N+++DK+ H K+ DFGL K      A++ T   GT
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGT 168
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             Y+ PE  +  D    VD +  GVV+YE++  +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 121/272 (44%), Gaps = 46/272 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL------------ISAKEAIVKG-----NG 491
           T  Y+ PE       +  VD +A GV++YE+            I   E IV G     + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
Query: 492 SSADSKGL------VALFEEVLNLPDPIEDLR 517
            S+D K L      V L +   NL D + D++
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIK 292

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLA 330
           ++ +   +G G FG V   E      +      + V +L  +  I+ +D+  +  RE + 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGE------HQLTGHKVAVKIL-NRQKIRSLDVVGKIKRE-IQ 63
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
            LK+  H H + L ++I        F+V EY+  G L +++   GR     + R+   + 
Sbjct: 64  NLKLFRHPHIIKLYQVIS--TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
           SA  ++Y H H V   +HRD+K  N+L+D + +AK+ADFGL+ +   G     +   G+ 
Sbjct: 122 SA--VDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSP 174
Query: 451 GYMPPE------YAQYGDVSPKVDVYAFGVVLYELISA 482
            Y  PE      YA      P+VD+++ GV+LY L+  
Sbjct: 175 NYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCG 207

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 129/299 (43%), Gaps = 30/299 (10%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G+G FG+V          N+    L+ V  L         D Q  R+F  E+++L  +
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNT--GALVAVKQLQHSGP----DQQ--RDFQREIQILKAL 65
Query: 339 HHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGL 395
           H   +V+  G         L LV EY+ +G L + L+   R  L  S  +  +    +G+
Sbjct: 66  HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGM 124
Query: 396 EYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT---FGY 452
           EY+        +HRD+ + NIL++   H K+ADFGL KL  +       R  G    F Y
Sbjct: 125 EYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
             PE       S + DV++FGVVLYEL +  +   K    SA+   ++    +V  L   
Sbjct: 182 A-PESLSDNIFSRQSDVWSFGVVLYELFTYCD---KSCSPSAEFLRMMGCERDVPAL--- 234
Query: 513 IEDLRKLVDPRLGDNCPLDSVL--KMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
               R L     G   P       ++ +L K+C    PQ RPS  ++   L  L S + 
Sbjct: 235 ---CRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 290

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 30/218 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLA 330
           ++ +   +G G FG V   E      +      + V +L  +  I+ +D+  +  RE + 
Sbjct: 12  HYVLGDTLGVGTFGKVKIGE------HQLTGHKVAVKIL-NRQKIRSLDVVGKIKRE-IQ 63
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
            LK+  H H + L ++I        F+V EY+  G L +++   GR     + R+   + 
Sbjct: 64  NLKLFRHPHIIKLYQVIS--TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
           SA  ++Y H H V   +HRD+K  N+L+D + +AK+ADFGL+ +   G     +   G+ 
Sbjct: 122 SA--VDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSP 174
Query: 451 GYMPPE------YAQYGDVSPKVDVYAFGVVLYELISA 482
            Y  PE      YA      P+VD+++ GV+LY L+  
Sbjct: 175 NYAAPEVISGRLYA-----GPEVDIWSCGVILYALLCG 207

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 94/186 (50%), Gaps = 19/186 (10%)
Query: 313 QKAAIKKMDMQASR----EFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENG-- 365
           +K AIK+++++  +    E L E++ ++  HH N+V     + V+  L+LV + +  G  
Sbjct: 41  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100
Query: 366 -NLSEHLRGSGRDP---LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN 421
            ++ +H+   G      L  S+   I  +   GLEY+H++     IHRD+K+ NIL+ ++
Sbjct: 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGED 157
Query: 422 FHAKVADFGLTKLTEVGSA----SLPTRLVGTFGYMPPE-YAQYGDVSPKVDVYAFGVVL 476
              ++ADFG++     G       +    VGT  +M PE   Q      K D+++FG+  
Sbjct: 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217
Query: 477 YELISA 482
            EL + 
Sbjct: 218 IELATG 223

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 121/272 (44%), Gaps = 46/272 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL------------ISAKEAIVKG-----NG 491
           T  Y+ PE       +  VD +A GV++YE+            I   E IV G     + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
Query: 492 SSADSKGL------VALFEEVLNLPDPIEDLR 517
            S+D K L      V L +   NL D + D++
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIK 292

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 94/186 (50%), Gaps = 19/186 (10%)
Query: 313 QKAAIKKMDMQASR----EFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENG-- 365
           +K AIK+++++  +    E L E++ ++  HH N+V     + V+  L+LV + +  G  
Sbjct: 36  EKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 95
Query: 366 -NLSEHLRGSGRDP---LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN 421
            ++ +H+   G      L  S+   I  +   GLEY+H++     IHRD+K+ NIL+ ++
Sbjct: 96  LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGED 152
Query: 422 FHAKVADFGLTKLTEVGSA----SLPTRLVGTFGYMPPE-YAQYGDVSPKVDVYAFGVVL 476
              ++ADFG++     G       +    VGT  +M PE   Q      K D+++FG+  
Sbjct: 153 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 212
Query: 477 YELISA 482
            EL + 
Sbjct: 213 IELATG 218

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS--REFLA 330
           N+ +   IG+G F  V             L+R I     +    I K  + +S  ++   
Sbjct: 15  NYRLLKTIGKGNFAKVK------------LARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 331 ELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E++++  ++H N+V+L      E +L+LV EY   G + ++L   GR     +      +
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
            SA  ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +   E    +      G 
Sbjct: 123 VSA--VQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDAFCGA 175
Query: 450 FGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
             Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++Y++ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHK-ETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++   V+   LV+L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 93  KRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + KVADFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHK-ETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + KV DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 108/237 (45%), Gaps = 21/237 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           AT  +    +IG G +G VY A       + +    + +  +      + + +   RE +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR------DPHSGHFVALKSVRVPNGEEGLPISTVRE-V 54
Query: 330 AELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
           A L+ L    H N+VRL+  C       E  + LV+E+++  +L  +L  +    LP  +
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET 113
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
              +     RGL+++H + +   +HRD+K  NIL+      K+ADFGL ++     A  P
Sbjct: 114 IKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP 170
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
             +V T  Y  PE       +  VD+++ G +  E+   K  +  GN S AD  G +
Sbjct: 171 --VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGN-SEADQLGKI 223

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 36/230 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 45
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 104
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 105 IKSYLFQLLQGLSFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 160
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 161 THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 136/290 (46%), Gaps = 23/290 (7%)
Query: 229 GLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKI-GQGGFGA 287
           GL  P  + V +    A     L+++   + +++ + E     +++ +  ++ G+GGFG 
Sbjct: 141 GLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGE 200
Query: 288 VYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI 347
           V+  +++         +L     L +K   K+   Q +   + E K+L  VH   +V L 
Sbjct: 201 VFACQMKA------TGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFIVSLA 251
Query: 348 -GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR---GLEYIHEHTV 403
             +  +  L LV   +  G++  H+     D  P     +    +A+   GLE++H+  +
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-PGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LVGTFGYMPPEYAQYGD 462
              I+RD+K  N+L+D + + +++D GL    E+ +    T+   GT G+M PE     +
Sbjct: 311 ---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 463 VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA-LFEEVLNLPD 511
               VD +A GV LYE+I+A+    +  G   ++K L   + E+ +  PD
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKELKQRVLEQAVTYPD 414

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 130/278 (46%), Gaps = 32/278 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLS-RLICVNLLMQKAAIK------------ 318
           + +++  +IG+G +G V  A    E  N+Y + +++    L+++A               
Sbjct: 13  NQYTLKDEIGKGSYGVVKLA--YNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 319 ------KMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLR 372
                 +  ++   + +A LK L H + + LV ++    E  L++V+E +  G + E   
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--- 127
Query: 373 GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
                PL          D  +G+EY+H   +   IHRDIK +N+L+ ++ H K+ADFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 433 KLTEVGSASLPTRLVGTFGYMPPE-YAQYGDV--SPKVDVYAFGVVLYELISAKEAIVKG 489
              + GS +L +  VGT  +M PE  ++   +     +DV+A GV LY  +  +   +  
Sbjct: 185 NEFK-GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDN 527
                 SK + +   E  + PD  EDL+ L+   L  N
Sbjct: 244 RIMCLHSK-IKSQALEFPDQPDIAEDLKDLITRMLDKN 280

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 136/290 (46%), Gaps = 23/290 (7%)
Query: 229 GLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKI-GQGGFGA 287
           GL  P  + V +    A     L+++   + +++ + E     +++ +  ++ G+GGFG 
Sbjct: 141 GLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGE 200
Query: 288 VYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI 347
           V+  +++         +L     L +K   K+   Q +   + E K+L  VH   +V L 
Sbjct: 201 VFACQMKA------TGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFIVSLA 251
Query: 348 -GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR---GLEYIHEHTV 403
             +  +  L LV   +  G++  H+     D  P     +    +A+   GLE++H+  +
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-PGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LVGTFGYMPPEYAQYGD 462
              I+RD+K  N+L+D + + +++D GL    E+ +    T+   GT G+M PE     +
Sbjct: 311 ---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 463 VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA-LFEEVLNLPD 511
               VD +A GV LYE+I+A+    +  G   ++K L   + E+ +  PD
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKELKQRVLEQAVTYPD 414

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 136/290 (46%), Gaps = 23/290 (7%)
Query: 229 GLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKI-GQGGFGA 287
           GL  P  + V +    A     L+++   + +++ + E     +++ +  ++ G+GGFG 
Sbjct: 141 GLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGE 200
Query: 288 VYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI 347
           V+  +++         +L     L +K   K+   Q +   + E K+L  VH   +V L 
Sbjct: 201 VFACQMKA------TGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFIVSLA 251
Query: 348 -GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR---GLEYIHEHTV 403
             +  +  L LV   +  G++  H+     D  P     +    +A+   GLE++H+  +
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-PGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LVGTFGYMPPEYAQYGD 462
              I+RD+K  N+L+D + + +++D GL    E+ +    T+   GT G+M PE     +
Sbjct: 311 ---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 463 VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA-LFEEVLNLPD 511
               VD +A GV LYE+I+A+    +  G   ++K L   + E+ +  PD
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKELKQRVLEQAVTYPD 414

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 45
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 104
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 105 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 160
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+  
Sbjct: 161 THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 44
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 103
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 104 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 159
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+  
Sbjct: 160 THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 44
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 45  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 103
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 160
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 161 Y-THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 208

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 115/235 (48%), Gaps = 28/235 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V   + R   G     +LI + +   K AI+        + + E
Sbjct: 16  DDFERISELGAGNGGVVTKVQHR-PSGLIMARKLIHLEI---KPAIRN-------QIIRE 64
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ + R P     +V IA+ 
Sbjct: 65  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV- 123
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             RGL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 124 -LRGLAYLREKHQI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 175
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           T  YM PE  Q    S + D+++ G+ L EL   +  I        D+K L A+F
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI-----PPPDAKELEAIF 225

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K  +++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKEIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + +V DFGL K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 36/230 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 45
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 104
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 105 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 160
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 161 THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 126/270 (46%), Gaps = 16/270 (5%)
Query: 267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           + +  ++F + + +G+G F  VY AE      + +    + + ++ +KA  K   +Q  +
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAE------SIHTGLEVAIKMIDKKAMYKAGMVQRVQ 59
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
               E+K+   + H +++ L  Y  + + ++LV E   NG ++ +L+   + P   +   
Sbjct: 60  N---EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEAR 115
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
                   G+ Y+H H +   +HRD+  +N+L+ +N + K+ADFGL    ++      T 
Sbjct: 116 HFMHQIITGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT- 171
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
           L GT  Y+ PE A       + DV++ G + Y L+  +         +  +K ++A +E 
Sbjct: 172 LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM 231
Query: 506 VLNLPDPIEDL-RKLVDPRLGDNCPLDSVL 534
              L    +DL  +L+     D   L SVL
Sbjct: 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 44
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 103
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 104 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 159
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+  
Sbjct: 160 THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 36/230 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 52
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 53  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 111
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 112 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 167
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 168 THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 214

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS--REFLA 330
           N+ +   IG+G F  V             L+R I     +    I K  + +S  ++   
Sbjct: 15  NYRLLKTIGKGNFAKVK------------LARHILTGKEVAVKIIDKTQLNSSSLQKLFR 62
Query: 331 ELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+++   ++H N+V+L      E +L+LV EY   G + ++L   GR     +      +
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI 122
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
            SA  ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +   E    +      G 
Sbjct: 123 VSA--VQYCHQKFI---VHRDLKAENLLLDADXNIKIADFGFS--NEFTFGNKLDAFCGA 175
Query: 450 FGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
             Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 50/289 (17%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E+    ++F +   IG+G FG V   +++         R+  + +L +   +K+ +   
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKN------TERIYAMKILNKWEMLKRAETAC 120
Query: 325 SRE-----FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
            RE        + + +T +H+        +  E  L+LV +Y   G+L   L     D L
Sbjct: 121 FREERDVLVNGDCQWITALHY-------AFQDENHLYLVMDYYVGGDLLT-LLSKFEDKL 172
Query: 380 P------WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LT 432
           P      +   + +A+DS   L Y+H         RDIK  N+L+D N H ++ADFG   
Sbjct: 173 PEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGSCL 223
Query: 433 KLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAK---- 483
           K+ + G+    +  VGT  Y+ PE  Q      G   P+ D ++ GV +YE++  +    
Sbjct: 224 KMNDDGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 282
Query: 484 -EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL-RKLV---DPRLGDN 527
            E++V+  G   + +        V ++ +  +DL ++L+   + RLG N
Sbjct: 283 AESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQN 331

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 122/272 (44%), Gaps = 46/272 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN +      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHK-ETGNHF-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL------------ISAKEAIVKG-----NG 491
           T  Y+ PE       +  VD +A GV++YE+            I   E IV G     + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
Query: 492 SSADSKGL------VALFEEVLNLPDPIEDLR 517
            S+D K L      V L +   NL D + D++
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIK 292

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 49
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 50  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 108
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 109 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 164
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+  
Sbjct: 165 THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 213

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 122/272 (44%), Gaps = 46/272 (16%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN +      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHK-ETGNHF-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL------------ISAKEAIVKG-----NG 491
           T  Y+ PE       +  VD +A GV++YE+            I   E IV G     + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
Query: 492 SSADSKGL------VALFEEVLNLPDPIEDLR 517
            S+D K L      V L +   NL D + D++
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKDGVNDIK 292

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 28/235 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V+    +   G     +LI + +   K AI+        + + E
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEI---KPAIR-------NQIIRE 116
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 117 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 175
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 176 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 227
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           T  YM PE  Q    S + D+++ G+ L E+   +  I        D+K L  +F
Sbjct: 228 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI-----PPPDAKELELMF 277

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 46
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E+++  +L + +  S    +P 
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPL 105
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 163 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 210

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 45
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 104
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 105 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 160
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+  
Sbjct: 161 THEVVTLWYRAPEILLGXKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS--REFLA 330
           N+ +   IG+G F  V             L+R I     +    I K  + +S  ++   
Sbjct: 8   NYRLLKTIGKGNFAKVK------------LARHILTGKEVAVKIIDKTQLNSSSLQKLFR 55
Query: 331 ELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E++++  ++H N+V+L      E +L+LV EY   G + ++L   G     W    +   
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHG-----WMKEKEARA 110
Query: 390 DSAR---GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
              +    ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +     G+  L T  
Sbjct: 111 KFRQIVSAVQYCHQKFI---VHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-KLDT-F 165
Query: 447 VGTFGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISA 482
            G+  Y  PE  Q      P+VDV++ GV+LY L+S 
Sbjct: 166 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 131/289 (45%), Gaps = 50/289 (17%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E+    ++F +   IG+G FG V   +++         R+  + +L +   +K+ +   
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKN------TERIYAMKILNKWEMLKRAETAC 136
Query: 325 SRE-----FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
            RE        + + +T +H+        +  E  L+LV +Y   G+L   L     D L
Sbjct: 137 FREERDVLVNGDCQWITALHY-------AFQDENHLYLVMDYYVGGDLLT-LLSKFEDKL 188
Query: 380 P------WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LT 432
           P      +   + +A+DS   L Y+H         RDIK  N+L+D N H ++ADFG   
Sbjct: 189 PEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGSCL 239
Query: 433 KLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAK---- 483
           K+ + G+    +  VGT  Y+ PE  Q      G   P+ D ++ GV +YE++  +    
Sbjct: 240 KMNDDGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY 298
Query: 484 -EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL-RKLV---DPRLGDN 527
            E++V+  G   + +        V ++ +  +DL ++L+   + RLG N
Sbjct: 299 AESLVETYGKIMNHEERFQFPSHVTDVSEEAKDLIQRLICSRERRLGQN 347

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 108/237 (45%), Gaps = 21/237 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           AT  +    +IG G +G VY A       + +    + +  +      + + +   RE +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR------DPHSGHFVALKSVRVPNGEEGLPISTVRE-V 54
Query: 330 AELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
           A L+ L    H N+VRL+  C       E  + LV+E+++  +L  +L  +    LP  +
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET 113
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
              +     RGL+++H + +   +HRD+K  NIL+      K+ADFGL ++     A  P
Sbjct: 114 IKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP 170
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
             +V T  Y  PE       +  VD+++ G +  E+   K  +  GN S AD  G +
Sbjct: 171 --VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGN-SEADQLGKI 223

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 36/230 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 52
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 53  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 111
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 112 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 167
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 168 THEVVTLWYRAPEILLGXKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 214

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 43
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPL 102
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 160 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 43
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 102
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 160 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 43
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 102
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 160 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 47
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 48  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 106
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 107 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 163
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 164 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 211

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 45
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 46  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 104
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 105 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 161
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 162 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 209

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 46
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 105
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 163 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 45
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 46  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 104
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 105 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 161
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 162 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 209

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 43
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 102
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 160 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 123/305 (40%), Gaps = 66/305 (21%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKV 334
           ++G+  FG VY   L G                 Q  AIK +  +A      EF  E  +
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQ----------TQAVAIKTLKDKAEGPLREEFRHEAML 65
Query: 335 LTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR--------GSGRD------PL 379
              + H N+V L+G   +   L +++ Y  +G+L E L         GS  D       L
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK------ 433
                V +    A G+EY+  H V   +H+D+ + N+L+    + K++D GL +      
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 434 -LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
               +G++ LP R      +M PE   YG  S   D++++GVVL+E+ S       G   
Sbjct: 183 YYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS- 235
Query: 493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
              ++ +V +      LP P             D+CP      M +    C  E+P  RP
Sbjct: 236 ---NQDVVEMIRNRQVLPCP-------------DDCPAWVYALMIE----CWNEFPSRRP 275
Query: 553 SMRSI 557
             + I
Sbjct: 276 RFKDI 280

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + KV DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN +      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHK-ETGNHF-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ P        +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 44
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 45  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 103
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 160
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 161 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 208

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 46
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 105
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 163 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 210

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + KV DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 43
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 102
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 160 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 207

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYA-ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           S  +D + +   +G GG   V+ A +LR       L R + V +L    A    D     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLR-------LHRDVAVKVLRADLA---RDPSFYL 57
Query: 327 EFLAELKVLTHVHHLNLVRLI----GYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPW 381
            F  E +    ++H  +V +          G L ++V EY++   L + +   G  P+  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTP 115
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSA 440
              +++  D+ + L + H++ +   IHRD+K ANI+I      KV DFG+ + + + G++
Sbjct: 116 KRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 441 SLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
              T  ++GT  Y+ PE A+   V  + DVY+ G VLYE+++ +
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 46
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++ + +L + +  S    +P 
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPL 105
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 163 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 210

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 36/236 (15%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA--- 330
           F+   +IG+G FG V+                   N   Q  AIK +D++ + + +    
Sbjct: 25  FTKLERIGKGSFGEVFKG---------------IDNRTQQVVAIKIIDLEEAEDEIEDIQ 69
Query: 331 -ELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ VL+      + +  G  ++GS L+++ EY+  G+  + LR    D    ++ ++  
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEI 129
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
           L   +GL+Y+H       IHRDIK+AN+L+ +    K+ADFG+  +LT+          V
Sbjct: 130 L---KGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFV 181
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           GT  +M PE  Q      K D+++ G+   EL        KG   ++D   +  LF
Sbjct: 182 GTPFWMAPEVIQQSAYDSKADIWSLGITAIEL-------AKGEPPNSDMHPMRVLF 230

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 45
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 46  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 104
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 105 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT 161
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 162 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 209

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 108/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 44
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P 
Sbjct: 45  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 103
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT 160
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 161 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 208

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 44
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 103
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 104 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 160
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
             +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+  
Sbjct: 161 HEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYA-ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           S  +D + +   +G GG   V+ A +LR       L R + V +L    A    D     
Sbjct: 8   SHLSDRYELGEILGFGGMSEVHLARDLR-------LHRDVAVKVLRADLA---RDPSFYL 57
Query: 327 EFLAELKVLTHVHHLNLVRLIGY----CVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPW 381
            F  E +    ++H  +V +          G L ++V EY++   L + +   G  P+  
Sbjct: 58  RFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTP 115
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSA 440
              +++  D+ + L + H++ +   IHRD+K ANI+I      KV DFG+ + + + G++
Sbjct: 116 KRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 441 SLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
              T  ++GT  Y+ PE A+   V  + DVY+ G VLYE+++ +
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 45
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++ + +L + +  S    +P 
Sbjct: 46  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPL 104
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 105 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 161
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 162 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 209

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 106/230 (46%), Gaps = 36/230 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 44
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L   +  S    +P   
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPL 103
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 104 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY- 159
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           T  V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 160 THEVVTLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 206

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 123/305 (40%), Gaps = 66/305 (21%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKV 334
           ++G+  FG VY   L G                 Q  AIK +  +A      EF  E  +
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQ----------TQAVAIKTLKDKAEGPLREEFRHEAML 82
Query: 335 LTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR--------GSGRDPLPWSSR- 384
              + H N+V L+G   +   L +++ Y  +G+L E L         GS  D     S  
Sbjct: 83  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 142
Query: 385 -----VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK------ 433
                V +    A G+EY+  H V   +H+D+ + N+L+    + K++D GL +      
Sbjct: 143 EPPDFVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 199
Query: 434 -LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
               +G++ LP R      +M PE   YG  S   D++++GVVL+E+ S       G   
Sbjct: 200 YYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS- 252
Query: 493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
              ++ +V +      LP P             D+CP      M +    C  E+P  RP
Sbjct: 253 ---NQDVVEMIRNRQVLPCP-------------DDCPAWVYALMIE----CWNEFPSRRP 292
Query: 553 SMRSI 557
             + I
Sbjct: 293 RFKDI 297

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 113/236 (47%), Gaps = 39/236 (16%)
Query: 273 NFSMSHKIGQGGFGAVYYA---ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           N  +   +G+G FG V  A    L+G  G +     + V +L + A+  ++     R+ L
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYT----TVAVKMLKENASPSEL-----RDLL 74
Query: 330 AELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR------------ 376
           +E  VL  V+H ++++L G C + G L L+ EY + G+L   LR S +            
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 377 ----------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
                       L     +  A   ++G++Y+ E ++   +HRD+ + NIL+ +    K+
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSL---VHRDLAARNILVAEGRKMKI 191
Query: 427 ADFGLTK-LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           +DFGL++ + E  S    ++      +M  E       + + DV++FGV+L+E+++
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 44
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 103
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 104 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 160
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
             +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+  
Sbjct: 161 HEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 36/230 (15%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-- 327
           +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E  
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETEGV 46
Query: 328 ---FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               + E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P   
Sbjct: 47  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL 105
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
                    +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  
Sbjct: 106 IKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYX 162
Query: 444 TRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 163 HEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 208

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G FG V     +         R   + +L ++  I K ++  +   + E
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHT---VTE 60
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-AL 389
            +VL +  H  L  L   +     L  V EY   G L  HL    R+ +    R +    
Sbjct: 61  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 117
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
           +    LEY+H   V   ++RDIK  N+++DK+ H K+ DFGL K      A++     GT
Sbjct: 118 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGT 173
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             Y+ PE  +  D    VD +  GVV+YE++  +
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G FG V     +         R   + +L ++  I K ++  +   + E
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHT---VTE 55
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-AL 389
            +VL +  H  L  L   +     L  V EY   G L  HL    R+ +    R +    
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
           +    LEY+H   V   ++RDIK  N+++DK+ H K+ DFGL K      A++     GT
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGT 168
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             Y+ PE  +  D    VD +  GVV+YE++  +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G FG V     +         R   + +L ++  I K ++  +   + E
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHT---VTE 55
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-AL 389
            +VL +  H  L  L   +     L  V EY   G L  HL    R+ +    R +    
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
           +    LEY+H   V   ++RDIK  N+++DK+ H K+ DFGL K      A++     GT
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGT 168
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             Y+ PE  +  D    VD +  GVV+YE++  +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 18/214 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G FG V     +         R   + +L ++  I K ++  +   + E
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA------TGRYYAMKILRKEVIIAKDEVAHT---VTE 55
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-AL 389
            +VL +  H  L  L   +     L  V EY   G L  HL    R+ +    R +    
Sbjct: 56  SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
           +    LEY+H   V   ++RDIK  N+++DK+ H K+ DFGL K      A++     GT
Sbjct: 113 EIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKX-FCGT 168
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
             Y+ PE  +  D    VD +  GVV+YE++  +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 46
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++ + +L + +  S    +P 
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPL 105
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 163 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 210

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 14/221 (6%)
Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-----HHLNLVRLIG 348
           RG Y    L RL   + +     +KK ++    E +  ++   HV     +H  LV L  
Sbjct: 19  RGSYAKVLLVRLKKTDRIYAMKVVKK-ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 77
Query: 349 -YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYI 407
            +  E  LF V EY+  G+L  H++   +  LP       + + +  L Y+HE  +   I
Sbjct: 78  CFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGI---I 132
Query: 408 HRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKV 467
           +RD+K  N+L+D   H K+ D+G+ K   +      +   GT  Y+ PE  +  D    V
Sbjct: 133 YRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 191
Query: 468 DVYAFGVVLYELISAKEAI-VKGNGSSADSKGLVALFEEVL 507
           D +A GV+++E+++ +    + G+  + D      LF+ +L
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 22/225 (9%)
Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-----HHLNLVRLIG 348
           RG Y    L RL   + +     +KK ++    E +  ++   HV     +H  LV L  
Sbjct: 30  RGSYAKVLLVRLKKTDRIYAMKVVKK-ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 88
Query: 349 -YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP----WSSRVQIALDSARGLEYIHEHTV 403
            +  E  LF V EY+  G+L  H++   + P      +S+ + +AL+      Y+HE  +
Sbjct: 89  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHERGI 142
Query: 404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV 463
              I+RD+K  N+L+D   H K+ D+G+ K   +      +   GT  Y+ PE  +  D 
Sbjct: 143 ---IYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDY 198
Query: 464 SPKVDVYAFGVVLYELISAKEAI-VKGNGSSADSKGLVALFEEVL 507
              VD +A GV+++E+++ +    + G+  + D      LF+ +L
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 243

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 28/235 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V+    +   G     +LI + +   K AI+        + + E
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEI---KPAIRN-------QIIRE 54
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 113
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 114 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 165
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           T  YM PE  Q    S + D+++ G+ L E+   +  I        D+K L  +F
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI-----PPPDAKELELMF 215

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 28/235 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V+    +   G     +LI + +   K AI+        + + E
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEI---KPAIRN-------QIIRE 54
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 113
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 114 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 165
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           T  YM PE  Q    S + D+++ G+ L E+   +  I        D+K L  +F
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI-----PPPDAKELELMF 215

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/290 (24%), Positives = 135/290 (46%), Gaps = 23/290 (7%)
Query: 229 GLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKI-GQGGFGA 287
           GL  P  + V +    A     L++    + +++ + E     +++ +  ++ G+GGFG 
Sbjct: 141 GLFQPLLRAVLAHLGQAPFQEFLDSKYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGE 200
Query: 288 VYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI 347
           V+  +++         +L     L +K   K+   Q +   + E K+L  VH   +V L 
Sbjct: 201 VFACQMKA------TGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFIVSLA 251
Query: 348 -GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR---GLEYIHEHTV 403
             +  +  L LV   +  G++  H+     D  P     +    +A+   GLE++H+  +
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN-PGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LVGTFGYMPPEYAQYGD 462
              I+RD+K  N+L+D + + +++D GL    E+ +    T+   GT G+M PE     +
Sbjct: 311 ---IYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 463 VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA-LFEEVLNLPD 511
               VD +A GV LYE+I+A+    +  G   ++K L   + E+ +  PD
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKELKQRVLEQAVTYPD 414

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 108/237 (45%), Gaps = 21/237 (8%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           AT  +    +IG G +G VY A       + +    + +  +      + + +   RE +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKAR------DPHSGHFVALKSVRVPNGEEGLPISTVRE-V 54
Query: 330 AELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
           A L+ L    H N+VRL+  C       E  + LV+E+++  +L  +L  +    LP  +
Sbjct: 55  ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAET 113
Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
              +     RGL+++H + +   +HRD+K  NIL+      K+ADFGL ++     A  P
Sbjct: 114 IKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP 170
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
             +V T  Y  PE       +  VD+++ G +  E+   K  +  GN S AD  G +
Sbjct: 171 --VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK-PLFCGN-SEADQLGKI 223

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 44
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++ + +L + +  S    +P 
Sbjct: 45  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPL 103
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPENLLINTEGAIKLADFGLARAFGVPVRT 160
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 161 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           + +NF    KIG+G +G VY A  +L GE                   A+KK+ +    E
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------------VALKKIRLDTETE 46
Query: 328 -----FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                 + E+ +L  ++H N+V+L+     E  L+LV+E++   +L   +  S    +P 
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPL 105
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 442 LPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
               +V T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+
Sbjct: 163 YXHEVV-TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGD 210

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYA-ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           S  +D + +   +G GG   V+ A +LR       L R + V +L    A    D     
Sbjct: 25  SHLSDRYELGEILGFGGMSEVHLARDLR-------LHRDVAVKVLRADLA---RDPSFYL 74
Query: 327 EFLAELKVLTHVHHLNLVRLI----GYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPW 381
            F  E +    ++H  +V +          G L ++V EY++   L + +   G  P+  
Sbjct: 75  RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTP 132
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSA 440
              +++  D+ + L + H++ +   IHRD+K ANI+I      KV DFG+ + + + G++
Sbjct: 133 KRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 441 SLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
              T  ++GT  Y+ PE A+   V  + DVY+ G VLYE+++ +
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 14/221 (6%)
Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-----HHLNLVRLIG 348
           RG Y    L RL   + +     +KK ++    E +  ++   HV     +H  LV L  
Sbjct: 15  RGSYAKVLLVRLKKTDRIYAMKVVKK-ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 73
Query: 349 -YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYI 407
            +  E  LF V EY+  G+L  H++   +  LP       + + +  L Y+HE  +   I
Sbjct: 74  CFQTESRLFFVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEISLALNYLHERGI---I 128
Query: 408 HRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKV 467
           +RD+K  N+L+D   H K+ D+G+ K   +      +   GT  Y+ PE  +  D    V
Sbjct: 129 YRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSV 187
Query: 468 DVYAFGVVLYELISAKEAI-VKGNGSSADSKGLVALFEEVL 507
           D +A GV+++E+++ +    + G+  + D      LF+ +L
Sbjct: 188 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 228

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/130 (31%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN 415
           ++V EY++   L + +   G  P+     +++  D+ + L + H++ +   IHRD+K AN
Sbjct: 92  YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGI---IHRDVKPAN 146
Query: 416 ILIDKNFHAKVADFGLTK-LTEVGSASLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFG 473
           ILI      KV DFG+ + + + G++   T  ++GT  Y+ PE A+   V  + DVY+ G
Sbjct: 147 ILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 474 VVLYELISAK 483
            VLYE+++ +
Sbjct: 207 CVLYEVLTGE 216

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 28/235 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V+    +   G     +LI + +   K AI+        + + E
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEI---KPAIRN-------QIIRE 54
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 113
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 114 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 165
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           T  YM PE  Q    S + D+++ G+ L E+   +  I        D+K L  +F
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI-----PPPDAKELELMF 215

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 28/235 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V+    +   G     +LI + +   K AI+        + + E
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEI---KPAIRN-------QIIRE 54
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 113
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 114 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 165
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           T  YM PE  Q    S + D+++ G+ L E+   +  I        D+K L  +F
Sbjct: 166 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI-----PPPDAKELELMF 215

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 26/227 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           +NF    KIG+G +G VY A  +L GE       RL      +   AI+           
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR----------- 51
Query: 330 AELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P        
Sbjct: 52  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYL 109
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  T  V 
Sbjct: 110 FQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV 165
Query: 449 TFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+  
Sbjct: 166 TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 209

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 26/227 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           +NF    KIG+G +G VY A  +L GE       RL      +   AI+           
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR----------- 50
Query: 330 AELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ +L  ++H N+V+L+     E  L+LV+E++   +L + +  S    +P        
Sbjct: 51  -EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYL 108
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +  T  V 
Sbjct: 109 FQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV 164
Query: 449 TFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
           T  Y  PE     +Y   S  VD+++ G +  E+++ + A+  G+  
Sbjct: 165 TLWYRAPEILLGCKY--YSTAVDIWSLGCIFAEMVT-RRALFPGDSE 208

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 28/235 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V+    +   G     +LI + +   K AI+        + + E
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHK-PSGLVMARKLIHLEI---KPAIRN-------QIIRE 81
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 82  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 140
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +    S+    VG
Sbjct: 141 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVG 192
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           T  YM PE  Q    S + D+++ G+ L E+   +  I        D+K L  +F
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI-----PPPDAKELELMF 242

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 36/215 (16%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA---AIKKMDMQASREFLAELKVL 335
           KIG+G +G V+         N    +++ +   ++      IKK+        L E+++L
Sbjct: 10  KIGEGSYGVVFKCR------NRDTGQIVAIKKFLESEDDPVIKKIA-------LREIRML 56
Query: 336 THVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSE---HLRGSGRDPLPWSSRVQIALDS 391
             + H NLV L+  +  +  L LV+EY ++  L E   + RG     +P      I   +
Sbjct: 57  KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-----VPEHLVKSITWQT 111
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
            + + + H+H     IHRD+K  NILI K+   K+ DFG  +L   G +      V T  
Sbjct: 112 LQAVNFCHKHNC---IHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRW 167
Query: 452 YMPPEY----AQYGDVSPKVDVYAFGVVLYELISA 482
           Y  PE      QYG   P VDV+A G V  EL+S 
Sbjct: 168 YRSPELLVGDTQYG---PPVDVWAIGCVFAELLSG 199

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   + + E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHK-ESGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY+  G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T   + PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 22/225 (9%)
Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-----HHLNLVRLIG 348
           RG Y    L RL   + +     +KK ++    E +  ++   HV     +H  LV L  
Sbjct: 62  RGSYAKVLLVRLKKTDRIYAMRVVKK-ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHS 120
Query: 349 -YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP----WSSRVQIALDSARGLEYIHEHTV 403
            +  E  LF V EY+  G+L  H++   + P      +S+ + +AL+      Y+HE  +
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHERGI 174
Query: 404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV 463
              I+RD+K  N+L+D   H K+ D+G+ K   +      +   GT  Y+ PE  +  D 
Sbjct: 175 ---IYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDY 230
Query: 464 SPKVDVYAFGVVLYELISAKEAI-VKGNGSSADSKGLVALFEEVL 507
              VD +A GV+++E+++ +    + G+  + D      LF+ +L
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 78/143 (54%), Gaps = 10/143 (6%)
Query: 356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN 415
           ++V EY++   L + +   G  P+     +++  D+ + L + H++ +   IHRD+K AN
Sbjct: 92  YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGI---IHRDVKPAN 146
Query: 416 ILIDKNFHAKVADFGLTK-LTEVGSASLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFG 473
           I+I      KV DFG+ + + + G++   T  ++GT  Y+ PE A+   V  + DVY+ G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 474 VVLYELISAKEAIVKGNGSSADS 496
            VLYE+++ +       G S DS
Sbjct: 207 CVLYEVLTGEPPFT---GDSPDS 226

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 110/242 (45%), Gaps = 51/242 (21%)
Query: 273 NFSMSHKIGQGGFGAVYYA---ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           N  +   +G+G FG V  A    L+G  G +     + V +L + A+  ++     R+ L
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYT----TVAVKMLKENASPSEL-----RDLL 74
Query: 330 AELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR------------ 376
           +E  VL  V+H ++++L G C + G L L+ EY + G+L   LR S +            
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 377 ----------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
                       L     +  A   ++G++Y+ E  +   +HRD+ + NIL+ +    K+
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKI 191
Query: 427 ADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           +DFGL++         +     +P + +         Y      + + DV++FGV+L+E+
Sbjct: 192 SDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIY------TTQSDVWSFGVLLWEI 245
Query: 480 IS 481
           ++
Sbjct: 246 VT 247

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 40/301 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICV--NLLMQKAAIKKMDMQASREFLA 330
           +  +  K+G G FG V   E     G +    + C+  ++L Q  A+         +F+ 
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD--------DFIR 64
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRG-SGRDPLPWSSRVQIAL 389
           E+  +  + H NL+RL G  +   + +V E    G+L + LR   G   L   SR   A+
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AV 122
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--LPTRLV 447
             A G+ Y+       +IHRD+ + N+L+      K+ DFGL +          +     
Sbjct: 123 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV 506
             F +  PE  +    S   D + FGV L+E+ +  +E  +  NGS      L  + +E 
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEG 235
Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS 566
             LP P             ++CP D    M Q    C    P+ RP+  ++   L+    
Sbjct: 236 ERLPRP-------------EDCPQDIYNVMVQ----CWAHKPEDRPTFVALRDFLLEAQP 278
Query: 567 T 567
           T
Sbjct: 279 T 279

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 116/264 (43%), Gaps = 34/264 (12%)
Query: 272 DNFSMSHKIGQGGFGAVYYAE---LRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
           D+F +   IG+G FG V   +    +  Y   Y+++  CV            +    R  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV------------ERNEVRNV 62
Query: 329 LAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
             EL+++  + H  LV L   +  E  +F+V + +  G+L  HL+ +        +    
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH--FKEETVKLF 120
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
             +    L+Y+    +   IHRD+K  NIL+D++ H  + DF +  +  +   +  T + 
Sbjct: 121 ICELVMALDYLQNQRI---IHRDMKPDNILLDEHGHVHITDFNIAAM--LPRETQITTMA 175
Query: 448 GTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           GT  YM PE     +    S  VD ++ GV  YEL+  +        SS  SK +V  FE
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY--HIRSSTSSKEIVHTFE 233
Query: 505 -EVLNLP-----DPIEDLRKLVDP 522
             V+  P     + +  L+KL++P
Sbjct: 234 TTVVTYPSAWSQEMVSLLKKLLEP 257

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 111/252 (44%), Gaps = 54/252 (21%)
Query: 260 VEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK 319
           +E +  E S   DN  +   IG+G +GAVY   L                   +  A+K 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE-----------------RPVAVKV 43
Query: 320 MDMQASREFLAELKV--LTHVHHLNLVRLI----GYCVEGSL--FLVYEYIENGNLSEHL 371
                 + F+ E  +  +  + H N+ R I        +G +   LV EY  NG+L ++L
Sbjct: 44  FSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL 103
Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIH------EHTVPVYIHRDIKSANILIDKNFHAK 425
                D   W S  ++A    RGL Y+H      +H  P   HRD+ S N+L+  +    
Sbjct: 104 SLHTSD---WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160
Query: 426 VADFGLT-KLT--------EVGSASLPTRLVGTFGYMPPEYAQYGDVS--------PKVD 468
           ++DFGL+ +LT        E  +A++    VGT  YM PE  + G V+         +VD
Sbjct: 161 ISDFGLSMRLTGNRLVRPGEEDNAAISE--VGTIRYMAPEVLE-GAVNLRDXESALKQVD 217
Query: 469 VYAFGVVLYELI 480
           +YA G++ +E+ 
Sbjct: 218 MYALGLIYWEIF 229

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 41  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 91
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   LV+L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + +V DFG  K  +  +      L G
Sbjct: 152 LT----FEYLHSLDL---IYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWX----LCG 200
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 201 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 48/244 (19%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           E+     +N      +G G FG V  A     +G      ++ V + M K+     + +A
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEA 95
Query: 325 SREFLAELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLR---------- 372
               ++ELK+++H+  H N+V L+G C  G  + ++ EY   G+L   LR          
Sbjct: 96  ---LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 373 --------GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
                    S RD L +SS+V      A+G+ ++        IHRD+ + N+L+     A
Sbjct: 153 AFAIANSTASTRDLLHFSSQV------AQGMAFLASKNC---IHRDVAARNVLLTNGHVA 203
Query: 425 KVADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLY 477
           K+ DFGL +           G+A LP +      +M PE       + + DV+++G++L+
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLW 257
Query: 478 ELIS 481
           E+ S
Sbjct: 258 EIFS 261

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 110/242 (45%), Gaps = 51/242 (21%)
Query: 273 NFSMSHKIGQGGFGAVYYA---ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           N  +   +G+G FG V  A    L+G  G +     + V +L + A+  ++     R+ L
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGYT----TVAVKMLKENASPSEL-----RDLL 74
Query: 330 AELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR------------ 376
           +E  VL  V+H ++++L G C + G L L+ EY + G+L   LR S +            
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 377 ----------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
                       L     +  A   ++G++Y+ E  +   +HRD+ + NIL+ +    K+
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKI 191
Query: 427 ADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           +DFGL++         +     +P + +         Y      + + DV++FGV+L+E+
Sbjct: 192 SDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY------TTQSDVWSFGVLLWEI 245
Query: 480 IS 481
           ++
Sbjct: 246 VT 247

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   L +L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + KV DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   L +L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + KV DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F     +G G FG V   +   E GN Y      + +L ++  +K   ++ +   L E
Sbjct: 42  DQFERIKTLGTGSFGRVMLVK-HMETGNHY-----AMKILDKQKVVKLKQIEHT---LNE 92
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIA 388
            ++L  V+   L +L   +    +L++V EY   G +  HLR  GR  +P       QI 
Sbjct: 93  KRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIV 152
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L      EY+H   +   I+RD+K  N++ID+  + KV DFG  K  +  +      L G
Sbjct: 153 LT----FEYLHSLDL---IYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWX----LCG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  Y+ PE       +  VD +A GV++YE+ + 
Sbjct: 202 TPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 74/130 (56%), Gaps = 7/130 (5%)
Query: 356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN 415
           ++V EY++   L + +   G  P+     +++  D+ + L + H++ +   IHRD+K AN
Sbjct: 92  YIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGI---IHRDVKPAN 146
Query: 416 ILIDKNFHAKVADFGLTK-LTEVGSASLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFG 473
           I+I      KV DFG+ + + + G++   T  ++GT  Y+ PE A+   V  + DVY+ G
Sbjct: 147 IMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG 206
Query: 474 VVLYELISAK 483
            VLYE+++ +
Sbjct: 207 CVLYEVLTGE 216

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 45/254 (17%)
Query: 252 NAITVDKSVEFSY-EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL 310
           N+ T     +  Y E+     +N      +G G FG V  A     +G      ++ V +
Sbjct: 17  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT---AFGLGKEDAVLKVAV 73
Query: 311 LMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLS 368
            M K+     + +A    ++ELK+++H+  H N+V L+G C  G  + ++ EY   G+L 
Sbjct: 74  KMLKSTAHADEKEA---LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 130
Query: 369 EHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
             LR                 RD L +SS+V      A+G+ ++        IHRD+ + 
Sbjct: 131 NFLRRKAEADLDKEDGRPLELRDLLHFSSQV------AQGMAFLASKNC---IHRDVAAR 181
Query: 415 NILIDKNFHAKVADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKV 467
           N+L+     AK+ DFGL +           G+A LP +      +M PE       + + 
Sbjct: 182 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQS 235
Query: 468 DVYAFGVVLYELIS 481
           DV+++G++L+E+ S
Sbjct: 236 DVWSYGILLWEIFS 249

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 40/301 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICV--NLLMQKAAIKKMDMQASREFLA 330
           +  +  K+G G FG V   E     G +    + C+  ++L Q  A+         +F+ 
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD--------DFIR 70
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRG-SGRDPLPWSSRVQIAL 389
           E+  +  + H NL+RL G  +   + +V E    G+L + LR   G   L   SR   A+
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AV 128
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--LPTRLV 447
             A G+ Y+       +IHRD+ + N+L+      K+ DFGL +          +     
Sbjct: 129 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 185
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV 506
             F +  PE  +    S   D + FGV L+E+ +  +E  +  NGS      L  + +E 
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEG 241
Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS 566
             LP P             ++CP D    M Q    C    P+ RP+  ++   L+    
Sbjct: 242 ERLPRP-------------EDCPQDIYNVMVQ----CWAHKPEDRPTFVALRDFLLEAQP 284
Query: 567 T 567
           T
Sbjct: 285 T 285

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 40/301 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICV--NLLMQKAAIKKMDMQASREFLA 330
           +  +  K+G G FG V   E     G +    + C+  ++L Q  A+         +F+ 
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD--------DFIR 60
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRG-SGRDPLPWSSRVQIAL 389
           E+  +  + H NL+RL G  +   + +V E    G+L + LR   G   L   SR   A+
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AV 118
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--LPTRLV 447
             A G+ Y+       +IHRD+ + N+L+      K+ DFGL +          +     
Sbjct: 119 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRK 175
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV 506
             F +  PE  +    S   D + FGV L+E+ +  +E  +  NGS      L  + +E 
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEG 231
Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS 566
             LP P             ++CP D    M Q    C    P+ RP+  ++   L+    
Sbjct: 232 ERLPRP-------------EDCPQDIYNVMVQ----CWAHKPEDRPTFVALRDFLLEAQP 274
Query: 567 T 567
           T
Sbjct: 275 T 275

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 45/254 (17%)
Query: 252 NAITVDKSVEFSY-EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL 310
           N+ T     +  Y E+     +N      +G G FG V  A     +G      ++ V +
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT---AFGLGKEDAVLKVAV 81
Query: 311 LMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLS 368
            M K+     + +A    ++ELK+++H+  H N+V L+G C  G  + ++ EY   G+L 
Sbjct: 82  KMLKSTAHADEKEA---LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 369 EHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
             LR                 RD L +SS+V      A+G+ ++        IHRD+ + 
Sbjct: 139 NFLRRKAEADLDKEDGRPLELRDLLHFSSQV------AQGMAFLASKNC---IHRDVAAR 189
Query: 415 NILIDKNFHAKVADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKV 467
           N+L+     AK+ DFGL +           G+A LP +      +M PE       + + 
Sbjct: 190 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQS 243
Query: 468 DVYAFGVVLYELIS 481
           DV+++G++L+E+ S
Sbjct: 244 DVWSYGILLWEIFS 257

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 40/301 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICV--NLLMQKAAIKKMDMQASREFLA 330
           +  +  K+G G FG V   E     G +    + C+  ++L Q  A+         +F+ 
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD--------DFIR 70
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRG-SGRDPLPWSSRVQIAL 389
           E+  +  + H NL+RL G  +   + +V E    G+L + LR   G   L   SR   A+
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AV 128
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--LPTRLV 447
             A G+ Y+       +IHRD+ + N+L+      K+ DFGL +          +     
Sbjct: 129 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV 506
             F +  PE  +    S   D + FGV L+E+ +  +E  +  NGS      L  + +E 
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEG 241
Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS 566
             LP P             ++CP D    M Q    C    P+ RP+  ++   L+    
Sbjct: 242 ERLPRP-------------EDCPQDIYNVMVQ----CWAHKPEDRPTFVALRDFLLEAQP 284
Query: 567 T 567
           T
Sbjct: 285 T 285

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 105/236 (44%), Gaps = 59/236 (25%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--EFLAELKVLTH 337
           +GQG FG V  A       N+  SR           AIKK+     +    L+E+ +L  
Sbjct: 14  LGQGAFGQVVKAR------NALDSRYY---------AIKKIRHTEEKLSTILSEVMLLAS 58
Query: 338 VHHLNLVRLIGYCVE--------------GSLFLVYEYIENGNL-----SEHLRGSGRDP 378
           ++H  +VR     +E               +LF+  EY ENG L     SE+L    RD 
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-NQQRDE 117
Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK----- 433
             W    QI       L YIH   +   IHRD+K  NI ID++ + K+ DFGL K     
Sbjct: 118 Y-WRLFRQIL----EALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 434 --LTEVGSASLP------TRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELI 480
             + ++ S +LP      T  +GT  Y+  E     G  + K+D+Y+ G++ +E+I
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 40/301 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICV--NLLMQKAAIKKMDMQASREFLA 330
           +  +  K+G G FG V   E     G +    + C+  ++L Q  A+         +F+ 
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD--------DFIR 60
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRG-SGRDPLPWSSRVQIAL 389
           E+  +  + H NL+RL G  +   + +V E    G+L + LR   G   L   SR   A+
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AV 118
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--LPTRLV 447
             A G+ Y+       +IHRD+ + N+L+      K+ DFGL +          +     
Sbjct: 119 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV 506
             F +  PE  +    S   D + FGV L+E+ +  +E  +  NGS      L  + +E 
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEG 231
Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS 566
             LP P             ++CP D    M Q    C    P+ RP+  ++   L+    
Sbjct: 232 ERLPRP-------------EDCPQDIYNVMVQ----CWAHKPEDRPTFVALRDFLLEAQP 274
Query: 567 T 567
           T
Sbjct: 275 T 275

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 129/307 (42%), Gaps = 45/307 (14%)
Query: 270 ATDNFSMSHKIGQGGFGAVY---YAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           A ++  ++  +G+G FG VY   Y   +GE  N           +  K   K   +    
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKIN-----------VAVKTCKKDCTLDNKE 70
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +F++E  ++ ++ H ++V+LIG   E   +++ E    G L  +L    ++ L   + V 
Sbjct: 71  KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVL 129
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE---VGSASLP 443
            +L   + + Y+        +HRDI   NIL+      K+ DFGL++  E      AS+ 
Sbjct: 130 YSLQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV- 185
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           TRL     +M PE   +   +   DV+ F V ++E++S      K      ++K ++ + 
Sbjct: 186 TRL--PIKWMSPESINFRRFTTASDVWMFAVCMWEILS----FGKQPFFWLENKDVIGVL 239
Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
           E+   LP P             D CP   VL    L   C    P  RP    +V +L  
Sbjct: 240 EKGDRLPKP-------------DLCP--PVL--YTLMTRCWDYDPSDRPRFTELVCSLSD 282
Query: 564 LSSTTED 570
           +    +D
Sbjct: 283 VYQMEKD 289

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 245 AGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSR 304
           +G+P+  N+   +  V  +  +     + F     +G+G FG V   + +         R
Sbjct: 122 SGSPSD-NSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA------TGR 174
Query: 305 LICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIE 363
              + +L ++  + K ++  +   L E +VL +  H  L  L   +     L  V EY  
Sbjct: 175 YYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231
Query: 364 NGNLSEHLRGSGRDPLPWSSRVQI-ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF 422
            G L  HL    R+ +    R +    +    L+Y+H     VY  RD+K  N+++DK+ 
Sbjct: 232 GGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKNVVY--RDLKLENLMLDKDG 286
Query: 423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           H K+ DFGL K      A++ T   GT  Y+ PE  +  D    VD +  GVV+YE++  
Sbjct: 287 HIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 483 K 483
           +
Sbjct: 346 R 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 107/241 (44%), Gaps = 18/241 (7%)
Query: 245 AGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSR 304
           +G+P+  N+   +  V  +  +     + F     +G+G FG V   + +         R
Sbjct: 125 SGSPSD-NSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKA------TGR 177
Query: 305 LICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIE 363
              + +L ++  + K ++  +   L E +VL +  H  L  L   +     L  V EY  
Sbjct: 178 YYAMKILKKEVIVAKDEVAHT---LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 234
Query: 364 NGNLSEHLRGSGRDPLPWSSRVQI-ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF 422
            G L  HL    R+ +    R +    +    L+Y+H     VY  RD+K  N+++DK+ 
Sbjct: 235 GGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKNVVY--RDLKLENLMLDKDG 289
Query: 423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           H K+ DFGL K      A++ T   GT  Y+ PE  +  D    VD +  GVV+YE++  
Sbjct: 290 HIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 348
Query: 483 K 483
           +
Sbjct: 349 R 349

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 48/244 (19%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           E+     +N      +G G FG V  A     +G      ++ V + M K+     + +A
Sbjct: 39  EKWEFPRNNLQFGKTLGAGAFGKVVEAT---AFGLGKEDAVLKVAVKMLKSTAHADEKEA 95
Query: 325 SREFLAELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG--------- 373
               ++ELK+++H+  H N+V L+G C  G  + ++ EY   G+L   LR          
Sbjct: 96  ---LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 374 ---------SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
                    S RD L +SS+V      A+G+ ++        IHRD+ + N+L+     A
Sbjct: 153 AFAIANSTLSTRDLLHFSSQV------AQGMAFLASKNC---IHRDVAARNVLLTNGHVA 203
Query: 425 KVADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLY 477
           K+ DFGL +           G+A LP +      +M PE       + + DV+++G++L+
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLW 257
Query: 478 ELIS 481
           E+ S
Sbjct: 258 EIFS 261

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 129/307 (42%), Gaps = 45/307 (14%)
Query: 270 ATDNFSMSHKIGQGGFGAVY---YAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           A ++  ++  +G+G FG VY   Y   +GE  N           +  K   K   +    
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKIN-----------VAVKTCKKDCTLDNKE 54
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +F++E  ++ ++ H ++V+LIG   E   +++ E    G L  +L    ++ L   + V 
Sbjct: 55  KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVL 113
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE---VGSASLP 443
            +L   + + Y+        +HRDI   NIL+      K+ DFGL++  E      AS+ 
Sbjct: 114 YSLQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV- 169
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           TRL     +M PE   +   +   DV+ F V ++E++S      K      ++K ++ + 
Sbjct: 170 TRL--PIKWMSPESINFRRFTTASDVWMFAVCMWEILS----FGKQPFFWLENKDVIGVL 223
Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
           E+   LP P             D CP   VL    L   C    P  RP    +V +L  
Sbjct: 224 EKGDRLPKP-------------DLCP--PVL--YTLMTRCWDYDPSDRPRFTELVCSLSD 266
Query: 564 LSSTTED 570
           +    +D
Sbjct: 267 VYQMEKD 273

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/307 (24%), Positives = 129/307 (42%), Gaps = 45/307 (14%)
Query: 270 ATDNFSMSHKIGQGGFGAVY---YAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           A ++  ++  +G+G FG VY   Y   +GE  N           +  K   K   +    
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKIN-----------VAVKTCKKDCTLDNKE 58
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +F++E  ++ ++ H ++V+LIG   E   +++ E    G L  +L    ++ L   + V 
Sbjct: 59  KFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVL 117
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE---VGSASLP 443
            +L   + + Y+        +HRDI   NIL+      K+ DFGL++  E      AS+ 
Sbjct: 118 YSLQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV- 173
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           TRL     +M PE   +   +   DV+ F V ++E++S      K      ++K ++ + 
Sbjct: 174 TRL--PIKWMSPESINFRRFTTASDVWMFAVCMWEILS----FGKQPFFWLENKDVIGVL 227
Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
           E+   LP P             D CP   VL    L   C    P  RP    +V +L  
Sbjct: 228 EKGDRLPKP-------------DLCP--PVL--YTLMTRCWDYDPSDRPRFTELVCSLSD 270
Query: 564 LSSTTED 570
           +    +D
Sbjct: 271 VYQMEKD 277

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 40/287 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICV--NLLMQKAAIKKMDMQASREFLA 330
           +  +  K+G G FG V   E     G +    + C+  ++L Q  A+         +F+ 
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD--------DFIR 60
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRG-SGRDPLPWSSRVQIAL 389
           E+  +  + H NL+RL G  +   + +V E    G+L + LR   G   L   SR   A+
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AV 118
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--LPTRLV 447
             A G+ Y+       +IHRD+ + N+L+      K+ DFGL +          +     
Sbjct: 119 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV 506
             F +  PE  +    S   D + FGV L+E+ +  +E  +  NGS      L  + +E 
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEG 231
Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
             LP P             ++CP D    M Q    C    P+ RP+
Sbjct: 232 ERLPRP-------------EDCPQDIYNVMVQ----CWAHKPEDRPT 261

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 127/289 (43%), Gaps = 51/289 (17%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G FG VY      +  N  +   + + +L +  + K     A++E L E  V+  V 
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIP--VAIKVLRENTSPK-----ANKEILDEAYVMAGVG 77
Query: 340 HLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLR-GSGR----DPLPWSSRVQIALDSARG 394
              + RL+G C+  ++ LV + +  G L +H+R   GR    D L W  ++      A+G
Sbjct: 78  SPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKG 131
Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMP 454
           + Y+ +  +   +HRD+ + N+L+    H K+ DFGL +L ++      T      G +P
Sbjct: 132 MSYLEDVRL---VHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHADGGKVP 184
Query: 455 PEYAQYGDV-----SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
            ++     +     + + DV+++GV ++EL++       G  +                +
Sbjct: 185 IKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--------------EI 230
Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           PD +E   +L  P +   C +D  + M +    C     + RP  R +V
Sbjct: 231 PDLLEKGERLPQPPI---CTIDVYMIMVK----CWMIDSECRPRFRELV 272

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F    ++G G  G V+    +   G     +LI + +   K AI+        + + E
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPS-GLVMARKLIHLEI---KPAIRN-------QIIRE 57
Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +V IA+ 
Sbjct: 58  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV- 116
Query: 391 SARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLVG 448
             +GL Y+ E H +   +HRD+K +NIL++     K+ DFG++ +L +     +    VG
Sbjct: 117 -IKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----EMANEFVG 168
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           T  YM PE  Q    S + D+++ G+ L E+
Sbjct: 169 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 199

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 40/287 (13%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICV--NLLMQKAAIKKMDMQASREFLA 330
           +  +  K+G G FG V   E     G +    + C+  ++L Q  A+         +F+ 
Sbjct: 13  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD--------DFIR 64
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRG-SGRDPLPWSSRVQIAL 389
           E+  +  + H NL+RL G  +   + +V E    G+L + LR   G   L   SR   A+
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AV 122
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--LPTRLV 447
             A G+ Y+       +IHRD+ + N+L+      K+ DFGL +          +     
Sbjct: 123 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 179
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV 506
             F +  PE  +    S   D + FGV L+E+ +  +E  +  NGS      L  + +E 
Sbjct: 180 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEG 235
Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
             LP P             ++CP D    M Q    C    P+ RP+
Sbjct: 236 ERLPRP-------------EDCPQDIYNVMVQ----CWAHKPEDRPT 265

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 104/235 (44%), Gaps = 43/235 (18%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           +F     +G+GGFG V+ A+ + +  N  + R+   N  + +  +           + E+
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV-----------MREV 54
Query: 333 KVLTHVHHLNLVRLIGYCVEGS-------------LFLVYEYIENGNLSEHLRGSGRDPL 379
           K L  + H  +VR     +E +             L++  +     NL + +  +GR  +
Sbjct: 55  KALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTI 112
Query: 380 PWSSR---VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL----- 431
               R   + I L  A  +E++H   +   +HRD+K +NI    +   KV DFGL     
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 432 ------TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                 T LT + + +  T  VGT  YM PE       S KVD+++ G++L+EL+
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 261 EFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM 320
           EF     +K +DN+ +  ++G+G F  V    +    G  + +++I           KK+
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKII---------NTKKL 67
Query: 321 DMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRG----SG 375
             +  ++   E ++   + H N+VRL     E S  +LV++ +  G L E +      S 
Sbjct: 68  SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE 127
Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLT 432
            D    S  +Q  L+S   + Y H + +   +HR++K  N+L+    K    K+ADFGL 
Sbjct: 128 ADA---SHCIQQILES---IAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLA 178
Query: 433 KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
              EV  +       GT GY+ PE  +    S  VD++A GV+LY L+
Sbjct: 179 --IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 115/260 (44%), Gaps = 51/260 (19%)
Query: 252 NAITVDKSVEFSY-EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL 310
           N+ T     +  Y E+     +N      +G G FG V  A     +G      ++ V +
Sbjct: 25  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT---AFGLGKEDAVLKVAV 81
Query: 311 LMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLS 368
            M K+     + +A    ++ELK+++H+  H N+V L+G C  G  + ++ EY   G+L 
Sbjct: 82  KMLKSTAHADEKEA---LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 369 EHLRG--------------------SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIH 408
             LR                     S RD L +SS+V      A+G+ ++        IH
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQV------AQGMAFLASKNC---IH 189
Query: 409 RDIKSANILIDKNFHAKVADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQYG 461
           RD+ + N+L+     AK+ DFGL +           G+A LP +      +M PE     
Sbjct: 190 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFDC 243
Query: 462 DVSPKVDVYAFGVVLYELIS 481
             + + DV+++G++L+E+ S
Sbjct: 244 VYTVQSDVWSYGILLWEIFS 263

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
            K  ++F     +G+G F  V  A           SR   + +L ++  IK+  +     
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR 59
Query: 328 FLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
              E  V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +    
Sbjct: 60  ---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 116
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTR 445
             + SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +    
Sbjct: 117 AEIVSA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 171
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            VGT  Y+ PE           D++A G ++Y+L++       GN
Sbjct: 172 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 216

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
            K  ++F     +G+G F  V  A           SR   + +L ++  IK+  +     
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR 58
Query: 328 FLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
              E  V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +    
Sbjct: 59  ---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 115
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTR 445
             + SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +    
Sbjct: 116 AEIVSA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 170
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            VGT  Y+ PE           D++A G ++Y+L++       GN
Sbjct: 171 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 215

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 18/222 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 37  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 87
Query: 332 LKVLTHVHHLNLVRLIGYCVEG--SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
             V++ + H   V+L  +C +    L+    Y +NG L +++R  G      +      +
Sbjct: 88  RDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 146
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVG 448
            SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VG
Sbjct: 147 VSA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
           T  Y+ PE           D++A G ++Y+L++       GN
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 243

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 111/248 (44%), Gaps = 30/248 (12%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           + +    K+G+G +G VY A+           R++ +  +   A  + +   A RE    
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAK-------DSQGRIVALKRIRLDAEDEGIPSTAIRE---- 69
Query: 332 LKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENG---NLSEHLRGSGRDPLPWSSRVQI 387
           + +L  +HH N+V LI     E  L LV+E++E      L E+  G         S+++I
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ------DSQIKI 123
Query: 388 AL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            L    RG+ + H+H +   +HRD+K  N+LI+ +   K+ADFGL +   +   S    +
Sbjct: 124 YLYQLLRGVAHCHQHRI---LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV 506
           V  +   P         S  VD+++ G +  E+I+ K           D   L  +F  +
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF----PGVTDDDQLPKIF-SI 235
Query: 507 LNLPDPIE 514
           L  P+P E
Sbjct: 236 LGTPNPRE 243

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 111/248 (44%), Gaps = 30/248 (12%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           + +    K+G+G +G VY A+           R++ +  +   A  + +   A RE    
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAK-------DSQGRIVALKRIRLDAEDEGIPSTAIRE---- 69
Query: 332 LKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENG---NLSEHLRGSGRDPLPWSSRVQI 387
           + +L  +HH N+V LI     E  L LV+E++E      L E+  G         S+++I
Sbjct: 70  ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ------DSQIKI 123
Query: 388 AL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            L    RG+ + H+H +   +HRD+K  N+LI+ +   K+ADFGL +   +   S    +
Sbjct: 124 YLYQLLRGVAHCHQHRI---LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEV 180
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV 506
           V  +   P         S  VD+++ G +  E+I+ K           D   L  +F  +
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF----PGVTDDDQLPKIF-SI 235
Query: 507 LNLPDPIE 514
           L  P+P E
Sbjct: 236 LGTPNPRE 243

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 108/238 (45%), Gaps = 16/238 (6%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK 333
           F +   +G+GG+G V+  ++R   G +   ++  + +L +   ++     A  +  AE  
Sbjct: 19  FELLRVLGKGGYGKVF--QVRKVTGAN-TGKIFAMKVLKKAMIVRNAKDTAHTK--AERN 73
Query: 334 VLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
           +L  V H  +V LI  +   G L+L+ EY+  G L   L   G       +      + +
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEIS 131
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
             L ++H+  +   I+RD+K  NI+++   H K+ DFGL K   +   ++     GT  Y
Sbjct: 132 MALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGTIEY 187
Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP 510
           M PE       +  VD ++ G ++Y++++        N      K +  + +  LNLP
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----RKKTIDKILKCKLNLP 241

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 110/242 (45%), Gaps = 24/242 (9%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK 333
           F +   +G+GG+G V+  ++R   G +   ++  + +L +   ++     A  +  AE  
Sbjct: 19  FELLRVLGKGGYGKVF--QVRKVTGAN-TGKIFAMKVLKKAMIVRNAKDTAHTK--AERN 73
Query: 334 VLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSG----RDPLPWSSRVQIA 388
           +L  V H  +V LI  +   G L+L+ EY+  G L   L   G         + + + +A
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L       ++H+  +   I+RD+K  NI+++   H K+ DFGL K   +   ++     G
Sbjct: 134 LG------HLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCG 183
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
           T  YM PE       +  VD ++ G ++Y++++        N      K +  + +  LN
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN----RKKTIDKILKCKLN 239
Query: 509 LP 510
           LP
Sbjct: 240 LP 241

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
            K  ++F     +G+G F  V  A           SR   + +L ++  IK+  +     
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR 57
Query: 328 FLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
              E  V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +    
Sbjct: 58  ---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 114
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTR 445
             + SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +    
Sbjct: 115 AEIVSA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 169
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            VGT  Y+ PE           D++A G ++Y+L++       GN
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 115/268 (42%), Gaps = 41/268 (15%)
Query: 237 TVESTGPAAGTPTSLNAITVDKSVEF----SYEELSKATDNFSMSHKIGQGGFGAVYYAE 292
           + E  GP    P    A    K++      S++      D + +   IG G +G V  A 
Sbjct: 16  SAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSAR 75
Query: 293 LRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKVLTHVHHLNLVRL- 346
            R               L  Q+ AIKK+      +  ++  L ELK+L H  H N++ + 
Sbjct: 76  RR---------------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 120
Query: 347 ------IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE 400
                 + Y    S+++V + +E+ +L + +  S   PL             RGL+Y+H 
Sbjct: 121 DILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 401 HTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEY 457
             V   IHRD+K +N+L+++N   K+ DFG+ +      A      T  V T  Y  PE 
Sbjct: 178 AQV---IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 458 A-QYGDVSPKVDVYAFGVVLYELISAKE 484
                + +  +D+++ G +  E+++ ++
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
            K  ++F     +G+G F  V  A           SR   + +L ++  IK+  +     
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR 56
Query: 328 FLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
              E  V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +    
Sbjct: 57  ---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYT 113
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTR 445
             + SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +    
Sbjct: 114 AEIVSA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 168
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            VGT  Y+ PE           D++A G ++Y+L++       GN
Sbjct: 169 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 213

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 32  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 82
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIV 142
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 143 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE       S   D++A G ++Y+L++       GN
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 25/217 (11%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D F    K+G G FG V+  E R    +S L R+I       K   K        +  AE
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEER----SSGLERVI-------KTINKDRSQVPMEQIEAE 70
Query: 332 LKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHL---RGSGRDPLPWSSRVQI 387
           ++VL  + H N++++     +  ++++V E  E G L E +   +  G+  L      ++
Sbjct: 71  IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAEL 129
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILI-DKNFHA--KVADFGLTKLTEVGSASLPT 444
                  L Y H   V   +H+D+K  NIL  D + H+  K+ DFGL +L +    S  T
Sbjct: 130 MKQMMNALAYFHSQHV---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS--T 184
Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              GT  YM PE  +  DV+ K D+++ GVV+Y L++
Sbjct: 185 NAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLT 220

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 46/261 (17%)
Query: 252 NAITVDKSVEFSY-EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL 310
           N+ T     +  Y E+     +N      +G G FG V  A     +G      ++ V +
Sbjct: 10  NSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT---AFGLGKEDAVLKVAV 66
Query: 311 LMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLS 368
            M K+     + +A    ++ELK+++H+  H N+V L+G C  G  + ++ EY   G+L 
Sbjct: 67  KMLKSTAHADEKEA---LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 123
Query: 369 EHLR-----------GSGRDP----------LPWSSRVQIALDSARGLEYIHEHTVPVYI 407
             LR             G+DP          L     +  +   A+G+ ++        I
Sbjct: 124 NFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC---I 180
Query: 408 HRDIKSANILIDKNFHAKVADFGLTK-------LTEVGSASLPTRLVGTFGYMPPEYAQY 460
           HRD+ + N+L+     AK+ DFGL +           G+A LP +      +M PE    
Sbjct: 181 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK------WMAPESIFD 234
Query: 461 GDVSPKVDVYAFGVVLYELIS 481
              + + DV+++G++L+E+ S
Sbjct: 235 CVYTVQSDVWSYGILLWEIFS 255

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/258 (25%), Positives = 112/258 (43%), Gaps = 31/258 (12%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E+    D+F +   IG+G F  V   +++ + G  Y  +++    ++++  +     + 
Sbjct: 54  KEVRLQRDDFEILKVIGRGAFSEVAVVKMK-QTGQVYAMKIMNKWDMLKRGEVSCFREER 112
Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSG-RDPLPWS- 382
                 + + +T +H         +  E  L+LV EY   G+L   L   G R P   + 
Sbjct: 113 DVLVNGDRRWITQLH-------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR 165
Query: 383 ---SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
              + + +A+DS   L Y+H         RDIK  NIL+D+  H ++ADFG         
Sbjct: 166 FYLAEIVMAIDSVHRLGYVH---------RDIKPDNILLDRCGHIRLADFGSCLKLRADG 216
Query: 440 ASLPTRLVGTFGYMPPEYAQ-------YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS 492
                  VGT  Y+ PE  Q        G   P+ D +A GV  YE+   +        S
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA--DS 274
Query: 493 SADSKGLVALFEEVLNLP 510
           +A++ G +  ++E L+LP
Sbjct: 275 TAETYGKIVHYKEHLSLP 292

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 123/291 (42%), Gaps = 51/291 (17%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL---- 329
           F+   +IG+G FG VY                   N   +  AIK +D++ + + +    
Sbjct: 21  FTKLDRIGKGSFGEVYKG---------------IDNHTKEVVAIKIIDLEEAEDEIEDIQ 65
Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ VL+      + R  G Y     L+++ EY+  G+  + L+     PL  +    I 
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPG---PLEETYIATIL 122
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
            +  +GL+Y+H       IHRDIK+AN+L+ +    K+ADFG+  +LT+          V
Sbjct: 123 REILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NXFV 177
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           GT  +M PE  +      K D+++ G+   EL        KG   ++D   +  LF    
Sbjct: 178 GTPFWMAPEVIKQSAYDFKADIWSLGITAIEL-------AKGEPPNSDLHPMRVLFLIPK 230
Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           N P  +E          G +          +  + C  + P+ RP+ + ++
Sbjct: 231 NSPPTLE----------GQHSK-----PFKEFVEACLNKDPRFRPTAKELL 266

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 115/268 (42%), Gaps = 41/268 (15%)
Query: 237 TVESTGPAAGTPTSLNAITVDKSVEF----SYEELSKATDNFSMSHKIGQGGFGAVYYAE 292
           + E  GP    P    A    K++      S++      D + +   IG G +G V  A 
Sbjct: 15  SAEPPGPVKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSAR 74
Query: 293 LRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKVLTHVHHLNLVRL- 346
            R               L  Q+ AIKK+      +  ++  L ELK+L H  H N++ + 
Sbjct: 75  RR---------------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 119
Query: 347 ------IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE 400
                 + Y    S+++V + +E+ +L + +  S   PL             RGL+Y+H 
Sbjct: 120 DILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 401 HTVPVYIHRDIKSANILIDKNFHAKVADFGLTK---LTEVGSASLPTRLVGTFGYMPPEY 457
             V   IHRD+K +N+L+++N   K+ DFG+ +    +        T  V T  Y  PE 
Sbjct: 177 AQV---IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 458 A-QYGDVSPKVDVYAFGVVLYELISAKE 484
                + +  +D+++ G +  E+++ ++
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V   + +         R   + +L ++  + K ++  +   L E +VL +  
Sbjct: 18  LGKGTFGKVILVKEKA------TGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSR 68
Query: 340 HLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-ALDSARGLEY 397
           H  L  L   +     L  V EY   G L  HL    R+ +    R +    +    L+Y
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDY 125
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H     VY  RD+K  N+++DK+ H K+ DFGL K      A++     GT  Y+ PE 
Sbjct: 126 LHSEKNVVY--RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYLAPEV 182
Query: 458 AQYGDVSPKVDVYAFGVVLYELISAK 483
            +  D    VD +  GVV+YE++  +
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V   + +         R   + +L ++  + K ++  +   L E +VL +  
Sbjct: 17  LGKGTFGKVILVKEKA------TGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQNSR 67
Query: 340 HLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-ALDSARGLEY 397
           H  L  L   +     L  V EY   G L  HL    R+ +    R +    +    L+Y
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDY 124
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H     VY  RD+K  N+++DK+ H K+ DFGL K      A++     GT  Y+ PE 
Sbjct: 125 LHSEKNVVY--RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYLAPEV 181
Query: 458 AQYGDVSPKVDVYAFGVVLYELISAK 483
            +  D    VD +  GVV+YE++  +
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 268 SKATDN-FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           S+ T N F     +G+G FG V   + +         R   + +L ++  + K ++  + 
Sbjct: 3   SRVTMNEFEYLKLLGKGTFGKVILVKEKA------TGRYYAMKILKKEVIVAKDEVAHT- 55
Query: 327 EFLAELKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             L E +VL +  H  L  L   +     L  V EY   G L  HL    R+ +    R 
Sbjct: 56  --LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL---SRERVFSEDRA 110
Query: 386 QI-ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
           +    +    L+Y+H     VY  RD+K  N+++DK+ H K+ DFGL K      A++  
Sbjct: 111 RFYGAEIVSALDYLHSEKNVVY--RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX 168
Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
              GT  Y+ PE  +  D    VD +  GVV+YE++  +
Sbjct: 169 -FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF-LAE 331
           N+ +   +G+G FG V  A      G     ++I       K  + K DMQ   E  ++ 
Sbjct: 15  NYQIVKTLGEGSFGKVKLA-YHTTTGQKVALKII------NKKVLAKSDMQGRIEREISY 67
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
           L++L H H + L  +I    +  + +V EY  N  L +++    RD +      +     
Sbjct: 68  LRLLRHPHIIKLYDVIK--SKDEIIMVIEYAGN-ELFDYI--VQRDKMSEQEARRFFQQI 122
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
              +EY H H +   +HRD+K  N+L+D++ + K+ADFGL+ +   G+  L T   G+  
Sbjct: 123 ISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-LKTS-CGSPN 177
Query: 452 YMPPEYAQYGDV--SPKVDVYAFGVVLYELISAK 483
           Y  PE    G +   P+VDV++ GV+LY ++  +
Sbjct: 178 YAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRR 210

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF-LAE 331
           N+ +   +G+G FG V  A      G     ++I       K  + K DMQ   E  ++ 
Sbjct: 9   NYQIVKTLGEGSFGKVKLA-YHTTTGQKVALKII------NKKVLAKSDMQGRIEREISY 61
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
           L++L H H + L  +I    +  + +V EY  N  L +++    RD +      +     
Sbjct: 62  LRLLRHPHIIKLYDVIK--SKDEIIMVIEYAGN-ELFDYI--VQRDKMSEQEARRFFQQI 116
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
              +EY H H +   +HRD+K  N+L+D++ + K+ADFGL+ +   G+  L T   G+  
Sbjct: 117 ISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-LKTS-CGSPN 171
Query: 452 YMPPEYAQYGDV--SPKVDVYAFGVVLYELISAK 483
           Y  PE    G +   P+VDV++ GV+LY ++  +
Sbjct: 172 YAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRR 204

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF-LAE 331
           N+ +   +G+G FG V  A      G     ++I       K  + K DMQ   E  ++ 
Sbjct: 5   NYQIVKTLGEGSFGKVKLA-YHTTTGQKVALKII------NKKVLAKSDMQGRIEREISY 57
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
           L++L H H + L  +I    +  + +V EY  N  L +++    RD +      +     
Sbjct: 58  LRLLRHPHIIKLYDVIK--SKDEIIMVIEYAGN-ELFDYI--VQRDKMSEQEARRFFQQI 112
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
              +EY H H +   +HRD+K  N+L+D++ + K+ADFGL+ +   G+  L T   G+  
Sbjct: 113 ISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-LKTS-CGSPN 167
Query: 452 YMPPEYAQYGDV--SPKVDVYAFGVVLYELISAK 483
           Y  PE    G +   P+VDV++ GV+LY ++  +
Sbjct: 168 YAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRR 200

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF-LAE 331
           N+ +   +G+G FG V  A      G     ++I       K  + K DMQ   E  ++ 
Sbjct: 14  NYQIVKTLGEGSFGKVKLA-YHTTTGQKVALKII------NKKVLAKSDMQGRIEREISY 66
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
           L++L H H + L  +I    +  + +V EY  N  L +++    RD +      +     
Sbjct: 67  LRLLRHPHIIKLYDVIK--SKDEIIMVIEYAGN-ELFDYI--VQRDKMSEQEARRFFQQI 121
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
              +EY H H +   +HRD+K  N+L+D++ + K+ADFGL+ +   G+  L T   G+  
Sbjct: 122 ISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF-LKTS-CGSPN 176
Query: 452 YMPPEYAQYGDV--SPKVDVYAFGVVLYELISAK 483
           Y  PE    G +   P+VDV++ GV+LY ++  +
Sbjct: 177 YAAPEVIS-GKLYAGPEVDVWSCGVILYVMLCRR 209

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           L    +++ +   IG+G FG V     +         ++  + LL +   IK+ D   S 
Sbjct: 70  LQMKAEDYDVVKVIGRGAFGEVQLVRHKAS------QKVYAMKLLSKFEMIKRSD---SA 120
Query: 327 EFLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPW---- 381
            F  E  ++   +   +V+L   +  +  L++V EY+  G+L  +L  +   P  W    
Sbjct: 121 FFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-NLMSNYDVPEKWAKFY 179
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LTKLTEVGSA 440
           ++ V +ALD+      IH   +   IHRD+K  N+L+DK+ H K+ADFG   K+ E G  
Sbjct: 180 TAEVVLALDA------IHSMGL---IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 230
Query: 441 SLPTRLVGTFGYMPPEY--AQYGD--VSPKVDVYAFGVVLYELI 480
              T  VGT  Y+ PE   +Q GD     + D ++ GV L+E++
Sbjct: 231 HCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 32  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 82
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 143 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 30  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 80
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 141 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 32  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 82
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 143 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 104/236 (44%), Gaps = 59/236 (25%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--EFLAELKVLTH 337
           +GQG FG V  A       N+  SR           AIKK+     +    L+E+ +L  
Sbjct: 14  LGQGAFGQVVKAR------NALDSRYY---------AIKKIRHTEEKLSTILSEVMLLAS 58
Query: 338 VHHLNLVRLIGYCVE--------------GSLFLVYEYIENGNL-----SEHLRGSGRDP 378
           ++H  +VR     +E               +LF+  EY EN  L     SE+L    RD 
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENL-NQQRDE 117
Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK----- 433
             W    QI       L YIH   +   IHRD+K  NI ID++ + K+ DFGL K     
Sbjct: 118 Y-WRLFRQIL----EALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 434 --LTEVGSASLP------TRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELI 480
             + ++ S +LP      T  +GT  Y+  E     G  + K+D+Y+ G++ +E+I
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           +L    +++ +   IG+G FG V     +         ++  + LL +   IK+ D   S
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS------TRKVYAMKLLSKFEMIKRSD---S 113
Query: 326 REFLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPW--- 381
             F  E  ++   +   +V+L   +  +  L++V EY+  G+L  +L  +   P  W   
Sbjct: 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARF 172
Query: 382 -SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LTKLTEVGS 439
            ++ V +ALD+      IH      +IHRD+K  N+L+DK+ H K+ADFG   K+ + G 
Sbjct: 173 YTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 440 ASLPTRLVGTFGYMPPEY--AQYGD--VSPKVDVYAFGVVLYELI 480
               T  VGT  Y+ PE   +Q GD     + D ++ GV LYE++
Sbjct: 224 VRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 24/201 (11%)
Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLT-HVHHLNLVRLIGYCV 351
           G YG  Y  R +    L   AAIK MD+      E   E+ +L  + HH N+    G  +
Sbjct: 35  GTYGQVYKGRHVKTGQL---AAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 352 -------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVP 404
                  +  L+LV E+   G++++ ++ +  + L       I  +  RGL ++H+H V 
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV- 150
Query: 405 VYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS 464
             IHRDIK  N+L+ +N   K+ DFG++   +       T  +GT  +M PE     D +
Sbjct: 151 --IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIAC-DEN 206
Query: 465 P------KVDVYAFGVVLYEL 479
           P      K D+++ G+   E+
Sbjct: 207 PDATYDFKSDLWSLGITAIEM 227

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 33  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 83
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 84  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 143
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 144 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 239

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 32  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 82
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 143 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 35  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 85
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 86  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 145
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 146 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 241

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 33  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 83
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 84  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 143
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 144 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 239

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 30/211 (14%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL-AELKVL 335
           KIG+G  G V  A  R ++               ++ A+K MD+  Q  RE L  E+ ++
Sbjct: 52  KIGEGSTGIVCLA--REKHSG-------------RQVAVKMMDLRKQQRRELLFNEVVIM 96
Query: 336 THVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
               H N+V +   Y V   L+++ E+++ G L++ +     +    ++  +  L   + 
Sbjct: 97  RDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QA 153
Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR--LVGTFGY 452
           L Y+H   V   IHRDIKS +IL+  +   K++DFG        S  +P R  LVGT  +
Sbjct: 154 LAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKXLVGTPYW 207
Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           M PE       + +VD+++ G+++ E++  +
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 32  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 82
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 143 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 30  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 80
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 141 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 32  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 82
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 83  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 142
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 143 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 238

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           +K +DN+ +  ++G+G F  V    +    G  + +++I           KK+  +  ++
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKII---------NTKKLSARDFQK 50
Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRG----SGRDPLPWS 382
              E ++   + H N+VRL     E S  +LV++ +  G L E +      S  D    S
Sbjct: 51  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA---S 107
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGS 439
             +Q  L+S   + Y H + +   +HR++K  N+L+    K    K+ADFGL    EV  
Sbjct: 108 HCIQQILES---IAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVND 159
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           +       GT GY+ PE  +    S  VD++A GV+LY L+
Sbjct: 160 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 200

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           +L    +++ +   IG+G FG V     +         ++  + LL +   IK+ D   S
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS------TRKVYAMKLLSKFEMIKRSD---S 118
Query: 326 REFLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPW--- 381
             F  E  ++   +   +V+L   +  +  L++V EY+  G+L  +L  +   P  W   
Sbjct: 119 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARF 177
Query: 382 -SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LTKLTEVGS 439
            ++ V +ALD+      IH      +IHRD+K  N+L+DK+ H K+ADFG   K+ + G 
Sbjct: 178 YTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 440 ASLPTRLVGTFGYMPPEY--AQYGD--VSPKVDVYAFGVVLYELI 480
               T  VGT  Y+ PE   +Q GD     + D ++ GV LYE++
Sbjct: 229 VRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 83/281 (29%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 82
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR---- 384
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+ ++    
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARF 142
Query: 385 -------VQIALDSARGLEY--------------------IHEHTVPVYIHRD------- 410
                    I +D  R L+                     + E   P  +++D       
Sbjct: 143 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 202
Query: 411 -----------------------IKSANILIDKNFHAKVADFGLTK-------LTEVGSA 440
                                  + + NIL+ +    K+ DFGL +           G A
Sbjct: 203 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 263 RLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           +K +DN+ +  ++G+G F  V    +    G  + +++I           KK+  +  ++
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKII---------NTKKLSARDFQK 51
Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRG----SGRDPLPWS 382
              E ++   + H N+VRL     E S  +LV++ +  G L E +      S  D    S
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA---S 108
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGS 439
             +Q  L+S   + Y H + +   +HR++K  N+L+    K    K+ADFGL    EV  
Sbjct: 109 HCIQQILES---IAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVND 160
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           +       GT GY+ PE  +    S  VD++A GV+LY L+
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 83/281 (29%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 80
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR---- 384
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+ ++    
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARF 140
Query: 385 -------VQIALDSARGLEY--------------------IHEHTVPVYIHRD------- 410
                    I +D  R L+                     + E   P  +++D       
Sbjct: 141 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 200
Query: 411 -----------------------IKSANILIDKNFHAKVADFGLTK-------LTEVGSA 440
                                  + + NIL+ +    K+ DFGL +           G A
Sbjct: 201 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 261 RLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           +L    +++ +   IG+G FG V     +         ++  + LL +   IK+ D   S
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKS------TRKVYAMKLLSKFEMIKRSD---S 118
Query: 326 REFLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPW--- 381
             F  E  ++   +   +V+L   +  +  L++V EY+  G+L  +L  +   P  W   
Sbjct: 119 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARF 177
Query: 382 -SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LTKLTEVGS 439
            ++ V +ALD+      IH      +IHRD+K  N+L+DK+ H K+ADFG   K+ + G 
Sbjct: 178 YTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 440 ASLPTRLVGTFGYMPPEY--AQYGD--VSPKVDVYAFGVVLYELI 480
               T  VGT  Y+ PE   +Q GD     + D ++ GV LYE++
Sbjct: 229 VRCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 27/211 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           K+G+G +  VY        G S L+     NL+  K    + +  A    + E+ +L  +
Sbjct: 9   KLGEGTYATVYK-------GKSKLTD----NLVALKEIRLEHEEGAPCTAIREVSLLKDL 57
Query: 339 HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H N+V L      E SL LV+EY++  +L ++L   G + +   +         RGL Y
Sbjct: 58  KHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAY 115
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL----VGTFGYM 453
            H   V   +HRD+K  N+LI++    K+ADFGL +     + S+PT+     V T  Y 
Sbjct: 116 CHRQKV---LHRDLKPQNLLINERGELKLADFGLAR-----AKSIPTKTYDNEVVTLWYR 167
Query: 454 PPE-YAQYGDVSPKVDVYAFGVVLYELISAK 483
           PP+      D S ++D++  G + YE+ + +
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           +K +DN+ +  ++G+G F  V    +    G  + +++I           KK+  +  ++
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRC-VHKTTGLEFAAKII---------NTKKLSARDFQK 51
Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRG----SGRDPLPWS 382
              E ++   + H N+VRL     E S  +LV++ +  G L E +      S  D    S
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA---S 108
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGS 439
             +Q  L+S   + Y H + +   +HR++K  N+L+    K    K+ADFGL    EV  
Sbjct: 109 HCIQQILES---IAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLA--IEVND 160
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           +       GT GY+ PE  +    S  VD++A GV+LY L+
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 30  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 80
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 141 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/287 (24%), Positives = 109/287 (37%), Gaps = 90/287 (31%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           A +   +   +G+G FG V  A   G    S   R + V +L + A   +      +  +
Sbjct: 25  ARERLKLGKSLGRGAFGKVVQASAFG-IKKSPTCRTVAVKMLKEGATASEY-----KALM 78
Query: 330 AELKVLTHV-HHLNLVRLIG--------------YCVEGSL------------------- 355
            ELK+LTH+ HHLN+V L+G              YC  G+L                   
Sbjct: 79  TELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAAL 138
Query: 356 -----------------------------FLVYEYIENGNLS-----EHLRGSGRDPLPW 381
                                        F    + E+ +LS     E   G  ++P+  
Sbjct: 139 HMEPKKEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITM 198
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-------L 434
              +  +   ARG+E++        IHRD+ + NIL+ +N   K+ DFGL +        
Sbjct: 199 EDLISYSFQVARGMEFLSSRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKNPDY 255
Query: 435 TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              G   LP +      +M PE       S K DV+++GV+L+E+ S
Sbjct: 256 VRKGDTRLPLK------WMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 83/281 (29%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 75
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR---- 384
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+ ++    
Sbjct: 76  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARF 135
Query: 385 -------VQIALDSARGLEY--------------------IHEHTVPVYIHRD------- 410
                    I +D  R L+                     + E   P  +++D       
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 411 -----------------------IKSANILIDKNFHAKVADFGLTK-------LTEVGSA 440
                                  + + NIL+ +    K+ DFGL +           G A
Sbjct: 196 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 256 RLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 274 FSMSHKIGQGGFGAVYYA---ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           + +   +G+G FG V  A   + + +    ++SR      L++K+    M M+  RE ++
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQ-----LLKKS---DMHMRVERE-IS 61
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
            LK+L H H + L  +I       + +V EY   G L +++    R       R    + 
Sbjct: 62  YLKLLRHPHIIKLYDVI--TTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQII 118
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
            A  +EY H H +   +HRD+K  N+L+D N + K+ADFGL+ +   G+  L T   G+ 
Sbjct: 119 CA--IEYCHRHKI---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKTS-CGSP 171
Query: 451 GYMPPEYAQYGDV--SPKVDVYAFGVVLYELISAK 483
            Y  PE    G +   P+VDV++ G+VLY ++  +
Sbjct: 172 NYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 112/281 (39%), Gaps = 83/281 (29%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +   R + V +L + A          R  ++E
Sbjct: 20  DRLKLGKPLGRGAFGQVIEADAFG-IDKTATCRTVAVKMLKEGAT-----HSEHRALMSE 73
Query: 332 LKVLTHV-HHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR---- 384
           LK+L H+ HHLN+V L+G C +  G L ++ E+ + GNLS +LR    + +P+ ++    
Sbjct: 74  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARF 133
Query: 385 -------VQIALDSARGLEY--------------------IHEHTVPVYIHRD------- 410
                    I +D  R L+                     + E   P  +++D       
Sbjct: 134 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 193
Query: 411 -----------------------IKSANILIDKNFHAKVADFGLTK-------LTEVGSA 440
                                  + + NIL+ +    K+ DFGL +           G A
Sbjct: 194 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            LP +      +M PE       + + DV++FGV+L+E+ S
Sbjct: 254 RLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 49
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 50  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 110 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 49
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 50  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 110 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 49
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 50  ENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 110 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 165 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 49
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 50  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 110 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 49
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 50  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 110 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---F 328
           D + +  ++G G FG VY A+      N   S L         AA K +D ++  E   +
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQ------NKETSVL---------AAAKVIDTKSEEELEDY 81
Query: 329 LAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           + E+ +L    H N+V+L+  +  E +L+++ E+   G +   +    R PL  S    +
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVV 140
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
              +   L Y+H++ +   IHRD+K+ NIL   +   K+ADFG++      +       +
Sbjct: 141 CKQTLDALNYLHDNKI---IHRDLKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFI 196
Query: 448 GTFGYMPPE--YAQYGDVSP---KVDVYAFGVVLYEL 479
           GT  +M PE    +     P   K DV++ G+ L E+
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 47
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 48  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 107
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 108 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 14  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 64
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 65  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 124
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 125 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 220

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 49
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 50  ENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 110 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 256 VDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           VD   E  Y +     + F+   KIG+G FG V+                   N   +  
Sbjct: 11  VDLGTENLYFQSMDPEELFTKLEKIGKGSFGEVFKG---------------IDNRTQKVV 55
Query: 316 AIKKMDMQASREFLA----ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEH 370
           AIK +D++ + + +     E+ VL+      + +  G Y  +  L+++ EY+  G+  + 
Sbjct: 56  AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL 115
Query: 371 LRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
           L      PL  +    I  +  +GL+Y+H       IHRDIK+AN+L+ ++   K+ADFG
Sbjct: 116 LEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFG 169
Query: 431 LT-KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           +  +LT+          VGT  +M PE  +      K D+++ G+   EL
Sbjct: 170 VAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 217

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 15/170 (8%)
Query: 323 QASREFL-AELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHL-RGSG-R 376
           +A ++ L +E+ +L  + H N+VR     ++    +L++V EY E G+L+  + +G+  R
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 377 DPLPWSSRVQIALDSARGLEYIHE-----HTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
             L     +++       L+  H      HTV   +HRD+K AN+ +D   + K+ DFGL
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTV---LHRDLKPANVFLDGKQNVKLGDFGL 162
Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            ++      S     VGT  YM PE       + K D+++ G +LYEL +
Sbjct: 163 ARILN-HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 49
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 50  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 110 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 29  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 79
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 80  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 139
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 140 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 235

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 49
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 50  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 110 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLIL 115
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++  E  +    ++ 
Sbjct: 116 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG 172
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F  V  A           SR   + +L ++  IK+  +        E
Sbjct: 29  EDFKFGKILGEGSFSTVVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 79
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 80  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 139
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 140 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 235

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 86/170 (50%), Gaps = 15/170 (8%)
Query: 323 QASREFL-AELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHL-RGSG-R 376
           +A ++ L +E+ +L  + H N+VR     ++    +L++V EY E G+L+  + +G+  R
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 377 DPLPWSSRVQIALDSARGLEYIHE-----HTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
             L     +++       L+  H      HTV   +HRD+K AN+ +D   + K+ DFGL
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTV---LHRDLKPANVFLDGKQNVKLGDFGL 162
Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            ++      S     VGT  YM PE       + K D+++ G +LYEL +
Sbjct: 163 ARILN-HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 62/313 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +  S    +G G FG V  A   G    S  +  + V +L   A + + +       ++E
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLI-KSDAAMTVAVKMLKPSAHLTERE-----ALMSE 76
Query: 332 LKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS------ 383
           LKVL+++ +H+N+V L+G C + G   ++ EY   G+L   LR   RD    S       
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIM 135
Query: 384 -----------RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
                       +  +   A+G+ ++        IHRD+ + NIL+      K+ DFGL 
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 192
Query: 433 KLTE-------VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +  +        G+A LP +      +M PE       + + DV+++G+ L+EL S   +
Sbjct: 193 RDIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
                G   DSK     F +++      E  R L         P  +  +M  + K C  
Sbjct: 247 PYP--GMPVDSK-----FYKMIK-----EGFRML--------SPEHAPAEMYDIMKTCWD 286
Query: 546 EYPQLRPSMRSIV 558
             P  RP+ + IV
Sbjct: 287 ADPLKRPTFKQIV 299

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 116/245 (47%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY    +G +        I V ++  + A      +A++E L E 
Sbjct: 50  EFKKIKVLGSGAFGTVY----KGLWIPEGEKVKIPVAIMELREATSP---KANKEILDEA 102
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 103 YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 161
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 162 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 214
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 215 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 270
Query: 508 NLPDP 512
            LP P
Sbjct: 271 RLPQP 275

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 108/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G +G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 32/229 (13%)
Query: 263 SYEELSK---ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK 319
            YE +++     D + +  ++G G FG VY A+      N   S L         AA K 
Sbjct: 25  QYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQ------NKETSVL---------AAAKV 69
Query: 320 MDMQASRE---FLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSG 375
           +D ++  E   ++ E+ +L    H N+V+L+  +  E +L+++ E+   G +   +    
Sbjct: 70  IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 129
Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT 435
           R PL  S    +   +   L Y+H++ +   IHRD+K+ NIL   +   K+ADFG++   
Sbjct: 130 R-PLTESQIQVVCKQTLDALNYLHDNKI---IHRDLKAGNILFTLDGDIKLADFGVSA-K 184
Query: 436 EVGSASLPTRLVGTFGYMPPE--YAQYGDVSP---KVDVYAFGVVLYEL 479
                      +GT  +M PE    +     P   K DV++ G+ L E+
Sbjct: 185 NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 26/232 (11%)
Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH 337
            KIG+G +G V+ A+ R  +    L R+           +   D       L E+ +L  
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRV----------RLDDDDEGVPSSALREICLLKE 57
Query: 338 VHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
           + H N+VRL      +  L LV+E+ +  +L ++      D  P   +        +GL 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLLKGLG 115
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL----VGTFGY 452
           + H   V   +HRD+K  N+LI++N   K+ADFGL +     +  +P R     V T  Y
Sbjct: 116 FCHSRNV---LHRDLKPQNLLINRNGELKLADFGLAR-----AFGIPVRCYSAEVVTLWY 167
Query: 453 MPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
            PP+      + S  +D+++ G +  EL +A   +  GN      K +  L 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLL 219

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 62/313 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +  S    +G G FG V  A   G    S  +  + V +L   A + + +       ++E
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLI-KSDAAMTVAVKMLKPSAHLTERE-----ALMSE 99
Query: 332 LKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS------ 383
           LKVL+++ +H+N+V L+G C + G   ++ EY   G+L   LR   RD    S       
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIM 158
Query: 384 -----------RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
                       +  +   A+G+ ++        IHRD+ + NIL+      K+ DFGL 
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 215
Query: 433 KLTE-------VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +  +        G+A LP +      +M PE       + + DV+++G+ L+EL S   +
Sbjct: 216 RHIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 269
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
                G   DSK     F +++      E  R L         P  +  +M  + K C  
Sbjct: 270 PYP--GMPVDSK-----FYKMIK-----EGFRML--------SPEHAPAEMYDIMKTCWD 309
Query: 546 EYPQLRPSMRSIV 558
             P  RP+ + IV
Sbjct: 310 ADPLKRPTFKQIV 322

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 29/217 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---F 328
           D + +  ++G G FG VY A+      N   S L         AA K +D ++  E   +
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQ------NKETSVL---------AAAKVIDTKSEEELEDY 81
Query: 329 LAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           + E+ +L    H N+V+L+  +  E +L+++ E+   G +   +    R PL  S    +
Sbjct: 82  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVV 140
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
              +   L Y+H++ +   IHRD+K+ NIL   +   K+ADFG++              +
Sbjct: 141 CKQTLDALNYLHDNKI---IHRDLKAGNILFTLDGDIKLADFGVSA-KNTRXIQRRDSFI 196
Query: 448 GTFGYMPPE--YAQYGDVSP---KVDVYAFGVVLYEL 479
           GT  +M PE    +     P   K DV++ G+ L E+
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 118/253 (46%), Gaps = 38/253 (15%)
Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           +++     D +     +G G F  V  AE      +    +L+ +  + +KA   K   +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAE------DKRTQKLVAIKCIAKKALEGK---E 60
Query: 324 ASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG----RDP 378
            S E   E+ VL  + H N+V L   Y   G L+L+ + +  G L + +   G    RD 
Sbjct: 61  GSME--NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD- 117
Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL---IDKNFHAKVADFGLTKLT 435
              +SR+   +  A  ++Y+H+  +   +HRD+K  N+L   +D++    ++DFGL+K+ 
Sbjct: 118 ---ASRLIFQVLDA--VKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSKME 169
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
           + GS  + +   GT GY+ PE       S  VD ++ GV+ Y L+         N    D
Sbjct: 170 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----D 223
Query: 496 SKGLVALFEEVLN 508
           +K    LFE++L 
Sbjct: 224 AK----LFEQILK 232

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 16/221 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G F     A           SR   + +L ++  IK+  +        E
Sbjct: 30  EDFKFGKILGEGSFSTTVLAR------ELATSREYAIKILEKRHIIKENKVPYVTR---E 80
Query: 332 LKVLTHVHHLNLVRL-IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             V++ + H   V+L   +  +  L+    Y +NG L +++R  G      +      + 
Sbjct: 81  RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGT 449
           SA  LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K L+     +     VGT
Sbjct: 141 SA--LEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             Y+ PE           D++A G ++Y+L++       GN
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 74/307 (24%), Positives = 132/307 (42%), Gaps = 45/307 (14%)
Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL 329
           ++  F    K+G G +  VY            L++   V + +++  +   +   S   +
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKG----------LNKTTGVYVALKEVKLDSEEGTPSTA-I 51
Query: 330 AELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHL--RGSGRDP--LPWSSR 384
            E+ ++  + H N+VRL      E  L LV+E+++N +L +++  R  G  P  L  +  
Sbjct: 52  REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
                   +GL + HE+ +   +HRD+K  N+LI+K    K+ DFGL +   +   +  +
Sbjct: 111 KYFQWQLLQGLAFCHENKI---LHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV---- 500
            +V  +   P         S  +D+++ G +L E+I+ K  +  G       K +     
Sbjct: 168 EVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK-PLFPGTNDEEQLKLIFDIMG 226
Query: 501 ----ALFEEVLNLPD--------PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
               +L+  V  LP         P  DLR+++ P   +  PLD  L M  L  +      
Sbjct: 227 TPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE--PLDGNL-MDFLHGLL----- 278
Query: 549 QLRPSMR 555
           QL P MR
Sbjct: 279 QLNPDMR 285

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 62/313 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +  S    +G G FG V  A   G    S  +  + V +L   A + + +       ++E
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLI-KSDAAMTVAVKMLKPSAHLTERE-----ALMSE 92
Query: 332 LKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS------ 383
           LKVL+++ +H+N+V L+G C + G   ++ EY   G+L   LR   RD    S       
Sbjct: 93  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIM 151
Query: 384 -----------RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
                       +  +   A+G+ ++        IHRD+ + NIL+      K+ DFGL 
Sbjct: 152 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 208
Query: 433 KLTE-------VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +  +        G+A LP +      +M PE       + + DV+++G+ L+EL S   +
Sbjct: 209 RDIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 262
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
                G   DSK     F +++      E  R L         P  +  +M  + K C  
Sbjct: 263 PYP--GMPVDSK-----FYKMIK-----EGFRML--------SPEHAPAEMYDIMKTCWD 302
Query: 546 EYPQLRPSMRSIV 558
             P  RP+ + IV
Sbjct: 303 ADPLKRPTFKQIV 315

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 62/313 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +  S    +G G FG V  A   G    S  +  + V +L   A + + +       ++E
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLI-KSDAAMTVAVKMLKPSAHLTERE-----ALMSE 99
Query: 332 LKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS------ 383
           LKVL+++ +H+N+V L+G C + G   ++ EY   G+L   LR   RD    S       
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIM 158
Query: 384 -----------RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
                       +  +   A+G+ ++        IHRD+ + NIL+      K+ DFGL 
Sbjct: 159 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 215
Query: 433 KLTE-------VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +  +        G+A LP +      +M PE       + + DV+++G+ L+EL S   +
Sbjct: 216 RDIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 269
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
                G   DSK     F +++      E  R L         P  +  +M  + K C  
Sbjct: 270 PYP--GMPVDSK-----FYKMIK-----EGFRML--------SPEHAPAEMYDIMKTCWD 309
Query: 546 EYPQLRPSMRSIV 558
             P  RP+ + IV
Sbjct: 310 ADPLKRPTFKQIV 322

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           ++ TD++ +  ++G+G F  V    ++      Y +++I           KK+  +  ++
Sbjct: 27  TRFTDDYQLFEELGKGAFSVVRRC-VKKTPTQEYAAKII---------NTKKLSARDHQK 76
Query: 328 FLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
              E ++   + H N+VRL      EG  +LV++ +  G L E +    R+    +    
Sbjct: 77  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDI--VAREYYSEADASH 134
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLP 443
                   + +IH+H +   +HRD+K  N+L+    K    K+ADFGL  +   G     
Sbjct: 135 CIHQILESVNHIHQHDI---VHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAW 190
Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
               GT GY+ PE  +       VD++A GV+LY L+
Sbjct: 191 FGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILL 227

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL---- 329
           F+   KIG+G FG V+                   N   +  AIK +D++ + + +    
Sbjct: 24  FTKLEKIGKGSFGEVFKG---------------IDNRTQKVVAIKIIDLEEAEDEIEDIQ 68
Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ VL+      + +  G Y  +  L+++ EY+  G+  + L      PL  +    I 
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATIL 125
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
            +  +GL+Y+H       IHRDIK+AN+L+ ++   K+ADFG+  +LT+          V
Sbjct: 126 REILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFV 180
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           GT  +M PE  +      K D+++ G+   EL
Sbjct: 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 212

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 78/313 (24%), Positives = 130/313 (41%), Gaps = 62/313 (19%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +  S    +G G FG V  A   G    S  +  + V +L   A + + +       ++E
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLI-KSDAAMTVAVKMLKPSAHLTERE-----ALMSE 94
Query: 332 LKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS------ 383
           LKVL+++ +H+N+V L+G C + G   ++ EY   G+L   LR   RD    S       
Sbjct: 95  LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLR-RKRDSFICSKTSPAIM 153
Query: 384 -----------RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
                       +  +   A+G+ ++        IHRD+ + NIL+      K+ DFGL 
Sbjct: 154 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 210
Query: 433 KLTE-------VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +  +        G+A LP +      +M PE       + + DV+++G+ L+EL S   +
Sbjct: 211 RDIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 264
Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
                G   DSK     F +++      E  R L         P  +  +M  + K C  
Sbjct: 265 PYP--GMPVDSK-----FYKMIK-----EGFRML--------SPEHAPAEMYDIMKTCWD 304
Query: 546 EYPQLRPSMRSIV 558
             P  RP+ + IV
Sbjct: 305 ADPLKRPTFKQIV 317

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL---- 329
           F+   KIG+G FG V+                   N   +  AIK +D++ + + +    
Sbjct: 9   FTKLEKIGKGSFGEVFKG---------------IDNRTQKVVAIKIIDLEEAEDEIEDIQ 53
Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ VL+      + +  G Y  +  L+++ EY+  G+  + L      PL  +    I 
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATIL 110
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
            +  +GL+Y+H       IHRDIK+AN+L+ ++   K+ADFG+  +LT+          V
Sbjct: 111 REILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFV 165
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           GT  +M PE  +      K D+++ G+   EL
Sbjct: 166 GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 197

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 69
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVR-EHKDNIGSQYLLNWCVQIA 128
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 129 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 181
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 237
Query: 508 NLPDP 512
            LP P
Sbjct: 238 RLPQP 242

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL---- 329
           F+   KIG+G FG V+                   N   +  AIK +D++ + + +    
Sbjct: 9   FTKLEKIGKGSFGEVFKG---------------IDNRTQKVVAIKIIDLEEAEDEIEDIQ 53
Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ VL+      + +  G Y  +  L+++ EY+  G+  + L      PL  +    I 
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATIL 110
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
            +  +GL+Y+H       IHRDIK+AN+L+ ++   K+ADFG+  +LT+          V
Sbjct: 111 REILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFV 165
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           GT  +M PE  +      K D+++ G+   EL
Sbjct: 166 GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 197

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 45/229 (19%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---RE-FL 329
           + M  ++G GGFG V    LR  + ++            ++ AIK+   + S   RE + 
Sbjct: 17  WEMKERLGTGGFGYV----LRWIHQDTG-----------EQVAIKQCRQELSPKNRERWC 61
Query: 330 AELKVLTHVHHLNLVR-------LIGYCVEGSLFLVYEYIENGNLSEHLR------GSGR 376
            E++++  ++H N+V        L          L  EY E G+L ++L       G   
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 121
Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK 433
            P+    R  ++ D +  L Y+HE+ +   IHRD+K  NI++    +    K+ D G  K
Sbjct: 122 GPI----RTLLS-DISSALRYLHENRI---IHRDLKPENIVLQPGPQRLIHKIIDLGYAK 173
Query: 434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
             E+    L T  VGT  Y+ PE  +    +  VD ++FG + +E I+ 
Sbjct: 174 --ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 85  KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 143
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++  E  +    ++ 
Sbjct: 144 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 200
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 201 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 15/170 (8%)
Query: 323 QASREFL-AELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHL-RGSG-R 376
           +A ++ L +E+ +L  + H N+VR     ++    +L++V EY E G+L+  + +G+  R
Sbjct: 46  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 105
Query: 377 DPLPWSSRVQIALDSARGLEYIHE-----HTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
             L     +++       L+  H      HTV   +HRD+K AN+ +D   + K+ DFGL
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTV---LHRDLKPANVFLDGKQNVKLGDFGL 162
Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            ++            VGT  YM PE       + K D+++ G +LYEL +
Sbjct: 163 ARILN-HDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 45/229 (19%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---RE-FL 329
           + M  ++G GGFG V    LR  + ++            ++ AIK+   + S   RE + 
Sbjct: 16  WEMKERLGTGGFGYV----LRWIHQDTG-----------EQVAIKQCRQELSPKNRERWC 60
Query: 330 AELKVLTHVHHLNLVR-------LIGYCVEGSLFLVYEYIENGNLSEHLR------GSGR 376
            E++++  ++H N+V        L          L  EY E G+L ++L       G   
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTK 433
            P+    R  ++ D +  L Y+HE+ +   IHRD+K  NI++    +    K+ D G  K
Sbjct: 121 GPI----RTLLS-DISSALRYLHENRI---IHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172
Query: 434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
             E+    L T  VGT  Y+ PE  +    +  VD ++FG + +E I+ 
Sbjct: 173 --ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 71
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 130
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 131 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 183
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 239
Query: 508 NLPDP 512
            LP P
Sbjct: 240 RLPQP 244

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 69
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 70  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 128
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 129 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 181
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 182 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 237
Query: 508 NLPDP 512
            LP P
Sbjct: 238 RLPQP 242

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 62  KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 120
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++  E  +    ++ 
Sbjct: 121 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPK-----ANKEILDEA 72
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 73  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 131
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 132 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 184
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 240
Query: 508 NLPDP 512
            LP P
Sbjct: 241 RLPQP 245

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 68
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVR-EHKDNIGSQYLLNWCVQIA 127
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 128 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 180
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 236
Query: 508 NLPDP 512
            LP P
Sbjct: 237 RLPQP 241

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 115
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++  E  +    ++ 
Sbjct: 116 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPK-----ANKEILDEA 93
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 94  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 152
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 153 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 205
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 206 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 261
Query: 508 NLPDP 512
            LP P
Sbjct: 262 RLPQP 266

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 68
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 127
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 128 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 180
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 236
Query: 508 NLPDP 512
            LP P
Sbjct: 237 RLPQP 241

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 115
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++  E  +    ++ 
Sbjct: 116 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 70
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 129
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 130 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 182
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 238
Query: 508 NLPDP 512
            LP P
Sbjct: 239 RLPQP 243

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 59  KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 117
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++  E  +    ++ 
Sbjct: 118 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 174
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 175 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS---- 325
            +++ +   +G+G  G V  A                VN + ++A A+K +DM+ +    
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCP 48
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E+ +   ++H N+V+  G+  EG++ +L  EY   G L + +      P P + R
Sbjct: 49  ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 108
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LP 443
               L +  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L 
Sbjct: 109 FFHQLMA--GVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 163
Query: 444 TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
            ++ GT  Y+ PE  +  +   + VDV++ G+VL  +++ +
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEG 353
           +G YG  Y  R +   + +    I + D + S+    E+ +  H+ H N+V+ +G   E 
Sbjct: 32  KGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 91
Query: 354 SLFLVY-EYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR---GLEYIHEHTVPVYIHR 409
               ++ E +  G+LS  LR S   PL  + +  I   + +   GL+Y+H++ +   +HR
Sbjct: 92  GFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQT-IGFYTKQILEGLKYLHDNQI---VHR 146
Query: 410 DIKSANILIDKNFHA-KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG--DVSPK 466
           DIK  N+LI+      K++DFG +K    G         GT  YM PE    G       
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 467 VDVYAFGVVLYELISAK 483
            D+++ G  + E+ + K
Sbjct: 206 ADIWSLGCTIIEMATGK 222

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 60  KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 118
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++  E  +    ++ 
Sbjct: 119 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 175
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 176 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D +     +G+G FG V   +      +    +   V ++ ++   +K D ++    L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCK------DKITGQECAVKVISKRQVKQKTDKES---LLR 75
Query: 331 ELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+++L  + H N+++L  +  + G  +LV E    G L + +    R     ++R+   +
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLPTRL 446
            S  G+ Y+H++ +   +HRD+K  N+L++   K+ + ++ DFGL+  T   ++      
Sbjct: 136 LS--GITYMHKNKI---VHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDK 188
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           +GT  Y+ PE   +G    K DV++ GV+LY L+S 
Sbjct: 189 IGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPK-----ANKEILDEA 71
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 130
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 131 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 183
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 239
Query: 508 NLPDP 512
            LP P
Sbjct: 240 RLPQP 244

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPK-----ANKEILDEA 75
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 134
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 135 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 187
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 243
Query: 508 NLPDP 512
            LP P
Sbjct: 244 RLPQP 248

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 54  KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 112
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++  E  +    ++ 
Sbjct: 113 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 169
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 68
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 127
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 128 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 180
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 236
Query: 508 NLPDP 512
            LP P
Sbjct: 237 RLPQP 241

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D +     +G+G FG V   +      +    +   V ++ ++   +K D ++    L 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCK------DKITGQECAVKVISKRQVKQKTDKES---LLR 99
Query: 331 ELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+++L  + H N+++L  +  + G  +LV E    G L + +    R     ++R+   +
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 159
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLPTRL 446
            S  G+ Y+H++ +   +HRD+K  N+L++   K+ + ++ DFGL+  T   ++      
Sbjct: 160 LS--GITYMHKNKI---VHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDK 212
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           +GT  Y+ PE   +G    K DV++ GV+LY L+S 
Sbjct: 213 IGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 247

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 78
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 79  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 137
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 138 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 190
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 191 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 246
Query: 508 NLPDP 512
            LP P
Sbjct: 247 RLPQP 251

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D +     +G+G FG V   +      +    +   V ++ ++   +K D ++    L 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCK------DKITGQECAVKVISKRQVKQKTDKES---LLR 98
Query: 331 ELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+++L  + H N+++L  +  + G  +LV E    G L + +    R     ++R+   +
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 158
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLPTRL 446
            S  G+ Y+H++ +   +HRD+K  N+L++   K+ + ++ DFGL+  T   ++      
Sbjct: 159 LS--GITYMHKNKI---VHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDK 211
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           +GT  Y+ PE   +G    K DV++ GV+LY L+S 
Sbjct: 212 IGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 246

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPK-----ANKEILDEA 71
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 130
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 131 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 183
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 239
Query: 508 NLPDP 512
            LP P
Sbjct: 240 RLPQP 244

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 68
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 127
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 128 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 180
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 236
Query: 508 NLPDP 512
            LP P
Sbjct: 237 RLPQP 241

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 70
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 129
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 130 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 182
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 238
Query: 508 NLPDP 512
            LP P
Sbjct: 239 RLPQP 243

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D +     +G+G FG V   +      +    +   V ++ ++   +K D ++    L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCK------DKITGQECAVKVISKRQVKQKTDKES---LLR 81
Query: 331 ELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+++L  + H N+++L  +  + G  +LV E    G L + +    R     ++R+   +
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 141
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLPTRL 446
            S  G+ Y+H++ +   +HRD+K  N+L++   K+ + ++ DFGL+  T   ++      
Sbjct: 142 LS--GITYMHKNKI---VHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKMKDK 194
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           +GT  Y+ PE   +G    K DV++ GV+LY L+S 
Sbjct: 195 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 71
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 72  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 130
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 131 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 183
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 184 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 239
Query: 508 NLPDP 512
            LP P
Sbjct: 240 RLPQP 244

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPK-----ANKEILDEA 74
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 75  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 133
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 134 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 186
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 187 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 242
Query: 508 NLPDP 512
            LP P
Sbjct: 243 RLPQP 247

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 114/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 62
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 121
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 122 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 174
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 230
Query: 508 NLPDP 512
            LP P
Sbjct: 231 RLPQP 235

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 13/197 (6%)
Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEG 353
           +G YG  Y  R +   + +    I + D + S+    E+ +  H+ H N+V+ +G   E 
Sbjct: 18  KGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN 77
Query: 354 SLFLVY-EYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR---GLEYIHEHTVPVYIHR 409
               ++ E +  G+LS  LR S   PL  + +  I   + +   GL+Y+H++ +   +HR
Sbjct: 78  GFIKIFMEQVPGGSLSALLR-SKWGPLKDNEQT-IGFYTKQILEGLKYLHDNQI---VHR 132
Query: 410 DIKSANILIDKNFHA-KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG--DVSPK 466
           DIK  N+LI+      K++DFG +K    G         GT  YM PE    G       
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 191
Query: 467 VDVYAFGVVLYELISAK 483
            D+++ G  + E+ + K
Sbjct: 192 ADIWSLGCTIIEMATGK 208

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 116/249 (46%), Gaps = 30/249 (12%)
Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           +++     D +     +G G F  V  AE      +    +L+ +  + ++A   K   +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAE------DKRTQKLVAIKCIAKEALEGK---E 60
Query: 324 ASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            S E   E+ VL  + H N+V L   Y   G L+L+ + +  G L + +   G      +
Sbjct: 61  GSME--NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDA 118
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL---IDKNFHAKVADFGLTKLTEVGS 439
           SR+   +  A  ++Y+H+  +   +HRD+K  N+L   +D++    ++DFGL+K+ + GS
Sbjct: 119 SRLIFQVLDA--VKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 173
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
             + +   GT GY+ PE       S  VD ++ GV+ Y L+         N    D+K  
Sbjct: 174 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DAK-- 225
Query: 500 VALFEEVLN 508
             LFE++L 
Sbjct: 226 --LFEQILK 232

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLIL 495
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++  E  +    ++ 
Sbjct: 496 YAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 102/236 (43%), Gaps = 59/236 (25%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--EFLAELKVLTH 337
           +GQG FG V  A       N+  SR           AIKK+     +    L+E+ +L  
Sbjct: 14  LGQGAFGQVVKAR------NALDSRYY---------AIKKIRHTEEKLSTILSEVXLLAS 58
Query: 338 VHHLNLVRLIGYCVE--------------GSLFLVYEYIENGNL-----SEHLRGSGRDP 378
           ++H  +VR     +E               +LF+  EY EN  L     SE+L    RD 
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENL-NQQRDE 117
Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK----- 433
             W    QI       L YIH   +   IHR++K  NI ID++ + K+ DFGL K     
Sbjct: 118 Y-WRLFRQIL----EALSYIHSQGI---IHRNLKPXNIFIDESRNVKIGDFGLAKNVHRS 169
Query: 434 --LTEVGSASLP------TRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELI 480
             + ++ S +LP      T  +GT  Y+  E     G  + K+D Y+ G++ +E I
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 106/216 (49%), Gaps = 21/216 (9%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D +     +G+G FG V   +      +    +   V ++ ++   +K D ++    L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCK------DKITGQECAVKVISKRQVKQKTDKES---LLR 75
Query: 331 ELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+++L  + H N+ +L  +  + G  +LV E    G L + +    R     ++R+   +
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLPTRL 446
            S  G+ Y H++ +   +HRD+K  N+L++   K+ + ++ DFGL+  T   ++      
Sbjct: 136 LS--GITYXHKNKI---VHRDLKPENLLLESKSKDANIRIIDFGLS--THFEASKKXKDK 188
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           +GT  Y+ PE   +G    K DV++ GV+LY L+S 
Sbjct: 189 IGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSG 223

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 118/253 (46%), Gaps = 38/253 (15%)
Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           +++     D +     +G G F  V  AE      +    +L+ +  + ++A   K   +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAE------DKRTQKLVAIKCIAKEALEGK---E 60
Query: 324 ASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG----RDP 378
            S E   E+ VL  + H N+V L   Y   G L+L+ + +  G L + +   G    RD 
Sbjct: 61  GSME--NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD- 117
Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL---IDKNFHAKVADFGLTKLT 435
              +SR+   +  A  ++Y+H+  +   +HRD+K  N+L   +D++    ++DFGL+K+ 
Sbjct: 118 ---ASRLIFQVLDA--VKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSKME 169
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
           + GS  + +   GT GY+ PE       S  VD ++ GV+ Y L+         N    D
Sbjct: 170 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----D 223
Query: 496 SKGLVALFEEVLN 508
           +K    LFE++L 
Sbjct: 224 AK----LFEQILK 232

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 118/253 (46%), Gaps = 38/253 (15%)
Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           +++     D +     +G G F  V  AE      +    +L+ +  + ++A   K   +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAE------DKRTQKLVAIKCIAKEALEGK---E 60
Query: 324 ASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG----RDP 378
            S E   E+ VL  + H N+V L   Y   G L+L+ + +  G L + +   G    RD 
Sbjct: 61  GSME--NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERD- 117
Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL---IDKNFHAKVADFGLTKLT 435
              +SR+   +  A  ++Y+H+  +   +HRD+K  N+L   +D++    ++DFGL+K+ 
Sbjct: 118 ---ASRLIFQVLDA--VKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSKME 169
Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
           + GS  + +   GT GY+ PE       S  VD ++ GV+ Y L+         N    D
Sbjct: 170 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----D 223
Query: 496 SKGLVALFEEVLN 508
           +K    LFE++L 
Sbjct: 224 AK----LFEQILK 232

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           D + MS  +G G  G V  A            R  C  + ++  + +K  + ++RE    
Sbjct: 10  DEYIMSKTLGSGACGEVKLA----------FERKTCKKVAIKIISKRKFAIGSAREADPA 59
Query: 328 --FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
                E+++L  ++H  ++++  +      ++V E +E G L + + G+ R  L  ++  
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 117
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASL 442
                    ++Y+HE+ +   IHRD+K  N+L+   +++   K+ DFG +K+  +G  SL
Sbjct: 118 LYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 172
Query: 443 PTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISA 482
              L GT  Y+ PE          +  VD ++ GV+L+  +S 
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGF   +      +    +  +++  +LL++    +KM M        E+ +   + 
Sbjct: 25  LGKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSM--------EISIHRSLA 75
Query: 340 HLNLVRLIGYCVEGS-LFLVYEYIENGNLSE--HLRGSGRDPLPWSSRVQIALDSARGLE 396
           H ++V   G+  +   +F+V E     +L E    R +  +P       QI L    G +
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQ 131
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y+H + V   IHRD+K  N+ ++++   K+ DFGL    E       T L GT  Y+ PE
Sbjct: 132 YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPE 187
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAK 483
                  S +VDV++ G ++Y L+  K
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           D + MS  +G G  G V  A            R  C  + ++  + +K  + ++RE    
Sbjct: 9   DEYIMSKTLGSGACGEVKLA----------FERKTCKKVAIKIISKRKFAIGSAREADPA 58
Query: 328 --FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
                E+++L  ++H  ++++  +      ++V E +E G L + + G+ R  L  ++  
Sbjct: 59  LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 116
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASL 442
                    ++Y+HE+ +   IHRD+K  N+L+   +++   K+ DFG +K+  +G  SL
Sbjct: 117 LYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 171
Query: 443 PTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISA 482
              L GT  Y+ PE          +  VD ++ GV+L+  +S 
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 99/195 (50%), Gaps = 17/195 (8%)
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
           +A++E L E  V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +   
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQ 124
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             +   +  A+G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+   
Sbjct: 125 YLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEK 179
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                G  G +P ++     +  ++     DV+++GV ++EL++       G  +S  S 
Sbjct: 180 EYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS- 236
Query: 498 GLVALFEEVLNLPDP 512
              ++ E+   LP P
Sbjct: 237 ---SILEKGERLPQP 248

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGF   +      +    +  +++  +LL++    +KM M        E+ +   + 
Sbjct: 29  LGKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSM--------EISIHRSLA 79
Query: 340 HLNLVRLIGYCVEGS-LFLVYEYIENGNLSE--HLRGSGRDPLPWSSRVQIALDSARGLE 396
           H ++V   G+  +   +F+V E     +L E    R +  +P       QI L    G +
Sbjct: 80  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQ 135
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y+H + V   IHRD+K  N+ ++++   K+ DFGL    E       T L GT  Y+ PE
Sbjct: 136 YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPE 191
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAK 483
                  S +VDV++ G ++Y L+  K
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           D + MS  +G G  G V  A            R  C  + ++  + +K  + ++RE    
Sbjct: 149 DEYIMSKTLGSGACGEVKLA----------FERKTCKKVAIRIISKRKFAIGSAREADPA 198
Query: 328 --FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
                E+++L  ++H  ++++  +      ++V E +E G L + + G+ R  L  ++  
Sbjct: 199 LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 256
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASL 442
                    ++Y+HE+ +   IHRD+K  N+L+   +++   K+ DFG +K+  +G  SL
Sbjct: 257 LYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 311
Query: 443 PTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISA 482
              L GT  Y+ PE          +  VD ++ GV+L+  +S 
Sbjct: 312 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           D + MS  +G G  G V  A            R  C  + ++  + +K  + ++RE    
Sbjct: 135 DEYIMSKTLGSGACGEVKLA----------FERKTCKKVAIRIISKRKFAIGSAREADPA 184
Query: 328 --FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
                E+++L  ++H  ++++  +      ++V E +E G L + + G+ R  L  ++  
Sbjct: 185 LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 242
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASL 442
                    ++Y+HE+ +   IHRD+K  N+L+   +++   K+ DFG +K+  +G  SL
Sbjct: 243 LYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 297
Query: 443 PTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISA 482
              L GT  Y+ PE          +  VD ++ GV+L+  +S 
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V   + R      Y  ++I       KA+ K  D       L E+++L  + 
Sbjct: 30  LGKGSFGEVLKCKDRIT-QQEYAVKVI------NKASAKNKDTST---ILREVELLKKLD 79
Query: 340 HLNLVRLIGYCVEGSLF-LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
           H N+++L     + S F +V E    G L + +    R     ++R+   + S  G+ Y+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYM 137
Query: 399 HEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
           H+H +   +HRD+K  NIL++   K+   K+ DFGL+   +  +  +  R +GT  Y+ P
Sbjct: 138 HKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR-IGTAYYIAP 192
Query: 456 EYAQYGDVSPKVDVYAFGVVLYELISA 482
           E  + G    K DV++ GV+LY L+S 
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 20/207 (9%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGF   +      +    +  +++  +LL++    +KM M        E+ +   + 
Sbjct: 25  LGKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSM--------EISIHRSLA 75
Query: 340 HLNLVRLIGYCVEGS-LFLVYEYIENGNLSE--HLRGSGRDPLPWSSRVQIALDSARGLE 396
           H ++V   G+  +   +F+V E     +L E    R +  +P       QI L    G +
Sbjct: 76  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQ 131
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y+H + V   IHRD+K  N+ ++++   K+ DFGL    E       T L GT  Y+ PE
Sbjct: 132 YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPE 187
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAK 483
                  S +VDV++ G ++Y L+  K
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           D + MS  +G G  G V  A            R  C  + ++  + +K  + ++RE    
Sbjct: 10  DEYIMSKTLGSGACGEVKLA----------FERKTCKKVAIKIISKRKFAIGSAREADPA 59
Query: 328 --FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
                E+++L  ++H  ++++  +      ++V E +E G L + + G+ R  L  ++  
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 117
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASL 442
                    ++Y+HE+ +   IHRD+K  N+L+   +++   K+ DFG +K+  +G  SL
Sbjct: 118 LYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 172
Query: 443 PTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISA 482
              L GT  Y+ PE          +  VD ++ GV+L+  +S 
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           D + MS  +G G  G V  A            R  C  + ++  + +K  + ++RE    
Sbjct: 10  DEYIMSKTLGSGACGEVKLA----------FERKTCKKVAIKIISKRKFAIGSAREADPA 59
Query: 328 --FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
                E+++L  ++H  ++++  +      ++V E +E G L + + G+ R  L  ++  
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 117
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASL 442
                    ++Y+HE+ +   IHRD+K  N+L+   +++   K+ DFG +K+  +G  SL
Sbjct: 118 LYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 172
Query: 443 PTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISA 482
              L GT  Y+ PE          +  VD ++ GV+L+  +S 
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 26/232 (11%)
Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH 337
            KIG+G +G V+ A+ R  +    L R+           +   D       L E+ +L  
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRV----------RLDDDDEGVPSSALREICLLKE 57
Query: 338 VHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE 396
           + H N+VRL      +  L LV+E+ +  +L ++      D  P   +        +GL 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLLKGLG 115
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL----VGTFGY 452
           + H   V   +HRD+K  N+LI++N   K+A+FGL +     +  +P R     V T  Y
Sbjct: 116 FCHSRNV---LHRDLKPQNLLINRNGELKLANFGLAR-----AFGIPVRCYSAEVVTLWY 167
Query: 453 MPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
            PP+      + S  +D+++ G +  EL +A   +  GN      K +  L 
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 104/223 (46%), Gaps = 29/223 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           D + MS  +G G  G V  A            R  C  + ++  + +K  + ++RE    
Sbjct: 16  DEYIMSKTLGSGACGEVKLA----------FERKTCKKVAIKIISKRKFAIGSAREADPA 65
Query: 328 --FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
                E+++L  ++H  ++++  +      ++V E +E G L + + G+ R  L  ++  
Sbjct: 66  LNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 123
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASL 442
                    ++Y+HE+ +   IHRD+K  N+L+   +++   K+ DFG +K+  +G  SL
Sbjct: 124 LYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 178
Query: 443 PTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISA 482
              L GT  Y+ PE          +  VD ++ GV+L+  +S 
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 65
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 66  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 124
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
            G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+        G  G 
Sbjct: 125 EGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEKEYHAEG--GK 177
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 178 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 233
Query: 508 NLPDP 512
            LP P
Sbjct: 234 RLPQP 238

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 99/195 (50%), Gaps = 17/195 (8%)
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
           +A++E L E  V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +   
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQ 117
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             +   +  A+G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+   
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEK 172
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                G  G +P ++     +  ++     DV+++GV ++EL++       G  +S  S 
Sbjct: 173 EYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS- 229
Query: 498 GLVALFEEVLNLPDP 512
              ++ E+   LP P
Sbjct: 230 ---SILEKGERLPQP 241

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 99/195 (50%), Gaps = 17/195 (8%)
Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
           +A++E L E  V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +   
Sbjct: 66  KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQ 124
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             +   +  A+G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL  +G+   
Sbjct: 125 YLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKL--LGAEEK 179
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                G  G +P ++     +  ++     DV+++GV ++EL++       G  +S  S 
Sbjct: 180 EYHAEG--GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS- 236
Query: 498 GLVALFEEVLNLPDP 512
              ++ E+   LP P
Sbjct: 237 ---SILEKGERLPQP 248

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 14/210 (6%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++FS+   IG+GGFG VY    + + G  Y  +  C++   ++  +K+ +  A  E +  
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCR-KADTGKMYAMK--CLD--KKRIKMKQGETLALNERIML 242
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
             V T      +     +     L  + + +  G+L  HL   G      +     A + 
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEI 300
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
             GLE++H   V   ++RD+K ANIL+D++ H +++D GL       S   P   VGT G
Sbjct: 301 ILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHG 354
Query: 452 YMPPEYAQYG-DVSPKVDVYAFGVVLYELI 480
           YM PE  Q G       D ++ G +L++L+
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 14/210 (6%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++FS+   IG+GGFG VY    + + G  Y  +  C++   ++  +K+ +  A  E +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCR-KADTGKMYAMK--CLD--KKRIKMKQGETLALNERIML 243
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
             V T      +     +     L  + + +  G+L  HL   G      +     A + 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEI 301
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
             GLE++H   V   ++RD+K ANIL+D++ H +++D GL       S   P   VGT G
Sbjct: 302 ILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHG 355
Query: 452 YMPPEYAQYG-DVSPKVDVYAFGVVLYELI 480
           YM PE  Q G       D ++ G +L++L+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 40/246 (16%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D F +  ++G+G    VY  + +G      L           K   K +D +  R    
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYAL-----------KVLKKTVDKKIVR---T 97
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG----RDPLPWSSRV 385
           E+ VL  + H N+++L   +     + LV E +  G L + +   G    RD    +  V
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA---ADAV 154
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---NFHAKVADFGLTKLTEVGSASL 442
           +  L++   + Y+HE+ +   +HRD+K  N+L      +   K+ADFGL+K+ E     L
Sbjct: 155 KQILEA---VAYLHENGI---VHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVL 206
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
              + GT GY  PE  +     P+VD+++ G++ Y L+   E          D +G   +
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY-------DERGDQFM 259
Query: 503 FEEVLN 508
           F  +LN
Sbjct: 260 FRRILN 265

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 14/210 (6%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++FS+   IG+GGFG VY    + + G  Y  +  C++   ++  +K+ +  A  E +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCR-KADTGKMYAMK--CLD--KKRIKMKQGETLALNERIML 243
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
             V T      +     +     L  + + +  G+L  HL   G      +     A + 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEI 301
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
             GLE++H   V   ++RD+K ANIL+D++ H +++D GL       S   P   VGT G
Sbjct: 302 ILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHG 355
Query: 452 YMPPEYAQYG-DVSPKVDVYAFGVVLYELI 480
           YM PE  Q G       D ++ G +L++L+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 14/210 (6%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++FS+   IG+GGFG VY    + + G  Y  +  C++   ++  +K+ +  A  E +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCR-KADTGKMYAMK--CLD--KKRIKMKQGETLALNERIML 243
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
             V T      +     +     L  + + +  G+L  HL   G      +     A + 
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEI 301
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
             GLE++H   V   ++RD+K ANIL+D++ H +++D GL       S   P   VGT G
Sbjct: 302 ILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHG 355
Query: 452 YMPPEYAQYG-DVSPKVDVYAFGVVLYELI 480
           YM PE  Q G       D ++ G +L++L+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 45/218 (20%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ--------ASREFLAE 331
           +G+G F  VY A  R +  N             Q  AIKK+ +          +R  L E
Sbjct: 18  LGEGQFATVYKA--RDKNTN-------------QIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 332 LKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           +K+L  + H N++ L+  +  + ++ LV++++E  +L   ++ +     P   +  + L 
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM-LM 120
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL---- 446
           + +GLEY+H+H +   +HRD+K  N+L+D+N   K+ADFGL K     S   P R     
Sbjct: 121 TLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAK-----SFGSPNRAYXHQ 172
Query: 447 VGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELI 480
           V T  Y  PE       YG     VD++A G +L EL+
Sbjct: 173 VVTRWYRAPELLFGARMYG---VGVDMWAVGCILAELL 207

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 70
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 129
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFG  KL  +G+        G  G 
Sbjct: 130 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEG--GK 182
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 238
Query: 508 NLPDP 512
            LP P
Sbjct: 239 RLPQP 243

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 72
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 73  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 131
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFG  KL  +G+        G  G 
Sbjct: 132 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEG--GK 184
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 185 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 240
Query: 508 NLPDP 512
            LP P
Sbjct: 241 RLPQP 245

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 70
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 129
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFG  KL  +G+        G  G 
Sbjct: 130 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEG--GK 182
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 238
Query: 508 NLPDP 512
            LP P
Sbjct: 239 RLPQP 243

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V   + R      Y  ++I       KA+ K  D       L E+++L  + 
Sbjct: 30  LGKGSFGEVLKCKDRIT-QQEYAVKVI------NKASAKNKDTST---ILREVELLKKLD 79
Query: 340 HLNLVRLIGYCVEGSLF-LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
           H N+++L     + S F +V E    G L + +    R     ++R+   + S  G+ Y+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYM 137
Query: 399 HEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
           H+H +   +HRD+K  NIL++   K+   K+ DFGL+   +  +  +  R +GT  Y+ P
Sbjct: 138 HKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR-IGTAYYIAP 192
Query: 456 EYAQYGDVSPKVDVYAFGVVLYELISA 482
           E  + G    K DV++ GV+LY L+S 
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+G FG V   + R      Y  ++I       KA+ K  D       L E+++L  + 
Sbjct: 30  LGKGSFGEVLKCKDRIT-QQEYAVKVI------NKASAKNKDTST---ILREVELLKKLD 79
Query: 340 HLNLVRLIGYCVEGSLF-LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
           H N+++L     + S F +V E    G L + +    R     ++R+   + S  G+ Y+
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYM 137
Query: 399 HEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
           H+H +   +HRD+K  NIL++   K+   K+ DFGL+   +  +  +  R +GT  Y+ P
Sbjct: 138 HKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR-IGTAYYIAP 192
Query: 456 EYAQYGDVSPKVDVYAFGVVLYELISA 482
           E  + G    K DV++ GV+LY L+S 
Sbjct: 193 EVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 57  KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLIL 115
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+      K+ DFGL++  E  +    ++ 
Sbjct: 116 YAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG 172
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 173 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D++ +  ++G G FG V+    R   GN++ ++ +       K  ++K           E
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERAT-GNNFAAKFVMTPHESDKETVRK-----------E 204
Query: 332 LKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           ++ ++ + H  LV L   +  +  + ++YE++  G L E +     + +     V+    
Sbjct: 205 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQ 263
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILI--DKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
             +GL ++HE+    Y+H D+K  NI+    ++   K+ DFGLT  L    S  + T   
Sbjct: 264 VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 317
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           GT  +  PE A+   V    D+++ GV+ Y L+S 
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPE--GEKVKIPVAIKELREATSPK-----ANKEILDEA 75
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 76  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 134
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFG  KL  +G+        G  G 
Sbjct: 135 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEG--GK 187
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 188 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 243
Query: 508 NLPDP 512
            LP P
Sbjct: 244 RLPQP 248

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 68
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 127
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFG  KL  +G+        G  G 
Sbjct: 128 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEG--GK 180
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 181 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 236
Query: 508 NLPDP 512
            LP P
Sbjct: 237 RLPQP 241

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/245 (23%), Positives = 113/245 (46%), Gaps = 24/245 (9%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
            F     +G G FG VY      E     +   + +  L +  + K     A++E L E 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPK-----ANKEILDEA 70
Query: 333 KVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA 392
            V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +   +  A
Sbjct: 71  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIA 129
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
           +G+ Y+ +  +   +HRD+ + N+L+    H K+ DFG  KL  +G+        G  G 
Sbjct: 130 KGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGRAKL--LGAEEKEYHAEG--GK 182
Query: 453 MPPEYAQYGDVSPKV-----DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           +P ++     +  ++     DV+++GV ++EL++       G  +S  S    ++ E+  
Sbjct: 183 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 238
Query: 508 NLPDP 512
            LP P
Sbjct: 239 RLPQP 243

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 23/215 (10%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D++ +  ++G G FG V+    R   GN++ ++ +       K  ++K           E
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERAT-GNNFAAKFVMTPHESDKETVRK-----------E 98
Query: 332 LKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           ++ ++ + H  LV L   +  +  + ++YE++  G L E +     + +     V+    
Sbjct: 99  IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEYMRQ 157
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILI--DKNFHAKVADFGLT-KLTEVGSASLPTRLV 447
             +GL ++HE+    Y+H D+K  NI+    ++   K+ DFGLT  L    S  + T   
Sbjct: 158 VCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 211
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           GT  +  PE A+   V    D+++ GV+ Y L+S 
Sbjct: 212 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 28/218 (12%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           TD + +   IG+G F  V    ++   G+ Y +++I           KK+  +  ++   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRC-VKLCTGHEYAAKII---------NTKKLSARDHQKLER 52
Query: 331 ELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRG----SGRDPLPWSSRV 385
           E ++   + H N+VRL      EG  +LV++ +  G L E +      S  D    S  +
Sbjct: 53  EARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADA---SHCI 109
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASL 442
           Q  L++      +H H + V +HRD+K  N+L+    K    K+ADFGL  +   G    
Sbjct: 110 QQILEAV-----LHCHQMGV-VHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQA 162
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                GT GY+ PE  +       VD++A GV+LY L+
Sbjct: 163 WFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILL 200

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 256 VDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           VD   E  Y +  +  +N  +   +G+G +G V          N    R++ +   ++  
Sbjct: 12  VDLGTENLYFQSMEKYENLGL---VGEGSYGMVMKCR------NKDTGRIVAIKKFLESD 62
Query: 316 AIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSE-HLRG 373
             K +   A RE    +K+L  + H NLV L+  C +    +LV+E++++  L +  L  
Sbjct: 63  DDKMVKKIAMRE----IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP 118
Query: 374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
           +G D   +    +       G+ + H H +   IHRDIK  NIL+ ++   K+ DFG  +
Sbjct: 119 NGLD---YQVVQKYLFQIINGIGFCHSHNI---IHRDIKPENILVSQSGVVKLCDFGFAR 172
Query: 434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVS--PKVDVYAFGVVLYELISAK 483
            T      +    V T  Y  PE    GDV     VDV+A G ++ E+   +
Sbjct: 173 -TLAAPGEVYDDEVATRWYRAPELL-VGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           TD + +  ++G+G F  V    ++   G  Y +++I           KK+  +  ++   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRC-MKIPTGQEYAAKII---------NTKKLSARDHQKLER 52
Query: 331 ELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E ++   + H N+VRL      EG  +LV++ +  G L E +         + S    + 
Sbjct: 53  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASH 107
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTRL 446
              + LE ++   +   +HRD+K  N+L+    K    K+ADFGL  +   G        
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGF 166
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            GT GY+ PE  +       VD++A GV+LY L+
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILL 200

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGF   +      +    +  +++  +LL++    +KM M        E+ +   + 
Sbjct: 47  LGKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSM--------EISIHRSLA 97
Query: 340 HLNLVRLIGYCVEGS-LFLVYEYIENGNLSE--HLRGSGRDPLPWSSRVQIALDSARGLE 396
           H ++V   G+  +   +F+V E     +L E    R +  +P       QI L    G +
Sbjct: 98  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQ 153
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y+H + V   IHRD+K  N+ ++++   K+ DFGL    E         L GT  Y+ PE
Sbjct: 154 YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 209
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAK 483
                  S +VDV++ G ++Y L+  K
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGF   +      +    +  +++  +LL++    +KM M        E+ +   + 
Sbjct: 49  LGKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSM--------EISIHRSLA 99
Query: 340 HLNLVRLIGYCVEGS-LFLVYEYIENGNLSE--HLRGSGRDPLPWSSRVQIALDSARGLE 396
           H ++V   G+  +   +F+V E     +L E    R +  +P       QI L    G +
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQ 155
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y+H + V   IHRD+K  N+ ++++   K+ DFGL    E         L GT  Y+ PE
Sbjct: 156 YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 211
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAK 483
                  S +VDV++ G ++Y L+  K
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/243 (27%), Positives = 108/243 (44%), Gaps = 38/243 (15%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK 333
           F     +G G F  V  AE +         +L  V  + +KA   K   ++S E   E+ 
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKA------TGKLFAVKCIPKKALKGK---ESSIE--NEIA 72
Query: 334 VLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG----RDPLPWSSRVQIA 388
           VL  + H N+V L   Y     L+LV + +  G L + +   G    +D    S+ ++  
Sbjct: 73  VLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDA---STLIRQV 129
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTR 445
           LD+   + Y+H   +   +HRD+K  N+L    D+     ++DFGL+K+   G   + + 
Sbjct: 130 LDA---VYYLHRMGI---VHRDLKPENLLYYSQDEESKIMISDFGLSKME--GKGDVMST 181
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
             GT GY+ PE       S  VD ++ GV+ Y L+         N    DSK    LFE+
Sbjct: 182 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DSK----LFEQ 233
Query: 506 VLN 508
           +L 
Sbjct: 234 ILK 236

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 20/207 (9%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G+GGF   +      +    +  +++  +LL++    +KM M        E+ +   + 
Sbjct: 23  LGKGGFAKCFEIS-DADTKEVFAGKIVPKSLLLKPHQREKMSM--------EISIHRSLA 73
Query: 340 HLNLVRLIGYCVEGS-LFLVYEYIENGNLSE--HLRGSGRDPLPWSSRVQIALDSARGLE 396
           H ++V   G+  +   +F+V E     +L E    R +  +P       QI L    G +
Sbjct: 74  HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL----GCQ 129
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           Y+H + V   IHRD+K  N+ ++++   K+ DFGL    E         L GT  Y+ PE
Sbjct: 130 YLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPE 185
Query: 457 YAQYGDVSPKVDVYAFGVVLYELISAK 483
                  S +VDV++ G ++Y L+  K
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 4/154 (2%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           +FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S + 
Sbjct: 437 KFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVR-KFSLDLASLIL 495
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
            A   +  L Y+       ++HRDI + N+L+      K+ DFGL++  E  +    ++ 
Sbjct: 496 YAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                +M PE   +   +   DV+ FGV ++E++
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           KIG+G +G VY A+    YG ++          ++K  ++K D       + E+ +L  +
Sbjct: 9   KIGEGTYGVVYKAQ--NNYGETFA---------LKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 339 HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H N+V+L      +  L LV+E+++     + L       L   +     L    G+ Y
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
            H+  V   +HRD+K  N+LI++    K+ADFGL +   +        +V  +   P   
Sbjct: 116 CHDRRV---LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 458 AQYGDVSPKVDVYAFGVVLYELISA 482
                 S  +D+++ G +  E+++ 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           TD + +  ++G+G F  V    ++   G  Y +++I           KK+  +  ++   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRC-MKIPTGQEYAAKII---------NTKKLSARDHQKLER 52
Query: 331 ELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E ++   + H N+VRL      EG  +LV++ +  G L E +         + S    + 
Sbjct: 53  EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR-----EYYSEADASH 107
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTRL 446
              + LE ++   +   +HRD+K  N+L+    K    K+ADFGL  +   G        
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGF 166
Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            GT GY+ PE  +       VD++A GV+LY L+
Sbjct: 167 AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILL 200

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 30/226 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR- 326
           S   D++ M  ++G G F  V     +G  G  Y ++ I           KK  + +SR 
Sbjct: 22  SMVEDHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFI-----------KKRRLXSSRR 69
Query: 327 -----EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
                E   E+ +L  + H N++ L   +  +  + L+ E +  G L + L  + ++ L 
Sbjct: 70  GVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLT 127
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTE 436
                Q       G+ Y+H   +    H D+K  NI L+DKN      K+ DFG+    E
Sbjct: 128 EDEATQFLKQILDGVHYLHSKRIA---HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 184
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
            G+      + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 185 AGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           KIG+G +G VY A+    YG ++          ++K  ++K D       + E+ +L  +
Sbjct: 9   KIGEGTYGVVYKAQ--NNYGETFA---------LKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 339 HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H N+V+L      +  L LV+E+++     + L       L   +     L    G+ Y
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
            H+  V   +HRD+K  N+LI++    K+ADFGL +   +        +V  +   P   
Sbjct: 116 CHDRRV---LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 458 AQYGDVSPKVDVYAFGVVLYELISA 482
                 S  +D+++ G +  E+++ 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 30/226 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR- 326
           S   D++ M  ++G G F  V     +G  G  Y ++ I           KK  + +SR 
Sbjct: 1   SMVEDHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFI-----------KKRRLSSSRR 48
Query: 327 -----EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
                E   E+ +L  + H N++ L   +  +  + L+ E +  G L + L  + ++ L 
Sbjct: 49  GVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLT 106
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTE 436
                Q       G+ Y+H   +    H D+K  NI L+DKN      K+ DFG+    E
Sbjct: 107 EDEATQFLKQILDGVHYLHSKRIA---HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
            G+      + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 164 AGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           KIG+G +G VY A+    YG ++          ++K  ++K D       + E+ +L  +
Sbjct: 9   KIGEGTYGVVYKAQ--NNYGETFA---------LKKIRLEKEDEGIPSTTIREISILKEL 57
Query: 339 HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H N+V+L      +  L LV+E+++     + L       L   +     L    G+ Y
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
            H+  V   +HRD+K  N+LI++    K+ADFGL +   +        +V  +   P   
Sbjct: 116 CHDRRV---LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVL 172
Query: 458 AQYGDVSPKVDVYAFGVVLYELISA 482
                 S  +D+++ G +  E+++ 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 12/158 (7%)
Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLF-LVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
           E   E+ +L  + H N+++L     +   F LV E+ E G L E +    R         
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI--INRHKFDECDAA 149
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILID-KN--FHAKVADFGLTKLTEVGSASL 442
            I      G+ Y+H+H +   +HRDIK  NIL++ KN   + K+ DFGL+         L
Sbjct: 150 NIMKQILSGICYLHKHNI---VHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKL 205
Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             RL GT  Y+ PE  +    + K DV++ GV++Y L+
Sbjct: 206 RDRL-GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL 241

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 115/248 (46%), Gaps = 41/248 (16%)
Query: 252 NAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYG--NSYLSRLICVN 309
           N I ++K V+    E  K  +++ +   + QG F  +   E   ++     Y   L+   
Sbjct: 15  NLIYLNKYVK----EKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKK 70
Query: 310 LLMQKAAIKKMDMQAS-REFLAELKVLTHVHHLNLVRLIGYCV--EG------SLFLVYE 360
               K+   K+ +++   +F  EL+++T + +        YC+  EG       ++++YE
Sbjct: 71  RDFTKSNNDKISIKSKYDDFKNELQIITDIKN-------EYCLTCEGIITNYDEVYIIYE 123
Query: 361 YIENGNL---SEHLRGSGRDP---LPWSSRVQIALDSARGLEYIH-EHTVPVYIHRDIKS 413
           Y+EN ++    E+     ++    +P      I         YIH E  +    HRD+K 
Sbjct: 124 YMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI---CHRDVKP 180
Query: 414 ANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY----AQYGDVSPKVDV 469
           +NIL+DKN   K++DFG ++   V      +R  GT+ +MPPE+    + Y     KVD+
Sbjct: 181 SNILMDKNGRVKLSDFGESEYM-VDKKIKGSR--GTYEFMPPEFFSNESSYN--GAKVDI 235
Query: 470 YAFGVVLY 477
           ++ G+ LY
Sbjct: 236 WSLGICLY 243

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR----- 326
           D++ M  ++G G F  V     +G  G  Y ++ I           KK  + +SR     
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFI-----------KKRRLSSSRRGVSR 59
Query: 327 -EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
            E   E+ +L  + H N++ L   +  +  + L+ E +  G L + L  + ++ L     
Sbjct: 60  EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEA 117
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSA 440
            Q       G+ Y+H   +    H D+K  NI L+DKN      K+ DFG+    E G+ 
Sbjct: 118 TQFLKQILDGVHYLHSKRIA---HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 174
Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
                + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 175 F--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 33/216 (15%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           +IG+G F  VY            L     V +   +   +K+     + F  E + L  +
Sbjct: 33  EIGRGSFKTVYKG----------LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGL 82
Query: 339 HHLNLVRLIGY---CVEGS--LFLVYEYIENGNLSEHLRGSGRDPLP----WSSRVQIAL 389
            H N+VR        V+G   + LV E   +G L  +L+      +     W  ++    
Sbjct: 83  QHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI---- 138
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILID-KNFHAKVADFGLTKLTEVGSASLPTRLVG 448
              +GL+++H  T P+ IHRD+K  NI I       K+ D GL  L     AS    ++G
Sbjct: 139 --LKGLQFLHTRTPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIG 192
Query: 449 TFGYMPPE-YAQYGDVSPKVDVYAFGVVLYELISAK 483
           T  +  PE Y +  D S  VDVYAFG    E  +++
Sbjct: 193 TPEFXAPEXYEEKYDES--VDVYAFGXCXLEXATSE 226

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 32/189 (16%)
Query: 316 AIKKMDMQASR---EFLAELKVLTHVH---------HLNLVRLI-GYCVEGSLFLVYEYI 362
           A+K M++ A R   E L E++  T            H +++ LI  Y     +FLV++ +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182
Query: 363 ENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF 422
             G L ++L  + +  L       I       + ++H + +   +HRD+K  NIL+D N 
Sbjct: 183 RKGELFDYL--TEKVALSEKETRSIMRSLLEAVSFLHANNI---VHRDLKPENILLDDNM 237
Query: 423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE---------YAQYGDVSPKVDVYAFG 473
             +++DFG +   E G       L GT GY+ PE         +  YG    +VD++A G
Sbjct: 238 QIRLSDFGFSCHLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGK---EVDLWACG 292
Query: 474 VVLYELISA 482
           V+L+ L++ 
Sbjct: 293 VILFTLLAG 301

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM-QKAAIKKMDMQA----- 324
           +D +    K+G G +G V                L+C + L   + AIK +   +     
Sbjct: 20  SDRYQRVKKLGSGAYGEV----------------LLCKDKLTGAERAIKIIKKSSVTTTS 63
Query: 325 -SREFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            S   L E+ VL  + H N+++L  +  +  + +LV E    G L + +    R      
Sbjct: 64  NSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI--ILRQKFSEV 121
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGS 439
               I      G  Y+H+H +   +HRD+K  N+L++   ++   K+ DFGL+   EVG 
Sbjct: 122 DAAVIMKQVLSGTTYLHKHNI---VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG- 177
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             +  RL GT  Y+ PE  +      K DV++ GV+LY L+
Sbjct: 178 GKMKERL-GTAYYIAPEVLR-KKYDEKCDVWSCGVILYILL 216

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 95/217 (43%), Gaps = 17/217 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D + +   IG+G F  V    +  E G  +  +++ V        +   D++        
Sbjct: 24  DVYELCEVIGKGAFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QIAL 389
           LK   H H + L  L  Y  +G L++V+E+++  +L   +         +S  V      
Sbjct: 83  LK---HPHIVEL--LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTR- 445
                L Y H++ +   IHRD+K  N+L+   + +   K+ DFG+    ++G + L    
Sbjct: 138 QILEALRYCHDNNI---IHRDVKPENVLLASKENSAPVKLGDFGVA--IQLGESGLVAGG 192
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
            VGT  +M PE  +       VDV+  GV+L+ L+S 
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D +     IG G FG               ++RL+   L  +  A+K ++  A+ +   
Sbjct: 19  SDRYDFVKDIGSGNFG---------------VARLMRDKLTKELVAVKYIERGAAIDENV 63
Query: 331 ELKVLTH--VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           + +++ H  + H N+VR     +  + L ++ EY   G L E +  +GR           
Sbjct: 64  QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR----------F 113
Query: 388 ALDSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKN--FHAKVADFGLTKLTEV 437
           + D AR        G+ Y H   +    HRD+K  N L+D +     K+ DFG +K + +
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170
Query: 438 GSASLPTRLVGTFGYMPPEYAQYGDVSPKV-DVYAFGVVLYELI 480
            S   P   VGT  Y+ PE     +   K+ DV++ GV LY ++
Sbjct: 171 HSQ--PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVML 212

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM-QKAAIKKMDMQA----- 324
           +D +    K+G G +G V                L+C + L   + AIK +   +     
Sbjct: 3   SDRYQRVKKLGSGAYGEV----------------LLCKDKLTGAERAIKIIKKSSVTTTS 46
Query: 325 -SREFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            S   L E+ VL  + H N+++L  +  +  + +LV E    G L + +    R      
Sbjct: 47  NSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEI--ILRQKFSEV 104
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGS 439
               I      G  Y+H+H +   +HRD+K  N+L++   ++   K+ DFGL+   EVG 
Sbjct: 105 DAAVIMKQVLSGTTYLHKHNI---VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG- 160
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             +  RL GT  Y+ PE  +      K DV++ GV+LY L+
Sbjct: 161 GKMKERL-GTAYYIAPEVLR-KKYDEKCDVWSCGVILYILL 199

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 44/224 (19%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D + +   IG G FG      +R +  N     L+ V  + +    +K+D    RE   
Sbjct: 18  SDRYELVKDIGAGNFGVARL--MRDKQANE----LVAVKYIERG---EKIDENVKRE--- 65
Query: 331 ELKVLTH--VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
              ++ H  + H N+VR     +  + L +V EY   G L E +  +GR           
Sbjct: 66  ---IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----------F 112
Query: 388 ALDSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKN--FHAKVADFGLTKLTEV 437
           + D AR        G+ Y H   V    HRD+K  N L+D +     K+ADFG +K + +
Sbjct: 113 SEDEARFFFQQLISGVSYAHAMQV---AHRDLKLENTLLDGSPAPRLKIADFGYSKASVL 169
Query: 438 GSASLPTRLVGTFGYMPPEYAQYGDVSPKV-DVYAFGVVLYELI 480
            S   P   VGT  Y+ PE     +   KV DV++ GV LY ++
Sbjct: 170 HSQ--PKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 28/215 (13%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK 333
           + +  ++G+G F  V    ++   G  Y +++I           KK+  +  ++   E +
Sbjct: 24  YQLFEELGKGAFSVVRRC-VKVLAGQEYAAKII---------NTKKLSARDHQKLEREAR 73
Query: 334 VLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRG----SGRDPLPWSSRVQIA 388
           +   + H N+VRL      EG  +L+++ +  G L E +      S  D    S  +Q  
Sbjct: 74  ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA---SHCIQQI 130
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGSASLPTR 445
           L++      +H H + V +HRD+K  N+L+    K    K+ADFGL    E G       
Sbjct: 131 LEAV-----LHCHQMGV-VHRDLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFG 183
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             GT GY+ PE  +       VD++A GV+LY L+
Sbjct: 184 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 218

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 28/221 (12%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           ++ T+ + +  ++G+G F  V    ++   G  Y + +I           KK+  +  ++
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRC-VKVLAGQEYAAMII---------NTKKLSARDHQK 56
Query: 328 FLAELKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRG----SGRDPLPWS 382
              E ++   + H N+VRL      EG  +L+++ +  G L E +      S  D    S
Sbjct: 57  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADA---S 113
Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAKVADFGLTKLTEVGS 439
             +Q  L++      +H H + V +HR++K  N+L+    K    K+ADFGL    E G 
Sbjct: 114 HCIQQILEAV-----LHCHQMGV-VHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GE 166
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                   GT GY+ PE  +       VD++A GV+LY L+
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D + +  ++G G FG V+   +    G  ++++ I     + K  +K            E
Sbjct: 51  DYYDILEELGSGAFGVVHRC-VEKATGRVFVAKFINTPYPLDKYTVKN-----------E 98
Query: 332 LKVLTHVHHLNLVRLI-GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           + ++  +HH  L+ L   +  +  + L+ E++  G L + +       +  +  +     
Sbjct: 99  ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQ 157
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILID--KNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           +  GL+++HEH++   +H DIK  NI+ +  K    K+ DFGL   T++    +      
Sbjct: 158 ACEGLKHMHEHSI---VHLDIKPENIMCETKKASSVKIIDFGLA--TKLNPDEIVKVTTA 212
Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           T  +  PE      V    D++A GV+ Y L+S 
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           +G G F  V+  + R         +L  +  + +  A +   ++       E+ VL  + 
Sbjct: 17  LGSGAFSEVFLVKQR------LTGKLFALKCIKKSPAFRDSSLEN------EIAVLKKIK 64
Query: 340 HLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYI 398
           H N+V L   Y      +LV + +  G L + +   G      +S V   + SA  ++Y+
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSA--VKYL 122
Query: 399 HEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPP 455
           HE+ +   +HRD+K  N+L    ++N    + DFGL+K+ + G  S      GT GY+ P
Sbjct: 123 HENGI---VHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA---CGTPGYVAP 176
Query: 456 EYAQYGDVSPKVDVYAFGVVLYELI 480
           E       S  VD ++ GV+ Y L+
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILL 201

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +  +S    +G G FG V+ A +  E     + + I    +++   I+  D +  +  L 
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTA-VDKEKNKEVVVKFIKKEKVLEDCWIE--DPKLGKVTL- 78
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQIA 388
           E+ +L+ V H N+++++  +  +G   LV E   +G +L   +    R   P +S +   
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           L SA G  Y+    +   IHRDIK  NI+I ++F  K+ DFG     E G   L     G
Sbjct: 139 LVSAVG--YLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCG 191
Query: 449 TFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELI 480
           T  Y  PE         P++++++ GV LY L+
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 48  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 100
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 157
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+   A      V T  Y  PE    +   +  VD+++ G ++
Sbjct: 158 VNEDCELKILDFGLARHTDDEMAG----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 477 YELISAK 483
            EL++ +
Sbjct: 214 AELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 48  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 100
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 157
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+   A      V T  Y  PE    +   +  VD+++ G ++
Sbjct: 158 VNEDCELKILDFGLARHTDDEMAG----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 477 YELISAK 483
            EL++ +
Sbjct: 214 AELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 44  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 96
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 97  DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 153
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+   A      V T  Y  PE    +   +  VD+++ G ++
Sbjct: 154 VNEDCELKILDFGLARHTDDEMAG----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 209
Query: 477 YELISAK 483
            EL++ +
Sbjct: 210 AELLTGR 216

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR- 326
            K  D + +  ++G G F  V     +   G  Y ++ I           KK   +ASR 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFI-----------KKRQSRASRR 55
Query: 327 -----EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
                E   E+ +L  V H N++ L   Y     + L+ E +  G L + L  + ++ L 
Sbjct: 56  GVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLS 113
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTE 436
                        G+ Y+H   +    H D+K  NI L+DKN    H K+ DFGL    E
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIA---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
            G       + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 19/180 (10%)
Query: 316 AIKKMDMQASRE----FLAELKVLTHVHHLN-LVRLIG-YCVEGSLFLVYEYIENGNLSE 369
           A+K+M    ++E     L +L V+   H    +V+  G +     +F+  E +  G  +E
Sbjct: 54  AVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAE 111
Query: 370 HLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVAD 428
            L+   + P+P     ++ +   + L Y+ E H V   IHRD+K +NIL+D+    K+ D
Sbjct: 112 KLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV---IHRDVKPSNILLDERGQIKLCD 168
Query: 429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSP-----KVDVYAFGVVLYELISAK 483
           FG++       A    R  G   YM PE     D +      + DV++ G+ L EL + +
Sbjct: 169 FGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 91/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +  S +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDSELKILDFGLCRHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 108
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 109 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 165
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T    A   T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 166 NEDCELKILDFGLARHT----ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 478 ELISAK 483
           EL++ +
Sbjct: 222 ELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 108
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 109 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 165
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T    A   T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 166 NEDCELKILDFGLARHT----ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 478 ELISAK 483
           EL++ +
Sbjct: 222 ELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 108
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 109 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 165
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T    A   T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 166 NEDCELKILDFGLARHT----ADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 478 ELISAK 483
           EL++ +
Sbjct: 222 ELLTGR 227

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR- 326
            K  D + +  ++G G F  V     +   G  Y ++ I           KK   +ASR 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFI-----------KKRQSRASRR 55
Query: 327 -----EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
                E   E+ +L  V H N++ L   Y     + L+ E +  G L + L  + ++ L 
Sbjct: 56  GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLS 113
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTE 436
                        G+ Y+H   +    H D+K  NI L+DKN    H K+ DFGL    E
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIA---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
            G       + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR- 326
            K  D + +  ++G G F  V     +   G  Y ++ I           KK   +ASR 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFI-----------KKRQSRASRR 55
Query: 327 -----EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
                E   E+ +L  V H N++ L   Y     + L+ E +  G L + L  + ++ L 
Sbjct: 56  GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLS 113
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTE 436
                        G+ Y+H   +    H D+K  NI L+DKN    H K+ DFGL    E
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIA---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
            G       + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDMQASR--EFLAELKVLTHVHHLNLVRLIGYCVE 352
           G YG   L R    ++      I+K  +  S   + L E+ VL  + H N+++L  +  +
Sbjct: 48  GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107
Query: 353 G-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDI 411
             + +LV E  + G L + +    R          I      G+ Y+H+H +   +HRD+
Sbjct: 108 KRNYYLVMECYKGGELFDEI--IHRMKFNEVDAAVIIKQVLSGVTYLHKHNI---VHRDL 162
Query: 412 KSANILI---DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVD 468
           K  N+L+   +K+   K+ DFGL+ + E     +  RL GT  Y+ PE  +      K D
Sbjct: 163 KPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERL-GTAYYIAPEVLR-KKYDEKCD 219
Query: 469 VYAFGVVLYELISA 482
           V++ GV+L+ L++ 
Sbjct: 220 VWSIGVILFILLAG 233

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 101/226 (44%), Gaps = 44/226 (19%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA-----ELKV 334
           +G G +GAV  A + G  G               K AIKK+      E  A     EL++
Sbjct: 33  VGSGAYGAVCSA-VDGRTG--------------AKVAIKKLYRPFQSELFAKRAYRELRL 77
Query: 335 LTHVHHLNLVRLIGYCVEGS-------LFLVYEYI--ENGNLSEHLRGSGRDPLPWSSRV 385
           L H+ H N++ L+               +LV  ++  + G L +H +  G D      R+
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGED------RI 130
Query: 386 Q-IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
           Q +     +GL YIH   +   IHRD+K  N+ ++++   K+ DFGL +  +   + +  
Sbjct: 131 QFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMXG 184
Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            +V  +   P     +   +  VD+++ G ++ E+I+ K  + KG+
Sbjct: 185 XVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFKGS 229

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 40/222 (18%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D + +   IG G FG      +R +  N     L+ V  + +    +K+D    RE + 
Sbjct: 17  SDRYELVKDIGSGNFGVARL--MRDKQSNE----LVAVKYIERG---EKIDENVKREIIN 67
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
              +     H N+VR     +  + L +V EY   G L E +  +GR           + 
Sbjct: 68  HRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----------FSE 113
Query: 390 DSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKN--FHAKVADFGLTKLTEVGS 439
           D AR        G+ Y H   V    HRD+K  N L+D +     K+ DFG +K + + S
Sbjct: 114 DEARFFFQQLISGVSYCHAMQV---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 170
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKV-DVYAFGVVLYELI 480
              P   VGT  Y+ PE     +   KV DV++ GV LY ++
Sbjct: 171 Q--PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 210

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR- 326
            K  D + +  ++G G F  V     +   G  Y ++ I           KK   +ASR 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFI-----------KKRQSRASRR 55
Query: 327 -----EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
                E   E+ +L  V H N++ L   Y     + L+ E +  G L + L  + ++ L 
Sbjct: 56  GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLS 113
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTE 436
                        G+ Y+H   +    H D+K  NI L+DKN    H K+ DFGL    E
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIA---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
            G       + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR- 326
            K  D + +  ++G G F  V     +   G  Y ++ I           KK   +ASR 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFI-----------KKRQSRASRR 55
Query: 327 -----EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
                E   E+ +L  V H N++ L   Y     + L+ E +  G L + L  + ++ L 
Sbjct: 56  GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLS 113
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTE 436
                        G+ Y+H   +    H D+K  NI L+DKN    H K+ DFGL    E
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIA---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
            G       + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 30/226 (13%)
Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR- 326
            K  D + +  ++G G F  V     +   G  Y ++ I           KK   +ASR 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFI-----------KKRQSRASRR 55
Query: 327 -----EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
                E   E+ +L  V H N++ L   Y     + L+ E +  G L + L  + ++ L 
Sbjct: 56  GVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLS 113
Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTE 436
                        G+ Y+H   +    H D+K  NI L+DKN    H K+ DFGL    E
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIA---HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170
Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
            G       + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 171 DGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 106
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 107 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 163
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 164 NEDXELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 478 ELISAK 483
           EL++ +
Sbjct: 220 ELLTGR 225

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 91/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 44  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 96
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +   ++     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 97  DVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 153
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++
Sbjct: 154 VNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 209
Query: 477 YELISAK 483
            EL++ +
Sbjct: 210 AELLTGR 216

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 88/183 (48%), Gaps = 24/183 (13%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNL 367
           K A+KK+       + A R +  EL++L H+ H N++ L+      +     E   +  L
Sbjct: 78  KIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLDVFTPATSL---EEFNDVYL 133
Query: 368 SEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKN 421
             HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ ++++
Sbjct: 134 VTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNED 190
Query: 422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELI 480
              K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ EL+
Sbjct: 191 CELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELL 246
Query: 481 SAK 483
           + +
Sbjct: 247 TGR 249

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 92/193 (47%), Gaps = 29/193 (15%)
Query: 313 QKAAIKKM---DMQASREFLAELKVLTHVHHLNLVRL--------------IGYCVE-GS 354
           ++ AIKK+   D Q+ +  L E+K++  + H N+V++              +G   E  S
Sbjct: 37  KRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS 96
Query: 355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
           +++V EY+E  +L+  L    + PL             RGL+YIH   V   +HRD+K A
Sbjct: 97  VYIVQEYMET-DLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSANV---LHRDLKPA 149
Query: 415 NILID-KNFHAKVADFGLTKLTE---VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVY 470
           N+ I+ ++   K+ DFGL ++ +        L   LV  +   P       + +  +D++
Sbjct: 150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 209
Query: 471 AFGVVLYELISAK 483
           A G +  E+++ K
Sbjct: 210 AAGCIFAEMLTGK 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 106
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 107 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 163
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 164 NEDXELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 478 ELISAK 483
           EL++ +
Sbjct: 220 ELLTGR 225

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 60  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 112
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 113 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 169
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 170 NEDXELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 225
Query: 478 ELISAK 483
           EL++ +
Sbjct: 226 ELLTGR 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 61  RVAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 113
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 114 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 170
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 171 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 478 ELISAK 483
           EL++ +
Sbjct: 227 ELLTGR 232

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTDDEM----TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDXELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 61  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 113
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 114 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 170
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 171 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 478 ELISAK 483
           EL++ +
Sbjct: 227 ELLTGR 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 103
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 104 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 160
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 161 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 478 ELISAK 483
           EL++ +
Sbjct: 217 ELLTGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 61  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 113
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 114 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 170
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 171 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 478 ELISAK 483
           EL++ +
Sbjct: 227 ELLTGR 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 47  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 99
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 100 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 156
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 157 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 212
Query: 478 ELISAK 483
           EL++ +
Sbjct: 213 ELLTGR 218

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 50/93 (53%), Gaps = 4/93 (4%)
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
           + +G++Y+H + V   IHRD+K  N+ ++ +   K+ DFGL    E       T L GT 
Sbjct: 151 TIQGVQYLHNNRV---IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTP 206
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            Y+ PE       S +VD+++ G +LY L+  K
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 103
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 104 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 160
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 161 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 478 ELISAK 483
           EL++ +
Sbjct: 217 ELLTGR 222

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 44  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 96
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 97  DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 153
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++
Sbjct: 154 VNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 209
Query: 477 YELISAK 483
            EL++ +
Sbjct: 210 AELLTGR 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 56  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 108
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 109 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 165
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 166 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221
Query: 478 ELISAK 483
           EL++ +
Sbjct: 222 ELLTGR 227

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 9/191 (4%)
Query: 295 GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI-GYCVEG 353
           G +G  +        L +    IK   M+   E   E+ V+  + H NL++L   +  + 
Sbjct: 100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN 159
Query: 354 SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS 413
            + LV EY++ G L + +     + L     +        G+ ++H+  +   +H D+K 
Sbjct: 160 DIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMHQMYI---LHLDLKP 215
Query: 414 ANIL-IDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYA 471
            NIL ++++    K+ DFGL +  +     L     GT  ++ PE   Y  VS   D+++
Sbjct: 216 ENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 472 FGVVLYELISA 482
            GV+ Y L+S 
Sbjct: 274 VGVIAYMLLSG 284

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 45  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 97
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 98  VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 154
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 155 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210
Query: 478 ELISAK 483
           EL++ +
Sbjct: 211 ELLTGR 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 106
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 107 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 163
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 164 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 478 ELISAK 483
           EL++ +
Sbjct: 220 ELLTGR 225

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 60  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 112
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 113 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 169
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 170 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 225
Query: 478 ELISAK 483
           EL++ +
Sbjct: 226 ELLTGR 231

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 48  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 100
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 101 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 157
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 158 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 213
Query: 478 ELISAK 483
           EL++ +
Sbjct: 214 ELLTGR 219

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 48  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 100
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 157
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++
Sbjct: 158 VNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 477 YELISAK 483
            EL++ +
Sbjct: 214 AELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 68  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 120
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 121 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 177
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++
Sbjct: 178 VNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 233
Query: 477 YELISAK 483
            EL++ +
Sbjct: 234 AELLTGR 240

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 58  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 110
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 111 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 167
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++
Sbjct: 168 VNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 223
Query: 477 YELISAK 483
            EL++ +
Sbjct: 224 AELLTGR 230

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 46  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 98
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 99  VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 155
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 156 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 478 ELISAK 483
           EL++ +
Sbjct: 212 ELLTGR 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 46  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 98
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 99  VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 155
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 156 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 211
Query: 478 ELISAK 483
           EL++ +
Sbjct: 212 ELLTGR 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 72  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 124
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 125 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 181
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 182 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 237
Query: 478 ELISAK 483
           EL++ +
Sbjct: 238 ELLTGR 243

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 68  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 120
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 121 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 177
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 178 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 233
Query: 478 ELISAK 483
           EL++ +
Sbjct: 234 ELLTGR 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 54  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 106
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 107 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 163
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 164 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 219
Query: 478 ELISAK 483
           EL++ +
Sbjct: 220 ELLTGR 225

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 67  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 119
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 120 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 176
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++
Sbjct: 177 VNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 232
Query: 477 YELISAK 483
            EL++ +
Sbjct: 233 AELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 69  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 121
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 122 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 178
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 179 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 478 ELISAK 483
           EL++ +
Sbjct: 235 ELLTGR 240

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 294 RGEYGNSYLSRLICVNLLMQKA-----AIKKM----DMQASREFLAELKVLTHVHHLN-L 343
           RG YG+        VN ++ K      A+K++    D +  ++ L +L V+        +
Sbjct: 32  RGAYGS--------VNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 344 VRLIGYCV-EGSLFLVYEYIENG--NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE 400
           V+  G    EG  ++  E +        +++     D +P     +I L + + L ++ E
Sbjct: 84  VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 401 HTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY--- 457
           +     IHRDIK +NIL+D++ + K+ DFG++   ++  +   TR  G   YM PE    
Sbjct: 144 NLK--IIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 458 -AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            A       + DV++ G+ LYEL + +    K N
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 107
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 164
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 165 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 478 ELISAK 483
           EL++ +
Sbjct: 221 ELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 103
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 104 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 160
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 161 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 478 ELISAK 483
           EL++ +
Sbjct: 217 ELLTGR 222

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 51  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 103
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 104 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 160
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 161 NEDSELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 478 ELISAK 483
           EL++ +
Sbjct: 217 ELLTGR 222

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 36/242 (14%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKV 334
           +G G +G+V          ++Y +RL       QK A+KK+      +  +R    EL++
Sbjct: 36  VGSGAYGSV---------CSAYDARL------RQKVAVKKLSRPFQSLIHARRTYRELRL 80
Query: 335 LTHVHHLNLVRLIGYCVEGSLFLVYE--YIENGNLSEHLRGSGRDPLPWSSRVQ-IALDS 391
           L H+ H N++ L+      +    +   Y+    +   L    +        VQ +    
Sbjct: 81  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQL 140
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
            RGL+YIH   +   IHRD+K +N+ ++++   ++ DFGL +  +       T  V T  
Sbjct: 141 LRGLKYIHSAGI---IHRDLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRW 193
Query: 452 YMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP 510
           Y  PE    +   +  VD+++ G ++ EL+  K A+  G+      K ++    EV+  P
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK-ALFPGSDYIDQLKRIM----EVVGTP 248
Query: 511 DP 512
            P
Sbjct: 249 SP 250

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 107
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 164
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 165 NEDSELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 478 ELISAK 483
           EL++ +
Sbjct: 221 ELLTGR 226

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/242 (24%), Positives = 107/242 (44%), Gaps = 36/242 (14%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKV 334
           +G G +G+V          ++Y +RL       QK A+KK+      +  +R    EL++
Sbjct: 28  VGSGAYGSV---------CSAYDARL------RQKVAVKKLSRPFQSLIHARRTYRELRL 72
Query: 335 LTHVHHLNLVRLIGYCVEGSLFLVYE--YIENGNLSEHLRGSGRDPLPWSSRVQ-IALDS 391
           L H+ H N++ L+      +    +   Y+    +   L    +        VQ +    
Sbjct: 73  LKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQL 132
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
            RGL+YIH   +   IHRD+K +N+ ++++   ++ DFGL +  +       T  V T  
Sbjct: 133 LRGLKYIHSAGI---IHRDLKPSNVAVNEDCELRILDFGLARQADEEM----TGYVATRW 185
Query: 452 YMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP 510
           Y  PE    +   +  VD+++ G ++ EL+  K A+  G+      K ++    EV+  P
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK-ALFPGSDYIDQLKRIM----EVVGTP 240
Query: 511 DP 512
            P
Sbjct: 241 SP 242

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/227 (21%), Positives = 100/227 (44%), Gaps = 28/227 (12%)
Query: 263 SYEELSKATDN---FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK 319
            YE + +  D    + +  ++G G FG VY A+      N     L    ++  K+    
Sbjct: 7   EYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAK------NKETGALAAAKVIETKSE--- 57
Query: 320 MDMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDP 378
              +   +++ E+++L    H  +V+L+G Y  +G L+++ E+   G +   +    R  
Sbjct: 58  ---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL 114
Query: 379 LPWSSRVQIALDSA-RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
                ++Q+        L ++H   +   IHRD+K+ N+L+      ++ADFG++    +
Sbjct: 115 T--EPQIQVVCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSA-KNL 168
Query: 438 GSASLPTRLVGTFGYMPPEYAQYGDVSP-----KVDVYAFGVVLYEL 479
            +       +GT  +M PE      +       K D+++ G+ L E+
Sbjct: 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 113/274 (41%), Gaps = 49/274 (17%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
           + +F +   +G+G +G V  A  +  GE                   AIKK++      F
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEI-----------------VAIKKIEPFDKPLF 52
Query: 329 ----LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYE-YIENGNLSEHLRGSGRDPLPWSS 383
               L E+K+L H  H N++ +       S     E YI    +   L       +    
Sbjct: 53  ALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD 112
Query: 384 RVQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA-- 440
            +Q  +  + R ++ +H   V   IHRD+K +N+LI+ N   KV DFGL ++ +  +A  
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 441 SLPT-------RLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
           S PT         V T  Y  PE     A+Y   S  +DV++ G +L EL   +  I  G
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKY---SRAMDVWSCGCILAELF-LRRPIFPG 225
Query: 490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
                D +  + L   ++  P    DLR +  PR
Sbjct: 226 R----DYRHQLLLIFGIIGTPHSDNDLRCIESPR 255

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 49/274 (17%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
           + +F +   +G+G +G V  A  +  GE                   AIKK++      F
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEI-----------------VAIKKIEPFDKPLF 52
Query: 329 ----LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYE-YIENGNLSEHLRGSGRDPLPWSS 383
               L E+K+L H  H N++ +       S     E YI    +   L       +    
Sbjct: 53  ALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD 112
Query: 384 RVQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE------ 436
            +Q  +  + R ++ +H   V   IHRD+K +N+LI+ N   KV DFGL ++ +      
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 437 ---VGSASLPTRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
               G  S  T  V T  Y  PE     A+Y   S  +DV++ G +L EL   +  I  G
Sbjct: 170 SEPTGQQSGMTEXVATRWYRAPEVMLTSAKY---SRAMDVWSCGCILAELF-LRRPIFPG 225
Query: 490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
                D +  + L   ++  P    DLR +  PR
Sbjct: 226 R----DYRHQLLLIFGIIGTPHSDNDLRCIESPR 255

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/208 (22%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           ++G G FG VY A+      N     L    ++  K+       +   +++ E+++L   
Sbjct: 18  ELGDGAFGKVYKAK------NKETGALAAAKVIETKSE------EELEDYIVEIEILATC 65
Query: 339 HHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSA-RGLE 396
            H  +V+L+G Y  +G L+++ E+   G +   +    R       ++Q+        L 
Sbjct: 66  DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVVCRQMLEALN 123
Query: 397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE 456
           ++H   +   IHRD+K+ N+L+      ++ADFG++    + +       +GT  +M PE
Sbjct: 124 FLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPE 179
Query: 457 YAQYGDVSP-----KVDVYAFGVVLYEL 479
                 +       K D+++ G+ L E+
Sbjct: 180 VVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 49/274 (17%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
           + +F +   +G+G +G V  A  +  GE                   AIKK++      F
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEI-----------------VAIKKIEPFDKPLF 52
Query: 329 ----LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYE-YIENGNLSEHLRGSGRDPLPWSS 383
               L E+K+L H  H N++ +       S     E YI    +   L       +    
Sbjct: 53  ALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDD 112
Query: 384 RVQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE------ 436
            +Q  +  + R ++ +H   V   IHRD+K +N+LI+ N   KV DFGL ++ +      
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 437 ---VGSASLPTRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
               G  S  T  V T  Y  PE     A+Y   S  +DV++ G +L EL   +  I  G
Sbjct: 170 SEPTGQQSGMTEYVATRWYRAPEVMLTSAKY---SRAMDVWSCGCILAELF-LRRPIFPG 225
Query: 490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
                D +  + L   ++  P    DLR +  PR
Sbjct: 226 R----DYRHQLLLIFGIIGTPHSDNDLRCIESPR 255

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 55  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 107
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 108 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 164
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 165 NEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 220
Query: 478 ELISAK 483
           EL++ +
Sbjct: 221 ELLTGR 226

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 55/107 (51%), Gaps = 14/107 (13%)
Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-----------TK 433
           + I +  A  +E++H   +   +HRD+K +NI    +   KV DFGL           T 
Sbjct: 167 LHIFIQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           LT + + +     VGT  YM PE     + S KVD+++ G++L+EL+
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 72  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 124
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 125 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 181
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+          V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 182 NEDCELKILDFGLARHTDDEMXG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 237
Query: 478 ELISAK 483
           EL++ +
Sbjct: 238 ELLTGR 243

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 54  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 106
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 107 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 163
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+       T  V T  Y  PE    +   +  VD+++ G ++
Sbjct: 164 VNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 219
Query: 477 YELISAK 483
            EL++ +
Sbjct: 220 AELLTGR 226

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 44/202 (21%)
Query: 315 AAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYCVEGSLFLVY-----------EYI 362
            A+K+M +      L E+K+LT    H N++R   YC E +   +Y           + +
Sbjct: 42  VAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLV 99
Query: 363 ENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID--- 419
           E+ N+S+      ++  P S   QIA     G+ ++H   +   IHRD+K  NIL+    
Sbjct: 100 ESKNVSDENLKLQKEYNPISLLRQIA----SGVAHLHSLKI---IHRDLKPQNILVSTSS 152
Query: 420 ----------KNFHAKVADFGLTKLTEVGSASLPTRL---VGTFGYMPPEYAQYGD---- 462
                     +N    ++DFGL K  + G +S  T L    GT G+  PE  +  +    
Sbjct: 153 RFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQT 212
Query: 463 ---VSPKVDVYAFGVVLYELIS 481
              ++  +D+++ G V Y ++S
Sbjct: 213 KRRLTRSIDIFSMGCVFYYILS 234

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 68  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 120
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 121 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 177
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DFGL + T+          V T  Y  PE    +   +  VD+++ G ++
Sbjct: 178 VNEDCELKILDFGLARHTDDEMXG----XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 233
Query: 477 YELISAK 483
            EL++ +
Sbjct: 234 AELLTGR 240

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 89/227 (39%), Gaps = 16/227 (7%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
            +F    ++G G +G V+    + E G  Y  +         K   +K+    S E + +
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSK-EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
                   H   VRL     EG +  +   +   +L +H    G   LP +       D+
Sbjct: 116 --------HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGAS-LPEAQVWGYLRDT 166
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
              L ++H   +   +H D+K ANI +      K+ DFGL  L E+G+A       G   
Sbjct: 167 LLALAHLHSQGL---VHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPR 221
Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
           YM PE  Q G      DV++ G+ + E+    E    G G     +G
Sbjct: 222 YMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG 267

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/250 (23%), Positives = 98/250 (39%), Gaps = 45/250 (18%)
Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
           +E     +   +   IG+G FG VY+    GE                   AI+ +D++ 
Sbjct: 26  QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE------------------VAIRLIDIER 67
Query: 325 SRE-----FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
             E     F  E+       H N+V  +G C+      +   +  G     +    +  L
Sbjct: 68  DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL 127
Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT---E 436
             +   QIA +  +G+ Y+H   +   +H+D+KS N+  D N    + DFGL  ++   +
Sbjct: 128 DVNKTRQIAQEIVKGMGYLHAKGI---LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183
Query: 437 VGSASLPTRLV-GTFGYMPPEYAQYGDVSPKV-----------DVYAFGVVLYELISAKE 484
            G      R+  G   ++ PE  +   +SP             DV+A G + YEL  A+E
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIR--QLSPDTEEDKLPFSKHSDVFALGTIWYEL-HARE 240
Query: 485 AIVKGNGSSA 494
              K   + A
Sbjct: 241 WPFKTQPAEA 250

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 120/288 (41%), Gaps = 55/288 (19%)
Query: 238 VESTGPAAGTPTSLNAITVDKSVEFSYEELSKAT----DNFSMSHKIGQGGFGAVYYAEL 293
           +E +GP AG               F  +EL+K              +G G +G+V     
Sbjct: 5   LEMSGPRAG---------------FYRQELNKTVWEVPQRLQGLRPVGSGAYGSV----- 44
Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKVLTHVHHLNLVRLIG 348
                ++Y +RL       QK A+KK+      +  +R    EL++L H+ H N++ L+ 
Sbjct: 45  ----CSAYDARL------RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLD 94
Query: 349 YCVEGSLFLVYE--YIENGNLSEHLRGSGRDPLPWSSRVQ-IALDSARGLEYIHEHTVPV 405
                +    +   Y+    +   L    +        VQ +     RGL+YIH   +  
Sbjct: 95  VFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI-- 152
Query: 406 YIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVS 464
            IHRD+K +N+ ++++   ++ DFGL +  +       T  V T  Y  PE    +   +
Sbjct: 153 -IHRDLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRWYRAPEIMLNWMHYN 207
Query: 465 PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
             VD+++ G ++ EL+  K A+  G+      K ++    EV+  P P
Sbjct: 208 QTVDIWSVGCIMAELLQGK-ALFPGSDYIDQLKRIM----EVVGTPSP 250

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
           + +G++Y+H + V   IHRD+K  N+ ++ +   K+ DFGL    E         L GT 
Sbjct: 135 TIQGVQYLHNNRV---IHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTP 190
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            Y+ PE       S +VD+++ G +LY L+  K
Sbjct: 191 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 90/186 (48%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ D+GL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDYGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
           + +G++Y+H + V   IHRD+K  N+ ++ +   K+ DFGL    E         L GT 
Sbjct: 151 TIQGVQYLHNNRV---IHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKXLCGTP 206
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            Y+ PE       S +VD+++ G +LY L+  K
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D + +   IG G FG      +R +  N     L+ V  + +    +K+     RE + 
Sbjct: 18  SDRYELVKDIGSGNFGVARL--MRDKQSNE----LVAVKYIERG---EKIAANVKREIIN 68
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
              +     H N+VR     +  + L +V EY   G L E +  +GR           + 
Sbjct: 69  HRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----------FSE 114
Query: 390 DSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKN--FHAKVADFGLTKLTEVGS 439
           D AR        G+ Y H   V    HRD+K  N L+D +     K+ DFG +K + + S
Sbjct: 115 DEARFFFQQLISGVSYCHAMQV---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 171
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKV-DVYAFGVVLYELI 480
              P   VGT  Y+ PE     +   KV DV++ GV LY ++
Sbjct: 172 Q--PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 4/93 (4%)
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
           + +G++Y+H + V   IHRD+K  N+ ++ +   K+ DFGL    E         L GT 
Sbjct: 151 TIQGVQYLHNNRV---IHRDLKLGNLFLNDDMDVKIGDFGLATKIEF-DGERKKDLCGTP 206
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            Y+ PE       S +VD+++ G +LY L+  K
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLY 477
           +++   K+ DFGL + T+       T  V T  Y  PE        +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDFGLARHTDDEM----TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 13/170 (7%)
Query: 318 KKMDMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGR 376
           K+M+    +E  A LK+     H N+V+L   +  +   FLV E +  G L E ++    
Sbjct: 46  KRMEANTQKEITA-LKLCEG--HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH 102
Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTK 433
                +S +   L SA      H H V V +HRD+K  N+L    + N   K+ DFG  +
Sbjct: 103 FSETEASYIMRKLVSAVS----HMHDVGV-VHRDLKPENLLFTDENDNLEIKIIDFGFAR 157
Query: 434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           L    +  L T    T  Y  PE           D+++ GV+LY ++S +
Sbjct: 158 LKPPDNQPLKTPCF-TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D + +   IG G FG      +R +  N     L+ V  + +    +K+D    RE + 
Sbjct: 18  SDRYELVKDIGSGNFGVARL--MRDKQSNE----LVAVKYIERG---EKIDENVKREIIN 68
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
              +     H N+VR     +  + L +V EY   G L E +  +GR           + 
Sbjct: 69  HRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----------FSE 114
Query: 390 DSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKN--FHAKVADFGLTKLTEVGS 439
           D AR        G+ Y H   V    HRD+K  N L+D +     K+  FG +K + + S
Sbjct: 115 DEARFFFQQLISGVSYCHAMQV---CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHS 171
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKV-DVYAFGVVLYELI 480
              P   VGT  Y+ PE     +   KV DV++ GV LY ++
Sbjct: 172 Q--PKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S
Sbjct: 177 IFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D + +   IG G FG      +R +  N     L+ V  + +    +K+D    RE + 
Sbjct: 18  SDRYELVKDIGSGNFGVARL--MRDKQSNE----LVAVKYIERG---EKIDENVKREIIN 68
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
              +     H N+VR     +  + L +V EY   G L E +  +GR           + 
Sbjct: 69  HRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----------FSE 114
Query: 390 DSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKN--FHAKVADFGLTKLTEVGS 439
           D AR        G+ Y H   V    HRD+K  N L+D +     K+  FG +K + + S
Sbjct: 115 DEARFFFQQLISGVSYCHAMQV---CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHS 171
Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKV-DVYAFGVVLYELI 480
              P   VGT  Y+ PE     +   KV DV++ GV LY ++
Sbjct: 172 Q--PKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE        L+ +  ++Q  A K            
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGE--------LVAIKKVLQGKAFKNR---------- 62
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 179 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 217

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE        L+ +  ++Q  A K            
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGE--------LVAIKKVLQGKAFKNR---------- 62
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 179 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
           K  DN+ + H IG+G +G VY A  +    N  + +   VN + +       D+   +  
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKK---VNRMFE-------DLIDCKRI 74
Query: 329 LAELKVLTHVHHLNLVRLIGYCVEGSLFLVYE-YIENGNLSEHLRGSGRDPLPWSSR--V 385
           L E+ +L  +    ++RL    +   L    E YI        L+   + P+  + +   
Sbjct: 75  LREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVK 134
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            I  +   G ++IHE  +   IHRD+K AN L++++   K+ DFGL +
Sbjct: 135 TILYNLLLGEKFIHESGI---IHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 104/253 (41%), Gaps = 56/253 (22%)
Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK 333
           + +   IGQG +G V  A +  +      +R I    +M K  I++++ +       E++
Sbjct: 28  YHLKGAIGQGSYGVVRVA-IENQ------TRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 334 VLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNL------------------------- 367
           ++  +HH N+ RL   Y  E  + LV E    G+L                         
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 368 ------SEHLRGS---GRDPLPWSSRVQIALDSAR----GLEYIHEHTVPVYIHRDIKSA 414
                  E + GS    R+ L +  R ++  +  R     L Y+H   +    HRDIK  
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI---CHRDIKPE 197
Query: 415 NILI--DKNFHAKVADFGLTK---LTEVGSASLPTRLVGTFGYMPPEYAQYGDVS--PKV 467
           N L   +K+F  K+ DFGL+K       G     T   GT  ++ PE     + S  PK 
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 468 DVYAFGVVLYELI 480
           D ++ GV+L+ L+
Sbjct: 258 DAWSAGVLLHLLL 270

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 96
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 155
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 213 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 251

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 98
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 157
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 158 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 214
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 215 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 253

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT--EVGSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+LI+     K+ DFGL ++   E       T  V T 
Sbjct: 155 RGLKYIHSANV---LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATR 211
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE        L+ +  ++Q  A K            
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGE--------LVAIKKVLQGKAFKNR---------- 62
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHY-SRAKQTLPV 121
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 179 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 96
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 155
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 213 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 251

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 75
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 134
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 135 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 191
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 192 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 230

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 81
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 140
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 141 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 197
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 198 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 236

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 90
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 149
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 150 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 206
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 207 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 245

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 67
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 126
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 127 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 183
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 184 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 222

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 100
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 159
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 160 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 216
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 217 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 255

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 70
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 129
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 130 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 186
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 187 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 225

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 74
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 133
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 134 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 190
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 191 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 229

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+  FGL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILGFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 62
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 179 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 63
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 122
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 123 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 179
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 180 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 218

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 62
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 179 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 217

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 74
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 133
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 134 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 190
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 191 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 229

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 141
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 200
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 201 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 257
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 258 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 296

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 66
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 125
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 126 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 182
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 183 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 221

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D + +   IG+G F  V    +  E G  +  +++ V        +   D++        
Sbjct: 26  DVYELCEVIGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 84
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QIAL 389
           LK   H H + L+    Y  +G L++V+E+++  +L   +         +S  V      
Sbjct: 85  LK---HPHIVELLET--YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 139
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILI-DKNFHAKVADFGLTKLTEVGSASL-PTRLV 447
                L Y H++ +   IHRD+K   +L+  K   A V   G     ++G + L     V
Sbjct: 140 QILEALRYCHDNNI---IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 196
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           GT  +M PE  +       VDV+  GV+L+ L+S 
Sbjct: 197 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ D GL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDAGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 62
Query: 331 ELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +         E  L LV +Y+      ++ H     +  LP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 179 NV--SYICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D + +   IG+G F  V    +  E G  +  +++ V        +   D++        
Sbjct: 24  DVYELCEVIGKGPFSVVRRC-INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QIAL 389
           LK   H H + L  L  Y  +G L++V+E+++  +L   +         +S  V      
Sbjct: 83  LK---HPHIVEL--LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILI-DKNFHAKVADFGLTKLTEVGSASL-PTRLV 447
                L Y H++ +   IHRD+K   +L+  K   A V   G     ++G + L     V
Sbjct: 138 QILEALRYCHDNNI---IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           GT  +M PE  +       VDV+  GV+L+ L+S 
Sbjct: 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ D GL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDRGLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 62
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 120
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 121 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 175
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/187 (26%), Positives = 89/187 (47%), Gaps = 30/187 (16%)
Query: 313 QKAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN 366
            + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N
Sbjct: 48  HRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFN 100
Query: 367 ---LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANIL 417
              L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ 
Sbjct: 101 DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLA 157
Query: 418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL 476
           ++++   K+ DF L + T+       T  V T  Y  PE    +   +  VD+++ G ++
Sbjct: 158 VNEDCELKILDFYLARHTDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 213
Query: 477 YELISAK 483
            EL++ +
Sbjct: 214 AELLTGR 220

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 62
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 120
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 121 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 175
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 95/222 (42%), Gaps = 39/222 (17%)
Query: 273 NFSMSHKIGQGGFGAVYYAEL--RGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +++ +  IG G FG VY A+L   GE                   AIKK+ +Q  R    
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL-----------------VAIKKV-LQDKRFKNR 62
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGS-------LFLVYEYIENG--NLSEHLRGSGRDPLPW 381
           EL+++  + H N+VRL  +            L LV +Y+      ++ H     +  LP 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHY-SRAKQTLPV 121
Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSA 440
                      R L YIH   +    HRDIK  N+L+D +    K+ DFG  K    G  
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178
Query: 441 SLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELI 480
           ++    + +  Y  PE   +G  D +  +DV++ G VL EL+
Sbjct: 179 NV--SXICSRYYRAPELI-FGATDYTSSIDVWSAGCVLAELL 217

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/271 (22%), Positives = 120/271 (44%), Gaps = 36/271 (13%)
Query: 298 GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL-- 355
           G  +  R    +++++   ++    + SR+F  E   L    H N++ ++G C       
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 356 -FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
             L+  ++  G+L   L       +  S  V+ ALD ARG+ ++H    P+     + S 
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSR 142
Query: 415 NILIDKNFHAKVADFGLTKLTEVG-SASLPTRLVGTFGYMPPEYAQYG--DVSPK-VDVY 470
           +++ID++  A+++      + +V  S   P R+     ++ PE  Q    D + +  D++
Sbjct: 143 SVMIDEDMTARIS------MADVKFSFQSPGRMYAP-AWVAPEALQKKPEDTNRRSADMW 195
Query: 471 AFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPL 530
           +F V+L+EL++ +  +   + S+ +    VAL           E LR  + P +  +   
Sbjct: 196 SFAVLLWELVTRE--VPFADLSNMEIGMKVAL-----------EGLRPTIPPGISPH--- 239
Query: 531 DSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                +++L K+C  E P  RP    IV  L
Sbjct: 240 -----VSKLMKICMNEDPAKRPKFDMIVPIL 265

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 89/192 (46%), Gaps = 28/192 (14%)
Query: 313 QKAAIKKMDMQASREFLA-----ELKVLTHVHHLNLVRLIGYCVEGS-------LFLVYE 360
           +K AIKK+      E  A     EL +L H+ H N++ L+      S        +LV  
Sbjct: 68  EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 127
Query: 361 YIENGNLSEHLRGSGRDPLPWSSRVQ-IALDSARGLEYIHEHTVPVYIHRDIKSANILID 419
           +++  +L + +     +      ++Q +     +GL+YIH   V   +HRD+K  N+ ++
Sbjct: 128 FMQT-DLQKIMGMEFSE-----EKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNLAVN 178
Query: 420 KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYE 478
           ++   K+ DFGL +  +       T  V T  Y  PE    +   +  VD+++ G ++ E
Sbjct: 179 EDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAE 234
Query: 479 LISAKEAIVKGN 490
           +++ K  + KG 
Sbjct: 235 MLTGK-TLFKGK 245

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 30/186 (16%)
Query: 314 KAAIKKMD------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGN- 366
           + A+KK+       + A R +  EL++L H+ H N++ L+       +F     +E  N 
Sbjct: 49  RVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL------DVFTPARSLEEFND 101
Query: 367 --LSEHLRGSGRDPLPWSSR-----VQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILI 418
             L  HL G+  + +    +     VQ  +    RGL+YIH   +   IHRD+K +N+ +
Sbjct: 102 VYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAV 158
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ D GL + T+       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 159 NEDCELKILDGGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 214
Query: 478 ELISAK 483
           EL++ +
Sbjct: 215 ELLTGR 220

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 53/296 (17%)
Query: 274 FSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +S+  +IG GG   V+    E +  Y   Y++        +++A  + +D  + R  +A 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--------LEEADNQTLD--SYRNEIAY 79
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL-PWSSRVQIALD 390
           L  L   H   ++RL  Y +      +Y  +E GN+  +     +  + PW  R     +
Sbjct: 80  LNKLQQ-HSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKN 135
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL-PTRLVGT 449
               +  IH+H +   +H D+K AN LI      K+ DFG+    +  + S+     VGT
Sbjct: 136 MLEAVHTIHQHGI---VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 450 FGYMPPEYAQYGDVSPK-----------VDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
             YMPPE  +    S +            DV++ G +LY +   K               
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------------- 238
Query: 499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM 554
               F++++N    I  L  ++DP      P      +  + K C +  P+ R S+
Sbjct: 239 ----FQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/259 (23%), Positives = 107/259 (41%), Gaps = 43/259 (16%)
Query: 248 PTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLIC 307
           P SL   +     +F  + +        +   + +GGF  VY A+  G      L RL+ 
Sbjct: 4   PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS 63
Query: 308 VNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL-----------F 356
                 +A I+++       F+ +L       H N+V+   +C   S+           F
Sbjct: 64  NEEEKNRAIIQEVC------FMKKLS-----GHPNIVQ---FCSAASIGKEESDTGQAEF 109
Query: 357 LVYEYIENGNLSEHLRG-SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN 415
           L+   +  G L E L+    R PL   + ++I   + R ++++H    P+ IHRD+K  N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI-IHRDLKVEN 168
Query: 416 ILIDKNFHAKVADFG----LTKLTEVGSASLPTRLV-------GTFGYMPPE----YAQY 460
           +L+      K+ DFG    ++   +   ++    LV        T  Y  PE    Y+ +
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228
Query: 461 GDVSPKVDVYAFGVVLYEL 479
             +  K D++A G +LY L
Sbjct: 229 -PIGEKQDIWALGCILYLL 246

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 90/193 (46%), Gaps = 30/193 (15%)
Query: 313 QKAAIKKMDMQASREFLA-----ELKVLTHVHHLNLVRLIGYCVEGS-------LFLVYE 360
           +K AIKK+      E  A     EL +L H+ H N++ L+      S        +LV  
Sbjct: 50  EKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP 109
Query: 361 YIENGNLSEHLRGSGRDPLPWSS-RVQ-IALDSARGLEYIHEHTVPVYIHRDIKSANILI 418
           +++     + + G     L +S  ++Q +     +GL+YIH   V   +HRD+K  N+ +
Sbjct: 110 FMQTD--LQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNLAV 159
Query: 419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLY 477
           +++   K+ DFGL +  +       T  V T  Y  PE    +   +  VD+++ G ++ 
Sbjct: 160 NEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 478 ELISAKEAIVKGN 490
           E+++ K  + KG 
Sbjct: 216 EMLTGK-TLFKGK 227

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 16/165 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           DN+ + H IG+G +G VY A  +    N  + +   VN + +       D+   +  L E
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKK---VNRMFE-------DLIDCKRILRE 75
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYE-YIENGNLSEHLRGSGRDPLPWSSR--VQIA 388
           + +L  +    ++RL    +   L    E YI        L+   + P+  +      I 
Sbjct: 76  ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL 135
Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            +   G  +IHE  +   IHRD+K AN L++++   KV DFGL +
Sbjct: 136 YNLLLGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 72/313 (23%), Positives = 126/313 (40%), Gaps = 53/313 (16%)
Query: 257 DKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQK 314
           DK+   + E +S     +S+  +IG GG   V+    E +  Y   Y++        +++
Sbjct: 41  DKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--------LEE 92
Query: 315 AAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGS 374
           A  + +D  + R  +A L  L   H   ++RL  Y +      +Y  +E GN+  +    
Sbjct: 93  ADNQTLD--SYRNEIAYLNKLQQ-HSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLK 147
Query: 375 GRDPL-PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            +  + PW  R     +    +  IH+H +   +H D+K AN LI      K+ DFG+  
Sbjct: 148 KKKSIDPWE-RKSYWKNMLEAVHTIHQHGI---VHSDLKPANFLIVDGM-LKLIDFGIAN 202
Query: 434 LTEVGSASL-PTRLVGTFGYMPPEYAQYGDVSPK-----------VDVYAFGVVLYELIS 481
             +  + S+     VGT  YMPPE  +    S +            DV++ G +LY +  
Sbjct: 203 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262
Query: 482 AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAK 541
            K                   F++++N    I  L  ++DP      P      +  + K
Sbjct: 263 GKTP-----------------FQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLK 302
Query: 542 VCTQEYPQLRPSM 554
            C +  P+ R S+
Sbjct: 303 CCLKRDPKQRISI 315

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 53/296 (17%)
Query: 274 FSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +S+  +IG GG   V+    E +  Y   Y++        +++A  + +D  + R  +A 
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--------LEEADNQTLD--SYRNEIAY 63
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL-PWSSRVQIALD 390
           L  L   H   ++RL  Y +      +Y  +E GN+  +     +  + PW  R     +
Sbjct: 64  LNKLQQ-HSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKN 119
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL-PTRLVGT 449
               +  IH+H +   +H D+K AN LI      K+ DFG+    +  + S+     VGT
Sbjct: 120 MLEAVHTIHQHGI---VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 175
Query: 450 FGYMPPEYAQYGDVSPK-----------VDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
             YMPPE  +    S +            DV++ G +LY +   K               
Sbjct: 176 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------------- 222
Query: 499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM 554
               F++++N    I  L  ++DP      P      +  + K C +  P+ R S+
Sbjct: 223 ----FQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 271

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 103/233 (44%), Gaps = 22/233 (9%)
Query: 256 VDKSVEFSYEELSKATDNFSM--SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQ 313
           VD   E  Y +  +  +NF +  S ++G+G F  V    +    G  Y ++ +       
Sbjct: 11  VDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQC-ISKSTGQEYAAKFL------- 62
Query: 314 KAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS--LFLVYEYIENGNLSEHL 371
           K   +  D +A  E L E+ VL        V  +    E +  + L+ EY   G +    
Sbjct: 63  KKRRRGQDCRA--EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120
Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF---HAKVAD 428
                + +  +  +++      G+ Y+H++ +   +H D+K  NIL+   +     K+ D
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNI---VHLDLKPQNILLSSIYPLGDIKIVD 177
Query: 429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           FG+++  ++G A     ++GT  Y+ PE   Y  ++   D++  G++ Y L++
Sbjct: 178 FGMSR--KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 321 DMQASRE-FLAELKVLTHVH-HLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRD 377
           ++Q  RE  L E+ +L  V  H N+++L   Y      FLV++ ++ G L ++L      
Sbjct: 49  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 108
Query: 378 PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
               + ++  AL     LE I        +HRD+K  NIL+D + + K+ DFG +   + 
Sbjct: 109 SEKETRKIMRAL-----LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 163
Query: 438 GSASLPTRLVGTFGYMPPEYAQ--YGDVSP----KVDVYAFGVVLYELISA 482
           G       + GT  Y+ PE  +    D  P    +VD+++ GV++Y L++ 
Sbjct: 164 GEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 35/217 (16%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF----LAELKVL 335
           IG+G +G V  A     Y N        VN +  + AIKK+     + +    L E+K+L
Sbjct: 51  IGEGAYGMVCSA-----YDN--------VNKV--RVAIKKISPFEHQTYCQRTLREIKIL 95
Query: 336 THVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ------IAL 389
               H N++ +       ++    E +++  L  HL G+    L  +  +          
Sbjct: 96  LRFRHENIIGINDIIRAPTI----EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLY 151
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLV 447
              RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V
Sbjct: 152 QILRGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 448 GTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            T  Y  PE        +  +D+++ G +L E++S +
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 43/225 (19%)
Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
           K+G+GGF  V   E   +     L R++C     ++ A ++ DM   R F          
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMH--RLF---------- 83
Query: 339 HHLNLVRLIGYCV-----EGSLFLVYEYIENGNLS---EHLRGSG----RDPLPWSSRVQ 386
           +H N++RL+ YC+     +   +L+  + + G L    E L+  G     D + W     
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW----- 138
Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           + L   RGLE IH      Y HRD+K  NIL+       + D G      +        L
Sbjct: 139 LLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 447 V--------GTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELI 480
                     T  Y  PE      +  +  + DV++ G VLY ++
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 20/217 (9%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE +  
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIER 63
Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           E+ +L  + H N++ L   Y  +  + L+ E +  G L + L  + ++ L      +   
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL--AEKESLTEEEATEFLK 121
Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANI-LIDKNF---HAKVADFGLTKLTEVGSASLPTR 445
               G+ Y+H   +    H D+K  NI L+D+N      K+ DFGL    + G+      
Sbjct: 122 QILNGVYYLHSLQIA---HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KN 176
Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           + GT  ++ PE   Y  +  + D+++ GV+ Y L+S 
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 53/296 (17%)
Query: 274 FSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +S+  +IG GG   V+    E +  Y   Y++        +++A  + +D  + R  +A 
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--------LEEADNQTLD--SYRNEIAY 59
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL-PWSSRVQIALD 390
           L  L   H   ++RL  Y +      +Y  +E GN+  +     +  + PW  R     +
Sbjct: 60  LNKLQQ-HSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKN 115
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL-PTRLVGT 449
               +  IH+H +   +H D+K AN LI      K+ DFG+    +  + S+     VGT
Sbjct: 116 MLEAVHTIHQHGI---VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 171
Query: 450 FGYMPPEYAQYGDVSPK-----------VDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
             YMPPE  +    S +            DV++ G +LY +   K               
Sbjct: 172 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------------- 218
Query: 499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM 554
               F++++N    I  L  ++DP      P      +  + K C +  P+ R S+
Sbjct: 219 ----FQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 267

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/313 (23%), Positives = 126/313 (40%), Gaps = 53/313 (16%)
Query: 257 DKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQK 314
           DK+   + E +S     +S+  +IG GG   V+    E +  Y   Y++        +++
Sbjct: 41  DKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--------LEE 92
Query: 315 AAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGS 374
           A  + +D  + R  +A L  L   H   ++RL  Y +      +Y  +E GN+  +    
Sbjct: 93  ADNQTLD--SYRNEIAYLNKLQQ-HSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLK 147
Query: 375 GRDPL-PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            +  + PW  R     +    +  IH+H +   +H D+K AN LI      K+ DFG+  
Sbjct: 148 KKKSIDPWE-RKSYWKNMLEAVHTIHQHGI---VHSDLKPANFLIVDGM-LKLIDFGIAN 202
Query: 434 LTEVGSASL-PTRLVGTFGYMPPEYAQYGDVSPK-----------VDVYAFGVVLYELIS 481
             +  + S+     VGT  YMPPE  +    S +            DV++ G +LY +  
Sbjct: 203 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262
Query: 482 AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAK 541
            K                   F++++N    I  L  ++DP      P      +  + K
Sbjct: 263 GKTP-----------------FQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLK 302
Query: 542 VCTQEYPQLRPSM 554
            C +  P+ R S+
Sbjct: 303 CCLKRDPKQRISI 315

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 53/296 (17%)
Query: 274 FSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +S+  +IG GG   V+    E +  Y   Y++        +++A  + +D  + R  +A 
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--------LEEADNQTLD--SYRNEIAY 60
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL-PWSSRVQIALD 390
           L  L   H   ++RL  Y +      +Y  +E GN+  +     +  + PW  R     +
Sbjct: 61  LNKLQQ-HSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKN 116
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL-PTRLVGT 449
               +  IH+H +   +H D+K AN LI      K+ DFG+    +  + S+     VGT
Sbjct: 117 MLEAVHTIHQHGI---VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGT 172
Query: 450 FGYMPPEYAQYGDVSPK-----------VDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
             YMPPE  +    S +            DV++ G +LY +   K               
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------------- 219
Query: 499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM 554
               F++++N    I  L  ++DP      P      +  + K C +  P+ R S+
Sbjct: 220 ----FQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 107/234 (45%), Gaps = 40/234 (17%)
Query: 274 FSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-REFLA 330
           + +  K+G+G +G V+ +  R  GE        ++ V  +   A     D Q + RE + 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGE--------VVAVKKIFD-AFQNSTDAQRTFREIMI 61
Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
             ++  H + +NL+ ++    +  ++LV++Y+E  +L   +R +  +P+    +  +   
Sbjct: 62  LTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPV---HKQYVVYQ 117
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL---------------- 434
             + ++Y+H   +   +HRD+K +NIL++   H KVADFGL++                 
Sbjct: 118 LIKVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSIN 174
Query: 435 --TEVGSASLP--TRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAK 483
             TE      P  T  V T  Y  PE         K +D+++ G +L E++  K
Sbjct: 175 ENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 321 DMQASREF-LAELKVLTHVH-HLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRD 377
           ++Q  RE  L E+ +L  V  H N+++L   Y      FLV++ ++ G L ++L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 378 PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
               + ++  AL     LE I        +HRD+K  NIL+D + + K+ DFG +   + 
Sbjct: 122 SEKETRKIMRAL-----LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 438 GSASLPTRLVGTFGYMPPEYAQ--YGDVSP----KVDVYAFGVVLYELISA 482
           G       + GT  Y+ PE  +    D  P    +VD+++ GV++Y L++ 
Sbjct: 177 GEKL--REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 139 RGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 139 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 321 DMQASRE-FLAELKVLTHVH-HLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRD 377
           ++Q  RE  L E+ +L  V  H N+++L   Y      FLV++ ++ G L ++L      
Sbjct: 62  EVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL 121
Query: 378 PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
               + ++  AL     LE I        +HRD+K  NIL+D + + K+ DFG +   + 
Sbjct: 122 SEKETRKIMRAL-----LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
Query: 438 GSASLPTRLVGTFGYMPPEYAQ--YGDVSP----KVDVYAFGVVLYELISA 482
           G       + GT  Y+ PE  +    D  P    +VD+++ GV++Y L++ 
Sbjct: 177 GEKL--RSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 40/198 (20%)
Query: 315 AAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYCVEGSLFLVY-----------EYI 362
            A+K+M +      L E+K+LT    H N++R   YC E +   +Y           + +
Sbjct: 60  VAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLV 117
Query: 363 ENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID--- 419
           E+ N+S+      ++  P S   QIA   A      H H++ + IHRD+K  NIL+    
Sbjct: 118 ESKNVSDENLKLQKEYNPISLLRQIASGVA------HLHSLKI-IHRDLKPQNILVSTSS 170
Query: 420 ----------KNFHAKVADFGLTKLTEVGSASLPTRL---VGTFGYMPPEYAQYG---DV 463
                     +N    ++DFGL K  + G       L    GT G+  PE  +      +
Sbjct: 171 RFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRL 230
Query: 464 SPKVDVYAFGVVLYELIS 481
           +  +D+++ G V Y ++S
Sbjct: 231 TRSIDIFSMGCVFYYILS 248

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 135 RGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 140 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 141 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 132 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 139 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 40/198 (20%)
Query: 315 AAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYCVEGSLFLVY-----------EYI 362
            A+K+M +      L E+K+LT    H N++R   YC E +   +Y           + +
Sbjct: 60  VAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLV 117
Query: 363 ENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID--- 419
           E+ N+S+      ++  P S   QIA   A      H H++ + IHRD+K  NIL+    
Sbjct: 118 ESKNVSDENLKLQKEYNPISLLRQIASGVA------HLHSLKI-IHRDLKPQNILVSTSS 170
Query: 420 ----------KNFHAKVADFGLTKLTEVGSASLPTRL---VGTFGYMPPEYAQYG---DV 463
                     +N    ++DFGL K  + G       L    GT G+  PE  +      +
Sbjct: 171 RFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRL 230
Query: 464 SPKVDVYAFGVVLYELIS 481
           +  +D+++ G V Y ++S
Sbjct: 231 TRSIDIFSMGCVFYYILS 248

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 137 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 139 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 135 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 139 RGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 137 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 133 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 133 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 143 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 135 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 155 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 135 RGLKYIHSANV---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NLS+               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLSQ--------------VIQMELDHERMSYLLYQMLVGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ GV++ E+I  
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 135 RGLKYIHSANV---LHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +         T  V T 
Sbjct: 137 RGLKYIHSANV---LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 44/202 (21%)
Query: 315 AAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYCVEGSLFLVY-----------EYI 362
            A+K+M +      L E+K+LT    H N++R   YC E +   +Y           + +
Sbjct: 42  VAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY--YCSETTDRFLYIALELCNLNLQDLV 99
Query: 363 ENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID--- 419
           E+ N+S+      ++  P S   QIA   A      H H++ + IHRD+K  NIL+    
Sbjct: 100 ESKNVSDENLKLQKEYNPISLLRQIASGVA------HLHSLKI-IHRDLKPQNILVSTSS 152
Query: 420 ----------KNFHAKVADFGLTKLTEVGSASLPTRL---VGTFGYMPPEYAQYGD---- 462
                     +N    ++DFGL K  + G       L    GT G+  PE  +  +    
Sbjct: 153 RFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQT 212
Query: 463 ---VSPKVDVYAFGVVLYELIS 481
              ++  +D+++ G V Y ++S
Sbjct: 213 KRRLTRSIDIFSMGCVFYYILS 234

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/312 (21%), Positives = 125/312 (40%), Gaps = 66/312 (21%)
Query: 256 VDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           V K +E  YE + + ++ F +  KIG+G F +VY A  + + G              +K 
Sbjct: 5   VKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPE------------EKI 52
Query: 316 AIKKM-DMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS--LFLVYEYIENGNLSEHLR 372
           A+K +          AEL+ LT     + V  + YC   +  + +   Y+E+ +  + L 
Sbjct: 53  ALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL- 111
Query: 373 GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGL 431
               + L +    +  L+  + L+ IH+  +   +HRD+K +N L ++      + DFGL
Sbjct: 112 ----NSLSFQEVREYMLNLFKALKRIHQFGI---VHRDVKPSNFLYNRRLKKYALVDFGL 164
Query: 432 TKLTE---------VGSASLPTRL------------------VGTFGYMPPE-YAQYGDV 463
            + T          V S +   R                    GT G+  PE   +  + 
Sbjct: 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQ 224
Query: 464 SPKVDVYAFGVVLYELISAKEAIVKGN-------------GSSADSKGLVALFEEVLNLP 510
           +  +D+++ GV+   L+S +    K +             GS    +      + +L   
Sbjct: 225 TTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSK 284
Query: 511 D-PIEDLRKLVD 521
           + P +DLRKL +
Sbjct: 285 EVPAQDLRKLCE 296

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 57/129 (44%), Gaps = 9/129 (6%)
Query: 355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
           L ++ E +E G L   ++  G          +I  D    ++++H H +    HRD+K  
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI---AHRDVKPE 157
Query: 415 NILI---DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYA 471
           N+L    +K+   K+ DFG  K T   +   P     T  Y+ PE           D+++
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---TPYYVAPEVLGPEKYDKSCDMWS 214
Query: 472 FGVVLYELI 480
            GV++Y L+
Sbjct: 215 LGVIMYILL 223

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 57/129 (44%), Gaps = 9/129 (6%)
Query: 355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
           L ++ E +E G L   ++  G          +I  D    ++++H H +    HRD+K  
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI---AHRDVKPE 138
Query: 415 NILI---DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYA 471
           N+L    +K+   K+ DFG  K T   +   P     T  Y+ PE           D+++
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY---TPYYVAPEVLGPEKYDKSCDMWS 195
Query: 472 FGVVLYELI 480
            GV++Y L+
Sbjct: 196 LGVIMYILL 204

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NLS+               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLSQ--------------VIQMELDHERMSYLLYQMLVGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ GV++ E+I  
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 53/224 (23%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQASREFLAELKVLTHV 338
           +G G  G + Y   RG + N    R + V  ++ +  +    ++Q  RE           
Sbjct: 32  LGHGAEGTIVY---RGMFDN----RDVAVKRILPECFSFADREVQLLRE---------SD 75
Query: 339 HHLNLVRLIGYCVEGSLFLVY-----------EYIENGNLSEHLRGSGRDPLPWSSRVQI 387
            H N++R   +C E      Y           EY+E  + + HL   G +P      + +
Sbjct: 76  EHPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFA-HL---GLEP------ITL 123
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILID-KNFHAK----VADFGLTKLTEVGSASL 442
              +  GL ++H   +   +HRD+K  NILI   N H K    ++DFGL K   VG  S 
Sbjct: 124 LQQTTSGLAHLHSLNI---VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 443 PTR--LVGTFGYMPPEY-AQYGDVSP--KVDVYAFGVVLYELIS 481
             R  + GT G++ PE  ++    +P   VD+++ G V Y +IS
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 331 ELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           E+++L  + H N+++L+       +  +++V EY   G + E L        P       
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGY 114
Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
                 GLEY+H   +   +H+DIK  N+L+      K++  G+ +     +A    R  
Sbjct: 115 FCQLIDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 448 -GTFGYMPPEYAQYGDVSP--KVDVYAFGVVLYELISA 482
            G+  + PPE A   D     KVD+++ GV LY + + 
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 71/313 (22%), Positives = 125/313 (39%), Gaps = 53/313 (16%)
Query: 257 DKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQK 314
           DK+   + E +S     +S+  +IG GG   V+    E +  Y   Y++        +++
Sbjct: 41  DKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--------LEE 92
Query: 315 AAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGS 374
           A  + +D  + R  +A L  L   H   ++RL  Y +      +Y  +E GN+  +    
Sbjct: 93  ADNQTLD--SYRNEIAYLNKLQQ-HSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLK 147
Query: 375 GRDPL-PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
            +  + PW  R     +    +  IH+H +   +H D+K AN LI      K+ DFG+  
Sbjct: 148 KKKSIDPWE-RKSYWKNMLEAVHTIHQHGI---VHSDLKPANFLIVDGM-LKLIDFGIAN 202
Query: 434 LTEVGSASL-PTRLVGTFGYMPPEYAQYGDVSPK-----------VDVYAFGVVLYELIS 481
             +  + S+     VG   YMPPE  +    S +            DV++ G +LY +  
Sbjct: 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262
Query: 482 AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAK 541
            K                   F++++N    I  L  ++DP      P      +  + K
Sbjct: 263 GKTP-----------------FQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLK 302
Query: 542 VCTQEYPQLRPSM 554
            C +  P+ R S+
Sbjct: 303 CCLKRDPKQRISI 315

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 114/258 (44%), Gaps = 53/258 (20%)
Query: 257 DKSVEFSY----EELSKA-TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN-- 309
           DK V+ SY      +SK+  DN   S ++G   F  +   +     G S    ++C    
Sbjct: 25  DKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIG-SGAQGIVCAAYD 83
Query: 310 -LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------ 355
            +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      
Sbjct: 84  AVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142
Query: 356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPV 405
           +LV E ++  NL +               +Q+ LD  R          G++++H   +  
Sbjct: 143 YLVMELMD-ANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI-- 185
Query: 406 YIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSP 465
            IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE         
Sbjct: 186 -IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKE 242
Query: 466 KVDVYAFGVVLYELISAK 483
            VD+++ G ++ E++  K
Sbjct: 243 NVDIWSVGCIMGEMVRHK 260

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/296 (22%), Positives = 118/296 (39%), Gaps = 53/296 (17%)
Query: 274 FSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +S+  +IG GG   V+    E +  Y   Y++        +++A  + +D  + R  +A 
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN--------LEEADNQTLD--SYRNEIAY 79
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL-PWSSRVQIALD 390
           L  L   H   ++RL  Y +      +Y  +E GN+  +     +  + PW  R     +
Sbjct: 80  LNKLQQ-HSDKIIRLYDYEITDQY--IYMVMECGNIDLNSWLKKKKSIDPWE-RKSYWKN 135
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLVGT 449
               +  IH+H +   +H D+K AN LI      K+ DFG+  ++       +    VGT
Sbjct: 136 MLEAVHTIHQHGI---VHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGT 191
Query: 450 FGYMPPEYAQYGDVSPK-----------VDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
             YMPPE  +    S +            DV++ G +LY +   K               
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP------------- 238
Query: 499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM 554
               F++++N    I  L  ++DP      P      +  + K C +  P+ R S+
Sbjct: 239 ----FQQIIN---QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +            V T 
Sbjct: 139 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 48/94 (51%), Gaps = 6/94 (6%)
Query: 393 RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV--GSASLPTRLVGTF 450
           RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +            V T 
Sbjct: 140 RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 451 GYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAK 483
            Y  PE        +  +D+++ G +L E++S +
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NLS+               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLSQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ G ++ E+I  
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NLS+               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLSQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ G ++ E+I  
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NLS+               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLSQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ G ++ E+I  
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 113/272 (41%), Gaps = 38/272 (13%)
Query: 298 GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL-- 355
           G  +  R    +++++   ++    + SR+F  E   L    H N++ ++G C       
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83
Query: 356 -FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
             L+  +   G+L   L       +  S  V+ ALD ARG  ++H    P+     + S 
Sbjct: 84  PTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT-LEPLIPRHALNSR 142
Query: 415 NILIDKNFHAKV--ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG--DVSPK-VDV 469
           ++ ID++  A++  AD   +     G    P        ++ PE  Q    D + +  D 
Sbjct: 143 SVXIDEDXTARISXADVKFS-FQSPGRXYAP-------AWVAPEALQKKPEDTNRRSADX 194
Query: 470 YAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCP 529
           ++F V+L+EL++ +  +   + S+ +    VAL           E LR  + P +  +  
Sbjct: 195 WSFAVLLWELVTRE--VPFADLSNXEIGXKVAL-----------EGLRPTIPPGISPH-- 239
Query: 530 LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                 +++L K+C  E P  RP    IV  L
Sbjct: 240 ------VSKLXKICXNEDPAKRPKFDXIVPIL 265

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NLS+               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLSQ--------------VIQMELDHERMSYLLYQMLVGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ G ++ E+I  
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/258 (24%), Positives = 114/258 (44%), Gaps = 53/258 (20%)
Query: 257 DKSVEFSY----EELSKA-TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN-- 309
           DK V+ SY      +SK+  DN   S ++G   F  +   +     G S    ++C    
Sbjct: 25  DKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIG-SGAQGIVCAAYD 83
Query: 310 -LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------ 355
            +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      
Sbjct: 84  AVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142
Query: 356 FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPV 405
           +LV E ++  NL +               +Q+ LD  R          G++++H   +  
Sbjct: 143 YLVMELMD-ANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI-- 185
Query: 406 YIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSP 465
            IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE         
Sbjct: 186 -IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKE 242
Query: 466 KVDVYAFGVVLYELISAK 483
            VD+++ G ++ E++  K
Sbjct: 243 NVDIWSVGCIMGEMVRHK 260

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 62/138 (44%), Gaps = 17/138 (12%)
Query: 351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRD 410
           ++G L++    I   +L+  LR  G    P +  +   + SA    +    T     HRD
Sbjct: 105 IDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGAT-----HRD 159
Query: 411 IKSANILIDKNFHAKVADFGLT------KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS 464
           +K  NIL+  +  A + DFG+       KLT++G+       VGT  Y  PE       +
Sbjct: 160 VKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT------VGTLYYXAPERFSESHAT 213
Query: 465 PKVDVYAFGVVLYELISA 482
            + D+YA   VLYE ++ 
Sbjct: 214 YRADIYALTCVLYECLTG 231

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 LVMELM-DANLXQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 LVMELM-DANLXQ--------------VIQMELDHERMSYLLYQMLXGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E ++  NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 LVMELMD-ANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 106
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 107 LVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 148
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 207 VDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 LVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 48  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 106
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 107 LVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 148
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 207 VDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 LVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 46  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 104
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 105 LVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 146
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 147 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 204
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 205 VDIWSVGCIMGEMVRHK 221

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 47  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 LVMELM-DANLXQ--------------VIQMELDHERMSYLLYQMLXGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 48  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 107 IVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 148
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 149 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ G ++ E+I  
Sbjct: 207 VDIWSVGCIMGEMIKG 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 99
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 100 LVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 141
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 200 VDIWSVGCIMGEMVRHK 216

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 41  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 99
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 100 LVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 141
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 200 VDIWSVGCIMGEMVRHK 216

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ G ++ E+I  
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 99  LVMELM-DANLXQ--------------VIQMELDHERMSYLLYQMLXGIKHLHSAGI--- 140
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 141 IHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 199 VDIWSVGCIMGEMVRHK 215

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + +L      +
Sbjct: 40  VLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           LV E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 99  LVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 140
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 141 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 199 VDIWSVGCIMGEMVRHK 215

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ G ++ E+I  
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 294 RGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQASREFLAELKVLTHVHHLNLVRLIG 348
           RG YG+ Y ++        +  A+K+++     M A RE +A L+ L H + ++L ++  
Sbjct: 31  RGTYGHVYKAKRK-DGKDDKDYALKQIEGTGISMSACRE-IALLRELKHPNVISLQKVFL 88
Query: 349 YCVEGSLFLVYEYIENG--NLSEHLRGS--GRDP--LPWSSRVQIALDSARGLEYIHEHT 402
              +  ++L+++Y E+   ++ +  R S   + P  LP      +      G+ Y+H + 
Sbjct: 89  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 403 VPVYIHRDIKSANILI----DKNFHAKVADFGLTKLTEVGSASLP--TRLVGTFGYMPPE 456
           V   +HRD+K ANIL+     +    K+AD G  +L       L     +V TF Y  PE
Sbjct: 149 V---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205
Query: 457 Y---AQYGDVSPKVDVYAFGVVLYELISAK 483
               A++   +  +D++A G +  EL++++
Sbjct: 206 LLLGARH--YTKAIDIWAIGCIFAELLTSE 233

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 125 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 180
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 220

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPEVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ G ++ E+I  
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 128 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 183
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 223

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 129 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 184
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 224

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 52  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 110
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 111 IVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 152
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 153 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 210
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 211 VDLWSVGCIMGEMVCHK 227

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 172 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 227
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 267

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 129 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 184
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 224

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 172 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 227
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 267

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 41  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 99
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 100 IVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 141
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ + T  V T  Y  PE          
Sbjct: 142 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 200 VDLWSVGCIMGEMVCHK 216

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 130 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 185
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 225

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 157 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 212
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 252

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 130 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 185
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 225

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 11/92 (11%)
Query: 407 IHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSP 465
           +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+ +Y     
Sbjct: 132 LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEWIRYHRYHG 188
Query: 466 K-VDVYAFGVVLYELISA------KEAIVKGN 490
           +   V++ G++LY+++         E I++G 
Sbjct: 189 RSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 220

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 130 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 185
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 225

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 145 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 200
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 240

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 145 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 200
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 240

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/263 (21%), Positives = 113/263 (42%), Gaps = 59/263 (22%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D + + H IG G +G V  A  + E       R++ +  +++       D+   +  L E
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLE------KRVVAIKKILRVFE----DLIDCKRILRE 102
Query: 332 LKVLTHVHHLNLVRLIGYCVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
           + +L  ++H ++V+++   +         L++V E  ++       +   R P+ + + +
Sbjct: 103 IAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD-----FKKLFRTPV-YLTEL 156
Query: 386 QIA---LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT---EVGS 439
            I     +   G++Y+H   +   +HRD+K AN L++++   KV DFGL +     E G+
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 440 ASLP-----------------------TRLVGTFGYMPPEYAQYGD-VSPKVDVYAFGVV 475
           + LP                       T  V T  Y  PE     +  +  +DV++ G +
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 476 LYELISAKEAIVKGNGSSADSKG 498
             EL++    ++K N +    +G
Sbjct: 274 FAELLN----MIKENVAYHADRG 292

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 144 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 199
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 239

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 164 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 219
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 259

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 172 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 227
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 267

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 145 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 200
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 201 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 240

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 144 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 199
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 200 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 239

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 177 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 232
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 233 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 272

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 152 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 207
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA------KEAIVKGN 490
            +Y     +   V++ G++LY+++         E I++G 
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 247

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/196 (24%), Positives = 88/196 (44%), Gaps = 44/196 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 49  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 107
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 108 IVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 149
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ +    V T  Y  PE          
Sbjct: 150 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMVPFVVTRYYRAPEVILGMGYKEN 207
Query: 467 VDVYAFGVVLYELISA 482
           VD+++ G ++ E+I  
Sbjct: 208 VDIWSVGCIMGEMIKG 223

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRL-ICVNLLMQKAAIKKMDMQASREFLAE 331
            + +   +G+GGFG V+        G+    RL + + ++ +   +    +  S     E
Sbjct: 32  EYRLGPLLGKGGFGTVFA-------GHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLE 84
Query: 332 LKVLTHVH----HLNLVRLIGY--CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
           + +L  V     H  ++RL+ +    EG + ++   +   +L +++   G  PL      
Sbjct: 85  VALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSR 142
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILID-KNFHAKVADFGLTKLTEVGSASLPT 444
                    +++ H   V   +HRDIK  NILID +   AK+ DFG   L         T
Sbjct: 143 CFFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY---T 196
Query: 445 RLVGTFGYMPPEYA---QYGDVSPKVDVYAFGVVLYELISA 482
              GT  Y PPE+    QY  +     V++ G++LY+++  
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALP--ATVWSLGILLYDMVCG 235

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 127/292 (43%), Gaps = 47/292 (16%)
Query: 242 GPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSY 301
           GP  G+  SLNA         + E   K  D F +    GQG FG V      G+  ++ 
Sbjct: 1   GP--GSMMSLNAAAA------ADERSRKEMDRFQVERMAGQGTFGTVQL----GKEKSTG 48
Query: 302 LSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV--------EG 353
           +S  + +  ++Q    +  ++Q     + +L VL   HH N+V+L  Y          + 
Sbjct: 49  MS--VAIKKVIQDPRFRNRELQ----IMQDLAVL---HHPNIVQLQSYFYTLGERDRRDI 99
Query: 354 SLFLVYEYIENGNLSEHLRGSGRD---PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRD 410
            L +V EY+ +  L    R   R    P P   +V       R +  +H  +V V  HRD
Sbjct: 100 YLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSIGCLHLPSVNV-CHRD 156
Query: 411 IKSANILIDK-NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD--VSPKV 467
           IK  N+L+++ +   K+ DFG  K  ++  +      + +  Y  PE   +G+   +  V
Sbjct: 157 IKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAYICSRYYRAPELI-FGNQHYTTAV 213
Query: 468 DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKL 519
           D+++ G +  E++   E I +G+ S+     +V     VL  P   E LRKL
Sbjct: 214 DIWSVGCIFAEMMLG-EPIFRGDNSAGQLHEIV----RVLGCPS-REVLRKL 259

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 158 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 213
Query: 458 AQYGDVSPK-VDVYAFGVVLYELI 480
            +Y     +   V++ G++LY+++
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 157 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 212
Query: 458 AQYGDVSPK-VDVYAFGVVLYELI 480
            +Y     +   V++ G++LY+++
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/86 (36%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 125 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 180
Query: 458 AQYGDVSPK-VDVYAFGVVLYELISA 482
            +Y     +   V++ G++LY+++  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 158 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 213
Query: 458 AQYGDVSPK-VDVYAFGVVLYELI 480
            +Y     +   V++ G++LY+++
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 158 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 213
Query: 458 AQYGDVSPK-VDVYAFGVVLYELI 480
            +Y     +   V++ G++LY+++
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 158 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 213
Query: 458 AQYGDVSPK-VDVYAFGVVLYELI 480
            +Y     +   V++ G++LY+++
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 157 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 212
Query: 458 AQYGDVSPK-VDVYAFGVVLYELI 480
            +Y     +   V++ G++LY+++
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 399 HEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           H H   V +HRDIK  NILID N    K+ DFG   L +    ++ T   GT  Y PPE+
Sbjct: 157 HCHNCGV-LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPPEW 212
Query: 458 AQYGDVSPK-VDVYAFGVVLYELI 480
            +Y     +   V++ G++LY+++
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 36/216 (16%)
Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG G FG V+ A+L                +   + AIKK+ +Q  R    EL+++  V 
Sbjct: 48  IGNGSFGVVFQAKL----------------VESDEVAIKKV-LQDKRFKNRELQIMRIVK 90
Query: 340 HLNLVRLIGYCV-------EGSLFLVYEYIENG--NLSEHLRGSGRDPLPWSSRVQIALD 390
           H N+V L  +         E  L LV EY+       S H     +  +P          
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHY-AKLKQTMPMLLIKLYMYQ 149
Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSASLPTRLVGT 449
             R L YIH   +    HRDIK  N+L+D      K+ DFG  K+   G  ++    + +
Sbjct: 150 LLRSLAYIHSIGI---CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV--SXICS 204
Query: 450 FGYMPPEYAQYG--DVSPKVDVYAFGVVLYELISAK 483
             Y  PE   +G  + +  +D+++ G V+ EL+  +
Sbjct: 205 RYYRAPELI-FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ +    V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 206 VDIWSVGCIMGEMVCHK 222

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 15/181 (8%)
Query: 316 AIKKMDMQASREFLAELKVL-THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG 373
           A+K +D ++ R+   E+++L  +  H N++ L     +G  ++LV E +  G L + +  
Sbjct: 56  AVKVID-KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL- 113
Query: 374 SGRDPLPWSSRVQIALDS-ARGLEYIHEHTVPVYIHRDIKSANIL-IDKNFHA---KVAD 428
             R            L +  + +EY+H   V   +HRD+K +NIL +D++ +    ++ D
Sbjct: 114 --RQKFFSEREASFVLHTIGKTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICD 168
Query: 429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
           FG  K     +  L T    T  ++ PE  +        D+++ G++LY +++       
Sbjct: 169 FGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227
Query: 489 G 489
           G
Sbjct: 228 G 228

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 89/197 (45%), Gaps = 44/197 (22%)
Query: 310 LLMQKAAIKKM------DMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSL------F 356
           +L +  AIKK+         A R +  EL ++  V+H N++ L+  +  + SL      +
Sbjct: 47  ILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105
Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR----------GLEYIHEHTVPVY 406
           +V E + + NL +               +Q+ LD  R          G++++H   +   
Sbjct: 106 IVMELM-DANLCQ--------------VIQMELDHERMSYLLYQMLCGIKHLHSAGI--- 147
Query: 407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK 466
           IHRD+K +NI++  +   K+ DFGL +    G++ +    V T  Y  PE          
Sbjct: 148 IHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRYYRAPEVILGMGYKEN 205
Query: 467 VDVYAFGVVLYELISAK 483
           VD+++ G ++ E++  K
Sbjct: 206 VDLWSVGCIMGEMVCHK 222

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 85/181 (46%), Gaps = 15/181 (8%)
Query: 316 AIKKMDMQASREFLAELKVL-THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG 373
           A+K +D ++ R+   E+++L  +  H N++ L     +G  ++LV E +  G L + +  
Sbjct: 56  AVKVID-KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL- 113
Query: 374 SGRDPLPWSSRVQIALDS-ARGLEYIHEHTVPVYIHRDIKSANIL-IDKNFHA---KVAD 428
             R            L +  + +EY+H   V   +HRD+K +NIL +D++ +    ++ D
Sbjct: 114 --RQKFFSEREASFVLHTIGKTVEYLHSQGV---VHRDLKPSNILYVDESGNPECLRICD 168
Query: 429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
           FG  K     +  L T    T  ++ PE  +        D+++ G++LY +++       
Sbjct: 169 FGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFAN 227
Query: 489 G 489
           G
Sbjct: 228 G 228

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 49/99 (49%), Gaps = 10/99 (10%)
Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
           +IA+   + LE++H       IHRD+K +N+LI+     K+ DFG++       A   T 
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK--TI 212
Query: 446 LVGTFGYMPPEYA-----QYGDVSPKVDVYAFGVVLYEL 479
             G   YM PE       Q G  S K D+++ G+ + EL
Sbjct: 213 DAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIEL 250

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVE------GSLFLVYEYIENGNLSEHLRGSGRDPL 379
           +  L E+++L H HH N++ L    V         L+LV E +   +L++ +        
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH------- 125
Query: 380 PWSSRVQIALDSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
               R+ I+    +        GL  +HE  V   +HRD+   NIL+  N    + DF L
Sbjct: 126 --DQRIVISPQHIQYFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNL 180
Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            +  E  + +  T  V    Y  PE   Q+   +  VD+++ G V+ E+ + K A+ +G+
Sbjct: 181 AR--EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGS 237
Query: 491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGD 526
                   +V    EV+  P  IED+     P   D
Sbjct: 238 TFYNQLNKIV----EVVGTP-KIEDVVMFSSPSARD 268

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVE------GSLFLVYEYIENGNLSEHLRGSGRDPL 379
           +  L E+++L H HH N++ L    V         L+LV E +   +L++ +        
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH------- 125
Query: 380 PWSSRVQIALDSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
               R+ I+    +        GL  +HE  V   +HRD+   NIL+  N    + DF L
Sbjct: 126 --DQRIVISPQHIQYFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNL 180
Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            +  E  + +  T  V    Y  PE   Q+   +  VD+++ G V+ E+ + K A+ +G+
Sbjct: 181 AR--EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGS 237
Query: 491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGD 526
                   +V    EV+  P  IED+     P   D
Sbjct: 238 TFYNQLNKIV----EVVGTP-KIEDVVMFSSPSARD 268

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 87/180 (48%), Gaps = 13/180 (7%)
Query: 316 AIKKMDMQASREFLAELKVL-THVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG 373
           A+K +D ++ R+   E+++L  +  H N++ L     +G  +++V E ++ G L + +  
Sbjct: 51  AVKIID-KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR 109
Query: 374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL-IDKNFHA---KVADF 429
                   +S V   +   + +EY+H   V   +HRD+K +NIL +D++ +    ++ DF
Sbjct: 110 QKFFSEREASAVLFTI--TKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDF 164
Query: 430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
           G  K     +  L T    T  ++ PE  +        D+++ GV+LY +++       G
Sbjct: 165 GFAKQLRAENGLLMTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 55/256 (21%), Positives = 110/256 (42%), Gaps = 22/256 (8%)
Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D++ +  K+G+G +  V+      E  N   +  + V +L     +KK  ++   + L  
Sbjct: 37  DDYQLVRKLGRGKYSEVF------EAINITNNEKVVVKIL---KPVKKNKIKREIKILEN 87
Query: 332 LKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
           L+   ++  + L  ++   V  +  LV+E++ N +  + L  +  D   +  R  +  + 
Sbjct: 88  LRGGPNI--ITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTD---YDIRFYM-YEI 140
Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSASLPTRLVGTF 450
            + L+Y H   +   +HRD+K  N++ID      ++ D+GL +    G      R+   +
Sbjct: 141 LKALDYCHSMGI---MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASRY 196
Query: 451 GYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP 510
              P     Y      +D+++ G +L  +I  KE    G+  + D    +A      +L 
Sbjct: 197 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVRIAKVLGTEDLY 255
Query: 511 DPIEDLRKLVDPRLGD 526
           D I+     +DPR  D
Sbjct: 256 DYIDKYNIELDPRFND 271
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	589
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-118
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-114
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-110
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-101
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-89
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	4e-69
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-66
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-66
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-66
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	6e-65
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-63
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-63
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-62
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-62
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-61
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-61
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-61
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-60
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-56
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-47
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-47
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-47
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-45
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-45
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-45
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-45
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-45
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-45
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-44
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-44
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-44
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-44
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-44
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-43
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-43
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-43
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-43
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-43
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-43
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-43
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-43
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-43
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-43
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-43
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-43
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-43
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-42
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-42
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-41
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-41
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-41
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-41
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-41
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-41
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-41
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-40
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-40
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-40
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	5e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-40
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-39
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-39
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	9e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-36
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-36
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-33
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-31
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-30
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-30
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-30
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-30
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-30
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-29
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-28
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-28
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-26
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-25
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-25
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-25
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-25
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-25
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-25
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-25
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-25
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-24
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-24
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-24
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-24
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-24
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-23
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-23
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-23
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-23
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-23
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-23
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-23
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	8e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	9e-23
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-22
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-22
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-22
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-22
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	9e-21
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-20
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-20
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-19
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-19
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-15
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	7e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	6e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-10
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	5e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	7e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  351 bits (904), Expect = e-118
 Identities = 113/312 (36%), Positives = 165/312 (52%), Gaps = 37/312 (11%)

Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELR-GEYGNSYLSRLICVNLLMQKAAIKKM 320
           FS  EL  A+DNFS  + +G+GGFG VY   L  G                    A+K++
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG-----------------TLVAVKRL 62

Query: 321 DMQAS----REFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRG-- 373
             + +     +F  E+++++   H NL+RL G+C+  +   LVY Y+ NG+++  LR   
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122

Query: 374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
             + PL W  R +IAL SARGL Y+H+H  P  IHRD+K+ANIL+D+ F A V DFGL K
Sbjct: 123 ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182

Query: 434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS 493
           L +     + T + GT G++ PEY   G  S K DV+ +GV+L ELI+ + A      ++
Sbjct: 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

Query: 494 ADSKGLVA----LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQ 549
            D   L+     L +E        + L  LVD  L  N   + V ++ Q+A +CTQ  P 
Sbjct: 243 DDDVMLLDWVKGLLKE--------KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPM 294

Query: 550 LRPSMRSIVVAL 561
            RP M  +V  L
Sbjct: 295 ERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  343 bits (882), Expect = e-114
 Identities = 112/329 (34%), Positives = 166/329 (50%), Gaps = 32/329 (9%)

Query: 240 STGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGN 299
               +     S + +   +S      +L +AT+NF     IG G FG VY   LR     
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG--- 63

Query: 300 SYLSRLICVNLLMQKAAIKKMD---MQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-L 355
                         K A+K+      Q   EF  E++ L+   H +LV LIG+C E + +
Sbjct: 64  -------------AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110

Query: 356 FLVYEYIENGNLSEHLRGSGRD--PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS 413
            L+Y+Y+ENGNL  HL GS      + W  R++I + +ARGL Y+H   +   IHRD+KS
Sbjct: 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVKS 167

Query: 414 ANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAF 472
            NIL+D+NF  K+ DFG++K       + L T + GT GY+ PEY   G ++ K DVY+F
Sbjct: 168 INILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227

Query: 473 GVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDS 532
           GVVL+E++ A+ AIV+        + +V L E  +   +    L ++VDP L D    +S
Sbjct: 228 GVVLFEVLCARSAIVQSL-----PREMVNLAEWAVESHNN-GQLEQIVDPNLADKIRPES 281

Query: 533 VLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           + K    A  C     + RPSM  ++  L
Sbjct: 282 LRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  331 bits (850), Expect = e-110
 Identities = 103/322 (31%), Positives = 168/322 (52%), Gaps = 45/322 (13%)

Query: 262 FSYEELSKATDNFS------MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           FS+ EL   T+NF         +K+G+GGFG VY   +                      
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-----------------TTV 57

Query: 316 AIKKMD-------MQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNL 367
           A+KK+         +  ++F  E+KV+    H NLV L+G+  +G  L LVY Y+ NG+L
Sbjct: 58  AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117

Query: 368 SEHLRG-SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
            + L    G  PL W  R +IA  +A G+ ++HE+     IHRDIKSANIL+D+ F AK+
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKI 174

Query: 427 ADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +DFGL + +E  + + + +R+VGT  YM PE  + G+++PK D+Y+FGVVL E+I+   A
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 233

Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
           +        + + L+ + EE+ +     + +   +D ++  +    SV  M  +A  C  
Sbjct: 234 V----DEHREPQLLLDIKEEIEDEE---KTIEDYIDKKMN-DADSTSVEAMYSVASQCLH 285

Query: 546 EYPQLRPSMRSIVVALMTLSST 567
           E    RP ++ +   L  ++++
Sbjct: 286 EKKNKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  308 bits (792), Expect = e-101
 Identities = 87/336 (25%), Positives = 141/336 (41%), Gaps = 52/336 (15%)

Query: 259 SVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK 318
            V+   E L   +    +     +G FG V+ A+L                   +  A+K
Sbjct: 11  GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-----------------EYVAVK 53

Query: 319 KMDMQASREFLAELKV--LTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHL 371
              +Q  + +  E +V  L  + H N+++ IG    G+     L+L+  + E G+LS+ L
Sbjct: 54  IFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL 113

Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIHEHTV-------PVYIHRDIKSANILIDKNFHA 424
           +    + + W+    IA   ARGL Y+HE          P   HRDIKS N+L+  N  A
Sbjct: 114 K---ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA 170

Query: 425 KVADFGLTKLTEVGSASLPT-RLVGTFGYMPPEYAQYG-----DVSPKVDVYAFGVVLYE 478
            +ADFGL    E G ++  T   VGT  YM PE  +       D   ++D+YA G+VL+E
Sbjct: 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230

Query: 479 LISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLV-----DPRLGDNCPLDSV 533
           L S   A              +  FEE +     +ED++++V      P L D     + 
Sbjct: 231 LASRCTAA------DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284

Query: 534 LK-MAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT 568
           +  + +  + C     + R S   +   +  +   T
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  277 bits (710), Expect = 8e-89
 Identities = 76/356 (21%), Positives = 127/356 (35%), Gaps = 59/356 (16%)

Query: 260 VEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK 319
           +E +  E S   DN  +   IG+G +GAVY   L                      A+K 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP-----------------VAVKV 43

Query: 320 MDMQASREFLAELKV--LTHVHHLNLVRLIGYCVEGS------LFLVYEYIENGNLSEHL 371
                 + F+ E  +  +  + H N+ R I      +        LV EY  NG+L ++L
Sbjct: 44  FSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL 103

Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIHE------HTVPVYIHRDIKSANILIDKNFHAK 425
                    W S  ++A    RGL Y+H       H  P   HRD+ S N+L+  +    
Sbjct: 104 S---LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160

Query: 426 VADFGLTKLTEVGSASL-------PTRLVGTFGYMPPEYAQ-------YGDVSPKVDVYA 471
           ++DFGL+                     VGT  YM PE  +             +VD+YA
Sbjct: 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220

Query: 472 FGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVD-----PRLGD 526
            G++ +E+      +  G             F+  +      ED++ LV      P+  +
Sbjct: 221 LGLIYWEIFMRCTDLFPGES----VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE 276

Query: 527 NCPLDSVL--KMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENH 580
               +S+    + +  + C  +  + R + +     +  L    E     S   +H
Sbjct: 277 AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score =  221 bits (565), Expect = 4e-69
 Identities = 108/206 (52%), Positives = 136/206 (66%)

Query: 25  CTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTR 84
           C   C  ALASYY+  G+ L+ I Q L SS+   + +    IL YN  + +KD +   +R
Sbjct: 1   CRTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSR 60

Query: 85  INVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDR 144
           + VPFPC+C  G+FLGH F +S+   DTYE+VA   Y+NLT   SLQ  N +P T IP  
Sbjct: 61  VLVPFPCECQPGDFLGHNFSYSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLS 120

Query: 145 GTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRG 204
            TLNV VNCSCGD  VSK + LFVTYPLRP DSL SIAR+ G+S  +LQ YNPGVNF  G
Sbjct: 121 ATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGVNFNSG 180

Query: 205 SGLVFIPGRDANGVFPALESSSTGGL 230
           +G+V++PGRD NG FP  +SS   G+
Sbjct: 181 NGIVYVPGRDPNGAFPPFKSSKQDGV 206

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  218 bits (557), Expect = 2e-66
 Identities = 80/317 (25%), Positives = 130/317 (41%), Gaps = 55/317 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR-EFLA 330
               +   +G+G FG V  A+ R                  +  AIK+++ ++ R  F+ 
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRA-----------------KDVAIKQIESESERKAFIV 50

Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDP-LPWSSRVQIAL 389
           EL+ L+ V+H N+V+L G C+   + LV EY E G+L   L G+   P    +  +   L
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLN-PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-HAKVADFGLTKLTEVGSASLPTRLVG 448
             ++G+ Y+H       IHRD+K  N+L+       K+ DFG     +       T   G
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----TNNKG 165

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
           +  +M PE  +  + S K DV+++G++L+E+I+ ++                  F+E+  
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP-----------------FDEIGG 208

Query: 509 LPDPI-----EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
               I        R    P L  N P      +  L   C  + P  RPSM  IV  +  
Sbjct: 209 PAFRIMWAVHNGTR----PPLIKNLPKP----IESLMTRCWSKDPSQRPSMEEIVKIMTH 260

Query: 564 LSSTTEDWDVGSFYENH 580
           L       D    Y   
Sbjct: 261 LMRYFPGADEPLQYPCQ 277

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  218 bits (558), Expect = 3e-66
 Identities = 77/325 (23%), Positives = 132/325 (40%), Gaps = 54/325 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
               M  +IG+G +G V+  + RGE           V       A+K         +  E
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWRGEK----------V-------AVKVFFTTEEASWFRE 79

Query: 332 LKV--LTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
            ++     + H N++  I   ++G+     L+L+ +Y ENG+L ++L+      L   S 
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSM 136

Query: 385 VQIALDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
           +++A  S  GL ++H         P   HRD+KS NIL+ KN    +AD GL       +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196

Query: 440 ASL---PTRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
             +   P   VGT  YMPPE         +       D+Y+FG++L+E+           
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-------RC 249

Query: 491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVD-----PRLGDNCPLDSVLK-MAQLAKVCT 544
            S    +     + +++      ED+R++V      P   +    D  L+ M +L   C 
Sbjct: 250 VSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309

Query: 545 QEYPQLRPSMRSIVVALMTLSSTTE 569
              P  R +   +   L  +S + +
Sbjct: 310 AHNPASRLTALRVKKTLAKMSESQD 334

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  216 bits (552), Expect = 9e-66
 Identities = 85/322 (26%), Positives = 137/322 (42%), Gaps = 70/322 (21%)

Query: 261 EFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM 320
           +  + +L+       +  KIG G FG V+ AE  G                    A+K +
Sbjct: 33  DIPWCDLN-------IKEKIGAGSFGTVHRAEWHG-----------------SDVAVKIL 68

Query: 321 DMQ-----ASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGS 374
             Q        EFL E+ ++  + H N+V  +G   +   L +V EY+  G+L   L  S
Sbjct: 69  MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128

Query: 375 G-RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
           G R+ L    R+ +A D A+G+ Y+H    P+ +HR++KS N+L+DK +  KV DFGL++
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLHNRNPPI-VHRNLKSPNLLVDKKYTVKVCDFGLSR 187

Query: 434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKE--------A 485
           L      S      GT  +M PE  +    + K DVY+FGV+L+EL + ++         
Sbjct: 188 LKASTFLSS-KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246

Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
           +V                  V       +  R      +  N       ++A + + C  
Sbjct: 247 VVAA----------------VGF-----KCKR----LEIPRNLN----PQVAAIIEGCWT 277

Query: 546 EYPQLRPSMRSIVVALMTLSST 567
             P  RPS  +I+  L  L  +
Sbjct: 278 NEPWKRPSFATIMDLLRPLIKS 299

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  214 bits (546), Expect = 6e-65
 Identities = 80/327 (24%), Positives = 120/327 (36%), Gaps = 63/327 (19%)

Query: 261 EFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM 320
            F   +L            +G+G FG       R                  +   +K++
Sbjct: 6   IFRPSDLI-------HGEVLGKGCFGQAIKVTHRETG---------------EVMVMKEL 43

Query: 321 ---DMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGR 376
              D +  R FL E+KV+  + H N+++ IG    +  L  + EYI+ G L   ++    
Sbjct: 44  IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS 103

Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE 436
              PWS RV  A D A G+ Y+H       IHRD+ S N L+ +N +  VADFGL +L  
Sbjct: 104 -QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMV 159

Query: 437 -------------VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
                                 +VG   +M PE         KVDV++FG+VL E+I   
Sbjct: 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219

Query: 484 EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVC 543
            A              +    +         ++R  +D     NCP         +   C
Sbjct: 220 NA----------DPDYLPRTMDF------GLNVRGFLDRYCPPNCPPS----FFPITVRC 259

Query: 544 TQEYPQLRPSMRSIVVALMTLSSTTED 570
               P+ RPS   +   L TL      
Sbjct: 260 CDLDPEKRPSFVKLEHWLETLRMHLAG 286

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  207 bits (530), Expect = 7e-63
 Identities = 77/299 (25%), Positives = 128/299 (42%), Gaps = 48/299 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-----ASR 326
              ++  +IG G FG VY  +  G+           V       A+K +++        +
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGD-----------V-------AVKMLNVTAPTPQQLQ 65

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            F  E+ VL    H+N++  +GY     L +V ++ E  +L  HL  +          + 
Sbjct: 66  AFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLID 124

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TR 445
           IA  +ARG++Y+H  +    IHRD+KS NI + ++   K+ DFGL       S S    +
Sbjct: 125 IARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQ 181

Query: 446 LVGTFGYMPPEYAQYGDVSP---KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
           L G+  +M PE  +  D +P   + DVYAFG+VLYEL++ +          ++      +
Sbjct: 182 LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-------SNINNRDQI 234

Query: 503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
            E V                ++  NCP      M +L   C ++    RPS   I+  +
Sbjct: 235 IEMVGR------GSLSPDLSKVRSNCPKR----MKRLMAECLKKKRDERPSFPRILAEI 283

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  207 bits (528), Expect = 2e-62
 Identities = 79/316 (25%), Positives = 129/316 (40%), Gaps = 54/316 (17%)

Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV- 334
           +   +G+G +G V+    +GE           V       A+K    +  + +  E ++ 
Sbjct: 12  LLECVGKGRYGEVWRGSWQGEN----------V-------AVKIFSSRDEKSWFRETELY 54

Query: 335 -LTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
               + H N++  I   +        L+L+  Y E G+L ++L+      L   S ++I 
Sbjct: 55  NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIV 111

Query: 389 LDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL- 442
           L  A GL ++H         P   HRD+KS NIL+ KN    +AD GL  +    +  L 
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171

Query: 443 --PTRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
                 VGT  YM PE           D   +VD++AFG+VL+E+            S+ 
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-------RMVSNG 224

Query: 495 DSKGLVALFEEVLNLPDPIEDLRKLVD-----PRLGDNCPLDSVLK-MAQLAKVCTQEYP 548
             +     F +V+      ED+RK+V      P + +    D  L  +A+L K C  + P
Sbjct: 225 IVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNP 284

Query: 549 QLRPSMRSIVVALMTL 564
             R +   I   L  +
Sbjct: 285 SARLTALRIKKTLTKI 300

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  206 bits (525), Expect = 4e-62
 Identities = 79/340 (23%), Positives = 143/340 (42%), Gaps = 70/340 (20%)

Query: 242 GPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSY 301
           G   G+          +    +  E+           +IG+GGFG V+            
Sbjct: 1   GAMGGSE-----FPKSRLPTLADNEIE-------YEKQIGKGGFGLVHKGR--------L 40

Query: 302 LSRLICVNLLMQKAAIKKMDMQAS----------REFLAELKVLTHVHHLNLVRLIGYCV 351
           +     V       AIK + +  S          +EF  E+ ++++++H N+V+L G   
Sbjct: 41  VKDKSVV-------AIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93

Query: 352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDI 411
                +V E++  G+L   L      P+ WS ++++ LD A G+EY+     P+ +HRD+
Sbjct: 94  NP-PRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQNPPI-VHRDL 150

Query: 412 KSANILIDK-----NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE--YAQYGDVS 464
           +S NI +          AKVADFGL++ +        + L+G F +M PE   A+    +
Sbjct: 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGLLGNFQWMAPETIGAEEESYT 206

Query: 465 PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRL 524
            K D Y+F ++LY +++ +    + +        ++             E LR    P +
Sbjct: 207 EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-----------EGLR----PTI 251

Query: 525 GDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
            ++CP     ++  + ++C    P+ RP    IV  L  L
Sbjct: 252 PEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  204 bits (520), Expect = 1e-61
 Identities = 58/317 (18%), Positives = 118/317 (37%), Gaps = 63/317 (19%)

Query: 256 VDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA 315
           ++K     +++L+          K+ +   G ++    +G                    
Sbjct: 1   MNKHSGIDFKQLN-------FLTKLNENHSGELWKGRWQG-----------------NDI 36

Query: 316 AIKKMDMQ-----ASREFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENGNL 367
            +K + ++      SR+F  E   L    H N++ ++G C         L+  ++  G+L
Sbjct: 37  VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL 96

Query: 368 SEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA 427
              L       +  S  V+ ALD ARG+ ++H     +     + S +++ID++  A+++
Sbjct: 97  YNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI-PRHALNSRSVMIDEDMTARIS 155

Query: 428 DFGLTKLTEVGSASLPTRLVGTFGYMPPE---YAQYGDVSPKVDVYAFGVVLYELISAKE 484
              +    +          +    ++ PE              D+++F V+L+EL++ + 
Sbjct: 156 MADVKFSFQSPGR------MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209

Query: 485 AIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCT 544
                + S+ +    VAL           E LR    P +           +++L K+C 
Sbjct: 210 PF--ADLSNMEIGMKVAL-----------EGLR----PTIPPGISP----HVSKLMKICM 248

Query: 545 QEYPQLRPSMRSIVVAL 561
            E P  RP    IV  L
Sbjct: 249 NEDPAKRPKFDMIVPIL 265

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  205 bits (522), Expect = 4e-61
 Identities = 76/321 (23%), Positives = 132/321 (41%), Gaps = 58/321 (18%)

Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV- 334
           +   IG+G FG V+  + RGE           V       A+K    +  R +  E ++ 
Sbjct: 46  LQESIGKGRFGEVWRGKWRGEE----------V-------AVKIFSSREERSWFREAEIY 88

Query: 335 -LTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
               + H N++  I    + +     L+LV +Y E+G+L ++L    R  +     +++A
Sbjct: 89  QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLA 145

Query: 389 LDSARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL- 442
           L +A GL ++H   V     P   HRD+KS NIL+ KN    +AD GL    +  + ++ 
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205

Query: 443 --PTRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
             P   VGT  YM PE        ++ +   + D+YA G+V +E+               
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-------RCSIGG 258

Query: 495 DSKGLVALFEEVLNLPDPIEDLRKLVD--------PRLGDNCPLDSVLKMAQLAKVCTQE 546
             +     + +++     +E++RK+V         P    +C       MA++ + C   
Sbjct: 259 IHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR--VMAKIMRECWYA 316

Query: 547 YPQLRPSMRSIVVALMTLSST 567
               R +   I   L  LS  
Sbjct: 317 NGAARLTALRIKKTLSQLSQQ 337

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  200 bits (511), Expect = 3e-60
 Identities = 81/322 (25%), Positives = 128/322 (39%), Gaps = 71/322 (22%)

Query: 261 EFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM 320
           E  + EL+       +   IG GGFG VY A   G                  + A+K  
Sbjct: 3   EIDFAELT-------LEEIIGIGGFGKVYRAFWIG-----------------DEVAVKAA 38

Query: 321 DMQAS-------REFLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLR 372
                            E K+   + H N++ L G C++  +L LV E+   G L+  L 
Sbjct: 39  RHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS 98

Query: 373 GSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH--------A 424
           G     +P    V  A+  ARG+ Y+H+  +   IHRD+KS+NILI +            
Sbjct: 99  GK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155

Query: 425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKE 484
           K+ DFGL +     +        G + +M PE  +    S   DV+++GV+L+EL++ + 
Sbjct: 156 KITDFGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV 212

Query: 485 AIVKGNGSSADSKGL--VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKV 542
                       +G+  +A+   V         L       +   CP       A+L + 
Sbjct: 213 P----------FRGIDGLAVAYGVAM-----NKLA----LPIPSTCP----EPFAKLMED 249

Query: 543 CTQEYPQLRPSMRSIVVALMTL 564
           C    P  RPS  +I+  L T+
Sbjct: 250 CWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  192 bits (489), Expect = 1e-56
 Identities = 65/328 (19%), Positives = 116/328 (35%), Gaps = 86/328 (26%)

Query: 261 EFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM 320
           +  +E+L        +   IG+G FG VY+    GE           V       AI+ +
Sbjct: 29  DIPFEQLE-------IGELIGKGRFGQVYHGRWHGE-----------V-------AIRLI 63

Query: 321 DMQ-----ASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGS 374
           D++       + F  E+       H N+V  +G C+    L ++    +   L   +R  
Sbjct: 64  DIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR-D 122

Query: 375 GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL 434
            +  L  +   QIA +  +G+ Y+H   +   +H+D+KS N+  D      + DFGL  +
Sbjct: 123 AKIVLDVNKTRQIAQEIVKGMGYLHAKGI---LHKDLKSKNVFYDNG-KVVITDFGLFSI 178

Query: 435 TEVGSASLP----TRLVGTFGYMPPE---------YAQYGDVSPKVDVYAFGVVLYELIS 481
           + V  A           G   ++ PE                S   DV+A G + YEL +
Sbjct: 179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238

Query: 482 AK--------EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSV 533
            +        EAI+   G      G+          P+  +                +  
Sbjct: 239 REWPFKTQPAEAIIWQMG-----TGM---------KPNLSQ-----------IGMGKE-- 271

Query: 534 LKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
             ++ +   C     + RP+   ++  L
Sbjct: 272 --ISDILLFCWAFEQEERPTFTKLMDML 297

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  170 bits (432), Expect = 1e-47
 Identities = 75/318 (23%), Positives = 127/318 (39%), Gaps = 84/318 (26%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
           ++  +  +IG+G FG V+   LR +                   A+K            +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADN---------------TLVAVKSCRETLPPDLKAK 158

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           FL E ++L    H N+VRLIG C +   +++V E ++ G+    LR  G   L   + +Q
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQ 217

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE-------VGS 439
           +  D+A G+EY+        IHRD+ + N L+ +    K++DFG+++           G 
Sbjct: 218 MVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGL 274

Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-------------AKEAI 486
             +P +      +  PE   YG  S + DV++FG++L+E  S              +E +
Sbjct: 275 RQVPVK------WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328

Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
            KG                   LP P             + CP      + +L + C   
Sbjct: 329 EKGG-----------------RLPCP-------------ELCPDA----VFRLMEQCWAY 354

Query: 547 YPQLRPSMRSIVVALMTL 564
            P  RPS  +I   L ++
Sbjct: 355 EPGQRPSFSTIYQELQSI 372

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  167 bits (424), Expect = 2e-47
 Identities = 71/316 (22%), Positives = 126/316 (39%), Gaps = 49/316 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREF 328
            +     ++G+G FG+V          N+            +  A+KK+     +  R+F
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNT-----------GEVVAVKKLQHSTEEHLRDF 58

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             E+++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLL 117

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS------ 439
           Q      +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+           
Sbjct: 118 QYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK 174

Query: 440 --ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                P        +  PE       S   DV++FGVVLYEL +  E             
Sbjct: 175 EPGESPIF------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

Query: 498 GLV----ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
           G       +   ++ L   +++  +L  P   D CP +    +  +   C       RPS
Sbjct: 229 GNDKQGQMIVFHLIEL---LKNNGRLPRP---DGCPDE----IYMIMTECWNNNVNQRPS 278

Query: 554 MRSIVVALMTLSSTTE 569
            R + + +  +     
Sbjct: 279 FRDLALRVDQIRDNMA 294

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  167 bits (426), Expect = 2e-47
 Identities = 71/316 (22%), Positives = 126/316 (39%), Gaps = 49/316 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREF 328
            +     ++G+G FG+V          N+            +  A+KK+     +  R+F
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNT-----------GEVVAVKKLQHSTEEHLRDF 89

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             E+++L  + H N+V+  G C      +L L+ EY+  G+L ++L+   ++ +     +
Sbjct: 90  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLL 148

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS------ 439
           Q      +G+EY+       YIHRD+ + NIL++     K+ DFGLTK+           
Sbjct: 149 QYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 205

Query: 440 --ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                P        +  PE       S   DV++FGVVLYEL +  E             
Sbjct: 206 EPGESPIF------WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259

Query: 498 GLV----ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
           G       +   ++ L   +++  +L  P   D CP +    +  +   C       RPS
Sbjct: 260 GNDKQGQMIVFHLIEL---LKNNGRLPRP---DGCPDE----IYMIMTECWNNNVNQRPS 309

Query: 554 MRSIVVALMTLSSTTE 569
            R + + +  +     
Sbjct: 310 FRDLALRVDQIRDQMA 325

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  162 bits (411), Expect = 1e-45
 Identities = 79/326 (24%), Positives = 135/326 (41%), Gaps = 73/326 (22%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREF 328
            +  +  ++G+G FG V+ AE                       A+K +    + A ++F
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKD----------KMLVAVKALKDPTLAARKDF 64

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSR--- 384
             E ++LT++ H ++V+  G C +G  L +V+EY+++G+L++ LR  G D +        
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 385 -----------VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                      + IA   A G+ Y+       ++HRD+ + N L+  N   K+ DFG+++
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSR 181

Query: 434 LTE-------VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                      G   LP R      +MPPE   Y   + + DV++FGV+L+E+ +     
Sbjct: 182 DVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFT----- 230

Query: 487 VKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKV 542
             G       S           EV+     I   R L  P     CP +    +  +   
Sbjct: 231 -YGKQPWFQLSN---------TEVIEC---ITQGRVLERP---RVCPKE----VYDVMLG 270

Query: 543 CTQEYPQLRPSMRSIVVALMTLSSTT 568
           C Q  PQ R +++ I   L  L   T
Sbjct: 271 CWQREPQQRLNIKEIYKILHALGKAT 296

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  160 bits (407), Expect = 3e-45
 Identities = 69/216 (31%), Positives = 111/216 (51%), Gaps = 33/216 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
               +   IG+G FG V   + RG                  K A+K  K D   ++ FL
Sbjct: 21  KELKLLQTIGKGEFGDVMLGDYRG-----------------NKVAVKCIKNDAT-AQAFL 62

Query: 330 AELKVLTHVHHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           AE  V+T + H NLV+L+G  V  +G L++V EY+  G+L ++LR  GR  L     ++ 
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--LPTR 445
           +LD    +EY+  +    ++HRD+ + N+L+ ++  AKV+DFGLTK       +  LP +
Sbjct: 123 SLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK 179

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                 +  PE  +    S K DV++FG++L+E+ S
Sbjct: 180 ------WTAPEALREKKFSTKSDVWSFGILLWEIYS 209

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  160 bits (407), Expect = 3e-45
 Identities = 81/317 (25%), Positives = 133/317 (41%), Gaps = 76/317 (23%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           +   +  ++G G FG V+     G                  K A+K  K    +   FL
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHT----------------KVAVKSLKQGSMSPDAFL 56

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           AE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +  + +A 
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLP 443
             A G+ +I E     YIHRD+++ANIL+      K+ADFGL +L      T    A  P
Sbjct: 117 QIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSADSKGL 499
            +      +  PE   YG  + K DV++FG++L E+++       G     G +      
Sbjct: 174 IK------WTAPEAINYGTFTIKSDVWSFGILLTEIVT------HGRIPYPGMTN----- 216

Query: 500 VALFEEVLN-------LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
                EV+        +  P             DNCP +    + QL ++C +E P+ RP
Sbjct: 217 ----PEVIQNLERGYRMVRP-------------DNCPEE----LYQLMRLCWKERPEDRP 255

Query: 553 SMRSIVVALMTLSSTTE 569
           +   +   L    + TE
Sbjct: 256 TFDYLRSVLEDFFTATE 272

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  165 bits (420), Expect = 4e-45
 Identities = 83/310 (26%), Positives = 131/310 (42%), Gaps = 54/310 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
            + +M HK+G G +G VY    +                     A+K  K D     EFL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYS---------------LTVAVKTLKEDTMEVEEFL 264

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E  V+  + H NLV+L+G C      +++ E++  GNL ++LR   R  +     + +A
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASL 442
              +  +EY+ +     +IHR++ + N L+ +N   KVADFGL++L      T    A  
Sbjct: 325 TQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 381

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
           P +         PE   Y   S K DV+AFGV+L+E+ +   +   G     D   +  L
Sbjct: 382 PIKW------TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI----DLSQVYEL 431

Query: 503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM 562
            E+   +  P             + CP     K+ +L + C Q  P  RPS   I  A  
Sbjct: 432 LEKDYRMERP-------------EGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFE 474

Query: 563 TLSSTTEDWD 572
           T+   +   D
Sbjct: 475 TMFQESSISD 484

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  164 bits (417), Expect = 6e-45
 Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 54/306 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT----------------RVAIKTLKPGTMSPEAFL 227

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLP 443
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L      T    A  P
Sbjct: 288 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 344

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
            +      +  PE A YG  + K DV++FG++L EL +       G  +           
Sbjct: 345 IK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------- 387

Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
            EVL+    +E   ++  P     CP      +  L   C ++ P+ RP+   +   L  
Sbjct: 388 REVLDQ---VERGYRMPCP---PECPES----LHDLMCQCWRKEPEERPTFEYLQAFLED 437

Query: 564 LSSTTE 569
             ++TE
Sbjct: 438 YFTSTE 443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  159 bits (405), Expect = 8e-45
 Identities = 83/314 (26%), Positives = 131/314 (41%), Gaps = 62/314 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
            + +M HK+G G +G VY    +                     A+K  K D     EFL
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYS---------------LTVAVKTLKEDTMEVEEFL 57

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E  V+  + H NLV+L+G C      +++ E++  GNL ++LR   R  +     + +A
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE------VGSASL 442
              +  +EY+ +     +IHRD+ + N L+ +N   KVADFGL++L           A  
Sbjct: 118 TQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 174

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSADSKG 498
           P +      +  PE   Y   S K DV+AFGV+L+E+ +       G     G       
Sbjct: 175 PIK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDL---- 218

Query: 499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
                 +V  L   +E   ++  P   + CP      + +L + C Q  P  RPS   I 
Sbjct: 219 -----SQVYEL---LEKDYRMERP---EGCPEK----VYELMRACWQWNPSDRPSFAEIH 263

Query: 559 VALMTLSSTTEDWD 572
            A  T+   +   D
Sbjct: 264 QAFETMFQESSISD 277

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  159 bits (405), Expect = 2e-44
 Identities = 73/318 (22%), Positives = 125/318 (39%), Gaps = 55/318 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
                   +G+G FG V        Y  +       V       A+K +      Q    
Sbjct: 31  RYLKKIRDLGEGHFGKVS----LYCYDPTNDGTGEMV-------AVKALKADAGPQHRSG 79

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
           +  E+ +L  ++H ++++  G C +    SL LV EY+  G+L ++L    R  +  +  
Sbjct: 80  WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQL 136

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS----- 439
           +  A     G+ Y+H      YIHRD+ + N+L+D +   K+ DFGL K    G      
Sbjct: 137 LLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193

Query: 440 ---ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
                 P        +  PE  +        DV++FGV LYEL++        +  S+ S
Sbjct: 194 REDGDSPVF------WYAPECLKEYKFYYASDVWSFGVTLYELLT--------HCDSSQS 239

Query: 497 KGLVALFEEVLNLPD-PIEDLRKLVDP--RLG--DNCPLDSVLKMAQLAKVCTQEYPQLR 551
                L    +      +  L +L++   RL   D CP +    +  L K C +     R
Sbjct: 240 PPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAE----VYHLMKNCWETEASFR 295

Query: 552 PSMRSIVVALMTLSSTTE 569
           P+  +++  L T+    +
Sbjct: 296 PTFENLIPILKTVHEKYQ 313

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  159 bits (403), Expect = 2e-44
 Identities = 68/313 (21%), Positives = 124/313 (39%), Gaps = 53/313 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
                   +G+G FG V       E  N+       V       A+K +          +
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTG----EQV-------AVKSLKPESGGNHIAD 69

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
              E+++L +++H N+V+  G C E     + L+ E++ +G+L E+L    ++ +    +
Sbjct: 70  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQ 128

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS----- 439
           ++ A+   +G++Y+       Y+HRD+ + N+L++     K+ DFGLTK  E        
Sbjct: 129 LKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 185

Query: 440 ---ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
                 P        +  PE           DV++FGV L+EL++           S  S
Sbjct: 186 KDDRDSPVF------WYAPECLMQSKFYIASDVWSFGVTLHELLT--------YCDSDSS 231

Query: 497 KGLVALFEEVLNLPD-PIEDLRKLVDP--RLG--DNCPLDSVLKMAQLAKVCTQEYPQLR 551
              + L           +  L   +    RL    NCP +    + QL + C +  P  R
Sbjct: 232 PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDE----VYQLMRKCWEFQPSNR 287

Query: 552 PSMRSIVVALMTL 564
            S ++++     L
Sbjct: 288 TSFQNLIEGFEAL 300

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  162 bits (413), Expect = 3e-44
 Identities = 89/336 (26%), Positives = 145/336 (43%), Gaps = 67/336 (19%)

Query: 244 AAGTPTSLNAITVDKSVEFSYEELSKAT-----DNFSMSHKIGQGGFGAVYYAELRGEYG 298
           A G  T L    V +    + +E  ++          +   IG+G FG V   + RG   
Sbjct: 160 ADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRG--- 216

Query: 299 NSYLSRLICVNLLMQKAAIK--KMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE--GS 354
                          K A+K  K D   ++ FLAE  V+T + H NLV+L+G  VE  G 
Sbjct: 217 --------------NKVAVKCIKNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261

Query: 355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
           L++V EY+  G+L ++LR  GR  L     ++ +LD    +EY+  +    ++HRD+ + 
Sbjct: 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAAR 318

Query: 415 NILIDKNFHAKVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAF 472
           N+L+ ++  AKV+DFGLTK       +  LP +      +  PE  +    S K DV++F
Sbjct: 319 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFSTKSDVWSF 372

Query: 473 GVVLYELISAKEAIVKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNC 528
           G++L+E+ S       G                  ++V+     +E   K+  P   D C
Sbjct: 373 GILLWEIYS------FGRVPYPRIPL---------KDVVPR---VEKGYKMDAP---DGC 411

Query: 529 PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
           P      +  + K C       RP+   +   L  +
Sbjct: 412 PPA----VYDVMKNCWHLDAATRPTFLQLREQLEHI 443

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  159 bits (403), Expect = 3e-44
 Identities = 78/312 (25%), Positives = 130/312 (41%), Gaps = 42/312 (13%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREF 328
            +     ++G+G FG+V          N+       V       A+K++        R+F
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTG----ALV-------AVKQLQHSGPDQQRDF 71

Query: 329 LAELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             E+++L  +H   +V+  G        SL LV EY+ +G L + L+   R  L  S  +
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLL 130

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS------ 439
             +    +G+EY+        +HRD+ + NIL++   H K+ADFGL KL  +        
Sbjct: 131 LYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187

Query: 440 --ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                P        +  PE       S + DV++FGVVLYEL +  +     +       
Sbjct: 188 EPGQSPIF------WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           G       +  L + +E+ ++L  P     CP +    + +L K+C    PQ RPS  ++
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAP---PACPAE----VHELMKLCWAPSPQDRPSFSAL 294

Query: 558 VVALMTLSSTTE 569
              L  L S + 
Sbjct: 295 GPQLDMLWSGSR 306

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  163 bits (415), Expect = 4e-44
 Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 54/306 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK  K    +   FL
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT----------------RVAIKTLKPGTMSPEAFL 310

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLP 443
             A G+ Y+       Y+HRD+++ANIL+ +N   KVADFGL +L      T    A  P
Sbjct: 371 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 427

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
            +      +  PE A YG  + K DV++FG++L EL +       G  +           
Sbjct: 428 IK------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----------- 470

Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
            EVL+    +E   ++  P     CP      +  L   C ++ P+ RP+   +   L  
Sbjct: 471 REVLDQ---VERGYRMPCP---PECPES----LHDLMCQCWRKEPEERPTFEYLQAFLED 520

Query: 564 LSSTTE 569
             ++TE
Sbjct: 521 YFTSTE 526

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  159 bits (404), Expect = 6e-44
 Identities = 85/383 (22%), Positives = 155/383 (40%), Gaps = 84/383 (21%)

Query: 223 ESSSTGGLVFPAYKTVESTGPAAGTPT----SLNAITVDKSVEFSYEELSKATDNFSMSH 278
           ESSS+     P  +        A TP     S   +  D   EF  ++L+       +  
Sbjct: 35  ESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLT-------LGK 87

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKV 334
            +G+G FG V  AE  G   +     +          A+K +   A+     + ++E+++
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTV--------AVKMLKDDATEKDLSDLVSEMEM 139

Query: 335 LTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGS--------------GRDP 378
           +  +  H N++ L+G C  +G L+++ EY   GNL E+LR                  + 
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV- 437
           + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL +     
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNI 256

Query: 438 ------GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN- 490
                  +  LP +      +M PE       + + DV++FGV+++E+ +       G  
Sbjct: 257 DYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT------LGGS 304

Query: 491 ---GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEY 547
              G            EE+  L   +++  ++  P    NC  +    +  + + C    
Sbjct: 305 PYPGIPV---------EELFKL---LKEGHRMDKP---ANCTNE----LYMMMRDCWHAV 345

Query: 548 PQLRPSMRSIVVALMTLSSTTED 570
           P  RP+ + +V  L  + + T +
Sbjct: 346 PSQRPTFKQLVEDLDRILTLTTN 368

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  157 bits (400), Expect = 1e-43
 Identities = 85/368 (23%), Positives = 146/368 (39%), Gaps = 77/368 (20%)

Query: 234 AYKTVESTGPAAGTPTSLNAITVDKSVEFSYE---ELSKATDNFSMSHKIGQGGFGAVYY 290
           A  +  S  P  G  + L    ++    FS      + +   +  +  ++G+G FG V+ 
Sbjct: 2   AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKR--RDIVLKWELGEGAFGKVFL 59

Query: 291 AELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREFLAELKVLTHVHHLNLVRLI 347
           AE                       A+K +      A ++F  E ++LT + H ++VR  
Sbjct: 60  AECHNLLPEQD----------KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF 109

Query: 348 GYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSR-------------VQIALDSAR 393
           G C EG  L +V+EY+ +G+L+  LR  G D    +               + +A   A 
Sbjct: 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA 169

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-------TEVGSASLPTRL 446
           G+ Y+       ++HRD+ + N L+ +    K+ DFG+++           G   LP R 
Sbjct: 170 GMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR- 225

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSADSKGLVAL 502
                +MPPE   Y   + + DV++FGVVL+E+ +       G       S         
Sbjct: 226 -----WMPPESILYRKFTTESDVWSFGVVLWEIFT------YGKQPWYQLSN-------- 266

Query: 503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM 562
             E ++    I   R+L  P     CP +    +  + + C Q  PQ R S++ +   L 
Sbjct: 267 -TEAIDC---ITQGRELERP---RACPPE----VYAIMRGCWQREPQQRHSIKDVHARLQ 315

Query: 563 TLSSTTED 570
            L+     
Sbjct: 316 ALAQAPPV 323

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  157 bits (398), Expect = 1e-43
 Identities = 77/323 (23%), Positives = 136/323 (42%), Gaps = 66/323 (20%)

Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----D 321
            +            IG+G FG VY+ E   +  N              + AIK +    +
Sbjct: 15  LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNR------------IQCAIKSLSRITE 62

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPL 379
           MQ    FL E  ++  ++H N++ LIG  +  EG   ++  Y+ +G+L + +R S +   
Sbjct: 63  MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNP 121

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE--- 436
                +   L  ARG+EY+ E     ++HRD+ + N ++D++F  KVADFGL +      
Sbjct: 122 TVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178

Query: 437 ------VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
                    A LP +      +   E  Q    + K DV++FGV+L+EL++      +G 
Sbjct: 179 YYSVQQHRHARLPVK------WTALESLQTYRFTTKSDVWSFGVLLWELLT------RGA 226

Query: 491 ----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
                             ++ +    +   R+L  P   + CP      + Q+ + C + 
Sbjct: 227 PPYRHIDP---------FDLTHF---LAQGRRLPQP---EYCPDS----LYQVMQQCWEA 267

Query: 547 YPQLRPSMRSIVVALMTLSSTTE 569
            P +RP+ R +V  +  + S   
Sbjct: 268 DPAVRPTFRVLVGEVEQIVSALL 290

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  157 bits (398), Expect = 2e-43
 Identities = 69/325 (21%), Positives = 132/325 (40%), Gaps = 72/325 (22%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK-----KMDMQASR 326
           +   +   +G+G FG+V    L+ E G S             K A+K         +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTS------------LKVAVKTMKLDNSSQREIE 81

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVE------GSLFLVYEYIENGNLSEHLRGS----GR 376
           EFL+E   +    H N++RL+G C+E          ++  +++ G+L  +L  S    G 
Sbjct: 82  EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141

Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-- 434
             +P  + ++  +D A G+EY+       ++HRD+ + N ++  +    VADFGL+K   
Sbjct: 142 KHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198

Query: 435 -----TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
                 +   A +P +      ++  E       + K DV+AFGV ++E+ +      +G
Sbjct: 199 SGDYYRQGRIAKMPVK------WIAIESLADRVYTSKSDVWAFGVTMWEIAT------RG 246

Query: 490 N----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQ 545
                G             E+ +    +    +L  P   ++C  +    + ++   C +
Sbjct: 247 MTPYPGVQN---------HEMYDY---LLHGHRLKQP---EDCLDE----LYEIMYSCWR 287

Query: 546 EYPQLRPSMRSIVVALMTLSSTTED 570
             P  RP+   + + L  L  +  D
Sbjct: 288 TDPLDRPTFSVLRLQLEKLLESLPD 312

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  155 bits (395), Expect = 2e-43
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 35/219 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
            + +   ++G G FG V Y + RG+Y                  AIK  K    +  EF+
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRGQY----------------DVAIKMIKEGSMSEDEFI 67

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E KV+ ++ H  LV+L G C +   +F++ EY+ NG L  +LR   R        +++ 
Sbjct: 68  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMC 126

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASL 442
            D    +EY+       ++HRD+ + N L++     KV+DFGL++       T    +  
Sbjct: 127 KDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 183

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           P R      + PPE   Y   S K D++AFGV+++E+ S
Sbjct: 184 PVR------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  157 bits (399), Expect = 2e-43
 Identities = 80/327 (24%), Positives = 129/327 (39%), Gaps = 51/327 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
              +    IG G FG VY   L+   G   +             AIK +      +   +
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEV-----------PVAIKTLKAGYTEKQRVD 92

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           FL E  ++    H N++RL G   +   + ++ EY+ENG L + LR            V 
Sbjct: 93  FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVG 151

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           +    A G++Y+       Y+HRD+ + NIL++ N   KV+DFGL+++ E    +  T  
Sbjct: 152 MLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208

Query: 447 VGTFGY--MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSADSKGLV 500
            G        PE   Y   +   DV++FG+V++E+++       G       S       
Sbjct: 209 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT------YGERPYWELSN------ 256

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
               EV+     I D  +L  P    +CP      + QL   C Q+    RP    IV  
Sbjct: 257 ---HEVMKA---INDGFRLPTP---MDCPSA----IYQLMMQCWQQERARRPKFADIVSI 303

Query: 561 LMTLSSTTEDWDVGSFYENHALVNLMS 587
           L  L    +     + ++    + L S
Sbjct: 304 LDKLIRAPDSLKTLADFDPRVSIRLPS 330

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  158 bits (402), Expect = 2e-43
 Identities = 80/402 (19%), Positives = 154/402 (38%), Gaps = 78/402 (19%)

Query: 213 RDANGVFPALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYE---ELSK 269
                +         G   +  +   +   P          +      E   +   EL +
Sbjct: 9   HHDYDIPTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPR 68

Query: 270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQAS 325
             D   +   +G+G FG V  AE  G   +                A+K +      +  
Sbjct: 69  --DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV--------AVKMLKSDATEKDL 118

Query: 326 REFLAELKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGS--------- 374
            + ++E++++  +  H N++ L+G C  +G L+++ EY   GNL E+L+           
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178

Query: 375 -----GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF 429
                  + L     V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADF
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADF 235

Query: 430 GLTKLTEV-------GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           GL +            +  LP +      +M PE       + + DV++FGV+L+E+ + 
Sbjct: 236 GLARDIHHIDYYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFT- 288

Query: 483 KEAIVKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQ 538
                 G     G            EE+  L   +++  ++  P    NC  +    +  
Sbjct: 289 -----LGGSPYPGVPV---------EELFKL---LKEGHRMDKP---SNCTNE----LYM 324

Query: 539 LAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENH 580
           + + C    P  RP+ + +V  L  + + T + ++G ++ +H
Sbjct: 325 MMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHHH 366

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  155 bits (394), Expect = 2e-43
 Identities = 64/313 (20%), Positives = 119/313 (38%), Gaps = 61/313 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
           ++  ++  +G+G FG VY        G                 A+K       +    +
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKI------------NVAVKTCKKDCTLDNKEK 59

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           F++E  ++ ++ H ++V+LIG   E   +++ E    G L  +L    ++ L   + V  
Sbjct: 60  FMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLY 118

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSAS 441
           +L   + + Y+        +HRDI   NIL+      K+ DFGL++        +     
Sbjct: 119 SLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 175

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSADSK 497
           LP +      +M PE   +   +   DV+ F V ++E++S       G            
Sbjct: 176 LPIK------WMSPESINFRRFTTASDVWMFAVCMWEILS------FGKQPFFWLEN--- 220

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                 ++V+ +   +E   +L  P   D CP      +  L   C    P  RP    +
Sbjct: 221 ------KDVIGV---LEKGDRLPKP---DLCPPV----LYTLMTRCWDYDPSDRPRFTEL 264

Query: 558 VVALMTLSSTTED 570
           V +L  +    +D
Sbjct: 265 VCSLSDVYQMEKD 277

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  160 bits (406), Expect = 2e-43
 Identities = 74/310 (23%), Positives = 130/310 (41%), Gaps = 62/310 (20%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           ++  +  K+G G FG V+ A                      K A+K  K    +   FL
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHT----------------KVAVKTMKPGSMSVEAFL 231

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           AE  V+  + H  LV+L     +  ++++ E++  G+L + L+       P    +  + 
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASLP 443
             A G+ +I +     YIHRD+++ANIL+  +   K+ADFGL ++      T    A  P
Sbjct: 292 QIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFP 348

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSADSKGL 499
            +      +  PE   +G  + K DV++FG++L E+++       G     G S      
Sbjct: 349 IK------WTAPEAINFGSFTIKSDVWSFGILLMEIVT------YGRIPYPGMSN----- 391

Query: 500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
                EV+     +E   ++  P   +NCP +    +  +   C +  P+ RP+   I  
Sbjct: 392 ----PEVIRA---LERGYRMPRP---ENCPEE----LYNIMMRCWKNRPEERPTFEYIQS 437

Query: 560 ALMTLSSTTE 569
            L    + TE
Sbjct: 438 VLDDFYTATE 447

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  155 bits (393), Expect = 3e-43
 Identities = 61/219 (27%), Positives = 103/219 (47%), Gaps = 35/219 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
              +   +IG G FG V+      +                 K AIK  +    +  +F+
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYWLNKD----------------KVAIKTIREGAMSEEDFI 51

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E +V+  + H  LV+L G C+E + + LV E++E+G LS++LR + R      + + + 
Sbjct: 52  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMC 110

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASL 442
           LD   G+ Y+ E      IHRD+ + N L+ +N   KV+DFG+T+       T       
Sbjct: 111 LDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 167

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           P +      +  PE   +   S K DV++FGV+++E+ S
Sbjct: 168 PVK------WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  156 bits (397), Expect = 3e-43
 Identities = 93/342 (27%), Positives = 147/342 (42%), Gaps = 75/342 (21%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           ++      IG+G FG V  A ++ +                  AAIK+M   AS    R+
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLR-------------MDAAIKRMKEYASKDDHRD 71

Query: 328 FLAELKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGS----------- 374
           F  EL+VL  + HH N++ L+G C   G L+L  EY  +GNL + LR S           
Sbjct: 72  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131

Query: 375 ---GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
                  L     +  A D ARG++Y+ +     +IHRD+ + NIL+ +N+ AK+ADFGL
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 188

Query: 432 TKLTEV----GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIV 487
           ++  EV        LP R      +M  E   Y   +   DV+++GV+L+E++S      
Sbjct: 189 SRGQEVYVKKTMGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVS------ 236

Query: 488 KGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVC 543
            G     G +           E+      +    +L  P    NC  +    +  L + C
Sbjct: 237 LGGTPYCGMTC---------AELYEK---LPQGYRLEKP---LNCDDE----VYDLMRQC 277

Query: 544 TQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYENHALVNL 585
            +E P  RPS   I+V+L  +    + +   + YE      +
Sbjct: 278 WREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGI 319

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  154 bits (392), Expect = 3e-43
 Identities = 59/219 (26%), Positives = 102/219 (46%), Gaps = 35/219 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK--KMDMQASREFL 329
           +  ++  ++G G FG V   + +G+Y                  A+K  K    +  EF 
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQY----------------DVAVKMIKEGSMSEDEFF 51

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E + +  + H  LV+  G C +   +++V EYI NG L  +LR  G+  L  S  +++ 
Sbjct: 52  QEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMC 110

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSASL 442
            D   G+ ++  H    +IHRD+ + N L+D++   KV+DFG+T+               
Sbjct: 111 YDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF 167

Query: 443 PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           P +      +  PE   Y   S K DV+AFG++++E+ S
Sbjct: 168 PVK------WSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  156 bits (396), Expect = 4e-43
 Identities = 73/330 (22%), Positives = 138/330 (41%), Gaps = 73/330 (22%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           D  ++   +G+G FG V  AE  G   +     +          A+K +   A+     +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV--------AVKMLKDDATEKDLSD 86

Query: 328 FLAELKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGS----------- 374
            ++E++++  +  H N++ L+G C  +G L+++ EY   GNL E+LR             
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146

Query: 375 ---GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
                + + +   V      ARG+EY+        IHRD+ + N+L+ +N   K+ADFGL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGL 203

Query: 432 TKLTEV-------GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKE 484
            +            +  LP +      +M PE       + + DV++FGV+++E+ +   
Sbjct: 204 ARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFT--- 254

Query: 485 AIVKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLA 540
               G     G            EE+  L   +++  ++  P    NC  +    +  + 
Sbjct: 255 ---LGGSPYPGIPV---------EELFKL---LKEGHRMDKP---ANCTNE----LYMMM 292

Query: 541 KVCTQEYPQLRPSMRSIVVALMTLSSTTED 570
           + C    P  RP+ + +V  L  + + T +
Sbjct: 293 RDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  155 bits (395), Expect = 5e-43
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 32/221 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
             F     +G G FG VY      E         I V       AIK++      +A++E
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVK----IPV-------AIKELREATSPKANKE 63

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
            L E  V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +  
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNW 122

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS-------A 440
            +  A+G+ Y+ +      +HRD+ + N+L+    H K+ DFGL KL             
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            +P +      +M  E   +   + + DV+++GV ++EL++
Sbjct: 180 KVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  154 bits (391), Expect = 7e-43
 Identities = 67/312 (21%), Positives = 113/312 (36%), Gaps = 61/312 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
           +   +   IG+G FG V+          +               AIK            +
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPA------------LAVAIKTCKNCTSDSVREK 62

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S +  
Sbjct: 63  FLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILY 121

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSAS 441
           A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++        +     
Sbjct: 122 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 178

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSADSK 497
           LP +      +M PE   +   +   DV+ FGV ++E++        G     G      
Sbjct: 179 LPIK------WMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKN--- 223

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                  +V+     IE+  +L  P    NCP      +  L   C    P  RP    +
Sbjct: 224 ------NDVIGR---IENGERLPMP---PNCPPT----LYSLMTKCWAYDPSRRPRFTEL 267

Query: 558 VVALMTLSSTTE 569
              L T+    +
Sbjct: 268 KAQLSTILEEEK 279

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  155 bits (393), Expect = 9e-43
 Identities = 85/332 (25%), Positives = 145/332 (43%), Gaps = 70/332 (21%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           +  +MS ++GQG FG VY    +G   +              + AIK ++  AS     E
Sbjct: 25  EKITMSRELGQGSFGMVYEGVAKGVVKDEP----------ETRVAIKTVNEAASMRERIE 74

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLR--------GSGRDP 378
           FL E  V+   +  ++VRL+G   +G    ++ E +  G+L  +LR             P
Sbjct: 75  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE-- 436
              S  +Q+A + A G+ Y++ +    ++HRD+ + N ++ ++F  K+ DFG+T+     
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191

Query: 437 -----VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN- 490
                 G   LP R      +M PE  + G  +   DV++FGVVL+E+ +          
Sbjct: 192 DYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQ 239

Query: 491 ---GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEY 547
              G S          E+VL     + +   L  P   DNCP      + +L ++C Q  
Sbjct: 240 PYQGLSN---------EQVLRF---VMEGGLLDKP---DNCPDM----LFELMRMCWQYN 280

Query: 548 PQLRPSMRSIVVALMTLSSTTEDWDVGSFYEN 579
           P++RPS   I+ ++         +   SFY +
Sbjct: 281 PKMRPSFLEIISSIKEE--MEPGFREVSFYYS 310

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  152 bits (386), Expect = 8e-42
 Identities = 67/325 (20%), Positives = 126/325 (38%), Gaps = 73/325 (22%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK-----KMDMQASR 326
             F++   +G+G FG+V  A+L+ E G+              K A+K      +      
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSF------------VKVAVKMLKADIIASSDIE 70

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEG-------SLFLVYEYIENGNLSEHLRGS----G 375
           EFL E   +    H ++ +L+G  +            ++  ++++G+L   L  S     
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130

Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT 435
              LP  + V+  +D A G+EY+       +IHRD+ + N ++ ++    VADFGL++  
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKI 187

Query: 436 EV-------GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
                     ++ LP +      ++  E       +   DV+AFGV ++E+++      +
Sbjct: 188 YSGDYYRQGCASKLPVK------WLALESLADNLYTVHSDVWAFGVTMWEIMT------R 235

Query: 489 GN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCT 544
           G     G             E+ N    +    +L  P     C  +    +  L   C 
Sbjct: 236 GQTPYAGIEN---------AEIYNY---LIGGNRLKQP---PECMEE----VYDLMYQCW 276

Query: 545 QEYPQLRPSMRSIVVALMTLSSTTE 569
              P+ RPS   + + L  +     
Sbjct: 277 SADPKQRPSFTCLRMELENILGHLS 301

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  152 bits (386), Expect = 9e-42
 Identities = 77/322 (23%), Positives = 131/322 (40%), Gaps = 68/322 (21%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
            N ++   +G G FG VY  ++ G   +              + A+K +    S     +
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPS----------PLQVAVKTLPEVCSEQDELD 79

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD-----PLPW 381
           FL E  +++  +H N+VR IG  ++    F++ E +  G+L   LR +         L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139

Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---NFHAKVADFGLTKLTE-- 436
              + +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +     
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

Query: 437 -----VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN- 490
                 G A LP +      +MPPE    G  + K D ++FGV+L+E+ S       G  
Sbjct: 197 SYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------LGYM 244

Query: 491 ---GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEY 547
                S          +EVL     +    ++  P    NCP      + ++   C Q  
Sbjct: 245 PYPSKSN---------QEVLEF---VTSGGRMDPP---KNCPGP----VYRIMTQCWQHQ 285

Query: 548 PQLRPSMRSIVVALMTLSSTTE 569
           P+ RP+   I+  +   +   +
Sbjct: 286 PEDRPNFAIILERIEYCTQDPD 307

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  150 bits (382), Expect = 1e-41
 Identities = 71/308 (23%), Positives = 129/308 (41%), Gaps = 44/308 (14%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKV 334
           ++G G FG+V     R           I V       AIK +    +   + E + E ++
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQ------IDV-------AIKVLKQGTEKADTEEMMREAQI 63

Query: 335 LTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
           +  + +  +VRLIG C   +L LV E    G L + L G   + +P S+  ++    + G
Sbjct: 64  MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMG 122

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF--GY 452
           ++Y+ E     ++HRD+ + N+L+    +AK++DFGL+K      +    R  G +   +
Sbjct: 123 MKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179

Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
             PE   +   S + DV+++GV ++E +S       G       KG      EV+     
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALS------YGQKPYKKMKG-----PEVMAF--- 225

Query: 513 IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWD 572
           IE  +++  P     CP +    +  L   C     + RP   ++   +     +     
Sbjct: 226 IEQGKRMECP---PECPPE----LYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278

Query: 573 VGSFYENH 580
            G  + +H
Sbjct: 279 EGHHHHHH 286

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  152 bits (385), Expect = 1e-41
 Identities = 78/309 (25%), Positives = 124/309 (40%), Gaps = 52/309 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
               +   IG G  G V Y  LR           + V       AIK +      +  R+
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRD-----VPV-------AIKALKAGYTERQRRD 96

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           FL+E  ++    H N++RL G    G    +V EY+ENG+L   LR +          V 
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVG 155

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           +      G+ Y+ +     Y+HRD+ + N+L+D N   KV+DFGL+++ E    +  T  
Sbjct: 156 MLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212

Query: 447 VGTFGY--MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSADSKGLV 500
            G        PE   +   S   DV++FGVV++E+++       G       +       
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA------YGERPYWNMTN------ 260

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA 560
               +V++    +E+  +L  P     CP      + QL   C  +    RP    IV  
Sbjct: 261 ---RDVISS---VEEGYRLPAP---MGCPHA----LHQLMLDCWHKDRAQRPRFSQIVSV 307

Query: 561 LMTLSSTTE 569
           L  L  + E
Sbjct: 308 LDALIRSPE 316

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  150 bits (381), Expect = 2e-41
 Identities = 75/320 (23%), Positives = 125/320 (39%), Gaps = 74/320 (23%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
                  ++G+  FG VY   L G        +   V       AIK +    +     E
Sbjct: 9   SAVRFMEELGEDRFGKVYKGHLFGPAPGE---QTQAV-------AIKTLKDKAEGPLREE 58

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSR-- 384
           F  E  +   + H N+V L+G   +   L +++ Y  +G+L E L          S+   
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 385 ------------VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT 432
                       V +    A G+EY+  H     +H+D+ + N+L+    + K++D GL 
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLF 175

Query: 433 KL-------TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
           +          +G++ LP R      +M PE   YG  S   D++++GVVL+E+ S    
Sbjct: 176 REVYAADYYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS---- 225

Query: 486 IVKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAK 541
              G     G S          ++V+ +   I + + L  P   D+CP      +  L  
Sbjct: 226 --YGLQPYCGYSN---------QDVVEM---IRNRQVLPCP---DDCPAW----VYALMI 264

Query: 542 VCTQEYPQLRPSMRSIVVAL 561
            C  E+P  RP  + I   L
Sbjct: 265 ECWNEFPSRRPRFKDIHSRL 284

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  151 bits (383), Expect = 2e-41
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 32/221 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
                   +G G FG V+      E  +      I V        IK +      Q+ + 
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIK----IPV-------CIKVIEDKSGRQSFQA 61

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
               +  +  + H ++VRL+G C   SL LV +Y+  G+L +H+R   R  L     +  
Sbjct: 62  VTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNW 120

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS-------A 440
            +  A+G+ Y+ EH     +HR++ + N+L+      +VADFG+  L            A
Sbjct: 121 GVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             P +      +M  E   +G  + + DV+++GV ++EL++
Sbjct: 178 KTPIK------WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  150 bits (381), Expect = 3e-41
 Identities = 73/314 (23%), Positives = 131/314 (41%), Gaps = 66/314 (21%)

Query: 275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLA 330
             +  IG+G FG VY+  L    G                 A+K +    D+    +FL 
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKK------------IHCAVKSLNRITDIGEVSQFLT 75

Query: 331 ELKVLTHVHHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           E  ++    H N++ L+G C+  EGS  +V  Y+++G+L   +R +          +   
Sbjct: 76  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFG 134

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS--------- 439
           L  A+G++Y+       ++HRD+ + N ++D+ F  KVADFGL +               
Sbjct: 135 LQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTG 191

Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSAD 495
           A LP +      +M  E  Q    + K DV++FGV+L+EL++      +G       +  
Sbjct: 192 AKLPVK------WMALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNT- 238

Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
                    ++      +   R+L+ P   + CP      + ++   C     ++RPS  
Sbjct: 239 --------FDITVY---LLQGRRLLQP---EYCPDP----LYEVMLKCWHPKAEMRPSFS 280

Query: 556 SIVVALMTLSSTTE 569
            +V  +  + ST  
Sbjct: 281 ELVSRISAIFSTFI 294

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  150 bits (380), Expect = 5e-41
 Identities = 81/331 (24%), Positives = 133/331 (40%), Gaps = 75/331 (22%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           D   +   +G+G FG V  A+  G    +            +  A+K +   A+    R 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTAT----------CRTVAVKMLKEGATHSEHRA 76

Query: 328 FLAELKVLTHV-HHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
            ++ELK+L H+ HHLN+V L+G C    G L ++ E+ + GNLS +LR    + +P+   
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 385 --------------VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
                         +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFG 193

Query: 431 LTKL-------TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           L +           G A LP +      +M PE       + + DV++FGV+L+E+ S  
Sbjct: 194 LARDIYKDPDYVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFS-- 245

Query: 484 EAIVKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQL 539
                G     G   D        EE       +++  ++  P   D    +    M Q 
Sbjct: 246 ----LGASPYPGVKID--------EEFCRR---LKEGTRMRAP---DYTTPE----MYQT 283

Query: 540 AKVCTQEYPQLRPSMRSIVVALMTLSSTTED 570
              C    P  RP+   +V  L  L      
Sbjct: 284 MLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 314

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  149 bits (378), Expect = 5e-41
 Identities = 50/218 (22%), Positives = 89/218 (40%), Gaps = 24/218 (11%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM------DMQAS 325
            +  +  K+G G FG V   E     G +     + V       A+K +        +A 
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKT-----VSV-------AVKCLKPDVLSQPEAM 65

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
            +F+ E+  +  + H NL+RL G  +   + +V E    G+L + LR   +      +  
Sbjct: 66  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLS 124

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
           + A+  A G+ Y+       +IHRD+ + N+L+      K+ DFGL +           +
Sbjct: 125 RYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181

Query: 446 LVGTFGY--MPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                 +    PE  +    S   D + FGV L+E+ +
Sbjct: 182 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  151 bits (383), Expect = 6e-41
 Identities = 73/327 (22%), Positives = 133/327 (40%), Gaps = 69/327 (21%)

Query: 275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLA 330
             +  IG+G FG VY+  L    G                 A+K +    D+    +FL 
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKK------------IHCAVKSLNRITDIGEVSQFLT 139

Query: 331 ELKVLTHVHHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           E  ++    H N++ L+G C+  EGS  +V  Y+++G+L   +R +          +   
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFG 198

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV---------GS 439
           L  A+G++++       ++HRD+ + N ++D+ F  KVADFGL +               
Sbjct: 199 LQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255

Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSAD 495
           A LP +      +M  E  Q    + K DV++FGV+L+EL++      +G       +  
Sbjct: 256 AKLPVK------WMALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNT- 302

Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
                    ++      +   R+L+ P   + CP      + ++   C     ++RPS  
Sbjct: 303 --------FDITVY---LLQGRRLLQP---EYCPDP----LYEVMLKCWHPKAEMRPSFS 344

Query: 556 SIVVALMTL---SSTTEDWDVGSFYEN 579
            +V  +  +           V + Y N
Sbjct: 345 ELVSRISAIFSTFIGEHYVHVNATYVN 371

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  150 bits (381), Expect = 6e-41
 Identities = 69/319 (21%), Positives = 123/319 (38%), Gaps = 72/319 (22%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           +N      +G G FG V  A   G      +           K A+K +   A       
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL----------KVAVKMLKSTAHADEKEA 95

Query: 328 FLAELKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR- 384
            ++ELK+++H+  H N+V L+G C   G + ++ EY   G+L   LR   R      +  
Sbjct: 96  LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155

Query: 385 -----------VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                      +  +   A+G+ ++        IHRD+ + N+L+     AK+ DFGL +
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLAR 212

Query: 434 L-------TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI 486
                      G+A LP +      +M PE       + + DV+++G++L+E+ S     
Sbjct: 213 DIMNDSNYIVKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS----- 261

Query: 487 VKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKV 542
             G     G   +         +   L   ++D  ++  P      P +    +  + + 
Sbjct: 262 -LGLNPYPGILVN--------SKFYKL---VKDGYQMAQP---AFAPKN----IYSIMQA 302

Query: 543 CTQEYPQLRPSMRSIVVAL 561
           C    P  RP+ + I   L
Sbjct: 303 CWALEPTHRPTFQQICSFL 321

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  149 bits (378), Expect = 9e-41
 Identities = 71/332 (21%), Positives = 130/332 (39%), Gaps = 76/332 (22%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
           +  S    +G G FG V  A   G   +                A+K +     +     
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM----------TVAVKMLKPSAHLTEREA 72

Query: 328 FLAELKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR- 384
            ++ELKVL+++ +H+N+V L+G C + G   ++ EY   G+L   LR      +   +  
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132

Query: 385 ---------------VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF 429
                          +  +   A+G+ ++        IHRD+ + NIL+      K+ DF
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDF 189

Query: 430 GLTKL-------TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISA 482
           GL +           G+A LP +      +M PE       + + DV+++G+ L+EL S 
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELFS- 242

Query: 483 KEAIVKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQ 538
                 G+    G   D         +   +   I++  +++ P   ++ P +    M  
Sbjct: 243 -----LGSSPYPGMPVD--------SKFYKM---IKEGFRMLSP---EHAPAE----MYD 279

Query: 539 LAKVCTQEYPQLRPSMRSIVVALMTLSSTTED 570
           + K C    P  RP+ + IV  +    S + +
Sbjct: 280 IMKTCWDADPLKRPTFKQIVQLIEKQISESTN 311

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  149 bits (379), Expect = 9e-41
 Identities = 53/221 (23%), Positives = 100/221 (45%), Gaps = 32/221 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
             F     +G G FG VY      E         I V       AIK++      +A++E
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVK----IPV-------AIKELREATSPKANKE 63

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
            L E  V+  V + ++ RL+G C+  ++ L+ + +  G L +++R   +D +     +  
Sbjct: 64  ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNW 122

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS-------A 440
            +  A+G+ Y+ +      +HRD+ + N+L+    H K+ DFGL KL             
Sbjct: 123 CVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            +P +      +M  E   +   + + DV+++GV ++EL++
Sbjct: 180 KVPIK------WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  155 bits (393), Expect = 2e-40
 Identities = 67/312 (21%), Positives = 113/312 (36%), Gaps = 61/312 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
           +   +   IG+G FG V+          +               AIK            +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPA------------MAVAIKTCKNCTSDSVREK 437

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           FL E   +    H ++V+LIG   E  ++++ E    G L   L+   +  L  +S +  
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILY 496

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL------TEVGSAS 441
           A   +  L Y+       ++HRDI + N+L+  N   K+ DFGL++        +     
Sbjct: 497 AYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSSADSK 497
           LP +      +M PE   +   +   DV+ FGV ++E++        G     G      
Sbjct: 554 LPIK------WMAPESINFRRFTSASDVWMFGVCMWEILM------HGVKPFQGVKN--- 598

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                  +V+     IE+  +L  P    NCP      +  L   C    P  RP    +
Sbjct: 599 ------NDVIGR---IENGERLPMP---PNCPPT----LYSLMTKCWAYDPSRRPRFTEL 642

Query: 558 VVALMTLSSTTE 569
              L T+    +
Sbjct: 643 KAQLSTILEEEK 654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  150 bits (380), Expect = 2e-40
 Identities = 78/297 (26%), Positives = 125/297 (42%), Gaps = 44/297 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
            N S+   +G G FG V    L+           I V       AIK +      +  R+
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKE-----ISV-------AIKTLKVGYTEKQRRD 92

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           FL E  ++    H N++RL G   +   + +V EY+ENG+L   LR            V 
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVG 151

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           +    A G++Y+ +     Y+HRD+ + NILI+ N   KV+DFGL ++ E    +  T  
Sbjct: 152 MLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208

Query: 447 VGTFGY--MPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
            G        PE   Y   +   DV+++G+VL+E++S       G     +        +
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS------YGERPYWEMSN-----Q 257

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           +V+     +++  +L  P    +CP      + QL   C Q+    RP    IV  L
Sbjct: 258 DVIKA---VDEGYRLPPP---MDCPAA----LYQLMLDCWQKDRNNRPKFEQIVSIL 304

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  149 bits (378), Expect = 3e-40
 Identities = 77/322 (23%), Positives = 131/322 (40%), Gaps = 68/322 (21%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
            N ++   +G G FG VY  ++ G   +              + A+K +    S     +
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPS----------PLQVAVKTLPEVCSEQDELD 120

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD-----PLPW 381
           FL E  +++  +H N+VR IG  ++    F++ E +  G+L   LR +         L  
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180

Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---NFHAKVADFGLTKLTE-- 436
              + +A D A G +Y+ E+    +IHRDI + N L+        AK+ DFG+ +     
Sbjct: 181 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237

Query: 437 -----VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN- 490
                 G A LP +      +MPPE    G  + K D ++FGV+L+E+ S       G  
Sbjct: 238 GYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS------LGYM 285

Query: 491 ---GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEY 547
                S          +EVL     +    ++  P    NCP      + ++   C Q  
Sbjct: 286 PYPSKSN---------QEVLEF---VTSGGRMDPP---KNCPGP----VYRIMTQCWQHQ 326

Query: 548 PQLRPSMRSIVVALMTLSSTTE 569
           P+ RP+   I+  +   +   +
Sbjct: 327 PEDRPNFAIILERIEYCTQDPD 348

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  147 bits (372), Expect = 4e-40
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 31/232 (13%)

Query: 263 SYEELSKAT-----DNFSMSHK-IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAA 316
           + EE+            ++  K +G G FG V     + +        +  V       A
Sbjct: 2   ALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMK------KVVKTV-------A 48

Query: 317 IKK-----MDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHL 371
           +K       D     E LAE  V+  + +  +VR+IG C   S  LV E  E G L+++L
Sbjct: 49  VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYL 108

Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
           +      +   + +++    + G++Y+ E     ++HRD+ + N+L+    +AK++DFGL
Sbjct: 109 Q--QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGL 163

Query: 432 TKLTEVGSASLPTRLVGTF--GYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           +K           +  G +   +  PE   Y   S K DV++FGV+++E  S
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  147 bits (373), Expect = 5e-40
 Identities = 75/328 (22%), Positives = 129/328 (39%), Gaps = 82/328 (25%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
            N  +   +G+G FG V  A      G +               A+K +   AS    R+
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAG----------YTTVAVKMLKENASPSELRD 72

Query: 328 FLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGS------------ 374
            L+E  VL  V+H ++++L G C  +G L L+ EY + G+L   LR S            
Sbjct: 73  LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132

Query: 375 ----------GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
                         L     +  A   ++G++Y+ E      +HRD+ + NIL+ +    
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKM 189

Query: 425 KVADFGLTKL-------TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLY 477
           K++DFGL++         +     +P +      +M  E       + + DV++FGV+L+
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLW 243

Query: 478 ELISAKEAIVKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSV 533
           E+++       G     G            E + NL   ++   ++  P   DNC  +  
Sbjct: 244 EIVT------LGGNPYPGIPP---------ERLFNL---LKTGHRMERP---DNCSEE-- 280

Query: 534 LKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
             M +L   C ++ P  RP    I   L
Sbjct: 281 --MYRLMLQCWKQEPDKRPVFADISKDL 306

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  146 bits (370), Expect = 7e-40
 Identities = 64/311 (20%), Positives = 117/311 (37%), Gaps = 63/311 (20%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD---MQASREF 328
           ++   +  +GQG F  ++    R       L     V        +K +D      S  F
Sbjct: 8   EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHE-TEV-------LLKVLDKAHRNYSESF 59

Query: 329 LAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
                +++ + H +LV   G CV G    LV E+++ G+L  +L+   ++ +    ++++
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEV 118

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDK--------NFHAKVADFGLTK-LTEVG 438
           A   A  + ++ E+T    IH ++ + NIL+ +            K++D G++  +    
Sbjct: 119 AKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

Query: 439 SASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                        ++PPE  +     +   D ++FG  L+E+                S 
Sbjct: 176 ILQERIP------WVPPECIENPKNLNLATDKWSFGTTLWEIC---------------SG 214

Query: 498 GLVALF----EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
           G   L     +  L      ED  +L  P       L      A L   C    P  RPS
Sbjct: 215 GDKPLSALDSQRKLQF---YEDRHQLPAP---KAAEL------ANLINNCMDYEPDHRPS 262

Query: 554 MRSIVVALMTL 564
            R+I+  L +L
Sbjct: 263 FRAIIRDLNSL 273

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  147 bits (372), Expect = 1e-39
 Identities = 74/346 (21%), Positives = 133/346 (38%), Gaps = 85/346 (24%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
           +N      +G G FG V  A   G                  + A+K +    D      
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGV----------SIQVAVKMLKEKADSSEREA 94

Query: 328 FLAELKVLTHV-HHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGS----------- 374
            ++ELK++T +  H N+V L+G C + G ++L++EY   G+L  +LR             
Sbjct: 95  LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154

Query: 375 ----------GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
                       + L +   +  A   A+G+E++   +    +HRD+ + N+L+      
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVV 211

Query: 425 KVADFGLTKL-------TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLY 477
           K+ DFGL +           G+A LP +      +M PE    G  + K DV+++G++L+
Sbjct: 212 KICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLW 265

Query: 478 ELISAKEAIVKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSV 533
           E+ S       G     G   D             L   I++  K+  P        +  
Sbjct: 266 EIFS------LGVNPYPGIPVD--------ANFYKL---IQNGFKMDQP---FYATEE-- 303

Query: 534 LKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGSFYEN 579
             +  + + C     + RPS  ++   L    +  E+    + Y+N
Sbjct: 304 --IYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE----AMYQN 343

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  146 bits (370), Expect = 1e-39
 Identities = 80/339 (23%), Positives = 128/339 (37%), Gaps = 73/339 (21%)

Query: 239 ESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYG 298
           E +    G P            +  Y  L     NF +  KIG+G F  VY A      G
Sbjct: 3   EQSQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRA-ACLLDG 57

Query: 299 NSYLSRLICVNLLMQKAAIKK------MDMQASREFLAELKVLTHVHHLNLVRLIGYCVE 352
                            A+KK      MD +A  + + E+ +L  ++H N+++     +E
Sbjct: 58  VPV--------------ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103

Query: 353 -GSLFLVYEYIENGNLSEHLRGSGRDPLP------WSSRVQIALDSARGLEYIHEHTVPV 405
              L +V E  + G+LS  ++   +          W   VQ+       LE++H   V  
Sbjct: 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS----ALEHMHSRRV-- 157

Query: 406 YIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSP 465
            +HRDIK AN+ I      K+ D GL +       +    LVGT  YM PE       + 
Sbjct: 158 -MHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGYNF 215

Query: 466 KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN-----LPDPI--EDLRK 518
           K D+++ G +LYE+ + +           D   L +L +++       LP     E+LR+
Sbjct: 216 KSDIWSLGCLLYEMAALQSPF------YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269

Query: 519 LVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           LV                     +C    P+ RP +  +
Sbjct: 270 LV--------------------NMCINPDPEKRPDVTYV 288

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  146 bits (370), Expect = 2e-39
 Identities = 72/302 (23%), Positives = 124/302 (41%), Gaps = 67/302 (22%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-----QASR 326
           + +    KIG+G FG     +   + G  Y               IK++++     +   
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTED-GRQY--------------VIKEINISRMSSKERE 68

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLP----W 381
           E   E+ VL ++ H N+V+      E GSL++V +Y E G+L + +              
Sbjct: 69  ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128

Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
              VQI L     L+++H+  +   +HRDIKS NI + K+   ++ DFG+ ++       
Sbjct: 129 DWFVQICL----ALKHVHDRKI---LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL 181

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
                +GT  Y+ PE  +    + K D++A G VLYEL + K A         ++  +  
Sbjct: 182 ARA-CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF--------EAGSMKN 232

Query: 502 LFEEVLN-----LPDPI-EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
           L  ++++     +      DLR LV                        +  P+ RPS+ 
Sbjct: 233 LVLKIISGSFPPVSLHYSYDLRSLV--------------------SQLFKRNPRDRPSVN 272

Query: 556 SI 557
           SI
Sbjct: 273 SI 274

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  146 bits (370), Expect = 3e-39
 Identities = 85/337 (25%), Positives = 136/337 (40%), Gaps = 82/337 (24%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASRE 327
           +N      IG+G FG V+ A   G                    A+K +          +
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEP----------FTMVAVKMLKEEASADMQAD 96

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSR-- 384
           F  E  ++    + N+V+L+G C  G  + L++EY+  G+L+E LR      +   S   
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156

Query: 385 --------------------VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
                               + IA   A G+ Y+ E     ++HRD+ + N L+ +N   
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVV 213

Query: 425 KVADFGLTKLTEV-------GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLY 477
           K+ADFGL++           G+ ++P R      +MPPE   Y   + + DV+A+GVVL+
Sbjct: 214 KIADFGLSRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLW 267

Query: 478 ELISAKEAIVKGN----GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSV 533
           E+ S       G     G +          EEV+     + D   L  P   +NCPL+  
Sbjct: 268 EIFS------YGLQPYYGMAH---------EEVIYY---VRDGNILACP---ENCPLE-- 304

Query: 534 LKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED 570
             +  L ++C  + P  RPS  SI   L  +    E 
Sbjct: 305 --LYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG 339

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  144 bits (365), Expect = 4e-39
 Identities = 68/319 (21%), Positives = 115/319 (36%), Gaps = 79/319 (24%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
            +F     +G+GGFG V+ A+ + +   +Y              AIK++ +        +
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVD-DCNY--------------AIKRIRLPNRELAREK 49

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVE-------------GSLFLVYEYIENGNLSEHLRGS 374
            + E+K L  + H  +VR     +E               L++  +     NL + + G 
Sbjct: 50  VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR 109

Query: 375 GRDPLP-----WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF 429
                          +QIA      +E++H   +   +HRD+K +NI    +   KV DF
Sbjct: 110 CTIEERERSVCLHIFLQIAE----AVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDF 162

Query: 430 GLTK-----------LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYE 478
           GL             LT + + +  T  VGT  YM PE       S KVD+++ G++L+E
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222

Query: 479 LISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQ 538
           L+                      F   +     + D+R L  P L              
Sbjct: 223 LLYP--------------------FSTQMERVRTLTDVRNLKFPPL----FTQKYPCEYV 258

Query: 539 LAKVCTQEYPQLRPSMRSI 557
           + +      P  RP   +I
Sbjct: 259 MVQDMLSPSPMERPEAINI 277

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  143 bits (362), Expect = 7e-39
 Identities = 61/235 (25%), Positives = 96/235 (40%), Gaps = 46/235 (19%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
            +   +F     IG GGFG V+ A+ R + G +Y               IK++    + +
Sbjct: 7   KRFGMDFKEIELIGSGGFGQVFKAKHRID-GKTY--------------VIKRVKYN-NEK 50

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVE-----------------GSLFLVYEYIENGNLSEH 370
              E+K L  + H+N+V   G                       LF+  E+ + G L + 
Sbjct: 51  AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110

Query: 371 LRGSGRDPLP----WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV 426
           +     + L          QI      G++YIH   +   I+RD+K +NI +      K+
Sbjct: 111 IEKRRGEKLDKVLALELFEQITK----GVDYIHSKKL---INRDLKPSNIFLVDTKQVKI 163

Query: 427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            DFGL    +  +    TR  GT  YM PE     D   +VD+YA G++L EL+ 
Sbjct: 164 GDFGLVTSLK--NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  140 bits (354), Expect = 9e-38
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 26/214 (12%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           ++F +   +G+G FG VY A  +        S+ I    ++ KA ++K  +  Q  RE  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQ-------SKFILALKVLFKAQLEKAGVEHQLRRE-- 59

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSR--VQ 386
             +++ +H+ H N++RL GY  + + ++L+ EY   G +   L+   +     ++    +
Sbjct: 60  --VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           +A      L Y H   V   IHRDIK  N+L+      K+ADFG +      S+     L
Sbjct: 118 LAN----ALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTD-L 167

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            GT  Y+PPE  +      KVD+++ GV+ YE +
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  145 bits (367), Expect = 3e-37
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 23/209 (11%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKV 334
           ++G G FG+V     R           I V       AIK +    +   + E + E ++
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQ------IDV-------AIKVLKQGTEKADTEEMMREAQI 389

Query: 335 LTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
           +  + +  +VRLIG C   +L LV E    G L + L G   + +P S+  ++    + G
Sbjct: 390 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMG 448

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY-- 452
           ++Y+ E     ++HR++ + N+L+    +AK++DFGL+K      +    R  G +    
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505

Query: 453 MPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             PE   +   S + DV+++GV ++E +S
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALS 534

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  137 bits (346), Expect = 2e-36
 Identities = 62/245 (25%), Positives = 95/245 (38%), Gaps = 55/245 (22%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-- 325
            +   +F     +GQG FG V  A    +    Y              AIKK+       
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALD-SRYY--------------AIKKIRHTEEKL 46

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGS--------------LFLVYEYIENGNLSEHL 371
              L+E+ +L  ++H  +VR     +E                LF+  EY ENG L + +
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106

Query: 372 RGSGRDPLPWSSR---VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
                +           QI       L YIH   +   IHRD+K  NI ID++ + K+ D
Sbjct: 107 HSENLNQQRDEYWRLFRQILE----ALSYIHSQGI---IHRDLKPMNIFIDESRNVKIGD 159

Query: 429 FGLTKLTE-------------VGSASLPTRLVGTFGYMPPE-YAQYGDVSPKVDVYAFGV 474
           FGL K                 GS+   T  +GT  Y+  E     G  + K+D+Y+ G+
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219

Query: 475 VLYEL 479
           + +E+
Sbjct: 220 IFFEM 224

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  136 bits (345), Expect = 3e-36
 Identities = 60/306 (19%), Positives = 100/306 (32%), Gaps = 59/306 (19%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREFL 329
           ++    K+G+GGF  V   E   +                   A+K++   + Q   E  
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDG---------------HFYALKRILCHEQQDREEAQ 74

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHL--RGSGRDPLPWS 382
            E  +    +H N++RL+ YC+         +L+  + + G L   +       + L   
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134

Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
             + + L   RGLE IH      Y HRD+K  NIL+       + D G      +     
Sbjct: 135 QILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191

Query: 443 PTRL--------VGTFGYMPPE---YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG 491
              L          T  Y  PE      +  +  + DV++ G VLY ++          G
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF---------G 242

Query: 492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR 551
                      ++ V         L       +  +    S L   QL        P  R
Sbjct: 243 EGP--------YDMV-FQKGDSVALAVQNQLSIPQSPRHSSALW--QLLNSMMTVDPHQR 291

Query: 552 PSMRSI 557
           P +  +
Sbjct: 292 PHIPLL 297

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (342), Expect = 6e-36
 Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 27/209 (12%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFLA----EL 332
           K+G GG   VY AE      ++ L+  +         AIK +    +   E L     E+
Sbjct: 18  KLGGGGMSTVYLAE------DTILNIKV---------AIKAIFIPPREKEETLKRFEREV 62

Query: 333 KVLTHVHHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
              + + H N+V +I    E    +LV EYIE   LSE++   G  PL   + +      
Sbjct: 63  HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQI 120

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFG 451
             G+++ H+  +   +HRDIK  NILID N   K+ DFG+ K     S +    ++GT  
Sbjct: 121 LDGIKHAHDMRI---VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177

Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           Y  PE A+        D+Y+ G+VLYE++
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEML 206

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  134 bits (340), Expect = 7e-36
 Identities = 59/303 (19%), Positives = 114/303 (37%), Gaps = 60/303 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +++ + + IG G +G       +           I V    ++     M     +  ++E
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKS-------DGKILV---WKELDYGSMTEAEKQMLVSE 55

Query: 332 LKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHLRGSGRD--PLP----WS 382
           + +L  + H N+VR     ++    +L++V EY E G+L+  +    ++   L       
Sbjct: 56  VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115

Query: 383 SRVQIALDSARGLEYIHEHTVPVY--IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
              Q+ L     L+  H  +   +  +HRD+K AN+ +D   + K+ DFGL ++    ++
Sbjct: 116 VMTQLTL----ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
              T  VGT  YM PE       + K D+++ G +LYEL +              +    
Sbjct: 172 FAKT-FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--------TAFSQK 222

Query: 501 ALFEEVLN-LPDPI-----EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM 554
            L  ++       I     ++L +++                              RPS+
Sbjct: 223 ELAGKIREGKFRRIPYRYSDELNEII--------------------TRMLNLKDYHRPSV 262

Query: 555 RSI 557
             I
Sbjct: 263 EEI 265

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  134 bits (340), Expect = 8e-36
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           D+F +   +G+G FG VY A  +        ++ I    ++ K+ ++K  +  Q  RE  
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQ-------NKFIMALKVLFKSQLEKEGVEHQLRRE-- 64

Query: 330 AELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR--VQ 386
             +++ +H+ H N++R+  Y      ++L+ E+   G L + L+  GR     S+    +
Sbjct: 65  --IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           +A      L Y HE  V   IHRDIK  N+L+      K+ADFG +      S    T +
Sbjct: 123 LAD----ALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRT-M 172

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            GT  Y+PPE  +      KVD++  GV+ YE +
Sbjct: 173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL 206

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  135 bits (341), Expect = 1e-35
 Identities = 57/215 (26%), Positives = 90/215 (41%), Gaps = 39/215 (18%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE------FLAEL 332
            +G+GG G VY AE      ++   R++         A+K M    S +         E 
Sbjct: 41  LVGRGGMGDVYEAE------DTVRERIV---------ALKLMSETLSSDPVFRTRMQREA 85

Query: 333 KVLTHVHHLNLVRLIGY-CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
           +    +   ++V +  +  ++G L++    I   +L+  LR  G  PL     V I    
Sbjct: 86  RTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQI 143

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL------TKLTEVGSASLPTR 445
              L+  H        HRD+K  NIL+  +  A + DFG+       KLT++G+      
Sbjct: 144 GSALDAAHAAGA---THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT----- 195

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            VGT  YM PE       + + D+YA   VLYE +
Sbjct: 196 -VGTLYYMAPERFSESHATYRADIYALTCVLYECL 229

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  133 bits (337), Expect = 3e-35
 Identities = 61/286 (21%), Positives = 109/286 (38%), Gaps = 53/286 (18%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-----REFLAELK 333
           +IG+G F  VY   L  E                 + A  ++  +       + F  E +
Sbjct: 33  EIGRGSFKTVYKG-LDTETT--------------VEVAWCELQDRKLTKSERQRFKEEAE 77

Query: 334 VLTHVHHLNLVRLIGYCV-----EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +L  + H N+VR           +  + LV E + +G L  +L+      +         
Sbjct: 78  MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWC 135

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILID-KNFHAKVADFGLTKLTEVGSASLPTRLV 447
               +GL+++H  T P+ IHRD+K  NI I       K+ D GL  L     AS    ++
Sbjct: 136 RQILKGLQFLHTRTPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVI 191

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           GT  +M PE  +       VDVYAFG+ + E+ +++          ++ +    ++  V 
Sbjct: 192 GTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVT 243

Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
           +         K+  P + +            + + C ++    R S
Sbjct: 244 S-GVKPASFDKVAIPEVKE------------IIEGCIRQNKDERYS 276

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (333), Expect = 1e-34
 Identities = 65/305 (21%), Positives = 105/305 (34%), Gaps = 70/305 (22%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----- 322
           S    +F    ++G G +G V+    + + G  Y              A+K+        
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKED-GRLY--------------AVKRSMSPFRGP 97

Query: 323 QASREFLAELKVLTHV-HHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
           +     LAE+     V  H   VRL   +   G L+L  E     +L +H    G   LP
Sbjct: 98  KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGA-SLP 155

Query: 381 ----WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE 436
               W       L     L ++H   +   +H D+K ANI +      K+ DFGL    E
Sbjct: 156 EAQVWGYLRDTLL----ALAHLHSQGL---VHLDVKPANIFLGPRGRCKLGDFGLLV--E 206

Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
           +G+A       G   YM PE  Q G      DV++ G+ + E+    E            
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNME------------ 253

Query: 497 KGLVALFEEVLNLPDPIEDLRKLVD----PRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP 552
                       LP   E  ++L      P        +    +  +  +  +  P+LR 
Sbjct: 254 ------------LPHGGEGWQQLRQGYLPPEFTAGLSSE----LRSVLVMMLEPDPKLRA 297

Query: 553 SMRSI 557
           +  ++
Sbjct: 298 TAEAL 302

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  135 bits (341), Expect = 1e-33
 Identities = 45/213 (21%), Positives = 81/213 (38%), Gaps = 40/213 (18%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKV 334
            I  GG G +Y A                 N+  +   +K +    D +A    +AE + 
Sbjct: 87  CIAHGGLGWIYLAL--------------DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF 132

Query: 335 LTHVHHLNLVRLI------GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           L  V H ++V++           +   ++V EY+   +L           LP +  +   
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYL 188

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPTRLV 447
           L+    L Y+H   +   ++ D+K  NI++ +    K+ D G  +++   G       L 
Sbjct: 189 LEILPALSYLHSIGL---VYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LY 238

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           GT G+  PE  +    +   D+Y  G  L  L 
Sbjct: 239 GTPGFQAPEIVR-TGPTVATDIYTVGRTLAALT 270

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  127 bits (322), Expect = 6e-33
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 37/217 (17%)

Query: 279 KIGQGGFGAVYYAE-LRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFLA----E 331
            +G GG   V+ A  LR         R +         A+K +  D+     F      E
Sbjct: 19  ILGFGGMSEVHLARDLR-------DHRDV---------AVKVLRADLARDPSFYLRFRRE 62

Query: 332 LKVLTHVHHLNLVRLIGYCVEGSL-----FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            +    ++H  +V +       +      ++V EY++   L + +   G  P+     ++
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 120

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR- 445
           +  D+ + L + H++ +   IHRD+K ANI+I      KV DFG+ +       S+ T+ 
Sbjct: 121 VIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQT 176

Query: 446 --LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             ++GT  Y+ PE A+   V  + DVY+ G VLYE++
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  128 bits (323), Expect = 6e-33
 Identities = 50/260 (19%), Positives = 100/260 (38%), Gaps = 35/260 (13%)

Query: 242 GPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYG--- 298
           GP       L+  +    +    +E  K  +++ +   + QG F  +   E   ++    
Sbjct: 1   GPLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALK 60

Query: 299 ----NSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EG 353
               +    +         K +IK        E    L+++T + +   +   G      
Sbjct: 61  KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE----LQIITDIKNEYCLTCEGIITNYD 116

Query: 354 SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV----------QIALDSARGLEYIHEH-T 402
            ++++YEY+EN ++ +           ++  +           +         YIH    
Sbjct: 117 EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLN----SFSYIHNEKN 172

Query: 403 VPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE--YAQY 460
           +    HRD+K +NIL+DKN   K++DFG ++        +     GT+ +MPPE    + 
Sbjct: 173 I---CHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKG-SRGTYEFMPPEFFSNES 226

Query: 461 GDVSPKVDVYAFGVVLYELI 480
                KVD+++ G+ LY + 
Sbjct: 227 SYNGAKVDIWSLGICLYVMF 246

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  124 bits (314), Expect = 4e-32
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 38/220 (17%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF-- 328
              ++   KIGQG  G VY A      G              Q+ AI++M++Q   +   
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDV-ATG--------------QEVAIRQMNLQQQPKKEL 63

Query: 329 -LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            + E+ V+    + N+V  +  Y V   L++V EY+  G+L++ +       +      Q
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCM---DEGQ 117

Query: 387 IAL---DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASL 442
           IA    +  + LE++H + V   IHRDIKS NIL+  +   K+ DFG   ++T       
Sbjct: 118 IAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITP----EQ 170

Query: 443 PTR--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
             R  +VGT  +M PE        PKVD+++ G++  E+I
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  123 bits (311), Expect = 7e-32
 Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 21/213 (9%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F + + +G+G F  VY AE       S  + L     ++ K A+ K  M   +    E
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAE-------SIHTGLEVAIKMIDKKAMYKAGMV--QRVQNE 61

Query: 332 LKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR---VQI 387
           +K+   + H +++ L  Y      ++LV E   NG ++ +L+   +      +R    QI
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI 121

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
                 G+ Y+H H +   +HRD+  +N+L+ +N + K+ADFGL    ++      T L 
Sbjct: 122 I----TGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LC 173

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           GT  Y+ PE A       + DV++ G + Y L+
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLL 206

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  124 bits (312), Expect = 1e-31
 Identities = 59/216 (27%), Positives = 107/216 (49%), Gaps = 30/216 (13%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-REFL 329
            + F +  K+G+G +G+VY A                     Q  AIK++ +++  +E +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKA---------------IHKETGQIVAIKQVPVESDLQEII 72

Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ ++      ++V+  G Y     L++V EY   G++S+ +R   +  L   +  +IA
Sbjct: 73  KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TL---TEDEIA 128

Query: 389 L---DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPT 444
                + +GLEY+H       IHRDIK+ NIL++   HAK+ADFG+  +LT+  +     
Sbjct: 129 TILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--N 183

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            ++GT  +M PE  Q    +   D+++ G+   E+ 
Sbjct: 184 TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMA 219

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  122 bits (309), Expect = 3e-31
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 38/220 (17%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF-- 328
                   KIG+G  G V  A  +   G              ++ A+K MD++  +    
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREK-HSG--------------RQVAVKMMDLRKQQRREL 88

Query: 329 -LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
              E+ ++    H N+V +   Y V   L+++ E+++ G L++ +       L   +  Q
Sbjct: 89  LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RL---NEEQ 142

Query: 387 IAL---DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASL 442
           IA       + L Y+H   V   IHRDIKS +IL+  +   K++DFG   ++++     +
Sbjct: 143 IATVCEAVLQALAYLHAQGV---IHRDIKSDSILLTLDGRVKLSDFGFCAQISK----DV 195

Query: 443 PTR--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           P R  LVGT  +M PE       + +VD+++ G+++ E++
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMV 235

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  122 bits (308), Expect = 4e-31
 Identities = 56/231 (24%), Positives = 88/231 (38%), Gaps = 49/231 (21%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK-----KMDMQASRE 327
            +S+  +IG GG   V+      E    Y              AIK     + D Q    
Sbjct: 29  IYSILKQIGSGGSSKVFQV--LNEKKQIY--------------AIKYVNLEEADNQTLDS 72

Query: 328 FLAE---LKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
           +  E   L  L   H   ++RL  Y + +  +++V E   N +L+  L+           
Sbjct: 73  YRNEIAYLNKLQQ-HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 130

Query: 384 RV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                +       +  IH+H +   +H D+K AN LI      K+ DFG+    +  + S
Sbjct: 131 SYWKNML----EAVHTIHQHGI---VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 182

Query: 442 LPTR-LVGTFGYMPPE-----------YAQYGDVSPKVDVYAFGVVLYELI 480
           +     VGT  YMPPE                 +SPK DV++ G +LY + 
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  123 bits (310), Expect = 6e-31
 Identities = 41/229 (17%), Positives = 81/229 (35%), Gaps = 40/229 (17%)

Query: 271 TDNFSMSHKIGQG--GFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASRE 327
              + +   IG+G      V  A                     +   ++++++   S E
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLA--------------RYKPT-GEYVTVRRINLEACSNE 68

Query: 328 FL----AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
            +     EL V    +H N+V     +  +  L++V  ++  G+  + +     D +   
Sbjct: 69  MVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-- 126

Query: 383 SRVQIAL---DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG-LTKLTEVG 438
             + IA       + L+YIH       +HR +K+++ILI  +    ++       +   G
Sbjct: 127 -ELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182

Query: 439 S-----ASLPTRLVGTFGYMPPEYAQYGDV--SPKVDVYAFGVVLYELI 480
                    P   V    ++ PE  Q        K D+Y+ G+   EL 
Sbjct: 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  122 bits (307), Expect = 7e-31
 Identities = 64/354 (18%), Positives = 115/354 (32%), Gaps = 96/354 (27%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSY-----------------------LSR 304
           S+   +F     +G+GGFG V+ A+ + +   +Y                       L++
Sbjct: 2   SRYLTDFEPIQCMGRGGFGVVFEAKNKVD-DCNYAIKRIRLPNRELAREKVMREVKALAK 60

Query: 305 LICVNLLMQKAA------------------------IKKMDMQASREFLAELKVLTHVHH 340
           L    ++    A                                      +++ +     
Sbjct: 61  LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST 120

Query: 341 LNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP-----WSSRVQIALDSARG 394
            N V  +     +  L++  +     NL + +                  +QIA      
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE----A 176

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-----------LTEVGSASLP 443
           +E++H   +   +HRD+K +NI    +   KV DFGL             LT + + +  
Sbjct: 177 VEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
           T  VGT  YM PE     + S KVD+++ G++L+EL+ +                     
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-----------------Q 276

Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
            E + +   I D+R L  P L          +   + +      P  RP    I
Sbjct: 277 MERVRI---ITDVRNLKFPLL----FTQKYPQEHMMVQDMLSPSPTERPEATDI 323

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  122 bits (307), Expect = 1e-30
 Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 49/234 (20%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK-----KMDMQASRE 327
            +S+  +IG GG   V+                  +N   Q  AIK     + D Q    
Sbjct: 10  IYSILKQIGSGGSSKVF----------------QVLNEKKQIYAIKYVNLEEADNQTLDS 53

Query: 328 FLAE---LKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
           +  E   L  L   H   ++RL  Y + +  +++V E   N +L+  L+           
Sbjct: 54  YRNEIAYLNKLQQ-HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 111

Query: 384 RV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                +       +  IH+H +   +H D+K AN LI      K+ DFG+    +  + S
Sbjct: 112 SYWKNMLE----AVHTIHQHGI---VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 163

Query: 442 -LPTRLVGTFGYMPPE-----------YAQYGDVSPKVDVYAFGVVLYELISAK 483
            +    VGT  YMPPE                 +SPK DV++ G +LY +   K
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  120 bits (303), Expect = 1e-30
 Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 20/212 (9%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
             +     +G+GGF   +      +    +  +++       K+ + K   +   +   E
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDA-DTKEVFAGKIV------PKSLLLKPHQRE--KMSME 65

Query: 332 LKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR--VQIA 388
           + +   + H ++V   G+      +F+V E     +L E  +       P +     QI 
Sbjct: 66  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
                G +Y+H + V   IHRD+K  N+ ++++   K+ DFGL    E         L G
Sbjct: 126 ----LGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCG 177

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           T  Y+ PE       S +VDV++ G ++Y L+
Sbjct: 178 TPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLL 209

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  120 bits (304), Expect = 1e-30
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 40/228 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR----E 327
           D++ +   IG G    V  A               C     +K AIK+++++  +    E
Sbjct: 15  DDYELQEVIGSGATAVVQAA--------------YCAPK-KEKVAIKRINLEKCQTSMDE 59

Query: 328 FLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR-- 384
            L E++ ++  HH N+V     + V+  L+LV + +  G++ + ++         S    
Sbjct: 60  LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119

Query: 385 -VQIAL---DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGS 439
              IA    +   GLEY+H++     IHRD+K+ NIL+ ++   ++ADFG+   L   G 
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 440 ASLPTR---LVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELI 480
            +        VGT  +M PE       Y     K D+++FG+   EL 
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYD---FKADIWSFGITAIELA 221

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  122 bits (308), Expect = 1e-30
 Identities = 61/271 (22%), Positives = 97/271 (35%), Gaps = 49/271 (18%)

Query: 236 KTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRG 295
                          L     DK+   + E +S     +S+  +IG GG   V+      
Sbjct: 20  TAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVF------ 73

Query: 296 EYGNSYLSRLICVNLLMQKAAIK-----KMDMQASREFLAE---LKVLTHVHHLNLVRLI 347
                       +N   Q  AIK     + D Q    +  E   L  L   H   ++RL 
Sbjct: 74  ----------QVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ-HSDKIIRLY 122

Query: 348 GYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QIALDSARGLEYIHEHTVP 404
            Y + +  +++V E   N +L+  L+                +       +  IH+H + 
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE----AVHTIHQHGI- 176

Query: 405 VYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR-LVGTFGYMPPE------- 456
             +H D+K AN LI      K+ DFG+    +  + S+     VG   YMPPE       
Sbjct: 177 --VHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 457 ----YAQYGDVSPKVDVYAFGVVLYELISAK 483
                     +SPK DV++ G +LY +   K
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  121 bits (305), Expect = 2e-30
 Identities = 51/251 (20%), Positives = 99/251 (39%), Gaps = 21/251 (8%)

Query: 233 PAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAE 292
                 ++  P    P +  A    K +     +  ++   +     +G+GGF   +   
Sbjct: 3   APADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVD-PRSRRRYVRGRFLGKGGFAKCFEIS 61

Query: 293 LRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV- 351
              +    +  +++       K+ + K   +   +   E+ +   + H ++V   G+   
Sbjct: 62  DA-DTKEVFAGKIV------PKSLLLKPHQRE--KMSMEISIHRSLAHQHVVGFHGFFED 112

Query: 352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR--VQIALDSARGLEYIHEHTVPVYIHR 409
              +F+V E     +L E  +       P +     QI      G +Y+H + V   IHR
Sbjct: 113 NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV----LGCQYLHRNRV---IHR 165

Query: 410 DIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDV 469
           D+K  N+ ++++   K+ DFGL    E         L GT  Y+ PE       S +VDV
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDV 224

Query: 470 YAFGVVLYELI 480
           ++ G ++Y L+
Sbjct: 225 WSIGCIMYTLL 235

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  119 bits (301), Expect = 3e-30
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 35/219 (15%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR---- 326
            + F+   KIG+G FG V+                I      +  AIK +D++ +     
Sbjct: 21  EELFTKLEKIGKGSFGEVFKG--------------IDNRT-QKVVAIKIIDLEEAEDEIE 65

Query: 327 EFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
           +   E+ VL+      + +  G Y  +  L+++ EY+  G+  + L      PL      
Sbjct: 66  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PGPL---DET 119

Query: 386 QIAL---DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSAS 441
           QIA    +  +GL+Y+H       IHRDIK+AN+L+ ++   K+ADFG+  +LT+     
Sbjct: 120 QIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                VGT  +M PE  +      K D+++ G+   EL 
Sbjct: 177 --NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELA 213

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  119 bits (300), Expect = 3e-30
 Identities = 65/321 (20%), Positives = 110/321 (34%), Gaps = 81/321 (25%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQAS- 325
           S+ T  F    KIG G FG+V+                 CV  L     AIK+     + 
Sbjct: 7   SRYTTEFHELEKIGSGEFGSVF----------------KCVKRLDGCIYAIKRSKKPLAG 50

Query: 326 ----REFLAELKVLTHV-HHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
               +  L E+     +  H ++VR    +  +  + +  EY   G+L++ +  + R   
Sbjct: 51  SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS 110

Query: 380 PWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN---------------- 421
            +       + L   RGL YIH  ++   +H DIK +NI I +                 
Sbjct: 111 YFKEAELKDLLLQVGRGLRYIHSMSL---VHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167

Query: 422 ---FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS--PKVDVYAFGVVL 476
                 K+ D G      V   S P    G   ++  E  Q  + +  PK D++A  + +
Sbjct: 168 SNKVMFKIGDLGH-----VTRISSPQVEEGDSRFLANEVLQ-ENYTHLPKADIFALALTV 221

Query: 477 YELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKM 536
                A+                           D   ++R+   PR+      +     
Sbjct: 222 VCAAGAEPL---------------------PRNGDQWHEIRQGRLPRIPQVLSQE----F 256

Query: 537 AQLAKVCTQEYPQLRPSMRSI 557
            +L KV     P+ RPS  ++
Sbjct: 257 TELLKVMIHPDPERRPSAMAL 277

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  122 bits (306), Expect = 3e-30
 Identities = 39/279 (13%), Positives = 83/279 (29%), Gaps = 46/279 (16%)

Query: 280 IGQGGFGAVYYAE--------------LRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           +GQ    A   A                     ++ + ++    L ++     K   QA 
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 326 RE--FLAELKVLTHVHHLNLVRLIGYCVEG---SLFLVYEYIENGNLSEHL-----RGSG 375
               F+    ++       ++R+     +    S F +Y  ++  NL           S 
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSST 204

Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLT 435
              L   +R+Q+ L   R L  +H + +   +H  ++  +I++D+     +  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 436 EVGSASLPTRLVGTFGYMPPEYAQY-----GDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
              + S   R              +       ++   D +  G+ +Y +          +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC-------AD 314

Query: 491 ---GSSADSKGLVALFEEVLNLPDPIEDL-RKL--VDPR 523
                 A   G   +F    N+P P+  L          
Sbjct: 315 LPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 353

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  120 bits (303), Expect = 4e-30
 Identities = 50/298 (16%), Positives = 95/298 (31%), Gaps = 47/298 (15%)

Query: 265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA 324
            E    +    + H +G+G F  VY A                     QK  +K      
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKN----------KQKFVLKVQKPAN 107

Query: 325 SREF---LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHL---RGSGRD 377
             EF      ++ L        ++    +  +    LV E    G L   +   + +   
Sbjct: 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK 167

Query: 378 PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI-----------DKNFHAKV 426
            +P    +  A+     +E +H+  +   IH DIK  N ++           D +    +
Sbjct: 168 VMPQGLVISFAMRMLYMIEQVHDCEI---IHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224

Query: 427 ADFGLTK-LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA 485
            D G +  +      ++ T    T G+   E       + ++D +     +Y ++     
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

Query: 486 IVKGNGSSADSKGLV----------ALFEEVLNLPDP-----IEDLRKLVDPRLGDNC 528
            VK  G     +GL             F  +LN+PD      ++ LR+ +      + 
Sbjct: 285 KVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  119 bits (300), Expect = 5e-30
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 23/242 (9%)

Query: 246 GTPTSLNAITVDKSVEFSYEELSKAT-DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSR 304
           GT                  +  K   ++F     +G+G F  V  A           SR
Sbjct: 3   GTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELAT------SR 56

Query: 305 LICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIE 363
              + +L +K  I K +         E  V++ + H   V+L      +  L+    Y +
Sbjct: 57  EYAIKIL-EKRHIIKENKVPY--VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 113

Query: 364 NGNLSEHLRGSGRDPLPWSSRV---QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK 420
           NG L +++R  G       +R    +I       LEY+H   +   IHRD+K  NIL+++
Sbjct: 114 NGELLKYIRKIGSFDET-CTRFYTAEIVS----ALEYLHGKGI---IHRDLKPENILLNE 165

Query: 421 NFHAKVADFGLTKLTEVGSASLPTR-LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
           + H ++ DFG  K+    S        VGT  Y+ PE           D++A G ++Y+L
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 225

Query: 480 IS 481
           ++
Sbjct: 226 VA 227

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  119 bits (301), Expect = 6e-30
 Identities = 58/278 (20%), Positives = 101/278 (36%), Gaps = 51/278 (18%)

Query: 248 PTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLIC 307
           P SL   +     +F  + +        +   + +GGF  VY A  +             
Sbjct: 4   PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEA--QDVGSG-------- 53

Query: 308 VNLLMQKAAIKKM---DMQASREFLAELKVLTHV-HHLNLVRLIGYCVEGS--------L 355
                ++ A+K++   + + +R  + E+  +  +  H N+V+       G          
Sbjct: 54  -----REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108

Query: 356 FLVYEYIENGNLSEHL-RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA 414
           FL+   +  G L E L +   R PL   + ++I   + R ++++H    P+ IHRD+K  
Sbjct: 109 FLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI-IHRDLKVE 167

Query: 415 NILIDKNFHAKVADFGLTKLTEVGSASLPTRL-----------VGTFGYMPPE---YAQY 460
           N+L+      K+ DFG             +               T  Y  PE       
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227

Query: 461 GDVSPKVDVYAFGVVLYELI--------SAKEAIVKGN 490
             +  K D++A G +LY L          AK  IV G 
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  118 bits (298), Expect = 7e-30
 Identities = 49/223 (21%), Positives = 97/223 (43%), Gaps = 37/223 (16%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS---RE 327
            + + +  ++G G FG VY A+ +                    AA K ++ ++     +
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKE---------------TGALAAAKVIETKSEEELED 62

Query: 328 FLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           ++ E+++L    H  +V+L+G Y  +G L+++ E+   G +   +    R  L   +  Q
Sbjct: 63  YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR-GL---TEPQ 118

Query: 387 IAL---DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASL 442
           I +        L ++H   +   IHRD+K+ N+L+      ++ADFG+  K  +      
Sbjct: 119 IQVVCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR- 174

Query: 443 PTRLVGTFGYMPPE-----YAQYGDVSPKVDVYAFGVVLYELI 480
               +GT  +M PE       +      K D+++ G+ L E+ 
Sbjct: 175 -DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (300), Expect = 7e-30
 Identities = 53/252 (21%), Positives = 99/252 (39%), Gaps = 31/252 (12%)

Query: 238 VESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEY 297
           ++  GP       +      K V++ Y E        +   ++G+G FG V+  +     
Sbjct: 27  LQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPRVGRGSFGEVHRMK----- 78

Query: 298 GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-LF 356
            +                A+KK+ ++  R    EL     +    +V L G   EG  + 
Sbjct: 79  -DKQTGFQC---------AVKKVRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVN 126

Query: 357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI 416
           +  E +E G+L + ++  G   LP    +     +  GLEY+H   +   +H D+K+ N+
Sbjct: 127 IFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRI---LHGDVKADNV 181

Query: 417 LIDKN-FHAKVADFG----LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYA 471
           L+  +   A + DFG    L       S      + GT  +M PE         KVD+++
Sbjct: 182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 241

Query: 472 FGVVLYELISAK 483
              ++  +++  
Sbjct: 242 SCCMMLHMLNGC 253

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  122 bits (308), Expect = 1e-29
 Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 28/282 (9%)

Query: 207 LVFIPGRDANGVFPALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEE 266
           +  +P +        LE      L     +        A     L++I  ++ +++ + E
Sbjct: 118 IPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLE 177

Query: 267 LSKAT-DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
               T + F     +G+GGFG V   ++R         ++     L +K  IKK   +A 
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRAT------GKMYACKKL-EKKRIKKRKGEAM 230

Query: 326 REFLAELKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
              L E ++L  V+   +V L  Y    + +L LV   +  G+L  H+   G+   P  +
Sbjct: 231 A--LNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EA 286

Query: 384 RV-----QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG 438
           R      +I      GLE +H   +   ++RD+K  NIL+D + H +++D GL     V 
Sbjct: 287 RAVFYAAEICC----GLEDLHRERI---VYRDLKPENILLDDHGHIRISDLGLAV--HVP 337

Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
                   VGT GYM PE  +    +   D +A G +LYE+I
Sbjct: 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI 379

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (298), Expect = 2e-29
 Identities = 40/329 (12%), Positives = 83/329 (25%), Gaps = 46/329 (13%)

Query: 233 PAYKTVESTGPAAGTPTSLNAITVDKSVEFSYE-ELSKATDNFSMSHKIGQGGFGAVYYA 291
             Y   E+    A    ++ A    ++ E + +  LS+      +   +  G    V+  
Sbjct: 22  IGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLV 81

Query: 292 ------------------ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK 333
                             E                  L+ ++  +  D +        + 
Sbjct: 82  RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141

Query: 334 VLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSE-----HLRGSGRDPLPWSSRVQIA 388
           V +      L          +  L+       +L             R      +   + 
Sbjct: 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILT 200

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
               R    +    +   +H      N+ I  +    + D     L +VG+         
Sbjct: 201 AQLIRLAANLQSKGL---VHGHFTPDNLFIMPDGRLMLGDVSA--LWKVGTRG--PASSV 253

Query: 449 TFGYMPPEYAQ--YGDVSPKVDVYAFGVVLYELISAK---EAIVKGNGSSADSKGLVAL- 502
              Y P E+        +  ++ +  G+ +Y +         +  G   S     L    
Sbjct: 254 PVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPG 313

Query: 503 -----FEEVLNLPDPIEDL-RKL--VDPR 523
                F     LPD ++ L  +    D R
Sbjct: 314 TDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  118 bits (297), Expect = 3e-29
 Identities = 48/300 (16%), Positives = 89/300 (29%), Gaps = 59/300 (19%)

Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----- 320
           EL +          +GQ    A   A    E G S+   +          AIK+M     
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125

Query: 321 ------------DMQASREFLAELKVLTHVHHLNLVRLIGY---CVEGSLFLVYEYIENG 365
                         +    F+    ++       ++R+          S F +Y  ++  
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-S 184

Query: 366 NLSEHL-----RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK 420
           NL           S    L   +R+Q+ L   R L  +H + +   +H  ++  +I++D+
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL---VHTYLRPVDIVLDQ 241

Query: 421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-----------GDVSPKVDV 469
                +  F                   + G+ PPE                 ++   D 
Sbjct: 242 RGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296

Query: 470 YAFGVVLYELISAKEAIVKGN---GSSADSKGLVALFEEVLNLPDPIEDL-RKL--VDPR 523
           +A G+V+Y +          +      A   G   +F    N+P P+  L          
Sbjct: 297 WALGLVIYWIWC-------ADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 349

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  119 bits (299), Expect = 1e-28
 Identities = 62/239 (25%), Positives = 105/239 (43%), Gaps = 27/239 (11%)

Query: 251 LNAITVDKSVEFSYEELSKAT-DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN 309
           L+++   + +++ + E      D F     +G+GGFG V+  +++         +L    
Sbjct: 163 LDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT------GKLYACK 216

Query: 310 LLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNL 367
            L  K  +KK         + E K+L  VH   +V L  Y    +  L LV   +  G++
Sbjct: 217 KL-NKKRLKKRKGYQGA--MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDI 272

Query: 368 SEHLRGSGRDPLPWS-SRV-----QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN 421
             H+     D   +   R      QI      GLE++H+  +   I+RD+K  N+L+D +
Sbjct: 273 RYHIYNVDEDNPGFQEPRAIFYTAQIVS----GLEHLHQRNI---IYRDLKPENVLLDDD 325

Query: 422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            + +++D GL    + G         GT G+M PE     +    VD +A GV LYE+I
Sbjct: 326 GNVRISDLGLAVELKAGQTKTKGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI 383

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  115 bits (290), Expect = 2e-28
 Identities = 68/267 (25%), Positives = 103/267 (38%), Gaps = 53/267 (19%)

Query: 233 PAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAE 292
           P  + +   G     P    A ++                 FS   +IG G FGAVY+A 
Sbjct: 15  PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74

Query: 293 LRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS------REFLAELKVLTHVHHLNLVRL 346
                               +  AIKKM           ++ + E++ L  + H N ++ 
Sbjct: 75  DVRN---------------SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119

Query: 347 IG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV----QIAL---DSARGLEYI 398
            G Y  E + +LV EY           GS  D L    +     +IA     + +GL Y+
Sbjct: 120 RGCYLREHTAWLVMEYCL---------GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 399 HEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR--LVGTFGYMPPE 456
           H H +   IHRD+K+ NIL+ +    K+ DFG        ++ +      VGT  +M PE
Sbjct: 171 HSHNM---IHRDVKAGNILLSEPGLVKLGDFGS-------ASIMAPANSFVGTPYWMAPE 220

Query: 457 YAQYGDVS---PKVDVYAFGVVLYELI 480
                D      KVDV++ G+   EL 
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELA 247

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (288), Expect = 4e-28
 Identities = 62/292 (21%), Positives = 126/292 (43%), Gaps = 33/292 (11%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF--- 328
           D+F    ++G G  G V+                    L+M   A K + ++        
Sbjct: 33  DDFEKISELGAGNGGVVFKV------------SHKPSGLVM---ARKLIHLEIKPAIRNQ 77

Query: 329 -LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            + EL+VL   +   +V   G +  +G + +  E+++ G+L + L+ +GR P     +  
Sbjct: 78  IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-- 135

Query: 387 IALDSARGLEYIH-EHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLPT 444
           +++   +GL Y+  +H +   +HRD+K +NIL++     K+ DFG+  +L +    S+  
Sbjct: 136 VSIAVIKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMAN 188

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
             VGT  YM PE  Q    S + D+++ G+ L E+   +  I   +    +      +  
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
           +    P       + ++    D+ P  ++ ++  L  +  +  P+L   + S
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL--LDYIVNEPPPKLPSGVFS 298

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  115 bits (289), Expect = 5e-28
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 32/219 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F +   IG+G FG V   +        Y  +       M K    + +   +     E
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDT-KKMYAMKY------MNKQKCVERNEVRN--VFKE 65

Query: 332 LKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV---- 385
           L+++  + H  LV L  Y    E  +F+V + +  G+L  HL+ +          V    
Sbjct: 66  LQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKLFI 121

Query: 386 -QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
            ++ +     L+Y+    +   IHRD+K  NIL+D++ H  + DF +     +   +  T
Sbjct: 122 CELVM----ALDYLQNQRI---IHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQIT 172

Query: 445 RLVGTFGYMPPEYAQYGDV---SPKVDVYAFGVVLYELI 480
            + GT  YM PE          S  VD ++ GV  YEL+
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  117 bits (295), Expect = 6e-28
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 39/231 (16%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAE--LRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           ++    + M  ++G GGFG V        GE                 + AIK+   + S
Sbjct: 10  TQTCGPWEMKERLGTGGFGYVLRWIHQDTGE-----------------QVAIKQCRQELS 52

Query: 326 REFLA----ELKVLTHVHHLNLVRLI-------GYCVEGSLFLVYEYIENGNLSEHLRGS 374
            +       E++++  ++H N+V                   L  EY E G+L ++L   
Sbjct: 53  PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF 112

Query: 375 GRD-PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA---KVADFG 430
                L       +  D +  L Y+HE+ +   IHRD+K  NI++         K+ D G
Sbjct: 113 ENCCGLKEGPIRTLLSDISSALRYLHENRI---IHRDLKPENIVLQPGPQRLIHKIIDLG 169

Query: 431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             K  E+    L T  VGT  Y+ PE  +    +  VD ++FG + +E I+
Sbjct: 170 YAK--ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  115 bits (289), Expect = 8e-28
 Identities = 52/233 (22%), Positives = 90/233 (38%), Gaps = 57/233 (24%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL 332
           +F     +G G  G + Y  +                   +  A+K++  +       E+
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDN----------------RDVAVKRILPECFSFADREV 68

Query: 333 KVLTHV-HHLNLVRLIG-------------YCVEGSLFLVYEYIENGNLSEHLRGSGRDP 378
           ++L     H N++R                 C   +L    EY+E  + +      G +P
Sbjct: 69  QLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQ---EYVEQKDFAH----LGLEP 120

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI-----DKNFHAKVADFGLTK 433
           +       +   +  GL ++H   +   +HRD+K  NILI          A ++DFGL K
Sbjct: 121 I------TLLQQTTSGLAHLHSLNI---VHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171

Query: 434 LTEVGSASLPTR--LVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELIS 481
              VG  S   R  + GT G++ PE        + +  VD+++ G V Y +IS
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  112 bits (282), Expect = 1e-27
 Identities = 51/238 (21%), Positives = 93/238 (39%), Gaps = 48/238 (20%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMD---- 321
           S +   + +S  +GQG    V+    +  G+                   AIK  +    
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGD-----------------LFAIKVFNNISF 47

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVE-----GSLFLVYEYIENGNLSEHLRGSGR 376
           ++     + E +VL  ++H N+V+L  + +E         L+ E+   G+L   L     
Sbjct: 48  LRPVDVQMREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN 105

Query: 377 D-PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI----DKNFHAKVADFGL 431
              LP S  + +  D   G+ ++ E+ +   +HR+IK  NI+     D     K+ DFG 
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162

Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV--------SPKVDVYAFGVVLYELIS 481
            +  E+        L GT  Y+ P+  +   +           VD+++ GV  Y   +
Sbjct: 163 AR--ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  114 bits (287), Expect = 1e-27
 Identities = 63/304 (20%), Positives = 112/304 (36%), Gaps = 85/304 (27%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +       +G G  G V +    G +               +  A+K+M +      L E
Sbjct: 15  NLVVSEKILGYGSSGTVVFQ---GSFQG-------------RPVAVKRMLIDFCDIALME 58

Query: 332 LKVLTHV-HHLNLVRLIG-------------YCVEGSLFLVYEYIENGNLSEHLRGSGRD 377
           +K+LT    H N++R                 C   +L    + +E+ N+S+      ++
Sbjct: 59  IKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQ---DLVESKNVSDENLKLQKE 114

Query: 378 PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID-------------KNFHA 424
             P S   QIA     G+ ++H   +   IHRD+K  NIL+              +N   
Sbjct: 115 YNPISLLRQIA----SGVAHLHSLKI---IHRDLKPQNILVSTSSRFTADQQTGAENLRI 167

Query: 425 KVADFGLTKLTEVGSASLPTRL---VGTFGYMPPE-------YAQYGDVSPKVDVYAFGV 474
            ++DFGL K  + G +S  T L    GT G+  PE             ++  +D+++ G 
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227

Query: 475 VLYELISA-----------KEAIVKG--NGSSADSKGLVALFEEVLNLPDPIEDLRKL-- 519
           V Y ++S            +  I++G  +          +L  E  +L      + ++  
Sbjct: 228 VFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDL------ISQMID 281

Query: 520 VDPR 523
            DP 
Sbjct: 282 HDPL 285

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 3e-27
 Identities = 60/234 (25%), Positives = 99/234 (42%), Gaps = 52/234 (22%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS--REF 328
              F +   +G G +G VY      + G              Q AAIK MD+      E 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHV-KTG--------------QLAAIKVMDVTGDEEEEI 67

Query: 329 LAELKVL-THVHHLNLVRLIG-------YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
             E+ +L  + HH N+    G         ++  L+LV E+   G++++ ++ +  + L 
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL- 126

Query: 381 WSSRVQIAL---DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
                 IA    +  RGL ++H+H V   IHRDIK  N+L+ +N   K+ DFG+      
Sbjct: 127 --KEEWIAYICREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGV------ 175

Query: 438 GSASLPTRL------VGTFGYMPPEYAQYGDVS-----PKVDVYAFGVVLYELI 480
            SA L   +      +GT  +M PE     +        K D+++ G+   E+ 
Sbjct: 176 -SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  111 bits (280), Expect = 7e-27
 Identities = 51/238 (21%), Positives = 93/238 (39%), Gaps = 48/238 (20%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMD---- 321
           S +   + +S  +GQG    V+    +  G+                   AIK  +    
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGD-----------------LFAIKVFNNISF 47

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVE-----GSLFLVYEYIENGNLSEHLRGSGR 376
           ++     + E +VL  ++H N+V+L  + +E         L+ E+   G+L   L     
Sbjct: 48  LRPVDVQMREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN 105

Query: 377 -DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI----DKNFHAKVADFGL 431
              LP S  + +  D   G+ ++ E+ +   +HR+IK  NI+     D     K+ DFG 
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162

Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV--------SPKVDVYAFGVVLYELIS 481
            +  E+        L GT  Y+ P+  +   +           VD+++ GV  Y   +
Sbjct: 163 AR--ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  112 bits (282), Expect = 7e-27
 Identities = 56/222 (25%), Positives = 99/222 (44%), Gaps = 27/222 (12%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            D + MS  +G G  G V  A  R         R+I        +A +            
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKT-CKKVAIRIISKRKFAIGSAREADPALN---VET 189

Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QIA 388
           E+++L  ++H  ++++  +      ++V E +E G L + + G+ R           Q+ 
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTR 445
           L     ++Y+HE+ +   IHRD+K  N+L+   +++   K+ DFG +K+  +G  SL   
Sbjct: 250 L----AVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 300

Query: 446 LVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELIS 481
           L GT  Y+ PE       A Y      VD ++ GV+L+  +S
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYN---RAVDCWSLGVILFICLS 339

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  113 bits (283), Expect = 2e-26
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 34/220 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++FS+   IG+GGFG VY        G  Y  +       + K  IK    +     L E
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT-GKMYAMKC------LDKKRIKMKQGETLA--LNE 239

Query: 332 LKVLTHVHHLN---LVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV- 385
             +L+ V   +   +V +  Y       L  + + +  G+L  HL   G         + 
Sbjct: 240 RIMLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMR 295

Query: 386 ----QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
               +I L    GLE++H   V   ++RD+K ANIL+D++ H +++D GL          
Sbjct: 296 FYAAEIIL----GLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 348

Query: 442 LPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELI 480
                VGT GYM PE  Q G       D ++ G +L++L+
Sbjct: 349 --AS-VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  108 bits (271), Expect = 3e-26
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 37/226 (16%)

Query: 280 IGQGGFGAVYYAE------------------LRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           IG+G +G V  A                   +R                       +   
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLP- 380
            Q  +E +A LK L H + + LV ++    E  L++V+E +  G + E        PL  
Sbjct: 81  EQVYQE-IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSE 136

Query: 381 WSSRV---QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
             +R     +      G+EY+H   +   IHRDIK +N+L+ ++ H K+ADFG++   + 
Sbjct: 137 DQARFYFQDLIK----GIEYLHYQKI---IHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

Query: 438 GSASLPTRLVGTFGYMPPE--YAQYGDVS-PKVDVYAFGVVLYELI 480
             A L    VGT  +M PE         S   +DV+A GV LY  +
Sbjct: 190 SDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  107 bits (270), Expect = 3e-26
 Identities = 63/249 (25%), Positives = 105/249 (42%), Gaps = 44/249 (17%)

Query: 249 TSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICV 308
           ++         +E+ YE      D       +G+G +G VY                   
Sbjct: 4   STEEGDCESDLLEYDYE-----YDENGDRVVLGKGTYGIVYAG----------------R 42

Query: 309 NLLMQKA-AIKKMDMQASREFLA---ELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIE 363
           +L  Q   AIK++  + SR       E+ +  H+ H N+V+ +G   E   + +  E + 
Sbjct: 43  DLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102

Query: 364 NGNLSEHLRGSGRDPLPWSSRV------QIALDSARGLEYIHEHTVPVYIHRDIKSANIL 417
            G+LS  LR     PL  + +       QI L    GL+Y+H++ +   +HRDIK  N+L
Sbjct: 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQI-L---EGLKYLHDNQI---VHRDIKGDNVL 154

Query: 418 ID-KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV--SPKVDVYAFGV 474
           I+  +   K++DFG +K     +    T   GT  YM PE    G        D+++ G 
Sbjct: 155 INTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGC 213

Query: 475 VLYELISAK 483
            + E+ + K
Sbjct: 214 TIIEMATGK 222

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  110 bits (276), Expect = 9e-26
 Identities = 51/242 (21%), Positives = 102/242 (42%), Gaps = 20/242 (8%)

Query: 248 PTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLIC 307
                 I ++  + +  ++  K  +++    K+G G +G V   + +    +    ++I 
Sbjct: 13  NLYFQGIAINPGM-YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEK-NGHSEKAIKVIK 70

Query: 308 VNLLMQKAAIKKMDMQASRE--FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIEN 364
            +   +                   E+ +L  + H N+++L      +   +LV E+ E 
Sbjct: 71  KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEG 130

Query: 365 GNLSEHLRGSGRDPLPWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---D 419
           G L E +    +     ++ +  QI      G+ Y+H+H +   +HRDIK  NIL+   +
Sbjct: 131 GELFEQIINRHKFDECDAANIMKQIL----SGICYLHKHNI---VHRDIKPENILLENKN 183

Query: 420 KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYEL 479
              + K+ DFGL+              +GT  Y+ PE  +    + K DV++ GV++Y L
Sbjct: 184 SLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240

Query: 480 IS 481
           + 
Sbjct: 241 LC 242

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  109 bits (274), Expect = 1e-25
 Identities = 49/217 (22%), Positives = 99/217 (45%), Gaps = 26/217 (11%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           ++ +    K+G G +G V     +         ++I      +K ++         E   
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVT-HVERAIKII------RKTSVSTSSNSKLLE--- 85

Query: 331 ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QI 387
           E+ VL  + H N+++L  +   + + +LV E  + G L + +    +     ++ +  Q+
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV 145

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPT 444
                 G+ Y+H+H +   +HRD+K  N+L+   +K+   K+ DFGL+ + E        
Sbjct: 146 ----LSGVTYLHKHNI---VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--K 196

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             +GT  Y+ PE  +      K DV++ GV+L+ L++
Sbjct: 197 ERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  106 bits (266), Expect = 2e-25
 Identities = 52/232 (22%), Positives = 94/232 (40%), Gaps = 47/232 (20%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            D + MS  +G G  G V  A  R +       ++I        +A +            
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFER-KTCKKVAIKIISKRKFAIGSAREADPALNVET--- 64

Query: 331 ELKVLTHVHHLNLVRLIGYCVEGSLFLVYEY----------IENGNLSEHLRGSGRDPLP 380
           E+++L  ++H  ++++  +      ++V E           + N  L E           
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE------AT--- 115

Query: 381 WSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLT 435
                  Q+ L     ++Y+HE+ +   IHRD+K  N+L+   +++   K+ DFG +K+ 
Sbjct: 116 -CKLYFYQMLL----AVQYLHENGI---IHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167

Query: 436 EVGSASLPTRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELIS 481
              S  + T L GT  Y+ PE       A Y      VD ++ GV+L+  +S
Sbjct: 168 GETSL-MRT-LCGTPTYLAPEVLVSVGTAGYN---RAVDCWSLGVILFICLS 214

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  108 bits (271), Expect = 2e-25
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 31/221 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F +   IG+G FG V   +L+        +  +    ++ K  + K    A   F  E
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKN-------ADKVFAMKILNKWEMLKRAETAC--FREE 124

Query: 332 LKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHL-RGSGRDPLPWSSRVQIA 388
             VL +     +  L  Y    + +L+LV +Y   G+L   L +   R P   + R  +A
Sbjct: 125 RDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMA-RFYLA 182

Query: 389 -LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
            +  A  ++ +H+     Y+HRDIK  NIL+D N H ++ADFG             +  V
Sbjct: 183 EMVIA--IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237

Query: 448 GTFGYMPPE--------YAQYGDVSPKVDVYAFGVVLYELI 480
           GT  Y+ PE          +YG   P+ D ++ GV +YE++
Sbjct: 238 GTPDYISPEILQAMEGGKGRYG---PECDWWSLGVCMYEML 275

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  106 bits (267), Expect = 2e-25
 Identities = 70/240 (29%), Positives = 114/240 (47%), Gaps = 45/240 (18%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-F-- 328
             +    KIGQG FG V+ A       +    + +         A+KK+ M+  +E F  
Sbjct: 17  SKYEKLAKIGQGTFGEVFKAR------HRKTGQKV---------ALKKVLMENEKEGFPI 61

Query: 329 --LAELKVLTHVHHLNLVRLIGYCVE---------GSLFLVYEYIENGNLSEHLRGSGRD 377
             L E+K+L  + H N+V LI  C           GS++LV+++ E+ +L+  L  +   
Sbjct: 62  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS-NVLV 119

Query: 378 PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
               S   ++      GL YIH + +   +HRD+K+AN+LI ++   K+ADFGL +   +
Sbjct: 120 KFTLSEIKRVMQMLLNGLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSL 176

Query: 438 GSASLP---TRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
              S P   T  V T  Y PPE       YG   P +D++  G ++ E+   +  I++GN
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYG---PPIDLWGAGCIMAEMW-TRSPIMQGN 232

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  108 bits (271), Expect = 3e-25
 Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 25/217 (11%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +D +     +G+G FG V   + +   G     ++I    + QK   + +        L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESL--------LR 75

Query: 331 ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QI 387
           E+++L  + H N+++L  +   +G  +LV E    G L + +    R     ++R+  Q+
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPT 444
                 G+ Y+H++ +   +HRD+K  N+L+    K+ + ++ DFGL+   E        
Sbjct: 136 ----LSGITYMHKNKI---VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--K 186

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             +GT  Y+ PE    G    K DV++ GV+LY L+S
Sbjct: 187 DKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLS 222

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  105 bits (265), Expect = 3e-25
 Identities = 61/236 (25%), Positives = 107/236 (45%), Gaps = 24/236 (10%)

Query: 250 SLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN 309
           S+  I +   V+  +E+       F +   +GQG FG V+  +           +L  + 
Sbjct: 4   SIKEIAITHHVKEGHEKAD--PSQFELLKVLGQGSFGKVFLVKKISGSDAR---QLYAMK 58

Query: 310 LLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNL 367
           +L +KA +K  D         E  +L  V+H  +V+L  Y    EG L+L+ +++  G+L
Sbjct: 59  VL-KKATLKVRDRV---RTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDL 113

Query: 368 SEHLRGSGRDPLPWSSRV---QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
              L            +    ++AL     L+++H   +   I+RD+K  NIL+D+  H 
Sbjct: 114 FTRLSKEVMFTEEDV-KFYLAELAL----ALDHLHSLGI---IYRDLKPENILLDEEGHI 165

Query: 425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           K+ DFGL+K   +          GT  YM PE       +   D ++FGV+++E++
Sbjct: 166 KLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  105 bits (265), Expect = 5e-25
 Identities = 65/236 (27%), Positives = 104/236 (44%), Gaps = 26/236 (11%)

Query: 251 LNAITVDKSVEFSYEELSKAT-DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN 309
           L     D   ++     + A  D F     +G G FG V   + +   GN Y  ++    
Sbjct: 19  LAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKES-GNHYAMKI---- 73

Query: 310 LLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLS 368
             + K  + K+        L E ++L  V+   LV+L        +L++V EY+  G + 
Sbjct: 74  --LDKQKVVKLKQIEH--TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 369 EHLRGSGRDPLPWSSR---VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK 425
            HLR  GR   P + R    QI L      EY+H   +   I+RD+K  N+LID+  + +
Sbjct: 130 SHLRRIGRFSEPHA-RFYAAQIVL----TFEYLHSLDL---IYRDLKPENLLIDQQGYIQ 181

Query: 426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           V DFG  K  +  + +    L GT   + PE       +  VD +A GV++YE+ +
Sbjct: 182 VTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  105 bits (263), Expect = 5e-25
 Identities = 56/279 (20%), Positives = 99/279 (35%), Gaps = 62/279 (22%)

Query: 252 NAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLL 311
           +  +  +++ F    L +    + +   IGQG +G V  A            +++     
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQT-RAIRAIKIM----- 59

Query: 312 MQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEH 370
             K  I++++ +       E++++  +HH N+ RL      E  + LV E    G+L + 
Sbjct: 60  -NKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK 118

Query: 371 LRGSGRDPLPWSSRVQIALDSAR------------------------------------- 393
           L     D     +   +                                           
Sbjct: 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178

Query: 394 -GLEYIHEHTVPVYIHRDIKSANILI--DKNFHAKVADFGLTKLTEVGSASLPTRL---V 447
             L Y+H   +    HRDIK  N L   +K+F  K+ DFGL+K     +      +    
Sbjct: 179 SALHYLHNQGI---CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA 235

Query: 448 GTFGYMPPE-----YAQYGDVSPKVDVYAFGVVLYELIS 481
           GT  ++ PE        YG   PK D ++ GV+L+ L+ 
Sbjct: 236 GTPYFVAPEVLNTTNESYG---PKCDAWSAGVLLHLLLM 271

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  106 bits (267), Expect = 5e-25
 Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 45/229 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D+F +   IG+G F  V   +++        +  +    +M K  + K    +   F  E
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQ-------TGQVYAMKIMNKWDMLKRGEVSC--FREE 111

Query: 332 LKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
             VL +     + +L  +    E  L+LV EY   G+L   L   G          +I  
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGE---------RIPA 161

Query: 390 DSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
           + AR         ++ +H      Y+HRDIK  NIL+D+  H ++ADFG           
Sbjct: 162 EMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV 218

Query: 442 LPTRLVGTFGYMPPE----------YAQYGDVSPKVDVYAFGVVLYELI 480
                VGT  Y+ PE             YG   P+ D +A GV  YE+ 
Sbjct: 219 RSLVAVGTPDYLSPEILQAVGGGPGTGSYG---PECDWWALGVFAYEMF 264

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  105 bits (263), Expect = 6e-25
 Identities = 78/377 (20%), Positives = 129/377 (34%), Gaps = 118/377 (31%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D   +   +G+G FG V  A+  G    +    +        K   +       R  ++E
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAV------KMLKEGATHSEHRALMSE 75

Query: 332 LKVLTHV-HHLNLVRLIG--------------YCVEGSL--FL----------------- 357
           LK+L H+ HHLN+V L+G              +C  G+L  +L                 
Sbjct: 76  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARF 135

Query: 358 ----------------------------VYEYIENGNLS-----EHLRGSGRDPLPWSSR 384
                                          ++E  +LS     E      +D L     
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL-------TEV 437
           +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFGL +           
Sbjct: 196 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252

Query: 438 GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN----GSS 493
           G A LP +      +M PE       + + DV++FGV+L+E+ S       G     G  
Sbjct: 253 GDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSL------GASPYPGVK 300

Query: 494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
            D        EE       +++  ++  P   D    +    M Q    C    P  RP+
Sbjct: 301 ID--------EEFCRR---LKEGTRMRAP---DYTTPE----MYQTMLDCWHGEPSQRPT 342

Query: 554 MRSIVVALMT-LSSTTE 569
              +V  L   L +  +
Sbjct: 343 FSELVEHLGNLLQANAQ 359

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  104 bits (262), Expect = 7e-25
 Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 25/214 (11%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
            +F +   +G G FG V+    R        +       +++K  + ++          E
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRH-------NGRYYAMKVLKKEIVVRLKQVEH--TNDE 56

Query: 332 LKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV---QI 387
             +L+ V H  ++R+ G       +F++ +YIE G L   LR S R P P  ++    ++
Sbjct: 57  RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP-VAKFYAAEV 115

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
            L     LEY+H   +   I+RD+K  NIL+DKN H K+ DFG  K     + +    L 
Sbjct: 116 CL----ALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LC 164

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           GT  Y+ PE       +  +D ++FG+++YE+++
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  104 bits (263), Expect = 8e-25
 Identities = 60/213 (28%), Positives = 89/213 (41%), Gaps = 22/213 (10%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F     +G+G FG V     +         R   + +L +K  I   D  A    + E
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKAT------GRYYAMKIL-RKEVIIAKDEVAH--TVTE 55

Query: 332 LKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS--RVQI 387
            +VL +  H  L  L  Y       L  V EY   G L  HL          +     +I
Sbjct: 56  SRVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
                  LEY+H   V   ++RDIK  N+++DK+ H K+ DFGL K   +   +      
Sbjct: 115 VS----ALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFC 166

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           GT  Y+ PE  +  D    VD +  GVV+YE++
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (261), Expect = 9e-25
 Identities = 63/223 (28%), Positives = 94/223 (42%), Gaps = 36/223 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF--- 328
           + +    KIG+G +G V+    R + G              Q  AIKK            
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNR-DTG--------------QIVAIKKFLESEDDPVIKK 47

Query: 329 --LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             L E+++L  + H NLV L+  +  +  L LV+EY ++  +   L    +  +P     
Sbjct: 48  IALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELD-RYQRGVPEHLVK 105

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-T 444
            I   + + + + H+H     IHRD+K  NILI K+   K+ DFG  +   +   S    
Sbjct: 106 SITWQTLQAVNFCHKHNC---IHRDVKPENILITKHSVIKLCDFGFAR--LLTGPSDYYD 160

Query: 445 RLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAK 483
             V T  Y  PE      QY    P VDV+A G V  EL+S  
Sbjct: 161 DEVATRWYRSPELLVGDTQY---GPPVDVWAIGCVFAELLSGV 200

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  103 bits (259), Expect = 2e-24
 Identities = 56/248 (22%), Positives = 100/248 (40%), Gaps = 37/248 (14%)

Query: 246 GTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRL 305
           G     ++  VD   E  Y    ++ + +     +G+G +G V     + + G       
Sbjct: 2   GHHHHHHSSGVDLGTENLY---FQSMEKYENLGLVGEGSYGMVMKCRNK-DTG------- 50

Query: 306 ICVNLLMQKAAIKKMDMQASREF-----LAELKVLTHVHHLNLVRLIGYCV-EGSLFLVY 359
                  +  AIKK       +      + E+K+L  + H NLV L+  C  +   +LV+
Sbjct: 51  -------RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103

Query: 360 EYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID 419
           E++++  + + L     + L +    +       G+ + H H +   IHRDIK  NIL+ 
Sbjct: 104 EFVDH-TILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSHNI---IHRDIKPENILVS 158

Query: 420 KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVV 475
           ++   K+ DFG  +             V T  Y  PE      +Y      VDV+A G +
Sbjct: 159 QSGVVKLCDFGFARTLAAPGEVY-DDEVATRWYRAPELLVGDVKY---GKAVDVWAIGCL 214

Query: 476 LYELISAK 483
           + E+   +
Sbjct: 215 VTEMFMGE 222

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (264), Expect = 2e-24
 Identities = 57/217 (26%), Positives = 102/217 (47%), Gaps = 26/217 (11%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            + +++   +G+G FG V   + R      Y  ++I       KA+ K  D         
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRIT-QQEYAVKVI------NKASAKNKDTSTILR--- 70

Query: 331 ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QI 387
           E+++L  + H N+++L        S ++V E    G L + +    R     ++R+  Q+
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPT 444
                 G+ Y+H+H +   +HRD+K  NIL+   +K+   K+ DFGL+   +  +     
Sbjct: 131 ----FSGITYMHKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--K 181

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             +GT  Y+ PE  + G    K DV++ GV+LY L+S
Sbjct: 182 DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLS 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  103 bits (260), Expect = 3e-24
 Identities = 67/243 (27%), Positives = 94/243 (38%), Gaps = 26/243 (10%)

Query: 243 PAAGTPTSLNAITVDKSVEFSYEELSKAT-DNFSMSHKIGQGGFGAVYYAELRGEYGNSY 301
           P              + +         A   +F     IG+G FG V  A  + E     
Sbjct: 8   PELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE----- 62

Query: 302 LSRLICVNLLMQKAAIKKMDMQASREFLAELKVLT-HVHHLNLVRLIGYC--VEGSLFLV 358
                 V +L QK AI K   +     ++E  VL  +V H  LV L  +       L+ V
Sbjct: 63  -EVFYAVKVL-QKKAILKKKEEKH--IMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFV 117

Query: 359 YEYIENGNLSEHLRGSGRDPLPWSSR---VQIALDSARGLEYIHEHTVPVYIHRDIKSAN 415
            +YI  G L  HL+       P + R    +IA      L Y+H   +   ++RD+K  N
Sbjct: 118 LDYINGGELFYHLQRERCFLEPRA-RFYAAEIAS----ALGYLHSLNI---VYRDLKPEN 169

Query: 416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVV 475
           IL+D   H  + DFGL K   +   S  +   GT  Y+ PE          VD +  G V
Sbjct: 170 ILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAV 228

Query: 476 LYE 478
           LYE
Sbjct: 229 LYE 231

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  103 bits (259), Expect = 3e-24
 Identities = 65/252 (25%), Positives = 101/252 (40%), Gaps = 25/252 (9%)

Query: 239 ESTGPAAGTPTSLNAITVDKSVEFSYEELSKAT-DNFSMSHKIGQGGFGAVYYAELRGEY 297
            ++         L  +  +           K   +NF +   +G G +G V+       +
Sbjct: 20  GTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGH 79

Query: 298 GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYC--VEGS 354
                 +L  + +L +KA I +           E +VL H+     LV L  Y    E  
Sbjct: 80  DTG---KLYAMKVL-KKATIVQKAKTTEHT-RTERQVLEHIRQSPFLVTLH-YAFQTETK 133

Query: 355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRV---QIALDSARGLEYIHEHTVPVYIHRDI 411
           L L+ +YI  G L  HL    R       ++   +I L     LE++H+  +   I+RDI
Sbjct: 134 LHLILDYINGGELFTHLSQRERFTEHEV-QIYVGEIVL----ALEHLHKLGI---IYRDI 185

Query: 412 KSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE---YAQYGDVSPKVD 468
           K  NIL+D N H  + DFGL+K              GT  YM P+       G     VD
Sbjct: 186 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH-DKAVD 244

Query: 469 VYAFGVVLYELI 480
            ++ GV++YEL+
Sbjct: 245 WWSLGVLMYELL 256

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  104 bits (261), Expect = 3e-24
 Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 30/219 (13%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +++ +   IG+G FG V     +        +R +    L+ K  + K    A   F  E
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKS-------TRKVYAMKLLSKFEMIKRSDSAF--FWEE 119

Query: 332 LKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA- 388
             ++   +   +V+L  Y    +  L++V EY+  G+L   +  +   P  W+ R   A 
Sbjct: 120 RDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWA-RFYTAE 176

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           +  A  L+ IH      +IHRD+K  N+L+DK+ H K+ADFG                VG
Sbjct: 177 VVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231

Query: 449 TFGYMPPE-------YAQYGDVSPKVDVYAFGVVLYELI 480
           T  Y+ PE          YG    + D ++ GV LYE++
Sbjct: 232 TPDYISPEVLKSQGGDGYYG---RECDWWSVGVFLYEML 267

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  102 bits (256), Expect = 5e-24
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 40/233 (17%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
            +A   +    +IG+G +G V+ A      G              +  A+K++ +Q   E
Sbjct: 7   CRADQQYECVAEIGEGAYGKVFKARDLKNGG--------------RFVALKRVRVQTGEE 52

Query: 328 -----FLAE---LKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRG 373
                 + E   L+ L    H N+VRL   C       E  L LV+E+++  +L+ +L  
Sbjct: 53  GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK 111

Query: 374 SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
                +P  +   +     RGL+++H H V   +HRD+K  NIL+  +   K+ADFGL +
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLAR 168

Query: 434 LTEVGSASLPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAK 483
                     T +V T  Y  PE    + Y   +  VD+++ G +  E+   K
Sbjct: 169 --IYSFQMALTSVVVTLWYRAPEVLLQSSY---ATPVDLWSVGCIFAEMFRRK 216

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  102 bits (257), Expect = 5e-24
 Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 53/259 (20%)

Query: 242 GPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSY 301
           GP   + T      + +  EF     +K +DN+ +  ++G+G F  V     +   G  +
Sbjct: 1   GPHMASMTG--GQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTT-GLEF 57

Query: 302 LSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYE 360
            +++I          +   D Q       E ++   + H N+VRL      E   +LV++
Sbjct: 58  AAKII------NTKKLSARDFQKLER---EARICRKLQHPNIVRLHDSIQEESFHYLVFD 108

Query: 361 Y----------IENGNLSEHLRGSGRDPLPWSSRV--QIALDSARGLEYIHEHTVPVYIH 408
                      +     SE       D    +S    QI       + Y H + +   +H
Sbjct: 109 LVTGGELFEDIVAREFYSE------AD----ASHCIQQI----LESIAYCHSNGI---VH 151

Query: 409 RDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE---YAQYGD 462
           R++K  N+L+    K    K+ADFGL        A       GT GY+ PE      Y  
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW--HGFAGTPGYLSPEVLKKDPYS- 208

Query: 463 VSPKVDVYAFGVVLYELIS 481
               VD++A GV+LY L+ 
Sbjct: 209 --KPVDIWACGVILYILLV 225

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  101 bits (253), Expect = 6e-24
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 42/233 (18%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
             +    KIG+G +G V+ A+      N     ++         A+K++ +    E    
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAK------NRETHEIV---------ALKRVRLDDDDEGVPS 46

Query: 328 -FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             L E+ +L  + H N+VRL      +  L LV+E+ +  +L ++   S    L      
Sbjct: 47  SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD-SCNGDLDPEIVK 104

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
                  +GL + H   V   +HRD+K  N+LI++N   K+A+FGL +     +  +P R
Sbjct: 105 SFLFQLLKGLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFGLAR-----AFGIPVR 156

Query: 446 ----LVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
                V T  Y PP+       Y   S  +D+++ G +  EL +A   +  GN
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLY---STSIDMWSAGCIFAELANAGRPLFPGN 206

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  103 bits (259), Expect = 7e-24
 Identities = 62/212 (29%), Positives = 90/212 (42%), Gaps = 19/212 (8%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           + F     +G+G FG V   + +         R   + +L +K  I   D  A    L E
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKAT------GRYYAMKIL-KKEVIVAKDEVAH--TLTE 198

Query: 332 LKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI-A 388
            +VL +  H  L  L  Y       L  V EY   G L  HL            R +   
Sbjct: 199 NRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYG 254

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            +    L+Y+H     VY  RD+K  N+++DK+ H K+ DFGL K      A++ T   G
Sbjct: 255 AEIVSALDYLHSEKNVVY--RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCG 311

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
           T  Y+ PE  +  D    VD +  GVV+YE++
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 343

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  101 bits (254), Expect = 1e-23
 Identities = 63/272 (23%), Positives = 109/272 (40%), Gaps = 59/272 (21%)

Query: 233 PAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFS----MSHKIGQGGFGAV 288
                 E+    + +  + +A     S+   Y       D  S    +  ++G+G    V
Sbjct: 10  GVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIV 69

Query: 289 YYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG 348
           Y  + +G     Y  +++           K +D +  R    E+ VL  + H N+++L  
Sbjct: 70  YRCKQKGT-QKPYALKVL----------KKTVDKKIVRT---EIGVLLRLSHPNIIKLKE 115

Query: 349 -YCVEGSLFLVYEY----------IENGNLSEHLRGSGRDPLPWSSRV--QIALDSARGL 395
            +     + LV E           +E G  SE      RD    ++    QI       +
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSE------RD----AADAVKQI----LEAV 161

Query: 396 EYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGY 452
            Y+HE+ +   +HRD+K  N+L      +   K+ADFGL+K+ E         + GT GY
Sbjct: 162 AYLHENGI---VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGY 216

Query: 453 MPPE---YAQYGDVSPKVDVYAFGVVLYELIS 481
             PE      YG   P+VD+++ G++ Y L+ 
Sbjct: 217 CAPEILRGCAYG---PEVDMWSVGIITYILLC 245

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  101 bits (253), Expect = 1e-23
 Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 24/216 (11%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           + F +   +G+GG+G V+              ++  + +L +   ++     A     AE
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTG---KIFAMKVLKKAMIVRNAKDTAHT--KAE 71

Query: 332 LKVLTHVHHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV---- 385
             +L  V H  +V LI Y     G L+L+ EY+  G L   L   G              
Sbjct: 72  RNILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYL 127

Query: 386 -QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
            +I++     L ++H+  +   I+RD+K  NI+++   H K+ DFGL K +        T
Sbjct: 128 AEISM----ALGHLHQKGI---IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
              GT  YM PE       +  VD ++ G ++Y+++
Sbjct: 181 -FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML 215

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  101 bits (253), Expect = 1e-23
 Identities = 58/214 (27%), Positives = 104/214 (48%), Gaps = 23/214 (10%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++F +   +G+G FG V+ AE +        ++   +  L +K  +   D       + E
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKT------NQFFAIKAL-KKDVVLMDDDVEC--TMVE 67

Query: 332 LKVLTHV-HHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS--RVQ 386
            +VL+    H  L  +       + +LF V EY+  G+L  H++   +  L  ++    +
Sbjct: 68  KRVLSLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE 126

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           I L    GL+++H   +   ++RD+K  NIL+DK+ H K+ADFG+ K   +   +     
Sbjct: 127 IIL----GLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTF 178

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            GT  Y+ PE       +  VD ++FGV+LYE++
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 212

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  101 bits (253), Expect = 2e-23
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           DNF     +G+G FG V  A ++          L  V +L +K  I + D       + E
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKET------GDLYAVKVL-KKDVILQDDDVEC--TMTE 73

Query: 332 LKVLTHV-HHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS--RVQ 386
            ++L+   +H  L +L   C      LF V E++  G+L  H++ S R     +     +
Sbjct: 74  KRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE 132

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           I       L ++H+  +   I+RD+K  N+L+D   H K+ADFG+ K   + +       
Sbjct: 133 IIS----ALMFLHDKGI---IYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATF 184

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            GT  Y+ PE  Q     P VD +A GV+LYE++
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML 218

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  102 bits (255), Expect = 2e-23
 Identities = 68/266 (25%), Positives = 101/266 (37%), Gaps = 59/266 (22%)

Query: 237 TVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGE 296
           + +  G    T  +      D+  E SY +             IG G FG VY A+L  +
Sbjct: 29  SRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV----------IGNGSFGVVYQAKLC-D 77

Query: 297 YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV----- 351
            G              +  AIKK+ +Q  R    EL+++  + H N+VRL  Y       
Sbjct: 78  SG--------------ELVAIKKV-LQDKRFKNRELQIMRKLDHCNIVRLR-YFFYSSGE 121

Query: 352 ---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV------QIALDSARGLEYIHEHT 402
              E  L LV +Y+    +    R   R               Q+     R L YIH   
Sbjct: 122 KKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF----RSLAYIHSFG 176

Query: 403 VPVYIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSASLPTRLVGTFGYMPPE----Y 457
           +    HRDIK  N+L+D +    K+ DFG  K    G  +     + +  Y  PE     
Sbjct: 177 I---CHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAPELIFGA 231

Query: 458 AQYGDVSPKVDVYAFGVVLYELISAK 483
             Y   +  +DV++ G VL EL+  +
Sbjct: 232 TDY---TSSIDVWSAGCVLAELLLGQ 254

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =   99 bits (250), Expect = 2e-23
 Identities = 59/245 (24%), Positives = 100/245 (40%), Gaps = 49/245 (20%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQAS 325
           S AT  +    +IG G +G VY A     G +                  A+K + +   
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHF-----------------VALKSVRVPNG 47

Query: 326 REFLAE-----------LKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLS 368
                            L+ L    H N+VRL+  C       E  + LV+E+++  +L 
Sbjct: 48  GGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLR 106

Query: 369 EHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
            +L  +    LP  +   +     RGL+++H + +   +HRD+K  NIL+      K+AD
Sbjct: 107 TYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTSGGTVKLAD 163

Query: 429 FGLTKLTEVGSASLPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAKEA 485
           FGL +          T +V T  Y  PE    + Y   +  VD+++ G +  E+   ++ 
Sbjct: 164 FGLAR--IYSYQMALTPVVVTLWYRAPEVLLQSTY---ATPVDMWSVGCIFAEMFR-RKP 217

Query: 486 IVKGN 490
           +  GN
Sbjct: 218 LFCGN 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  100 bits (252), Expect = 2e-23
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 23/214 (10%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
            +F+    +G+G FG V  +E +G         L  V +L +K  + + D       + E
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGT------DELYAVKIL-KKDVVIQDDDVEC--TMVE 70

Query: 332 LKVLTHV-HHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS--RVQ 386
            +VL        L +L   C      L+ V EY+  G+L  H++  GR   P +     +
Sbjct: 71  KRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           IA+    GL ++    +   I+RD+K  N+++D   H K+ADFG+ K   +         
Sbjct: 130 IAI----GLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTF 181

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
            GT  Y+ PE   Y      VD +AFGV+LYE++
Sbjct: 182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 215

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  100 bits (251), Expect = 2e-23
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 51/219 (23%)

Query: 280 IGQGGFGAVYYAE--LRGEYGNSYLSRLICVNLLMQKAAIK-----KMDMQASREFLAEL 332
           IG+G F  V  A   L G                  + AIK     +++  + ++   E+
Sbjct: 23  IGKGNFAKVKLARHILTGR-----------------EVAIKIIDKTQLNPTSLQKLFREV 65

Query: 333 KVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QI 387
           +++  ++H N+V+L  + V   E +L+L+ EY   G + ++L   GR     +     QI
Sbjct: 66  RIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI 123

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
                  ++Y H+  +   +HRD+K+ N+L+D + + K+ADFG +    VG   L     
Sbjct: 124 V----SAVQYCHQKRI---VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDA-FC 174

Query: 448 GTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELI 480
           G   Y  PE      Y       P+VDV++ GV+LY L+
Sbjct: 175 GAPPYAAPELFQGKKYD-----GPEVDVWSLGVILYTLV 208

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  103 bits (257), Expect = 3e-23
 Identities = 76/407 (18%), Positives = 138/407 (33%), Gaps = 29/407 (7%)

Query: 86  NVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRG 145
           NVP  C   + E  G  +  +    +    V     + +    +           IPD  
Sbjct: 147 NVPSLCGTDHTERRGRIYIQAHIDREVLIVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPK 206

Query: 146 TLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNF---- 201
           + +     +   +   +    F           +          +   ++   ++F    
Sbjct: 207 SESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISE 266

Query: 202 ---TRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDK 258
                  G   +  ++    F                +  E      GT           
Sbjct: 267 LQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTI 326

Query: 259 SVEFSYEELSKAT-DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI 317
           S   +     +    +F+    +G+G FG V  +E +G       +  +    +++K  +
Sbjct: 327 SKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG-------TDELYAVKILKKDVV 379

Query: 318 KKMDMQASREFLAELKVLTHV-HHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGS 374
            + D       + E +VL        L +L   C      L+ V EY+  G+L  H++  
Sbjct: 380 IQDDDVEC--TMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV 436

Query: 375 GRDPLPWSSRVQI-ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK 433
           GR   P        A + A GL ++    +   I+RD+K  N+++D   H K+ADFG+ K
Sbjct: 437 GRFKEP---HAVFYAAEIAIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIADFGMCK 490

Query: 434 LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELI 480
              +          GT  Y+ PE   Y      VD +AFGV+LYE++
Sbjct: 491 E-NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 61/227 (26%), Positives = 104/227 (45%), Gaps = 45/227 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYA-ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--- 327
           + +    K+G+G +G VY A + +G                    A+K++ + A  E   
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRI-----------------VALKRIRLDAEDEGIP 63

Query: 328 --FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
              + E+ +L  +HH N+V LI     E  L LV+E++E  +L + L    +  L  S  
Sbjct: 64  STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD-ENKTGLQDSQI 121

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
                   RG+ + H+H +   +HRD+K  N+LI+ +   K+ADFGL +     +  +P 
Sbjct: 122 KIYLYQLLRGVAHCHQHRI---LHRDLKPQNLLINSDGALKLADFGLAR-----AFGIPV 173

Query: 445 R----LVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
           R     V T  Y  P+      +Y   S  VD+++ G +  E+I+ K
Sbjct: 174 RSYTHEVVTLWYRAPDVLMGSKKY---STSVDIWSIGCIFAEMITGK 217

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 98.8 bits (247), Expect = 4e-23
 Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 50/229 (21%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            + +++   +G+G FG V   + R      Y  ++I       KA+ K  D         
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRIT-QQEYAVKVI------NKASAKNKDTSTILR--- 70

Query: 331 ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY----------IENGNLSEHLRGSGRDPL 379
           E+++L  + H N+++L        S ++V E           I+    SE       D  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE------HD-- 122

Query: 380 PWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKL 434
             ++R+  Q+      G+ Y+H+H +   +HRD+K  NIL+   +K+   K+ DFGL+  
Sbjct: 123 --AARIIKQV----FSGITYMHKHNI---VHRDLKPENILLESKEKDCDIKIIDFGLST- 172

Query: 435 TEVGSASLPTRLVGTFGYMPPE--YAQYGDVSPKVDVYAFGVVLYELIS 481
                 +     +GT  Y+ PE     Y     K DV++ GV+LY L+S
Sbjct: 173 -CFQQNTKMKDRIGTAYYIAPEVLRGTYD---EKCDVWSAGVILYILLS 217

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 99.2 bits (248), Expect = 5e-23
 Identities = 52/223 (23%), Positives = 97/223 (43%), Gaps = 37/223 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF- 328
           + +    K+G+G +  VY  + +                       A+K++ ++      
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNL-----------------VALKEIRLEHEEGAP 44

Query: 329 ---LAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
              + E+ +L  + H N+V L      E SL LV+EY++  +L ++L     + +   + 
Sbjct: 45  CTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD-DCGNIINMHNV 102

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
                   RGL Y H   V   +HRD+K  N+LI++    K+ADFGL +   + + +   
Sbjct: 103 KLFLFQLLRGLAYCHRQKV---LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-D 158

Query: 445 RLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
             V T  Y PP+       Y   S ++D++  G + YE+ + +
Sbjct: 159 NEVVTLWYRPPDILLGSTDY---STQIDMWGVGCIFYEMATGR 198

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 99.2 bits (248), Expect = 7e-23
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 25/216 (11%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
            +F +   IG+G +  V    L+         R+  + ++ +K  +   +         E
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKT------DRIYAMKVV-KKELVNDDEDIDW--VQTE 59

Query: 332 LKVLTHV-HHLNLVRLIGYC--VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--- 385
             V     +H  LV L   C   E  LF V EY+  G+L  H++   + P   + R    
Sbjct: 60  KHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSA 117

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
           +I+L     L Y+HE  +   I+RD+K  N+L+D   H K+ D+G+ K   +      + 
Sbjct: 118 EISL----ALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTST 169

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             GT  Y+ PE  +  D    VD +A GV+++E+++
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.4 bits (246), Expect = 8e-23
 Identities = 57/229 (24%), Positives = 91/229 (39%), Gaps = 52/229 (22%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAA--IKKMDMQASREF 328
              F     +G G F  V+  + R   G  +             A   IKK         
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLT-GKLF-------------ALKCIKKSPAFRDSSL 53

Query: 329 LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEY----------IENGNLSEHLRGSGRD 377
             E+ VL  + H N+V L   Y      +LV +           +E G  +E      +D
Sbjct: 54  ENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTE------KD 107

Query: 378 PLPWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLT 432
               +S V  Q+       ++Y+HE+ +   +HRD+K  N+L    ++N    + DFGL+
Sbjct: 108 ----ASLVIQQVL----SAVKYLHENGI---VHRDLKPENLLYLTPEENSKIMITDFGLS 156

Query: 433 KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
           K+ + G     +   GT GY+ PE       S  VD ++ GV+ Y L+ 
Sbjct: 157 KMEQNGIM---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 99.3 bits (248), Expect = 8e-23
 Identities = 59/255 (23%), Positives = 100/255 (39%), Gaps = 41/255 (16%)

Query: 240 STGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGN 299
           S G + G    L+    D   E  YE          +   IG+G F  V     R   G 
Sbjct: 2   SPGISGGGGGILDMADDDVLFEDVYE----------LCEVIGKGPFSVVRRCINRET-GQ 50

Query: 300 SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC-VEGSLFLV 358
            +  +++ V        +   D++       E  +   + H ++V L+     +G L++V
Sbjct: 51  QFAVKIVDVAKFTSSPGLSTEDLKR------EASICHMLKHPHIVELLETYSSDGMLYMV 104

Query: 359 YEYIENGNLSEHLRGSGRDPLPWSSRV------QIALDSARGLEYIHEHTVPVYIHRDIK 412
           +E+++  +L   +         +S  V      QI       L Y H++ +   IHRD+K
Sbjct: 105 FEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI----LEALRYCHDNNI---IHRDVK 157

Query: 413 SANILI---DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE---YAQYGDVSPK 466
              +L+   + +   K+  FG+             R VGT  +M PE      YG     
Sbjct: 158 PHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVVKREPYG---KP 213

Query: 467 VDVYAFGVVLYELIS 481
           VDV+  GV+L+ L+S
Sbjct: 214 VDVWGCGVILFILLS 228

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 98.5 bits (246), Expect = 9e-23
 Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 32/223 (14%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            D + +  ++G G F  V     +   G  Y ++ I      +K   +      SRE + 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFI------KKRQSRASRRGVSREEIE 63

Query: 331 -ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG----RDPLPWSSR 384
            E+ +L  V H N++ L   Y     + L+ E +  G L + L         +    ++ 
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE----ATS 119

Query: 385 V--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI-DKNFHA---KVADFGLTKLTEVG 438
              QI      G+ Y+H   +    H D+K  NI++ DKN      K+ DFGL    E+ 
Sbjct: 120 FIKQIL----DGVNYLHTKKI---AHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIE 170

Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                  + GT  ++ PE   Y  +  + D+++ GV+ Y L+S
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 97.3 bits (243), Expect = 9e-23
 Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 61/226 (26%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLL-MQKAAIKKMDMQASREFLA----ELKV 334
           +G+G +G V  A                VN +  +  A+K +DM+ + +       E+ +
Sbjct: 15  LGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58

Query: 335 LTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
              ++H N+V+   Y         +L  EY   G L + +               +    
Sbjct: 59  NKMLNHENVVKF--YGHRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPD 106

Query: 392 AR--------GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-- 441
           A+        G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163

Query: 442 LPTRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELIS 481
           L     GT  Y+ PE      +      +  VDV++ G+VL  +++
Sbjct: 164 LNKM-CGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLA 203

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 56/244 (22%), Positives = 93/244 (38%), Gaps = 51/244 (20%)

Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-- 320
           + E   K  D F +    GQG FG V   + +   G                 AIKK+  
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEK-STG--------------MSVAIKKVIQ 58

Query: 321 -DMQASREFLAELKVLTHVHHLNLVRLIGYCV---------EGSLFLVYEYIENGNLSEH 370
                +RE L  ++ L  +HH N+V+L              +  L +V EY+ +  L   
Sbjct: 59  DPRFRNRE-LQIMQDLAVLHHPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRC 115

Query: 371 LRGSGRDPLPWSSRV------QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA 424
            R   R  +     +      Q+     R +  +H  +V V  HRDIK  N+L+++    
Sbjct: 116 CRNYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPSVNV-CHRDIKPHNVLVNEADGT 170

Query: 425 -KVADFGLTKLTEVGSASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYEL 479
            K+ DFG  K       +     + +  Y  PE       Y   +  VD+++ G +  E+
Sbjct: 171 LKLCDFGSAKKLSPSEPN--VAYICSRYYRAPELIFGNQHY---TTAVDIWSVGCIFAEM 225

Query: 480 ISAK 483
           +  +
Sbjct: 226 MLGE 229

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 98.6 bits (246), Expect = 1e-22
 Identities = 54/223 (24%), Positives = 92/223 (41%), Gaps = 32/223 (14%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL- 329
            D + +  ++G G F  V     +   G  Y ++ I      +K   +       RE + 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREK-STGLEYAAKFI------KKRQSRASRRGVCREEIE 63

Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG----RDPLPWSSR 384
            E+ +L  V H N++ L   Y     + L+ E +  G L + L         +    ++ 
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE----ATS 119

Query: 385 V--QIALDSARGLEYIHEHTVPVYIHRDIKSANIL-IDKNFHA---KVADFGLTKLTEVG 438
              QI      G+ Y+H   +    H D+K  NI+ +DKN      K+ DFGL    E G
Sbjct: 120 FIKQIL----DGVNYLHTKKI---AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172

Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                  + GT  ++ PE   Y  +  + D+++ GV+ Y L+S
Sbjct: 173 VEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 99.3 bits (248), Expect = 1e-22
 Identities = 56/232 (24%), Positives = 88/232 (37%), Gaps = 50/232 (21%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
              ++    IG G FG V+ A                  +   + AIKK+ +Q  R    
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQA----------------KLVESDEVAIKKV-LQDKRFKNR 81

Query: 331 ELKVLTHVHHLNLVRLIGYCV--------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
           EL+++  V H N+V L             E  L LV EY+    +    R   +      
Sbjct: 82  ELQIMRIVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP 139

Query: 383 SRV------QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-KVADFGLTKLT 435
             +      Q+     R L YIH   +    HRDIK  N+L+D      K+ DFG  K+ 
Sbjct: 140 MLLIKLYMYQLL----RSLAYIHSIGI---CHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

Query: 436 EVGSASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAK 483
             G  +     + +  Y  PE       Y   +  +D+++ G V+ EL+  +
Sbjct: 193 IAGEPN--VSYICSRYYRAPELIFGATNY---TTNIDIWSTGCVMAELMQGQ 239

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 50/229 (21%), Positives = 91/229 (39%), Gaps = 52/229 (22%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
              +++ + IG+G +G V  A  +G       ++ I       K  ++ +D      F  
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGT-RIRRAAKKI------PKYFVEDVDR-----FKQ 55

Query: 331 ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY----------IENGNLSEHLRGSGRDPL 379
           E++++  + H N++RL         ++LV E           +      E       D  
Sbjct: 56  EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE------SD-- 107

Query: 380 PWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKL 434
             ++R+   +       + Y H+  V    HRD+K  N L      +   K+ DFGL   
Sbjct: 108 --AARIMKDV----LSAVAYCHKLNV---AHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158

Query: 435 TEVGSASLPTRLVGTFGYMPPE--YAQYGDVSPKVDVYAFGVVLYELIS 481
            + G   +    VGT  Y+ P+     YG   P+ D ++ GV++Y L+ 
Sbjct: 159 FKPG--KMMRTKVGTPYYVSPQVLEGLYG---PECDEWSAGVMMYVLLC 202

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 39/225 (17%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK---KMDMQASRE 327
            D F    K+G G FG V+  E R   G                  IK   K   Q   E
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSS-GLER--------------VIKTINKDRSQVPME 65

Query: 328 -FLAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR- 384
              AE++VL  + H N++++   +    ++++V E  E G L E +  +       S   
Sbjct: 66  QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125

Query: 385 -----VQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTE 436
                 Q+       L Y H   V   +H+D+K  NIL      +   K+ DFGL +L +
Sbjct: 126 VAELMKQM----MNALAYFHSQHV---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178

Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
               S  T   GT  YM PE  +  DV+ K D+++ GVV+Y L++
Sbjct: 179 SDEHS--TNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT 220

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 35/222 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           + +    KIG+G +G VY A+                N   +  A+KK+ ++   E    
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQ----------------NNYGETFALKKIRLEKEDEGIPS 45

Query: 328 -FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             + E+ +L  + H N+V+L      +  L LV+E+++  +L + L       L   +  
Sbjct: 46  TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD-VCEGGLESVTAK 103

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
              L    G+ Y H+  V   +HRD+K  N+LI++    K+ADFGL +   +      T 
Sbjct: 104 SFLLQLLNGIAYCHDRRV---LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-TH 159

Query: 446 LVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
            + T  Y  P+      +Y   S  +D+++ G +  E+++  
Sbjct: 160 EIVTLWYRAPDVLMGSKKY---STTIDIWSVGCIFAEMVNGT 198

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 98.0 bits (245), Expect = 2e-22
 Identities = 63/234 (26%), Positives = 105/234 (44%), Gaps = 43/234 (18%)

Query: 266 ELSKATDNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           ++      +     +G+G F  VY A  +   +           V       AIKK+ + 
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQI----------V-------AIKKIKLG 46

Query: 324 ASREF--------LAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGS 374
              E         L E+K+L  + H N++ L+     + ++ LV++++E  +L   ++ +
Sbjct: 47  HRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDN 105

Query: 375 GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL 434
               L  S      L + +GLEY+H+H +   +HRD+K  N+L+D+N   K+ADFGL K 
Sbjct: 106 SL-VLTPSHIKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAK- 160

Query: 435 TEVGSASLP-TRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
              GS +   T  V T  Y  PE       Y      VD++A G +L EL+   
Sbjct: 161 -SFGSPNRAYTHQVVTRWYRAPELLFGARMY---GVGVDMWAVGCILAELLLRV 210

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 47/223 (21%), Positives = 82/223 (36%), Gaps = 39/223 (17%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAA--IKKMDMQASREF 328
            D + +  ++G G FG V+    +   G  +              A  I           
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKAT-GRVF-------------VAKFINTPYPLDKYTV 95

Query: 329 LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG-----RDPLPWS 382
             E+ ++  +HH  L+ L   +  +  + L+ E++  G L + +          +     
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE----V 151

Query: 383 SRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI--DKNFHAKVADFGLTKLTEVG 438
                Q   +   GL+++HEH++   +H DIK  NI+    K    K+ DFGL       
Sbjct: 152 INYMRQA-CE---GLKHMHEHSI---VHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204

Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                     T  +  PE      V    D++A GV+ Y L+S
Sbjct: 205 EIV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 99.3 bits (248), Expect = 2e-22
 Identities = 56/230 (24%), Positives = 90/230 (39%), Gaps = 50/230 (21%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           T+ + +  ++G+G F  V         G  Y + +I          +   D Q       
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLA-GQEYAAMII------NTKKLSARDHQKLER--- 59

Query: 331 ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEY----------IENGNLSEHLRGSGRDPL 379
           E ++   + H N+VRL      EG  +L+++           +     SE       D  
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE------AD-- 111

Query: 380 PWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKL 434
             +S    QI       + + H+  V   +HR++K  N+L+    K    K+ADFGL   
Sbjct: 112 --ASHCIQQI----LEAVLHCHQMGV---VHRNLKPENLLLASKLKGAAVKLADFGLAIE 162

Query: 435 TEVGSASLPTRLVGTFGYMPPE---YAQYGDVSPKVDVYAFGVVLYELIS 481
            E    +      GT GY+ PE      YG     VD++A GV+LY L+ 
Sbjct: 163 VEGEQQAWFGF-AGTPGYLSPEVLRKDPYG---KPVDLWACGVILYILLV 208

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 51/230 (22%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +DN+ +  ++G+G F  V     +   G  + +++I          +   D Q       
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTT-GLEFAAKII------NTKKLSARDFQKLER--- 54

Query: 331 ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEY----------IENGNLSEHLRGSGRDPL 379
           E ++   + H N+VRL      E   +LV++           +     SE       D  
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE------AD-- 106

Query: 380 PWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKL 434
             +S    QI       + Y H + +   +HR++K  N+L+    K    K+ADFGL   
Sbjct: 107 --ASHCIQQI----LESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVKLADFGLAIE 157

Query: 435 TEVGSASLPTRLVGTFGYMPPE---YAQYGDVSPKVDVYAFGVVLYELIS 481
                A       GT GY+ PE      Y      VD++A GV+LY L+ 
Sbjct: 158 VNDSEAW--HGFAGTPGYLSPEVLKKDPYS---KPVDIWACGVILYILLV 202

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 61/226 (26%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM-QKAAIKKMDMQASREFLA----ELKV 334
           +G+G +G V  A                VN +  +  A+K +DM+ + +       E+ +
Sbjct: 15  LGEGAYGEVQLA----------------VNRVTEEAVAVKIVDMKRAVDCPENIKKEICI 58

Query: 335 LTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
              ++H N+V+   Y         +L  EY   G L + +               +    
Sbjct: 59  NKMLNHENVVKF--YGHRREGNIQYLFLEYCSGGELFDRIEPDIG----------MPEPD 106

Query: 392 AR--------GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-- 441
           A+        G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +    
Sbjct: 107 AQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163

Query: 442 LPTRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELIS 481
           L     GT  Y+ PE      +      +  VDV++ G+VL  +++
Sbjct: 164 LNKM-CGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLA 203

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 98.2 bits (245), Expect = 3e-22
 Identities = 60/252 (23%), Positives = 106/252 (42%), Gaps = 26/252 (10%)

Query: 237 TVESTGPAAGTPTSLNAITVDKSVEFSYEELSKAT-DNFSMSHKIGQGGFGAVYYAELRG 295
           T E+        + +       +   S +  S     +F +   IG+G +  V    L+ 
Sbjct: 16  TTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKK 75

Query: 296 EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYC--VE 352
                   R+  + ++ +K  +   +         E  V     +H  LV L   C   E
Sbjct: 76  T------DRIYAMRVV-KKELVNDDEDIDW--VQTEKHVFEQASNHPFLVGLH-SCFQTE 125

Query: 353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV---QIALDSARGLEYIHEHTVPVYIHR 409
             LF V EY+  G+L  H++   + P   + R    +I+L     L Y+HE  +   I+R
Sbjct: 126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAEISL----ALNYLHERGI---IYR 177

Query: 410 DIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDV 469
           D+K  N+L+D   H K+ D+G+ K   +      +   GT  Y+ PE  +  D    VD 
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 236

Query: 470 YAFGVVLYELIS 481
           +A GV+++E+++
Sbjct: 237 WALGVLMFEMMA 248

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 54/232 (23%), Positives = 97/232 (41%), Gaps = 46/232 (19%)

Query: 270 ATDNFSMSHKIGQGGFGAVYYAELR--GEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE 327
           ++  F    K+G G +  VY    +  G Y                  A+K++ + +   
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVY-----------------VALKEVKLDSEEG 45

Query: 328 F----LAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIEN---GNLSEHLRGSGRDPL 379
                + E+ ++  + H N+VRL      E  L LV+E+++N     +     G+    L
Sbjct: 46  TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGL 105

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
             +          +GL + HE+ +   +HRD+K  N+LI+K    K+ DFGL +     +
Sbjct: 106 ELNLVKYFQWQLLQGLAFCHENKI---LHRDLKPQNLLINKRGQLKLGDFGLAR-----A 157

Query: 440 ASLPTR----LVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
             +P       V T  Y  P+       Y   S  +D+++ G +L E+I+ K
Sbjct: 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTY---STSIDIWSCGCILAEMITGK 206

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 49/234 (20%), Positives = 99/234 (42%), Gaps = 48/234 (20%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            +N+     +G+G    V     +      Y  ++I V      +A +  +++ +   L 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFSAEEVQELREA--TLK 72

Query: 331 ELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEY----------IENGNLSEHLRGSGRDP 378
           E+ +L  V  H N+++L       +  FLV++            E   LSE      ++ 
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE------KE- 125

Query: 379 LPWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE 436
              + ++   +       +  +H+  +   +HRD+K  NIL+D + + K+ DFG +   +
Sbjct: 126 ---TRKIMRALL----EVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSCQLD 175

Query: 437 VGSASLPTRLVGTFGYMPPE---------YAQYGDVSPKVDVYAFGVVLYELIS 481
            G       + GT  Y+ PE         +  YG    +VD+++ GV++Y L++
Sbjct: 176 PG--EKLREVCGTPSYLAPEIIECSMNDNHPGYG---KEVDMWSTGVIMYTLLA 224

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 95.2 bits (237), Expect = 7e-22
 Identities = 33/276 (11%), Positives = 76/276 (27%), Gaps = 61/276 (22%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
             G       + A       ++ L R + +  +  +     +     +E L+    L+ +
Sbjct: 38  FHGGVPPLQFWQAL------DTALDRQVALTFVDPQGV---LPDDVLQETLSRTLRLSRI 88

Query: 339 HHLNLVRLIGYCVEGSL-FLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
               + R++      +   +V E+I  G+L E               ++     A   + 
Sbjct: 89  DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADA 144

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
            H   V          + + +  +    +A                         MP   
Sbjct: 145 AHRAGV---ALSIDHPSRVRVSIDGDVVLAY---------------------PATMPD-- 178

Query: 458 AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLR 517
                 +P+ D+   G  LY L+  +  + +    S    GL     +    P    D+ 
Sbjct: 179 -----ANPQDDIRGIGASLYALLVNRWPLPEAGVRS----GLAPAERDTAGQPIEPADID 229

Query: 518 KLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
           + +         + +V     +          +R +
Sbjct: 230 RDIPF------QISAVA-ARSVQGD-----GGIRSA 253

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 96.7 bits (241), Expect = 7e-22
 Identities = 57/285 (20%), Positives = 109/285 (38%), Gaps = 50/285 (17%)

Query: 220 PALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHK 279
              +  S    +    K +    P         ++  +  +   +    +    +     
Sbjct: 43  SLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDEL-PDWAAAKEFYQKYDPKDV 101

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH 339
           IG+G    V     R   G+ +  +++ V          +   +A+R    E  +L  V 
Sbjct: 102 IGRGVSSVVRRCVHRAT-GHEFAVKIMEVTAERLSPEQLEEVREATRR---ETHILRQVA 157

Query: 340 -HLNLVRLIGYCVEGS-LFLVYEY----------IENGNLSEHLRGSGRDPLPWSSRV-- 385
            H +++ LI      S +FLV++            E   LSE      ++    +  +  
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE------KE----TRSIMR 207

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
            +       + ++H + +   +HRD+K  NIL+D N   +++DFG +   E G       
Sbjct: 208 SLL----EAVSFLHANNI---VHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRE 258

Query: 446 LVGTFGYMPPE---------YAQYGDVSPKVDVYAFGVVLYELIS 481
           L GT GY+ PE         +  YG    +VD++A GV+L+ L++
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYG---KEVDLWACGVILFTLLA 300

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 95.9 bits (239), Expect = 8e-22
 Identities = 54/224 (24%), Positives = 91/224 (40%), Gaps = 38/224 (16%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA-- 330
            +S    +G G FG V+ A  +             V   ++K  + +       +     
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDK-------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT 77

Query: 331 -ELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGN-LSEHLRGSGRDPLPWSSRV 385
            E+ +L+ V H N++++    +   +G   LV E   +G  L   +    R   P +S +
Sbjct: 78  LEIAILSRVEHANIIKV--LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI 135

Query: 386 --QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
             Q+       + Y+    +   IHRDIK  NI+I ++F  K+ DFG     E G     
Sbjct: 136 FRQLV----SAVGYLRLKDI---IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-FY 187

Query: 444 TRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELIS 481
           T   GT  Y  PE      Y       P++++++ GV LY L+ 
Sbjct: 188 T-FCGTIEYCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVF 225

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 51/229 (22%), Positives = 94/229 (41%), Gaps = 44/229 (19%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-FL 329
            D++ M  ++G G F  V     +   G  Y ++ I      +K  +       SRE   
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQK-GTGKEYAAKFI------KKRRLSSSRRGVSREEIE 56

Query: 330 AELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEY----------IENGNLSEHLRGSGRDP 378
            E+ +L  + H N++ L   +  +  + L+ E            E  +L+E       + 
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE------DE- 109

Query: 379 LPWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI----DKNFHAKVADFGLT 432
              +++   QI      G+ Y+H   +    H D+K  NI++      N   K+ DFG+ 
Sbjct: 110 ---ATQFLKQIL----DGVHYLHSKRI---AHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159

Query: 433 KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              E G+      + GT  ++ PE   Y  +  + D+++ GV+ Y L+S
Sbjct: 160 HKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 46/218 (21%)

Query: 280 IGQGGFGAVYYAE--LRGEYGNSYLSRLICVNL-LMQKAAIKKMDM--QASREFLAELKV 334
           +G G FG V   E  L G            V + ++ +  I+ +D+  +  RE    ++ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHK----------VAVKILNRQKIRSLDVVGKIKRE----IQN 64

Query: 335 LTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV--QIAL 389
           L    H ++++L  Y V       F+V EY+  G L +++   GR     + R+  QI  
Sbjct: 65  LKLFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
                ++Y H H V   +HRD+K  N+L+D + +AK+ADFGL+ +   G   L T   G+
Sbjct: 123 ----AVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS-CGS 173

Query: 450 FGYMPPE------YAQYGDVSPKVDVYAFGVVLYELIS 481
             Y  PE      YA      P+VD+++ GV+LY L+ 
Sbjct: 174 PNYAAPEVISGRLYA-----GPEVDIWSCGVILYALLC 206

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 49/231 (21%), Positives = 93/231 (40%), Gaps = 48/231 (20%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           D +    K+G+G +G VY A       ++  +  +         AIK++ ++   E    
Sbjct: 34  DRYRRITKLGEGTYGEVYKAI------DTVTNETV---------AIKRIRLEHEEEGVPG 78

Query: 328 -FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             + E+ +L  + H N++ L         L L++EY EN +L +++  +    +      
Sbjct: 79  TAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP--DVSMRVIK 135

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA-----KVADFGLTKLTEVGSA 440
                   G+ + H       +HRD+K  N+L+  +  +     K+ DFGL +       
Sbjct: 136 SFLYQLINGVNFCHSRRC---LHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF----- 187

Query: 441 SLPTR----LVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAK 483
            +P R     + T  Y PPE       Y   S  VD+++   +  E++   
Sbjct: 188 GIPIRQFTHEIITLWYRPPEILLGSRHY---STSVDIWSIACIWAEMLMKT 235

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 51/229 (22%), Positives = 91/229 (39%), Gaps = 44/229 (19%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            D +    ++G G F  V     +   G  Y ++ I      +K   K      SRE + 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKST-GLQYAAKFI------KKRRTKSSRRGVSREDIE 62

Query: 331 -ELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEY----------IENGNLSEHLRGSGRDP 378
            E+ +L  + H N++ L   Y  +  + L+ E            E  +L+E       + 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE------EE- 115

Query: 379 LPWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI----DKNFHAKVADFGLT 432
              ++    QI      G+ Y+H   +    H D+K  NI++          K+ DFGL 
Sbjct: 116 ---ATEFLKQIL----NGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

Query: 433 KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
              + G+      + GT  ++ PE   Y  +  + D+++ GV+ Y L+S
Sbjct: 166 HKIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.4 bits (240), Expect = 3e-21
 Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 25/216 (11%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAA--IKKMDMQASREF 328
            D++ +  ++G G FG V+    R   GN++             AA  +           
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERAT-GNNF-------------AAKFVMTPHESDKETV 201

Query: 329 LAELKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
             E++ ++ + H  LV L   +  +  + ++YE++  G L E +     + +     V+ 
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV-ADEHNKMSEDEAVEY 260

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILI-DKNFHA-KVADFGLTKLTEVGSASLPTR 445
                +GL ++HE+     +H D+K  NI+   K  +  K+ DFGLT   +   +     
Sbjct: 261 MRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KV 315

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
             GT  +  PE A+   V    D+++ GV+ Y L+S
Sbjct: 316 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 44/221 (19%), Positives = 91/221 (41%), Gaps = 36/221 (16%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            + + ++  +G+G FG V+          +Y+++ +          +K  D    ++   
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSS-KKTYMAKFV---------KVKGTDQVLVKK--- 50

Query: 331 ELKVLTHVHHLNLVRLIGYC-VEGSLFLVYEYIENGNLSEHLRGSG-----RDPLPWSSR 384
           E+ +L    H N++ L         L +++E+I   ++ E +  S      R+       
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE----IVS 106

Query: 385 V--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI--DKNFHAKVADFGLTKLTEVGSA 440
              Q+       L+++H H +    H DI+  NI+    ++   K+ +FG  +  + G  
Sbjct: 107 YVHQVC----EALQFLHSHNI---GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                L     Y  PE  Q+  VS   D+++ G ++Y L+S
Sbjct: 160 F--RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 49/221 (22%), Positives = 87/221 (39%), Gaps = 36/221 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           ++     ++G G  G V+              R      ++   A+K+M    +    + 
Sbjct: 25  NDLENLGEMGSGTCGQVWKM------------RFRKTGHVI---AVKQMRRSGNKEENKR 69

Query: 328 FLAELKVLTH-VHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
            L +L V+        +V+  G +     +F+  E +         R  G  P     + 
Sbjct: 70  ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK- 128

Query: 386 QIALDSARGLEYIH-EHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSASLP 443
            + +   + L Y+  +H V   IHRD+K +NIL+D+    K+ DFG+  +L +  +    
Sbjct: 129 -MTVAIVKALYYLKEKHGV---IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--- 181

Query: 444 TRLVGTFGYMPPEYAQYGDV-----SPKVDVYAFGVVLYEL 479
            R  G   YM PE     D        + DV++ G+ L EL
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.8 bits (231), Expect = 9e-21
 Identities = 52/239 (21%), Positives = 98/239 (41%), Gaps = 38/239 (15%)

Query: 255 TVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK 314
            +  S E  ++      ++     +IG+G +G+V                      +M  
Sbjct: 8   KLKISPEQHWD---FTAEDLKDLGEIGRGAYGSVNKM------------VHKPSGQIM-- 50

Query: 315 AAIKKMDMQAS----REFLAELKVLTH-VHHLNLVRLIG-YCVEGSLFLVYEYIENG--N 366
            A+K++         ++ L +L V+        +V+  G    EG  ++  E +      
Sbjct: 51  -AVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDK 109

Query: 367 LSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH-EHTVPVYIHRDIKSANILIDKNFHAK 425
             +++     D +P     +I L + + L ++     +   IHRDIK +NIL+D++ + K
Sbjct: 110 FYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI---IHRDIKPSNILLDRSGNIK 166

Query: 426 VADFGL-TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSP----KVDVYAFGVVLYEL 479
           + DFG+  +L +  +    TR  G   YM PE             + DV++ G+ LYEL
Sbjct: 167 LCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 58/271 (21%), Positives = 89/271 (32%), Gaps = 68/271 (25%)

Query: 240 STGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGN 299
           S+G             +  +     +E       + +   +G GGFG+VY    R     
Sbjct: 11  SSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI-RVSDN- 68

Query: 300 SYLSRLICVNLLMQKAAIK-----KMDMQASREFLA----ELKVLTHVHHL--NLVRLIG 348
                           AIK     ++              E+ +L  V      ++RL  
Sbjct: 69  -------------LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL-- 113

Query: 349 YCV---EGSLFLVYEY-----------IENGNLSEHLRGSGRDPLPWSSR---VQIALDS 391
                   S  L+ E             E G L E L           +R    Q+    
Sbjct: 114 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----------ARSFFWQVL--- 159

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHAKVADFGLTKLTEVGSASLPTRLVGTF 450
              + + H   V   +HRDIK  NILID N    K+ DFG   L +           GT 
Sbjct: 160 -EAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTD-FDGTR 212

Query: 451 GYMPPEYAQYGD-VSPKVDVYAFGVVLYELI 480
            Y PPE+ +Y         V++ G++LY+++
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 57/227 (25%), Positives = 83/227 (36%), Gaps = 68/227 (29%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM-QKAAIK------KMDMQASREFLAEL 332
           IG G FG                      + L  +  A+K       +D    RE    +
Sbjct: 28  IGSGNFGVARLMR----------------DKLTKELVAVKYIERGAAIDENVQRE----I 67

Query: 333 KVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
                + H N+VR     V      L ++ EY   G L E +  +GR           + 
Sbjct: 68  INHRSLRHPNIVRF--KEVILTPTHLAIIMEYASGGELYERICNAGR----------FSE 115

Query: 390 DSAR--------GLEYIHEHTVPVYIHRDIKSANILIDKNFHA--KVADFGLTKLTEVGS 439
           D AR        G+ Y H   +    HRD+K  N L+D +     K+ DFG +K + +  
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171

Query: 440 ASLPTRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELI 480
            S P   VGT  Y+ PE      Y          DV++ GV LY ++
Sbjct: 172 -SQPKSTVGTPAYIAPEVLLRQEYD-----GKIADVWSCGVTLYVML 212

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 36/222 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           D+     ++G+G +G V               R +    +M   A+K++    +    + 
Sbjct: 7   DDLEPIMELGRGAYGVVEKM------------RHVPSGQIM---AVKRIRATVNSQEQKR 51

Query: 328 FLAELKVLTH-VHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
            L +L +    V     V   G    EG +++  E + + +L +  +            +
Sbjct: 52  LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDI 110

Query: 386 --QIALDSARGLEYIH-EHTVPVYIHRDIKSANILIDKNFHAKVADFGL-TKLTEVGSAS 441
             +IA+   + LE++H + +V   IHRD+K +N+LI+     K+ DFG+   L +  +  
Sbjct: 111 LGKIAVSIVKALEHLHSKLSV---IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK- 166

Query: 442 LPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYEL 479
                 G   YM PE           S K D+++ G+ + EL
Sbjct: 167 --DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 47/221 (21%), Positives = 94/221 (42%), Gaps = 44/221 (19%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLL-MQKAAIKKMD---MQASREFLA----E 331
           +G+G +G V                   ++   + + A+K +    ++      A    E
Sbjct: 13  LGEGSYGKVKEV----------------LDSETLCRRAVKILKKKKLRRIPNGEANVKKE 56

Query: 332 LKVLTHVHHLNLVRL---IGYCVEGSLFLVYEYIENGN--LSEHLRGSGRDPLPWSSRV- 385
           +++L  + H N+++L   +    +  +++V EY   G   + + +    R P+  +    
Sbjct: 57  IQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYF 115

Query: 386 -QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--L 442
            Q+      GLEY+H   +   +H+DIK  N+L+      K++  G+ +     +A    
Sbjct: 116 CQLID----GLEYLHSQGI---VHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168

Query: 443 PTRLVGTFGYMPPEYAQYGDV--SPKVDVYAFGVVLYELIS 481
            T   G+  + PPE A   D     KVD+++ GV LY + +
Sbjct: 169 RTS-QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 92.2 bits (229), Expect = 3e-20
 Identities = 51/232 (21%), Positives = 95/232 (40%), Gaps = 40/232 (17%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-ASREFLAELKVLTH 337
           K+G+G +G VY A+ +    +             +  A+K+++    S     E+ +L  
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDD-------------KDYALKQIEGTGISMSACREIALLRE 74

Query: 338 VHHLNLVRLIGYCV---EGSLFLVYEYIEN------GNLSEHLRGSGRDPLPWSSRVQIA 388
           + H N++ L    +   +  ++L+++Y E+                    LP      + 
Sbjct: 75  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA----KVADFGLTKL--TEVGSASL 442
                G+ Y+H + V   +HRD+K ANIL+          K+AD G  +L  + +   + 
Sbjct: 135 YQILDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 443 PTRLVGTFGYMPPEY----AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
              +V TF Y  PE       Y   +  +D++A G +  EL++  E I    
Sbjct: 192 LDPVVVTFWYRAPELLLGARHY---TKAIDIWAIGCIFAELLT-SEPIFHCR 239

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 92.9 bits (231), Expect = 3e-20
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 58/223 (26%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM-QKAAIK----------KMDMQASREF 328
           +G G FG V   +                + L   K A+K           +  +  RE 
Sbjct: 24  LGVGTFGKVKVGK----------------HELTGHKVAVKILNRQKIRSLDVVGKIRRE- 66

Query: 329 LAELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
              ++ L    H ++++L  Y V      +F+V EY+  G L +++  +GR     S R+
Sbjct: 67  ---IQNLKLFRHPHIIKL--YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRL 121

Query: 386 --QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
             QI      G++Y H H V   +HRD+K  N+L+D + +AK+ADFGL+ +   G   L 
Sbjct: 122 FQQILS----GVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LR 173

Query: 444 TRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELI 480
           T   G+  Y  PE      YA      P+VD+++ GV+LY L+
Sbjct: 174 TS-CGSPNYAAPEVISGRLYA-----GPEVDIWSSGVILYALL 210

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 61/280 (21%), Positives = 108/280 (38%), Gaps = 48/280 (17%)

Query: 223 ESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVE---FSYEELSKATDNFS---- 275
           +S S        +   + T          +A+ VD       F +  ++      +    
Sbjct: 31  DSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT 90

Query: 276 --MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAA--IKKMDMQASREFLAE 331
              +  +G G FG V+  E     G                AA  IK   M+   E   E
Sbjct: 91  VSKTEILGGGRFGQVHKCEETAT-GLKL-------------AAKIIKTRGMKDKEEVKNE 136

Query: 332 LKVLTHVHHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG-----RDPLPWSSRV 385
           + V+  + H NL++L   +  +  + LV EY++ G L + +          D    +   
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD----TILF 192

Query: 386 --QIALDSARGLEYIHEHTVPVYIHRDIKSANIL-IDKNFHA-KVADFGLTKLTEVGSAS 441
             QI  +   G+ ++H+  +   +H D+K  NIL ++++    K+ DFGL +        
Sbjct: 193 MKQI-CE---GIRHMHQMYI---LHLDLKPENILCVNRDAKQIKIIDFGLAR--RYKPRE 243

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
                 GT  ++ PE   Y  VS   D+++ GV+ Y L+S
Sbjct: 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 58/274 (21%), Positives = 88/274 (32%), Gaps = 74/274 (27%)

Query: 240 STGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGN 299
            T P  G P          +     ++       + +   +G+GGFG V+    R     
Sbjct: 3   LTKPLQGPPAP----PGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGH-RLTDR- 56

Query: 300 SYLSRLICVNLLMQKAAIKKMD-------------MQASREFLAELKVLTHVHHLNLVRL 346
                         + AIK +              +    E     KV     H  ++RL
Sbjct: 57  -------------LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103

Query: 347 IGYCV---EGSLFLVYEY-----------IENGNLSEHLRGSGRDPLPWSSR---VQIAL 389
                   +    LV E             E G L E             SR    Q+  
Sbjct: 104 --LDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP-----------SRCFFGQVV- 149

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILID-KNFHAKVADFGLTKLTEVGSASLPTRLVG 448
                +++ H   V   +HRDIK  NILID +   AK+ DFG   L             G
Sbjct: 150 ---AAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTD-FDG 200

Query: 449 TFGYMPPEYAQYGD-VSPKVDVYAFGVVLYELIS 481
           T  Y PPE+       +    V++ G++LY+++ 
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 88.5 bits (220), Expect = 3e-19
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 50/228 (21%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREF 328
           TD + +   IG G +        +      +              A+K +D   +   E 
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKAT-NMEF--------------AVKIIDKSKRDPTE- 64

Query: 329 LAELKVLTH-VHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSG----RDPLPWS 382
             E+++L     H N++ L     +G  +++V E ++ G L + +        R+    +
Sbjct: 65  --EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE----A 118

Query: 383 SRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANIL-IDKNFHA---KVADFGLTKLTE 436
           S V   I     + +EY+H   V   +HRD+K +NIL +D++ +    ++ DFG  K   
Sbjct: 119 SAVLFTI----TKTVEYLHAQGV---VHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171

Query: 437 VGSASLPTRLVGTFGYMPPE---YAQYGDVSPKVDVYAFGVVLYELIS 481
             +  L T    T  ++ PE      Y       D+++ GV+LY +++
Sbjct: 172 AENGLLMT-PCYTANFVAPEVLERQGYD---AACDIWSLGVLLYTMLT 215

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 59/224 (26%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM-QKAAIK----------KMDMQASREF 328
           +G+G FG V  A                 +    QK A+K           M M+  RE 
Sbjct: 17  LGEGSFGKVKLAT----------------HYKTQQKVALKFISRQLLKKSDMHMRVERE- 59

Query: 329 LAELKVLTHVHHLNLVRLIGYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
              +  L  + H ++++L  Y V      + +V EY   G L +++    R       R 
Sbjct: 60  ---ISYLKLLRHPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRF 113

Query: 386 --QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
             QI       +EY H H +   +HRD+K  N+L+D N + K+ADFGL+ +   G+  L 
Sbjct: 114 FQQII----CAIEYCHRHKI---VHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LK 165

Query: 444 TRLVGTFGYMPPE------YAQYGDVSPKVDVYAFGVVLYELIS 481
           T   G+  Y  PE      YA      P+VDV++ G+VLY ++ 
Sbjct: 166 T-SCGSPNYAAPEVINGKLYA-----GPEVDVWSCGIVLYVMLV 203

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 53/244 (21%), Positives = 101/244 (41%), Gaps = 42/244 (17%)

Query: 257 DKSVEFSYEE-LSKATDNFS-----MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNL 310
              V+   E    ++ +NF+      S ++G+G F  V     +   G  Y ++ +    
Sbjct: 8   SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISK-STGQEYAAKFL---- 62

Query: 311 LMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG-YCVEGSLFLVYEYIENGNLS 368
             +K    +       E L E+ VL        ++ L   Y     + L+ EY   G + 
Sbjct: 63  --KKRRRGQDCRA---EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIF 117

Query: 369 EHL--RGSG----RDPLPWSSRV--QIALDSARGLEYIHEHTVPVYIHRDIKSANILI-- 418
                  +      D      R+  QI L+   G+ Y+H++ +   +H D+K  NIL+  
Sbjct: 118 SLCLPELAEMVSEND----VIRLIKQI-LE---GVYYLHQNNI---VHLDLKPQNILLSS 166

Query: 419 -DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLY 477
                  K+ DFG+++  ++G A     ++GT  Y+ PE   Y  ++   D++  G++ Y
Sbjct: 167 IYPLGDIKIVDFGMSR--KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224

Query: 478 ELIS 481
            L++
Sbjct: 225 MLLT 228

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 46/218 (21%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQASREFLAELKVLTH 337
            +G+G F                     CV+    +A A+K +  +       E+  L  
Sbjct: 18  PLGEGSFSICR----------------KCVHKKSNQAFAVKIISKRMEANTQKEITALKL 61

Query: 338 V-HHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSG----RDPLPWSSRV--QIAL 389
              H N+V+L   +  +   FLV E +  G L E ++        +    +S +  ++  
Sbjct: 62  CEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE----ASYIMRKLV- 116

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTRL 446
                + ++H+  V   +HRD+K  N+L    + N   K+ DFG  +L    +  L T  
Sbjct: 117 ---SAVSHMHDVGV---VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP- 169

Query: 447 VGTFGYMPPE---YAQYGDVSPKVDVYAFGVVLYELIS 481
             T  Y  PE      Y       D+++ GV+LY ++S
Sbjct: 170 CFTLHYAAPELLNQNGYD---ESCDLWSLGVILYTMLS 204

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 46/233 (19%), Positives = 96/233 (41%), Gaps = 45/233 (19%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            D++ +  K+G+G +  V+ A +                   +K  +K +     ++   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEA-INITNN--------------EKVVVKILKPVKKKKIKR 79

Query: 331 ELKVLTHV-HHLNLVRL---IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           E+K+L ++    N++ L   +   V  +  LV+E++ N +  +         L     ++
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLT-DYDIR 133

Query: 387 I----ALDSARGLEYIHEHTVPVYIHRDIKSANILID-KNFHAKVADFGLTKLTEVGSAS 441
                 L   + L+Y H   +   +HRD+K  N++ID ++   ++ D+GL +    G   
Sbjct: 134 FYMYEIL---KALDYCHSMGI---MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187

Query: 442 LPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
                V +  +  PE    Y  Y      +D+++ G +L  +I  KE    G+
Sbjct: 188 --NVRVASRYFKGPELLVDYQMY---DYSLDMWSLGCMLASMIFRKEPFFHGH 235

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 84.4 bits (209), Expect = 8e-18
 Identities = 49/263 (18%), Positives = 90/263 (34%), Gaps = 79/263 (30%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
           +  +S+   +G G FG V                        ++ A+KK+      +   
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIES---------------GKRFALKKVLQDPRYK-NR 49

Query: 331 ELKVLTHVHHLNLVRLI---------------------------------------GYCV 351
           EL ++  + H+N+++L+                                           
Sbjct: 50  ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQ 109

Query: 352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV------QIALDSARGLEYIHEHTVPV 405
              L ++ EY+ +  L + L+   R        +      Q+     R + +IH   +  
Sbjct: 110 NKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSLGI-- 162

Query: 406 YIHRDIKSANILIDKNFHA-KVADFGLTKLTEVGSASLPTRLVGTFGYMPPE----YAQY 460
             HRDIK  N+L++   +  K+ DFG  K       S     + +  Y  PE      +Y
Sbjct: 163 -CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEY 219

Query: 461 GDVSPKVDVYAFGVVLYELISAK 483
              +P +D+++ G V  ELI  K
Sbjct: 220 ---TPSIDLWSIGCVFGELILGK 239

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 60/278 (21%), Positives = 103/278 (37%), Gaps = 58/278 (20%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-----DMQAS 325
              +++   I  G +GAV                   V+      AIK++     D +  
Sbjct: 21  QSPYTVQRFISSGSYGAVCAG----------------VDSEGIPVAIKRVFNTVSDGRTV 64

Query: 326 REF---------LAELKVLTHVHHLNLVRLIGYCVEGS------LFLVYEYIENGNLSEH 370
                       L E+++L H HH N++ L    V         L+LV E +   +L++ 
Sbjct: 65  NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQV 123

Query: 371 LRGSGRDPLPWSSRVQ-IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF 429
           +    R  +     +Q        GL  +HE  V   +HRD+   NIL+  N    + DF
Sbjct: 124 IH-DQRIVIS-PQHIQYFMYHILLGLHVLHEAGV---VHRDLHPGNILLADNNDITICDF 178

Query: 430 GLTKLTEVGSASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAKEA 485
            L +     +    T  V    Y  PE    +  +   +  VD+++ G V+ E+ + K A
Sbjct: 179 NLAREDTADANK--THYVTHRWYRAPELVMQFKGF---TKLVDMWSAGCVMAEMFNRK-A 232

Query: 486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
           + +G+         +    EV+  P   ED+     P 
Sbjct: 233 LFRGS----TFYNQLNKIVEVVGTPKI-EDVVMFSSPS 265

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 50/227 (22%), Positives = 89/227 (39%), Gaps = 51/227 (22%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIK---KMDMQASREFLAELKVL 335
           +G+G    V                  C+NL+  +  A+K   K           E+++L
Sbjct: 21  LGEGAHARVQ----------------TCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64

Query: 336 THV-HHLNLVRLIG-YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR--VQIALDS 391
                H N++ LI  +  E   +LV+E +  G++  H+         ++      +  D 
Sbjct: 65  YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDV 120

Query: 392 ARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTR--- 445
           A  L+++H   +    HRD+K  NIL    ++    K+ DF L    ++     P     
Sbjct: 121 ASALDFLHNKGI---AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPE 177

Query: 446 ---LVGTFGYMPPE--------YAQYGDVSPKVDVYAFGVVLYELIS 481
                G+  YM PE         + Y     + D+++ GV+LY L+S
Sbjct: 178 LLTPCGSAEYMAPEVVEAFSEEASIYD---KRCDLWSLGVILYILLS 221

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 44/218 (20%), Positives = 81/218 (37%), Gaps = 40/218 (18%)

Query: 277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKMDMQASREFLAELKVL 335
              +G G  G V                  C +    +  A+K +    S +   E+   
Sbjct: 34  KQVLGLGVNGKVL----------------ECFHRRTGQKCALKLLY--DSPKARQEVDHH 75

Query: 336 THV-HHLNLVRLIGYC-----VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
                  ++V ++         +  L ++ E +E G L   ++  G          +I  
Sbjct: 76  WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR 135

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLPTRL 446
           D    ++++H H +    HRD+K  N+L    +K+   K+ DFG  K T   +   P   
Sbjct: 136 DIGTAIQFLHSHNI---AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP--- 189

Query: 447 VGTFGYMPPE---YAQYGDVSPKVDVYAFGVVLYELIS 481
             T  Y+ PE     +Y       D+++ GV++Y L+ 
Sbjct: 190 CYTPYYVAPEVLGPEKYD---KSCDMWSLGVIMYILLC 224

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.9 bits (195), Expect = 6e-16
 Identities = 61/281 (21%), Positives = 108/281 (38%), Gaps = 71/281 (25%)

Query: 271 TDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQ 323
              ++    IG+G +G V  A   L                    + AIKK+        
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKV-----------------RVAIKKISPFEHQTY 68

Query: 324 ASREFLAELKVLTHVHHLNLVRLIGYCVEGS------LFLVYEY--------IENGNLS- 368
             R  L E+K+L    H N++ +       +      +++V +         ++  +LS 
Sbjct: 69  CQRT-LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN 127

Query: 369 EHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
           +H+              QI     RGL+YIH   V   +HRD+K +N+L++     K+ D
Sbjct: 128 DHIC---------YFLYQIL----RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICD 171

Query: 429 FGLTKLTEVGSASLP--TRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISA 482
           FGL ++ +         T  V T  Y  PE       Y   +  +D+++ G +L E++S 
Sbjct: 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY---TKSIDIWSVGCILAEMLSN 228

Query: 483 KEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
           +  I  G          +     +L  P   EDL  +++ +
Sbjct: 229 R-PIFPGK----HYLDQLNHILGILGSPSQ-EDLNCIINLK 263

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 61/269 (22%), Positives = 110/269 (40%), Gaps = 52/269 (19%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
              +     +G G +G+V  A  +                  +K AIKK+      E  A
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDK---------------RSGEKVAIKKLSRPFQSEIFA 67

Query: 331 -----ELKVLTHVHHLNLVRLIGYCVEGS-------LFLVYEYIENGNLSEHLRGSGRDP 378
                EL +L H+ H N++ L+      S        +LV  +++  +L + +     + 
Sbjct: 68  KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE 126

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG 438
                  Q+     +GL+YIH   V   +HRD+K  N+ ++++   K+ DFGL +  +  
Sbjct: 127 KIQYLVYQML----KGLKYIHSAGV---VHRDLKPGNLAVNEDCELKILDFGLARHADAE 179

Query: 439 SASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
                T  V T  Y  PE    +  Y   +  VD+++ G ++ E+++ K  + KG     
Sbjct: 180 M----TGYVVTRWYRAPEVILSWMHY---NQTVDIWSVGCIMAEMLTGK-TLFKGK---- 227

Query: 495 DSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
           D    +    +V  +P   E ++KL D  
Sbjct: 228 DYLDQLTQILKVTGVPGT-EFVQKLNDKA 255

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 57/280 (20%), Positives = 98/280 (35%), Gaps = 56/280 (20%)

Query: 220 PALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFS--YEELSKATDNFSMS 277
           PA         +           P       + +    K       Y+  S+        
Sbjct: 17  PAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ-------- 68

Query: 278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIKKM-DMQASREFLAELKVL 335
             +G G  G V                    N   Q+  A+K + D   +R    E+++ 
Sbjct: 69  -VLGLGINGKVL----------------QIFNKRTQEKFALKMLQDCPKARR---EVELH 108

Query: 336 THV-HHLNLVRLIG-----YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR--VQI 387
                  ++VR++      Y     L +V E ++ G L   +    R    ++ R   +I
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEI 166

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANIL-IDKNFHA--KVADFGLTKLTEVGSASLPT 444
                  ++Y+H   +    HRD+K  N+L   K  +A  K+ DFG  K T   + SL T
Sbjct: 167 MKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTT 222

Query: 445 RLVGTFGYMPPE---YAQYGDVSPKVDVYAFGVVLYELIS 481
               T  Y+ PE     +Y       D+++ GV++Y L+ 
Sbjct: 223 P-CYTPYYVAPEVLGPEKYD---KSCDMWSLGVIMYILLC 258

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 59/270 (21%), Positives = 110/270 (40%), Gaps = 53/270 (19%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            + +     +G G +G+V  A                      + A+KK+         A
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDT---------------KTGLRVAVKKLSRPFQSIIHA 72

Query: 331 -----ELKVLTHVHHLNLVRLI-----GYCVEG--SLFLVYEYIENGNLSEHLRGSGRDP 378
                EL++L H+ H N++ L+        +E    ++LV   +   +L+  ++      
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTD 131

Query: 379 LPWSSRV-QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
                 + QI     RGL+YIH   +   IHRD+K +N+ ++++   K+ DFGL +    
Sbjct: 132 DHVQFLIYQIL----RGLKYIHSADI---IHRDLKPSNLAVNEDCELKILDFGLAR---- 180

Query: 438 GSASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS 493
            +A   T  V T  Y  PE    +  Y   +  VD+++ G ++ EL++ +  +  G    
Sbjct: 181 HTADEMTGYVATRWYRAPEIMLNWMHY---NQTVDIWSVGCIMAELLTGR-TLFPGT--- 233

Query: 494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
            D    + L   ++  P   E L+K+    
Sbjct: 234 -DHIDQLKLILRLVGTPGA-ELLKKISSES 261

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 75.9 bits (187), Expect = 6e-15
 Identities = 50/226 (22%), Positives = 93/226 (41%), Gaps = 39/226 (17%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
              +     IG G  G V  A                  +L +  AIKK+      +  A
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDA---------------ILERNVAIKKLSRPFQNQTHA 68

Query: 331 -----ELKVLTHVHHLNLVRLIG-YCVEGS------LFLVYEYIENGNLSEHLRGSGRDP 378
                EL ++  V+H N++ L+  +  + S      +++V E ++  NL + ++      
Sbjct: 69  KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDH- 126

Query: 379 LPWSSRVQIAL-DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
                R+   L     G++++H   +   IHRD+K +NI++  +   K+ DFGL +    
Sbjct: 127 ----ERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAG- 178

Query: 438 GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            ++ + T  V T  Y  PE          VD+++ G ++ E+I   
Sbjct: 179 -TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 35/179 (19%), Positives = 63/179 (35%), Gaps = 30/179 (16%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK-------------K 319
            + +     +   G +Y A           +         QK ++K              
Sbjct: 43  QWKLKSFQTRDNQGILYEAA-------PTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNF 95

Query: 320 MDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSL--FLVYEYIENG-NLSEHLRGSGR 376
               A    + + K L     L +   +G+ V      FLV   +  G +L   L  S +
Sbjct: 96  FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPK 153

Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV--ADFGLTK 433
             L   S +Q+A      LE++HE+    Y+H ++ + NI +D    ++V  A +G   
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 57/228 (25%), Positives = 102/228 (44%), Gaps = 38/228 (16%)

Query: 313 QKAAIKKMDMQASREFLA-----ELKVLTHVHHLNLVRLI-------GYCVEGSLFLVYE 360
            K AIKK+      E  A     EL++L H+ H N++ L+               +LV  
Sbjct: 51  AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110

Query: 361 YIENGNLSEHLRGSGRDPLPWSSRVQ-IALDSARGLEYIHEHTVPVYIHRDIKSANILID 419
           ++   +L + ++    + L    R+Q +     +GL YIH   +   IHRD+K  N+ ++
Sbjct: 111 FMGT-DLGKLMK---HEKLG-EDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVN 162

Query: 420 KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVV 475
           ++   K+ DFGL +     + S  T  V T  Y  PE    + +Y   +  VD+++ G +
Sbjct: 163 EDCELKILDFGLAR----QADSEMTGYVVTRWYRAPEVILNWMRY---TQTVDIWSVGCI 215

Query: 476 LYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
           + E+I+ K  + KG+    D    +    +V   P   E +++L    
Sbjct: 216 MAEMITGK-TLFKGS----DHLDQLKEIMKVTGTPPA-EFVQRLQSDE 257

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.0 bits (187), Expect = 7e-15
 Identities = 40/233 (17%), Positives = 82/233 (35%), Gaps = 54/233 (23%)

Query: 221 ALESSSTGGLVFPAYKTVESTGPAAGTPTSLNAITVDKSVEFSYEELSKATDNFSMSHKI 280
           +   ++         +   S     G     +  +   +         +  D + + H I
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLI 61

Query: 281 GQGGFGAVYYAELRGEYGNSYLSRLICVNLLM-QKAAIKKMDMQASREFLA-----ELKV 334
           G G +G V  A                 + L  +  AIKK+               E+ +
Sbjct: 62  GTGSYGHVCEA----------------YDKLEKRVVAIKKILRVFEDLIDCKRILREIAI 105

Query: 335 LTHVHHLNLVRLIGYCVEGS------LFLVYEYIE---------NGNLS-EHLRGSGRDP 378
           L  ++H ++V+++   +         L++V E  +            L+  H++      
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK------ 159

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
              +    +      G++Y+H   +   +HRD+K AN L++++   KV DFGL
Sbjct: 160 ---TLLYNLL----VGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGL 202

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 76.0 bits (187), Expect = 7e-15
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 45/229 (19%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
              +     IG G  G V  A                     +  AIKK+      +  A
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDA-VLD--------------RNVAIKKLSRPFQNQTHA 105

Query: 331 -----ELKVLTHVHHLNLVRLI-------GYCVEGSLFLVYEYIENGNLSEHLRGSGRDP 378
                EL ++  V+H N++ L+              ++LV E ++  NL + ++      
Sbjct: 106 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----E 160

Query: 379 LPWSSRVQIALDSA-RGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
           L    R+   L     G++++H   +   IHRD+K +NI++  +   K+ DFGL +    
Sbjct: 161 L-DHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR--TA 214

Query: 438 GSASLPTRLVGTFGYMPPEY---AQYGDVSPKVDVYAFGVVLYELISAK 483
           G++ + T  V T  Y  PE      Y      VD+++ G ++ E++  K
Sbjct: 215 GTSFMMTPYVVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHK 260

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 77/288 (26%)

Query: 271 TDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMD-----MQ 323
           + +F +   +G+G +G V  A  +  GE                   AIKK++     + 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGE-----------------IVAIKKIEPFDKPLF 52

Query: 324 ASREFLAELKVLTHVHHLNLVRLI------GYCVEGSLFLVYEY--------IENGNLS- 368
           A R  L E+K+L H  H N++ +        +     ++++ E         I    LS 
Sbjct: 53  ALRT-LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD 111

Query: 369 EHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD 428
           +H++             Q  L   R ++ +H   V   IHRD+K +N+LI+ N   KV D
Sbjct: 112 DHIQ---------YFIYQT-L---RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCD 155

Query: 429 FGLTKLTEVGSASLP---------TRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGVV 475
           FGL ++ +  +A               V T  Y  PE     A+Y   S  +DV++ G +
Sbjct: 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY---SRAMDVWSCGCI 212

Query: 476 LYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPR 523
           L EL   +  I  G     D +  + L   ++  P    DLR +  PR
Sbjct: 213 LAELFLRR-PIFPGR----DYRHQLLLIFGIIGTPHSDNDLRCIESPR 255

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 56/249 (22%), Positives = 98/249 (39%), Gaps = 72/249 (28%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM-QKAAIKKMDMQ----AS 325
              +     +G GG G V+ A                V+    ++ AIKK+ +       
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSA----------------VDNDCDKRVAIKKIVLTDPQSVK 53

Query: 326 REFLAELKVLTHVHHLNLVRLI---------------GYCVEGSLFLVYEY--------I 362
              L E+K++  + H N+V++                      S+++V EY        +
Sbjct: 54  HA-LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL 112

Query: 363 ENGNLS-EHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID-K 420
           E G L  EH R             Q+     RGL+YIH   V   +HRD+K AN+ I+ +
Sbjct: 113 EQGPLLEEHAR---------LFMYQLL----RGLKYIHSANV---LHRDLKPANLFINTE 156

Query: 421 NFHAKVADFGLTKLTEVGSASLP--TRLVGTFGYMPPE----YAQYGDVSPKVDVYAFGV 474
           +   K+ DFGL ++ +   +     +  + T  Y  P        Y   +  +D++A G 
Sbjct: 157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY---TKAIDMWAAGC 213

Query: 475 VLYELISAK 483
           +  E+++ K
Sbjct: 214 IFAEMLTGK 222

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 52/182 (28%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
            DN+ + H IG+G +G VY A  +                  +  AIKK++         
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDK-NTE--------------KNVAIKKVNRMFEDLIDC 69

Query: 331 -----ELKVLTHVHHLNLVRLIGYCVEGS------LFLVYEYIE---------NGNLS-E 369
                E+ +L  +    ++RL    +         L++V E  +            L+ E
Sbjct: 70  KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE 129

Query: 370 HLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF 429
           H++         +    + L    G  +IHE  +   IHRD+K AN L++++   KV DF
Sbjct: 130 HIK---------TILYNL-L---LGENFIHESGI---IHRDLKPANCLLNQDCSVKVCDF 173

Query: 430 GL 431
           GL
Sbjct: 174 GL 175

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 40/176 (22%), Positives = 76/176 (43%), Gaps = 24/176 (13%)

Query: 273 NFSMSHKIGQGGFGAVYYAELR-GEYGNSYLSRLICVN------LLMQKAAIKKMDMQAS 325
            + +   IGQGGFG +Y A++   E   S    ++ V       L  +    ++    A 
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA---AK 92

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSL-----FLVYEYIENG-NLSEHLRGSGRDPL 379
            E + +      + +L + +  G  +         F++ +    G +L +    + +   
Sbjct: 93  PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK-RF 149

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV--ADFGLTK 433
              + +Q++L     LEYIHEH    Y+H DIK++N+L++     +V   D+GL  
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.0 bits (152), Expect = 6e-11
 Identities = 47/275 (17%), Positives = 79/275 (28%), Gaps = 69/275 (25%)

Query: 250 SLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVN 309
           S+   +    V FS+      T+      KIG+G FG V+                I + 
Sbjct: 1   SMGECSQKGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIADHT------PVAIKII 51

Query: 310 LLMQKAAIKKMDMQASREFLAELKVLTHVHHL---------NLVRLIG-YCVEGS----- 354
            +     +     +   E L E+ +   +  L           + L   +CV+GS     
Sbjct: 52  AIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLL 111

Query: 355 -------------------------LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
                                    LF+V E+   G   E +R         ++   I  
Sbjct: 112 LKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSS---LATAKSILH 168

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL------- 442
                L          + HRD+   N+L+ K    K+      K + + S  L       
Sbjct: 169 QLTASLAVAEAS--LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDY 226

Query: 443 -------PTRLVGTFGYMPPEYAQYGDVSPKVDVY 470
                     +V     M  +    GD   + D+Y
Sbjct: 227 TLSRLERDGIVVFCDVSMDEDLFT-GDGDYQFDIY 260

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 53/255 (20%), Positives = 99/255 (38%), Gaps = 76/255 (29%)

Query: 271 TDNFSMSHKIGQGGFGAVYYA--ELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREF 328
              + +  K+G+G +G V+ +     GE                   A+KK+        
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGE-----------------VVAVKKIFDAFQNST 50

Query: 329 LA-----ELKVLTHVH-HLNLVRLIGYCVEGS---LFLVYEYIENGNLSEHLRGSGRDPL 379
            A     E+ +LT +  H N+V L+      +   ++LV++Y+E  +L   +R    + L
Sbjct: 51  DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRA---NIL 106

Query: 380 PWSSRV-------QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL- 431
                V       Q+ +   + ++Y+H   +   +HRD+K +NIL++   H KVADFGL 
Sbjct: 107 ---EPVHKQYVVYQL-I---KVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLS 156

Query: 432 ---------TKLTEVGSASLPTRLVGTFGYM----------PPE----YAQYGDVSPKVD 468
                    T    +               +           PE      +Y   +  +D
Sbjct: 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY---TKGID 213

Query: 469 VYAFGVVLYELISAK 483
           +++ G +L E++  K
Sbjct: 214 MWSLGCILGEILCGK 228

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 43/218 (19%), Positives = 76/218 (34%), Gaps = 58/218 (26%)

Query: 276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-DMQASREFLAELKV 334
            S  +G G  G V     +      +              A+K + D   +R    E+++
Sbjct: 22  TSQVLGLGINGKVLQIFNKRT-QEKF--------------ALKMLQDCPKARR---EVEL 63

Query: 335 LTHV-HHLNLVRLIG-----YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR--VQ 386
                   ++VR++      Y     L +V E ++ G L    R   R    ++ R   +
Sbjct: 64  HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASE 121

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLP 443
           I       ++Y+H   +    HRD+K  N+L      N   K+ DFG  K  E       
Sbjct: 122 IMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRPNAILKLTDFGFAK--ET----TG 172

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS 481
            +              Y       D+++ GV++Y L+ 
Sbjct: 173 EK--------------YD---KSCDMWSLGVIMYILLC 193

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 41/165 (24%), Positives = 74/165 (44%), Gaps = 17/165 (10%)

Query: 279 KIGQGGFGAVYYAE--LRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLT 336
           KIG GGFG +Y A    + E    ++ ++         + +K     A ++ + +     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 337 HVHHLNLVRLIGYCVEGSL-----FLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQIALD 390
            + +L +    G  +         F+V E +  G +L +    +G      S+ +Q+ + 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT--FKKSTVLQLGIR 159

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV--ADFGLTK 433
               LEYIHE+    Y+H DIK+AN+L+      +V  AD+GL+ 
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 59.3 bits (144), Expect = 8e-10
 Identities = 39/172 (22%), Positives = 66/172 (38%), Gaps = 32/172 (18%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLL-MQKAAIKKMDMQASREFLA 330
            ++ +  +IG+G FG ++                   NLL  Q+ AIK    ++    L 
Sbjct: 10  VHYKVGRRIGEGSFGVIF----------------EGTNLLNNQQVAIKFEPRRSDAPQLR 53

Query: 331 -ELKVLTHVHHLNLV-RLIGYCVEGSL-FLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQ 386
            E +    +     +  +  +  EG    LV + +  G +L + L   GR      +   
Sbjct: 54  DEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGR-KFSVKTVAM 110

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK-----VADFGLTK 433
            A      ++ IHE +    ++RDIK  N LI +          V DFG+ K
Sbjct: 111 AAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 40/170 (23%), Positives = 69/170 (40%), Gaps = 30/170 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLL-MQKAAIKKMDMQASREFLA 330
           + F +  KIG G FG +Y                +  N+   ++ AIK  +++     L 
Sbjct: 7   NKFRLGRKIGSGSFGEIY----------------LGTNIQTNEEVAIKLENVKTKHPQLL 50

Query: 331 -ELKVLTHVHHLNLV-RLIGYCVEGSL-FLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQ 386
            E K+   +     +  +  + VEG    LV + +  G +L +      R  L   + + 
Sbjct: 51  YESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSR-KLSLKTVLM 107

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK---VADFGLTK 433
           +A      +E++H      ++HRDIK  N L+     A    + DFGL K
Sbjct: 108 LADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 38/169 (22%), Positives = 63/169 (37%), Gaps = 28/169 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA- 330
           + + +  KIG G FG +Y     G    +            ++ AIK   ++     L  
Sbjct: 9   NRYRLGRKIGSGSFGDIY----LGTDIAA-----------GEEVAIKLECVKTKHPQLHI 53

Query: 331 ELKVLTHVHHLNLV-RLIGYCVEGSL-FLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQI 387
           E K+   +     +  +     EG    +V E +  G +L +      R      + + +
Sbjct: 54  ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRK-FSLKTVLLL 110

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK---VADFGLTK 433
           A      +EYIH      +IHRD+K  N L+          + DFGL K
Sbjct: 111 ADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 38/171 (22%), Positives = 63/171 (36%), Gaps = 32/171 (18%)

Query: 273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM-QKAAIKKMDMQASREFLA- 330
           NF +  KIG G FG +                    NL   +  AIK   M++    L  
Sbjct: 10  NFRVGKKIGCGNFGELRLG----------------KNLYTNEYVAIKLEPMKSRAPQLHL 53

Query: 331 ELKVLTHVHH-LNLVRLIGYCVEGSL-FLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQI 387
           E +    +     + ++  +   G    +V E +  G +L +      R      + + I
Sbjct: 54  EYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR-TFSLKTVLMI 110

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK-----VADFGLTK 433
           A+     +EY+H       I+RD+K  N LI +  +       + DF L K
Sbjct: 111 AIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 53/268 (19%), Positives = 97/268 (36%), Gaps = 67/268 (25%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIK------KMDMQ 323
            D + +   IG+G FG V                    + + Q+  AIK          Q
Sbjct: 53  MDRYEIDSLIGKGSFGQVVK----------------AYDRVEQEWVAIKIIKNKKAFLNQ 96

Query: 324 ASREFLAELKVLTHVHHL------NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGR 376
           A      E+++L  ++         +V L  + +    L LV+E +   NL + LR +  
Sbjct: 97  A----QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNF 151

Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI--DKNFHAKVADFGLTKL 434
             +  +   + A      L ++    + + IH D+K  NIL+   K    K+ DF     
Sbjct: 152 RGVSLNLTRKFAQQMCTALLFLATPELSI-IHCDLKPENILLCNPKRSAIKIVDF----- 205

Query: 435 TEVGSASLPTRLVGTF----GYMPPE------YAQYGDVSPKVDVYAFGVVLYELISAKE 484
              GS+    + +  +     Y  PE      Y         +D+++ G +L E+ + + 
Sbjct: 206 ---GSSCQLGQRIYQYIQSRFYRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE- 255

Query: 485 AIVKGNGSSADSKGLVALFEEVLNLPDP 512
            +  G     +    +    EVL +P  
Sbjct: 256 PLFSGA----NEVDQMNKIVEVLGIPPA 279

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 52.5 bits (125), Expect = 3e-07
 Identities = 91/643 (14%), Positives = 176/643 (27%), Gaps = 212/643 (32%)

Query: 46  FIAQTLRSSLVD-----PNDVE-----LTTILSYNKQLSNK--DSLLADTRINVPFPCDC 93
                L    +D      + V        T+LS  +++  K  + +L   RIN  F    
Sbjct: 41  MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVL---RINYKFLMSP 97

Query: 94  INGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIP----------- 142
           I  E      Q S+ +   Y +   R Y++       Q    Y  +R+            
Sbjct: 98  IKTE----QRQPSMMT-RMYIEQRDRLYNDN------QVFAKYNVSRLQPYLKLRQALLE 146

Query: 143 DRGTLNVTVN----C--SCGDADVSKQYRLFVTYP-----------LRPGDSLQSIARNV 185
            R   NV ++       +    DV   Y++                  P   L+ + +  
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQK-- 204

Query: 186 GLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESSSTGGLVFPAYKT-------V 238
            L   +  N+       R      I  R       ++++     L    Y+        V
Sbjct: 205 -LLYQIDPNWTS-----RSDHSSNIKLR-----IHSIQAELRRLLKSKPYENCLLVLLNV 253

Query: 239 ESTGPAAGTPTSLNA---------ITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVY 289
           ++         + NA          T  K V       +  T + S+ H           
Sbjct: 254 QN-------AKAWNAFNLSCKILLTTRFKQVTDFLS--AATTTHISLDHH--SMTLTPDE 302

Query: 290 YAELRGEYGN---SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL 346
              L  +Y +     L R +      + + I +      R+ LA      HV+   L  +
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI----RDGLATWDNWKHVNCDKLTTI 358

Query: 347 IGYCVEGSLFL-------VYEYI----ENGNLSEHLRGSGRDPLP--WSSRVQ------- 386
           I   +     L       +++ +     + ++   L       L   W   ++       
Sbjct: 359 IESSLN---VLEPAEYRKMFDRLSVFPPSAHIPTIL-------LSLIWFDVIKSDVMVVV 408

Query: 387 --------IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVG 438
                   +          I        I+ ++K   +  +   H  + D          
Sbjct: 409 NKLHKYSLVEKQPKESTISIPS------IYLELK-VKLENEYALHRSIVDH--------- 452

Query: 439 SASLPTRLVGTFGYMPPEYAQYGDVSP-KVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                        Y  P+     D+ P  +D Y +  + + L + +              
Sbjct: 453 -------------YNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP------------ 487

Query: 498 GLVALFEEV-LNL--------------------PDPIEDLRKLVDPRLGDNCPLDSVLKM 536
             + LF  V L+                      + ++ L+    P + DN P    L  
Sbjct: 488 ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY-KPYICDNDPKYERLVN 546

Query: 537 AQLAKVCTQEYPQLRPSMRSIV-VALMTLSSTTEDWDVGSFYE 578
           A L  +   E   +      ++ +ALM         +  + +E
Sbjct: 547 AILDFLPKIEENLICSKYTDLLRIALMA--------EDEAIFE 581

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 51/254 (20%), Positives = 97/254 (38%), Gaps = 59/254 (23%)

Query: 280 IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIK------KMDMQASREFLAEL 332
           IG+G FG V                    +  + +  A+K      +   QA      E+
Sbjct: 105 IGKGSFGQVVK----------------AYDHKVHQHVALKMVRNEKRFHRQA----AEEI 144

Query: 333 KVLTHVHHL------NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
           ++L H+         N++ ++        + + +E +   NL E ++ +           
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVR 203

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA--KVADFGLTKLTEVGSASLP 443
           + A    + L+ +H++ +   IH D+K  NIL+ +   +  KV DF        GS+   
Sbjct: 204 KFAHSILQCLDALHKNRI---IHCDLKPENILLKQQGRSGIKVIDF--------GSSCYE 252

Query: 444 TRLVGT-----FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG 498
            + V T     F Y  PE          +D+++ G +L EL++    ++ G     D   
Sbjct: 253 HQRVYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGY-PLLPGE----DEGD 306

Query: 499 LVALFEEVLNLPDP 512
            +A   E+L +P  
Sbjct: 307 QLACMIELLGMPSQ 320

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 64/236 (27%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIK-----KMDMQASREFLAEL 332
           K+G G F  V                 +  +++     A+K     K+  +A+ +   E+
Sbjct: 26  KLGWGHFSTV----------------WLAKDMVNNTHVAMKIVRGDKVYTEAAED---EI 66

Query: 333 KVLTHVHHL-----------NLVRLIGY----CVEGS-LFLVYEYIENGNLSEHLRGSGR 376
           K+L  V+             ++++L+ +       G  + +V+E +   NL   ++    
Sbjct: 67  KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH 125

Query: 377 DPLPWSSRVQIALDSARGLEYIH-EHTVPVYIHRDIKSANILID------KNFHAKVADF 429
             +P     QI+     GL+Y+H    +   IH DIK  N+L++           K+AD 
Sbjct: 126 RGIPLIYVKQISKQLLLGLDYMHRRCGI---IHTDIKPENVLMEIVDSPENLIQIKIADL 182

Query: 430 GL-TKLTEVGSASLPTRLVGTFGYMPPE---YAQYGDVSPKVDVYAFGVVLYELIS 481
           G      E  + S+ TR      Y  PE    A +G      D+++   +++ELI+
Sbjct: 183 GNACWYDEHYTNSIQTRE-----YRSPEVLLGAPWG---CGADIWSTACLIFELIT 230

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.2 bits (112), Expect = 9e-06
 Identities = 49/297 (16%), Positives = 97/297 (32%), Gaps = 77/297 (25%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA 330
              + +  K+G G F  V+ +      G  +++  +         + +     A  E   
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLS--WDIQGKKFVAMKVVK-------SAEHYTETALDE--- 83

Query: 331 ELKVLTHVHHLN--------LVRLIGY-CVEGS----LFLVYEYIENG-NLSEHLRGSGR 376
            +++L  V + +        +V+L+    + G     + +V+E +  G +L + +  S  
Sbjct: 84  -IRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNY 140

Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI------------------ 418
             LP     +I     +GL+Y+H       IH DIK  NIL+                  
Sbjct: 141 QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198

Query: 419 -----------------------DKNFHAKVADFGLTKLTEVGSASL----PTRLVGTFG 451
                                        K A+    K+ ++G+A       T  + T  
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ 258

Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI-VKGNGSSADSKGLVALFEEVL 507
           Y   E       +   D+++   + +EL +                +  +AL  E+L
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELL 315

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 46/272 (16%), Positives = 98/272 (36%), Gaps = 75/272 (27%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA--AIK------KMDMQASREFLA 330
            +G+G FG V                + C++        A+K      +    A     +
Sbjct: 21  TLGEGAFGKV----------------VECIDHKAGGRHVAVKIVKNVDRYCEAA----RS 60

Query: 331 ELKVLTHVHHL------NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
           E++VL H++          V+++ +    G + +V+E +   +  + ++ +G  P     
Sbjct: 61  EIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFR-LD 118

Query: 384 RVQ-IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV----- 437
            ++ +A    + + ++H + +    H D+K  NIL  ++ + +  +  + +         
Sbjct: 119 HIRKMAYQICKSVNFLHSNKL---THTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Query: 438 ------GSASLPTRLVGT-----FGYMPPE------YAQYGDVSPKVDVYAFGVVLYELI 480
                 GSA+       T       Y  PE      +      S   DV++ G +L E  
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRH-YRAPEVILALGW------SQPCDVWSIGCILIEYY 228

Query: 481 SAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
                +   +    DSK  +A+ E +L     
Sbjct: 229 LG-FTVFPTH----DSKEHLAMMERILGPLPK 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 46/270 (17%), Positives = 88/270 (32%), Gaps = 71/270 (26%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK------KMDMQASREFLAEL 332
            +G+G FG V                         + A+K      K    A      E+
Sbjct: 26  NLGEGTFGKVVECLDHARGK--------------SQVALKIIRNVGKYREAA----RLEI 67

Query: 333 KVLTHVHHL------NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
            VL  +           V +  +    G + + +E +   N  E L+ +   P P    V
Sbjct: 68  NVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENNFQPYP-LPHV 125

Query: 386 Q-IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV------- 437
           + +A      L ++HE+ +    H D+K  NIL   +    + +   +   +        
Sbjct: 126 RHMAYQLCHALRFLHENQL---THTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIR 182

Query: 438 ----GSASLPTRLVGT-----FGYMPPE------YAQYGDVSPKVDVYAFGVVLYELISA 482
               GSA+       T       Y PPE      +      +   DV++ G +L+E    
Sbjct: 183 VADFGSATFDHEHHTTIVATRH-YRPPEVILELGW------AQPCDVWSIGCILFEYYRG 235

Query: 483 KEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
              + +      +++  + + E++L     
Sbjct: 236 -FTLFQT----HENREHLVMMEKILGPIPS 260

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 47/276 (17%), Positives = 96/276 (34%), Gaps = 79/276 (28%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKA-AIK------KMDMQASREFLAE 331
           K+G G FG V                L+C ++  +K  A+K      K    A      E
Sbjct: 42  KMGDGTFGRV----------------LLCQHIDNKKYYAVKVVRNIKKYTRSA----KIE 81

Query: 332 LKVLTHV-----HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             +L  +     ++ N+V+  G  +    + L++E +   +L E +  +  +       +
Sbjct: 82  ADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFH-IEDI 139

Query: 386 Q-IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV------- 437
           +   ++  + L Y+ + ++    H D+K  NIL+D  +  K                   
Sbjct: 140 KLYCIEILKALNYLRKMSL---THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

Query: 438 ----------GSASLPTRLVGT-----FGYMPPE------YAQYGDVSPKVDVYAFGVVL 476
                     G A+  +   G+       Y  PE      +          D+++FG VL
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQ-YRAPEVILNLGW------DVSSDMWSFGCVL 249

Query: 477 YELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP 512
            EL +    + + +    +    +A+ E ++     
Sbjct: 250 AELYTG-SLLFRTH----EHMEHLAMMESIIQPIPK 280

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	589
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.71
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.52
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.47
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	99.21
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	99.16
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	99.13
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	99.08
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.08
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.99
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.89
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.8
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.8
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.7
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.44
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.1
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.98
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	97.96
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	97.96
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.91
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.74
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.62
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.24
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.2
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.17
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.9
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.82
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.49
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	96.35
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.2
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.03
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.03
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	95.95
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.88
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.64
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.42
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.49
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.67
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.38
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.74
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	81.72
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	80.58

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.1e-53  Score=426.08  Aligned_cols=263  Identities=27%  Similarity=0.488  Sum_probs=202.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||+||+|+++++         ++++...    ......+..++|.+|+++|++++|||||+++++
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~~---------vAvK~~~----~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHGD---------VAVKILK----VVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSSE---------EEEEECC----CSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECCc---------EEEEEEE----ecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            346788999999999999999986543         1111110    111234556789999999999999999999999


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +.++.+|||||||++|+|.+++.... .++++.+++.|+.|||.||+|||++++   |||||||+|||+++++.+||+||
T Consensus       101 ~~~~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~I---iHRDlKp~NILl~~~~~~Ki~DF  176 (307)
T 3omv_A          101 MTKDNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNI---IHRDMKSNNIFLHEGLTVKIGDF  176 (307)
T ss_dssp             ECSSSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTC---BCSCCCSSSEEEETTEEEEECCC
T ss_pred             EECCeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCc---cCCccCHHHEEECCCCcEEEeec
Confidence            98888999999999999999997654 349999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCC-CCCCcccccCCCCCchhcccC---CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          430 GLTKLTEVGS-ASLPTRLVGTFGYMPPEYAQY---GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       430 gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|+...... .......+||+.|||||++.+   +.|+.++|||||||++|||+||+.||.....    .......   
T Consensus       177 Gla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~----~~~~~~~---  249 (307)
T 3omv_A          177 GLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN----RDQIIFM---  249 (307)
T ss_dssp             SSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHH---
T ss_pred             cCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh----HHHHHHH---
Confidence            9998654322 223345689999999999853   4689999999999999999999999954321    1111111   


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      +..         ....|.+ ...+.+++..+.+|+.+||+.||++|||+.||+++|+.|+.
T Consensus       250 ~~~---------~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          250 VGR---------GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             HHT---------TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             Hhc---------CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            111         1111211 12344556679999999999999999999999999998864

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-52  Score=427.76  Aligned_cols=261  Identities=26%  Similarity=0.481  Sum_probs=199.0

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh---cCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK---MDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~---~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ++|.+.++||+|+||+||+|++++..... ..+         .+|+|.   ......++|.+|+++|++++|||||++++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~-~~~---------~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g  110 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQ-DKM---------LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFG  110 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC----CE---------EEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCC-CCe---------EEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            56788999999999999999876421100 011         223332   23455678999999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCC
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSG-------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA  414 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~  414 (589)
                      ++.+ +.+|||||||++|+|.+++....             ..++++.+++.|+.||+.||+|||++++   |||||||+
T Consensus       111 ~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i---iHRDLKp~  187 (329)
T 4aoj_A          111 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATR  187 (329)
T ss_dssp             EECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGG
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCe---ecccccHh
Confidence            9975 46999999999999999997643             2459999999999999999999999998   99999999


Q ss_pred             cEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCC
Q 037010          415 NILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGS  492 (589)
Q Consensus       415 NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~  492 (589)
                      |||+++++.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... 
T Consensus       188 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-  266 (329)
T 4aoj_A          188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-  266 (329)
T ss_dssp             GEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-
T ss_pred             hEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-
Confidence            99999999999999999986543322 22344679999999999999999999999999999999999 8999854321 


Q ss_pred             CCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                          .   ..+..+.          ....+.    .|..++..+.+|+.+||+.||++|||++||+++|+.+...
T Consensus       267 ----~---~~~~~i~----------~g~~~~----~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          267 ----T---EAIDCIT----------QGRELE----RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ----H---HHHHHHH----------HTCCCC----CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----H---HHHHHHH----------cCCCCC----CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                1   1111111          111122    2334455789999999999999999999999999988754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.8e-52  Score=421.81  Aligned_cols=261  Identities=27%  Similarity=0.480  Sum_probs=203.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc---CHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~---~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      .++|.+.++||+|+||+||+|++.+..... ..+         .+|+|.+   ..+..++|.+|+++|++++|||||+++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~-~~~---------~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~   81 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQ-DKI---------LVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFY   81 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC-----CE---------EEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCC-CCE---------EEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEE
Confidence            357889999999999999999876421110 011         2233322   345567899999999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSG-----------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      +++.+ +.+|||||||++|+|.++|...+           ...+++.+++.++.||+.||+|||++++   +||||||+|
T Consensus        82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i---iHRDlKp~N  158 (299)
T 4asz_A           82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRN  158 (299)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGG
T ss_pred             EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCccCHhh
Confidence            99875 46999999999999999997642           3469999999999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSS  493 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~  493 (589)
                      ||+++++.+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||++|||+| |+.||.....  
T Consensus       159 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--  236 (299)
T 4asz_A          159 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--  236 (299)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--
T ss_pred             EEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence            99999999999999999865433222 2233579999999999999999999999999999999999 8999854321  


Q ss_pred             CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                         .   .....+..          ...+    ..|..++..+.+|+.+||+.||++|||++||++.|+.+..
T Consensus       237 ---~---~~~~~i~~----------~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          237 ---N---EVIECITQ----------GRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             ---H---HHHHHHHH----------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---H---HHHHHHHc----------CCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence               1   11211111          1111    2234455679999999999999999999999999988764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.6e-52  Score=428.55  Aligned_cols=254  Identities=26%  Similarity=0.438  Sum_probs=198.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|+++++||+|+||+||+|++..++ ..++.|.+..         ........+.+.+|+++|++++|||||++++++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~-~~vAiK~i~~---------~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~   92 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDG-RQYVIKEINI---------SRMSSKEREESRREVAVLANMKHPNIVQYRESF   92 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTC-CEEEEEEEEC---------TTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCC-CEEEEEEEeh---------HHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE
Confidence            378999999999999999999987653 2222222211         122344567789999999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.+|||||||+||+|.++|.......+++.+++.++.||+.||+|||+++|   +||||||+|||++.++.+||+||
T Consensus        93 ~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~I---iHRDlKp~NILl~~~g~vKl~DF  169 (350)
T 4b9d_A           93 EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI---LHRDIKSQNIFLTKDGTVQLGDF  169 (350)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTC---EETTCCGGGEEECTTCCEEECST
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCCHHHEEECCCCCEEEccc
Confidence            65 569999999999999999987766668999999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+|+...... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||....        ....+..+...
T Consensus       170 Gla~~~~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~  240 (350)
T 4b9d_A          170 GIARVLNSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISG  240 (350)
T ss_dssp             TEESCCCHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHT
T ss_pred             ccceeecCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcC
Confidence            9998653221 12234689999999999999999999999999999999999999995432        12222222221


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .          .+    ..+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       241 ~----------~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          241 S----------FP----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             C----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             C----------CC----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1          01    1233344578999999999999999999999987

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4e-52  Score=421.17  Aligned_cols=259  Identities=26%  Similarity=0.438  Sum_probs=201.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      +++++.++||+|+||+||+|.+.+..... ..+         .+|+|.++    ....++|.+|+.+|++++|||||+++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~-~~~---------~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~   95 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGE-QTQ---------AVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLL   95 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC--------CE---------EEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCC-CCe---------EEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            45678899999999999999975421100 011         23333332    22346799999999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      |++.+ +.+|||||||++|+|.++|....              ...+++.+++.|+.|||.||+|||++++   ||||||
T Consensus        96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~i---iHRDLK  172 (308)
T 4gt4_A           96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV---VHKDLA  172 (308)
T ss_dssp             EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCS
T ss_pred             eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCC---CCCCcc
Confidence            99875 56899999999999999996542              2358999999999999999999999998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCC-CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGS-ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGN  490 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~  490 (589)
                      |+|||+++++.+||+|||+++...... ....+...||+.|||||++.++.|+.++|||||||++|||+| |+.||....
T Consensus       173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            999999999999999999998654332 223345689999999999999999999999999999999999 888984322


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      .        ......+..              ......|.+++..+.+|+.+||+.||++|||++||+++|+...
T Consensus       253 ~--------~~~~~~i~~--------------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          253 N--------QDVVEMIRN--------------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             H--------HHHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             H--------HHHHHHHHc--------------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            1        111222111              1111234455667999999999999999999999999998653

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.4e-51  Score=407.36  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=192.8

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  352 (589)
                      |++.++||+|+||+||+|.+..++... +.|.+.         .+.......+.+.+|+++|++++|||||++++++.+ 
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~v-AiK~i~---------~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   97 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEV-AWCELQ---------DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEE-EEEEEE---------GGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEE-EEEEEc---------hhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence            367788999999999999987653222 222111         112334455678999999999999999999998753 


Q ss_pred             ----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeeccCCCcEEEcC-CCcEE
Q 037010          353 ----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT--VPVYIHRDIKSANILIDK-NFHAK  425 (589)
Q Consensus       353 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~--i~~~vH~Dlkp~NILl~~-~~~vk  425 (589)
                          +.+|||||||+||+|.+++....  ++++..++.++.||+.||+|||+++  |   +||||||+|||++. ++.+|
T Consensus        98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~I---iHRDlKp~NILl~~~~g~vK  172 (290)
T 3fpq_A           98 VKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPI---IHRDLKCDNIFITGPTGSVK  172 (290)
T ss_dssp             ETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCC---CCCCCCGGGEEESSTTSCEE
T ss_pred             cCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCE---EecccChhheeEECCCCCEE
Confidence                34899999999999999998754  4999999999999999999999998  7   99999999999974 79999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||+|+....   ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.....       .......
T Consensus       173 l~DFGla~~~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~  241 (290)
T 3fpq_A          173 IGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRR  241 (290)
T ss_dssp             ECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHH
T ss_pred             EEeCcCCEeCCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHH
Confidence            999999985432   23345789999999999864 699999999999999999999999953321       1122222


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +.....+             ...+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       242 i~~~~~~-------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          242 VTSGVKP-------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HTTTCCC-------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHcCCCC-------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2221111             01111223468999999999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-51  Score=412.90  Aligned_cols=252  Identities=23%  Similarity=0.384  Sum_probs=200.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++++.||+|+||+||+|++..++ ..++.|.+..     ....+.   ...+.+.+|+++|++++|||||++++++.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~-~~~AiK~i~k-----~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~  102 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATS-REYAIKILEK-----RHIIKE---NKVPYVTRERDVMSRLDHPFFVKLYFTFQ  102 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEH-----HHHHHT---TCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCC-CEEEEEEEEH-----HHCCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            57999999999999999999987653 2333332221     111111   12356889999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|||||||+||+|.+++...+  .+++.+++.++.||+.||+|||+++|   +||||||+|||++.++.+||+|||
T Consensus       103 ~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~I---iHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          103 DDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCCHHHeEEcCCCCEEEEEcC
Confidence            5 56999999999999999998765  39999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCC-CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGS-ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      +|+...... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+        ....+..+...
T Consensus       178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~  249 (311)
T 4aw0_A          178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKL  249 (311)
T ss_dssp             TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT
T ss_pred             CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcC
Confidence            998764332 233455789999999999999999999999999999999999999995422        12222222221


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                 +..    .|...+..+.+|+.+||+.||++|||++|++.+
T Consensus       250 -----------~~~----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          250 -----------EYD----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             -----------CCC----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             -----------CCC----CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence                       111    223334568999999999999999999987544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-51  Score=419.33  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=199.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      +.|++.++||+|+||+||+|.+..++ ..++.|.+...         .  ....+.+.+|+++|++++|||||++++++.
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg-~~vAiK~i~~~---------~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  141 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSG-KLVAVKKMDLR---------K--QQRRELLFNEVVIMRDYQHENVVEMYNSYL  141 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEGG---------G--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCC-CEEEEEEEecC---------c--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            56999999999999999999987663 23333322111         0  111235778999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|||||||+||+|.+++...   .+++.+++.++.||+.||+|||+++|   +||||||+|||++.+|.+||+|||
T Consensus       142 ~~~~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~I---iHRDlKp~NILl~~~g~vKl~DFG  215 (346)
T 4fih_A          142 VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFG  215 (346)
T ss_dssp             ETTEEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCCHHHEEECCCCCEEEecCc
Confidence            4 5699999999999999999764   39999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....        ...+..+..  
T Consensus       216 la~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~--  284 (346)
T 4fih_A          216 FCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRD--  284 (346)
T ss_dssp             TCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH--
T ss_pred             CceecCCCC-CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHc--
Confidence            998764332 233457899999999999999999999999999999999999999954221        112222211  


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                              ...+.+  ..+...+..+.+|+.+||+.||++|||++|+++|=
T Consensus       285 --------~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp  325 (346)
T 4fih_A          285 --------NLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  325 (346)
T ss_dssp             --------SSCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             --------CCCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence                    111111  12234456789999999999999999999999983

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.4e-51  Score=421.62  Aligned_cols=274  Identities=26%  Similarity=0.415  Sum_probs=211.0

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCC-Ccc
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH-LNL  343 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~h-pnI  343 (589)
                      .+.....++|++.++||+|+||+||+|.+.+... ....+.++++...     +.......+++.+|+++|.++.| |||
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~-~~~~k~VAvK~l~-----~~~~~~~~~~~~~E~~il~~l~hhpnI  130 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLK-----EGATHSEHRALMSELKILIHIGHHLNV  130 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSS-TTCEEEEEEEEEC-----TTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCc-ccCCeEEEEEEEc-----cccChHHHHHHHHHHHHHHHcCCCCcE
Confidence            3334456889999999999999999999876432 2222333332221     11223445679999999999965 999


Q ss_pred             eeEeeEEEe--CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 037010          344 VRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYI  407 (589)
Q Consensus       344 v~l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~v  407 (589)
                      |+++++|.+  +.+|||||||++|+|.++|+...              ...+++.+++.++.|||.||+|||++++   |
T Consensus       131 V~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~i---i  207 (353)
T 4ase_A          131 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---I  207 (353)
T ss_dssp             CCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTC---C
T ss_pred             EEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCe---e
Confidence            999999864  35899999999999999997532              2358999999999999999999999999   9


Q ss_pred             eeccCCCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcc
Q 037010          408 HRDIKSANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEA  485 (589)
Q Consensus       408 H~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p  485 (589)
                      ||||||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.|
T Consensus       208 HRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P  287 (353)
T 4ase_A          208 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  287 (353)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence            999999999999999999999999986543322 22344679999999999999999999999999999999998 8999


Q ss_pred             cccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      |......    ..+....             .....+.    .|..++..+.+++.+||+.||++|||++||++||..+.
T Consensus       288 f~~~~~~----~~~~~~i-------------~~g~~~~----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          288 YPGVKID----EEFCRRL-------------KEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             STTCCCS----HHHHHHH-------------HHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCHH----HHHHHHH-------------HcCCCCC----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            9543211    1111111             1111222    23344457899999999999999999999999999886


Q ss_pred             ccc
Q 037010          566 STT  568 (589)
Q Consensus       566 ~~~  568 (589)
                      ...
T Consensus       347 q~~  349 (353)
T 4ase_A          347 QAN  349 (353)
T ss_dssp             HHT
T ss_pred             HHh
Confidence            543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-51  Score=418.92  Aligned_cols=254  Identities=20%  Similarity=0.248  Sum_probs=197.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .+.|++.++||+|+||.||+|++..++. .++.|              .++.+  ....+|+++|++++|||||++++++
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~-~vAiK--------------~i~~~--~~~~~E~~il~~l~HpnIV~l~~~~  119 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGF-QCAVK--------------KVRLE--VFRVEELVACAGLSSPRIVPLYGAV  119 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCC-EEEEE--------------EEETT--TCCTHHHHTTTTCCCTTBCCEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCC-EEEEE--------------EECHH--HhHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4578899999999999999999876532 22222              22111  0123599999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-cEEEEe
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-HAKVAD  428 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-~vkl~D  428 (589)
                      .+ +.+|||||||+||+|.+++...+  ++++.+++.++.||+.||+|||+++|   |||||||+|||++.+| ++||+|
T Consensus       120 ~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~I---iHRDlKp~NILl~~~g~~vKl~D  194 (336)
T 4g3f_A          120 REGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRI---LHGDVKADNVLLSSDGSRAALCD  194 (336)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTE---ECSCCCGGGEEECTTSCCEEECC
T ss_pred             EECCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecccCHHHEEEeCCCCEEEEee
Confidence            75 46899999999999999998764  49999999999999999999999998   9999999999999987 699999


Q ss_pred             ccCccccccCCCC----CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          429 FGLTKLTEVGSAS----LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       429 fgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||+|+........    .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.......    .    ..
T Consensus       195 FGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~----~~  266 (336)
T 4g3f_A          195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP----L----CL  266 (336)
T ss_dssp             CTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC----C----HH
T ss_pred             CCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----H----HH
Confidence            9999876433221    1223579999999999999999999999999999999999999996543221    1    11


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      .+...+.+.            ...+++.+..+.+|+.+||+.||.+|||+.|++++|.....
T Consensus       267 ~i~~~~~~~------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          267 KIASEPPPI------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             HHHHSCCGG------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCc------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            111111110            11233445678999999999999999999999999866553

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.9e-50  Score=399.63  Aligned_cols=250  Identities=23%  Similarity=0.350  Sum_probs=184.2

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||+||+|.+..++ ..++.|.+...     ..   ........+.+|+++|++++|||||++++++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~-~~vAiK~i~~~-----~~---~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   83 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTG-QKVALKIINKK-----VL---AKSDMQGRIEREISYLRLLRHPHIIKLYDVIK   83 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTC-CEEEEEEEECC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCC-CEEEEEEEeHH-----Hc---CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            68999999999999999999876653 23333222111     00   01122456889999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||+ +|+|.+++...+  ++++.+++.++.||+.||+|||++++   +||||||+|||+++++++||+|||
T Consensus        84 ~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~I---iHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           84 SKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKI---VHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             CSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCTTTEEECTTCCEEECCSS
T ss_pred             ECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCChHHeEECCCCCEEEeecC
Confidence            4 5699999999 679999998765  49999999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      +|+.....  ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||....        ....+..+...
T Consensus       158 la~~~~~~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--------~~~~~~~i~~~  227 (275)
T 3hyh_A          158 LSNIMTDG--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--------IPVLFKNISNG  227 (275)
T ss_dssp             CC-----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHT
T ss_pred             CCeecCCC--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcC
Confidence            99865432  22345789999999999988876 579999999999999999999994321        12222222211


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .           ..    .|...+..+.+|+.+||+.||++|||++|+++|=
T Consensus       228 ~-----------~~----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp  264 (275)
T 3hyh_A          228 V-----------YT----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDD  264 (275)
T ss_dssp             C-----------CC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCH
T ss_pred             C-----------CC----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCc
Confidence            1           11    2233445789999999999999999999999973

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.2e-50  Score=422.00  Aligned_cols=251  Identities=21%  Similarity=0.330  Sum_probs=199.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      +.|++.++||+|+||.||+|.+..++. .++.|.+...           .....+.+.+|+++|++++|||||++++++.
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~-~vAiK~i~~~-----------~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~  218 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGK-LVAVKKMDLR-----------KQQRRELLFNEVVIMRDYQHENVVEMYNSYL  218 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCC-EEEEEEEEST-----------TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCC-EEEEEEEecc-----------chhHHHHHHHHHHHHHhCCCCCCCceEEEEE
Confidence            579999999999999999999876632 2222222111           1112245778999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|||||||+||+|.+++...   .+++.+++.++.||+.||+|||+++|   |||||||+|||++.+|.+||+|||
T Consensus       219 ~~~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~I---iHRDiKp~NILl~~~g~vKl~DFG  292 (423)
T 4fie_A          219 VGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGV---IHRDIKSDSILLTHDGRVKLSDFG  292 (423)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSTTTEEECTTCCEEECCCT
T ss_pred             ECCEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecccCCHHHEEEcCCCCEEEecCc
Confidence            4 5699999999999999999754   39999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....        ...+..+..  
T Consensus       293 la~~~~~~~-~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~--  361 (423)
T 4fie_A          293 FCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMIRD--  361 (423)
T ss_dssp             TCEECCSSC-CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH--
T ss_pred             cceECCCCC-ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHc--
Confidence            998654332 233557899999999999999999999999999999999999999954221        112222211  


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                              ...+.+  ..+...+..+.+|+.+||+.||++|||++|+++|=
T Consensus       362 --------~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp  402 (423)
T 4fie_A          362 --------NLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHP  402 (423)
T ss_dssp             --------SCCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             --------CCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence                    111111  11223445789999999999999999999999983

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.7e-50  Score=404.21  Aligned_cols=269  Identities=26%  Similarity=0.417  Sum_probs=195.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHH--HHHHHHccCCCCcceeEeeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL--AELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~--~E~~il~~l~hpnIv~l~~~  349 (589)
                      ++|.+.++||+|+||+||+|++++.                 .+|+|.++....+.+.  .|+..+.+++|||||+++++
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~-----------------~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~   65 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGE-----------------EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA   65 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTE-----------------EEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCE-----------------EEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEE
Confidence            4688899999999999999988643                 3344444433333333  45556678899999999998


Q ss_pred             EEeC-----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeeccCCCcEEEc
Q 037010          350 CVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT-----VPVYIHRDIKSANILID  419 (589)
Q Consensus       350 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~-----i~~~vH~Dlkp~NILl~  419 (589)
                      +.++     .+|||||||++|+|.+++...   ++++..+.+++.|++.||+|||++.     -+.|+||||||+|||++
T Consensus        66 ~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~  142 (303)
T 3hmm_A           66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  142 (303)
T ss_dssp             EEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             EEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC
Confidence            8743     479999999999999999864   3899999999999999999999871     12349999999999999


Q ss_pred             CCCcEEEEeccCccccccCCCC---CCcccccCCCCCchhcccCC------CCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          420 KNFHAKVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYG------DVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       420 ~~~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      .++.+||+|||+++........   .....+||+.|||||++.+.      .++.++|||||||++|||+||+.|+....
T Consensus       143 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~  222 (303)
T 3hmm_A          143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             CCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccc
Confidence            9999999999999876543322   22346799999999998654      46789999999999999999998875433


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhH-----hhcCCCCCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLR-----KLVDPRLGDNC-PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~-----~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ........       ........+.+.     ..++|.++... +.+.+..+.+|+.+||+.||++|||+.||++.|+++
T Consensus       223 ~~~~p~~~-------~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          223 DYQLPYYD-------LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCCCTTTT-------TSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccchh-------cccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            21110000       000001111111     12223332221 235667899999999999999999999999999988


Q ss_pred             ccc
Q 037010          565 SST  567 (589)
Q Consensus       565 ~~~  567 (589)
                      ...
T Consensus       296 ~~~  298 (303)
T 3hmm_A          296 SQQ  298 (303)
T ss_dssp             HHC
T ss_pred             HHH
Confidence            643

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-50  Score=405.58  Aligned_cols=252  Identities=22%  Similarity=0.333  Sum_probs=191.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccc--cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGE--YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++++.||+|+||+||+|++..+  .+..++.|.+.....         ......++.+|+++|++++|||||++++
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---------~~~~~~~~~~E~~il~~l~HpnIv~l~~   93 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL---------KVRDRVRTKMERDILVEVNHPFIVKLHY   93 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE---------EEEECC------CCCCCCCCTTEECEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc---------ChHHHHHHHHHHHHHHHCCCCCCCeEEE
Confidence            36799999999999999999987532  222333332211100         0011224677999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +.+|+|||||+||+|.+++...+  ++++.+++.++.||+.||+|||++++   +||||||+|||++.++.+||+
T Consensus        94 ~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~I---iHRDlKp~NILl~~~g~vKl~  168 (304)
T 3ubd_A           94 AFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGI---IYRDLKPENILLDEEGHIKLT  168 (304)
T ss_dssp             EEEETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCCGGGEEECTTSCEEEE
T ss_pred             EEEECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---cCCCCCHHHeEEcCCCCEEec
Confidence            8764 56999999999999999998765  49999999999999999999999999   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||....        ....+..+.
T Consensus       169 DFGla~~~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~  239 (304)
T 3ubd_A          169 DFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMIL  239 (304)
T ss_dssp             SSEEEEC------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred             ccccceeccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHH
Confidence            999998643322 23345789999999999999999999999999999999999999995422        112222222


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                      ..           ..    ..|...+..+.+|+.+||+.||++|||     ++|+++|
T Consensus       240 ~~-----------~~----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          240 KA-----------KL----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HC-----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             cC-----------CC----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            11           11    123334457899999999999999998     5788877

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-48  Score=392.33  Aligned_cols=251  Identities=26%  Similarity=0.381  Sum_probs=181.8

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||+||+|+++.++. .++.|.+..          .......+.+.+|+++|++++|||||++++++.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~-~vAiK~i~~----------~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   73 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDC-NYAIKRIRL----------PNRELAREKVMREVKALAKLEHPGIVRYFNAWL   73 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCC-EEEEEEEEE----------CSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCC-EEEEEEEec----------cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            469999999999999999999876532 222221110          112334567889999999999999999999775


Q ss_pred             eC-------------cEEEEEEecCCCChHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          352 EG-------------SLFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       352 ~~-------------~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      +.             .+|+|||||++|+|.+++..... ...++..++.++.||+.||+|||++++   +||||||+|||
T Consensus        74 ~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~I---iHRDlKp~NIL  150 (299)
T 4g31_A           74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGL---MHRDLKPSNIF  150 (299)
T ss_dssp             EEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEE
T ss_pred             ecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcC---ccccCcHHHeE
Confidence            32             26899999999999999987643 234566788999999999999999999   99999999999


Q ss_pred             EcCCCcEEEEeccCccccccCCCC-----------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCccc
Q 037010          418 IDKNFHAKVADFGLTKLTEVGSAS-----------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI  486 (589)
Q Consensus       418 l~~~~~vkl~Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~  486 (589)
                      ++.++.+||+|||+|+........           ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||
T Consensus       151 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf  227 (299)
T 4g31_A          151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF  227 (299)
T ss_dssp             ECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             ECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CC
Confidence            999999999999999865432211           1234579999999999999999999999999999999996   66


Q ss_pred             ccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       487 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...       ......+..+.....+              ....+....+.+|+.+||+.||++|||+.|+++|
T Consensus       228 ~~~-------~~~~~~~~~~~~~~~p--------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          228 STQ-------MERVRTLTDVRNLKFP--------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             SSH-------HHHHHHHHHHHTTCCC--------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCc-------cHHHHHHHHHhcCCCC--------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            211       1111112222111100              0011223356789999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=392.13  Aligned_cols=270  Identities=23%  Similarity=0.320  Sum_probs=197.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++++.||+|+||+||+|.+..++. .++.|.+.     .    ........+.+.+|+++|++++|||||++++++
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~-~vAiK~i~-----~----~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  122 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQ-QVAIKKIP-----N----AFDVVTNAKRTLRELKILKHFKHDNIIAIKDIL  122 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCC-EEEEEEET-----T----TTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCC-EEEEEEEC-----c----cccchHHHHHHHHHHHHHHhcCCCCcceEeeee
Confidence            4789999999999999999999876532 22222111     0    111233456788999999999999999999976


Q ss_pred             Ee-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          351 VE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       351 ~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      ..       +.+|||||||. |+|.+++....  ++++.+++.++.||+.||+|||++|+   |||||||+|||++.++.
T Consensus       123 ~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~i---iHRDlKP~NIl~~~~~~  196 (398)
T 4b99_A          123 RPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQV---IHRDLKPSNLLVNENCE  196 (398)
T ss_dssp             CCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTCC
T ss_pred             ecccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcC---cCCCcCccccccCCCCC
Confidence            42       46899999996 58999997654  49999999999999999999999999   99999999999999999


Q ss_pred             EEEEeccCccccccCC---CCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          424 AKVADFGLTKLTEVGS---ASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      +||+|||+|+......   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...+.     ...
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-----~~~  271 (398)
T 4b99_A          197 LKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-----VHQ  271 (398)
T ss_dssp             EEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-----HHH
T ss_pred             EEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH-----HHH
Confidence            9999999998653321   2233457899999999998764 569999999999999999999999954321     122


Q ss_pred             HHHHHHHhcCCChHH----------hhHhhcCCCCCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIE----------DLRKLVDPRLGDN---CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~----------~l~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..........+....          .....+.+.....   ..+.....+.+|+.+||+.||.+|||++|+++|=
T Consensus       272 l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  346 (398)
T 4b99_A          272 LQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP  346 (398)
T ss_dssp             HHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred             HHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence            222222222221110          0000011100000   0012245688999999999999999999999983

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.1e-46  Score=386.93  Aligned_cols=207  Identities=25%  Similarity=0.409  Sum_probs=164.6

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccC-CCC
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHV-HHL  341 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l-~hp  341 (589)
                      ++.+....++|++.++||+|+||+||+|+++...+.   .+         .+|+|.+.. ....++.+|+++|+.+ +||
T Consensus        13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~---~~---------~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~   80 (361)
T 4f9c_A           13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGP---EE---------KIALKHLIPTSHPIRIAAELQCLTVAGGQD   80 (361)
T ss_dssp             HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSC---EE---------EEEEEEECTTSCHHHHHHHHHHHHHTCSBT
T ss_pred             HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCC---CC---------EEEEEEEccccCHHHHHHHHHHHHHhcCCC
Confidence            445556678999999999999999999987532111   11         222332211 1234577899999988 699


Q ss_pred             cceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          342 NLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       342 nIv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ||+++++++.+ +++|+||||+++|+|.+++.     .+++.+++.++.||+.||+|||++|+   +||||||+|||++.
T Consensus        81 nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gI---iHRDiKPeNiLl~~  152 (361)
T 4f9c_A           81 NVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGI---VHRDVKPSNFLYNR  152 (361)
T ss_dssp             TBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEET
T ss_pred             CCceEEEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCcCCHHHeEEeC
Confidence            99999997764 56999999999999999984     38999999999999999999999998   99999999999987


Q ss_pred             C-CcEEEEeccCccccccCCC---------------------------CCCcccccCCCCCchhcccCC-CCCcccchhh
Q 037010          421 N-FHAKVADFGLTKLTEVGSA---------------------------SLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYA  471 (589)
Q Consensus       421 ~-~~vkl~Dfgla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwS  471 (589)
                      + +.+||+|||+|+.......                           ...+..+||+.|||||++.+. .|+.++||||
T Consensus       153 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWS  232 (361)
T 4f9c_A          153 RLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS  232 (361)
T ss_dssp             TTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHH
T ss_pred             CCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhh
Confidence            6 7999999999975432211                           112335799999999998765 5899999999


Q ss_pred             HHHHHHHHHcCCcccccCC
Q 037010          472 FGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       472 lGvll~elltG~~p~~~~~  490 (589)
                      +||++|||+||+.||..+.
T Consensus       233 lG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          233 AGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             HHHHHHHHHHTCSSSSCCS
T ss_pred             hHHHHHHHHHCCCCCCCCC
Confidence            9999999999999996554

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-45  Score=402.15  Aligned_cols=256  Identities=23%  Similarity=0.307  Sum_probs=199.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++++.||+|+||.||+|++..+ +..++.|.+.     +.............+...++++++.++|||||++++++
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~t-g~~~AiK~i~-----K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f  261 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADT-GKMYAMKCLD-----KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF  261 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT-CCEEEEEEEE-----HHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCC-CCEEEEEEEe-----HHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE
Confidence            36899999999999999999998765 3333333332     22222222333333445568888999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.+|||||||+||+|.++|...+  .+++..++.++.||+.||+|||++||   |||||||+|||++.+|++||+||
T Consensus       262 ~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gI---iHRDLKPeNILld~~G~vKL~DF  336 (689)
T 3v5w_A          262 HTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDL  336 (689)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCSGGGEEECTTSCEEECCC
T ss_pred             EECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCchHHeEEeCCCCEEeccc
Confidence            64 56999999999999999998765  39999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |+|+.....   .....+||+.|||||++.. ..|+.++|||||||++|||++|+.||.......     ..........
T Consensus       337 GlA~~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~  408 (689)
T 3v5w_A          337 GLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLT  408 (689)
T ss_dssp             TTCEECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHH
T ss_pred             ceeeecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcC
Confidence            999865432   2345789999999999964 579999999999999999999999995433211     1112222211


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                      .           ..    ..|...+..+.+|+.+||+.||.+|++     ++||++|
T Consensus       409 ~-----------~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          409 M-----------AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             C-----------CC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             C-----------CC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            1           11    223344557899999999999999998     7999888

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.4e-45  Score=399.93  Aligned_cols=253  Identities=20%  Similarity=0.307  Sum_probs=199.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.++.++. .++.|.+.           .......+.+.+|+++|++++|||||++++++
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~-~~AiK~i~-----------~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~  223 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGN-NFAAKFVM-----------TPHESDKETVRKEIQTMSVLRHPTLVNLHDAF  223 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEE-----------CCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCC-EEEEEEEe-----------ccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4689999999999999999999876633 22222211           11233445688899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC--CcEEEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN--FHAKVA  427 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~--~~vkl~  427 (589)
                      .+ +.+|||||||+||+|.++|.... ..+++.+++.++.||+.||+|||++++   +||||||+|||++.+  +.+||+
T Consensus       224 ~~~~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~i---iHRDlKp~Nill~~~~~~~vKl~  299 (573)
T 3uto_A          224 EDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLI  299 (573)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSSSCCCEEEC
T ss_pred             EECCEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eeccCChhhccccCCCCCCEEEe
Confidence            75 56999999999999999997543 349999999999999999999999998   999999999999754  899999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++.....  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....        ...+..+.
T Consensus       300 DFG~a~~~~~~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~  369 (573)
T 3uto_A          300 DFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVK  369 (573)
T ss_dssp             CCSSCEECCTT--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHH
T ss_pred             eccceeEccCC--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHH
Confidence            99999876432  223446899999999999999999999999999999999999999954321        12222222


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...           ..+........+..+.+|+.+||+.||.+|||++|+++|
T Consensus       370 ~~~-----------~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          370 SCD-----------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             TTC-----------CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hCC-----------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            211           111111122344578999999999999999999999998

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=100.00  E-value=1.4e-43  Score=334.47  Aligned_cols=201  Identities=53%  Similarity=0.969  Sum_probs=177.2

Q ss_pred             CccchHHHhhheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeeecccCCCcccceeee
Q 037010           25 CTKGCDTALASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCINGEFLGHTFQ  104 (589)
Q Consensus        25 ~~~~~~~~~~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~~~~~~~~~~~~~~~  104 (589)
                      |+++|+.+|++|+|++|||||.||++||+++.+-.+++.++|+++||++++++.|.+||.|.||.+|.|..+.+......
T Consensus         1 ~~~~C~~a~~~Y~V~~GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~   80 (212)
T 4eby_A            1 CRTSCPLALASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGDFLGHNFS   80 (212)
T ss_dssp             CCCCCSCEEEEEECCTTCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTTEEEEEEE
T ss_pred             CCCCCccceEEEEeCCCCCHHHHHHHHCCCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCccccCceE
Confidence            88999999999999999999999999999932111222399999999997788999999999999999987666656789


Q ss_pred             EEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEeeecCCCcccCCceeEEEEEeCCCCCCHhHhHhh
Q 037010          105 FSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARN  184 (589)
Q Consensus       105 y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~  184 (589)
                      |+||+|||||.||+++|+||+++++|+++|++.++.|++||+|.||..|+|+..+.+.+....++|+|++|||||+||++
T Consensus        81 Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~~~~Y~V~~GDTL~~IA~~  160 (212)
T 4eby_A           81 YSVRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSLSSIARS  160 (212)
T ss_dssp             EECCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEECCCCCTTTCSSCCCEEEEECCTTCCHHHHHHH
T ss_pred             EEecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCCcCCCcccccCCCCeEEEEECCCCcHHHHHHH
Confidence            99999999999997789899999999999998888999999999999999988766666677789999999999999999


Q ss_pred             cCCCHHHHhhcCCCCCcccCcceEEecCCCCCCCCCccccC
Q 037010          185 VGLSESLLQNYNPGVNFTRGSGLVFIPGRDANGVFPALESS  225 (589)
Q Consensus       185 ~~~~~~~l~~~N~~~~~~~~g~~~~iP~~~~~~~~p~~~~s  225 (589)
                      ||+++++|++||+..++..+++.++||+.+.++.+++.+++
T Consensus       161 fgvsv~~L~~~N~~~~~~~~~g~l~IP~~~~~~~~~~~~~~  201 (212)
T 4eby_A          161 SGVSADILQRYNPGVNFNSGNGIVYVPGRDPNGAFPPFKSS  201 (212)
T ss_dssp             HTSCHHHHHHHSTTCCTTSCSSEEEEECCCTTSCCCCCCC-
T ss_pred             HCcCHHHHHHhcCCCccCCCCCEEEecCCCCCCccCCcccc
Confidence            99999999999998877777778999999998888777443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.8e-44  Score=367.67  Aligned_cols=290  Identities=38%  Similarity=0.618  Sum_probs=226.0

Q ss_pred             CCCccccHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHc
Q 037010          257 DKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLT  336 (589)
Q Consensus       257 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~  336 (589)
                      .....++..++....++|++.+.||+|+||.||+|.+.+  +...+.|.+..     ..     .......+.+|+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~-----~~-----~~~~~~~~~~e~~~l~   82 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD--GTLVAVKRLKE-----ER-----TQGGELQFQTEVEMIS   82 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSS--SCCEEEEECCC---------------CCCHHHHHHHGGG
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecC--CCEEEEEEecc-----cc-----CchHHHHHHHHHHHHH
Confidence            345678889999999999999999999999999997542  22222222111     00     0111125788999999


Q ss_pred             cCCCCcceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceEeec
Q 037010          337 HVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIALDSARGLEYIHEH---TVPVYIHRD  410 (589)
Q Consensus       337 ~l~hpnIv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qia~aL~~LH~~---~i~~~vH~D  410 (589)
                      +++||||+++++++.+ +..++||||+.+|+|.+++.....  .++++..++.++.|++.||+|||++   ++   +|||
T Consensus        83 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~i---vH~D  159 (326)
T 3uim_A           83 MAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI---IHRD  159 (326)
T ss_dssp             TCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCE---ECCC
T ss_pred             hccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe---EeCC
Confidence            9999999999998864 468999999999999999987543  3589999999999999999999999   87   9999


Q ss_pred             cCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          411 IKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       411 lkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      |||+|||++.++.+||+|||++...............||+.|+|||++.+..++.++|||||||++|+|+||+.||....
T Consensus       160 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  239 (326)
T 3uim_A          160 VKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR  239 (326)
T ss_dssp             CSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred             CchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccc
Confidence            99999999999999999999998765444444445679999999999988899999999999999999999999995221


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ...........+.....    ....+....+..+....+.+.+..+.+++.+||+.||.+|||++||+++|+...
T Consensus       240 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          240 LANDDDVMLLDWVKGLL----KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             HTTTSCSBHHHHHTTTT----SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             cccccchhHHHHHHHHh----hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            11111112222222211    122344555666667788889999999999999999999999999999997643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.1e-43  Score=361.41  Aligned_cols=289  Identities=38%  Similarity=0.613  Sum_probs=223.5

Q ss_pred             cccHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCC
Q 037010          261 EFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH  340 (589)
Q Consensus       261 ~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~h  340 (589)
                      .+...++....++|++.+.||+|+||.||+|.+..  +...+.|...           .......+.+.+|++++++++|
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~-----------~~~~~~~~~~~~E~~~l~~l~h   94 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD--GAKVALKRRT-----------PESSQGIEEFETEIETLSFCRH   94 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTT--CCEEEEEECC-----------SCCSSHHHHHHHHHHGGGSCCC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECC--CCEEEEEEec-----------ccChHHHHHHHHHHHHHHhCCC
Confidence            34455566778999999999999999999998643  2222222111           0112234678899999999999


Q ss_pred             CcceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          341 LNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR--DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       341 pnIv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      |||+++++++.+ +..|+||||+++|+|.+++.....  ..+++..++.++.|++.||+|||++++   +||||||+|||
T Consensus        95 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i---vH~dlkp~Nil  171 (321)
T 2qkw_B           95 PHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI---IHRDVKSINIL  171 (321)
T ss_dssp             TTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCSTTEE
T ss_pred             CCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCe---ecCCCCHHHEE
Confidence            999999998864 468999999999999999976542  358999999999999999999999998   99999999999


Q ss_pred             EcCCCcEEEEeccCccccccCC-CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          418 IDKNFHAKVADFGLTKLTEVGS-ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       418 l~~~~~vkl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      ++.++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......... 
T Consensus       172 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~-  250 (321)
T 2qkw_B          172 LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-  250 (321)
T ss_dssp             ECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC-
T ss_pred             ECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH-
Confidence            9999999999999998643222 22223456899999999998889999999999999999999999999654432221 


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccc
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDW  571 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~  571 (589)
                       ....+......    ...+...+++.+....+.+.+..+.+++.+||+.||++|||++|++++|+.+....++|
T Consensus       251 -~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~~  320 (321)
T 2qkw_B          251 -NLAEWAVESHN----NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV  320 (321)
T ss_dssp             -CHHHHTHHHHT----TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCCC
T ss_pred             -HHHHHhhhccc----cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccCc
Confidence             11111111111    11233455666666778889999999999999999999999999999999887665543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8e-43  Score=364.34  Aligned_cols=268  Identities=25%  Similarity=0.436  Sum_probs=204.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCC-ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGN-SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~-~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|++.+.... ......++++...     +.......+++.+|+++++++ +||||+++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECC-----TTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEec-----CCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            47899999999999999999987542211 1111112221111     111234556789999999999 8999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGR--------------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      ++.+ +.+|+||||+.+|+|.+++.....              ..+++..++.++.||+.||+|||++++   +||||||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp  231 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLAA  231 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCG
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe---eccccch
Confidence            8864 568999999999999999986532              348899999999999999999999998   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~  491 (589)
                      +|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999986543222 22233567889999999998999999999999999999999 8888843211


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                           ......   +          .....    ...+..++..+.+++.+||+.||.+|||++|++++|+.+....
T Consensus       312 -----~~~~~~---~----------~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          312 -----EELFKL---L----------KEGHR----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             -----GGHHHH---H----------HTTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----HHHHHH---H----------hcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                 111111   1          11111    1223344557999999999999999999999999999887543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=352.38  Aligned_cols=268  Identities=29%  Similarity=0.426  Sum_probs=207.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++.. .+.|.+           ........+.+.+|++++++++||||+++++++
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~-va~K~~-----------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   76 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEV-MVMKEL-----------IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL   76 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCE-EEEEEE-----------SCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcE-EEEEEe-----------ccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEE
Confidence            46799999999999999999998765322 211111           122445667789999999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..++||||+++|+|.+++..... .+++.+++.++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i---vH~dlkp~Nil~~~~~~~kl~Df  152 (310)
T 3s95_A           77 YKDKRLNFITEYIKGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSMNI---IHRDLNSHNCLVRENKNVVVADF  152 (310)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSTTSEEECTTSCEEECCC
T ss_pred             ecCCeeEEEEEecCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCCcCeEEECCCCCEEEeec
Confidence            75 468999999999999999987533 49999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCC-------------CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          430 GLTKLTEVGSASL-------------PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       430 gla~~~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      |++..........             .....||+.|+|||++.+..++.++||||||+++|||++|..|+..........
T Consensus       153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~  232 (310)
T 3s95_A          153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF  232 (310)
T ss_dssp             TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred             ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence            9998654322211             114579999999999999999999999999999999999999885433322111


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccccCC
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVG  574 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~  574 (589)
                      .....                ...+......++    ..+.+++.+||+.||++|||++++++.|+.++.....+.+.
T Consensus       233 ~~~~~----------------~~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~~~~~  290 (310)
T 3s95_A          233 GLNVR----------------GFLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL  290 (310)
T ss_dssp             SBCHH----------------HHHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHHCCCC
T ss_pred             hhhhh----------------ccccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccCcccC
Confidence            11110                111111112223    35899999999999999999999999999998766554443

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-42  Score=348.97  Aligned_cols=263  Identities=21%  Similarity=0.344  Sum_probs=193.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..+.....   .++++...     ........+.+.+|+.++++++||||++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~---~vaiK~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   84 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPAL---AVAIKTCK-----NCTSDSVREKFLQEALTMRQFDHPHIVKLIGV   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCE---EEEEEECT-----TTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCce---EEEEEecc-----ccCCHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence            45789999999999999999998865422111   01111100     01123445678899999999999999999999


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +.++..|+||||+.+++|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           85 ITENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             ECSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEEECC-
T ss_pred             EccCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---ecccccHHHEEECCCCCEEECcc
Confidence            88888999999999999999998654 348999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++...............+++.|+|||++....++.++||||||+++|||++ |..||.....     ....   ..+..
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~~~---~~i~~  232 (281)
T 1mp8_A          161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVI---GRIEN  232 (281)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHH---HHHHT
T ss_pred             ccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HHHH---HHHHc
Confidence            9998664433333334567889999999988899999999999999999997 8888853321     1111   11111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                                ....    ..+...+..+.+++.+||+.||++|||+.|++++|..+..
T Consensus       233 ----------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          233 ----------GERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ----------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------CCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                      0011    1233444578999999999999999999999999998764

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-42  Score=353.14  Aligned_cols=266  Identities=29%  Similarity=0.475  Sum_probs=196.8

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .....++|++.+.||+|+||+||+|++.+.   ..+.|.+.         .........+++.+|++++++++||||+++
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~---~vavK~~~---------~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~   99 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGS---DVAVKILM---------EQDFHAERVNEFLREVAIMKRLRHPNIVLF   99 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEETTE---EEEEEEEC---------CCCCSHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEECCC---cEEEEEec---------CCCCCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            334467899999999999999999987543   12222111         111234455678899999999999999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeeccCCCcEEEcCCC
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIALDSARGLEYIHEHT--VPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~aL~~LH~~~--i~~~vH~Dlkp~NILl~~~~  422 (589)
                      ++++.+ +..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+++  +   +||||||+|||++.++
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~i---vH~Dikp~NIll~~~~  176 (309)
T 3p86_A          100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI---VHRNLKSPNLLVDKKY  176 (309)
T ss_dssp             EEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCC---CCTTCCGGGEEECTTC
T ss_pred             EEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCE---ECCCCChhhEEEeCCC
Confidence            998875 458999999999999999986542 23889999999999999999999999  8   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...   
T Consensus       177 ~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-----~~~---  247 (309)
T 3p86_A          177 TVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-----AQV---  247 (309)
T ss_dssp             CEEECCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-----HHH---
T ss_pred             cEEECCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH---
Confidence            99999999997543221 222346799999999999999999999999999999999999999843221     111   


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      ......         ....    ...+...+..+.+|+.+||+.||.+|||++|+++.|+.+.....
T Consensus       248 ~~~~~~---------~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          248 VAAVGF---------KCKR----LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             HHHHHH---------SCCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             HHHHHh---------cCCC----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            111100         0001    12333445578999999999999999999999999998876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.3e-42  Score=356.52  Aligned_cols=261  Identities=21%  Similarity=0.358  Sum_probs=202.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.+.||+|+||+||+|.+..++.....           ++++|.+.    ....+++.+|++++++++||||+++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   82 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI-----------PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL   82 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCE-----------EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEE-----------EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence            46799999999999999999997665322210           12222221    2234678899999999999999999


Q ss_pred             eeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          347 IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       347 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++++.++..++|+|++.+|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i---vH~Dikp~NIll~~~~~~kl  158 (327)
T 3poz_A           83 LGICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKI  158 (327)
T ss_dssp             EEEEESSSEEEEEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEEETTEEEE
T ss_pred             EEEEecCCeEEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCe---eCCCCChheEEECCCCCEEE
Confidence            999998889999999999999999987543 49999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHH
Q 037010          427 ADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      +|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....     ....... 
T Consensus       159 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~-  232 (327)
T 3poz_A          159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSIL-  232 (327)
T ss_dssp             CCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHH-
T ss_pred             ccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHHHH-
Confidence            999999865433222 2223456889999999999999999999999999999999 9999843221     1111111 


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                                      ........+..++..+.+++.+||+.||.+|||++|++++|+.+....
T Consensus       233 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          233 ----------------EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             ----------------HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             ----------------HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence                            111111223445567999999999999999999999999998887543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.7e-42  Score=351.71  Aligned_cols=270  Identities=29%  Similarity=0.416  Sum_probs=202.4

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeE
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      ...++|++.+.||+|+||+||+|++.+.                 .+++|.+..  ........|+.++++++||||+++
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----------------~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   83 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLLNE-----------------YVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQF   83 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEETTE-----------------EEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred             cchhhchhhheecccCceEEEEEEECCC-----------------EEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhh
Confidence            3457899999999999999999987642                 223333221  223345568899999999999999


Q ss_pred             eeEEEeC-----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCceEeecc
Q 037010          347 IGYCVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH----------TVPVYIHRDI  411 (589)
Q Consensus       347 ~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~----------~i~~~vH~Dl  411 (589)
                      ++++.++     .+|+||||+++|+|.+++....   +++..++.++.|++.||+|||++          ++   +||||
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~i---vH~Dl  157 (322)
T 3soc_A           84 IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI---SHRDI  157 (322)
T ss_dssp             EEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEE---ECSCC
T ss_pred             cceeccCCCCCceEEEEEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCE---EeCCC
Confidence            9988643     2799999999999999997643   89999999999999999999999          87   99999


Q ss_pred             CCCcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccC-----CCCCcccchhhHHHHHHHHHcCCcc
Q 037010          412 KSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQY-----GDVSPKVDVYAFGVVLYELISAKEA  485 (589)
Q Consensus       412 kp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSlGvll~elltG~~p  485 (589)
                      ||+|||++.++.+||+|||+++........ ......||+.|+|||++.+     ..++.++|||||||++|||+||+.|
T Consensus       158 kp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~p  237 (322)
T 3soc_A          158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTA  237 (322)
T ss_dssp             SGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTT
T ss_pred             ChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999865433222 2233679999999999876     3566789999999999999999999


Q ss_pred             cccCCCCCCChhhHHHHHHHHhcCCChHHhhHh-hcCCCCCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 037010          486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRK-LVDPRLGDNC-----PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV  559 (589)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  559 (589)
                      |...........     .......+. ...+.. ..........     ....+..+.+|+.+||+.||++|||++|+++
T Consensus       238 f~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          238 ADGPVDEYMLPF-----EEEIGQHPS-LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             SSSCCCCCCCTT-----HHHHCSSCC-HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcchhccch-----hhhhccCCc-hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            965443221110     001111111 122221 1111111111     2245567999999999999999999999999


Q ss_pred             HHHhcccc
Q 037010          560 ALMTLSST  567 (589)
Q Consensus       560 ~L~~l~~~  567 (589)
                      .|+++...
T Consensus       312 ~L~~l~~~  319 (322)
T 3soc_A          312 RITQMQRL  319 (322)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99988743

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=353.14  Aligned_cols=263  Identities=27%  Similarity=0.431  Sum_probs=203.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh----cCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~----~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.+.||+|+||.||+|.+..++....            .+++|.    ......+.+.+|++++++++||||+++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~------------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~  115 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDV------------PVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL  115 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCE------------EEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCc------------eEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            4679999999999999999999865432210            122222    233455678999999999999999999


Q ss_pred             eeEEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++++.++ ..|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+|
T Consensus       116 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~k  191 (325)
T 3kul_A          116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCK  191 (325)
T ss_dssp             EEEECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEE
T ss_pred             EEEEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCe---eCCCCCcceEEECCCCCEE
Confidence            9988754 5899999999999999997653 349999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |+|||++.........  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....     .   ..
T Consensus       192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~---~~  263 (325)
T 3kul_A          192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-----R---DV  263 (325)
T ss_dssp             ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----H---HH
T ss_pred             ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-----H---HH
Confidence            9999999865433221  1222456788999999998899999999999999999999 9999843221     1   11


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDW  571 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~  571 (589)
                      ...+..          .    .....+..++..+.+|+.+||+.||.+|||++||++.|+.+....+.-
T Consensus       264 ~~~~~~----------~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~  318 (325)
T 3kul_A          264 ISSVEE----------G----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL  318 (325)
T ss_dssp             HHHHHT----------T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred             HHHHHc----------C----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence            111111          1    111223344557999999999999999999999999999988665543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-42  Score=345.69  Aligned_cols=255  Identities=27%  Similarity=0.469  Sum_probs=201.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|.+...  ..              +++|.+..  ...+++.+|++++++++||||+++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~--------------vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   72 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNK--DK--------------VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG   72 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT--EE--------------EEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhhceeeheecCCCccEEEEEEecCC--Ce--------------EEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            46799999999999999999987643  11              22222221  11246888999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +..|+||||+++++|.+++..... .+++..++.++.|++.||+|||++++   +||||||+||+++.++.+||+
T Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~kl~  148 (269)
T 4hcu_A           73 VCLEQAPICLVFEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVS  148 (269)
T ss_dssp             EECSSSSEEEEEECCTTCBHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECGGGCEEEC
T ss_pred             EEecCCceEEEEEeCCCCcHHHHHHhcCc-ccCHHHHHHHHHHHHHHHHHHHhCCe---ecCCcchheEEEcCCCCEEec
Confidence            8875 468999999999999999976543 48999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....        .......
T Consensus       149 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~  220 (269)
T 4hcu_A          149 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDI  220 (269)
T ss_dssp             CTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHH
T ss_pred             cccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHH
Confidence            999998654333223334567888999999998899999999999999999999 8888843211        1111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ..          ....    ..+...+..+.+++.+||+.||.+|||++|++++|+.+...
T Consensus       221 ~~----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          221 ST----------GFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HT----------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hc----------CccC----CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            11          1111    12223345789999999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.7e-42  Score=344.77  Aligned_cols=272  Identities=24%  Similarity=0.371  Sum_probs=203.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..+.. ..+.|.+...        ........+.+.+|++++++++||||++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~~~--------~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   79 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNI-KVAIKAIFIP--------PREKEETLKRFEREVHNSSQLSHQNIVSMIDV   79 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCS-EEEEEEEECC--------SSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCC-eEEEEEeccC--------ccccHHHHHHHHHHHHHHhcCCCCCCceEEEe
Confidence            35789999999999999999998765532 2222211100        01234455778899999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+++++|.+++....  ++++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus        80 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~Dlkp~Nil~~~~~~~kl~D  154 (294)
T 4eqm_A           80 DEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRI---VHRDIKPQNILIDSNKTLKIFD  154 (294)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECC
T ss_pred             eeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCCEEEEe
Confidence            875 45899999999999999998764  48999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++...............||+.|+|||.+.+..++.++||||||+++|+|+||+.||.....       ..........
T Consensus       155 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~  227 (294)
T 4eqm_A          155 FGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIAIKHIQD  227 (294)
T ss_dssp             CSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHHHHHHSS
T ss_pred             CCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhhc
Confidence            999986544333333446799999999999999999999999999999999999999954321       1111111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhcccccccccC
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-SMRSIVVALMTLSSTTEDWDV  573 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~l~~~~~~~~~  573 (589)
                      ....   ...        ..+.+.+..+.+++.+||+.||.+|| +++++.+.|..+.......+.
T Consensus       228 ~~~~---~~~--------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~  282 (294)
T 4eqm_A          228 SVPN---VTT--------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED  282 (294)
T ss_dssp             CCCC---HHH--------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred             cCCC---cch--------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence            1100   000        11223345789999999999999998 999999999988766554443

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.4e-43  Score=373.79  Aligned_cols=259  Identities=24%  Similarity=0.461  Sum_probs=205.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++|++.+.||+|+||.||+|.++..  .              .+++|.+..  ...+++.+|+++|++++||||++++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~--~--------------~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~  249 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKH--T--------------KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH  249 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTT--E--------------EEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCc--c--------------EEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEE
Confidence            457899999999999999999987642  1              122222221  1245788999999999999999999


Q ss_pred             eEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          348 GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       348 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +++.++..|+||||+.+|+|.+++.......+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+
T Consensus       250 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i---vHrDlkp~Nill~~~~~~kl~  326 (454)
T 1qcf_A          250 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAANILVSASLVCKIA  326 (454)
T ss_dssp             EEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCSGGGEEECTTCCEEEC
T ss_pred             EEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCCHHHEEECCCCcEEEe
Confidence            99988889999999999999999986544458899999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||+++..............+++.|+|||++..+.++.++|||||||++|||+| |+.||....     .........  
T Consensus       327 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~-----~~~~~~~i~--  399 (454)
T 1qcf_A          327 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALE--  399 (454)
T ss_dssp             STTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHH--
T ss_pred             eCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHH--
Confidence            999998654322222233456788999999998899999999999999999999 999984321     111111111  


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                                 ....    ...+..++..+.+|+.+||+.||++|||+++|++.|+.+....+
T Consensus       400 -----------~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          400 -----------RGYR----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             -----------HTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             -----------cCCC----CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence                       1111    12233445679999999999999999999999999999876544

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6e-42  Score=346.83  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=197.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||+||+|.+..++. ..+.|.+...         .  ....+.+.+|+.++++++||||++++++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~~~---------~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~   85 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQ-EVAIRQMNLQ---------Q--QPKKELIINEILVMRENKNPNIVNYLDS   85 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCC-EEEEEEEEGG---------G--CSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCc-EEEEEEeecc---------c--ccHHHHHHHHHHHHhcCCCCCCCeEeEE
Confidence            34689999999999999999998765532 2222211110         0  1113457789999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+++|+|.+++...   .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~Dlkp~Nil~~~~~~~kl~D  159 (297)
T 3fxz_A           86 YLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTD  159 (297)
T ss_dssp             EEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECC
T ss_pred             EEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCc---eeCCCCHHHEEECCCCCEEEee
Confidence            764 5689999999999999999865   38999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ...   ..... 
T Consensus       160 fg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~---~~~~~-  229 (297)
T 3fxz_A          160 FGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRA---LYLIA-  229 (297)
T ss_dssp             CTTCEECCSTTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHH---HHHHH-
T ss_pred             CCCceecCCccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHH---HHHHH-
Confidence            999886543322 23446799999999999999999999999999999999999999954321     111   10100 


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                               ....+  ....+...+..+.+|+.+||+.||++|||++|+++|-
T Consensus       230 ---------~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  271 (297)
T 3fxz_A          230 ---------TNGTP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ  271 (297)
T ss_dssp             ---------HHCSC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             ---------hCCCC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence                     00001  1122344556789999999999999999999999874

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.2e-41  Score=349.27  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=200.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+..         ........+.+.+|+++|++++||||++++++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~vaiK~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~   82 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGR-EVAIKIIDK---------TQLNPTSLQKLFREVRIMKILNHPNIVKLFEV   82 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEEEG---------GGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCC-EEEEEEEEh---------hcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            45789999999999999999999866532 222222111         12234455678899999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+++|+|.+++.....  +++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--l~~~~~~~~~~qi~~al~~lH~~~i---vHrDlkp~NIll~~~~~~kl~D  157 (328)
T 3fe3_A           83 IETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRI---VHRDLKAENLLLDADMNIKIAD  157 (328)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECS
T ss_pred             EEECCEEEEEEECCCCCcHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHCCE---eccCCCHHHEEEcCCCCEEEee
Confidence            874 568999999999999999977643  8999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCC-cccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++......  .......||+.|+|||++.+..++ .++|||||||++|+|++|+.||....        .......+.
T Consensus       158 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~  227 (328)
T 3fe3_A          158 FGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVL  227 (328)
T ss_dssp             TTCCGGGSSS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred             ccCceecCCC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence            9999865432  223456899999999999887765 79999999999999999999995432        111121111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..           ..    ..|...+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       228 ~~-----------~~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~  266 (328)
T 3fe3_A          228 RG-----------KY----RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR  266 (328)
T ss_dssp             HC-----------CC----CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred             hC-----------CC----CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence            11           01    12333445689999999999999999999999983

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.6e-42  Score=342.73  Aligned_cols=257  Identities=26%  Similarity=0.451  Sum_probs=200.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++|++.+.||+|+||.||+|.+.+.  ...              ++|....  ...+++.+|++++++++||||++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~v--------------avK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   69 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQ--YDV--------------AVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFY   69 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTT--EEE--------------EEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCc--eeE--------------EEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEE
Confidence            457899999999999999999987643  112              2222211  1234578899999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..|+||||+++++|.+++..... .+++..++.++.|++.||+|||++++   +||||||+||+++.++.+||
T Consensus        70 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~~l  145 (268)
T 3sxs_A           70 GVCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQF---IHRDLAARNCLVDRDLCVKV  145 (268)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTE---EESSCSGGGEEECTTCCEEE
T ss_pred             EEEccCCceEEEEEccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCcCcceEEECCCCCEEE
Confidence            98875 468999999999999999976532 48999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||++...............+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||.....     .   .....
T Consensus       146 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~---~~~~~  217 (268)
T 3sxs_A          146 SDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-----S---EVVLK  217 (268)
T ss_dssp             CCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-----H---HHHHH
T ss_pred             ccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-----H---HHHHH
Confidence            9999998654433333334556788999999998899999999999999999999 9999843221     1   11111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      ...          ....    ..+...+..+.+++.+||+.||.+|||++|++++|+.+..+.
T Consensus       218 ~~~----------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          218 VSQ----------GHRL----YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             HHT----------TCCC----CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             HHc----------CCCC----CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            111          1111    112223447899999999999999999999999999998653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=356.20  Aligned_cols=277  Identities=25%  Similarity=0.431  Sum_probs=210.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCC-ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGN-SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~-~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  347 (589)
                      ..++|++.+.||+|+||.||+|.+.+.... ......++++...     +........++.+|+++++++ +||||++++
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-----SDATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEEC-----TTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeec-----cccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            346899999999999999999997653221 1111112221111     112344557788999999999 899999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      +++.+ +..|+||||+.+|+|.+++....              ...+++..++.++.|++.||+|||++++   +|||||
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlk  218 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLA  218 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCC
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCC
Confidence            98875 46899999999999999998754              2358999999999999999999999998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGN  490 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~  490 (589)
                      |+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       219 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~  298 (382)
T 3tt0_A          219 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP  298 (382)
T ss_dssp             GGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986543222 22333567889999999999999999999999999999999 998884321


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED  570 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~  570 (589)
                           ...   ....+.          .....    ..+..++..+.+|+.+||+.||++|||++||+++|+.+......
T Consensus       299 -----~~~---~~~~~~----------~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          299 -----VEE---LFKLLK----------EGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             -----HHH---HHHHHH----------TTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             -----HHH---HHHHHH----------cCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                 111   111111          11111    22333445789999999999999999999999999999988777


Q ss_pred             ccCCCc
Q 037010          571 WDVGSF  576 (589)
Q Consensus       571 ~~~~~~  576 (589)
                      .+.+..
T Consensus       357 ~~~~~~  362 (382)
T 3tt0_A          357 QEMGYY  362 (382)
T ss_dssp             CC----
T ss_pred             CCCCCC
Confidence            776544

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8e-42  Score=345.93  Aligned_cols=260  Identities=26%  Similarity=0.417  Sum_probs=195.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHcc--CCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH--VHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~--l~hpnIv~l~  347 (589)
                      ..++|++.+.||+|+||.||+|.+.+.                 .+++|.+.......+..|.+++..  ++||||++++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----------------~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~   68 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQGE-----------------NVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI   68 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETTE-----------------EEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECCE-----------------EEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEE
Confidence            457899999999999999999987432                 334444443344455667776665  7999999999


Q ss_pred             eEEEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEeeccCCC
Q 037010          348 GYCVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH--------EHTVPVYIHRDIKSA  414 (589)
Q Consensus       348 ~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH--------~~~i~~~vH~Dlkp~  414 (589)
                      +++.+     ...|+||||+++|+|.+++...   .+++..++.++.|++.||+|||        ++++   +||||||+
T Consensus        69 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i---vH~Dlkp~  142 (301)
T 3q4u_A           69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI---AHRDLKSK  142 (301)
T ss_dssp             EEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE---ECSCCCGG
T ss_pred             EeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe---ecCCCChH
Confidence            97643     2489999999999999999643   4999999999999999999999        8887   99999999


Q ss_pred             cEEEcCCCcEEEEeccCccccccCCCC---CCcccccCCCCCchhcccCC------CCCcccchhhHHHHHHHHHcC---
Q 037010          415 NILIDKNFHAKVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYG------DVSPKVDVYAFGVVLYELISA---  482 (589)
Q Consensus       415 NILl~~~~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwSlGvll~elltG---  482 (589)
                      |||++.++.+||+|||++.........   ......||+.|+|||++.+.      .++.++|||||||++|||+||   
T Consensus       143 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~  222 (301)
T 3q4u_A          143 NILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS  222 (301)
T ss_dssp             GEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCB
T ss_pred             hEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcC
Confidence            999999999999999999765433221   12235799999999999776      556799999999999999999   


Q ss_pred             -------CcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 037010          483 -------KEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLG-DNCPLDSVLKMAQLAKVCTQEYPQLRPSM  554 (589)
Q Consensus       483 -------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~  554 (589)
                             +.||.............    .......        ...+.+. ...+...+..+.+|+.+||+.||++|||+
T Consensus       223 ~~~~~~~~~pf~~~~~~~~~~~~~----~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  290 (301)
T 3q4u_A          223 NGIVEDYKPPFYDVVPNDPSFEDM----RKVVCVD--------QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTA  290 (301)
T ss_dssp             TTBCCCCCCTTTTTSCSSCCHHHH----HHHHTTS--------CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred             ccccccccccccccCCCCcchhhh----hHHHhcc--------CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCH
Confidence                   67774433222111111    1111100        0011111 11223467789999999999999999999


Q ss_pred             HHHHHHHHhc
Q 037010          555 RSIVVALMTL  564 (589)
Q Consensus       555 ~evl~~L~~l  564 (589)
                      +|+++.|+.+
T Consensus       291 ~~i~~~L~~i  300 (301)
T 3q4u_A          291 LRIKKTLTKI  300 (301)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHhcc
Confidence            9999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.7e-42  Score=351.32  Aligned_cols=266  Identities=21%  Similarity=0.365  Sum_probs=202.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.+.||+|+||.||+|.+..+......           ++++|..    .....+++.+|++++++++||||+++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~-----------kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~   82 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI-----------PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL   82 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCE-----------EEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCC
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEE-----------EEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEE
Confidence            47899999999999999999998765332211           1122222    12234568889999999999999999


Q ss_pred             eeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          347 IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       347 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++++.++..++++|++.+|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus        83 ~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIl~~~~~~~kL  158 (327)
T 3lzb_A           83 LGICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKI  158 (327)
T ss_dssp             CEEEESSSEEEEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEEETTEEEE
T ss_pred             EEEEecCCceEEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCC---cCCCCCHHHEEEcCCCCEEE
Confidence            999998889999999999999999987543 48999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHH
Q 037010          427 ADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      +|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....     ........
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~~  233 (327)
T 3lzb_A          159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILE  233 (327)
T ss_dssp             CCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHH
T ss_pred             ccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHH
Confidence            999999865432221 2223456889999999999999999999999999999999 9999843321     11111111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccccC
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDV  573 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~  573 (589)
                                       .......+...+..+.+++.+||+.||.+|||++|+++.|..+......+..
T Consensus       234 -----------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  285 (327)
T 3lzb_A          234 -----------------KGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLV  285 (327)
T ss_dssp             -----------------TTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHHHBC
T ss_pred             -----------------cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCceEE
Confidence                             1111122334455789999999999999999999999999998876554433

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4e-42  Score=345.22  Aligned_cols=256  Identities=25%  Similarity=0.452  Sum_probs=198.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH--HHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ--ASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++|++.+.||+|+||.||++.+.+.  ..              +++|.+...  ..+++.+|++++++++||||++++
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~--------------vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   85 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQ--YD--------------VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLY   85 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTT--EE--------------EEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCC--Ce--------------EEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEE
Confidence            356899999999999999999987643  11              222222211  234678899999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..|+||||+.+++|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dikp~Nili~~~~~~kl  161 (283)
T 3gen_A           86 GVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKV  161 (283)
T ss_dssp             EEECSSSSEEEEECCCTTCBHHHHHHCGGG-CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCSGGGEEECTTSCEEE
T ss_pred             EEEecCCCeEEEEeccCCCcHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCc---cCCCCccceEEEcCCCCEEE
Confidence            98875 468999999999999999976432 49999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||++...............+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||.....     .   .....
T Consensus       162 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----~---~~~~~  233 (283)
T 3gen_A          162 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----S---ETAEH  233 (283)
T ss_dssp             CSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----H---HHHHH
T ss_pred             ccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----h---HHHHH
Confidence            9999998654332222333567888999999998899999999999999999998 9999843221     1   11111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      +.          .....    ..+...+..+.+++.+||+.||.+|||++|++++|..+...
T Consensus       234 ~~----------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          234 IA----------QGLRL----YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HH----------TTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Hh----------cccCC----CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            11          11111    12223345789999999999999999999999999988643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.1e-42  Score=353.54  Aligned_cols=262  Identities=22%  Similarity=0.366  Sum_probs=201.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.+.||+|+||.||+|.+..++.....           ++++|...    ......+.+|+.++++++||||+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~-----------kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   80 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKI-----------PVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL   80 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCE-----------EEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEE-----------EEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeE
Confidence            46799999999999999999998765332211           11111111    1112345679999999999999999


Q ss_pred             eeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          347 IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       347 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++++.++..++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus        81 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dikp~Nil~~~~~~~kl  156 (325)
T 3kex_A           81 LGLCPGSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQV  156 (325)
T ss_dssp             EEEECBSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTC---CCSCCSSTTEEESSSSCEEE
T ss_pred             EEEEcCCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCC---CCCccchheEEECCCCeEEE
Confidence            99998888999999999999999998653 348899999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHH
Q 037010          427 ADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      +|||+++........ ......+|+.|+|||++.+..++.++|||||||++|+|+| |+.||.....     ........
T Consensus       157 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~  231 (325)
T 3kex_A          157 ADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEVPDLLE  231 (325)
T ss_dssp             CSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THHHHHHH
T ss_pred             CCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHHHHHHH
Confidence            999999876443322 2234567889999999998999999999999999999999 9999854321     11111111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      .             ....    ..+...+..+.+++.+||..||.+|||++|++++|..+.....
T Consensus       232 ~-------------~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~~  279 (325)
T 3kex_A          232 K-------------GERL----AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP  279 (325)
T ss_dssp             T-------------TCBC----CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSHH
T ss_pred             c-------------CCCC----CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            1             0011    1122233357899999999999999999999999998876543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.1e-42  Score=369.43  Aligned_cols=259  Identities=29%  Similarity=0.497  Sum_probs=200.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++|++.++||+|+||.||+|.+.++  .              .+++|.+..  ...+++.+|+++|++++||||++++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~--~--------------~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~  245 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGT--T--------------RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY  245 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT--E--------------EEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCC--c--------------eEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEE
Confidence            346789999999999999999988653  1              122222221  1235688999999999999999999


Q ss_pred             eEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          348 GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       348 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +++.++..|+||||+.+|+|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+
T Consensus       246 ~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i---vHrDlkp~Nill~~~~~~kl~  322 (452)
T 1fmk_A          246 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVA  322 (452)
T ss_dssp             EEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCChhhEEECCCCCEEEC
Confidence            99988889999999999999999986544458999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||+++..............+++.|+|||.+..+.++.++|||||||++|||+| |+.||.....     .   .....+
T Consensus       323 DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~---~~~~~i  394 (452)
T 1fmk_A          323 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----R---EVLDQV  394 (452)
T ss_dssp             CCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----H---HHHHHH
T ss_pred             CCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHH
Confidence            999998654332222233457889999999998899999999999999999999 8988843211     1   111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      ..              ......+..++..+.+|+.+||+.||++|||+++|++.|+.+....+
T Consensus       395 ~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          395 ER--------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             HT--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             Hc--------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            11              11122344455679999999999999999999999999999876544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1e-41  Score=341.94  Aligned_cols=265  Identities=22%  Similarity=0.364  Sum_probs=202.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+....+...   .++++...     +.......+.+.+|++++++++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~---~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   81 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKI---NVAVKTCK-----KDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGI   81 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEE---EEEEEECC-----TTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcc---eEEEEecc-----cccCchHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            35689999999999999999998765432211   11111110     11123445678899999999999999999999


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +.++..|+||||+.+++|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        82 ~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           82 IEEEPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             ECSSSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEEEETTEEEECCC
T ss_pred             EcCCCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCccceEEECCCCcEEeCcc
Confidence            98888899999999999999997654 348999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++...............+++.|+|||.+.+..++.++||||||+++|+|+| |+.||.....     .........   
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~~~~~~~---  229 (281)
T 3cc6_A          158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDVIGVLEK---  229 (281)
T ss_dssp             CGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGHHHHHHH---
T ss_pred             CCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHHHHHHhc---
Confidence            9998654433333334567889999999988899999999999999999998 9999853221     111111111   


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                                .....    .+...+..+.+++.+||..||.+|||+.|++++|+.+....
T Consensus       230 ----------~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          230 ----------GDRLP----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             ----------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----------CCCCC----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence                      11111    12223456899999999999999999999999999886543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9e-41  Score=339.43  Aligned_cols=286  Identities=34%  Similarity=0.614  Sum_probs=218.4

Q ss_pred             CccccHHHHHhhcCCCccc------eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHH
Q 037010          259 SVEFSYEELSKATDNFSMS------HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL  332 (589)
Q Consensus       259 ~~~~~~~~~~~~~~~y~~~------~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~  332 (589)
                      ...++++++...+++|...      +.||+|+||.||+|.+.+.   ..+.|.+..     .  .........+.+.+|+
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~vavK~~~~-----~--~~~~~~~~~~~~~~E~   81 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT---TVAVKKLAA-----M--VDITTEELKQQFDQEI   81 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSC---EEEEEEECC-----C--TTSCTTTHHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCc---eEEEEEEec-----c--cCcchHHHHHHHHHHH
Confidence            4567888999988888776      9999999999999986432   222221110     0  0001123356788999


Q ss_pred             HHHccCCCCcceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 037010          333 KVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSG-RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRD  410 (589)
Q Consensus       333 ~il~~l~hpnIv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~D  410 (589)
                      +++++++||||+++++++.+ +..++||||+++++|.+++.... ..++++..++.++.|++.||+|||++++   +|||
T Consensus        82 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~d  158 (307)
T 2nru_A           82 KVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRD  158 (307)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSC
T ss_pred             HHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCe---ecCC
Confidence            99999999999999998874 46899999999999999997532 3458999999999999999999999998   9999


Q ss_pred             cCCCcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccC
Q 037010          411 IKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG  489 (589)
Q Consensus       411 lkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~  489 (589)
                      |||+||+++.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccC
Confidence            9999999999999999999999865432221 2234578999999998864 5899999999999999999999999654


Q ss_pred             CCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      .....    ............   ..+...+++.+ ...+...+..+.+++.+||+.||.+|||+++++++|+.+..
T Consensus       238 ~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          238 REPQL----LLDIKEEIEDEE---KTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             BSSSB----TTHHHHHHHTTS---CCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cchHH----HHHHHHHhhhhh---hhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            33221    111222222211   12334444444 34567788899999999999999999999999999998864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.3e-41  Score=343.79  Aligned_cols=274  Identities=23%  Similarity=0.371  Sum_probs=201.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEcc---ccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRG---EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      ..++|++.+.||+|+||.||+|++..   ..+...+.|.+           +.......+.+.+|++++++++||||+++
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~-----------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   76 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-----------QHSTEEHLRDFEREIEILKSLQHDNIVKY   76 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEE-----------SCCCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEc-----------ccCCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            35789999999999999999998632   11222222111           11234455678899999999999999999


Q ss_pred             eeEEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          347 IGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       347 ~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      ++++.+   ...++||||+++|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.
T Consensus        77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dikp~Nil~~~~~~  152 (295)
T 3ugc_A           77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENR  152 (295)
T ss_dssp             EEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTE
T ss_pred             EEEEecCCCCceEEEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcCCc---ccCCCCHhhEEEcCCCe
Confidence            998753   458999999999999999987543 48999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCC--CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          424 AKVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      +||+|||++........  .......++..|+|||.+.+..++.++||||||+++|||+||..|+....         ..
T Consensus       153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~---------~~  223 (295)
T 3ugc_A          153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP---------AE  223 (295)
T ss_dssp             EEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH---------HH
T ss_pred             EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh---------HH
Confidence            99999999986543322  11223457788999999998999999999999999999999998873211         01


Q ss_pred             HHHHHhcCCCh---HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          502 LFEEVLNLPDP---IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       502 ~~~~~~~~~~~---~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ........+..   ...+...+........+..++..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          224 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            11111111110   0111112222222233445556799999999999999999999999999988754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.3e-41  Score=351.44  Aligned_cols=280  Identities=17%  Similarity=0.209  Sum_probs=202.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEcccc----CCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCccee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEY----GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~----~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      ..++|++.+.||+|+||.||+|.+..+.    +...+.|............++.+.......+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            4568999999999999999999886642    223333332221111111111111112234566888899999999999


Q ss_pred             EeeEEEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc-
Q 037010          346 LIGYCVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID-  419 (589)
Q Consensus       346 l~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~-  419 (589)
                      +++++.+     ...|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||++++   +||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~i---iHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---EEecCCHHHEEEec
Confidence            9998764     2379999999 999999998753 359999999999999999999999998   9999999999998 


Q ss_pred             -CCCcEEEEeccCccccccCCCC------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCC
Q 037010          420 -KNFHAKVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS  492 (589)
Q Consensus       420 -~~~~vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~  492 (589)
                       .++.+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             8899999999999765432211      113356999999999999999999999999999999999999999643221


Q ss_pred             CCChhhHHHHHHHHhcCCChHHhhHhhcCCCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLG-DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                          ............     ..+..++++.+. ..+    +..+.+++..||..||.+||++++|++.|..+...
T Consensus       268 ----~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          268 ----PKYVRDSKIRYR-----ENIASLMDKCFPAANA----PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             ----HHHHHHHHHHHH-----HCHHHHHHHHSCTTCC----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHHHHHHHhh-----hhHHHHHHHhcccccC----HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence                111111111111     112222222211 222    34689999999999999999999999999887654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.9e-42  Score=345.46  Aligned_cols=258  Identities=26%  Similarity=0.473  Sum_probs=203.9

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeE
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      ...++|++.+.||+|+||.||+|.+.+.  ...              ++|....  ...+.+.+|++++++++||||+++
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~v--------------avK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   73 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYNGH--TKV--------------AVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL   73 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTT--EEE--------------EEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEcCC--cEE--------------EEEEecCCcccHHHHHHHHHHHHhCCCcCcceE
Confidence            3457899999999999999999986542  112              2222211  123568889999999999999999


Q ss_pred             eeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          347 IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       347 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++++.++..++||||+++++|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus        74 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~kl  150 (279)
T 1qpc_A           74 YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKI  150 (279)
T ss_dssp             EEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHhhEEEcCCCCEEE
Confidence            999988889999999999999999976543358999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....     .   .....
T Consensus       151 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~---~~~~~  222 (279)
T 1qpc_A          151 ADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----P---EVIQN  222 (279)
T ss_dssp             CCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----H---HHHHH
T ss_pred             CCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-----H---HHHHH
Confidence            9999998765433333334567889999999988889999999999999999999 8888843211     1   11111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      +..          ....    ..+...+..+.+++.+||+.||++|||++++++.|+.+...
T Consensus       223 ~~~----------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          223 LER----------GYRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             HHT----------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Hhc----------ccCC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            111          1111    12233445789999999999999999999999999887654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.6e-41  Score=338.84  Aligned_cols=263  Identities=28%  Similarity=0.502  Sum_probs=194.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||.||+|.+.++    .+.|.+         ..........+.+.+|++++++++||||++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~----vavK~~---------~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKML---------NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSSE----EEEEEE---------SCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcCc----eEEEEE---------eccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            457899999999999999999986542    111111         1112234455778899999999999999999998


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +.++..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i---~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           89 STAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSI---IHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             ECSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEETTTEEEECCC
T ss_pred             ccCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCc---ccccCccceEEECCCCCEEEccc
Confidence            88888999999999999999997554 349999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCC-CCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          430 GLTKLTEVGS-ASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       430 gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |++....... ........||+.|+|||.+.   ...++.++||||||+++|+|++|+.||.....    ..........
T Consensus       165 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~  240 (289)
T 3og7_A          165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIEMVGR  240 (289)
T ss_dssp             C------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC----HHHHHHHHHH
T ss_pred             eeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch----HHHHHHHhcc
Confidence            9997543221 22223467999999999986   56788999999999999999999999954322    1111111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      .            ...+.+ .....+++..+.+|+.+||+.||.+|||++|+++.|+.+..
T Consensus       241 ~------------~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          241 G------------SLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             T------------SCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             c------------ccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            1            011111 11223444579999999999999999999999999998864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=5.8e-42  Score=371.36  Aligned_cols=258  Identities=28%  Similarity=0.446  Sum_probs=205.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++|++.++||+|+||.||+|.+..+..               .+++|.+..  ...+++.+|+++|++++||||++++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~---------------~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  282 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSL---------------TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL  282 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTE---------------EEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCe---------------EEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEE
Confidence            34678999999999999999999875421               222332221  1245788999999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..|+||||+.+|+|.+++.......+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||
T Consensus       283 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i---vHrDlkp~NIll~~~~~~kl  359 (495)
T 1opk_A          283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKV  359 (495)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECGGGCEEE
T ss_pred             EEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCChhhEEECCCCcEEE
Confidence            99875 468999999999999999987666679999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||+++..............+++.|+|||++....++.++|||||||++|||+| |+.||.....     ......   
T Consensus       360 ~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----~~~~~~---  431 (495)
T 1opk_A          360 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL---  431 (495)
T ss_dssp             CCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHH---
T ss_pred             eecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHH---
Confidence            9999998654333222333456789999999998899999999999999999999 8888843321     111111   


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                                    +........+..++..+.+|+.+||+.||.+|||+++|++.|+.+...
T Consensus       432 --------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          432 --------------LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             --------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             --------------HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence                          111111223444556799999999999999999999999999988643

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.6e-41  Score=336.53  Aligned_cols=254  Identities=20%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+.+.   ..+.|.+.         .........+.+.+|++++++++||||+++++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~avK~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQGN---DIVVKVLK---------VRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC   76 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETTE---EEEEEEEC---------CTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECCe---eEEEEEec---------ccccCHHHHHHHHHHHHHHHhcCCCchhheEEEE
Confidence            46799999999999999999998643   22222111         1122344556789999999999999999999988


Q ss_pred             Ee---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeeccCCCcEEEcCCCcEE
Q 037010          351 VE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT--VPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       351 ~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~--i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      .+   +..++||||+++|+|.+++.......+++..++.++.|++.||+|||+++  +   +||||||+|||++.++.++
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i---~H~dikp~Nil~~~~~~~~  153 (271)
T 3kmu_A           77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI---PRHALNSRSVMIDEDMTAR  153 (271)
T ss_dssp             CTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCC---TTCCCSGGGEEECTTSCEE
T ss_pred             ccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCce---ecCCCccceEEEcCCccee
Confidence            75   45899999999999999999876667999999999999999999999999  7   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCc---ccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSP---KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |+|||++....      .....||+.|+|||.+.+..++.   ++|||||||++|||++|+.||.....        ...
T Consensus       154 l~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~  219 (271)
T 3kmu_A          154 ISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN--------MEI  219 (271)
T ss_dssp             EEGGGSCCTTS------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH--------HHH
T ss_pred             EEeccceeeec------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh--------HHH
Confidence            99998875422      12356899999999998665544   79999999999999999999843211        111


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      ......         ....+    ..+...+..+.+++.+||+.||++|||++|+++.|..+..
T Consensus       220 ~~~~~~---------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          220 GMKVAL---------EGLRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHH---------SCCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHh---------cCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            111110         11112    2333445579999999999999999999999999998864

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=349.87  Aligned_cols=273  Identities=27%  Similarity=0.479  Sum_probs=205.8

Q ss_pred             HHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCccee
Q 037010          266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       266 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      ......++|++.+.||+|+||.||+|.+.+.... ...+.++++...     +.......+.+.+|++++++++||||++
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~hp~iv~  114 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPY-EPFTMVAVKMLK-----EEASADMQADFQREAALMAEFDNPNIVK  114 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTT-SSEEEEEEEECC-----TTCCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCC-CCceeEEEEEec-----cccCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            3445568999999999999999999998752110 001111111111     1123344567899999999999999999


Q ss_pred             EeeEEEe-CcEEEEEEecCCCChHHHHhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 037010          346 LIGYCVE-GSLFLVYEYIENGNLSEHLRGSG----------------------RDPLPWSSRVQIALDSARGLEYIHEHT  402 (589)
Q Consensus       346 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qia~aL~~LH~~~  402 (589)
                      +++++.+ +..|+||||+++|+|.+++....                      ...+++.+++.++.||+.||+|||+++
T Consensus       115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~  194 (343)
T 1luf_A          115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK  194 (343)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            9998874 46899999999999999998642                      146899999999999999999999999


Q ss_pred             CCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc
Q 037010          403 VPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS  481 (589)
Q Consensus       403 i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt  481 (589)
                      +   +||||||+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||+|
T Consensus       195 i---vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  271 (343)
T 1luf_A          195 F---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  271 (343)
T ss_dssp             C---CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             e---ecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence            8   9999999999999999999999999976533221 12233568899999999988899999999999999999999


Q ss_pred             -CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          482 -AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       482 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                       |+.||.....        ......+..             ... ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       272 ~g~~p~~~~~~--------~~~~~~~~~-------------~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          272 YGLQPYYGMAH--------EEVIYYVRD-------------GNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TTCCTTTTSCH--------HHHHHHHHT-------------TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCcCCCCCh--------HHHHHHHhC-------------CCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence             9989843211        111111111             110 12233444579999999999999999999999999


Q ss_pred             HHhcccccc
Q 037010          561 LMTLSSTTE  569 (589)
Q Consensus       561 L~~l~~~~~  569 (589)
                      |+++....+
T Consensus       330 L~~~~~~~~  338 (343)
T 1luf_A          330 LQRMCERAE  338 (343)
T ss_dssp             HHHTTC---
T ss_pred             HHHHHhhhh
Confidence            999886443

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.6e-41  Score=344.93  Aligned_cols=252  Identities=25%  Similarity=0.365  Sum_probs=197.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|++..++ ..++.|.+     ........   .....+.+|+++|++++||||+++++++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vaiK~~-----~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~l~~~~   74 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATG-RYYAMKIL-----RKEVIIAK---DEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEE-----EHHHHHHT---TCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCC-CEEEEEEE-----eHHHhhhh---hHHHHHHHHHHHHHhCCCCcCcceEEEE
Confidence            467999999999999999999977553 22332222     11111111   1234577899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        75 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~vkL~DF  149 (337)
T 1o6l_A           75 QTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCcCCHHHEEECCCCCEEEeec
Confidence            74 56899999999999999998654  48999999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+...
T Consensus       150 G~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~  220 (337)
T 1o6l_A          150 GLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME  220 (337)
T ss_dssp             TTCBCSCCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC
T ss_pred             cchhhcccC-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcC
Confidence            999853322 2223456899999999999999999999999999999999999999953221        1112221111


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                                 ..    ..|...+..+.+|+.+||+.||.+||     +++|+++|
T Consensus       221 -----------~~----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          221 -----------EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----------CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----------CC----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                       11    12333445789999999999999999     99999988

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.8e-41  Score=363.39  Aligned_cols=253  Identities=29%  Similarity=0.471  Sum_probs=201.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|.+.+.                 .+++|.++. ...+.+.+|+++|++++||||+++++
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----------------~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  253 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYRGN-----------------KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG  253 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTE-----------------EEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEecCC-----------------eEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEE
Confidence            456899999999999999999987643                 222222221 12356889999999999999999999


Q ss_pred             EEEeC--cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          349 YCVEG--SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       349 ~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++.+.  ..|+||||+++|+|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus       254 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i---vHrDlkp~Nill~~~~~~kl  330 (450)
T 1k9a_A          254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKV  330 (450)
T ss_dssp             EEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECTTSCEEE
T ss_pred             EEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCCHhhEEECCCCCEEE
Confidence            87643  58999999999999999988766568999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||+++.....    .....+++.|+|||.+.+..++.++|||||||++|||+| |+.||......     ...   ..
T Consensus       331 ~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~---~~  398 (450)
T 1k9a_A          331 SDFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVV---PR  398 (450)
T ss_dssp             CCCTTCEECC----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----THH---HH
T ss_pred             eeCCCccccccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHH---HH
Confidence            999999854321    122357889999999999999999999999999999998 99998543221     111   11


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      +          .....    ...+..++..+.+|+.+||+.||.+|||++++++.|+.+....
T Consensus       399 i----------~~~~~----~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          399 V----------EKGYK----MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             H----------HTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             H----------HcCCC----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            1          11111    1233444567999999999999999999999999999887553

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.6e-42  Score=344.39  Aligned_cols=259  Identities=29%  Similarity=0.445  Sum_probs=207.6

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCCCCcceeE
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      ...++|++.+.||+|+||.||+|.+..+..               .+++|...  ....+.+.+|++++++++||||+++
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---------------~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   74 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSL---------------TVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL   74 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTE---------------EEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCE---------------EEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            356789999999999999999999876421               12222221  2234568889999999999999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++++.+ +..|+||||+.+++|.+++.......+++..++.++.|++.||+|||++++   +||||||+||+++.++.+|
T Consensus        75 ~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~~  151 (288)
T 3kfa_A           75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVK  151 (288)
T ss_dssp             EEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTC---CCSCCSGGGEEECGGGCEE
T ss_pred             EEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCc---cCCCCCcceEEEcCCCCEE
Confidence            998874 468999999999999999988777779999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |+|||++...............+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....     ....... 
T Consensus       152 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~-  225 (288)
T 3kfa_A          152 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELL-  225 (288)
T ss_dssp             ECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHH-
T ss_pred             EccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHH-
Confidence            99999998765443333344567889999999998899999999999999999999 8888843221     1111111 


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                                  .....    ...+...+..+.+++.+||..||.+|||++|+++.|+.+...
T Consensus       226 ------------~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          226 ------------EKDYR----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ------------HTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------hccCC----CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                        11111    122334445799999999999999999999999999887654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-41  Score=351.65  Aligned_cols=277  Identities=26%  Similarity=0.404  Sum_probs=208.7

Q ss_pred             ccccHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-
Q 037010          260 VEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-  338 (589)
Q Consensus       260 ~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-  338 (589)
                      ..+...+.....++|++.+.||+|+||.||+|.+.+... ....+.++++...     +.......+.+.+|++++.++ 
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~   83 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLK-----EGATHSEHRALMSELKILIHIG   83 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEEC-----TTCCHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccc-cccceEEEEEEec-----CcCCHHHHHHHHHHHHHHHhhc
Confidence            344455556677899999999999999999998754211 1111122222111     112334456789999999999 


Q ss_pred             CCCcceeEeeEEEeC--cEEEEEEecCCCChHHHHhcCCC----------------------------------------
Q 037010          339 HHLNLVRLIGYCVEG--SLFLVYEYIENGNLSEHLRGSGR----------------------------------------  376 (589)
Q Consensus       339 ~hpnIv~l~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------  376 (589)
                      +||||+++++++.+.  ..++||||+++|+|.+++.....                                        
T Consensus        84 ~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (359)
T 3vhe_A           84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSA  163 (359)
T ss_dssp             CCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------
T ss_pred             CCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccc
Confidence            799999999988753  38999999999999999976542                                        


Q ss_pred             ------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          377 ------------------------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       377 ------------------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                                              ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||++
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~i---vH~Dikp~NIll~~~~~~kl~Dfg~a  240 (359)
T 3vhe_A          164 SSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLA  240 (359)
T ss_dssp             --------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEECCCGGG
T ss_pred             ccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChhhEEEcCCCcEEEEeccce
Confidence                                    128899999999999999999999998   99999999999999999999999999


Q ss_pred             cccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          433 KLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       433 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      ........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......    ........      
T Consensus       241 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~~------  310 (359)
T 3vhe_A          241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRLK------  310 (359)
T ss_dssp             SCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----HHHHHHHH------
T ss_pred             eeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----HHHHHHHH------
Confidence            86533222 22334678899999999998999999999999999999999 99998543221    11111111      


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                             .....    ..+...+..+.+++.+||+.||.+|||++|++++|+.+..
T Consensus       311 -------~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          311 -------EGTRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             -------HTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------cCCCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence                   11111    1223334568999999999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.9e-42  Score=358.27  Aligned_cols=260  Identities=26%  Similarity=0.448  Sum_probs=200.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+.          +....+..+++.+|+++|++++||||++++++
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~-~vavK~~~----------~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  180 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNT-LVAVKSCR----------ETLPPDLKAKFLQEARILKQYSHPNIVRLIGV  180 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCC-EEEEEECC----------TTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCe-EEEEEEcc----------ccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            35678999999999999999999875422 22222111          11223344568889999999999999999999


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+++|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus       181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i---vHrDlkp~Nil~~~~~~~kl~D  256 (377)
T 3cbl_A          181 CTQKQPIYIVMELVQGGDFLTFLRTEGA-RLRVKTLLQMVGDAAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISD  256 (377)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCCcEEEEEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCc---CCcccCHHHEEEcCCCcEEECc
Confidence            875 468999999999999999976532 48999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCC-CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGSASL-PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ||+++......... .....+++.|+|||.+..+.++.++|||||||++|||+| |+.||.....     ....   ..+
T Consensus       257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~~~~---~~~  328 (377)
T 3cbl_A          257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTR---EFV  328 (377)
T ss_dssp             GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----HHHH---HHH
T ss_pred             CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHH---HHH
Confidence            99997543221111 112345778999999998899999999999999999998 8888843211     1111   111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                                    ........+..++..+.+|+.+||+.||++|||++++++.|+.+..
T Consensus       329 --------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          329 --------------EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             --------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------------HcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence                          1111112233445578999999999999999999999999998864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-41  Score=353.04  Aligned_cols=260  Identities=18%  Similarity=0.297  Sum_probs=198.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ..++.|.+......     ........+.+.+|+++|++++||||++++++
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~~avK~i~~~~~~-----~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~   83 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTG-LEYAAKFIKKRQSR-----ASRRGVCREEIEREVSILRQVLHPNIITLHDV   83 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEBCSST-----TCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCC-CEEEEEEEEccccc-----cccchhHHHHHHHHHHHHHhCCCcCCCcEEEE
Confidence            4578999999999999999999987653 23333322111000     00000123567889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC----cE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF----HA  424 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~----~v  424 (589)
                      +.+ +..|+||||+.+|+|.+++....  .+++..++.++.||+.||+|||++|+   +||||||+|||++.++    .+
T Consensus        84 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~~~~~~~v  158 (361)
T 2yab_A           84 YENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKI---AHFDLKPENIMLLDKNIPIPHI  158 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESCTTSSSCCE
T ss_pred             EEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEeCCCCCccCE
Confidence            875 46899999999999999997654  49999999999999999999999998   9999999999998776    79


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||+|||++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....        ...+.
T Consensus       159 kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~  228 (361)
T 2yab_A          159 KLIDFGLAHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLA  228 (361)
T ss_dssp             EECCCSSCEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH
T ss_pred             EEEecCCceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHH
Confidence            99999999865432  223446799999999999988999999999999999999999999954321        11222


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+.....           ..........+..+.+|+.+||..||.+|||++|+++|-
T Consensus       229 ~i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp  274 (361)
T 2yab_A          229 NITAVSY-----------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (361)
T ss_dssp             HHHTTCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HHHhcCC-----------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            2221110           000000112234689999999999999999999999873

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=341.04  Aligned_cols=277  Identities=18%  Similarity=0.243  Sum_probs=206.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|.+..     ..     .....+.+.+|++++++++||||+++++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~-----~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGD-LFAIKVFNN-----IS-----FLRPVDVQMREFEVLKKLNHKNIVKLFAIE   76 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEECG-----GG-----GGSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCc-EEEEEEecc-----cc-----ccchHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence            4689999999999999999999876532 222222111     00     011234567899999999999999999988


Q ss_pred             EeC---cEEEEEEecCCCChHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE----cCCC
Q 037010          351 VEG---SLFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI----DKNF  422 (589)
Q Consensus       351 ~~~---~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl----~~~~  422 (589)
                      .+.   ..|+||||+++++|.+++..... ..+++..++.++.|++.||+|||++++   +||||||+|||+    +.++
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~~~  153 (319)
T 4euu_A           77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQS  153 (319)
T ss_dssp             ECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEECTTSCE
T ss_pred             ecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHEEEeccCCCCc
Confidence            643   58999999999999999986543 348999999999999999999999998   999999999999    7888


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhccc--------CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCC
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ--------YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA  494 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~  494 (589)
                      .+||+|||++.......  ......||+.|+|||++.        +..++.++|||||||++|||+||+.||........
T Consensus       154 ~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  231 (319)
T 4euu_A          154 VYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (319)
T ss_dssp             EEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG
T ss_pred             eEEEccCCCceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch
Confidence            89999999998654332  223467999999999885        57889999999999999999999999965443222


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhh------c--CCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKL------V--DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~------~--d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ..............  .....+...      .  +.......+......+.+++.+||+.||++|||++|+++|..+-.
T Consensus       232 ~~~~~~~~~~~~p~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          232 NKEVMYKIITGKPS--GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             CHHHHHHHHHHCCT--TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             hHHHHHHHhcCCCc--ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            22222222211100  000000000      0  011122456788889999999999999999999999999987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.4e-41  Score=335.33  Aligned_cols=257  Identities=30%  Similarity=0.462  Sum_probs=188.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+.+.   ..+.|.+.     ..  .........+.+.+|+++++.++||||+++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~vavK~~~-----~~--~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGD---EVAVKAAR-----HD--PDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC   75 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTE---EEEEEEC-----------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCC---eEEEEEEe-----cC--CcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            46899999999999999999987643   22221111     00  0000112235688899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC--------C
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK--------N  421 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~--------~  421 (589)
                      .+ +..|+||||+++++|.+++...   .+++..++.++.|++.||+|||++++.+++||||||+|||++.        +
T Consensus        76 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           76 LKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             CCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             ecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence            75 4589999999999999998643   4899999999999999999999999333499999999999986        6


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      +.+||+|||++.......   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....        ..
T Consensus       153 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~  221 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--------LA  221 (271)
T ss_dssp             CCEEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--------HH
T ss_pred             cceEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HH
Confidence            789999999997553322   2245789999999999988999999999999999999999999943221        01


Q ss_pred             HHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       502 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ....             ..........+...+..+.+++.+||+.||.+|||++|++++|+.+
T Consensus       222 ~~~~-------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          222 VAYG-------------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHH-------------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHHh-------------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1111             1111111223334455799999999999999999999999999864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=355.24  Aligned_cols=265  Identities=25%  Similarity=0.386  Sum_probs=202.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.+.||+|+||.||+|.+.+..... ..+         .+++|.+    ......++.+|+.++++++||||+++
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~-~~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~  139 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDP-SPL---------QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC  139 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC------CCE---------EEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCC-cce---------eEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeE
Confidence            467999999999999999999975431110 011         2233332    34455678899999999999999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGR-----DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ++++.+ +..|+||||+++|+|.+++.....     ..+++..++.++.|++.||+|||++++   +||||||+|||++.
T Consensus       140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~  216 (367)
T 3l9p_A          140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTC  216 (367)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESC
T ss_pred             EEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCe---eCCCCChhhEEEec
Confidence            998875 458999999999999999976432     348999999999999999999999999   99999999999985


Q ss_pred             CC---cEEEEeccCccccccC-CCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCC
Q 037010          421 NF---HAKVADFGLTKLTEVG-SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSAD  495 (589)
Q Consensus       421 ~~---~vkl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~  495 (589)
                      ++   .+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||+| |..||.....    
T Consensus       217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~----  292 (367)
T 3l9p_A          217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN----  292 (367)
T ss_dssp             SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred             CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----
Confidence            55   5999999999754322 2223344678999999999988999999999999999999998 8888843211    


Q ss_pred             hhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccc
Q 037010          496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED  570 (589)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~  570 (589)
                          ......+..          ....    ..+..++..+.+|+.+||+.||.+|||+++|+++|+.+......
T Consensus       293 ----~~~~~~i~~----------~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~  349 (367)
T 3l9p_A          293 ----QEVLEFVTS----------GGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  349 (367)
T ss_dssp             ----HHHHHHHHT----------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             ----HHHHHHHHc----------CCCC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhh
Confidence                111111111          1111    12333445789999999999999999999999999888765443

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.2e-41  Score=352.52  Aligned_cols=262  Identities=26%  Similarity=0.411  Sum_probs=190.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEcccc--CCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEY--GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~--~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|++....  +...+.|.+.          ........+++.+|++++++++||||+++++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~----------~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~  113 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----------VGYTEKQRRDFLGEASIMGQFDHPNIIRLEG  113 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECC----------TTCCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEec----------CccCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            468999999999999999999876321  1112211111          0113344567899999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +..|+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||++++   +||||||+|||++.++.+||+
T Consensus       114 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kl~  189 (373)
T 2qol_A          114 VVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVS  189 (373)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEEEC
T ss_pred             EEeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eCCCCCcceEEEcCCCCEEEC
Confidence            9875 45899999999999999998654 348999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCC--CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHH
Q 037010          428 DFGLTKLTEVGSASL--PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       428 Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |||+++.........  .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.....     ..   ...
T Consensus       190 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~---~~~  261 (373)
T 2qol_A          190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QD---VIK  261 (373)
T ss_dssp             CC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HH---HHH
T ss_pred             cCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HH---HHH
Confidence            999998654332211  112345778999999998999999999999999999998 9999843221     11   111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      .+.              .......+.+++..+.+++.+||+.||.+||+++||++.|..+....
T Consensus       262 ~i~--------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          262 AVD--------------EGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHH--------------TTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHH--------------cCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            111              11111123344567999999999999999999999999998886543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.5e-41  Score=338.23  Aligned_cols=258  Identities=26%  Similarity=0.487  Sum_probs=196.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHH---HHHHHHHHHHHccCCCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA---SREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      .++|++.+.||+|+||.||+|.+..+.. ..+.|.+......       .....   .+.+.+|++++++++||||++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~~~~~~-------~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   89 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKS-VVAIKSLILGDSE-------GETEMIEKFQEFQREVFIMSNLNHPNIVKLY   89 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCC-EEEEEECCCCTTT-------CCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hccceehhccccCCceeEEEEEEcCCce-EEEEEEeeccccc-------cchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence            4789999999999999999999876532 2222221111000       01111   15688899999999999999999


Q ss_pred             eEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeeccCCCcEEEcCCCc--
Q 037010          348 GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT--VPVYIHRDIKSANILIDKNFH--  423 (589)
Q Consensus       348 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~--i~~~vH~Dlkp~NILl~~~~~--  423 (589)
                      +++.+.. ++||||+++|+|.+++.... .++++..++.++.|++.||+|||+++  +   +||||||+|||++.++.  
T Consensus        90 ~~~~~~~-~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~i---vH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           90 GLMHNPP-RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPI---VHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             EEETTTT-EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCC---BCSCCSGGGEEESCCCTTC
T ss_pred             eeecCCC-eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCe---ecCCCCcceEEEeccCCCC
Confidence            9886555 79999999999999987654 35999999999999999999999999  8   99999999999988776  


Q ss_pred             ---EEEEeccCccccccCCCCCCcccccCCCCCchhcc--cCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhh
Q 037010          424 ---AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA--QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG  498 (589)
Q Consensus       424 ---vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~  498 (589)
                         +||+|||+++....    ......||+.|+|||++  ....++.++|||||||++|||++|+.||......   .  
T Consensus       165 ~~~~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~--  235 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG---K--  235 (287)
T ss_dssp             SCCEEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC---H--
T ss_pred             ceeEEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc---H--
Confidence               99999999874322    22346799999999998  4456789999999999999999999999543221   0  


Q ss_pred             HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                       .......             .........+...+..+.+++.+||+.||.+|||++|+++.|+.+
T Consensus       236 -~~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          236 -IKFINMI-------------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             -HHHHHHH-------------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             -HHHHHHH-------------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence             0111111             111111223344456799999999999999999999999999865

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.7e-41  Score=352.71  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=195.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|++..++ ..++.|.+..     ..   .......+.+.+|..++.++ +||||++++++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~-~~~AvK~~~k-----~~---~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~  121 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTD-RIYAMRVVKK-----EL---VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC  121 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEEEG-----GG---TC----CCHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCC-CEEEEEEEEh-----hh---ccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEE
Confidence            467999999999999999999987652 2222222211     10   01122234577899999877 89999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|
T Consensus       122 ~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~gi---vHrDLKp~NILl~~~g~ikL~D  196 (396)
T 4dc2_A          122 FQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTD  196 (396)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECC
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---EeccCCHHHEEECCCCCEEEee
Confidence            875 56999999999999999998754  39999999999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh-hHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK-GLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~-~~~~~~~~~~  507 (589)
                      ||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ........+.
T Consensus       197 FGla~~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~  275 (396)
T 4dc2_A          197 YGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  275 (396)
T ss_dssp             CTTCBCCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH
T ss_pred             cceeeecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh
Confidence            9999853222 2233457899999999999999999999999999999999999999954322111111 1111111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM------RSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  560 (589)
                      ..           ..    ..|...+..+.+|+.+||+.||.+||++      +|+++|
T Consensus       276 ~~-----------~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          276 EK-----------QI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HC-----------CC----CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             cc-----------cc----CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            11           11    2233445578999999999999999995      688777

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.1e-41  Score=348.70  Aligned_cols=275  Identities=21%  Similarity=0.312  Sum_probs=208.3

Q ss_pred             CCCccccHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHH
Q 037010          257 DKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKV  334 (589)
Q Consensus       257 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~i  334 (589)
                      ++...+++.+.....++|++.++||+|+||.||+|.+..++.               .+++|.+.  ......+..|+++
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------------~vavK~~~~~~~~~~~~~~e~~~   84 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK---------------YYAVKVVRNIKKYTRSAKIEADI   84 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCC---------------EEEEEEECSCHHHHHHHHHHHHH
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCe---------------EEEEEEeccchhhhhhhHHHHHH
Confidence            455667777777788999999999999999999999865522               22333322  3344566779999


Q ss_pred             HccCC-----CCcceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 037010          335 LTHVH-----HLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIH  408 (589)
Q Consensus       335 l~~l~-----hpnIv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH  408 (589)
                      +++++     ||||+++++++.. +..|+||||+ +++|.+++.......+++..++.++.||+.||+|||++++   +|
T Consensus        85 l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH  160 (360)
T 3llt_A           85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSL---TH  160 (360)
T ss_dssp             HHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE---EC
T ss_pred             HHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe---ee
Confidence            99886     9999999998764 5689999999 8899999998776679999999999999999999999998   99


Q ss_pred             eccCCCcEEEcC-------------------------CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCC
Q 037010          409 RDIKSANILIDK-------------------------NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV  463 (589)
Q Consensus       409 ~Dlkp~NILl~~-------------------------~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  463 (589)
                      |||||+|||++.                         ++.+||+|||++.....    ......||+.|+|||++.+..+
T Consensus       161 rDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~  236 (360)
T 3llt_A          161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGW  236 (360)
T ss_dssp             SCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCC
T ss_pred             CCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCC
Confidence            999999999975                         78999999999986432    2234678999999999999999


Q ss_pred             CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCC---------CC----CCCCC-
Q 037010          464 SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDP---------RL----GDNCP-  529 (589)
Q Consensus       464 s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~---------~l----~~~~~-  529 (589)
                      +.++|||||||++|+|++|+.||....     ............... +...+......         ..    +.... 
T Consensus       237 ~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~  310 (360)
T 3llt_A          237 DVSSDMWSFGCVLAELYTGSLLFRTHE-----HMEHLAMMESIIQPI-PKNMLYEATKTNGSKYVNKDELKLAWPENASS  310 (360)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHTCCC-CHHHHHHHTTSGGGGGEETTTTEECTTTTCSC
T ss_pred             CCccchHHHHHHHHHHHHCCCCCCCCc-----HHHHHHHHHHhcCCC-CHHHHhhhhhccCccccCcccceecCcccccc
Confidence            999999999999999999999995432     222222333322221 11111111100         00    00000 


Q ss_pred             ---------------hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          530 ---------------LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       530 ---------------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                     ......+.+|+.+||+.||++|||++|+++|
T Consensus       311 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          311 INSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             HHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                           0111467899999999999999999999876

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8e-41  Score=356.61  Aligned_cols=257  Identities=21%  Similarity=0.296  Sum_probs=197.5

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||+|.+..++. .++.|.+..         +.......+.+.+|++++++++||||+++++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~-~~a~K~i~~---------~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~   77 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQ-EYAAMIINT---------KKLSARDHQKLEREARICRLLKHPNIVRLHD   77 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTE-EEEEEEEES---------CSCHHHHHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCc-EEEEEEEEc---------ccCCHHHHHHHHHHHHHHHhCCCcCCCeEEE
Confidence            346789999999999999999998766532 222222211         1122234566889999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc---CCCcE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHA  424 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~---~~~~v  424 (589)
                      ++.+ +..|+||||+.+|+|.+++....  .+++..+..++.||+.||+|||++++   +||||||+|||++   .++.+
T Consensus        78 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~gi---vHrDlKp~NIll~~~~~~~~v  152 (444)
T 3soa_A           78 SISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGV---VHRNLKPENLLLASKLKGAAV  152 (444)
T ss_dssp             EEECSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSSTTEEESBSSTTCCE
T ss_pred             EEEECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEEeccCCCCcE
Confidence            8875 46899999999999999998764  39999999999999999999999999   9999999999998   46789


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....     ..   ....
T Consensus       153 kL~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~-----~~---~~~~  223 (444)
T 3soa_A          153 KLADFGLAIEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED-----QH---RLYQ  223 (444)
T ss_dssp             EECCCSSCBCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HH---HHHH
T ss_pred             EEccCceeEEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc-----HH---HHHH
Confidence            999999997654332 22244689999999999998899999999999999999999999994422     11   1112


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+....           ...........+..+.+|+.+||+.||.+|||+.|+++|
T Consensus       224 ~i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          224 QIKAGA-----------YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HHHHTC-----------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhCC-----------CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            111110           001111112334578999999999999999999999998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.3e-41  Score=356.87  Aligned_cols=256  Identities=18%  Similarity=0.248  Sum_probs=187.7

Q ss_pred             cCCCccc-eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHH-ccCCCCcceeEee
Q 037010          271 TDNFSMS-HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL-THVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~  348 (589)
                      .++|.+. +.||+|+||+||+|.+..++. .              +++|.+..  ...+.+|++++ +..+||||+++++
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~-~--------------vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~  122 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQE-K--------------FALKMLQD--CPKARREVELHWRASQCPHIVRIVD  122 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCC-E--------------EEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCC-E--------------EEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeE
Confidence            4567776 789999999999999876532 2              22222211  12455688876 4458999999999


Q ss_pred             EEEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC---
Q 037010          349 YCVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---  420 (589)
Q Consensus       349 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~---  420 (589)
                      ++..     +.+|+||||+++|+|.+++.......+++..++.++.||+.||+|||++++   +||||||+|||++.   
T Consensus       123 ~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~Nill~~~~~  199 (400)
T 1nxk_A          123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRP  199 (400)
T ss_dssp             EEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSSST
T ss_pred             EEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCc---cccCcCcceEEEecCCC
Confidence            7753     458999999999999999988766679999999999999999999999998   99999999999987   


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      ++.+||+|||+++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus       200 ~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  277 (400)
T 1nxk_A          200 NAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT  277 (400)
T ss_dssp             TCCEEECCCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred             CccEEEEecccccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence            789999999999865322  223456789999999999999999999999999999999999999965543322111111


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                      ......               ...........+..+.+|+.+||+.||.+|||++|+++|-.-
T Consensus       278 ~i~~~~---------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  325 (400)
T 1nxk_A          278 RIRMGQ---------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  325 (400)
T ss_dssp             HHHHTC---------------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             HHHcCc---------------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence            111000               001111112344578999999999999999999999998543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5.4e-41  Score=341.93  Aligned_cols=266  Identities=25%  Similarity=0.400  Sum_probs=203.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+....+.. ..+.++++...     +.......+.+.+|++++++++||||++++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~-~~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRA-GYTTVAVKMLK-----ENASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCS-SEEEEEEEECC-----TTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCccc-CcceEEEEecc-----CCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            4578999999999999999999875432110 01111111111     11234455678899999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGR----------------------DPLPWSSRVQIALDSARGLEYIHEHTVPVY  406 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~  406 (589)
                      +.+ +..|+||||+++++|.+++.....                      ..+++..++.++.|++.||+|||++++   
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---  171 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL---  171 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTE---
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCC---
Confidence            864 468999999999999999986542                      348899999999999999999999998   


Q ss_pred             EeeccCCCcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCc
Q 037010          407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKE  484 (589)
Q Consensus       407 vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~  484 (589)
                      +||||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999865432221 2233467889999999988889999999999999999999 999


Q ss_pred             ccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          485 AIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       485 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ||.....     ........             ....    ...+...+..+.+++.+||+.||.+|||++|++++|+++
T Consensus       252 p~~~~~~-----~~~~~~~~-------------~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          252 PYPGIPP-----ERLFNLLK-------------TGHR----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             SSTTCCG-----GGHHHHHH-------------TTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCH-----HHHHHHhh-------------cCCc----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            9843321     11111111             1111    122334445799999999999999999999999999987


Q ss_pred             cc
Q 037010          565 SS  566 (589)
Q Consensus       565 ~~  566 (589)
                      ..
T Consensus       310 ~~  311 (314)
T 2ivs_A          310 MV  311 (314)
T ss_dssp             HH
T ss_pred             Hh
Confidence            64

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=340.57  Aligned_cols=266  Identities=27%  Similarity=0.438  Sum_probs=196.0

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC--CCCccee
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV--HHLNLVR  345 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l--~hpnIv~  345 (589)
                      ....++|++.+.||+|+||.||+|.+.+.                 .+++|.+.......+..|.+++..+  +||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----------------~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~   95 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGE-----------------KVAVKVFFTTEEASWFRETEIYQTVLMRHENILG   95 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEETTE-----------------EEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCC
T ss_pred             cccccceEEEeEeecCCCeEEEEEEECCc-----------------eEEEEEEeccccchhhhHHHHHHHHhhcCCCeee
Confidence            34567899999999999999999987632                 2333333322333445566666555  8999999


Q ss_pred             EeeEEEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCceEeeccC
Q 037010          346 LIGYCVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH--------TVPVYIHRDIK  412 (589)
Q Consensus       346 l~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~--------~i~~~vH~Dlk  412 (589)
                      +++++.+     ...|+||||+++|+|.+++...   .+++..++.++.|++.||+|||++        ++   +|||||
T Consensus        96 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i---vH~Dik  169 (337)
T 3mdy_A           96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI---AHRDLK  169 (337)
T ss_dssp             EEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE---ECSCCC
T ss_pred             EEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE---Eecccc
Confidence            9998764     3589999999999999999764   389999999999999999999998        77   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCCC---CCcccccCCCCCchhcccCCCCCcc------cchhhHHHHHHHHHcC-
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYGDVSPK------VDVYAFGVVLYELISA-  482 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~------sDvwSlGvll~elltG-  482 (589)
                      |+|||++.++.+||+|||++.........   ......||+.|+|||++.+..++..      +|||||||++|||+|| 
T Consensus       170 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~  249 (337)
T 3mdy_A          170 SKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRC  249 (337)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             hHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhcc
Confidence            99999999999999999999765432222   1124579999999999987766655      9999999999999999 


Q ss_pred             ---------CcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCC-CChHHHHHHHHHHHHhcccCCCCCC
Q 037010          483 ---------KEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDN-CPLDSVLKMAQLAKVCTQEYPQLRP  552 (589)
Q Consensus       483 ---------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RP  552 (589)
                               +.||...........    ........        ....+..... .+.+++..+.+|+.+||+.||.+||
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~----~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp  317 (337)
T 3mdy_A          250 VSGGIVEEYQLPYHDLVPSDPSYE----DMREIVCI--------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL  317 (337)
T ss_dssp             CBTTBCCCCCCTTTTTSCSSCCHH----HHHHHHTT--------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred             CcccccccccccHhhhcCCCCchh----hhHHHHhh--------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCC
Confidence                     444433222111111    11111110        0111111111 1236778899999999999999999


Q ss_pred             CHHHHHHHHHhccccc
Q 037010          553 SMRSIVVALMTLSSTT  568 (589)
Q Consensus       553 s~~evl~~L~~l~~~~  568 (589)
                      |++|++++|+.+....
T Consensus       318 s~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          318 TALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHHHhhc
Confidence            9999999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-41  Score=344.96  Aligned_cols=255  Identities=18%  Similarity=0.295  Sum_probs=198.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ..++.|.+.            ........+.+|+++++.++||||++++++
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~a~K~~~------------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~   69 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSK-KTYMAKFVK------------VKGTDQVLVKKEISILNIARHRNILHLHES   69 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEEC------------CCTHHHHHHHHHHHHHHHSCCTTBCCEEEE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCC-cEEEEEEEe------------cCcccHHHHHHHHHHHHhCCCCCCCeEeEE
Confidence            3578999999999999999999977652 222222211            112334567889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC--CCcEEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK--NFHAKV  426 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~--~~~vkl  426 (589)
                      +.+ +..|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.  ++.+||
T Consensus        70 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gi---vH~Dlkp~NIl~~~~~~~~~kl  145 (321)
T 1tki_A           70 FESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNI---GHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSSSCCCEEE
T ss_pred             EecCCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCC---CcCCCCHHHEEEccCCCCCEEE
Confidence            865 56899999999999999997653 348999999999999999999999998   99999999999987  789999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      +|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        ......+
T Consensus       146 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i  215 (321)
T 1tki_A          146 IEFGQARQLKPGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENI  215 (321)
T ss_dssp             CCCTTCEECCTTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH
T ss_pred             EECCCCeECCCCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHH
Confidence            9999998654322  22346799999999999988899999999999999999999999954321        1122222


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ......           .......+.+..+.+|+.+||..||.+|||++|+++|-.
T Consensus       216 ~~~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          216 MNAEYT-----------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             HHTCCC-----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             HcCCCC-----------CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            211100           000000122347899999999999999999999999854

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5e-41  Score=345.59  Aligned_cols=252  Identities=22%  Similarity=0.317  Sum_probs=195.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|.+.     .....+.   +....+.+|+++++.++||||+++++++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~-~vaiK~~~-----~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~   78 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQ-KVALKFIS-----RQLLKKS---DMHMRVEREISYLKLLRHPHIIKLYDVI   78 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEE-----HHHHHHT---TCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCC-EEEEEEEe-----hHHccch---hHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            4789999999999999999999866532 22222211     1110000   1124578899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+ +|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        79 ~~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~gi---vH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           79 TTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKI---VHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             ECSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCSTTTEEECTTCCEEECCS
T ss_pred             EeCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCchhhEEEcCCCCEEEEEe
Confidence            75 5689999999 679999997654  39999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++.......  ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........             
T Consensus       153 G~s~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-------------  217 (336)
T 3h4j_B          153 GLSNIMTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-------------  217 (336)
T ss_dssp             SCTBTTTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-------------
T ss_pred             ccceeccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-------------
Confidence            9998654322  2344679999999999987776 68999999999999999999999543321100             


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                               ..+... ....|...+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       218 ---------~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          218 ---------KKVNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             ---------CCCCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             ---------HHHHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence                     000000 01223334557899999999999999999999999854

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.5e-41  Score=348.39  Aligned_cols=253  Identities=26%  Similarity=0.400  Sum_probs=193.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|++..++ ..++.|.+     .......   ....+.+.+|.++++.+ +||||+++++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~AvK~~-----~~~~~~~---~~~~~~~~~E~~il~~~~~hp~Iv~l~~   91 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETG-DLYAVKVL-----KKDVILQ---DDDVECTMTEKRILSLARNHPFLTQLFC   91 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEE-----EHHHHHH---HTTHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCC-CEEEEEEE-----EHHHhcc---hhHHHHHHHHHHHHHhccCCCceeeEEE
Confidence            3578999999999999999999987653 22222222     1111111   12234577899999988 6999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++++||+
T Consensus        92 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gi---vHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A           92 CFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGI---IYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---cccCCCHHHEEECCCCCEEEc
Confidence            8875 56899999999999999998754  39999999999999999999999999   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ...+..+.
T Consensus       167 DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~  237 (353)
T 3txo_A          167 DFGMCKEGICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAIL  237 (353)
T ss_dssp             CCTTCBCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred             cccceeecccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence            99999753322 2223446899999999999988999999999999999999999999954321        12222222


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM------RSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  560 (589)
                      ..             .  ...|......+.+|+.+||+.||.+||++      +|+++|
T Consensus       238 ~~-------------~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          238 ND-------------E--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HC-------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             cC-------------C--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            11             1  11233344578999999999999999999      888887

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.5e-41  Score=343.00  Aligned_cols=281  Identities=25%  Similarity=0.372  Sum_probs=205.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEcc---ccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRG---EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      .++|++.+.||+|+||.||+|++..   ..+...+.|.+           +.......+.+.+|++++++++||||++++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~-----------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   90 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL-----------QHSGPDQQRDFQREIQILKALHSDFIVKYR   90 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEE-----------SSCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEe-----------ccCCHHHHHHHHHHHHHHHhcCCCceeEEE
Confidence            4689999999999999999998632   11222222111           112334456788999999999999999999


Q ss_pred             eEEE---eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          348 GYCV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       348 ~~~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      +++.   ++..|+||||+++++|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dikp~NIl~~~~~~~  166 (327)
T 3lxl_A           91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESEAHV  166 (327)
T ss_dssp             EEEECSSSCEEEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEETTEE
T ss_pred             EEEecCCCceEEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCChhhEEECCCCCE
Confidence            9875   2458999999999999999976432 48999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          425 KVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      ||+|||++.........  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....         ..
T Consensus       167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---------~~  237 (327)
T 3lxl_A          167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA---------EF  237 (327)
T ss_dssp             EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---------HH
T ss_pred             EEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc---------hh
Confidence            99999999865433221  22335688889999999988899999999999999999999999843211         00


Q ss_pred             HHHH--hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccccCCC
Q 037010          503 FEEV--LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGS  575 (589)
Q Consensus       503 ~~~~--~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~  575 (589)
                      ....  .........+...+........+...+..+.+|+.+||+.||.+|||++|++++|+.+......|+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~  312 (327)
T 3lxl_A          238 LRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHA  312 (327)
T ss_dssp             HHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----------
T ss_pred             hhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccccc
Confidence            0000  001111222333333333334455566789999999999999999999999999999998888777643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.7e-42  Score=373.76  Aligned_cols=259  Identities=29%  Similarity=0.497  Sum_probs=205.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++|++.++||+|+||.||+|.+.++  .              .+++|.+..  ...+++.+|+++|++++||||++++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~--~--------------~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  328 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGT--T--------------RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLY  328 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTT--E--------------EEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCC--c--------------eEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEE
Confidence            456789999999999999999988653  1              122222221  1235688999999999999999999


Q ss_pred             eEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          348 GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       348 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +++.++..|+||||+.+|+|.+++.......+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+
T Consensus       329 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i---vHrDlkp~NIll~~~~~~kl~  405 (535)
T 2h8h_A          329 AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVA  405 (535)
T ss_dssp             EEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCCHhhEEEcCCCcEEEc
Confidence            99988889999999999999999976544458999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||+++..............++..|+|||++....++.++|||||||++|||+| |+.||.....     .   .....+
T Consensus       406 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~---~~~~~i  477 (535)
T 2h8h_A          406 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----R---EVLDQV  477 (535)
T ss_dssp             CTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----H---HHHHHH
T ss_pred             ccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----H---HHHHHH
Confidence            999998654322112223456789999999988899999999999999999999 8888843211     1   111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      ..              ......+..++..+.+|+.+||+.||++|||+++|++.|+.+....+
T Consensus       478 ~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          478 ER--------------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             HT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             Hc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            11              11112334455679999999999999999999999999999876544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-41  Score=335.86  Aligned_cols=255  Identities=27%  Similarity=0.460  Sum_probs=200.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|.+.+.  ...              ++|....  ...+++.+|++++++++||||+++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~v--------------aiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   70 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNK--DKV--------------AIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG   70 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTT--EEE--------------EEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCC--CeE--------------EEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            46899999999999999999987532  122              2222211  11246788999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +..|+||||+++++|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+||+++.++.+||+
T Consensus        71 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~Nili~~~~~~kl~  146 (267)
T 3t9t_A           71 VCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVS  146 (267)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCCGGGEEECGGGCEEEC
T ss_pred             EEccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCchheEEECCCCCEEEc
Confidence            8875 46899999999999999998654 348999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||++...............+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....        ......+
T Consensus       147 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i  218 (267)
T 3t9t_A          147 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDI  218 (267)
T ss_dssp             CTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHH
T ss_pred             ccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHH
Confidence            999998654322222233567889999999988899999999999999999999 8888843211        1111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ..          ....    ..+...+..+.+++.+||+.||.+|||+++++++|..+...
T Consensus       219 ~~----------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          219 ST----------GFRL----YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HT----------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hc----------CCcC----CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            11          1111    12223345789999999999999999999999999988754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4.4e-41  Score=344.65  Aligned_cols=256  Identities=21%  Similarity=0.326  Sum_probs=195.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..+.. ..+.|.+..+          ......+.+.+|+.+++.++||||++++++
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~-~vavK~~~~~----------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~   73 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEE-AVAVKIVDMK----------RAVDCPENIKKEICINKMLNHENVVKFYGH   73 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEECC-----------------CHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCc-EEEEEEEEcc----------cccchHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            35789999999999999999998876532 2222221110          011223457889999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.++ ..|+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~gi---vH~Dlkp~NIll~~~~~~kl~D  148 (323)
T 3tki_A           74 RREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISD  148 (323)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECC
T ss_pred             EecCCeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccccchHHEEEeCCCCEEEEE
Confidence            8754 5899999999999999987653  48999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCC-CCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ||++........ .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......    ..   ....
T Consensus       149 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~---~~~~  221 (323)
T 3tki_A          149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QE---YSDW  221 (323)
T ss_dssp             CTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS----HH---HHHH
T ss_pred             eeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH----HH---HHHH
Confidence            999986543222 22334689999999999987765 778999999999999999999995443211    11   1111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ...             .............+.+|+.+||+.||.+|||++|+++|-
T Consensus       222 ~~~-------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          222 KEK-------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             HTT-------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             hcc-------------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence            110             000011123345788999999999999999999999884

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.1e-41  Score=358.67  Aligned_cols=268  Identities=22%  Similarity=0.326  Sum_probs=201.6

Q ss_pred             cHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCc
Q 037010          263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLN  342 (589)
Q Consensus       263 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpn  342 (589)
                      ...++....++|++.++||+|+||+||+|++..++ ..++.|.+     ......+.   .....+.+|.+++..++|||
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-~~vAvK~~-----~~~~~~~~---~~~~~~~~E~~il~~~~hp~  135 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD-KVFAMKIL-----NKWEMLKR---AETACFREERDVLVNGDSKW  135 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEE-----EHHHHHHT---TTTCCHHHHHHHHHHSCTTT
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCC-cEEEEEEE-----EHHHhhhH---HHHHHHHHHHHHHHhCCCCC
Confidence            34555566789999999999999999999987652 22222221     11111111   01123778999999999999


Q ss_pred             ceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          343 LVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       343 Iv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      |+++++++.+ +.+|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.+
T Consensus       136 Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~gi---iHrDLKp~NILl~~~  211 (437)
T 4aw2_A          136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHY---VHRDIKPDNILMDMN  211 (437)
T ss_dssp             BCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTT
T ss_pred             EEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---EecccCHHHeeEcCC
Confidence            9999998875 46899999999999999998643 349999999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      +.+||+|||+++.............+||+.|+|||++.     ...++.++|||||||++|||++|+.||.....     
T Consensus       212 g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~-----  286 (437)
T 4aw2_A          212 GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-----  286 (437)
T ss_dssp             SCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-----
T ss_pred             CCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh-----
Confidence            99999999999865444333334468999999999986     56789999999999999999999999954321     


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQL--RPSMRSIVVAL  561 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L  561 (589)
                         ......+...      .....-+..    ..+.+..+.+|+++||..+|++  ||+++|+++|-
T Consensus       287 ---~~~~~~i~~~------~~~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          287 ---VETYGKIMNH------KERFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             ---HHHHHHHHTH------HHHCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             ---hHHHHhhhhc------cccccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence               1112222110      000111111    1123446899999999888888  99999999983

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.2e-40  Score=344.21  Aligned_cols=260  Identities=24%  Similarity=0.352  Sum_probs=197.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|++..++ ..++.|.+..     ..   .......+.+.+|.+++.++ +||||++++++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~aiK~~~~-----~~---~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~   78 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTD-RIYAMKVVKK-----EL---VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC   78 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEEEG-----GG---SCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCC-CEEEEEEEEh-----HH---hcchHHHHHHHHHHHHHHhcCCCCccCeEEEE
Confidence            367999999999999999999987652 2222222211     10   11234456678899999887 89999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++++||+|
T Consensus        79 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~~kL~D  153 (345)
T 3a8x_A           79 FQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGI---IYRDLKLDNVLLDSEGHIKLTD  153 (345)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCHHHEEECCCCCEEEEe
Confidence            865 56899999999999999998654  38999999999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh-hhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS-KGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~  507 (589)
                      ||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .........+.
T Consensus       154 FG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~  232 (345)
T 3a8x_A          154 YGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  232 (345)
T ss_dssp             GGGCBCSCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred             ccccccccCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence            9999753222 222345689999999999999999999999999999999999999995432211110 01111111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH------HHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM------RSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~~  560 (589)
                      ..           ..    ..|...+..+.+|+.+||+.||.+||++      +|+++|
T Consensus       233 ~~-----------~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          233 EK-----------QI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HC-----------CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             cC-----------CC----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            11           11    1233445578999999999999999995      788877

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.8e-41  Score=338.94  Aligned_cols=270  Identities=23%  Similarity=0.409  Sum_probs=203.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH----HHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----QASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~----~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.+.||+|+||.||+|.+.......  .         ..+++|.+..    ...+.+.+|++++++++||||+++
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~--~---------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   88 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNT--G---------EQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY   88 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSC--S---------EEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCcc--C---------eEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeee
Confidence            356899999999999999999853221100  1         1223333321    123568889999999999999999


Q ss_pred             eeEEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          347 IGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       347 ~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      ++++.+   ...++||||+++++|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.
T Consensus        89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dikp~Nil~~~~~~  164 (302)
T 4e5w_A           89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQ  164 (302)
T ss_dssp             EEEEEC---CCEEEEEECCTTCBHHHHHHHHTT-TCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEETTE
T ss_pred             eeEEecCCCceEEEEEEeCCCCcHHHHHHhccc-cCCHHHHHHHHHHHHHHHHHhhcCCc---ccCCCchheEEEcCCCC
Confidence            998864   448999999999999999965543 48999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCC--CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          424 AKVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      +||+|||++........  .......||..|+|||.+.+..++.++||||||+++|+|+||..|+....          .
T Consensus       165 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----------~  234 (302)
T 4e5w_A          165 VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM----------A  234 (302)
T ss_dssp             EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH----------H
T ss_pred             EEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh----------h
Confidence            99999999986644322  12334568889999999988899999999999999999999998863211          1


Q ss_pred             HHHHHhcCCC---hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          502 LFEEVLNLPD---PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       502 ~~~~~~~~~~---~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ..........   ....+...+........+...+..+.+|+.+||+.||.+|||++|+++.|+.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          235 LFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111111111   111122222222223344455668999999999999999999999999998874

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=333.95  Aligned_cols=263  Identities=22%  Similarity=0.388  Sum_probs=203.2

Q ss_pred             cCCCccce-eeccCCcEEEEEEEEcccc-CCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSH-KIGQGGFGAVYYAELRGEY-GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|.+.+ .||+|+||.||+|.+.... +...+.|.+.          +.......+++.+|++++++++||||+++++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   77 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK----------QGTEKADTEEMMREAQIMHQLDNPYIVRLIG   77 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEEC----------SSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecC----------CccchhHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            45677776 9999999999999865432 2112221111          0123345667889999999999999999999


Q ss_pred             EEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          349 YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       349 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      ++.++..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++++   +||||||+||+++.++.+||+|
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nili~~~~~~kl~D  153 (287)
T 1u59_A           78 VCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISD  153 (287)
T ss_dssp             EEESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEEETTEEEECC
T ss_pred             EecCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCE---eeCCCchheEEEcCCCCEEECc
Confidence            998888999999999999999997543 359999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          429 FGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       429 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      ||++.........  ......+|+.|+|||++.+..++.++||||||+++|||+| |+.||.....     ..   ....
T Consensus       154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~---~~~~  225 (287)
T 1u59_A          154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PE---VMAF  225 (287)
T ss_dssp             CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HH---HHHH
T ss_pred             ccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HH---HHHH
Confidence            9999865433221  1223456889999999988889999999999999999999 9999854321     11   1111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      +..          ...+    ..+...+..+.+++.+||+.||.+|||+++++++|..+.....
T Consensus       226 i~~----------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          226 IEQ----------GKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             HHT----------TCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             Hhc----------CCcC----CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            111          1111    2233445679999999999999999999999999998875443

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.8e-41  Score=344.87  Aligned_cols=269  Identities=21%  Similarity=0.379  Sum_probs=191.6

Q ss_pred             HHHhhcCCCccceeeccCCcEEEEEEEEccccCC--ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcc
Q 037010          266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGN--SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNL  343 (589)
Q Consensus       266 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnI  343 (589)
                      +.....++|++.+.||+|+||.||+|.+..+.+.  ..+.|.+.         .........+++.+|++++++++||||
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~~i   87 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK---------ADIIASSDIEEFLREAACMKEFDHPHV   87 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC---------------CHHHHHHHHHHHHHTTCCCTTB
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEec---------ccccCHHHHHHHHHHHHHHHHCCCCce
Confidence            3444567899999999999999999987665321  11111110         001122345678899999999999999


Q ss_pred             eeEeeEEEeCc-------EEEEEEecCCCChHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          344 VRLIGYCVEGS-------LFLVYEYIENGNLSEHLRGSG----RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       344 v~l~~~~~~~~-------~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      +++++++.+..       .++||||+.+|+|.+++....    ...+++..++.++.|++.||+|||++++   +|||||
T Consensus        88 v~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i---vH~Dik  164 (323)
T 3qup_A           88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF---IHRDLA  164 (323)
T ss_dssp             CCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCS
T ss_pred             ehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCc---ccCCCC
Confidence            99999886542       389999999999999996532    2258999999999999999999999998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGN  490 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~  490 (589)
                      |+|||++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       165 p~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~  244 (323)
T 3qup_A          165 ARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE  244 (323)
T ss_dssp             GGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence            9999999999999999999986543222 12223456789999999998899999999999999999999 888885432


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      .     ...   .......          ..    ...+...+..+.+|+.+||+.||++|||+.++++.|+.+....
T Consensus       245 ~-----~~~---~~~~~~~----------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          245 N-----AEI---YNYLIGG----------NR----LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             G-----GGH---HHHHHTT----------CC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             h-----HHH---HHHHhcC----------CC----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            1     111   1111110          01    1223344457999999999999999999999999999887654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.1e-41  Score=355.91  Aligned_cols=264  Identities=23%  Similarity=0.334  Sum_probs=199.8

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcce
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLV  344 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv  344 (589)
                      .++....++|++.+.||+|+||.||+|++..++ ..++.|.+     ......+..   ....+.+|.++++.++||||+
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-~~~AiK~~-----~k~~~~~~~---~~~~~~~E~~il~~l~hp~Iv  132 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-KVYAMKLL-----SKFEMIKRS---DSAFFWEERDIMAFANSPWVV  132 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEE-----EHHHHHHTC---CCSTHHHHHHHHHHCCCTTBC
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCC-cEEEEEEE-----ehhhhhhhH---HHHHHHHHHHHHHhCCCCCCC
Confidence            344455689999999999999999999987652 22222222     111111111   112367899999999999999


Q ss_pred             eEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          345 RLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       345 ~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      ++++++.+ +.+|+||||++||+|.+++...   .+++..++.++.||+.||+|||++++   +||||||+|||++.++.
T Consensus       133 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~gi---vHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGF---IHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             CEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSC
T ss_pred             eEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCCHHHeeECCCCC
Confidence            99998875 4589999999999999999764   38999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCC----CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD----VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      +||+|||+++.............+||+.|+|||++....    ++.++|||||||++|||++|+.||.....        
T Consensus       207 ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------  278 (410)
T 3v8s_A          207 LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------  278 (410)
T ss_dssp             EEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------
T ss_pred             EEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------
Confidence            999999999865443333334578999999999997655    88999999999999999999999954321        


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQL--RPSMRSIVVALM  562 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L~  562 (589)
                      ......+...      ... +  ..+  .....+..+.+|+.+||+.+|.+  ||+++||++|-.
T Consensus       279 ~~~~~~i~~~------~~~-~--~~p--~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~  332 (410)
T 3v8s_A          279 VGTYSKIMNH------KNS-L--TFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  332 (410)
T ss_dssp             HHHHHHHHTH------HHH-C--CCC--TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred             hhHHHHHHhc------ccc-c--cCC--CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence            1122222110      000 0  000  01123456899999999999988  999999999953

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-40  Score=346.40  Aligned_cols=257  Identities=21%  Similarity=0.317  Sum_probs=199.2

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||+|.+..++ ..++.|.+..         +.......+.+.+|++++++++||||+++++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~~---------~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~   95 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTG-LEFAAKIINT---------KKLSARDFQKLEREARICRKLQHPNIVRLHD   95 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEET---------TTCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCC-CEEEEEEEEc---------ccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34578999999999999999999887653 2222222211         1223345567889999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC---CcE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN---FHA  424 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~---~~v  424 (589)
                      ++.+ +..|+||||+.+|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.+   +.+
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i---vH~Dlkp~NIll~~~~~~~~~  170 (362)
T 2bdw_A           96 SIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAV  170 (362)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSGGGEEESCSSTTCCE
T ss_pred             EEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCchHHEEEecCCCCCCE
Confidence            8875 45899999999999999997654  48999999999999999999999999   999999999999765   459


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||+|||++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     .   ....
T Consensus       171 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~---~~~~  240 (362)
T 2bdw_A          171 KLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----H---RLYA  240 (362)
T ss_dssp             EECCCTTCBCCTTC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHH
T ss_pred             EEeecCcceEecCC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----H---HHHH
Confidence            99999999865422  223446899999999999988999999999999999999999999954321     1   1111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+....           ...........+..+.+|+.+||+.||.+|||+.|+++|-
T Consensus       241 ~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  286 (362)
T 2bdw_A          241 QIKAGA-----------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  286 (362)
T ss_dssp             HHHHTC-----------CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred             HHHhCC-----------CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            111100           0001111123345789999999999999999999999883

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=346.16  Aligned_cols=259  Identities=18%  Similarity=0.308  Sum_probs=196.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. .++.|.+.....     .........+.+.+|+++|++++||||+++++++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~avK~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   83 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGL-QYAAKFIKKRRT-----KSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   83 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCC-EEEEEEEEBCCS-----TTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCc-EEEEEEEEcccc-----ccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4679999999999999999999876532 222222211100     0000001235678899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC----cEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF----HAK  425 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~----~vk  425 (589)
                      .+ +..|+||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++    .+|
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           84 ENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCe---EcCCCCHHHEEEecCCCCCCCEE
Confidence            75 46899999999999999997643  49999999999999999999999998   9999999999998887    899


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     .   .....
T Consensus       159 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~---~~~~~  228 (326)
T 2y0a_A          159 IIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-----Q---ETLAN  228 (326)
T ss_dssp             ECCCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-----H---HHHHH
T ss_pred             EEECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-----H---HHHHH
Confidence            99999998654322  22346799999999999989999999999999999999999999943221     1   11111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      +....           ...........+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       229 ~~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          229 VSAVN-----------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             HHHTC-----------CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             HHhcC-----------CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence            11100           0000000112234689999999999999999999999973

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=338.80  Aligned_cols=249  Identities=26%  Similarity=0.419  Sum_probs=197.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|++..++ ..++.|.+.     .....+.   ...+.+.+|..+++.++||||+++++++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~-----~~~~~~~---~~~~~~~~E~~~l~~l~hp~Iv~~~~~~   75 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNG-RYYAMKVLK-----KEIVVRL---KQVEHTNDERLMLSIVTHPFIIRMWGTF   75 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEE-----HHHHHHT---TCHHHHHHHHHHHHSCCBTTBCCEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCC-CEEEEEEEE-----HHHhhhh---hHHHHHHHHHHHHhhCCCCCCceEeEEE
Confidence            467999999999999999999987552 233333221     1111111   1234567899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        76 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           76 QDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDI---IYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCChheEEEcCCCCEEEeec
Confidence            75 46899999999999999998754  38999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+++....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||....        .......+...
T Consensus       151 g~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~  218 (318)
T 1fot_A          151 GFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNA  218 (318)
T ss_dssp             SSCEECSS----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHC
T ss_pred             CcceecCC----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhC
Confidence            99986432    2234679999999999999999999999999999999999999995432        11122222211


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                                   .+  ..|...+..+.+++.+||+.||.+||     +++|+++|
T Consensus       219 -------------~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          219 -------------EL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -------------CC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------------CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                         11  12333445789999999999999999     89999988

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.9e-41  Score=340.82  Aligned_cols=261  Identities=24%  Similarity=0.402  Sum_probs=189.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHh---------------hcCHHHHHHHHHHHHHH
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIK---------------KMDMQASREFLAELKVL  335 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik---------------~~~~~~~~~~~~E~~il  335 (589)
                      .++|++.+.||+|+||.||+|.+..++ ...+.|.+............               .......+.+.+|++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDN-TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTT-EEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCC-cEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            478999999999999999999876653 23333332221111000000               00112235688999999


Q ss_pred             ccCCCCcceeEeeEEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          336 THVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       336 ~~l~hpnIv~l~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      ++++||||+++++++.+   +..|+||||+++++|.+++..   .++++..++.++.|++.||+|||++++   +|||||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlk  164 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKI---IHRDIK  164 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCC
Confidence            99999999999998874   458999999999999886543   359999999999999999999999998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCC---CCcccchhhHHHHHHHHHcCCcccccC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD---VSPKVDVYAFGVVLYELISAKEAIVKG  489 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwSlGvll~elltG~~p~~~~  489 (589)
                      |+|||++.++.+||+|||++........ ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999986543222 223467999999999997655   478899999999999999999999432


Q ss_pred             CCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       490 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .        .......+...             ..........+..+.+|+.+||+.||++|||++|+++|
T Consensus       244 ~--------~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          244 R--------IMCLHSKIKSQ-------------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             S--------HHHHHHHHHHC-------------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             c--------HHHHHHHHhcc-------------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            1        11111111110             00001112234568999999999999999999999876

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=341.60  Aligned_cols=269  Identities=25%  Similarity=0.416  Sum_probs=195.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHH--HccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV--LTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~i--l~~l~hpnIv~l~  347 (589)
                      ..++|++.+.||+|+||.||+|.+.+.                 .+++|.+.......+..|.++  +..++||||++++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----------------~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~   73 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSLDER-----------------PVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFI   73 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTE-----------------EEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEECCe-----------------EEEEEEeeccchhhHHHHHHHHHHHhccCcchhhhe
Confidence            357899999999999999999976432                 233333332223334444444  4558999999999


Q ss_pred             eEEEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCceEeeccC
Q 037010          348 GYCVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH---------TVPVYIHRDIK  412 (589)
Q Consensus       348 ~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~---------~i~~~vH~Dlk  412 (589)
                      +++..      ..+|+||||+++|+|.+++....   .++..++.++.|++.||+|||++         ++   +|||||
T Consensus        74 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~i---vH~Dik  147 (336)
T 3g2f_A           74 VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI---SHRDLN  147 (336)
T ss_dssp             EEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCE---ECSSCS
T ss_pred             ecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccce---eecccc
Confidence            75531      24789999999999999997654   58899999999999999999999         87   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCC-------CCCCcccccCCCCCchhcccC-------CCCCcccchhhHHHHHHH
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGS-------ASLPTRLVGTFGYMPPEYAQY-------GDVSPKVDVYAFGVVLYE  478 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwSlGvll~e  478 (589)
                      |+|||++.++.+||+|||++.......       ........||+.|+|||++.+       ..++.++|||||||++||
T Consensus       148 p~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~e  227 (336)
T 3g2f_A          148 SRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE  227 (336)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHH
T ss_pred             cceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHH
Confidence            999999999999999999998654321       111223579999999999876       456789999999999999


Q ss_pred             HHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhc-----CCCCCCCC--ChHHHHHHHHHHHHhcccCCCCC
Q 037010          479 LISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLV-----DPRLGDNC--PLDSVLKMAQLAKVCTQEYPQLR  551 (589)
Q Consensus       479 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~-----d~~l~~~~--~~~~~~~l~~li~~cl~~dP~~R  551 (589)
                      |++|..||...............   . .......+.....+     .+.+....  ....+..+.+|+.+||+.||++|
T Consensus       228 ll~g~~p~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  303 (336)
T 3g2f_A          228 IFMRCTDLFPGESVPEYQMAFQT---E-VGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR  303 (336)
T ss_dssp             HHTTBGGGSTTSCCCCCCCTTHH---H-HCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGS
T ss_pred             HHhcCCcCCCccchhHHHHhhhc---c-cCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhC
Confidence            99999888665443222111111   1 11111111111111     12222211  23466789999999999999999


Q ss_pred             CCHHHHHHHHHhcc
Q 037010          552 PSMRSIVVALMTLS  565 (589)
Q Consensus       552 Ps~~evl~~L~~l~  565 (589)
                      ||++|+++.|+.+.
T Consensus       304 ps~~e~l~~L~~ll  317 (336)
T 3g2f_A          304 LTAQXAEERMAELM  317 (336)
T ss_dssp             CCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHH
Confidence            99999999999988

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=345.00  Aligned_cols=287  Identities=18%  Similarity=0.216  Sum_probs=201.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccc--cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGE--YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|.+...  .+...+.|.............+.........+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            47899999999999999999998752  2222333322211100000111111111235678999999999999999999


Q ss_pred             EEEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-
Q 037010          349 YCVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-  422 (589)
Q Consensus       349 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-  422 (589)
                      ++.+     +..|+||||+ +++|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCcCHHHEEEccCCC
Confidence            8765     3589999999 999999998765  59999999999999999999999998   9999999999998887 


Q ss_pred             -cEEEEeccCccccccCCCC------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC
Q 037010          423 -HAKVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD  495 (589)
Q Consensus       423 -~vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~  495 (589)
                       .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||+||+.||......   
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---  266 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD---  266 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC---
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc---
Confidence             9999999999865432211      113457999999999999889999999999999999999999999543221   


Q ss_pred             hhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccccCCC
Q 037010          496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWDVGS  575 (589)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~~~~  575 (589)
                      ................  ..+......   .    ..+..+.+++.+||+.||++|||+++|++.|+.+......++.+.
T Consensus       267 ~~~~~~~~~~~~~~~~--~~~~~~~~~---~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~~~  337 (345)
T 2v62_A          267 PVAVQTAKTNLLDELP--QSVLKWAPS---G----SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFST  337 (345)
T ss_dssp             HHHHHHHHHHHHHTTT--HHHHHHSCT---T----SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCCCC
T ss_pred             cHHHHHHHHhhccccc--HHHHhhccc---c----ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCccc
Confidence            1111111111111100  111111110   1    233479999999999999999999999999998876555555433

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=9.8e-41  Score=336.69  Aligned_cols=264  Identities=23%  Similarity=0.364  Sum_probs=201.3

Q ss_pred             HhhcCCCccce-eeccCCcEEEEEEEEcccc-CCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCccee
Q 037010          268 SKATDNFSMSH-KIGQGGFGAVYYAELRGEY-GNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       268 ~~~~~~y~~~~-~LG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      ....++|++.+ .||+|+||.||+|.+.... +...+.|.+.     ..    .......+++.+|++++++++||||++
T Consensus        12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~-----~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~   82 (291)
T 1xbb_A           12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK-----NE----ANDPALKDELLAEANVMQQLDNPYIVR   82 (291)
T ss_dssp             BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC--------------CHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred             eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeec-----cc----ccCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            33456788888 9999999999999764332 1111111111     00    011123467889999999999999999


Q ss_pred             EeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          346 LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       346 l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      +++++.++..|+||||+.+++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dikp~Nil~~~~~~~k  157 (291)
T 1xbb_A           83 MIGICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAK  157 (291)
T ss_dssp             EEEEEESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEETTEEE
T ss_pred             EEEEECCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCe---EcCCCCcceEEEeCCCcEE
Confidence            999998888999999999999999998754  48999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |+|||++.........  ......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||.....     ..   .
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~---~  229 (291)
T 1xbb_A          158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SE---V  229 (291)
T ss_dssp             ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH---H
T ss_pred             EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HH---H
Confidence            9999999865433221  1122456788999999988889999999999999999999 9999843221     11   1


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ...+..          ...    ...+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       230 ~~~~~~----------~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          230 TAMLEK----------GER----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             HHHHHT----------TCC----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHc----------CCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            111111          111    122334455799999999999999999999999999887643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=347.27  Aligned_cols=254  Identities=23%  Similarity=0.366  Sum_probs=196.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++ ..++.|.+.     .......   ...+.+.+|+++|++++||||+++++++
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~-~~~AiK~~~-----~~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~   84 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTK-KMYAMKYMN-----KQKCVER---NEVRNVFKELQIMQGLEHPFLVNLWYSF   84 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTC-CEEEEEEEE-----HHHHHHT---TCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCC-CEEEEEEEe-----hhhcccH---HHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            467999999999999999999987653 222222221     1111111   1235678899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+.+|+|.+++....  .+++..++.++.||+.||+|||++|+   +||||||+|||++.++.+||+||
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~g~vkL~DF  159 (384)
T 4fr4_A           85 QDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRI---IHRDMKPDNILLDEHGHVHITDF  159 (384)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCC
T ss_pred             EeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCcHHHeEECCCCCEEEecc
Confidence            75 56899999999999999998654  49999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccC---CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQY---GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |++......  .......||+.|+|||++..   ..++.++|||||||++|||++|+.||.......     ........
T Consensus       160 G~a~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~~~  232 (384)
T 4fr4_A          160 NIAAMLPRE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIVHTF  232 (384)
T ss_dssp             TTCEECCTT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHHHHH
T ss_pred             ceeeeccCC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHH
Confidence            999865432  23345789999999999863   468999999999999999999999995433211     11111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-MRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~  560 (589)
                      ...           .    ...+...+..+.+|+.+||+.||.+||+ ++++++|
T Consensus       233 ~~~-----------~----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          233 ETT-----------V----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             HHC-----------C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             hhc-----------c----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            110           1    1223344557899999999999999999 7887765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-40  Score=344.79  Aligned_cols=260  Identities=19%  Similarity=0.273  Sum_probs=195.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++ ..++.|.+....      .........+.+.+|++++++++||||+++++++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~------~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETG-QQFAVKIVDVAK------FTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEHHH------HHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCC-CEEEEEEEEhhh------ccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            467999999999999999999887653 222222221110      0011111235688899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc---E
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH---A  424 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~---v  424 (589)
                      .+ +..|+||||+++++|.+++...  ....+++..++.++.||+.||+|||++++   +||||||+|||++.++.   +
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i---vHrDlkp~NIl~~~~~~~~~v  172 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI---IHRDVKPHCVLLASKENSAPV  172 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECSSSTTCCE
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCChHHeEEecCCCCCcE
Confidence            65 5689999999999999888653  23358999999999999999999999998   99999999999986654   9


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....      .   ..+.
T Consensus       173 kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~---~~~~  242 (351)
T 3c0i_A          173 KLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------E---RLFE  242 (351)
T ss_dssp             EECCCTTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------H---HHHH
T ss_pred             EEecCcceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------H---HHHH
Confidence            999999998654322 22344679999999999998899999999999999999999999995421      1   1122


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+......           .........+..+.+|+.+||+.||++|||+.|+++|-
T Consensus       243 ~i~~~~~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp  288 (351)
T 3c0i_A          243 GIIKGKYK-----------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP  288 (351)
T ss_dssp             HHHHTCCC-----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHcCCCC-----------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCh
Confidence            21111000           00000012234789999999999999999999999874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.6e-40  Score=347.87  Aligned_cols=278  Identities=18%  Similarity=0.237  Sum_probs=198.7

Q ss_pred             hcCCCccceeeccC--CcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQG--GFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++|++.++||+|  +||.||+|.+..++. ..+.|.+.         ......+..+.+.+|++++++++||||++++
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~-~vavK~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   92 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGE-YVTVRRIN---------LEACSNEMVTFLQGELHVSKLFNHPNIVPYR   92 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCC-EEEEEEEE---------GGGSCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCC-EEEEEEec---------ccccChHHHHHHHHHHHHHHhCCCCCCCcEe
Confidence            35689999999999  999999999876532 22222211         1122344556788899999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..|+||||+++|+|.+++.......+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||
T Consensus        93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i---vHrDlkp~NIll~~~~~~kl  169 (389)
T 3gni_B           93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYL  169 (389)
T ss_dssp             EEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEE
T ss_pred             EEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEE
Confidence            98865 568999999999999999988765669999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCC------CCCCcccccCCCCCchhcccC--CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhh
Q 037010          427 ADFGLTKLTEVGS------ASLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG  498 (589)
Q Consensus       427 ~Dfgla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~  498 (589)
                      +|||.+.......      ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||............
T Consensus       170 ~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~  249 (389)
T 3gni_B          170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK  249 (389)
T ss_dssp             CCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC
T ss_pred             cccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            9999886432211      111223478999999999977  67999999999999999999999999654322111111


Q ss_pred             HHHHHHHHhcCCC-hHHhh-------------Hhhc---------CCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 037010          499 LVALFEEVLNLPD-PIEDL-------------RKLV---------DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR  555 (589)
Q Consensus       499 ~~~~~~~~~~~~~-~~~~l-------------~~~~---------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  555 (589)
                      ............. +.+.+             ...+         ........+...+..+.+|+.+||+.||++|||++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~  329 (389)
T 3gni_B          250 LNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAS  329 (389)
T ss_dssp             --------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             hcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHH
Confidence            1000000000000 00000             0000         00000112333455799999999999999999999


Q ss_pred             HHHHH
Q 037010          556 SIVVA  560 (589)
Q Consensus       556 evl~~  560 (589)
                      |+++|
T Consensus       330 ell~h  334 (389)
T 3gni_B          330 TLLNH  334 (389)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99988

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=7e-41  Score=343.58  Aligned_cols=253  Identities=25%  Similarity=0.378  Sum_probs=190.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|++..++. .++.|.+..          .......+.+.+|+++|++++||||++++++
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~vavK~~~~----------~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   72 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDC-NYAIKRIRL----------PNRELAREKVMREVKALAKLEHPGIVRYFNA   72 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCC-EEEEEEEEC----------CSTTTHHHHHHHHHHHHTSCCCTTBCCEEEE
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCc-EEEEEEeec----------CCchhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            35679999999999999999999875532 222221110          0112344678899999999999999999998


Q ss_pred             EEeC----------------------------------------------------------cEEEEEEecCCCChHHHH
Q 037010          350 CVEG----------------------------------------------------------SLFLVYEYIENGNLSEHL  371 (589)
Q Consensus       350 ~~~~----------------------------------------------------------~~~lv~e~~~~gsL~~~l  371 (589)
                      +.+.                                                          ..++||||+++++|.+++
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  152 (332)
T 3qd2_B           73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM  152 (332)
T ss_dssp             EEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHH
T ss_pred             EEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHH
Confidence            7532                                                          279999999999999999


Q ss_pred             hcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCC----------
Q 037010          372 RGSGR-DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA----------  440 (589)
Q Consensus       372 ~~~~~-~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~----------  440 (589)
                      ..... ...++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||++........          
T Consensus       153 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~  229 (332)
T 3qd2_B          153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL---MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA  229 (332)
T ss_dssp             HTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------
T ss_pred             hcccCccchhhHHHHHHHHHHHHHHHHHHhCCe---eecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccc
Confidence            87543 235566789999999999999999998   9999999999999999999999999986544321          


Q ss_pred             -CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhh
Q 037010          441 -SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKL  519 (589)
Q Consensus       441 -~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  519 (589)
                       .......||+.|+|||++.+..++.++|||||||++|||++|..|+.          ..............+       
T Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~----------~~~~~~~~~~~~~~~-------  292 (332)
T 3qd2_B          230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM----------ERVRIITDVRNLKFP-------  292 (332)
T ss_dssp             --CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH----------HHHHHHHHHHTTCCC-------
T ss_pred             cccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh----------HHHHHHHHhhccCCC-------
Confidence             12233579999999999999999999999999999999999876641          111111111111100       


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          520 VDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       520 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                             .........+.+|+.+||+.||.+|||++|+++|
T Consensus       293 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          293 -------LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             -------HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             -------cccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence                   0112333467899999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-40  Score=339.33  Aligned_cols=265  Identities=25%  Similarity=0.432  Sum_probs=198.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.+.||+|+||.||+|.+..+.+...  .         .+++|..    .......+.+|++++++++||||+++
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~--~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~  111 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKE--V---------PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL  111 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCE--E---------EEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCcc--c---------cEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcE
Confidence            4678899999999999999998875533211  0         1222222    23445678899999999999999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++++.+ +..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+|
T Consensus       112 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIl~~~~~~~k  187 (333)
T 1mqb_A          112 EGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCK  187 (333)
T ss_dssp             EEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEE
T ss_pred             EEEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCChheEEECCCCcEE
Confidence            998875 56899999999999999998653 348999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |+|||++.........  ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....     .   ..
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~---~~  259 (333)
T 1mqb_A          188 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----H---EV  259 (333)
T ss_dssp             ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H---HH
T ss_pred             ECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----H---HH
Confidence            9999999865432211  1122356788999999998899999999999999999999 9999843211     1   11


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWD  572 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~  572 (589)
                      ...+..          ...    ...+...+..+.+++.+||+.||.+||++.+++++|+.+........
T Consensus       260 ~~~~~~----------~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~  315 (333)
T 1mqb_A          260 MKAIND----------GFR----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLK  315 (333)
T ss_dssp             HHHHHT----------TCC----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGG
T ss_pred             HHHHHC----------CCc----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhh
Confidence            111111          011    11233445578999999999999999999999999998876555443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2e-40  Score=343.19  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=197.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++ ..++.|.+.     .....+.   ...+.+.+|+++|++++||||+++++++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~-----~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~  110 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESG-NHYAMKILD-----KQKVVKL---KQIEHTLNEKRILQAVNFPFLVKLEFSF  110 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEE-----HHHHHHT---TCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCC-CEEEEEEEE-----hHHhccH---HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            468999999999999999999987653 223322221     1111111   1234677899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+||
T Consensus       111 ~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~~kL~DF  185 (350)
T 1rdq_E          111 KDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDF  185 (350)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCC
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCccceEEECCCCCEEEccc
Confidence            75 56899999999999999998754  38999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||....        .......+...
T Consensus       186 g~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~  253 (350)
T 1rdq_E          186 GFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSG  253 (350)
T ss_dssp             TTCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC
T ss_pred             ccceeccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcC
Confidence            999865322    234679999999999999999999999999999999999999995432        11122222111


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVAL  561 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~L  561 (589)
                                 ..    ..|...+..+.+++.+||+.||.+||+     ++|+++|-
T Consensus       254 -----------~~----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          254 -----------KV----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             -----------CC----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             -----------CC----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence                       11    123334457899999999999999999     89999884

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.3e-40  Score=338.90  Aligned_cols=266  Identities=23%  Similarity=0.382  Sum_probs=204.2

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccc----cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcc
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGE----YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNL  343 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~----~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnI  343 (589)
                      ...++|++.+.||+|+||.||+|.+.+.    .+...+.|.+     .     +.......+.+.+|+++++++ +||||
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~-----~-----~~~~~~~~~~~~~E~~~l~~l~~h~~i   89 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-----K-----PSAHLTEREALMSELKVLSYLGNHMNI   89 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEE-----C-----TTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhc-----C-----cchhHHHHHHHHHHHHHHhhcccCCCe
Confidence            3457899999999999999999986431    1111211111     0     111233456788999999999 89999


Q ss_pred             eeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 037010          344 VRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR----------------DPLPWSSRVQIALDSARGLEYIHEHTVPVY  406 (589)
Q Consensus       344 v~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~  406 (589)
                      +++++++.+ +..++||||+++|+|.+++.....                ..+++..++.++.|++.||+|||++++   
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---  166 (313)
T 1t46_A           90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---  166 (313)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC---
T ss_pred             eeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe---
Confidence            999998864 568999999999999999986543                248999999999999999999999998   


Q ss_pred             EeeccCCCcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCc
Q 037010          407 IHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKE  484 (589)
Q Consensus       407 vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~  484 (589)
                      +||||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|+| |+.
T Consensus       167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  246 (313)
T 1t46_A          167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS  246 (313)
T ss_dssp             CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999865433221 1233567889999999988899999999999999999999 998


Q ss_pred             ccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          485 AIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       485 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ||......    ........             ......    .+...+..+.+++.+||+.||.+|||++|++++|+++
T Consensus       247 p~~~~~~~----~~~~~~~~-------------~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          247 PYPGMPVD----SKFYKMIK-------------EGFRML----SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             SSTTCCSS----HHHHHHHH-------------HTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcccch----hHHHHHhc-------------cCCCCC----CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            88543221    11111111             111111    1223345789999999999999999999999999987


Q ss_pred             cccc
Q 037010          565 SSTT  568 (589)
Q Consensus       565 ~~~~  568 (589)
                      ....
T Consensus       306 ~~~~  309 (313)
T 1t46_A          306 ISES  309 (313)
T ss_dssp             HHHT
T ss_pred             HHHh
Confidence            7543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-40  Score=339.74  Aligned_cols=277  Identities=23%  Similarity=0.381  Sum_probs=204.9

Q ss_pred             CCC-ccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          272 DNF-SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y-~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ++| ++.++||+|+||.||++.+.......  .+.++++...     +.......+.+.+|++++++++||||+++++++
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~--~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGT--GEMVAVKALK-----ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCC  102 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--C--CEEEEEEEEC-----TTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCC--CcEEEEEEec-----cccChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence            344 89999999999999998764321110  1111111111     112234456788999999999999999999988


Q ss_pred             Ee---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          351 VE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       351 ~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      .+   ...++||||+++|+|.+++....   +++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~i---vH~Dikp~Nil~~~~~~~kl~  176 (318)
T 3lxp_A          103 EDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIG  176 (318)
T ss_dssp             EETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEEC
T ss_pred             ecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCchheEEEcCCCCEEEC
Confidence            75   35899999999999999997654   8999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCC--CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          428 DFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       428 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |||++........  .......+|+.|+|||++.+..++.++||||||+++|+|+||+.||.....          ....
T Consensus       177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~----------~~~~  246 (318)
T 3lxp_A          177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT----------KFLE  246 (318)
T ss_dssp             CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----------HHHH
T ss_pred             CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccch----------hhhh
Confidence            9999986643322  122335678899999999988999999999999999999999999843211          0111


Q ss_pred             HhcCCC---hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccccc
Q 037010          506 VLNLPD---PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDW  571 (589)
Q Consensus       506 ~~~~~~---~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~  571 (589)
                      ......   ....+...+........+...+..+.+|+.+||+.||.+|||++|+++.|+.+...-...
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          247 LIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             hhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            111111   011122222222223334455567999999999999999999999999999887554433

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-40  Score=337.31  Aligned_cols=270  Identities=24%  Similarity=0.324  Sum_probs=195.5

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.++||+|+||+||+|.+..  +...+.|.+..         ..........+.+|++++++++||||+++++
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~---------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   86 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ--GRIVALKRIRL---------DAEDEGIPSTAIREISLLKELHHPNIVSLID   86 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETT--SCEEEEEEEC---------------CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECC--CCEEEEEEEec---------ccccchhhHHHHHHHHHHHHcCCCCEeeeee
Confidence            346889999999999999999998743  23222222111         0111122356788999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i---vH~Dikp~NIl~~~~~~~kl~  161 (311)
T 3niz_A           87 VIHSERCLTLVFEFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRI---LHRDLKPQNLLINSDGALKLA  161 (311)
T ss_dssp             EECCSSCEEEEEECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEEC
T ss_pred             EEccCCEEEEEEcCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCchHhEEECCCCCEEEc
Confidence            8864 468999999986 8888887654 348999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......    ..... ....
T Consensus       162 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~-i~~~  235 (311)
T 3niz_A          162 DFGLARAFGIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD----DQLPK-IFSI  235 (311)
T ss_dssp             CCTTCEETTSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT----THHHH-HHHH
T ss_pred             cCcCceecCCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH----HHHHH-HHHH
Confidence            9999986543222 2234578999999999875 56899999999999999999999999543322    12222 2222


Q ss_pred             hcCCChH-----HhhHhhcCCCCC--CC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPI-----EDLRKLVDPRLG--DN-----CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~-----~~l~~~~d~~l~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...+.+.     .++....+....  ..     ..+.....+.+|+.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          236 LGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            2221111     001111110000  00     011233478899999999999999999999987

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=344.73  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=192.6

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCC--CcceeE
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH--LNLVRL  346 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~h--pnIv~l  346 (589)
                      ...++|++.+.||+|+||.||++.+..  +..++.|.+.         .........+.+.+|+++|++++|  |||+++
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~---------~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~   74 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVN---------LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL   74 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTT--SCEEEEEEEE---------CTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCC--CCEEEEEEee---------ccccchHHHHHHHHHHHHHHhhhhcCCceEEE
Confidence            346789999999999999999998643  2222222211         112234455678899999999976  999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++++.+ +..|+||| +.+++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++ ++.+|
T Consensus        75 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i---iHrDikp~NIll~-~~~~k  147 (343)
T 3dbq_A           75 YDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGI---VHSDLKPANFLIV-DGMLK  147 (343)
T ss_dssp             EEEEECSSEEEEEEC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEEE-TTEEE
T ss_pred             eeeEeeCCEEEEEEe-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCcceEEEE-CCcEE
Confidence            998875 45899999 55779999998754  48999999999999999999999998   9999999999997 57899


Q ss_pred             EEeccCccccccCCCC-CCcccccCCCCCchhcccC-----------CCCCcccchhhHHHHHHHHHcCCcccccCCCCC
Q 037010          426 VADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQY-----------GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS  493 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~  493 (589)
                      |+|||++......... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....  
T Consensus       148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--  225 (343)
T 3dbq_A          148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--  225 (343)
T ss_dssp             ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--
T ss_pred             EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--
Confidence            9999999865433222 2234679999999999854           6789999999999999999999999943211  


Q ss_pred             CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                                        ....+...+++......+......+.+|+.+||+.||.+|||++|+++|..
T Consensus       226 ------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          226 ------------------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             ------------------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ------------------HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence                              111222333333333334444457899999999999999999999999853

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.9e-40  Score=339.17  Aligned_cols=265  Identities=26%  Similarity=0.426  Sum_probs=202.0

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHcc--CCCCccee
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH--VHHLNLVR  345 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~--l~hpnIv~  345 (589)
                      ....++|++.+.||+|+||.||+|.+.+.                 .+++|.+.......+.+|.+++..  ++||||++
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----------------~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~  100 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWRGE-----------------EVAVKIFSSREERSWFREAEIYQTVMLRHENILG  100 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEETTE-----------------EEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCC
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEcCc-----------------cEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEE
Confidence            44567899999999999999999987532                 334444443344567778888877  78999999


Q ss_pred             EeeEEEeC-----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEeeccC
Q 037010          346 LIGYCVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH--------EHTVPVYIHRDIK  412 (589)
Q Consensus       346 l~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH--------~~~i~~~vH~Dlk  412 (589)
                      +++++.+.     ..|+||||+++|+|.+++...   ++++..++.++.|++.||+|||        ++++   +|||||
T Consensus       101 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i---vH~Dlk  174 (342)
T 1b6c_B          101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI---AHRDLK  174 (342)
T ss_dssp             EEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE---ECSCCS
T ss_pred             EEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCe---eeCCCC
Confidence            99988753     689999999999999999764   3899999999999999999999        7887   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCCC---CCcccccCCCCCchhcccCC------CCCcccchhhHHHHHHHHHcC-
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYG------DVSPKVDVYAFGVVLYELISA-  482 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwSlGvll~elltG-  482 (589)
                      |+|||++.++.+||+|||++.........   ......||+.|+|||++.+.      .++.++|||||||++|||+|| 
T Consensus       175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~  254 (342)
T 1b6c_B          175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC  254 (342)
T ss_dssp             GGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             HHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence            99999999999999999999865443321   22345799999999998765      344789999999999999999 


Q ss_pred             ---------CcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCC-CChHHHHHHHHHHHHhcccCCCCCC
Q 037010          483 ---------KEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDN-CPLDSVLKMAQLAKVCTQEYPQLRP  552 (589)
Q Consensus       483 ---------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RP  552 (589)
                               +.||...........   .....+..         ...++.+... ...+....+.+|+.+||+.||.+||
T Consensus       255 ~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp  322 (342)
T 1b6c_B          255 SIGGIHEDYQLPYYDLVPSDPSVE---EMRKVVCE---------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL  322 (342)
T ss_dssp             CBTTBCCCCCCTTTTTSCSSCCHH---HHHHHHTT---------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred             CcCCcccccccCccccCcCcccHH---HHHHHHHH---------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC
Confidence                     566644322211111   11111111         1112222111 1236677899999999999999999


Q ss_pred             CHHHHHHHHHhcccc
Q 037010          553 SMRSIVVALMTLSST  567 (589)
Q Consensus       553 s~~evl~~L~~l~~~  567 (589)
                      |++||+++|+.+...
T Consensus       323 s~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          323 TALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHHH
Confidence            999999999988754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=367.86  Aligned_cols=259  Identities=23%  Similarity=0.407  Sum_probs=198.8

Q ss_pred             cCCCccce-eeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCccee
Q 037010          271 TDNFSMSH-KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       271 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      .+++.+.+ .||+|+||.||+|.+.......             .+++|.++    ....+++.+|+++|++++||||++
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~-------------~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~  400 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQI-------------DVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR  400 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEE-------------EEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcE-------------EEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEee
Confidence            34555555 8999999999999876432211             12222221    123467889999999999999999


Q ss_pred             EeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          346 LIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       346 l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      +++++.++..|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++++   +||||||+|||++.++.+|
T Consensus       401 l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~i---iHrDlkp~NILl~~~~~vk  476 (613)
T 2ozo_A          401 LIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAK  476 (613)
T ss_dssp             EEEEEESSSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEE
T ss_pred             EEEEeccCCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCE---EcCcCCHHHEEEcCCCcEE
Confidence            999998888999999999999999997653 359999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCCC--CcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSASL--PTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |+|||+++.........  .....+++.|+|||++....++.++|||||||++|||+| |+.||.....     ..   .
T Consensus       477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~---~  548 (613)
T 2ozo_A          477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PE---V  548 (613)
T ss_dssp             ECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----HH---H
T ss_pred             EeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HH---H
Confidence            99999998654322211  122345689999999998999999999999999999998 9999854322     11   1


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      ...+..              ......+..++..+.+|+.+||+.||++||++++|++.|+.+....
T Consensus       549 ~~~i~~--------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          549 MAFIEQ--------------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             HHHHHT--------------TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHc--------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            111111              1112234445567999999999999999999999999998876443

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.5e-40  Score=334.71  Aligned_cols=264  Identities=25%  Similarity=0.399  Sum_probs=196.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||+|+||.||+|.+..+.+....   ++++..     .+.......+.+.+|++++++++||||+++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~---~avk~~-----~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH---CAVKSL-----NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEE---EEEEEE-----TTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeE---EEEEec-----ccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence            45789999999999999999987654332111   111100     0112334556788999999999999999999986


Q ss_pred             E--eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          351 V--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       351 ~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      .  ++..++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus        96 ~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~kl~D  171 (298)
T 3f66_A           96 LRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVAD  171 (298)
T ss_dssp             CCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTCCEEECS
T ss_pred             EcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCchheEEECCCCCEEECc
Confidence            5  346899999999999999997644 348999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCC---CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          429 FGLTKLTEVGSA---SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       429 fgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      ||++........   .......+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.......    ....   .
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~~~~---~  244 (298)
T 3f66_A          172 FGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITV---Y  244 (298)
T ss_dssp             CGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT----THHH---H
T ss_pred             ccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH----HHHH---H
Confidence            999986533221   12233567889999999998899999999999999999999665543322211    1111   1


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ..          .....    ..+...+..+.+++.+||+.||.+|||++|+++.|+.+...
T Consensus       245 ~~----------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          245 LL----------QGRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             HH----------TTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             Hh----------cCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            11          11111    11223345789999999999999999999999999988754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.6e-40  Score=338.66  Aligned_cols=271  Identities=23%  Similarity=0.389  Sum_probs=199.0

Q ss_pred             cHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCC--ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCC
Q 037010          263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGN--SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH  340 (589)
Q Consensus       263 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~--~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~h  340 (589)
                      ..+++....++|.+.+.||+|+||.||+|.+....+.  ..+.|.+.         .........+.+.+|++++++++|
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~---------~~~~~~~~~~~~~~e~~~l~~l~h   95 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMK---------LDNSSQREIEEFLSEAACMKDFSH   95 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC------------CCCHHHHHHHHHHHHHHHTCCC
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEe---------ccccchhHHHHHHHHHHHHhcCCC
Confidence            3444555678899999999999999999987654222  12222111         111233445678899999999999


Q ss_pred             CcceeEeeEEEeC------cEEEEEEecCCCChHHHHhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 037010          341 LNLVRLIGYCVEG------SLFLVYEYIENGNLSEHLRGS----GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRD  410 (589)
Q Consensus       341 pnIv~l~~~~~~~------~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~D  410 (589)
                      |||+++++++.+.      ..++||||+++++|.+++...    ....+++..++.++.|++.||.|||++++   +|||
T Consensus        96 ~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~d  172 (313)
T 3brb_A           96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNF---LHRD  172 (313)
T ss_dssp             TTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTC---CCCC
T ss_pred             CCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCc---ccCC
Confidence            9999999988643      359999999999999999532    23459999999999999999999999998   9999


Q ss_pred             cCCCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCccccc
Q 037010          411 IKSANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVK  488 (589)
Q Consensus       411 lkp~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~  488 (589)
                      |||+|||++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus       173 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  252 (313)
T 3brb_A          173 LAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG  252 (313)
T ss_dssp             CSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence            999999999999999999999986543221 12233467889999999999999999999999999999999 8888743


Q ss_pred             CCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ...     ....   .....          ...+    ..+...+..+.+++.+||..||.+|||+++++++|..+...
T Consensus       253 ~~~-----~~~~---~~~~~----------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          253 VQN-----HEMY---DYLLH----------GHRL----KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             CCG-----GGHH---HHHHT----------TCCC----CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCH-----HHHH---HHHHc----------CCCC----CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            221     1111   11111          1111    12333445799999999999999999999999999988754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.4e-40  Score=341.71  Aligned_cols=253  Identities=26%  Similarity=0.411  Sum_probs=196.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|++..++ ..++.|.     .........   ...+.+..|.+++..+ +||||+++++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~AiK~-----~~~~~~~~~---~~~~~~~~E~~~l~~~~~hp~iv~l~~   88 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTD-ELYAVKI-----LKKDVVIQD---DDVECTMVEKRVLALPGKPPFLTQLHS   88 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEE-EEEEEEE-----EEHHHHHHT---TCHHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCC-CEEEEEE-----EEHHHhhcc---hHHHHHHHHHHHHHhcCCCCEEeeEEE
Confidence            4578999999999999999999987642 2222222     211111111   1234577899999988 7999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +.+|+||||++||+|.+++....  .+++..++.++.||+.||+|||++|+   +||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           89 CFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCE---EeccCCHHHEEEcCCCcEEEE
Confidence            8775 56899999999999999998754  38999999999999999999999999   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....        ....+..+.
T Consensus       164 DFG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~  234 (353)
T 2i0e_A          164 DFGMCKENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIM  234 (353)
T ss_dssp             CCTTCBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred             eCCcccccccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHH
Confidence            99999853222 222345689999999999999999999999999999999999999995321        112222222


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                      ..           ..    ..|...+..+.+|+.+||+.||.+||+     ++|+++|
T Consensus       235 ~~-----------~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          235 EH-----------NV----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HC-----------CC----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             hC-----------CC----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11           11    123344557899999999999999995     6888887

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=337.56  Aligned_cols=253  Identities=29%  Similarity=0.484  Sum_probs=192.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-HHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-MQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||++.+.+.                 .+++|... ....+.+.+|++++++++||||++++++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----------------~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   69 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWRAK-----------------DVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA   69 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTE-----------------EEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEB
T ss_pred             HhHeeeeeEeecCCCceEEEEEECCe-----------------eEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence            46789999999999999999987542                 22333322 2234678899999999999999999998


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceEeeccCCCcEEEcCCCc-E
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIALDSARGLEYIHE---HTVPVYIHRDIKSANILIDKNFH-A  424 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~aL~~LH~---~~i~~~vH~Dlkp~NILl~~~~~-v  424 (589)
                      +. +..|+||||+++|+|.+++..... ..+++..++.++.|++.||+|||+   +++   +||||||+|||++.++. +
T Consensus        70 ~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~i---vH~dlkp~NIll~~~~~~~  145 (307)
T 2eva_A           70 CL-NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL---IHRDLKPPNLLLVAGGTVL  145 (307)
T ss_dssp             CT-TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCC---CCCCCSGGGEEEETTTTEE
T ss_pred             Ec-CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCe---ecCCCChhHEEEeCCCCEE
Confidence            76 457999999999999999986543 247889999999999999999999   777   99999999999988886 7


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||+||+.||......      ......
T Consensus       146 kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~  215 (307)
T 2eva_A          146 KICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMW  215 (307)
T ss_dssp             EECCCCC----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHH
T ss_pred             EEcccccccccccc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHH
Confidence            99999998754322    22356899999999999989999999999999999999999999533221      111111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      ....          ...+..    +...+..+.+++.+||+.||.+|||++|++++|..+....
T Consensus       216 ~~~~----------~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          216 AVHN----------GTRPPL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             HHHT----------TCCCCC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             HHhc----------CCCCCc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            1111          111112    2233456899999999999999999999999999887544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=343.84  Aligned_cols=265  Identities=24%  Similarity=0.410  Sum_probs=200.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccC-CCCcce
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHV-HHLNLV  344 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l-~hpnIv  344 (589)
                      ..++|++.+.||+|+||.||+|.+.+..... ..+         .+++|.+    .....+.+.+|+++++++ +||||+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~-~~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv  112 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTG-VSI---------QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV  112 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSS-CEE---------EEEEEEECC------CHHHHHHHHHHHHHCCCTTBC
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCC-cce---------EEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCee
Confidence            4578999999999999999999974321110 011         1222222    122345688999999999 899999


Q ss_pred             eEeeEEEe-CcEEEEEEecCCCChHHHHhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 037010          345 RLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR---------------------DPLPWSSRVQIALDSARGLEYIHEHT  402 (589)
Q Consensus       345 ~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qia~aL~~LH~~~  402 (589)
                      ++++++.+ +..|+||||+++|+|.+++.....                     ..+++..++.++.|++.||+|||+++
T Consensus       113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  192 (344)
T 1rjb_A          113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS  192 (344)
T ss_dssp             CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            99998864 568999999999999999986542                     23789999999999999999999999


Q ss_pred             CCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc
Q 037010          403 VPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS  481 (589)
Q Consensus       403 i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt  481 (589)
                      +   +||||||+|||++.++.+||+|||++......... ......||+.|+|||.+.+..++.++|||||||++|+|+|
T Consensus       193 i---vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          193 C---VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             E---EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             c---ccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence            8   99999999999999999999999999865433221 2233567889999999988899999999999999999998


Q ss_pred             -CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          482 -AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       482 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                       |..||......    ........             ....    ...+...+..+.+|+.+||+.||.+|||++|++++
T Consensus       270 ~g~~p~~~~~~~----~~~~~~~~-------------~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  328 (344)
T 1rjb_A          270 LGVNPYPGIPVD----ANFYKLIQ-------------NGFK----MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  328 (344)
T ss_dssp             TSCCSSTTCCCS----HHHHHHHH-------------TTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccCCcH----HHHHHHHh-------------cCCC----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence             99998543221    11111111             1111    12233344579999999999999999999999999


Q ss_pred             HHhccccc
Q 037010          561 LMTLSSTT  568 (589)
Q Consensus       561 L~~l~~~~  568 (589)
                      |..+....
T Consensus       329 l~~~~~~~  336 (344)
T 1rjb_A          329 LGCQLADA  336 (344)
T ss_dssp             HHHHC---
T ss_pred             HHHHHHHH
Confidence            99887543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-40  Score=346.95  Aligned_cols=256  Identities=21%  Similarity=0.294  Sum_probs=186.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||++.+..++. ..+.|.+..            .....+.+.+|+.++++++||||++++++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~vavK~~~~------------~~~~~~~~~~E~~~l~~l~hpniv~~~~~   84 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKE-LVAVKYIER------------GAAIDENVQREIINHRSLRHPNIVRFKEV   84 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCC-EEEEEEEES------------STTSCHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCc-EEEEEEEec------------CccccHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            35789999999999999999999876532 222222110            01112457789999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc--EEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH--AKV  426 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~--vkl  426 (589)
                      +.+ +..|+||||+.+|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.  +||
T Consensus        85 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i---vH~Dlkp~Nill~~~~~~~~kl  159 (361)
T 3uc3_A           85 ILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKI  159 (361)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CSCCCCGGGEEECSSSSCCEEE
T ss_pred             EeeCCEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEcCCCCceEEE
Confidence            875 56899999999999999997654  39999999999999999999999998   99999999999987765  999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcc-cchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPK-VDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||+++.....  .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......    ........
T Consensus       160 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~  233 (361)
T 3uc3_A          160 CDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----DYRKTIQR  233 (361)
T ss_dssp             CCCCCC-----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC----CHHHHHHH
T ss_pred             eecCcccccccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH----HHHHHHHH
Confidence            999998743222  22234679999999999988877665 899999999999999999996543321    11222222


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ...             ...........+..+.+|+.+||+.||++|||++|+++|-.
T Consensus       234 ~~~-------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          234 ILS-------------VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             HHT-------------TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             Hhc-------------CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            221             11111111123346899999999999999999999999944

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.1e-40  Score=332.54  Aligned_cols=267  Identities=22%  Similarity=0.358  Sum_probs=190.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..  +...+.|.+....         ......+.+.+|++++++++||||+++++++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~~aiK~~~~~~---------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   70 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNY--GETFALKKIRLEK---------EDEGIPSTTIREISILKELKHSNIVKLYDVIH   70 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT--SCEEEEEEECCSS---------GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCC--CCEEEEEEEeccc---------cccccchhHHHHHHHHHhcCCCCEeeeeeEEc
Confidence            579999999999999999998732  2333332221110         00111245778999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        71 ~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~Dfg  145 (288)
T 1ob3_A           71 TKKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKPQNLLINREGELKIADFG  145 (288)
T ss_dssp             CSSCEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECCTT
T ss_pred             cCCeEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCCEEEeECc
Confidence            4 569999999986 9999987653 348999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....    ........ .....
T Consensus       146 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~-~~~~~  219 (288)
T 1ob3_A          146 LARAFGIPV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIF-RILGT  219 (288)
T ss_dssp             HHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH-HHHCC
T ss_pred             cccccCccc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHH-HHHCC
Confidence            998654222 12234578999999999865 4589999999999999999999999853221    11122222 11111


Q ss_pred             CChH--HhhHh--hcCCCCC-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPI--EDLRK--LVDPRLG-------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~--~~l~~--~~d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +...  .....  ..++...       .......+..+.+|+.+||+.||++|||++|+++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1100  00000  1111111       01112344578999999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.7e-41  Score=345.79  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=184.0

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC-HHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD-MQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~-~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ...++|++.+.||+|+||.||+|.+..+.. ..              ++|.+. ....+.+.+|++++++++||||++++
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~v--------------avK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~  114 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQK-PY--------------ALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK  114 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCC-EE--------------EEEEEEC----------CHHHHHCCCTTBCCEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCc-EE--------------EEEEeccchhHHHHHHHHHHHHhCCCCCCccee
Confidence            356789999999999999999999876522 22              222221 11234577899999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC---CCc
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---NFH  423 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~---~~~  423 (589)
                      +++.+ +..++||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.   ++.
T Consensus       115 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dikp~NIll~~~~~~~~  189 (349)
T 2w4o_A          115 EIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGI---VHRDLKPENLLYATPAPDAP  189 (349)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEESSSSTTCC
T ss_pred             eeEecCCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EecCCCcccEEEecCCCCCC
Confidence            98875 45899999999999999997654  48999999999999999999999998   99999999999975   889


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +||+|||++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......       ...+
T Consensus       190 ~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~  260 (349)
T 2w4o_A          190 LKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMF  260 (349)
T ss_dssp             EEECCCC------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHH
T ss_pred             EEEccCccccccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHH
Confidence            999999999865432  2223467999999999999889999999999999999999999999543221       1112


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..+....           .........+.+..+.+|+.+||+.||++|||+.|+++|-
T Consensus       261 ~~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  307 (349)
T 2w4o_A          261 RRILNCE-----------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP  307 (349)
T ss_dssp             HHHHTTC-----------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             HHHHhCC-----------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence            2222110           0011111223445789999999999999999999999974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-40  Score=343.89  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=195.8

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEe
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLI  347 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  347 (589)
                      ...++|++.+.||+|+||.||+|+++.++ ..++.|.     .........   .....+..|.+++..+ +||||++++
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vaiK~-----~~~~~~~~~---~~~~~~~~E~~il~~~~~hp~iv~l~   84 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTN-QFFAIKA-----LKKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHMF   84 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTT-EEEEEEE-----EEHHHHHHT---TCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCC-CEEEEEE-----EEhHHhhhh---hhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence            34678999999999999999999987652 2222222     211111111   1234567788898876 899999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||
T Consensus        85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           85 CTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCChhhEEECCCCCEEE
Confidence            98875 56899999999999999998754  38999999999999999999999999   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      +|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ...+..+
T Consensus       160 ~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i  230 (345)
T 1xjd_A          160 ADFGMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSI  230 (345)
T ss_dssp             CCCTTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred             eEChhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHH
Confidence            9999997543222 223456899999999999999999999999999999999999999953221        1122222


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR-SIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  560 (589)
                      ...           .+.    .+...+..+.+|+.+||+.||.+||++. |+++|
T Consensus       231 ~~~-----------~~~----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          231 RMD-----------NPF----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             HHC-----------CCC----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             HhC-----------CCC----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            111           111    2233445789999999999999999998 77766

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-40  Score=340.47  Aligned_cols=269  Identities=29%  Similarity=0.472  Sum_probs=203.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCc-cchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNS-YLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~-~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|.+..++... .+.|.+     .     +.......+.+.+|+++++++ +||||+++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~-----~-----~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   93 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----K-----EYASKDDHRDFAGELEVLCKLGHHPNIINLLG   93 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEE-----E-----CC------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeee-----c-----cccchHHHHHHHHHHHHHHhccCCCchhhhce
Confidence            367999999999999999999887653211 011110     0     011123345688899999999 8999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      ++.+ +..|+||||+++++|.+++....              ...+++..++.++.|++.||+|||++++   +||||||
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp  170 (327)
T 1fvr_A           94 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAA  170 (327)
T ss_dssp             EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSG
T ss_pred             eeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCcc
Confidence            8875 46899999999999999997653              2458999999999999999999999998   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGS  492 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~  492 (589)
                      +|||++.++.+||+|||++......  .......+++.|+|||++.+..++.++|||||||++|||+| |+.||..... 
T Consensus       171 ~NIl~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-  247 (327)
T 1fvr_A          171 RNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-  247 (327)
T ss_dssp             GGEEECGGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred             ceEEEcCCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-
Confidence            9999999999999999998743221  12233467889999999988889999999999999999998 9999843321 


Q ss_pred             CCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccccc
Q 037010          493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWD  572 (589)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~  572 (589)
                             ......+.          ....    ...+...+..+.+|+.+||..||.+|||++|++++|..+......+.
T Consensus       248 -------~~~~~~~~----------~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  306 (327)
T 1fvr_A          248 -------AELYEKLP----------QGYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  306 (327)
T ss_dssp             -------HHHHHHGG----------GTCC----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             -------HHHHHHhh----------cCCC----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence                   11111111          1111    12233445579999999999999999999999999999887766555


Q ss_pred             CCCc
Q 037010          573 VGSF  576 (589)
Q Consensus       573 ~~~~  576 (589)
                      ....
T Consensus       307 ~~~~  310 (327)
T 1fvr_A          307 NTTL  310 (327)
T ss_dssp             CCBC
T ss_pred             ccch
Confidence            4433

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.6e-41  Score=336.05  Aligned_cols=252  Identities=30%  Similarity=0.482  Sum_probs=193.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||++.+.+.   .              +++|.... ...+.+.+|++++++++||||++++++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~--------------vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   82 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGN---K--------------VAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV   82 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTE---E--------------EEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCC---E--------------EEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            57899999999999999999987532   2              22222221 134568889999999999999999998


Q ss_pred             EEe--CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          350 CVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       350 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +.+  +..|+||||+++++|.+++.......+++..++.++.|++.||+|||++++   +||||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~~l~  159 (278)
T 1byg_A           83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVS  159 (278)
T ss_dssp             ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTSCEEEC
T ss_pred             EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCc---cccCCCcceEEEeCCCcEEEe
Confidence            653  358999999999999999987654447899999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||++......    .....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||.....     ...   ...+
T Consensus       160 Dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~---~~~~  227 (278)
T 1byg_A          160 DFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDV---VPRV  227 (278)
T ss_dssp             CCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGH---HHHH
T ss_pred             ecccccccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHH---HHHH
Confidence            99998754322    123467889999999988899999999999999999998 9998843221     111   1111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      .          ....    ...+...+..+.+++.+||+.||.+|||++|+++.|+.+....
T Consensus       228 ~----------~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          228 E----------KGYK----MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             T----------TTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             h----------cCCC----CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            1          1111    1223344457899999999999999999999999999887543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.7e-40  Score=337.45  Aligned_cols=265  Identities=20%  Similarity=0.310  Sum_probs=202.0

Q ss_pred             ccccHHHHHhhcCC----------CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHH
Q 037010          260 VEFSYEELSKATDN----------FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL  329 (589)
Q Consensus       260 ~~~~~~~~~~~~~~----------y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~  329 (589)
                      ..++++++..+.+.          |+..++||+|+||.||+|.+..++. ..+.|.+..           ......+.+.
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~-~vavK~~~~-----------~~~~~~~~~~   90 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR-QVAVKMMDL-----------RKQQRRELLF   90 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEET-----------TTCCSHHHHH
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCc-EEEEEEEec-----------cchhHHHHHH
Confidence            34566666555442          7788899999999999998865422 222222111           0111234578


Q ss_pred             HHHHHHccCCCCcceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 037010          330 AELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIH  408 (589)
Q Consensus       330 ~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH  408 (589)
                      +|+.++++++||||+++++++.. +..|+||||+++++|.+++...   .+++..++.++.|++.||+|||++++   +|
T Consensus        91 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~i---vH  164 (321)
T 2c30_A           91 NEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGV---IH  164 (321)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTE---EC
T ss_pred             HHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCe---ec
Confidence            89999999999999999998865 5689999999999999998753   49999999999999999999999998   99


Q ss_pred             eccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCccccc
Q 037010          409 RDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK  488 (589)
Q Consensus       409 ~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~  488 (589)
                      |||||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       165 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             CCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999886543222 22446799999999999999999999999999999999999999953


Q ss_pred             CCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                      ...        ......+.          ....+.+  ..+...+..+.+++.+||+.||++|||++|+++|-.-
T Consensus       244 ~~~--------~~~~~~~~----------~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  298 (321)
T 2c30_A          244 DSP--------VQAMKRLR----------DSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFL  298 (321)
T ss_dssp             SCH--------HHHHHHHH----------HSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             CCH--------HHHHHHHh----------cCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            321        11111111          1111111  1122344578999999999999999999999998543

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.8e-40  Score=339.57  Aligned_cols=271  Identities=25%  Similarity=0.422  Sum_probs=203.1

Q ss_pred             HHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCccee
Q 037010          266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       266 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      +.....++|++.+.||+|+||.||+|.+.+..... ..+.++++...     +........++.+|++++++++||||++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~-~~~~vaiK~~~-----~~~~~~~~~~~~~E~~~l~~l~h~~i~~   92 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDE-PETRVAIKTVN-----EAASMRERIEFLNEASVMKEFNCHHVVR   92 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTE-EEEEEEEEECC-----TTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCC-CceEEEEEecc-----cccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence            33455688999999999999999999876411100 01111111111     1112334556889999999999999999


Q ss_pred             EeeEEEe-CcEEEEEEecCCCChHHHHhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcE
Q 037010          346 LIGYCVE-GSLFLVYEYIENGNLSEHLRGSG--------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANI  416 (589)
Q Consensus       346 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NI  416 (589)
                      +++++.+ +..++||||+.+|+|.+++....        ..++++..++.++.|++.||+|||++++   +||||||+||
T Consensus        93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dikp~NI  169 (322)
T 1p4o_A           93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNC  169 (322)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC---BCSCCSGGGE
T ss_pred             eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCccceE
Confidence            9998875 45899999999999999997532        1357899999999999999999999998   9999999999


Q ss_pred             EEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCC
Q 037010          417 LIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSA  494 (589)
Q Consensus       417 Ll~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~  494 (589)
                      |++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....   
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---  246 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---  246 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---
T ss_pred             EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---
Confidence            999999999999999975533221 11223467889999999988899999999999999999999 7888743211   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                           ......+..             ... ...+...+..+.+++.+||+.||.+|||+.|++++|+.+...
T Consensus       247 -----~~~~~~~~~-------------~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          247 -----EQVLRFVME-------------GGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             -----HHHHHHHHT-------------TCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             -----HHHHHHHHc-------------CCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence                 111111111             000 112233445789999999999999999999999999887653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=8.4e-40  Score=330.01  Aligned_cols=269  Identities=23%  Similarity=0.311  Sum_probs=196.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.++||+|+||+||+|.+..++. ..+.|.+..         ..........+.+|++++++++||||+++++++.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   71 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHE-IVALKRVRL---------DDDDEGVPSSALREICLLKELKHKNIVRLHDVLH   71 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCC-EEEEEEEES---------SCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCc-eEEEEeeec---------cCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE
Confidence            579999999999999999999876532 222222111         0112233456788999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i---vH~dikp~Nil~~~~~~~kl~Dfg  146 (292)
T 3o0g_A           72 SDKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEcCCCCEEEeecc
Confidence            5 468999999986 6666665533 349999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCC-CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD-VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      ++....... .......||+.|+|||++.+.. ++.++|||||||++|||++|..||.....    ..............
T Consensus       147 ~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~----~~~~~~~i~~~~~~  221 (292)
T 3o0g_A          147 LARAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGT  221 (292)
T ss_dssp             TCEECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCC
T ss_pred             cceecCCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC----HHHHHHHHHHHhCC
Confidence            998654322 2234467899999999987665 89999999999999999999999754432    11222222222222


Q ss_pred             CChH--HhhHhhcCCC---------CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPI--EDLRKLVDPR---------LGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~--~~l~~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +...  .......+..         ............+.+|+.+||+.||++|||++|+++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            2111  0111111100         0011223445678999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-40  Score=347.24  Aligned_cols=260  Identities=26%  Similarity=0.409  Sum_probs=190.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh----cCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~----~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..|++.+.||+|+||.||+|.+....+...            .+++|.    ......+++.+|++++++++||||++++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~------------~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~  156 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKI------------HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL  156 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEE------------EEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEE------------EEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence            357788999999999999998765432211            112221    1234456789999999999999999999


Q ss_pred             eEEE--eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          348 GYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       348 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      +++.  ++..|+||||+++|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+|
T Consensus       157 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlkp~NIll~~~~~~k  232 (373)
T 3c1x_A          157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVK  232 (373)
T ss_dssp             EEECCCSSCCEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEE
T ss_pred             EEEEcCCCCeEEEEECCCCCCHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHHCCE---ecCccchheEEECCCCCEE
Confidence            9875  3468999999999999999976543 48899999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCC---CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHH
Q 037010          426 VADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~  501 (589)
                      |+|||+++........   ......+|+.|+|||.+.+..++.++|||||||++|||+| |..||......     ....
T Consensus       233 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-----~~~~  307 (373)
T 3c1x_A          233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITV  307 (373)
T ss_dssp             ECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-----CHHH
T ss_pred             EeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-----HHHH
Confidence            9999999855332211   1233567889999999998999999999999999999999 55555332211     1111


Q ss_pred             HHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       502 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                         ....          ....    ..+..++..+.+++.+||+.||++|||++|++++|+.+.....
T Consensus       308 ---~~~~----------~~~~----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          308 ---YLLQ----------GRRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             ---HHHT----------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             ---HHHc----------CCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence               1111          1111    1122344578999999999999999999999999998875443

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-40  Score=344.64  Aligned_cols=253  Identities=19%  Similarity=0.318  Sum_probs=197.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++ ...+.|.+.           .........+.+|+++|++++||||+++++++
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~-~~~a~K~~~-----------~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~  117 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATG-RVFVAKFIN-----------TPYPLDKYTVKNEISIMNQLHHPKLINLHDAF  117 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEE-----------CCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCC-CEEEEEEec-----------ccchhhHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence            468999999999999999999887653 222222211           11122345678899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC--CCcEEEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK--NFHAKVA  427 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~--~~~vkl~  427 (589)
                      .+ +..|+||||+.+|+|.+++.... ..+++..++.++.||+.||+|||++++   +||||||+|||++.  ++.+||+
T Consensus       118 ~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~~~~~vkL~  193 (387)
T 1kob_A          118 EDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSI---VHLDIKPENIMCETKKASSVKII  193 (387)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccchHHeEEecCCCCceEEE
Confidence            75 46899999999999999997653 348999999999999999999999998   99999999999974  5789999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.
T Consensus       194 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~i~  263 (387)
T 1kob_A          194 DFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVK  263 (387)
T ss_dssp             CCTTCEECCTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHH
T ss_pred             ecccceecCCCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence            999998654322  22345799999999999999999999999999999999999999954321        11111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...           ...........+..+.+|+.+||+.||.+|||++|+++|
T Consensus       264 ~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          264 RCD-----------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             HCC-----------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hCC-----------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            110           011111222344578999999999999999999999997

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-40  Score=338.17  Aligned_cols=278  Identities=26%  Similarity=0.408  Sum_probs=208.5

Q ss_pred             ccccHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-
Q 037010          260 VEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-  338 (589)
Q Consensus       260 ~~~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-  338 (589)
                      ..+.........++|++.+.||+|+||.||+|.+.+.... ...+.++++...     +.......+.+.+|+++++++ 
T Consensus        15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~   88 (316)
T 2xir_A           15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKT-ATCRTVAVKMLK-----EGATHSEHRALMSELKILIHIG   88 (316)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSST-TCEEEEEEEEEC-----TTCCHHHHHHHHHHHHHHHHHC
T ss_pred             ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCcc-ccceEEEEEecc-----cCCCcHHHHHHHHHHHHHHhcc
Confidence            3444555556678999999999999999999987542110 111112221111     112234456788999999999 


Q ss_pred             CCCcceeEeeEEEeC--cEEEEEEecCCCChHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 037010          339 HHLNLVRLIGYCVEG--SLFLVYEYIENGNLSEHLRGSGR--------------DPLPWSSRVQIALDSARGLEYIHEHT  402 (589)
Q Consensus       339 ~hpnIv~l~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~aL~~LH~~~  402 (589)
                      +||||+++++++.+.  ..++||||+++|+|.+++.....              ..+++..++.++.|++.||+|||+++
T Consensus        89 ~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  168 (316)
T 2xir_A           89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK  168 (316)
T ss_dssp             CCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            799999999988643  48999999999999999987543              22789999999999999999999999


Q ss_pred             CCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc
Q 037010          403 VPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS  481 (589)
Q Consensus       403 i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt  481 (589)
                      +   +||||||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|+|
T Consensus       169 i---~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t  245 (316)
T 2xir_A          169 C---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  245 (316)
T ss_dssp             C---CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             c---ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence            8   9999999999999999999999999986543222 12233567889999999998899999999999999999998


Q ss_pred             -CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          482 -AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       482 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                       |+.||......    ........             ......    .+...+..+.+++.+||+.||.+|||++|++++
T Consensus       246 ~g~~p~~~~~~~----~~~~~~~~-------------~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          246 LGASPYPGVKID----EEFCRRLK-------------EGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             TSCCSSTTCCCS----HHHHHHHH-------------HTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcccchh----HHHHHHhc-------------cCccCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             99998443211    11111111             111111    122334568999999999999999999999999


Q ss_pred             HHhcccc
Q 037010          561 LMTLSST  567 (589)
Q Consensus       561 L~~l~~~  567 (589)
                      |..+...
T Consensus       305 L~~~~~~  311 (316)
T 2xir_A          305 LGNLLQA  311 (316)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHhh
Confidence            9988643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-40  Score=339.51  Aligned_cols=261  Identities=18%  Similarity=0.196  Sum_probs=198.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|.+..++ ...+.|.+..             ....+.+.+|+++++++ +||||++++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~-------------~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   73 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTN-EYVAIKLEPM-------------KSRAPQLHLEYRFYKQLGSGDGIPQVYYF   73 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTT-EEEEEEEEET-------------TCSSCCHHHHHHHHHHHCSCTTSCCEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCC-cEEEEEEecc-------------ccchHHHHHHHHHHHHhhCCCCCCEEEEE
Confidence            578999999999999999999876542 2222221110             01123477899999999 89999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc-----
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH-----  423 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~-----  423 (589)
                      +.++ ..|+||||+ +++|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.     
T Consensus        74 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i---iHrDlkp~Nill~~~~~~~~~~  148 (330)
T 2izr_A           74 GPCGKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQV  148 (330)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECCGGGTCTTS
T ss_pred             EecCCccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCCHHHeeeccCCCCCCce
Confidence            8754 579999999 899999998653 359999999999999999999999998   99999999999998887     


Q ss_pred             EEEEeccCccccccCCCC------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          424 AKVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      +||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ..
T Consensus       149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~  226 (330)
T 2izr_A          149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LK  226 (330)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HH
T ss_pred             EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HH
Confidence            999999999865433221      1234689999999999999999999999999999999999999996543211  11


Q ss_pred             hHHHHHH-HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          498 GLVALFE-EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       498 ~~~~~~~-~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ....... .....  +.+    ..    ..    ..+ .+.+++.+||+.||.+||++++|++.|..+...
T Consensus       227 ~~~~~i~~~~~~~--~~~----~~----~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          227 ERYQKIGDTKRAT--PIE----VL----CE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HHHHHHHHHHHHS--CHH----HH----TT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhhhccC--CHH----HH----hc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            1111111 10000  000    00    01    122 789999999999999999999999999877643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=335.69  Aligned_cols=274  Identities=23%  Similarity=0.290  Sum_probs=193.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC---CCCcceeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV---HHLNLVRL  346 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l---~hpnIv~l  346 (589)
                      ..++|++.++||+|+||+||+|.+..++ ...+.|.+......      .........+.+|+++++++   +||||+++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~------~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~   79 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSG-HFVALKSVRVPNGG------GGGGGLPISTVREVALLRRLEAFEHPNVVRL   79 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTC-CEEEEEEEEEECCC------TTSSCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCC-cEEEEEEEeccccc------ccccccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence            4679999999999999999999876552 22222221110000      00000012344566666555   59999999


Q ss_pred             eeEEEeC------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          347 IGYCVEG------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       347 ~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ++++...      ..++||||+.+ +|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dlkp~Nil~~~  155 (308)
T 3g33_A           80 MDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI---VHRDLKPENILVTS  155 (308)
T ss_dssp             EEEEEECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCTTTEEECT
T ss_pred             eeeeeccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEcC
Confidence            9988643      37899999974 99999988776669999999999999999999999998   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      ++.+||+|||++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....
T Consensus       156 ~~~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~  228 (308)
T 3g33_A          156 GGTVKLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-----ADQL  228 (308)
T ss_dssp             TSCEEECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-----HHHH
T ss_pred             CCCEEEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence            999999999999865422  223456899999999999989999999999999999999999999954321     1122


Q ss_pred             HHHHHHhcCCChHHhh------HhhcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDL------RKLVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l------~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .........+......      .....+...   ....++....+.+|+.+||+.||++|||++|+++|-
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~  298 (308)
T 3g33_A          229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS  298 (308)
T ss_dssp             HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence            2222222211110000      000000000   001123345789999999999999999999999873

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.5e-40  Score=335.22  Aligned_cols=265  Identities=21%  Similarity=0.358  Sum_probs=191.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..+. ...+.|.+...        ..........+.+|++++++++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   80 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDH-RDVAVKVLRAD--------LARDPSFYLRFRREAQNAAALNHPAIVAVYDT   80 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEECTT--------TTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCC-ceEEEEEeCcc--------ccCCHHHHHHHHHHHHHHHcCCCCCcceEEEe
Confidence            3578999999999999999999976552 22222221110        01123345678899999999999999999998


Q ss_pred             EEeC-----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          350 CVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       350 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      +...     ..|+||||+++++|.+++....  ++++..++.++.|++.||+|||++++   +||||||+|||++.++.+
T Consensus        81 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~  155 (311)
T 3ork_A           81 GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAV  155 (311)
T ss_dssp             EEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEEETTSCE
T ss_pred             eeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---CcCCCCHHHEEEcCCCCE
Confidence            7532     2599999999999999998654  48999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCC--CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          425 KVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      ||+|||++........  .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....       ....
T Consensus       156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~  228 (311)
T 3ork_A          156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVA  228 (311)
T ss_dssp             EECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHH
T ss_pred             EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHH
Confidence            9999999986543222  122335789999999999999999999999999999999999999944321       1111


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH-HHhcccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA-LMTLSST  567 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~-L~~l~~~  567 (589)
                      .........+...            .....+..+.+++.+||+.||.+||+..+++.+ +.++...
T Consensus       229 ~~~~~~~~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          229 YQHVREDPIPPSA------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             HHHHHCCCCCHHH------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             HHHhcCCCCCccc------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            1111111111000            011233468999999999999999977666655 5555433

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-40  Score=330.39  Aligned_cols=265  Identities=25%  Similarity=0.356  Sum_probs=200.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      -.|++.++||+|+||.||+|.+..+.....   .++.+..     .+.......+.+.+|++++++++||||+++++++.
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~---~~aiK~~-----~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   92 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRI---QCAIKSL-----SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIML   92 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEE---EEEEEEE-----TTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCcee---eeeeeec-----cccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence            356677999999999999998765432211   0111111     01123345567889999999999999999999886


Q ss_pred             eC-c-EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          352 EG-S-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       352 ~~-~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +. . .++||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        93 ~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dikp~Nili~~~~~~kl~Df  168 (298)
T 3pls_A           93 PPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADF  168 (298)
T ss_dssp             CSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTCCEEECCT
T ss_pred             cCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCcceEEEcCCCcEEeCcC
Confidence            43 3 589999999999999998643 358999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCC---CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          430 GLTKLTEVGS---ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       430 gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |++.......   ........+++.|+|||.+.+..++.++||||||+++|+|++|..|+......    ........  
T Consensus       169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~----~~~~~~~~--  242 (298)
T 3pls_A          169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP----FDLTHFLA--  242 (298)
T ss_dssp             TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG----GGHHHHHH--
T ss_pred             CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH----HHHHHHhh--
Confidence            9997543221   12223356789999999999999999999999999999999977776433221    11111111  


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                                 ....    ...+...+..+.+++.+||+.||.+|||++++++.|+.+.....
T Consensus       243 -----------~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          243 -----------QGRR----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             -----------TTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             -----------cCCC----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence                       1111    11223344578999999999999999999999999998876544

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.6e-40  Score=332.41  Aligned_cols=266  Identities=24%  Similarity=0.363  Sum_probs=192.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+...        .........++.+|++++++++||||++++++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~vavK~~~~~--------~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~  100 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGV-PVALKKVQIF--------DLMDAKARADCIKEIDLLKQLNHPNVIKYYAS  100 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCC-EEEEEEECTT--------SSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCc-eEEEEeeehh--------hccCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            34679999999999999999998765432 2222211100        01224455678899999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +.+ +..++||||+++++|.+++...  ....+++..++.++.|++.||.|||++++   +||||||+||+++.++.+||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dl~p~NIl~~~~~~~kl  177 (310)
T 2wqm_A          101 FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV---MHRDIKPANVFITATGVVKL  177 (310)
T ss_dssp             EEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEE
T ss_pred             EEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCe---eCCCCcHHHEEEcCCCCEEE
Confidence            865 5689999999999999999752  23458999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      +|||++........ ......|++.|+|||.+....++.++||||||+++|+|++|+.||.....      ........+
T Consensus       178 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~  250 (310)
T 2wqm_A          178 GDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKI  250 (310)
T ss_dssp             CCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHH
T ss_pred             EeccceeeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHh
Confidence            99999876543221 22335789999999999988999999999999999999999999854321      111111111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ..             .......+...+..+.+++.+||+.||.+|||+++|+++|.++...
T Consensus       251 ~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          251 EQ-------------CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             HT-------------TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hc-------------ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            11             0111111123345789999999999999999999999999998744

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=351.02  Aligned_cols=267  Identities=22%  Similarity=0.305  Sum_probs=199.7

Q ss_pred             cHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCc
Q 037010          263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLN  342 (589)
Q Consensus       263 ~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpn  342 (589)
                      ..++.....++|++.+.||+|+||.||+|+++.++ ..++.|.+..     ....+   ....+.+.+|.+++.+++|||
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~-~~vAiK~l~k-----~~~~~---~~~~~~~~~E~~il~~~~hp~  122 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTG-QVYAMKIMNK-----WDMLK---RGEVSCFREERDVLVNGDRRW  122 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEH-----HHHHH---HGGGCCHHHHHHHHHHSCTTT
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCC-CEEEEEEEeH-----HHhhh---HHHHHHHHHHHHHHHhcCCCC
Confidence            34555566789999999999999999999987542 2333222211     11111   111234678999999999999


Q ss_pred             ceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          343 LVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       343 Iv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      |+++++++.+ +.+|+||||+++|+|.+++...+. .+++..++.++.||+.||+|||++++   +||||||+|||++.+
T Consensus       123 Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~gi---iHrDLKp~NILld~~  198 (412)
T 2vd5_A          123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRLGY---VHRDIKPDNILLDRC  198 (412)
T ss_dssp             BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTT
T ss_pred             eeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCe---eecccCHHHeeecCC
Confidence            9999998875 568999999999999999986532 49999999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhccc-------CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCC
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-------YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA  494 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~  494 (589)
                      +++||+|||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||.....   
T Consensus       199 g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---  275 (412)
T 2vd5_A          199 GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---  275 (412)
T ss_dssp             SCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---
T ss_pred             CCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---
Confidence            99999999999876543332334468999999999986       45789999999999999999999999954321   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHH
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR---PSMRSIVVAL  561 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~L  561 (589)
                           ...+..+...      -.....+..    +...+..+.+|+.+||. +|.+|   |+++|+++|-
T Consensus       276 -----~~~~~~i~~~------~~~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          276 -----AETYGKIVHY------KEHLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             -----HHHHHHHHTH------HHHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             -----HHHHHHHHhc------ccCcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence                 1111121110      000001111    12234478999999999 99998   6999999884

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.7e-40  Score=341.45  Aligned_cols=269  Identities=22%  Similarity=0.365  Sum_probs=204.4

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeE
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRL  346 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l  346 (589)
                      ....++|++.+.||+|+||.||+|.+...+... ..+.++++...     ........+.+.+|+++++++ +||||+++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~  115 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKED-AVLKVAVKMLK-----STAHADEKEALMSELKIMSHLGQHENIVNL  115 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSC-CCCEEEEEEEC-----TTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCccc-chhHHHHHhcc-----cccChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            344688999999999999999999987653321 11112211111     112234456788999999999 89999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSG------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      ++++.+ +..|+||||+++|+|.+++....            ...+++..++.++.|++.||+|||++++   +||||||
T Consensus       116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp  192 (333)
T 2i1m_A          116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNC---IHRDVAA  192 (333)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSG
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCc---ccCCccc
Confidence            998874 56899999999999999997542            2358999999999999999999999998   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~  491 (589)
                      +|||++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||.....
T Consensus       193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence            9999999999999999999865433221 2233567889999999988899999999999999999999 8888844321


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      .    .........             .....    .+...+..+.+++.+||+.||.+|||++|++++|+.+..
T Consensus       273 ~----~~~~~~~~~-------------~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          273 N----SKFYKLVKD-------------GYQMA----QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             S----HHHHHHHHH-------------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             h----HHHHHHHhc-------------CCCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            1    111111111             11111    122234578999999999999999999999999988764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5e-40  Score=332.25  Aligned_cols=265  Identities=16%  Similarity=0.188  Sum_probs=200.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ...+.|.+.             .....+.+.+|+++++++ +|+|++++++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~-------------~~~~~~~~~~e~~~~~~l~~~~~i~~~~~   73 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNN-QQVAIKFEP-------------RRSDAPQLRDEYRTYKLLAGCTGIPNVYY   73 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTT-EEEEEEEEE-------------CCTTSCCHHHHHHHHHHTTTCTTCCCEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCC-cEEEEEEec-------------cCCccHHHHHHHHHHHHHhcCCCCCeEEe
Confidence            4578999999999999999999876542 222222110             011123467799999999 7999999999


Q ss_pred             EEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc----
Q 037010          349 YCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH----  423 (589)
Q Consensus       349 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~----  423 (589)
                      ++.++ ..++||||+ +++|.+++.... .++++..++.++.|++.||+|||++++   +||||||+|||++.++.    
T Consensus        74 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dlkp~NIl~~~~~~~~~~  148 (298)
T 1csn_A           74 FGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNAN  148 (298)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECCSSSTTTT
T ss_pred             ecCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHHHEEeccCCCCCCC
Confidence            88754 589999999 899999998654 349999999999999999999999998   99999999999987766    


Q ss_pred             -EEEEeccCccccccCCCC------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          424 -AKVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       424 -vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                       +||+|||++.........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~  227 (298)
T 1csn_A          149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-K  227 (298)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-H
T ss_pred             eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-H
Confidence             999999999865433221      22446799999999999999999999999999999999999999965432211 1


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      .............+  ...        +..    ..+..+.+++.+||+.||++|||+++|++.|..+....
T Consensus       228 ~~~~~~~~~~~~~~--~~~--------~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          228 QKYERIGEKKQSTP--LRE--------LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HHHHHHHHHHHHSC--HHH--------HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhhccCcc--HHH--------HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            11111111111100  000        011    22347899999999999999999999999999887543

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.7e-41  Score=334.90  Aligned_cols=252  Identities=27%  Similarity=0.432  Sum_probs=198.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ...+|++.+.||+|+||.||+|.+..++. ..+.|.+..              . .+.+.+|++++++++||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~--------------~-~~~~~~e~~~l~~l~h~~i~~~~~~   72 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGK-TYVIKRVKY--------------N-NEKAEREVKALAKLDHVNIVHYNGC   72 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCC-EEEEEEEEC--------------C-SGGGHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCe-EEEEEEecc--------------c-cHHHHHHHHHHHhCCCCCEEEEeee
Confidence            45679999999999999999999875432 222222111              0 1245679999999999999999997


Q ss_pred             EEe-----------------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          350 CVE-----------------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       350 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      +..                 ...|+||||+++++|.+++.......+++..++.++.|++.||.|||++++   +|+|||
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dlk  149 (284)
T 2a19_B           73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKL---INRDLK  149 (284)
T ss_dssp             EEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCS
T ss_pred             EeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe---eeccCC
Confidence            642                 237899999999999999987655569999999999999999999999998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGS  492 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~  492 (589)
                      |+|||++.++.+||+|||++.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|..|+...   
T Consensus       150 p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---  224 (284)
T 2a19_B          150 PSNIFLVDTKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---  224 (284)
T ss_dssp             GGGEEEEETTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---
T ss_pred             HHHEEEcCCCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---
Confidence            999999999999999999988654322  223457899999999999889999999999999999999999887321   


Q ss_pred             CCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          493 SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       493 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                             ......             ..+..+...+    +..+.+++.+||+.||.+|||+.|++++|..+....+
T Consensus       225 -------~~~~~~-------------~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          225 -------SKFFTD-------------LRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             -------HHHHHH-------------HHTTCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             -------HHHHHH-------------hhcccccccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence                   111111             1111122223    3468899999999999999999999999998876544

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.4e-40  Score=327.68  Aligned_cols=253  Identities=25%  Similarity=0.416  Sum_probs=194.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..+.. ..+.|.+..     ....   .......+.+|++++++++||||++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~-----~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   77 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKF-ILALKVLFK-----AQLE---KAGVEHQLRREVEIQSHLRHPNILRLYGY   77 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEEEH-----HHHH---HHTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCc-EEEEEEEec-----cccc---hhhHHHHHHHHHHHHHcCCCCCCcchhhe
Confidence            35789999999999999999998876532 222222111     1000   01113457889999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.++ ..++||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus        78 ~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i---~H~dlkp~Nili~~~~~~~l~D  152 (279)
T 3fdn_A           78 FHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIAD  152 (279)
T ss_dssp             EECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTC---EECCCCGGGEEECTTSCEEECS
T ss_pred             EecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecccCChHhEEEcCCCCEEEEe
Confidence            8754 5899999999999999998754  38999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++......   ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....        .......+..
T Consensus       153 fg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~  221 (279)
T 3fdn_A          153 FGWSVHAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISR  221 (279)
T ss_dssp             CCEESCC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH
T ss_pred             ccccccCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHh
Confidence            9988654322   2234678999999999998899999999999999999999999984321        1111111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                                 ...    ..+...+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       222 -----------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          222 -----------VEF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             -----------TCC----CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             -----------CCC----CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence                       111    122333456899999999999999999999999954

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.2e-40  Score=341.71  Aligned_cols=250  Identities=19%  Similarity=0.286  Sum_probs=173.3

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeEEEeC-c
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGYCVEG-S  354 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~-~  354 (589)
                      .+.||+|+||.||+|.+..++.               .+++|.+.......+.+|+++++++. ||||+++++++.++ .
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~---------------~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQ---------------AFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCC---------------EEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCccccCCCeEEEEEEECCCCC---------------EEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            4789999999999999876522               22333333333456678999999997 99999999988754 5


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC---cEEEEeccC
Q 037010          355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF---HAKVADFGL  431 (589)
Q Consensus       355 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~---~vkl~Dfgl  431 (589)
                      .|+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++   .+||+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i---vH~Dlkp~NIll~~~~~~~~~kl~Dfg~  155 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGV---VHRDLKPENLLFTDENDNLEIKIIDFGF  155 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred             EEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---eecCCCHHHEEEecCCCcccEEEecccc
Confidence            899999999999999998754  49999999999999999999999998   9999999999997765   899999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCC
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD  511 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  511 (589)
                      +........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .........+.    
T Consensus       156 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~i~----  229 (325)
T 3kn6_A          156 ARLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKKIK----  229 (325)
T ss_dssp             CEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHHHT----
T ss_pred             ceecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHHHH----
Confidence            986543222 223467899999999999999999999999999999999999999654321110 11111222211    


Q ss_pred             hHHhhHhhcCCCCC--CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          512 PIEDLRKLVDPRLG--DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       512 ~~~~l~~~~d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                               .....  .....+.+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       230 ---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~  272 (325)
T 3kn6_A          230 ---------KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE  272 (325)
T ss_dssp             ---------TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred             ---------cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence                     11110  001122345789999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.4e-40  Score=332.07  Aligned_cols=259  Identities=22%  Similarity=0.378  Sum_probs=195.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC---HHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD---MQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~---~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      .++|++.+.||+|+||.||+|.+..+........        ..+++|...   ....+.+.+|++++++++||||++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~--------~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHE--------TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNY   78 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEE--------EEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEE
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccc--------hhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEE
Confidence            4689999999999999999998876532110000        012222221   22345688999999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc---
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH---  423 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~---  423 (589)
                      +++.+ +..++||||+.+|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.   
T Consensus        79 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~~~  154 (289)
T 4fvq_A           79 GVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKT  154 (289)
T ss_dssp             EEECCTTCCEEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEEEECCBGGG
T ss_pred             EEEEeCCCCEEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhCCe---ECCCcCcceEEEecCCcccc
Confidence            98875 458999999999999999987543 38999999999999999999999998   99999999999988877   


Q ss_pred             -----EEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          424 -----AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       424 -----vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                           +||+|||++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.....    ..
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~----~~  225 (289)
T 4fvq_A          155 GNPPFIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD----SQ  225 (289)
T ss_dssp             TBCCEEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC----HH
T ss_pred             cccceeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc----hH
Confidence                 99999999864421     123568899999999977 6789999999999999999997766533221    11


Q ss_pred             hHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      .......   .            ...+....    +..+.+++.+||+.||.+|||++|++++|+.+.+...
T Consensus       226 ~~~~~~~---~------------~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          226 RKLQFYE---D------------RHQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             HHHHHHH---T------------TCCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             HHHHHhh---c------------cCCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence            1111110   0            11111112    2358899999999999999999999999999986443

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.4e-40  Score=337.53  Aligned_cols=270  Identities=24%  Similarity=0.422  Sum_probs=203.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCC-ccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGN-SYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~-~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  347 (589)
                      ..++|++.+.||+|+||.||+|.+.+.... ....+.++++...     +.......+.+.+|+++++++ +||||++++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  107 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSDLVSEMEMMKMIGKHKNIINLL  107 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECC-----TTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeec-----cCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence            357899999999999999999997642211 0011111111111     112334556788999999999 899999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGR--------------DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      +++.+ +..|+||||+.+|+|.+++.....              ..+++..++.++.|++.||+|||++++   +|||||
T Consensus       108 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlk  184 (334)
T 2pvf_A          108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKC---IHRDLA  184 (334)
T ss_dssp             EEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCS
T ss_pred             EEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCe---eCCCCc
Confidence            98874 468999999999999999986542              248899999999999999999999998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGN  490 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~  490 (589)
                      |+|||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus       185 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~  264 (334)
T 2pvf_A          185 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  264 (334)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence            9999999999999999999986543221 12233467889999999988889999999999999999999 998884321


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                           ......   .+.          ......    .+...+..+.+++.+||+.||.+|||++|++++|+.+.....
T Consensus       265 -----~~~~~~---~~~----------~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          265 -----VEELFK---LLK----------EGHRMD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             -----HHHHHH---HHH----------HTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -----HHHHHH---HHh----------cCCCCC----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence                 111111   111          111111    223344578999999999999999999999999998875443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-39  Score=326.37  Aligned_cols=256  Identities=21%  Similarity=0.311  Sum_probs=198.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+.         .+.......+.+.+|++++++++||||++++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~---------~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGL-EFAAKIIN---------TKKLSARDFQKLEREARICRKLQHPNIVRLHDS   73 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEE---------GGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCc-eEEEEEee---------cccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence            46889999999999999999998876532 22222221         112334455678899999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc---EE
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH---AK  425 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~---vk  425 (589)
                      +.++ ..++||||+.+++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+||+++.++.   +|
T Consensus        74 ~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dikp~Nil~~~~~~~~~~k  148 (284)
T 3kk8_A           74 IQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGI---VHRNLKPENLLLASKAKGAAVK  148 (284)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEESSSSTTCCEE
T ss_pred             EEcCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---CcCCCCHHHEEEecCCCCCcEE
Confidence            8754 5799999999999999987754  38999999999999999999999998   99999999999976655   99


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....     ...   ...
T Consensus       149 l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-----~~~---~~~  218 (284)
T 3kk8_A          149 LADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRL---YAQ  218 (284)
T ss_dssp             ECCCTTCEECCSS--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH---HHH
T ss_pred             EeeceeeEEcccC--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-----hHH---HHH
Confidence            9999999765432  222346799999999999999999999999999999999999999944221     111   111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      +....           ...........+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       219 ~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (284)
T 3kk8_A          219 IKAGA-----------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  263 (284)
T ss_dssp             HHHTC-----------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred             HHhcc-----------ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence            11100           0001111123345689999999999999999999999984

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.1e-39  Score=346.83  Aligned_cols=267  Identities=21%  Similarity=0.243  Sum_probs=192.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++.. .+.|.+.     ..    .......+++.+|+++|++++||||++++++
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~-vAiK~~~-----~~----~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  129 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN-VAIKKLS-----RP----FQNQTHAKRAYRELVLMKCVNHKNIISLLNV  129 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEE-EEEEEEE-----SG----GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCE-EEEEEEC-----cc----ccChHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            467899999999999999999988765322 2222111     00    1233455678899999999999999999998


Q ss_pred             EEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +..       ..+|+||||+++ +|.+.+..    .+++..++.++.||+.||+|||++++   +||||||+|||++.++
T Consensus       130 ~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~i---iHrDlkp~NIll~~~~  201 (464)
T 3ttj_A          130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDC  201 (464)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTS
T ss_pred             EccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCChHhEEEeCCC
Confidence            853       247999999987 57777653    38899999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+||+|||+++.....  ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||....     .......
T Consensus       202 ~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~-----~~~~~~~  274 (464)
T 3ttj_A          202 TLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD-----YIDQWNK  274 (464)
T ss_dssp             CEEECCCCCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH
T ss_pred             CEEEEEEEeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence            9999999999865432  23345789999999999999999999999999999999999999995432     1111112


Q ss_pred             HHHHhcCCChH------HhhHhhcCCCCC-CCC-----------------ChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 037010          503 FEEVLNLPDPI------EDLRKLVDPRLG-DNC-----------------PLDSVLKMAQLAKVCTQEYPQLRPSMRSIV  558 (589)
Q Consensus       503 ~~~~~~~~~~~------~~l~~~~d~~l~-~~~-----------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl  558 (589)
                      ....+..+.+.      ......++.... ...                 .......+.+|+.+||+.||++|||++|++
T Consensus       275 i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L  354 (464)
T 3ttj_A          275 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL  354 (464)
T ss_dssp             HHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            22222222110      011111111100 000                 011256789999999999999999999999


Q ss_pred             HHH
Q 037010          559 VAL  561 (589)
Q Consensus       559 ~~L  561 (589)
                      +|-
T Consensus       355 ~Hp  357 (464)
T 3ttj_A          355 QHP  357 (464)
T ss_dssp             TST
T ss_pred             cCh
Confidence            983

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.4e-40  Score=335.70  Aligned_cols=255  Identities=22%  Similarity=0.371  Sum_probs=188.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEcc--ccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRG--EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|+...  ..+...+.|.+..     ....+  .......+.+|+++|++++||||+++++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~-----~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~   88 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKK-----AMIVR--NAKDTAHTKAERNILEEVKHPFIVDLIY   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECC-----C----------------HHHHHHHCCCTTBCCEEE
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEH-----HHhhh--hhhHHHHHHHHHHHHHhCCCCCccceeE
Confidence            4689999999999999999998753  2222222222211     10000  1123345778999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +..|+||||+++++|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~i---vH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           89 AFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGI---IYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             EEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCTTTEEECTTSCEEEC
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCE---EcccCCHHHeEECCCCcEEEE
Confidence            8874 56999999999999999998654  38899999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.
T Consensus       164 Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~  234 (327)
T 3a62_A          164 DFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKIL  234 (327)
T ss_dssp             CCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHH
T ss_pred             eCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH
Confidence            999987543221 222346799999999999988999999999999999999999999954321        11112211


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVAL  561 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  561 (589)
                      ..           ..    ..+...+..+.+|+.+||+.||.+||     +++|+++|-
T Consensus       235 ~~-----------~~----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          235 KC-----------KL----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             HT-----------CC----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             hC-----------CC----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence            11           01    12333445789999999999999999     888999884

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=335.75  Aligned_cols=248  Identities=22%  Similarity=0.286  Sum_probs=184.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      .++|++.++||+|+||+||+|.+..++. ..+.|.+..         .........+...|+..+.++ +||||++++++
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~-~vavK~~~~---------~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~  125 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGR-LYAVKRSMS---------PFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA  125 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSC-EEEEEEESS---------SCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCe-EEEEEEecc---------cccChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence            3679999999999999999999875532 222221100         011223334455566655555 89999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.++ ..|+||||+ +++|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus       126 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIll~~~~~~kl~D  200 (311)
T 3p1a_A          126 WEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGL---VHLDVKPANIFLGPRGRCKLGD  200 (311)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECGGGCEEECC
T ss_pred             EEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---ecCCCCHHHEEECCCCCEEEcc
Confidence            8754 589999999 669999987764 359999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++......  .......||+.|+|||++.+ .++.++|||||||++|||++|..++...           ..+..+..
T Consensus       201 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-----------~~~~~~~~  266 (311)
T 3p1a_A          201 FGLLVELGTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-----------EGWQQLRQ  266 (311)
T ss_dssp             CTTCEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH-----------HHHHHHTT
T ss_pred             ceeeeecccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc-----------cHHHHHhc
Confidence            9998765432  22334579999999999875 7999999999999999999998776321           11111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...+             ...+...+..+.+++.+||+.||++|||++|+++|
T Consensus       267 ~~~~-------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          267 GYLP-------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             TCCC-------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCC-------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            1100             01111234578999999999999999999999976

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.8e-40  Score=332.93  Aligned_cols=265  Identities=22%  Similarity=0.369  Sum_probs=196.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCc--cchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNS--YLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~--~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|.+....+..  .+.|.+..     ..   ....+..+.+.+|++++++++||||+++++
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~-----~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   88 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKP-----DV---LSQPEAMDDFIREVNAMHSLDHRNLIRLYG   88 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC----------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEcc-----Cc---cCCHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence            467999999999999999999876543321  12221110     00   001234567889999999999999999999


Q ss_pred             EEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          349 YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       349 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      ++.++..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||++++   +|+||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dikp~Nili~~~~~~kl~D  164 (291)
T 1u46_A           89 VVLTPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGD  164 (291)
T ss_dssp             EECSSSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEEEETTEEEECC
T ss_pred             EEccCCceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCchheEEEcCCCCEEEcc
Confidence            998888999999999999999998653 248999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          429 FGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       429 fgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      ||++.........  ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....        ......
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~  236 (291)
T 1u46_A          165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHK  236 (291)
T ss_dssp             CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHH
T ss_pred             ccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHH
Confidence            9999865433221  1223467888999999988889999999999999999999 9999843321        111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      +...             ......+...+..+.+++.+||..||.+|||+.+++++|..+....
T Consensus       237 ~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          237 IDKE-------------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             HHTS-------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HHcc-------------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            1111             1111122334557999999999999999999999999999887544

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-39  Score=350.26  Aligned_cols=252  Identities=23%  Similarity=0.400  Sum_probs=196.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|.+.+.||+|+||.||+|.+..++. ..+.|.+..     .. ...  .+....+.+|+++++.++||||+++++++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~-~vAvK~i~~-----~~-~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~   85 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGH-KVAVKILNR-----QK-IRS--LDVVGKIRREIQNLKLFRHPHIIKLYQVI   85 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCC-EEEEEEEEH-----HH-HHH--TTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCC-EEEEEEEEh-----hh-ccC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            4789999999999999999999875532 222222211     10 000  01234678899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~gi---vHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           86 STPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             ECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTE---ECSCCSGGGEEECTTCCEEECCC
T ss_pred             EECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCC---CcccccHHHEEEecCCCeEEEec
Confidence            75 56899999999999999997654  49999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++......  .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....        ......+..
T Consensus       161 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~  230 (476)
T 2y94_A          161 GLSNMMSDG--EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICD  230 (476)
T ss_dssp             SSCEECCTT--CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHT
T ss_pred             cchhhcccc--ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhc
Confidence            999865432  22344679999999999987765 6899999999999999999999954321        111222211


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                   ...  ..|...+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       231 -------------~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp  268 (476)
T 2y94_A          231 -------------GIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE  268 (476)
T ss_dssp             -------------TCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCH
T ss_pred             -------------CCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCH
Confidence                         111  11223345689999999999999999999999973

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.1e-40  Score=343.55  Aligned_cols=270  Identities=22%  Similarity=0.328  Sum_probs=188.9

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEe
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLI  347 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~  347 (589)
                      ...++|++.+.||+|+||.||+|.+..++.. .+.|.+.         ..........++.+|+.+++++. ||||++++
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-vaiK~i~---------~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~   75 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEV-VAVKKIF---------DAFQNSTDAQRTFREIMILTELSGHENIVNLL   75 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCE-EEEEEEC---------C--CCHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCE-EEEEEec---------ccccChHHHHHHHHHHHHHHhccCCCCCCeee
Confidence            3568999999999999999999988765322 2221110         00123344567788999999997 99999999


Q ss_pred             eEEEeC---cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          348 GYCVEG---SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       348 ~~~~~~---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      +++..+   .+|+||||+.+ +|.+++...   .+++..+..++.|++.||+|||++|+   +||||||+|||++.++.+
T Consensus        76 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i---vHrDlkp~NIll~~~~~~  148 (388)
T 3oz6_A           76 NVLRADNDRDVYLVFDYMET-DLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGL---LHRDMKPSNILLNAECHV  148 (388)
T ss_dssp             EEEECTTSSCEEEEEECCSE-EHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCE
T ss_pred             eEEecCCCCEEEEEecccCc-CHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCE---EeCCCCHHHeEEcCCCCE
Confidence            988632   58999999985 899999764   48999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccC--------------------CCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCC
Q 037010          425 KVADFGLTKLTEVG--------------------SASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAK  483 (589)
Q Consensus       425 kl~Dfgla~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~  483 (589)
                      ||+|||+++.....                    .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus       149 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  228 (388)
T 3oz6_A          149 KVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK  228 (388)
T ss_dssp             EECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             EecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCC
Confidence            99999999864321                    1112234689999999999876 67899999999999999999999


Q ss_pred             cccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhc------------------CCCCCCC------------CChHHH
Q 037010          484 EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLV------------------DPRLGDN------------CPLDSV  533 (589)
Q Consensus       484 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------------------d~~l~~~------------~~~~~~  533 (589)
                      .||....     ..............+... .+....                  .......            .+.+..
T Consensus       229 ~pf~~~~-----~~~~~~~i~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (388)
T 3oz6_A          229 PIFPGSS-----TMNQLERIIGVIDFPSNE-DVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN  302 (388)
T ss_dssp             CSCCCSS-----HHHHHHHHHHHHCCCCHH-HHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCC
T ss_pred             CCCCCCC-----HHHHHHHHHHhcCCCCHH-HHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCC
Confidence            9995432     112222222233322211 110000                  0000000            001223


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          534 LKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       534 ~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..+.+|+.+||+.||.+|||++|+++|-
T Consensus       303 ~~~~dll~~~L~~dP~~R~t~~e~l~Hp  330 (388)
T 3oz6_A          303 EEALDLLDKLLQFNPNKRISANDALKHP  330 (388)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTST
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhCCH
Confidence            4689999999999999999999999993

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.4e-39  Score=326.28  Aligned_cols=251  Identities=22%  Similarity=0.349  Sum_probs=193.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ...|++.+.||+|+||.||+|.+..+.... +.|.+         ..........+.+.+|++++++++||||+++++++
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~v-a~k~~---------~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   94 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEV-AWCEL---------QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSW   94 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEE-EEEEE---------EGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEE-EEEEe---------cchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            355889999999999999999877653221 11111         11123344567788999999999999999999987


Q ss_pred             Ee-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeeccCCCcEEEc-CCC
Q 037010          351 VE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT--VPVYIHRDIKSANILID-KNF  422 (589)
Q Consensus       351 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~--i~~~vH~Dlkp~NILl~-~~~  422 (589)
                      .+     ...++||||+++++|.+++....  .+++..++.++.|++.||+|||+++  +   +||||||+|||++ .++
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i---~H~dikp~Nil~~~~~~  169 (290)
T 1t4h_A           95 ESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPI---IHRDLKCDNIFITGPTG  169 (290)
T ss_dssp             EEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCC---CCSCCCGGGEEESSTTS
T ss_pred             ccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCE---EECCCCHHHEEEECCCC
Confidence            53     34899999999999999998654  3899999999999999999999999  7   9999999999997 789


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+||+|||++......   ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.....       ....
T Consensus       170 ~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~  238 (290)
T 1t4h_A          170 SVKIGDLGLATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQI  238 (290)
T ss_dssp             CEEECCTTGGGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHH
T ss_pred             CEEEeeCCCccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHH
Confidence            9999999999754322   223467999999999886 4689999999999999999999999943221       1111


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .........             ....+...+..+.+++.+||+.||.+|||++|+++|
T Consensus       239 ~~~~~~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          239 YRRVTSGVK-------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HHHHTTTCC-------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccCC-------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            222211110             011111222468999999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1e-39  Score=343.14  Aligned_cols=254  Identities=24%  Similarity=0.392  Sum_probs=191.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC--CCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH--HLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||.||+|.+..  +..++.|.+..         ........+.+.+|+++|++++  ||||+++++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~--~~~vaiK~~~~---------~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~  123 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNL---------EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD  123 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT--CCEEEEEEEEC---------TTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC--CCEEEEEEEec---------ccccHHHHHHHHHHHHHHHHcccCCCeEEEEEE
Confidence            4569999999999999999998653  33333322211         1223445677889999999996  599999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.. +.+|+||| +.+++|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++ ++.+||+
T Consensus       124 ~~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i---vHrDlkp~NIll~-~~~~kl~  196 (390)
T 2zmd_A          124 YEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGI---VHSDLKPANFLIV-DGMLKLI  196 (390)
T ss_dssp             EEECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTC---CCCCCCGGGEEES-SSCEEEC
T ss_pred             EEecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCHHHEEEE-CCeEEEE
Confidence            8875 45899999 56789999998764  48899999999999999999999998   9999999999995 5799999


Q ss_pred             eccCccccccCCCC-CCcccccCCCCCchhcccC-----------CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC
Q 037010          428 DFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQY-----------GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD  495 (589)
Q Consensus       428 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~  495 (589)
                      |||+++........ ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....    
T Consensus       197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----  272 (390)
T 2zmd_A          197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN----  272 (390)
T ss_dssp             CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC----
T ss_pred             ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH----
Confidence            99999865433221 2334679999999999864           4688999999999999999999999943211    


Q ss_pred             hhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                         ..             ..+...+++......+......+.+|+.+||+.||.+|||++|+++|-.
T Consensus       273 ---~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  323 (390)
T 2zmd_A          273 ---QI-------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  323 (390)
T ss_dssp             ---HH-------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ---HH-------------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence               01             1122223332222233333457899999999999999999999999853

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.6e-40  Score=342.47  Aligned_cols=252  Identities=27%  Similarity=0.375  Sum_probs=186.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHH-HccCCCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV-LTHVHHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~i-l~~l~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|++..+. ..++.|.+..     ...   ........+.+|..+ ++.++||||++++++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~~AiK~~~~-----~~~---~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~  107 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEE-VFYAVKVLQK-----KAI---LKKKEEKHIMSERNVLLKNVKHPFLVGLHFS  107 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTC-CEEEEEEEEG-----GGB---C-------------CCBCCCCCTTBCCEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCC-CEEEEEEEEH-----HHh---hhhHHHHHHHHHHHHHHHhCCCCCCCCEEEE
Confidence            467999999999999999999987652 2223322211     110   111223455667776 577899999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +.+|+||||++||+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++++||+|
T Consensus       108 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gi---vHrDlkp~NIll~~~g~ikL~D  182 (373)
T 2r5t_A          108 FQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNI---VYRDLKPENILLDSQGHIVLTD  182 (373)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECC
T ss_pred             EEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCHHHEEECCCCCEEEee
Confidence            764 56899999999999999998754  38899999999999999999999999   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....        ....+..+..
T Consensus       183 FG~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~  253 (373)
T 2r5t_A          183 FGLCKENIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILN  253 (373)
T ss_dssp             CCBCGGGBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHH
T ss_pred             CccccccccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHh
Confidence            9999853322 223345789999999999999999999999999999999999999995321        1122222222


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH----HHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR----SIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~----evl~~  560 (589)
                      .+           .    ..+...+..+.+|+.+||+.||.+||++.    ++++|
T Consensus       254 ~~-----------~----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          254 KP-----------L----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             SC-----------C----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             cc-----------c----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence            11           1    12233445789999999999999999974    55554

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.5e-40  Score=365.27  Aligned_cols=253  Identities=24%  Similarity=0.393  Sum_probs=193.3

Q ss_pred             eeeccCCcEEEEEEEEccccC-CccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEeCcEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYG-NSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLF  356 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~-~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  356 (589)
                      ++||+|+||.||+|.+..... ...+.|.+     ...    .......+++.+|+++|++++||||+++++++.++..+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~-----~~~----~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~  445 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-----KNE----ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWM  445 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEE-----CGG----GGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEe-----ccc----cCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            479999999999997654321 12222211     110    11122346788999999999999999999999888899


Q ss_pred             EEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccc
Q 037010          357 LVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE  436 (589)
Q Consensus       357 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~  436 (589)
                      +||||+.+|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||+++...
T Consensus       446 lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~i---iHrDLkp~NILl~~~~~~kL~DFGla~~~~  520 (635)
T 4fl3_A          446 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALR  520 (635)
T ss_dssp             EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEEECCTTHHHHTT
T ss_pred             EEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCE---eCCCCChHhEEEeCCCCEEEEEcCCccccc
Confidence            9999999999999997654  48999999999999999999999998   999999999999999999999999998654


Q ss_pred             cCCC--CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChH
Q 037010          437 VGSA--SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPI  513 (589)
Q Consensus       437 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (589)
                      ....  .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....     ..   ....+       
T Consensus       521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~---~~~~i-------  585 (635)
T 4fl3_A          521 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SE---VTAML-------  585 (635)
T ss_dssp             C-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH---HHHHH-------
T ss_pred             cCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HH---HHHHH-------
Confidence            3322  12233456789999999999999999999999999999998 9999844321     11   11111       


Q ss_pred             HhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          514 EDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       514 ~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                             ........+..++..+.+|+.+||+.||++|||+++|++.|+.+..
T Consensus       586 -------~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          586 -------EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             -------HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   1111123344455679999999999999999999999999987653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.5e-39  Score=328.35  Aligned_cols=266  Identities=20%  Similarity=0.246  Sum_probs=197.5

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc-CHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-DMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~-~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ...++|++.+.||+|+||.||+|.+..+.. .              +++|.. ......++.+|+++++.++|++++..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~--------------vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~   70 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGE-E--------------VAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI   70 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTE-E--------------EEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCc-e--------------EEEEeecccccchHHHHHHHHHHHhcCCCCCCee
Confidence            346789999999999999999998765422 2              222211 112223477899999999998888777


Q ss_pred             eEEE--eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE---cCCC
Q 037010          348 GYCV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNF  422 (589)
Q Consensus       348 ~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl---~~~~  422 (589)
                      .++.  ++..++||||+ +++|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||+   +.++
T Consensus        71 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i---vH~Dlkp~NIl~~~~~~~~  145 (296)
T 4hgt_A           71 RWCGAEGDYNVMVMELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGN  145 (296)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECCGGGTT
T ss_pred             eeecCCCCceEEEEEcc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeeeeccCCCC
Confidence            6553  34579999999 8899999985433 49999999999999999999999998   999999999999   7889


Q ss_pred             cEEEEeccCccccccCCC------CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          423 HAKVADFGLTKLTEVGSA------SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      .+||+|||++........      .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......... 
T Consensus       146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-  224 (296)
T 4hgt_A          146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-  224 (296)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-
T ss_pred             eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-
Confidence            999999999986544322      1223467999999999999999999999999999999999999999654332221 


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      .............+  ..    ..    ...+    +..+.+++.+||+.||++|||++++++.|..+.....
T Consensus       225 ~~~~~~~~~~~~~~--~~----~~----~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          225 QKYERISEKKMSTP--IE----VL----CKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             SHHHHHHHHHHHSC--HH----HH----TTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hhhhhhhcccccch--hh----hh----hccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            11111111111111  00    00    0122    3468999999999999999999999999988876543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-39  Score=353.90  Aligned_cols=258  Identities=25%  Similarity=0.348  Sum_probs=201.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ..++.|.+.     .....+.   .....+.+|+++|++++||||++++++
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg-~~vAvK~l~-----k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~  252 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATG-KMYACKKLE-----KKRIKKR---KGEAMALNEKQILEKVNSRFVVSLAYA  252 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEE-----HHHHHHT---TCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCC-CEEEEEEEE-----hHhhhhh---HHHHHHHHHHHHHHHcCCCCEeeEEEE
Confidence            4578999999999999999999987653 333333221     1111111   113457789999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +.+|+||||++||+|.+++.......+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|
T Consensus       253 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gI---vHrDLKPeNILld~~g~vKL~D  329 (576)
T 2acx_A          253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI---VYRDLKPENILLDDHGHIRISD  329 (576)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTSCEEECC
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCE---eccCCchheEEEeCCCCeEEEe
Confidence            765 569999999999999999988766669999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .   .......+..
T Consensus       330 FGla~~~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~---~~~i~~~i~~  403 (576)
T 2acx_A          330 LGLAVHVPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-K---REEVERLVKE  403 (576)
T ss_dssp             CTTCEECCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-C---HHHHHHHHHH
T ss_pred             cccceecccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-h---HHHHHHHhhc
Confidence            99998654322  2234589999999999998899999999999999999999999996543211 1   1111111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                      .           ..    ..+...+..+.+|+.+||+.||.+||     +++|+++|
T Consensus       404 ~-----------~~----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          404 V-----------PE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             C-----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             c-----------cc----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            1           11    22333445789999999999999999     88999988

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-39  Score=337.32  Aligned_cols=266  Identities=21%  Similarity=0.215  Sum_probs=194.0

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      +....++|++.+.||+|+||.||+|.+..+. ...+.|.+..      ...........+.+.+|++++++++||||+++
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vaiK~~~~------~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTR-AIRAIKIMNK------NKIRQINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEH------HHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCC-ceEEEeehhh------hhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            3456788999999999999999999876653 2222222211      11112223345678899999999999999999


Q ss_pred             eeEEEeC-cEEEEEEecCCCChHHHHhcCC--------------------------------------CCCCCHHHHHHH
Q 037010          347 IGYCVEG-SLFLVYEYIENGNLSEHLRGSG--------------------------------------RDPLPWSSRVQI  387 (589)
Q Consensus       347 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~~~~~~~~~i  387 (589)
                      ++++.++ ..++||||+++|+|.+++....                                      ...+++..++.+
T Consensus        94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence            9988754 5899999999999999985211                                      112356778899


Q ss_pred             HHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC--cEEEEeccCccccccCCC---CCCcccccCCCCCchhcccC--
Q 037010          388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF--HAKVADFGLTKLTEVGSA---SLPTRLVGTFGYMPPEYAQY--  460 (589)
Q Consensus       388 ~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~--~vkl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--  460 (589)
                      +.|++.||+|||++++   +||||||+|||++.++  .+||+|||++........   .......||+.|+|||++..  
T Consensus       174 ~~qi~~~l~~LH~~~i---vH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  250 (345)
T 3hko_A          174 MRQIFSALHYLHNQGI---CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN  250 (345)
T ss_dssp             HHHHHHHHHHHHHTTE---ECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS
T ss_pred             HHHHHHHHHHHHHCCc---cccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC
Confidence            9999999999999998   9999999999998776  899999999986533221   12344679999999999865  


Q ss_pred             CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHH
Q 037010          461 GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLA  540 (589)
Q Consensus       461 ~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li  540 (589)
                      ..++.++|||||||++|||++|+.||.....        ......+.....           ..........+..+.+|+
T Consensus       251 ~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li  311 (345)
T 3hko_A          251 ESYGPKCDAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKL-----------CFENPNYNVLSPLARDLL  311 (345)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCC-----------CTTSGGGGGSCHHHHHHH
T ss_pred             CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhccc-----------ccCCcccccCCHHHHHHH
Confidence            6789999999999999999999999943321        111122211110           000111112345789999


Q ss_pred             HHhcccCCCCCCCHHHHHHHH
Q 037010          541 KVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       541 ~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+||+.||.+|||+.|+++|-
T Consensus       312 ~~~l~~~p~~Rps~~~~l~hp  332 (345)
T 3hko_A          312 SNLLNRNVDERFDAMRALQHP  332 (345)
T ss_dssp             HHHSCSCTTTSCCHHHHHHSH
T ss_pred             HHHcCCChhHCCCHHHHhcCh
Confidence            999999999999999999984

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.4e-40  Score=351.67  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=188.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. .++.|.+.     ....   ........+.+|++++++++||||+++++++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~vaiK~~~-----~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~  217 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGR-YYAMKILK-----KEVI---VAKDEVAHTLTENRVLQNSRHPFLTALKYSF  217 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEE-----HHHH---C-------------CCCCCSCTTSCCEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCC-EEEEEEEE-----hhhh---hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE
Confidence            4679999999999999999999876532 22222211     1110   1122335577899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      .+ +.+|+||||+++|+|.+++....  .+++..++.++.|++.||+|||+ +++   +||||||+|||++.++.+||+|
T Consensus       218 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~gi---iHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          218 QTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNV---VYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             EETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCC---CCCCCCGGGEEECSSSCEEECC
T ss_pred             eeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCE---EECCCCHHHEEECCCCCEEEcc
Confidence            75 56899999999999999997654  48999999999999999999998 898   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+..
T Consensus       293 FG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~  363 (446)
T 4ejn_A          293 FGLCKEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILM  363 (446)
T ss_dssp             CCCCCTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH
T ss_pred             CCCceeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHh
Confidence            99997533222 223446899999999999999999999999999999999999999954321        111211111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L  561 (589)
                      .           ..    ..|...+..+.+|+.+||+.||.+||     +++|+++|-
T Consensus       364 ~-----------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          364 E-----------EI----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             C-----------CC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             C-----------CC----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence            1           11    12233445789999999999999999     999999883

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.5e-40  Score=347.51  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=189.6

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc-CHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-DMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~-~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ...++|.+.+.||+|+||.||+|.+..+.. ..+.|.+.....    ..... .......+.+|+++|++++||||++++
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~-~vavK~~~~~~~----~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~  206 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCK-KVAIRIISKRKF----AIGSAREADPALNVETEIEILKKLNHPCIIKIK  206 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCC-EEEEEEEEGGGG----TTC--------CCHHHHHHHHHHCCCTTBCCCC
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCc-EEEEEEEEechh----cccccccchhHHHHHHHHHHHHhCCCCCEeeEE
Confidence            346899999999999999999999876532 233332221111    00000 112223478899999999999999999


Q ss_pred             eEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC---cE
Q 037010          348 GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF---HA  424 (589)
Q Consensus       348 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~---~v  424 (589)
                      +++..+..|+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++   .+
T Consensus       207 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i---vHrDlkp~NIll~~~~~~~~~  281 (419)
T 3i6u_A          207 NFFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLI  281 (419)
T ss_dssp             EEEESSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESSSSSSCCE
T ss_pred             EEEecCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCChHhEEEecCCCcceE
Confidence            9998888999999999999999987654  49999999999999999999999998   9999999999996544   59


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      ||+|||+++.....  .......||+.|+|||++.   ...++.++|||||||++|+|++|+.||.......    ....
T Consensus       282 kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~  355 (419)
T 3i6u_A          282 KITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKD  355 (419)
T ss_dssp             EECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC----CHHH
T ss_pred             EEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH----HHHH
Confidence            99999999865422  2234467999999999985   3678899999999999999999999995433211    1111


Q ss_pred             HHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       502 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ....... ... .            ......+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       356 ~i~~~~~-~~~-~------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          356 QITSGKY-NFI-P------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             HHHTTCC-CCC-H------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHhcCCC-CCC-c------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence            1110000 000 0            00012344789999999999999999999999873

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-39  Score=333.33  Aligned_cols=266  Identities=21%  Similarity=0.343  Sum_probs=181.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++ ...+.|.+...          ......+.+.+|++++++++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   72 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTG-VYVALKEVKLD----------SEEGTPSTAIREISLMKELKHENIVRLYDVI   72 (317)
T ss_dssp             ---------------CEEEEEECSSSC-CEEEEEEEECC----------STTCSCHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCC-cEEEEEEeecc----------cccccHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence            468999999999999999999876542 22222221110          0111224577899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSG----RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      .+ +..|+||||+.+ +|.+++....    ...+++..++.++.|++.||+|||++++   +||||||+|||++.++.+|
T Consensus        73 ~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i---vH~Dlkp~NIl~~~~~~~k  148 (317)
T 2pmi_A           73 HTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI---LHRDLKPQNLLINKRGQLK  148 (317)
T ss_dssp             CCTTEEEEEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEE
T ss_pred             EECCeEEEEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCChHHeEEcCCCCEE
Confidence            75 468999999984 9999987542    2358999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....     ........
T Consensus       149 l~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~  222 (317)
T 2pmi_A          149 LGDFGLARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIF  222 (317)
T ss_dssp             ECCCSSCEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHH
T ss_pred             ECcCccceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHH
Confidence            999999986543222 2234578999999999876 4689999999999999999999999954321     12222222


Q ss_pred             HHhcCCChH--Hh------------------hHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          505 EVLNLPDPI--ED------------------LRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~--~~------------------l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .....+...  ..                  +...+.+....    ..+..+.+|+.+||+.||++|||++|+++|-
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp  295 (317)
T 2pmi_A          223 DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALHHP  295 (317)
T ss_dssp             HHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             HHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhCCh
Confidence            222211100  00                  01111111111    2334789999999999999999999999873

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=326.68  Aligned_cols=255  Identities=24%  Similarity=0.386  Sum_probs=176.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ...+.|.+..     ....+   ....+.+.+|++++++++||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~-----~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTG-LEVAIKMIDK-----KAMYK---AGMVQRVQNEVKIHCQLKHPSILELYNY   79 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEH-----HHHHH---TTCHHHHHHHHHHHTTBCCTTBCCEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCC-ceEEEEEeeh-----hhhhh---hhHHHHHHHHHHHHHhCCCCCeEeEEEE
Confidence            3467999999999999999999876542 2222222211     11000   0113567889999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.++ ..|+||||+++++|.+++.... .++++..++.++.|++.||+|||++++   +||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nili~~~~~~kl~d  155 (278)
T 3cok_A           80 FEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGI---LHRDLTLSNLLLTRNMNIKIAD  155 (278)
T ss_dssp             EECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSSCCGGGEEECTTCCEEECC
T ss_pred             EccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHEEEcCCCCEEEEe
Confidence            8754 5899999999999999998653 358999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......        ...    
T Consensus       156 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~----  222 (278)
T 3cok_A          156 FGLATQLKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--------TLN----  222 (278)
T ss_dssp             CTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------
T ss_pred             ecceeeccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------HHH----
Confidence            999986543222 2233578999999999998889999999999999999999999995433211        000    


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                               ......  ...+...+..+.+++.+||+.||++|||++++++|-
T Consensus       223 ---------~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  264 (278)
T 3cok_A          223 ---------KVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP  264 (278)
T ss_dssp             ----------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred             ---------HHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence                     000000  112233445789999999999999999999999873

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-38  Score=324.81  Aligned_cols=266  Identities=21%  Similarity=0.267  Sum_probs=192.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ...+.|.+..     .   ........+.+.+|++++++++||||++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~-----~---~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~  102 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRE-RIVALKLMSE-----T---LSSDPVFRTRMQREARTAGRLQEPHVVPIHDF  102 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTT-EEEEEEECGG-----G---GGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCC-eEEEEEecCc-----c---cccCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence            3578999999999999999999876542 2222222211     1   01123345678899999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+++++|.+++....  ++++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus       103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dlkp~NIl~~~~~~~kl~D  177 (309)
T 2h34_A          103 GEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGA---THRDVKPENILVSADDFAYLVD  177 (309)
T ss_dssp             EEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECS
T ss_pred             EeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcC---CcCCCChHHEEEcCCCCEEEec
Confidence            865 56899999999999999998754  48999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++...............|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....        .........
T Consensus       178 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~  249 (309)
T 2h34_A          178 FGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQ  249 (309)
T ss_dssp             CCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHS
T ss_pred             CccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhcc
Confidence            999876544333333446789999999999989999999999999999999999999843211        111111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhcccccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-SMRSIVVALMTLSSTTE  569 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~l~~~~~  569 (589)
                      ....            ....+.+.+..+.+++.+||+.||++|| +++++++.|..+.....
T Consensus       250 ~~~~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          250 AIPR------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CCCC------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CCCC------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            1100            0111223334689999999999999999 99999999998775544

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7e-40  Score=345.33  Aligned_cols=280  Identities=18%  Similarity=0.248  Sum_probs=208.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+..     .     ......+.+.+|++++++++||||++++++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~-~vaiK~~~~-----~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~   75 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGD-LFAIKVFNN-----I-----SFLRPVDVQMREFEVLKKLNHKNIVKLFAI   75 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEECG-----G-----GGGSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCc-EEEEEEecc-----c-----cccchHHHHHHHHHHHHhcCCCCCCeEEEe
Confidence            35689999999999999999999876532 222222110     0     001123456789999999999999999998


Q ss_pred             EEeC---cEEEEEEecCCCChHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE----cCC
Q 037010          350 CVEG---SLFLVYEYIENGNLSEHLRGSGR-DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI----DKN  421 (589)
Q Consensus       350 ~~~~---~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl----~~~  421 (589)
                      +.+.   ..|+||||+++|+|.+++..... ..+++..++.++.|++.||+|||++++   +||||||+|||+    +.+
T Consensus        76 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~~  152 (396)
T 4eut_A           76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI---VHRNIKPGNIMRVIGEDGQ  152 (396)
T ss_dssp             EECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEEEECTTSC
T ss_pred             eccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCE---EECCcCHHHEEEeecCCCc
Confidence            8743   58999999999999999976532 348999999999999999999999998   999999999999    778


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC--------CCCCcccchhhHHHHHHHHHcCCcccccCCCCC
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY--------GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS  493 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~  493 (589)
                      +.+||+|||+++......  ......||+.|+|||++..        ..++.++|||||||++|||++|+.||.......
T Consensus       153 ~~~kL~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~  230 (396)
T 4eut_A          153 SVYKLTDFGAARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (396)
T ss_dssp             EEEEECCGGGCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred             eeEEEecCCCceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence            889999999998654322  2234679999999998864        567889999999999999999999997544433


Q ss_pred             CChhhHHHHHHHHhcCCCh-HHhhHhh------c--CCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          494 ADSKGLVALFEEVLNLPDP-IEDLRKL------V--DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~-~~~l~~~------~--d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ...........   ..+.. ...+...      .  +.......+......+.+++.+||+.||++|||++|+++.+..+
T Consensus       231 ~~~~~~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          231 RNKEVMYKIIT---GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             TCHHHHHHHHH---SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             chHHHHHHHhc---CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            22222222211   11110 0000000      0  01112234577888999999999999999999999999999888


Q ss_pred             cccc
Q 037010          565 SSTT  568 (589)
Q Consensus       565 ~~~~  568 (589)
                      ....
T Consensus       308 l~~~  311 (396)
T 4eut_A          308 LHRM  311 (396)
T ss_dssp             HTCE
T ss_pred             hhce
Confidence            7654

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.1e-40  Score=340.23  Aligned_cols=274  Identities=15%  Similarity=0.172  Sum_probs=200.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCccee-----
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVR-----  345 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~-----  345 (589)
                      .++|++.+.||+|+||.||+|.+..+......       .....+++|.....  +.+.+|++++++++||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~-------~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSG-------PQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC------------------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCcccccc-------ccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhh
Confidence            47899999999999999999998764210000       00112233332211  35778999999999999987     


Q ss_pred             ----------EeeEEEe--CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          346 ----------LIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       346 ----------l~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                                +++++..  +..|+||||+ +++|.+++.......+++..++.++.|++.||+|||++++   +||||||
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dikp  187 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY---VHGNVTA  187 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTC---BCSCCCG
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCCH
Confidence                      5666653  5689999999 9999999987644569999999999999999999999998   9999999


Q ss_pred             CcEEEcCCC--cEEEEeccCccccccCCCC------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcc
Q 037010          414 ANILIDKNF--HAKVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA  485 (589)
Q Consensus       414 ~NILl~~~~--~vkl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p  485 (589)
                      +|||++.++  .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999998  8999999999765432211      12335799999999999988999999999999999999999999


Q ss_pred             cccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      |......   ................      ...+...   .....+..+.+|+.+||+.||.+|||++++++.|..+.
T Consensus       268 f~~~~~~---~~~~~~~~~~~~~~~~------~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  335 (352)
T 2jii_A          268 WTNCLPN---TEDIMKQKQKFVDKPG------PFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL  335 (352)
T ss_dssp             TGGGTTC---HHHHHHHHHHHHHSCC------CEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             cccCCcC---HHHHHHHHHhccCChh------hhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence            9654321   1112221111111110      0111100   00122357999999999999999999999999999887


Q ss_pred             cccc
Q 037010          566 STTE  569 (589)
Q Consensus       566 ~~~~  569 (589)
                      ....
T Consensus       336 ~~~~  339 (352)
T 2jii_A          336 QDLR  339 (352)
T ss_dssp             HHTT
T ss_pred             HhcC
Confidence            5543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-40  Score=342.49  Aligned_cols=256  Identities=18%  Similarity=0.299  Sum_probs=194.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ..++.|.+.              .. .....+|++++.++ +||||+++++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~~avK~~~--------------~~-~~~~~~E~~~l~~~~~hp~iv~~~~   83 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATN-MEFAVKIID--------------KS-KRDPTEEIEILLRYGQHPNIITLKD   83 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEEE--------------TT-TCCCHHHHHHHHHHTTSTTBCCEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCC-CEEEEEEEE--------------cc-cCChHHHHHHHHHhcCCCCcCeEEE
Confidence            4578999999999999999999987652 222222211              10 01234588888887 7999999999


Q ss_pred             EEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC----Cc
Q 037010          349 YCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN----FH  423 (589)
Q Consensus       349 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~----~~  423 (589)
                      ++.++ ..|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++|+   +||||||+|||+.++    +.
T Consensus        84 ~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~gi---vHrDlkp~NIl~~~~~~~~~~  158 (342)
T 2qr7_A           84 VYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGV---VHRDLKPSNILYVDESGNPES  158 (342)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEESSSSCSGGG
T ss_pred             EEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---EeccCCHHHEEEecCCCCcCe
Confidence            88754 5899999999999999998654  48999999999999999999999998   999999999998433    35


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......  .   ....+
T Consensus       159 ~kl~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~---~~~~~  232 (342)
T 2qr7_A          159 IRICDFGFAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--T---PEEIL  232 (342)
T ss_dssp             EEECCCTTCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--C---HHHHH
T ss_pred             EEEEECCCcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--C---HHHHH
Confidence            99999999986543322 234467899999999998888999999999999999999999999643221  1   11111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                      ..+...           ...+........+..+.+|+.+||..||++|||++|+++|-.-
T Consensus       233 ~~i~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          233 ARIGSG-----------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             HHHHHC-----------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             HHHccC-----------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence            111110           0111122223445678999999999999999999999998543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=327.71  Aligned_cols=269  Identities=26%  Similarity=0.323  Sum_probs=191.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.++||+|+||.||+|.+..++. ..+.|.+.         .........+.+.+|++++++++||||+++++++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   71 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQ-IVAIKKFL---------ESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF   71 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEEC---------CCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCc-EEEEEEee---------ccccchHHHHHHHHHHHHHHhCCCCCccchhhee
Confidence            3689999999999999999999876532 22222110         0111223345678899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..++||||+.+++|.+++....  .+++..+..++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        72 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~kl~Df  146 (311)
T 4agu_A           72 RRKRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNC---IHRDVKPENILITKHSVIKLCDF  146 (311)
T ss_dssp             EETTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCC
T ss_pred             ecCCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCC---cCCCCChhhEEEcCCCCEEEeeC
Confidence            75 46899999999999999887654  48999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....     ............
T Consensus       147 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~  220 (311)
T 4agu_A          147 GFARLLTGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLG  220 (311)
T ss_dssp             TTCEECC-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHC
T ss_pred             CCchhccCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhc
Confidence            99986543222 2234578999999999865 6789999999999999999999999844321     112222222222


Q ss_pred             CCChHH-hh-------HhhcCCCCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPIE-DL-------RKLVDPRLGDNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~-~l-------~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...+.. ..       .....+......+     .+.+..+.+|+.+||+.||.+|||++|+++|
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          221 DLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             SCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            111100 00       0000000000000     1234568999999999999999999999988

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=329.19  Aligned_cols=265  Identities=21%  Similarity=0.288  Sum_probs=197.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||++.+..++. ..+.|.+           +.......+.+.+|++++++++||||++++++
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~-----------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGH-FYALKRI-----------LCHEQQDREEAQREADMHRLFNHPNILRLVAY   94 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCC-EEEEEEE-----------EESSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCc-EEEEEEE-----------ecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            35789999999999999999999765432 2222211           01133455678899999999999999999998


Q ss_pred             EEe-----CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVE-----GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~-----~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +..     ...|+||||+.+|+|.+++...  ....+++..++.++.|++.||+|||++++   +||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~dlkp~NIl~~~~~  171 (317)
T 2buj_A           95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY---AHRDLKPTNILLGDEG  171 (317)
T ss_dssp             EEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTS
T ss_pred             EEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEEcCCC
Confidence            752     3588999999999999999763  23459999999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCC--------CCcccccCCCCCchhcccCCC---CCcccchhhHHHHHHHHHcCCcccccCCC
Q 037010          423 HAKVADFGLTKLTEVGSAS--------LPTRLVGTFGYMPPEYAQYGD---VSPKVDVYAFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~~sDvwSlGvll~elltG~~p~~~~~~  491 (589)
                      .+||+|||++.........        ......||+.|+|||++....   ++.++||||||+++|+|++|+.||.....
T Consensus       172 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  251 (317)
T 2buj_A          172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ  251 (317)
T ss_dssp             CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH
T ss_pred             CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc
Confidence            9999999988754321111        011245799999999987543   68899999999999999999999842110


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                      ...   ...             ........    ...+...+..+.+++.+||+.||.+|||+++++++|..+.....
T Consensus       252 ~~~---~~~-------------~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          252 KGD---SVA-------------LAVQNQLS----IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             TTS---CHH-------------HHHHCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             ccc---hhh-------------HHhhccCC----CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            000   000             00001000    11122334579999999999999999999999999999875443

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.8e-39  Score=324.71  Aligned_cols=251  Identities=24%  Similarity=0.401  Sum_probs=195.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..+.. ..+.|.+.     .....+.   ...+.+.+|++++++++||||+++++++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~vaiK~~~-----~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKF-IMALKVLF-----KSQLEKE---GVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTE-EEEEEEEE-----HHHHHHT---TCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCc-EEEEEEEc-----ccccchH---HHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            4679999999999999999998765422 22222111     1100000   1134678899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+||+++.++.+||+||
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~Df  158 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADF  158 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCSGGGEEECTTCCEEECCC
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCHHHEEEcCCCCEEEecc
Confidence            75 46899999999999999998754  38999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++......   ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.....        ......+...
T Consensus       159 g~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~  227 (284)
T 2vgo_A          159 GWSVHAPSL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIVNV  227 (284)
T ss_dssp             TTCEECSSS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTT
T ss_pred             cccccCccc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHhcc
Confidence            998754322   22346789999999999998999999999999999999999999843221        1111111111


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                 +.    ..+...+..+.+++.+||+.||.+|||++|+++|-
T Consensus       228 -----------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~  264 (284)
T 2vgo_A          228 -----------DL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP  264 (284)
T ss_dssp             -----------CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred             -----------cc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence                       11    12333445789999999999999999999999974

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.6e-39  Score=334.85  Aligned_cols=254  Identities=27%  Similarity=0.415  Sum_probs=193.1

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|.+..++. ..+.|.+...        ........+++.+|++++++++||||+++++++.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~-~vaiK~~~~~--------~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  124 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSE-VVAIKKMSYS--------GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL  124 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTE-EEEEEEEESC--------SSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCe-EEEEEEEccc--------cccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            458999999999999999998765422 1221111100        0011233467889999999999999999999886


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+. |+|.+++.... .++++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus       125 ~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          125 REHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSGGGEEEETTTEEEECCCT
T ss_pred             ECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEECCCCCEEEeecc
Confidence            5 56899999997 58888886543 358999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ++.....     .....||+.|+|||++.   .+.++.++|||||||++|||++|+.||.....        ........
T Consensus       200 ~a~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~--------~~~~~~~~  266 (348)
T 1u5q_A          200 SASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIA  266 (348)
T ss_dssp             TCBSSSS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH
T ss_pred             CceecCC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHH
Confidence            9976532     23357999999999884   56789999999999999999999999854321        11111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ..          ..+..   .+...+..+.+|+.+||+.||++|||++++++|..-..
T Consensus       267 ~~----------~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          267 QN----------ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             HS----------CCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             hc----------CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence            10          01111   12223456899999999999999999999999865443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=340.72  Aligned_cols=248  Identities=22%  Similarity=0.306  Sum_probs=186.6

Q ss_pred             cceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-Cc
Q 037010          276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GS  354 (589)
Q Consensus       276 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  354 (589)
                      ..+.||+|+||.||+|.+..++. ..+.|.+.           .......+++.+|+++|++++||||+++++++.+ +.
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~-~vavK~~~-----------~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGL-KLAAKIIK-----------TRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND  160 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCC-EEEEEEEE-----------CCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEecCcCEEEEEEEEcCCCc-EEEEEEEc-----------ccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            36789999999999998766532 22222111           1122345678899999999999999999998875 46


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE--cCCCcEEEEeccCc
Q 037010          355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI--DKNFHAKVADFGLT  432 (589)
Q Consensus       355 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl--~~~~~vkl~Dfgla  432 (589)
                      .|+||||+++++|.+++.... ..+++..++.++.||+.||+|||++++   +||||||+|||+  +.++.+||+|||++
T Consensus       161 ~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          161 IVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYI---LHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             EEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             EEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCc---ccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence            899999999999999987543 248999999999999999999999998   999999999999  56789999999999


Q ss_pred             cccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCCh
Q 037010          433 KLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDP  512 (589)
Q Consensus       433 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  512 (589)
                      .......  ......||+.|+|||++....++.++|||||||++|||++|+.||.....        ......+..... 
T Consensus       237 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~-  305 (373)
T 2x4f_A          237 RRYKPRE--KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRW-  305 (373)
T ss_dssp             EECCTTC--BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCC-
T ss_pred             eecCCcc--ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccC-
Confidence            8654322  22345799999999999988999999999999999999999999954321        111222211110 


Q ss_pred             HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          513 IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       513 ~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                .+........+..+.+|+.+||+.||.+|||++|+++|
T Consensus       306 ----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          306 ----------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ----------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                      00001111234578999999999999999999999997

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.8e-40  Score=340.36  Aligned_cols=252  Identities=22%  Similarity=0.359  Sum_probs=193.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ...+.|.+..........   ........+.+|++++++++||||++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~-~~vavK~~~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~   97 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKN-KEVVVKFIKKEKVLEDCW---IEDPKLGKVTLEIAILSRVEHANIIKVLDI   97 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTT-EEEEEEEEESTTSCTTSE---EEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCC-cEEEEEEEehhhcccccc---cchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4578999999999999999999876653 222222221111000000   000112345679999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCC-ChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          350 CVEG-SLFLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +.++ ..++||||+.+| +|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~~~kL~  172 (335)
T 3dls_A           98 FENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDI---IHRDIKDENIVIAEDFTIKLI  172 (335)
T ss_dssp             EECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEEC
T ss_pred             EeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EEeccCHHHEEEcCCCcEEEe
Confidence            8754 588999999777 9999998654  39999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||++......  .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....               
T Consensus       173 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------  235 (335)
T 3dls_A          173 DFGSAAYLERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------------  235 (335)
T ss_dssp             CCTTCEECCTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------------
T ss_pred             ecccceECCCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------------
Confidence            99999865432  22344679999999999988776 8899999999999999999999843110               


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                  ......  ..+...+..+.+|+.+||+.||++|||++|+++|-
T Consensus       236 ------------~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          236 ------------TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             ------------GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             ------------HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                        000000  11222344689999999999999999999999984

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.5e-40  Score=336.09  Aligned_cols=260  Identities=18%  Similarity=0.296  Sum_probs=196.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+......     ........+++.+|++++++++||||++++++
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   83 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGL-EYAAKFIKKRQSR-----ASRRGVSREEIEREVSILRQVLHHNVITLHDV   83 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEEEBCSSS-----SCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCe-EEEEEEEeccccc-----ccccchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            34679999999999999999999876532 2222222111000     00000123568889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC----cE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF----HA  424 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~----~v  424 (589)
                      +.+ +..|+||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++    .+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i---vH~dikp~NIl~~~~~~~~~~~  158 (321)
T 2a2a_A           84 YENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKI---AHFDLKPENIMLLDKNIPIPHI  158 (321)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESCTTSSSCCE
T ss_pred             EecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCChHHEEEecCCCCcCCE
Confidence            875 46899999999999999998643  48999999999999999999999998   9999999999999887    79


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||+|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        .....
T Consensus       159 kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~  228 (321)
T 2a2a_A          159 KLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLA  228 (321)
T ss_dssp             EECCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHH
T ss_pred             EEccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHH
Confidence            999999998654322  22446799999999999989999999999999999999999999943221        11111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+.....           ..........+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       229 ~i~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp  274 (321)
T 2a2a_A          229 NITSVSY-----------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHP  274 (321)
T ss_dssp             HHHTTCC-----------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred             HHHhccc-----------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence            1111100           000000012234689999999999999999999999873

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.5e-39  Score=363.16  Aligned_cols=261  Identities=22%  Similarity=0.347  Sum_probs=202.2

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh----cCHHHHHHHHHHHHHHccCCCCcc
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASREFLAELKVLTHVHHLNL  343 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~----~~~~~~~~~~~E~~il~~l~hpnI  343 (589)
                      ....++|++.+.||+|+||.||+|.+..+.....            .+++|.    ......+.+.+|+.++++++||||
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~------------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI  453 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAM------------AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI  453 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCE------------EEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccE------------EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCC
Confidence            3345789999999999999999998865432211            112221    223445678899999999999999


Q ss_pred             eeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          344 VRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       344 v~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      +++++++.++..|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.
T Consensus       454 v~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~gi---vHrDikp~NILl~~~~~  529 (656)
T 2j0j_A          454 VKLIGVITENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDC  529 (656)
T ss_dssp             CCEEEEECSSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTE
T ss_pred             CeEEEEEecCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCc---cccccchHhEEEeCCCC
Confidence            99999998888999999999999999998653 348999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +||+|||+++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....     ..   .
T Consensus       530 vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~~---~  601 (656)
T 2j0j_A          530 VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----ND---V  601 (656)
T ss_dssp             EEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HH---H
T ss_pred             EEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----HH---H
Confidence            9999999998664433333334567889999999988899999999999999999997 8888843211     11   1


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      ...+.          .....    ..+..++..+.+++.+||+.||.+|||+.|+++.|..+..
T Consensus       602 ~~~i~----------~~~~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          602 IGRIE----------NGERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             HHHHH----------HTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH----------cCCCC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            11111          11111    1233444578999999999999999999999999998753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3e-39  Score=350.95  Aligned_cols=258  Identities=24%  Similarity=0.353  Sum_probs=199.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|++..++ ..++.|.+.     .....+.   .....+.+|+++|++++||||+++++++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg-~~vAiK~l~-----k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~~  254 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATG-KLYACKKLN-----KKRLKKR---KGYQGAMVEKKILAKVHSRFIVSLAYAF  254 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTC-CEEEEEEEE-----HHHHHHT---TCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCC-cEEEEEEEE-----hHHhhhh---HHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence            478999999999999999999987653 233333221     1111111   1234677899999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      .+ +.+|+||||++||+|.+++....  ...+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+
T Consensus       255 ~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gI---vHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          255 ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI---IYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             ECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTSCEEEC
T ss_pred             eeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCC---cccCCChHHEEEeCCCCEEEe
Confidence            64 56999999999999999997654  3459999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......    ........+.
T Consensus       332 DFGla~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~----~~~~~~~~i~  406 (543)
T 3c4z_A          332 DLGLAVELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRVL  406 (543)
T ss_dssp             CCTTCEECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC----CHHHHHHHHH
T ss_pred             ecceeeeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch----hHHHHHHHHh
Confidence            9999986543322 2234589999999999999999999999999999999999999996543211    1111222221


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM-----RSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  560 (589)
                      ..             .  ...|...+..+.+|+.+||+.||.+||++     +++++|
T Consensus       407 ~~-------------~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          407 EQ-------------A--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             HC-------------C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             hc-------------c--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            11             0  12233445578999999999999999965     778876

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=9.9e-40  Score=335.06  Aligned_cols=266  Identities=26%  Similarity=0.394  Sum_probs=197.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCccee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      ..++|++.+.||+|+||.||+|.+.+..... ..+         .+++|.+    ......++.+|+.++++++||||++
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~-~~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   97 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDP-SPL---------QVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR   97 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC---------CC---------EEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCC-ccc---------eEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCe
Confidence            3578999999999999999999854321100 001         2223322    3345567889999999999999999


Q ss_pred             EeeEEEe-CcEEEEEEecCCCChHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc
Q 037010          346 LIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR-----DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID  419 (589)
Q Consensus       346 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~  419 (589)
                      +++++.+ +..|+||||+++++|.+++.....     ..+++..++.++.|++.||.|||++++   +||||||+|||++
T Consensus        98 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i---~H~dlkp~NIli~  174 (327)
T 2yfx_A           98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLT  174 (327)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEES
T ss_pred             EEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCe---ecCcCCHhHEEEe
Confidence            9998875 468999999999999999987542     348899999999999999999999998   9999999999998


Q ss_pred             C---CCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCC
Q 037010          420 K---NFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSA  494 (589)
Q Consensus       420 ~---~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~  494 (589)
                      .   +..+||+|||++........ .......||+.|+|||++....++.++||||||+++|+|+| |+.||.....   
T Consensus       175 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---  251 (327)
T 2yfx_A          175 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---  251 (327)
T ss_dssp             CSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred             cCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---
Confidence            4   44699999999875433221 22234568899999999988899999999999999999998 8888843211   


Q ss_pred             ChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccc
Q 037010          495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED  570 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~  570 (589)
                        .   .....+..          ...+.    .+...+..+.+++.+||+.||.+|||+.+++++|..+......
T Consensus       252 --~---~~~~~~~~----------~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~  308 (327)
T 2yfx_A          252 --Q---EVLEFVTS----------GGRMD----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV  308 (327)
T ss_dssp             --H---HHHHHHHT----------TCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHH
T ss_pred             --H---HHHHHHhc----------CCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHH
Confidence              1   11111111          11111    2233445789999999999999999999999999888765443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.2e-39  Score=336.98  Aligned_cols=268  Identities=23%  Similarity=0.372  Sum_probs=198.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..+. ...+.|.+.          +.......+.+.+|++++++++||||+++++++
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~va~K~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  100 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSG-LVMARKLIH----------LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF  100 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEE----------CCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCC-cEEEEEEec----------cccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence            468999999999999999999987553 222222111          112344556788999999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      .+ +..|+||||+++++|.+++....  .+++..+..++.|++.||+|||++ ++   +||||||+|||++.++.+||+|
T Consensus       101 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i---~H~dlkp~Nil~~~~~~~kl~D  175 (360)
T 3eqc_A          101 YSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLCD  175 (360)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCC---CCSCCSGGGEEECTTCCEEECC
T ss_pred             EECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCE---EcCCccHHHEEECCCCCEEEEE
Confidence            65 56899999999999999998754  389999999999999999999996 88   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH---
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE---  505 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~---  505 (589)
                      ||++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     .........   
T Consensus       176 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~  247 (360)
T 3eqc_A          176 FGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA-----KELELMFGCQVE  247 (360)
T ss_dssp             CCCCHHHHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH-----HHHHHHHC----
T ss_pred             CCCCcccccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhccccc
Confidence            9998754322   12345789999999999999999999999999999999999999954321     111000000   


Q ss_pred             ----------------------HhcCC-ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          506 ----------------------VLNLP-DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       506 ----------------------~~~~~-~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                                            ..... ...+.+............+...+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             --------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             ccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                                  00000 0001111111111111112223457999999999999999999999999854

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.4e-39  Score=325.73  Aligned_cols=265  Identities=20%  Similarity=0.256  Sum_probs=199.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ...+.|.+..             ....+++.+|+++++.++|++++..+.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~-------------~~~~~~~~~e~~~l~~l~~~~~i~~~~~   72 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAG-EEVAIKLECV-------------KTKHPQLHIESKIYKMMQGGVGIPTIRW   72 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTT-EEEEEEEEES-------------CSSCCHHHHHHHHHHHHTTSTTCCCEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCC-cEEEEEEecC-------------CcchhHHHHHHHHHHHhhcCCCCCcccc
Confidence            4578999999999999999999876542 2222221110             0112357789999999999887777765


Q ss_pred             EE--eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE---cCCCcE
Q 037010          350 CV--EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHA  424 (589)
Q Consensus       350 ~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl---~~~~~v  424 (589)
                      +.  ++..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||+   +.++.+
T Consensus        73 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~dlkp~NIl~~~~~~~~~~  147 (296)
T 3uzp_A           73 CGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLV  147 (296)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECCGGGTTCE
T ss_pred             ccCCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHeEEecCCCCCeE
Confidence            53  34579999999 889999997543 359999999999999999999999998   999999999999   588899


Q ss_pred             EEEeccCccccccCCCC------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhh
Q 037010          425 KVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG  498 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~  498 (589)
                      ||+|||++.........      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... ..
T Consensus       148 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~  226 (296)
T 3uzp_A          148 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QK  226 (296)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SH
T ss_pred             EEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-hh
Confidence            99999999865543221      124467999999999999999999999999999999999999999654322211 11


Q ss_pred             HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      ...........+  ..    .+    ...+    +..+.+++.+||+.||.+|||+++|++.|+.+....
T Consensus       227 ~~~~~~~~~~~~--~~----~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          227 YERISEKKMSTP--IE----VL----CKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHHHHHHSC--HH----HH----TTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hhhhcccccCCc--hH----HH----HhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            111111111111  00    00    1122    346899999999999999999999999998876554

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.9e-39  Score=322.93  Aligned_cols=255  Identities=21%  Similarity=0.326  Sum_probs=195.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+...          ......+.+.+|+++++.++||||++++++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEE-AVAVKIVDMK----------RAVDCPENIKKEICINKMLNHENVVKFYGH   73 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCC-EEEEEEEEGG----------GCTTHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCc-EEEEEEeeec----------cchhhhHHHHHHHHHHHhcCCCCceeeeeE
Confidence            34679999999999999999998875532 2222221110          111234567889999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.++ ..|+||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +|+||||+||+++.++.+||+|
T Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~d  148 (276)
T 2yex_A           74 RREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISD  148 (276)
T ss_dssp             EEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECC
T ss_pred             EEcCCEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCe---eccCCChHHEEEccCCCEEEee
Confidence            8754 5899999999999999987543  48999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCC-CCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ||++........ .......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.......    ..   ....
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~---~~~~  221 (276)
T 2yex_A          149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QE---YSDW  221 (276)
T ss_dssp             CTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS----HH---HHHH
T ss_pred             CCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH----HH---HHHh
Confidence            999976543221 22334678999999999987665 779999999999999999999995543211    01   1111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ....             .........+..+.+++.+||+.||.+|||++|+++|
T Consensus       222 ~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          222 KEKK-------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             HTTC-------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             hhcc-------------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence            1100             0001112334578999999999999999999999886

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.7e-39  Score=329.03  Aligned_cols=261  Identities=19%  Similarity=0.291  Sum_probs=195.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|.+..++.               .+++|.+.....+.+.+|++++++++ ||||++++++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------------~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~   99 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNE---------------KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADI   99 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCC---------------EEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCc---------------EEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeee
Confidence            4789999999999999999998766532               23333333333456888999999997 9999999998


Q ss_pred             EEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-cEE
Q 037010          350 CVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-HAK  425 (589)
Q Consensus       350 ~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-~vk  425 (589)
                      +.+   ...++||||+.+++|.+++..     +++..++.++.|++.||+|||++++   +||||||+|||++.++ .+|
T Consensus       100 ~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dikp~Nil~~~~~~~~k  171 (330)
T 3nsz_A          100 VKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGI---MHRDVKPHNVMIDHEHRKLR  171 (330)
T ss_dssp             EECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTTTEEE
T ss_pred             eccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCe---eeCCCCHHHEEEcCCCCEEE
Confidence            875   358999999999999999853     8899999999999999999999998   9999999999999776 899


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |+|||++.......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......   ..+.. ..
T Consensus       172 l~Dfg~a~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~l~~-~~  245 (330)
T 3nsz_A          172 LIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVR-IA  245 (330)
T ss_dssp             ECCCTTCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH---HHHHH-HH
T ss_pred             EEeCCCceEcCCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH---HHHHH-HH
Confidence            99999998654322  2234578999999999876 678999999999999999999999995543211   11111 11


Q ss_pred             HHhcCCChH-----------HhhHhhcCCC--------CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPI-----------EDLRKLVDPR--------LGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~-----------~~l~~~~d~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .....+...           ..+.......        .....+...+..+.+|+.+||+.||.+|||++|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            111100000           0011111110        0111122245679999999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-39  Score=346.57  Aligned_cols=274  Identities=22%  Similarity=0.331  Sum_probs=183.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++.. ++.|.+.     .    ........+++.+|+++|++++||||++++++
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-vaiK~i~-----~----~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  120 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRV-VAIKKIL-----R----VFEDLIDCKRILREIAILNRLNHDHVVKVLDI  120 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CE-EEEEEEC-----S----TTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcE-EEEEEec-----h----hhcCHHHHHHHHHHHHHHHhCCCCCCCceEEE
Confidence            357899999999999999999988765322 2211110     0    01123445678899999999999999999998


Q ss_pred             EEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          350 CVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       350 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      +..      +.+|+||||+. ++|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.
T Consensus       121 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~i---iHrDlKp~NILl~~~~~  194 (458)
T 3rp9_A          121 VIPKDVEKFDELYVVLEIAD-SDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGI---LHRDLKPANCLVNQDCS  194 (458)
T ss_dssp             CCCSCTTTCCCEEEEECCCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTCC
T ss_pred             EecCCcccCceEEEEEeccc-cchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCc---CCCCCChhhEEECCCCC
Confidence            742      35899999985 59999997654  49999999999999999999999999   99999999999999999


Q ss_pred             EEEEeccCccccccCCC--------------------------CCCcccccCCCCCchhcc-cCCCCCcccchhhHHHHH
Q 037010          424 AKVADFGLTKLTEVGSA--------------------------SLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVL  476 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwSlGvll  476 (589)
                      +||+|||+++.......                          ...+..+||+.|+|||++ ....++.++|||||||++
T Consensus       195 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il  274 (458)
T 3rp9_A          195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF  274 (458)
T ss_dssp             EEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred             EeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHH
Confidence            99999999986542211                          122346789999999976 566799999999999999


Q ss_pred             HHHHcC-----------CcccccCCCCCC---------------ChhhHHHHHHHHhcCCChHHhh--------HhhcCC
Q 037010          477 YELISA-----------KEAIVKGNGSSA---------------DSKGLVALFEEVLNLPDPIEDL--------RKLVDP  522 (589)
Q Consensus       477 ~elltG-----------~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l--------~~~~d~  522 (589)
                      |||+||           +.+|........               ............+..+.. +.+        ...+..
T Consensus       275 ~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~-~~~~~~~~~~~~~~~~~  353 (458)
T 3rp9_A          275 AELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE-EDIEALEKEDAKRYIRI  353 (458)
T ss_dssp             HHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCH-HHHHTSSCHHHHHHHTT
T ss_pred             HHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCH-HHHhhcCCHHHHHHHHh
Confidence            999994           444422110000               001111122222222221 111        111110


Q ss_pred             ---CCCC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          523 ---RLGD---NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       523 ---~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                         ....   ...+.....+.+|+.+||..||++|||++|+++|
T Consensus       354 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             SCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence               0000   0112234578999999999999999999999999

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=333.28  Aligned_cols=271  Identities=23%  Similarity=0.376  Sum_probs=202.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEcc---ccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRG---EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      .++|++.+.||+|+||.||+|.+..   ..+...+.|.+.           .......+.+.+|++++++++||||++++
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~-----------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~  108 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ-----------HSTEEHLRDFEREIEILKSLQHDNIVKYK  108 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEES-----------SCCSHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEec-----------cCCHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            4678999999999999999998632   122222222111           11234456788999999999999999999


Q ss_pred             eEEEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          348 GYCVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       348 ~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      +++..   ...++||||+++++|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+
T Consensus       109 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dikp~NIli~~~~~~  184 (326)
T 2w1i_A          109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRV  184 (326)
T ss_dssp             EEECC----CCEEEECCCTTCBHHHHHHHSTT-SSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEEEETTEE
T ss_pred             EEEEecCCCceEEEEECCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCE---eccCCCcceEEEcCCCcE
Confidence            98753   257999999999999999987543 48999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          425 KVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      ||+|||++.........  ......++..|+|||.+.+..++.++||||||+++|||+||..|+....         .. 
T Consensus       185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~---------~~-  254 (326)
T 2w1i_A          185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP---------AE-  254 (326)
T ss_dssp             EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH---------HH-
T ss_pred             EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH---------HH-
Confidence            99999999865433221  1223457788999999988889999999999999999999999874210         00 


Q ss_pred             HHHHhcCCCh----HHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          503 FEEVLNLPDP----IEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       503 ~~~~~~~~~~----~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      +.........    ...+...+........+..++..+.+++.+||+.||++|||++|+++.|+.++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          255 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            1111111100    011112222111122334455679999999999999999999999999998864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.7e-39  Score=334.59  Aligned_cols=254  Identities=20%  Similarity=0.345  Sum_probs=199.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|.+.+.||+|+||.||++.+..+. ..++.|.+....        .......+.+.+|++++++++||||++++++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~a~K~~~~~~--------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  109 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTK-EVFAGKIVPKSL--------LLKPHQREKMSMEISIHRSLAHQHVVGFHGF  109 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEGGG--------CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCC-CEEEEEEechhh--------hcCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            3468999999999999999999887653 222222221110        1123445678889999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.++ ..|+||||+.+++|.+++....  .+++.+++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus       110 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~NIl~~~~~~~kl~D  184 (335)
T 2owb_A          110 FEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGD  184 (335)
T ss_dssp             EECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECTTCCEEECC
T ss_pred             EecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCC---EecCCCchhEEEcCCCCEEEee
Confidence            8754 5899999999999999987654  48999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....        ......+..
T Consensus       185 fg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~  255 (335)
T 2owb_A          185 FGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKK  255 (335)
T ss_dssp             CTTCEECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHH
T ss_pred             ccCceecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHhc
Confidence            999986543222 22346799999999999988999999999999999999999999843221        111111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .           ...+    +......+.+|+.+||+.||++|||++|+++|-
T Consensus       256 ~-----------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          256 N-----------EYSI----PKHINPVAASLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             T-----------CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             C-----------CCCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            0           1111    223334689999999999999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.5e-40  Score=328.82  Aligned_cols=257  Identities=23%  Similarity=0.364  Sum_probs=196.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++ ...+.|.+..         ........+.+.+|++++++++||||+++++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~---------~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDG-KILVWKELDY---------GSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRI   74 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTC-CEEEEEEEEC---------TTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCC-cEEEEEEEEc---------ccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            468999999999999999999887553 2222222111         112334556788999999999999999999977


Q ss_pred             Ee---CcEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeeccCCCcEEEcC
Q 037010          351 VE---GSLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHT-----VPVYIHRDIKSANILIDK  420 (589)
Q Consensus       351 ~~---~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~-----i~~~vH~Dlkp~NILl~~  420 (589)
                      .+   +..|+||||+++++|.+++....  ...+++..++.++.|++.||+|||+++     +   +||||||+|||++.
T Consensus        75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~i---vH~dl~p~NIl~~~  151 (279)
T 2w5a_A           75 IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV---LHRDLKPANVFLDG  151 (279)
T ss_dssp             EEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC---------CCCCCSGGGEEECS
T ss_pred             ecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCee---EEeccchhhEEEcC
Confidence            53   46899999999999999997532  345899999999999999999999999     8   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      ++.+||+|||++....... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....     .... 
T Consensus       152 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~-  224 (279)
T 2w5a_A          152 KQNVKLGDFGLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QKEL-  224 (279)
T ss_dssp             SSCEEECCCCHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHH-
T ss_pred             CCCEEEecCchheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC-----HHHH-
Confidence            9999999999987653221 11223578999999999998899999999999999999999999984331     1111 


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT  563 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~  563 (589)
                        ...+.          ....+.    .+...+..+.+++.+||+.||.+|||++|+++++..
T Consensus       225 --~~~i~----------~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          225 --AGKIR----------EGKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             --HHHHH----------HTCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             --HHHHh----------hccccc----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence              11111          111111    223344578999999999999999999999987653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.3e-39  Score=331.61  Aligned_cols=270  Identities=21%  Similarity=0.299  Sum_probs=186.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||.||+|.+..++. ..+.|.+..         ........+.+.+|++++++++||||++++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNE-TVAIKRIRL---------EHEEEGVPGTAIREVSLLKELQHRNIIELKSV  101 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTE-EEEEEECCC---------CC--------CHHHHHHGGGCCCTTBCCEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCc-eEEEEEEcc---------cccccccchhHHHHHHHHHHcCCCCcceEEEE
Confidence            35689999999999999999998766522 222221110         01112233457789999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE-----cCCCc
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI-----DKNFH  423 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl-----~~~~~  423 (589)
                      +.+ +..|+||||+.+ +|.+++.....  +++..++.++.||+.||+|||++++   +||||||+|||+     +.++.
T Consensus       102 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~~i---vH~Dlkp~NIll~~~~~~~~~~  175 (329)
T 3gbz_A          102 IHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRC---LHRDLKPQNLLLSVSDASETPV  175 (329)
T ss_dssp             EEETTEEEEEEECCSE-EHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEEC-----CCE
T ss_pred             EecCCEEEEEEecCCC-CHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCE---ECCCCCHHHEEEecCCCCccce
Confidence            875 468999999985 99999987653  8999999999999999999999998   999999999999     45566


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +||+|||++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....    ...+...
T Consensus       176 ~kl~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~  250 (329)
T 3gbz_A          176 LKIGDFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----IDQLFKI  250 (329)
T ss_dssp             EEECCTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred             EEECcCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HHHHHHH
Confidence            9999999998654322 222345789999999998764 589999999999999999999999954321    1122222


Q ss_pred             HHHHhcCCChHH--hhHhhc--CCCCC---CC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          503 FEEVLNLPDPIE--DLRKLV--DPRLG---DN-----CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       503 ~~~~~~~~~~~~--~l~~~~--d~~l~---~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .. ....+....  ......  .....   ..     .+......+.+|+.+||+.||.+|||++|+++|-
T Consensus       251 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  320 (329)
T 3gbz_A          251 FE-VLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP  320 (329)
T ss_dssp             HH-HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             HH-HhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence            21 222111100  000000  00000   00     0111345789999999999999999999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.8e-39  Score=323.39  Aligned_cols=252  Identities=21%  Similarity=0.306  Sum_probs=193.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..+.....+ |.+..           ......+.+.+|++++++++||||++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~-k~~~~-----------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAA-KKIPK-----------YFVEDVDRFKQEIEIMKSLDHPNIIRLYET   74 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEE-EEEEG-----------GGCSCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEE-Eeehh-----------hccchHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            456799999999999999999998765322221 11110           001123567889999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE---cCCCcEE
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAK  425 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl---~~~~~vk  425 (589)
                      +.++ ..|+||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||+   +.++.+|
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~~~~~  149 (277)
T 3f3z_A           75 FEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNV---AHRDLKPENFLFLTDSPDSPLK  149 (277)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESSSSTTCCEE
T ss_pred             EecCCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cCCCCCHHHEEEecCCCCCcEE
Confidence            8754 5899999999999999997754  38999999999999999999999998   999999999999   7888999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++.......  ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....     ..   ....
T Consensus       150 l~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~---~~~~  218 (277)
T 3f3z_A          150 LIDFGLAARFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD-----SE---VMLK  218 (277)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HH---HHHH
T ss_pred             EEecccceeccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH-----HH---HHHH
Confidence            99999998654322  2234679999999999865 489999999999999999999999944221     11   1111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +.....           ........+.+..+.+++.+||+.||.+|||+.|+++|
T Consensus       219 ~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          219 IREGTF-----------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHCCC-----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHhCCC-----------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111100           00000000224578999999999999999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.2e-39  Score=335.10  Aligned_cols=265  Identities=19%  Similarity=0.258  Sum_probs=191.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++.. .+.|.+..         ........+++.+|+++|++++||||++++++
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~-vaiK~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~   92 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAK-VAIKKLYR---------PFQSELFAKRAYRELRLLKHMRHENVIGLLDV   92 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCE-EEEEECSS---------TTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCE-EEEEEeCc---------cccCHHHHHHHHHHHHHHHhCCCcCCCCceee
Confidence            457899999999999999999998665322 22221110         01123345678899999999999999999998


Q ss_pred             EEeC-------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVEG-------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~~-------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +..+       .+|+||||+ +++|.+++...   .+++..+..++.|++.||+|||++|+   +||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~  165 (367)
T 1cm8_A           93 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDC  165 (367)
T ss_dssp             ECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTC
T ss_pred             EecCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCcCHHHEEEcCCC
Confidence            8643       369999999 77999999763   48999999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      .+||+|||+++....    ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.....     .....
T Consensus       166 ~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~  236 (367)
T 1cm8_A          166 ELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLK  236 (367)
T ss_dssp             CEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             CEEEEeeeccccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence            999999999986532    2344678999999999876 6799999999999999999999999954321     11112


Q ss_pred             HHHHHhcCCChH----------HhhHhhcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          502 LFEEVLNLPDPI----------EDLRKLVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       502 ~~~~~~~~~~~~----------~~l~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ........+...          ..+...+.....   ..........+.+|+.+||+.||.+|||++|+++|
T Consensus       237 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          237 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            222222221110          000011110000   01122334578999999999999999999999998

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.2e-39  Score=336.66  Aligned_cols=267  Identities=19%  Similarity=0.248  Sum_probs=200.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCC--------C
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVH--------H  340 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~--------h  340 (589)
                      .++|++.++||+|+||.||+|.+..++ .              .+++|.+.  ....+.+.+|++++++++        |
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~--------------~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~  100 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGK-K--------------FVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNR  100 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTT-E--------------EEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGG
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCC-e--------------EEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCc
Confidence            578999999999999999999876542 2              22333222  234466788999998885        7


Q ss_pred             CcceeEeeEEE-----eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCC
Q 037010          341 LNLVRLIGYCV-----EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSA  414 (589)
Q Consensus       341 pnIv~l~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~  414 (589)
                      +||+++++++.     ....|+||||+ +++|.+++.......+++..++.++.||+.||+|||++ ++   +||||||+
T Consensus       101 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~gi---vHrDikp~  176 (397)
T 1wak_A          101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI---IHTDIKPE  176 (397)
T ss_dssp             GGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE---ECCCCSGG
T ss_pred             ceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHH
Confidence            88999999775     23589999999 56788877766556699999999999999999999998 88   99999999


Q ss_pred             cEEEcCCC-------------------------------------------------cEEEEeccCccccccCCCCCCcc
Q 037010          415 NILIDKNF-------------------------------------------------HAKVADFGLTKLTEVGSASLPTR  445 (589)
Q Consensus       415 NILl~~~~-------------------------------------------------~vkl~Dfgla~~~~~~~~~~~~~  445 (589)
                      |||++.++                                                 .+||+|||++......    ...
T Consensus       177 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~  252 (397)
T 1wak_A          177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTE  252 (397)
T ss_dssp             GEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCS
T ss_pred             HeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----Ccc
Confidence            99998775                                                 7999999999865432    234


Q ss_pred             cccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC-hhhHHHHHHHHhcCCChHHhhH-----hh
Q 037010          446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD-SKGLVALFEEVLNLPDPIEDLR-----KL  519 (589)
Q Consensus       446 ~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~-----~~  519 (589)
                      ..||+.|+|||++.+..++.++|||||||++|||+||+.||......... ......................     ..
T Consensus       253 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  332 (397)
T 1wak_A          253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF  332 (397)
T ss_dssp             CCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT
T ss_pred             CCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc
Confidence            57899999999999999999999999999999999999999655443322 1222222223322221110000     00


Q ss_pred             cCC-----CC--------------CCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          520 VDP-----RL--------------GDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       520 ~d~-----~l--------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...     .+              ....+.+....+.+|+.+||+.||++|||++|+++|
T Consensus       333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             BCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            000     00              012456777889999999999999999999999987

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.7e-39  Score=340.38  Aligned_cols=275  Identities=20%  Similarity=0.310  Sum_probs=193.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+.     .    ........+++.+|+++|++++||||++++++
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~vAiK~~~-----~----~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~   93 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEK-NVAIKKVN-----R----MFEDLIDCKRILREITILNRLKSDYIIRLYDL   93 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTE-EEEEEEEC-----S----TTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCc-EEEEEEeC-----c----hhcChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            46789999999999999999999876532 12211110     0    01123445678899999999999999999998


Q ss_pred             EEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          350 CVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       350 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      +..      +.+|+||||+.+ +|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~gi---vHrDlkp~NILl~~~~~  167 (432)
T 3n9x_A           94 IIPDDLLKFDELYIVLEIADS-DLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGI---IHRDLKPANCLLNQDCS  167 (432)
T ss_dssp             CCCSCTTTCCCEEEEEECCSE-EHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCC
T ss_pred             EecCCCCcCCeEEEEEecCCc-CHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCC---CCCCCCHHHeEECCCCC
Confidence            764      358999999975 9999997653  49999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCC---------------------CCCcccccCCCCCchhcc-cCCCCCcccchhhHHHHHHHHHc
Q 037010          424 AKVADFGLTKLTEVGSA---------------------SLPTRLVGTFGYMPPEYA-QYGDVSPKVDVYAFGVVLYELIS  481 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~sDvwSlGvll~ellt  481 (589)
                      +||+|||+++.......                     ...+..+||+.|+|||++ ....++.++|||||||++|||++
T Consensus       168 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~  247 (432)
T 3n9x_A          168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN  247 (432)
T ss_dssp             EEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred             EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence            99999999986543221                     122457899999999985 56679999999999999999998


Q ss_pred             CCcccc----------cCCCCCC----------C---hhhHHHHHHHHhcCCChH-------HhhHhhcCCCC-CCCCC-
Q 037010          482 AKEAIV----------KGNGSSA----------D---SKGLVALFEEVLNLPDPI-------EDLRKLVDPRL-GDNCP-  529 (589)
Q Consensus       482 G~~p~~----------~~~~~~~----------~---~~~~~~~~~~~~~~~~~~-------~~l~~~~d~~l-~~~~~-  529 (589)
                      |..||.          .+.....          .   ...........+..+...       ......+.... ....+ 
T Consensus       248 g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (432)
T 3n9x_A          248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINL  327 (432)
T ss_dssp             TCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCH
T ss_pred             cccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCH
Confidence            655443          2211100          0   011111222223322211       01111111000 00000 


Q ss_pred             ----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          530 ----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       530 ----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                          +..+..+.+|+.+||+.||.+|||++|+++|
T Consensus       328 ~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          328 KQKYPSISDDGINLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             HHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                1234578999999999999999999999998

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-40  Score=339.90  Aligned_cols=262  Identities=24%  Similarity=0.365  Sum_probs=195.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEcc--ccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRG--EYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~--~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~  347 (589)
                      .++|++.+.||+|+||.||+|++..  ..+...+.|.+.......       .....+.+.+|+++|+++ +||||++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~  125 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-------KAKTTEHTRTERQVLEHIRQSPFLVTLH  125 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-------EESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh-------hhhHHHHHHHHHHHHHHccCCCceeEEE
Confidence            4679999999999999999998753  122333322221110000       001123355689999999 699999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..|+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus       126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~Dlkp~NIll~~~~~~kl  200 (355)
T 1vzo_A          126 YAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVL  200 (355)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEE
T ss_pred             EEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEECCCCcEEE
Confidence            98765 56899999999999999998754  48999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccC--CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      +|||+++..............||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......    .......
T Consensus       201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~~~~  276 (355)
T 1vzo_A          201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISR  276 (355)
T ss_dssp             SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHH
T ss_pred             eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----hHHHHHH
Confidence            9999998654333333445689999999999975  357899999999999999999999996433221    1111111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVALMT  563 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L~~  563 (589)
                      .....           .+    ..+.+.+..+.+|+.+||..||.+||     |++|+++|..-
T Consensus       277 ~~~~~-----------~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          277 RILKS-----------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             HHHHC-----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             HHhcc-----------CC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence            11111           11    22334455789999999999999999     99999998643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2e-39  Score=332.12  Aligned_cols=261  Identities=22%  Similarity=0.319  Sum_probs=192.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh-cCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK-MDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ...+.|.+....    ..... ........+.+|++++++++||||+++++
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~----~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   82 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTC-KKVAIKIISKRK----FAIGSAREADPALNVETEIEILKKLNHPCIIKIKN   82 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEECC-------------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCC-cEEEEEEeehhh----hhhcccccchhhhhHHHHHHHHHhCCCCCCceEee
Confidence            4568999999999999999999887652 222222221110    00000 01122345788999999999999999999


Q ss_pred             EEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc---EE
Q 037010          349 YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH---AK  425 (589)
Q Consensus       349 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~---vk  425 (589)
                      ++.++..|+||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.   +|
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           83 FFDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGI---IHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             EEESSSEEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESSSSSSCCEE
T ss_pred             EEcCCceEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCCHHHEEEecCCCCCeEE
Confidence            998888999999999999999997643  48999999999999999999999998   99999999999987654   99


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      |+|||++......  .......||+.|+|||++.   ...++.++|||||||++|+|++|+.||.......    .+...
T Consensus       158 l~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~  231 (322)
T 2ycf_A          158 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SLKDQ  231 (322)
T ss_dssp             ECCCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CHHHH
T ss_pred             EccCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HHHHH
Confidence            9999999865321  1123357899999999873   5678999999999999999999999995433221    11111


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...... . ....            ...+.+..+.+|+.+||+.||++|||++|+++|
T Consensus       232 ~~~~~~-~-~~~~------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          232 ITSGKY-N-FIPE------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHHTCC-C-CCHH------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHhCcc-c-cCch------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            111000 0 0000            001223478999999999999999999999976

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-39  Score=324.99  Aligned_cols=253  Identities=25%  Similarity=0.367  Sum_probs=187.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|.+.++||+|+||.||+|.+..+.. ..+.|.+..          .......+.+.+|++++++++||||+++++++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~aiK~~~~----------~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   89 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGL-ERVIKTINK----------DRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF   89 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCC-EEEEEEEEG----------GGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCc-eEEEEEeec----------cccchhHHHHHHHHHHHHhCCCchHHhHHHhe
Confidence            4679999999999999999998766532 222221111          11111235678899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE---cCCCcE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHA  424 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl---~~~~~v  424 (589)
                      .+ +..|+||||+++|+|.+++...  ....+++..++.++.|++.||+|||++++   +||||||+|||+   +.++.+
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i---vH~dikp~NIl~~~~~~~~~~  166 (285)
T 3is5_A           90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV---VHKDLKPENILFQDTSPHSPI  166 (285)
T ss_dssp             ECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEESSSSTTCCE
T ss_pred             ecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCE---EECCCCHHHEEEecCCCCCCE
Confidence            75 4689999999999999998653  23459999999999999999999999998   999999999999   456789


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||+|||++.......  ......||+.|+|||.+. +.++.++||||||+++|||++|+.||.....     .   ....
T Consensus       167 kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----~---~~~~  235 (285)
T 3is5_A          167 KIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----E---EVQQ  235 (285)
T ss_dssp             EECCCCCCCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHH
T ss_pred             EEEeeecceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----H---HHHh
Confidence            999999997654322  224467899999999986 5789999999999999999999999954221     1   1111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ....           ..+..... ....+..+.+|+.+||+.||++|||++|+++|
T Consensus       236 ~~~~-----------~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          236 KATY-----------KEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             HHHH-----------CCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             hhcc-----------CCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1110           01111100 01123468899999999999999999999976

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-38  Score=322.24  Aligned_cols=255  Identities=20%  Similarity=0.342  Sum_probs=199.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ...+.|.+....        .......+.+.+|++++++++||||++++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~a~K~~~~~~--------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   83 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTK-EVFAGKIVPKSL--------LLKPHQREKMSMEISIHRSLAHQHVVGFHGF   83 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEGGG--------CCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCC-ceEEEEEechhh--------ccCHHHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence            3468999999999999999999987653 222222221110        1123445678889999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.++ ..|+||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~d  158 (294)
T 2rku_A           84 FEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRV---IHRDLKLGNLFLNEDLEVKIGD  158 (294)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCEEECC
T ss_pred             eccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCChHhEEEcCCCCEEEEe
Confidence            8754 5899999999999999987654  48999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....        .........
T Consensus       159 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~  229 (294)
T 2rku_A          159 FGLATKVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKK  229 (294)
T ss_dssp             CTTCEECCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHT
T ss_pred             ccCceecccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhh
Confidence            999986543222 22346789999999999988899999999999999999999999843221        111111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      .           ..    ..+......+.+++.+||+.||++|||++|+++|-.
T Consensus       230 ~-----------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~  268 (294)
T 2rku_A          230 N-----------EY----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF  268 (294)
T ss_dssp             T-----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHH
T ss_pred             c-----------cC----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            0           11    122233457899999999999999999999999854

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=333.78  Aligned_cols=264  Identities=23%  Similarity=0.363  Sum_probs=189.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH----HHHHHHHHHHHHccCCCCcceeEe
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ----ASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ++|++.+.||+|+||.||+|.+..++. .              +++|.+...    ....+.+|++++++++||||++++
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~-~--------------vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   66 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDN-L--------------VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH   66 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCC-E--------------EEEEEECC------CCCCCCCHHHHSCCCCTTBCCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCc-E--------------EEEEEEecccccccchhHHHHHHHHHhcCCCCCCeee
Confidence            579999999999999999999875532 2              222222211    111345699999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..++||||+.+ +|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus        67 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~i---vH~Dikp~NIl~~~~~~~kl  141 (324)
T 3mtl_A           67 DIIHTEKSLTLVFEYLDK-DLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQKV---LHRDLKPQNLLINERGELKL  141 (324)
T ss_dssp             EEEECSSCEEEEEECCSE-EHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTE---EESSCCGGGEEECTTCCEEE
T ss_pred             eEEeeCCEEEEEeccccc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCc---cCCCcCHHHEEECCCCCEEE
Confidence            98874 568999999985 99999887543 58999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....     ..........
T Consensus       142 ~Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~i~~  215 (324)
T 3mtl_A          142 ADFGLARAKSIPTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST-----VEEQLHFIFR  215 (324)
T ss_dssp             CSSSEEECC-------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHH
T ss_pred             ccCcccccccCCcc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHH
Confidence            99999975443222 2234578999999999876 568999999999999999999999994432     1222222222


Q ss_pred             HhcCCChH--------HhhHhhcCCCCCCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          506 VLNLPDPI--------EDLRKLVDPRLGDN----CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       506 ~~~~~~~~--------~~l~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ....+...        ........+.....    ........+.+|+.+||+.||.+|||++|+++|-
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  283 (324)
T 3mtl_A          216 ILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP  283 (324)
T ss_dssp             HHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             HhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence            22222110        00111111110000    0112345689999999999999999999999983

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.6e-39  Score=334.72  Aligned_cols=260  Identities=17%  Similarity=0.199  Sum_probs=197.6

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC---CCcce
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH---HLNLV  344 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~---hpnIv  344 (589)
                      ....++|++.++||+|+||.||+|.+..... ....         ..+++|........++..|++++++++   |+||+
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~---------~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv  130 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLND-AKNK---------QKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM  130 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC--------CC---------CCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBC
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcc-cccC---------cEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhh
Confidence            3456789999999999999999996432100 0011         133444444334456677777777776   99999


Q ss_pred             eEeeEEE-eCcEEEEEEecCCCChHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          345 RLIGYCV-EGSLFLVYEYIENGNLSEHLRGS---GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       345 ~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ++++++. ++..|+||||+++|+|.+++...   ....+++..++.++.||+.||+|||++++   +||||||+|||++.
T Consensus       131 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~i---vHrDiKp~NIll~~  207 (365)
T 3e7e_A          131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEI---IHGDIKPDNFILGN  207 (365)
T ss_dssp             CEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCSGGGEEECG
T ss_pred             hhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCe---ecCCCCHHHEEecc
Confidence            9999886 45699999999999999999752   23459999999999999999999999998   99999999999998


Q ss_pred             -----------CCcEEEEeccCccccccC-CCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCccccc
Q 037010          421 -----------NFHAKVADFGLTKLTEVG-SASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK  488 (589)
Q Consensus       421 -----------~~~vkl~Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~  488 (589)
                                 ++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence                       899999999999754322 22233446799999999999999999999999999999999999999854


Q ss_pred             CCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhcccc
Q 037010          489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR-PSMRSIVVALMTLSST  567 (589)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~l~~~  567 (589)
                      ......                        .+...+ ...+  ....+.+++..|++.+|.+| |+++++.+.|+.....
T Consensus       288 ~~~~~~------------------------~~~~~~-~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          288 NEGGEC------------------------KPEGLF-RRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EETTEE------------------------EECSCC-TTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCce------------------------eechhc-cccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            432110                        001111 1111  24467889999999999998 6788888888776644

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.4e-39  Score=326.56  Aligned_cols=263  Identities=19%  Similarity=0.337  Sum_probs=194.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|.+......     ........+.+.+|++++++++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~avK~~~~~~~~-----~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   77 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGK-EYAAKFIKKRRLS-----SSRRGVSREEIEREVNILREIRHPNIITLHDIF   77 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEEEBCSST-----TCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCC-eeehHHhhhcccc-----ccccchHHHHHHHHHHHHHhCCCCCeeehhhee
Confidence            4579999999999999999999876532 2222222111000     000011245688899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC----cEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF----HAK  425 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~----~vk  425 (589)
                      .+ +..++||||+++++|.+++....  .+++..++.++.|++.||.|||++++   +||||||+||+++.++    .+|
T Consensus        78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRI---AHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEESCSSSSSCCEE
T ss_pred             cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc---cCCCCChHHEEEecCCCCCCceE
Confidence            75 45899999999999999997654  48999999999999999999999998   9999999999998877    899


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++.......  ......|++.|+|||++.+..++.++||||||+++|+|++|+.||.....        ......
T Consensus       153 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~  222 (283)
T 3bhy_A          153 LIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTN  222 (283)
T ss_dssp             ECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH
T ss_pred             EEecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHH
Confidence            99999998654322  22345789999999999989999999999999999999999999844221        111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhcc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTLS  565 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l~  565 (589)
                      +....           ...........+..+.+++.+||..||.+|||+.|+++|  +..+.
T Consensus       223 ~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          223 ISAVN-----------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             HHTTC-----------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             hHhcc-----------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            11110           000000011223468999999999999999999999997  44443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=333.38  Aligned_cols=257  Identities=22%  Similarity=0.319  Sum_probs=181.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~  348 (589)
                      ...+|++.+.||+|+||.||+|.+..++. .++.|.+           +.......+.+.+|+.+++++. ||||+++++
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~-----------~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~   93 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGR-EYALKRL-----------LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS   93 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCC-EEEEEEE-----------EESSHHHHHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCc-EEEEEEe-----------cCCchHHHHHHHHHHHHHHHhccCCChhhccc
Confidence            44689999999999999999999866532 2222211           1113344567888999999996 999999999


Q ss_pred             EEEe---------CcEEEEEEecCCCChHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeeccCCCcE
Q 037010          349 YCVE---------GSLFLVYEYIENGNLSEHLRGS-GRDPLPWSSRVQIALDSARGLEYIHEHT--VPVYIHRDIKSANI  416 (589)
Q Consensus       349 ~~~~---------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qia~aL~~LH~~~--i~~~vH~Dlkp~NI  416 (589)
                      ++..         ...+++|||+. |+|.+++... ...++++..++.++.|++.||+|||+++  +   +||||||+||
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~i---vH~Dikp~NI  169 (337)
T 3ll6_A           94 AASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPI---IHRDLKVENL  169 (337)
T ss_dssp             EEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCC---BCCCCCGGGC
T ss_pred             cccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCE---EEccCCcccE
Confidence            8741         23789999996 5999988652 2345999999999999999999999999  8   9999999999


Q ss_pred             EEcCCCcEEEEeccCccccccCCCC-----------CCcccccCCCCCchhcc---cCCCCCcccchhhHHHHHHHHHcC
Q 037010          417 LIDKNFHAKVADFGLTKLTEVGSAS-----------LPTRLVGTFGYMPPEYA---QYGDVSPKVDVYAFGVVLYELISA  482 (589)
Q Consensus       417 Ll~~~~~vkl~Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~~sDvwSlGvll~elltG  482 (589)
                      |++.++.+||+|||++.........           ......||+.|+|||++   .+..++.++|||||||++|+|++|
T Consensus       170 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g  249 (337)
T 3ll6_A          170 LLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR  249 (337)
T ss_dssp             EECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred             EECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence            9999999999999999865432211           11134689999999998   566789999999999999999999


Q ss_pred             CcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          483 KEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       483 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      +.||......        ....             ...........    ...+.+|+.+||+.||.+|||++|++++|.
T Consensus       250 ~~p~~~~~~~--------~~~~-------------~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          250 QHPFEDGAKL--------RIVN-------------GKYSIPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             SCCC---------------------------------CCCCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcchhHH--------Hhhc-------------CcccCCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            9998432210        0000             00111111122    235789999999999999999999999999


Q ss_pred             hcccc
Q 037010          563 TLSST  567 (589)
Q Consensus       563 ~l~~~  567 (589)
                      .+...
T Consensus       305 ~~~~~  309 (337)
T 3ll6_A          305 EIAAA  309 (337)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            88754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.9e-39  Score=322.19  Aligned_cols=249  Identities=24%  Similarity=0.323  Sum_probs=190.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+..         .........++.+|+..+.++ +||||+++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~~---------~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~   78 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGC-IYAIKRSKK---------PLAGSVDEQNALREVYAHAVLGQHSHVVRYFS   78 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEEC---------CCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCc-eEEEEEecc---------cccccHHHHHHHHHHHHHHHhCCCCCeeeeee
Confidence            45789999999999999999999875532 222221110         001123345678899999999 8999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC----
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSG--RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN----  421 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~----  421 (589)
                      ++.+ +..++||||+++++|.+++....  ...+++..++.++.|++.||+|||++++   +||||||+|||++.+    
T Consensus        79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dikp~NIl~~~~~~~~  155 (289)
T 1x8b_A           79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSL---VHMDIKPSNIFISRTSIPN  155 (289)
T ss_dssp             EEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEC------
T ss_pred             eeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCE---eecCCCHHHEEEcCCCCCc
Confidence            8875 56899999999999999997642  1458999999999999999999999998   999999999999844    


Q ss_pred             ---------------CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcc
Q 037010          422 ---------------FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEA  485 (589)
Q Consensus       422 ---------------~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p  485 (589)
                                     ..+||+|||++......     ....||+.|+|||.+.+. .++.++|||||||++|+|++|..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~  230 (289)
T 1x8b_A          156 AASEEGDEDDWASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL  230 (289)
T ss_dssp             --------------CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence                           47999999998865432     224589999999998765 667899999999999999999876


Q ss_pred             cccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          486 IVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       486 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      +...        .   .+..+.          ....+.+    +...+..+.+++.+||+.||++|||++|+++|-
T Consensus       231 ~~~~--------~---~~~~~~----------~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          231 PRNG--------D---QWHEIR----------QGRLPRI----PQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             CSSS--------H---HHHHHH----------TTCCCCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             Ccch--------h---HHHHHH----------cCCCCCC----CcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            5221        0   111111          1111222    233345789999999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.5e-38  Score=356.06  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=198.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|++..++ ..++.|.+     ........   ...+.+..|.++|..+ +||+|+++++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~-~~vAvK~l-----~~~~~~~~---~~~~~~~~E~~~l~~~~~~~~i~~l~~  409 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTD-ELYAVKIL-----KKDVVIQD---DDVECTMVEKRVLALPGKPPFLTQLHS  409 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSC-CEEEEEEE-----EHHHHHHT---TTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCC-cEEEEEEE-----eccccccH---HHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence            4578999999999999999999987653 22222222     11111111   1234567799999988 7999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++++||+
T Consensus       410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gI---iHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          410 CFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGI---IYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             ECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSE---ECCCCCSTTEEECSSSCEEEC
T ss_pred             EEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---EeccCChhhEEEcCCCcEEEe
Confidence            8765 56899999999999999998764  39999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....        ....+..+.
T Consensus       485 DFGla~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~  555 (674)
T 3pfq_A          485 DFGMCKENIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIM  555 (674)
T ss_dssp             CCTTCEECCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred             ecceeeccccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHH
Confidence            99999853322 223345789999999999999999999999999999999999999995422        112222222


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM-----RSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~  560 (589)
                      .             ..+  .+|...+..+.+|+.+||+.||.+||++     +||++|
T Consensus       556 ~-------------~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          556 E-------------HNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             S-------------SCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             h-------------CCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            2             111  2334455679999999999999999997     888877

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.8e-38  Score=317.21  Aligned_cols=253  Identities=23%  Similarity=0.357  Sum_probs=187.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+..     .....   .+..+.+.+|++++++++||||++++++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~~-----~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~   79 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGH-KVAVKILNR-----QKIRS---LDVVGKIKREIQNLKLFRHPHIIKLYQV   79 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEEEH-----HHHHH---TTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCc-eEEEEEecc-----ccccc---hhHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            45789999999999999999999875432 222222111     10000   0123467889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+.+++|.+++....  .+++..++.++.|++.||+|||++++   +|+||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~l~d  154 (276)
T 2h6d_A           80 ISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMV---VHRDLKPENVLLDAHMNAKIAD  154 (276)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCS---SCCCCCGGGEEECTTSCEEECC
T ss_pred             EecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCChhhEEECCCCCEEEee
Confidence            875 46899999999999999998654  38999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      ||++.......  ......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....     .   ......+.
T Consensus       155 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~---~~~~~~~~  224 (276)
T 2h6d_A          155 FGLSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----V---PTLFKKIR  224 (276)
T ss_dssp             CCGGGCCCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHH
T ss_pred             cccccccCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----H---HHHHHHhh
Confidence            99987654322  2234578999999999987765 689999999999999999999984321     1   11111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..           ..    ..+...+..+.+++.+||+.||.+|||++|+++|-
T Consensus       225 ~~-----------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~  263 (276)
T 2h6d_A          225 GG-----------VF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHE  263 (276)
T ss_dssp             HC-----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             cC-----------cc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence            10           01    11223345689999999999999999999999984

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.4e-38  Score=336.92  Aligned_cols=264  Identities=19%  Similarity=0.273  Sum_probs=195.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccC------CCC
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHV------HHL  341 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l------~hp  341 (589)
                      ...+|++.+.||+|+||.||+|.+..+..               .+++|.+.  ......+.+|+++++.+      .|+
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~---------------~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~  159 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQ---------------HVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTM  159 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTE---------------EEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCS
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCc---------------EEEEEEECCccchHHHHHHHHHHHHHHhhccccCCc
Confidence            35689999999999999999998776522               22233222  22334566677777666      678


Q ss_pred             cceeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          342 NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       342 nIv~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ||+++++++. .+..++||||+. ++|.+++.......+++..++.++.||+.||+|||++++   +||||||+|||++.
T Consensus       160 ~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlKp~NILl~~  235 (429)
T 3kvw_A          160 NVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRI---IHCDLKPENILLKQ  235 (429)
T ss_dssp             CBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTE---ECSCCSGGGEEESS
T ss_pred             CEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEEcc
Confidence            9999999876 456899999996 599999988776679999999999999999999999998   99999999999999


Q ss_pred             CCc--EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhh
Q 037010          421 NFH--AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG  498 (589)
Q Consensus       421 ~~~--vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~  498 (589)
                      ++.  +||+|||++.....    ......||+.|+|||++.+..++.++|||||||++|||+||+.||....     ...
T Consensus       236 ~~~~~vkL~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~-----~~~  306 (429)
T 3kvw_A          236 QGRSGIKVIDFGSSCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED-----EGD  306 (429)
T ss_dssp             TTSCCEEECCCTTCEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHH
T ss_pred             CCCcceEEeecccceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC-----HHH
Confidence            887  99999999975432    2234678999999999999999999999999999999999999984432     122


Q ss_pred             HHHHHHHHhcCCChHH-----hhHhhcCCCC------------------------------CCC------CChHHHHHHH
Q 037010          499 LVALFEEVLNLPDPIE-----DLRKLVDPRL------------------------------GDN------CPLDSVLKMA  537 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~-----~l~~~~d~~l------------------------------~~~------~~~~~~~~l~  537 (589)
                      ...........+...-     .....++..-                              ...      .+......+.
T Consensus       307 ~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  386 (429)
T 3kvw_A          307 QLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL  386 (429)
T ss_dssp             HHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHH
T ss_pred             HHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHH
Confidence            2222333333222110     0001111000                              000      0011134689


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHH
Q 037010          538 QLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       538 ~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      +|+.+||+.||++|||++|+++|-
T Consensus       387 dli~~~L~~dP~~Rpta~e~L~Hp  410 (429)
T 3kvw_A          387 DFLKQCLEWDPAVRMTPGQALRHP  410 (429)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTST
T ss_pred             HHHHHHCCCChhhCCCHHHHhCCh
Confidence            999999999999999999999983

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.4e-39  Score=348.15  Aligned_cols=265  Identities=22%  Similarity=0.308  Sum_probs=194.2

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHH--hhcCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI--KKMDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~i--k~~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      ...++|++.++||+|+||+||+|.+..+. ...+.|.+...........  ........+.+.+|+++|++++||||+++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~-~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGH-SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTC-CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCC-cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            35688999999999999999999987653 2233332221111100000  00001224568899999999999999999


Q ss_pred             eeEEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC---
Q 037010          347 IGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF---  422 (589)
Q Consensus       347 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~---  422 (589)
                      ++++.++ ..|+||||+.+|+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNI---VHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEESSTTCCS
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeCCCcHHHEEEecCCCCc
Confidence            9988754 5899999999999999997754  39999999999999999999999998   9999999999998776   


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+||+|||++.......  ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.....     .   ..
T Consensus       187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~---~~  255 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-----Q---DI  255 (504)
T ss_dssp             SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HH
T ss_pred             cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----H---HH
Confidence            69999999998654322  234467999999999987 5699999999999999999999999954321     1   11


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ...+.....           ..........+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       256 ~~~i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          256 IKKVEKGKY-----------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             HHHHHHCCC-----------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHcCCC-----------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence            222111100           000000012234689999999999999999999999984

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.2e-39  Score=324.44  Aligned_cols=254  Identities=23%  Similarity=0.388  Sum_probs=197.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .+.|++.+.||+|+||.||+|.+..++ ...+.|.+...          ......+.+.+|+.++++++||||+++++++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   89 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQ-KVVAIKIIDLE----------EAEDEIEDIQQEITVLSQCDSPYVTKYYGSY   89 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTC-CEEEEEEEETT----------TCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCC-cEEEEEEeccc----------ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            456999999999999999999876543 22222222110          0112345688899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +..|+||||+++++|.+++...   ++++..++.++.|++.||.|||++++   +|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~Df  163 (303)
T 3a7i_A           90 LKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADF  163 (303)
T ss_dssp             EETTEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCC
T ss_pred             ecCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCChheEEECCCCCEEEeec
Confidence            65 5689999999999999998753   48999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....     ...   ...+   
T Consensus       164 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~---~~~~---  231 (303)
T 3a7i_A          164 GVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-----MKV---LFLI---  231 (303)
T ss_dssp             TTCEECBTTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHH---HHHH---
T ss_pred             ccceecCcccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-----HHH---HHHh---
Confidence            99976543221 22346789999999999999999999999999999999999999843211     111   1111   


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                             .....+.+..    ..+..+.+|+.+||+.||.+|||++|+++|..-.
T Consensus       232 -------~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          232 -------PKNNPPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             -------HHSCCCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             -------hcCCCCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence                   1111122222    3344689999999999999999999999986543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=330.07  Aligned_cols=260  Identities=21%  Similarity=0.336  Sum_probs=192.1

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCc
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLN  342 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpn  342 (589)
                      ..++....++|++.+.||+|+||.||+|.+..++. ..+.|.+.            ........+.+|+++++++ +|||
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~vaiK~~~------------~~~~~~~~~~~e~~~l~~l~~h~~   82 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQ-LAAIKVMD------------VTGDEEEEIKQEINMLKKYSHHRN   82 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEE------------CCSSTTHHHHHHHHHHHHHCCSTT
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCC-eEEEEEEe------------cCcccHHHHHHHHHHHHhccCCCC
Confidence            34445567899999999999999999999865432 22222211            0111234677899999998 7999


Q ss_pred             ceeEeeEEEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          343 LVRLIGYCVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       343 Iv~l~~~~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      |+++++++..       +..|+||||+++++|.+++.......+++..++.++.|++.||.|||++++   +|+||||+|
T Consensus        83 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~dlkp~N  159 (326)
T 2x7f_A           83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKV---IHRDIKGQN  159 (326)
T ss_dssp             BCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGG
T ss_pred             eeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCcHHH
Confidence            9999998764       458999999999999999987655569999999999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      ||++.++.+||+|||++........ ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||....
T Consensus       160 Il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          160 VLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             EEECTTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             EEEcCCCCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999876542221 223457899999999986     5678999999999999999999999984322


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .     ..   ........          ..+.   ..+...+..+.+++.+||..||.+|||++++++|-
T Consensus       239 ~-----~~---~~~~~~~~----------~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp  288 (326)
T 2x7f_A          239 P-----MR---ALFLIPRN----------PAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP  288 (326)
T ss_dssp             H-----HH---HHHHHHHS----------CCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred             H-----HH---HHHHhhcC----------cccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhCh
Confidence            1     11   11111110          0111   11222345789999999999999999999999973

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.4e-38  Score=319.16  Aligned_cols=257  Identities=22%  Similarity=0.320  Sum_probs=193.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..+. ...+.|.+..     ... .. .......+.+|++++++++||||++++++
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~-~~~avK~~~~-----~~~-~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETL-CRRAVKILKK-----KKL-RR-IPNGEANVKKEIQLLRRLRHKNVIQLVDV   74 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTC-CEEEEEEECH-----HHH-HH-STTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCC-cEEEEEEecc-----ccc-cc-cchhHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            3578999999999999999999876542 2222222111     100 00 11234568899999999999999999998


Q ss_pred             EE---eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          350 CV---EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       350 ~~---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +.   .+..|+||||+.++ |.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i---~H~dlkp~NIl~~~~~~~kl  150 (305)
T 2wtk_C           75 LYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGI---VHKDIKPGNLLLTTGGTLKI  150 (305)
T ss_dssp             EECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEE
T ss_pred             EEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCe---eecCCCcccEEEcCCCcEEe
Confidence            74   23589999999886 8888877666679999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCC-CCCCcccccCCCCCchhcccCCC--CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          427 ADFGLTKLTEVGS-ASLPTRLVGTFGYMPPEYAQYGD--VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       427 ~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +|||++....... ........||+.|+|||++.+..  ++.++||||||+++|||++|+.||....        .....
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~  222 (305)
T 2wtk_C          151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLF  222 (305)
T ss_dssp             CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHH
T ss_pred             eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHH
Confidence            9999998654221 11223456899999999987543  4779999999999999999999985321        11111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..+...           ...    .+.+.+..+.+++.+||+.||.+|||++|+++|-
T Consensus       223 ~~i~~~-----------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          223 ENIGKG-----------SYA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             HHHHHC-----------CCC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             HHHhcC-----------CCC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence            111111           111    2223345789999999999999999999999984

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.6e-38  Score=327.68  Aligned_cols=269  Identities=21%  Similarity=0.296  Sum_probs=197.2

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||+|.+..++. ..+.|.+.          +.......+.+.+|++++++++||||+++++
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~vaiK~~~----------~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   92 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKV-RVAIKKIS----------PFEHQTYCQRTLREIKILLRFRHENIIGIND   92 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTE-EEEEEEEC----------CTTCHHHHHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCe-EEEEEEec----------cccCcHHHHHHHHHHHHHHhcCCCCCcccee
Confidence            345789999999999999999998765522 11111110          0112344567889999999999999999999


Q ss_pred             EEEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          349 YCVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       349 ~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      ++..      ...|+||||+.+ +|.+++...   .+++..++.++.|++.||+|||++++   +||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIl~~~~~  165 (364)
T 3qyz_A           93 IIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTC  165 (364)
T ss_dssp             EECCSSTTTCCCEEEEEECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTC
T ss_pred             EEecCCccccceEEEEEcccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCChHhEEECCCC
Confidence            8853      258999999975 999998764   38999999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCC--CCcccccCCCCCchhccc-CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          423 HAKVADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      .+||+|||++.........  ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.....     ...
T Consensus       166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~  240 (364)
T 3qyz_A          166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQ  240 (364)
T ss_dssp             CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGH
T ss_pred             CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHH
Confidence            9999999999865432221  124468999999999865 44589999999999999999999999954322     112


Q ss_pred             HHHHHHHhcCCChHHhhHhh--------c-CCCCCCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKL--------V-DPRLGDNC-----PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~--------~-d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..........+.. +.+...        . ........     ..+....+.+|+.+||+.||.+|||++|+++|-
T Consensus       241 ~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          241 LNHILGILGSPSQ-EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             HHHHHHHHCSCCH-HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             HHHHHHHhCCCCH-HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence            2222222222211 111100        0 00000011     122345789999999999999999999999984

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.8e-38  Score=331.62  Aligned_cols=264  Identities=19%  Similarity=0.258  Sum_probs=187.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+..         ........+.+.+|+++++.++||||++++++
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~vavK~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   92 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILER-NVAIKKLSR---------PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV   92 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTE-EEEEEEEEC---------TTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCc-eEEEEEecc---------ccCChHHHHHHHHHHHHHHhcCCCCccceEEe
Confidence            35789999999999999999998765532 222221110         01223445678899999999999999999998


Q ss_pred             EEeC-------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVEG-------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~~-------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +...       ..|+||||+.+ +|.+++..    .+++..+..++.|++.||+|||++++   +||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dlkp~NIl~~~~~  164 (371)
T 2xrw_A           93 FTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDC  164 (371)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTS
T ss_pred             eccccccccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCe---ecccCCHHHEEEcCCC
Confidence            8632       57999999976 78888863    38899999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+||+|||++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....        ...
T Consensus       165 ~~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~  234 (371)
T 2xrw_A          165 TLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--------IDQ  234 (371)
T ss_dssp             CEEECCCCC------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH
T ss_pred             CEEEEEeecccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH--------HHH
Confidence            9999999999865322  223346799999999999988999999999999999999999999954321        111


Q ss_pred             HHHHhc---CCChH------HhhHhhc--CCCCC----------------CCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 037010          503 FEEVLN---LPDPI------EDLRKLV--DPRLG----------------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMR  555 (589)
Q Consensus       503 ~~~~~~---~~~~~------~~l~~~~--d~~l~----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  555 (589)
                      +..+..   .+.+.      ..+....  .+...                ...+......+.+|+.+||+.||.+|||++
T Consensus       235 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~  314 (371)
T 2xrw_A          235 WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVD  314 (371)
T ss_dssp             HHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHH
T ss_pred             HHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHH
Confidence            111111   01000      0000000  00000                000122356899999999999999999999


Q ss_pred             HHHHHH
Q 037010          556 SIVVAL  561 (589)
Q Consensus       556 evl~~L  561 (589)
                      |+++|-
T Consensus       315 e~l~hp  320 (371)
T 2xrw_A          315 EALQHP  320 (371)
T ss_dssp             HHHHSH
T ss_pred             HHhCCc
Confidence            999984

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=8.9e-39  Score=328.57  Aligned_cols=271  Identities=22%  Similarity=0.319  Sum_probs=193.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|.+.         .........+.+.+|++++++++||||+++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~---------~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   93 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGR-IVAIKKFL---------ESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC   93 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCC-EEEEEEEE---------SCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCc-eEEEEEEe---------cCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe
Confidence            4689999999999999999999876532 22222110         0112233445678899999999999999999988


Q ss_pred             EeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .++ ..|+||||+.+++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        94 ~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i---vH~dlkp~Nil~~~~~~~kl~Df  168 (331)
T 4aaa_A           94 KKKKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNI---IHRDIKPENILVSQSGVVKLCDF  168 (331)
T ss_dssp             EETTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECCC
T ss_pred             ecCCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCE---EccCcChheEEEcCCCcEEEEeC
Confidence            754 5899999999999988876544  39999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.....    .............
T Consensus       169 g~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~  243 (331)
T 4aaa_A          169 GFARTLAAPG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD----IDQLYHIMMCLGN  243 (331)
T ss_dssp             TTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCS
T ss_pred             CCceeecCCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCC
Confidence            9997654322 222345789999999998765 789999999999999999999999854321    1111111111111


Q ss_pred             CCChHHhh-------HhhcCCCCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDL-------RKLVDPRLGDNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l-------~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ........       .....+......+     +..+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp  308 (331)
T 4aaa_A          244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD  308 (331)
T ss_dssp             CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             CChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            11000000       0011111111111     13356799999999999999999999999873

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.2e-39  Score=333.92  Aligned_cols=275  Identities=21%  Similarity=0.299  Sum_probs=196.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHH------hhcCHHHHHHHHHHHHHHccCCCCcc
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI------KKMDMQASREFLAELKVLTHVHHLNL  343 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~i------k~~~~~~~~~~~~E~~il~~l~hpnI  343 (589)
                      ..++|++.+.||+|+||.||+|.+   .+...+.|.+...........      ........+.+.+|++++++++||||
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            357899999999999999999987   222222222211100000000      00000112678899999999999999


Q ss_pred             eeEeeEEEe-CcEEEEEEecCCCChHHH------HhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCCCc
Q 037010          344 VRLIGYCVE-GSLFLVYEYIENGNLSEH------LRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKSAN  415 (589)
Q Consensus       344 v~l~~~~~~-~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp~N  415 (589)
                      +++++++.+ +..|+||||+++++|.++      +.......+++..++.++.|++.||+|||+ +++   +||||||+|
T Consensus       106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i---~H~dl~p~N  182 (348)
T 2pml_X          106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI---CHRDVKPSN  182 (348)
T ss_dssp             CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCE---ECCCCCGGG
T ss_pred             ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCE---eecCCChHh
Confidence            999998875 468999999999999999      665445679999999999999999999999 998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCc-ccchhhHHHHHHHHHcCCcccccCCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSP-KVDVYAFGVVLYELISAKEAIVKGNGSS  493 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~sDvwSlGvll~elltG~~p~~~~~~~~  493 (589)
                      ||++.++.+||+|||++......   ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||...... 
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-  258 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-  258 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-
T ss_pred             EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-
Confidence            99999999999999999865332   22346789999999999877 6666 999999999999999999999543221 


Q ss_pred             CChhhHHHHHHHHhcCCC----hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          494 ADSKGLVALFEEVLNLPD----PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~----~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                            ......+.....    ..........+..........+..+.+|+.+||+.||.+|||++|+++|
T Consensus       259 ------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          259 ------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             ------HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ------HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  112222221100    0000000000000000113344578999999999999999999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.5e-39  Score=330.12  Aligned_cols=263  Identities=21%  Similarity=0.297  Sum_probs=188.4

Q ss_pred             cCCCccc-eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          271 TDNFSMS-HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      .++|++. +.||+|+||.||+|.+..++ ...+.|.+..           ........+.+|++++.++ +||||+++++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~-----------~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~   78 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITS-QEYAVKIIEK-----------QPGHIRSRVFREVEMLYQCQGHRNVLELIE   78 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSC-CEEEEEEEEC-----------CSSCCHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCC-cEEEEEEEee-----------CcchhHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            4678884 78999999999999876543 2222222110           0112235678899999885 7999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc---E
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH---A  424 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~---v  424 (589)
                      ++.+ +..|+||||+++|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.   +
T Consensus        79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~dlkp~Nil~~~~~~~~~~  153 (316)
T 2ac3_A           79 FFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGI---AHRDLKPENILCEHPNQVSPV  153 (316)
T ss_dssp             EEEETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEESCSSSSCSE
T ss_pred             EEeeCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCc---eeCCCCHHHEEEccCCCcCce
Confidence            8875 56899999999999999998754  48999999999999999999999998   99999999999988765   9


Q ss_pred             EEEeccCccccccCCC------CCCcccccCCCCCchhcccC-----CCCCcccchhhHHHHHHHHHcCCcccccCCCCC
Q 037010          425 KVADFGLTKLTEVGSA------SLPTRLVGTFGYMPPEYAQY-----GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS  493 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~  493 (589)
                      ||+|||++........      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||.......
T Consensus       154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~  233 (316)
T 2ac3_A          154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD  233 (316)
T ss_dssp             EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred             EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence            9999999875432211      11123569999999999864     568899999999999999999999996654322


Q ss_pred             CChhh-------HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          494 ADSKG-------LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       494 ~~~~~-------~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..+..       .......+....           ...........+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          234 CGWDRGEACPACQNMLFESIQEGK-----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             SCC----CCHHHHHHHHHHHHHCC-----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             ccccccccchhHHHHHHHHHhccC-----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence            11110       011111111100           0000000012334789999999999999999999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.4e-38  Score=344.46  Aligned_cols=255  Identities=22%  Similarity=0.345  Sum_probs=193.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||+||+|.+..++ ..++.|.+..     .. .   .......+.+|+++|++++||||++++++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~-----~~-~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~   89 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQ-QEYAVKVINK-----AS-A---KNKDTSTILREVELLKKLDHPNIMKLFEI   89 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTC-CEEEEEEEEH-----HH-H---BCSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCC-CEEEEEEEec-----cc-c---cchHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            4567999999999999999999987553 2222222111     10 0   11123567889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc---CCCcEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAK  425 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~---~~~~vk  425 (589)
                      +.+ +..|+||||+.+|+|.+++....  .+++..++.++.|++.||.|||++++   +||||||+|||++   .++.+|
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i---vH~Dlkp~Nil~~~~~~~~~~k  164 (486)
T 3mwu_A           90 LEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNI---VHRDLKPENILLESKEKDCDIK  164 (486)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEESSSSTTCCEE
T ss_pred             EEcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---EeccCchHHEEEecCCCCCCEE
Confidence            875 46899999999999999997654  48999999999999999999999998   9999999999995   456799


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++.......  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....        ......
T Consensus       165 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~  233 (486)
T 3mwu_A          165 IIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKR  233 (486)
T ss_dssp             ECSCSCTTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred             EEECCcCeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence            99999998654322  2344679999999999875 699999999999999999999999954321        111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      +.....           ..........+..+.+|+.+||+.||.+|||+.|+++|-
T Consensus       234 i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          234 VETGKY-----------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             HHHTCC-----------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             HHhCCC-----------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence            111100           000011123345789999999999999999999999984

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.6e-39  Score=331.00  Aligned_cols=264  Identities=16%  Similarity=0.320  Sum_probs=197.5

Q ss_pred             HHHHhhcCCCccc-eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCc
Q 037010          265 EELSKATDNFSMS-HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLN  342 (589)
Q Consensus       265 ~~~~~~~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpn  342 (589)
                      .......++|.+. +.||+|+||.||+|.+..++ ..++.|.+...         ........++.+|+.+++++ +|||
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~---------~~~~~~~~~~~~e~~~l~~l~~~~~   90 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTG-QEYAAKFLKKR---------RRGQDCRAEILHEIAVLELAKSCPR   90 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEESE---------ETTEECHHHHHHHHHHHHHTTTCTT
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCC-CEEEEEEEehh---------hcchHHHHHHHHHHHHHHhccCCCC
Confidence            3345556778887 89999999999999887653 22222221110         01111235678899999999 4699


Q ss_pred             ceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-
Q 037010          343 LVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-  420 (589)
Q Consensus       343 Iv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-  420 (589)
                      |+++++++.+ +..|+||||+.+|+|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++. 
T Consensus        91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~gi---vH~Dikp~NIl~~~~  167 (327)
T 3lm5_A           91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI---VHLDLKPQNILLSSI  167 (327)
T ss_dssp             BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEESCB
T ss_pred             EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe---ecCcCChHHEEEecC
Confidence            9999998875 458999999999999999977656679999999999999999999999998   99999999999987 


Q ss_pred             --CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhh
Q 037010          421 --NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG  498 (589)
Q Consensus       421 --~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~  498 (589)
                        ++.+||+|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ..
T Consensus       168 ~~~~~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~  240 (327)
T 3lm5_A          168 YPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN-----QE  240 (327)
T ss_dssp             TTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH
T ss_pred             CCCCcEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hH
Confidence              7899999999998654322  22346799999999999999999999999999999999999999944221     11


Q ss_pred             HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      .   ...+..           .............+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       241 ~---~~~i~~-----------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~  290 (327)
T 3lm5_A          241 T---YLNISQ-----------VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSW  290 (327)
T ss_dssp             H---HHHHHH-----------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred             H---HHHHHh-----------cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence            1   111111           0111111222334557899999999999999999999998843

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-38  Score=326.90  Aligned_cols=277  Identities=25%  Similarity=0.291  Sum_probs=191.9

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ....++|++.+.||+|+||.||+|.+..++ ...+.|.+.....      ........+.+.+|++++++++||||++++
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTN-QIVAIKKIKLGHR------SEAKDGINRTALREIKLLQELSHPNIIGLL   78 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCC-SEEEEEEC------------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCC-cEEEEEEEecCCc------chhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence            344678999999999999999999876542 2222222211000      000111123577899999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||
T Consensus        79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~~~kl  153 (346)
T 1ua2_A           79 DAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKL  153 (346)
T ss_dssp             EEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCCEEE
T ss_pred             EEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCE---ECCCCCHHHEEEcCCCCEEE
Confidence            98864 568999999987 8998887654 358899999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|||++....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.....    ...+...+..
T Consensus       154 ~Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~~~~~i~~~  228 (346)
T 1ua2_A          154 ADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFET  228 (346)
T ss_dssp             CCCGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHH
T ss_pred             EecccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHH
Confidence            9999998654322 223446789999999998654 589999999999999999999988843321    1122222221


Q ss_pred             HhcCCChH--HhhHhhcCCCC---CCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          506 VLNLPDPI--EDLRKLVDPRL---GDNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       506 ~~~~~~~~--~~l~~~~d~~l---~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                       ...+...  .......+...   ....+     ...+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          229 -LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             -HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             -cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence             1111110  00000000000   00011     223457999999999999999999999999854

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-38  Score=330.80  Aligned_cols=285  Identities=21%  Similarity=0.247  Sum_probs=197.4

Q ss_pred             ccHHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCC
Q 037010          262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHL  341 (589)
Q Consensus       262 ~~~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hp  341 (589)
                      ....++....++|++.+.||+|+||.||+|.+..  +...+.|.+...................+.+.+|++++++++||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   89 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP   89 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT--SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC--CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence            3456778889999999999999999999998654  33333332211111000000011233456788999999999999


Q ss_pred             cceeEeeEEEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          342 NLVRLIGYCVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       342 nIv~l~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      ||+++++++..      ...|+||||+. |+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|
T Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp~N  164 (362)
T 3pg1_A           90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGV---VHRDLHPGN  164 (362)
T ss_dssp             TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGG
T ss_pred             CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcC---EecCCChHH
Confidence            99999998742      24799999998 58988887553 359999999999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCC
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA  494 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~  494 (589)
                      ||++.++.+||+|||++......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....    
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----  238 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST----  238 (362)
T ss_dssp             EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS----
T ss_pred             EEEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC----
Confidence            99999999999999999754322  22244678999999998876 678999999999999999999999995432    


Q ss_pred             ChhhHHHHHHHHhcCCChHH-------hhHhhcCCCCCC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          495 DSKGLVALFEEVLNLPDPIE-------DLRKLVDPRLGD-------NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       495 ~~~~~~~~~~~~~~~~~~~~-------~l~~~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                       ..............+....       .....+......       ..+......+.+|+.+||+.||.+|||++|+++|
T Consensus       239 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          239 -FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             -HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence             1122222222222222111       011111111110       0112234568999999999999999999999998

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-38  Score=323.05  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=195.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+.           .......+.+.+|++++++++||||++++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~-----------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGK-LFALKCIK-----------KSPAFRDSSLENEIAVLKKIKHENIVTLEDI   74 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEEE-----------CC------HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCC-EEEEEEEe-----------cccccchHHHHHHHHHHHhCCCCCeeehhhh
Confidence            45689999999999999999999865432 22222111           0111223457789999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE---cCCCcEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAK  425 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl---~~~~~vk  425 (589)
                      +.+ +..|+||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+||++   +.++.+|
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dikp~NIl~~~~~~~~~~k  149 (304)
T 2jam_A           75 YESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGI---VHRDLKPENLLYLTPEENSKIM  149 (304)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCSCCGGGCEESSSSTTCCEE
T ss_pred             cccCCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCCHHHEEEecCCCCCCEE
Confidence            875 45899999999999999997654  38999999999999999999999998   999999999999   7888999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++......   ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.....     .   .....
T Consensus       150 l~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~---~~~~~  218 (304)
T 2jam_A          150 ITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----S---KLFEK  218 (304)
T ss_dssp             BCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----H---HHHHH
T ss_pred             EccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----H---HHHHH
Confidence            9999998754321   22345789999999999989999999999999999999999999854321     1   11111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      +....           ...........+..+.+++.+||+.||.+|||++|+++|-.
T Consensus       219 i~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  264 (304)
T 2jam_A          219 IKEGY-----------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPW  264 (304)
T ss_dssp             HHHCC-----------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             HHcCC-----------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            11110           00111122334457899999999999999999999998743

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-38  Score=320.04  Aligned_cols=255  Identities=19%  Similarity=0.265  Sum_probs=179.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH-HHHHHHHHHHHHccCCCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-ASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+..          ..... ..+.+.++...++.++||||+++++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~----------~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~   73 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQ-IMAVKRIRA----------TVNSQEQKRLLMDLDISMRTVDCPFTVTFYG   73 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTE-EEEEEEEC-------------CHHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCe-EEEEEEeec----------ccCcHHHHHHHHHHHHHHHhCCCCeEEEEee
Confidence            35789999999999999999999865422 222221110          01112 2233444555688889999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      ++.+ +..|+||||+++ +|.+++...  ....+++..++.++.|++.||+|||++ ++   +||||||+|||++.++.+
T Consensus        74 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i---~H~dlkp~Nil~~~~~~~  149 (290)
T 3fme_A           74 ALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV---IHRDVKPSNVLINALGQV  149 (290)
T ss_dssp             EEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCC---CCCCCSGGGCEECTTCCE
T ss_pred             eeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCe---ecCCCCHHHEEECCCCCE
Confidence            8875 569999999985 888877642  334599999999999999999999998 98   999999999999999999


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcc----cCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA----QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      ||+|||++.......  ......||+.|+|||++    ....++.++|||||||++|+|+||+.||.....      .. 
T Consensus       150 kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~-  220 (290)
T 3fme_A          150 KMCDFGISGYLVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PF-  220 (290)
T ss_dssp             EBCCC-----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HH-
T ss_pred             EEeecCCcccccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hH-
Confidence            999999997654322  22334789999999996    566789999999999999999999999843211      11 


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ........             .......+...+..+.+++.+||+.||++|||++|+++|-
T Consensus       221 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp  268 (290)
T 3fme_A          221 QQLKQVVE-------------EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP  268 (290)
T ss_dssp             HHHHHHHH-------------SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             HHHHHHhc-------------cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence            11111111             1111111223345789999999999999999999999973

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.7e-38  Score=344.54  Aligned_cols=254  Identities=21%  Similarity=0.324  Sum_probs=189.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..+.. ..+.|.+..     .    .........+.+|++++++++||||++++++
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~-~~aiK~~~~-----~----~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  104 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHV-ERAIKIIRK-----T----SVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF  104 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCC-EEEEEEEEC--------------CTTHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCc-EEEEEEEec-----c----ccCchHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            34679999999999999999999876532 222222111     0    0011123567889999999999999999998


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC---CcEE
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN---FHAK  425 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~---~~vk  425 (589)
                      +.++ ..|+||||+.+|+|.+++....  .+++..++.++.||+.||.|||++++   +||||||+|||++..   +.+|
T Consensus       105 ~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~~~~~~k  179 (494)
T 3lij_A          105 FEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNI---VHRDLKPENLLLESKEKDALIK  179 (494)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEESCSSTTCCEE
T ss_pred             EEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCChhhEEEeCCCCCCcEE
Confidence            8754 6899999999999999987654  38999999999999999999999998   999999999999764   4599


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++.......  ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.....     .   .....
T Consensus       180 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~---~~~~~  248 (494)
T 3lij_A          180 IVDFGLSAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----Q---EILRK  248 (494)
T ss_dssp             ECCCTTCEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHHH
T ss_pred             EEECCCCeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHH
Confidence            99999998654322  234467999999999986 5799999999999999999999999954321     1   11111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +.....           ..........+..+.+|+.+||+.||.+|||++|+++|
T Consensus       249 i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          249 VEKGKY-----------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHHTCC-----------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHhCCC-----------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            111100           00000011234568999999999999999999999988

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=9.6e-38  Score=320.98  Aligned_cols=265  Identities=20%  Similarity=0.281  Sum_probs=198.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCC------cc
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHL------NL  343 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hp------nI  343 (589)
                      ..++|++.+.||+|+||.||+|.+....+...+.|.+.            ......+.+.+|++++++++|+      ++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~------------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i   79 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK------------NVDRYCEAARSEIQVLEHLNTTDPNSTFRC   79 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEC------------SSHHHHHHHHHHHHHHHHHHHHCTTCTTCB
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEe------------cCCchhHHHHHHHHHHHHhhhcCCCCceee
Confidence            45789999999999999999998754433333322211            1123345677888888888655      59


Q ss_pred             eeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC--
Q 037010          344 VRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK--  420 (589)
Q Consensus       344 v~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~--  420 (589)
                      +++++++.+ +..++||||+ +++|.+++......++++..++.++.|++.||+|||++++   +||||||+|||++.  
T Consensus        80 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~  155 (339)
T 1z57_A           80 VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKL---THTDLKPENILFVQSD  155 (339)
T ss_dssp             CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESCCC
T ss_pred             EeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCC---cCCCCCHHHEEEeccc
Confidence            999998764 5689999999 8899999988776679999999999999999999999998   99999999999987  


Q ss_pred             -----------------CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCC
Q 037010          421 -----------------NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK  483 (589)
Q Consensus       421 -----------------~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~  483 (589)
                                       ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  231 (339)
T 1z57_A          156 YTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF  231 (339)
T ss_dssp             EEEEEC----CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             cccccCCccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence                             668999999999764322    23467899999999999889999999999999999999999


Q ss_pred             cccccCCCCCCChhhHHHHHHHHhcCCChHHhhH--------------------------hhcCCCC-CCCCChHHHHHH
Q 037010          484 EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLR--------------------------KLVDPRL-GDNCPLDSVLKM  536 (589)
Q Consensus       484 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--------------------------~~~d~~l-~~~~~~~~~~~l  536 (589)
                      .||....     ................ ...+.                          ....+.. ....+......+
T Consensus       232 ~pf~~~~-----~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  305 (339)
T 1z57_A          232 TVFPTHD-----SKEHLAMMERILGPLP-KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL  305 (339)
T ss_dssp             CSCCCSC-----HHHHHHHHHHHHCSCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred             CCCCCCC-----hHHHHHHHHHHhCCCC-HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHH
Confidence            9995432     2222233333322111 11000                          0000000 011234567789


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHH
Q 037010          537 AQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       537 ~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+|+.+||+.||.+|||++|+++|
T Consensus       306 ~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          306 FDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHhCcCcccccCHHHHhcC
Confidence            999999999999999999999987

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-38  Score=332.41  Aligned_cols=267  Identities=20%  Similarity=0.312  Sum_probs=197.8

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCc
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLN  342 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpn  342 (589)
                      ++......++|++.+.||+|+||.||+|.+..++ ...+.|.+......   ..........+.+.+|+++++++ +|||
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g-~~vavK~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~~hp~  161 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG-HEFAVKIMEVTAER---LSPEQLEEVREATRRETHILRQVAGHPH  161 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEETTSSC---CCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCC-cEEEEEEEEccccc---cCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            3444556678999999999999999999986543 23333322111000   00000112245678899999999 7999


Q ss_pred             ceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          343 LVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       343 Iv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      |+++++++.. +..|+||||+++++|.+++....  .+++..++.++.|++.||.|||++|+   +|+||||+|||++.+
T Consensus       162 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi---~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNI---VHRDLKPENILLDDN  236 (365)
T ss_dssp             BCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTT
T ss_pred             EeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEECCC
Confidence            9999998875 56899999999999999998654  48999999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC------CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCC
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY------GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD  495 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~  495 (589)
                      +.+||+|||++.......  ......||+.|+|||++.+      ..++.++|||||||++|+|++|+.||....     
T Consensus       237 ~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----  309 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----  309 (365)
T ss_dssp             CCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred             CCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----
Confidence            999999999988654322  2344679999999998853      368899999999999999999999994321     


Q ss_pred             hhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       496 ~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..   .....+.....           ........+.+..+.+++.+||+.||++|||++|+++|
T Consensus       310 ~~---~~~~~i~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          310 QI---LMLRMIMEGQY-----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HH---HHHHHHHHTCC-----------CCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HH---HHHHHHHhCCC-----------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11   11111111000           00000001123468999999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.9e-39  Score=347.97  Aligned_cols=257  Identities=22%  Similarity=0.334  Sum_probs=196.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+.....        ......+.+.+|++++++++||||++++++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~avK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   94 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQ-ECAVKVISKRQV--------KQKTDKESLLREVQLLKQLDHPNIMKLYEF   94 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEETTTC--------CBSSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCC-EEEEEEEEhhhc--------ccchHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            35679999999999999999999875532 222222211000        001224568889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE---cCCCcEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAK  425 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl---~~~~~vk  425 (589)
                      +.+ +..|+||||+.+|+|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||+   +.++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i---vH~Dlkp~Nil~~~~~~~~~~k  169 (484)
T 3nyv_A           95 FEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKI---VHRDLKPENLLLESKSKDANIR  169 (484)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESSSSTTCCEE
T ss_pred             EEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHHHEEEecCCCCCcEE
Confidence            875 46899999999999999997654  48999999999999999999999998   999999999999   5678999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++.......  ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....        ......
T Consensus       170 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~  238 (484)
T 3nyv_A          170 IIDFGLSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKK  238 (484)
T ss_dssp             ECCTTHHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred             EEeeeeeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence            99999998654322  2244679999999999875 799999999999999999999999954321        111122


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      +....           ...........+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       239 i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          239 VEKGK-----------YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             HHHCC-----------CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             HHcCC-----------CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence            11110           00000111234457899999999999999999999999843

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.3e-38  Score=318.29  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=187.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+            .......+.+.+|++++++++||||++++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   70 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSR-YYAIKKI------------RHTEEKLSTILSEVMLLASLNHQYVVRYYAA   70 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC-EEEEEEE------------EEEHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCe-EEEEEEE------------eccHHHHHHHHHHHHHHHhcCchHHHHHHHH
Confidence            45679999999999999999998765532 2222211            0122345678899999999999999999997


Q ss_pred             EEe--------------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          350 CVE--------------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       350 ~~~--------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      +.+              +..|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|
T Consensus        71 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dlkp~N  146 (303)
T 1zy4_A           71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGI---IHRDLKPMN  146 (303)
T ss_dssp             EEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGG
T ss_pred             HHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCe---ecccCCHHh
Confidence            643              34799999999999999998644 347888999999999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCC-------------CCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHc
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGS-------------ASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELIS  481 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~ellt  481 (589)
                      ||++.++.+||+|||++.......             ........||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus       147 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          147 IFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             EEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred             EEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence            999999999999999997653221             1122345789999999998754 68999999999999999998


Q ss_pred             CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          482 AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       482 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                         ||...       .........+..           .....+...+...+..+.+++.+||+.||.+|||++|+++|
T Consensus       227 ---p~~~~-------~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          227 ---PFSTG-------MERVNILKKLRS-----------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             ---CCSSH-------HHHHHHHHHHHS-----------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---ccCCc-------hhHHHHHHhccc-----------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence               44211       111111111111           11122233444555678999999999999999999999987

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=323.54  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=191.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+..             ....+++.+|++++++++||||++++++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~vaiK~~~~-------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~   92 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQ-IVAIKQVPV-------------ESDLQEIIKEISIMQQCDSPHVVKYYGS   92 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCC-EEEEEEEET-------------TSCCHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCC-EEEEEecCc-------------hHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence            45789999999999999999998875432 222222110             1123467889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+.+++|.+++.... ..+++..++.++.|++.||.|||++++   +|+||||+||+++.++.+||+|
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl~d  168 (314)
T 3com_A           93 YFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLAD  168 (314)
T ss_dssp             EEETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECC
T ss_pred             EEeCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCC---cCCCcCHHHEEECCCCCEEEee
Confidence            764 56899999999999999997433 348999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ..  . ......
T Consensus       169 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~--~-~~~~~~  239 (314)
T 3com_A          169 FGVAGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP-----MR--A-IFMIPT  239 (314)
T ss_dssp             CTTCEECBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH-----HH--H-HHHHHH
T ss_pred             cccchhhhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh-----HH--H-HHHHhc
Confidence            999976543222 22345789999999999988999999999999999999999999843221     11  1 111100


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                ...+.  ...+...+..+.+++.+||..||.+|||++++++|-
T Consensus       240 ----------~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          240 ----------NPPPT--FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             ----------SCCCC--CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             ----------CCCcc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence                      00111  112333445789999999999999999999999874

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-38  Score=328.19  Aligned_cols=263  Identities=21%  Similarity=0.326  Sum_probs=190.5

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||+|.+..++. .++.|              .+... .....+|+++++.++||||+++++
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~-~vAiK--------------~~~~~-~~~~~~E~~il~~l~hpnIv~l~~   67 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGK-RFALK--------------KVLQD-PRYKNRELDIMKVLDHVNIIKLVD   67 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCC-EEEEE--------------EEECC-TTSCCHHHHHHTTCCCTTBCCEEE
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCC-EEEEE--------------EEecC-cchHHHHHHHHHHcCCCCccchhh
Confidence            456789999999999999999999876532 22222              11100 011235999999999999999999


Q ss_pred             EEEe---------------------------------------CcEEEEEEecCCCChHHHHhc--CCCCCCCHHHHHHH
Q 037010          349 YCVE---------------------------------------GSLFLVYEYIENGNLSEHLRG--SGRDPLPWSSRVQI  387 (589)
Q Consensus       349 ~~~~---------------------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i  387 (589)
                      ++..                                       ..+++||||+.+ +|.+.+..  .....+++..++.+
T Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i  146 (383)
T 3eb0_A           68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIY  146 (383)
T ss_dssp             EEEEC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred             eeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHH
Confidence            7732                                       127899999985 88777754  23345999999999


Q ss_pred             HHHHHHHHHHHHhCCCCceEeeccCCCcEEEc-CCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCc
Q 037010          388 ALDSARGLEYIHEHTVPVYIHRDIKSANILID-KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSP  465 (589)
Q Consensus       388 ~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~-~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~  465 (589)
                      +.||+.||+|||++|+   +||||||+|||++ .++.+||+|||+++......  ......||+.|+|||++.+. .++.
T Consensus       147 ~~qi~~aL~~LH~~gi---~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~  221 (383)
T 3eb0_A          147 IYQLFRAVGFIHSLGI---CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTP  221 (383)
T ss_dssp             HHHHHHHHHHHHTTTE---ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCT
T ss_pred             HHHHHHHHHHHHHCcC---ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCc
Confidence            9999999999999998   9999999999997 68899999999998654322  23446789999999988764 5899


Q ss_pred             ccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCC-------------CCCChHH
Q 037010          466 KVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLG-------------DNCPLDS  532 (589)
Q Consensus       466 ~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~-------------~~~~~~~  532 (589)
                      ++|||||||++|||++|+.||....     ..............+... .+.. .++...             ...+...
T Consensus       222 ~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~~g~p~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (383)
T 3eb0_A          222 SIDLWSIGCVFGELILGKPLFSGET-----SIDQLVRIIQIMGTPTKE-QMIR-MNPHYTEVRFPTLKAKDWRKILPEGT  294 (383)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCHH-HHHH-HCTTC--CCCCCCCCCCHHHHSCTTC
T ss_pred             chhhhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCCCCHH-HHHH-hCcccccccCCccCcccHHhhCCCCC
Confidence            9999999999999999999995432     112222222222322221 1111 111110             0022234


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          533 VLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       533 ~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +..+.+|+.+||+.||.+|||+.|+++|
T Consensus       295 ~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          295 PSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            4578999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.4e-40  Score=342.87  Aligned_cols=245  Identities=16%  Similarity=0.166  Sum_probs=180.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHH---HHHccCCCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAEL---KVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~---~il~~l~hpnIv~l~  347 (589)
                      .++|++.+.||+|+||.||+|.+..++ ...+.|.+...        ........+.+.+|+   +++++++||||++++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~vavK~~~~~--------~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~  142 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETG-ESFEVHVPYFT--------ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  142 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCC-CEEEEEEEEEC--------C-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCC-cEEEEEEEeec--------cccchHHHHHHHHHHHHHHhccccCCHHHHHHH
Confidence            468999999999999999999876542 22222221100        011223446688899   455566899999998


Q ss_pred             -------eEEEeC------------------cEEEEEEecCCCChHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHH
Q 037010          348 -------GYCVEG------------------SLFLVYEYIENGNLSEHLRGSGR-----DPLPWSSRVQIALDSARGLEY  397 (589)
Q Consensus       348 -------~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qia~aL~~  397 (589)
                             +++.+.                  ..|+||||+ +|+|.+++.....     ..+++..++.++.||+.||+|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  221 (377)
T 3byv_A          143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  221 (377)
T ss_dssp             HCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHH
Confidence                   554432                  278999999 5799999986432     123357888899999999999


Q ss_pred             HHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-----------CCCcc
Q 037010          398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-----------DVSPK  466 (589)
Q Consensus       398 LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~  466 (589)
                      ||++++   +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.+
T Consensus       222 LH~~~i---vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  293 (377)
T 3byv_A          222 LHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS  293 (377)
T ss_dssp             HHHTTE---ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred             HHhCCe---ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChh
Confidence            999998   9999999999999999999999999985322    2234567 999999999877           89999


Q ss_pred             cchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhccc
Q 037010          467 VDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE  546 (589)
Q Consensus       467 sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~  546 (589)
                      +|||||||++|||++|+.||........                     ...... . ...+    +..+.+|+.+||+.
T Consensus       294 ~DvwSlG~il~elltg~~Pf~~~~~~~~---------------------~~~~~~-~-~~~~----~~~~~~li~~~L~~  346 (377)
T 3byv_A          294 FDAWALGLVIYWIWCADLPITKDAALGG---------------------SEWIFR-S-CKNI----PQPVRALLEGFLRY  346 (377)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC------CC---------------------SGGGGS-S-CCCC----CHHHHHHHHHHTCS
T ss_pred             hhHHHHHHHHHHHHHCCCCCcccccccc---------------------hhhhhh-h-ccCC----CHHHHHHHHHHcCC
Confidence            9999999999999999999854322110                     001111 0 0122    34689999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 037010          547 YPQLRPSMRSIVVA  560 (589)
Q Consensus       547 dP~~RPs~~evl~~  560 (589)
                      ||++|||+.|+++|
T Consensus       347 dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          347 PKEDRLLPLQAMET  360 (377)
T ss_dssp             SGGGCCCHHHHHTS
T ss_pred             CchhCCCHHHHhhC
Confidence            99999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3e-38  Score=319.32  Aligned_cols=264  Identities=20%  Similarity=0.276  Sum_probs=196.6

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEe
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLI  347 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~  347 (589)
                      ...++|++.+.||+|+||.||+|.+..++ ...+.|.+........  .........+.+.+|+++++++. ||||++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~   90 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTC-KEYAVKIIDVTGGGSF--SAEEVQELREATLKEVDILRKVSGHPNIIQLK   90 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEEETTCSTTC--CHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcC-ceEEEEEEeccccccc--CHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence            34678999999999999999999986653 2222222211100000  00001123456788999999995 99999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..|+||||+++++|.+++....  .+++..++.++.|++.||+|||++++   +|+||||+||+++.++.+||
T Consensus        91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~kl  165 (298)
T 1phk_A           91 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNI---VHRDLKPENILLDDDMNIKL  165 (298)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEE
T ss_pred             eeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCcceEEEcCCCcEEE
Confidence            98875 45899999999999999998753  48999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhccc------CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ------YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      +|||++.......  ......|++.|+|||++.      ...++.++||||||+++|+|++|+.||.....     .   
T Consensus       166 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~---  235 (298)
T 1phk_A          166 TDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----M---  235 (298)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---
T ss_pred             ecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----H---
Confidence            9999998654322  223467899999999884      45688999999999999999999999843211     1   


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .....+....           ...........+..+.+++.+||+.||.+|||++|+++|-
T Consensus       236 ~~~~~~~~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (298)
T 1phk_A          236 LMLRMIMSGN-----------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  285 (298)
T ss_dssp             HHHHHHHHTC-----------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             HHHHHHhcCC-----------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence            1111111100           0011111123455799999999999999999999999863

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.8e-39  Score=324.13  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=178.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCccee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      ..++|++.+.||+|+||.||+|.+..++. .              +++|...    ....+++.+|++++++++||||++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~--------------vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~   77 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKE-K--------------VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS   77 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----C-E--------------EEEECCC----------------CCCCCCCTTBCC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCc-E--------------EEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEee
Confidence            46789999999999999999998765422 2              2222222    123456788999999999999999


Q ss_pred             EeeEEEe-CcEEEEEEecCCCChHHHHhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE
Q 037010          346 LIGYCVE-GSLFLVYEYIENGNLSEHLRGS------GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI  418 (589)
Q Consensus       346 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl  418 (589)
                      +++++.+ +..|+||||+++++|.+++...      ....+++..++.++.|++.||+|||++++   +||||||+||++
T Consensus        78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dl~p~Nil~  154 (303)
T 2vwi_A           78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL  154 (303)
T ss_dssp             EEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEE
T ss_pred             EEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCC---CCCCCChhhEEE
Confidence            9998864 5699999999999999999741      23458999999999999999999999998   999999999999


Q ss_pred             cCCCcEEEEeccCccccccCCC----CCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCC
Q 037010          419 DKNFHAKVADFGLTKLTEVGSA----SLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS  493 (589)
Q Consensus       419 ~~~~~vkl~Dfgla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~  493 (589)
                      +.++.+||+|||++........    .......||+.|+|||++.. ..++.++||||||+++|+|++|+.||.....  
T Consensus       155 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--  232 (303)
T 2vwi_A          155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP--  232 (303)
T ss_dssp             CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG--
T ss_pred             cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch--
Confidence            9999999999999875543211    11233578999999999865 5689999999999999999999999854321  


Q ss_pred             CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                        ....   ............  ....++.....+    +..+.+++.+||+.||.+|||++|+++|
T Consensus       233 --~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          233 --MKVL---MLTLQNDPPSLE--TGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             --GGHH---HHHHTSSCCCTT--C-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --hhHH---HHHhccCCCccc--cccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              1111   111111111000  001111111223    3468999999999999999999999987

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-38  Score=330.34  Aligned_cols=267  Identities=19%  Similarity=0.302  Sum_probs=179.5

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||+|.+..++. ..+.|.+..         ........+.+.+|+++|++++||||+++++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~vaiK~~~~---------~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~   95 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGL-RVAVKKLSR---------PFQSIIHAKRTYRELRLLKHMKHENVIGLLD   95 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTE-EEEEEECSS---------TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCC-EEEEEEeCc---------cccCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            345899999999999999999998766532 222221110         0112334567889999999999999999999


Q ss_pred             EEEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          349 YCVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       349 ~~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      ++..       ...|+|||++ +++|.+++..   ..+++..++.++.||+.||+|||++|+   +||||||+|||++.+
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~gi---vH~Dlkp~NIll~~~  168 (367)
T 2fst_X           96 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNED  168 (367)
T ss_dssp             EECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTT
T ss_pred             EEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCe---eeCCCCHhhEEECCC
Confidence            8753       3479999999 6799998875   349999999999999999999999999   999999999999999


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      +.+||+|||+++.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....     .....
T Consensus       169 ~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~l  239 (367)
T 2fst_X          169 CELKILDFGLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQL  239 (367)
T ss_dssp             CCEEECC-------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHH
T ss_pred             CCEEEeecccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHH
Confidence            99999999999764321    234679999999999876 678999999999999999999999995432     11222


Q ss_pred             HHHHHHhcCCChH-------HhhHhhcCC--CCCC-C---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          501 ALFEEVLNLPDPI-------EDLRKLVDP--RLGD-N---CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       501 ~~~~~~~~~~~~~-------~~l~~~~d~--~l~~-~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .........+...       ......+..  .... .   ........+.+|+.+||+.||.+|||++|+++|-
T Consensus       240 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          240 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             HHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence            2222222222110       000111100  0000 0   0012234689999999999999999999999983

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.8e-38  Score=328.99  Aligned_cols=271  Identities=25%  Similarity=0.346  Sum_probs=193.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|.+...         .........+.+|++++++++||||+++++++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~~~---------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   85 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQ-KVALKKVLME---------NEKEGFPITALREIKILQLLKHENVVNLIEIC   85 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCC-EEEEEECCCS---------SCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCC-EEEEEEEecc---------cccccchHHHHHHHHHHHhccCCCcccHhhee
Confidence            4689999999999999999999876532 2222211110         11111224567899999999999999999987


Q ss_pred             Ee---------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          351 VE---------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       351 ~~---------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      .+         +..|+||||+.+ +|.+.+..... .+++..++.++.|++.||+|||++++   +||||||+|||++.+
T Consensus        86 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i---vH~Dlkp~NIl~~~~  160 (351)
T 3mi9_A           86 RTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV-KFTLSEIKRVMQMLLNGLYYIHRNKI---LHRDMKAANVLITRD  160 (351)
T ss_dssp             EEC--------CEEEEEEECCSE-EHHHHHHCTTS-CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTT
T ss_pred             eccccccccCCceEEEEEeccCC-CHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCCe---eCCCCCHHHEEEcCC
Confidence            64         347999999986 88888776543 49999999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCC---CCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          422 FHAKVADFGLTKLTEVGS---ASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      +.+||+|||++.......   ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....     ..
T Consensus       161 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~  235 (351)
T 3mi9_A          161 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQ  235 (351)
T ss_dssp             SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HH
T ss_pred             CCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC-----hH
Confidence            999999999998654222   122344678999999998875 468999999999999999999999985432     12


Q ss_pred             hHHHHHHHHhcCCChH--Hhh-----HhhcCCCCCCCCCh-H------HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          498 GLVALFEEVLNLPDPI--EDL-----RKLVDPRLGDNCPL-D------SVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       498 ~~~~~~~~~~~~~~~~--~~l-----~~~~d~~l~~~~~~-~------~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..............+.  ...     ...+.......... +      ....+.+|+.+||+.||++|||++|+++|-
T Consensus       236 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  313 (351)
T 3mi9_A          236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  313 (351)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence            2222222222211110  000     00000000000000 0      123588999999999999999999999983

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.1e-38  Score=317.68  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=189.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|.....||+|+||.||+|.+..+.. ..+.|.+.           .......+.+.+|+.++++++||||+++++++.
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~vaiK~~~-----------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   89 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQV-RIAIKEIP-----------ERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS   89 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCC-EEEEEEEE-----------CCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCe-EEEEEEcc-----------CCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE
Confidence            445566799999999999999766532 11111110           111233456888999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-CCcEEEEe
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSG-RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-NFHAKVAD  428 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-~~~vkl~D  428 (589)
                      + +..++||||+++++|.+++.... ...+++..++.++.|++.||+|||++++   +|+||||+||+++. ++.+||+|
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dl~p~Nil~~~~~~~~kl~D  166 (295)
T 2clq_A           90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI---VHRDIKGDNVLINTYSGVLKISD  166 (295)
T ss_dssp             ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTTCCEEECC
T ss_pred             eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCE---EccCCChhhEEEECCCCCEEEee
Confidence            5 46899999999999999998653 3346788999999999999999999998   99999999999987 89999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCC--CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD--VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      ||++....... .......||+.|+|||++....  ++.++||||||+++|+|++|+.||......      ........
T Consensus       167 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~  239 (295)
T 2clq_A          167 FGTSKRLAGIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP------QAAMFKVG  239 (295)
T ss_dssp             TTTCEESCC------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH------HHHHHHHH
T ss_pred             cccccccCCCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch------hHHHHhhc
Confidence            99998654322 1223457899999999986643  789999999999999999999998542210      00111100


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                                .....+.    .+...+..+.+++.+||+.||++|||++|+++|-
T Consensus       240 ----------~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~  280 (295)
T 2clq_A          240 ----------MFKVHPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLVDE  280 (295)
T ss_dssp             ----------HHCCCCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred             ----------ccccccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence                      0111122    2333445789999999999999999999999873

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.2e-39  Score=335.73  Aligned_cols=257  Identities=9%  Similarity=0.009  Sum_probs=174.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHH---HHHHccCCCCcceeEe
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE---LKVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E---~~il~~l~hpnIv~l~  347 (589)
                      ..+|++.+.||+|+||.||+|.+..++ ...+.|.+.....        ......+.+.+|   +++|++ +||||++++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-~~vavK~~~~~~~--------~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~  130 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERL-EDFALKVFTMGAE--------NSRSELERLHEATFAAARLLG-ESPEEARDR  130 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEEECCST--------THHHHHHHHHHHHHHHHHHHC----------
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCC-ceeEEEEEEeccc--------ccccHHHHHHHHHHHHHHhcc-cChhhhhhc
Confidence            345899999999999999999987652 2222222111100        011233456667   455666 799988754


Q ss_pred             -------eEEEe------------------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHH------HHHHHHHHHHHH
Q 037010          348 -------GYCVE------------------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR------VQIALDSARGLE  396 (589)
Q Consensus       348 -------~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~qia~aL~  396 (589)
                             +++..                  ...|+||||+. |+|.+++..... .+++..+      ..++.||+.||+
T Consensus       131 ~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~  208 (371)
T 3q60_A          131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAA  208 (371)
T ss_dssp             -CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHH
Confidence                   33321                  23799999999 799999986532 2455566      778899999999


Q ss_pred             HHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccC--CCCCcccchhhHHH
Q 037010          397 YIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGV  474 (589)
Q Consensus       397 ~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGv  474 (589)
                      |||++++   +||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++|||||||
T Consensus       209 ~LH~~~i---vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          209 NLQSKGL---VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HHHHTTE---EETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HHHHCCC---ccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            9999998   99999999999999999999999999865321    113567799999999987  67999999999999


Q ss_pred             HHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 037010          475 VLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSM  554 (589)
Q Consensus       475 ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~  554 (589)
                      ++|||+||+.||..........          ...    ...................+..+.+|+.+||+.||++|||+
T Consensus       282 il~elltg~~Pf~~~~~~~~~~----------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  347 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKGS----------WKR----PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP  347 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTTC----------CCB----CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH
T ss_pred             HHHHHHhCCCCCCCcCcccccc----------hhh----hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence            9999999999996553221100          000    00000001111111122445679999999999999999999


Q ss_pred             HHHHHH
Q 037010          555 RSIVVA  560 (589)
Q Consensus       555 ~evl~~  560 (589)
                      .|+++|
T Consensus       348 ~e~l~h  353 (371)
T 3q60_A          348 LEAMET  353 (371)
T ss_dssp             HHHTTS
T ss_pred             HHHhcC
Confidence            999876

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.1e-38  Score=332.90  Aligned_cols=262  Identities=26%  Similarity=0.345  Sum_probs=189.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||+|+||.||+|.+..++.. .+.|.+.     ..          .....+|+++|++++||||+++++++
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~-vaiK~~~-----~~----------~~~~~~E~~il~~l~hpniv~l~~~~  116 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVL-----QD----------KRFKNRELQIMRKLDHCNIVRLRYFF  116 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCE-EEEEEEE-----CC----------TTSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcE-EEEEEec-----cc----------chhHHHHHHHHHHcCCCCccceeeEE
Confidence            34699999999999999999998765322 2222111     00          01123599999999999999999977


Q ss_pred             Ee-----C--cEEEEEEecCCCChHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          351 VE-----G--SLFLVYEYIENGNLSEHLRG--SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       351 ~~-----~--~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      ..     +  .+++||||+.+ +|.+.+..  .....+++..++.++.||+.||+|||++++   +||||||+|||++.+
T Consensus       117 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~NILl~~~  192 (420)
T 1j1b_A          117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPD  192 (420)
T ss_dssp             EEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE---ECSCCSGGGEEEETT
T ss_pred             eccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCc---cccCCChhhEEEeCC
Confidence            42     1  26799999986 66666543  233459999999999999999999999998   999999999999955


Q ss_pred             -CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          422 -FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       422 -~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                       +.+||+|||+++......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....    ...+
T Consensus       193 ~~~~kl~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l  266 (420)
T 1j1b_A          193 TAVLKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQL  266 (420)
T ss_dssp             TTEEEECCCTTCEECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHH
T ss_pred             CCeEEeccchhhhhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHH
Confidence             678999999998654322  22446789999999998654 799999999999999999999999954321    1122


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCC-------------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGD-------------NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~-------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ... ...+..+. .+.+... ++....             ..+...+..+.+|+.+||+.||.+|||+.|+++|-
T Consensus       267 ~~i-~~~lg~p~-~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          267 VEI-IKVLGTPT-REQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             HHH-HHHHCSCC-HHHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHH-HHHhCCCC-HHHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence            222 22222222 1222221 111110             01223345789999999999999999999999883

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.2e-38  Score=324.51  Aligned_cols=273  Identities=25%  Similarity=0.356  Sum_probs=196.4

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC---CCCcce
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV---HHLNLV  344 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l---~hpnIv  344 (589)
                      ....++|++.+.||+|+||.||+|.+....+...+.|.+.....         .......+.+|+++++++   +||||+
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~~~e~~~l~~l~~~~h~~i~   77 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---------EEGMPLSTIREVAVLRHLETFEHPNVV   77 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC---------TTSCBCTHHHHHHHHHHHHHTCCTTBC
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcc---------cccCCchhhHHHHHHHhhhccCCCCeE
Confidence            34568899999999999999999998644343333332211100         000111344566666555   899999


Q ss_pred             eEeeEEE------eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE
Q 037010          345 RLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI  418 (589)
Q Consensus       345 ~l~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl  418 (589)
                      ++++++.      +...++||||+. |+|.+++.......+++..++.++.|++.||+|||++|+   +||||||+|||+
T Consensus        78 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi---~H~dlkp~Nili  153 (326)
T 1blx_A           78 RLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILV  153 (326)
T ss_dssp             CEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEE
T ss_pred             eeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCc---eeccCCHHHeEE
Confidence            9999875      235899999998 599999988766669999999999999999999999998   999999999999


Q ss_pred             cCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhh
Q 037010          419 DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG  498 (589)
Q Consensus       419 ~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~  498 (589)
                      +.++.+||+|||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     ..
T Consensus       154 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~  226 (326)
T 1blx_A          154 TSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VD  226 (326)
T ss_dssp             CTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH
T ss_pred             cCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----HH
Confidence            999999999999997654221  22346789999999999988999999999999999999999999854321     11


Q ss_pred             HHHHHHHHhcCCChHHhhH------hhcCC---CCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          499 LVALFEEVLNLPDPIEDLR------KLVDP---RLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~------~~~d~---~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...........+.......      .....   ........+.+..+.+|+.+||+.||.+|||++|+++|
T Consensus       227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1111112122111110000      00000   00011223345578999999999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-38  Score=321.80  Aligned_cols=254  Identities=20%  Similarity=0.363  Sum_probs=190.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+..           ......+.+.+|++++++++||||++++++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~-~~aiK~~~~-----------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   84 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGA-LAAAKVIET-----------KSEEELEDYIVEIEILATCDHPYIVKLLGA   84 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCC-EEEEEEEC---------------CCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCc-EEEEEEecC-----------CCHHHHHHHHHHHHHHhcCCCCCEeeeeee
Confidence            45789999999999999999999875422 222221110           011224568889999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||+++++|.+++.... ..+++..++.++.|++.||.|||++++   +||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~~kl~D  160 (302)
T 2j7t_A           85 YYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLAD  160 (302)
T ss_dssp             EECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEECTTSCEEECC
T ss_pred             eeeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCc---ccCCCCHHHEEECCCCCEEEEE
Confidence            864 56899999999999999987643 348999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcc-----cCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYA-----QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      ||++....... .......||+.|+|||++     ....++.++||||||+++|+|++|+.||.....        ....
T Consensus       161 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~  231 (302)
T 2j7t_A          161 FGVSAKNLKTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVL  231 (302)
T ss_dssp             CHHHHHHHHHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH
T ss_pred             CCCCccccccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH--------HHHH
Confidence            99875432111 112335789999999988     466789999999999999999999999843221        1111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .......          .+.  ...+...+..+.+++.+||+.||.+|||++|+++|
T Consensus       232 ~~~~~~~----------~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          232 LKIAKSD----------PPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             HHHHHSC----------CCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             HHHhccC----------Ccc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1111110          000  11233445578999999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=329.44  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=190.9

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ....++|++.+.||+|+||.||+|.+.+.    .+.|.+...         .......+.+.+|++++++++||||++++
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~----~avk~~~~~---------~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   95 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWHGE----VAIRLIDIE---------RDNEDQLKAFKREVMAYRQTRHENVVLFM   95 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEESSS----EEEEECCCC---------SCCCCCCCCCCTTGGGGTTCCCTTBCCCC
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEcCe----EEEEEeecC---------CCCHHHHHHHHHHHHHHhcCCCCCEeEEE
Confidence            33468899999999999999999987542    222211110         01111123456799999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||++ ++.+||
T Consensus        96 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i---~H~dlkp~NIl~~-~~~~~l  170 (319)
T 2y4i_B           96 GACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGI---LHKDLKSKNVFYD-NGKVVI  170 (319)
T ss_dssp             EEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSTTEEEC---CCEE
T ss_pred             EEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCc---cccCCChhhEEEe-CCCEEE
Confidence            98875 46899999999999999997654 358999999999999999999999998   9999999999998 679999


Q ss_pred             EeccCccccccCC----CCCCcccccCCCCCchhcccC---------CCCCcccchhhHHHHHHHHHcCCcccccCCCCC
Q 037010          427 ADFGLTKLTEVGS----ASLPTRLVGTFGYMPPEYAQY---------GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS  493 (589)
Q Consensus       427 ~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~  493 (589)
                      +|||++.......    ........||+.|+|||.+..         ..++.++|||||||++|||++|+.||.....  
T Consensus       171 ~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--  248 (319)
T 2y4i_B          171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--  248 (319)
T ss_dssp             CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--
T ss_pred             eecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence            9999987543211    112233568999999999864         4578899999999999999999999843221  


Q ss_pred             CChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccc
Q 037010          494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED  570 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~  570 (589)
                         .   .....+..          ...+...   +...+..+.+++.+||..||.+|||++++++.|+.+......
T Consensus       249 ---~---~~~~~~~~----------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          249 ---E---AIIWQMGT----------GMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             ---H---HHHHHHHT----------TCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             ---H---HHHHHhcc----------CCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence               1   11111111          1111111   112233589999999999999999999999999998876554

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.2e-38  Score=322.86  Aligned_cols=261  Identities=24%  Similarity=0.395  Sum_probs=192.6

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC--CC
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH--HL  341 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~--hp  341 (589)
                      +..+....++|++.+.||+|+||.||++.+..  +...+.|.+..         +.......+.+.+|++++++++  ||
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~---------~~~~~~~~~~~~~E~~~l~~l~~~~~   88 (313)
T 3cek_A           20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNL---------EEADNQTLDSYRNEIAYLNKLQQHSD   88 (313)
T ss_dssp             CCEEEETTEEEEEEEEEECCSSEEEEEEECTT--CCEEEEEEEEC---------SSCCHHHHHHHHHHHHHHHHHGGGCT
T ss_pred             eeeeeeccceEEEEEEecCCCCEEEEEEEcCC--CcEEEEEEecc---------ccccccchHHHHHHHHHHHhccccCC
Confidence            33444556789999999999999999998653  23233222211         1223445567889999999997  59


Q ss_pred             cceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          342 NLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       342 nIv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ||+++++++.+ +..|+||| +.+++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||+++
T Consensus        89 ~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~dlkp~NIl~~~  162 (313)
T 3cek_A           89 KIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGI---VHSDLKPANFLIVD  162 (313)
T ss_dssp             TBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEEET
T ss_pred             ceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCc---eecCCCcccEEEEC
Confidence            99999998875 45889999 56789999998754  48999999999999999999999998   99999999999964


Q ss_pred             CCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccC-----------CCCCcccchhhHHHHHHHHHcCCccccc
Q 037010          421 NFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQY-----------GDVSPKVDVYAFGVVLYELISAKEAIVK  488 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~sDvwSlGvll~elltG~~p~~~  488 (589)
                       +.+||+|||++......... ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||..
T Consensus       163 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          163 -GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             -TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             -CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence             89999999999865433221 2234578999999999865           4788899999999999999999999843


Q ss_pred             CCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       489 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ...      . .             ..+...+++......+...+..+.+++.+||+.||.+|||++|+++|-.
T Consensus       242 ~~~------~-~-------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  295 (313)
T 3cek_A          242 IIN------Q-I-------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  295 (313)
T ss_dssp             CCS------H-H-------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             HHH------H-H-------------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence            221      0 1             1112222222222233333457899999999999999999999999853

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=4.8e-38  Score=328.19  Aligned_cols=267  Identities=21%  Similarity=0.283  Sum_probs=196.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCC---------
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVH---------  339 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~---------  339 (589)
                      .++|++.+.||+|+||.||+|.+..++.               .+++|.+.  ....+.+.+|++++++++         
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---------------~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~   82 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNT---------------HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS   82 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTE---------------EEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHH
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCc---------------EEEEEEecCCccchhhhhHHHHHHHHhhcccccchhc
Confidence            4689999999999999999998765422               22233222  223456778888888875         


Q ss_pred             --CCcceeEeeEEEeC-----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeecc
Q 037010          340 --HLNLVRLIGYCVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDI  411 (589)
Q Consensus       340 --hpnIv~l~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dl  411 (589)
                        ||||+++++++...     ..++|||++ +++|.+++.......+++..++.++.||+.||+|||++ ++   +||||
T Consensus        83 ~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~i---vH~Di  158 (373)
T 1q8y_A           83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI---IHTDI  158 (373)
T ss_dssp             HHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE---ECSCC
T ss_pred             cccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCE---EecCC
Confidence              89999999987632     588999999 88999999886666799999999999999999999998 98   99999


Q ss_pred             CCCcEEEc------CCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcc
Q 037010          412 KSANILID------KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEA  485 (589)
Q Consensus       412 kp~NILl~------~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p  485 (589)
                      ||+|||++      ..+.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus       159 kp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  234 (373)
T 1q8y_A          159 KPENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL  234 (373)
T ss_dssp             SGGGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             ChHHeEEeccCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            99999994      3448999999999865422    2345789999999999998999999999999999999999999


Q ss_pred             cccCCCCCCC-hhhHHHHHHHHhcCCChHHhh------HhhcCCC-------------------CCCCCChHHHHHHHHH
Q 037010          486 IVKGNGSSAD-SKGLVALFEEVLNLPDPIEDL------RKLVDPR-------------------LGDNCPLDSVLKMAQL  539 (589)
Q Consensus       486 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l------~~~~d~~-------------------l~~~~~~~~~~~l~~l  539 (589)
                      |......... ................. ..+      .......                   -....+...+..+.+|
T Consensus       235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  313 (373)
T 1q8y_A          235 FEPDEGHSYTKDDDHIAQIIELLGELPS-YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF  313 (373)
T ss_dssp             C---------CHHHHHHHHHHHHCSCCH-HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred             CCCCcccccCChHHHHHHHHHhcCCCCH-HHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHH
Confidence            9654432211 11111122222221111 000      0000000                   0113456778899999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHH
Q 037010          540 AKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       540 i~~cl~~dP~~RPs~~evl~~L  561 (589)
                      +.+||+.||.+|||++|+++|-
T Consensus       314 i~~~L~~dP~~Rpt~~ell~hp  335 (373)
T 1q8y_A          314 LSPMLQLDPRKRADAGGLVNHP  335 (373)
T ss_dssp             HGGGGCSSTTTCBCHHHHHTCG
T ss_pred             HHHHhccCccccCCHHHHhhCh
Confidence            9999999999999999999984

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=333.18  Aligned_cols=274  Identities=22%  Similarity=0.331  Sum_probs=179.2

Q ss_pred             cCCCcc-ceeeccCCcEEEEEEEEcccc-CCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          271 TDNFSM-SHKIGQGGFGAVYYAELRGEY-GNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       271 ~~~y~~-~~~LG~G~~g~Vy~~~~~~~~-~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      .+.|++ +++||+|+||.||+|.+.... +..++.|              .+.. .....+.+|+++|++++||||++++
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK--------------~~~~~~~~~~~~~E~~~l~~l~hpniv~~~   84 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK--------------QIEGTGISMSACREIALLRELKHPNVISLQ   84 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEE--------------ECSSSSCCHHHHHHHHHHHHCCCTTBCCCC
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEE--------------EECCCCCCHHHHHHHHHHHhcCCCCeeeEe
Confidence            345666 568999999999999976432 2222222              2211 1123567899999999999999999


Q ss_pred             eEEEe---CcEEEEEEecCCCChHHHHhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          348 GYCVE---GSLFLVYEYIENGNLSEHLRGS-------GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       348 ~~~~~---~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      +++.+   ...|+||||+.+ +|.+++...       ....+++..++.++.||+.||+|||++++   +||||||+|||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~i---vH~Dlkp~NIl  160 (405)
T 3rgf_A           85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWV---LHRDLKPANIL  160 (405)
T ss_dssp             EEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEE
T ss_pred             eEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCE---eCCCcCHHHeE
Confidence            98853   458999999975 888887532       12248999999999999999999999998   99999999999


Q ss_pred             E----cCCCcEEEEeccCccccccCCC--CCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          418 I----DKNFHAKVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       418 l----~~~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      +    +.++.+||+|||+++.......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       161 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          161 VMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             ECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             EecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            9    6778999999999986543211  22234679999999999876 458999999999999999999999996543


Q ss_pred             CCCC----ChhhHHHHHHHHhcCCChH--Hhh---------HhhcCCCCCCCCC---------hHHHHHHHHHHHHhccc
Q 037010          491 GSSA----DSKGLVALFEEVLNLPDPI--EDL---------RKLVDPRLGDNCP---------LDSVLKMAQLAKVCTQE  546 (589)
Q Consensus       491 ~~~~----~~~~~~~~~~~~~~~~~~~--~~l---------~~~~d~~l~~~~~---------~~~~~~l~~li~~cl~~  546 (589)
                      ....    ............+..+...  ..+         ...........+.         ......+.+|+.+||+.
T Consensus       241 ~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~  320 (405)
T 3rgf_A          241 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM  320 (405)
T ss_dssp             ------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCS
T ss_pred             ccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccC
Confidence            3211    1111122222222222110  000         0000000000000         00133688999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 037010          547 YPQLRPSMRSIVVALM  562 (589)
Q Consensus       547 dP~~RPs~~evl~~L~  562 (589)
                      ||.+|||++|+++|-.
T Consensus       321 dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          321 DPIKRITSEQAMQDPY  336 (405)
T ss_dssp             SGGGSCCHHHHHTSGG
T ss_pred             CcccCCCHHHHhcChh
Confidence            9999999999999954

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.5e-38  Score=331.15  Aligned_cols=266  Identities=23%  Similarity=0.329  Sum_probs=189.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      ..+|++.+.||+|+||.||+|.+..+.. ..+.+...      .   +       ....+|+++++.++||||+++++++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~------~---~-------~~~~~E~~il~~l~h~niv~l~~~~  101 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQ------D---K-------RFKNRELQIMRIVKHPNVVDLKAFF  101 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEEC------C---T-------TSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEec------C---c-------chHHHHHHHHHhCCCCCcceEEEEE
Confidence            4679999999999999999998765422 22221110      0   0       1122599999999999999999987


Q ss_pred             Ee-Cc------EEEEEEecCCCChHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc-C
Q 037010          351 VE-GS------LFLVYEYIENGNLSEHLRG--SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID-K  420 (589)
Q Consensus       351 ~~-~~------~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~-~  420 (589)
                      .. +.      +++||||+.++ +.+.+..  .....+++..++.++.||+.||+|||++++   +||||||+|||++ .
T Consensus       102 ~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i---vHrDlkp~Nill~~~  177 (394)
T 4e7w_A          102 YSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGI---CHRDIKPQNLLLDPP  177 (394)
T ss_dssp             EEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEETT
T ss_pred             EecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc---cCCCCCHHHEEEcCC
Confidence            52 21      78999999875 4443321  123459999999999999999999999998   9999999999999 7


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      ++.+||+|||+++......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....     ...
T Consensus       178 ~~~~kL~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~  250 (394)
T 4e7w_A          178 SGVLKLIDFGSAKILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG-----IDQ  250 (394)
T ss_dssp             TTEEEECCCTTCEECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH
T ss_pred             CCcEEEeeCCCcccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHH
Confidence            9999999999998654322  23446789999999998654 589999999999999999999999954321     111


Q ss_pred             HHHHHHHhcCCChHHhhHhh----cCCCCCC--------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhcc
Q 037010          500 VALFEEVLNLPDPIEDLRKL----VDPRLGD--------NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTLS  565 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~----~d~~l~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l~  565 (589)
                      ..........+.. +.+...    ....+..        ..+...+..+.+|+.+||+.||.+|||+.|+++|  +..+.
T Consensus       251 l~~i~~~~g~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          251 LVEIIKVLGTPSR-EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             HHHHHHHHCCCCH-HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             HHHHHHHhCCCCH-HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence            2222222222221 111111    1111110        0112234579999999999999999999999998  44443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.7e-37  Score=319.84  Aligned_cols=265  Identities=20%  Similarity=0.284  Sum_probs=197.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCc------c
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLN------L  343 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpn------I  343 (589)
                      ..++|++.+.||+|+||.||+|.+..+++...+.|.+.            ......+.+.+|++++++++|++      +
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~------------~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~   84 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR------------NVGKYREAARLEINVLKKIKEKDKENKFLC   84 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEC------------SCHHHHHHHHHHHHHHHHHHHHCTTSCSCB
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEc------------ccccchhHHHHHHHHHHHHhhcCCCCceeE
Confidence            45789999999999999999999876543333322211            11233456778899988887655      8


Q ss_pred             eeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE----
Q 037010          344 VRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI----  418 (589)
Q Consensus       344 v~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl----  418 (589)
                      +.+++++. ++..++||||+ +++|.+++......++++..++.++.||+.||+|||++++   +||||||+|||+    
T Consensus        85 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i---vH~Dlkp~NIll~~~~  160 (355)
T 2eu9_A           85 VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQL---THTDLKPENILFVNSE  160 (355)
T ss_dssp             CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEESCCC
T ss_pred             EEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEEEeccc
Confidence            88888776 45689999999 6688888877765679999999999999999999999998   999999999999    


Q ss_pred             ---------------cCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCC
Q 037010          419 ---------------DKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK  483 (589)
Q Consensus       419 ---------------~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~  483 (589)
                                     +.++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  236 (355)
T 2eu9_A          161 FETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF  236 (355)
T ss_dssp             EEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCC
Confidence                           56789999999999764322    23467999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCChhhHHHHHHHHhcCCChHHhhHh--------------------------hcCCCC-CCCCChHHHHHH
Q 037010          484 EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRK--------------------------LVDPRL-GDNCPLDSVLKM  536 (589)
Q Consensus       484 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~--------------------------~~d~~l-~~~~~~~~~~~l  536 (589)
                      .||....     ................ ...+..                          ...+.. ...........+
T Consensus       237 ~pf~~~~-----~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  310 (355)
T 2eu9_A          237 TLFQTHE-----NREHLVMMEKILGPIP-SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQL  310 (355)
T ss_dssp             CSCCCSS-----HHHHHHHHHHHHCCCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHH
T ss_pred             CCCCCCC-----HHHHHHHHHHHcCCCc-HHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHH
Confidence            9995432     1222222222222111 111000                          000000 001123446689


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHH
Q 037010          537 AQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       537 ~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+|+.+||+.||.+|||++|+++|
T Consensus       311 ~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          311 FDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHhcCChhhCcCHHHHhcC
Confidence            999999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.2e-38  Score=325.52  Aligned_cols=269  Identities=20%  Similarity=0.277  Sum_probs=194.1

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+.          +.........+.+|++++++++||||++++++
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~----------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   77 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGE-IVAIKKIE----------PFDKPLFALRTLREIKILKHFKHENIITIFNI   77 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTE-EEEEEEEC----------CCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCc-EEEEEeec----------ccccchHHHHHHHHHHHHHhCcCCCcCCeeee
Confidence            45789999999999999999998875422 22221110          01123345567889999999999999999998


Q ss_pred             EEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          350 CVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       350 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      +..      ...|+||||+.+ +|.+++...   .+++..++.++.|++.||+|||++++   +||||||+|||++.++.
T Consensus        78 ~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~i---vH~Dlkp~Nil~~~~~~  150 (353)
T 2b9h_A           78 QRPDSFENFNEVYIIQELMQT-DLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNV---IHRDLKPSNLLINSNCD  150 (353)
T ss_dssp             CCCSCSTTCCCEEEEECCCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECTTCC
T ss_pred             ecccccCccceEEEEEeccCc-cHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCe---ecCCCCHHHeEEcCCCc
Confidence            753      458999999974 999998763   48999999999999999999999998   99999999999999999


Q ss_pred             EEEEeccCccccccCCCC---------CCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCC
Q 037010          424 AKVADFGLTKLTEVGSAS---------LPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSS  493 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~  493 (589)
                      +||+|||++.........         ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||....   
T Consensus       151 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---  227 (353)
T 2b9h_A          151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD---  227 (353)
T ss_dssp             EEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---
T ss_pred             EEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC---
Confidence            999999999865432111         1123578999999998754 678999999999999999999999995432   


Q ss_pred             CChhhHHHHHHHHhcCCChHH--------hhHhhcCC--CCCC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 037010          494 ADSKGLVALFEEVLNLPDPIE--------DLRKLVDP--RLGD----NCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV  559 (589)
Q Consensus       494 ~~~~~~~~~~~~~~~~~~~~~--------~l~~~~d~--~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~  559 (589)
                        ..............+....        .....+..  ....    ......+..+.+|+.+||+.||.+|||++|+++
T Consensus       228 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          228 --YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             --HHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --cHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence              1111111222222111000        00010000  0000    001233457899999999999999999999999


Q ss_pred             HH
Q 037010          560 AL  561 (589)
Q Consensus       560 ~L  561 (589)
                      |-
T Consensus       306 hp  307 (353)
T 2b9h_A          306 HP  307 (353)
T ss_dssp             SG
T ss_pred             Cc
Confidence            83

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.9e-38  Score=325.51  Aligned_cols=256  Identities=18%  Similarity=0.239  Sum_probs=168.3

Q ss_pred             hcCCCccce-eeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          270 ATDNFSMSH-KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ..++|.+.+ .||+|+||.||+|.+..++. ..+              +|.+.... ....+....++.++||||+++++
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~-~va--------------vK~~~~~~-~~~~e~~~~~~~~~h~~i~~~~~   89 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQ-KCA--------------LKLLYDSP-KARQEVDHHWQASGGPHIVCILD   89 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCC-EEE--------------EEEEESSH-HHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCC-EEE--------------EEEecCcH-HHHHHHHHHHHhcCCCChHHHHH
Confidence            457888855 69999999999999876532 222              22221110 11111223356678999999999


Q ss_pred             EEEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC---
Q 037010          349 YCVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---  420 (589)
Q Consensus       349 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~---  420 (589)
                      ++..     ...++||||+++|+|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.   
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~i---vH~dlkp~NIll~~~~~  166 (336)
T 3fhr_A           90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI---AHRDVKPENLLYTSKEK  166 (336)
T ss_dssp             EEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEESCSST
T ss_pred             HHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCCCCHHHEEEEecCC
Confidence            8753     237899999999999999998776679999999999999999999999998   99999999999976   


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      ++.+||+|||++......   ......||+.|+|||++....++.++|||||||++|+|++|+.||..............
T Consensus       167 ~~~~kl~Dfg~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (336)
T 3fhr_A          167 DAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR  243 (336)
T ss_dssp             TCCEEECCCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred             CceEEEeccccceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH
Confidence            455999999999755322   22345789999999999888999999999999999999999999954433211000000


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      ...               ..............+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       244 ~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          244 RIR---------------LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             ----------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             hhh---------------ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            000               00001111111234457899999999999999999999999854

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.6e-38  Score=337.57  Aligned_cols=263  Identities=20%  Similarity=0.250  Sum_probs=194.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCc-ceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLN-LVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~  348 (589)
                      ..++|++.++||+|+||.||+|.+..+.. .++.|.+..             .....++.+|+++++.++|++ +..+..
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-~vAvK~~~~-------------~~~~~~~~~E~~il~~L~~~~~i~~i~~   70 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE-EVAIKLENV-------------KTKHPQLLYESKIYRILQGGTGIPNVRW   70 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCC-EEEEEEEET-------------TCSSCCHHHHHHHHHHTTTSTTCCCEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCc-EEEEEEecc-------------ccccHHHHHHHHHHHHhcCCCCCCeEEE
Confidence            35789999999999999999999765532 222221110             011124677999999998754 444444


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEE---cCCCcE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHA  424 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl---~~~~~v  424 (589)
                      ++.+ +..++||||+ +++|.+++..... .+++..++.++.||+.||+|||++++   +||||||+|||+   +.++.+
T Consensus        71 ~~~~~~~~~lvme~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~gI---vHrDIKP~NILl~~~~~~~~v  145 (483)
T 3sv0_A           71 FGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF---LHRDIKPDNFLMGLGRRANQV  145 (483)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECCGGGTTCE
T ss_pred             EEeeCCEEEEEEECC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCE---eecccCcceEEEecCCCCCeE
Confidence            5544 4578999999 8899999985433 49999999999999999999999998   999999999999   688999


Q ss_pred             EEEeccCccccccCCCC------CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhh
Q 037010          425 KVADFGLTKLTEVGSAS------LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKG  498 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~  498 (589)
                      ||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus       146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~  224 (483)
T 3sv0_A          146 YIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQK  224 (483)
T ss_dssp             EECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-HHH
T ss_pred             EEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-HHH
Confidence            99999999865543221      12246799999999999999999999999999999999999999965332111 111


Q ss_pred             HHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          499 LVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       499 ~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      +.........  ...+.+.        ..+    +..+.+|+..||+.+|++||++++|++.|..+..
T Consensus       225 ~~~i~~~~~~--~~~~~l~--------~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          225 YEKISEKKVA--TSIEALC--------RGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             HHHHHHHHHH--SCHHHHH--------TTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHhhcccc--ccHHHHh--------cCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            1111111110  0001110        122    3468999999999999999999999999988754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=317.38  Aligned_cols=268  Identities=22%  Similarity=0.313  Sum_probs=187.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+           +.......+++.+|++++++++||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~-----------~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   76 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDK-RVAIKKI-----------VLTDPQSVKHALREIKIIRRLDHDNIVKVFEI   76 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTE-EEEEEEE-----------ECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCe-EEEEEEE-----------ecCChHHHHHHHHHHHHHHhcCCCCeeEEEEe
Confidence            45789999999999999999999876422 2221111           11133455678899999999999999999987


Q ss_pred             EE---------------eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCC
Q 037010          350 CV---------------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSA  414 (589)
Q Consensus       350 ~~---------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~  414 (589)
                      +.               .+..|+||||+. |+|.+++...   ++++..++.++.|++.||+|||++++   +||||||+
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~  149 (320)
T 2i6l_A           77 LGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANV---LHRDLKPA  149 (320)
T ss_dssp             ECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSGG
T ss_pred             ccccccccccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCE---ecCCCCHH
Confidence            63               245899999998 5999998653   48999999999999999999999998   99999999


Q ss_pred             cEEEc-CCCcEEEEeccCccccccCCC--CCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          415 NILID-KNFHAKVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       415 NILl~-~~~~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      |||++ +++.+||+|||++........  .......+|+.|+|||.+.. ..++.++|||||||++|||++|+.||....
T Consensus       150 Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          150 NLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             GEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            99997 567999999999986542211  12233567999999998754 678999999999999999999999995432


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcC------------CCCC-CCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVD------------PRLG-DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI  557 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d------------~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  557 (589)
                      .    .......... ..... .+...+...            +... .......+..+.+|+.+||+.||.+|||++|+
T Consensus       230 ~----~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  303 (320)
T 2i6l_A          230 E----LEQMQLILES-IPVVH-EEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA  303 (320)
T ss_dssp             H----HHHHHHHHHH-SCCCC-HHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             H----HHHHHHHHHh-cCCCc-hhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence            1    1111111111 11110 011111000            0000 00112234578999999999999999999999


Q ss_pred             HHHHH
Q 037010          558 VVALM  562 (589)
Q Consensus       558 l~~L~  562 (589)
                      ++|-.
T Consensus       304 l~hp~  308 (320)
T 2i6l_A          304 LSHPY  308 (320)
T ss_dssp             HTSHH
T ss_pred             hCCcc
Confidence            99843

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=4.3e-37  Score=322.46  Aligned_cols=269  Identities=22%  Similarity=0.252  Sum_probs=195.6

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCC-CC
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVH-HL  341 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~-hp  341 (589)
                      .......++|++.+.||+|+||.||+|.+..++.               .+++|.+.  .....++..|+++++.++ |+
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~---------------~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~  111 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQE---------------WVAIKIIKNKKAFLNQAQIEVRLLELMNKHD  111 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTE---------------EEEEEEECSSHHHHHHHHHHHHHHHHHHHCS
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCc---------------EEEEEEEeccHHHHHHHHHHHHHHHHHHhcc
Confidence            3444567899999999999999999998765421               22233222  223455667888887774 44


Q ss_pred             -----cceeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh--CCCCceEeeccCC
Q 037010          342 -----NLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE--HTVPVYIHRDIKS  413 (589)
Q Consensus       342 -----nIv~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~--~~i~~~vH~Dlkp  413 (589)
                           +|+++++++. ++..|+||||+.+ +|.+++.......+++..++.++.|++.||.|||.  .++   +||||||
T Consensus       112 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~i---vHrDlkp  187 (382)
T 2vx3_A          112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSI---IHCDLKP  187 (382)
T ss_dssp             SGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCE---ECCCCSG
T ss_pred             cccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCE---EcCCCCc
Confidence                 4899998776 4568999999965 99999988765669999999999999999999995  566   9999999


Q ss_pred             CcEEEc--CCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCC
Q 037010          414 ANILID--KNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~--~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~  491 (589)
                      +|||++  .++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       188 ~NIll~~~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          188 ENILLCNPKRSAIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             GGEEESSTTSCCEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ccEEEecCCCCcEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999994  5778999999999865322    2346789999999999999999999999999999999999999954321


Q ss_pred             CCCChhhHHHHHHHHhcCCChHH-----hhHhhcCCCC-----------------------------------------C
Q 037010          492 SSADSKGLVALFEEVLNLPDPIE-----DLRKLVDPRL-----------------------------------------G  525 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~-----~l~~~~d~~l-----------------------------------------~  525 (589)
                           .............+....     .....++...                                         .
T Consensus       264 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  338 (382)
T 2vx3_A          264 -----VDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGE  338 (382)
T ss_dssp             -----HHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTC
T ss_pred             -----HHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcccccc
Confidence                 122222222222111100     0000000000                                         0


Q ss_pred             CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          526 DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       526 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ..........+.+|+.+||+.||++|||++|+++|-
T Consensus       339 ~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp  374 (382)
T 2vx3_A          339 SGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHS  374 (382)
T ss_dssp             TTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred             ccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCc
Confidence            011223445789999999999999999999999873

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.8e-37  Score=321.57  Aligned_cols=265  Identities=18%  Similarity=0.265  Sum_probs=191.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|.+.+.||+|+||.||+|.+..++. ..+.|.+..         ........+.+.+|++++++++||||++++++
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~vaiK~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  109 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGE-KVAIKKLSR---------PFQSEIFAKRAYRELLLLKHMQHENVIGLLDV  109 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTE-EEEEEEECS---------TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCC-EEEEEEecc---------cccchhHHHHHHHHHHHHHhcCCCCchhhhhh
Confidence            45789999999999999999998876532 222221110         01123345678899999999999999999998


Q ss_pred             EEeCc-------EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVEGS-------LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~~~-------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +....       .|+||||+. ++|.+++..    .+++..++.++.|++.||+|||++++   +||||||+|||++.++
T Consensus       110 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~i---vH~Dikp~NIll~~~~  181 (371)
T 4exu_A          110 FTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNLAVNEDC  181 (371)
T ss_dssp             ECSCSSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTC
T ss_pred             eeccCCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCC---cCCCcCHHHeEECCCC
Confidence            86432       399999998 488888743    38999999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      .+||+|||++......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....     ......
T Consensus       182 ~~kL~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~  252 (371)
T 4exu_A          182 ELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLT  252 (371)
T ss_dssp             CEEECSTTCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHH
T ss_pred             CEEEEecCcccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHH
Confidence            9999999999854322    234678999999999876 688999999999999999999999995432     111111


Q ss_pred             HHHHHhcCCChH----------HhhHhhcCCCCCCC---CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          502 LFEEVLNLPDPI----------EDLRKLVDPRLGDN---CPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       502 ~~~~~~~~~~~~----------~~l~~~~d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ........+...          ......+.......   .....+..+.+|+.+||+.||.+|||++|+++|-
T Consensus       253 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  325 (371)
T 4exu_A          253 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  325 (371)
T ss_dssp             HHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence            111111111110          00111111110000   1122345789999999999999999999999983

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.2e-37  Score=321.69  Aligned_cols=269  Identities=23%  Similarity=0.308  Sum_probs=183.5

Q ss_pred             HHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCccee
Q 037010          266 ELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVR  345 (589)
Q Consensus       266 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~  345 (589)
                      ......++|++.+.||+|+||.||+|.+..++. ..+.|.+..            .......+.+|++.+..++||||++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~------------~~~~~~~~~~~~~~l~~l~h~niv~   83 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGM-SVAIKKVIQ------------DPRFRNRELQIMQDLAVLHHPNIVQ   83 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCC-EEEEEEEEC------------CTTCCCHHHHHHHHHHHHCCTTBCC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCC-EEEEEEEec------------CccccHHHHHHHHHHHhcCCCCccc
Confidence            345667899999999999999999999876532 222221110            0111124556788888889999999


Q ss_pred             EeeEEEe-Cc-------EEEEEEecCCCChHHHHhc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEeeccCC
Q 037010          346 LIGYCVE-GS-------LFLVYEYIENGNLSEHLRG--SGRDPLPWSSRVQIALDSARGLEYIH--EHTVPVYIHRDIKS  413 (589)
Q Consensus       346 l~~~~~~-~~-------~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~qia~aL~~LH--~~~i~~~vH~Dlkp  413 (589)
                      +++++.. +.       .++||||+.+ +|.+.+..  .....+++..++.++.|++.||.|||  ++++   +||||||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~i---vH~Dlkp  159 (360)
T 3e3p_A           84 LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV---CHRDIKP  159 (360)
T ss_dssp             EEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCC---BCSCCCG
T ss_pred             HHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCe---ecCcCCH
Confidence            9998753 21       7899999987 55554432  23345889999999999999999999  9998   9999999


Q ss_pred             CcEEEcC-CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCC
Q 037010          414 ANILIDK-NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~~-~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~  491 (589)
                      +|||++. ++.+||+|||++.......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.... 
T Consensus       160 ~NIll~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-  236 (360)
T 3e3p_A          160 HNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-  236 (360)
T ss_dssp             GGEEEETTTTEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred             HHEEEeCCCCcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-
Confidence            9999996 8999999999998654322  22346789999999998654 48999999999999999999999995432 


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCC----------------CCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLG----------------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMR  555 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~----------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~  555 (589)
                          ..............+.. +.+ ..+++...                ...+...+..+.+|+.+||+.||.+|||+.
T Consensus       237 ----~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  310 (360)
T 3e3p_A          237 ----SAGQLHEIVRVLGCPSR-EVL-RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY  310 (360)
T ss_dssp             ----HHHHHHHHHHHHCCCCH-HHH-HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             ----hHHHHHHHHHHcCCCCH-HHH-HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHH
Confidence                12222222222222211 111 11111100                111223466899999999999999999999


Q ss_pred             HHHHH
Q 037010          556 SIVVA  560 (589)
Q Consensus       556 evl~~  560 (589)
                      |+++|
T Consensus       311 e~l~h  315 (360)
T 3e3p_A          311 EALCH  315 (360)
T ss_dssp             HHTTS
T ss_pred             HHhcC
Confidence            99998

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.8e-37  Score=318.22  Aligned_cols=258  Identities=22%  Similarity=0.363  Sum_probs=172.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHH-HHccCCCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELK-VLTHVHHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~-il~~l~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|.+.          +........++..|+. +++.++||||++++++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~vaiK~~~----------~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~   89 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQ-IMAVKRIR----------STVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA   89 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTE-EEEEEEEE----------CCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCC-EEEEEEee----------cccCchHHHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence            4789999999999999999999865422 22222111          0112233345555666 7788899999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRG---SGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      +.+ +..|+||||+.+ +|.+++..   .....+++..+..++.|++.||.|||++ ++   +||||||+|||++.++.+
T Consensus        90 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i---vH~dlkp~NIll~~~~~~  165 (327)
T 3aln_A           90 LFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI---IHRDIKPSNILLDRSGNI  165 (327)
T ss_dssp             EECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSC---CCSCCCGGGEEEETTTEE
T ss_pred             EEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCE---eECCCCHHHEEEcCCCCE
Confidence            874 568999999986 88887763   2244589999999999999999999999 98   999999999999999999


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcc----cCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA----QYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      ||+|||++.......  ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||......        
T Consensus       166 kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------  235 (327)
T 3aln_A          166 KLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--------  235 (327)
T ss_dssp             EECCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------
T ss_pred             EEccCCCceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--------
Confidence            999999997654322  22334789999999998    4567899999999999999999999998542210        


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                        ......       ......+.+........+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       236 --~~~~~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  288 (327)
T 3aln_A          236 --FDQLTQ-------VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPF  288 (327)
T ss_dssp             ------CC-------CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             --HHHHHH-------HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChH
Confidence              000000       00001111111112234457999999999999999999999998743

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.9e-37  Score=319.26  Aligned_cols=265  Identities=18%  Similarity=0.258  Sum_probs=191.7

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|.+.+.||+|+||.||+|.+..++. ..+.|.+..         ........+.+.+|+.++++++||||++++++
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~~---------~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   91 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGE-KVAIKKLSR---------PFQSEIFAKRAYRELLLLKHMQHENVIGLLDV   91 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTE-EEEEEEESS---------TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCC-EEEEEEecc---------cccchHHHHHHHHHHHHHHhcCCCCcccHhhe
Confidence            35789999999999999999998866532 222221110         01123345678899999999999999999998


Q ss_pred             EEeC-------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVEG-------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~~-------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +.+.       ..|+||||+.+ +|.+++..    .+++..++.++.|++.||+|||++++   +||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~i---vH~dlkp~NIl~~~~~  163 (353)
T 3coi_A           92 FTPASSLRNFYDFYLVMPFMQT-DLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGV---VHRDLKPGNLAVNEDC  163 (353)
T ss_dssp             ECSCSSGGGCCCCEEEEECCSE-EGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSSCCGGGEEECTTC
T ss_pred             EecccccccceeEEEEeccccC-CHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCc---ccCCCCHHHEeECCCC
Confidence            8643       25999999974 88887743    38999999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      .+||+|||++......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....     .....
T Consensus       164 ~~kl~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~  234 (353)
T 3coi_A          164 ELKILDFGLARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-----LDQLT  234 (353)
T ss_dssp             CEEECSTTCTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH-----HHHHH
T ss_pred             cEEEeecccccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence            9999999999764322    234578999999999876 6789999999999999999999999954321     11111


Q ss_pred             HHHHHhcCCChH----------HhhHhhcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          502 LFEEVLNLPDPI----------EDLRKLVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       502 ~~~~~~~~~~~~----------~~l~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ........+...          ......+.....   .......+..+.+|+.+||+.||++|||++|+++|-
T Consensus       235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  307 (353)
T 3coi_A          235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  307 (353)
T ss_dssp             HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence            111111111100          000000000000   112234456799999999999999999999999983

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=319.87  Aligned_cols=252  Identities=24%  Similarity=0.375  Sum_probs=184.8

Q ss_pred             HhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC----CCCcc
Q 037010          268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV----HHLNL  343 (589)
Q Consensus       268 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l----~hpnI  343 (589)
                      ....++|++.+.||+|+||.||+|.+..++ ...+.|.+......     ..........+.+|+++++++    +||||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~-----~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i  100 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDR-LQVAIKVIPRNRVL-----GWSPLSDSVTCPLEVALLWKVGAGGGHPGV  100 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTC-CEEEEEECCSTTTC-------------CCCCHHHHHHHHHHSSCCCSSB
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCC-eEEEEEEEeccccc-----ccccchhhHHHHHHHHHHHhhcccCCCCCe
Confidence            445688999999999999999999876542 22222222111100     000011223355688888888    89999


Q ss_pred             eeEeeEEE-eCcEEEEEEe-cCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc-C
Q 037010          344 VRLIGYCV-EGSLFLVYEY-IENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID-K  420 (589)
Q Consensus       344 v~l~~~~~-~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~-~  420 (589)
                      +++++++. ++..++|||+ +.+++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+||+++ .
T Consensus       101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGV---VHRDIKDENILIDLR  175 (312)
T ss_dssp             CCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTE---ECCCCSGGGEEEETT
T ss_pred             eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eecCCChhhEEEeCC
Confidence            99999876 4568999999 78999999998754  48999999999999999999999998   9999999999999 8


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCC-cccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVS-PKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      ++.+||+|||++......   ......||+.|+|||++....+. .++||||||+++|+|++|+.||...          
T Consensus       176 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----------  242 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----------  242 (312)
T ss_dssp             TTEEEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----------
T ss_pred             CCeEEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----------
Confidence            899999999999865432   22346789999999998766664 5899999999999999999998321          


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      .    .....           ..    ..+......+.+++.+||+.||++|||++|+++|-.
T Consensus       243 ~----~~~~~-----------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~  286 (312)
T 2iwi_A          243 Q----EILEA-----------EL----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW  286 (312)
T ss_dssp             H----HHHHT-----------CC----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred             H----HHhhh-----------cc----CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence            0    00000           01    122233456899999999999999999999998743

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3e-37  Score=310.48  Aligned_cols=256  Identities=22%  Similarity=0.339  Sum_probs=193.2

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ...++|++.+.||+|+||.||+|.+..++. ..+.|.+...         .......+.+.+|++++++++||||+++++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~-~valK~~~~~---------~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   88 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQ-EYAVKVINKA---------SAKNKDTSTILREVELLKKLDHPNIMKLFE   88 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEEGG---------GBSSSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCc-EEEEEEeccc---------ccchHHHHHHHHHHHHHHhccCCCccEEEE
Confidence            345789999999999999999998865432 2222221110         111122456788999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC---CcE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN---FHA  424 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~---~~v  424 (589)
                      ++.+ +..|+||||+.+++|.+++....  .+++..++.++.|++.||+|||++++   +|+||||+||+++.+   +.+
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i---~H~dl~p~NIlv~~~~~~~~~  163 (287)
T 2wei_A           89 ILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNI---VHRDLKPENILLESKEKDCDI  163 (287)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESCSSTTCCE
T ss_pred             EEeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eccCCChhhEEEecCCCcccE
Confidence            8875 46899999999999999987654  48999999999999999999999998   999999999999754   479


Q ss_pred             EEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          425 KVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      ||+|||++.......  ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....     .   ....
T Consensus       164 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~---~~~~  232 (287)
T 2wei_A          164 KIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----Y---DILK  232 (287)
T ss_dssp             EECSTTGGGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H---HHHH
T ss_pred             EEeccCcceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----H---HHHH
Confidence            999999988654322  2233568999999999875 589999999999999999999999854321     1   1111


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .+....         .....  ......+..+.+++.+||..||.+|||++|+++|-
T Consensus       233 ~~~~~~---------~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp  278 (287)
T 2wei_A          233 RVETGK---------YAFDL--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (287)
T ss_dssp             HHHHCC---------CCCCS--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred             HHHcCC---------CCCCc--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCH
Confidence            111110         00000  00112345789999999999999999999999974

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.8e-37  Score=329.27  Aligned_cols=251  Identities=21%  Similarity=0.320  Sum_probs=177.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~  350 (589)
                      +.|.+.+.||+|+||+||.+....  +.              .+++|.+..+..+.+.+|+++|+++ +||||+++++++
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~--g~--------------~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~   78 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQ--GR--------------PVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE   78 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESS--SS--------------EEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEEC--Ce--------------EEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE
Confidence            456667899999999998654322  22              2333333322334567899999876 899999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC---
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDP-----LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN---  421 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~---  421 (589)
                      .+ +..|+||||+. |+|.+++.......     ..+..++.++.||+.||+|||++++   +||||||+|||++.+   
T Consensus        79 ~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDLkp~NILl~~~~~~  154 (434)
T 2rio_A           79 TTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKI---IHRDLKPQNILVSTSSRF  154 (434)
T ss_dssp             ECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEECCHHH
T ss_pred             ecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCc---cccCCChHhEEEecCccc
Confidence            75 45899999996 59999998654321     1233457899999999999999998   999999999999754   


Q ss_pred             ----------CcEEEEeccCccccccCCCC---CCcccccCCCCCchhcccC-------CCCCcccchhhHHHHHHHHHc
Q 037010          422 ----------FHAKVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQY-------GDVSPKVDVYAFGVVLYELIS  481 (589)
Q Consensus       422 ----------~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~sDvwSlGvll~ellt  481 (589)
                                +.+||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||+|
T Consensus       155 ~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt  234 (434)
T 2rio_A          155 TADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS  234 (434)
T ss_dssp             HSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHh
Confidence                      48999999999876543221   1234579999999999865       678999999999999999999


Q ss_pred             -CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          482 -AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       482 -G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                       |+.||.....      ...........            .+......+...+..+.+|+.+||+.||.+|||+.|+++|
T Consensus       235 ~g~~Pf~~~~~------~~~~i~~~~~~------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          235 KGKHPFGDKYS------RESNIIRGIFS------------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             TSCCTTCSTTT------HHHHHHHTCCC------------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCCchh------hHHHHhcCCCC------------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence             8989843221      01111111100            0111122245667789999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.6e-38  Score=321.77  Aligned_cols=252  Identities=22%  Similarity=0.340  Sum_probs=189.7

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC--CCcce
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH--HLNLV  344 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~--hpnIv  344 (589)
                      .....++|++.+.||+|+||.||+|.+..++ ...+.|.+.......     .........+.+|++++++++  ||||+
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDN-LPVAIKHVEKDRISD-----WGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTT-EEEEEEEEEGGGCCC-----EEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCC-cEEEEEEEecccchh-----hhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            3445688999999999999999999876553 222222221110000     000001123556899999986  59999


Q ss_pred             eEeeEEEe-CcEEEEEEecCC-CChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc-CC
Q 037010          345 RLIGYCVE-GSLFLVYEYIEN-GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID-KN  421 (589)
Q Consensus       345 ~l~~~~~~-~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~-~~  421 (589)
                      ++++++.+ +..++|||++.+ ++|.+++....  .+++..++.++.|++.||+|||++++   +||||||+|||++ ++
T Consensus       112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~i---vH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          112 RLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGV---LHRDIKDENILIDLNR  186 (320)
T ss_dssp             CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTT
T ss_pred             EEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCc---EeCCCCHHHEEEeCCC
Confidence            99998875 468999999986 89999998754  48999999999999999999999998   9999999999999 78


Q ss_pred             CcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          422 FHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      +.+||+|||++......   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....          
T Consensus       187 ~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----------  253 (320)
T 3a99_A          187 GELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------  253 (320)
T ss_dssp             TEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------
T ss_pred             CCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----------
Confidence            89999999999865432   2234579999999999876665 678999999999999999999983210          


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                          .....           .......    .+..+.+|+.+||+.||++|||++|+++|-
T Consensus       254 ----~~~~~-----------~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          254 ----EIIRG-----------QVFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             ----HHHHC-----------CCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             ----hhhcc-----------ccccccc----CCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence                00000           0011122    334689999999999999999999999873

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.8e-37  Score=326.78  Aligned_cols=250  Identities=22%  Similarity=0.293  Sum_probs=177.8

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ...+|.+.+.||+|+||+||......  +.              .+++|.+..+....+.+|+++|+++ +||||+++++
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~--~~--------------~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~   85 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFD--NR--------------DVAVKRILPECFSFADREVQLLRESDEHPNVIRYFC   85 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESS--SS--------------EEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeC--Ce--------------EEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEE
Confidence            34579999999999999965433222  11              2334433322223356799999999 7999999999


Q ss_pred             EEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-----CC
Q 037010          349 YCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-----NF  422 (589)
Q Consensus       349 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-----~~  422 (589)
                      ++.++ ..|+||||+.+ +|.+++..... ...+..++.++.||+.||+|||++++   +||||||+|||++.     ..
T Consensus        86 ~~~~~~~~~lv~E~~~g-~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~i---vHrDlKp~NIll~~~~~~~~~  160 (432)
T 3p23_A           86 TEKDRQFQYIAIELCAA-TLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLNI---VHRDLKPHNILISMPNAHGKI  160 (432)
T ss_dssp             EEEETTEEEEEEECCSE-EHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTTC---CCCCCSTTSEEECCCBTTTBC
T ss_pred             EEecCCEEEEEEECCCC-CHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCcC---EeCCCCHHHEEEecCCCCCce
Confidence            88754 58999999974 99999987653 25555677899999999999999998   99999999999953     23


Q ss_pred             cEEEEeccCccccccCCC--CCCcccccCCCCCchhccc---CCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCCh
Q 037010          423 HAKVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADS  496 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~  496 (589)
                      .+||+|||+++.......  .......||+.|+|||++.   ...++.++|||||||++|||+| |..||.....     
T Consensus       161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----  235 (432)
T 3p23_A          161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----  235 (432)
T ss_dssp             CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----
T ss_pred             eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----
Confidence            688999999986543321  2233467999999999997   4567889999999999999999 8888843211     


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                          ..........          ... ....+......+.+|+.+||+.||.+|||++|+++|
T Consensus       236 ----~~~~~~~~~~----------~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          236 ----RQANILLGAC----------SLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ----HHHHHHTTCC----------CCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----HHHHHHhccC----------Ccc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                0111111100          000 011123445568899999999999999999999976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=307.93  Aligned_cols=255  Identities=20%  Similarity=0.300  Sum_probs=171.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHH-HHHHHHHHHHHHccCCCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ-ASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      ..++|++.+.||+|+||.||+|.+..++. ..+.|.+..          ..... ..+.+.++..+++.++||||+++++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vavK~~~~----------~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   91 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGH-VIAVKQMRR----------SGNKEENKRILMDLDVVLKSHDCPYIVQCFG   91 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCC-EEEEEEEET----------TSCHHHHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCe-EEEEEEecc----------cccchHHHHHHHHHHHHHHhcCCCceeeEEE
Confidence            35679999999999999999999875532 222222111          01112 2233444556788889999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      ++.+ +..|+||||+ ++.+..+.... ...+++..++.++.|++.||.|||++ ++   +|+||||+|||++.++.+||
T Consensus        92 ~~~~~~~~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i---~H~dlkp~Nil~~~~~~~kl  166 (318)
T 2dyl_A           92 TFITNTDVFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGV---IHRDVKPSNILLDERGQIKL  166 (318)
T ss_dssp             EEECSSEEEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCGGGEEECTTSCEEE
T ss_pred             EEecCCcEEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCE---EeCCCCHHHEEECCCCCEEE
Confidence            8875 5689999999 44555544432 34589999999999999999999995 98   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      +|||++.......  ......||+.|+|||++.     ...++.++|||||||++|||++|+.||.....       ...
T Consensus       167 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~  237 (318)
T 2dyl_A          167 CDFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFE  237 (318)
T ss_dssp             CCCTTC----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHH
T ss_pred             EECCCchhccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHH
Confidence            9999987554322  223457899999999984     45788999999999999999999999853221       111


Q ss_pred             HHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       502 ~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      ........          ..+.+..  ....+..+.+++.+||+.||.+|||++|+++|-
T Consensus       238 ~~~~~~~~----------~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~  285 (318)
T 2dyl_A          238 VLTKVLQE----------EPPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHS  285 (318)
T ss_dssp             HHHHHHHS----------CCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             HHHHHhcc----------CCCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCH
Confidence            11111111          1111111  112334689999999999999999999999873

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.5e-36  Score=333.90  Aligned_cols=282  Identities=20%  Similarity=0.251  Sum_probs=196.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++ ...+.|.+.          +.......+.+.+|++++++++||||+++++++
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg-~~VAVKvi~----------~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~   81 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTG-EQVAIKQCR----------QELSPKNRERWCLEIQIMKKLNHPNVVSAREVP   81 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTT-CCEEECCCC----------SCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCC-cEEEEEEec----------ccCCHHHHHHHHHHHHHHHhCCCCCCCceeeee
Confidence            368999999999999999999876542 222222111          112344556788999999999999999999876


Q ss_pred             E-------eCcEEEEEEecCCCChHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          351 V-------EGSLFLVYEYIENGNLSEHLRGSG-RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       351 ~-------~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      .       ++..|+||||+++|+|.+++.... ...+++..++.++.|++.||+|||++++   +||||||+|||++.++
T Consensus        82 ~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gI---VHrDLKP~NILl~~~g  158 (676)
T 3qa8_A           82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRI---IHRDLKPENIVLQPGP  158 (676)
T ss_dssp             TTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTB---CCCCCCSTTEEEECCS
T ss_pred             cccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCC---ccCCCCHHHeEeecCC
Confidence            4       235789999999999999998754 2358999999999999999999999998   9999999999998766


Q ss_pred             c---EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          423 H---AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       423 ~---vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      .   +||+|||++.......  ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.............
T Consensus       159 ~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i  236 (676)
T 3qa8_A          159 QRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV  236 (676)
T ss_dssp             SSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC
T ss_pred             CceeEEEccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh
Confidence            4   9999999998654322  2344689999999999999999999999999999999999999995432100000000


Q ss_pred             HH-HHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHH-----HHHHHHhccccc
Q 037010          500 VA-LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS-----IVVALMTLSSTT  568 (589)
Q Consensus       500 ~~-~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~l~~~~  568 (589)
                      .. ..............+.-.-........+...+..+.+++.+||..||++|||++|     +.+.+..+....
T Consensus       237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence            00 0000000000000000000001123355667889999999999999999999988     445565555444

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.1e-35  Score=297.02  Aligned_cols=242  Identities=14%  Similarity=0.113  Sum_probs=176.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+..++ ...+.|.+....        ....+..+.+.+|++++.+++||||++++++
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~-~~vavK~~~~~~--------~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~   99 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALD-RQVALTFVDPQG--------VLPDDVLQETLSRTLRLSRIDKPGVARVLDV   99 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTT-EEEEEEESCTTC--------CSCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCC-ceEEEEEECccc--------ccCHHHHHHHHHHHHHHhcCCCCCcceeeEE
Confidence            3478999999999999999999986542 222222211100        1123445678899999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +..|+||||++|++|.+++...    ....++..++.|++.||+|||++|+   +||||||+|||++.++.+||++
T Consensus       100 ~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~gi---vH~Dikp~NIll~~~g~~kl~~  172 (286)
T 3uqc_A          100 VHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGV---ALSIDHPSRVRVSIDGDVVLAY  172 (286)
T ss_dssp             EEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCSGGGEEEETTSCEEECS
T ss_pred             EEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCC---ccCCCCcccEEEcCCCCEEEEe
Confidence            875 4689999999999999999542    4556788999999999999999999   9999999999999999999985


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ++                     |++       .++.++|||||||++|||+||+.||.............    .....
T Consensus       173 ~~---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~  220 (286)
T 3uqc_A          173 PA---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----RDTAG  220 (286)
T ss_dssp             CC---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----BCTTS
T ss_pred             cc---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----HHhcc
Confidence            43                     333       36889999999999999999999996543321000000    00000


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTEDWD  572 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~~~  572 (589)
                      ......            ....+.+..+.+++.+||+.||++| |++|+++.|.++.......+
T Consensus       221 ~~~~~~------------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~~  271 (286)
T 3uqc_A          221 QPIEPA------------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRTE  271 (286)
T ss_dssp             CBCCHH------------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC------
T ss_pred             CCCChh------------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCccC
Confidence            000000            0112234468999999999999999 99999999999887665433

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-35  Score=332.98  Aligned_cols=242  Identities=21%  Similarity=0.333  Sum_probs=184.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.+.||+|+||.||+|.+....+...+.|.+.          +.........+.+|++++++++||||++++++
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~----------~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  147 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLV----------HSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF  147 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESC----------SSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeC----------ccCCHHHHHHHHHHHHHHHhcCCCCcCeEeee
Confidence            45899999999999999999999875333332222111          11123445678899999999999999999998


Q ss_pred             EEe-Cc-----EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          350 CVE-GS-----LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       350 ~~~-~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      +.+ +.     .|+||||+++++|.+++..    .+++.+++.++.||+.||+|||++++   +||||||+|||++.+ .
T Consensus       148 ~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~gi---iHrDlkp~NIll~~~-~  219 (681)
T 2pzi_A          148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGL---VYNDLKPENIMLTEE-Q  219 (681)
T ss_dssp             EEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECSS-C
T ss_pred             EeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCC---eecccChHHeEEeCC-c
Confidence            864 33     6999999999999988754    49999999999999999999999998   999999999999886 8


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +||+|||+++.....     ....||+.|+|||++.++ ++.++|||||||++|+|++|..||........         
T Consensus       220 ~kl~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------  284 (681)
T 2pzi_A          220 LKLIDLGAVSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------  284 (681)
T ss_dssp             EEECCCTTCEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------
T ss_pred             EEEEecccchhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------
Confidence            999999999865432     345799999999998754 48899999999999999999988743211000         


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHhc
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-MRSIVVALMTL  564 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~l  564 (589)
                            +.              ..........+.+++.+||+.||.+||+ ++++.+.|..+
T Consensus       285 ------~~--------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          285 ------PE--------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             ------CT--------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ------cc--------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                  00              0001122346889999999999999995 55555555544

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3e-35  Score=297.77  Aligned_cols=230  Identities=18%  Similarity=0.308  Sum_probs=173.4

Q ss_pred             cCCCccc-eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHH-ccCCCCcceeEee
Q 037010          271 TDNFSMS-HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVL-THVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~-~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il-~~l~hpnIv~l~~  348 (589)
                      .++|.+. +.||+|+||.||+|.+..++. .              +++|.+..  ...+.+|++++ +.++||||+++++
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~-~--------------vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~   78 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQE-K--------------FALKMLQD--CPKARREVELHWRASQCPHIVRIVD   78 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCC-E--------------EEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCc-E--------------EEEEEecc--cHHHHHHHHHHHHhccCCCchhHHh
Confidence            4567777 789999999999998765522 2              22222221  13456688887 5668999999999


Q ss_pred             EEEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC---
Q 037010          349 YCVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---  420 (589)
Q Consensus       349 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~---  420 (589)
                      ++.+     +..|+||||+++|+|.+++.......+++..++.++.|++.||+|||++++   +||||||+|||++.   
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i---~H~dlkp~Nil~~~~~~  155 (299)
T 3m2w_A           79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRP  155 (299)
T ss_dssp             EEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESSSST
T ss_pred             hhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCCCCHHHEEEecCCC
Confidence            8753     458999999999999999998776679999999999999999999999998   99999999999988   


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      ++.+||+|||++....                       +..++.++|||||||++|||+||+.||..........    
T Consensus       156 ~~~~kl~Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~----  208 (299)
T 3m2w_A          156 NAILKLTDFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----  208 (299)
T ss_dssp             TCCEEECCCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C----
T ss_pred             CCcEEEeccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH----
Confidence            7889999999986432                       2456789999999999999999999995432211000    


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCP----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                          ....         ......  ...+    ...+..+.+|+.+||+.||.+|||++|+++|-.
T Consensus       209 ----~~~~---------~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~  259 (299)
T 3m2w_A          209 ----GMKT---------RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  259 (299)
T ss_dssp             ----CSCC---------SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ----HHHH---------HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence                0000         000000  0111    123457899999999999999999999999854

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-35  Score=314.08  Aligned_cols=245  Identities=16%  Similarity=0.164  Sum_probs=172.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCC-Cccee----
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH-LNLVR----  345 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~h-pnIv~----  345 (589)
                      ..+|...+.||+|+||.||+|.+..++. ..+.|.+...        ........+.+.+|+.+++.++| +|...    
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~-~vAvK~~~~~--------~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~  147 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGE-SFEVHVPYFT--------ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH  147 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEECCS--------CC----CCHHHHHHHHGGGGSTTCCSHHHHHHH
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCC-ceEEEEEecC--------CCccHHHHHHHHHHHHHHHhhccCCCHHHHHHh
Confidence            4568888999999999999999876533 2222211100        00011224567889999999977 32111    


Q ss_pred             -----------E------eeEEEe------CcEEEEEEecCCCChHHHHh-----cCCCCCCCHHHHHHHHHHHHHHHHH
Q 037010          346 -----------L------IGYCVE------GSLFLVYEYIENGNLSEHLR-----GSGRDPLPWSSRVQIALDSARGLEY  397 (589)
Q Consensus       346 -----------l------~~~~~~------~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~qia~aL~~  397 (589)
                                 +      ..+...      ...+++|+++ +++|.+++.     .....++++..++.++.|++.||+|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  226 (413)
T 3dzo_A          148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS  226 (413)
T ss_dssp             TCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHH
Confidence                       1      111111      1356777766 569999885     2223457788999999999999999


Q ss_pred             HHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcc----------cCCCCCccc
Q 037010          398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYA----------QYGDVSPKV  467 (589)
Q Consensus       398 LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~s  467 (589)
                      ||++++   +||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++
T Consensus       227 LH~~~i---iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~  298 (413)
T 3dzo_A          227 LHHYGL---VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAF  298 (413)
T ss_dssp             HHHTTE---ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHH
T ss_pred             HHhCCc---ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchh
Confidence            999998   99999999999999999999999998764322    234567 999999998          556688999


Q ss_pred             chhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccC
Q 037010          468 DVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEY  547 (589)
Q Consensus       468 DvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~d  547 (589)
                      |||||||++|||+||+.||........                     ....+...  ..++    ..+.+|+.+||+.|
T Consensus       299 DvwSlGvil~elltg~~Pf~~~~~~~~---------------------~~~~~~~~--~~~~----~~~~~li~~~l~~d  351 (413)
T 3dzo_A          299 DTWTLGLAIYWIWCADLPNTDDAALGG---------------------SEWIFRSC--KNIP----QPVRALLEGFLRYP  351 (413)
T ss_dssp             HHHHHHHHHHHHHHSSCCCCTTGGGSC---------------------SGGGGSSC--CCCC----HHHHHHHHHHTCSS
T ss_pred             hHHHHHHHHHHHHHCCCCCCCcchhhh---------------------HHHHHhhc--ccCC----HHHHHHHHHHccCC
Confidence            999999999999999999954321110                     00111100  1223    46899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 037010          548 PQLRPSMRSIVVA  560 (589)
Q Consensus       548 P~~RPs~~evl~~  560 (589)
                      |++|||+.|+++|
T Consensus       352 P~~Rpt~~~~l~~  364 (413)
T 3dzo_A          352 KEDRLLPLQAMET  364 (413)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             hhhCcCHHHHHhC
Confidence            9999998887665

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=9e-35  Score=299.32  Aligned_cols=251  Identities=16%  Similarity=0.162  Sum_probs=175.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC---------CC
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH---------HL  341 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~---------hp  341 (589)
                      .++|++.+.||+|+||.||+|++.+   ...+.|.+.......   .........+.+.+|++++++++         ||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~vAvK~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~   92 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADH---TPVAIKIIAIEGPDL---VNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE   92 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETT---EEEEEEEEEESCSSC---BTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred             cccchheeeecccCceEEEEEEeCC---ceEEEEEEecCCccc---cccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence            4679999999999999999998733   222222221110000   00001112245677888877775         77


Q ss_pred             cceeEeeEEE-------------------------------eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHH
Q 037010          342 NLVRLIGYCV-------------------------------EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD  390 (589)
Q Consensus       342 nIv~l~~~~~-------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~q  390 (589)
                      ||+++.+.+.                               ++.+|+||||+++|++.+.+..   ..+++..++.++.|
T Consensus        93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~q  169 (336)
T 2vuw_A           93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQ  169 (336)
T ss_dssp             CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHH
T ss_pred             chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHH
Confidence            7777766432                               4579999999999987777754   34899999999999


Q ss_pred             HHHHHHHHH-hCCCCceEeeccCCCcEEEcCCC--------------------cEEEEeccCccccccCCCCCCcccccC
Q 037010          391 SARGLEYIH-EHTVPVYIHRDIKSANILIDKNF--------------------HAKVADFGLTKLTEVGSASLPTRLVGT  449 (589)
Q Consensus       391 ia~aL~~LH-~~~i~~~vH~Dlkp~NILl~~~~--------------------~vkl~Dfgla~~~~~~~~~~~~~~~gt  449 (589)
                      |+.||+||| ++++   +||||||+|||++.++                    .+||+|||+++....      ....||
T Consensus       170 i~~aL~~lH~~~~i---vHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt  240 (336)
T 2vuw_A          170 LTASLAVAEASLRF---EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFC  240 (336)
T ss_dssp             HHHHHHHHHHHHCC---BCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECC
T ss_pred             HHHHHHHHHHhCCE---eECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEe
Confidence            999999999 9998   9999999999999887                    899999999986542      235799


Q ss_pred             CCCCchhcccCCCCCcccchhhHHHH-HHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCC
Q 037010          450 FGYMPPEYAQYGDVSPKVDVYAFGVV-LYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNC  528 (589)
Q Consensus       450 ~~y~aPE~~~~~~~s~~sDvwSlGvl-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~  528 (589)
                      +.|+|||++.+.. +.++|||||+++ .+++++|..||...       ..............        ..........
T Consensus       241 ~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~~--------~~~~~~~~~~  304 (336)
T 2vuw_A          241 DVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQM--------TFKTKCNTPA  304 (336)
T ss_dssp             CCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHTC--------CCSSCCCSHH
T ss_pred             ecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhhh--------ccCcccchhh
Confidence            9999999998665 899999998777 78889999888210       00000111111000        0001111112


Q ss_pred             ChHHHHHHHHHHHHhcccCCCCCCCHHHHH-HH
Q 037010          529 PLDSVLKMAQLAKVCTQEYPQLRPSMRSIV-VA  560 (589)
Q Consensus       529 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~  560 (589)
                      +...+..+.+|+.+||+.|     |++|++ +|
T Consensus       305 ~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          305 MKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            3457788999999999976     999998 66

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=9.2e-29  Score=271.13  Aligned_cols=153  Identities=23%  Similarity=0.217  Sum_probs=115.7

Q ss_pred             HHHHHHHHHHHHccC-CCCcceeEeeEEEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 037010          324 ASREFLAELKVLTHV-HHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH  401 (589)
Q Consensus       324 ~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~  401 (589)
                      ..+++.+|+++|+++ .|+||+++++++.++ .+||||||++|++|.++|...+  +++..   +|+.||+.||+|||++
T Consensus       284 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~  358 (569)
T 4azs_A          284 NKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ  358 (569)
T ss_dssp             HHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC
Confidence            446799999999999 699999999998754 6999999999999999998764  35543   5889999999999999


Q ss_pred             CCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc
Q 037010          402 TVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS  481 (589)
Q Consensus       402 ~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt  481 (589)
                      ||   |||||||+|||++++|++||+|||+++...... ......+||+.|||||++.+ .+..++|+||+|+++++|.+
T Consensus       359 GI---IHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~  433 (569)
T 4azs_A          359 GF---WHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ  433 (569)
T ss_dssp             TC---EESCCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred             Cc---eeccCchHhEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence            99   999999999999999999999999998654332 23445789999999999975 56778999999999998877


Q ss_pred             CCccc
Q 037010          482 AKEAI  486 (589)
Q Consensus       482 G~~p~  486 (589)
                      +..++
T Consensus       434 ~~~~~  438 (569)
T 4azs_A          434 PWSNW  438 (569)
T ss_dssp             THHHH
T ss_pred             ccchh
Confidence            76554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=4.7e-26  Score=248.24  Aligned_cols=190  Identities=15%  Similarity=0.185  Sum_probs=135.8

Q ss_pred             ccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc-CHHHHHHHHHHHHHHccCCCCcceeEeeEEE-e
Q 037010          275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-DMQASREFLAELKVLTHVHHLNLVRLIGYCV-E  352 (589)
Q Consensus       275 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~  352 (589)
                      ...+.||+|+||.||+|...+.   ..+.|....+...    .+.. .....+++.+|+++|++++||||+++..++. +
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~---~~~~k~~~~~~~~----~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~  411 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDF---DVIIKERVKKGYR----DERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL  411 (540)
T ss_dssp             ---------CCEEEEEEECSSC---EEEEEEECCCTTS----CHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET
T ss_pred             CCCCEEeeCCCEEEEEEEECCC---eEEEEEEeccccc----chhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC
Confidence            4467899999999999954432   1111111111110    0011 1122456889999999999999995544443 4


Q ss_pred             CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCc
Q 037010          353 GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLT  432 (589)
Q Consensus       353 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla  432 (589)
                      +..|+||||+++++|.+++..          ++.++.|++.||+|||++++   +||||||+|||++.  .+||+|||++
T Consensus       412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gI---iHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDV---IHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTE---ECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcC---ccCCCCHHHEEECC--eEEEEECccC
Confidence            567999999999999999875          45899999999999999998   99999999999998  9999999999


Q ss_pred             cccccCCCC------CCcccccCCCCCchhcccC--CCCCcccchhhHHHHHHHHHcCCccc
Q 037010          433 KLTEVGSAS------LPTRLVGTFGYMPPEYAQY--GDVSPKVDVYAFGVVLYELISAKEAI  486 (589)
Q Consensus       433 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~s~~sDvwSlGvll~elltG~~p~  486 (589)
                      +........      ......||+.|||||++..  ..|+..+|+|+..+-..+...++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            876432111      1134689999999999976  67888899999999988888777655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=3.3e-22  Score=199.95  Aligned_cols=163  Identities=13%  Similarity=0.088  Sum_probs=118.0

Q ss_pred             HHHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--------HHHHHHHHHHHHH
Q 037010          264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--------QASREFLAELKVL  335 (589)
Q Consensus       264 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--------~~~~~~~~E~~il  335 (589)
                      ...+......|.+.+.||+|+||.||+|.+ .+ +...+.|.+....... ...+....        .....+.+|+++|
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~-g~~valK~~~~~~~~~-~~~~~~~~~~~~~w~~~~~~~~~~E~~~l  158 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYS-EK-FGECVVKFHKVGHTSF-KKVKEKRDYGDLHFSVLAIRSARNEFRAL  158 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEE-TT-TEEEEEEEECC-------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEe-CC-CCEEEEEEEECCCCch-hhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence            344455567788899999999999999998 32 3333333322111000 00000000        2345688999999


Q ss_pred             ccCCCCcceeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          336 THVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       336 ~~l~hpnIv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      ++++  | +++.+++..+..|+||||++|++|.+ +..        .....++.|++.||+|||++|+   +||||||+|
T Consensus       159 ~~l~--~-~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~gi---iHrDlkp~N  223 (282)
T 1zar_A          159 QKLQ--G-LAVPKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGI---VHGDLSQYN  223 (282)
T ss_dssp             HHTT--T-SSSCCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTE---ECSCCSTTS
T ss_pred             Hhcc--C-CCcCeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCC---EeCCCCHHH
Confidence            9998  5 66666666667899999999999998 421        2345799999999999999998   999999999


Q ss_pred             EEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhccc
Q 037010          416 ILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQ  459 (589)
Q Consensus       416 ILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~  459 (589)
                      ||++ ++.+||+|||++..              +..++|||++.
T Consensus       224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9999 99999999999863              34578999874

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.80  E-value=1.4e-19  Score=170.43  Aligned_cols=107  Identities=20%  Similarity=0.236  Sum_probs=93.2

Q ss_pred             eeeEEeccCcchhcchhhhccCcCcH--------HHHhhcC-CCC-CCCCCCCcEEEEEeeecCCCcccCCceeEEEEEe
Q 037010          102 TFQFSINSGDTYEKVATRYYSNLTDA--------ASLQRIN-NYP-PTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYP  171 (589)
Q Consensus       102 ~~~y~V~~Gdtl~~Ia~~~~~~l~~~--------~~l~~~N-~~~-~~~l~~g~~l~ip~~~~~~~~~~~~~~~~~~~y~  171 (589)
                      ...|+|++|||||.|| ++|+  +++        ++|+++| ++. ++.|++||.|.||..|.|....   ......+|+
T Consensus         9 ~~~Y~V~~GDTL~~IA-~~~~--vsv~~~~~~~~~~I~~~Np~l~~~~~l~~Gq~L~IP~~~~~~~~~---~~~~~~~Y~   82 (212)
T 4eby_A            9 LASYYLENGTTLSVIN-QNLN--SSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQPGD---FLGHNFSYS   82 (212)
T ss_dssp             EEEEECCTTCCHHHHH-HHTC--CSSSCCCSSCCHHHHTTCTTCSCTTSCCTTCEEEEEECCEEETTT---EEEEEEEEE
T ss_pred             eEEEEeCCCCCHHHHH-HHHC--CCchhccccCHHHHHHhccCCCCcCccCCCCEEEEeccccccCCc---cccCceEEE
Confidence            4579999999999999 7899  898        9999999 785 7899999999999999886421   223356899


Q ss_pred             CCCCCCHhHhH-hhcC--CCHHHHhhcCCCC-CcccCcceEEecCCC
Q 037010          172 LRPGDSLQSIA-RNVG--LSESLLQNYNPGV-NFTRGSGLVFIPGRD  214 (589)
Q Consensus       172 v~~gdtl~~ia-~~~~--~~~~~l~~~N~~~-~~~~~g~~~~iP~~~  214 (589)
                      |++|||||+|| ++|+  +++++|+++|+.. +.+.+|+.+.||...
T Consensus        83 V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~~~~l~~Gq~L~IP~~~  129 (212)
T 4eby_A           83 VRQEDTYERVAISNYANLTTMESLQARNPFPATNIPLSATLNVLVNC  129 (212)
T ss_dssp             CCTTCCHHHHHHTTTTTSSCHHHHHHHCCSCTTCCCTTCEEEEEEEC
T ss_pred             ecCCCcHHHHHHHhcCCCCCHHHHHHhcCCCcccCCCCCEEEEcCCC
Confidence            99999999999 8999  9999999999954 689999999999764

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.71  E-value=3.4e-18  Score=168.59  Aligned_cols=150  Identities=16%  Similarity=0.092  Sum_probs=101.0

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCc--cchhhhhhhhhhHhHHHh------h------c-CHHHHHHHHHHHHHHc
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNS--YLSRLICVNLLMQKAAIK------K------M-DMQASREFLAELKVLT  336 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~--~~~~~~~~~~~~~~~~ik------~------~-~~~~~~~~~~E~~il~  336 (589)
                      .-|.+.+.||+|+||.||+|.+..++ ..  .+.|.+...........+      .      . .......+.+|+++|.
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  125 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDG-KPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE  125 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETT-EEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCC-cEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence            34678899999999999999874332 22  333322111000000000      0      0 0112235778999999


Q ss_pred             cCCCCcc--eeEeeEEEeCcEEEEEEecCC-C----ChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEe
Q 037010          337 HVHHLNL--VRLIGYCVEGSLFLVYEYIEN-G----NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIH-EHTVPVYIH  408 (589)
Q Consensus       337 ~l~hpnI--v~l~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH-~~~i~~~vH  408 (589)
                      ++.|+++  ..+++   .+..++||||+.+ |    +|.++...     .++..+..++.|++.+|.||| ++|+   +|
T Consensus       126 ~l~~~~i~~p~~~~---~~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~gi---vH  194 (258)
T 1zth_A          126 RAKEAGVSVPQPYT---YMKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAEL---VH  194 (258)
T ss_dssp             HHHHTTCCCCCEEE---EETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCE---EC
T ss_pred             HHHhCCCCCCeEEE---cCCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCE---Ee
Confidence            9988764  23332   2356899999942 3    67766543     234567789999999999999 9998   99


Q ss_pred             eccCCCcEEEcCCCcEEEEeccCcccc
Q 037010          409 RDIKSANILIDKNFHAKVADFGLTKLT  435 (589)
Q Consensus       409 ~Dlkp~NILl~~~~~vkl~Dfgla~~~  435 (589)
                      |||||+|||++.  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999988  9999999998753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=5.5e-15  Score=151.89  Aligned_cols=154  Identities=12%  Similarity=0.129  Sum_probs=97.6

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHH------HhhcCHH-----HHHHHHHHHHHH
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAA------IKKMDMQ-----ASREFLAELKVL  335 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~------ik~~~~~-----~~~~~~~E~~il  335 (589)
                      +.....-|++.+.||+|+||.||+|.+..  +...+.|.+.......+..      .......     ..-...+|...|
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~--G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL  167 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEK--GKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFM  167 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTT--CCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCC--CCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            33334459999999999999999998643  4444444432211100000      0000000     011123567777


Q ss_pred             ccCCCCcceeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCc
Q 037010          336 THVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN  415 (589)
Q Consensus       336 ~~l~hpnIv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~N  415 (589)
                      .++.+.++.-..-+... ..+|||||++|++|.++..        ......++.|++.+|.+||++|+   |||||||.|
T Consensus       168 ~rL~~~gv~vp~p~~~~-~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gI---VHrDLKp~N  235 (397)
T 4gyi_A          168 KALYEEGFPVPEPIAQS-RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGL---IHGDFNEFN  235 (397)
T ss_dssp             HHHHHTTCSCCCEEEEE-TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTE---ECSCCSTTS
T ss_pred             HHHHhcCCCCCeeeecc-CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCC---cCCCCCHHH
Confidence            77754443221112222 3379999999988866432        12345688999999999999998   999999999


Q ss_pred             EEEcCCC----------cEEEEeccCccc
Q 037010          416 ILIDKNF----------HAKVADFGLTKL  434 (589)
Q Consensus       416 ILl~~~~----------~vkl~Dfgla~~  434 (589)
                      ||+++++          .+.|+||+.+..
T Consensus       236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          236 ILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             EEEeCCCCcccccccccceEEEEeCCccc
Confidence            9998776          489999997654

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.52  E-value=1.3e-15  Score=137.59  Aligned_cols=95  Identities=18%  Similarity=0.124  Sum_probs=75.3

Q ss_pred             eeeeEEeccCcchhcchhhhccCcCcHHHHhhcCCCC-CCCCCCCcEEEEEeeecCCCcccCCceeEEEEEeCCCCCCHh
Q 037010          101 HTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYP-PTRIPDRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQ  179 (589)
Q Consensus       101 ~~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~-~~~l~~g~~l~ip~~~~~~~~~~~~~~~~~~~y~v~~gdtl~  179 (589)
                      ....|+||+|||||.|| ++|+  +++.+|+++|++. ++.|++||+|.||.....+.............|.|++||||+
T Consensus        61 ~~~~y~V~~GDTL~~IA-~~~~--~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~GdtL~  137 (167)
T 2l9y_A           61 GTATVTVQQGDTLRDIG-RRFD--CDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGAGNFWDSARDVRLVDGGKVLE  137 (167)
T ss_dssp             SCEEEEECTTCCHHHHH-HHTT--CCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSSCCGGGGEEEEEEETTTTEEE
T ss_pred             CCceEEECCCCcHHHHH-HHcC--CCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccccccccccceEEEeCCcCChH
Confidence            45689999999999999 6788  8999999999987 589999999999975432111111111223579999999999


Q ss_pred             HhHhhcCCCHHHHhhcCCC
Q 037010          180 SIARNVGLSESLLQNYNPG  198 (589)
Q Consensus       180 ~ia~~~~~~~~~l~~~N~~  198 (589)
                      +||++||.+++..+.+|..
T Consensus       138 aIA~r~G~~v~s~i~Ln~~  156 (167)
T 2l9y_A          138 AELRYSGGWNRSRIYLDEH  156 (167)
T ss_dssp             EEEEETTEEEEEEECGGGT
T ss_pred             HHHHHcCCceEEEEEcccc
Confidence            9999999988888888763

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.47  E-value=1.3e-14  Score=131.06  Aligned_cols=91  Identities=15%  Similarity=0.096  Sum_probs=74.0

Q ss_pred             hheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeeeecccC---CCcccceeeeEEeccC
Q 037010           34 ASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPFPCDCI---NGEFLGHTFQFSINSG  110 (589)
Q Consensus        34 ~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~~~~~~---~~~~~~~~~~y~V~~G  110 (589)
                      .+|+|++|||||.||++|+++        ..+|+++| ++.+++.|.+||+|.||....-.   ..........|+|++|
T Consensus        63 ~~y~V~~GDTL~~IA~~~~~~--------~~~l~~~N-~~~~~~~i~~Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~G  133 (167)
T 2l9y_A           63 ATVTVQQGDTLRDIGRRFDCD--------FHEIARRN-NIQNEDLIYPGQVLQVPTKGGSGGGAGNFWDSARDVRLVDGG  133 (167)
T ss_dssp             EEEEECTTCCHHHHHHHTTCC--------HHHHHHHH-TCCGGGCCCTTEEEEESCCCCCSSSSCCGGGGEEEEEEETTT
T ss_pred             ceEEECCCCcHHHHHHHcCCC--------HHHHHHHc-CCCCcccccCCCEEEEcCCCCccccccccccccceEEEeCCc
Confidence            379999999999999999999        99999999 99899999999999999763321   1111123467999999


Q ss_pred             cchhcchhhhccCcCcHHHHhhcCCC
Q 037010          111 DTYEKVATRYYSNLTDAASLQRINNY  136 (589)
Q Consensus       111 dtl~~Ia~~~~~~l~~~~~l~~~N~~  136 (589)
                      |||+.||++ |+  ++++....+|..
T Consensus       134 dtL~aIA~r-~G--~~v~s~i~Ln~~  156 (167)
T 2l9y_A          134 KVLEAELRY-SG--GWNRSRIYLDEH  156 (167)
T ss_dssp             TEEEEEEEE-TT--EEEEEEECGGGT
T ss_pred             CChHHHHHH-cC--CceEEEEEcccc
Confidence            999999955 77  678877777763

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=99.21  E-value=1e-11  Score=127.38  Aligned_cols=108  Identities=14%  Similarity=0.161  Sum_probs=84.5

Q ss_pred             hhheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCC----CcccCCCCeEEeeeecccC--------------
Q 037010           33 LASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSN----KDSLLADTRINVPFPCDCI--------------   94 (589)
Q Consensus        33 ~~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~----~~~~~~g~~l~ip~~~~~~--------------   94 (589)
                      +..|+|++||||+.||++||++        .++|.++| ++..    .+.|.+||+|.||....-.              
T Consensus         7 ~~~~~Vk~GDTL~~Ia~r~gvs--------~~~l~~~n-~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~   77 (361)
T 2gu1_A            7 RIHYMVKVGDTLSGIFAQLGVP--------YSILQKIL-SVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKA   77 (361)
T ss_dssp             CEEEECCTTCCHHHHHHHTTCC--------HHHHHHHH-HHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEE
T ss_pred             ceEEEECCCCcHHHHHHHcCCC--------HHHHHHHH-hhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceE
Confidence            4479999999999999999999        99999999 5432    4689999999999752100              


Q ss_pred             ------CCccc---------ceeeeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCC------CCCCCCcEEEEEee
Q 037010           95 ------NGEFL---------GHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPP------TRIPDRGTLNVTVN  152 (589)
Q Consensus        95 ------~~~~~---------~~~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~------~~l~~g~~l~ip~~  152 (589)
                            ++.+.         .....|+|+.|||||.|| +.|+  ++.+.|+++|++..      ..|++||++.|+..
T Consensus        78 ~~~~~~~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA-~~~G--vs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           78 IYTRENDGSFSYDFQEISGEWREILFSGEINGSFSVSA-RRVG--LTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             EEEECTTSCEEEEEEECCCEEEEEEEEEESSSCHHHHH-HHTT--CCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             EEEecCCCcceeeecccCceEEEEEEEEEECCcHHHHH-HHcC--CCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence                  01010         012468999999999999 8888  89999999998542      46999999999975

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.16  E-value=1.6e-11  Score=96.41  Aligned_cols=61  Identities=18%  Similarity=0.240  Sum_probs=53.7

Q ss_pred             CCCeEEeeeecccCCCcccceeeeEEeccCcchhcchhhhccCcCcHHHHhhcCCCC-CCCCCCCcEEEEEeee
Q 037010           81 ADTRINVPFPCDCINGEFLGHTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYP-PTRIPDRGTLNVTVNC  153 (589)
Q Consensus        81 ~g~~l~ip~~~~~~~~~~~~~~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~-~~~l~~g~~l~ip~~~  153 (589)
                      .||.+.||..         .....|+||+|||||.|| ++|+  +++++|+++|++. ++.|++||+|.||...
T Consensus         3 ~Gq~l~ip~~---------~~~~~y~V~~GDTL~~IA-~~~~--~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A            3 SGSSGCSPVR---------ERRLEHQLEPGDTLAGLA-LKYG--VTMEQIKRANRLYTNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             CCCCCCCCCC---------EEEEEECCCTTCCHHHHH-HHHT--CCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred             CCcEeeccCC---------CCcEEEEECCCCcHHHHH-HHHC--cCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence            6999999965         134679999999999999 8888  8999999999987 6799999999999864

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=99.13  E-value=2e-11  Score=125.18  Aligned_cols=110  Identities=16%  Similarity=0.124  Sum_probs=83.4

Q ss_pred             eeeeEEeccCcchhcchhhhccCcCcHHHHhhcCCCC-----CCCCCCCcEEEEEeeecCCCc----------------c
Q 037010          101 HTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNYP-----PTRIPDRGTLNVTVNCSCGDA----------------D  159 (589)
Q Consensus       101 ~~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~-----~~~l~~g~~l~ip~~~~~~~~----------------~  159 (589)
                      ....|+|++||||+.|| ++|+  +++++|+++|++.     .+.|++||+|.||....-...                .
T Consensus         6 ~~~~~~Vk~GDTL~~Ia-~r~g--vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~   82 (361)
T 2gu1_A            6 KRIHYMVKVGDTLSGIF-AQLG--VPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTRE   82 (361)
T ss_dssp             -CEEEECCTTCCHHHHH-HHTT--CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEEC
T ss_pred             CceEEEECCCCcHHHHH-HHcC--CCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEec
Confidence            34679999999999999 8898  8999999999865     368999999999964211000                0


Q ss_pred             cCC----------ceeEEEEEeCCCCCCHhHhHhhcCCCHHHHhhcCCCC----C---cccCcceEEecCC
Q 037010          160 VSK----------QYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGV----N---FTRGSGLVFIPGR  213 (589)
Q Consensus       160 ~~~----------~~~~~~~y~v~~gdtl~~ia~~~~~~~~~l~~~N~~~----~---~~~~g~~~~iP~~  213 (589)
                      ...          .......|+|+.|||||.||++||++.++|++||++.    +   .+++|+.+.++..
T Consensus        83 ~~g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           83 NDGSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             TTSCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             CCCcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence            000          0112346899999999999999999999999999752    2   4889999877754

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.08  E-value=7.9e-11  Score=92.38  Aligned_cols=62  Identities=18%  Similarity=0.164  Sum_probs=53.4

Q ss_pred             CCcEEEEEeeecCCCcccCCceeEEEEEeCCCCCCHhHhHhhcCCCHHHHhhcCCCC--CcccCcceEEecCCCCC
Q 037010          143 DRGTLNVTVNCSCGDADVSKQYRLFVTYPLRPGDSLQSIARNVGLSESLLQNYNPGV--NFTRGSGLVFIPGRDAN  216 (589)
Q Consensus       143 ~g~~l~ip~~~~~~~~~~~~~~~~~~~y~v~~gdtl~~ia~~~~~~~~~l~~~N~~~--~~~~~g~~~~iP~~~~~  216 (589)
                      .||.|.||..            ....+|+|++|||||+||++||+++++|+++|+..  +.+.+|+.+.||....+
T Consensus         3 ~Gq~l~ip~~------------~~~~~y~V~~GDTL~~IA~~~~~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~~~   66 (77)
T 2djp_A            3 SGSSGCSPVR------------ERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLYTNDSIFLKKTLYIPILTEP   66 (77)
T ss_dssp             CCCCCCCCCC------------EEEEEECCCTTCCHHHHHHHHTCCHHHHHHHHTCCCSSCGGGSSCEEEEEECCS
T ss_pred             CCcEeeccCC------------CCcEEEEECCCCcHHHHHHHHCcCHHHHHHHcCCCCccccCCCCEEEECCCCCC
Confidence            5888888843            24578999999999999999999999999999975  58899999999987543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.08  E-value=8.8e-11  Score=115.44  Aligned_cols=144  Identities=14%  Similarity=0.141  Sum_probs=100.9

Q ss_pred             hhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEe
Q 037010          269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLI  347 (589)
Q Consensus       269 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~  347 (589)
                      ...+.|++...++.|+.+.||++...+   ..++.|......     .      .....+.+|.++++.+. +..+.+++
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~~---~~~vlK~~~~~~-----~------~~~~~~~~E~~~l~~l~~~~~vP~v~   76 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGEN---ENLYLKMTDSRY-----K------GTTYDVEREKDMMLWLEGKLPVPKVL   76 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECSS---CEEEEEEECGGG-----T------TSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred             HHhccceeEeeccCCCCCeEEEEECCC---CcEEEEeCCccc-----C------CCHHHHHHHHHHHHHHhcCCCCCeEE
Confidence            445679899999999999999986432   223322221100     0      11124667888888884 66777888


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----------------------
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTV-----------------------  403 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i-----------------------  403 (589)
                      +++.+ +..|+|||+++|.+|.+.+.       +......++.+++.+|..||+...                       
T Consensus        77 ~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T 3tm0_A           77 HFERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             EEEEETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             EEEecCCceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence            87764 46899999999999987632       112234678899999999998110                       


Q ss_pred             ---------------------------------CceEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          404 ---------------------------------PVYIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       404 ---------------------------------~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                                                       +.++|+|++|.||+++++..+.|+||+.+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                             236999999999999876556799998764

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.99  E-value=1.4e-10  Score=82.03  Aligned_cols=45  Identities=16%  Similarity=0.341  Sum_probs=41.5

Q ss_pred             eeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEe
Q 037010          103 FQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTV  151 (589)
Q Consensus       103 ~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~  151 (589)
                      ..|+|++|||||+|| ++|+  +++++|+++|+ .++.|++||+|.||.
T Consensus         3 ~~y~V~~GDtl~~Ia-~~~~--~~~~~l~~~N~-~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIA-KRHG--VNIKDVMRWNS-DTANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHH-HHHT--CCHHHHHHHCS-CGGGCCTTEEEECCC
T ss_pred             EEEEEcCCCcHHHHH-HHHC--cCHHHHHHhCC-CCCcCCcCCEEEEec
Confidence            469999999999999 7888  89999999999 778999999999985

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.89  E-value=1.1e-09  Score=77.33  Aligned_cols=44  Identities=18%  Similarity=0.372  Sum_probs=41.0

Q ss_pred             heeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCCCCCcccCCCCeEEeee
Q 037010           35 SYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQLSNKDSLLADTRINVPF   89 (589)
Q Consensus        35 ~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~~~~~~~~~g~~l~ip~   89 (589)
                      .|+|++|||||+||++||++        .++|.++|+   +++.|.+||.|.||.
T Consensus         4 ~y~V~~GDtl~~Ia~~~~~~--------~~~l~~~N~---~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            4 TYRVRKGDSLSSIAKRHGVN--------IKDVMRWNS---DTANLQPGDKLTLFV   47 (48)
T ss_dssp             EEEECTTCCHHHHHHHHTCC--------HHHHHHHCS---CGGGCCTTEEEECCC
T ss_pred             EEEEcCCCcHHHHHHHHCcC--------HHHHHHhCC---CCCcCCcCCEEEEec
Confidence            69999999999999999999        999999994   567899999999996

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.80  E-value=5.3e-09  Score=107.71  Aligned_cols=143  Identities=15%  Similarity=0.252  Sum_probs=98.3

Q ss_pred             ccceeeccCCcEEEEEEEEccccCCccchhhhh--hhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC--CCcceeEeeEE
Q 037010          275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLIC--VNLLMQKAAIKKMDMQASREFLAELKVLTHVH--HLNLVRLIGYC  350 (589)
Q Consensus       275 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~--~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~~~  350 (589)
                      ...+.|+.|.++.||++...+   ..++.|...  ...     .     ......+.+|.++++.+.  +..+.+++.++
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~---~~~vlr~~~~p~~~-----~-----~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~  107 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPG---QTYVMRAKPGPKSK-----L-----LPSAHAIEREYRVMDALAGTDVPVAKMYALC  107 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSS---CEEEEECCCC--------------------CHHHHHHHHHHHTTSSSCCCCEEEEE
T ss_pred             ceEEEcCCcccceEEEEEECC---ceEEEEeCCCCCCC-----C-----CCcHHHHHHHHHHHHHhhcCCCCCCcEEEEC
Confidence            346789999999999987543   222222211  000     0     011235677999998886  45577888877


Q ss_pred             EeC----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------
Q 037010          351 VEG----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT------------------------  402 (589)
Q Consensus       351 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~------------------------  402 (589)
                      .+.    ..|+||||++|..+.+..    ...++..+...++.+++..|..||...                        
T Consensus       108 ~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3dxp_A          108 EDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT  183 (359)
T ss_dssp             CCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred             CCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence            653    379999999998775421    123677888899999999999999831                        


Q ss_pred             -------------------------------CCceEeeccCCCcEEEcCCCc--EEEEeccCccc
Q 037010          403 -------------------------------VPVYIHRDIKSANILIDKNFH--AKVADFGLTKL  434 (589)
Q Consensus       403 -------------------------------i~~~vH~Dlkp~NILl~~~~~--vkl~Dfgla~~  434 (589)
                                                     -+.++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                           134799999999999987653  68999998864

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.80  E-value=2e-09  Score=105.25  Aligned_cols=138  Identities=15%  Similarity=0.130  Sum_probs=88.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCc--ceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLN--LVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpn--Iv~l~~  348 (589)
                      ...|.+....+.|..+.||++...+  +...+.|....              .....+.+|+++++.+.+.+  +.++++
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~--g~~~vlK~~~~--------------~~~~~~~~E~~~l~~l~~~~~~vP~~~~   82 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQG--RPVLFVKTDLS--------------GALNELQDEAARLSWLATTGVPCAAVLD   82 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTT--SCCEEEEEECS--------------CTTSCHHHHHHHHHHHHTTTCCBCCEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCC--CCeEEEEeCCc--------------ccchhhhHHHHHHHHHHhCCCCCCeEEE
Confidence            3455554444456679999986432  22233332111              01123566888888885444  455777


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC------------------------
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTV------------------------  403 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i------------------------  403 (589)
                      +..+ +..|+||||++|.+|.  ...     ..   ...++.+++..|..||....                        
T Consensus        83 ~~~~~~~~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (264)
T 1nd4_A           83 VVTEAGRDWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGL  152 (264)
T ss_dssp             EEECSSCEEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTC
T ss_pred             eccCCCCCEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCC
Confidence            6654 4689999999998884  211     11   22566777888888887530                        


Q ss_pred             -------------------------------CceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          404 -------------------------------PVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       404 -------------------------------~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                                                     ..++|+|++|.|||+++++.+.|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          153 VDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                           1269999999999998776677999998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.70  E-value=5.5e-09  Score=105.01  Aligned_cols=182  Identities=21%  Similarity=0.299  Sum_probs=114.4

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCc--ceeEeeEEEeC
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLN--LVRLIGYCVEG  353 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpn--Iv~l~~~~~~~  353 (589)
                      .+.++.|....||++.      ...+.|..             ........+.+|.++|+.+. +..  +.+++.+...+
T Consensus        25 i~~~~~G~~n~v~~v~------~~~vlR~~-------------~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~   85 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN------RDFIFKFP-------------KHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS   85 (304)
T ss_dssp             CCEEEECSSEEEEEST------TSEEEEEE-------------SSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC
T ss_pred             eEecCCCCcceEEEEC------CEEEEEec-------------CCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC
Confidence            4668999999999863      11221111             01123456778999988773 322  23344333222


Q ss_pred             ----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------
Q 037010          354 ----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT---------------------------  402 (589)
Q Consensus       354 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~---------------------------  402 (589)
                          ..|+|||+++|.+|.+....    .++..++..++.+++..|..||+..                           
T Consensus        86 ~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (304)
T 3sg8_A           86 ETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL  161 (304)
T ss_dssp             SSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence                24899999999888764332    2677778888889999999998621                           


Q ss_pred             ----------------------------CCceEeeccCCCcEEEcC--CCcEEEEeccCccccccCCCCCCcccccCCCC
Q 037010          403 ----------------------------VPVYIHRDIKSANILIDK--NFHAKVADFGLTKLTEVGSASLPTRLVGTFGY  452 (589)
Q Consensus       403 ----------------------------i~~~vH~Dlkp~NILl~~--~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y  452 (589)
                                                  -+.++|+|++|.||++++  ...+.|+||+.+.......     .......+
T Consensus       162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-----Dl~~~~~~  236 (304)
T 3sg8_A          162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-----DFISLMED  236 (304)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-----HHHTTCCT
T ss_pred             cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-----HHHHHHhh
Confidence                                        124699999999999988  4567899999886532210     00001111


Q ss_pred             ---Cchhccc-----CCCC---------CcccchhhHHHHHHHHHcCCccc
Q 037010          453 ---MPPEYAQ-----YGDV---------SPKVDVYAFGVVLYELISAKEAI  486 (589)
Q Consensus       453 ---~aPE~~~-----~~~~---------s~~sDvwSlGvll~elltG~~p~  486 (589)
                         ..|+...     .+..         ....+.|+++.++|.+.+|..+|
T Consensus       237 ~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          237 DEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             TTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             ccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               2232111     0111         12368999999999999999876

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.10  E-value=6.8e-06  Score=80.52  Aligned_cols=104  Identities=18%  Similarity=0.170  Sum_probs=73.4

Q ss_pred             HHHHHHHHHHHccCC-CCcceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 037010          325 SREFLAELKVLTHVH-HLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT  402 (589)
Q Consensus       325 ~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~  402 (589)
                      ..++.+|..+|+.+. +--+-+++.++.+ +..|+|||+++|.++.+.....      ......+..+++..|..||...
T Consensus        63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~  136 (272)
T 4gkh_A           63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIP  136 (272)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSC
T ss_pred             HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCC
Confidence            345677888888774 3235566777654 5689999999998887765432      1233456667777777777421


Q ss_pred             C-------------------------------------------------------CceEeeccCCCcEEEcCCCcEEEE
Q 037010          403 V-------------------------------------------------------PVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       403 i-------------------------------------------------------~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      .                                                       +.++|+|+.+.|||++.++.+-|+
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~vi  216 (272)
T 4gkh_A          137 VCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCI  216 (272)
T ss_dssp             GGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred             cccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEE
Confidence            1                                                       127999999999999987767799


Q ss_pred             eccCccc
Q 037010          428 DFGLTKL  434 (589)
Q Consensus       428 Dfgla~~  434 (589)
                      ||+.+..
T Consensus       217 Dwe~a~~  223 (272)
T 4gkh_A          217 DVGRVGI  223 (272)
T ss_dssp             CCTTCEE
T ss_pred             ECccccc
Confidence            9997753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.98  E-value=2.3e-05  Score=78.51  Aligned_cols=135  Identities=19%  Similarity=0.283  Sum_probs=87.3

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCC---cceeEeeEEE--
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHL---NLVRLIGYCV--  351 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~~~~--  351 (589)
                      .+.++.|....||+.   +   ..++.|..             ........+.+|.++|+.+.+.   .+.+.+.+..  
T Consensus        24 v~~l~~G~~n~v~~v---g---~~~VlR~~-------------~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~   84 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---N---GDWVFRFP-------------KSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS   84 (306)
T ss_dssp             EEEEEECSSEEEEEE---T---TTEEEEEE-------------SSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT
T ss_pred             eeecCCCcceeEEEE---C---CEEEEEec-------------CCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC
Confidence            466888999999987   1   12222210             1122345677899999988642   2445555553  


Q ss_pred             eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 037010          352 EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT-----------------------------  402 (589)
Q Consensus       352 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~-----------------------------  402 (589)
                      ++..|+|||+++|.+|.+..-.    .++..+...++.+++..|..||+..                             
T Consensus        85 ~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~  160 (306)
T 3tdw_A           85 DGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQV  160 (306)
T ss_dssp             TSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHT
T ss_pred             CCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhc
Confidence            3458899999999888763221    1344555556666666666666432                             


Q ss_pred             ----------------------------CCceEeeccCCCcEEEcC---CCc-EEEEeccCccc
Q 037010          403 ----------------------------VPVYIHRDIKSANILIDK---NFH-AKVADFGLTKL  434 (589)
Q Consensus       403 ----------------------------i~~~vH~Dlkp~NILl~~---~~~-vkl~Dfgla~~  434 (589)
                                                  -+.++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       161 ~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          161 FPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             ccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                        123699999999999987   455 48999997764

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=97.96  E-value=5.3e-06  Score=74.68  Aligned_cols=45  Identities=33%  Similarity=0.560  Sum_probs=41.2

Q ss_pred             EEEeCCCCCCHhHhHhhcCCCHHHHhhcCCCCC-cccCcceEEecC
Q 037010          168 VTYPLRPGDSLQSIARNVGLSESLLQNYNPGVN-FTRGSGLVFIPG  212 (589)
Q Consensus       168 ~~y~v~~gdtl~~ia~~~~~~~~~l~~~N~~~~-~~~~g~~~~iP~  212 (589)
                      ++|+|++||||+.||++|+++..+|+++|+..+ .+++|+.+.+|.
T Consensus         3 ~~y~V~~GdtL~~IA~~f~~g~~~l~~aNp~vd~~l~~g~~i~ip~   48 (165)
T 4a1k_A            3 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIPG   48 (165)
T ss_dssp             EEEECCTTCCHHHHHHHTTCCHHHHHHHCGGGGGCCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCCCHHHHHHhCccCCCccCCCccccCcc
Confidence            689999999999999999999999999999764 568899999995

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=97.96  E-value=2.8e-06  Score=76.54  Aligned_cols=46  Identities=15%  Similarity=0.299  Sum_probs=40.9

Q ss_pred             eeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEe
Q 037010          103 FQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTV  151 (589)
Q Consensus       103 ~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~  151 (589)
                      .+|+||+||||+.|| ++|+  ++.++|+++|+.....|.+||+|.||.
T Consensus         3 ~~y~V~~GdtL~~IA-~~f~--~g~~~l~~aNp~vd~~l~~g~~i~ip~   48 (165)
T 4a1k_A            3 LTYQVKQGDTLNSIA-ADFR--ISTAALLQANPSLQAGLTAGQSIVIPG   48 (165)
T ss_dssp             EEEECCTTCCHHHHH-HHTT--CCHHHHHHHCGGGGGCCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHH-HHhC--CCHHHHHHhCccCCCccCCCccccCcc
Confidence            579999999999999 8888  899999999995545689999999983

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.62  E-value=2.8e-05  Score=79.48  Aligned_cols=31  Identities=26%  Similarity=0.404  Sum_probs=25.5

Q ss_pred             CceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          404 PVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       404 ~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      +.++|+|+.+.|||++++..+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            3469999999999999654578999997753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.24  E-value=0.00026  Score=73.42  Aligned_cols=30  Identities=23%  Similarity=0.377  Sum_probs=25.0

Q ss_pred             CceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          404 PVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       404 ~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      +.++|+|+.+.||+++.+ .++++||..+..
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            346999999999999876 489999987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.20  E-value=0.00055  Score=68.40  Aligned_cols=76  Identities=16%  Similarity=0.211  Sum_probs=49.2

Q ss_pred             ccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC---CCcceeEeeEEE
Q 037010          275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH---HLNLVRLIGYCV  351 (589)
Q Consensus       275 ~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~---hpnIv~l~~~~~  351 (589)
                      .-.+.|+.|....+|+....   +..++.|...              ......+..|.+.|+.|.   ...+.+++.+..
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~---~~~~vlK~~~--------------~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~  101 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDE---VQTVFVKINE--------------RSYRSMFRAEADQLALLAKTNSINVPLVYGIGN  101 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESS---SCEEEEEEEE--------------GGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE
T ss_pred             eeeEEeCCccceeeeEEEEC---CCeEEEEeCC--------------cccHHHHHHHHHHHHHHHhhCCCCcceEEEEee
Confidence            34577999999999998642   2223222211              111345667888887773   345677777665


Q ss_pred             -eCcEEEEEEecCCCCh
Q 037010          352 -EGSLFLVYEYIENGNL  367 (589)
Q Consensus       352 -~~~~~lv~e~~~~gsL  367 (589)
                       ++..|+|||++++..+
T Consensus       102 ~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A          102 SQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             CSSEEEEEEECCCCCCC
T ss_pred             cCCceEEEEEeccCCCC
Confidence             3568999999998764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.17  E-value=0.00062  Score=68.65  Aligned_cols=29  Identities=24%  Similarity=0.294  Sum_probs=25.8

Q ss_pred             ceEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          405 VYIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                      .++|+|+++.|||++.++.+.|+||+.+.
T Consensus       223 ~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          223 NLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             ceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            36999999999999888889999999764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.90  E-value=0.0054  Score=56.95  Aligned_cols=100  Identities=15%  Similarity=0.181  Sum_probs=65.4

Q ss_pred             ChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcc
Q 037010          366 NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR  445 (589)
Q Consensus       366 sL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~  445 (589)
                      +|.+.|...+ .|+++.++|.++.|.+.+|.-+-.+.-+  ..+=+.|..|++..+|.|.+.+ ..+.            
T Consensus        34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc------------
Confidence            7888887665 4699999999999999988776321111  2233457899999999988774 2111            


Q ss_pred             cccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCC
Q 037010          446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK  483 (589)
Q Consensus       446 ~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~  483 (589)
                       .....+.|||... ...+.+.=|||||+++|.-+--.
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence             0122366888763 34466788999999999988533

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.82  E-value=0.0021  Score=67.03  Aligned_cols=79  Identities=10%  Similarity=0.073  Sum_probs=46.6

Q ss_pred             CceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCC---CCCcccchhhHHHHHHHHH
Q 037010          404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG---DVSPKVDVYAFGVVLYELI  480 (589)
Q Consensus       404 ~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~sDvwSlGvll~ell  480 (589)
                      +.++|+|++|.|||++.++ +.++||+.+........-...-..-...|++|+.....   ......++.++...+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            3469999999999998776 99999998875321100000000001235666544311   1112345568888888887


Q ss_pred             cCC
Q 037010          481 SAK  483 (589)
Q Consensus       481 tG~  483 (589)
                      +++
T Consensus       311 ~~~  313 (420)
T 2pyw_A          311 NKR  313 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.49  E-value=0.0055  Score=61.17  Aligned_cols=43  Identities=19%  Similarity=0.297  Sum_probs=30.5

Q ss_pred             HHHHHHHHHhC---CC-CceEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          391 SARGLEYIHEH---TV-PVYIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       391 ia~aL~~LH~~---~i-~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                      +...++.++..   .. ..++|+|+.+.|||++.+..+.|+||+.+.
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            33445555532   11 246999999999999887656899998765

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=96.35  E-value=0.011  Score=60.08  Aligned_cols=109  Identities=10%  Similarity=0.053  Sum_probs=72.5

Q ss_pred             hhheeccCCCCHHHHHHHhcCCCCCCCccchhhHhhhccCC---CCCcccCCCCeEEeeeecccC----------CCcc-
Q 037010           33 LASYYVWIGSNLTFIAQTLRSSLVDPNDVELTTILSYNKQL---SNKDSLLADTRINVPFPCDCI----------NGEF-   98 (589)
Q Consensus        33 ~~~y~v~~g~~l~~ia~~~~~~~~~~~~~~~~~i~~~N~~~---~~~~~~~~g~~l~ip~~~~~~----------~~~~-   98 (589)
                      +-.|+|++||||..|-+++|++        ..++.+.+...   .+...|.+||+|.+.....-.          .... 
T Consensus        14 W~~~~V~~GDTL~~IL~r~Gls--------~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~l~~l~~~~~~~~~~~   85 (371)
T 3slu_A           14 WVQEAVQPGDSLADVLARSGMA--------RDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERN   85 (371)
T ss_dssp             EEEEECCTTCCHHHHHHHTTCC--------HHHHHHHHTTC------CCBCSSSEEEEEECTTSCEEEEEEEECCTTEEE
T ss_pred             eEEEEECCCCcHHHHHHHcCCC--------HHHHHHHHHhccccCchhhCCCCCEEEEEECCCCCeEEEEEEecCCCcee
Confidence            4469999999999999999999        77777766322   244689999999987652100          0000 


Q ss_pred             -cc---eeeeEE----------------eccCcchhcchhhhccCcCcHHHHhhcCCC-CC----CCCCCCcEEEEEee
Q 037010           99 -LG---HTFQFS----------------INSGDTYEKVATRYYSNLTDAASLQRINNY-PP----TRIPDRGTLNVTVN  152 (589)
Q Consensus        99 -~~---~~~~y~----------------V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~-~~----~~l~~g~~l~ip~~  152 (589)
                       ..   ....|+                +.-.++||..| +..+  ++.+.+++.+.+ ..    ..|++|+.+.|...
T Consensus        86 ~v~i~~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~-~~ag--l~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~  161 (371)
T 3slu_A           86 LVALEKKGGIWRRSASEADMKVLPTLRSVVVKTSARGSL-ARAE--VPVEIRESLSGIFAGRFSLDGLKEGDAVRLIYD  161 (371)
T ss_dssp             EEEEEEETTEEEECCCGGGEEEEEEEEEEECSSCHHHHH-HHTT--CCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEE
T ss_pred             EEEEEecCCeeEEEeeecccceeeeEEEEEEeccHHHHH-HHcC--CCHHHHHHHHHHHccCcCHHHcCCCCEEEEEEE
Confidence             00   000122                33488999999 6666  688888777652 21    25899999999875

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.20  E-value=0.0035  Score=63.05  Aligned_cols=31  Identities=35%  Similarity=0.516  Sum_probs=26.5

Q ss_pred             ceEeeccCCCcEEEcCC----CcEEEEeccCcccc
Q 037010          405 VYIHRDIKSANILIDKN----FHAKVADFGLTKLT  435 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~~----~~vkl~Dfgla~~~  435 (589)
                      .++|+|+.+.||+++.+    +.+.|+||+.+...
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            46999999999999874    68999999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.03  E-value=0.002  Score=67.51  Aligned_cols=75  Identities=21%  Similarity=0.230  Sum_probs=41.0

Q ss_pred             ceeeccCCcEEEEEEEEccc------cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcc-eeEeeE
Q 037010          277 SHKIGQGGFGAVYYAELRGE------YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNL-VRLIGY  349 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~------~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~  349 (589)
                      .+.|+.|....+|++...+.      .+...+.|.....           .  ....+..|..+++.+...++ .++++.
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----------~--~~~~li~E~~~l~~L~~~g~~P~l~~~  144 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----------E--TESHLVAESVIFTLLSERHLGPKLYGI  144 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----------C--CHHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----------C--cHHHHHHHHHHHHHHHhCCCCCcEEEE
Confidence            56788888999999976431      1122333322110           0  00233357777777642233 455554


Q ss_pred             EEeCcEEEEEEecCCCCh
Q 037010          350 CVEGSLFLVYEYIENGNL  367 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL  367 (589)
                      +.+   .+|+||++|.+|
T Consensus       145 ~~~---g~v~e~l~G~~l  159 (429)
T 1nw1_A          145 FSG---GRLEEYIPSRPL  159 (429)
T ss_dssp             ETT---EEEECCCCEEEC
T ss_pred             eCC---CEEEEEeCCccc
Confidence            432   389999987443

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.03  E-value=0.0048  Score=60.68  Aligned_cols=80  Identities=14%  Similarity=0.144  Sum_probs=45.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCC---cceeEee
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHL---NLVRLIG  348 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hp---nIv~l~~  348 (589)
                      ....-.+.+|.|..+.||+.+..+.  ..++.|....+.           ......+..|.+.|+.|..-   .+.++++
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG--~~~~vK~~~~~~-----------~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~   81 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADG--TPLFVKALPDDA-----------PALDGLFRAEALGLDWLGRSFGSPVPQVAG   81 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTS--CEEEEEECCTTC-----------CCCTTHHHHHHHHHHHHTCSTTCCSCCEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCC--CEEEEEEeCCCC-----------cchhhHHHHHHHHHHHHHhhCCCCcceEEe
Confidence            4556678899999999999986542  233333211110           00012356688888777422   2333333


Q ss_pred             EEEeCcEEEEEEecCCCCh
Q 037010          349 YCVEGSLFLVYEYIENGNL  367 (589)
Q Consensus       349 ~~~~~~~~lv~e~~~~gsL  367 (589)
                      +   +.-++|||+++++..
T Consensus        82 ~---~~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           82 W---DDRTLAMEWVDERPP   97 (288)
T ss_dssp             E---ETTEEEEECCCCCCC
T ss_pred             c---cCceEEEEeecccCC
Confidence            2   234789999987653

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=95.95  E-value=0.013  Score=59.35  Aligned_cols=109  Identities=11%  Similarity=0.084  Sum_probs=71.8

Q ss_pred             eeeeEEeccCcchhcchhhhccCcCcHHHHhhcCCC-----CCCCCCCCcEEEEEeeecCCCcc----cC--CceeEE-E
Q 037010          101 HTFQFSINSGDTYEKVATRYYSNLTDAASLQRINNY-----PPTRIPDRGTLNVTVNCSCGDAD----VS--KQYRLF-V  168 (589)
Q Consensus       101 ~~~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~-----~~~~l~~g~~l~ip~~~~~~~~~----~~--~~~~~~-~  168 (589)
                      .+..|+|++||||..|- ++++  ++..++.+.+..     ....|++||.|.+.+...-.-..    ..  ....+. +
T Consensus        13 ~W~~~~V~~GDTL~~IL-~r~G--ls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~l~~l~~~~~~~~~~~~v~i   89 (371)
T 3slu_A           13 YWVQEAVQPGDSLADVL-ARSG--MARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERNLVAL   89 (371)
T ss_dssp             EEEEEECCTTCCHHHHH-HHTT--CCHHHHHHHHTTC------CCBCSSSEEEEEECTTSCEEEEEEEECCTTEEEEEEE
T ss_pred             ceEEEEECCCCcHHHHH-HHcC--CCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCCCeEEEEEEecCCCceeEEEE
Confidence            56789999999999999 7887  788888877653     23589999999998642110000    00  000000 0


Q ss_pred             -----EEe----------------CCCCCCHhHhHhhcCCCHHHHhhcCCC----CC--cccCcceEEecC
Q 037010          169 -----TYP----------------LRPGDSLQSIARNVGLSESLLQNYNPG----VN--FTRGSGLVFIPG  212 (589)
Q Consensus       169 -----~y~----------------v~~gdtl~~ia~~~~~~~~~l~~~N~~----~~--~~~~g~~~~iP~  212 (589)
                           .|.                ..-.+||+..|.+.|++.+.+++++.+    .|  -+++|+.+-+.-
T Consensus        90 ~~~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~agl~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~  160 (371)
T 3slu_A           90 EKKGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIFAGRFSLDGLKEGDAVRLIY  160 (371)
T ss_dssp             EEETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEE
T ss_pred             EecCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHcCCCHHHHHHHHHHHccCcCHHHcCCCCEEEEEE
Confidence                 122                233789999999999999888887753    12  367777765553

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.88  E-value=0.0045  Score=61.33  Aligned_cols=29  Identities=21%  Similarity=0.244  Sum_probs=24.6

Q ss_pred             ceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          405 VYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .++|+|+.+.||+ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4799999999999 5667889999987764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.64  E-value=0.0082  Score=61.55  Aligned_cols=143  Identities=16%  Similarity=0.168  Sum_probs=73.8

Q ss_pred             ceeeccCCcEEEEEEEEccc------cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeE
Q 037010          277 SHKIGQGGFGAVYYAELRGE------YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGY  349 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~------~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  349 (589)
                      .+.|..|-...+|++...+.      .+..++.|.....          .  .......+|.++++.+. +.-..+++++
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----------~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~  122 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----------L--QGVDSLVLESVMFAILAERSLGPQLYGV  122 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---------------CCHHHHHHHHHHHHHHHHTTSSCCEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----------c--chHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence            45677788888999876421      1123333322110          0  01223446888887774 2222455555


Q ss_pred             EEeCcEEEEEEecCCCChHH--------------H---HhcCC---CCCCC--HHHHHHHHHHHHH--------------
Q 037010          350 CVEGSLFLVYEYIENGNLSE--------------H---LRGSG---RDPLP--WSSRVQIALDSAR--------------  393 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~--------------~---l~~~~---~~~~~--~~~~~~i~~qia~--------------  393 (589)
                      +.+   .+||||++|..|..              .   ++...   ..+..  +.++.++..++..              
T Consensus       123 ~~~---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~  199 (379)
T 3feg_A          123 FPE---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEM  199 (379)
T ss_dssp             ETT---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHH
T ss_pred             cCC---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhh
Confidence            443   38999999865531              1   11110   11122  3445555443321              


Q ss_pred             -----HHHHH----HhCCC-CceEeeccCCCcEEEcCC----CcEEEEeccCccc
Q 037010          394 -----GLEYI----HEHTV-PVYIHRDIKSANILIDKN----FHAKVADFGLTKL  434 (589)
Q Consensus       394 -----aL~~L----H~~~i-~~~vH~Dlkp~NILl~~~----~~vkl~Dfgla~~  434 (589)
                           .++.|    ...+. ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       200 ~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          200 YSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             TTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                 22333    22221 247999999999999876    6899999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.42  E-value=0.0092  Score=62.82  Aligned_cols=75  Identities=15%  Similarity=0.115  Sum_probs=40.1

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcc-eeEeeEEEeCcE
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNL-VRLIGYCVEGSL  355 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~~~~~~~  355 (589)
                      .+.|+.|-...+|++...+. +..++.|......   .   ..+.      ..+|..+++.|...++ .++++.+ ++  
T Consensus       113 i~~lsgG~tN~~y~v~~~~~-~~~~vLRi~g~~~---~---~~id------R~~E~~vl~~L~~~gl~P~ll~~~-~~--  176 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSK-QAKYLIRLYGPKT---D---EIIN------REREKKISCILYNKNIAKKIYVFF-TN--  176 (458)
T ss_dssp             EEEECC--CEEEEEEEETTT-TEEEEEEEECC-C---C---SCSC------HHHHHHHHHHHTTSSSBCCEEEEE-TT--
T ss_pred             EEEcCCCeEeEEEEEEECCC-CceEEEEECCCCh---h---hhcC------HHHHHHHHHHHHhcCCCCCEEEEe-CC--
Confidence            56788888899999876541 1233333321110   0   0011      1357888887764444 4556555 23  


Q ss_pred             EEEEEecCCCCh
Q 037010          356 FLVYEYIENGNL  367 (589)
Q Consensus       356 ~lv~e~~~~gsL  367 (589)
                      .+||||++|.+|
T Consensus       177 G~v~e~I~G~~l  188 (458)
T 2qg7_A          177 GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEECCCSEEC
T ss_pred             eEEEEeeCCccC
Confidence            359999987544

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.67  E-value=0.68  Score=42.81  Aligned_cols=120  Identities=11%  Similarity=0.141  Sum_probs=77.4

Q ss_pred             HHHHHccCCCCcceeEeeEEE-eCcEEEEEEecCCC-ChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 037010          331 ELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENG-NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIH  408 (589)
Q Consensus       331 E~~il~~l~hpnIv~l~~~~~-~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH  408 (589)
                      |+.+|. ..||+.+..- +.. ++.+.+.++.-..+ ++.. +.     .++...+++++.+|+....+++.+     +|
T Consensus        36 el~LL~-~~~~~Fl~~~-I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~r-----~t  102 (215)
T 4ann_A           36 LMYLLE-QHSPYFIDAE-LTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRTR-----YT  102 (215)
T ss_dssp             GGGGGG-SCCTTBCCEE-EEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGSS-----EE
T ss_pred             HHHHHh-ccCCcccceE-EEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcCc-----eE
Confidence            444443 2688888763 333 44455555443322 2222 22     277889999999998877555443     79


Q ss_pred             eccCCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCccc
Q 037010          409 RDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAI  486 (589)
Q Consensus       409 ~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~  486 (589)
                      --|.|+||+++.++.+++.-.|+...                  ++|.     .++...=.-.+=|++..+++++..|
T Consensus       103 f~L~P~NL~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          103 FVLAPDELFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CCCSGGGEEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EEEecceEEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999999999999997775332                  1222     1122222346778999999998877

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.38  E-value=0.15  Score=52.53  Aligned_cols=29  Identities=24%  Similarity=0.485  Sum_probs=24.6

Q ss_pred             eEeeccCCCcEEE------cCCCcEEEEeccCccc
Q 037010          406 YIHRDIKSANILI------DKNFHAKVADFGLTKL  434 (589)
Q Consensus       406 ~vH~Dlkp~NILl------~~~~~vkl~Dfgla~~  434 (589)
                      ++|+|+.+.|||+      +++..+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5899999999999      4456799999988764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.74  E-value=1  Score=41.78  Aligned_cols=113  Identities=10%  Similarity=0.057  Sum_probs=73.4

Q ss_pred             CCCcceeEeeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceEeeccCCCcEE
Q 037010          339 HHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLE-YIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       339 ~hpnIv~l~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~-~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      .||++ ..---..++.+.+.++.-+++.=+..+..     ++...+++++.+|+.... +++.+     +|--|.|+||+
T Consensus        48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-----~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-----TTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLM  116 (219)
T ss_dssp             SCSSS-EEEEEECSSEEEEEEECCTTCEEHHHHHT-----SCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEE
T ss_pred             cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHHHHh-----cCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEE
Confidence            57877 33222334556666665544333333432     778889999888876655 44433     89999999999


Q ss_pred             EcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccc-hhhHHHHHHHHHcCCccc
Q 037010          418 IDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVD-VYAFGVVLYELISAKEAI  486 (589)
Q Consensus       418 l~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sD-vwSlGvll~elltG~~p~  486 (589)
                      ++.++.+++.-.|+-..                  ++|.-+     + ..| .-++=|++..++.++..|
T Consensus       117 f~~~~~p~i~hRGi~~~------------------lpP~e~-----~-ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          117 FNRALEPFFLHVGVKES------------------LPPDEW-----D-DERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             ECTTCCEEESCCEETTT------------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCH
T ss_pred             EeCCCcEEEEEcCCccc------------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCH
Confidence            99999999998775322                  233211     1 123 336778889999988776

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=81.72  E-value=0.78  Score=45.29  Aligned_cols=28  Identities=21%  Similarity=0.315  Sum_probs=24.1

Q ss_pred             ceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          405 VYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .++|+|+++.|||++ + .+.|+||+.+..
T Consensus       196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          196 LRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             EECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            359999999999998 4 899999987653

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=80.58  E-value=0.65  Score=46.92  Aligned_cols=29  Identities=24%  Similarity=0.541  Sum_probs=23.8

Q ss_pred             ceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          405 VYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .++|+|+.+.|||++++. +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            369999999999997654 89999987653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	589
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-69
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-69
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-61
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-59
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-55
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-54
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-54
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-52
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-44
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	7e-41
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-38
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-33
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-17
d1y7ma2	48	d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term	0.003

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  223 bits (569), Expect = 3e-69
 Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 42/300 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFL 329
           +   +  ++G G FG V+     G                  K A+K +     +   FL
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGH----------------TKVAVKSLKQGSMSPDAFL 56

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           AE  ++  + H  LVRL     +  ++++ EY+ENG+L + L+      L  +  + +A 
Sbjct: 57  AEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ +I E      IHRD+++ANIL+      K+ADFGL +L E    +        
Sbjct: 117 QIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173

Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE   YG  + K DV++FG++L E+++                    +    +  
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR-----------------IPYPGMTN 216

Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
           P+ I++L +       DNCP +    + QL ++C +E P+ RP+   +   L    + TE
Sbjct: 217 PEVIQNLERGYRMVRPDNCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 9e-69
 Identities = 77/305 (25%), Positives = 132/305 (43%), Gaps = 48/305 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-----QASR 326
              ++  +IG G FG VY  +  G+                   A+K +++     Q  +
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDV------------------AVKMLNVTAPTPQQLQ 49

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            F  E+ VL    H+N++  +GY     L +V ++ E  +L  HL             + 
Sbjct: 50  AFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLID 108

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP-TR 445
           IA  +A+G++Y+H  ++   IHRD+KS NI + ++   K+ DFGL  +    S S    +
Sbjct: 109 IARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165

Query: 446 LVGTFGYMPPEYAQYGD---VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL 502
           L G+  +M PE  +  D    S + DVYAFG+VLYEL++ +      N        ++ +
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----IIFM 221

Query: 503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM 562
                  PD           ++  NCP      M +L   C ++    RP    I+ ++ 
Sbjct: 222 VGRGYLSPDL---------SKVRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIE 268

Query: 563 TLSST 567
            L+ +
Sbjct: 269 LLARS 273

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 7e-66
 Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 48/293 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE-FLA 330
               +   IG+G FG V   + RG                  K A+K +   A+ + FLA
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRG-----------------NKVAVKCIKNDATAQAFLA 49

Query: 331 ELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           E  V+T + H NLV+L+G  VE  G L++V EY+  G+L ++LR  GR  L     ++ +
Sbjct: 50  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 109

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           LD    +EY+  +     +HRD+ + N+L+ ++  AKV+DFGLTK       S       
Sbjct: 110 LDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKL 162

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
              +  PE  +    S K DV++FG++L+E+ S                    +    + 
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----------------VPYPRIP 205

Query: 509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           L D +  + K       D CP      + ++ K C      +RPS   +   L
Sbjct: 206 LKDVVPRVEKGYKMDAPDGCPPA----VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 9e-63
 Identities = 75/300 (25%), Positives = 124/300 (41%), Gaps = 42/300 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFL 329
           ++  +  K+GQG FG V+     G                  + AIK +     +   FL
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGT----------------TRVAIKTLKPGTMSPEAFL 60

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
            E +V+  + H  LV+L     E  +++V EY+  G+L + L+G     L     V +A 
Sbjct: 61  QEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 120

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
             A G+ Y+        +HRD+++ANIL+ +N   KVADFGL +L E    +        
Sbjct: 121 QIASGMAYVERMNY---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177

Query: 450 FGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
             +  PE A YG  + K DV++FG++L EL +       G                    
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-------------------- 217

Query: 510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE 569
                ++   V+      CP +    +  L   C ++ P+ RP+   +   L    ++TE
Sbjct: 218 -MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-62
 Identities = 75/314 (23%), Positives = 133/314 (42%), Gaps = 54/314 (17%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFL--AELKVLT 336
            IG+G FG V+  + RG                 ++ A+K    +  R +   AE+    
Sbjct: 10  SIGKGRFGEVWRGKWRG-----------------EEVAVKIFSSREERSWFREAEIYQTV 52

Query: 337 HVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDS 391
            + H N++  I    + +     L+LV +Y E+G+L ++L    R  +     +++AL +
Sbjct: 53  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALST 109

Query: 392 ARGLEYIHEHTV-----PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL---P 443
           A GL ++H   V     P   HRD+KS NIL+ KN    +AD GL    +  + ++   P
Sbjct: 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169

Query: 444 TRLVGTFGYMPPEY------AQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
              VGT  YM PE        ++ +   + D+YA G+V +E+                 +
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-------RCSIGGIHE 222

Query: 498 GLVALFEEVLNLPDPIEDLRKLV-----DPRLGDNCPLDSVLK-MAQLAKVCTQEYPQLR 551
                + +++     +E++RK+V      P + +       L+ MA++ + C       R
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282

Query: 552 PSMRSIVVALMTLS 565
            +   I   L  LS
Sbjct: 283 LTALRIKKTLSQLS 296

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 3e-61
 Identities = 69/327 (21%), Positives = 130/327 (39%), Gaps = 53/327 (16%)

Query: 265 EELSKATDNFSMSH-KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           ++L    DN  ++  ++G G FG+V     R                     AIK +   
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQ-------------IDVAIKVLKQG 47

Query: 324 AS----REFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPL 379
                  E + E +++  + +  +VRLIG C   +L LV E    G L + L G  R+ +
Sbjct: 48  TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK-REEI 106

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
           P S+  ++    + G++Y+ E      +HRD+ + N+L+    +AK++DFGL+K      
Sbjct: 107 PVSNVAELLHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163

Query: 440 ASLPTR--LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
           +    R        +  PE   +   S + DV+++GV ++E +S  +   K         
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-------- 215

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                    +  P+ +  + +         CP +    +  L   C     + RP   ++
Sbjct: 216 ---------MKGPEVMAFIEQGKRMECPPECPPE----LYALMSDCWIYKWEDRPDFLTV 262

Query: 558 VVAL----MTLSSTTEDWDVGSFYENH 580
              +     +L+S  E    G  + +H
Sbjct: 263 EQRMRACYYSLASKVE----GHHHHHH 285

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (515), Expect = 3e-61
 Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 42/305 (13%)

Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
           +Y++      + +M HK+G G +G VY    +                     A+K +  
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK---------------YSLTVAVKTLKE 52

Query: 323 QAS--REFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPL 379
                 EFL E  V+  + H NLV+L+G C      +++ E++  GNL ++LR   R  +
Sbjct: 53  DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 112

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
                + +A   +  +EY+ +      IHRD+ + N L+ +N   KVADFGL++L    +
Sbjct: 113 SAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169

Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
            +          +  PE   Y   S K DV+AFGV+L+E+ +   +   G          
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--------- 220

Query: 500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVV 559
                        +  + +L++       P     K+ +L + C Q  P  RPS   I  
Sbjct: 221 ------------DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268

Query: 560 ALMTL 564
           A  T+
Sbjct: 269 AFETM 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (507), Expect = 6e-60
 Identities = 70/321 (21%), Positives = 128/321 (39%), Gaps = 55/321 (17%)

Query: 262 FSYEELSKATDNFS---------MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLM 312
           F++E+ ++A   F+         +   IG G FG V    L+                  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIF---------- 56

Query: 313 QKAAIKKMDMQAS----REFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNL 367
              AIK +    +    R+FL+E  ++    H N++ L G   + + + ++ E++ENG+L
Sbjct: 57  --VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 114

Query: 368 SEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA 427
              LR +          V +    A G++Y+ +      +HRD+ + NIL++ N   KV+
Sbjct: 115 DSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCKVS 170

Query: 428 DFGLTKLTEVGSASLPTR----LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           DFGL++  E  ++               +  PE  QY   +   DV+++G+V++E++S  
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230

Query: 484 EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVC 543
           E                             +D+   ++       P+D    + QL   C
Sbjct: 231 ERPYWD---------------------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDC 269

Query: 544 TQEYPQLRPSMRSIVVALMTL 564
            Q+    RP    IV  L  +
Sbjct: 270 WQKDRNHRPKFGQIVNTLDKM 290

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 8e-60
 Identities = 63/294 (21%), Positives = 117/294 (39%), Gaps = 44/294 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFL 329
            + +   ++G G FG V Y + RG+                   AIK +     +  EF+
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQ----------------YDVAIKMIKEGSMSEDEFI 47

Query: 330 AELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E KV+ ++ H  LV+L G C +   +F++ EY+ NG L  +LR   R        +++ 
Sbjct: 48  EEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMC 106

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
            D    +EY+        +HRD+ + N L++     KV+DFGL++       +       
Sbjct: 107 KDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 163

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
              + PPE   Y   S K D++AFGV+++E+ S  +   +                    
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER-----------------FT 206

Query: 509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM 562
             +  E + + +               +  +   C  E    RP+ + ++  ++
Sbjct: 207 NSETAEHIAQGLRLYRPHLASEK----VYTIMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 3e-59
 Identities = 71/299 (23%), Positives = 129/299 (43%), Gaps = 44/299 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFL 329
              +   +IG G FG V+      +                 K AIK +     +  +F+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNK----------------DKVAIKTIREGAMSEEDFI 48

Query: 330 AELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E +V+  + H  LV+L G C+E   + LV+E++E+G LS++LR + R      + + + 
Sbjct: 49  EEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-TQRGLFAAETLLGMC 107

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVG 448
           LD   G+ Y+ E  V   IHRD+ + N L+ +N   KV+DFG+T+       +  T    
Sbjct: 108 LDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 164

Query: 449 TFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN 508
              +  PE   +   S K DV++FGV+++E+ S  +                 +  E  +
Sbjct: 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK-----------------IPYENRS 207

Query: 509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST 567
             + +ED+                   + Q+   C +E P+ RP+   ++  L  ++ +
Sbjct: 208 NSEVVEDISTGFRLYKPRLASTH----VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (503), Expect = 4e-59
 Identities = 59/295 (20%), Positives = 120/295 (40%), Gaps = 29/295 (9%)

Query: 267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS- 325
           +    D+F    ++G G  G V+    +                     A K + ++   
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKP---------------SGLVMARKLIHLEIKP 45

Query: 326 ---REFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
               + + EL+VL   +   +V   G     G + +  E+++ G+L + L+ +GR  +P 
Sbjct: 46  AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPE 103

Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
               ++++   +GL Y+ E      +HRD+K +NIL++     K+ DFG++        S
Sbjct: 104 QILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDS 158

Query: 442 LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA 501
           +    VGT  YM PE  Q    S + D+++ G+ L E+   +  I   +    +      
Sbjct: 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218

Query: 502 LFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
           +  +    P       + +     D+ P  ++ ++  L  +  +  P+L   + S
Sbjct: 219 VEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFEL--LDYIVNEPPPKLPSGVFS 271

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 1e-58
 Identities = 65/290 (22%), Positives = 119/290 (41%), Gaps = 46/290 (15%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-----REFLAELK 333
           ++G G FG V     + +                +  A+K +  +A+      E LAE  
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVV-------------KTVAVKILKNEANDPALKDELLAEAN 60

Query: 334 VLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSAR 393
           V+  + +  +VR+IG C   S  LV E  E G L+++L+ +    +   + +++    + 
Sbjct: 61  VMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSM 118

Query: 394 GLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL--TEVGSASLPTRLVGTFG 451
           G++Y+ E      +HRD+ + N+L+    +AK++DFGL+K    +       T       
Sbjct: 119 GMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 452 YMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPD 511
           +  PE   Y   S K DV++FGV+++E  S  +   +G                 +   +
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----------------MKGSE 218

Query: 512 PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
               L K         CP +    M  L  +C     + RP   ++ + L
Sbjct: 219 VTAMLEKGERMGCPAGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (496), Expect = 2e-58
 Identities = 79/327 (24%), Positives = 128/327 (39%), Gaps = 62/327 (18%)

Query: 263 SYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM 322
               L    +N      IG+G FG V+ A   G                    A+K +  
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEP----------FTMVAVKMLKE 53

Query: 323 QAS----REFLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD 377
           +AS     +F  E  ++    + N+V+L+G C  G  + L++EY+  G+L+E LR     
Sbjct: 54  EASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPH 113

Query: 378 ----------------------PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSAN 415
                                 PL  + ++ IA   A G+ Y+ E      +HRD+ + N
Sbjct: 114 TVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRN 170

Query: 416 ILIDKNFHAKVADFGLTK-LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGV 474
            L+ +N   K+ADFGL++ +                 +MPPE   Y   + + DV+A+GV
Sbjct: 171 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGV 230

Query: 475 VLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVL 534
           VL+E+ S       G                        E +  + D  +   CP +  L
Sbjct: 231 VLWEIFSYGLQPYYGM--------------------AHEEVIYYVRDGNILA-CPENCPL 269

Query: 535 KMAQLAKVCTQEYPQLRPSMRSIVVAL 561
           ++  L ++C  + P  RPS  SI   L
Sbjct: 270 ELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 2e-57
 Identities = 70/357 (19%), Positives = 130/357 (36%), Gaps = 70/357 (19%)

Query: 235 YKTVESTGPAAG--TPTSLNAITVDKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAE 292
            + V+ TG +              D   EF         +N      +G G FG V  A 
Sbjct: 5   LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPR-------ENLEFGKVLGSGAFGKVMNAT 57

Query: 293 LRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----REFLAELKVLTHV-HHLNLVRLI 347
             G                  + A+K +  +A        ++ELK++T +  H N+V L+
Sbjct: 58  AYGISKTGV----------SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLL 107

Query: 348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGR---------------------DPLPWSSRV 385
           G C   G ++L++EY   G+L  +LR                         + L +   +
Sbjct: 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 167

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEVGSASLPT 444
             A   A+G+E++   +    +HRD+ + N+L+      K+ DFGL + +    +  +  
Sbjct: 168 CFAYQVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 224

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
                  +M PE    G  + K DV+++G++L+E+ S       G               
Sbjct: 225 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI-------------- 270

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                     +  KL+      + P  +  ++  + + C     + RPS  ++   L
Sbjct: 271 ------PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 7e-56
 Identities = 89/334 (26%), Positives = 141/334 (42%), Gaps = 59/334 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           ++      IG+G FG V  A ++              + L   AAIK+M   AS    R+
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKK-------------DGLRMDAAIKRMKEYASKDDHRD 56

Query: 328 FLAELKVLTHV-HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRG------------ 373
           F  EL+VL  + HH N++ L+G C   G L+L  EY  +GNL + LR             
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 374 --SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
             S    L     +  A D ARG++Y+ +      IHRD+ + NIL+ +N+ AK+ADFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGL 173

Query: 432 TKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG 491
           ++  EV      T       +M  E   Y   +   DV+++GV+L+E++S          
Sbjct: 174 SRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------- 224

Query: 492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR 551
                          +   +  E L +        NC  +    +  L + C +E P  R
Sbjct: 225 ----------TPYCGMTCAELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYER 270

Query: 552 PSMRSIVVALMTLSSTTEDWDVGSFYENHALVNL 585
           PS   I+V+L  +    + +   + YE      +
Sbjct: 271 PSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGI 304

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 1e-55
 Identities = 65/313 (20%), Positives = 113/313 (36%), Gaps = 56/313 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           +  S    +G G FG V  A   G   +                A+K +   A       
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDA----------AMTVAVKMLKPSAHLTEREA 72

Query: 328 FLAELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRD-------- 377
            ++ELKVL+++ +H+N+V L+G C  G    ++ EY   G+L   LR             
Sbjct: 73  LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132

Query: 378 --------PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF 429
                    L     +  +   A+G+ ++        IHRD+ + NIL+      K+ DF
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDF 189

Query: 430 GLTK-LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
           GL + +    +  +         +M PE       + + DV+++G+ L+EL S   +   
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
           G                            K++        P  +  +M  + K C    P
Sbjct: 250 GM--------------------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 549 QLRPSMRSIVVAL 561
             RP+ + IV  +
Sbjct: 290 LKRPTFKQIVQLI 302

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 3e-55
 Identities = 75/319 (23%), Positives = 129/319 (40%), Gaps = 51/319 (15%)

Query: 258 KSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI 317
           + V      L     +F+    IG+G FG VY+  L    G                 A+
Sbjct: 18  QHVVIGPSSL---IVHFN--EVIGRGHFGCVYHGTLLDNDGKKIH------------CAV 60

Query: 318 KKM----DMQASREFLAELKVLTHVHHLNLVRLIGYCV--EGSLFLVYEYIENGNLSEHL 371
           K +    D+    +FL E  ++    H N++ L+G C+  EGS  +V  Y+++G+L   +
Sbjct: 61  KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120

Query: 372 RGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
           R    +P      +   L  A+G++++        +HRD+ + N ++D+ F  KVADFGL
Sbjct: 121 RNETHNP-TVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGL 176

Query: 432 TKL---TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVK 488
            +     E  S    T       +M  E  Q    + K DV++FGV+L+EL++       
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA---- 232

Query: 489 GNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYP 548
                             +N  D    L +       + CP      + ++   C     
Sbjct: 233 -------------PPYPDVNTFDITVYLLQGRRLLQPEYCPDP----LYEVMLKCWHPKA 275

Query: 549 QLRPSMRSIVVALMTLSST 567
           ++RPS   +V  +  + ST
Sbjct: 276 EMRPSFSELVSRISAIFST 294

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 4e-55
 Identities = 62/308 (20%), Positives = 124/308 (40%), Gaps = 42/308 (13%)

Query: 269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQA 324
           K T+ F     +G G FG VY      E              +    AIK++      +A
Sbjct: 7   KETE-FKKIKVLGSGAFGTVYKGLWIPEG-----------EKVKIPVAIKELREATSPKA 54

Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
           ++E L E  V+  V + ++ RL+G C+  ++ L+ + +  G L ++     +D +     
Sbjct: 55  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDY-VREHKDNIGSQYL 113

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
           +   +  A+G+ Y+ +  +   +HRD+ + N+L+    H K+ DFGL KL          
Sbjct: 114 LNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170

Query: 445 -RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
                   +M  E   +   + + DV+++GV ++EL++       G      +  + ++ 
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----PASEISSIL 226

Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMT 563
           E+   LP P               C +D    +  +   C       RP  R +++    
Sbjct: 227 EKGERLPQP-------------PICTID----VYMIMVKCWMIDADSRPKFRELIIEFSK 269

Query: 564 LSSTTEDW 571
           ++   + +
Sbjct: 270 MARDPQRY 277

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 5e-55
 Identities = 57/299 (19%), Positives = 108/299 (36%), Gaps = 44/299 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM------DMQAS 325
            +  +  K+G G FG V   E     G                 A+K +        +A 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGK------------TVSVAVKCLKPDVLSQPEAM 55

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
            +F+ E+  +  + H NL+RL G  +   + +V E    G+L +      +      +  
Sbjct: 56  DDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-LRKHQGHFLLGTLS 114

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS--LP 443
           + A+  A G+ Y+        IHRD+ + N+L+      K+ DFGL +          + 
Sbjct: 115 RYAVQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
                 F +  PE  +    S   D + FGV L+E+ +  +    G            + 
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-------LNGSQIL 224

Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM 562
            ++    + +            ++CP D    +  +   C    P+ RP+  ++   L+
Sbjct: 225 HKIDKEGERLPRP---------EDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 6e-55
 Identities = 58/303 (19%), Positives = 118/303 (38%), Gaps = 51/303 (16%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS-- 325
           S+A +++ + + IG G +G       +                  +    K++D  +   
Sbjct: 1   SRA-EDYEVLYTIGTGSYGRCQKIRRKS---------------DGKILVWKELDYGSMTE 44

Query: 326 ---REFLAELKVLTHVHHLNLVRLIGYCVE---GSLFLVYEYIENGNLSEHLRGSGRD-- 377
              +  ++E+ +L  + H N+VR     ++    +L++V EY E G+L+  +    ++  
Sbjct: 45  AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ 104

Query: 378 PLPWSSRVQIALDSARGLEYIHEHTVPV--YIHRDIKSANILIDKNFHAKVADFGLTKLT 435
            L     +++       L+  H  +      +HRD+K AN+ +D   + K+ DFGL ++ 
Sbjct: 105 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164

Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
              + S     VGT  YM PE       + K D+++ G +LYEL +              
Sbjct: 165 NHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------------ 211

Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
                  F    +  +    +R+    R+      +    + ++           RPS+ 
Sbjct: 212 -----PPFTA-FSQKELAGKIREGKFRRIPYRYSDE----LNEIITRMLNLKDYHRPSVE 261

Query: 556 SIV 558
            I+
Sbjct: 262 EIL 264

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 7e-55
 Identities = 66/297 (22%), Positives = 111/297 (37%), Gaps = 43/297 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
              +    IG G FG VY   L+   G                 AIK +    +     +
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGK-----------KEVPVAIKTLKAGYTEKQRVD 55

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
           FL E  ++    H N++RL G   +   + ++ EY+ENG   +               V 
Sbjct: 56  FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG-ALDKFLREKDGEFSVLQLVG 114

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR- 445
           +    A G++Y+         HRD+ + NIL++ N   KV+DFGL+++ E    +  T  
Sbjct: 115 MLRGIAAGMKYLANMNYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 446 -LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
                  +  PE   Y   +   DV++FG+V++E+++  E                    
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------------- 217

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL 561
                     ++ K ++       P+D    + QL   C Q+    RP    IV  L
Sbjct: 218 -------SNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-54
 Identities = 66/294 (22%), Positives = 111/294 (37%), Gaps = 53/294 (18%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM------DMQAS 325
           ++F +   +G+G FG VY A  +                     A+K +           
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQ---------------SKFILALKVLFKAQLEKAGVE 50

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
            +   E+++ +H+ H N++RL GY  +   ++L+ EY   G +   L+            
Sbjct: 51  HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRT 108

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
                + A  L Y H   V   IHRDIK  N+L+      K+ADFG +       +S  T
Sbjct: 109 ATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRT 162

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
            L GT  Y+PPE  +      KVD+++ GV+ YE +  K           ++      ++
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF--------EANTYQETYK 214

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
            +  +     D    V     D            L     +  P  RP +R ++
Sbjct: 215 RISRVEFTFPD---FVTEGARD------------LISRLLKHNPSQRPMLREVL 253

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-54
 Identities = 61/297 (20%), Positives = 105/297 (35%), Gaps = 41/297 (13%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           +   +   IG+G FG V+          +               AIK      S     +
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPAL------------AVAIKTCKNCTSDSVREK 54

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           FL E   +    H ++V+LIG   E  ++++ E    G L        +  L  +S +  
Sbjct: 55  FLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGEL-RSFLQVRKYSLDLASLILY 113

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLV 447
           A   +  L Y+        +HRDI + N+L+  N   K+ DFGL++  E  +    ++  
Sbjct: 114 AYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
               +M PE   +   +   DV+ FGV ++E++                        + +
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----------------KPFQGV 213

Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL 564
              D I  +       +  NCP      +  L   C    P  RP    +   L T+
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 4e-54
 Identities = 60/291 (20%), Positives = 111/291 (38%), Gaps = 53/291 (18%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-----DMQASREFLAELK 333
           +IG+G F  VY                        + A  ++          + F  E +
Sbjct: 16  EIGRGSFKTVYKGLDTE---------------TTVEVAWCELQDRKLTKSERQRFKEEAE 60

Query: 334 VLTHVHHLNLVRLIGYCV-----EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           +L  + H N+VR           +  + LV E + +G L  +L+      +         
Sbjct: 61  MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWC 118

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILI-DKNFHAKVADFGLTKLTEVGSASLPTRLV 447
               +GL+++H  T P+ IHRD+K  NI I       K+ D GL  L     AS    ++
Sbjct: 119 RQILKGLQFLHTRTPPI-IHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVI 174

Query: 448 GTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL 507
           GT  +M PE  +       VDVYAFG+ + E+ +++          ++ +    ++  V 
Sbjct: 175 GTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPY-------SECQNAAQIYRRVT 226

Query: 508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           +   P     K+  P + +            + + C ++    R S++ ++
Sbjct: 227 SGVKP-ASFDKVAIPEVKE------------IIEGCIRQNKDERYSIKDLL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 5e-53
 Identities = 60/306 (19%), Positives = 114/306 (37%), Gaps = 52/306 (16%)

Query: 264 YEELSK---ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM 320
           YE +++     D + +  ++G G FG VY A+ +                    AA K +
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETS---------------VLAAAKVI 45

Query: 321 DM---QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGR 376
           D    +   +++ E+ +L    H N+V+L+     E +L+++ E+   G +   +    R
Sbjct: 46  DTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER 105

Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE 436
            PL  S    +   +   L Y+H++ +   IHRD+K+ NIL   +   K+ADFG++    
Sbjct: 106 -PLTESQIQVVCKQTLDALNYLHDNKI---IHRDLKAGNILFTLDGDIKLADFGVSAKNT 161

Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGD-----VSPKVDVYAFGVVLYELISAKEAIVKGNG 491
             +       +GT  +M PE              K DV++ G+ L E+   +        
Sbjct: 162 -RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE-------- 212

Query: 492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLR 551
                   + +  ++     P             D              K C ++    R
Sbjct: 213 PPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD------------FLKKCLEKNVDAR 260

Query: 552 PSMRSI 557
            +   +
Sbjct: 261 WTTSQL 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-52
 Identities = 57/293 (19%), Positives = 112/293 (38%), Gaps = 47/293 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM----QASRE 327
           +++ +   +G+G +G V  A  R                  +  A+K +DM         
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRV---------------TEEAVAVKIVDMKRAVDCPEN 49

Query: 328 FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
              E+ +   ++H N+V+  G+       +L  EY   G L + +       +P     +
Sbjct: 50  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQR 107

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTR 445
                  G+ Y+H   +    HRDIK  N+L+D+  + K++DFGL  +    +   L  +
Sbjct: 108 FFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164

Query: 446 LVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE 504
           + GT  Y+ PE  +  +  +  VDV++ G+VL  +++ +    + + S          + 
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYS 217

Query: 505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           +       +   +K +D                 L      E P  R ++  I
Sbjct: 218 DWKEKKTYLNPWKK-IDSAPLA------------LLHKILVENPSARITIPDI 257

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  178 bits (453), Expect = 4e-52
 Identities = 68/298 (22%), Positives = 107/298 (35%), Gaps = 56/298 (18%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM------QA 324
              FS   +IG G FGAVY+A                     +  AIKKM        + 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVR---------------NSEVVAIKKMSYSGKQSNEK 58

Query: 325 SREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
            ++ + E++ L  + H N ++  G  + E + +LV EY                PL    
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVE 116

Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
              +   + +GL Y+H H +   IHRD+K+ NIL+ +    K+ DFG   +         
Sbjct: 117 IAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168

Query: 444 TRLVGTFGYMPPEYAQ---YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
              VGT  +M PE       G    KVDV++ G+   EL   K  +   N         +
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AM 220

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
           +    +     P              +               C Q+ PQ RP+   ++
Sbjct: 221 SALYHIAQNESP---------ALQSGHWSEY----FRNFVDSCLQKIPQDRPTSEVLL 265

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 5e-51
 Identities = 74/304 (24%), Positives = 136/304 (44%), Gaps = 48/304 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           +  +MS ++GQG FG VY    +G   +              + AIK ++  AS     E
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEP----------ETRVAIKTVNEAASMRERIE 69

Query: 328 FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRD--------P 378
           FL E  V+   +  ++VRL+G         ++ E +  G+L  +LR             P
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTK-LTEV 437
              S  +Q+A + A G+ Y++ +     +HRD+ + N ++ ++F  K+ DFG+T+ + E 
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 438 GSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                  + +    +M PE  + G  +   DV++FGVVL+E+ +  E   +G        
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------- 239

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                           + LR +++  L D  P +    + +L ++C Q  P++RPS   I
Sbjct: 240 -------------SNEQVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285

Query: 558 VVAL 561
           + ++
Sbjct: 286 ISSI 289

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 6e-50
 Identities = 75/315 (23%), Positives = 126/315 (40%), Gaps = 55/315 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           D   +   +G+G FG V  A+  G    +            +  A+K +   A+    R 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTA----------TCRTVAVKMLKEGATHSEHRA 62

Query: 328 FLAELKVLTH-VHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSG--------- 375
            ++ELK+L H  HHLN+V L+G C +  G L ++ E+ + GNLS +LR            
Sbjct: 63  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 376 -----RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG 430
                +D L     +  +   A+G+E++        IHRD+ + NIL+ +    K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFG 179

Query: 431 LTK-LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKG 489
           L + + +               +M PE       + + DV++FGV+L+E+ S        
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------- 231

Query: 490 NGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQ 549
                      + +  V    +    L++    R  D    +    M Q    C    P 
Sbjct: 232 --------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPS 279

Query: 550 LRPSMRSIVVALMTL 564
            RP+   +V  L  L
Sbjct: 280 QRPTFSELVEHLGNL 294

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 1e-49
 Identities = 73/319 (22%), Positives = 135/319 (42%), Gaps = 56/319 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS----RE 327
           D   +   +G+G FG V  AE  G   +            + K A+K +   A+     +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNR--------VTKVAVKMLKSDATEKDLSD 64

Query: 328 FLAELKVLTHV-HHLNLVRLIGYCVEGS-LFLVYEYIENGNLSEHLRGSG---------- 375
            ++E++++  +  H N++ L+G C +   L+++ EY   GNL E+L+             
Sbjct: 65  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124

Query: 376 ----RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
                + L     V  A   ARG+EY+        IHRD+ + N+L+ ++   K+ADFGL
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGL 181

Query: 432 TK-LTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGN 490
            + +  +      T       +M PE       + + DV++FGV+L+E+ +   +   G 
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241

Query: 491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQL 550
                                P+E+L KL+      + P +   ++  + + C    P  
Sbjct: 242 ---------------------PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQ 280

Query: 551 RPSMRSIVVAL---MTLSS 566
           RP+ + +V  L   + L+S
Sbjct: 281 RPTFKQLVEDLDRIVALTS 299

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 6e-48
 Identities = 62/294 (21%), Positives = 113/294 (38%), Gaps = 52/294 (17%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASRE 327
              ++   KIGQG  G VY A                     Q+ AI++M          
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVA---------------TGQEVAIRQMNLQQQPKKEL 63

Query: 328 FLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQ 386
            + E+ V+    + N+V  +   +    L++V EY+  G+L++ +       +       
Sbjct: 64  IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAA 120

Query: 387 IALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRL 446
           +  +  + LE++H + V   IHRDIKS NIL+  +   K+ DFG         +   + +
Sbjct: 121 VCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STM 176

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV 506
           VGT  +M PE        PKVD+++ G++  E+I  +                   +   
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE-----------------PPYLN- 218

Query: 507 LNLPDPIEDLRKLV---DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
               +P+  L  +     P L +   L ++ +       C     + R S + +
Sbjct: 219 ---ENPLRALYLIATNGTPELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKEL 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 9e-47
 Identities = 51/223 (22%), Positives = 89/223 (39%), Gaps = 28/223 (12%)

Query: 269 KATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM------ 322
           K  ++F     +G+G F  V  A                     ++ AIK ++       
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELA---------------TSREYAIKILEKRHIIKE 49

Query: 323 QASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPW 381
                   E  V++ + H   V+L      +  L+    Y +NG L +++R  G      
Sbjct: 50  NKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDE 107

Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
           +       +    LEY+H   +   IHRD+K  NIL++++ H ++ DFG  K+    S  
Sbjct: 108 TCTRFYTAEIVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164

Query: 442 LP-TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
                 VGT  Y+ PE           D++A G ++Y+L++  
Sbjct: 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  161 bits (409), Expect = 2e-45
 Identities = 53/292 (18%), Positives = 99/292 (33%), Gaps = 46/292 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM---DMQASREF 328
           D++ +  ++G G FG V+    R                     A K +           
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERA---------------TGNNFAAKFVMTPHESDKETV 70

Query: 329 LAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
             E++ ++ + H  LV L      +  + ++YE++  G L E +       +     V+ 
Sbjct: 71  RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEY 129

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILI--DKNFHAKVADFGLTKLTEVGSASLPTR 445
                +GL ++HE+     +H D+K  NI+    ++   K+ DFGLT   +   +   T 
Sbjct: 130 MRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT- 185

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
             GT  +  PE A+   V    D+++ GV+ Y L+S               +        
Sbjct: 186 -TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF--------GGENDDETLRN 236

Query: 506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           V +    +       D         D         +      P  R ++   
Sbjct: 237 VKSCDWNM-------DDSAFSGISED----GKDFIRKLLLADPNTRMTIHQA 277

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 5e-44
 Identities = 61/302 (20%), Positives = 112/302 (37%), Gaps = 49/302 (16%)

Query: 264 YEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQ 323
           +++     D +     +G G F  V  AE +                  +  AIK +  +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKR---------------TQKLVAIKCIAKK 45

Query: 324 AS----REFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDP 378
           A          E+ VL  + H N+V L       G L+L+ + +  G L + +   G   
Sbjct: 46  ALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--F 103

Query: 379 LPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLT 435
                  ++       ++Y+H+  +   +HRD+K  N+L    D++    ++DFGL+K+ 
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160

Query: 436 EVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSAD 495
           + GS  + +   GT GY+ PE       S  VD ++ GV+ Y L+               
Sbjct: 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF--------Y 210

Query: 496 SKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR 555
            +    LFE++L             D    D+             +   ++ P+ R +  
Sbjct: 211 DENDAKLFEQILKAEYEF-------DSPYWDDISDS----AKDFIRHLMEKDPEKRFTCE 259

Query: 556 SI 557
             
Sbjct: 260 QA 261

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  158 bits (400), Expect = 6e-44
 Identities = 54/293 (18%), Positives = 104/293 (35%), Gaps = 48/293 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD---MQASREF 328
           D + +  ++G G FG V+    +                  +    K ++          
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKA---------------TGRVFVAKFINTPYPLDKYTV 73

Query: 329 LAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
             E+ ++  +HH  L+ L     +   + L+ E++  G L + +       +  +  +  
Sbjct: 74  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINY 132

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILID--KNFHAKVADFGLTKLTEVGSASLPTR 445
              +  GL+++HEH++   +H DIK  NI+ +  K    K+ DFGL    ++    +   
Sbjct: 133 MRQACEGLKHMHEHSI---VHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKV 187

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
              T  +  PE      V    D++A GV+ Y L+S               +  +   + 
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF--------AGEDDLETLQN 239

Query: 506 VLNL-PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           V     +  ED    V P   D              K   Q+ P+ R ++   
Sbjct: 240 VKRCDWEFDEDAFSSVSPEAKD------------FIKNLLQKEPRKRLTVHDA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-43
 Identities = 71/306 (23%), Positives = 120/306 (39%), Gaps = 32/306 (10%)

Query: 267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR 326
           L +A   +    +IG+G +G V+ A      G     R + +  +  +   + M +   R
Sbjct: 2   LCRADQQYECVAEIGEGAYGKVFKARDLKNGG-----RFVALKRVRVQTGEEGMPLSTIR 56

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
           E +A L+ L    H N+VRL   C       E  L LV+E+++      +L       +P
Sbjct: 57  E-VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVP 114

Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA 440
             +   +     RGL+++H H V   +HRD+K  NIL+  +   K+ADFGL ++      
Sbjct: 115 TETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTSSGQIKLADFGLARIYS--FQ 169

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
              T +V T  Y  PE       +  VD+++ G +  E+   K          +     +
Sbjct: 170 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF-----RGSSDVDQL 224

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLK---------MAQLAKVCTQEYPQLR 551
               +V+ LP   +  R +  PR   +      ++            L   C    P  R
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 284

Query: 552 PSMRSI 557
            S  S 
Sbjct: 285 ISAYSA 290

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  156 bits (395), Expect = 3e-43
 Identities = 60/253 (23%), Positives = 102/253 (40%), Gaps = 18/253 (7%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           ++FS+   IG+GGFG VY              ++  +  L +K    K     +      
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKAD------TGKMYAMKCLDKKRIKMKQGETLALNERIM 57

Query: 332 LKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALD 390
           L +++      +V +         L  + + +  G+L  HL          +     A +
Sbjct: 58  LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAE 115

Query: 391 SARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTF 450
              GLE++H   V   ++RD+K ANIL+D++ H +++D GL       S   P   VGT 
Sbjct: 116 IILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTH 169

Query: 451 GYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL 509
           GYM PE  Q G       D ++ G +L++L+       +                  + L
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMTLTMAVEL 228

Query: 510 PDPI-EDLRKLVD 521
           PD    +LR L++
Sbjct: 229 PDSFSPELRSLLE 241

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 7e-43
 Identities = 48/292 (16%), Positives = 101/292 (34%), Gaps = 47/292 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE--FL 329
           + + ++  +G+G FG V+                       +    K + ++ + +    
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETS---------------SKKTYMAKFVKVKGTDQVLVK 49

Query: 330 AELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
            E+ +L    H N++ L         L +++E+I   ++ E +  S    L     V   
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYV 108

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILID--KNFHAKVADFGLTKLTEVGSASLPTRL 446
                 L+++H H +    H DI+  NI+    ++   K+ +FG  +  + G       L
Sbjct: 109 HQVCEALQFLHSHNI---GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLL 163

Query: 447 VGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV 506
                Y  PE  Q+  VS   D+++ G ++Y L+S              ++    + E +
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF--------LAETNQQIIENI 215

Query: 507 LN-LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
           +N      E+  K +     D                   +  + R +    
Sbjct: 216 MNAEYTFDEEAFKEISIEAMD------------FVDRLLVKERKSRMTASEA 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  152 bits (386), Expect = 7e-43
 Identities = 61/299 (20%), Positives = 113/299 (37%), Gaps = 52/299 (17%)

Query: 268 SKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM------D 321
           S  +D + +   +G GG   V+ A                   L +  A+K +      D
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLR---------------LHRDVAVKVLRADLARD 47

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCVE-----GSLFLVYEYIENGNLSEHLRGSGR 376
                 F  E +    ++H  +V +              ++V EY++   L + +   G 
Sbjct: 48  PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG- 106

Query: 377 DPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTE 436
            P+     +++  D+ + L + H++ +   IHRD+K ANI+I      KV DFG+ +   
Sbjct: 107 -PMTPKRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVKVMDFGIARAIA 162

Query: 437 VGSASLP--TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSA 494
               S+     ++GT  Y+ PE A+   V  + DVY+ G VLYE+++ +      +  S 
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS- 221

Query: 495 DSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
                   ++ V   P P     + +   L              +      + P+ R  
Sbjct: 222 ------VAYQHVREDPIPPSARHEGLSADLDA------------VVLKALAKNPENRYQ 262

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  151 bits (382), Expect = 3e-42
 Identities = 49/294 (16%), Positives = 107/294 (36%), Gaps = 37/294 (12%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           +N+     +G+G    V     +      Y   +  +++    +   +   +     L E
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHK-PTCKEY--AVKIIDVTGGGSFSAEEVQELREATLKE 59

Query: 332 LKVLTHVH-HLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIAL 389
           + +L  V  H N+++L          FLV++ ++ G L ++L       L      +I  
Sbjct: 60  VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMR 117

Query: 390 DSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGT 449
                +  +H+  +   +HRD+K  NIL+D + + K+ DFG +   ++        + GT
Sbjct: 118 ALLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGT 172

Query: 450 FGYMPPEYAQ------YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF 503
             Y+ PE  +      +     +VD+++ GV++Y L++               +  + + 
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--------WHRKQMLML 224

Query: 504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
             +++                 D+        +  L        PQ R +    
Sbjct: 225 RMIMSGNYQF-------GSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEA 267

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 4e-41
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 29/220 (13%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS------ 325
           ++F +   +G+G FG V+ AE +                  Q  AIK +           
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKK---------------TNQFFAIKALKKDVVLMDDDV 46

Query: 326 REFLAELKVLTHV-HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
              + E +VL+    H  L  +      + +LF V EY+  G+L  H++   +     S 
Sbjct: 47  ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSR 104

Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLP 443
               A +   GL+++H   +   ++RD+K  NIL+DK+ H K+ADFG+ K   +G  +  
Sbjct: 105 ATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKT 160

Query: 444 TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
               GT  Y+ PE       +  VD ++FGV+LYE++  +
Sbjct: 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (373), Expect = 7e-41
 Identities = 66/304 (21%), Positives = 119/304 (39%), Gaps = 43/304 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           +NF    KIG+G +G VY A  +               L  +  A+KK+ +    E    
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNK---------------LTGEVVALKKIRLDTETEGVPS 46

Query: 328 -FLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             + E+ +L  ++H N+V+L+     E  L+LV+E++ + +L + +  S    +P     
Sbjct: 47  TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK 105

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
                  +GL + H H V   +HRD+K  N+LI+     K+ADFGL +   V   +    
Sbjct: 106 SYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK------------EAIVKGNGSS 493
           +V  +   P         S  VD+++ G +  E+++ +              I +  G+ 
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTP 222

Query: 494 ADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS 553
            +      ++  V ++PD      K          P         L        P  R S
Sbjct: 223 DEV-----VWPGVTSMPDYKPSFPKWARQDFSKVVPPLD-EDGRSLLSQMLHYDPNKRIS 276

Query: 554 MRSI 557
            ++ 
Sbjct: 277 AKAA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  145 bits (367), Expect = 8e-40
 Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 31/219 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM------DMQAS 325
            +F +   +G G FG V+    R                  +  A+K +       ++  
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRH---------------NGRYYAMKVLKKEIVVRLKQV 48

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
                E  +L+ V H  ++R+ G   +   +F++ +YIE G L   LR S R P P +  
Sbjct: 49  EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF 108

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
              A +    LEY+H   +   I+RD+K  NIL+DKN H K+ DFG  K        +  
Sbjct: 109 --YAAEVCLALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTY 159

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            L GT  Y+ PE       +  +D ++FG+++YE+++  
Sbjct: 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 198

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 52/297 (17%), Positives = 99/297 (33%), Gaps = 49/297 (16%)

Query: 272 DNFSMSHK-IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREF 328
           D++ ++ + +G G  G V     +                  +K A+K +    +A RE 
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKR---------------TQEKFALKMLQDCPKARREV 55

Query: 329 LAELKVLTHVHHLNLVRLIGYC-----VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSS 383
               +        ++VR++            L +V E ++ G L   ++  G        
Sbjct: 56  ELHWRAS---QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112

Query: 384 RVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---NFHAKVADFGLTKLTEVGSA 440
             +I       ++Y+H   +    HRD+K  N+L      N   K+ DFG  K  E  S 
Sbjct: 113 ASEIMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSH 167

Query: 441 SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV 500
           +  T    T  Y+ PE           D+++ GV++Y L+         +G +       
Sbjct: 168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227

Query: 501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
            +       P+P                  +    +  L +   +  P  R ++   
Sbjct: 228 RIRMGQYEFPNPEW-----------SEVSEE----VKMLIRNLLKTEPTQRMTITEF 269

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (364), Expect = 1e-39
 Identities = 54/299 (18%), Positives = 86/299 (28%), Gaps = 47/299 (15%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASR-EFLA 330
           + + +  KIG G FG +Y                       ++ AIK   ++    +   
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIA---------------AGEEVAIKLECVKTKHPQLHI 51

Query: 331 ELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           E K+   +     +  I +C        +V E +           S        + + +A
Sbjct: 52  ESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLA 109

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILI---DKNFHAKVADFGLTKLTEVGSASLP-- 443
                 +EYIH       IHRD+K  N L+    K     + DFGL K            
Sbjct: 110 DQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP 166

Query: 444 ----TRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL 499
                 L GT  Y         + S + D+ + G VL               ++   K  
Sbjct: 167 YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-- 224

Query: 500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV 558
                    +  PIE L K          P +     A     C       +P    + 
Sbjct: 225 -YERISEKKMSTPIEVLCK--------GYPSE----FATYLNFCRSLRFDDKPDYSYLR 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-39
 Identities = 48/301 (15%), Positives = 97/301 (32%), Gaps = 40/301 (13%)

Query: 262 FSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD 321
           F  E +    D +    ++G G F  V     +                + ++       
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKS------TGLQYAAKFIKKRRTKSSRR 53

Query: 322 MQASREFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLP 380
             +  +   E+ +L  + H N++ L      +  + L+ E +  G L + L    ++ L 
Sbjct: 54  GVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLT 111

Query: 381 WSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN----FHAKVADFGLTKLTE 436
                +       G+ Y+H   +    H D+K  NI++          K+ DFGL    +
Sbjct: 112 EEEATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168

Query: 437 VGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS 496
            G+      + GT  ++ PE   Y  +  + D+++ GV+ Y L+S               
Sbjct: 169 FGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF--------LG 218

Query: 497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRS 556
                    V  +    E            N             +    + P+ R +++ 
Sbjct: 219 DTKQETLANVSAVNYEFE-------DEYFSNTSAL----AKDFIRRLLVKDPKKRMTIQD 267

Query: 557 I 557
            
Sbjct: 268 S 268

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  141 bits (356), Expect = 1e-38
 Identities = 51/323 (15%), Positives = 92/323 (28%), Gaps = 56/323 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQA-SREFLA 330
            ++ +  +IG+G FG ++                    L  Q+ AIK    ++ + +   
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNL---------------LNNQQVAIKFEPRRSDAPQLRD 49

Query: 331 ELKVLTHVHHLNLVRLIGYCVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           E +    +     +  + Y  +      LV + +  G   E L           +    A
Sbjct: 50  EYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAA 107

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH-----AKVADFGLTKLTEVGSAS-- 441
                 ++ IHE ++   ++RDIK  N LI +          V DFG+ K          
Sbjct: 108 KQMLARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164

Query: 442 ----LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK 497
                   L GT  YM        + S + D+ A G V    +          G  A + 
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW---QGLKAATN 221

Query: 498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                         P+ +L            P +      +             P    +
Sbjct: 222 KQKYERIGEKKQSTPLRELCA--------GFPEE----FYKYMHYARNLAFDATPDYDYL 269

Query: 558 VVALMTLSSTTE-------DWDV 573
                 +            DW++
Sbjct: 270 QGLFSKVLERLNTTEDENFDWNL 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 3e-38
 Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 20/286 (6%)

Query: 279 KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV 338
            +G+G F  VY A  +        ++++ +   ++     +     +R  L E+K+L  +
Sbjct: 5   FLGEGQFATVYKARDKN------TNQIVAIKK-IKLGHRSEAKDGINRTALREIKLLQEL 57

Query: 339 HHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEY 397
            H N++ L+       ++ LV++++E          S    L  S      L + +GLEY
Sbjct: 58  SHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEY 115

Query: 398 IHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEY 457
           +H+H +   +HRD+K  N+L+D+N   K+ADFGL K          T  V T  Y  PE 
Sbjct: 116 LHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPEL 171

Query: 458 AQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDL 516
                +    VD++A G +L EL+     +   +     ++    L          +  L
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 517 RKLVDPRLGDNCPLDSVLKMA-----QLAKVCTQEYPQLRPSMRSI 557
              V  +     PL  +   A      L +      P  R +    
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  139 bits (351), Expect = 6e-38
 Identities = 59/298 (19%), Positives = 112/298 (37%), Gaps = 33/298 (11%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
           + +    KIG+G +G VY A+                    +  A+KK+ ++   E    
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYG----------------ETFALKKIRLEKEDEGIPS 45

Query: 328 -FLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             + E+ +L  + H N+V+L         L LV+E+++           G   L   +  
Sbjct: 46  TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAK 103

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
              L    G+ Y H+  V   +HRD+K  N+LI++    K+ADFGL +   +        
Sbjct: 104 SFLLQLLNGIAYCHDRRV---LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
           +V  +   P         S  +D+++ G +  E+++        + +    +    L   
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220

Query: 506 VL-NLPDPIEDLRKLVDPRLGDNCPLDSVLK-----MAQLAKVCTQEYPQLRPSMRSI 557
              N P+  E  +   +  + +  P +S LK        L     +  P  R + +  
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 9e-38
 Identities = 59/311 (18%), Positives = 107/311 (34%), Gaps = 49/311 (15%)

Query: 271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASR 326
              ++    IG+G +G V  A                      + AIKK+         +
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNV---------------NKVRVAIKKISPFEHQTYCQ 51

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCVEGS-----LFLVYEYIENGNLSEHLRGSGRDPLPW 381
             L E+K+L    H N++ +       +        +  ++   +L + L+      L  
Sbjct: 52  RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSN 108

Query: 382 SSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS 441
                      RGL+YIH   V   +HRD+K +N+L++     K+ DFGL ++ +     
Sbjct: 109 DHICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165

Query: 442 --LPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAK------------EAI 486
               T  V T  Y  PE        +  +D+++ G +L E++S +              I
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225

Query: 487 VKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQE 546
           +   GS +       +  +  N    +    K+   RL  N    ++     L       
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL----DLLDKMLTF 281

Query: 547 YPQLRPSMRSI 557
            P  R  +   
Sbjct: 282 NPHKRIEVEQA 292

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-37
 Identities = 71/324 (21%), Positives = 107/324 (33%), Gaps = 61/324 (18%)

Query: 257 DKSVEFSYEELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAA 316
           D+  E SY +             IG G FG VY A+L                   +  A
Sbjct: 15  DRPQEVSYTDT----------KVIGNGSFGVVYQAKLCD---------------SGELVA 49

Query: 317 IKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGS-------LFLVYEYIENGNLSE 369
           IKK+  Q  R    EL+++  + H N+VRL  +            L LV +Y+       
Sbjct: 50  IKKVL-QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108

Query: 370 HLRGS-GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHAKVA 427
               S  +  LP            R L YIH   +    HRDIK  N+L+D +    K+ 
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAVLKLC 165

Query: 428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK---- 483
           DFG  K    G     + +   +   P       D +  +DV++ G VL EL+  +    
Sbjct: 166 DFGSAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224

Query: 484 --------EAIVKGNGSSADS--KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSV 533
                     I+K  G+      + +   + E            K+  PR          
Sbjct: 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEA----- 279

Query: 534 LKMAQLAKVCTQEYPQLRPSMRSI 557
                L     +  P  R +    
Sbjct: 280 ---IALCSRLLEYTPTARLTPLEA 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 5e-37
 Identities = 77/320 (24%), Positives = 127/320 (39%), Gaps = 61/320 (19%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
             +    KIGQG FG V+ A  R                  QK A+KK+ M+  +E    
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRK---------------TGQKVALKKVLMENEKEGFPI 54

Query: 328 -FLAELKVLTHVHHLNLVRLIGYCV---------EGSLFLVYEYIENGNLSEHLRGSGRD 377
             L E+K+L  + H N+V LI  C          +GS++LV+++ E+           + 
Sbjct: 55  TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK- 113

Query: 378 PLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV 437
               S   ++      GL YIH + +   +HRD+K+AN+LI ++   K+ADFGL +   +
Sbjct: 114 -FTLSEIKRVMQMLLNGLYYIHRNKI---LHRDMKAANVLITRDGVLKLADFGLARAFSL 169

Query: 438 GSAS---LPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAK---------- 483
              S     T  V T  Y PPE      D  P +D++  G ++ E+ +            
Sbjct: 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229

Query: 484 --EAIVKGNGS----SADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMA 537
               I +  GS       +     L+E++  +      ++  +   + D   LD + K+ 
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289

Query: 538 QLAKVCTQEYPQLRPSMRSI 557
            L        P  R      
Sbjct: 290 VLD-------PAQRIDSDDA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 1e-36
 Identities = 59/291 (20%), Positives = 98/291 (33%), Gaps = 47/291 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
             + +   +G GGFG+VY             +  + +  + +       ++        E
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVS------DNLPVAIKHVEKDRISDWGELPNGTRVPME 57

Query: 332 LKVLTHVH--HLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIA 388
           + +L  V      ++RL+ +     S  L+ E  E            R  L         
Sbjct: 58  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFF 116

Query: 389 LDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHAKVADFGLTKLTEVGSASLPTRLV 447
                 + + H   V   +HRDIK  NILID N    K+ DFG   L +    ++ T   
Sbjct: 117 WQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD 170

Query: 448 GTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV 506
           GT  Y PPE+ +Y         V++ G++LY+++                      FE  
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-----------------IPFEH- 212

Query: 507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
               + I   +     R+   C          L + C    P  RP+   I
Sbjct: 213 ---DEEIIRGQVFFRQRVSSEC--------QHLIRWCLALRPSDRPTFEEI 252

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 8e-36
 Identities = 55/219 (25%), Positives = 85/219 (38%), Gaps = 28/219 (12%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS------ 325
           ++F     +G+G FG V     +                  +  A+K +  +        
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKA---------------TGRYYAMKILRKEVIIAKDEV 49

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
              + E +VL +  H  L  L         L  V EY   G L  HL             
Sbjct: 50  AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERA 107

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
                +    LEY+H   V   ++RDIK  N+++DK+ H K+ DFGL K      A++  
Sbjct: 108 RFYGAEIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK- 163

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
              GT  Y+ PE  +  D    VD +  GVV+YE++  +
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 5e-35
 Identities = 62/300 (20%), Positives = 108/300 (36%), Gaps = 35/300 (11%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASRE---- 327
             +    KIG+G +G V+ A+ R  +               +  A+K++ +    E    
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETH---------------EIVALKRVRLDDDDEGVPS 46

Query: 328 -FLAELKVLTHVHHLNLVRLIGYCVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRV 385
             L E+ +L  + H N+VRL         L LV+E+ +          +G          
Sbjct: 47  SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI--VK 104

Query: 386 QIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPTR 445
                  +GL + H   V   +HRD+K  N+LI++N   K+A+FGL +   +        
Sbjct: 105 SFLFQLLKGLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161

Query: 446 LVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL--- 502
           +V  +   P         S  +D+++ G +  EL +A   +  GN      K +  L   
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221

Query: 503 -----FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI 557
                +  +  LPD            L +  P  +      L +   +  P  R S    
Sbjct: 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNAT-GRDLLQNLLKCNPVQRISAEEA 280

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (324), Expect = 8e-34
 Identities = 58/311 (18%), Positives = 114/311 (36%), Gaps = 54/311 (17%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAE 331
           D++ +  K+G+G +  V+ A                     +K  +K +     ++   E
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINIT---------------NNEKVVVKILKPVKKKKIKRE 79

Query: 332 LKVLTHV-HHLNLVRLIGYC---VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQI 387
           +K+L ++    N++ L       V  +  LV+E++ N +  +  +      L        
Sbjct: 80  IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFY 134

Query: 388 ALDSARGLEYIHEHTVPVYIHRDIKSANILID-KNFHAKVADFGLTKLTEVGSASLPTRL 446
             +  + L+Y H   +    HRD+K  N++ID ++   ++ D+GL +    G        
Sbjct: 135 MYEILKALDYCHSMGIM---HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVR 189

Query: 447 VGTFGYMPPE-YAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE 505
           V +  +  PE    Y      +D+++ G +L  +I  KE    G+    D+   +    +
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH----DNYDQLVRIAK 245

Query: 506 VLNLPDPIEDLRKL---VDPRLGDNCPLDSVLKMAQLAKVCTQEY--------------- 547
           VL   D  + + K    +DPR  D     S  +  +      Q                 
Sbjct: 246 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 305

Query: 548 -PQLRPSMRSI 557
             Q R + R  
Sbjct: 306 DHQSRLTAREA 316

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-33
 Identities = 60/324 (18%), Positives = 111/324 (34%), Gaps = 57/324 (17%)

Query: 262 FSYEELSKAT----DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAI 317
           F  +E++K        +     +G G +GAV  A                      K AI
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDG---------------RTGAKVAI 48

Query: 318 KKMDMQASRE-----FLAELKVLTHVHHLNLVRLIGYCVEGS-------LFLVYEYIENG 365
           KK+      E        EL++L H+ H N++ L+               +LV  ++   
Sbjct: 49  KKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD 108

Query: 366 NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK 425
                        L       +     +GL YIH       IHRD+K  N+ ++++   K
Sbjct: 109 LGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELK 161

Query: 426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK-- 483
           + DFGL +  +   + +   +V  +   P     +   +  VD+++ G ++ E+I+ K  
Sbjct: 162 ILDFGLARQAD---SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

Query: 484 ----------EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSV 533
                     + I+K  G+           +E  N    + +L K     +  N    +V
Sbjct: 219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278

Query: 534 LKMAQLAKVCTQEYPQLRPSMRSI 557
                L +       + R +    
Sbjct: 279 ----NLLEKMLVLDAEQRVTAGEA 298

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  126 bits (317), Expect = 1e-32
 Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 31/219 (14%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQAS------ 325
           D F     +G G FG V   + +                     A+K +D Q        
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKE---------------SGNHYAMKILDKQKVVKLKQI 85

Query: 326 REFLAELKVLTHVHHLNLVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSR 384
              L E ++L  V+   LV+L     +  +L++V EY+  G +  HLR  GR        
Sbjct: 86  EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHA 143

Query: 385 VQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASLPT 444
              A       EY+H   +   I+RD+K  N+LID+  + +V DFG  K  +        
Sbjct: 144 RFYAAQIVLTFEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTW 196

Query: 445 RLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
            L GT   + PE       +  VD +A GV++YE+ +  
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-31
 Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 28/223 (12%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-------DMQA 324
           +NF +   +G G +G V+              R I  +   +  A+K +         + 
Sbjct: 24  ENFELLKVLGTGAYGKVFLV------------RKISGHDTGKLYAMKVLKKATIVQKAKT 71

Query: 325 SREFLAELKVLTHV-HHLNLVRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWS 382
           +     E +VL H+     LV L      E  L L+ +YI  G L  HL    R+     
Sbjct: 72  TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEH 129

Query: 383 SRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSASL 442
                  +    LE++H+  +   I+RDIK  NIL+D N H  + DFGL+K         
Sbjct: 130 EVQIYVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 186

Query: 443 PTRLVGTFGYMPPEYAQYGD--VSPKVDVYAFGVVLYELISAK 483
                GT  YM P+  + GD      VD ++ GV++YEL++  
Sbjct: 187 AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 1e-29
 Identities = 54/324 (16%), Positives = 117/324 (36%), Gaps = 55/324 (16%)

Query: 261 EFSYEELSKA----TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAA 316
            F  +EL+K      + +     +G G +G+V  A                      + A
Sbjct: 3   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT---------------KTGLRVA 47

Query: 317 IKKM-----DMQASREFLAELKVLTHVHHLNLVRLIGYCV------EGSLFLVYEYIENG 365
           +KK+      +  ++    EL++L H+ H N++ L+          E +   +  ++   
Sbjct: 48  VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107

Query: 366 NLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK 425
           +L+  ++      L       +     RGL+YIH       IHRD+K +N+ ++++   K
Sbjct: 108 DLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 161

Query: 426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK-- 483
           + DFGL + T+     +   +   +   P     +   +  VD+++ G ++ EL++ +  
Sbjct: 162 ILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

Query: 484 ----------EAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSV 533
                     + I++  G+           E   N    +  + K+    +       +V
Sbjct: 219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV 278

Query: 534 LKMAQLAKVCTQEYPQLRPSMRSI 557
                L +         R +    
Sbjct: 279 ----DLLEKMLVLDSDKRITAAQA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 4e-28
 Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 37/224 (16%)

Query: 272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM-----DMQASR 326
             +     IG G  G V  A                  +L +  AIKK+     +   ++
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDA---------------VLDRNVAIKKLSRPFQNQTHAK 61

Query: 327 EFLAELKVLTHVHHLNLVRLIGYCV-------EGSLFLVYEYIENGNLSEHLRGSGRDPL 379
               EL ++  V+H N++ L+              ++LV E ++               L
Sbjct: 62  RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----EL 116

Query: 380 PWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGS 439
                  +      G++++H       IHRD+K +NI++  +   K+ DFGL +    G+
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GT 171

Query: 440 ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
           + + T  V T  Y  PE          VD+++ G ++ E++  K
Sbjct: 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 95.9 bits (237), Expect = 4e-22
 Identities = 41/230 (17%), Positives = 76/230 (33%), Gaps = 38/230 (16%)

Query: 274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM--DMQASREFLAE 331
           + +  K+G G F  V+ A+                       A+K +  D   +     E
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMV---------------NNTHVAMKIVRGDKVYTEAAEDE 59

Query: 332 LKVLTHVHHLNLVRLIGYCVEG----------------SLFLVYEYIENGNLSEHLRGSG 375
           +K+L  V+  +  +                         + +V+E +    L+   +   
Sbjct: 60  IKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH 119

Query: 376 RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN-FHAKVADFGLTKL 434
           R   P     QI+     GL+Y+H       IH DIK  N+L++       +    +  L
Sbjct: 120 RGI-PLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADL 176

Query: 435 -TEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAK 483
                     T  + T  Y  PE           D+++   +++ELI+  
Sbjct: 177 GNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 79.1 bits (194), Expect = 1e-17
 Identities = 24/157 (15%), Positives = 48/157 (30%), Gaps = 11/157 (7%)

Query: 275 SMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKV 334
           ++   +G+G   AV+      E     + +   V     K  +K+        F      
Sbjct: 3   AIGKLMGEGKESAVFNC--YSEKFGECVVKFHKVGHTSFK-KVKEKRDYGDLHFSVLAIR 59

Query: 335 LTHVHHLNLVRLIGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARG 394
                   L +L G  V      VY +  N  L E +       +   +  ++       
Sbjct: 60  SARNEFRALQKLQGLAVPK----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEE 115

Query: 395 LEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL 431
           +   +   +   +H D+   N+L+       + DF  
Sbjct: 116 VAKFYHRGI---VHGDLSQYNVLVS-EEGIWIIDFPQ 148

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

 Score = 33.7 bits (77), Expect = 0.003
 Identities = 18/47 (38%), Positives = 27/47 (57%), Gaps = 3/47 (6%)

Query: 168 VTYPLRPGDSLQSIARNVGLSESLLQNYNPGVN--FTRGSGLVFIPG 212
           +TY ++ GD+L SIA +  +S + L   NP +    T G  +V IPG
Sbjct: 2   LTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIV-IPG 47

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	589
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.83
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.33
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.32
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.24
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.24
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.03
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.24
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.78
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.53
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	94.66
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	91.93

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=407.51  Aligned_cols=263  Identities=27%  Similarity=0.486  Sum_probs=200.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||+||+|+++++    .+.|.+.         .........+.+.+|+++|++++||||++++++
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~----vAvK~~~---------~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~   72 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWHGD----VAVKMLN---------VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   72 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESSSE----EEEEECC---------CSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEECCE----EEEEEEE---------cccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence            357899999999999999999976542    1111110         111223445678999999999999999999999


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +.++.+|+||||+++|+|.+++..... ++++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        73 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~~i---vHrDlKp~NiLl~~~~~~Kl~DF  148 (276)
T d1uwha_          73 STAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAKSI---IHRDLKSNNIFLHEDLTVKIGDF  148 (276)
T ss_dssp             ECSSSCEEEEECCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEETTSSEEECCC
T ss_pred             EeccEEEEEEecCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcCCE---eccccCHHHEEEcCCCCEEEccc
Confidence            988889999999999999999976543 49999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCC-CCCcccccCCCCCchhcccC---CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          430 GLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQY---GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       430 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|+....... .......||+.|||||++.+   +.++.++|||||||++|||+||+.||.....    ..........
T Consensus       149 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----~~~~~~~~~~  224 (276)
T d1uwha_         149 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGR  224 (276)
T ss_dssp             CCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHHHH
T ss_pred             cceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----HHHHHHHHhc
Confidence            99986543322 23344689999999999864   3589999999999999999999999954321    1111111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      ..            ..+.+ ...+.+++..+.+|+.+||+.||.+|||++||+++|+.+..
T Consensus       225 ~~------------~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         225 GY------------LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             TS------------CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC------------CCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            11            11111 12233445579999999999999999999999999998864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=410.01  Aligned_cols=259  Identities=27%  Similarity=0.483  Sum_probs=207.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++|++.++||+|+||.||+|.+++.  .              .+|+|.++.  ...+++.+|+++|++++|||||+++
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~--~--------------~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~   74 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGH--T--------------KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY   74 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTT--E--------------EEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECCC--C--------------EEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEE
Confidence            346899999999999999999997643  1              122332221  1235689999999999999999999


Q ss_pred             eEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          348 GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       348 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +++.++..|+||||+++|+|.+++......++++..++.++.||+.||+|||++++   +||||||+|||+++++.+||+
T Consensus        75 g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~i---vHrDiKp~NIll~~~~~~Kl~  151 (272)
T d1qpca_          75 AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAANILVSDTLSCKIA  151 (272)
T ss_dssp             EEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEEC
T ss_pred             eeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc---ccCccchhheeeecccceeec
Confidence            99988889999999999999998876655569999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++..............||+.|+|||++..+.++.++|||||||++|||+||..|+.....       .......+.
T Consensus       152 DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~  224 (272)
T d1qpca_         152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLE  224 (272)
T ss_dssp             CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHH
T ss_pred             cccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHH
Confidence            9999987654444444556789999999999989999999999999999999998777643321       111111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                                ....+    ..|...+..+.+|+.+||+.||++|||++||++.|+..-+++
T Consensus       225 ----------~~~~~----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst  271 (272)
T d1qpca_         225 ----------RGYRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (272)
T ss_dssp             ----------TTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ----------hcCCC----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence                      11122    223344557899999999999999999999999998765443

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-51  Score=410.20  Aligned_cols=259  Identities=29%  Similarity=0.467  Sum_probs=208.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEe
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ..++|++.++||+|+||+||+|.++.++. .              +|+|.++.  ...+++.+|+++|++++|||||+++
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~-~--------------vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~   79 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSL-T--------------VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL   79 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTE-E--------------EEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCe-E--------------EEEEEECCccchHHHHHHHHHHHHhCCCCCEecCC
Confidence            35679999999999999999999876522 1              22222211  1235688999999999999999999


Q ss_pred             eEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          348 GYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       348 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.+ +..|+||||+++|+|.+++.......+++..++.++.||+.||+|||++++   +||||||+|||+++++.+||
T Consensus        80 ~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~i---iHrDlKp~NILl~~~~~~Kl  156 (287)
T d1opja_          80 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKV  156 (287)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEE
T ss_pred             ccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCc---ccCccccCeEEECCCCcEEE
Confidence            98875 568999999999999999988776779999999999999999999999998   99999999999999999999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      +|||+++..............|++.|+|||++.++.++.++|||||||++|||++|..|+.....    ....   ..  
T Consensus       157 ~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~---~~--  227 (287)
T d1opja_         157 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQV---YE--  227 (287)
T ss_dssp             CCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHH---HH--
T ss_pred             ccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHH---HH--
Confidence            99999987654444334445689999999999999999999999999999999998888744322    1111   11  


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                                  .+........+...+..+.+|+.+||+.||++|||++||++.|+.+...
T Consensus       228 ------------~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         228 ------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             ------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             ------------HHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                        1111111223444556799999999999999999999999999887543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-51  Score=401.71  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=192.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||+||+|.+.+.  .              .+|+|.+.  ....+++.+|++++++++||||+++++
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~--~--------------~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g   67 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNK--D--------------KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG   67 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTT--E--------------EEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCC--C--------------EEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccc
Confidence            46799999999999999999987643  1              12222222  112356889999999999999999999


Q ss_pred             EEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++. ++..|+||||+++|+|.+++.... ..+++..++.++.|++.||+|||++++   +||||||+|||+++++.+||+
T Consensus        68 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~i---iHrDlKp~Nill~~~~~~Kl~  143 (263)
T d1sm2a_          68 VCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACV---IHRDLAARNCLVGENQVIKVS  143 (263)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCTTCSGGGEEECGGGCEEEC
T ss_pred             eeccCCceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccce---eecccchhheeecCCCCeEec
Confidence            887 456999999999999999987654 348999999999999999999999999   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++..............||+.|+|||++.+..++.++|||||||++|||+|+..|+.....    ...   ....+.
T Consensus       144 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~----~~~---~~~~i~  216 (263)
T d1sm2a_         144 DFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS----NSE---VVEDIS  216 (263)
T ss_dssp             SCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC----HHH---HHHHHH
T ss_pred             ccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC----HHH---HHHHHH
Confidence            9999987654443334446789999999999999999999999999999999997666533221    111   111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                                ....+    ..|..++..+.+|+.+||+.||++|||++||+++|++++.
T Consensus       217 ----------~~~~~----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         217 ----------TGFRL----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ----------HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------hcCCC----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                      11111    1233344578999999999999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.9e-50  Score=404.80  Aligned_cols=259  Identities=25%  Similarity=0.421  Sum_probs=194.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh----cCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~----~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.++||+|+||+||+|.++.++....+            +++|.    ......++|.+|+++|++++|||||++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~------------vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l   92 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIF------------VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHL   92 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEE------------EEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEE------------EEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccE
Confidence            35788999999999999999998765332211            12222    234455679999999999999999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++++.+ +.+|+|||||++|+|.+++..... .+++.+++.++.||+.||+|||++++   +||||||+|||++.++.+|
T Consensus        93 ~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~~i---iHrDlKp~NILl~~~~~~K  168 (299)
T d1jpaa_          93 EGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADMNY---VHRDLAARNILVNSNLVCK  168 (299)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEE
T ss_pred             EEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhCCC---ccCccccceEEECCCCcEE
Confidence            999864 569999999999999998876543 48999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCC----CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHH
Q 037010          426 VADFGLTKLTEVGSAS----LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~  500 (589)
                      |+|||+++........    ......||+.|||||.+..+.++.++|||||||++|||+| |+.||.....     .   
T Consensus       169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-----~---  240 (299)
T d1jpaa_         169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-----Q---  240 (299)
T ss_dssp             ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----H---
T ss_pred             ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-----H---
Confidence            9999999865433221    1122467899999999999999999999999999999998 8888843221     1   


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      .....+..              ......+.+++..+.+|+.+||+.||.+|||++||++.|+++...
T Consensus       241 ~~~~~i~~--------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         241 DVINAIEQ--------------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHc--------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            11111111              111123444556799999999999999999999999999987654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-50  Score=395.42  Aligned_cols=249  Identities=25%  Similarity=0.428  Sum_probs=198.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||+||+|+++.++ ..++.|.+..     ....+.   ...+.+.+|++++++++||||+++++++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~-~~vAiK~i~~-----~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~   76 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSK-FILALKVLFK-----AQLEKA---GVEHQLRREVEIQSHLRHPNILRLYGYFH   76 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEH-----HHHHHT---TCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCC-cEEEEEEEch-----HHccCh---HHHHHHHHHHHHHHhcCCCCCCeEEEEEE
Confidence            57999999999999999999987653 2222222211     111111   12346788999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||+++|+|.+++....  ++++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        77 ~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~i---vHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          77 DATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEECCCC
T ss_pred             ECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe---eeeeeccccceecCCCCEeecccc
Confidence            5 46899999999999999998654  39999999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +++.....   ......||+.|||||++.+..++.++|||||||++|||+||+.||....        ....+..+... 
T Consensus       152 ~a~~~~~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~-  219 (263)
T d2j4za1         152 WSVHAPSS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRV-  219 (263)
T ss_dssp             SCSCCCCC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTT-
T ss_pred             eeeecCCC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcC-
Confidence            99765322   2345689999999999999999999999999999999999999994321        11222222211 


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                +.    ..|...+..+.+|+.+||+.||++|||++|+++|
T Consensus       220 ----------~~----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         220 ----------EF----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ----------CC----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                      11    1233344578999999999999999999999987

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-50  Score=400.01  Aligned_cols=254  Identities=21%  Similarity=0.331  Sum_probs=195.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||+||+|+++.++ ..++.|.+...          ...+..+++.+|+++|++++||||+++++++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~-~~vAiK~i~~~----------~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~   72 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTE-EAVAVKIVDMK----------RAVDCPENIKKEICINKMLNHENVVKFYGHR   72 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEECC-----------------CHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCC-CEEEEEEEehh----------hcchHHHHHHHHHHHHHhCCCCCEeeEeeee
Confidence            467999999999999999999987653 22222222110          1112335688999999999999999999988


Q ss_pred             EeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .++ ..|+||||+++|+|.+++....  .+++.+++.++.||+.||+|||++|+   +||||||+|||+++++.+||+||
T Consensus        73 ~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~I---iHrDiKp~NILl~~~~~~KL~DF  147 (271)
T d1nvra_          73 REGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGI---THRDIKPENLLLDERDNLKISDF  147 (271)
T ss_dssp             EETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECTTCCEEECCC
T ss_pred             ccCceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCC---ccCcccHHHEEECCCCCEEEccc
Confidence            754 5899999999999999997543  49999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCC-CCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          430 GLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       430 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |+|+....... ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||.......    ...   ....
T Consensus       148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~----~~~---~~~~  220 (271)
T d1nvra_         148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QEY---SDWK  220 (271)
T ss_dssp             TTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS----HHH---HHHH
T ss_pred             hhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH----HHH---HHHh
Confidence            99987643332 23345789999999999988776 578999999999999999999995443211    111   1111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .             ...........+..+.+|+.+||+.||++|||++|+++|
T Consensus       221 ~-------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         221 E-------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             T-------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             c-------------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1             111111122334578899999999999999999999876

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-50  Score=398.32  Aligned_cols=257  Identities=22%  Similarity=0.348  Sum_probs=190.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||+||+|+++.++ ..++.|.+..         ........+.+.+|+++|++++||||+++++++
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~-~~vAvK~i~~---------~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   72 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDG-KILVWKELDY---------GSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRI   72 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEECC---------TTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCC-CEEEEEEECh---------hhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE
Confidence            367999999999999999999987653 2222222211         122334456788999999999999999999987


Q ss_pred             Ee---CcEEEEEEecCCCChHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CceEeeccCCCcEEEcCCCc
Q 037010          351 VE---GSLFLVYEYIENGNLSEHLRGS--GRDPLPWSSRVQIALDSARGLEYIHEHTV--PVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       351 ~~---~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qia~aL~~LH~~~i--~~~vH~Dlkp~NILl~~~~~  423 (589)
                      .+   +.+|+||||+++|+|.+++...  ....+++..++.++.|++.||+|||+++.  ..|+||||||+|||++.++.
T Consensus        73 ~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~  152 (269)
T d2java1          73 IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN  152 (269)
T ss_dssp             EC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC
T ss_pred             EeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc
Confidence            53   4589999999999999998653  23459999999999999999999999760  11399999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      +||+|||+++...... .......||+.|||||++.+..++.++|||||||++|||+||+.||....     ..   ...
T Consensus       153 vkl~DFG~a~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-----~~---~~~  223 (269)
T d2java1         153 VKLGDFGLARILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-----QK---ELA  223 (269)
T ss_dssp             EEECCHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HH---HHH
T ss_pred             EEEeeccceeecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-----HH---HHH
Confidence            9999999998764322 22345789999999999999999999999999999999999999994321     11   111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..+...          ..+    ..+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       224 ~~i~~~----------~~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         224 GKIREG----------KFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             HHHHHT----------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHcC----------CCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            111111          111    1233344578999999999999999999999876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=396.13  Aligned_cols=261  Identities=23%  Similarity=0.404  Sum_probs=202.7

Q ss_pred             cCCCcccee-eccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          271 TDNFSMSHK-IGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~-LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      .++|.+.+. ||+|+||.||+|.++.......    ++++...     +.......+++.+|+++|++++|||||+++++
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~----vAvK~l~-----~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~   77 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQID----VAIKVLK-----QGTEKADTEEMMREAQIMHQLDNPYIVRLIGV   77 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEE----EEEEEEC-----SSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEE----EEEEEEC-----hhcCHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence            456777774 9999999999998765432211    1111110     11234456789999999999999999999999


Q ss_pred             EEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          350 CVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      +.++.+|+||||+++|+|.+++.... ..+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~i---iHrDlKp~Nill~~~~~~Kl~DF  153 (285)
T d1u59a_          78 CQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDF  153 (285)
T ss_dssp             EESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEEETTEEEECCC
T ss_pred             eccCeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCe---ecCcCchhheeeccCCceeeccc
Confidence            98888999999999999999986543 359999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCCC--CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          430 GLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       430 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |+++.......  .......||+.|+|||++..+.++.++|||||||++|||+| |+.||.....     ..   ....+
T Consensus       154 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~~---~~~~i  225 (285)
T d1u59a_         154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PE---VMAFI  225 (285)
T ss_dssp             TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HH---HHHHH
T ss_pred             hhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----HH---HHHHH
Confidence            99986643322  12233568999999999999999999999999999999998 8999854321     11   11111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                      .          +...+    ..|.+++..+.+|+.+||+.||++|||+.+|++.|+....
T Consensus       226 ~----------~~~~~----~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         226 E----------QGKRM----ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             H----------TTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             H----------cCCCC----CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1          11112    2344455678999999999999999999999999876543

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=396.86  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=198.3

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.++||+|+||+||+|.+..++ ..++.|.+...         .  ....+.+.+|+++|++++||||+++++++.
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~-~~vAvK~~~~~---------~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   87 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATG-QEVAIRQMNLQ---------Q--QPKKELIINEILVMRENKNPNIVNYLDSYL   87 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTC-CEEEEEEEEGG---------G--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCC-CEEEEEEEecc---------c--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEE
Confidence            57999999999999999999977653 22322222110         1  112356889999999999999999999886


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||+++|+|.+++...   ++++.+++.++.||+.||+|||++|+   +||||||+|||++.++.+||+|||
T Consensus        88 ~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~i---iHrDiKp~NILl~~~~~vkl~DFG  161 (293)
T d1yhwa1          88 VGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFG  161 (293)
T ss_dssp             ETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECCCT
T ss_pred             ECCEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCC---cccCCcHHHeEECCCCcEeeccch
Confidence            5 5689999999999999988764   39999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....     .   ........  
T Consensus       162 ~a~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~---~~~~~~~~--  230 (293)
T d1yhwa1         162 FCAQITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----L---RALYLIAT--  230 (293)
T ss_dssp             TCEECCSTT-CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H---HHHHHHHH--
T ss_pred             hheeecccc-ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----H---HHHHHHHh--
Confidence            998754332 233456899999999999999999999999999999999999999953321     1   11111110  


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                              .-.+.  -..+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       231 --------~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         231 --------NGTPE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             --------HCSCC--CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             --------CCCCC--CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    00011  12234455679999999999999999999999987

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=394.71  Aligned_cols=262  Identities=21%  Similarity=0.339  Sum_probs=195.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++++.||+|+||.||+|.+..+.+.....   +++..     .+.......+.+.+|+++|++++||||+++++++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~v---aik~~-----~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~   77 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAV---AIKTC-----KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI   77 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEE---EEEEC-----TTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEE---EEEEe-----ccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            468999999999999999999887653322211   11100     0112334456789999999999999999999999


Q ss_pred             EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       351 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      .++.+|+||||+++|+|.+++.... .++++..++.++.||+.||+|||++++   +||||||+||+++.++.+||+|||
T Consensus        78 ~~~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~i---iHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          78 TENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             CSSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEEEETTEEEECC--
T ss_pred             ecCeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCe---eccccchhheeecCCCcEEEccch
Confidence            8888999999999999999887654 358999999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      +++..............||+.|+|||++.+..++.++|||||||++|||+| |..||.....     ....   ..+.. 
T Consensus       154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~~---~~i~~-  224 (273)
T d1mp8a_         154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVI---GRIEN-  224 (273)
T ss_dssp             -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHH---HHHHT-
T ss_pred             hheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHHH---HHHHc-
Confidence            998765444444455678999999999999999999999999999999998 7878743321     1111   11111 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                               ...+    ..+.+++..+.+|+.+||..||++|||++||+++|+.+..
T Consensus       225 ---------~~~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         225 ---------GERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             ---------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                     1111    2344455679999999999999999999999999988764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=391.04  Aligned_cols=252  Identities=26%  Similarity=0.458  Sum_probs=202.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++.++||+|+||+||+|++++.  ..              +|+|.++  ....+++.+|++++++++||||+++++
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~--~~--------------vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g   66 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQ--YD--------------VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG   66 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTT--EE--------------EEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCC--CE--------------EEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEE
Confidence            46899999999999999999997542  12              2222211  112356889999999999999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ +.+++||||+.+|+|.+++..... .+++..+++++.|++.||+|||++++   +||||||+|||+++++.+||+
T Consensus        67 ~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~i---iH~dlk~~Nill~~~~~~kl~  142 (258)
T d1k2pa_          67 VCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQF---LHRDLAARNCLVNDQGVVKVS  142 (258)
T ss_dssp             EECCSSSEEEEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTTB---CCSCCSGGGEEECTTCCEEEC
T ss_pred             EEeeCCceEEEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcCc---ccccccceeEEEcCCCcEEEC
Confidence            8875 579999999999999999776543 48899999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||+++..............||+.|+|||.+....++.++|||||||++|||+| |+.||.....     ..   ....+
T Consensus       143 DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----~~---~~~~i  214 (258)
T d1k2pa_         143 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SE---TAEHI  214 (258)
T ss_dssp             CCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HH---HHHHH
T ss_pred             cchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----HH---HHHHH
Confidence            999998665544444455779999999999999999999999999999999998 7888843321     11   11111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      .          +...    ...|...+..+.+|+.+||+.||++|||++|++++|.++
T Consensus       215 ~----------~~~~----~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         215 A----------QGLR----LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             H----------TTCC----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             H----------hCCC----CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            1          1111    123334456799999999999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-49  Score=388.12  Aligned_cols=248  Identities=23%  Similarity=0.371  Sum_probs=191.9

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-  352 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-  352 (589)
                      |++.++||+|+||+||+|.+..+... .+.|.+         ..+.......+.+.+|+++|++++|||||++++++.+ 
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~-va~K~i---------~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   80 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVE-VAWCEL---------QDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   80 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCE-EEEEEE---------EGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeE-EEEEEE---------chhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence            36778899999999999998765322 222211         1122344455678999999999999999999998753 


Q ss_pred             ----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeeccCCCcEEEc-CCCcEE
Q 037010          353 ----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHT--VPVYIHRDIKSANILID-KNFHAK  425 (589)
Q Consensus       353 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~--i~~~vH~Dlkp~NILl~-~~~~vk  425 (589)
                          +.+|+||||+++|+|.+++....  .+++..++.++.||+.||+|||+++  +   +||||||+|||++ +++.+|
T Consensus        81 ~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~I---iHrDiKp~NILl~~~~~~~K  155 (270)
T d1t4ha_          81 VKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPI---IHRDLKCDNIFITGPTGSVK  155 (270)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCC---CCSCCCGGGEEESSTTSCEE
T ss_pred             cccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCE---EeCCcChhhceeeCCCCCEE
Confidence                24799999999999999998754  4899999999999999999999998  7   9999999999996 578999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||+++....   .......||+.|||||++.+ .++.++|||||||++|||+||+.||.....       .......
T Consensus       156 l~DFGla~~~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~  224 (270)
T d1t4ha_         156 IGDLGLATLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRR  224 (270)
T ss_dssp             ECCTTGGGGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHH
T ss_pred             EeecCcceeccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHH
Confidence            999999985432   22345789999999999875 699999999999999999999999953221       1112222


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +.....+             ...+......+.+|+.+||+.||++|||++|+++|
T Consensus       225 i~~~~~~-------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         225 VTSGVKP-------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             HTTTCCC-------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHcCCCC-------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            2221111             01111223468999999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=404.36  Aligned_cols=272  Identities=22%  Similarity=0.353  Sum_probs=198.5

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||+||+|++..++ ..++.|.+..          .......+++.+|+++|++++|||||+++++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~-~~vAiK~i~~----------~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~   72 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSG-LVMARKLIHL----------EIKPAIRNQIIRELQVLHECNSPYIVGFYGA   72 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTT-EEEEEEEEEC----------CCCTTHHHHHHHHGGGGGGCCCTTBCCEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCC-cEEEEEEECh----------hhCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            3578999999999999999999987652 2222222110          1122334678899999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEH-TVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~-~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +.+ +++|+||||+++|+|.+++...+.  +++..++.++.|++.||.|||++ ++   +||||||+|||++.++++||+
T Consensus        73 ~~~~~~~~iVmEy~~gg~L~~~l~~~~~--l~~~~~~~~~~qil~aL~yLH~~~~I---iHRDiKP~NILl~~~~~vkl~  147 (322)
T d1s9ja_          73 FYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKI---MHRDVKPSNILVNSRGEIKLC  147 (322)
T ss_dssp             EECSSEEEEEEECCTTEEHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHHHCC---CCSCCSGGGEEECTTCCEEEC
T ss_pred             EEECCEEEEEEEcCCCCcHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHHhCCE---EccccCHHHeeECCCCCEEEe
Confidence            875 569999999999999999987643  99999999999999999999974 88   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+|+.....   .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....................
T Consensus       148 DFGla~~~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  224 (322)
T d1s9ja_         148 DFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA  224 (322)
T ss_dssp             CCCCCHHHHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred             eCCCccccCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence            99999865432   224568999999999999999999999999999999999999999654322110000000000000


Q ss_pred             --------------------cCCC-hHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 --------------------NLPD-PIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 --------------------~~~~-~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                                          .... ..+.+........+.......+..+.+|+.+||+.||++|||++|+++|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                0000 0011111111111111111234578999999999999999999999998

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-49  Score=391.73  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=193.7

Q ss_pred             eeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEeCcEEE
Q 037010          278 HKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVEGSLFL  357 (589)
Q Consensus       278 ~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~l  357 (589)
                      ++||+|+||+||+|.++.....    +.+++|.....    .......+++.+|+++|++++|||||++++++.++..|+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~----~~vAvK~~~~~----~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~l   84 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVV----KTVAVKILKNE----ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWML   84 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSE----EEEEEEEEC---------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcC----eEEEEEEEChh----hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEE
Confidence            4699999999999987653211    11222211100    111233467899999999999999999999998888999


Q ss_pred             EEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCcccccc
Q 037010          358 VYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEV  437 (589)
Q Consensus       358 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~  437 (589)
                      ||||+++|+|.+++....  ++++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||+++....
T Consensus        85 vmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~i---iHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             EEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCc---ccCCCcchhhcccccCcccccchhhhhhccc
Confidence            999999999999998654  49999999999999999999999998   9999999999999999999999999986543


Q ss_pred             CCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHhcCCChHH
Q 037010          438 GSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIE  514 (589)
Q Consensus       438 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  514 (589)
                      ....  ......||+.|||||.+.+..++.++|||||||++|||+| |+.||....     ...   ....+.       
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-----~~~---~~~~i~-------  224 (277)
T d1xbba_         160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-----GSE---VTAMLE-------  224 (277)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHH---HHHHHH-------
T ss_pred             cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-----HHH---HHHHHH-------
Confidence            3222  2233578999999999999999999999999999999998 899984321     111   111111       


Q ss_pred             hhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          515 DLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       515 ~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                         +...+    ..|..++..+.+|+.+||+.||++|||+++|++.|+..
T Consensus       225 ---~~~~~----~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         225 ---KGERM----GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             ---TTCCC----CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---cCCCC----CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence               11111    23344456789999999999999999999998887654

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=396.58  Aligned_cols=259  Identities=29%  Similarity=0.491  Sum_probs=201.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH--HHHHHHHHHHHHHccCCCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM--QASREFLAELKVLTHVHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~E~~il~~l~hpnIv~l~~  348 (589)
                      .++|++++.||+|+||.||+|.++++.                .+|+|.+..  ...+.|.+|+.++++++|||||++++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~----------------~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   79 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTT----------------RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA   79 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTE----------------EEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCC----------------EEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEE
Confidence            467999999999999999999886541                122332221  12356889999999999999999999


Q ss_pred             EEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          349 YCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       349 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      ++.++..|+||||+++|+|..++.......+++.+++.++.||+.||+|||++++   +||||||+|||+++++.+||+|
T Consensus        80 ~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~i---vH~DlKp~NIll~~~~~~kl~D  156 (285)
T d1fmka3          80 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAANILVGENLVCKVAD  156 (285)
T ss_dssp             EECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECGGGCEEECC
T ss_pred             EEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhhe---ecccccceEEEECCCCcEEEcc
Confidence            9988889999999999999999877655569999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      ||+++..............||+.|+|||++..+.++.++|||||||++|||+||..|+.....       .......+. 
T Consensus       157 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~-  228 (285)
T d1fmka3         157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVE-  228 (285)
T ss_dssp             CCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHH-
T ss_pred             cchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHH-
Confidence            999987654433334446799999999999999999999999999999999998877744322       111111111 


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTE  569 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~  569 (589)
                               .    ......+.+++..+.+|+.+||+.||++|||+++|++.|+.......
T Consensus       229 ---------~----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         229 ---------R----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             ---------T----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             ---------h----cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence                     1    11122344555679999999999999999999999999987665543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=389.63  Aligned_cols=262  Identities=26%  Similarity=0.423  Sum_probs=198.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .+.|++.++||+|+||.||+|.++.+.+...  .         .+++|.+    ......++.+|+++|++++|||||++
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~--~---------~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~   74 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKE--V---------PVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL   74 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCE--E---------EEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEE--E---------EEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeee
Confidence            3568889999999999999999876543221  1         1223322    23445678999999999999999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      ++++.+ +..++||||+.+++|.+++..... .+++.+++.++.|++.||+|||++++   +||||||+|||++.++.+|
T Consensus        75 ~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~~~i---iHrDlKp~NILl~~~~~~K  150 (283)
T d1mqba_          75 EGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCK  150 (283)
T ss_dssp             EEEECSSSSEEEEEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTCCEE
T ss_pred             eEEEecCCceEEEEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhcccccc---ccCccccceEEECCCCeEE
Confidence            998874 568999999999999998876543 49999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          426 VADFGLTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      |+|||+++........  ......||+.|||||++.++.++.++|||||||++|||+||..|+.....    .   ...+
T Consensus       151 l~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~----~---~~~~  223 (283)
T d1mqba_         151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS----N---HEVM  223 (283)
T ss_dssp             ECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----H---HHHH
T ss_pred             EcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC----H---HHHH
Confidence            9999999865433221  22335689999999999999999999999999999999998777643321    1   1111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTT  568 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  568 (589)
                      ..+.          .    ......+.+++..+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus       224 ~~i~----------~----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         224 KAIN----------D----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             HHHH----------T----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHHh----------c----cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence            1111          1    1112234445567999999999999999999999999999887543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-49  Score=399.49  Aligned_cols=258  Identities=25%  Similarity=0.422  Sum_probs=200.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccC-CCCccee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHV-HHLNLVR  345 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l-~hpnIv~  345 (589)
                      .++|++++.||+|+||+||+|++.+...... .+         .+++|.+    .......+.+|+.+|.++ +|||||+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~-~~---------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~  105 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGV-SI---------QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN  105 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSC-EE---------EEEEEEECC------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccc-ee---------EEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeE
Confidence            4689999999999999999999876533221 11         1222222    223345688999999998 8999999


Q ss_pred             EeeEEEe-CcEEEEEEecCCCChHHHHhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 037010          346 LIGYCVE-GSLFLVYEYIENGNLSEHLRGSGR---------------------DPLPWSSRVQIALDSARGLEYIHEHTV  403 (589)
Q Consensus       346 l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~qia~aL~~LH~~~i  403 (589)
                      +++++.+ +.+|+||||+++|+|.+++.....                     ..+++..++.++.|++.||+|||++++
T Consensus       106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~I  185 (325)
T d1rjba_         106 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC  185 (325)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             EEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            9998874 569999999999999999976532                     358899999999999999999999998


Q ss_pred             CceEeeccCCCcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-
Q 037010          404 PVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-  481 (589)
Q Consensus       404 ~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-  481 (589)
                         +||||||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| 
T Consensus       186 ---iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         186 ---VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             ---EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             ---eeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence               99999999999999999999999999865443322 2234678999999999999999999999999999999998 


Q ss_pred             CCcccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          482 AKEAIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       482 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      |+.||......    ..+.....                 .......|..++..+.+|+.+||+.||++|||++||+++|
T Consensus       263 g~~Pf~~~~~~----~~~~~~~~-----------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L  321 (325)
T d1rjba_         263 GVNPYPGIPVD----ANFYKLIQ-----------------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  321 (325)
T ss_dssp             SCCSSTTCCCS----HHHHHHHH-----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCCCHH----HHHHHHHh-----------------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            89998432211    11111111                 1111123344456799999999999999999999999999


Q ss_pred             H
Q 037010          562 M  562 (589)
Q Consensus       562 ~  562 (589)
                      .
T Consensus       322 ~  322 (325)
T d1rjba_         322 G  322 (325)
T ss_dssp             H
T ss_pred             h
Confidence            5

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=390.71  Aligned_cols=255  Identities=23%  Similarity=0.380  Sum_probs=197.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++++.||+|+||+||+|.+..++ ..++.|.+.     .....+.   ...+.+.+|+++|++++||||+++++++
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~-~~vAvK~i~-----~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~   77 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATS-REYAIKILE-----KRHIIKE---NKVPYVTRERDVMSRLDHPFFVKLYFTF   77 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEE-----HHHHHHT---TCHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCC-CEEEEEEEe-----hHHccCH---HHHHHHHHHHHHHHHcCCCCeeEEEEEE
Confidence            367999999999999999999987653 223333221     1111111   1235688899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.+|+||||+++|+|.+++...+  .+++..++.++.|++.||+|||++++   +||||||+|||+++++.+||+||
T Consensus        78 ~~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~i---iHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          78 QDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGI---IHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTSCEEECCC
T ss_pred             EECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccE---EcCcCCccccccCCCceEEeccc
Confidence            75 56899999999999999988765  39999999999999999999999998   99999999999999999999999


Q ss_pred             cCccccccCC-CCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          430 GLTKLTEVGS-ASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       430 gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      |+++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||....        ....+..+..
T Consensus       153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~  224 (288)
T d1uu3a_         153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIK  224 (288)
T ss_dssp             TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHT
T ss_pred             ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHc
Confidence            9998764332 223344689999999999999999999999999999999999999995432        1122222222


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALM  562 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~  562 (589)
                      .           ...    .|...+..+.+|+.+||+.||.+|||++|++++..
T Consensus       225 ~-----------~~~----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~  263 (288)
T d1uu3a_         225 L-----------EYD----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP  263 (288)
T ss_dssp             T-----------CCC----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred             C-----------CCC----CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence            1           111    22334457899999999999999999999866543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=395.64  Aligned_cols=259  Identities=22%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC----HHHHHHHHHHHHHHccCCCCcceeEe
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD----MQASREFLAELKVLTHVHHLNLVRLI  347 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~----~~~~~~~~~E~~il~~l~hpnIv~l~  347 (589)
                      ++|++++.||+|+||+||+|.+..++.....           ++++|.+.    .+..+++.+|+++|++++|||||+++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~   77 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKI-----------PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL   77 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCE-----------EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEE-----------EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence            5699999999999999999998765322111           22333322    22346789999999999999999999


Q ss_pred             eEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          348 GYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       348 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +++.++..++++|++.+|+|.+++.... ..+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+
T Consensus        78 g~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~i---iHrDlKp~NIll~~~~~~kl~  153 (317)
T d1xkka_          78 GICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKIT  153 (317)
T ss_dssp             EEEESSSEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEEEETTEEEEC
T ss_pred             EEEecCCeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCc---ccCcchhhcceeCCCCCeEee
Confidence            9999999999999999999999988754 359999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHH
Q 037010          428 DFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       428 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||....     ...+......
T Consensus       154 DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~-----~~~~~~~i~~  228 (317)
T d1xkka_         154 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILEK  228 (317)
T ss_dssp             CCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----GGGHHHHHHH
T ss_pred             ccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHc
Confidence            99999876543332 2233568999999999999999999999999999999999 677763321     1112221111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                                   ...+    ..|..++..+.+|+.+||..||.+|||++||+++|..+...
T Consensus       229 -------------~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         229 -------------GERL----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             -------------TCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -------------CCCC----CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence                         1111    23344556799999999999999999999999999887644

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-49  Score=395.02  Aligned_cols=254  Identities=22%  Similarity=0.356  Sum_probs=185.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..+.|++.+.||+|+||+||+|+++.++ ..++.|.+...          ........+.+|+++|++++||||++++++
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~----------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~   75 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQ-KLVAIKCIAKK----------ALEGKEGSMENEIAVLHKIKHPNIVALDDI   75 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTC-CEEEEEEEEC--------------------CHHHHHHHTCCCTTBCCEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCC-CEEEEEEEchH----------HhhhHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            4577999999999999999999987653 22333222111          011223457789999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc---CCCcEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAK  425 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~---~~~~vk  425 (589)
                      +.+ +.+|+||||++||+|.+++....  ++++.++..++.||+.||+|||++++   +||||||+|||+.   +++.+|
T Consensus        76 ~~~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~i---iHrDiKp~Nil~~~~~~~~~vk  150 (307)
T d1a06a_          76 YESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGI---VHRDLKPENLLYYSLDEDSKIM  150 (307)
T ss_dssp             EECSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEESSSSTTCCEE
T ss_pred             EEECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhcee---eeEEecccceeecccCCCceEE
Confidence            875 56899999999999999998654  49999999999999999999999999   9999999999994   578999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||+++.....  ......+||+.|||||++.+..++.++|||||||++|||++|+.||....        .......
T Consensus       151 l~DFG~a~~~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~  220 (307)
T d1a06a_         151 ISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQ  220 (307)
T ss_dssp             ECCC--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHH
T ss_pred             EeccceeEEccCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence            9999999865432  22344689999999999999999999999999999999999999994321        1112222


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +....           .......+.+.+..+.+|+.+||+.||++|||++|+++|
T Consensus       221 i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         221 ILKAE-----------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             HHTTC-----------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhccC-----------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            22211           111122233445678999999999999999999999998

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-49  Score=391.27  Aligned_cols=252  Identities=21%  Similarity=0.347  Sum_probs=195.9

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      +.|++++.||+|+||+||+|++..++. .++.|.+..           ......+.+.+|+++|++++|||||++++++.
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~-~vAvK~i~~-----------~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~   79 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSV-LAAAKVIDT-----------KSEEELEDYMVEIDILASCDHPNIVKLLDAFY   79 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCC-EEEEEEEEC-----------SSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCe-EEEEEEECc-----------CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            468999999999999999999876532 222222211           11122346788999999999999999999876


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||+++|+|.+++.... .++++.+++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        80 ~~~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~i---vHrDiKp~NIll~~~~~~Kl~DFG  155 (288)
T d2jfla1          80 YENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKI---IHRDLKAGNILFTLDGDIKLADFG  155 (288)
T ss_dssp             ETTEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eCCeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCE---EEeecChhheeECCCCCEEEEech
Confidence            4 56999999999999999987643 359999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhccc-----CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQ-----YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      +|+...... .......||+.|+|||++.     ...|+.++|||||||++|||+||+.||.....     ..   .+..
T Consensus       156 ~a~~~~~~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~-----~~---~~~~  226 (288)
T d2jfla1         156 VSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP-----MR---VLLK  226 (288)
T ss_dssp             TCEECHHHH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GG---HHHH
T ss_pred             hhhccCCCc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH-----HH---HHHH
Confidence            997543221 1223467999999999883     45689999999999999999999999954321     11   1111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +....          .+.  ...+...+..+.+|+.+||+.||++|||++|+++|
T Consensus       227 i~~~~----------~~~--~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         227 IAKSE----------PPT--LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             HHHSC----------CCC--CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHcCC----------CCC--CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11110          011  12234455679999999999999999999999887

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.7e-48  Score=390.65  Aligned_cols=248  Identities=25%  Similarity=0.379  Sum_probs=192.6

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      .|+..+.||+|+||+||+|++..++ ..++.|.+....        ....+..+.+.+|+++|++++|||||++++++.+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~--------~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~   86 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNS-EVVAIKKMSYSG--------KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR   86 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTT-EEEEEEEEECCS--------SCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCC-cEEEEEEEchhh--------ccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE
Confidence            4899999999999999999987652 222222111000        0112344678899999999999999999998875


Q ss_pred             -CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccC
Q 037010          353 -GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGL  431 (589)
Q Consensus       353 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgl  431 (589)
                       +.+|+|||||.+|+|..++....  ++++.+++.++.||+.||+|||++|+   +||||||+|||++.++.+||+|||+
T Consensus        87 ~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~i---iHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          87 EHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             CCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCE---eccCCCcceEEECCCCCEEEeeccc
Confidence             56999999999999987766543  49999999999999999999999999   9999999999999999999999999


Q ss_pred             ccccccCCCCCCcccccCCCCCchhcccC---CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhc
Q 037010          432 TKLTEVGSASLPTRLVGTFGYMPPEYAQY---GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLN  508 (589)
Q Consensus       432 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~  508 (589)
                      +.....     .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.....        ......+..
T Consensus       162 a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~  228 (309)
T d1u5ra_         162 ASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ  228 (309)
T ss_dssp             CBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHH
T ss_pred             ccccCC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh
Confidence            986432     234679999999999853   4689999999999999999999999953211        111111111


Q ss_pred             CCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          509 LPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       509 ~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .          ..+.   ..+...+..+.+|+.+||+.||.+|||++|+++|
T Consensus       229 ~----------~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         229 N----------ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             S----------CCCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C----------CCCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            1          0111   1122334578999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=385.36  Aligned_cols=251  Identities=31%  Similarity=0.498  Sum_probs=194.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCH-HHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDM-QASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||.||+|.++++                 .+++|.++. ...+.+.+|++++++++||||++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-----------------~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~   68 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYRGN-----------------KVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV   68 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTE-----------------EEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEECCe-----------------EEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            45788999999999999999998653                 233333321 234568899999999999999999998


Q ss_pred             EEe--CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          350 CVE--GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       350 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      +.+  +.+|+||||+++|+|.+++.......+++..++.++.||+.||.|||++++   +||||||+|||++.++.+||+
T Consensus        69 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~i---vH~dlkp~Nil~~~~~~~kl~  145 (262)
T d1byga_          69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAARNVLVSEDNVAKVS  145 (262)
T ss_dssp             ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTSCEEEC
T ss_pred             EEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCce---eccccchHhheecCCCCEeec
Confidence            864  458999999999999999977655568999999999999999999999998   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      |||+++.....    .....+|+.|+|||++.++.++.++|||||||++|||+| |+.||.....     ....   ..+
T Consensus       146 dfg~s~~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~---~~i  213 (262)
T d1byga_         146 DFGLTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVV---PRV  213 (262)
T ss_dssp             CCCC----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHH---HHH
T ss_pred             ccccceecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHH---HHH
Confidence            99999864322    233567899999999998999999999999999999999 5666532211     1111   111


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                                .....+    ..+...+..+.+|+.+||+.||++|||+.|++++|+++++.
T Consensus       214 ----------~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         214 ----------EKGYKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             ----------TTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------HcCCCC----CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence                      111122    33444456789999999999999999999999999988653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-47  Score=393.35  Aligned_cols=253  Identities=20%  Similarity=0.307  Sum_probs=199.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|++..++ ..++.|.+.           .......+.+.+|+++|++++||||+++++++
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g-~~vAvK~i~-----------~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   92 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATG-NNFAAKFVM-----------TPHESDKETVRKEIQTMSVLRHPTLVNLHDAF   92 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTT-EEEEEEEEC-----------CCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCC-CEEEEEEEc-----------ccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            468999999999999999999987652 222222211           11233446788999999999999999999987


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc--CCCcEEEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID--KNFHAKVA  427 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~--~~~~vkl~  427 (589)
                      .+ +.+|+|||||+||+|.+++..... ++++..++.++.||+.||+|||++|+   +||||||+|||++  .++.+||+
T Consensus        93 ~~~~~~~ivmE~~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~~i---iHrDiKp~NIll~~~~~~~vkL~  168 (350)
T d1koaa2          93 EDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLI  168 (350)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSTTSCCEEEC
T ss_pred             EECCEEEEEEEcCCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhcCC---eeeeechhHeeeccCCCCeEEEe
Confidence            65 569999999999999999965433 49999999999999999999999998   9999999999995  46789999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||+++.....  .......||+.|||||++.+..++.++|||||||++|||+||+.||....        ....+..+.
T Consensus       169 DFG~a~~~~~~--~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~  238 (350)
T d1koaa2         169 DFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVK  238 (350)
T ss_dssp             CCTTCEECCTT--SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH
T ss_pred             ecchheecccc--cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHH
Confidence            99999865432  22344789999999999999999999999999999999999999994321        112222222


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...           ...........+..+.+|+.+||+.||++|||++|+++|
T Consensus       239 ~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         239 SCD-----------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HTC-----------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             hCC-----------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111           111111223344578999999999999999999999998

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=385.78  Aligned_cols=266  Identities=27%  Similarity=0.434  Sum_probs=195.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      ..++|++.++||+|+||.||+|.+...... ...+.+++|...     +.......+.+.+|.+++.++ +|+||+.+++
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~-~~~~~vAvK~l~-----~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKT-ATCRTVAVKMLK-----EGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSS-SCEEEEEEEEC---------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcc-cCCeEEEEEEEc-----cccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            357899999999999999999998764221 222223332211     112234456677888888777 6899999999


Q ss_pred             EEEe--CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          349 YCVE--GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       349 ~~~~--~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      ++.+  +.+++|||||++|+|.+++....              ...+++.+++.++.||+.||+|||++++   +|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~i---vHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKC---IHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCC---cCCcCC
Confidence            8764  35899999999999999997542              2348899999999999999999999999   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCc-ccccCC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKE-AIVKGN  490 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~-p~~~~~  490 (589)
                      |+|||+++++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||+||.. ||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986543322 23344679999999999999999999999999999999999865 553221


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      .    ...+....             .....+.    .+...+..+.+|+.+||+.||++|||++|+++||+.+.
T Consensus       242 ~----~~~~~~~~-------------~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         242 I----DEEFCRRL-------------KEGTRMR----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             C----SHHHHHHH-------------HHTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             H----HHHHHHHH-------------hcCCCCC----CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            1    11111111             1111222    23334457899999999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=382.09  Aligned_cols=264  Identities=23%  Similarity=0.380  Sum_probs=197.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|+++...+...   .++++......   ....+..+++.+|+++|++++||||+++++++
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~---~vAiK~l~~~~---~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~   80 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTV---SVAVKCLKPDV---LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   80 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEE---EEEEEC-----------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEE---EEEEEEEChhh---cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3679999999999999999998876543221   11111111000   01123456789999999999999999999999


Q ss_pred             EeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          351 VEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       351 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      .++..++||||+++|+|.+++..... .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~~lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~~i---iHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          81 LTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             CSSSCEEEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEEEETTEEEECCCT
T ss_pred             eecchheeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhCCE---eeeeecHHHhccccccceeeccch
Confidence            88889999999999999998876543 49999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCC--CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCCCCCChhhHHHHHHHHh
Q 037010          431 LTKLTEVGSAS--LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       431 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      +++........  ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.....        ......+.
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~  228 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKID  228 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHH
Confidence            99876433221  2233567889999999999999999999999999999998 8999843211        11122221


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      .             .......+.+.+..+.+|+.+||+.||++|||++||++.|.+++
T Consensus       229 ~-------------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         229 K-------------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             T-------------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             h-------------CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence            1             11112233444567999999999999999999999999988753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-48  Score=387.47  Aligned_cols=258  Identities=18%  Similarity=0.309  Sum_probs=198.4

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++++.||+|+||+||+|.++.++ ..++.|.+.....     .........+.+.+|+++|++++|||||++++++
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-~~~AvK~i~~~~~-----~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTG-LQYAAKFIKKRRT-----KSSRRGVSREDIEREVSILKEIQHPNVITLHEVY   82 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEEBCSS-----TTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCC-CEEEEEEEEhhhc-----chhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            478999999999999999999987653 2233332211100     0001111245688999999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC----cEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF----HAK  425 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~----~vk  425 (589)
                      .+ +.+|+|||||++|+|.+++....  ++++..++.++.|++.||+|||++++   +||||||+|||++.++    .+|
T Consensus        83 ~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~i---vHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          83 ENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQI---AHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcce---eecccccceEEEecCCCcccceE
Confidence            75 46899999999999999998764  49999999999999999999999998   9999999999998776    599


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |+|||++.......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||....        ....+..
T Consensus       158 l~DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~  227 (293)
T d1jksa_         158 IIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLAN  227 (293)
T ss_dssp             ECCCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred             ecchhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHH
Confidence            99999998764332  2345689999999999999999999999999999999999999995322        1112222


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +.....           ......+.+.+..+.+|+.+||+.||.+|||++|+++|
T Consensus       228 i~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         228 VSAVNY-----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHTTCC-----------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHhcCC-----------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            222110           00001112234468999999999999999999999987

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4e-47  Score=389.86  Aligned_cols=253  Identities=20%  Similarity=0.329  Sum_probs=200.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|.+..++ ..++.|.+.           .......+.+.+|+++|++++||||+++++++
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~-~~vAiK~i~-----------~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~   95 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATG-RVFVAKFIN-----------TPYPLDKYTVKNEISIMNQLHHPKLINLHDAF   95 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEE-----------CCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCC-CEEEEEEEC-----------CcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            467999999999999999999987653 223222211           11123345678899999999999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc--CCCcEEEE
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID--KNFHAKVA  427 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~--~~~~vkl~  427 (589)
                      .+ +.+|+|||||+||+|.+++.... .++++.+++.++.||+.||+|||++|+   +||||||+|||++  .++.+||+
T Consensus        96 ~~~~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~i---iHRDiKp~NILl~~~~~~~vkL~  171 (352)
T d1koba_          96 EDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSI---VHLDIKPENIMCETKKASSVKII  171 (352)
T ss_dssp             ECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EECCEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCe---eecccccccccccccCCCeEEEe
Confidence            75 56899999999999999887654 349999999999999999999999998   9999999999997  57899999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      |||++......  .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....        ...+..+.
T Consensus       172 DFGla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~  241 (352)
T d1koba_         172 DFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVK  241 (352)
T ss_dssp             CCTTCEECCTT--SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHH
T ss_pred             ecccceecCCC--CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence            99999876533  233456899999999999999999999999999999999999999943221        11222221


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..           +...........+..+.+|+.+||+.||.+|||++|+++|
T Consensus       242 ~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         242 RC-----------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             HC-----------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hC-----------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11           1111222333445578999999999999999999999987

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-47  Score=384.38  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=199.8

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++++.||+|+||.||+|+++.++ ..++.|.+.     +......   ...+.+.+|+++|++++||||+++++++
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~-~~~AiK~i~-----k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~   74 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATG-RYYAMKILR-----KEVIIAK---DEVAHTVTESRVLQNTRHPFLTALKYAF   74 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTC-CEEEEEEEE-----HHHHHHT---TCHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCC-CEEEEEEEc-----hhhccCH---HHHHHHHHHHHHHHhCCCCCEEEEEeee
Confidence            367999999999999999999987653 333333222     1111111   1235678899999999999999999988


Q ss_pred             EeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .++ .+|+||||++||+|.+++.....  +++..++.++.||+.||+|||++++   +||||||+|||++.+|++||+||
T Consensus        75 ~~~~~~~iv~ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~~i---iHRDlKP~NILl~~~g~vkl~DF  149 (337)
T d1o6la_          75 QTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDV---VYRDIKLENLMLDKDGHIKITDF  149 (337)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccccccccceeccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhcCc---cccccCHHHeEecCCCCEEEeec
Confidence            754 68999999999999999987654  8999999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+|+..... .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.        ..........
T Consensus       150 G~a~~~~~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~  220 (337)
T d1o6la_         150 GLCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME  220 (337)
T ss_dssp             TTCBCSCCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC
T ss_pred             ccccccccC-CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcC
Confidence            999865432 2233457899999999999999999999999999999999999999954321        1112221111


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                                 ...    .|...+..+.+|+.+||+.||.+||+     ++|+++|
T Consensus       221 -----------~~~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         221 -----------EIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -----------CCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -----------CCC----CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                       111    23334456899999999999999995     8999987

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.5e-46  Score=385.86  Aligned_cols=255  Identities=23%  Similarity=0.290  Sum_probs=196.2

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.+.||+|+||.||+|++..++ ..++.|.+..     .............+..+|+++++.++||||+++++++.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~-~~vAiK~i~~-----~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTG-KMYAMKCLDK-----KRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEH-----HHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCC-CEEEEEEEch-----HHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            68999999999999999999987653 3333333221     11111122222233445688899999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||++||+|.+++....  .+++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~i---iHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFV---VYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECSSSCEEECCCT
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCc---cceeeccceeEEcCCCcEEEeeec
Confidence            5 56999999999999999998764  38899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      +|+.....   ......||+.|+|||++.. ..++.++|||||||++|||+||+.||.......     ...........
T Consensus       153 la~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~  224 (364)
T d1omwa3         153 LACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTM  224 (364)
T ss_dssp             TCEECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSSSC
T ss_pred             eeeecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcccC
Confidence            99865432   2344689999999999864 568999999999999999999999996543211     11111111110


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPS-----MRSIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~  560 (589)
                                 .    ...+...+..+.+|+.+||+.||++|||     ++|+++|
T Consensus       225 -----------~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 -----------A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             -----------C----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             -----------C----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                       1    1223334457899999999999999999     7999987

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.8e-47  Score=376.67  Aligned_cols=263  Identities=21%  Similarity=0.350  Sum_probs=196.2

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      .++|++.+.||+|+||.||+|++..++ ..++.|.+....        ....+....+.+|+++|++++||||+++++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~-~~vAiK~i~~~~--------~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~   76 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLH-RDVAVKVLRADL--------ARDPSFYLRFRREAQNAAALNHPAIVAVYDTG   76 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEECSTT--------TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCC-CEEEEEEEchhh--------ccCHHHHHHHHHHHHHHHhcCCCCCCccccee
Confidence            578999999999999999999987652 222222211100        11234456789999999999999999999977


Q ss_pred             Ee-C----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEE
Q 037010          351 VE-G----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAK  425 (589)
Q Consensus       351 ~~-~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vk  425 (589)
                      .. +    .+|+||||++|++|.+++...+  ++++.+++.++.||+.||+|||++++   +||||||+|||++.++..+
T Consensus        77 ~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~i---iHrDiKP~NIll~~~~~~~  151 (277)
T d1o6ya_          77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGI---IHRDVKPANIMISATNAVK  151 (277)
T ss_dssp             EEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTSCEE
T ss_pred             eeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCc---cCccccCcccccCccccce
Confidence            53 2    2789999999999999987765  49999999999999999999999998   9999999999999999999


Q ss_pred             EEeccCccccccCCC--CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHH
Q 037010          426 VADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALF  503 (589)
Q Consensus       426 l~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~  503 (589)
                      |+|||.+........  .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....        ....
T Consensus       152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~  223 (277)
T d1o6ya_         152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVA  223 (277)
T ss_dssp             ECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHH
T ss_pred             eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH--------HHHH
Confidence            999999875433222  233446899999999999999999999999999999999999999953211        1111


Q ss_pred             HHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhccc
Q 037010          504 EEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-SMRSIVVALMTLSS  566 (589)
Q Consensus       504 ~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~l~~  566 (589)
                      .......           +........+.+..+.+++.+||+.||.+|| |++++++.|.+++.
T Consensus       224 ~~~~~~~-----------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         224 YQHVRED-----------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HHHHHCC-----------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             HHHHhcC-----------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            1111110           0001111223345789999999999999999 89999999988763

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-46  Score=379.46  Aligned_cols=264  Identities=28%  Similarity=0.466  Sum_probs=203.0

Q ss_pred             HHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCc
Q 037010          267 LSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLN  342 (589)
Q Consensus       267 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpn  342 (589)
                      ++...++|++.+.||+|+||+||+|++++..+... .+         .+|+|.+    ..+..+++.+|+++|++++|||
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~-~~---------~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~n   77 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEP-FT---------MVAVKMLKEEASADMQADFQREAALMAEFDNPN   77 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSS-EE---------EEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTT
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCC-Ce---------EEEEEEEChhcChHHHHHHHHHHHHHHhcCCCC
Confidence            34456789999999999999999999865321110 11         1223322    3344567999999999999999


Q ss_pred             ceeEeeEEEe-CcEEEEEEecCCCChHHHHhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 037010          343 LVRLIGYCVE-GSLFLVYEYIENGNLSEHLRGSG----------------------RDPLPWSSRVQIALDSARGLEYIH  399 (589)
Q Consensus       343 Iv~l~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~qia~aL~~LH  399 (589)
                      |+++++++.+ +..+++|||+.+|+|.+++....                      ...+++..++.++.|++.||+|||
T Consensus        78 iv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH  157 (301)
T d1lufa_          78 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS  157 (301)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc
Confidence            9999998864 56899999999999999996532                      234889999999999999999999


Q ss_pred             hCCCCceEeeccCCCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHH
Q 037010          400 EHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYE  478 (589)
Q Consensus       400 ~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~e  478 (589)
                      ++++   +||||||+|||++.++.+||+|||+++....... ...+...||+.|+|||.+.+..++.++|||||||++||
T Consensus       158 ~~~i---vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e  234 (301)
T d1lufa_         158 ERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE  234 (301)
T ss_dssp             HTTC---CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             cCCe---EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence            9999   9999999999999999999999999986543322 22334678999999999999999999999999999999


Q ss_pred             HHcCCc-ccccCCCCCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 037010          479 LISAKE-AIVKGNGSSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSI  557 (589)
Q Consensus       479 lltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev  557 (589)
                      |++|.. ||....     ..   +....+..          ...+    ..|.+++..+.+|+.+||+.||++||||.||
T Consensus       235 ll~~~~~p~~~~~-----~~---e~~~~v~~----------~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev  292 (301)
T d1lufa_         235 IFSYGLQPYYGMA-----HE---EVIYYVRD----------GNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSI  292 (301)
T ss_dssp             HHTTTCCTTTTSC-----HH---HHHHHHHT----------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HHccCCCCCCCCC-----HH---HHHHHHHc----------CCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            999975 442211     11   11111111          1111    2334445578999999999999999999999


Q ss_pred             HHHHHhcc
Q 037010          558 VVALMTLS  565 (589)
Q Consensus       558 l~~L~~l~  565 (589)
                      ++.|+++.
T Consensus       293 ~~~L~~i~  300 (301)
T d1lufa_         293 HRILQRMC  300 (301)
T ss_dssp             HHHHHHTT
T ss_pred             HHHHHHhc
Confidence            99999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-47  Score=381.40  Aligned_cols=260  Identities=33%  Similarity=0.520  Sum_probs=200.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccC-CCCcceeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHV-HHLNLVRL  346 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l-~hpnIv~l  346 (589)
                      ++|++.++||+|+||.||+|.+++++....             +++|.+    ..+..+++.+|+++|.++ +||||+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~-------------vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~   76 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMD-------------AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL   76 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEE-------------EEEEEEECC------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEE-------------EEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeE
Confidence            678999999999999999999876532211             122221    223345789999999999 79999999


Q ss_pred             eeEEEe-CcEEEEEEecCCCChHHHHhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 037010          347 IGYCVE-GSLFLVYEYIENGNLSEHLRGS--------------GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDI  411 (589)
Q Consensus       347 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dl  411 (589)
                      ++++.+ +.+|+||||+++|+|.+++...              ....+++..++.++.||+.||.|||++++   +||||
T Consensus        77 ~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~i---iHrDl  153 (309)
T d1fvra_          77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDL  153 (309)
T ss_dssp             EEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTE---ECSCC
T ss_pred             EEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCc---ccccc
Confidence            998875 4689999999999999999754              23469999999999999999999999998   99999


Q ss_pred             CCCcEEEcCCCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCC
Q 037010          412 KSANILIDKNFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       412 kp~NILl~~~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~  491 (589)
                      ||+|||++.++.+||+|||+++......  ......||..|+|||.+..+.++.++|||||||++|||++|..|+.....
T Consensus       154 kp~NIL~~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~  231 (309)
T d1fvra_         154 AARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT  231 (309)
T ss_dssp             SGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccceEEEcCCCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999999997543222  22335689999999999999999999999999999999998765432221


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSSTTED  570 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~~~  570 (589)
                             .......+.          +..++    ..+...+..+.+|+.+||+.||++|||++||+++|+++......
T Consensus       232 -------~~~~~~~i~----------~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~  289 (309)
T d1fvra_         232 -------CAELYEKLP----------QGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT  289 (309)
T ss_dssp             -------HHHHHHHGG----------GTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred             -------HHHHHHHHH----------hcCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence                   111122111          11122    23344556799999999999999999999999999988754433

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-46  Score=378.46  Aligned_cols=248  Identities=26%  Similarity=0.418  Sum_probs=197.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++++.||+|+||+||+|+++.++ ..++.|.+.     .....+.   ...+.+.+|+.+|++++||||+++++++.
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g-~~vAvK~i~-----~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~   74 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNG-RYYAMKVLK-----KEIVVRL---KQVEHTNDERLMLSIVTHPFIIRMWGTFQ   74 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEE-----HHHHHHT---TCHHHHHHHHHHHHSCCBTTBCCEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCC-CEEEEEEEc-----hHHccCH---HHHHHHHHHHHHHHhccCcChhheeeeEe
Confidence            57999999999999999999987653 233333221     1111111   12356888999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +.+|+||||+.||+|..++.....  +++..++.++.||+.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        75 ~~~~~~ivmE~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~~i---iHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          75 DAQQIFMIMDYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSKDI---IYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECTTSCEEECCCS
T ss_pred             eCCeeeeEeeecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccCcE---EccccCchheeEcCCCCEEEecCc
Confidence            5 568999999999999999987654  7888999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +++.....    .....||+.|||||++.+..|+.++|||||||++|||+||+.||....        .......+... 
T Consensus       150 ~a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~-  216 (316)
T d1fota_         150 FAKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNA-  216 (316)
T ss_dssp             SCEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHC-
T ss_pred             cceEeccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHcC-
Confidence            99875422    234689999999999999999999999999999999999999995432        11222222211 


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                                ..    ..|...+..+.+++.+||..||.+||     |++|+++|
T Consensus       217 ----------~~----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         217 ----------EL----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ----------CC----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----------CC----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                      11    22333445789999999999999996     99999987

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-47  Score=385.50  Aligned_cols=253  Identities=18%  Similarity=0.281  Sum_probs=194.0

Q ss_pred             cCCCccce-eeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHcc-CCCCcceeEee
Q 037010          271 TDNFSMSH-KIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTH-VHHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~-~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~-l~hpnIv~l~~  348 (589)
                      .++|++.. .||+|+||+||+|.+..++ ..+              |+|.++.  ...+.+|++++.+ .+||||+++++
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~-~~v--------------AiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~   72 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQ-EKF--------------ALKMLQD--CPKARREVELHWRASQCPHIVRIVD   72 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTC-CEE--------------EEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCC-CEE--------------EEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEE
Confidence            46898875 5999999999999987653 222              2222211  1345679988655 48999999999


Q ss_pred             EEEe-----CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC---
Q 037010          349 YCVE-----GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK---  420 (589)
Q Consensus       349 ~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~---  420 (589)
                      ++.+     ..+|+|||||+||+|.+++...+..++++.+++.++.||+.||+|||++++   +||||||+|||++.   
T Consensus        73 ~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~i---iHRDiKp~NIll~~~~~  149 (335)
T d2ozaa1          73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI---AHRDVKPENLLYTSKRP  149 (335)
T ss_dssp             EEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEESCSST
T ss_pred             EEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCC---ccccccccccccccccc
Confidence            8753     458999999999999999988766679999999999999999999999998   99999999999975   


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      ++.+||+|||+++......  ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||..........    
T Consensus       150 ~~~~Kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----  223 (335)
T d2ozaa1         150 NAILKLTDFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----  223 (335)
T ss_dssp             TCCEEECCCTTCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred             cccccccccceeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----
Confidence            5679999999998654332  2345689999999999999999999999999999999999999996544321100    


Q ss_pred             HHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .......           ......+.......+..+.+|+.+||+.||++|||++|+++|
T Consensus       224 ~~~~~i~-----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         224 GMKTRIR-----------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ----CCC-----------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHh-----------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            0000000           000011111112445679999999999999999999999997

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=375.24  Aligned_cols=267  Identities=25%  Similarity=0.431  Sum_probs=199.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCc-cchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNS-YLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~-~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~  348 (589)
                      .++|++++.||+|+||.||+|+..+..... .....+++|...     +........++.+|...+.++ +|||||++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~-----~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~   86 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-----SDATEKDLSDLISEMEMMKMIGKHKNIINLLG   86 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCC-----TTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEEC-----cccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence            468999999999999999999876643211 111112222111     123344557788899999888 7999999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCC
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSG--------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKS  413 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp  413 (589)
                      ++.+ +.+|+||||+++|+|.++|....              ...+++.+++.++.||+.||+|||++++   +||||||
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i---vHrDiKp  163 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC---IHRDLAA  163 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSG
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE---Eeeeecc
Confidence            8875 45999999999999999997653              2358999999999999999999999999   9999999


Q ss_pred             CcEEEcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHc-CCcccccCCC
Q 037010          414 ANILIDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELIS-AKEAIVKGNG  491 (589)
Q Consensus       414 ~NILl~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~ellt-G~~p~~~~~~  491 (589)
                      +|||++.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||+| |+.||.... 
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-  242 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-  242 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred             cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-
Confidence            9999999999999999999866543322 2344678999999999999999999999999999999998 566663221 


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                          ..   ..+..+          .....+    ..|...+..+.+|+.+||+.||++|||+.||++.|+++.+.
T Consensus       243 ----~~---~~~~~i----------~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         243 ----VE---ELFKLL----------KEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             ----HH---HHHHHH----------HTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----HH---HHHHHH----------HcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                11   111111          111112    23334455799999999999999999999999999988654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-46  Score=375.03  Aligned_cols=254  Identities=26%  Similarity=0.419  Sum_probs=197.8

Q ss_pred             ceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhh----cCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          277 SHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKK----MDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~----~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      .++||+|+||+||+|.+..+.+...            .+++|.    ......+++.+|+++|++++||||+++++++.+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~------------~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   99 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKI------------HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR   99 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CE------------EEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEE------------EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe
Confidence            5789999999999999876543221            112222    244556789999999999999999999998764


Q ss_pred             --CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          353 --GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       353 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                        +..++|||||++|+|.+++..... .+++..++.++.|++.||.|||+.++   +||||||+|||+++++.+||+|||
T Consensus       100 ~~~~~~lv~E~~~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~~i---iHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         100 SEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             TTTEEEEEEECCTTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHTTC---CCSCCSGGGEEECTTCCEEECSSG
T ss_pred             cCCceEEEEEEeecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhcccCc---ccCCccHHhEeECCCCCEEEeccc
Confidence              468999999999999999886543 47888999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCC---CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHh
Q 037010          431 LTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVL  507 (589)
Q Consensus       431 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~  507 (589)
                      +++........   ......||+.|+|||.+..+.++.++||||||+++|||+||+.||.......       .....+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-------~~~~~i~  248 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLL  248 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHH
T ss_pred             chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-------HHHHHHH
Confidence            99865433222   2233578999999999999999999999999999999999998875432111       1111111


Q ss_pred             cCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          508 NLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       508 ~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                                ....+.    .|..++..+.+|+.+||+.||++|||++||+++|+.+...
T Consensus       249 ----------~g~~~~----~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         249 ----------QGRRLL----QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ----------TTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----------cCCCCC----CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                      111111    2333445789999999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.4e-46  Score=368.49  Aligned_cols=261  Identities=20%  Similarity=0.294  Sum_probs=199.9

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  349 (589)
                      .++|++.+.||+|+||+||+|++..+ +..++.|.+.........  +.......+.+.+|+++|++++ ||||++++++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~-~~~~AvK~i~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~   78 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPT-CKEYAVKIIDVTGGGSFS--AEEVQELREATLKEVDILRKVSGHPNIIQLKDT   78 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTT-TEEEEEEEEETTCSTTCC--HHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             cccCEEceEEecCcCeEEEEEEECCC-CCEEEEEEEecccccchh--HHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee
Confidence            47899999999999999999987654 333333333221111000  0001123456889999999997 9999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEe
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVAD  428 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~D  428 (589)
                      +.+ +.+||||||+++|+|.+++..++  ++++.+++.++.||+.||+|||++++   +||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~i---vHrDlkp~Nill~~~~~~kl~D  153 (277)
T d1phka_          79 YETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNI---VHRDLKPENILLDDDMNIKLTD  153 (277)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEECTTCCEEECC
T ss_pred             cccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCC---cccccccceEEEcCCCCeEEcc
Confidence            875 46899999999999999998755  49999999999999999999999998   9999999999999999999999


Q ss_pred             ccCccccccCCCCCCcccccCCCCCchhcccC------CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          429 FGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY------GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       429 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      ||+++......  ......||+.|+|||.+.+      ..++.++||||+||++|||+||+.||.....        ...
T Consensus       154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~  223 (277)
T d1phka_         154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLM  223 (277)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH
T ss_pred             chheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHH
Confidence            99998764332  3345789999999998853      3578899999999999999999999954321        111


Q ss_pred             HHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ...+....           ..+........+..+.+|+.+||+.||.+|||++|+++|
T Consensus       224 ~~~i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         224 LRMIMSGN-----------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHHHHTC-----------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhCC-----------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            22222110           111122233455679999999999999999999999876

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.7e-46  Score=379.78  Aligned_cols=248  Identities=25%  Similarity=0.362  Sum_probs=197.2

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++++.||+|+||.||+|+++.++ ..++.|.+..     ....+.   ...+.+.+|+++|++++||||+++++++.
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g-~~~AvK~i~~-----~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~  111 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESG-NHYAMKILDK-----QKVVKL---KQIEHTLNEKRILQAVNFPFLVKLEFSFK  111 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTC-CEEEEEEEEH-----HHHHHT---TCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCC-CEEEEEEEch-----HHccCH---HHHHHHHHHHHHHHHcCCCcEeecccccc
Confidence            57999999999999999999987653 2333332211     111111   12346788999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|+||||+.+|+|.+++....  .+++..++.++.||+.||.|||++++   |||||||+|||++.++.+||+|||
T Consensus       112 ~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~i---iHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         112 DNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDL---IYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCE---ecCcCCHHHcccCCCCCEEeeece
Confidence            5 45899999999999999998765  39999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLP  510 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~  510 (589)
                      +++.....    .....||+.|||||++.+..++.++|||||||++|||+||+.||....        .......+... 
T Consensus       187 ~a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~-  253 (350)
T d1rdqe_         187 FAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSG-  253 (350)
T ss_dssp             TCEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC-
T ss_pred             eeeecccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhcC-
Confidence            99875422    234689999999999999999999999999999999999999995321        11122222111 


Q ss_pred             ChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          511 DPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       511 ~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                                ...    .+...+..+.+|+++||+.||.+|+     |++|+++|
T Consensus       254 ----------~~~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         254 ----------KVR----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----------CCC----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----------CCC----CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                      111    1233445789999999999999994     99999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-46  Score=374.77  Aligned_cols=268  Identities=24%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC-CCCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV-HHLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~  349 (589)
                      .++|++.++||+|+||.||+|++.+.... ...+.++++.+.     +........++.+|+.+++++ +|||||+++++
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~-~~~~~vAvK~i~-----~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKS-DAAMTVAVKMLK-----PSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSST-TCEEEEEEEEEC-----TTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccC-CCCeEEEEEEEC-----cccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            46899999999999999999998653221 112222222111     112234556788999999999 69999999999


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccC
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSG----------------RDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIK  412 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlk  412 (589)
                      +.++ ..|+||||+++|+|.+++....                ...+++..++.++.||+.||+|||++++   +|||||
T Consensus        96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~i---vHrDLK  172 (311)
T d1t46a_          96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLA  172 (311)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCS
T ss_pred             EeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCe---eecccc
Confidence            8754 5899999999999999997643                2358899999999999999999999998   999999


Q ss_pred             CCcEEEcCCCcEEEEeccCccccccCCC-CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCC
Q 037010          413 SANILIDKNFHAKVADFGLTKLTEVGSA-SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNG  491 (589)
Q Consensus       413 p~NILl~~~~~vkl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~  491 (589)
                      |+|||++.++.+|++|||+++....... .......||+.|+|||++..+.++.++|||||||++|||+|++.|+.....
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986654332 223346789999999999999999999999999999999996666543322


Q ss_pred             CCCChhhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 037010          492 SSADSKGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSST  567 (589)
Q Consensus       492 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  567 (589)
                      ..   ..+.....             ....+    ..+...+..+.+|+.+||+.||.+|||++||++.|+++...
T Consensus       253 ~~---~~~~~~i~-------------~~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         253 VD---SKFYKMIK-------------EGFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             SS---HHHHHHHH-------------HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH---HHHHHHHh-------------cCCCC----CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            11   11111111             11112    22333445799999999999999999999999999876543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-46  Score=375.86  Aligned_cols=253  Identities=18%  Similarity=0.303  Sum_probs=197.2

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++++.||+|+||+||+|.+..++ ..++.|.+..            .......+.+|+++|++++||||++++++
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~-~~~AiK~i~~------------~~~~~~~~~~Ei~il~~l~HpnIv~~~~~   69 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSK-KTYMAKFVKV------------KGTDQVLVKKEISILNIARHRNILHLHES   69 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTT-EEEEEEEECC------------CTHHHHHHHHHHHHHHHSCCTTBCCEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCC-cEEEEEEEcC------------CcccHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4688999999999999999999987653 2222222211            11223457789999999999999999998


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC--CcEEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN--FHAKV  426 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~--~~vkl  426 (589)
                      +.+ +.+|+|||||+||+|.+++...+ .++++.+++.++.||+.||+|||++|+   +||||||+|||++.+  ..+||
T Consensus        70 ~~~~~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~i---iHrDlKp~NIll~~~~~~~ikl  145 (321)
T d1tkia_          70 FESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNI---GHFDIRPENIIYQTRRSSTIKI  145 (321)
T ss_dssp             EEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEESSSSCCCEEE
T ss_pred             EEECCEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCC---CcccccccceeecCCCceEEEE
Confidence            764 56999999999999999997654 248999999999999999999999998   999999999999754  58999


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEV  506 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~  506 (589)
                      +|||+++.....  .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.....        ...+..+
T Consensus       146 ~DFG~~~~~~~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i  215 (321)
T d1tkia_         146 IEFGQARQLKPG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENI  215 (321)
T ss_dssp             CCCTTCEECCTT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHH
T ss_pred             cccchhhccccC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHH
Confidence            999999865432  223446789999999999999999999999999999999999999954321        1222222


Q ss_pred             hcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          507 LNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       507 ~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .....           .+......+.+..+.+|+.+||+.||.+|||++|+++|
T Consensus       216 ~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         216 MNAEY-----------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHTCC-----------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HhCCC-----------CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            22110           00000001223468999999999999999999999997

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=372.21  Aligned_cols=268  Identities=26%  Similarity=0.422  Sum_probs=194.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHH--HHHHHccCCCCcceeEeeE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLA--ELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~--E~~il~~l~hpnIv~l~~~  349 (589)
                      ++|.+.++||+|+||.||+|++++.                 .+|+|.+.....+++..  |+..+.+++||||++++++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~-----------------~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~   65 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGE-----------------EVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA   65 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTE-----------------EEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCE-----------------EEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEE
Confidence            5688899999999999999987543                 33444443333334444  4445567899999999998


Q ss_pred             EEeC-----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----CceEeeccCCCcEEEc
Q 037010          350 CVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTV-----PVYIHRDIKSANILID  419 (589)
Q Consensus       350 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i-----~~~vH~Dlkp~NILl~  419 (589)
                      +.+.     .+|+||||+++|+|.++++..   ++++..++.++.|++.||+|||+...     ..|+||||||+|||++
T Consensus        66 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~  142 (303)
T d1vjya_          66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  142 (303)
T ss_dssp             EEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC
T ss_pred             EEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc
Confidence            8642     479999999999999999865   38999999999999999999997411     2249999999999999


Q ss_pred             CCCcEEEEeccCccccccCCCC---CCcccccCCCCCchhcccCC------CCCcccchhhHHHHHHHHHcCCcccccCC
Q 037010          420 KNFHAKVADFGLTKLTEVGSAS---LPTRLVGTFGYMPPEYAQYG------DVSPKVDVYAFGVVLYELISAKEAIVKGN  490 (589)
Q Consensus       420 ~~~~vkl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~sDvwSlGvll~elltG~~p~~~~~  490 (589)
                      .++.+||+|||+++........   ......||+.|+|||++...      .++.++|||||||++|||+||..|+....
T Consensus       143 ~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~  222 (303)
T d1vjya_         143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  222 (303)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred             CCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence            9999999999999876543322   22346899999999998654      26778999999999999999998875433


Q ss_pred             CCCCChhhHHHHHHHHhcCCChHHhhH-----hhcCCCCCCCC-ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 037010          491 GSSADSKGLVALFEEVLNLPDPIEDLR-----KLVDPRLGDNC-PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTL  564 (589)
Q Consensus       491 ~~~~~~~~~~~~~~~~~~~~~~~~~l~-----~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l  564 (589)
                      ........       ........+.+.     ...+|.+.... +.+....+.+|+.+||+.||++|||+.||+++|+++
T Consensus       223 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         223 DYQLPYYD-------LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CCCCTTTT-------TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccchhh-------cccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            21111000       000001111111     11223322222 234566799999999999999999999999999988


Q ss_pred             cc
Q 037010          565 SS  566 (589)
Q Consensus       565 ~~  566 (589)
                      ..
T Consensus       296 ~~  297 (303)
T d1vjya_         296 SQ  297 (303)
T ss_dssp             HH
T ss_pred             HH
Confidence            64

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=373.18  Aligned_cols=251  Identities=25%  Similarity=0.422  Sum_probs=194.4

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHc-cCCCCcceeEeeEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLT-HVHHLNLVRLIGYC  350 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~  350 (589)
                      ++|++++.||+|+||+||+|.+..++ ..++.|.+     ......+.   +..+.+..|..++. .++||||+++++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~-~~vAvK~i-----~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~   72 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTN-QFFAIKAL-----KKDVVLMD---DDVECTMVEKRVLSLAWEHPFLTHMFCTF   72 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTT-EEEEEEEE-----EHHHHHHT---TCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCC-CEEEEEEE-----chhhccCh---HHHHHHHHHHHHHHHhCCCCcEEEEEEEE
Confidence            67999999999999999999987652 22222221     11111111   12234566777664 68999999999988


Q ss_pred             Ee-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEec
Q 037010          351 VE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADF  429 (589)
Q Consensus       351 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Df  429 (589)
                      .+ +.+|+||||+++|+|.+++.....  +++.+++.++.||+.||+|||++++   +||||||+|||+++++++||+||
T Consensus        73 ~~~~~~yivmEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~~i---iHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          73 QTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSKGI---VYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHTTC---BCCCCCGGGEEECTTSCEEECCC
T ss_pred             ccCCceeEEEeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCe---eeccCcccceeecCCCceecccc
Confidence            75 469999999999999999987654  8999999999999999999999999   99999999999999999999999


Q ss_pred             cCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          430 GLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       430 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      |+++...... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....        ...+..+.. 
T Consensus       148 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~-  217 (320)
T d1xjda_         148 GMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRM-  217 (320)
T ss_dssp             TTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH-
T ss_pred             chhhhccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHc-
Confidence            9998654322 233446899999999999999999999999999999999999999954321        112222111 


Q ss_pred             CChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHH-HHHHH
Q 037010          510 PDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMR-SIVVA  560 (589)
Q Consensus       510 ~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~~  560 (589)
                                -.+.+    |...+..+.+|+.+||+.||.+|||++ |+++|
T Consensus       218 ----------~~~~~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         218 ----------DNPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ----------CCCCC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ----------CCCCC----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                      11222    233445689999999999999999996 78765

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-45  Score=365.75  Aligned_cols=269  Identities=24%  Similarity=0.367  Sum_probs=194.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.++||+|+||+||+|.+..++. .++.|.+..     .    .......+.+.+|+++|++++||||+++++++.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~-~vAvK~i~~-----~----~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~   71 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGE-VVALKKIRL-----D----TETEGVPSTAIREISLLKELNHPNIVKLLDVIH   71 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCC-EEEEEEEC----------------CCHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCC-EEEEEEEeh-----h----hcChHHHHHHHHHHHHHHhCCCCcEEEeccccc
Confidence            689999999999999999999876532 222222111     0    111122356888999999999999999999887


Q ss_pred             eC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 EG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      ++ .+|+||||+.+ ++.+++.......+++..++.++.|++.||+|||++++   |||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~I---iHrDiKpeNIl~~~~~~~kl~DFG  147 (298)
T d1gz8a_          72 TENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV---LHRDLKPQNLLINTEGAIKLADFG  147 (298)
T ss_dssp             ETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECSTT
T ss_pred             cccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCE---EccccCchheeecccCcceeccCC
Confidence            54 68999999976 56666655555669999999999999999999999999   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCC-CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD-VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      +++...... .......||+.|+|||.+.... ++.++|||||||++|+|++|+.||.....    ...+...... ...
T Consensus       148 ~a~~~~~~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~----~~~~~~i~~~-~~~  221 (298)
T d1gz8a_         148 LARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRT-LGT  221 (298)
T ss_dssp             HHHHHCCCS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHH-HCC
T ss_pred             cceeccCCc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH----HHHHHHHHHh-cCC
Confidence            998654332 2334468999999999876655 57899999999999999999999953321    1112221211 111


Q ss_pred             CChH--HhhHhhcC--CCCCCCC-------ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPI--EDLRKLVD--PRLGDNC-------PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~--~~l~~~~d--~~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +...  .......+  .......       .......+.+|+.+||+.||++|||++|+++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         222 PDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1110  00111000  0000000       01233578999999999999999999999998

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=365.39  Aligned_cols=262  Identities=27%  Similarity=0.440  Sum_probs=202.3

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhc----CHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKM----DMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~----~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      .++|++.++||+|+||+||+|.+++..... ...         .+|+|.+    .......+.+|++++++++||||+++
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~-~~~---------~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~   88 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDE-PET---------RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   88 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTE-EEE---------EEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCC-CCc---------EEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeee
Confidence            478899999999999999999886532111 011         2233322    33445678999999999999999999


Q ss_pred             eeEEE-eCcEEEEEEecCCCChHHHHhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEE
Q 037010          347 IGYCV-EGSLFLVYEYIENGNLSEHLRGS--------GRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANIL  417 (589)
Q Consensus       347 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NIL  417 (589)
                      ++++. ++..++||||+.+|+|.+++...        ....+++..+..++.|++.||.|||++++   +||||||+|||
T Consensus        89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~i---vHrDlk~~NiL  165 (308)
T d1p4oa_          89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCM  165 (308)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC---BCSCCSGGGEE
T ss_pred             eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCe---eeceEcCCcee
Confidence            99886 45699999999999999998643        12347889999999999999999999998   99999999999


Q ss_pred             EcCCCcEEEEeccCccccccCCCC-CCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCCh
Q 037010          418 IDKNFHAKVADFGLTKLTEVGSAS-LPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADS  496 (589)
Q Consensus       418 l~~~~~vkl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~  496 (589)
                      +++++++||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||..|+.....     
T Consensus       166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-----  240 (308)
T d1p4oa_         166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-----  240 (308)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-----
T ss_pred             ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-----
Confidence            999999999999999865433222 22335789999999999999999999999999999999999654422211     


Q ss_pred             hhHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 037010          497 KGLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLSS  566 (589)
Q Consensus       497 ~~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~~  566 (589)
                        .......+.             +... ...+..++..+.+++.+||+.||.+|||++||+++|++...
T Consensus       241 --~~~~~~~i~-------------~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         241 --NEQVLRFVM-------------EGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             --HHHHHHHHH-------------TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             --HHHHHHHHH-------------hCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence              111121111             1111 12234445679999999999999999999999999987754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=364.16  Aligned_cols=267  Identities=24%  Similarity=0.242  Sum_probs=188.2

Q ss_pred             cceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe-Cc
Q 037010          276 MSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE-GS  354 (589)
Q Consensus       276 ~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~  354 (589)
                      .+++||+|+||+||+|++..++ ..++.|.+....      .........+.+.+|+++|++++|||||++++++.+ +.
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~-~~vAvK~i~~~~------~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~   74 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTN-QIVAIKKIKLGH------RSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   74 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCC-SEEEEEEC------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             cceEeccCcCeEEEEEEECCCC-cEEEEEEEehhh------hhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc
Confidence            4688999999999999977652 222222221110      000111122458889999999999999999998874 56


Q ss_pred             EEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          355 LFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       355 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .|+||||+.++++..++...  ..+++..+..++.||+.||+|||++++   +||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~i---iHrDiKp~NIli~~~~~~KL~DFG~a~~  149 (299)
T d1ua2a_          75 ISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHWI---LHRDLKPNNLLLDENGVLKLADFGLAKS  149 (299)
T ss_dssp             CEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccce---ecccCCcceEEecCCCccccccCccccc
Confidence            99999999997776665433  348899999999999999999999999   9999999999999999999999999986


Q ss_pred             cccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcCCChH
Q 037010          435 TEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNLPDPI  513 (589)
Q Consensus       435 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  513 (589)
                      ...... .....+||+.|+|||++.. ..++.++|||||||++|||+||+.||.....     .............+...
T Consensus       150 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-----~~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         150 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----LDQLTRIFETLGTPTEE  223 (299)
T ss_dssp             TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCTT
T ss_pred             cCCCcc-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-----HHHHHHHHHhcCCCChh
Confidence            543322 2334679999999998864 4679999999999999999999999843321     11111122222211110


Q ss_pred             Hh--hHhhcCCC-C--CCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          514 ED--LRKLVDPR-L--GDNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       514 ~~--l~~~~d~~-l--~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ..  ........ .  ....+     ......+.+|+.+||+.||++|||++|+++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            00  00000000 0  00111     1234578999999999999999999999987

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-46  Score=367.81  Aligned_cols=247  Identities=22%  Similarity=0.356  Sum_probs=188.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC--CCcceeEee
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH--HLNLVRLIG  348 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~--hpnIv~l~~  348 (589)
                      .++|++.+.||+|+||+||+|++..++ ...+.|.+........     .......++.+|+++|++++  ||||+++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~-----~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~   76 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDN-LPVAIKHVEKDRISDW-----GELPNGTRVPMEVVLLKKVSSGFSGVIRLLD   76 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEGGGCCCE-----EECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCC-CEEEEEEEehHHccch-----hhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence            468999999999999999999987653 2233332221111000     00001123557999999886  899999999


Q ss_pred             EEEe-CcEEEEEEecCC-CChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-CCcEE
Q 037010          349 YCVE-GSLFLVYEYIEN-GNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-NFHAK  425 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-~~~vk  425 (589)
                      ++.+ +..|+||||+.+ +++.+++....  .+++.+++.++.||+.||+|||++++   +||||||+|||++. ++.+|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~i---iHrDiKp~NIll~~~~~~vk  151 (273)
T d1xwsa_          77 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGV---LHRDIKDENILIDLNRGELK  151 (273)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCSGGGEEEETTTTEEE
T ss_pred             EEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCC---ccccCcccceEEecCCCeEE
Confidence            8875 568999999986 67888887654  49999999999999999999999998   99999999999985 47999


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCCCC-CcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDV-SPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |+|||+++....   ...+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||....              
T Consensus       152 l~DFG~a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------  214 (273)
T d1xwsa_         152 LIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------  214 (273)
T ss_dssp             ECCCTTCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------
T ss_pred             ECccccceeccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------
Confidence            999999986532   22345789999999999987665 567999999999999999999984210              


Q ss_pred             HHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .+...           .......+    +..+.+|+.+||+.||++|||++|+++|
T Consensus       215 ~i~~~-----------~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         215 EIIRG-----------QVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             HHHHC-----------CCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhhc-----------ccCCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11110           11122233    3468999999999999999999999987

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=365.56  Aligned_cols=271  Identities=24%  Similarity=0.331  Sum_probs=193.4

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccC---CCCcceeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHV---HHLNLVRL  346 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l---~hpnIv~l  346 (589)
                      ..++|+++++||+|+||+||+|++..+.+...+.|.+....         ........+.+|+++|+.+   +||||+++
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~---------~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~   75 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT---------GEEGMPLSTIREVAVLRHLETFEHPNVVRL   75 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEB---------CTTSCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhh---------ccchHHHHHHHHHHHHHHHhhcCCCCccee
Confidence            35789999999999999999999866544333333221110         0111112344566666555   89999999


Q ss_pred             eeEEEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC
Q 037010          347 IGYCVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK  420 (589)
Q Consensus       347 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~  420 (589)
                      ++++..      ...|++||++.++.+..... .....+++..++.++.|++.||+|||++++   +||||||+|||++.
T Consensus        76 ~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~i---vHrDiKp~NILi~~  151 (305)
T d1blxa_          76 FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRV---VHRDLKPQNILVTS  151 (305)
T ss_dssp             EEEEEEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECT
T ss_pred             eeeecccccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCE---EecCCCccEEEEcC
Confidence            998742      35899999998876654443 344559999999999999999999999999   99999999999999


Q ss_pred             CCcEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHH
Q 037010          421 NFHAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLV  500 (589)
Q Consensus       421 ~~~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~  500 (589)
                      ++.+||+|||+++.....  .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.....     ....
T Consensus       152 ~~~~kl~dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~~  224 (305)
T d1blxa_         152 SGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQL  224 (305)
T ss_dssp             TCCEEECSCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH
T ss_pred             CCCeeecchhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-----HHHH
Confidence            999999999998764332  223457899999999999999999999999999999999999999954321     1222


Q ss_pred             HHHHHHhcCCChHHhh------Hhhc---CCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          501 ALFEEVLNLPDPIEDL------RKLV---DPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       501 ~~~~~~~~~~~~~~~l------~~~~---d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .........+.....-      ....   ........+.+.+..+.+|+.+||+.||++|||++|+++|
T Consensus       225 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             HHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            2222222222111000      0000   0000011223344578899999999999999999999988

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.4e-44  Score=355.62  Aligned_cols=267  Identities=22%  Similarity=0.336  Sum_probs=190.6

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|++.++||+|+||+||+|+++.  +..++.|.+....         ......+.+.+|+++|++++||||+++++++.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~--~~~vAvK~i~~~~---------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   70 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNY--GETFALKKIRLEK---------EDEGIPSTTIREISILKELKHSNIVKLYDVIH   70 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETT--SCEEEEEEECCSS---------GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCC--CCEEEEEEEehhh---------cChHHHHHHHHHHHHHHhCCCCcEEeeeeecc
Confidence            689999999999999999998753  2333333221110         01112356888999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..|++||++.++.+..+....  ..+++..+..++.||+.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        71 ~~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~I---vHrDiKp~NIll~~~~~~kl~DfG  145 (286)
T d1ob3a_          71 TKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRV---LHRDLKPQNLLINREGELKIADFG  145 (286)
T ss_dssp             CSSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTSCEEECCTT
T ss_pred             cCCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcE---EecCCCCceeeEcCCCCEEecccc
Confidence            4 5689999999887666665544  349999999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      .+........ ......+++.|+|||.+.. ..++.++|||||||++|||++|+.||.....    ...+.... .....
T Consensus       146 ~a~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~-~~~~~  219 (286)
T d1ob3a_         146 LARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIF-RILGT  219 (286)
T ss_dssp             HHHHHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHH-HHHCC
T ss_pred             cceecccCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH----HHHHHHHH-HhhCC
Confidence            9986543222 2234578999999998865 4578999999999999999999999953321    11111111 11221


Q ss_pred             CChH--HhhHhhc--CCCCC-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPI--EDLRKLV--DPRLG-------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~--~~l~~~~--d~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +...  .......  .....       ..........+.+|+++||+.||++|||++|+++|
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         220 PNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1100  0011110  00000       11122334578999999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=353.15  Aligned_cols=269  Identities=20%  Similarity=0.263  Sum_probs=191.9

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|+++++||+|+||+||+|.++.++. .++.|.+.          +.......+++++|+++|++++||||++++++
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~-~vAvK~i~----------~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~   74 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKV-RVAIKKIS----------PFEHQTYCQRTLREIKILLRFRHENIIGINDI   74 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCS-EEEEEEEC----------CTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEE
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCc-EEEEEEEe----------hhcChHHHHHHHHHHHHHHHcCCCCCCcEEEE
Confidence            45789999999999999999999776532 22222211          01123445678899999999999999999998


Q ss_pred             EEeC-----cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcE
Q 037010          350 CVEG-----SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHA  424 (589)
Q Consensus       350 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~v  424 (589)
                      +...     ..+++++++.+|+|.+++...   ++++..++.++.|++.||+|||++++   +||||||+|||++.++.+
T Consensus        75 ~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~i---iHRDIKp~NILl~~~~~~  148 (345)
T d1pmea_          75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANV---LHRDLKPSNLLLNTTCDL  148 (345)
T ss_dssp             ECCSSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTCCE
T ss_pred             EeeccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC---cCCCCCcceEEECCCCCE
Confidence            8643     234455667789999999764   39999999999999999999999998   999999999999999999


Q ss_pred             EEEeccCccccccCCC--CCCcccccCCCCCchhccc-CCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          425 KVADFGLTKLTEVGSA--SLPTRLVGTFGYMPPEYAQ-YGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       425 kl~Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      ||+|||+++.......  ......+||+.|+|||++. ...++.++||||+||++|||++|+.||.....     .....
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-----~~~~~  223 (345)
T d1pmea_         149 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLN  223 (345)
T ss_dssp             EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH
T ss_pred             EEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-----HHHHH
Confidence            9999999986543322  2234467999999999984 45678999999999999999999999954321     11222


Q ss_pred             HHHHHhcCCChHHh-------h-HhhcCCCCCCCCC-----hHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          502 LFEEVLNLPDPIED-------L-RKLVDPRLGDNCP-----LDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       502 ~~~~~~~~~~~~~~-------l-~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      ........+.....       . ............+     ......+.+|+.+||+.||.+|||++|+++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         224 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            22222222221110       0 0000000001111     1223468899999999999999999999998

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.4e-43  Score=355.34  Aligned_cols=261  Identities=18%  Similarity=0.273  Sum_probs=193.1

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~  349 (589)
                      .++|+++++||+|+||+||+|++..++ .              .+|+|.++....+++.+|+++|++++ ||||++++++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~-~--------------~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~   98 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNN-E--------------KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADI   98 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTT-E--------------EEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCC-C--------------EEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEE
Confidence            368999999999999999999986652 1              33444433333456788999999995 9999999998


Q ss_pred             EEe---CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-cEE
Q 037010          350 CVE---GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-HAK  425 (589)
Q Consensus       350 ~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-~vk  425 (589)
                      +..   ..+++||||+.+++|.++..     .+++..++.++.||+.||+|||++|+   +||||||+|||++.++ .+|
T Consensus        99 ~~~~~~~~~~~v~e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~gI---vHrDiKp~NILi~~~~~~vk  170 (328)
T d3bqca1          99 VKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGI---MHRDVKPHNVMIDHEHRKLR  170 (328)
T ss_dssp             EECTTTCSEEEEEECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCCceeEEEeecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhccc---ccccccccceEEcCCCCeee
Confidence            863   35999999999999987642     48999999999999999999999998   9999999999998654 699


Q ss_pred             EEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHH
Q 037010          426 VADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFE  504 (589)
Q Consensus       426 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~  504 (589)
                      |+|||++.......  ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........    ......
T Consensus       171 l~DFG~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~----~~~~i~  244 (328)
T d3bqca1         171 LIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD----QLVRIA  244 (328)
T ss_dssp             ECCGGGCEECCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH----HHHHHH
T ss_pred             ecccccceeccCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH----HHHHHH
Confidence            99999998654332  23456789999999998654 579999999999999999999999965543211    111111


Q ss_pred             HHhcCC-----------ChHHhhHhhcCCC--------CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          505 EVLNLP-----------DPIEDLRKLVDPR--------LGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       505 ~~~~~~-----------~~~~~l~~~~d~~--------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .....+           .....+.......        ............+.+|+++||+.||++|||++|+++|
T Consensus       245 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111100           0000011111100        1111122344578999999999999999999999987

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-42  Score=353.28  Aligned_cols=270  Identities=19%  Similarity=0.260  Sum_probs=192.3

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|+++++||+|+||+||+|.+..++ ..++.|.+..         ........+.+.+|+++|++++|||||+++++
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~-~~vAiK~i~~---------~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~   85 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTG-AKVAIKKLYR---------PFQSELFAKRAYRELRLLKHMRHENVIGLLDV   85 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTC-CEEEEEECSS---------TTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCC-CEEEEEEEch---------hhcChHHHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            4678999999999999999999987653 2222222110         11233445678899999999999999999998


Q ss_pred             EEeC-------cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVEG-------SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~~-------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +...       .+|+||||+ +.+|..++...   ++++..++.++.||+.||+|||++|+   +||||||+|||++.++
T Consensus        86 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~I---iHrDiKp~NIL~~~~~  158 (346)
T d1cm8a_          86 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDC  158 (346)
T ss_dssp             ECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTTC
T ss_pred             eccCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCC---cccccCcchhhccccc
Confidence            8643       379999999 55787777543   39999999999999999999999998   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVA  501 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~  501 (589)
                      .+|++|||+++....    ..+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....     .....
T Consensus       159 ~~kl~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-----~~~~~  229 (346)
T d1cm8a_         159 ELKILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLK  229 (346)
T ss_dssp             CEEECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             ccccccccceeccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-----HHHHH
Confidence            999999999986532    2345689999999998865 4578999999999999999999999954321     11222


Q ss_pred             HHHHHhcCCCh----------HHhhHhhcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhcc
Q 037010          502 LFEEVLNLPDP----------IEDLRKLVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTLS  565 (589)
Q Consensus       502 ~~~~~~~~~~~----------~~~l~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l~  565 (589)
                      ........+..          .............   ..........+.+|+.+||+.||.+|||++|+++|  ++.+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            22222221110          0001111111000   11122334568899999999999999999999998  55554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-42  Score=347.22  Aligned_cols=271  Identities=24%  Similarity=0.316  Sum_probs=190.5

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYC  350 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~  350 (589)
                      -++|++.++||+|+||+||+|++..++ ..++.|.+..         .........++.+|+++|++++||||+++++++
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~---------~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~   78 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTG-QKVALKKVLM---------ENEKEGFPITALREIKILQLLKHENVVNLIEIC   78 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTC-CEEEEEEC-------------CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCC-CEEEEEEEeh---------hhcchHHHHHHHHHHHHHHHhcCCCccceEeee
Confidence            378999999999999999999987553 2222222111         111122235578899999999999999999876


Q ss_pred             Ee---------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCC
Q 037010          351 VE---------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKN  421 (589)
Q Consensus       351 ~~---------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~  421 (589)
                      ..         +..|+||||+.++.+..+....  ..+++..++.++.|++.||+|||++++   +||||||+|||++.+
T Consensus        79 ~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~~i---vHrDlKp~NILl~~~  153 (318)
T d3blha1          79 RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNKI---LHRDMKAANVLITRD  153 (318)
T ss_dssp             EC----------CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCCGGGEEECTT
T ss_pred             ecccccccccCceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccCCE---EecCcCchheeecCC
Confidence            43         3489999999887665444332  348999999999999999999999998   999999999999999


Q ss_pred             CcEEEEeccCccccccCCC---CCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          422 FHAKVADFGLTKLTEVGSA---SLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       422 ~~vkl~Dfgla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      +.+||+|||+++.......   .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....     ..
T Consensus       154 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-----~~  228 (318)
T d3blha1         154 GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-----EQ  228 (318)
T ss_dssp             SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HH
T ss_pred             CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-----HH
Confidence            9999999999976543221   222335799999999998754 68999999999999999999999985322     22


Q ss_pred             hHHHHHHHHhcCCChHH-------hhHhhcCCCCCCCCCh-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 037010          498 GLVALFEEVLNLPDPIE-------DLRKLVDPRLGDNCPL-------DSVLKMAQLAKVCTQEYPQLRPSMRSIVVAL  561 (589)
Q Consensus       498 ~~~~~~~~~~~~~~~~~-------~l~~~~d~~l~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~~L  561 (589)
                      .................       ..............+.       .....+.+|+.+||+.||++|||++|+++|=
T Consensus       229 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp  306 (318)
T d3blha1         229 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  306 (318)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence            22222222222211100       0000000000001111       1123567899999999999999999999984

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-42  Score=348.66  Aligned_cols=261  Identities=21%  Similarity=0.247  Sum_probs=187.7

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEee-E
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIG-Y  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~-~  349 (589)
                      .++|++.+.||+|+||.||+|.+..++. ..+.|.....             ...+++..|++++++++|+|++..+. +
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~-~vAvK~~~~~-------------~~~~~~~~E~~i~~~l~~~~~i~~~~~~   71 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGE-EVAIKLECVK-------------TKHPQLHIESKIYKMMQGGVGIPTIRWC   71 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTE-EEEEEEEESC-------------TTSCCHHHHHHHHHHSTTSTTCCCEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCC-EEEEEEEchh-------------ccCHHHHHHHHHHHHccCCCcccEEEEE
Confidence            4689999999999999999999876532 2222221110             11234677999999998877666654 4


Q ss_pred             EEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEc---CCCcEE
Q 037010          350 CVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILID---KNFHAK  425 (589)
Q Consensus       350 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~---~~~~vk  425 (589)
                      ..+ +..++||||+. ++|.+.+.... ..+++..++.++.|++.||+|||++++   +||||||+|||++   .+..+|
T Consensus        72 ~~~~~~~~ivme~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i---iHrDiKp~NIl~~~~~~~~~vk  146 (299)
T d1ckia_          72 GAEGDYNVMVMELLG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVY  146 (299)
T ss_dssp             EEETTEEEEEEECCC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTE---ECSCCCGGGEEECCGGGTTCEE
T ss_pred             EecCCEEEEEEEEcC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCe---eeccCCHhhccccccCCCceee
Confidence            444 45789999994 57777665543 349999999999999999999999998   9999999999985   455799


Q ss_pred             EEeccCccccccCCC------CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhH
Q 037010          426 VADFGLTKLTEVGSA------SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGL  499 (589)
Q Consensus       426 l~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~  499 (589)
                      |+|||+|+.......      .......||+.|||||.+.+..++.++|||||||++|||+||+.||........... .
T Consensus       147 l~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~  225 (299)
T d1ckia_         147 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-Y  225 (299)
T ss_dssp             ECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------H
T ss_pred             eeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-H
Confidence            999999987643322      122346799999999999999999999999999999999999999965433221111 1


Q ss_pred             HHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          500 VALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       500 ~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ..........+  ..        .+...+    +..+.+++..||+.+|++||+++++.+.|+.+.
T Consensus       226 ~~~~~~~~~~~--~~--------~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         226 ERISEKKMSTP--IE--------VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             HHHHHHHHHSC--HH--------HHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             HHhhcccCCCC--hh--------HhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            11111111100  00        011123    346899999999999999999998888777653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=356.41  Aligned_cols=266  Identities=24%  Similarity=0.305  Sum_probs=189.1

Q ss_pred             CCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEEe
Q 037010          273 NFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCVE  352 (589)
Q Consensus       273 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  352 (589)
                      +|+..++||+|+||+||+|++..++ ..++.|.+..     .          .....+|+++|++++||||+++++++..
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~-~~vAiK~i~~-----~----------~~~~~~Ei~il~~l~h~niv~~~~~~~~   84 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSG-ELVAIKKVLQ-----D----------KRFKNRELQIMRKLDHCNIVRLRYFFYS   84 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTC-CEEEEEEEEC-----C----------SSSCCHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCC-CEEEEEEECc-----c----------chHHHHHHHHHHhcCCCCCCcEEEEEEe
Confidence            5888899999999999999987653 2222222110     0          0122369999999999999999998742


Q ss_pred             -------CcEEEEEEecCCCChHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC-c
Q 037010          353 -------GSLFLVYEYIENGNLSEHLRG-SGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF-H  423 (589)
Q Consensus       353 -------~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~-~  423 (589)
                             ..+|+||||+.++.+...... .....+++.+++.++.||+.||+|||++|+   +||||||+|||++.++ .
T Consensus        85 ~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~I---iHrDiKp~NILl~~~~~~  161 (350)
T d1q5ka_          85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGI---CHRDIKPQNLLLDPDTAV  161 (350)
T ss_dssp             C--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECTTTCC
T ss_pred             cCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC---cccCCCcceEEEecCCCc
Confidence                   137899999987543333221 234469999999999999999999999998   9999999999999775 8


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccC-CCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQY-GDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +||+|||+++......  ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.....    ...+.. 
T Consensus       162 ~kl~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~----~~~l~~-  234 (350)
T d1q5ka_         162 LKLCDFGSAKQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVE-  234 (350)
T ss_dssp             EEECCCTTCEECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH----HHHHHH-
T ss_pred             eeEecccchhhccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH----HHHHHH-
Confidence            9999999998654332  2344689999999998764 5789999999999999999999999954321    111111 


Q ss_pred             HHHHhcCCChHHhhHhhcC----CCCC--------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhcc
Q 037010          503 FEEVLNLPDPIEDLRKLVD----PRLG--------DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA--LMTLS  565 (589)
Q Consensus       503 ~~~~~~~~~~~~~l~~~~d----~~l~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~l~  565 (589)
                      .......+. .+.+.....    ..+.        .......+..+.+|+.+||+.||++|||++|+++|  ++.+.
T Consensus       235 i~~~~g~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         235 IIKVLGTPT-REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             HHHHHCCCC-HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHHhCCCh-HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            112222211 111211111    0000        01122344578999999999999999999999988  55554

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=352.74  Aligned_cols=258  Identities=25%  Similarity=0.379  Sum_probs=195.5

Q ss_pred             CCCccceeeccCCcEEEEEEEEccc--cCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCC-CcceeEee
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGE--YGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH-LNLVRLIG  348 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~--~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~  348 (589)
                      ++|++++.||+|+||+||+|.....  .+..++.|.+.......       .....+.+.+|+++|++++| |||+++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~-------~~~~~~~~~~E~~il~~l~h~pnIv~~~~   96 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-------KAKTTEHTRTERQVLEHIRQSPFLVTLHY   96 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE-------EESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhcc-------chHHHHHHHHHHHHHHhccCCCeEEEeee
Confidence            6799999999999999999987442  23333333322111100       00112346679999999966 89999999


Q ss_pred             EEEe-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEE
Q 037010          349 YCVE-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVA  427 (589)
Q Consensus       349 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~  427 (589)
                      ++.+ ...+++|||+.+|+|.+++.....  +++..+..++.||+.||+|||++++   +||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~i---vHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_          97 AFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLGI---IYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTSCEEES
T ss_pred             eeccCCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCCE---EeccCCccceeecCCCCEEEe
Confidence            8764 568999999999999999987654  7789999999999999999999999   999999999999999999999


Q ss_pred             eccCccccccCCCCCCcccccCCCCCchhcccCC--CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHH
Q 037010          428 DFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG--DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEE  505 (589)
Q Consensus       428 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~  505 (589)
                      |||+++..............|++.|+|||.+.+.  .++.++|||||||+||||+||+.||........    .......
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~----~~~i~~~  247 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRR  247 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHH
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHh
Confidence            9999987654444444557899999999998654  468899999999999999999999965443221    1111111


Q ss_pred             HhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 037010          506 VLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRP-----SMRSIVVA  560 (589)
Q Consensus       506 ~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~  560 (589)
                      ....           .+    ..+.+.+..+.+|+.+||+.||++||     |++|+++|
T Consensus       248 ~~~~-----------~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         248 ILKS-----------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HHHC-----------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cccC-----------CC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            1111           11    12334456799999999999999999     48999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-42  Score=344.97  Aligned_cols=269  Identities=23%  Similarity=0.294  Sum_probs=199.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeEEE
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGYCV  351 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~  351 (589)
                      ++|+++++||+|+||+||+|++..++ ..++.|.+..         .........++.+|+++|++++||||+++++++.
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~-~~vAvK~i~~---------~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   71 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETH-EIVALKRVRL---------DDDDEGVPSSALREICLLKELKHKNIVRLHDVLH   71 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTC-CEEEEEEEES---------SCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCC-cEEEEEEEeh---------hhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc
Confidence            68999999999999999999987653 2222222211         0112234567889999999999999999999887


Q ss_pred             e-CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEEEecc
Q 037010          352 E-GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKVADFG  430 (589)
Q Consensus       352 ~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl~Dfg  430 (589)
                      + +..++++|++.+++|..++....  .+++..++.++.|++.||+|||++++   +||||||+|||++.++.+||+|||
T Consensus        72 ~~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~I---vHrDiKP~NIli~~~~~~kl~DFG  146 (292)
T d1unla_          72 SDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNV---LHRDLKPQNLLINRNGELKLANFG  146 (292)
T ss_dssp             CSSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTE---ECCCCSGGGEEECTTCCEEECCCT
T ss_pred             cccceeEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCE---eeecccCcccccccCCceeeeecc
Confidence            5 45889999999999988876554  48899999999999999999999998   999999999999999999999999


Q ss_pred             CccccccCCCCCCcccccCCCCCchhcccCCC-CCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHHHHHHhcC
Q 037010          431 LTKLTEVGSASLPTRLVGTFGYMPPEYAQYGD-VSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVALFEEVLNL  509 (589)
Q Consensus       431 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~  509 (589)
                      .++....... ......+++.|+|||.+.... ++.++|||||||++|||++|+.||..+..    ..............
T Consensus       147 ~a~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~----~~~~~~~~~~~~~~  221 (292)
T d1unla_         147 LARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGT  221 (292)
T ss_dssp             TCEECCSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCC
T ss_pred             hhhcccCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC----HHHHHHHHHhhcCC
Confidence            9987543322 233456788999999887654 68999999999999999999999865432    12222222222222


Q ss_pred             CChH--HhhHhhcCCC---------CCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          510 PDPI--EDLRKLVDPR---------LGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       510 ~~~~--~~l~~~~d~~---------l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      +...  .......+..         ............+.+|+.+||+.||.+|||++|+++|
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2110  0111111100         0112223445578999999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.5e-41  Score=340.31  Aligned_cols=261  Identities=17%  Similarity=0.215  Sum_probs=194.0

Q ss_pred             cCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCC-CcceeEeeE
Q 037010          271 TDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHH-LNLVRLIGY  349 (589)
Q Consensus       271 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~  349 (589)
                      .++|+++++||+|+||+||+|++..++ ...+.|...             .......+.+|+++++.++| +|++.++++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~-~~vAvK~~~-------------~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~   69 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNN-QQVAIKFEP-------------RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF   69 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTT-EEEEEEEEE-------------CCTTSCCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCC-CEEEEEEEc-------------cccCcHHHHHHHHHHHHhcCCCCCCEEEEE
Confidence            478999999999999999999987652 222222110             01112345678888888865 899999988


Q ss_pred             EEeC-cEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcC-----CCc
Q 037010          350 CVEG-SLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDK-----NFH  423 (589)
Q Consensus       350 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~-----~~~  423 (589)
                      +.++ ..|+||||+ +++|.+++..... .+++..+..++.|++.||+|||++|+   +||||||+|||++.     ++.
T Consensus        70 ~~~~~~~~~vme~~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~gi---iHrDiKp~Nili~~~~~~~~~~  144 (293)
T d1csna_          70 GQEGLHNVLVIDLL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANM  144 (293)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTTTE---ECCCCCGGGEEECCSSSTTTTC
T ss_pred             eecCCccEEEEEec-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHCCc---eeccCCccceeecCcccccCCc
Confidence            7754 588999999 6799999876543 59999999999999999999999998   99999999999964     578


Q ss_pred             EEEEeccCccccccCCC------CCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChh
Q 037010          424 AKVADFGLTKLTEVGSA------SLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSK  497 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~  497 (589)
                      +||+|||+++.......      .......||+.|||||.+.+..++.++|||||||++|||+||+.||......... .
T Consensus       145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-~  223 (293)
T d1csna_         145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-Q  223 (293)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-H
T ss_pred             eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-H
Confidence            99999999987543221      1233467999999999999999999999999999999999999999543332211 1


Q ss_pred             hHHHHHHHHhcCCChHHhhHhhcCCCCCCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 037010          498 GLVALFEEVLNLPDPIEDLRKLVDPRLGDNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVALMTLS  565 (589)
Q Consensus       498 ~~~~~~~~~~~~~~~~~~l~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~l~  565 (589)
                      ...........  .+..+        +...+|    .++.+++..|+..+|++||+++.+.+.|..+.
T Consensus       224 ~~~~i~~~~~~--~~~~~--------l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         224 KYERIGEKKQS--TPLRE--------LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHHHHHHHHHH--SCHHH--------HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHhccCC--CChHH--------hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            11111111100  00111        112233    46899999999999999999999888877654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-41  Score=349.77  Aligned_cols=266  Identities=20%  Similarity=0.244  Sum_probs=185.0

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|+++++||+|+||+||+|.+..++ ..++.|.+..         +........++.+|+.+|++++||||++++++
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~-~~vAvK~i~~---------~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~   84 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSR---------PFQNQTHAKRAYRELVLMKCVNHKNIISLLNV   84 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTT-EEEEEEEEES---------TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCC-CEEEEEEECh---------hhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            3478999999999999999999987652 2222222111         11223445678899999999999999999998


Q ss_pred             EEe-------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCC
Q 037010          350 CVE-------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNF  422 (589)
Q Consensus       350 ~~~-------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~  422 (589)
                      +..       ..+|+||||+.++ +.+.+.    ..+++..++.++.||+.||+|||++|+   +||||||+|||++.++
T Consensus        85 f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~gi---iHrDlKP~Nil~~~~~  156 (355)
T d2b1pa1          85 FTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDC  156 (355)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTC---CCSCCCGGGEEECTTC
T ss_pred             EecccccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhccc---ccccCCcccccccccc
Confidence            742       4589999999775 444443    238999999999999999999999999   9999999999999999


Q ss_pred             cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          423 HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       423 ~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      .+|++|||+++.....  .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.....    .......
T Consensus       157 ~~kl~df~~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~----~~~~~~i  230 (355)
T d2b1pa1         157 TLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKV  230 (355)
T ss_dssp             CEEECCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHH
T ss_pred             ceeeechhhhhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH----HHHHHHH
Confidence            9999999998765432  233456799999999999999999999999999999999999999953321    1111111


Q ss_pred             HHHHhcCCChH------HhhHh---------------hcCCCCC---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 037010          503 FEEVLNLPDPI------EDLRK---------------LVDPRLG---DNCPLDSVLKMAQLAKVCTQEYPQLRPSMRSIV  558 (589)
Q Consensus       503 ~~~~~~~~~~~------~~l~~---------------~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl  558 (589)
                      ... ...+.+.      .....               .......   ...+......+.+|+++||+.||++|||++|++
T Consensus       231 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL  309 (355)
T d2b1pa1         231 IEQ-LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL  309 (355)
T ss_dssp             HHH-HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHh-ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            111 1110000      00000               0000000   111234566889999999999999999999999


Q ss_pred             HH
Q 037010          559 VA  560 (589)
Q Consensus       559 ~~  560 (589)
                      +|
T Consensus       310 ~H  311 (355)
T d2b1pa1         310 QH  311 (355)
T ss_dssp             TS
T ss_pred             cC
Confidence            98

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=342.90  Aligned_cols=266  Identities=18%  Similarity=0.256  Sum_probs=189.6

Q ss_pred             hcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcceeEeeE
Q 037010          270 ATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNLVRLIGY  349 (589)
Q Consensus       270 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~  349 (589)
                      ..++|++.++||+|+||+||+|++..++ ..++.|.+..         ........+++.+|+++|++++||||++++++
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~-~~vAiK~i~~---------~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~   85 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTG-LRVAVKKLSR---------PFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   85 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTT-EEEEEEECSC---------TTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCC-CEEEEEEECc---------hhcChHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            4688999999999999999999877652 2222221110         11223445678899999999999999999998


Q ss_pred             EEe------CcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCc
Q 037010          350 CVE------GSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFH  423 (589)
Q Consensus       350 ~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~  423 (589)
                      +..      ...+++|+++.+|+|.+++...   ++++..++.++.||+.||+|||++|+   +||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~gi---iHrDiKp~NILi~~~~~  159 (348)
T d2gfsa1          86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNEDCE  159 (348)
T ss_dssp             ECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCGGGEEECTTCC
T ss_pred             EeeccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCC---cccccCCcccccccccc
Confidence            742      2356677888899999998653   49999999999999999999999999   99999999999999999


Q ss_pred             EEEEeccCccccccCCCCCCcccccCCCCCchhcccCC-CCCcccchhhHHHHHHHHHcCCcccccCCCCCCChhhHHHH
Q 037010          424 AKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYG-DVSPKVDVYAFGVVLYELISAKEAIVKGNGSSADSKGLVAL  502 (589)
Q Consensus       424 vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~sDvwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~  502 (589)
                      +|++|||++.....    ......||+.|+|||...+. .++.++|||||||++|+|++|+.||.....     ......
T Consensus       160 ~kl~dfg~a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-----~~~~~~  230 (348)
T d2gfsa1         160 LKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKL  230 (348)
T ss_dssp             EEECCC----CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH
T ss_pred             ccccccchhcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence            99999999875432    22346789999999987654 568899999999999999999999954321     111111


Q ss_pred             HHHHhcCCChH-------HhhHhhcCCCCC-CCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 037010          503 FEEVLNLPDPI-------EDLRKLVDPRLG-DNC-----PLDSVLKMAQLAKVCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       503 ~~~~~~~~~~~-------~~l~~~~d~~l~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~  560 (589)
                      .......+...       ............ ...     .......+.+|+.+||+.||++|||++|+++|
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            11111111110       000111110000 000     01233468899999999999999999999998

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-36  Score=314.35  Aligned_cols=266  Identities=21%  Similarity=0.264  Sum_probs=185.7

Q ss_pred             CCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcC--HHHHHHHHHHHHHHccCC----------
Q 037010          272 DNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMD--MQASREFLAELKVLTHVH----------  339 (589)
Q Consensus       272 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~--~~~~~~~~~E~~il~~l~----------  339 (589)
                      .+|+++++||+|+||+||+|++..++.               .+|+|.++  ....+.+.+|++++++++          
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~---------------~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~   77 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNT---------------HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM   77 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTE---------------EEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCC---------------EEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhc
Confidence            469999999999999999999876522               23333332  223345677888887774          


Q ss_pred             -CCcceeEeeEEEe---CcEEEEEEecCCCC-hHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccCC
Q 037010          340 -HLNLVRLIGYCVE---GSLFLVYEYIENGN-LSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHE-HTVPVYIHRDIKS  413 (589)
Q Consensus       340 -hpnIv~l~~~~~~---~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~-~~i~~~vH~Dlkp  413 (589)
                       |+||+++++++..   ...+++|+++..+. ............+++..++.++.||+.||+|||+ +|+   +||||||
T Consensus        78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~I---vHrDlKp  154 (362)
T d1q8ya_          78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI---IHTDIKP  154 (362)
T ss_dssp             HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE---ECSCCSG
T ss_pred             CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCc---ccccCCh
Confidence             5789999987653   34566666665543 3344444455568999999999999999999998 777   9999999


Q ss_pred             CcEEEcCCC------cEEEEeccCccccccCCCCCCcccccCCCCCchhcccCCCCCcccchhhHHHHHHHHHcCCcccc
Q 037010          414 ANILIDKNF------HAKVADFGLTKLTEVGSASLPTRLVGTFGYMPPEYAQYGDVSPKVDVYAFGVVLYELISAKEAIV  487 (589)
Q Consensus       414 ~NILl~~~~------~vkl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~sDvwSlGvll~elltG~~p~~  487 (589)
                      +|||++.++      .++++|||.+......    .....||+.|+|||++....++.++||||+||++++|++|+.||.
T Consensus       155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         155 ENVLMEIVDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             GGEEEEEEETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             hHeeeeccCcccccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence            999997655      4999999998754322    234679999999999999999999999999999999999999996


Q ss_pred             cCCCCCC-ChhhHHHHHHHHhcCCChHHhh------HhhcCC-----CC--------------CCCCChHHHHHHHHHHH
Q 037010          488 KGNGSSA-DSKGLVALFEEVLNLPDPIEDL------RKLVDP-----RL--------------GDNCPLDSVLKMAQLAK  541 (589)
Q Consensus       488 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l------~~~~d~-----~l--------------~~~~~~~~~~~l~~li~  541 (589)
                      ....... ............+..... ...      ....+.     ..              ....+......+.+|+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~lg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  309 (362)
T d1q8ya_         231 PDEGHSYTKDDDHIAQIIELLGELPS-YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  309 (362)
T ss_dssp             --------CHHHHHHHHHHHHCSCCH-HHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCccccccchhHHHHHHHHHhCCCCH-HHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence            5433221 111111111122222111 111      000000     00              11234567788999999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 037010          542 VCTQEYPQLRPSMRSIVVA  560 (589)
Q Consensus       542 ~cl~~dP~~RPs~~evl~~  560 (589)
                      +||+.||.+|||++|+++|
T Consensus       310 ~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         310 PMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             GGGCSSTTTCBCHHHHHTC
T ss_pred             HHCCCChhHCcCHHHHhcC
Confidence            9999999999999999998

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.83  E-value=1.6e-21  Score=181.19  Aligned_cols=175  Identities=13%  Similarity=0.116  Sum_probs=115.8

Q ss_pred             CccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHh-----HHH--hhcCHHHHHHHHHHHHHHccCCCCcceeE
Q 037010          274 FSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQK-----AAI--KKMDMQASREFLAELKVLTHVHHLNLVRL  346 (589)
Q Consensus       274 y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~-----~~i--k~~~~~~~~~~~~E~~il~~l~hpnIv~l  346 (589)
                      +.++++||+|+||.||+|.+.+  +...+.|..........     ...  .............|...+.++.|++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~--g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEK--FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETT--TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECCC--CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceE
Confidence            3578999999999999998753  33444443221111000     000  00011222345678899999999999888


Q ss_pred             eeEEEeCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccCCCcEEEcCCCcEEE
Q 037010          347 IGYCVEGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTVPVYIHRDIKSANILIDKNFHAKV  426 (589)
Q Consensus       347 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i~~~vH~Dlkp~NILl~~~~~vkl  426 (589)
                      +++.   ..+++|||+++..+.+         ++......++.|++.+|+|||++|+   +||||||+|||++++ .++|
T Consensus        80 ~~~~---~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~gi---iHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          80 YAWE---GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGI---VHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EEEE---TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTE---ECSCCSTTSEEEETT-EEEE
T ss_pred             EEec---CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCE---EEccCChhheeeeCC-CEEE
Confidence            7653   2379999999865543         3445567899999999999999998   999999999999865 5899


Q ss_pred             EeccCccccccCCCCCCcccccCCCCCch------hcccCCCCCcccchhhHHHHH
Q 037010          427 ADFGLTKLTEVGSASLPTRLVGTFGYMPP------EYAQYGDVSPKVDVYAFGVVL  476 (589)
Q Consensus       427 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~~sDvwSlGvll  476 (589)
                      +|||+|.........         .|...      |.+ ...|+.++|+||+.--+
T Consensus       144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            999998754321110         11111      111 35678899999986544

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.33  E-value=1.1e-13  Score=95.24  Aligned_cols=45  Identities=16%  Similarity=0.330  Sum_probs=42.2

Q ss_pred             eeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEE
Q 037010          103 FQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVT  150 (589)
Q Consensus       103 ~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip  150 (589)
                      .+|+||+|||||+|| ++|+  +++++|+++|++..+.|++||+|.||
T Consensus         2 i~y~V~~GDTL~~IA-~~y~--v~~~~i~~~N~~~~~~l~~Gq~L~IP   46 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIA-ADFR--ISTAALLQANPSLQAGLTAGQSIVIP   46 (48)
T ss_dssp             EEEECCTTCCHHHHH-HHTT--SCCCCCCCTSCTTCSSCCTTCEEEET
T ss_pred             EEEEECCCCCHHHHH-HHhC--CCHHHHHHHcCCCCCCCCCCCEEEeC
Confidence            469999999999999 8899  89999999999887789999999998

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.32  E-value=2.2e-13  Score=93.21  Aligned_cols=45  Identities=16%  Similarity=0.326  Sum_probs=41.4

Q ss_pred             eeEEeccCcchhcchhhhccCcCcHHHHhhcCCCCCCCCCCCcEEEEEe
Q 037010          103 FQFSINSGDTYEKVATRYYSNLTDAASLQRINNYPPTRIPDRGTLNVTV  151 (589)
Q Consensus       103 ~~y~V~~Gdtl~~Ia~~~~~~l~~~~~l~~~N~~~~~~l~~g~~l~ip~  151 (589)
                      .+|+||+|||||.|| ++|+  +++++|+++|++. +.|++||+|.||+
T Consensus         3 v~y~V~~GDTl~~IA-~~y~--vs~~~i~~~N~l~-~~l~~Gq~L~i~v   47 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIA-KRHG--VNIKDVMRWNSDT-ANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHH-HHHT--CCHHHHHHHCSCG-GGCCTTEEEECCC
T ss_pred             EEEEECCCCCHHHHH-HHHC--CCHHHHHHHcCCc-ccCcCCCEEEEEe
Confidence            479999999999999 8899  8999999999986 4699999999985

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.24  E-value=2.2e-12  Score=88.15  Aligned_cols=46  Identities=26%  Similarity=0.360  Sum_probs=43.0

Q ss_pred             EEEeCCCCCCHhHhHhhcCCCHHHHhhcCCCCCcccCcceEEecCC
Q 037010          168 VTYPLRPGDSLQSIARNVGLSESLLQNYNPGVNFTRGSGLVFIPGR  213 (589)
Q Consensus       168 ~~y~v~~gdtl~~ia~~~~~~~~~l~~~N~~~~~~~~g~~~~iP~~  213 (589)
                      ++|+|++||||++||++||+++++|++||+..+.+++|+.+.+|.+
T Consensus         3 v~y~V~~GDTl~~IA~~y~vs~~~i~~~N~l~~~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDTANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHTCCHHHHHHHCSCGGGCCTTEEEECCCC
T ss_pred             EEEEECCCCCHHHHHHHHCCCHHHHHHHcCCcccCcCCCEEEEEeC
Confidence            4799999999999999999999999999998888999999999863

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.24  E-value=1.8e-12  Score=89.08  Aligned_cols=45  Identities=33%  Similarity=0.553  Sum_probs=42.4

Q ss_pred             EEEeCCCCCCHhHhHhhcCCCHHHHhhcCCCC-CcccCcceEEecC
Q 037010          168 VTYPLRPGDSLQSIARNVGLSESLLQNYNPGV-NFTRGSGLVFIPG  212 (589)
Q Consensus       168 ~~y~v~~gdtl~~ia~~~~~~~~~l~~~N~~~-~~~~~g~~~~iP~  212 (589)
                      ++|+|++|||||+||++||+++++|+++|+.. +.+++|+.+.+|+
T Consensus         2 i~y~V~~GDTL~~IA~~y~v~~~~i~~~N~~~~~~l~~Gq~L~IPg   47 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQSIVIPG   47 (48)
T ss_dssp             EEEECCTTCCHHHHHHHTTSCCCCCCCTSCTTCSSCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhCCCHHHHHHHcCCCCCCCCCCCEEEeCC
Confidence            58999999999999999999999999999975 6899999999997

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.03  E-value=3.9e-06  Score=79.47  Aligned_cols=148  Identities=16%  Similarity=0.173  Sum_probs=89.0

Q ss_pred             HHHHhhcCCCccceeeccCCcEEEEEEEEccccCCccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCC-CCcc
Q 037010          265 EELSKATDNFSMSHKIGQGGFGAVYYAELRGEYGNSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVH-HLNL  343 (589)
Q Consensus       265 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~-hpnI  343 (589)
                      .++....+.|++.+..+.++.+.||+....+.   .++.|.......           .....+.+|...++.+. +--+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~---~~vlk~~~~~~~-----------~~~~~~~~E~~~l~~l~~~vpv   72 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENE---NLYLKMTDSRYK-----------GTTYDVEREKDMMLWLEGKLPV   72 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECSSC---EEEEEEECGGGT-----------TSTTCHHHHHHHHHHHTTTSCC
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCC---eEEEEEcCCCcc-----------cchhhHHHHHHHHHHHhccCCC
Confidence            35566677888777766555678998753222   222221111000           00112455777766653 3234


Q ss_pred             eeEeeEEE-eCcEEEEEEecCCCChHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-------------------
Q 037010          344 VRLIGYCV-EGSLFLVYEYIENGNLSEHLRGSGRDPLPWSSRVQIALDSARGLEYIHEHTV-------------------  403 (589)
Q Consensus       344 v~l~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qia~aL~~LH~~~i-------------------  403 (589)
                      .+++.+.. ++..|+||++++|.++.+.....       .....++.+++..+..||+...                   
T Consensus        73 P~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~  145 (263)
T d1j7la_          73 PKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL  145 (263)
T ss_dssp             CCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHH
T ss_pred             CcEEEEEecCCceEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHH
Confidence            55566655 45689999999998876654221       1123345566666666764321                   


Q ss_pred             -------------------------------------CceEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          404 -------------------------------------PVYIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       404 -------------------------------------~~~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                                                           +.++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                                 117999999999999987666799998765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.24  E-value=7.1e-05  Score=70.03  Aligned_cols=28  Identities=21%  Similarity=0.265  Sum_probs=24.5

Q ss_pred             eEeeccCCCcEEEcCCCcEEEEeccCcc
Q 037010          406 YIHRDIKSANILIDKNFHAKVADFGLTK  433 (589)
Q Consensus       406 ~vH~Dlkp~NILl~~~~~vkl~Dfgla~  433 (589)
                      ++|+|+.|.|||++++..+-|+||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            6999999999999887667899998764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.78  E-value=0.001  Score=66.35  Aligned_cols=29  Identities=24%  Similarity=0.395  Sum_probs=25.0

Q ss_pred             ceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          405 VYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .++|+|+.|.|||++++ .++|+||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCC-ceEEechhhccc
Confidence            36999999999999876 489999988764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.53  E-value=0.011  Score=56.45  Aligned_cols=30  Identities=20%  Similarity=0.177  Sum_probs=25.9

Q ss_pred             ceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          405 VYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .+||+|+.++||+++.+...-+.||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhcccccceeEeccccccc
Confidence            369999999999999887778999998753

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=94.66  E-value=0.011  Score=58.55  Aligned_cols=75  Identities=24%  Similarity=0.281  Sum_probs=41.1

Q ss_pred             ceeeccCCcEEEEEEEEccccC------CccchhhhhhhhhhHhHHHhhcCHHHHHHHHHHHHHHccCCCCcc-eeEeeE
Q 037010          277 SHKIGQGGFGAVYYAELRGEYG------NSYLSRLICVNLLMQKAAIKKMDMQASREFLAELKVLTHVHHLNL-VRLIGY  349 (589)
Q Consensus       277 ~~~LG~G~~g~Vy~~~~~~~~~------~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~E~~il~~l~hpnI-v~l~~~  349 (589)
                      .+.|+.|-.-.+|++.......      ...+.+... +         ...   .....+|..+++.+.-.++ .+++++
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~---------~~~---~idr~~E~~i~~~ls~~gl~Pkll~~  113 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N---------PET---ESHLVAESVIFTLLSERHLGPKLYGI  113 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S---------CCC---HHHHHHHHHHHHHHHHTTSSSCEEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C---------cch---hhHHHHHHHHHHHHHhCCCCCeEEEE
Confidence            4678888889999998654321      111111111 0         000   1123357777777742233 466665


Q ss_pred             EEeCcEEEEEEecCCCCh
Q 037010          350 CVEGSLFLVYEYIENGNL  367 (589)
Q Consensus       350 ~~~~~~~lv~e~~~~gsL  367 (589)
                      +.+   ++|+||++|..|
T Consensus       114 ~~~---g~I~efi~g~~l  128 (395)
T d1nw1a_         114 FSG---GRLEEYIPSRPL  128 (395)
T ss_dssp             ETT---EEEECCCCEEEC
T ss_pred             cCC---ceEEEEeccccC
Confidence            532   578999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=91.93  E-value=0.088  Score=50.12  Aligned_cols=28  Identities=21%  Similarity=0.316  Sum_probs=22.6

Q ss_pred             ceEeeccCCCcEEEcCCCcEEEEeccCccc
Q 037010          405 VYIHRDIKSANILIDKNFHAKVADFGLTKL  434 (589)
Q Consensus       405 ~~vH~Dlkp~NILl~~~~~vkl~Dfgla~~  434 (589)
                      .+||+|+.+.|||++++  ..++||+.+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            46999999999999743  45899997764